FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Xia, XH
   Xiao, CJ
   Shan, H
AF Xia, X. -H.
   Xiao, C. -J.
   Shan, H.
TI Facilitation of liver cancer SMCC7721 cell aging by sirtuin 4 via
   inhibiting JAK2/STAT3 signal pathway
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE Sirtuin 4; JAK2/STAT3; Liver cancer cell; Cell aging
ID HUMAN HEPATOCELLULAR-CARCINOMA; TUMOR PROGRESSION; SENESCENCE;
   APOPTOSIS; KINASE; GROWTH; DEATH; PROLIFERATION; INDUCTION; INVASION
AB OBJECTIVE: Liver cancer severely threatens public health. Molecular targeted treatment is the further of cancer treatment. The functional role of Sir-related enzymes 4 (sirtuin 4) in treating liver cancer still requires further investigation. This study aimed to elucidate the effect of sirtuin 4 on aging of SMCC7721 liver cancer cell line, to underlying molecular mechanism and potential application in clinics.
   MATERIALS AND METHODS: Adriamycin-induced aging model was established on SMCC7721 liver cancer cell line. Sirtuin 4 over-expression or siRNA plasmid was transfected. Cell aging was measured by beta-galactosidase approach. Aging-related proteins P53 and P16 were quantified in Western blot, which also examined activation of Janus kinase 2 (JAK2) signal pathway. CP-690550 was used to suppress JAK2 signal pathway for measuring aging status of SMCC7721 cells.
   RESULTS: In aged SMCC7721 cells, sirtuin 4 was up-regulated, whilst P53 and P16 protein levels were elevated, in accompanied with JAK2/STAT3 signal pathway. Transfection of sirtuin 4 over-expression plasmid or siRNA increased or decreased sirtuin 4 expression. Adriamycin-induced aging was enhanced or suppressed, accompanied with inhibited or potentiated JAK2 signal pathway in sirtuin 4 up-regulation or down-regulation cells, respectively. The usage of JAK2 signal inhibitor, CP-690550, enhanced Adriamycin-induced cell aging.
   CONCLUSIONS: Sirtuin 4 facilitates Adriamycin-induced aging of SMCC7721 liver cancer cells via inhibiting JAK2/STAT3 signal pathway, thus providing one novel anti-cancer strategy.
C1 [Xia, X. -H.; Shan, H.] Sun Yat Sen Univ, Intervent Radiol Inst, Guangzhou, Guangdong, Peoples R China.
   [Xia, X. -H.; Xiao, C. -J.] Guangdong 2 Prov Peoples Hosp, Dept Intervent, Guangzhou, Guangdong, Peoples R China.
C3 Sun Yat Sen University
RP Shan, H (corresponding author), Sun Yat Sen Univ, Intervent Radiol Inst, Guangzhou, Guangdong, Peoples R China.
EM hongshanmk@163.com
CR Barbagallo I, 2016, EUR REV MED PHARMACO, V20, P5223
   Borghesan M, 2016, CANCER RES, V76, P594, DOI 10.1158/0008-5472.CAN-15-1336
   Di Fazio P, 2016, ONCOTARGET, V7, P28998, DOI 10.18632/oncotarget.8585
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Feng XX, 2015, CANCER SCI, V106, P559, DOI 10.1111/cas.12632
   da Silva EFG, 2016, ONCOL REP, V36, P2647, DOI 10.3892/or.2016.5111
   Iwagami Y, 2016, HEPATOLOGY, V63, P1213, DOI 10.1002/hep.28411
   Jin Soojung, 2015, J Cancer Prev, V20, P241, DOI 10.15430/JCP.2015.20.4.241
   Kant R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050669
   Kim JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.115
   Kondylis V, 2015, CANCER CELL, V28, P582, DOI 10.1016/j.ccell.2015.10.001
   Lee N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165835
   Li D, 2016, HEPATOLOGY, V64, P1105, DOI [10.1002/hep.28637, 10.1002/hep.28837]
   Li XL, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0254-2
   Liu CC, 2016, ONCOTARGET, V7, P36988, DOI 10.18632/oncotarget.9234
   Park C, 2016, ASIAN PAC J TROP MED, V9, P336, DOI 10.1016/j.apjtm.2016.03.003
   Park C, 2016, INT J ONCOL, V48, P261, DOI 10.3892/ijo.2015.3233
   Saito T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12030
   Seol HS, 2016, CANCER LETT, V382, P157, DOI 10.1016/j.canlet.2016.08.028
   Tachtatzis PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127511
   Tsang DPF, 2016, J PATHOL, V238, P651, DOI 10.1002/path.4688
   Winkler J, 2016, ONCOTARGET, V7, P22883, DOI 10.18632/oncotarget.8256
   Xu GQ, 2015, ONCOTARGET, V6, P33636, DOI 10.18632/oncotarget.5602
   Xu XS, 2015, ONCOTARGET, V6, P3988, DOI 10.18632/oncotarget.2905
   Zhang N, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0776-2
   Zhang SY, 2015, EUR REV MED PHARMACO, V19, P455
   Zhao B, 2016, EUR REV MED PHARMACO, V20, P269
   Zhu RX, 2015, J PATHOL, V237, P38, DOI 10.1002/path.4554
NR 28
TC 20
Z9 20
U1 1
U2 8
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD MAR
PY 2017
VL 21
IS 6
BP 1248
EP 1253
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA ET0CM
UT WOS:000399929300011
PM 28387906
DA 2024-02-19
ER

PT J
AU Hussain, F
   Basu, S
   Heng, JJH
   Loo, LH
   Zink, D
AF Hussain, Faezah
   Basu, Sreetama
   Heng, Javen Jun Hao
   Loo, Lit-Hsin
   Zink, Daniele
TI Predicting direct hepatocyte toxicity in humans by combining
   high-throughput imaging of HepaRG cells and machine learning-based
   phenotypic profiling
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article; Early Access
DE Direct hepatocyte toxicity; Toxicity prediction; Phenotypic profiling;
   Hepatocyte senescence
ID NF-KAPPA-B; INDUCED LIVER-INJURY; CELLULAR SENESCENCE; IN-VITRO;
   MICROPATTERNED COCULTURES; CYTOCHROMES P450; DRUG-METABOLISM; HEPG2
   CELLS; DEATH; HEPATOTOXICITY
AB Accurate prediction of drug- and chemical-induced hepatotoxicity remains to be a problem for pharmaceutical companies as well as other industries and regulators. The goal of the current study was to develop an in vitro/in silico method for the rapid and accurate prediction of drug- and chemical-induced hepatocyte injury in humans. HepaRG cells were employed for high-throughput imaging in combination with phenotypic profiling. A reference set of 69 drugs and chemicals was screened at a range of 7 concentrations, and the cellular response values were used for training a supervised classifier and for determining assay performance by using tenfold cross-validation. The results showed that the best performing phenotypic features were related to nuclear translocation of RELA (RELA proto-oncogene, NF-kB subunit; also known as NF-kappa B p65), DNA organization, and the F-actin cytoskeleton. Using a subset of 30 phenotypic features, direct hepatocyte toxicity in humans could be predicted with a test sensitivity, specificity and balanced accuracy of 73%, 92%, and 83%, respectively. The method was applied to another set of 26 drugs and chemicals with unclear annotation and their hepatocyte toxicity in humans was predicted. The results also revealed that the identified discriminative phenotypic changes were related to cell death and cellular senescence. Whereas cell death-related endpoints are widely applied in in vitro toxicology, cellular senescence-related endpoints are not, although cellular senescence can be induced by various drugs and other small molecule compounds and plays an important role in liver injury and disease. These findings show how phenotypic profiling can reveal unexpected chemical-induced mechanisms in toxicology.
C1 [Hussain, Faezah; Heng, Javen Jun Hao; Zink, Daniele] NanoBio Lab, 31 Biopolis Way, Singapore 138669, Singapore.
   [Hussain, Faezah; Heng, Javen Jun Hao; Zink, Daniele] Inst Bioengn & Nanotechnol IBN, 31 Biopolis Way, Singapore 138669, Singapore.
   [Basu, Sreetama; Loo, Lit-Hsin] Bioinformat Inst, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore.
   [Loo, Lit-Hsin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, 16 Med Dr, Singapore 117600, Singapore.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Institute of
   Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering
   & Nanotechnology (IBN); Agency for Science Technology & Research
   (A*STAR); A*STAR - Bioinformatics Institute (BII); National University
   of Singapore
RP Zink, D (corresponding author), NanoBio Lab, 31 Biopolis Way, Singapore 138669, Singapore.; Zink, D (corresponding author), Inst Bioengn & Nanotechnol IBN, 31 Biopolis Way, Singapore 138669, Singapore.; Loo, LH (corresponding author), Bioinformat Inst, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore.; Loo, LH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, 16 Med Dr, Singapore 117600, Singapore.
EM loolh@bii.a-star.edu.sg; dzink@nbl.a-star.edu.sg
OI Loo, Lit-Hsin/0000-0001-6303-9840
FU NanoBio Lab; Bioinformatics Institute (Agency for Science, Technology
   and Research, Singapore); IBN
FX We thank Jia Jun Lee (IBN, Youth Research Programme) for his
   contributions to the experimental work. This work was supported by the
   NanoBio Lab, IBN and the Bioinformatics Institute (Agency for Science,
   Technology and Research, Singapore).
CR Abd El-Kader SM, 2015, WORLD J HEPATOL, V7, P846, DOI 10.4254/wjh.v7.i6.846
   Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12
   AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Albrecht W, 2019, ARCH TOXICOL, V93, P1609, DOI 10.1007/s00204-019-02492-9
   Andersson TB, 2012, EXPERT OPIN DRUG MET, V8, P909, DOI 10.1517/17425255.2012.685159
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   Anthérieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290
   Anthérieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173
   Buckalew VM, 1996, AM J KIDNEY DIS, V28, pS7, DOI 10.1016/S0272-6386(96)90562-4
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen DM, 2012, CLIN NEPHROL, V78, P54, DOI 10.5414/CN107414
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Ciarimboli G, 2014, ANTICANCER RES, V34, P547
   Desouza Melissa, 2012, Bioarchitecture, V2, P75
   Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938
   Emadali A, 2006, MOL CELL PROTEOMICS, V5, P1300, DOI 10.1074/mcp.M500393-MCP200
   Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11
   Fraczek J, 2013, ARCH TOXICOL, V87, P577, DOI 10.1007/s00204-012-0983-3
   Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320
   Frey N, 2018, NAT REV GASTRO HEPAT, V15, P81, DOI 10.1038/nrgastro.2017.146
   Garside H, 2014, TOXICOL IN VITRO, V28, P171, DOI 10.1016/j.tiv.2013.10.015
   Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4
   Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Hastie T., 2009, The Elements of Statistical Learning: Data Mining, Inference, and Prediction, V2nd
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hellmann A, 2011, CLIN PHARMACOKINET, V50, P781, DOI 10.2165/11594410-000000000-00000
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Gómez-Lechón MJ, 2014, EXPERT OPIN DRUG MET, V10, P1553, DOI 10.1517/17425255.2014.967680
   Kandasamy K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12337
   Khetani SR, 2013, TOXICOL SCI, V132, P107, DOI 10.1093/toxsci/kfs326
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Kohavi R., 1995, INT JOINT C ART INT, P1137, DOI DOI 10.1067/MOD.2000.109031
   Laksameethanasan D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S4
   Lee JYJ, 2018, ARCH TOXICOL, V92, P2055, DOI 10.1007/s00204-018-2213-0
   Li RD, 2017, ONCOL REP, V37, P442, DOI 10.3892/or.2016.5258
   Li Y, 2014, MOL PHARMACEUT, V11, P1982, DOI 10.1021/mp400637s
   Li Y, 2013, TOXICOL RES-UK, V2, P352, DOI 10.1039/c3tx50042j
   Lin ZW, 2012, TOXICOL SCI, V126, P114, DOI 10.1093/toxsci/kfr339
   Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032
   Loo LH, 2017, ATLA-ALTERN LAB ANIM, V45, P241, DOI 10.1177/026119291704500506
   López-Riera M, 2017, FRONT PHARMACOL, V8, DOI [10.3389/fpahr.2017.00003, 10.3389/fphar.2017.00003]
   Lübberstedt M, 2011, J PHARMACOL TOX MET, V63, P59, DOI 10.1016/j.vascn.2010.04.013
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Mavri-Damelin Demetra, 2007, Int J Biochem Cell Biol, V39, P555, DOI 10.1016/j.biocel.2006.10.007
   Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490
   Moujaber O, 2019, CELL MOL LIFE SCI, V76, P1169, DOI 10.1007/s00018-018-2999-1
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nagano T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31758
   Nishio K, 2005, HISTOCHEM CELL BIOL, V123, P263, DOI 10.1007/s00418-005-0766-5
   O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3
   Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838
   Persson M, 2013, J PHARMACOL TOX MET, V68, P302, DOI 10.1016/j.vascn.2013.08.001
   Petrova NV, 2016, AGING CELL, V15, P999, DOI 10.1111/acel.12518
   Proctor WR, 2017, ARCH TOXICOL, V91, P2849, DOI 10.1007/s00204-017-2002-1
   Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267
   Rai TS, 2012, BBA-GENE REGUL MECH, V1819, P322, DOI 10.1016/j.bbagrm.2011.07.014
   Randhawa Parmjeet S, 1997, Adv Anat Pathol, V4, P265, DOI 10.1097/00125480-199707000-00032
   Robertson JD, 2000, J STRUCT BIOL, V129, P346, DOI 10.1006/jsbi.2000.4254
   Rogalinska M, 2002, CELL MOL BIOL LETT, V7, P995
   Rovillain E, 2011, ONCOGENE, V30, P2356, DOI 10.1038/onc.2010.611
   Shahane SA, 2014, J BIOMOL SCREEN, V19, P66, DOI 10.1177/1087057113502851
   SIDRANSKY H, 1982, EXP MOL PATHOL, V36, P72, DOI 10.1016/0014-4800(82)90080-6
   Sirenko O, 2014, ASSAY DRUG DEV TECHN, V12, P43, DOI 10.1089/adt.2013.520
   Sjögren AK, 2019, ARCH TOXICOL, V93, P225, DOI 10.1007/s00204-018-2359-9
   Sjögren AK, 2018, ARCH TOXICOL, V92, P3175, DOI 10.1007/s00204-018-2284-y
   Su R, 2016, ARCH TOXICOL, V90, P2793, DOI 10.1007/s00204-015-1638-y
   TRASK OJ, 2004, NUCL FACTOR KAPPA B
   Underhill GH, 2018, CELL MOL GASTROENTER, V5, P426, DOI 10.1016/j.jcmgh.2017.11.012
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vinken M, 2018, ARCH TOXICOL, V92, P2981, DOI 10.1007/s00204-018-2297-6
   Wang C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0622-x
   Ware BR, 2015, TOXICOL SCI, V145, P252, DOI 10.1093/toxsci/kfv048
   Wisniewski JR, 2016, J PROTEOMICS, V136, P234, DOI 10.1016/j.jprot.2016.01.016
   Xiao M, 2018, ONCOTARGET, V9, P8772, DOI [10.18632/oncotarget.23622, DOI 10.18632/ONCOTARGET.23622]
   Xu JHJ, 2008, TOXICOL SCI, V105, P97, DOI 10.1093/toxsci/kfn109
   Yang L, 2012, NEPHROL DIAL TRANSPL, V27, P292, DOI 10.1093/ndt/gfr291
   Yosef R, 2017, EMBO J, V36, P2280, DOI 10.15252/embj.201695553
   You LT, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00813
   Zeigerer A, 2017, EXP CELL RES, V350, P242, DOI 10.1016/j.yexcr.2016.11.027
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zhang L, 2019, METHODS MOL BIOL, V1896, P231, DOI 10.1007/978-1-4939-8931-7_18
   Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06
NR 89
TC 8
Z9 8
U1 1
U2 25
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD 2020 AUG
PY 2020
VL 94
IS 8
BP 2749
EP 2767
DI 10.1007/s00204-020-02778-3
EA JUN 2020
PG 19
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA MT2HY
UT WOS:000539871000001
PM 32533217
DA 2024-02-19
ER

PT J
AU Fitzgerald, H
   Bonin, JL
   Khan, S
   Eid, M
   Sadhu, S
   Rahtes, A
   Lipscomb, M
   Biswas, N
   Decker, C
   Nabage, M
   Ramos, RB
   Duarte, GA
   Marinello, M
   Chen, AN
   Aydin, HB
   Mena, HA
   Gilliard, K
   Spite, M
   Dipersio, CM
   Adam, AP
   Macnamara, KC
   Fredman, G
AF Fitzgerald, Hannah
   Bonin, Jesse L.
   Khan, Sayeed
   Eid, Maya
   Sadhu, Sudeshna
   Rahtes, Allison
   Lipscomb, Masharh
   Biswas, Nirupam
   Decker, Christa
   Nabage, Melisande
   Ramos, Ramon Bossardi
   Duarte, Giesse Albeche
   Marinello, Michael
   Chen, Anne
   Aydin, Hasan Basri
   Mena, Hebe Agustina
   Gilliard, Kurrim
   Spite, Matthew
   Dipersio, C. Michael
   Adam, Alejandro P.
   Macnamara, Katherine C.
   Fredman, Gabrielle
TI Resolvin D2-G-Protein Coupled Receptor 18 Enhances Bone Marrow Function
   and Limits Steatosis and Hepatic Collagen Accumulation in Aging
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article; Early Access
ID NONALCOHOLIC STEATOHEPATITIS; ACUTE-INFLAMMATION; LIVER; D2;
   MACROPHAGES; RESOLUTION; PHENOTYPE; MONOCYTES; DYSREGULATION; DECLINE
AB Aging is associated with nonresolving inflammation and tissue dysfunction. Resolvin D2 (RvD2) is a proresolving ligand that acts through the G-protein-coupled receptor called GPR18. Unbiased RNA sequencing revealed increased Gpr18 expression in macrophages from old mice, and in livers from elderly humans, which was associated with increased steatosis and fibrosis in middle-aged (MA) and old mice. MA mice that lacked GPR18 on myeloid cells had exacerbated steatosis and hepatic fibrosis, which was associated with a decline in Mac2 thorn macrophages. Treatment of MA mice with RvD2 reduced steatosis and decreased hepatic fibrosis, correlating with increased Mac2 thorn macrophages, increased monocyte-derived macrophages, and elevated numbers of monocytes in the liver, blood, and bone marrow. RvD2 acted directly on the bone marrow to increase monocyte-macrophage progenitors. A transplantation assay further demonstrated that bone marrow from old mice facilitated hepatic collagen accumulation in young mice. Transient RvD2 treatment to mice transplanted with bone marrow from old mice prevented hepatic collagen accumulation. Together, this study demonstrates that RvD2-GPR18 signaling controls steatosis and fibrosis and provides a mechanistic-based therapy for promoting liver repair in aging.
C1 [Fitzgerald, Hannah; Khan, Sayeed; Eid, Maya; Sadhu, Sudeshna; Rahtes, Allison; Lipscomb, Masharh; Decker, Christa; Nabage, Melisande; Ramos, Ramon Bossardi; Duarte, Giesse Albeche; Marinello, Michael; Gilliard, Kurrim; Dipersio, C. Michael; Adam, Alejandro P.; Fredman, Gabrielle] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY USA.
   [Bonin, Jesse L.; Biswas, Nirupam] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY USA.
   [Chen, Anne; Aydin, Hasan Basri] Albany Med Coll, Dept Pathol, Albany, NY USA.
   [Dipersio, C. Michael] Albany Med Coll, Dept Surg, Albany, NY USA.
   [Mena, Hebe Agustina; Spite, Matthew] Harvard Med Sch, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA USA.
   Harvard Med Sch, Boston, MA USA.
C3 Albany Medical College; Albany Medical College; Albany Medical College;
   Albany Medical College; Harvard University; Harvard Medical School;
   Harvard University; Harvard Medical School
RP Fredman, G (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA.; Macnamara, KC (corresponding author), Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA.
EM macnamk@amc.edu; fredmag@amc.edu
RI Mena, Hebe Agustina/IYS-8523-2023
OI Chen, Anne/0000-0002-2945-8424; Biswas, Nirupam/0000-0002-3644-9913
FU NIH [HL153019, HL170249, HL106173, R35GM131842, AR063778]
FX Supported by NIH grants HL153019 (G.F.) , HL170249 (G.F. and K.C.M) ,
   HL106173 (M.S.) , R35GM131842 (K.C.M) , and AR063778 (C.M.D.) . H.F. and
   J.L.B. contributed equally to this work.
CR Arnardottir HH, 2014, J IMMUNOL, V193, P4235, DOI 10.4049/jimmunol.1401313
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x
   Börgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003
   Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650
   Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225
   Clària J, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.159023
   Colvin MM, 2017, J CLIN INVEST, V127, P2523, DOI 10.1172/JCI90601
   Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539
   De Maeyer RPH, 2021, IMMUNOL LETT, V230, P1, DOI 10.1016/j.imlet.2020.12.003
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Frisch BJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124213
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Giannakis N, 2019, NAT IMMUNOL, V20, P626, DOI 10.1038/s41590-019-0356-7
   Grover A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11075
   Hammoutene A, 2019, J HEPATOL, V70, P1278, DOI 10.1016/j.jhep.2019.02.012
   Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x
   Hendrikx T, 2022, J HEPATOL, V77, P1373, DOI 10.1016/j.jhep.2022.06.004
   Hou JC, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI135197
   Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342
   Juluri R, 2011, J CLIN GASTROENTEROL, V45, P55, DOI 10.1097/MCG.0b013e3181dd1348
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037
   Krenkel O, 2020, GUT, V69, P551, DOI 10.1136/gutjnl-2019-318382
   Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759
   Li JH, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106961
   Liu ZY, 2020, STAR PROTOC, V1, DOI 10.1016/j.xpro.2020.100029
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mak KM, 2013, ANAT REC, V296, P953, DOI 10.1002/ar.22694
   Markworth JF, 2021, AGING CELL, V20, DOI 10.1111/acel.13393
   Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096
   Nilsson AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158369
   Poscablo DM, 2021, STEM CELL REP, V16, P1598, DOI 10.1016/j.stemcr.2021.04.016
   Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Rymut N, 2020, FASEB J, V34, P597, DOI 10.1096/fj.201902126R
   Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592
   Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943
   Sharma M, 2020, CIRC RES, V127, P335, DOI 10.1161/CIRCRESAHA.119.316461
   Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Sugimoto S, 2022, NAT METAB, V4, P775, DOI 10.1038/s42255-022-00590-0
   Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146
   Valletta S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17942-7
   Wong CK, 2017, J IMMUNOL, V199, P1060, DOI 10.4049/jimmunol.1700397
   Wong WJ, 2023, NATURE, V616, DOI 10.1038/s41586-023-05857-4
   Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015
   Young K, 2021, CELL STEM CELL, V28, P1473, DOI 10.1016/j.stem.2021.03.017
   Zhang MJ, 2016, CIRCULATION, V134, P666, DOI 10.1161/CIRCULATIONAHA.116.021894
NR 53
TC 1
Z9 1
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD 2023 DEC
PY 2023
VL 193
IS 12
BP 1953
EP 1968
DI 10.1016/j.ajpath.2023.08.011
EA NOV 2023
PG 16
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA CI3I6
UT WOS:001124580700001
PM 37717941
OA Bronze
DA 2024-02-19
ER

PT J
AU Czibik, G
   Mezdari, Z
   Altintas, DM
   Bréhat, J
   Pini, M
   d'Humières, T
   Delmont, T
   Radu, C
   Breau, M
   Liang, H
   Martel, C
   Abatan, A
   Sarwar, R
   Marion, O
   Naushad, S
   Zhang, YY
   Halfaoui, M
   Suffee, N
   Morin, D
   Adnot, S
   Hatem, S
   Yavari, A
   Sawaki, D
   Derumeaux, G
AF Czibik, Gabor
   Mezdari, Zaineb
   Murat Altintas, Dogus
   Brehat, Juliette
   Pini, Maria
   d'Humieres, Thomas
   Delmont, Thais
   Radu, Costin
   Breau, Marielle
   Liang, Hao
   Martel, Cecile
   Abatan, Azania
   Sarwar, Rizwan
   Marion, Ophelie
   Naushad, Suzain
   Zhang, Yanyan
   Halfaoui, Maissa
   Suffee, Nadine
   Morin, Didier
   Adnot, Serge
   Hatem, Stephane
   Yavari, Arash
   Sawaki, Daigo
   Derumeaux, Genevieve
TI Dysregulated Phenylalanine Catabolism Plays a Key Role in the Trajectory
   of Cardiac Aging
SO CIRCULATION
LA English
DT Article
DE aging; phenylalanine; senescence
ID GTP-CYCLOHYDROLASE-I; HEART-FAILURE; HYDROXYLASE ACTIVITY; ELDERLY-MEN;
   TETRAHYDROBIOPTERIN; PLASMA; OVEREXPRESSION; DYSFUNCTION; INHIBITION;
   SENESCENCE
AB Background: Aging myocardium undergoes progressive cardiac hypertrophy and interstitial fibrosis with diastolic and systolic dysfunction. Recent metabolomics studies shed light on amino acids in aging. The present study aimed to dissect how aging leads to elevated plasma levels of the essential amino acid phenylalanine and how it may promote age-related cardiac dysfunction. Methods: We studied cardiac structure and function, together with phenylalanine catabolism in wild-type (WT) and p21(-/-) mice (male; 2-24 months), with the latter known to be protected from cellular senescence. To explore phenylalanine's effects on cellular senescence and ectopic phenylalanine catabolism, we treated cardiomyocytes (primary adult rat or human AC-16) with phenylalanine. To establish a role for phenylalanine in driving cardiac aging, WT male mice were treated twice a day with phenylalanine (200 mg/kg) for a month. We also treated aged WT mice with tetrahydrobiopterin (10 mg/kg), the essential cofactor for the phenylalanine-degrading enzyme PAH (phenylalanine hydroxylase), or restricted dietary phenylalanine intake. The impact of senescence on hepatic phenylalanine catabolism was explored in vitro in AML12 hepatocytes treated with Nutlin3a (a p53 activator), with or without p21-targeting small interfering RNA or tetrahydrobiopterin, with quantification of PAH and tyrosine levels. Results: Natural aging is associated with a progressive increase in plasma phenylalanine levels concomitant with cardiac dysfunction, whereas p21 deletion delayed these changes. Phenylalanine treatment induced premature cardiac deterioration in young WT mice, strikingly akin to that occurring with aging, while triggering cellular senescence, redox, and epigenetic changes. Pharmacological restoration of phenylalanine catabolism with tetrahydrobiopterin administration or dietary phenylalanine restriction abrogated the rise in plasma phenylalanine and reversed cardiac senescent alterations in aged WT mice. Observations from aged mice and human samples implicated age-related decline in hepatic phenylalanine catabolism as a key driver of elevated plasma phenylalanine levels and showed increased myocardial PAH-mediated phenylalanine catabolism, a novel signature of cardiac aging. Conclusions: Our findings establish a pathogenic role for increased phenylalanine levels in cardiac aging, linking plasma phenylalanine levels to cardiac senescence via dysregulated phenylalanine catabolism along a hepatic-cardiac axis. They highlight phenylalanine/PAH modulation as a potential therapeutic strategy for age-associated cardiac impairment.
C1 [Czibik, Gabor; Mezdari, Zaineb; Murat Altintas, Dogus; Brehat, Juliette; Pini, Maria; d'Humieres, Thomas; Delmont, Thais; Radu, Costin; Breau, Marielle; Liang, Hao; Abatan, Azania; Marion, Ophelie; Naushad, Suzain; Zhang, Yanyan; Halfaoui, Maissa; Morin, Didier; Adnot, Serge; Sawaki, Daigo; Derumeaux, Genevieve] Univ Paris Est Creteil, INSERM, U955, Creteil, France.
   [Martel, Cecile] Univ Paris Est Creteil, Mitol SAS, Creteil, France.
   [Czibik, Gabor; d'Humieres, Thomas; Adnot, Serge; Derumeaux, Genevieve] FHU SENEC, Henri Mondor Hosp, AP HP, Dept Physiol, Creteil, France.
   [Radu, Costin] FHU SENEC, Henri Mondor Hosp, AP HP, Dept Cardiac Surg, Creteil, France.
   [Sarwar, Rizwan; Yavari, Arash] Univ Oxford, Radcliffe Dept Med, Expt Therapeut, Oxford, England.
   [Yavari, Arash] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England.
   [Suffee, Nadine; Hatem, Stephane] Sorbonne Univ, UPMC, INSERM UMR S1166, Fac Med, Paris, France.
   [Suffee, Nadine; Hatem, Stephane] ICAN, Inst Cardiometab & Nutr, Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux
   Paris (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu -
   APHP; Hopital Universitaire Paul-Brousse - APHP; Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire
   Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Paul-Brousse - APHP; Universite Paris Cite; Hopital
   Universitaire Hotel-Dieu - APHP; Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire
   Henri-Mondor - APHP; University of Oxford; University of Oxford;
   Wellcome Centre for Human Genetics; Sorbonne Universite; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Sorbonne
   Universite
RP Czibik, G (corresponding author), Fac Med Creteil, IMRB INSERM U955, 8 Rue Gen Sarrail, F-94010 Creteil, France.
EM gaborczibik@yahoo.com; zaineb.mezdari@yahoo.com;
   dogus.altintas@yahoo.com; brehatjuliette@gmail.com; mpini25@gmail.com;
   thomasdhumieres@hotmail.fr; thais.delmont@hotmail.com;
   ncostin.radu@gmail.com; marielle.breau@inserm.fr; hao.liang91@yahoo.fr;
   cmartel@mitologics.com; azania.abatan@etu.u-pec.fr;
   rizwan.sarwar@rdm.ox.ac.uk; ophelie.marion972@gmail.com;
   suzain.naushad-khan@inserm.fr; yanyan.zhang@inserm.fr;
   maissa_91@live.fr; nadine.suffee@yahoo.com; didier.morin@inserm.fr;
   serge.adnot@inserm.fr; stephane.hatem@sorbonne-universite.fr;
   arash.yavari@well.ox.ac.uk; daigo.sawaki@inserm.fr;
   genevieve.derumeaux@inserm.fr
RI SAWAKI, Daigo/T-6871-2018; DERUMEAUX, Genevieve A/T-2489-2018; Suffee,
   Nadine/GYY-3811-2022; Czibik, Gabor/U-9295-2018; Altintas,
   Dogus/AAL-2866-2021; Pini, Maria/T-6292-2018
OI SAWAKI, Daigo/0000-0003-1417-2033; Czibik, Gabor/0000-0002-4914-6794;
   Altintas, Dogus/0000-0001-7153-4462; Pini, Maria/0000-0002-9995-5370;
   Delmont, Thais/0000-0001-6447-6313; ZHANG, yanyan/0000-0003-3330-4062;
   didier, MORIN/0000-0002-0967-1850; Mezdari, Zaineb/0000-0002-2520-8559;
   Brehat, Juliette/0000-0003-2063-5014
FU RHU-CARMMA Grant (Agence Nationale de la Recherche) [ANR-15-RHUS-0003];
   Agence Nationale de la Recherche (ANR) [ANR-15-RHUS-0003] Funding
   Source: Agence Nationale de la Recherche (ANR)
FX This work was supported by the RHU-CARMMA Grant (Agence Nationale de la
   Recherche: ANR-15-RHUS-0003).
CR Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a
   Alfaras I, 2016, CIRC RES, V118, P1626, DOI 10.1161/CIRCRESAHA.116.307475
   Anderson R, 2019, EMBO J, V38, DOI 10.15252/embj.2018100492
   Antoniades C, 2011, CIRCULATION, V124, P1860, DOI 10.1161/CIRCULATIONAHA.111.029272
   Arganda S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2052
   Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   BANCEL E, 1994, ANN BIOL CLIN-PARIS, V52, P667
   Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133
   Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4
   CABALLERO B, 1991, AM J CLIN NUTR, V53, P1249, DOI 10.1093/ajcn/53.5.1249
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0
   Cunnington C, 2012, CIRCULATION, V125, P1356, DOI 10.1161/CIRCULATIONAHA.111.038919
   CYNOBER L, 1983, ANN BIOL CLIN-PARIS, V41, P33
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Delles C, 2018, EUR J HEART FAIL, V20, P663, DOI 10.1002/ejhf.1076
   Derumeaux G, 2008, CIRC-CARDIOVASC IMAG, V1, P227, DOI 10.1161/CIRCIMAGING.107.745919
   Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170
   Diguet N, 2018, CIRCULATION, V137, P2256, DOI 10.1161/CIRCULATIONAHA.116.026099
   Du YH, 2008, CIRCULATION, V117, P1045, DOI 10.1161/CIRCULATIONAHA.107.748236
   Edwards C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0167-2
   Eriksson JG, 2017, AM J CLIN NUTR, V105, P144, DOI 10.3945/ajcn.116.130468
   Gilstrap LG, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.118.005407
   Harding CO, 2004, MOL GENET METAB, V81, P52, DOI 10.1016/j.ymgme.2003.10.002
   Hoekstra AS, 2015, ONCOTARGET, V6, P38777, DOI 10.18632/oncotarget.6091
   Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137
   Kouchiwa T, 2012, CLIN CHEM LAB MED, V50, P861, DOI 10.1515/cclm-2011-0846
   Kreis NN, 2015, ONCOGENE, V34, P1758, DOI 10.1038/onc.2014.133
   Kure S, 2004, MOL GENET METAB, V83, P150, DOI 10.1016/j.ymgme.2004.06.016
   Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7
   Lazzarini V, 2013, EUR J HEART FAIL, V15, P717, DOI 10.1093/eurjhf/hft028
   Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Obame FN, 2008, J PHARMACOL EXP THER, V326, P252, DOI 10.1124/jpet.108.138008
   Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x
   Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7
   Rosa AP, 2012, CELL MOL NEUROBIOL, V32, P1113, DOI 10.1007/s10571-012-9834-2
   Roy S, 2007, MOL BIOL CELL, V18, P4837, DOI 10.1091/mbc.E07-03-0270
   Sawaki D, 2018, CIRCULATION, V138, P809, DOI 10.1161/CIRCULATIONAHA.117.031358
   Tenori L, 2013, INT J CARDIOL, V168, pE113, DOI 10.1016/j.ijcard.2013.08.042
   Ternacle J, 2017, EUR HEART J-CARD IMG, V18, P1283, DOI 10.1093/ehjci/jew316
   Ternette N, 2013, CELL REP, V3, P689, DOI 10.1016/j.celrep.2013.02.013
   Thöny B, 2004, FEBS LETT, V577, P507, DOI 10.1016/j.febslet.2004.10.056
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293
   Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001
   ZIEGLER MG, 1976, NATURE, V261, P333, DOI 10.1038/261333a0
NR 48
TC 31
Z9 31
U1 4
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD AUG 17
PY 2021
VL 144
IS 7
BP 559
EP 574
DI 10.1161/CIRCULATIONAHA.121.054204
PG 16
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA UB8LV
UT WOS:000686091700010
PM 34162223
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Gong, H
   Pang, J
   Han, YW
   Dai, Y
   Dai, DP
   Cai, JP
   Zhang, TM
AF Gong, Huan
   Pang, Jing
   Han, Yiwen
   Dai, Yang
   Dai, Dapeng
   Cai, Jianping
   Zhang, Tie-Mei
TI Age-dependent tissue expression patterns of Sirt1 in
   senescence-accelerated mice
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE sirtuin 1; senescence-accelerated mouse; aging; brain; liver; skeletal
   muscle; white adipose tissues
ID CAENORHABDITIS-ELEGANS; CALORIE RESTRICTION; ALZHEIMERS-DISEASE;
   OXIDATIVE STRESS; KIDNEY-DISEASE; SAMP8 MOUSE; LIFE-SPAN; DEACETYLASE;
   MODEL; PROTECTS
AB Sirtuin 1 (Sirt1) has a range of molecular functions and has emerged as an important protein in aging and metabolic regulations. Studies have reported a correlation between disturbance of Sirt1 activity and the onset of aging- or obesity-associated diseases, including diabetes, cardiovascular disease and neurodegenerative disorders. However, a systematic investigation to examine the changes of Sirt1 expression in a wide range of ages and to what degree it changes has yet to be performed. To assess the effects of aging on the changes of Sirt1 expression, an in vivo model of aging, senescence-accelerated mouse prone 8 (SAM-P8) and a control counterpart strain, senescence-accelerated mouse resistant 1 (SAM-R1) was used. The mRNA and protein expression levels of Sirt1 were detected in four different tissues, including brain, liver, skeletal muscle and white adipose tissue, in both strains at different ages (1-, 4-, 8- and 12-month old). Therefore, different life stages, including young age prior to maturation, adult, middle age and old age were examined. The results identified that Sirt1 expression declined with age at the transcriptional and translational levels in the brain, liver, skeletal muscle and white adipose tissue in SAM-P8 and SAM-R1. The Sirt1 expression level was lower in SAM-P8 than in SAM-R1, particularly at old age. Among the four tissues, it was most significantly reduced in the brain.
C1 Beijing Hosp, Dept Cell Biol, Key Lab Geriatr, Beijing 100730, Peoples R China.
   Minist Hlth, Beijing Inst Geriatr, Beijing 100730, Peoples R China.
C3 Beijing Hospital
RP Zhang, TM (corresponding author), Beijing Hosp, Dept Cell Biol, 1 Dahualu, Beijing 100730, Peoples R China.
EM tmzhang126@126.com
OI GONG, HUAN/0000-0002-3942-8958
FU Research Special Fund for Public Welfare Industry of Health [201302008];
   National Natural Science Foundation of China [81300693]
FX The present study was supported by the Research Special Fund for Public
   Welfare Industry of Health to T.M.Z. (grant no. 201302008) and the
   National Natural Science Foundation of China to H.G. (grant no.
   81300693)
CR Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050
   Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014
   Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010
   Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x
   Campbell KH, 2008, CURR OPIN NEPHROL HY, V17, P298, DOI 10.1097/MNH.0b013e3282f5dd90
   Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100
   Chong ZZ, 2012, EXPERT OPIN THER TAR, V16, P167, DOI 10.1517/14728222.2012.648926
   Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x
   Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1
   Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758
   Lim JH, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/171383
   McBurney MW, 2003, MOL CANCER RES, V1, P402
   Miyamoto M, 1997, EXP GERONTOL, V32, P139, DOI 10.1016/S0531-5565(96)00061-7
   Morley JE, 2002, BIOGERONTOLOGY, V3, P57, DOI 10.1023/A:1015207429786
   Morley JE, 2012, BBA-MOL BASIS DIS, V1822, P650, DOI 10.1016/j.bbadis.2011.11.015
   Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514
   O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986
   POWERS DC, 1992, CELL IMMUNOL, V141, P444, DOI 10.1016/0008-8749(92)90162-I
   Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200
   Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799
   Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x
   Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440
   Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079
NR 29
TC 52
Z9 59
U1 0
U2 18
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD DEC
PY 2014
VL 10
IS 6
BP 3296
EP 3302
DI 10.3892/mmr.2014.2648
PG 7
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA AU9YM
UT WOS:000345947900075
PM 25323555
OA Bronze
DA 2024-02-19
ER

PT J
AU Bloomer, SA
   Zhang, HJ
   Brown, KE
   Kregel, KC
AF Bloomer, Steven A.
   Zhang, Hannah J.
   Brown, Kyle E.
   Kregel, Kevin C.
TI Differential Regulation of Hepatic Heme Oxygenase-1 Protein With Aging
   and Heat Stress
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Oxidative stress; Kupffer cells; Inflammation; Hyperthermia
ID OXIDATIVE STRESS; RAT-LIVER; ANTIOXIDANT ENZYME; KUPFFER CELLS;
   MONONUCLEAR PHAGOCYTES; GENE-EXPRESSION; CARBON-MONOXIDE; AGE;
   HEPATOCYTES; INJURY
AB Increased expression of heme oxygenase-1 (HO-1) in response to physiological stress is considered to be a protective response, which may be altered with aging. In this study, HO-1 expression was assessed following heat stress by immunoblotting of liver homogenates and isolated hepatocytes from young (6 months) and old (24 months) Fischer 344 rats and by immunohistochemistry. Livers of old rats showed higher baseline levels of HO-1, which was predominately localized to Kupffer cells. After heat stress, young animals showed a greater relative increase in hepatic HO-1, part of which was caused by increased numbers of nonparenchymal cells that were immunoreactive to HO-1. Consistent with these data, HO-1 was significantly upregulated after hyperthermia in vitro only in hepatocytes from young rats. Hence, aging alters stress-induced expression of HO-1 in a cell-specific manner, which may contribute to the diminished stress tolerance observed in older organisms.
C1 [Bloomer, Steven A.; Zhang, Hannah J.; Kregel, Kevin C.] Univ Iowa, Dept Integrat Physiol, Iowa City, IA 52242 USA.
   [Brown, Kyle E.] Iowa City Vet Adm Med Ctr, Iowa City, IA USA.
   [Brown, Kyle E.] Univ Iowa, Dept Internal Med, Div Gastroenterol Hepatol, Iowa City, IA 52242 USA.
   [Brown, Kyle E.; Kregel, Kevin C.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Radiat Oncol, Program Free Radical & Radiat Biol, Iowa City, IA 52242 USA.
C3 University of Iowa; University of Iowa; University of Iowa
RP Kregel, KC (corresponding author), Univ Iowa, Dept Integrat Physiol, 532 FH, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
OI Brown, Kyle/0000-0002-8206-036X
FU National Institutes of Health [AG-12350]; Veterans Administration
FX This research was supported by National Institutes of Health Grant
   AG-12350. K.E.B. was supported by a Merit Review grant from the Veterans
   Administration.
CR ABRAHAM NG, 1985, EXP GERONTOL, V20, P277, DOI 10.1016/0531-5565(85)90053-1
   ALAM J, 1992, J BIOL CHEM, V267, P21894
   Baier PK, 2005, EUR SURG RES, V37, P290, DOI 10.1159/000089239
   Bauer I, 1998, HEPATOLOGY, V27, P829, DOI 10.1002/hep.510270327
   Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891
   Bloomer SA, 2008, AM J PHYSIOL-REG I, V294, pR1165, DOI 10.1152/ajpregu.00719.2007
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Goda N, 1998, J CLIN INVEST, V101, P604, DOI 10.1172/JCI1324
   Gong PF, 2004, FREE RADICAL BIO MED, V36, P307, DOI 10.1016/j.freeradbiomed.2003.10.017
   Hall DM, 2001, J GERONTOL A-BIOL, V56, pB259, DOI 10.1093/gerona/56.6.B259
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200
   Kang MJ, 2005, BIOGERONTOLOGY, V6, P27, DOI 10.1007/s10522-004-7381-z
   Kato H, 2001, AM J TRANSPLANT, V1, P121, DOI 10.1034/j.1600-6143.2001.001002121.x
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393
   Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873
   Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680
   Öztezcan S, 2004, BIOGERONTOLOGY, V5, P99, DOI 10.1023/B:BGEN.0000025073.46100.01
   Patriarca S, 2007, BIOGERONTOLOGY, V8, P365, DOI 10.1007/s10522-006-9079-x
   Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9
   RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858
   SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889
   STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864
   Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800
   Videla LA, 2001, REDOX REP, V6, P155, DOI 10.1179/135100001101536265
   VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607
   WIDMANN JJ, 1975, AM J PATHOL, V80, P349
   Zhang HJ, 2006, J APPL PHYSIOL, V100, P1385, DOI 10.1152/japplphysiol.01046.2005
   Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
   Zhang HJ, 2002, J APPL PHYSIOL, V92, P1762, DOI 10.1152/japplphysiol.00733.2001
NR 34
TC 24
Z9 25
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2009
VL 64
IS 4
BP 419
EP 425
DI 10.1093/gerona/gln056
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 421XD
UT WOS:000264390700001
PM 19196643
OA Green Published
DA 2024-02-19
ER

PT J
AU Ma, M
   Long, Q
   Chen, F
   Zhang, T
   Wang, WQ
AF Ma, Ming
   Long, Qi
   Chen, Fei
   Zhang, Ting
   Wang, Wenqiao
TI Active vitamin D impedes the progression of non-alcoholic fatty liver
   disease by inhibiting cell senescence in a rat model
SO CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
LA English
DT Article
DE Non-alcoholic fatty liver disease; Active vitamin D; Oxidative stress;
   Cell senescence; P53-p21 signaling pathway; Vitamin D receptor
ID OXIDATIVE STRESS; D DEFICIENCY; CANCER; NAFLD; MYOFIBROBLASTS;
   INDUCTION; PROMOTES; PATHWAY; P21
AB Objective: Non-alcoholic fatty liver disease (NAFLD) refers to an accumulation of excess fat in liver due to causes other than alcohol use. The relationship between vitamin D (VD) and NAFLD has been previously studied. Therefore, we aimed to explore the mechanism involved active VD regulating the progression of NAFLD by inhibiting cell senescence and to provide a potential approach for further nutritional treatment of NAFLD.
   Methods: Following the induction with high-fat diet and intraperitoneal injection of corn oil, the successfully established NAFLD rat models were treated with 1,25(OH)2D3 at 1 mu g/kg, 5 mu g/kg or 10 mu g/kg. Meanwhile, the levels of factors related to oxidative stress, cell senescence, the p53-p21 signaling pathway and inflammation in liver were determined. Then, cell senescence was also measured by using senescence-associated B-galactosidase (SAB-gal) staining.
   Results: It was also found that active VD increased the concentration of VD in serum and VDR in liver of NAFLD rats, and alleviated hepatic fibrosis. Besides, treatment of 1,25(OH)2D3 at 1 mu g/kg, 5 mu g/kg or 10 mu g/kg reduced oxidative stress and inflammation, inhibited the p53-p21 signaling pathway and consequent cell senescence. Furthermore, treatment of 1,25(OH)2D3 at a dosage of 5 mu g/kg made the most impact on these factors.
   Conclusion: Collectively, the evidences from this study demonstrated that active VD could alleviate the development of NAFLD through blocking the p53-p21 signaling pathway, which provided a novel nutritional therapeutic insight for NAFLD. (c) 2019 Elsevier Masson SAS. All rights reserved.
C1 [Ma, Ming; Long, Qi; Chen, Fei; Zhang, Ting; Wang, Wenqiao] Zhejiang Univ, Sch Med, Natl Clin Res Ctr Child Hlth, Dept Clin Nutr,Childrens Hosp, 3333 Binsheng Rd, Hangzhou 310052, Peoples R China.
C3 Zhejiang University
RP Ma, M (corresponding author), Zhejiang Univ, Sch Med, Natl Clin Res Ctr Child Hlth, Dept Clin Nutr,Childrens Hosp, 3333 Binsheng Rd, Hangzhou 310052, Peoples R China.
EM maming73@zju.edu.cn
RI Jiang, Yuan/JED-3759-2023
FU Research Fund of Zhejiang Major Medical and Health Science and
   Technology a National Ministry of Health [WKJ-ZJ-1804]; Education
   Department Fund of Zhejiang Province [Y201635973]
FX This study was supported by Research Fund of Zhejiang Major Medical and
   Health Science and Technology a National Ministry of Health
   (WKJ-ZJ-1804)and Education Department Fund of Zhejiang Province
   (Y201635973).
CR Abu el Maaty MA, 2017, MOL CARCINOGEN, V56, P2486, DOI 10.1002/mc.22696
   Andrés V, 2014, ATHEROSCLEROSIS, V236, P444, DOI 10.1016/j.atherosclerosis.2014.07.031
   Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Clemente MG, 2016, WORLD J GASTROENTERO, V22, P8078, DOI 10.3748/wjg.v22.i36.8078
   Di Naso F, 2015, OBESITY, V23, P120, DOI 10.1002/oby.20919
   Ding L, 2017, MOL MED REP, V16, P9521, DOI 10.3892/mmr.2017.7789
   El-Sherbiny M, 2018, CHEM-BIOL INTERACT, V288, P65, DOI 10.1016/j.cbi.2018.04.010
   Eliades M, 2015, WORLD J GASTROENTERO, V21, P1718, DOI 10.3748/wjg.v21.i6.1718
   George N, 2012, BRIT J NUTR, V108, P1410, DOI 10.1017/S0007114511006830
   Gu ZF, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/134243
   Han YP, 2013, J GASTROEN HEPATOL, V28, P49, DOI 10.1111/jgh.12016
   Huang K, 2015, ENDOCR PRACT, V21, P1117, DOI 10.4158/EP15694.OR
   Iser D, 2013, AUST FAM PHYSICIAN, V42, P444
   Kenneally S, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000139
   Lu'o'ng KVQ, 2013, THER ADV RESPIR DIS, V7, P327, DOI 10.1177/1753465813503029
   Luong KVQ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-89
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639
   Kong M, 2014, AM J PHYSIOL-GASTR L, V307, pG883, DOI 10.1152/ajpgi.00427.2013
   Lebovics E, 2011, DIABETES-METAB RES, V27, P419, DOI 10.1002/dmrr.1198
   Li MX, 2017, LIFE SCI, V179, P88, DOI 10.1016/j.lfs.2017.04.021
   Linden MA, 2016, J PHYSIOL-LONDON, V594, P5271, DOI 10.1113/JP272235
   Maund SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081367
   Momtaz S, 2019, J CELL BIOCHEM, V120, P6209, DOI 10.1002/jcb.27909
   Muzaffar R, 2011, J NUCL MED, V52, P1408, DOI 10.2967/jnumed.111.091264
   Rinella ME, 2016, NAT REV GASTRO HEPAT, V13, P196, DOI 10.1038/nrgastro.2016.3
   Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737
   Ryz NR, 2012, AM J PHYSIOL-GASTR L, V303, pG1299, DOI 10.1152/ajpgi.00320.2012
   Seif AA, 2014, J PHYSIOL BIOCHEM, V70, P659, DOI 10.1007/s13105-014-0335-2
   Shany S, 2016, ANTICANCER RES, V36, P6225, DOI 10.21873/anticanres.11216
   Sharifi N, 2014, ENDOCRINE, V47, P70, DOI 10.1007/s12020-014-0336-5
   Sherif ZA, 2016, DIGEST DIS SCI, V61, P1214, DOI 10.1007/s10620-016-4143-0
   Su YB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194867
   Tarcin O, 2009, J CLIN ENDOCR METAB, V94, P4023, DOI 10.1210/jc.2008-1212
   Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3
   Trépo E, 2013, J HEPATOL, V59, P344, DOI 10.1016/j.jhep.2013.03.024
   Trovato FM, 2018, HISTOL HISTOPATHOL, V33, P1201, DOI 10.14670/HH-18-008
   Vanderschueren D, 2013, J CLIN ENDOCR METAB, V98, P995, DOI 10.1210/jc.2012-2772
   Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444
   Wu T, 2014, ANN CLIN LAB SCI, V44, P410
   Zhang PH, 2016, ORGANOGENESIS, V12, P143, DOI 10.1080/15476278.2016.1194148
   Zhou Z, 2017, CELL PROLIF, V50, DOI [10.1111/cpr.17319, DOI 10.1111/CPR.17319]
   Zhu CG, 2017, ENDOCR J, V64, P663, DOI 10.1507/endocrj.ej16-0542
   Zhu T, 2015, INT J MOL MED, V35, P1213, DOI 10.3892/ijmm.2015.2150
NR 46
TC 18
Z9 19
U1 0
U2 7
PU ELSEVIER MASSON, CORP OFF
PI PARIS
PA 65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE
SN 2210-7401
EI 2210-741X
J9 CLIN RES HEPATOL GAS
JI Clin. Res. Hepatol. Gastroenterol.
PD SEP
PY 2020
VL 44
IS 4
BP 513
EP 523
DI 10.1016/j.clinre.2019.10.007
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA NN2VP
UT WOS:000568651300030
PM 31810868
DA 2024-02-19
ER

PT J
AU Okatani, Y
   Wakatsuki, A
   Reiter, RJ
   Miyahara, Y
AF Okatani, Y
   Wakatsuki, A
   Reiter, RJ
   Miyahara, Y
TI Acutely administered melatonin restores hepatic mitochondrial physiology
   in old mice
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE aging; mitochondria; senescence-accelerated mice; free radical;
   respiratory chain; antioxidants
ID CENTRAL-NERVOUS-SYSTEM; SENESCENCE-ACCELERATED MOUSE; MICROSOMAL
   MEMBRANE FLUIDITY; FREE-RADICAL THEORY; FETAL-RAT BRAIN; OXIDATIVE
   DAMAGE; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE;
   LIPID-PEROXIDATION; RESPIRATORY-CHAIN
AB Damage to mitochondria as a result of the intrinsic generation of free radicals is theoretically involved in the processes of cellular aging. Herein, we investigated whether acutely administered melatonin, due to its free radical scavenging activity, would influence mitochondrial metabolism. Mitochondrial respiratory activity and respiratory chain complex I and IV activities in liver mitochondria from a strain of senescence-accelerated-prone mice (SAMP8) and a strain of senescence-accelerated-resistant mice (SAMR 1) were measured when the animals were 12 months of age. Respiratory control index (RCI), ADP/O ratio, State 3 respiration and dinitrophenol (DNP)-dependent uncoupled respiration were significantly lower in SAMP8 than in SAMR1. In contrast, State 4 respiration was significantly higher in SAMP8 than in SAMR1. Activities of complexes I and IV in SAMP8 were significantly lower than in SAMR1. Melatonin administration (10mg/kg body weight, intraperitoneally) 1 h prior to sacrifice significantly increased RCI, ADP/O ratio, State 3 respiration and DNP-induced uncoupled respiration in SAMP8 while also significantly reducing State 4 respiration in SAMP8. The injection of melatonin also significantly increased complex I activity in both mouse strains and complex IV activity in the liver of SAMP8 mice. These results document an age-related decrease in hepatic mitochondrial function in SAM which can be modified by an acute pharmacological injection of melatonin; the indole stimulated mitochondrial respiratory chain activity which would likely reduce deteriorative oxidative changes in mitochondria that normally occur in advanced age. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Kochi Med Sch, Dept Clin Nursing Sci, Nanko Ku, Kochi 7838505, Japan.
   Kochi Med Sch, Dept Obstet & Gynecol, Nanko Ku, Kochi 7838505, Japan.
   Univ Texas, Ctr Hlth Sci, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
C3 Kochi University; Kochi University; University of Texas System;
   University of Texas Health Science Center at San Antonio
RP Okatani, Y (corresponding author), Kochi Med Sch, Dept Clin Nursing Sci, Nanko Ku, Kochi 7838505, Japan.
CR Absi E, 2000, J PINEAL RES, V29, P40, DOI 10.1034/j.1600-079X.2000.290106.x
   Acuña-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165
   BARLOWWALDEN LR, 1995, NEUROCHEM INT, V26, P497, DOI 10.1016/0197-0186(94)00154-M
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8
   Ceraulo L, 1999, J PINEAL RES, V26, P108, DOI 10.1111/j.1600-079X.1999.tb00570.x
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   EDAMATSU R, 1995, BIOCHEM BIOPH RES CO, V211, P847, DOI 10.1006/bbrc.1995.1889
   FLOYD RA, 1993, TOXICOL IND HEALTH, V9, P197, DOI 10.1177/0748233793009001-214
   Garcia JJ, 1997, FEBS LETT, V408, P297, DOI 10.1016/S0014-5793(97)00447-X
   García JJ, 1998, J MEMBRANE BIOL, V162, P59, DOI 10.1007/s002329900342
   Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HOGEBOOM GH, 1955, METHOD ENZYMOL, V1, P16, DOI 10.1016/0076-6879(55)01007-0
   HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P253, DOI 10.1016/0892-0362(92)90004-T
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   LIVERA MA, 1997, FREE RADICAL BIO MED, V23, P706
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maestroni GJM, 2001, EXPERT OPIN INV DRUG, V10, P467, DOI 10.1517/13543784.10.3.467
   Martín M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   MORENOSANCHEZ R, 1991, BIOCHEM PHARMACOL, V41, P1479, DOI 10.1016/0006-2952(91)90564-L
   Morioka N, 1999, J PINEAL RES, V27, P202, DOI 10.1111/j.1600-079X.1999.tb00616.x
   NAKAHARA H, 1994, FREE RADICAL BIO MED, V16, P621
   Okatani Y, 2000, J PINEAL RES, V28, P89, DOI 10.1034/j.1600-079X.2001.280204.x
   Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x
   Okatani Y, 2002, NEUROBIOL AGING, V23, P639, DOI 10.1016/S0197-4580(02)00005-2
   Pablos M.I., 1997, NEUROENDOCRINOL LETT, V18, P49
   Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5
   Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360
   Reiter RJ, 1999, MECH AGEING DEV, V110, P157, DOI 10.1016/S0047-6374(99)00058-5
   Reiter RJ, 2001, ANN NY ACAD SCI, V939, P200
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237
   Reiter RJ., 2000, CURR TOP BIOPHYS, V24, P171
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tan DX, 2000, BIOL SIGNAL RECEPT, V9, P137
   Tesoriere L, 2001, J PINEAL RES, V31, P114, DOI 10.1034/j.1600-079x.2001.310204.x
   Turjanski AG, 2001, J PINEAL RES, V31, P97, DOI 10.1034/j.1600-079x.2001.310201.x
   Wakatsuki A, 2001, J PINEAL RES, V31, P167, DOI 10.1034/j.1600-079x.2001.310211.x
NR 46
TC 44
Z9 52
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD MAR
PY 2003
VL 35
IS 3
BP 367
EP 375
AR PII S1357-2725(02)00260-1
DI 10.1016/S1357-2725(02)00260-1
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 644FC
UT WOS:000180906400015
PM 12531250
DA 2024-02-19
ER

PT J
AU Myasoedova, KN
   Silachev, DN
   Petrov, AD
AF Myasoedova, K. N.
   Silachev, D. N.
   Petrov, A. D.
TI 10-(6'-Plastoquinonyl)decyltriphenylphosphonium (SkQ1) does not increase
   the level of cytochromes <i>P450</i> in rat liver and human hepatocyte
   cell culture
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE cytochrome P450; SkQ1; mitochondria-targeted antioxidant; hepatocyte
   culture
ID METABOLISM; SENESCENCE; EFFICACY; SAFETY
AB Mitochondria-targeted antioxidant SkQ1 did not increase the content of cytochromes P450 in livers of rats that were given SkQ1 in drinking water for 5 days in a dose (2.5 mu mol per kg body weight) that exceeded 10 times the SkQ1 therapeutic dose. SkQ1 did not affect the levels of cytochrome P450 forms CYP1A2, CYP2B6, and CYP3A4 in monolayer cultures of freshly isolated human hepatocytes, while specific inducers of these forms (omeprazole, phenobarbital, and rifampicin, respectively) significantly increased expression of the cytochromes P450 under the same conditions. We conclude that therapeutic doses of SkQ1 do not induce cytochromes P450 in liver, and the absence of the inducing effect cannot be explained by poor availability of hepatocytes to SkQ1 in vivo.
C1 [Myasoedova, K. N.] Lomonosov Moscow State Univ, Fac Fundamental Med, Moscow 119991, Russia.
   [Myasoedova, K. N.; Silachev, D. N.] Lomonosov Moscow State Univ, Inst Mitoengn, Moscow 119991, Russia.
   [Silachev, D. N.] Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow 119991, Russia.
   [Petrov, A. D.] Mitotech SA, 42 Rue Vallee, L-2661 Luxembourg, Luxembourg.
C3 Lomonosov Moscow State University; Lomonosov Moscow State University;
   Lomonosov Moscow State University
RP Myasoedova, KN (corresponding author), Lomonosov Moscow State Univ, Fac Fundamental Med, Moscow 119991, Russia.; Myasoedova, KN (corresponding author), Lomonosov Moscow State Univ, Inst Mitoengn, Moscow 119991, Russia.
EM skulach@belozersky.msu.ru; antonp@mitotechpharma.com
RI Silachev, Denis N/C-9464-2012; Silachev, Denis/ABE-8515-2020
OI Silachev, Denis/0000-0003-0581-9755
CR Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018
   Brzheskiy VV, 2015, ADV THER, V32, P1263, DOI 10.1007/s12325-015-0273-6
   Coon MJ, 2002, J BIOL CHEM, V277, P28351, DOI 10.1074/jbc.R200015200
   Dawson R.M.C, 1986, Data for biochemical research
   Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103
   Furge LL, 2006, BIOCHEM MOL BIOL EDU, V34, P66, DOI 10.1002/bmb.2006.49403402066
   Guengerich FP, 2006, P NATL ACAD SCI USA, V103, P13565, DOI 10.1073/pnas.0606333103
   Guguen-Guillouzo C., 1986, ISOLATED CULTURED HE, P1
   LANFORD RE, 1989, IN VITRO CELL DEV B, V25, P174
   Lyakhovich V. V., 1981, INDUCTION XENOBIOTIC
   Myasoedova KN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P965, DOI 10.1134/S0006297908090022
   Myasoedova KN, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1626, DOI 10.1134/S0006297915120123
   Myasoedova KN, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1130, DOI 10.1134/S0006297914100149
   Neroev VV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1317, DOI 10.1134/S0006297908120043
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Petrov A, 2016, ADV THER, V33, P96, DOI 10.1007/s12325-015-0274-5
   Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107
   Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Skulachev VP, 2013, PRINCIPLES BIOENERGE
   Yani E. V., 2012, PRAKT MED, V1, P134
NR 21
TC 0
Z9 0
U1 0
U2 1
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 0320-9725
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD DEC
PY 2016
VL 81
IS 12
BP 1488
EP 1491
DI 10.1134/S0006297916120105
PG 4
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA EF1NZ
UT WOS:000390092900010
PM 28259126
DA 2024-02-19
ER

PT J
AU Yousefzadeh, MJ
   Wilkinson, JE
   Hughes, B
   Gadela, N
   Ladiges, WC
   Vo, N
   Niedernhofer, LJ
   Huffman, DM
   Robbins, PD
AF Yousefzadeh, Matthew J.
   Wilkinson, John E.
   Hughes, Brian
   Gadela, Namrata
   Ladiges, Warren C.
   Vo, Nam
   Niedernhofer, Laura J.
   Huffman, Derek M.
   Robbins, Paul D.
TI Heterochronic parabiosis regulates the extent of cellular senescence in
   multiple tissues
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Parabiosis; Cellular senescence; SASP; Geropathology; Aging
ID SECRETORY PHENOTYPE; COGNITIVE FUNCTION; CELLS; AGE; REJUVENATION;
   CLEARANCE; NEUROGENESIS; PATHOLOGY; BLOOD; WNT
AB An increase in the burden of senescent cells in tissues with age contributes to driving aging and the onset of age-related diseases. Genetic and pharmacologic elimination of senescent cells extends both health span and life span in mouse models. Heterochronic parabiosis in mice has been used to identify bloodborne, circulating pro- and anti-geronic factors able to drive or slow aging, respectively. However, whether factors in the circulation also regulate senescence is unknown. Here, we measured the expression of senescence and senescence-associated secretory phenotype (SASP) markers in multiple tissues from 4- to 18-month-old male mice that were either isochronically or heterochronically paired for 2 months. In heterochronic parabionts, the age-dependent increase in senescence and SASP marker expression was reduced in old mice exposed to a young environment, while senescence markers were concurrently increased in young heterochronic parabionts. These findings were supported by geropathology analysis using the Geropathology Grading Platform that showed a trend toward reduced hepatic lesions in old heterochronic parabionts. In summary, these results demonstrate that senescence is regulated in part by circulating geronic factors and suggest that one of the possible mediators of the rejuvenating effects with heterochronic parabiosis is through the reduction of the senescent cell burden.
C1 [Yousefzadeh, Matthew J.; Hughes, Brian; Niedernhofer, Laura J.; Robbins, Paul D.] Univ Minnesota, Inst Biol Aging & Metab, Minneapolis, MN 55455 USA.
   [Yousefzadeh, Matthew J.; Hughes, Brian; Niedernhofer, Laura J.; Robbins, Paul D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.
   [Yousefzadeh, Matthew J.; Gadela, Namrata; Niedernhofer, Laura J.; Robbins, Paul D.] Scripps Res, Dept Mol Med, Jupiter, FL 33458 USA.
   [Yousefzadeh, Matthew J.; Gadela, Namrata; Niedernhofer, Laura J.; Robbins, Paul D.] Scripps Res, Ctr Aging, Jupiter, FL 33458 USA.
   [Wilkinson, John E.; Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.
   [Vo, Nam] Univ Pittsburgh, Pittsburgh, PA 15213 USA.
   [Huffman, Derek M.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.
   [Huffman, Derek M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.
   [Huffman, Derek M.] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities;
   State University System of Florida; University of Florida; Herbert
   Wertheim UF Scripps Institute for Biomedical Innovation & Technology;
   State University System of Florida; University of Florida; Herbert
   Wertheim UF Scripps Institute for Biomedical Innovation & Technology;
   University of Washington; University of Washington Seattle; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Yeshiva University; Albert Einstein College of Medicine;
   Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine
RP Robbins, PD (corresponding author), Scripps Res, Dept Mol Med, Jupiter, FL 33458 USA.; Robbins, PD (corresponding author), Scripps Res, Ctr Aging, Jupiter, FL 33458 USA.; Huffman, DM (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.; Huffman, DM (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.; Huffman, DM (corresponding author), Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA.
EM derek.huffman@einsteinmed.org; probbins@umn.edu
RI Wilkinson, John/JTV-0835-2023
FU American Federation for Aging Research; Einstein Nathan Shock Center
   [P30 AG038072]; Einstein Cancer Center [P30 CA013330]; The Irene Diamond
   Fund/American Federation on Aging Research Postdoctoral Transition
   Award;  [R21 AG055026];  [R01 AG044376];  [U19 AG056278];  [PO1
   AG043376];  [R01 AG063543];  [R56 AG059676];  [R56 AG4059675];  [P01
   AG062412]
FX This work was supported by R21 AG055026 (DMH), R01 AG044376 (NV), U19
   AG056278 (LJN, WCL, PDR), PO1 AG043376 (PDR, LJN), R01 AG063543 (LJN),
   R56 AG059676 (LJN), R56 AG4059675 (PDR), P01 AG062412 (PDR, LJN) and the
   American Federation for Aging Research (DMH), as well as the Einstein
   Nathan Shock Center (P30 AG038072) and Einstein Cancer Center (P30
   CA013330). MJY is supported by The Irene Diamond Fund/American
   Federation on Aging Research Postdoctoral Transition Award. The authors
   would like to thank Mariah Witt for editing the manuscript.
CR Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045
   Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x
   Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2015, AGING-US, V7, P754, DOI 10.18632/aging.100819
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Csipo T, 2020, GEROSCIENCE, V42, P51, DOI 10.1007/s11357-019-00140-9
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Haque S, 2020, GEROSCIENCE, V42, P183, DOI 10.1007/s11357-019-00120-z
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Khan SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39501
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Ladiges W, 2017, J GERONTOL A-BIOL, V72, P760, DOI 10.1093/gerona/glx019
   Ladiges W, 2016, PATHOBIOL AGING AGE, V6, DOI 10.3402/pba.v6.31478
   Ladiges W, 2016, J GERONTOL A-BIOL, V71, P431, DOI 10.1093/gerona/glv079
   Lawrence I, 2018, GEROSCIENCE, V40, P193, DOI 10.1007/s11357-018-0015-1
   LeBrasseur NK, 2015, NESTLE NUTR WORKS SE, V83, P11, DOI 10.1159/000382054
   Lewis KN, 2018, GEROSCIENCE, V40, P105, DOI 10.1007/s11357-018-0014-2
   Liendl L, 2020, GEROSCIENCE, V42, P377, DOI 10.1007/s11357-019-00053-7
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Patil P, 2019, AGING CELL, V18, DOI 10.1111/acel.12927
   Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Waaijer MEC, 2012, AGING CELL, V11, P722, DOI 10.1111/j.1474-9726.2012.00837.x
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Yousef H, 2015, ONCOTARGET, V6, P11959, DOI 10.18632/oncotarget.3851
   Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094
   Yousefzadeh MJ, 2019, METHODS MOL BIOL, V1896, P203, DOI 10.1007/978-1-4939-8931-7_17
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Yousefzadeh MJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12706
   Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 56
TC 43
Z9 46
U1 3
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2020 JUN
PY 2020
VL 42
IS 3
SI SI
BP 951
EP 961
DI 10.1007/s11357-020-00185-1
EA APR 2020
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA LX9MV
UT WOS:000527665900002
PM 32285290
OA Green Published
DA 2024-02-19
ER

PT J
AU Lavery, LW
   Goyns, MH
AF Lavery, LW
   Goyns, MH
TI Decline in the expression of C4 binding protein alpha-chain gene during
   ageing of the rat liver
SO BIOGERONTOLOGY
LA English
DT Article
DE ageing; C4BP; gene expression; liver
ID HUMAN C4B-BINDING PROTEIN; DIFFERENTIAL DISPLAY ANALYSIS;
   NON-HODGKINS-LYMPHOMAS; ACUTE-PHASE PROTEIN; AGING BRAIN; PATTERNS;
   CELLS; COMPLEMENT; COMPONENT; PROFILE
AB It appears that consistent changes in the levels of activity of a small cohort of genes (probably less than 1% of all active genes) occur in all mammalian cells during ageing. We have studied this phenomenon in rat liver using an optimised form of differential display. During this investigation we observed one gene which exhibited a decline in expression in livers from young adult (6 months) to aged adult (24 months) animals. The differential expression of this gene was confirmed by single strand conformational polymorphism( SSCP) gel analysis and Northern blotting. Densitometry of the latter indicated that there was a decline of 35% in its expression with age. Characterisation of the isolated PCR fragment demonstrated it to code for the alpha subchain of the complement 4 binding protein (C4BP). The C4BP is a key regulatory protein of the complement system and this observation therefore indicates that a decline in the efficiency of the complement system may be an important factor in the overall decline in immune function that has been observed during ageing.
C1 Univ Sunderland, Sch Sci, Sunderland SR2 3SD, England.
C3 University of Sunderland
RP Goyns, MH (corresponding author), Univ Sunderland, Sch Sci, Fleming Bldg,Wharncliffe St, Sunderland SR2 3SD, England.
CR Ausubel FM., 1993, Current Protocols in Molecular Biology
   BARNUM SR, 1990, COMPLEMENT INFLAMMAT, V7, P71, DOI 10.1159/000463131
   BARNUM SR, 1991, IMMUNOL RES, V10, P28, DOI 10.1007/BF02918165
   BILDER GE, 1975, J GERONTOL, V30, P641, DOI 10.1093/geronj/30.6.641
   Carter D, 1999, LEUKEMIA LYMPHOMA, V33, P343, DOI 10.3109/10428199909058434
   Charlton MA, 1999, CANCER LETT, V143, P45, DOI 10.1016/S0304-3835(99)00173-1
   DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847
   DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950
   GARCIA OC, 1995, J IMMUNOL, V155, P4037
   GARDNER ID, 1977, INFECT IMMUN, V16, P593, DOI 10.1128/IAI.16.2.593-598.1977
   Goyns MH, 1998, MECH AGEING DEV, V101, P73, DOI 10.1016/S0047-6374(97)00166-8
   Grierson AJ, 1996, LEUKEMIA LYMPHOMA, V23, P353, DOI 10.3109/10428199609054839
   HESSING M, 1990, J IMMUNOL, V144, P2632
   HIROKAWA K, 1988, ARCH PATHOL LAB MED, V112, P13
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   MAKINODAN T, 1962, P NATL ACAD SCI USA, V48, P234, DOI 10.1073/pnas.48.2.234
   MERRY BJ, 1994, PHYSL BASIS AGING GE, P285
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   PEPYS MB, 1997, INT J EXP CLIN INVES, V4, P274
   PETERSON WJ, 1972, CLIN EXP IMMUNOL, V12, P273
   PISCIOTT.AV, 1967, NATURE, V215, P193, DOI 10.1038/215193a0
   RADL J, 1973, IMMUNOLOGY, V112, P2271
   SAEKI T, 1989, BIOCHEM BIOPH RES CO, V164, P1446, DOI 10.1016/0006-291X(89)91832-9
   Salehi M, 1996, EXPERIENTIA, V52, P888, DOI 10.1007/BF01938876
   Salehi M, 1999, MECH AGEING DEV, V107, P61, DOI 10.1016/S0047-6374(98)00137-7
   SCHARFSTEIN J, 1978, J EXP MED, V148, P207, DOI 10.1084/jem.148.1.207
   Sheerin A, 2001, MECH AGEING DEV, V122, P1813, DOI 10.1016/S0047-6374(01)00319-0
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E
   Van Remmen Holly, 1995, P171
   VILLIERS M, 1981, FEBS LETT, V132, P49, DOI 10.1016/0014-5793(81)80425-5
   WELSH TR, 1986, J LAB CLIN MED, V107, P529
   ZACCARDI RJ, 1984, J BIOL CHEM, V259, P13674
NR 36
TC 7
Z9 7
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2002
VL 3
IS 4
BP 207
EP 211
DI 10.1023/A:1016251929165
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 572ZV
UT WOS:000176805600002
PM 12232502
DA 2024-02-19
ER

PT J
AU Khapre, RV
   Kondratova, AA
   Susova, O
   Kondratov, RV
AF Khapre, Rohini V.
   Kondratova, Anna A.
   Susova, Olga
   Kondratov, Roman V.
TI Circadian clock protein BMAL1 regulates cellular senescence in vivo
SO CELL CYCLE
LA English
DT Article
DE circadian clock; aging; senescence; oxidative stress; reactive oxygen
   species; cancer; anticancer drugs; DNA damage
ID DNA-DAMAGE RESPONSE; REPLICATIVE SENESCENCE; TUMOR SUPPRESSION;
   EXCISION-REPAIR; GENE; COMPONENT; RHYTHMS; DEFICIENCY; METABOLISM;
   FIBROBLAST
AB Deficiency of the circadian clock transcriptional factor BMAL1 results in the development of premature aging in mice. In agreement with the accelerated aging phenotype, we observed an increase in the number of senescent cells in different tissues (lungs, liver and spleen) of Bmal1(-/-) mice, which suggests the important role of BMAL1 in the control of senescence in vivo. However, no difference in the rate of proliferation and senescence between primary fibroblasts isolated from wildtype and Bmal1(-/-) mice has been detected, suggesting that BMAL1 does not play a significant role in replicative senescence in vitro. BMAL1-deficient fibroblasts had an increased sensitivity to hydrogen peroxide treatment and reduced sensitivity to DNA damaging anticancer drugs etoposide and daunorubicin. Increased sensitivity of Bmal1(-/-) cells to oxidative stress was p53-independent and correlated with the disrupted regulation of reactive oxygen species (ROS) homeostasis in BMAL1-deficient cells: indeed, circadian oscillations of ROS level can be induced in wild-type but not in Bmal1(-/-) cells. We propose that BMAL1 is important for the regulation of oxidative stress and DNA damage responses, while deregulation of these processes upon BMAL1 deficiency leads to development of stress induced senescence in vivo.
C1 [Khapre, Rohini V.; Susova, Olga; Kondratov, Roman V.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, BGES Dept, Cleveland, OH 44115 USA.
   [Kondratova, Anna A.] Cleveland State Univ, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44115 USA.
C3 University System of Ohio; Cleveland State University; Cleveland Clinic
   Foundation; University System of Ohio; Cleveland State University
RP Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, BGES Dept, Cleveland, OH 44115 USA.
EM r.kondratov@csuohio.edu
RI Susova, Olga/R-9570-2019
OI Susova, Olga/0000-0001-8192-7913; Kondratov, Roman/0000-0003-3449-745X
FU AHA [0835155N]; NIH [1R03AG033881]
FX We thank William Samsa for editorial help. This work was supported by
   AHA grant 0835155N to and NIH grants 1R03AG033881 R.V.K.
CR Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477
   Antoch MP, 2008, CELL CYCLE, V7, P1197, DOI 10.4161/cc.7.9.5886
   Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X
   Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027
   Bauer J, 2010, AGING-US, V2, P298, DOI 10.18632/aging.100146
   Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965
   Blagosklonny MV, 2010, CELL CYCLE, V9, P3151, DOI 10.4161/cc.9.16.13120
   Borgs L, 2009, CELL CYCLE, V8, P832, DOI 10.4161/cc.8.6.7869
   Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dubrovsky YV, 2010, AGING-US, V2, P936, DOI 10.18632/aging.100241
   Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO;2-1
   Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3
   Gachon F, 2010, AGING-US, V2, P101, DOI 10.18632/aging.100123
   Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564
   Gery S, 2010, CELL CYCLE, V9, P1097, DOI 10.4161/cc.9.6.11046
   Geyfman M, 2010, AGING-US, V2, P122, DOI 10.18632/aging.100130
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102
   Gréchez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200
   Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022
   Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001
   Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474
   HRUSHESKY WJM, 1985, SCIENCE, V228, P73, DOI 10.1126/science.3883493
   Kang TH, 2009, CELL CYCLE, V8, P1665, DOI 10.4161/cc.8.11.8707
   Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106
   Khapre RV, 2010, ANN MED, V42, P404, DOI 10.3109/07853890.2010.499134
   Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207
   Kondratov RV, 2007, AGEING RES REV, V6, P12, DOI 10.1016/j.arr.2007.02.003
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113
   Krishnan N, 2009, AGING-US, V1, P937, DOI 10.18632/aging.100103
   Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573
   Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104
   Mullenders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004798
   Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309
   Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005
   Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Young ME, 2007, SLEEP MED, V8, P656, DOI 10.1016/j.sleep.2006.12.010
   Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323
   Zhdanova IV, 2011, REV NEUROSCIENCE, V22, P27, DOI 10.1515/RNS.2011.005
NR 52
TC 99
Z9 115
U1 0
U2 18
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD DEC 1
PY 2011
VL 10
IS 23
BP 4162
EP 4169
DI 10.4161/cc.10.23.18381
PG 8
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 863IT
UT WOS:000298156700028
PM 22101268
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Hasegawa, G
AF Hasegawa, Goji
TI Decreased senescence marker protein-30 could be a factor that
   contributes to the worsening of glucose tolerance in normal aging
SO ISLETS
LA English
DT Article
DE aging; diabetes; insulin; senescence marker protein-30; knockout mice;
   high fat diet
ID SMP30/GNL KNOCKOUT MICE; BETA-CELL FUNCTION; OXIDATIVE STRESS; LIVER;
   DEFICIENCY; APOPTOSIS; BRAIN; MOUSE; FAS
AB In our recent paper, we proposed that senescence marker protein-30 (SMP30) could be a novel molecule which was involved in an impairment of beta-cell function with aging. SMP30 knockout (KO) mice and wild-type (WT) mice were fed a standard diet (SD) or a high fat diet (HFD) for 8 weeks from 7 weeks of age. In an intraperitoneal glucose tolerance test at 15 weeks of age, blood glucose levels in SD-fed KO mice were significantly increased by 25% at 30 min after glucose administration compared to SD-fed WT mice. Insulin levels in SD-fed KO mice were significantly decreased by 37% at 30 min postglucose compared to SD-fed WT mice. Interestingly, an insulin tolerance test showed a greater glucose lowering effect in SD-fed KO mice. Morphometric analysis revealed no differences in the degree of HFD-induced compensatory increase in beta-cell mass and proliferation. Collectively, these data indicate that impairment of the early phase of insulin secretion underlies glucose intolerance in KO mice. Decreased SMP30 may contribute to the worsening of glucose tolerance that occurs in normal aging.
C1 [Hasegawa, Goji] Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Grad Sch Med Sci, Kyoto, Japan.
C3 Kyoto Prefectural University of Medicine
RP Hasegawa, G (corresponding author), Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Grad Sch Med Sci, Kyoto, Japan.
EM goji@koto.kpu-m.ac.jp
CR Chang AM, 2006, J CLIN ENDOCR METAB, V91, P3303, DOI 10.1210/jc.2006-0913
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443
NR 17
TC 10
Z9 15
U1 0
U2 0
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1938-2014
J9 ISLETS
JI Islets
PD JUL-AUG
PY 2010
VL 2
IS 4
BP 258
EP 260
DI 10.4161/isl.2.4.12157
PG 3
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 752JW
UT WOS:000289688400008
PM 21099321
OA Bronze
DA 2024-02-19
ER

PT J
AU Jeon, OH
   Mehdipour, M
   Gil, TH
   Kang, MH
   Aguirre, NW
   Robinson, ZR
   Kato, C
   Etienne, J
   Lee, HG
   Alimirah, F
   Walavalkar, V
   Desprez, PY
   Conboy, MJ
   Campisi, J
   Conboy, IM
AF Jeon, Ok Hee
   Mehdipour, Melod
   Gil, Tae-Hwan
   Kang, Minha
   Aguirre, Nicholas W.
   Robinson, Zachery R.
   Kato, Cameron
   Etienne, Jessy
   Lee, Hyo Gyeong
   Alimirah, Fatouma
   Walavalkar, Vighnesh
   Desprez, Pierre-Yves
   Conboy, Michael J.
   Campisi, Judith
   Conboy, Irina M.
TI Systemic induction of senescence in young mice after single
   heterochronic blood exchange
SO NATURE METABOLISM
LA English
DT Article; Early Access
ID STEM-CELLS; NEUROGENESIS; REJUVENATION; METABOLISM; CLEARANCE; PATHWAY;
   MUSCLE; LIVER; OLD
AB Abstact Ageing is the largest risk factor for many chronic diseases. Studies of heterochronic parabiosis, substantiated by blood exchange and old plasma dilution, show that old-age-related factors are systemically propagated and have pro-geronic effects in young mice. However, the underlying mechanisms how bloodborne factors promote ageing remain largely unknown. Here, using heterochronic blood exchange in male mice, we show that aged mouse blood induces cell and tissue senescence in young animals after one single exchange. This induction of senescence is abrogated if old animals are treated with senolytic drugs before blood exchange, therefore attenuating the pro-geronic influence of old blood on young mice. Hence, cellular senescence is neither simply a response to stress and damage that increases with age, nor a chronological cell-intrinsic phenomenon. Instead, senescence quickly and robustly spreads to young mice from old blood. Clearing senescence cells that accumulate with age rejuvenates old circulating blood and improves the health of multiple tissues.
   A single transfer of blood from old male mice is shown to induce cellular and tissue senescence in young animals, unless old mice are treated with senolytic drugs before blood exchange.
C1 [Jeon, Ok Hee; Aguirre, Nicholas W.; Alimirah, Fatouma; Desprez, Pierre-Yves; Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA.
   [Jeon, Ok Hee; Gil, Tae-Hwan; Kang, Minha; Lee, Hyo Gyeong] Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea.
   [Mehdipour, Melod; Robinson, Zachery R.; Kato, Cameron; Etienne, Jessy; Conboy, Michael J.; Conboy, Irina M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Mehdipour, Melod; Robinson, Zachery R.; Kato, Cameron; Etienne, Jessy; Conboy, Michael J.; Conboy, Irina M.] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA.
   [Walavalkar, Vighnesh] Univ Calif San Francisco, Surg Pathol, San Francisco, CA 94143 USA.
   [Campisi, Judith] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
C3 Buck Institute for Research on Aging; Korea University; Korea University
   Medicine (KU Medicine); University of California System; University of
   California Berkeley; University of California System; University of
   California Berkeley; University of California System; University of
   California San Francisco; United States Department of Energy (DOE);
   Lawrence Berkeley National Laboratory
RP Jeon, OH; Campisi, J (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Jeon, OH (corresponding author), Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea.; Conboy, IM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Conboy, IM (corresponding author), Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA.; Campisi, J (corresponding author), Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
EM ojeon@korea.ac.kr; jcampisi@buckinstitute.org; iconboy@berkeley.edu
RI Jeon, Ok Hee/AAR-6270-2020
OI Jeon, Ok Hee/0000-0002-3725-7526; cho, junui/0000-0002-4883-7729;
   ETIENNE, Jessy/0000-0003-2173-6191; Kato, Cameron/0000-0002-8120-9345
FU Glenn Foundation for Medical Research; Korea University [K2006261,
   K2025261]; National Research Foundation of Korea Government [NRF
   2020R1C1C1009921]; NIH [T32 AG002266, P01 AG017242, R01 AG051729,
   1R01AG071787, R56 AG058819, R01 EB023776, R01 HL139605]; Pew Charitable
   Trust; Open Philanthropy Foundation; QB3 Calico Award;  [R56 AG052988
   SA23061]
FX We thank I. Silverstein for help with blood exchange procedures and T.
   Rando and a subaward from the Glenn Foundation for Medical Research for
   funding our early background work. This work was supported by a
   postdoctoral fellowship from the Glenn Foundation for Medical Research,
   Korea University grant nos. K2006261 and K2025261; the National Research
   Foundation of Korea Government grant nos. NRF 2020R1C1C1009921 (O.H.J.)
   and NIH T32 AG002266 (N.W.A.); the Pew Charitable Trust awarded to the
   Buck Institute for Research on Aging; by grants from the NIH nos. P01
   AG017242 and R01 AG051729 (J.C.); grant nos. NIH 1R01AG071787, R56
   AG058819, R01 EB023776, R01 HL139605, and the Open Philanthropy
   Foundation and the QB3 Calico Award (I.M.C.). A collaborative grant no.
   R56 AG052988 SA23061 (J.C. and I.M.C.) greatly aided these studies.
   Schematics of all experimental designs were created with BioRender.com.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067
   Cazin C, 2017, JOVE-J VIS EXP, DOI 10.3791/56201
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chang NC, 2018, CELL STEM CELL, V22, P755, DOI 10.1016/j.stem.2018.03.022
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Huang Q, 2018, J GERONTOL A-BIOL, V73, P421, DOI 10.1093/gerona/glx183
   Jeon OH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125019
   Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324
   Kaiping, 2008, ADIPOSE TISSUE PROTO
   Khrimian L, 2017, J EXP MED, V214, P2859, DOI 10.1084/jem.20171320
   Kishi S, 2019, J CLIN INVEST, V129, P4797, DOI 10.1172/JCI122313
   Lau A, 2019, J CLIN INVEST, V129, P4, DOI 10.1172/JCI123946
   Li L, 2018, SWISS MED WKLY, V148, DOI 10.4414/smw.2018.14607
   Li W, 2014, CIRC RES, V115, P997, DOI 10.1161/CIRCRESAHA.115.304591
   Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Mehdipour M, 2021, GEROSCIENCE, V43, P1, DOI 10.1007/s11357-020-00297-8
   Mehdipour M, 2020, AGING-US, V12, P8790, DOI 10.18632/aging.103418
   Mehdipour M, 2019, AGING-US, V11, P5628, DOI 10.18632/aging.102148
   Mehdipour M, 2018, SUBCELL BIOCHEM, V90, P119, DOI 10.1007/978-981-13-2835-0_5
   Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Petit C, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800447
   Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898
   Sousa-Victor P, 2019, NAT METAB, V1, P276, DOI 10.1038/s42255-018-0023-6
   Tang HY, 2019, PROTEIN CELL, V10, P370, DOI 10.1007/s13238-018-0591-y
   Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wan QL, 2019, AGING-US, V11, P3993, DOI 10.18632/aging.102033
   Wiley CD, 2017, AGING CELL, V16, P1043, DOI 10.1111/acel.12632
   Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yousef H, 2019, NAT MED, V25, P988, DOI 10.1038/s41591-019-0440-4
   Yousef H, 2015, ONCOTARGET, V6, P11959, DOI 10.18632/oncotarget.3851
   Zhu SS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221366
   Zhu Y, 2017, AGING-US, V9, P955, DOI 10.18632/aging.101202
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
NR 46
TC 33
Z9 33
U1 13
U2 50
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2522-5812
J9 NAT METAB
JI Nat. Metab.
PD 2022 AUG
PY 2022
VL 4
IS 8
BP 995
EP +
DI 10.1038/s42255-022-00609-6
EA JUL 2022
PG 29
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 4C8PS
UT WOS:000832498600001
PM 35902645
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Lin, PY
   Bai, YF
   Nian, XX
   Chi, J
   Chen, TZ
   Zhang, J
   Zhang, WP
   Zhou, B
   Liu, Y
   Zhao, Y
   Chi, J
   Chen, TZ
   Zhang, J
   Zhang, WP
   Zhou, B
AF Lin, Pengyan
   Bai, Yunfei
   Nian, Xinxin
   Chi, Jun
   Chen, Tianzhe
   Zhang, Jing
   Zhang, Wenpeng
   Zhou, Bin
   Liu, Yang
   Zhao, Yang
   Chi, Jun
   Chen, Tianzhe
   Zhang, Jing
   Zhang, Wenpeng
   Zhou, Bin
TI Chemically induced revitalization of damaged hepatocytes for
   regenerative liver repair
SO ISCIENCE
LA English
DT Article
ID TO-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; FIBROBLASTS; FIBROSIS;
   CELLS; MECHANISMS; STATE; MICE
AB In prolonged liver injury, hepatocytes undergo partial identity loss with decreased regenerative capacity, resulting in liver failure. Here, we identified a five compound (5C) combination that could restore hepatocyte identity and reverse the damage-associated phenotype (e.g., dysfunction, senescence, epithelial to mesenchymal transition, growth arrest, and pro-inflammatory gene expression) in damaged hepatocytes (dHeps) from CCl4-induced mice with chronic liver injury, resembling a direct chemical reprogramming approach. Systemic administration of 5C in mice with chronic liver injury promoted hepatocyte regener-ation, improved liver function, and ameliorated liver fibrosis. The hepatocyte-associated transcriptional networks were reestablished with chemical treatment as revealed by motif analysis of ATAC-seq, and a hepatocyte-enriched transcription factor, Foxa2, was found to be essential for hepatocyte revitalization. Overall, our findings indicate that the phenotype and transcriptional program of dHeps can be reprogrammed to generate functional and regenerative hepatocytes by using only small molecules, as an alter-native approach to liver repair and regeneration.
C1 [Lin, Pengyan; Bai, Yunfei; Liu, Yang; Zhao, Yang] Peking Univ, Beijing Key Lab Cardiometab Mol Med, State Key Lab Nat & Biomimet Drugs, Key Lab Cell Proliferat & Differentiat,Minist Educ, Beijing, Peoples R China.
   [Lin, Pengyan; Bai, Yunfei; Chi, Jun; Chen, Tianzhe; Zhang, Jing; Liu, Yang; Zhao, Yang; Chi, Jun; Chen, Tianzhe; Zhang, Jing] Plastech Pharmaceut Technol Co Ltd, Nanjing 210043, Peoples R China.
   [Nian, Xinxin; Zhao, Yang] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.
   [Zhang, Wenpeng; Zhang, Wenpeng] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing 100850, Peoples R China.
   [Zhou, Bin; Zhou, Bin] Chinese Acad Sci, Univ Chinese Acad Sci, Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Shanghai Inst Biochem & Ce, Shanghai, Peoples R China.
C3 Peking University; Peking University; Academy of Military Medical
   Sciences - China; Chinese Academy of Sciences; Center for Excellence in
   Molecular Cell Science, CAS; University of Chinese Academy of Sciences,
   CAS
RP Zhao, Y (corresponding author), Peking Univ, Beijing Key Lab Cardiometab Mol Med, State Key Lab Nat & Biomimet Drugs, Key Lab Cell Proliferat & Differentiat,Minist Educ, Beijing, Peoples R China.; Zhao, Y (corresponding author), Plastech Pharmaceut Technol Co Ltd, Nanjing 210043, Peoples R China.; Zhao, Y (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.
EM yangzhao@pku.edu.cn
RI bai, yunfei/IAM-5280-2023
OI bai, yunfei/0000-0003-4832-2888
FU National Key Research and Development Program of China [2018YFA0800504];
   National Natural Science Foundation of China [32170743, 31922020,
   31771645]; Nanjing Plastech Pharmaceutical Technology Co., Ltd.
FX We thank Xiaoxiao Ye, Dan Wang, Binbin Chen, Yonghu Zhu, Hui Xu, Qinyu
   Li, Yadong Zhuang, Yanni Huang, and colleagues in Nanjing Plastech
   Pharmaceutical Technology Co., Ltd for technical assistance. This work
   is supported by the National Key Research and Development Program of
   China (2018YFA0800504) , the National Natural Science Foundation of
   China (32170743, 31922020, and 31771645) , and funding from Nanjing
   Plastech Pharmaceutical Technology Co., Ltd. This study originated from
   and was inspired by a collaborative project between Peking University
   and Boehringer-Ingelheim Pharmaceutical International GmBH (BI) . During
   this joint project, Junqing Ye, Weiyi Zhang, and Michael Franti from BI,
   provided constructive advices in the design of chemical screening and
   hit identification. Schematic was created with biorender.com .
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Bai YF, 2023, HEPATOLOGY, V77, P1550, DOI 10.1002/hep.32686
   Bhushan B, 2014, AM J PATHOL, V184, P3013, DOI 10.1016/j.ajpath.2014.07.019
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807
   Brecklinghaus T, 2022, CHEM-BIOL INTERACT, V351, DOI 10.1016/j.cbi.2021.109728
   Chen F, 2020, CELL STEM CELL, V26, P27, DOI 10.1016/j.stem.2019.11.001
   Chen YP, 2021, SCIENCE, V373, P1537, DOI 10.1126/science.abg5159
   Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Filippov S, 2013, J LIPID RES, V54, P2095, DOI 10.1194/jlr.M035212
   Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97
   Gill D, 2022, ELIFE, V11, DOI 10.7554/eLife.71624
   He LJ, 2017, J CLIN INVEST, V127, P2968, DOI 10.1172/JCI93868
   Hishida T, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110730
   Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003
   Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116
   Joo MS, 2019, EBIOMEDICINE, V40, P488, DOI 10.1016/j.ebiom.2018.12.056
   Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200
   Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649
   Lehmann K, 2012, GASTROENTEROLOGY, V143, P1609, DOI 10.1053/j.gastro.2012.08.043
   Li WP, 2020, TRENDS CELL BIOL, V30, P329, DOI 10.1016/j.tcb.2020.01.007
   Loft A, 2021, CELL METAB, V33, P1685, DOI 10.1016/j.cmet.2021.06.005
   Lu YC, 2020, NATURE, V588, P124, DOI 10.1038/s41586-020-2975-4
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Nishikawa T, 2015, J CLIN INVEST, V125, P1533, DOI 10.1172/JCI73137
   Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263
   Sen B, 2019, CELL MOL GASTROENTER, V8, P73, DOI 10.1016/j.jcmgh.2019.03.001
   Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055
   Suda J, 2015, AM J PHYSIOL-GASTR L, V308, pG313, DOI 10.1152/ajpgi.00369.2014
   Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839
   Valdés F, 2002, MOL CANCER RES, V1, P68
   Wang C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23353-z
   Wang W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15831-6
   Xiang CG, 2019, SCIENCE, V364, P399, DOI 10.1126/science.aau7307
   Xie GH, 2013, AM J PHYSIOL-GASTR L, V305, pG881, DOI 10.1152/ajpgi.00289.2013
   Yang TH, 2021, J HEPATOL, V75, P1420, DOI 10.1016/j.jhep.2021.08.011
   Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 40
TC 0
Z9 0
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD DEC 15
PY 2023
VL 26
IS 12
AR 108532
DI 10.1016/j.isci.2023.108532
EA DEC 2023
PG 24
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DE4V9
UT WOS:001130350100001
PM 38144457
OA Green Accepted, gold
DA 2024-02-19
ER

PT J
AU Wan, Y
   Zhou, TH
   Slevin, E
   Koyama, S
   Li, XD
   Harrison, K
   Li, T
   Zhou, BR
   Lorenzo, SR
   Zhang, YD
   Xu, WJ
   Klaunig, JE
   Wu, CD
   Shetty, AK
   Huang, CK
   Meng, FY
AF Wan, Ying
   Zhou, Tianhao
   Slevin, Elise
   Koyama, Sachiko
   Li, Xuedong
   Harrison, Kelly
   Li, Tian
   Zhou, Bingru
   Lorenzo, Sugeily Ramos
   Zhang, Yudian
   Xu, Wenjuan
   Klaunig, James E.
   Wu, Chaodong
   Shetty, Ashok K.
   Huang, Chiung-Kuei
   Meng, Fanyin
TI Liver-specific deletion of microRNA-34a alleviates ductular reaction and
   liver fibrosis during experimental cholestasis
SO FASEB JOURNAL
LA English
DT Article
DE cellular senescence; cholestasis; ductular reaction; fibrosis; microRNA
ID CELLULAR SENESCENCE; MIR-34A; P53; EXPRESSION; PATHWAY; HEPATOCYTES;
   PHYSIOLOGY; OBESITY
AB Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by inflammatory responses and fibrotic scar formation leading to cholestasis. Ductular reaction and liver fibrosis are typical liver changes seen in human PSC and cholestasis patients. The current study aimed to clarify the role of liver-specific microRNA-34a in the cholestasis-associated ductular reaction and liver fibrosis. We demonstrated that miR-34a expression was significantly increased in human PSC livers along with the enhanced ductular reaction, cellular senescence, and liver fibrosis. A liver-specific miR-34a knockout mouse was established by crossing floxed miR-34a mice with albumin-promoter-driven Cre mice. Bile duct ligation (BDL) induced liver injury characterized by necrosis, fibrosis, and immune cell infiltration. In contrast, liver-specific miR-34a knockout in BDL mice resulted in decreased biliary ductular pathology associated with the reduced cholangiocyte senescence and fibrotic responses. The miR-34a-mediated ductular reactions may be functioning through Sirt-1-mediated senescence and fibrosis. The hepatocyte-derived conditioned medium promoted LPS-induced fibrotic responses and senescence in cholangiocytes, and miR-34a inhibitor suppressed these effects, further supporting the involvement of paracrine regulation. In conclusion, we demonstrated that liver-specific miR-34a plays an important role in ductular reaction and fibrotic responses in a BDL mouse model of cholestatic liver disease.
C1 [Wan, Ying; Li, Xuedong; Li, Tian; Zhou, Bingru; Zhang, Yudian] Southwest Med Univ, Sch Basic Med Sci, Dept Pathophysiol, Luzhou, Peoples R China.
   [Zhou, Tianhao; Slevin, Elise; Koyama, Sachiko; Xu, Wenjuan; Meng, Fanyin] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA.
   [Harrison, Kelly] Baylor Scott & White Mem Hosp, Dept Transplant Surg, Temple, TX USA.
   [Lorenzo, Sugeily Ramos] Penn State Univ World Campus, University Pk, PA USA.
   [Klaunig, James E.] Indiana Univ, Indiana Sch Publ Hlth, Dept Environm & Occupat Hlth, Lab Invest Toxicol & Pathol, Bloomington, IN USA.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA.
   [Shetty, Ashok K.] Inst Regenerat Med, Texas A&M Coll Med, Dept Mol & Cellular Med, College Stn, TX USA.
   [Huang, Chiung-Kuei] Tulane Univ Sch Med, Dept Pathol & Lab Med, New Orleans, LA USA.
   [Meng, Fanyin] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA.
   [Meng, Fanyin] Indiana Univ Sch Med, Indiana Ctr Liver Res, Richard L Roudebush VA Med Ctr, Dept Med, 702 Rotary Circle,Room 013, Indianapolis, IN 46202 USA.
   [Huang, Chiung-Kuei] Tulane Univ Sch Med, Dept Pathol, Lab Med, New Orleans, LA 70112 USA.
C3 Southwest Medical University; Indiana University System; Indiana
   University Bloomington; Baylor Health Care System; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Pennsylvania State
   University; Pennsylvania State University - University Park; Indiana
   University System; Indiana University Bloomington; Texas A&M University
   System; Texas A&M University College Station; Texas A&M University
   System; Texas A&M University College Station; Texas A&M Health Science
   Center; Tulane University; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Richard L. Roudebush VA Medical Center; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Richard L. Roudebush VA Medical Center; Indiana University System;
   Indiana University Bloomington; Tulane University
RP Meng, FY (corresponding author), Indiana Univ Sch Med, Indiana Ctr Liver Res, Richard L Roudebush VA Med Ctr, Dept Med, 702 Rotary Circle,Room 013, Indianapolis, IN 46202 USA.; Huang, CK (corresponding author), Tulane Univ Sch Med, Dept Pathol, Lab Med, New Orleans, LA 70112 USA.
EM chuang17@tulane.edu; mengf@iu.edu
RI li, xuedong/JYP-4367-2024; Shetty, Ashok/AAT-7273-2020
OI Shetty, Ashok/0000-0001-5049-6671; Koyama, Sachiko/0000-0002-6886-1961
FU HHS; NIH; National Institute on Alcohol Abuse and Alcoholism
FX HHS | NIH | National Institute on Alcohol Abuse and Alcoholism
CR Castro RE, 2013, J HEPATOL, V58, P119, DOI 10.1016/j.jhep.2012.08.008
   Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937
   Cui HC, 2017, AM J PHYSIOL-LUNG C, V312, pL415, DOI 10.1152/ajplung.00335.2016
   Cui HC, 2017, AM J RESP CELL MOL, V56, P168, DOI 10.1165/rcmb.2016-0163OC
   Daige CL, 2014, MOL CANCER THER, V13, P2352, DOI 10.1158/1535-7163.MCT-14-0209
   Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007
   Ding JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13729
   Fu T, 2014, MOL CELL BIOL, V34, P4130, DOI 10.1128/MCB.00596-14
   Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109
   He Y, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI141513
   Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710
   Iwagami Y, 2018, J CELL MOL MED, V22, P3987, DOI 10.1111/jcmm.13681
   Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172
   Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022
   Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957
   Krishnasamy Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163342
   Krstic J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030921
   Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003
   Lavery CA, 2016, OBESITY, V24, P1741, DOI 10.1002/oby.21561
   Lee SH, 2019, BMB REP, V52, P24, DOI 10.5483/BMBRep.2019.52.1.290
   Leon-Ponte M, 2005, IMMUNOL LETT, V96, P73, DOI 10.1016/j.imlet.2004.07.019
   Li M, 2018, FASEB J, V32, P500, DOI 10.1096/fj.201700612R
   Li XJ, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.152876
   Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nezami BG, 2014, GASTROENTEROLOGY, V146, P473, DOI 10.1053/j.gastro.2013.10.053
   Panasiuk A, 2006, WORLD J GASTROENTERO, V12, P6198, DOI 10.3748/wjg.v12.i38.6198
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Schueller F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010261
   Slabáková E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.495
   Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019
   Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104
   Tian XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158657
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wang XL, 2021, GUT, V70, P784, DOI 10.1136/gutjnl-2020-322526
   Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034
   Xiao FL, 2018, CELL BIOL INT, V42, P1370, DOI 10.1002/cbin.11022
   Xu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8466
   Yahagi N, 2004, J BIOL CHEM, V279, P20571, DOI 10.1074/jbc.M400884200
   Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105
   Zhang L, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1059-5
   Zhou N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22628
NR 43
TC 1
Z9 1
U1 2
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD FEB
PY 2023
VL 37
IS 2
AR e22731
DI 10.1096/fj.202201453R
PG 17
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 7L5DL
UT WOS:000905986100001
PM 36583714
DA 2024-02-19
ER

PT J
AU Diehl, AM
AF Diehl, AM
TI Recent Events in Alcoholic Liver Disease - V. Effects of ethanol on
   liver regeneration
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE cell senescence; progenitor cells; hepatocyte differentiation
ID NF-KAPPA-B; OXIDATIVE STRESS; MICE LACKING; STEM-CELLS; IN-VIVO; RAT;
   HEPATOCYTES; GLUTATHIONE; ACTIVATION; GROWTH
AB Liver regeneration is necessary to recover from alcoholic liver injury. Herein, we review evidence that ethanol interferes with liver regeneration. Briefly, alcoholic fatty livers demonstrate increased rates of hepatocyte death. The latter provides a regenerative stimulus. However, unlike mature hepatocytes in healthy adult livers, most surviving mature hepatocytes in alcoholic fatty livers cannot replicate. Therefore, less mature cells ( progenitors) must differentiate to replace dead hepatocytes. Little is known about the general mechanisms that modulate the differentiation of liver progenitors in adults. Delineation of these mechanisms and clarification of how ethanol influences them might suggest new therapies for alcoholic liver disease.
C1 Duke Univ, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.
C3 Duke University
RP Diehl, AM (corresponding author), Duke Univ, Dept Med, Div Gastroenterol, Genome Sci Res Bldg 1,Suite 1073,Box 3256, Durham, NC 27710 USA.
EM diehl004@mc.duke.edu
FU NIAAA NIH HHS [R0 AA-10154] Funding Source: Medline
CR [Anonymous], SCIENCE
   BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0
   Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200
   DEVI BG, 1993, HEPATOLOGY, V18, P648, DOI 10.1016/0270-9139(93)90367-V
   DIEHL AM, 1994, AM J PHYSIOL, V267, P552
   Gordon GJ, 2000, AM J PATHOL, V157, P771, DOI 10.1016/S0002-9440(10)64591-9
   Grompe M, 2003, MECH DEVELOP, V120, P99, DOI 10.1016/S0925-4773(02)00336-2
   Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487
   HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0
   Huang ZZ, 1998, HEPATOLOGY, V27, P147, DOI 10.1002/hep.510270123
   Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483
   Koteish A, 2002, ALCOHOL CLIN EXP RES, V26, P1710, DOI 10.1097/01.ALC.0000036923.77613.59
   Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200
   Ledda-Columbano GM, 1998, ONCOGENE, V17, P1039, DOI 10.1038/sj.onc.1202018
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lee FYJ, 1999, HEPATOLOGY, V29, P677, DOI 10.1002/hep.510290320
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819
   Rai RM, 1998, P NATL ACAD SCI USA, V95, P13829, DOI 10.1073/pnas.95.23.13829
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Thorgeirsson SS, 2003, SEMIN LIVER DIS, V23, P303
   Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev
   Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531
   Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100
   Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441
   Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837
NR 25
TC 39
Z9 45
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD JAN
PY 2005
VL 288
IS 1
BP G1
EP G6
DI 10.1152/ajpgi.00376.2004
PG 6
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 878PI
UT WOS:000225658500001
PM 15591584
DA 2024-02-19
ER

PT J
AU Chen, PH
   Chang, CH
   Lin, WS
   Nagabhushanam, K
   Ho, CT
   Pan, MH
AF Chen, Pin-Hua
   Chang, Chun-Han
   Lin, Wei-Sheng
   Nagabhushanam, Kalyanam
   Ho, Chi-Tang
   Pan, Min-Hsiung
TI <i>S</i>-Allylcysteine Ameliorates Aging Features via Regulating
   Mitochondrial Dynamics in Naturally Aged C57BL/6J Mice
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article; Early Access
DE aging; Caenorhabditis elegans; mitochondrial dynamics; naturally aged;
   S-allylcysteine (SAC)
ID BIOLOGICAL-PROPERTIES; OXIDATIVE STRESS; SENESCENT CELLS; OPEN-FIELD;
   LIFE-SPAN; HALLMARKS; FUSION; ATHEROSCLEROSIS; PROTECTS; CYSTEINE
AB Scope S-Allylcysteine (SAC) is the most abundant organosulfur molecule derived from aged garlic. The effects ofSAC on improving Aging in naturally aged C57BL/6J male mice and mitochondrial dynamics in Caenorhabditis elegans and its underlying mechanisms is evaluated. Methods and Results When mice have attained reproductive senescence at 60 weeks of age, SAC is supplemented to 0.05% and 0.2% into their normal diet for 12 weeks. The results show that SAC could significantly improve the level of hepatic optic atrophy 1 (OPA1) mRNA, which is a key factor for mitochondrial fusion, and consequently elevated the mitochondrial biogenesis-related proteins sirtuin 1 (SIRT1) and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), thus ameliorating oxidative stress, such as malondialdehyde (MDA) in the liver and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in urine. Among the biochemical markers of aging, SAC significantly reduces liver galactosidase beta 1 (GLB1) and senescence-associated beta-galactosidase (SA-beta gal), which are induced by replicative senescence. The mitochondria with green fluorescent protein (GFP)-tagged transgenic strain SJ4103 C. elegans is incubated with 5 or 50 mu M SAC, and SAC treated groups maintain the linear morphology of mitochondria. Conclusion SAC regulates mitochondrial dynamics and ameliorated aging to a significant degree. This study also confirms that mitochondrial dynamics are a promising target for screening materials to combat aging and as a direction for anti-aging product development.
C1 [Chen, Pin-Hua; Chang, Chun-Han; Lin, Wei-Sheng; Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.
   [Nagabhushanam, Kalyanam] Sabinsa Corp, 20 Lake Dr, East Windsor, NJ 08520 USA.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
   [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.
   [Pan, Min-Hsiung] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
C3 National Taiwan University; Rutgers University System; Rutgers
   University New Brunswick; China Medical University Taiwan; China Medical
   University Hospital - Taiwan; Asia University Taiwan
RP Pan, MH (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.; Pan, MH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.; Pan, MH (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
EM mhpan@ntu.edu.tw
RI Lin, Wei-Sheng/HKN-6627-2023; Pan, Min-Hsiung/AAT-8865-2021
OI Lin, Wei-Sheng/0000-0002-3606-8256; Pan, Min-Hsiung/0000-0002-5188-7030;
   Nagabhushanam, Kalyanam/0000-0001-9470-4110; Chang,
   Chun-Han/0000-0002-1920-1262
FU MOST [109-2320-B-002 -012 -MY3, 110-2320-B-002 -019 -MY3]
FX Y This study was supported by the MOST (109-2320-B-002 -012 -MY3,
   110-2320-B-002 -019 -MY3). The authors thank the Taiwan Animal
   Consortium, Taiwan Mouse Clinic, National Phenotyping Center, National
   Core Facility for Biopharmaceuticals.
CR Amano H, 2016, J NUTR, V146, p456S, DOI 10.3945/jn.114.201749
   Aunan JR, 2016, BRIT J SURG, V103, pE29, DOI 10.1002/bjs.10053
   Ben-Meir A, 2015, FERTIL STERIL, V104, P724, DOI 10.1016/j.fertnstert.2015.05.023
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chaudhari SN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00274-4
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Cho I, 2020, FOOD SCI NUTR, V8, P6633, DOI 10.1002/fsn3.1956
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Colín-González AL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/907162
   Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Corzo-Martínez M, 2007, TRENDS FOOD SCI TECH, V18, P609, DOI 10.1016/j.tifs.2007.07.011
   Crimmins EM, 2015, GERONTOLOGIST, V55, P901, DOI 10.1093/geront/gnv130
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Evans K, 2021, POSTGRAD MED, V133, P831, DOI 10.1080/00325481.2021.1942934
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Gibellini L, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/527209
   Gruber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019444
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Kandimalla R, 2016, HUM MOL GENET, V25, P4881, DOI 10.1093/hmg/ddw312
   Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591
   Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256
   Kodera Y, 2002, J AGR FOOD CHEM, V50, P622, DOI 10.1021/jf0106648
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lessard-Beaudoin M, 2015, EXP GERONTOL, V63, P27, DOI 10.1016/j.exger.2015.01.003
   Limdi JK, 2003, POSTGRAD MED J, V79, P307, DOI 10.1136/pmj.79.932.307
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Liu YJ, 2020, MECH AGEING DEV, V186, DOI 10.1016/j.mad.2020.111212
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma LN, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00009
   Michael B, 2007, TOXICOL PATHOL, V35, P742, DOI 10.1080/01926230701595292
   Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Noubissi A.A., SCI REP-UK, V11, P8945
   Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811
   Pérez-Severiano F, 2004, EUR J PHARMACOL, V489, P197, DOI 10.1016/j.ejphar.2004.03.001
   Ponti F, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00861
   Prieto J, 2016, CELL CYCLE, V15, P3240, DOI 10.1080/15384101.2016.1241930
   Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X
   Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Sarasija S, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2800
   Saravanan G, 2012, J DIABETES COMPLICAT, V26, P280, DOI 10.1016/j.jdiacomp.2012.03.024
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Seki M, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1306-1
   Sesso HD, 2005, ARCH INTERN MED, V165, P2420, DOI 10.1001/archinte.165.20.2420
   Shi HY, 2015, J NEUROCHEM, V133, P298, DOI 10.1111/jnc.12986
   Singhal G, 2020, BEHAV BRAIN RES, V383, DOI 10.1016/j.bbr.2020.112501
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111
   Sulston J., 1998, NEMATODE CAENORHABDI
   Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109
   Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x
   WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482
   Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
   Yuan YJ, 2016, MECH AGEING DEV, V155, P10, DOI 10.1016/j.mad.2016.02.003
   Zhang M, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1799-3
   Zhou BH, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138192
NR 65
TC 3
Z9 3
U1 4
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD 2022 APR
PY 2022
VL 66
IS 7
AR 2101077
DI 10.1002/mnfr.202101077
EA FEB 2022
PG 14
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 0F7AL
UT WOS:000753902800001
PM 35092643
DA 2024-02-19
ER

PT J
AU VOGT, BL
   RICHIE, JP
AF VOGT, BL
   RICHIE, JP
TI FASTING-INDUCED DEPLETION OF GLUTATHIONE IN THE AGING MOUSE
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
ID HEPATIC GLUTATHIONE; LIPID-PEROXIDATION; PROTECTIVE ROLE; LIFE-SPAN;
   RAT-LIVER; ACETAMINOPHEN; AGE; MOSQUITO; METABOLISM; CYSTEINE
AB Previous results indicate that aging is associated with a general deficiency of glutathione (GSH). As fasting is also known to lower hepatic GSH levels, we investigated the combined effects of aging and 24 hr of food deprivation on liver, kidney and blood GSH and cyst(e)ine levels in C57BL/6N mice of ages 6 (young), 12 (mature) and 24 (old) months. No age-related differences in baseline hepatic GSH were observed in these mice, consistent with previous findings where the deficiency in liver is not apparent until about 29 months of age. By 6 hr of fasting, an age-related reduction in hepatic GSH was evident, culminating in a 4-fold greater decrease during maturation, and a 5-fold greater decrease during aging (P < 0.001) compared to young animals. Liver weight also declined, decreasing total liver GSH content by 24% in young, 44% in mature, and 56% in old mice. Renal GSH and hepatic cyst(e)ine concentrations were unaffected by fasting. In young and mature mice, depletion of hepatic GSH was accompanied by a concomitant increase in blood GSH and kidney cyst(e)ine levels after 6 hr of fasting, suggesting enhancement of hepatic GSH efflux. However, in old animals, GSH depletion was associated with decreased blood GSH and kidney cyst(e)ine. Altogether, these results suggest that the stress of fasting reveals aging changes in hepatic GSH homeostasis occurring well before the GSH deficiency of aging is observed. These aging changes are likely due to decreased GSH turnover resulting from impaired biosynthesis.
C1 UNIV ARKANSAS MED SCI HOSP,DEPT INTERDISCIPLINARY TOXICOL,LITTLE ROCK,AR 72205.
C3 University of Arkansas System; University of Arkansas Medical Sciences
RP RICHIE, JP (corresponding author), AMER HLTH FDN,DIV NUTR CARCINGENESIS,1 DANA RD,VALHALLA,NY 10595, USA.
OI Richie, John/0000-0001-8239-2850
FU NIAAA NIH HHS [AA08479] Funding Source: Medline
CR ABRAHAM EC, 1978, BIOCHEM J, V174, P819, DOI 10.1042/bj1740819
   ANUNDI I, 1979, ACTA PHARMACOL TOX, V45, P45
   BECK LV, 1958, P SOC EXP BIOL MED, V97, P229
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   CHEN TS, 1990, DRUG METAB DISPOS, V18, P882
   COMFORT A, 1979, BIOL SENESCENCE
   GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627
   HARDING JJ, 1970, BIOCHEM J, V117, P957, DOI 10.1042/bj1170957
   HAYES MA, 1986, TOXICOL APPL PHARM, V85, P1, DOI 10.1016/0041-008X(86)90382-0
   HAZELTON GA, 1984, P SOC EXP BIOL MED, V176, P249
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HAZELTON GA, 1983, BIOCHEM J, V210, P289, DOI 10.1042/bj2100289
   Higashi T, 1983, Prog Clin Biol Res, V125, P419
   HUTCHINSON F, 1961, RADIAT RES, V14, P721, DOI 10.2307/3571013
   JAEGER RJ, 1974, EXP MOL PATHOL, V20, P187, DOI 10.1016/0014-4800(74)90053-7
   JAESCHKE H, 1985, BIOCHEM PHARMACOL, V34, P1029, DOI 10.1016/0006-2952(85)90606-9
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   KAPPUS H, 1991, MEMBRANE LIPID OXIDA, P103
   KETTERER B, 1988, MUTAT RES, V202, P343, DOI 10.1016/0027-5107(88)90197-2
   Lang C A, 1989, Prog Clin Biol Res, V287, P241
   LANG CA, 1992, J LAB CLIN MED, V120, P720
   LANGANIERE S, 1989, MECH AGEING DEV, V48, P221
   LAUTERBURG BH, 1980, J PHARMACOL EXP THER, V213, P54
   LAUTERBURG BH, 1981, J CLIN INVEST, V67, P1415, DOI 10.1172/JCI110170
   LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402
   MARRUYAMA E, 1968, J BIOCHEM-TOKYO, V63, P398
   MCINTYRE TM, 1980, INT J BIOCHEM, V12, P545, DOI 10.1016/0020-711X(80)90005-1
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211
   OOKHTENS M, 1987, BIOCHEM PHARMACOL, V36, P4015, DOI 10.1016/0006-2952(87)90473-4
   OOKHTENS M, 1985, J CLIN INVEST, V75, P258, DOI 10.1172/JCI111682
   OOKHTENS M, 1991, AM J PHYSL 1, V261, P6648
   OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705
   PESSAYRE D, 1979, GASTROENTEROLOGY, V77, P264
   PESSAYRE D, 1980, BIOCHEM PHARMACOL, V29, P2219, DOI 10.1016/0006-2952(80)90201-4
   RATHBUN WB, 1991, EXP EYE RES, V53, P205, DOI 10.1016/0014-4835(91)90075-P
   REED D J, 1984, Pharmacological Reviews, V36, p25S
   RICHIE JP, 1985, DRUG METAB DISPOS, V13, P14
   RICHIE JP, 1987, P SOC EXP BIOL MED, V184, P113
   RICHIE JP, 1988, P SOC EXP BIOL MED, V187, P235
   RICHIE JP, 1992, BIOCHEM PHARMACOL, V44, P129, DOI 10.1016/0006-2952(92)90046-L
   RICHIE JP, 1987, ANAL BIOCHEM, V163, P9, DOI 10.1016/0003-2697(87)90085-6
   RICHIE JP, 1991, POTENTIAL NUTRITIONA, P51
   RIKANS LE, 1989, LIFE SCI, V45, P1373, DOI 10.1016/0024-3205(89)90024-6
   RODRIGUEZ JV, 1987, CAN J PHYSIOL PHARM, V65, P84, DOI 10.1139/y87-016
   ROTHACKER DL, 1988, TOXICOL PATHOL, V16, P22, DOI 10.1177/019262338801600103
   SCHNELL RC, 1984, PHARMACOLOGY, V29, P149
   Snedecor G.W., 1980, STATISTICAL METHODS
   SOHAL RS, 1984, MECH AGEING DEV, V24, P185, DOI 10.1016/0047-6374(84)90070-8
   STRUBELT O, 1981, TOXICOL APPL PHARM, V60, P66, DOI 10.1016/0041-008X(81)90136-8
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   VINA JR, 1989, CRC HDB FREE RADICAL, V2, P121
   WHITE BP, 1987, TOXICOL LETT, V35, P217, DOI 10.1016/0378-4274(87)90209-8
   YOUNES M, 1980, RES COMMUN CHEM PATH, V27, P119
NR 55
TC 60
Z9 62
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD JUL 20
PY 1993
VL 46
IS 2
BP 257
EP 263
DI 10.1016/0006-2952(93)90412-P
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA LP958
UT WOS:A1993LP95800009
PM 8347148
DA 2024-02-19
ER

PT J
AU Chen, JN
   Zou, Q
   Lv, DJ
   Raza, MA
   Wang, X
   Chen, Y
   Xi, XY
   Li, PL
   Wen, AX
   Zhu, L
   Tang, GQ
   Li, MZ
   Li, XW
   Jiang, YZ
AF Chen, Jianning
   Zou, Qin
   Lv, Daojun
   Raza, Muhammad Ali
   Wang, Xue
   Chen, Yan
   Xi, Xiaoyu
   Li, Peilin
   Wen, Anxiang
   Zhu, Li
   Tang, Guoqing
   Li, Mingzhou
   Li, Xuewei
   Jiang, Yanzhi
TI Comprehensive transcriptional profiling of aging porcine liver
SO PEERJ
LA English
DT Article
DE Aging; Liver; Pig; Transcriptome
ID GENE-EXPRESSION; DNA METHYLATION; CIRCULAR RNAS; BLOOD-FLOW; METABOLISM;
   AGE; CHOLESTEROL; HOMEOSTASIS; LANDSCAPE; INSIGHTS
AB Background. Aging is a major risk factor for the development of many diseases, and the liver, as the most important metabolic organ, is significantly affected by aging. It has been shown that the liver weight tends to increase in rodents and decrease in humans with age. Pigs have a genomic structure, with physiological as well as biochemical features that are similar to those of humans, and have therefore been used as a valuable model for studying human diseases. The molecular mechanisms of the liver aging of large mammals on a comprehensive transcriptional level remain poorly understood. The pig is an ideal model animal to clearly and fully understand the molecular mechanism underlying human liver aging.
   Methods. In this study, four healthy female Yana pigs (an indigenous Chinese breed) were investigated: two young sows (180-days-old) and two old sows (8-years-old). High throughput RNA sequencing was performed to evaluate the expression profiles of messenger RNA, long non-coding RNAs, micro RNAs, and circular RNAs during the porcine liver aging process. Gene Ontology (GO) analysis was performed to investigate the biological functions of age-related genes.
   Results. A number of age-related genes were identified in the porcine liver. GO annotation showed that up-regulated genes were mainly related to immune response, while the down-regulated genes were mainly related to metabolism. Moreover, several lncRNAs and their target genes were also found to be differentially expressed during liver aging. In addition, the multi-group cooperative control relationships and constructed circRNA-miRNA co-expression networks were assessed during liver aging.
   Conclusions. Numerous age-related genes were identified and circRNA-miRNA co-expression networks that are active during porcine liver aging were constructed. These findings contribute to the understanding of the transcriptional foundations of liver aging and also provide further references that clarify human liver aging at the molecular level.
C1 [Chen, Jianning; Zou, Qin; Wang, Xue; Chen, Yan; Xi, Xiaoyu; Wen, Anxiang; Jiang, Yanzhi] Sichuan Agr Univ, Coll Life Sci, Dept Zool, Yaan, Sichuan, Peoples R China.
   [Lv, Daojun; Li, Peilin] Sichuan Weimu Modern Agr Sci & Technol Co Ltd, Chengdu, Sichuan, Peoples R China.
   [Raza, Muhammad Ali] Sichuan Agr Univ, Coll Agron, Dept Crop Cultivat & Farming Syst, Chengdu, Sichuan, Peoples R China.
   [Zhu, Li; Tang, Guoqing; Li, Mingzhou; Li, Xuewei] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.
C3 Sichuan Agricultural University; Sichuan Agricultural University;
   Sichuan Agricultural University
RP Jiang, YZ (corresponding author), Sichuan Agr Univ, Coll Life Sci, Dept Zool, Yaan, Sichuan, Peoples R China.
EM jiangyz04@163.com
RI Li, Mingzhou/H-1402-2011; Zou, Qin/GVU-2237-2022; Chen,
   Jianning/IWM-6205-2023; xu, chen/JNE-5010-2023; Tang,
   Guoqing/JVZ-2879-2024; Raza, Muhammad Ali/R-8597-2019
OI Raza, Muhammad Ali/0000-0003-3817-6848; Li, Mingzhou/0000-0001-8681-7684
FU National Key R&D Program of China [2018YFD0501204]; National Science
   Foundation of China [31530073]; Chengdu Local Good Varieties of
   Livestock and Poultry Resources Protection and Exploitation and
   Utilization of Construction Projects
FX This study was supported by the National Key R&D Program of China
   (2018YFD0501204), Key Program of National Science Foundation of China
   (Grant No. 31530073), and Chengdu Local Good Varieties of Livestock and
   Poultry Resources Protection and Exploitation and Utilization of
   Construction Projects. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adighibe O, 2006, NEUROBIOL AGING, V27, P1431, DOI 10.1016/j.neurobiolaging.2005.08.010
   [Anonymous], PLOS BIOL
   [Anonymous], GENETIC ASPECTS DOME
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI [10.1093/nar/gkh121, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Bysani M, 2017, EPIGENOMICS-UK, V9, P105, DOI 10.2217/epi-2016-0087
   Capri M, 2017, AGING CELL, V16, P262, DOI 10.1111/acel.12549
   Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099
   Chen JN, 2018, ONCOTARGET, V9, P1524, DOI 10.18632/oncotarget.23290
   Chen LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271
   Chen Y, 2019, ANIM PROD SCI, V59, P1147, DOI 10.1071/AN17450
   Dou C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21499
   Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024
   Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004
   Friedländer MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688
   Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200
   Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408
   Huse SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2066-3
   Jiang YZ, 2012, GENET MOL RES, V11, P166, DOI 10.4238/2012.January.27.3
   Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820
   Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158
   Ketterer C, 2011, J MOL MED, V89, P75, DOI 10.1007/s00109-010-0687-1
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kingsford C., 2015, BIORXIV, DOI [DOI 10.1101/021592, 10.1101/021592]
   KITANI K, 1994, ARCH GERONTOL GERIAT, V19, P145, DOI 10.1016/0167-4943(94)90036-1
   Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675
   Li JQ, 2015, AM J CANCER RES, V5, P472
   Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]
   Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179
   Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521
   Mimura S, 2014, INT J MOL MED, V34, P1065, DOI 10.3892/ijmm.2014.1892
   Mouzat K, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-145
   Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151
   Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106
   Vinod M, 2016, AM J PHYSIOL-ENDOC M, V311, pE175, DOI 10.1152/ajpendo.00510.2015
   Vinod M, 2014, BBA-MOL CELL BIOL L, V1841, P827, DOI 10.1016/j.bbalip.2014.02.006
   Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149
   Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   WOODHOUSE KW, 1990, BRIT MED BULL, V46, P22, DOI 10.1093/oxfordjournals.bmb.a072387
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31
   Zadravec D, 2011, CHEM PHYS LIPIDS, V164, pS2, DOI 10.1016/j.chemphyslip.2011.05.035
   Zhang ML, 2018, ONCOGENE, V37, P1805, DOI 10.1038/s41388-017-0019-9
   Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115
   Zhao YH, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120116
   Zhu J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1240-y
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 60
TC 6
Z9 6
U1 0
U2 7
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD MAY 17
PY 2019
VL 7
AR e6949
DI 10.7717/peerj.6949
PG 21
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA HY4WE
UT WOS:000468127800005
PM 31149403
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Grizzi, F
   Franceschini, B
   Gagliano, N
   Moscheni, C
   Annoni, G
   Vergani, C
   Hermonat, PL
   Chiriva-Internati, M
   Dioguardi, N
AF Grizzi, F
   Franceschini, B
   Gagliano, N
   Moscheni, C
   Annoni, G
   Vergani, C
   Hermonat, PL
   Chiriva-Internati, M
   Dioguardi, N
TI Mast cell density, hepatic stellate cell activation and TGF-β1
   transcripts in the aging Sprague-Dawley rat during early acute liver
   injury
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE liver; mast cells; hepatic stellate cells; myofibroblasts; CCl4
   intoxication; inflammation; collagen synthesis; transforming-growth
   factor-b(1)
ID FIBROSIS; CIRRHOSIS; DISEASES
AB Mast cells (MCs) have been indicated as a source of various inflammatory cytokines, chemokines and growth factors. This study evaluates liver tissue MC density as a quantitative marker of acute liver inflammation in 2- and 19- month old rats treated with carbon tetrachloride (CCl4) to assess the relationships between MC density, hepatocellular damage, mRNA encoding TGF-beta(1), hepatic stellate cell (HSC) activation and collagen levels. Consecutive histological sections from each age group were stained with toluidine blue to identify granulated MCs, Direct Red 80 to recognize collagen matrix, and by immunohistochemistry to identify activated hepatic stellate cells (HSCs), which were subsequently counted by means of a computer-aided image analysis. Histology showed hepatocellular necrosis with inflammatory cell infiltration and collagen matrix deposition. Two and 24 hours after intoxication, MC density had considerably increased in the younger rats, but less in those aged 19 months. Although the untreated older rats had a larger area occupied by activated HSCs than the untreated younger rats, the increase in the number of HSCs was greater in the younger rats both two and 24 hours after intoxication. The greater MC density in younger rats suggests that older rats have a reduced immune response or recruit fewer MCs. The activated HSCs and TGF-beta(1) transcripts did not increase significantly during the study period, thus indicating that these are later events in chemically induced hepatic toxicity. In conclusion, MC density may be an index of acute liver inflammation after CCl4 intoxication.
C1 Ist Clin Human, Direz Sci, I-20089 Milan, Italy.
   Fdn Michele Rodriguez, Ist Sci Misure Quantitat Med, Milan, Italy.
   Univ Milan, Dipartimento Anat Umana, I-20122 Milan, Italy.
   Osped Maggiore, Dipartimento Med Interna, IRCCS, Milan, Italy.
   Univ Arkansas Med Sci, Div Obstet & Gynecol, Little Rock, AR 72205 USA.
   Texas Tech Univ, Hlth Sci Ctr, Amarillo, TX USA.
   Don & Sybil Harrington Canc Ctr, Amarillo, TX USA.
C3 IRCCS Humanitas Research Hospital; University of Milan; IRCCS Ca Granda
   Ospedale Maggiore Policlinico; University of Arkansas System; University
   of Arkansas Medical Sciences; Texas Tech University System; Texas Tech
   University Health Science Center; Texas Tech University Health Sciences
   Center Amarillo
RP Grizzi, F (corresponding author), Ist Clin Human, Direz Sci, Via Manzoni 56, I-20089 Milan, Italy.
RI Moscheni, Claudia/H-9499-2017; Gagliano, Nicoletta/L-1485-2016;
   franceschini, barbara/AAB-8713-2020; Grizzi, Fabio/K-3448-2018
OI Moscheni, Claudia/0000-0001-6614-665X; Gagliano,
   Nicoletta/0000-0002-3393-3144; franceschini,
   barbara/0000-0001-6348-248X; Grizzi, Fabio/0000-0003-0925-742X
CR Ahmed AFKU, 2000, J PEDIATR SURG, V35, P1762, DOI 10.1053/jpsu.2000.19245
   Akiyoshi H, 1998, J HEPATOL, V29, P112, DOI 10.1016/S0168-8278(98)80185-2
   ATKINS FM, 1987, ARCH DERMATOL, V123, P191, DOI 10.1001/archderm.123.2.191
   Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558
   Benyon RC, 1999, CLIN EXP ALLERGY, V29, P155
   Di Girolamo N, 2000, Dev Immunol, V7, P131, DOI 10.1155/2000/82708
   DOI K, 1991, LAB ANIM, V25, P21, DOI 10.1258/002367791780808121
   FARRELL DJ, 1995, HEPATOLOGY, V22, P1175, DOI 10.1016/0270-9139(95)90627-4
   FODINGER M, 1994, BLOOD, V84, P2954
   Gaça MDA, 1999, J HEPATOL, V30, P850, DOI 10.1016/S0168-8278(99)80139-1
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007
   Grizzi F, 2002, ANAL QUANT CYTOL, V24, P63
   HOFFMAN J, 1955, ARCH PATHOL, V59, P429
   Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557
   Matsunaga Y, 2000, LIVER, V20, P152, DOI 10.1034/j.1600-0676.2000.020002152.x
   Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033
   Onori P, 2000, J HEPATOL, V33, P555, DOI 10.1034/j.1600-0641.2000.033004555.x
   Rioux KP, 1996, HEPATOLOGY, V23, P888, DOI 10.1053/jhep.1996.v23.pm0008666346
   SHERLOCK S, 1970, SCAND J GASTROENTERO, V5, P187
   STROBEL S, 1981, J CLIN PATHOL, V34, P851, DOI 10.1136/jcp.34.8.851
   Sugihara A, 1999, J HEPATOL, V30, P859, DOI 10.1016/S0168-8278(99)80140-8
   Terada T, 2000, J HEPATOL, V33, P961, DOI 10.1016/S0168-8278(00)80129-4
   Zimmermann A, 1999, J HEPATOL, V30, P646, DOI 10.1016/S0168-8278(99)80195-0
NR 24
TC 28
Z9 30
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0192-6233
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD MAR-APR
PY 2003
VL 31
IS 2
BP 173
EP 178
DI 10.1080/01926230390183643
PG 6
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA 648XC
UT WOS:000181175500001
PM 12696576
DA 2024-02-19
ER

PT J
AU Wang, DL
   Li, MK
   Ling, J
   Chen, SX
   Zhang, QK
   Liu, Z
   Huang, YJ
   Pan, CN
   Lin, YH
   Shi, ZX
   Zhang, P
   Zheng, YF
AF Wang, Dongliang
   Li, Mengke
   Ling, Jie
   Chen, Shuxia
   Zhang, Qikai
   Liu, Zhong
   Huang, Yanjing
   Pan, Caineng
   Lin, Yuheng
   Shi, Zhuoxing
   Zhang, Ping
   Zheng, Yingfeng
TI Assessing the effects of aging on the liver endothelial cell landscape
   using single-cell RNA sequencing
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article
ID NF-KAPPA-B; ANGIOGENESIS; EXPRESSION; REGULATORS; GENE
AB Endothelial cell (EC) function declines with age and contributes to the development of many vascular-related disease processes. Currently, the effects of aging on the molecular regulatory mechanisms of liver ECs have not been fully elucidated. Here, we employed single-cell RNA sequencing to map the transcriptome of ECs and analyzed their relationship with aging. We identified 8 different EC subtypes, interestingly, 2 of which were specially expressed in aged mice ECs namely aged capillary ECs (Aged ECs) and pro-inflammation capillary ECs (Proinfla.ECs). Double immunostaining for an EC marker (Cd31) and a marker of these specialized EC phenotypes confirmed the single-cell RNA sequencing data. Gene ontology analysis revealed that Aged ECs and Proinfla.ECs were associated with inflammatory response. Then we found that liver proliferating capillary ECs (Prolife.ECs) were most affected by senescence. Single-cell transcript analysis suggests that Prolife.ECs and angiogenic capillary ECs may form a poor microenvironment that promotes angiogenesis and tumorigenesis. Pseudotemporal trajectories revealed that Prolife.ECs have different differentiation pathways in young and aged mice. In aged mice, Prolife.ECs could specifically differentiate into an unstable state, which was mainly composed of angiogenic capillary ECs. Intercellular communication revealed inflammatory activation in old group. Overall, this work compared the single-cell RNA profiles of liver ECs in young and aged mice. These findings provide a new insight into liver aging and its molecular mechanisms, and further exploration of Aged ECs and Proinfla.ECs may help to elucidate the molecular mechanisms associated with senescence.
C1 [Wang, Dongliang; Li, Mengke; Ling, Jie; Chen, Shuxia; Zhang, Qikai; Liu, Zhong; Huang, Yanjing; Pan, Caineng; Lin, Yuheng; Shi, Zhuoxing; Zhang, Ping; Zheng, Yingfeng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.
C3 Sun Yat Sen University
RP Zheng, YF (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.
EM zhyfeng@mail.sysu.edu.cn
RI Ling, Jie/JJF-9995-2023; yang, zhou/JKI-3744-2023
OI Shi, Zhuoxing/0000-0001-7463-4979; Wang, Dongliang/0000-0003-0605-5726
FU National Natural Science Foundation of China [81721003]; State Key
   Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen
   University
FX This study was funded by the National Natural Science Foundation of
   China (81721003); the State Key Laboratory of Ophthalmology, Zhongshan
   Ophthalmic Center, Sun Yat-sen University. The funding body had no role
   in the study design, collection, management, analysis and interpretation
   of data, writing of the manuscript, and the decision to submit the
   manuscript for publication.
CR Akiel M, 2017, CANCER RES, V77, P4014, DOI 10.1158/0008-5472.CAN-16-2885
   Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122
   Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148
   Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567
   Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5
   Bloom SI, 2023, NAT REV CARDIOL, V20, P38, DOI 10.1038/s41569-022-00739-0
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Cines DB, 1998, BLOOD, V91, P3527
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8
   Donato AJ, 2008, AGING CELL, V7, P805, DOI 10.1111/j.1474-9726.2008.00438.x
   Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294
   Favre J, 2021, ELIFE, V10, DOI [10.7554/eLife.68695, 10.7554/eLife.68695.sa0, 10.7554/eLife.68695.sa1, 10.7554/eLife.68695.sa2]
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Grün D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039
   He XJ, 2020, NAT METAB, V2, P293, DOI 10.1038/s42255-020-0196-7
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986
   Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037
   Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008
   Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015
   Kerr A, 2022, ONCOGENE, V41, P3385, DOI 10.1038/s41388-022-02353-3
   Kirkland JL, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025908
   Koch PS, 2021, ANGIOGENESIS, V24, P289, DOI 10.1007/s10456-021-09780-y
   Kodama T, 2020, LAB INVEST, V100, P1140, DOI 10.1038/s41374-020-0441-4
   Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P1025, DOI 10.1093/gerona/glq135
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968
   Li ZG, 2011, J BIOL CHEM, V286, P41323, DOI 10.1074/jbc.M111.259184
   Ma S, 2020, CELL, V180, P984, DOI 10.1016/j.cell.2020.02.008
   Mao LP, 2021, MATRIX BIOL, V95, P1, DOI 10.1016/j.matbio.2020.10.001
   Markiewski MM, 2017, J IMMUNOL, V198, P2989, DOI 10.4049/jimmunol.1602057
   Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024
   Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X
   Metzemaekers M, 2020, CELL MOL IMMUNOL, V17, P433, DOI 10.1038/s41423-020-0412-0
   Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822
   Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544
   Peng K, 2021, J CELL PHYSIOL, V236, P1309, DOI 10.1002/jcp.29938
   Potente M, 2017, NAT REV MOL CELL BIO, V18, P477, DOI 10.1038/nrm.2017.36
   Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Shetty S, 2018, NAT REV GASTRO HEPAT, V15, P555, DOI 10.1038/s41575-018-0020-y
   Sinjab A, 2021, CANCER DISCOV, V11, P2506, DOI 10.1158/2159-8290.CD-20-1285
   Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203
   Yang RY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21099-2
   Ye BQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03008-2
   Yu JH, 2007, EUR J IMMUNOL, V37, P2549, DOI 10.1002/eji.200737088
   Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001
   Zhang Y, 2020, MOL NEUROBIOL, V57, P2377, DOI 10.1007/s12035-020-01887-5
NR 49
TC 3
Z9 3
U1 2
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD FEB
PY 2023
VL 7
IS 2
AR e0021
DI 10.1097/HC9.0000000000000021
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA Q6FJ7
UT WOS:001058457700009
PM 36724124
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, YJ
   Yang, G
   Huang, S
   Yang, XY
   Yuan, FY
   Song, YH
   Liu, SL
   Yu, X
AF Zhang, Yujing
   Yang, Gang
   Huang, Shuai
   Yang, Xinyue
   Yuan, Fengyan
   Song, Yinghui
   Liu, Sulai
   Yu, Xing
TI Regulation of Cr(VI)-Induced Premature Senescence in L02 Hepatocytes by
   ROS-Ca<SUP>2+</SUP>-NF-κB Signaling
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID CELL SENESCENCE; CALCIUM; MITOPHAGY; PATHWAY; INJURY
AB Stress-induced premature senescence may be involved in the pathogeneses of acute liver injury. Hexavalent chromium [Cr(VI)], a common environmental pollutant related to liver injury, likely leads to premature senescence in L02 hepatocytes. However, the underlying mechanisms regarding hepatocyte premature senility in Cr(VI) exposure remain poorly understood. In this study, we found that chronic exposure of L02 hepatocytes to Cr(VI) led to premature senescence characterized by increased beta-galactosidase activity, senescence-associated heterochromatin foci, G1 phase arrest, and decreased cell proliferation. Additionally, Cr(VI)-induced senescent L02 hepatocytes showed upregulated inflammation-related factors, such as IL-6 and fibroblast growth factor 23 (FGF23), which also exhibited reactive oxygen species (ROS) accumulation derived from mitochondria accompanied with increased concentration of intracellular calcium ions (Ca2+) and activity of nuclear factor kappa B (NF-kappa B). Of note is that ROS inhibition by N-acetyl-Lcysteine pretreatment not only alleviated Cr(VI)-induced premature senescence but also reduced the elevated intracellular Ca2+, activated NF-kappa B, and secretion of IL-6/FGF23. Intriguingly, the toxic effect of Cr(VI) upon premature senescence of L02 hepatocytes and increased levels of IL-6/FGF23 could be partially reversed by the intracellular Ca2+ chelator BAPTA-AM pretreatment. Furthermore, by utilizing the NF-kappa B inhibitor pyrrolidine dithiocarbamate (PDTC), we confirmed that NF-kappa B mediated IL-6/FGF23 to regulate the Cr(VI)-induced L02 hepatocyte premature senescence, whilst the concentration of intracellular Ca2+ was not influenced by PDTC. To the best of our knowledge, our data reports for the first time the role of ROS-Ca2+-NF-kappa B signaling pathway in Cr(VI)-induced premature senescence. Our results collectively shed light on further exploration of innovative intervention strategies and treatment targeting Cr(VI)-induced chronic liver damage related to premature senescence.
C1 [Zhang, Yujing; Yang, Gang; Huang, Shuai; Yang, Xinyue; Yuan, Fengyan; Yu, Xing] Hunan Normal Univ, Sch Med, Key Lab Mol Epidemiol Hunan Prov, Changsha, Peoples R China.
   [Song, Yinghui; Liu, Sulai] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Hepatobiliary Surg, Changsha 410015, Peoples R China.
   [Yu, Xing] Hunan Normal Univ, Sch Med, Key Lab Model Anim & Stem Cell Biol Hunan Prov, Changsha, Peoples R China.
   [Yu, Xing] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.
C3 Hunan Normal University; Hunan Normal University; Hunan Normal
   University; Griffith University; Griffith University - Gold Coast Campus
RP Yu, X (corresponding author), Hunan Normal Univ, Sch Med, Key Lab Mol Epidemiol Hunan Prov, Changsha, Peoples R China.; Liu, SL (corresponding author), Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Hepatobiliary Surg, Changsha 410015, Peoples R China.; Yu, X (corresponding author), Hunan Normal Univ, Sch Med, Key Lab Model Anim & Stem Cell Biol Hunan Prov, Changsha, Peoples R China.; Yu, X (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.
EM liusulai@hunnu.edu.cn; xingyu@hunnu.edu.cn
RI Zhang, Zhentao/JQV-7389-2023; Zhang, Y J/HLG-1022-2023; peng,
   yan/JCO-1763-2023; zhang, wb/JGM-5316-2023; Liu, DY/JPL-4171-2023; Wang,
   Tianqi/JJD-7473-2023; wang, chen/JED-7289-2023; sun, chen/JCP-0396-2023;
   Wang, Luyao/JLL-2001-2023; zhang, yu/HNS-5948-2023; JIN,
   LIYING/JFB-1980-2023; liang, shuang/JOK-5869-2023; Liu,
   Shao/JFK-0166-2023; Yang, Ying/ABD-2481-2022; Liu, Ying/ISU-1216-2023;
   yan, xiao/JVP-0766-2024; yan, wang/JRW-9981-2023
FU National Natural Science Foundation of China [81803272, 81874193];
   National Science of Foundation of Hunan Province [2020JJ5385,
   2021JJ30465]; Education Fund Item of Hunan Province [19C1155]; High
   Level Talents Converging Program of Hunan Province [2019RS1041]; Key
   Grant of Research and Development in Hunan Province [2020DK2002]; Youth
   Talent of Hunan [2020RC3066]; Natural Science Fund for Excellent Young
   Scholars of Hunan Province [2021JJ20003]; Large Instrument Platform
   Project of Hunan Normal University [21CSZ053, 21CSY054, 21CSY055,
   21CSY048]
FX This study was supported by the National Natural Science Foundation of
   China (81803272 and 81874193), National Science of Foundation of Hunan
   Province (2020JJ5385 and 2021JJ30465), Education Fund Item of Hunan
   Province (19C1155), the High Level Talents Converging Program of Hunan
   Province (2019RS1041), Key Grant of Research and Development in Hunan
   Province (2020DK2002), Youth Talent of Hunan (2020RC3066), Natural
   Science Fund for Excellent Young Scholars of Hunan Province
   (2021JJ20003), and the Large Instrument Platform Project of Hunan Normal
   University (21CSZ053, 21CSY054, 21CSY055, and 21CSY048).
CR Borodkina AV, 2016, AGING-US, V8, P3400, DOI 10.18632/aging.101130
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Calvo-Rodriguez M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041549
   Cardoso AL, 2018, AGEING RES REV, V47, P214, DOI 10.1016/j.arr.2018.07.004
   Cartwright T, 2016, FEBS J, V283, P1812, DOI 10.1111/febs.13627
   Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451
   Chen QY, 2019, TOXICOL APPL PHARM, V377, DOI 10.1016/j.taap.2019.114636
   Choi MC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070734
   Fao L, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100942
   Franca A, 2019, HEPATOLOGY, V69, P817, DOI 10.1002/hep.30228
   Gao ZY, 2020, TOXICOL LETT, V333, P261, DOI 10.1016/j.toxlet.2020.08.012
   Gong WX, 2019, CHIN J NAT MEDICINES, V17, P264, DOI 10.1016/S1875-5364(19)30030-5
   Hakeem A, 2007, MED SCI MONITOR, V13, pCS61
   Hempel N, 2017, CELL CALCIUM, V63, P70, DOI 10.1016/j.ceca.2017.01.007
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Herraiz-Martínez A, 2015, CARDIOVASC RES, V106, P76, DOI 10.1093/cvr/cvv046
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Janikiewicz J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0105-5
   Jiang CS, 2017, AGING CELL, V16, P1114, DOI 10.1111/acel.12643
   Kida Y, 2016, CAN J CARDIOL, V32, P634, DOI 10.1016/j.cjca.2015.11.022
   Krick S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00708
   Kumar S, 2019, AGING-US, V11, P4145, DOI 10.18632/aging.102043
   Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651
   Lee TY, 2020, KAOHSIUNG J MED SCI, V36, P89, DOI 10.1002/kjm2.12146
   Liang YH, 2021, ECOTOX ENVIRON SAFE, V219, DOI 10.1016/j.ecoenv.2021.112343
   Lin YN, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109249
   Linos A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-50
   Luo XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1670-6
   Lv YY, 2020, ENVIRON POLLUT, V259, DOI 10.1016/j.envpol.2019.113812
   Madreiter-Sokolowski CT, 2019, REDOX BIOL, V20, P458, DOI 10.1016/j.redox.2018.11.003
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Ortiz-Montero P, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0172-3
   Oubaha M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9440
   Paluvai H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020466
   Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665
   Ren XH, 2019, CHEMOSPHERE, V229, P284, DOI 10.1016/j.chemosphere.2019.04.113
   Ricke KM, 2020, J NEUROSCI, V40, P1975, DOI [10.1523/JNEUROSCI.1345-19.2019, 10.1523/JNEUROSCI.2779-19.2019]
   Saxena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12398-w
   Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245
   Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902
   Tian YQ, 2019, AGING CELL, V18, DOI 10.1111/acel.12858
   Wang LX, 2019, ECOTOX ENVIRON SAFE, V186, DOI 10.1016/j.ecoenv.2019.109767
   Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x
   Yang QY, 2022, J ADV RES, V35, P129, DOI 10.1016/j.jare.2021.04.002
   Yang QY, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114855
   Yi X, 2017, ENVIRON TOXICOL PHAR, V49, P27, DOI 10.1016/j.etap.2016.11.007
   Yi X, 2016, METALLOMICS, V8, P1273, DOI 10.1039/c6mt00204h
   Zhang TG, 2020, ENVIRON SCI POLLUT R, V27, P41585, DOI 10.1007/s11356-020-08501-0
   Zhang YJ, 2020, ECOTOX ENVIRON SAFE, V203, DOI 10.1016/j.ecoenv.2020.110928
   Zhang YJ, 2019, ECOTOX ENVIRON SAFE, V186, DOI 10.1016/j.ecoenv.2019.109749
   Zhang YJ, 2019, ECOTOX ENVIRON SAFE, V183, DOI 10.1016/j.ecoenv.2019.109465
   Zhang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34578
   Zhong HH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0996-9
NR 53
TC 5
Z9 5
U1 0
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD FEB 18
PY 2022
VL 2022
AR 7295224
DI 10.1155/2022/7295224
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 1I0MP
UT WOS:000796932200008
PM 35222804
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lin, YT
   Zhang, F
   Zhang, LD
   Chen, L
   Zheng, S
AF Lin, Yuting
   Zhang, Fang
   Zhang, Ludi
   Chen, Lian
   Zheng, Shan
TI Characteristics of SOX9-positive progenitor-like cells during
   cholestatic liver regeneration in biliary atresia
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Biliary atresia; Reactive ductular cells; Hepatic progenitor cells;
   Liver progenitor-like cells; SOX9
ID DUCTULAR REACTIONS; STEM-CELLS; HEPATOCYTES; CHOLANGIOCYTES; INSIGHT;
   STRESS; RATHER; INJURY
AB Background The progression of Biliary Atresia (BA) is associated with the number of reactive ductular cells (RDCs) whose heterogeneity in origin and evolution in humans remains unknown. SOX9-positive liver progenitor-like cells (LPLCs) have been shown to participate in RDCs and new hepatocyte formation during cholestatic liver regeneration in an animal model, which implies the possibility that hepatocyte-reprogrammed LPLCs could be a source of RDCs in BA. The present study aimed to elucidate the characteristics of SOX9-positive LPLCs in BA for exploring new possible therapeutic targets by manipulating the bi-differentiation process of LPLCs to prevent disease progression. Methods Twenty-eight patients, including 24 patients with BA and 4 patients with Congenital Choledochal Cyst as the control group, were retrospectively recruited. Liver biopsy samples were classified histologically using a 4-point scale based on fibrosis severity. LPLCs were detected by SOX9 and HNF4A double positive staining. Single immunohistochemistry, double immunohistochemistry, and multiple immunofluorescence staining were used to determine the different cell types and characteristics of LPLCs. Results The prognostic predictors of BA, namely total bile acid (TBA), RDCs, and fibrosis, were correlated to the emergence of LPLCs. SOX9 and HNF4A double-positive LPLCs co-stained rarely with relevant markers of portal hepatic progenitor cells (portal-HPCs), including CK19, CK7, EPCAM, PROM1 (CD133), TROP2, and AFP. Under cholestasis conditions, LPLCs acquired superior proliferation and anti-senescence ability among hepatocytes. Moreover, LPLCs arranged as a pseudo-rosette structure appeared from the periportal parenchyma to the portal region, which implied the differentiation from hepatocyte-reprogrammed LPLCs to RDCs with the progression of cholestasis. Conclusions LPLCs are associated with disease progression and prognostic factors of BA. The bipotent characteristics of LPLCs are different from those of portal-HPCs. As cholestasis progresses, LPLCs appear to gain superior proliferation and anti-senescence ability and continually differentiate to RDCs.
C1 [Lin, Yuting; Zheng, Shan] Fudan Univ, Childrens Hosp, Dept Pediat Surg, Natl Childrens Med Ctr,Shanghai Key Lab Birth Def, 399 Wan Yuan Rd, Shanghai 201102, Peoples R China.
   [Lin, Yuting; Zheng, Shan] Minist Hlth, Key Lab Neonatal Dis, 399 Wan Yuan Rd, Shanghai 201102, Peoples R China.
   [Zhang, Fang; Zhang, Ludi] Chinese Acad Sci, Univ Chinese Acad Sci, State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biochem, Shanghai 200031, Peoples R China.
   [Chen, Lian] Fudan Univ, Natl Childrens Med Ctr, Childrens Hosp, Dept Pathol, 399 Wan Yuan Rd, Shanghai 201102, Peoples R China.
C3 Fudan University; Chinese Academy of Sciences; Center for Excellence in
   Molecular Cell Science, CAS; University of Chinese Academy of Sciences,
   CAS; Fudan University
RP Zheng, S (corresponding author), Fudan Univ, Childrens Hosp, Dept Pediat Surg, Natl Childrens Med Ctr,Shanghai Key Lab Birth Def, 399 Wan Yuan Rd, Shanghai 201102, Peoples R China.; Zheng, S (corresponding author), Minist Hlth, Key Lab Neonatal Dis, 399 Wan Yuan Rd, Shanghai 201102, Peoples R China.
EM szheng@shmu.edu.cn
RI Lin, Yuting/HPE-4176-2023; lin, yt/IQT-6771-2023
OI Zheng, Shan/0000-0002-9712-4573
FU Clinical Research Plan of SHDC [SHDC2020CR2009A]; Shanghai Municipal Key
   Clinical Specialty [shslczdzk05703]; National Natural Science Foundation
   of China [81770519, 81873545, 81974059]; Science Foundation of Shanghai
   [18411969100, 19ZR1406600]; Children's National Medical Center
   [EK112520180211, EK112520180310, EK1125180104, EKYY20180204]
FX This study received financial support from the Clinical Research Plan of
   SHDC (No. SHDC2020CR2009A), the Shanghai Municipal Key Clinical
   Specialty (No. shslczdzk05703), the National Natural Science Foundation
   of China (Nos. 81770519, 81873545, and 81974059), The Science Foundation
   of Shanghai (Nos. 18411969100 and 19ZR1406600), and Children's National
   Medical Center (Nos. EK1125180104, EKYY20180204, EK112520180211, and
   EK112520180310).
CR Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2
   Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022
   DESMET V, 1995, PATHOL RES PRACT, V191, P513, DOI 10.1016/S0344-0338(11)80870-8
   El-Araby HA, 2021, HEPATOB PANCREAT DIS, V20, P154, DOI 10.1016/j.hbpd.2020.12.007
   El-Deiry WS, 2016, CANCER RES, V76, P5189, DOI 10.1158/0008-5472.CAN-16-2055
   Elisofon SA., 2020, PEDIATR TRANSPLANT, V24, P136
   EVARTS RP, 1989, CANCER RES, V49, P1541
   Fabris L, 2007, AM J PATHOL, V171, P641, DOI 10.2353/ajpath.2007.070073
   Fabris L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2953727
   Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613
   Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004
   Han XM, 2019, STEM CELL REP, V12, P624, DOI 10.1016/j.stemcr.2019.01.010
   Hukkinen M, 2020, SEMIN PEDIATR SURG, V29, DOI 10.1016/j.sempedsurg.2020.150943
   Jörs S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585
   JORGENSEN M, 1973, ACTA PATH MICRO IM A, VA 81, P663
   Kasahara M, 2017, PEDIATR SURG INT, V33, P1289, DOI 10.1007/s00383-017-4173-5
   Kim W R, 2019, Am J Transplant, V19 Suppl 2, P184, DOI 10.1111/ajt.15276
   Ko S, 2020, ANNU REV PATHOL-MECH, V15, P23, DOI 10.1146/annurev-pathmechdis-012419-032824
   Lampela H, 2014, J CLIN GASTROENTEROL, V48, P721, DOI 10.1097/MCG.0000000000000013
   Lázaro CA, 1998, CANCER RES, V58, P5514
   Li WP, 2020, TRENDS CELL BIOL, V30, P329, DOI 10.1016/j.tcb.2020.01.007
   Li WP, 2019, CELL STEM CELL, V25, P54, DOI 10.1016/j.stem.2019.06.008
   Limaye Pallavi B, 2010, Comp Hepatol, V9, P9, DOI 10.1186/1476-5926-9-9
   Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6
   Lunz JG, 2005, HEPATOLOGY, V41, P1262, DOI 10.1002/hep.20709
   Merrell AJ, 2021, HEPATOLOGY, V74, P444, DOI 10.1002/hep.31704
   Michalopoulos GK, 2015, GASTROENTEROLOGY, V149, P876, DOI 10.1053/j.gastro.2015.08.004
   Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600
   Nagahama Y, 2014, AM J PATHOL, V184, P3001, DOI 10.1016/j.ajpath.2014.07.005
   NAGORE N, 1989, LIVER, V9, P43
   Overi D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102917
   Planas-Paz L, 2019, CELL STEM CELL, V25, P39, DOI 10.1016/j.stem.2019.04.005
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Schaub JR, 2018, NATURE, V557, P247, DOI 10.1038/s41586-018-0075-5
   Segal JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11266-x
   Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005
   Shamloo B, 2019, CANCERS, V11, DOI 10.3390/cancers11081178
   Strain AJ, 2003, SEMIN LIVER DIS, V23, P373
   Suda H, 2014, PEDIATR SURG INT, V30, P481, DOI 10.1007/s00383-014-3497-7
   Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243
   Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008
   Theise ND, 2007, MODERN PATHOL, V20, pS3, DOI 10.1038/modpathol.3800693
   Turányi E, 2010, HISTOPATHOLOGY, V57, P607, DOI 10.1111/j.1365-2559.2010.03668.x
   Wu JF, 2021, EUR J PEDIATR, V180, P2539, DOI 10.1007/s00431-021-04098-9
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
   Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112
   Yanger K, 2011, DEV DYNAM, V240, P521, DOI 10.1002/dvdy.22561
NR 50
TC 1
Z9 2
U1 2
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD MAR 21
PY 2022
VL 13
IS 1
AR 114
DI 10.1186/s13287-022-02795-2
PG 11
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA ZX0BN
UT WOS:000771567500009
PM 35313986
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Neyrinck, AM
   Taminiau, B
   Walgrave, H
   Daube, G
   Cani, PD
   Bindels, LB
   Delzenne, NM
AF Neyrinck, Audrey M.
   Taminiau, Bernard
   Walgrave, Hannah
   Daube, Georges
   Cani, Patrice D.
   Bindels, Laure B.
   Delzenne, Nathalie M.
TI Spirulina Protects against Hepatic Inflammation in Aging: An Effect
   Related to the Modulation of the Gut Microbiota?
SO NUTRIENTS
LA English
DT Article
DE Spirulina; aging; microbiota; inflammaging; gut-liver axis
ID METABOLIC-DISORDERS; OBESITY; HEALTH; DIET; PHYCOCYANIN; PROMOTES; CELLS
AB Aging predisposes to hepatic dysfunction and inflammation that can contribute to the development of non-alcoholic fatty liver disease. Spirulina, a cyanobacterium used as a food additive or food supplement, has been shown to impact immune function. We have tested the potential hepatoprotective effect of a Spirulina in aged mice and to determine whether these effects can be related to a modulation of the gut microbiota. Old mice have been fed a standard diet supplemented with or without 5% Spirulina for six weeks. Among several changes of gut microbiota composition, an increase in Roseburia and Lactobacillus proportions occurs upon Spirulina treatment. Interestingly, parameters related to the innate immunity are upregulated in the small intestine of Spirulina-treated mice. Furthermore, the supplementation with Spirulina reduces several hepatic inflammatory and oxidative stress markers that are upregulated in old mice versus young mice. We conclude that the oral administration of a Spirulina is able to modulate the gut microbiota and to activate the immune system in the gut, a mechanism that may be involved in the improvement of the hepatic inflammation in aged mice. Those data open the way to new therapeutic tools in the management of immune alterations in aging, based on gut microbe-host interactions.
C1 [Neyrinck, Audrey M.; Walgrave, Hannah; Cani, Patrice D.; Bindels, Laure B.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.
   [Taminiau, Bernard; Daube, Georges] Univ Liege, FARAH, Fac Vet Med, B-4000 Liege, Belgium.
   [Cani, Patrice D.] UCL, Louvain Drug Res Inst, Walloon Excellence Life Sci & BIOtechnol WELBIO, B-1200 Brussels, Belgium.
C3 Universite Catholique Louvain; University of Liege; WELBIO; Universite
   Catholique Louvain
RP Delzenne, NM (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.
EM audrey.neyrinck@uclouvain.be; bernard.taminiau@ulg.ac.be;
   hannah.walgrave@student.kuleuven.be; georges.daube@ulg.ac.be;
   patrice.cani@uclouvain.be; laure.bindels@uclouvain.be;
   nathalie.delzenne@uclouvain.be
RI D., Cani Patrice/M-8055-2016; Delzenne, Nathalie/AAC-4628-2019; Bindels,
   Laure/T-7846-2019; Daube, Georges MN/A-7582-2011; Neyrinck,
   Audrey/AAE-7929-2019
OI D., Cani Patrice/0000-0003-2040-2448; Delzenne,
   Nathalie/0000-0003-2115-6082; Bindels, Laure/0000-0003-3747-3234;
   Neyrinck, Audrey/0000-0002-9435-3338; Walgrave,
   Hannah/0000-0003-3368-0690; Daube, Georges/0000-0002-9282-8408
FU FRS-FNRS; Wallonia by competitive cluster Wagralim (NUTRIGUTIOR project)
   [6918]; ERC [336452-ENIGMO]; Baillet Latour grant for medical research;
   FRS-FNRS via FRFS-WELBIO [WELBIO-CR-2012S-02R]
FX We thank Remi Selleslagh, Bouazza Es Saadi, and Veronique Allaeys for
   skillful technical assistance and Carine Nezer, Quality Partner s.a.,
   Herstal, Belgium, for performing the metagenetic analysis. L.B.B. is a
   postdoctoral researcher from the FRS-FNRS (Fond National de la Recherche
   Scientifique, Belgium). N.M.D. is a recipient of FRS-FNRS grants. N.M.D.
   and G.D. are recipients of grants from Wallonia supported by the
   competitive cluster Wagralim (NUTRIGUTIOR project, convention 6918).
   P.D.C., a research associate at the FRS-FNRS (Belgium), is a recipient
   of an ERC Starting Grant 2013 (European Research Council, Starting Grant
   336452-ENIGMO), Baillet Latour grant for medical research 2015, and is
   supported by the FRS-FNRS via the FRFS-WELBIO under grant number
   WELBIO-CR-2012S-02R.
CR Balachandran P, 2006, INT IMMUNOPHARMACOL, V6, P1808, DOI 10.1016/j.intimp.2006.08.001
   Barlow GM, 2015, NUTR CLIN PRACT, V30, P787, DOI 10.1177/0884533615609896
   Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Deng RT, 2010, CARDIOVASC THER, V28, pe33, DOI 10.1111/j.1755-5922.2010.00200.x
   Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225
   Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Ku CS, 2013, J MED FOOD, V16, P103, DOI 10.1089/jmf.2012.2468
   Lyons CL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050247
   Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381
   Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028
   Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101
   Neyrinck AM, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500899
   Neyrinck AM, 2016, TRENDS FOOD SCI TECH, V57, P256, DOI 10.1016/j.tifs.2016.08.012
   Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008
   Nikoletopoulou V, 2014, TRENDS ENDOCRIN MET, V25, P212, DOI 10.1016/j.tem.2013.12.003
   Nuhu A. A., 2013, J MAR BIOL, V2013, P1, DOI [DOI 10.1155/2013/325636, https://doi.org/10.1155/2013/325636, 10.1155/2013/325636]
   Pak W, 2012, J CLIN BIOCHEM NUTR, V51, P227, DOI 10.3164/jcbn.12-18
   Remirez D, 2002, INFLAMM RES, V51, P351, DOI 10.1007/PL00000314
   Romay C, 2001, ARZNEIMITTEL-FORSCH, V51, P733
   Santiago AF, 2011, IMMUNOBIOLOGY, V216, P1085, DOI 10.1016/j.imbio.2011.05.007
   Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684
   Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
   Serban MC, 2016, CLIN NUTR, V35, P842, DOI 10.1016/j.clnu.2015.09.007
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16
   Usharani, 2015, ADV BIOL RES, V9, P292, DOI [DOI 10.5829/IDOSI.ABR.2015.9.5.9610, 10.5829/idosi.abr.2015.9.5.9610]
   Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228
NR 33
TC 44
Z9 46
U1 0
U2 29
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2017
VL 9
IS 6
AR 633
DI 10.3390/nu9060633
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EY7NA
UT WOS:000404177100104
PM 28632181
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Zheng, Y
   Chen, XL
   Lu, T
   Lin, ZY
   Liu, CQ
   Yuan, D
   Yuan, CF
AF Zheng, Ying
   Chen, Xiaoling
   Lu, Ting
   Lin, Zhiyong
   Liu, Chaoqi
   Yuan, Ding
   Yuan, Chengfu
TI miR-871-5p/PGC1α Regulates Aging-Induced Lipid Deposition in Hepatocytes
   Through Fatty AcID-β-Oxidation
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article; Early Access
DE Aging; Fatty acid beta oxidation; miR-871-5p; Nonalcoholic fatty liver
   disease; Proliferator-activated receptor alpha
ID ACTIVATED RECEPTOR-ALPHA; CELLULAR SENESCENCE; METABOLISM; MICRORNAS
AB This study investigated the role of the miR-871-5p/proliferator-activated receptor alpha (PGC1 alpha) pathway in ameliorating hepatic steatosis. We examined miR-871-5p expression in liver tissues of aging mice and AML12 senescent cells co-induced by low serum and palmitic acid (PA). Bioinformatics and multiple experiments were employed to validate the expression level of the target gene PGC1 alpha for miR-871-5p. In this study, we aimed to investigate the potential role of miR-871-5p in regulating hepatic lipid deposition associated with aging. To do so, we performed in vitro transfection of both miR-871-5p mimic and inhibitor into senescent hepatocytes. Our results showed that miR-871-5p could inhibit PGC1 alpha expression and cause lipid deposition in the liver due to aging. miR-871-5p controls this process by regulating PGC1 alpha/fatty acid beta-oxidation. H&E staining displayed the appearance of fat vacuoles in the livers of aging mice, and fatty acid beta-oxidation-related genes (acyl-coenzyme A oxidase 1 carnitine palmitoyl transferase 1 alpha and peroxisome proliferator-activated receptor alpha) expression was significantly reduced. Lipogenic genes (sterol regulatory element binding protein 1C and fatty acid synthase) expression level was increased in the livers of aging mice. In AML12 cells co-induced by low serum and PA, miR-871-5p mimics decreased PGC1 alpha expression and increased lipid droplet accumulation in senescent hepatocytes. Conversely, miR-871-5p inhibitor promoted PGC1 alpha expression and reduced lipid deposition in senescent hepatocytes. Our findings suggest that inhibiting miR-871-5p could be crucial in ameliorating aging-associated hepatic steatosis. These findings offer valuable insights into the molecular mechanisms driving hepatic steatosis in aging.
C1 [Zheng, Ying; Chen, Xiaoling; Lu, Ting; Lin, Zhiyong; Liu, Chaoqi] China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotherapy, Yichang, Hubei, Peoples R China.
   [Zheng, Ying; Chen, Xiaoling; Lu, Ting; Lin, Zhiyong; Liu, Chaoqi; Yuan, Chengfu] China Three Gorges Univ, Coll Basic Med Sci, Yichang, Hubei, Peoples R China.
   [Yuan, Ding] China Three Gorges Univ, Coll Med & Hlth Sci, Yichang, Hubei, Peoples R China.
   [Yuan, Chengfu] Med Coll China Three Gorges, Third Grade Pharmacol Lab Chinese Med Approved Sta, Yichang, Hubei, Peoples R China.
C3 China Three Gorges University; China Three Gorges University; China
   Three Gorges University
RP Yuan, CF (corresponding author), China Three Gorges Univ, Coll Basic Med Sci, Yichang, Hubei, Peoples R China.; Yuan, D (corresponding author), China Three Gorges Univ, Coll Med & Hlth Sci, Yichang, Hubei, Peoples R China.; Yuan, CF (corresponding author), Med Coll China Three Gorges, Third Grade Pharmacol Lab Chinese Med Approved Sta, Yichang, Hubei, Peoples R China.
EM yuanding9732@163.com; yuancf46@ctgu.edu.cn
RI wang, xiaoxuan/JMP-6531-2023
FU National Natural Science Foundation of China [81974528, 82174035,
   81773959]; innovational group project of Hubei Province Natural Science
   Foundation in China [2021CFA015]; Central Funds Guiding the Local
   Science and Technology Development [2020ZYYD016]
FX The work was supported by grants from the National Natural Science
   Foundation of China (Grant No. 81974528 to C.F.Y., No. 82174035 to
   C.F.Y., and No. 81773959 to C.F.Y.), the innovational group project of
   Hubei Province Natural Science Foundation in China (Grant No. 2021CFA015
   to C.F.Y.), and the Central Funds Guiding the Local Science and
   Technology Development (Grant No. 2020ZYYD016 to C.F.Y.).
CR Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571
   Fafián-Labora J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1550-0
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   Gerasymchuk M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155281
   Gill JF, 2018, AGING CELL, V17, DOI 10.1111/acel.12697
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hochreuter MY, 2022, MOL METAB, V65, DOI 10.1016/j.molmet.2022.101581
   Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Liu CH, 2018, J HEPATOL, V69, P1335, DOI 10.1016/j.jhep.2018.08.008
   Mashek DG, 2013, ADV NUTR, V4, P697, DOI 10.3945/an.113.004648
   Mollet IG, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24043875
   Näär AM, 2018, TRENDS ENDOCRIN MET, V29, P667, DOI 10.1016/j.tem.2018.04.004
   Nguyen D, 2013, AGING CELL, V12, P415, DOI 10.1111/acel.12073
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Queiroz AL, 2021, MOL METAB, V51, DOI 10.1016/j.molmet.2021.101226
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f
   Spitler KM, 2020, J LIPID RES, V61, P1161, DOI 10.1194/jlr.R120000922
   Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500
   Tong YC, 2022, J NAT PROD, DOI 10.1021/acs.jnatprod.2c00259
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wan J, 2020, AGING CELL, V19, DOI 10.1111/acel.13238
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Wu L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2426-z
   Xu L, 2018, THERANOSTICS, V8, P5593, DOI 10.7150/thno.27425
NR 33
TC 1
Z9 1
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD 2023 AUG 4
PY 2023
DI 10.1093/gerona/glad185
EA AUG 2023
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA P5ZQ2
UT WOS:001051459700001
PM 37539727
DA 2024-02-19
ER

PT J
AU SCHMUCKER, DL
   WANG, RK
   SNYDER, D
   STROBEL, H
   MARTI, U
AF SCHMUCKER, DL
   WANG, RK
   SNYDER, D
   STROBEL, H
   MARTI, U
TI CALORIC RESTRICTION AFFECTS LIVER MICROSOMAL MONOOXYGENASES
   DIFFERENTIALLY IN AGING MALE-RATS
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
ID DRUG-METABOLIZING-ENZYMES; AGE-RELATED-CHANGES; DIETARY RESTRICTION;
   CYTOCHROME-P-450; SYSTEM; MICE
AB Caloric restriction (CR) extends life span and retards the onset of physiological changes and pathologies associated with aging, but the underlying mechanisms remain unresolved.  This study demonstrates that CR postpones the documented age-related declines in and/or enhances the activity and microsomal concentrations of several liver monooxygenases in male rats, i.e., NADPH cytochrome P-450 reductase, total cytochromes P-450.  However, the relative concentration of cytochrome P-450b + e did not exhibit statistically significant changes, whereas another isozyme, the male specific P-450h, declined significantly in both ad libitum-fed and CR rats as a function of increasing age.  While CR appears to retard age-associated changes in certain liver enzymes, this effect is by no means universal.  The hepatic monooxygenases constitute a well-characterized enzyme system in which to examine the perturbation of the aging process by CR.
C1 UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143.
   UNIV NOTRE DAME,LOBUND LAB,NOTRE DAME,IN 46556.
   UNIV TEXAS,HLTH SCI CTR,HOUSTON,TX 77225.
   UNIV BERN,DEPT CLIN PHARMACOL,CH-3000 BERN,SWITZERLAND.
C3 University of California System; University of California San Francisco;
   University of Notre Dame; University of Texas System; University of
   Texas Health Science Center Houston; University of Bern
RP SCHMUCKER, DL (corresponding author), VET ADM MED CTR,CELL BIOL & AGING SECT 151E,4150 CLEMENT ST,SAN FRANCISCO,CA 94121, USA.
CR BIRNBAUM LS, 1980, EXP GERONTOL, V15, P259, DOI 10.1016/0531-5565(80)90030-3
   BONKOVSKY HL, 1985, GASTROENTEROLOGY, V88, P458, DOI 10.1016/0016-5085(85)90507-4
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   GIL L, 1988, MOL CELL BIOCHEM, V79, P5, DOI 10.1007/BF00229392
   GOLD G, 1974, BIOCHEM PHARMACOL, V24, P2105
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1968, J BIOCHEM-TOKYO, V63, P406
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASORO EJ, 1985, J NUTR, V115, P842, DOI 10.1093/jn/115.7.842
   Masters B. S. S., 1967, METHOD ENZYMOL, V10, P565
   MORGAN ET, 1987, BIOCHEMISTRY-US, V26, P4193, DOI 10.1021/bi00388a003
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   RIKANS LE, 1981, MECH AGEING DEV, V16, P371, DOI 10.1016/0047-6374(81)90021-X
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   SACHAN DS, 1982, J NUTR, V112, P2301, DOI 10.1093/jn/112.12.2301
   SACHAN DS, 1982, BIOCHEM BIOPH RES CO, V104, P984, DOI 10.1016/0006-291X(82)91346-8
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SCHMUCKER DL, 1980, EXP GERONTOL, V15, P321, DOI 10.1016/0531-5565(80)90037-6
   SCHMUCKER DL, 1980, P SOC EXP BIOL MED, V165, P178
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SCHMUCKER DL, 1986, LIVER AGING, P3
   SNYDER DL, 1990, J GERONTOL, V45, pB52, DOI 10.1093/geronj/45.2.B52
   SNYDER DL, 1988, J GERONTOL, V43, pB168, DOI 10.1093/geronj/43.6.B168
   SNYDER DL, 1987, LAB ANIM SCI, V37, P320
   SNYDER DL, 1989, DIETARY RESTRICTION, V287
   STOHS SJ, 1980, AGE, V3, P88, DOI 10.1007/BF02432265
   SUN J, 1986, EXP GERONTOL, V21, P523, DOI 10.1016/0531-5565(86)90005-7
   WALFORD RL, 1987, J NUTR, V117, P1650, DOI 10.1093/jn/117.10.1650
   WU B, 1989, DIETARY RESTRICTION, P301
   YANG CS, 1988, PHARMACOL THERAPEUT, V38, P53, DOI 10.1016/0163-7258(88)90102-7
NR 35
TC 12
Z9 12
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD JAN
PY 1991
VL 46
IS 1
BP B23
EP B27
DI 10.1093/geronj/46.1.B23
PG 5
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FJ109
UT WOS:A1991FJ10900020
PM 1898745
OA Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Zheng, Y
   Chen, XL
   Lu, T
   Lin, ZY
   Liu, CQ
   Yuan, D
   Yuan, CF
AF Zheng, Ying
   Chen, Xiaoling
   Lu, Ting
   Lin, Zhiyong
   Liu, Chaoqi
   Yuan, Ding
   Yuan, Chengfu
TI miR-871-5p/PGC1α Regulates Aging-Induced Lipid Deposition in Hepatocytes
   Through Fatty Acid β-Oxidation
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Aging; Fatty acid beta oxidation; miR-871-5p; Nonalcoholic fatty liver
   disease; Proliferator-activated receptor alpha
ID ACTIVATED RECEPTOR-ALPHA; CELLULAR SENESCENCE; METABOLISM; MICRORNAS
AB This study investigated the role of the miR-871-5p/proliferator-activated receptor alpha (PGC1 alpha) pathway in ameliorating hepatic steatosis. We examined miR-871-5p expression in liver tissues of aging mice and AML12 senescent cells co-induced by low serum and palmitic acid (PA). Bioinformatics and multiple experiments were employed to validate the expression level of the target gene PGC1 alpha for miR-871-5p. In this study, we aimed to investigate the potential role of miR-871-5p in regulating hepatic lipid deposition associated with aging. To do so, we performed in vitro transfection of both miR-871-5p mimic and inhibitor into senescent hepatocytes. Our results showed that miR-871-5p could inhibit PGC1a expression and cause lipid deposition in the liver due to aging. miR-871-5p controls this process by regulating PGC1 alpha/fatty acid beta-oxidation. H&E staining displayed the appearance of fat vacuoles in the livers of aging mice, and fatty acid beta-oxidation-related genes (acyl-coenzyme A oxidase 1 carnitine palmitoyl transferase 1 alpha and peroxisome proliferator-activated receptor alpha) expression was significantly reduced. Lipogenic genes (sterol regulatory element binding protein 1C and fatty acid synthase) expression level was increased in the livers of aging mice. In AML12 cells co-induced by low serum and PA, miR-871-5p mimics decreased PGC1 alpha expression and increased lipid droplet accumulation in senescent hepatocytes. Conversely, miR-871-5p inhibitor promoted PGC1 alpha expression and reduced lipid deposition in senescent hepatocytes. Our findings suggest that inhibiting miR-871-5p could be crucial in ameliorating aging-associated hepatic steatosis. These findings offer valuable insights into the molecular mechanisms driving hepatic steatosis in aging.
C1 [Zheng, Ying; Chen, Xiaoling; Lu, Ting; Lin, Zhiyong; Liu, Chaoqi] China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotherapy, Yichang, Hubei, Peoples R China.
   [Zheng, Ying; Chen, Xiaoling; Lu, Ting; Lin, Zhiyong; Liu, Chaoqi; Yuan, Chengfu] China Three Gorges Univ, Coll Basic Med Sci, Yichang, Hubei, Peoples R China.
   [Yuan, Ding] China Three Gorges Univ, Coll Med & Hlth Sci, Yichang, Hubei, Peoples R China.
   [Yuan, Chengfu] Med Coll China Three Gorges, Grade Pharmacol Lab Chinese Med Approved State Ad, Yichang, Hubei, Peoples R China.
C3 China Three Gorges University; China Three Gorges University; China
   Three Gorges University
RP Yuan, CF (corresponding author), China Three Gorges Univ, Coll Basic Med Sci, Yichang, Hubei, Peoples R China.; Yuan, D (corresponding author), China Three Gorges Univ, Coll Med & Hlth Sci, Yichang, Hubei, Peoples R China.; Yuan, CF (corresponding author), Med Coll China Three Gorges, Grade Pharmacol Lab Chinese Med Approved State Ad, Yichang, Hubei, Peoples R China.
EM yuanding9732@163.com; yuancf46@ctgu.edu.cn
RI wang, xiaoxuan/JMP-6531-2023
FU National Natural Science Foundation of China [81974528, 82174035,
   81773959]; innovational group project of Hubei Province Natural Science
   Foundation in China [2021CFA015]; Central Funds Guiding the Local
   Science and Technology Development [2020ZYYD016]
FX The work was supported by grants from the National Natural Science
   Foundation of China (Grant No. 81974528 to C.F.Y., No. 82174035 to
   C.F.Y., and No. 81773959 to C.F.Y.), the innovational group project of
   Hubei Province Natural Science Foundation in China(Grant No. 2021CFA015
   to C.F.Y.), and the Central Funds Guiding the Local Science and
   Technology Development (Grant No. 2020ZYYD016 to C.F.Y.).
CR Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571
   Fafián-Labora J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1550-0
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   Gerasymchuk M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155281
   Gill JF, 2018, AGING CELL, V17, DOI 10.1111/acel.12697
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hochreuter MY, 2022, MOL METAB, V65, DOI 10.1016/j.molmet.2022.101581
   Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Liu CH, 2018, J HEPATOL, V69, P1335, DOI 10.1016/j.jhep.2018.08.008
   Mashek DG, 2013, ADV NUTR, V4, P697, DOI 10.3945/an.113.004648
   Mollet IG, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24043875
   Näär AM, 2018, TRENDS ENDOCRIN MET, V29, P667, DOI 10.1016/j.tem.2018.04.004
   Nguyen D, 2013, AGING CELL, V12, P415, DOI 10.1111/acel.12073
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Queiroz AL, 2021, MOL METAB, V51, DOI 10.1016/j.molmet.2021.101226
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f
   Spitler KM, 2020, J LIPID RES, V61, P1161, DOI 10.1194/jlr.R120000922
   Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500
   Tong YC, 2022, J NAT PROD, DOI 10.1021/acs.jnatprod.2c00259
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wan J, 2020, AGING CELL, V19, DOI 10.1111/acel.13238
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Wu L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2426-z
   Xu L, 2018, THERANOSTICS, V8, P5593, DOI 10.7150/thno.27425
NR 33
TC 1
Z9 1
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD OCT 28
PY 2023
VL 78
IS 11
BP 2007
EP 2015
DI 10.1093/gerona/glad185
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AD1O0
UT WOS:001116432800005
PM 37539727
DA 2024-02-19
ER

PT J
AU Walter, R
   Murasko, DM
   Sierra, F
AF Walter, R
   Murasko, DM
   Sierra, F
TI T-Kininogen is a biomarker of senescence in rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE biomarkers; aging; rat liver; T-kininogen; proteinase inhibitors
ID PHENOL-CHLOROFORM EXTRACTION; SINGLE-STEP METHOD; GENE-EXPRESSION; RNA
   ISOLATION; PLASMA; PROTEOLYSIS; RESTRICTION; OXIDATION; RECEPTORS;
   INCREASE
AB We have previously reported on the identification of T-kininogen (T-KG) as a gene whose expression is increased during senescence in male Sprague-Dawley (S-D) rats. Serum T-KG levels increase 2.5-4 months before the time of death for any given animal, irrespective of the actual age of the animal at the time of this event. Furthermore, dietary restriction (DR) delays, but does not prevent, the increase in serum T-KG levels. In the present study, we have assessed whether or not the age-related increase in T-KG is a common feature of senescence in other strains of rat. We have analyzed hepatic T-KG mRNA levels in male Fischer 344 rats (F344), as well as in male and female (Fischer 344 x Brown Norway)F1 rats (F1). In both of these strains, we observed a dramatic increase in hepatic T-KG mRNA levels when male rats approach senescence. The mRNA levels behave similarly in F1 and S-D rats, in that the increase occurs late in life, and it is either repressed or delayed by DR. In contrast, the increase in T-KG mRNA levels in F344 rats occurs earlier in life, and is not significantly affected by DR. Young female Fl rats fed ad libitum (AL) show a statistically significant (P = 0.0009) 2.6-fold higher level of T-KG mRNA, as compared to their male counterparts. Thus, while we still observe an age-related increase in this parameter in both AL and DR female F1 rats, the difference is statistically significant (P = 0.0001) only in DR animals. We conclude that the increase in T-KG gene expression is a common feature of senescence and that, at least in males of these commonly used rat strains, T-KG can be used as a reliable biomarker of aging. Since the increase in T-KG gene expression does not appear to correlate with inflammatory processes, and since different strains of animals succumb to different pathologies, these results further suggest that the increase in T-KG expression might be related to the process of aging per se, rather than to any given age-related pathology. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Allegheny Univ Hlth Sci, Ctr Gerontol Res, Philadelphia, PA 19129 USA.
   Allegheny Univ Hlth Sci, Dept Immunol & Microbiol, Philadelphia, PA 19129 USA.
C3 Drexel University; Drexel University
RP Sierra, F (corresponding author), Allegheny Univ Hlth Sci, Ctr Gerontol Res, Philadelphia, PA 19129 USA.
EM sierra@auhs.edu
FU NIA NIH HHS [R01 AG07719] Funding Source: Medline
CR ADELMAN RC, 1983, ALTERED PROTEINS AGI
   AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   ANDERSON KP, 1990, MOL ENDOCRINOL, V4, P543, DOI 10.1210/mend-4-4-543
   ANDERSON KP, 1989, NUCLEIC ACIDS RES, V17, P2835, DOI 10.1093/nar/17.7.2835
   [Anonymous], 1990, Longevity, senescence and the genome
   BRANN DW, 1995, ENDOCRINOLOGY, V136, P46, DOI 10.1210/en.136.1.46
   Busse R, 1996, DIABETES, V45, pS8, DOI 10.2337/diab.45.1.S8
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   FRIEDMAN V, 1990, MECH AGEING DEV, V52, P27, DOI 10.1016/0047-6374(90)90142-3
   FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222
   GREENBAUM LM, 1988, METHOD ENZYMOL, V163, P272
   HOLEHAN AM, 1985, MECH AGEING DEV, V32, P63, DOI 10.1016/0047-6374(85)90036-3
   HUGHES KA, 1994, NATURE, V367, P64, DOI 10.1038/367064a0
   INNIS RB, 1981, P NATL ACAD SCI-BIOL, V78, P2630, DOI 10.1073/pnas.78.4.2630
   JAZWINSKI SM, 1993, GENETICA, V91, P35, DOI 10.1007/BF01435986
   KLENIEWSKI J, 1991, EUR J HAEMATOL, V46, P257
   KUSHNER I, 1994, BAILLIERE CLIN RHEUM, V8, P513, DOI 10.1016/S0950-3579(05)80113-X
   MASORO EJ, 1995, OBES RES, V3, pS241, DOI 10.1002/j.1550-8528.1995.tb00470.x
   MCCARTER RJM, 1995, CLIN GERIATR MED, V11, P553, DOI 10.1016/S0749-0690(18)30256-8
   MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835
   OHISHI S, 1988, BIOCHEM BIOPH RES CO, V150, P1069, DOI 10.1016/0006-291X(88)90738-3
   OKAMOTO H, 1983, BIOCHEM BIOPH RES CO, V112, P701, DOI 10.1016/0006-291X(83)91519-X
   PIERPAOLI W, 1977, EXPERIENTIA, V33, P1612, DOI 10.1007/BF01934028
   PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
   REGOLI D, 1993, CAN J PHYSIOL PHARM, V71, P556, DOI 10.1139/y93-079
   Roth GS, 1997, MECH AGEING DEV, V98, P231, DOI 10.1016/S0047-6374(97)00110-3
   SIERRA F, 1992, J BIOL CHEM, V267, P10665
   Sierra F, 1995, MECH AGEING DEV, V84, P127, DOI 10.1016/0047-6374(95)01639-2
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   SUEYOSHI T, 1985, FEBS LETT, V182, P193, DOI 10.1016/0014-5793(85)81182-0
   WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A
   WEINDRUCH R, 1991, J GERONTOL, V46, pB87, DOI 10.1093/geronj/46.3.B87
NR 33
TC 16
Z9 17
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD DEC 1
PY 1998
VL 106
IS 1-2
BP 129
EP 144
DI 10.1016/S0047-6374(98)00107-9
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 150TG
UT WOS:000077680900006
PM 9883978
DA 2024-02-19
ER

PT J
AU Yi, HS
   Kim, SY
   Kim, JT
   Lee, YS
   Moon, JS
   Kim, M
   Kang, YE
   Joung, KH
   Lee, JH
   Kim, HJ
   Chun, K
   Shong, M
   Ku, BJ
AF Yi, Hyon-Seung
   Kim, So Yeon
   Kim, Jung Tae
   Lee, Young-Sun
   Moon, Ji Sun
   Kim, Mingyo
   Kang, Yea Eun
   Joung, Kyong Hye
   Lee, Ju Hee
   Kim, Hyun Jin
   Chun, Kwangsik
   Shong, Minho
   Ku, Bon Jeong
TI T-cell senescence contributes to abnormal glucose homeostasis in humans
   and mice
SO CELL DEATH & DISEASE
LA English
DT Article
ID INSULIN-RESISTANCE; ADIPOSE-TISSUE; TRANSCRIPTION FACTOR; INFLAMMATION;
   EXPRESSION; CYTOKINES; RISK; ASSOCIATION; ACTIVATION; RECEPTOR
AB Chronic inflammation is a driving force for the development of metabolic disease including diabetes and obesity. However, the functional characteristics of T-cell senescence in the abnormal glucose homeostasis are not fully understood. We studied the patients visiting a hospital for routine health check-ups, who were divided into two groups: normal controls and people with prediabetes. Gene expression profiling of peripheral blood mononuclear cells from normal controls and patients with type 2 diabetes was undertaken using microarray analysis. We also investigated the immunometabolic characteristics of peripheral and hepatic senescent T cells in the normal subjects and patients with prediabetes. Moreover, murine senescent T cells were tested functionally in the liver of normal or mice with metabolic deterioration caused by diet-induced obesity. Human senescent (CD28(-)CD57(+)) CD8(+) T cells are increased in the development of diabetes and proinflammatory cytokines and cytotoxic molecules are highly expressed in senescent T cells from patients with prediabetes. Moreover, we demonstrate that patients with prediabetes have higher concentrations of reactive oxygen species (ROS) in their senescent CD8(+) T cells via enhancing capacity to use glycolysis. These functional properties of senescent CD8(+) T cells contribute to the impairment of hepatic insulin sensitivity in humans. Furthermore, we found an increase of hepatic senescent T cells in mouse models of aging and diet-induced obesity. Adoptive transfer of senescent CD8(+) T cells also led to a significant deterioration in systemic abnormal glucose homeostasis, which is improved by ROS scavengers in mice. This study defines a new clinically relevant concept of T-cell senescence-mediated inflammatory responses in the pathophysiology of abnormal glucose homeostasis. We also found that T-cell senescence is associated with systemic inflammation and alters hepatic glucose homeostasis. The rational modulation of T-cell senescence would be a promising avenue for the treatment or prevention of diabetes.
C1 [Yi, Hyon-Seung; Kim, Jung Tae; Moon, Ji Sun; Kang, Yea Eun; Joung, Kyong Hye; Lee, Ju Hee; Kim, Hyun Jin; Shong, Minho; Ku, Bon Jeong] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Res Ctr Endocrine & Metab Dis, Daejeon 35015, South Korea.
   [Yi, Hyon-Seung; Kang, Yea Eun; Joung, Kyong Hye; Lee, Ju Hee; Kim, Hyun Jin; Shong, Minho; Ku, Bon Jeong] Chungnam Natl Univ, Sch Med, Dept Internal Med, Daejeon 35015, South Korea.
   [Kim, So Yeon] Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Lab Liver Res, Daejeon 34141, South Korea.
   [Kim, So Yeon] Cedars Sinai Med Ctr, Dept Med, Div Digest & Liver Dis, Los Angeles, CA 90048 USA.
   [Kim, Jung Tae] Chungnam Natl Univ, Sch Med, Dept Med Sci, 266 Munhwaro, Daejeon 35015, South Korea.
   [Lee, Young-Sun] Korea Univ, Coll Med, Dept Internal Med, Seoul 08308, South Korea.
   [Kim, Mingyo] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, 79 Gangnam Ro, Jinju 660702, Gyeongnam, South Korea.
   [Chun, Kwangsik] Chungnam Natl Univ, Sch Med, Dept Surg, Daejeon 35015, South Korea.
C3 Chungnam National University; Chungnam National University Hospital;
   Chungnam National University; Korea Advanced Institute of Science &
   Technology (KAIST); Cedars Sinai Medical Center; Chungnam National
   University; Korea University; Korea University Medicine (KU Medicine);
   Gyeongsang National University; Chungnam National University
RP Yi, HS; Ku, BJ (corresponding author), Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Res Ctr Endocrine & Metab Dis, Daejeon 35015, South Korea.; Yi, HS; Ku, BJ (corresponding author), Chungnam Natl Univ, Sch Med, Dept Internal Med, Daejeon 35015, South Korea.
EM jmpbooks@cnu.ac.kr; bonjeong@cnu.ac.kr
RI Lee, Young-Sun/ABI-6420-2020; Yi, Hyon-Seung/ABA-2729-2022;
   /H-7803-2012; Kim, Hyo Soo/J-2753-2012
OI Lee, Young-Sun/0000-0001-6396-0859; Kim, Mingyo/0000-0003-3744-8522; Yi,
   Hyon-Seung/0000-0002-3767-1954; Kim, Hyun Jin/0000-0002-6760-4963; Lee,
   Jin Sun/0000-0002-9345-724X; Shong, Minho/0000-0002-0247-7115; Lee, Ju
   Hee/0000-0001-5976-7175
FU National Research Foundation of Korea (NRF) - Ministry of Science, ICT,
   and Future Planning, Korea [NRF-2015R1C1A1A01052432,
   NRF-2018R1C1B6004439]; Korean Diabetes Association [2017F-1]; 
   [NRF-2016R1D1A1A09916900];  [NRF-2017R1E1A1A01075126]
FX This work was supported by the Basic Science Research Program, through
   the National Research Foundation of Korea (NRF), funded by the Ministry
   of Science, ICT, and Future Planning, Korea (NRF-2015R1C1A1A01052432;
   NRF-2018R1C1B6004439), the Research fund of the Korean Diabetes
   Association (H-S. Yi, 2017F-1), and NRF-2016R1D1A1A09916900;
   NRF-2017R1E1A1A01075126.
CR Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959
   Alber HF, 2009, INT J CARDIOL, V135, P27, DOI 10.1016/j.ijcard.2008.03.010
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342
   Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103
   Brugaletta S, 2006, HEART, V92, P249, DOI 10.1136/hrt.2004.052282
   Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159
   Byun JS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6862439
   Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110
   Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233
   Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172
   Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566
   Giubilato S, 2011, EUR HEART J, V32, P1214, DOI 10.1093/eurheartj/ehq499
   Grossmann V, 2015, DIABETES CARE, V38, P1356, DOI 10.2337/dc14-3008
   Haffner SM, 2003, DIABETES RES CLIN PR, V61, pS9, DOI 10.1016/S0168-8227(03)00122-0
   Hoffmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047155
   Jeng MY, 2018, J EXP MED, V215, P51, DOI 10.1084/jem.20161066
   Kaneto H, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/453892
   Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145
   Lee YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30656
   Link A, 2011, CLIN RES CARDIOL, V100, P147, DOI 10.1007/s00392-010-0225-8
   Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001
   Maeda T, 2002, ARTHRITIS RHEUM, V46, P379, DOI 10.1002/art.10133
   McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636
   Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1
   Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Ortiz-Suárez A, 2002, CLIN IMMUNOL, V104, P282, DOI 10.1006/clim.2002.5221
   Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x
   Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415
   Palmer BE, 2007, J ALLERGY CLIN IMMUN, V120, P184, DOI 10.1016/j.jaci.2007.03.009
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380
   Previte DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175549
   Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011
   Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105
   Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606
   Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812
   STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434
   Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x
   Vallejo AN, 1999, J IMMUNOL, V162, P6572
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013
   Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001
   Yi HS, 2014, HEPATOLOGY, V60, P1044, DOI 10.1002/hep.27137
   Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689
NR 48
TC 56
Z9 63
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAR 13
PY 2019
VL 10
AR 249
DI 10.1038/s41419-019-1494-4
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HQ4XG
UT WOS:000462414000002
PM 30867412
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ota, A
AF Ota, A
TI [<SUP>32</SUP>P]orthophosphate incorporation into phospholipids in rat
   liver mitochondria and ageing
SO BIOMEDICAL LETTERS
LA English
DT Article
DE mitochondria; phospholipids; ageing; oxygen stress; apoptosis
ID BINDING
AB Phosphate incorporation into phospholipids was examined in rat liver mitochondria. About 67% of the total phosphate incorporated was observed in phosphatidylcholine (lecithin). It is suggested that an excess amount of phospholipids or peroxidation of phospholipids might accelerate ageing. It may be that catalase, superoxide dismutase, peroxidase, nitric oxide, glutathione and redoxin eliminate peroxides in the cells and protect against inactivation of cytochrome oxidase. In this way cells could be defended from oxygen stress and decreased efficiency of energy production, and ageing and cancer, might be prevented. It is likely that the promotion of ageing is caused by the inactivation of cytochrome oxidase and it is assumed that physiological function of catalase, superoxide dismutase and peroxidase might prevent the inactivation of cytochrome oxidase, slow ageing and furthermore protect cells from apoptosis. It is suggested that as the mitochondrial functions decline so ageing accelerates.
RP Ota, A (corresponding author), Osaka Univ, Sch Med, Dept Mol Physiol Chem, 2-2 Yamadaoka, Suita, Osaka 565, Japan.
CR DITTMER JC, 1964, J LIPID RES, V5, P126
   FILLINGAME RH, 1980, ANNU REV BIOCHEM, V49, P1079, DOI 10.1146/annurev.bi.49.070180.005243
   GEAR ARL, 1967, J BIOL CHEM, V242, P3403
   GURR MI, 1965, BIOCHIM BIOPHYS ACTA, V106, P357, DOI 10.1016/0005-2760(65)90044-5
   LEHNINGER AL, 1971, ARCH BIOCHEM BIOPHYS, V143, P506, DOI 10.1016/0003-9861(71)90235-9
   Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275
   OHNISHI T, 1966, J BIOL CHEM, V241, P1797
   OTA A, 1979, INT J BIOCHEM, V10, P1033, DOI 10.1016/0020-711X(79)90085-5
   OTA A, 1983, CELL MOL BIOL, V29, P149
   OTA A, 1990, MED HYPOTHESES, V32, P37, DOI 10.1016/0306-9877(90)90065-M
   OTA A, 1982, INT J BIOCHEM, V14, P341, DOI 10.1016/0020-711X(82)90015-5
   OTA A, 1965, J BIOCHEM-TOKYO, V58, P515, DOI 10.1093/oxfordjournals.jbchem.a128235
   OTA A, 1980, MICROBIOS, V27, P133
   OTA A, 1964, J BIOCHEM-TOKYO, V55, P131
   OTA A, 1983, CELL MOL BIOL, V29, P465
   Ota A, 1996, BIOMED LETT, V54, P147
   OTA A, 1965, J BIOCHEM-TOKYO, V58, P137, DOI 10.1093/oxfordjournals.jbchem.a128175
   OTA A, 1979, 11 INT C BIOCH TOR C, P452
   OTA A, 1998, IN PRESS MED HYPOTHE
   OTA A, 1991, 3 INT C COMP PHYS BI, P481
   PARKER F, 1965, J LIPID RES, V6, P455
   SCHNEIDER WC, 1950, J BIOL CHEM, V183, P123
   SKIPSKI VP, 1965, BIOCHIM BIOPHYS ACTA, V106, P386, DOI 10.1016/0005-2760(65)90047-0
   WEINHOLD PA, 1965, BIOCHIM BIOPHYS ACTA, V106, P540, DOI 10.1016/0005-2760(65)90070-6
   YAMANAKA T, 1961, J BIOCHEM-TOKYO, V49, P414, DOI 10.1093/oxfordjournals.jbchem.a127319
   YAMANAKA T, 1962, J BIOCHEM-TOKYO, V51, P253, DOI 10.1093/oxfordjournals.jbchem.a127529
   YAMANAKA T, 1964, J BIOCH, V55, P131
   YAMANAKA T, 1964, 6 INT C BIOCH NEW YO
   Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615
NR 29
TC 0
Z9 0
U1 0
U2 1
PU FACULTY PRESS
PI CAMBRIDGE
PA 88 REGENT ST, CAMBRIDGE, CAMBS, ENGLAND CB2 1DP
SN 0961-088X
J9 BIOMED LETT
JI Biomed. Lett.
PY 1998
VL 57
IS 226
BP 121
EP 126
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 101XA
UT WOS:000074892400007
DA 2024-02-19
ER

PT J
AU Haduch, A
   Bromek, E
   Kuban, W
   Basinska-Ziobrón, A
   Danek, PJ
   Alenina, N
   Bader, M
   Daniel, WA
AF Haduch, Anna
   Bromek, Ewa
   Kuban, Wojciech
   Basinska-Ziobron, Agnieszka
   Danek, Przemyslaw
   Alenina, Natalia
   Bader, Michael
   Daniel, Wladyslawa
TI The effect of brain serotonin deficit (TPH2-KO) on the expression and
   activity of liver cytochrome P450 enzymes in aging male Dark Agouti rats
SO PHARMACOLOGICAL REPORTS
LA English
DT Article; Early Access
DE Cytochrome P450 and b(5); Rat liver; Ageing; Brain serotonin;
   TPH2-deficit; Serum hormones
ID AGE-RELATED-CHANGES; ANTIDEPRESSANT DRUGS; WISTAR RATS; METABOLISM;
   BIOTRANSFORMATION; PHARMACOKINETICS; ISOFORMS; PATHWAY; GENDER; SYSTEM
AB BackgroundLiver cytochrome P450 (CYP) greatly contributes to the metabolism of endogenous substances and drugs. Recent studies have demonstrated that CYP expression in the liver is controlled by the central nervous system via hormonal pathways. In particular, the expression of hepatic CYPs is negatively regulated by the brain serotoninergic system. The present study aimed to investigate changes in the function of the main liver drug-metabolizing CYP enzymes as a result of serotonin depletion in the brain of aging rats, caused by knockout of brain tryptophan hydroxylase gene (TPH2-KO).MethodsThe hepatic CYP mRNA (qRT-PCR), protein level (Western blotting) and activity (HPLC), and serum hormone levels (ELISA) were measured in Dark Agouti wild-type (WT) male rats (mature 3.5-month-old and senescent 21-month-old) and in TPH2-KO senescent animals.ResultsThe expression/activity of the studied CYPs decreased with age in the liver of wild-type rats. The deprivation of serotonin in the brain of aging males decreased the mRNA level of most of the studied CYPs (CYP1A/2A/2B/3A), and lowered the protein level of CYP2C11 and CYP3A. In contrast, the activities of CYP2C11, CYP3A and CYP2C6 were increased. The expression of cytochrome b5 decreased in aging rats, but increased in TPH2-deficient senescent animals. The serum concentration of growth hormone declined in the aged and further dropped down in TPH2-deficient senescent rats.ConclusionsRat liver cytochrome P450 functions deteriorate with age, which may impair drug metabolism. The TPH2 knockout, which deprives brain serotonin, affects cytochrome P450 expression and activity differently in mature and senescent male rats.
C1 [Haduch, Anna; Bromek, Ewa; Kuban, Wojciech; Basinska-Ziobron, Agnieszka; Danek, Przemyslaw; Daniel, Wladyslawa] Polish Acad Sci, Maj Inst Pharmacol, Dept Pharmacokinet & Drug Metab, Smetna 12, PL-31343 Krakow, Poland.
   [Alenina, Natalia; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Alenina, Natalia; Bader, Michael] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany.
   [Bader, Michael] Univ Lubeck, Inst Biol, Lubeck, Germany.
   [Bader, Michael] Charite, Berlin, Germany.
C3 Polish Academy of Sciences; Maj Institute of Pharmacology of the Polish
   Academy of Sciences; Helmholtz Association; Max Delbruck Center for
   Molecular Medicine; German Centre for Cardiovascular Research;
   University of Lubeck; Free University of Berlin; Humboldt University of
   Berlin; Charite Universitatsmedizin Berlin
RP Daniel, WA (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Pharmacokinet & Drug Metab, Smetna 12, PL-31343 Krakow, Poland.
EM nfdaniel@cyf-kr.edu.pl
OI Daniel, Wladyslawa Anna/0000-0002-1226-1721
FU Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow,
   Poland [NCN OPUS 23 2022/45/B/NZ7/02419]; Max-Delbrueck-Center for
   Molecular Medicine, Berlin, Germany
FX We gratefully acknowledge support from the grant NCN OPUS 23
   2022/45/B/NZ7/02419 and the Statutory Activity of the Maj Institute of
   Pharmacology, Polish Academy of Sciences, Krakow, Poland, and
   Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.
CR Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136
   Arivazhagan P, 2002, EXP GERONTOL, V37, P803, DOI 10.1016/S0531-5565(02)00015-3
   Bader M, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00288
   Bromek E, 2021, EXPERT OPIN DRUG MET, V17, P413, DOI 10.1080/17425255.2021.1872543
   Bromek E, 2019, DRUG METAB DISPOS, V47, P80, DOI 10.1124/dmd.118.083808
   Bromek E, 2018, DRUG METAB DISPOS, V46, P786, DOI 10.1124/dmd.117.079632
   Burin LM, 2022, PSYCHIAT RES, V314, DOI 10.1016/j.psychres.2022.114680
   Daniel WA, 2006, EUR NEUROPSYCHOPHARM, V16, P580, DOI 10.1016/j.euroneuro.2006.01.004
   Daniel WA, 2000, BRIT J PHARMACOL, V131, P287, DOI 10.1038/sj.bjp.0703540
   Daniel WA, 2022, BIOCHEM PHARMACOL, V199, DOI 10.1016/j.bcp.2022.115006
   Fan PH, 2023, CPT-PHARMACOMET SYST, V12, P1119, DOI 10.1002/psp4.12979
   GEORGE J, 1995, BIOCHEM PHARMACOL, V50, P727, DOI 10.1016/0006-2952(95)00192-3
   Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437
   Haduch A, 2006, EUR NEUROPSYCHOPHARM, V16, P178, DOI 10.1016/j.euroneuro.2005.08.004
   Haduch A, 2022, NEUROCHEM INT, V152, DOI 10.1016/j.neuint.2021.105223
   Haduch A, 2020, NEUROCHEM INT, V141, DOI 10.1016/j.neuint.2020.104884
   Jami ES, 2023, J MENT HEALTH, V32, P71, DOI 10.1080/09638237.2021.1922632
   Kaplan K, 2016, J APPL PHYSIOL, V120, P1070, DOI 10.1152/japplphysiol.01015.2015
   Kim D, 2021, DRUG METAB DISPOS, V49, P902, DOI 10.1124/dmd.121.000475
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Konstandi M, 2023, FRONT ENDOCRINOL, V14, DOI 10.3389/fendo.2023.1143835
   Kot M, 2008, BIOCHEM PHARMACOL, V75, P1538, DOI 10.1016/j.bcp.2007.12.017
   Míguez JM, 1999, J NEURAL TRANSM, V106, P1089, DOI 10.1007/s007020050225
   Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010
   Rysz M, 2016, BIOCHEM PHARMACOL, V112, P82, DOI 10.1016/j.bcp.2016.04.017
   Rysz M, 2016, BIOCHEM PHARMACOL, V99, P113, DOI 10.1016/j.bcp.2015.11.014
   Rysz M, 2015, DRUG METAB DISPOS, V43, P1345, DOI 10.1124/dmd.115.064980
   Saleem S, 2014, PAK J PHARM SCI, V27, P837
   Salmin SF, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3786
   Schenkman JB, 1999, DRUG METAB REV, V31, P351, DOI 10.1081/DMR-100101923
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226
   Shi SJ, 2011, CURR DRUG METAB, V12, P601, DOI 10.2174/138920011796504527
   Spies M, 2023, TRANSL PSYCHIAT, V13, DOI 10.1038/s41398-023-02506-2
   Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012
   Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6
   Warrington JS, 2004, J PHARM PHARMACOL, V56, P819, DOI 10.1211/0022357023529
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   Wauthier V, 2006, EXP GERONTOL, V41, P846, DOI 10.1016/j.exger.2006.06.046
   Wauthier V, 2006, LIFE SCI, V79, P1913, DOI 10.1016/j.lfs.2006.06.046
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   Xu SF, 2019, PEERJ, V7, DOI 10.7717/peerj.7429
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
NR 44
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1734-1140
EI 2299-5684
J9 PHARMACOL REP
JI Pharmacol. Rep.
PD 2023 DEC
PY 2023
VL 75
IS 6
SI SI
BP 1522
EP 1532
DI 10.1007/s43440-023-00540-x
EA OCT 2023
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA Y0ZF5
UT WOS:001091485100001
PM 37848703
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Gonzalez-Rellan, MJ
   Novoa, E
   Lima, ND
   Rodriguez, A
   Veyrat-Durebex, C
   Seoane, S
   Porteiro, B
   Fondevila, MF
   Fernandez, U
   Varela-Rey, M
   Senra, A
   Iglesias, C
   Escudero, A
   Fidalgo, M
   Guallar, D
   Perez-Fernandez, R
   Prevot, V
   Schwaninger, M
   López, M
   Dieguez, C
   Coppari, R
   Frühbeck, G
   Nogueiras, R
AF Gonzalez-Rellan, Maria J.
   Novoa, Eva
   da Silva Lima, Natalia
   Rodriguez, Amaia
   Veyrat-Durebex, Christelle
   Seoane, Samuel
   Porteiro, Begona
   Fondevila, Marcos F.
   Fernandez, Uxia
   Varela-Rey, Marta
   Senra, Ana
   Iglesias, Cristina
   Escudero, Adriana
   Fidalgo, Miguel
   Guallar, Diana
   Perez-Fernandez, Roman
   Prevot, Vincent
   Schwaninger, Markus
   Lopez, Miguel
   Dieguez, Carlos
   Coppari, Roberto
   Fruhbeck, Gema
   Nogueiras, Ruben
TI Hepatic p63 regulates glucose metabolism by repressing SIRT1
SO GUT
LA English
DT Article; Early Access
DE liver; glucose metabolism; diabetes mellitus; diet
ID P53; TAP63; TUMORIGENESIS; HOMEOSTASIS; STEATOSIS; CANCER
AB Objective p63 is a transcription factor within the p53 protein family that has key roles in development, differentiation and prevention of senescence, but its metabolic actions remain largely unknown. Herein, we investigated the physiological role of p63 in glucose metabolism. Design We used cell lines and mouse models to genetically manipulate p63 in hepatocytes. We also measured p63 in the liver of patients with obesity with or without type 2 diabetes (T2D). Results We show that hepatic p63 expression is reduced on fasting. Mice lacking the specific isoform TAp63 in the liver (p63LKO) display higher postprandial and pyruvate-induced glucose excursions. These mice have elevated SIRT1 levels, while SIRT1 knockdown in p63LKO mice normalises glycaemia. Overexpression of TAp63 in wild-type mice reduces postprandial, pyruvate-induced blood glucose and SIRT1 levels. Studies carried out in hepatocyte cell lines show that TAp63 regulates SIRT1 promoter by repressing its transcriptional activation. TAp63 also mediates the inhibitory effect of insulin on hepatic glucose production, as silencing TAp63 impairs insulin sensitivity. Finally, protein levels of TAp63 are reduced in obese persons with T2D and are negatively correlated with fasting glucose and homeostasis model assessment index. Conclusions. These results demonstrate that p63 physiologically regulates glucose homeostasis.
C1 [Gonzalez-Rellan, Maria J.; Novoa, Eva; da Silva Lima, Natalia; Seoane, Samuel; Porteiro, Begona; Fondevila, Marcos F.; Fernandez, Uxia; Senra, Ana; Iglesias, Cristina; Escudero, Adriana; Fidalgo, Miguel; Perez-Fernandez, Roman; Lopez, Miguel; Dieguez, Carlos; Nogueiras, Ruben] Univ Santiago de Compostela, Dept Physiol, CIMUS, Santiago De Compostela, Spain.
   [Gonzalez-Rellan, Maria J.; Rodriguez, Amaia; Lopez, Miguel; Dieguez, Carlos; Fruhbeck, Gema; Nogueiras, Ruben] CIBER Fisiopatol Obesidad & Nutr, CIBERobn, Madrid, Spain.
   [Rodriguez, Amaia; Fruhbeck, Gema] Clin Univ Navarra, Dept Endocrinol & Nutr, Metab Res Lab, Navarra, Spain.
   [Veyrat-Durebex, Christelle; Coppari, Roberto] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland.
   [Veyrat-Durebex, Christelle; Coppari, Roberto] Univ Geneva, Fac Med, Diabet Ctr, Geneva, Switzerland.
   [Varela-Rey, Marta] Univ Santiago de Compostela, Gene Regulatory Control Dis, CIMUS, Santiago De Compostela, Spain.
   [Guallar, Diana] Inst Invest Sanitaria, Dept Biochem, CIMUS, Santiago De Compostela, Spain.
   [Prevot, Vincent] Univ Lille, European Genom Inst Diabet EGID, Lab Dev & Plast Neuroendocrine Brain, INSERM, Paris, France.
   [Schwaninger, Markus] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, Lubeck, Germany.
   [Nogueiras, Ruben] Xunta Galicia, Galician Agcy Innovat GAIN, Santiago De Compostela, Spain.
C3 Universidade de Santiago de Compostela; CIBER - Centro de Investigacion
   Biomedica en Red; CIBEROBN; University of Navarra; University of Geneva;
   University of Geneva; Universidade de Santiago de Compostela;
   Universidade de Santiago de Compostela; Institut National de la Sante et
   de la Recherche Medicale (Inserm); Universite de Lille; University of
   Lubeck
RP Nogueiras, R (corresponding author), Inst Invest Sanitaria, Dept Physiol, CIMUS, Valencia, Spain.
EM ruben.nogueiras@usc.es
RI Schwaninger, Markus/JWP-5801-2024; López, Miguel/ABF-4844-2021; Guallar,
   Diana/AAJ-1812-2020; Coppari, Roberto/B-4799-2014; Gonzalez Rellan,
   Maria Jesus/GQR-0377-2022; Fidalgo, Miguel/I-7006-2019; Seoane, Samuel
   SSR/L-1309-2014; Prevot, Vincent/E-5720-2016; Perez-Fernandez,
   Roman/L-6342-2014
OI López, Miguel/0000-0002-7823-1648; Guallar, Diana/0000-0001-5834-7507;
   Gonzalez Rellan, Maria Jesus/0000-0001-8986-9244; Fidalgo,
   Miguel/0000-0003-1134-2674; Fernandez, Uxia/0000-0001-9728-2590; DA
   SILVA LIMA, NATALIA/0000-0001-9448-4090; Prevot,
   Vincent/0000-0001-7185-3615; Perez-Fernandez, Roman/0000-0002-5894-0615;
   COPPARI, Roberto/0000-0003-1288-6948; Fernandez Fondevila,
   Marcos/0000-0002-5099-3421
FU FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal
   de Investigacion [BFU2017-87721, RTI2018-101840-B-I00,
   RTI2018-099413-B-I00, RED2018-102379-T]; Xunta de Galicia [2016-PG068,
   2021-CP085, 2020-PG015]; Fundacion BBVA [BBM_BAS_0062]; Fundacion
   Atresmedia [2018-PO055]; Fundacion Jesus Serra [2021-003]; European
   Foundation for the Study of Diabetes [2018-PO069]; FIS-FEDER
   [PI19/00785, PI19/00990]; European Community's H2020 Framework Programme
   (ERC Synergy Grant) [2019-WATCH-810331]; Centro de Investigacion
   Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion
   (CIBERobn); CIBER de Enfermedades Hepaticas y Digestivas (CIBERehd);
   FEDER funds
FX This work has been supported by grants from FEDER/Ministerio de Ciencia,
   Innovacion y Universidades-Agencia Estatal de Investigacion (CD:
   BFU2017-87721; ML: RTI2018-101840-B-I00; RN: RTI2018-099413-B-I00 and
   RED2018-102379-T), Xunta de Galicia (ML: 2016-PG068; RN: 2021-CP085 and
   2020-PG015), Fundacion BBVA (RN: BBM_BAS_0062), Fundacion Atresmedia (ML
   and RN: 2018-PO055), Fundacion Jesus Serra (RN: 2021-003), European
   Foundation for the Study of Diabetes (RN: 2018-PO069) and FIS-FEDER (GF:
   PI19/00785; AR: PI19/00990). This research also received funding from
   the European Community's H2020 Framework Programme (ERC Synergy
   Grant-2019-WATCH-810331, to RN, VP and MS). Centro de Investigacion
   Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion
   (CIBERobn), CIBER de Enfermedades Hepaticas y Digestivas (CIBERehd).
   CIBERobn and CIBERehd are initiatives of the Instituto de Salud Carlos
   III (ISCIII) of Spain which is supported by FEDER funds.
CR Allocati N, 2012, EXP CELL RES, V318, P1285, DOI 10.1016/j.yexcr.2012.01.023
   Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019
   Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797
   Candi E, 2017, BIOCHEM BIOPH RES CO, V482, P440, DOI 10.1016/j.bbrc.2016.10.094
   de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136
   Edgerton DS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126974
   Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200
   Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008
   Geisler CE, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0122-x
   Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005
   Gonzalez-Rellan MJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25390-0
   Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988
   Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77
   Hsieh MH, 2019, CELL REP, V28, P1860, DOI 10.1016/j.celrep.2019.07.027
   Ihrie RA, 2006, CELL DEATH DIFFER, V13, P1614, DOI 10.1038/sj.cdd.4401871
   Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927
   Lee S, 2017, J ENDOCRINOL, V233, pR67, DOI 10.1530/JOE-17-0002
   Levine S, 2000, LAB ANIM-UK, V34, P301, DOI 10.1258/002367700780384735
   Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101
   Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349
   Liu Y, 2014, P NATL ACAD SCI USA, V111, pE2414, DOI 10.1073/pnas.1315605111
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Porteiro B, 2018, MOL METAB, V8, P132, DOI 10.1016/j.molmet.2017.12.005
   Porteiro B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15111
   Prokesch A, 2017, FASEB J, V31, P732, DOI 10.1096/fj.201600845R
   Quiñones M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05711-6
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Sabbisetti V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005877
   Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500
   Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006
   Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003
   Wang CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03796-7
   Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0
   Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107
NR 35
TC 2
Z9 2
U1 4
U2 18
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD 2023 MAR
PY 2023
VL 72
IS 3
BP 472
EP +
DI 10.1136/gutjnl-2021-326620
EA MAY 2022
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA A1HN6
UT WOS:000797587700001
PM 35580962
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Obata, M
   Imamura, E
   Yoshida, Y
   Goto, J
   Kishibe, K
   Yasuda, A
   Ogawa, K
AF Obata, M
   Imamura, E
   Yoshida, Y
   Goto, J
   Kishibe, K
   Yasuda, A
   Ogawa, K
TI Resistance of primary cultured mouse hepatic tumor cells to cellular
   senescence despite expression of p16<SUP>Ink4a</SUP>, p19<SUP>Arf</SUP>,
   p53, and p21<SUP>Waf1/Cip1</SUP>
SO MOLECULAR CARCINOGENESIS
LA English
DT Article
DE cultured tumor cells; experimental liver tumors; mice
ID SUPPRESSOR GENE; REPLICATIVE SENESCENCE; BETA-CATENIN; CYCLE ARREST;
   P53-DEPENDENT APOPTOSIS; TRANSCRIPTION FACTOR; ALLELIC LOSSES; EARLY
   EVENT; IN-VIVO; FREQUENT
AB Primary cultured mouse hepatic cells become senescent within a short period, although rare cells form colonies from which continuously proliferating cell lines can be established. In contrast, hepatic tumor (HT) cells show little senescence and higher colony-forming capacity. To assess this difference, we investigated p16(Ink4a)/p19(Arf)/p53/p21(Waf1/Cip1) expression in primary normal and FIT cells, together with cell lines established from both. In primary normal cells, p16(Ink4a)/p19(Arf) were expressed only in association with senescence and disappeared at later stages of colony formation. In contrast, primary HT cells showed sustained p16(Ink4a)/p19(Arf) expression from the beginning. No p16(Ink4a)/ p19(Arf) alterations, such as deletion, mutations, or hypermethylation, were detected in the primary HT cells, although most cell lines derived from either normal or HIT cell colonies lost p16(Ink4a), or p19(Arf) expression owing to hypermethylation or homozygous deletion of p16(Ink4a)/p19(Arf), On the other hand, primary normal and HT cells and most cell lines showed constitutively elevated expression of p53/p21(Waf1/Cip1), with a further increment after ultraviolet ir radiation, indicating a functionally normal p53 pathway. These results indicate that primary HT cells are resistant to senescence despite retaining p16(Ink4a)/p19(Arf)/p53/p21(Waf1/ciP1) expression and that loss of p16(Ink4a)/p19(Arf) function is associated only with establishment of the cell lines. (C) 2001 Wiley-Liss, Inc.
C1 Asahikawa Med Coll, Dept Pathol, Asahikawa, Hokkaido 078, Japan.
C3 Asahikawa Medical College
RP Ogawa, K (corresponding author), Asahikawa Med Coll, Dept Pathol, 2-1-1-1 East, Asahikawa, Hokkaido 078, Japan.
CR Asamoto M, 1998, CANCER LETT, V127, P9, DOI 10.1016/S0304-3835(97)00447-3
   Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867
   Belinsky SA, 1997, CARCINOGENESIS, V18, P115, DOI 10.1093/carcin/18.1.115
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Burkhart BA, 1999, EXP CELL RES, V247, P168, DOI 10.1006/excr.1998.4345
   Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x
   Carman TA, 1998, EXP CELL RES, V244, P33, DOI 10.1006/excr.1998.4207
   Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020
   de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
   de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434
   Devereux TR, 1999, ONCOGENE, V18, P4726, DOI 10.1038/sj.onc.1202858
   Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000
   Dulic V, 2000, MOL CELL BIOL, V20, P6741, DOI 10.1128/MCB.20.18.6741-6754.2000
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   ELDEIRY WS, 1995, CANCER RES, V55, P2910
   Gause PR, 1997, MOL CARCINOGEN, V20, P78, DOI 10.1002/(SICI)1098-2744(199709)20:1<78::AID-MC9>3.0.CO;2-E
   Gorospe M, 1999, GENE EXPRESSION, V7, P377
   Groth A, 2000, J BIOL CHEM, V275, P27473
   GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0
   Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6
   HARPER JW, 1993, CELL, V75, P805
   HAYFLICK L, 1975, FED PROC, V34, P9
   HEGI ME, 1994, CANCER RES, V54, P6257
   Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821
   HERZOG CR, 1995, ONCOGENE, V11, P1811
   Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993
   Ishizaki K, 2000, INT J CANCER, V86, P251
   Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476
   KADOHAMA T, 1994, ONCOGENE, V9, P2845
   KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634
   Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3
   KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201
   Lee GH, 1995, ONCOGENE, V11, P2281
   MANENTI G, 1995, MOL CARCINOGEN, V13, P191, DOI 10.1002/mc.2940130309
   MARONPOT RR, 1995, TOXICOLOGY, V101, P125, DOI 10.1016/0300-483X(95)03112-S
   MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686
   MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0
   NEWBOLD RF, 1982, NATURE, V299, P633, DOI 10.1038/299633a0
   NISHIMORI H, 1994, INT J CANCER, V59, P108, DOI 10.1002/ijc.2910590120
   NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   Ogawa K, 1999, CANCER RES, V59, P1830
   Ogawa K, 1999, CARCINOGENESIS, V20, P2083, DOI 10.1093/carcin/20.11.2083
   Palmero I, 1997, ONCOGENE, V15, P495, DOI 10.1038/sj.onc.1201212
   Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870
   Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880
   PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329
   Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2
   PONTEN J, 1976, BIOCHIM BIOPHYS ACTA, V458, P397, DOI 10.1016/0304-419X(76)90009-3
   Prives C, 1999, J PATHOL, V187, P112
   Qin LF, 1998, INT J CANCER, V79, P424, DOI 10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4
   QUELLE DE, 1995, CELL, V83, P993
   Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669
   QUELLE DE, 1995, ONCOGENE, V11, P635
   Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194
   Russo I, 1998, ONCOGENE, V17, P3417, DOI 10.1038/sj.onc.1202261
   SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170
   Santos J, 1996, ONCOGENE, V12, P669
   Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5
   Sherr CJ, 2000, CANCER RES, V60, P3689
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001
   TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299
   VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253
   WISEMAN RW, 1994, P NATL ACAD SCI USA, V91, P3759, DOI 10.1073/pnas.91.9.3759
   Wynford-Thomas D, 1999, J PATHOL, V187, P100
   XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0
   Yoshie M, 1998, CARCINOGENESIS, V19, P1103, DOI 10.1093/carcin/19.6.1103
   Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X
   Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997
   Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 78
TC 5
Z9 6
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0899-1987
EI 1098-2744
J9 MOL CARCINOGEN
JI Mol. Carcinog.
PD SEP
PY 2001
VL 32
IS 1
BP 9
EP 18
DI 10.1002/mc.1059
PG 10
WC Biochemistry & Molecular Biology; Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology
GA 480FE
UT WOS:000171450700002
PM 11568971
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   MOORE, DR
   SNOWDEN, CD
AF RIKANS, LE
   MOORE, DR
   SNOWDEN, CD
TI SEX-DEPENDENT DIFFERENCES IN THE EFFECTS OF AGING ON ANTIOXIDANT
   DEFENSE-MECHANISMS OF RAT-LIVER
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE AGING; SEXUAL DIMORPHISM; CATALASE; SUPEROXIDE DISMUTASE; GLUTATHIONE
   REDUCTASE; GLUTATHIONE PEROXIDASE
ID SUPEROXIDE-DISMUTASE ACTIVITY; DRUG-METABOLIZING-ENZYMES;
   AGE-RELATED-CHANGES; GLUTATHIONE-PEROXIDASE; DIETARY RESTRICTION;
   OXIDATIVE STRESS; LIPID-PEROXIDATION; FOOD RESTRICTION; ALLYL ALCOHOL;
   FEMALE RATS
AB Information about age-related factors that influence sensitivity to hepatotoxic injury is important to geriatric medicine and environmental health. The purpose of the present study was to determine whether age-associated changes occur in hepatic antioxidant defense mechanisms of male and female Fischer 344 rats. Liver homogenates and post-mitochondrial supernatant fractions from rats aged 4, 14, 24 and 29 months were analyzed for antioxidant enzyme activities and for vitamin E and malondialdehyde content. Age-associated changes in catalase and glutathione reductase activities were observed that could be described as sex-determined differences that disappeared in old age. Cytosolic superoxide dismutase and glutathione peroxidase activities displayed sex-dependent variations in activity but were unaffected by aging. Hepatic vitamin E concentrations were lower in male rats than in female rats and increased with age. Hepatic malondialdehyde concentrations also were lower in males than in females; malondialdehyde content increased in old males and decreased in old females. The results indicate that age-associated changes in enzymatic and nonenzymatic antioxidant defense mechanisms of rat liver are sex-dependent. In addition, comparison with findings from other studies in rats suggests that the effects of aging may also depend on the strain of rat.
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, DEPT PHARMACOL, COLL MED, POB 26901, OKLAHOMA CITY, OK 73190 USA.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   BORGHOFF SJ, 1986, DRUG METAB DISPOS, V14, P417
   Buege J A, 1978, Methods Enzymol, V52, P302
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CHEN TS, 1990, DRUG METAB DISPOS, V18, P882
   Crapo J D, 1978, Methods Enzymol, V53, P382
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   IMRE S, 1987, MECH AGEING DEV, V38, P259, DOI 10.1016/0047-6374(87)90094-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KAPPUS H, 1987, ARCH TOXICOL, V60, P144, DOI 10.1007/BF00296968
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   KIM JW, 1989, MECH AGEING DEV, V50, P277, DOI 10.1016/0047-6374(89)90105-X
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457
   PORTA EA, 1981, MECH AGEING DEV, V15, P297, DOI 10.1016/0047-6374(81)90137-8
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RIKANS LE, 1989, MECH AGEING DEV, V48, P267, DOI 10.1016/0047-6374(89)90088-2
   RIKANS LE, 1988, DRUG CHEM TOXICOL, V11, P237, DOI 10.3109/01480548809017880
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   RIKANS LE, 1989, DRUG METAB REV, V20, P87, DOI 10.3109/03602538908994145
   RIKANS LE, 1990, ALCOHOL CLIN EXP RES, V14, P872, DOI 10.1111/j.1530-0277.1990.tb01830.x
   RIKANS LE, 1989, LIFE SCI, V45, P1373, DOI 10.1016/0024-3205(89)90024-6
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   RIKANS LE, 1987, J PHARMACOL EXP THER, V243, P20
   RIKANS LE, 1987, ALCOHOL CLIN EXP RES, V11, P562, DOI 10.1111/j.1530-0277.1987.tb00175.x
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   VERHAGEN H, 1988, J LIQ CHROMATOGR, V11, P2977, DOI 10.1080/01483918808076773
   WEGLICKI WB, 1969, NATURE, V221, P185, DOI 10.1038/221185a0
   ZHANG LP, 1989, BIOCHIM BIOPHYS ACTA, V1006, P140, DOI 10.1016/0005-2760(89)90336-6
NR 40
TC 109
Z9 113
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
JI Biochim. Biophys. Acta
PD MAY 24
PY 1991
VL 1074
IS 1
BP 195
EP 200
DI 10.1016/0304-4165(91)90061-K
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA FQ679
UT WOS:A1991FQ67900033
PM 2043671
DA 2024-02-19
ER

PT J
AU Suzuki, A
   Sakaguchi, T
   Inaba, K
   Suzuki, S
   Konno, H
AF Suzuki, Atsushi
   Sakaguchi, Takanori
   Inaba, Keisuke
   Suzuki, Shohachi
   Konno, Hiroyuki
TI Impact of Cell Cycle Disruption on Impaired Hepatic Regeneration in Aged
   Livers with Ischemic Insult
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE aging; liver regeneration; IL-6/STAT3 pathway; cell cycle; ischemia and
   reperfusion injury
ID NF-KAPPA-B; REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY;
   HEPATOCELLULAR-CARCINOMA; ELDERLY-PATIENTS; RAT-LIVER; ACTIVATION; MICE;
   HEPATOCYTES; APOPTOSIS
AB Background. The number of elderly patients with hepatobiliary malignancies has increased with the steady growth of elderly population. However, the safety of major hepatectomy for elderly patients remains controversial. This study investigated the effect of aging on the hepatic regenerative response after partial resection of livers subjected to ischemic insult.
   Methods. Two-thirds hepatectomy following 1-h hepatic ischemia was performed in young (12-wk-old) and old (18-mo-old) rats under portosystemic shunt establishment by subcutaneous transposition of the spleen.
   Results. The survival rate 48 h after hepatectomy of the old rats was significantly lower (20%) than that of the young rats (53%), whereas all animals without hepatic ischemia were alive at 48 h. Hepatic necrosis and hepatocyte apoptosis during the early post-hepatectomy phase were more severe in the aged livers, which also showed delayed Akt activation. Liver mass restoration was significantly retarded in the old rats, despite higher plasma IL-6 levels, rapid and prolonged activation of hepatic STAT3, and increased hepatocyte nuclear cyclin D1 levels. In the young livers, cyclin E, which is essential for G1/S transition, and cyclin A, a marker of S phase, were observed in the nucleus from 24 h, reaching peaks 48 h after hepatectomy. In contrast, the old livers showed greatly delayed and decreased nuclear cyclin E and cyclin A levels.
   Conclusion. Age-related reductions in the regenerative ability of ischemically damaged livers may be caused by cell cycle disruption at either the late G1 phase or the G1/S transition, despite increased cyclin D1 levels and compensatory IL-6/STAT3 activation. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Suzuki, Atsushi] Hamamatsu Univ Sch Med, Dept Surg 2, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan.
   [Suzuki, Shohachi] Iwata City Hosp, Dept Surg, Iwata, Japan.
C3 Hamamatsu University School of Medicine
RP Suzuki, A (corresponding author), Hamamatsu Univ Sch Med, Dept Surg 2, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
EM maorio1215@ybb.ne.jp
CR BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0
   Bellas RE, 1997, AM J PATHOL, V151, P891
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3
   Debonera F, 2004, AM J TRANSPLANT, V4, P1964, DOI 10.1111/j.1600-6143.2004.00626.x
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Gagliano N, 2002, EXP GERONTOL, V37, P791, DOI 10.1016/S0531-5565(02)00022-0
   Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
   Haga S, 2005, J HEPATOL, V43, P799, DOI 10.1016/j.jhep.2005.03.027
   Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970
   Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X
   Harada N, 2004, J SURG RES, V121, P159, DOI 10.1016/j.jss.2004.04.016
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Huber N, 2009, HEPATOLOGY, V49, P1718, DOI 10.1002/hep.22840
   HUGUET C, 1992, SURGERY, V111, P251
   IJtsma AJC, 2008, J GASTROINTEST SURG, V12, P2196, DOI 10.1007/s11605-008-0563-2
   Imose M, 2003, LIVER INT, V23, P386, DOI 10.1034/j.1478-3231.2003.00867.x
   Kitano S, 1998, AM J PHYSIOL-CELL PH, V275, pC146, DOI 10.1152/ajpcell.1998.275.1.C146
   Kondo K, 2008, WORLD J SURG, V32, P2223, DOI 10.1007/s00268-008-9688-4
   Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG201, DOI 10.1152/ajpgi.00186.2006
   Kühnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421
   Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2
   Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200
   Matsumoto T, 2006, SURGERY, V140, P793, DOI 10.1016/j.surg.2006.04.010
   MEREDITH CG, 1981, CLIN EXP PHARMACOL P, V8, P651
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Morales-Ruiz M, 2007, AM J TRANSPLANT, V7, P769, DOI 10.1111/j.1600-6143.2006.01720.x
   MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U
   O'Farrell AM, 2000, J IMMUNOL, V164, P4607, DOI 10.4049/jimmunol.164.9.4607
   Ohtake Y, 2008, J HEPATOL, V48, P246, DOI 10.1016/j.jhep.2007.08.009
   Okamoto K, 2002, WORLD J SURG, V26, P1260, DOI 10.1007/s00268-002-6587-y
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Park Y, 2007, J SURG RES, V137, P96, DOI 10.1016/j.jss.2006.08.013
   Plümpe J, 2000, AM J PHYSIOL-GASTR L, V278, pG173, DOI 10.1152/ajpgi.2000.278.1.G173
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wüstefeld T, 2000, HEPATOLOGY, V32, P514, DOI 10.1053/jhep.2000.16604
NR 43
TC 8
Z9 8
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD APR
PY 2012
VL 173
IS 2
BP 267
EP 277
DI 10.1016/j.jss.2010.10.012
PG 11
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA 906IQ
UT WOS:000301339100019
PM 21109256
OA Green Submitted
DA 2024-02-19
ER

PT J
AU DEVASAGAYAM, TPA
AF DEVASAGAYAM, TPA
TI SENESCENCE-ASSOCIATED DECREASE OF NADPH-INDUCED LIPID-PEROXIDATION IN
   RAT-LIVER MICROSOMES
SO FEBS LETTERS
LA English
DT Article
RP DEVASAGAYAM, TPA (corresponding author), BHABHA ATOM RES CTR,DIV BIOCHEM,BOMBAY 400085,INDIA.
CR BAKERMAN S, 1969, AGING LIFE PROCESSES
   Bus J. S., 1979, REV BIOCH TOXICOLOGY, P125
   CUTLER RG, 1985, P NATL ACAD SCI USA, V82, P4798, DOI 10.1073/pnas.82.14.4798
   DEVASAGAYAM TPA, 1983, BIOCHIM BIOPHYS ACTA, V750, P91, DOI 10.1016/0005-2760(83)90207-2
   DEVASAGAYAM TPA, 1986, MECH AGEING DEV, V34, P13, DOI 10.1016/0047-6374(86)90101-6
   DEVASAGAYAM TPA, 1983, MECH AGEING DEV, V21, P365, DOI 10.1016/0047-6374(83)90053-2
   DEVASAGAYAM TPA, 1986, FEBS LETT, V199, P203, DOI 10.1016/0014-5793(86)80480-X
   DEVASAGAYAM TPA, 1985, BIOCHEM INT, V11, P833
   GALEOTTI T, 1984, FEBS LETT, V169, P169, DOI 10.1016/0014-5793(84)80312-9
   GRINNA LS, 1973, BIOCHEM BIOPH RES CO, V55, P773, DOI 10.1016/0006-291X(73)91211-4
   HOCHSTEIN P, 1963, BIOCHEM BIOPH RES CO, V12, P388, DOI 10.1016/0006-291X(63)90111-6
   LEUNG HW, 1981, BIOCHIM BIOPHYS ACTA, V664, P266
   LOKESH BR, 1981, J LIPID RES, V22, P905
   LU AYH, 1969, J BIOL CHEM, V244, P3714
   PEDERSON TC, 1972, BIOCHEM BIOPH RES CO, V48, P789, DOI 10.1016/0006-291X(72)90676-6
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   PUSHPENDRAN CK, 1983, DEV PHARMACOL THERAP, V6, P55, DOI 10.1159/000457277
   SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   TAKEUCHI N, 1976, EXP GERONTOL, V11, P179, DOI 10.1016/0531-5565(76)90031-0
   TAPPEL AL, 1973, FED PROC, V32, P1870
   VERICEL E, 1985, THROMB HAEMOSTASIS, V54, P553
   YAGI K, 1982, LIPID PEROXIDES BIOL
NR 24
TC 29
Z9 29
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD SEP 15
PY 1986
VL 205
IS 2
BP 246
EP 250
DI 10.1016/0014-5793(86)80906-1
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA E1064
UT WOS:A1986E106400016
PM 3091402
OA Bronze
DA 2024-02-19
ER

PT J
AU Brea, R
   Valdecantos, P
   Rada, P
   Alen, R
   García-Monzón, C
   Boscá, L
   Fuertes-Agudo, M
   Casado, M
   Martín-Sanz, P
   Valverde, AM
AF Brea, Rocio
   Valdecantos, Pilar
   Rada, Patricia
   Alen, Rosa
   Garcia-Monzon, Carmelo
   Bosca, Lisardo
   Fuertes-Agudo, Marina
   Casado, Marta
   Martin-Sanz, Paloma
   Valverde, Angela M.
TI Chronic treatment with acetaminophen protects against liver aging by
   targeting inflammation and oxidative stress
SO AGING-US
LA English
DT Article
DE APAP; aging; inflammation; liver; oxidative stress
ID TYROSINE-PHOSPHATASE 1B; AGE-ASSOCIATED CHANGES; HEME OXYGENASE-1;
   CYCLOOXYGENASE-2 EXPRESSION; T-CELL; INJURY; HEPATOTOXICITY; OBESITY;
   MICE; NRF2
AB The liver exhibits a variety of functions that are well-preserved during aging. However, the cellular hallmarks of aging increase the risk of hepatic alterations and development of chronic liver diseases. Acetaminophen (APAP) is a first choice for relieving mild-to-moderate pain. Most of the knowledge about APAP-mediated hepatotoxicity arises from acute overdose studies due to massive oxidative stress and inflammation, but little is known about its effect in age-related liver inflammation after chronic exposure. Our results show that chronic treatment of wild-type mice on the B6D2JRcc/Hsd genetic background with APAP at an infratherapeutic dose reduces liver alterations during aging without affecting body weight. This intervention attenuates age-induced mild oxidative stress by increasing HO-1, MnSOD and NQO1 protein levels and reducing ERK1/2 and p38 MAPK phosphorylation. More importantly, APAP treatment counteracts the increase in Cd8+and the reduction in Cd4+ T lymphocytes observed in the liver with age. This response was also found in peripheral blood mononuclear cells. In conclusion, chronic infratherapeutic APAP treatment protects mice from age-related liver alterations by attenuating oxidative stress and inflammation.
C1 [Brea, Rocio; Valdecantos, Pilar; Rada, Patricia; Alen, Rosa; Bosca, Lisardo; Martin-Sanz, Paloma; Valverde, Angela M.] CSIC UAM, Inst Invest Biorned Alberto Sols, Dept Metab & Cellular Signaling, Madrid 28029, Spain.
   [Valdecantos, Pilar; Rada, Patricia; Alen, Rosa; Valverde, Angela M.] ISCIII, Ctr Invest Biorned Red Diabet & Enfermedades Meta, Madrid 28029, Spain.
   [Garcia-Monzon, Carmelo] Hosp Univ Santa Cristina, Inst Invest Sanitaria Princesa, Liver Res Unit, Madrid 28009, Spain.
   [Bosca, Lisardo] ISCIII, Ctr Invest Biorned Red Enfermedades Cardiovasc CI, Madrid 28029, Spain.
   [Fuertes-Agudo, Marina; Casado, Marta] CSIC, Inst Biomed Valencia IBV, Valencia 46010, Spain.
   [Garcia-Monzon, Carmelo; Fuertes-Agudo, Marina; Casado, Marta; Martin-Sanz, Paloma] ISCIII, Ctr Invest Biorned Red Enfermedades Hepat & Diges, Madrid 28029, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de
   Salud Carlos III; Instituto de Salud Carlos III; Consejo Superior de
   Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de
   Valencia (IBV); Instituto de Salud Carlos III
RP Martín-Sanz, P; Valverde, AM (corresponding author), CSIC UAM, Inst Invest Biorned Alberto Sols, Dept Metab & Cellular Signaling, Madrid 28029, Spain.; Valverde, AM (corresponding author), ISCIII, Ctr Invest Biorned Red Diabet & Enfermedades Meta, Madrid 28029, Spain.; Martín-Sanz, P (corresponding author), ISCIII, Ctr Invest Biorned Red Enfermedades Hepat & Diges, Madrid 28029, Spain.
EM pmartins@iib.uam.es; avalverde@iib.uam.es
RI Bosca, Lisardo/A-2059-2008; Casado Pinna, Marta/L-2078-2014; Rada Llano,
   Patricia/G-7300-2015
OI Bosca, Lisardo/0000-0002-0253-5469; Casado Pinna,
   Marta/0000-0001-6457-4650; , PILAR/0000-0002-3239-4898; Rada Llano,
   Patricia/0000-0002-6731-2098; Alen, Rosa/0000-0003-1876-2612;
   Fuertes-Agudo, Marina/0000-0002-8146-6165; Martinez Valverde,
   Angela/0000-0003-1192-9045
FU AEI/FEDER, UE [SAF2016-75004-R, PID2019-108977RB-100,
   RTI2018-094052-B-100]; Fundacion Ramon Areces (Spain); CIBERdem
   (ISCIII); ISCIII/FEDER, UE [PI17/00535];  [S2017/BMD-3686]; 
   [S2017/BMD-3684]
FX SAF2016-75004-R, PID2019-108977RB-100 (AEI/FEDER, UE) to P. M-S. and
   M.C. and S2017/BMD-3686 (CM) to P. M-S, RTI2018-094052-B-100 (AEI/FEDER,
   UE), S2017/BMD-3684 (CM), Fundacion Ramon Areces (Spain) and CIBERdem
   (ISCIII) to A.M.V., and PI17/00535 (ISCIII/FEDER, UE) to C. G-M.
CR Abdalla MY, 2012, EUR J INTERN MED, V23, P649, DOI 10.1016/j.ejim.2012.05.001
   Mobasher MA, 2014, J BIOL CHEM, V289, P29406, DOI 10.1074/jbc.M113.539189
   Bacon BR, COMPREHENSIVE CLIN H
   Bauer I, 2000, J HEPATOL, V33, P395, DOI 10.1016/S0168-8278(00)80275-5
   Bhattacharjee J, 2017, HEPATOL COMMUN, V1, P299, DOI 10.1002/hep4.1041
   Bloomer SA, 2009, J GERONTOL A-BIOL, V64, P419, DOI 10.1093/gerona/gln056
   Bruzzì S, 2018, FREE RADICAL BIO MED, V124, P249, DOI 10.1016/j.freeradbiomed.2018.06.015
   Calder PC, 2017, AGEING RES REV, V40, P95, DOI 10.1016/j.arr.2017.09.001
   Chiew AL, 2020, J HEPATOL, V72, P450, DOI 10.1016/j.jhep.2019.10.030
   Chiu H, 2002, TOXICOL APPL PHARM, V181, P106, DOI 10.1006/taap.2002.9409
   Ding Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154375
   Emoto M, 2001, HEPATOLOGY, V33, P887, DOI 10.1053/jhep.2001.23504
   Farombi EO, 2006, J BIOCHEM MOL BIOL, V39, P479
   Fengler VHI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155163
   Francés DE, 2015, DIABETES, V64, P1522, DOI 10.2337/db14-0979
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Franceschi C, 2018, SEMIN IMMUNOL, V40, P1, DOI 10.1016/j.smim.2018.10.008
   Fujimoto K, 2009, TOXICOL PATHOL, V37, P193, DOI 10.1177/0192623308329282
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001
   González-Rodríguez A, 2018, MOL METAB, V7, P132, DOI 10.1016/j.molmet.2017.10.008
   González-Rodríguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x
   Haas JT, 2019, NAT METAB, V1, P604, DOI 10.1038/s42255-019-0076-1
   Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hsieh CC, 2003, MECH AGEING DEV, V124, P733, DOI 10.1016/S0047-6374(03)00083-6
   Hsieh CC, 2002, MECH AGEING DEV, V123, P1423, DOI 10.1016/S0047-6374(02)00084-2
   Huang MX, 2018, DIGEST LIVER DIS, V50, P175, DOI 10.1016/j.dld.2017.08.023
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3
   Jaeschke H, 2014, J CLIN TRANSL HEPATO, V2, P153, DOI 10.14218/JCTH.2014.00014
   Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3
   Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007
   Kane AE, 2016, EXP GERONTOL, V73, P95, DOI 10.1016/j.exger.2015.11.013
   Kaplowitz N, 2004, HEPATOLOGY, V40, P23, DOI 10.1002/hep.20312
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922
   Liu CY, 2016, INT J GERONTOL, V10, P105, DOI 10.1016/j.ijge.2015.10.004
   Long XY, 2020, FOOD SCI NUTR, V8, P237, DOI 10.1002/fsn3.1296
   Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969
   Mach J, 2014, J GERONTOL A-BIOL, V69, P387, DOI 10.1093/gerona/glt095
   Maes M, 2016, TOXICOL APPL PHARM, V290, P86, DOI 10.1016/j.taap.2015.11.016
   MARIANI E, 1990, CLIN EXP IMMUNOL, V81, P479
   Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018
   Mobasher MA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.150
   Moffit JS, 2007, TOXICOLOGY, V230, P197, DOI 10.1016/j.tox.2006.11.052
   Motiño O, 2016, BBA-MOL BASIS DIS, V1862, P1710, DOI 10.1016/j.bbadis.2016.06.009
   NEWTON I, 1994, PESTIC SCI, V41, P187, DOI 10.1002/ps.2780410304
   Nguyen NU, 2017, CHEM-BIOL INTERACT, V277, P129, DOI 10.1016/j.cbi.2017.09.007
   Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Pfeiffer E, 2015, EXP BIOL MED, V240, P645, DOI 10.1177/1535370214558025
   Nguyen P, 2018, CELL REP, V24, P1597, DOI 10.1016/j.celrep.2018.07.014
   Valdecantos MP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33949-z
   Premoli A, 2009, Minerva Gastroenterol Dietol, V55, P71
   Rada P, 2018, ANTIOXID REDOX SIGN, V28, P1187, DOI 10.1089/ars.2017.7373
   Ramachandran A, 2011, TOXICOL APPL PHARM, V251, P226, DOI 10.1016/j.taap.2011.01.004
   Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002
   Ros M, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165612
   Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005
   Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002
   Shan Z, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.26
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Smith A, 2006, MOUSE BIOMEDICAL RES, V2nd, P392
   Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639
   Sousa-Victor P, 2019, NAT METAB, V1, P276, DOI 10.1038/s42255-018-0023-6
   Speiser JL, 2019, COMPUT METH PROG BIO, V175, P111, DOI 10.1016/j.cmpb.2019.04.012
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Sundberg JP, 2016, VET PATHOL, V53, P456, DOI 10.1177/0300985815612556
   Sutti S, 2020, NAT REV GASTRO HEPAT, V17, P81, DOI 10.1038/s41575-019-0210-2
   Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007
   Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2
   Tajiri K, 2009, EUR J GASTROEN HEPAT, V21, P673, DOI 10.1097/MEG.0b013e32831bc3d6
   Taniguchi M, 2003, NAT IMMUNOL, V4, P1164, DOI 10.1038/ni1203-1164
   Tarazona R, 2000, MECH AGEING DEV, V121, P77
   Tittarelli R, 2017, EUR REV MED PHARMACO, V21, P95
   Valdecantos MP, 2017, HEPATOLOGY, V65, P950, DOI 10.1002/hep.28962
   Vallejo AN, 2007, TRENDS MOL MED, V13, P94, DOI 10.1016/j.molmed.2007.01.005
   Watanabe H, 1996, J EXP MED, V184, P687, DOI 10.1084/jem.184.2.687
   WEST D B, 1992, American Journal of Physiology, V262, pR1025
   Woolbright BL, 2017, J HEPATOL, V66, P836, DOI 10.1016/j.jhep.2016.11.017
   Xu JJ, 2008, FEBS LETT, V582, P1276, DOI 10.1016/j.febslet.2008.01.063
   Yan LJ, 2014, REDOX BIOL, V2, P165, DOI 10.1016/j.redox.2014.01.002
NR 85
TC 1
Z9 1
U1 2
U2 13
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD MAR 31
PY 2021
VL 13
IS 6
BP 7800
EP 7827
PG 28
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA RH1CF
UT WOS:000635963500010
PM 33780353
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Seo, E
   Oh, YS
   Kim, D
   Lee, MY
   Chae, S
   Jun, HS
AF Seo, Eunhui
   Oh, Yoon Sin
   Kim, Donghee
   Lee, Mi-Young
   Chae, Sungwook
   Jun, Hee-Sook
TI Protective Role of <i>Psoralea corylifolia</i> L. Seed Extract against
   Hepatic Mitochondrial Dysfunction Induced by Oxidative Stress or Aging
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID BETA-GALACTOSIDASE; LIVER-INJURY; RESVERATROL; SENESCENCE; BAKUCHIOL;
   GENE
AB The accumulation of oxidative damage and mitochondrial dysfunction is an important factor that contributes to aging. The Psoralea corylifolia seeds (PCS), commonly known as "Boh-Gol-Zhee" in Korea, have been used traditionally as a medicinal remedy. We investigated whether an extract of PCS has protective effects on oxidative stress and mitochondrial function in hepatocytes. The PCS extract showed an antisenescence effect on human diploid fibroblasts as evidenced by a decreased expression of p16(INK4a) mRNA and senescence-associated beta-galactosidase staining. PCS extract treatment reduced H2O2-induced reactive oxygen species (ROS) production in HepG2 cells, inhibited ROS production in hepatocytes of aged mice, and increased superoxide dismutase activity. In H2O2-treated HepG2 cells, PCS extract treatment recovered ATP production. PCS extract treatment recovered the oxygen consumption rate and inhibited reduction of mitochondrial membrane potential induced by oxidative stress, suggesting improvement of mitochondrial function. In addition, PCS extract treatment recovered peroxisome proliferator-activated receptor gamma coactivator 1 alpha and carnitine palmitoyltransferase 1 mRNA and protein expression, and inhibited mitochondrial genome damage. Treatment with the major component of PCS extract, bakuchiol, also recovered mitochondrial dysfunction. On the basis of these results, we conclude that PCS extract inhibits ROS production and mitochondrial dysfunction induced by oxidative stress in hepatocytes.
C1 [Seo, Eunhui; Kim, Donghee; Jun, Hee-Sook] Gachon Univ, Coll Pharm, Inchon 406840, South Korea.
   [Seo, Eunhui; Kim, Donghee; Jun, Hee-Sook] Gachon Univ, Gachon Inst Pharmaceut Sci, Inchon 406840, South Korea.
   [Seo, Eunhui; Oh, Yoon Sin; Kim, Donghee; Jun, Hee-Sook] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea.
   [Oh, Yoon Sin] Gil Hosp, Gachon Med Res Inst, Inchon 405760, South Korea.
   [Lee, Mi-Young; Chae, Sungwook] Korea Inst Oriental Med, KM Based Herbal Drug Res Grp, Taejon 305811, South Korea.
C3 Gachon University; Gachon University; Gachon University; Gachon
   University; Korea Institute of Oriental Medicine (KIOM)
RP Jun, HS (corresponding author), Gachon Univ, Coll Pharm, Inchon 406840, South Korea.
EM hsjun@gachon.ac.kr
RI 오, 윤신/AAS-2225-2020
FU Korea Institute of Oriental Medicine [K11101]
FX This study was supported by grant (K11101) from the Korea Institute of
   Oriental Medicine. HDF cells were kindly provided by Dr. Sang C. Park
   (Gachon University, Incheon, Korea). The authors thank Dr. Ann Kyle for
   editorial assistance.
CR Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bottoni P, 2012, ADV EXP MED BIOL, V942, P423, DOI 10.1007/978-94-007-2869-1_19
   Cho H, 2001, PLANTA MED, V67, P750, DOI 10.1055/s-2001-18347
   Das SK, 2010, INDIAN J BIOCHEM BIO, V47, P32
   Derbré F, 2012, AGE, V34, P669, DOI 10.1007/s11357-011-9264-y
   Forsberg L, 2001, ARCH BIOCHEM BIOPHYS, V389, P84, DOI 10.1006/abbi.2001.2295
   Galecka Elzbieta, 2008, Pol Merkur Lekarski, V25, P266
   Guo JM, 2005, FOOD CHEM, V91, P287, DOI 10.1016/j.foodchem.2004.04.029
   Haraguchi H, 2002, PHYTOTHER RES, V16, P539, DOI 10.1002/ptr.972
   Jan S, 2012, J ENVIRON RADIOACTIV, V113, P142, DOI 10.1016/j.jenvrad.2012.05.019
   Kasdallah-Grissa A, 2007, LIFE SCI, V80, P1033, DOI 10.1016/j.lfs.2006.11.044
   Khatune NA, 2004, FITOTERAPIA, V75, P228, DOI 10.1016/j.fitote.2003.12.018
   Kim SY, 2012, AGING CELL, V11, P1102, DOI 10.1111/acel.12012
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Movahed A, 2012, ARCH BIOCHEM BIOPHYS, V527, P74, DOI 10.1016/j.abb.2012.05.002
   Pang CY, 2008, FRONT BIOSCI-LANDMRK, V13, P3661, DOI 10.2741/2957
   Park EJ, 2005, PLANTA MED, V71, P508, DOI 10.1055/s-2005-864150
   Park EJ, 2007, EUR J PHARMACOL, V559, P115, DOI 10.1016/j.ejphar.2007.01.024
   Prasad NR, 2004, J ETHNOPHARMACOL, V91, P21, DOI 10.1016/j.jep.2003.11.010
   Qu H.-B., 2011, EVID-BASED COMPL ALT, V2011
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003
   SATO T, 1975, ACTA PATHOL JAPON, V25, P403
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7
   Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   Wei Yau-Huei, 2009, Chang Gung Med J, V32, P113
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Wheeler MD, 2001, GASTROENTEROLOGY, V120, P1241, DOI 10.1053/gast.2001.23253
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang NC, 2004, ANAL BIOCHEM, V325, P337, DOI 10.1016/j.ab.2003.11.012
   Yang WM, 2008, J ETHNOPHARMACOL, V117, P503, DOI 10.1016/j.jep.2008.02.016
   Yin S, 2004, BIOORGAN MED CHEM, V12, P4387, DOI 10.1016/j.bmc.2004.06.014
NR 39
TC 28
Z9 28
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2013
VL 2013
AR 678028
DI 10.1155/2013/678028
PG 9
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA 215FO
UT WOS:000324195200001
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Sasaki, M
   Ikeda, H
   Yamaguchi, J
   Miyakoshi, M
   Sato, Y
   Nakanuma, Y
AF Sasaki, Motoko
   Ikeda, Hiroko
   Yamaguchi, Junpei
   Miyakoshi, Masami
   Sato, Yasunori
   Nakanuma, Yasuni
TI Bile Ductular Cells Undergoing Cellular Senescence Increase in Chronic
   Liver Diseases Along With Fibrous Progression
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
DE Ductular reaction; Chronic liver disease; Cellular senescence;
   p16(INK4a); p21(WAF1/Cip1)
ID PRIMARY BILIARY-CIRRHOSIS; CHRONIC HEPATITIS; REPLICATIVE SENESCENCE;
   OXIDATIVE STRESS; PROGENITOR CELLS; EXPRESSION; DUCTS; IDENTIFICATION;
   REGENERATION; HEPATOCYTES
AB We investigated the pathologic significance of ductular reactions in chronic liver diseases with respect to cellular senescence. The expression of senescence-associated markers (p16(INK4a) and p21(WAF1/Cip1)), cell proliferation, cell cycle markers (cyclin D and cyclin A), and neural cell adhesion molecule (NCAM) was examined immunohistochemically in primary biliary cirrhosis (PBC, n = 37), chronic viral hepatitis (n = 39), nonalcoholic steatohepatitis (n = 25), and control normal livers (n = 12). The expression of p16(INK4a) and p21(WAF1/Cip1) was frequently found in ductular cells in the advanced stage of chronic liver diseases, especially in PBC (P <. 05). Double immunostaining disclosed that most senescent cells expressed cyclin D (G(1)-phase marker). NCAM was frequently coaxpressed in ductular cells showing senescence-associated markers. Some ductular cells in ductular reactions in chronic liver diseases were at G(1) arrest and undergoing cellular senescence. Such senescent cells may be involved in the progression of fibrosis of these diseases, particularly in PBC.
C1 [Sasaki, Motoko; Ikeda, Hiroko; Yamaguchi, Junpei; Miyakoshi, Masami; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
C3 Kanazawa University
RP Nakanuma, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
RI Sasaki, Motoko/K-5913-2015; YAMAGUCHI, Junpei/E-4440-2015
OI Sasaki, Motoko/0000-0003-2514-760X; 
FU Ministry of Education, Culture, Sports and Science and Technology of
   Japan, Tokyo [18590325]; Grants-in-Aid for Scientific Research
   [18590325] Funding Source: KAKEN
FX Supported in part by grant-in-aid 18590325 for Scientific Research (C)
   from the Ministry of Education, Culture, Sports and Science and
   Technology of Japan, Tokyo.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023
   [Anonymous], 2001, PATHOLOGY LIVER
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Crosby HA, 1998, HEPATOLOGY, V28, P980, DOI 10.1002/hep.510280412
   Demetris AJ, 1996, AM J PATHOL, V149, P439
   Demetris AJ, 2008, J HEPATOL, V48, P276, DOI 10.1016/j.jhep.2007.09.019
   DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X
   Ishikawa A, 2004, LAB INVEST, V84, P629, DOI 10.1038/labinvest.3700087
   Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238
   Kozaka K, 2007, HISTOPATHOLOGY, V51, P390, DOI 10.1111/j.1365-2559.2007.02735.x
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   LUDWIG J, 1991, SEMIN LIVER DIS, V11, P11, DOI 10.1055/s-2008-1040417
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209
   Omenetti A, 2008, GUT, V57, P1275, DOI 10.1136/gut.2008.148619
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   ROSKAMS T, 1990, AM J PATHOL, V137, P1019
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047
   Zhou HC, 2007, HEPATOLOGY, V45, P716, DOI 10.1002/hep.21557
NR 38
TC 44
Z9 47
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9173
EI 1943-7722
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD FEB
PY 2010
VL 133
IS 2
BP 212
EP 223
DI 10.1309/AJCPWMX47TREYWZG
PG 12
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 546FP
UT WOS:000273796900006
PM 20093230
OA Bronze
DA 2024-02-19
ER

PT J
AU Carracedo, S
   Lirussi, L
   Alsoe, L
   Segers, F
   Wang, CL
   Bartosova, Z
   Bohov, P
   Tekin, NB
   Kong, XY
   Esbensen, QY
   Chen, L
   Wennerström, A
   Kroustallaki, P
   Ceolotto, D
   Tönjes, A
   Berge, RK
   Bruheim, P
   Wong, G
   Böttcher, Y
   Halvorsen, B
   Nilsen, H
AF Carracedo, Sergio
   Lirussi, Lisa
   Alsoe, Lene
   Segers, Filip
   Wang, Changliang
   Bartosova, Zdenka
   Bohov, Pavol
   Tekin, Nuriye B.
   Kong, Xiang Yi
   Esbensen, Q. Ying
   Chen, Liang
   Wennerstrom, Anna
   Kroustallaki, Penelope
   Ceolotto, Deborah
   Tonjes, Anke
   Berge, Rolf Kristian
   Bruheim, Per
   Wong, Garry
   Bottcher, Yvonne
   Halvorsen, Bente
   Nilsen, Hilde
TI SMUG1 regulates fat homeostasis leading to a fatty liver phenotype in
   mice
SO DNA REPAIR
LA English
DT Article; Early Access
DE Smug1; Liver; DNA repair; Mouse; BER; Telomeres; Senescence
ID URACIL-DNA GLYCOSYLASE; BASE EXCISION-REPAIR; HEPATIC STEATOSIS;
   GENETIC-VARIATION; ACID-METABOLISM; EXPRESSION; ENZYME; DYSFUNCTION;
   ASSOCIATION; 5-HYDROXYMETHYLURACIL
AB Fatty liver diseases are a major health threat across the western world, leading to cirrhosis and premature morbidity and mortality. Recently, a correlation between the base excision repair enzyme SMUG1 and metabolic homeostasis was identified. As the molecular mechanisms remain unknown, we exploited a SMUG1-knockout mouse model to gain insights into this association by characterizing the liver phenotype in young vs old SMUG1-null mice. We observed increased weight and fat content in one-year old animals, with altered activity of enzymes important for fatty acids influx and uptake. Consistently, lipidomic profiling showed accumulation of free fatty acids and triglycerides in SMUG1-null livers. Old SMUG1-knockout mice also displayed increased hepatocyte senescence and DNA damage at telomeres. Interestingly, RNA sequencing revealed widespread changes in the expression of lipid metabolic genes already in three months old animals. In summary, SMUG1 modulates fat metabolism favouring net lipogenesis and resulting in development of a fatty liver phenotype.
C1 [Carracedo, Sergio; Lirussi, Lisa; Alsoe, Lene; Wennerstrom, Anna; Kroustallaki, Penelope; Ceolotto, Deborah; Bottcher, Yvonne; Nilsen, Hilde] Akershus Univ Hosp, Sect Clin Mol Biol, N-1474 Nordbyhagen, Norway.
   [Carracedo, Sergio; Lirussi, Lisa; Alsoe, Lene; Tekin, Nuriye B.; Esbensen, Q. Ying; Kroustallaki, Penelope; Bottcher, Yvonne; Nilsen, Hilde] Univ Oslo, Inst Clin Med, Dept Clin Mol Biol, N-0318 Oslo, Norway.
   [Segers, Filip; Kong, Xiang Yi; Halvorsen, Bente] Oslo Univ Hosp, Res Inst Internal Med, Inst Clin Med, N-0318 Oslo, Norway.
   [Wang, Changliang; Chen, Liang; Wong, Garry] Univ Macau, Fac Hlth Sci, Canc Ctr, Ctr Reprod Dev & Aging, Taipa, Macao, Peoples R China.
   [Bartosova, Zdenka; Bruheim, Per] NTNU Norwegian Univ Sci & Technol, Fac Nat Sci, Dept Biotechnol & Food Sci, N-7491 Trondheim, Norway.
   [Bohov, Pavol; Berge, Rolf Kristian] Univ Bergen, Dept Clin Sci, N-5020 Bergen, Norway.
   [Chen, Liang] Shantou Univ, Coll Engn, Dept Comp Sci, Shantou 515063, Peoples R China.
   [Tonjes, Anke] Univ Leipzig, Med Ctr, Med Dept Endocrinol 3, D-04109 Leipzig, Germany.
   [Nilsen, Hilde] Oslo Univ Hosp, Dept Microbiol, N-0424 Oslo, Norway.
C3 University of Oslo; University of Oslo; University of Oslo; University
   of Macau; Norwegian University of Science & Technology (NTNU);
   University of Bergen; Shantou University; Leipzig University; University
   of Oslo
RP Nilsen, H (corresponding author), Akershus Univ Hosp, Sect Clin Mol Biol, N-1474 Nordbyhagen, Norway.
EM hilde.nilsen@medisin.uio.no
RI Chen, Liang/Y-4460-2018
OI Chen, Liang/0000-0001-6644-477X; Kong, Xiang Yi/0000-0003-3244-344X
FU Norwegian Cancer Society [4501723-2013, 45017232015]; Research Council
   of Norway [2013/14477]; University of Oslo and Akershus University
   Hospital - Research Council of Norway [229633]; Akershus University
   Hospital; South East Regional Health Authority [274901, 2017029];
   Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
   [209933838, SFB1052]
FX We are grateful to Richard WilliamDoughty for help with histological
   analyses of liver tissues and Miriam Sander
   (https://www.logicallow.biz/) for input and manuscript editing. This
   work was funded by the Norwegian Cancer Society (Grant no 295901), The
   Research Council of Norway (grant no 2013/14477). PK was funded by the
   University of Oslo and Akershus University Hospital. This work has been
   funded by grants to H.N. from the Research Council of Norway (grant no.
   229633)., the Norwegian Cancer Society (grants no. 4501723-2013 and
   45017232015) and Akershus University Hospital, The South East Regional
   Health Authority (project no. 274901 and 2017029). AT was funded by
   grants from the Deutsche Forschungsgemeinschaft (DFG, German Research
   Foundation) -Project number 209933838 -Collaborative Research Center
   SFB1052 "Obesity Mechanisms".
CR Alsoe L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07314-5
   Alves-Paiva RM, 2018, LIVER INT, V38, P144, DOI 10.1111/liv.13529
   Anderson R, 2019, EMBO J, V38, DOI 10.15252/embj.2018100492
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bertot LC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050774
   Bjorndal B, 2012, METABOLISM, V61, P1461, DOI 10.1016/j.metabol.2012.03.012
   Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200
   Bordin DL, 2021, DNA REPAIR, V99, DOI 10.1016/j.dnarep.2021.103051
   Bruschi FV, 2017, HEPATIC MED-EVID RES, V9, P55, DOI 10.2147/HMER.S125718
   Casella G, 2019, NUCLEIC ACIDS RES, V47, P7294, DOI 10.1093/nar/gkz555
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Damen CWN, 2014, J LIPID RES, V55, P1772, DOI 10.1194/jlr.D047795
   Daugherity EK, 2012, CELL CYCLE, V11, P1918, DOI 10.4161/cc.20259
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224
   Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gawrieh S, 2010, OBES SURG, V20, P1698, DOI 10.1007/s11695-010-0171-6
   González-Rodríguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6
   Inaba Y, 2015, HEPATOLOGY, V61, P1343, DOI 10.1002/hep.27619
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   IWAI H, 1986, CHEM PHARM BULL, V34, P3471
   Jiang ZG, 2013, J BIOMED RES, V27, P1, DOI 10.7555/JBR.27.20120077
   Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126
   Jobert L, 2013, MOL CELL, V49, P339, DOI 10.1016/j.molcel.2012.11.010
   Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200
   Kemmerich K, 2012, NUCLEIC ACIDS RES, V40, P6016, DOI 10.1093/nar/gks259
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551
   Kiss T, 2020, GEROSCIENCE, V42, P429, DOI 10.1007/s11357-020-00177-1
   Kohjima M, 2007, INT J MOL MED, V20, P351
   Kroustallaki P, 2019, CELL REP, V28, P1690, DOI 10.1016/j.celrep.2019.07.040
   Kumar A, 2013, J CLIN EXP HEPATOL, V3, P12, DOI 10.1016/j.jceh.2012.10.009
   Lazzerini Denchi Eros, 2021, Genes Dev, V35, P1548, DOI 10.1101/gad.349030.121
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lindquist C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194978
   Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023
   Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439
   Mamrosh JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01694
   Martin-Grau M, 2022, WORLD J HEPATOL, V14, P304, DOI 10.4254/wjh.v14.i2.304
   Martínez P, 2013, CELL REP, V3, P2059, DOI 10.1016/j.celrep.2013.05.030
   Masaoka A, 2003, BIOCHEMISTRY-US, V42, P5003, DOI 10.1021/bi0273213
   Masoodi M, 2021, NAT REV GASTRO HEPAT, V18, P835, DOI 10.1038/s41575-021-00502-9
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Nakamuta M, 2008, INT J MOL MED, V22, P663, DOI 10.3892/ijmm_00000070
   Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pedersen HK, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.35
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rodriguez MADR, 2017, BBA-MOL CELL BIOL L, V1862, P1212, DOI 10.1016/j.bbalip.2017.07.007
   Rossiello F, 2022, NAT CELL BIOL, V24, P135, DOI 10.1038/s41556-022-00842-x
   Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6
   Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652
   Shin HK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97385-2
   Skarpengland T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28337
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Tönjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423
   Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65
   Vinknes KJ, 2013, OBESITY, V21, pE294, DOI 10.1002/oby.20011
   White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790
   Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098
   Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611
NR 69
TC 1
Z9 1
U1 1
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1568-7864
EI 1568-7856
J9 DNA REPAIR
JI DNA Repair
PD 2022 DEC
PY 2022
VL 120
AR 103410
DI 10.1016/j.dnarep.2022.103410
EA OCT 2022
PG 13
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA 5Q7GI
UT WOS:000873994800001
PM 36244177
DA 2024-02-19
ER

PT J
AU Djordjevic-Markovic, R
   Radic, O
   Jelic, V
   Radojcic, M
   Rapic-Otrin, V
   Ruzdijic, S
   Krstic-Demonacos, M
   Kanazir, S
   Kanazir, D
AF Djordjevic-Markovic, R
   Radic, O
   Jelic, V
   Radojcic, M
   Rapic-Otrin, V
   Ruzdijic, S
   Krstic-Demonacos, M
   Kanazir, S
   Kanazir, D
TI Glucocorticoid receptors in ageing rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE ageing; glucocorticoid receptor; TAT
ID TYROSINE AMINOTRANSFERASE; LIVER; GENE; TRANSCRIPTION; HORMONES; BINDING
AB The role of the glucocorticoid receptor (GR) in senescence was studied in rats of increasing age. Statistically significant changes in the number of GRs from rat liver were detected, whereas the affinity for the ligand triamcinolone acetonide (TA) did not change with increasing age, and was in the range of 1-2 nM. In all cases the number of receptors was lower in rats treated with hormone in vivo relative to untreated animals. In addition, we have found changes in GR activation, as measured by the binding to DNA cellulose in the mentioned age groups. Furthermore, expression of the glucocorticoid hormone (GH)-inducible gene, tyrosine amino transferase (TAT) also showed age-related alterations. We conclude that receptor function shows oscillatory changes during ageing. In addition, response to GH generally declines towards the older age. This. specific periodicity in functional characteristics of the GR may reconcile conflicting results about the receptor number and properties during the ageing process, and marks particular age at which individual organism shows the highest or the lowest sensitivity to the actions of GH. (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Inst Nucl Sci Vinca, Lab Mol Biol & Endocrinol, YU-11001 Belgrade, Yugoslavia.
   NICHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA.
   Inst Biol Sci Sinisa Stankov, YU-11000 Belgrade, Yugoslavia.
   Univ Glasgow IBLS, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland.
C3 University of Belgrade; National Institutes of Health (NIH) - USA; NIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD); University of Glasgow
RP Krstic-Demonacos, M (corresponding author), Inst Nucl Sci Vinca, Lab Mol Biol & Endocrinol, 090,POB 522, YU-11001 Belgrade, Yugoslavia.
EM mkrstic@udcf.gla.ac.uk
RI Kanazir, Selma/E-5495-2015
OI Kanazir, Selma/0000-0002-7229-5296
CR ARMANINI D, 1993, J STEROID BIOCHEM, V45, P191, DOI 10.1016/0960-0760(93)90141-I
   COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608
   DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X
   DJORDJEVIC-MARKOVIC R, 1991, Endocrine Regulations, V25, P199
   EVANS PJ, 1981, BIOCHIM BIOPHYS ACTA, V677, P433, DOI 10.1016/0304-4165(81)90257-9
   HAJI M, 1981, BRAIN RES, V204, P373, DOI 10.1016/0006-8993(81)90596-5
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   KALIMI M, 1975, J BIOL CHEM, V250, P1080
   KONOPLYA EF, 1986, MECH AGEING DEV, V35, P95, DOI 10.1016/0047-6374(86)90001-1
   KRSTIE M, 1995, THESIS U CALIFORNIA
   LANDFIELD PW, 1978, PARKINSONS DISEASE, V2, P179
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899
   PETROVIC JS, 1975, DEV BIOL, V45, P176, DOI 10.1016/0012-1606(75)90250-X
   Rhouma Khemais Ben, 1994, Archives Internationales de Physiologie de Biochimie et de Biophysique, V102, P97, DOI 10.3109/13813459408996113
   RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E
   ROBINETTE CL, 1978, FED PROC, V37, P283
   ROTH GS, 1982, MECH AGEING DEV, V20, P175, DOI 10.1016/0047-6374(82)90086-0
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   SCHWEIZERGROYER G, 1992, J STEROID BIOCHEM, V41, P747, DOI 10.1016/0960-0760(92)90416-G
   SHARMA R, 1987, BIOCHIM BIOPHYS ACTA, V930, P237, DOI 10.1016/0167-4889(87)90036-X
   SHARMA R, 1987, MECH AGEING DEV, V37, P249, DOI 10.1016/0047-6374(86)90042-4
   VANEEKELEN JAM, 1992, NEUROBIOL AGING, V13, P159, DOI 10.1016/0197-4580(92)90024-R
   VIJG J, 1993, COMP BIOCHEM PHYS B, V104, P429, DOI 10.1016/0305-0491(93)90264-6
   YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.ge.19.120185.001233
NR 25
TC 19
Z9 20
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 1999
VL 34
IS 8
BP 971
EP 982
DI 10.1016/S0531-5565(99)00067-4
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 265VV
UT WOS:000084267400007
PM 10673150
DA 2024-02-19
ER

PT J
AU VANBEZOOIJEN, RL
   WANG, RK
   LECHNER, MC
   SCHMUCKER, DL
AF VANBEZOOIJEN, RL
   WANG, RK
   LECHNER, MC
   SCHMUCKER, DL
TI AGING EFFECTS ON HEPATIC NADPH CYTOCHROME-P450 REDUCTASE,
   CYP2B(1-AND-2), AND POLYMERIC IMMUNOGLOBULIN RECEPTOR MESSENGER-RNAS IN
   MALE FISCHER-344 RATS
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE POLYMERIC IMMUNOGLOBULIN RECEPTOR; P450 REDUCTASE; CYP2B(1-AND-2);
   BETA-ACTIN; ALPHA(2U)-GLOBULIN; LIVER MESSENGER RNA EXPRESSION
ID AGE-RELATED-CHANGES; DIMERIC IMMUNOGLOBULIN; LIVER; EXPRESSION;
   ALPHA-2U-GLOBULIN; RESTRICTION; INDUCTION; SYSTEM; GENE
AB Aging perturbs the expression of many liver proteins, but the mechanisms remain unresolved. Expression of hepatic NADPH cytochrome P450 reductase, phenobarbital-induced CYP2B1&2, and the polymeric immunoglobulin receptor (pIgR) decline as a function of aging. We examined the effect of aging on the expression of the mRNA transcripts of these proteins, as well as those of alpha2u-globulin and beta-actin in male F344 rats. Despite age-related losses in the expression of P450 reductase and plasma membrane-bound pIgR in the rat liver (almost-equal-to 30-50%), aging is accompanied by 1) no change and 2) a modest decline (< 20%) in their respective mRNA steady state levels. On the other hand, the expression of phenobarbital-induced microsomal CYP2B1&2 and the steady state level of its mRNA exhibit parallel age-dependent shifts. The mRNA transcript for alpha2-globulin declines between maturity and old age, whereas the beta-actin mRNA level remains unchanged. These preliminary data are consistent with previous studies which suggest that aging may perturb hepatic CYP2B1&2 and alpha2-globulin at the transcriptional level, whereas changes in the expression of P450 reductase and pIgR may reflect posttranscriptional modifications.
C1 DEPT VET AFFAIRS MED CTR,CELL BIOL & AGING SECT 151E,4150 CLEMENT ST,SAN FRANCISCO,CA 94121.
   LEIDEN UNIV,2300 RA LEIDEN,NETHERLANDS.
   UNIV CALIF SAN FRANCISCO,DEPT ANAT,SAN FRANCISCO,CA 94143.
   UNIV CALIF SAN FRANCISCO,CTR LIVER,SAN FRANCISCO,CA 94143.
   GULBENKIAN INST SCI,BIOCHEM LAB,OEIRAS,PORTUGAL.
C3 Leiden University - Excl LUMC; Leiden University; University of
   California System; University of California San Francisco; University of
   California System; University of California San Francisco
CR BANTING G, 1989, FEBS LETT, V254, P177, DOI 10.1016/0014-5793(89)81034-8
   BONKOVSKY HL, 1985, GASTROENTEROLOGY, V88, P458, DOI 10.1016/0016-5085(85)90507-4
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DANIELS CK, 1985, J IMMUNOL, V134, P3855
   GONZALEZ F, 1982, BIOCHEMISTRY-US, V19, P1790
   GREGOIRE CD, 1992, GASTROENTEROLOGY, V103, P296, DOI 10.1016/0016-5085(92)91126-O
   HORBACH GJ, 1990, LIVER METABOLISM AGI, P95
   HORBACH GJMJ, 1990, BIOCHEM PHARMACOL, V40, P529, DOI 10.1016/0006-2952(90)90552-V
   HULING S, 1992, P NATL ACAD SCI USA, V89, P4260, DOI 10.1073/pnas.89.10.4260
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   KATZ RA, 1983, BIOCHIM BIOPHYS ACTA, V739, P258, DOI 10.1016/0167-4781(83)90099-4
   LECHNER MC, 1987, EUR J BIOCHEM, V16, P231
   OSORIOALMEIDA ML, 1986, BIOCHEM BIOPH RES CO, V134, P1182, DOI 10.1016/0006-291X(86)90375-X
   RATH PC, 1988, BIOCHEM BIOPH RES CO, V157, P1403, DOI 10.1016/S0006-291X(88)81031-3
   RICHARDSON A, 1987, P467
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   ROY AK, 1983, J BIOL CHEM, V258, P123
   SCHMUCKER DL, 1985, GASTROENTEROLOGY, V88, P436, DOI 10.1016/0016-5085(85)90504-9
   SCHMUCKER DL, 1980, P SOC EXP BIOL MED, V165, P178
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SCHMUCKER DL, 1991, J GERONTOL, V46, pB23, DOI 10.1093/geronj/46.1.B23
   SCHMUCKER DL, 1983, MECH AGEING DEV, V2, P137
   SCHMUCKER DL, 1984, EXP GERONTOL, V18, P313
   VANBEZOOIJEN CFA, 1987, AGING LIVER GASTROIN, V47, P199
NR 24
TC 12
Z9 12
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAR-APR
PY 1994
VL 29
IS 2
BP 187
EP 195
DI 10.1016/0531-5565(94)90050-7
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA ND217
UT WOS:A1994ND21700005
PM 7517894
DA 2024-02-19
ER

PT J
AU Higami, Y
   Shimokawa, I
   Okimoto, T
   Tomita, M
   Yuo, T
   Ikeda, T
AF Higami, Y
   Shimokawa, I
   Okimoto, T
   Tomita, M
   Yuo, T
   Ikeda, T
TI Effect of aging and dietary restriction on hepatocyte proliferation and
   death in male F344 rats
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE aging; dietary restriction; hepatocytes; cell proliferation;
   proliferating cell nuclear antigen; cell death; terminal dUTP nick end
   labeling (TUNEL); rat (Fischer 344)
ID CELL NUCLEAR ANTIGEN; AGE-RELATED-CHANGES; DNA-SYNTHESIS; NUTRITIONAL
   INFLUENCES; FISCHER-344 RATS; OXIDATIVE STRESS; OXYGEN RADICALS;
   APOPTOSIS; LIVER; REPAIR
AB The proliferation and death of hepatocytes in rats fed ad libitum and rats on dietary restriction were evaluated in 3 to 24-month-old rats by employing immunocytochemistry for proliferating cell nuclear antigen (PCNA) and terminal dUTP nick end labeling (TUNEL). These techniques were also used to examine hepatic tissue infiltrated with leukemic cells in 24-month-old rats fed ad libitum. PCNA-strongly positive hepatocytes, PCNA-positive hepatocytes, and TUNEL-positive hepatocytes were reported previously to be equivalent to hepatocytes in the S phase, hepatocytes in the cell cycle, and dying hepatocytes, respectively. The proportion of PCNA-strongly positive hepatocytes and PCNA-positive hepatocytes declined with age. Dietary restriction diminished PCNA-strongly positive hepatocytes significantly but not PCNA-positive hepatocytes in young rats, but the proportion of PCNA-strongly positive hepatocytes was significantly higher following dietary restriction than that in rats fed ad libitum in advanced age. Growth stimulation by leukemic cell infiltration resulted in a recovery of the age-related decline of PCNA-strongly positive hepatocytes. Aging was associated with a progressive in crease in the proportion of TUNEL-positive hepatocytes, with a smaller effect following dietary restriction than in rats fed ad libitum after 6 months of age. Our results indicate that age and dietary restriction induce proliferative inhibition. The inhibition depends on PCNA expression; this suggests that suppression of cell proliferation and cell death are enhanced in hepatocytes of senile rats.
RP Higami, Y (corresponding author), NAGASAKI UNIV,SCH MED,DEPT PATHOL,1-12-4 SAKAMOTO,NAGASAKI 852,JAPAN.
OI Shimokawa, Isao/0000-0001-8901-1029; Higami,
   Yoshikazu/0000-0003-1381-0777
CR BRALET MP, 1994, AM J PATHOL, V144, P896
   BUCHER NLR, 1964, CANCER RES, V24, P509
   CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262
   CHETSANGA CJ, 1975, NATURE, V253, P130, DOI 10.1038/253130a0
   CHILDS GV, 1987, MOL ENDOCRINOL, V1, P926, DOI 10.1210/mend-1-12-926
   ELDEIRY WS, 1994, CANCER RES, V54, P1169
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   FOLEY J, 1993, ENVIRON HEALTH PERSP, V101, P199, DOI 10.2307/3431868
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GRISHAM JW, 1994, AM J PATHOL, V144, P849
   HALEYZITLIN V, 1993, MUTAT RES, V295, P237, DOI 10.1016/0921-8734(93)90023-V
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HIGAMI Y, 1994, MUTAT RES-DNAGING G, V316, P59, DOI 10.1016/0921-8734(94)90008-6
   HIGAMI Y, 1994, LAB INVEST, V71, P650
   Higami Y, 1996, MUTAT RES-FUND MOL M, V357, P225, DOI 10.1016/0027-5107(96)00127-3
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   ISHIGAMI A, 1994, J CELL PHYSIOL, V158, P231, DOI 10.1002/jcp.1041580204
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LEDDACOLUMBANO GM, 1992, AM J PATHOL, V140, P545
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MCCONKEY DJ, 1988, TOXICOL LETT, V42, P123, DOI 10.1016/0378-4274(88)90069-0
   MERCER WE, 1991, P NATL ACAD SCI USA, V88, P1958, DOI 10.1073/pnas.88.5.1958
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0
   RAPPAPORT AM, 1954, ANAT REC, V119, P11, DOI 10.1002/ar.1091190103
   SAWADA N, 1988, CANCER RES, V48, P1618
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   SHINAGAWA T, 1991, J PATHOL, V165, P247, DOI 10.1002/path.1711650309
   Stefanski SA, 1990, PATHOLOGY FISCHER RA, P369
   TAHARA H, 1995, ONCOGENE, V10, P835
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   ZAJICEK G, 1985, LIVER, V5, P293
NR 36
TC 27
Z9 28
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD APR
PY 1997
VL 288
IS 1
BP 69
EP 77
DI 10.1007/s004410050793
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA WR522
UT WOS:A1997WR52200007
PM 9042773
DA 2024-02-19
ER

PT J
AU Stueck, AE
   Wanless, IR
AF Stueck, Ashley E.
   Wanless, Ian R.
TI Hepatocyte Buds Derived From Progenitor Cells Repopulate Regions of
   Parenchymal Extinction in Human Cirrhosis
SO HEPATOLOGY
LA English
DT Article
ID STEM-CELLS; LIVER-REGENERATION; DUCTULAR REACTION; HEPATITIS; FIBROSIS;
   SENESCENCE; CLASSIFICATION; PROLIFERATION; INJURY; CANALS
AB Repair of cirrhotic livers occurs, in part, by repopulation with hepatocytes through the stem/progenitor pathway. There remain many uncertainties regarding this pathway. Hepatocyte buds occurring in broad septa are hypothesized to be the anatomic manifestation of this pathway. Our purpose was to define a morphologic sequence of bud maturation to allow a quantitative measure of the importance of the stem/progenitor pathway in humans. Histologic sections from 37 liver resection specimens were stained with trichrome, epithelial cell adhesion molecule (EpCAM), K19, CD34, glutamine synthetase (GS), and Ki-67. Specimens were stratified by etiology (10 biliary, 22 nonbiliary, five controls) and stage. Buds were defined as clusters of hepatocytes within septa. Five levels of bud maturation (0-4) were defined by the progressive increase in hepatocyte progeny relative to cholangiocytes. Level 0 single-cell buds are K19(+)/GS(+)/EpCAM(+)/Heppar1(-). In level 1, the progeny are morphologically hepatocytes (K19(-)/GS(+)/EpCAM(+)/Heppar1(+)). In level 2-4 buds, hepatocytes increase and become progressively GS(-) and EpCAM(-). Associated endothelium is CD34(+) in level 1-2 buds and becomes CD34(-) near hepatic veins in level 3-4 buds. Progeny of the bud sequence may represent up to 70% of hepatocytes (immaturity index of 70%). In biliary disease, bud number is reduced in association with duct loss and cholestatic destruction of nascent buds. Conclusions: The stem/progenitor pathway, manifested anatomically by the bud sequence, is a major mechanism for repopulation of cirrhotic livers. The bud sequence reveals some critical features of hepatic morphogenesis, including that 1) the majority of distal cholangiocytes have stem-like properties, and 2) availability of bile ducts and/or venous drainage are limiting factors for regeneration. (Hepatology 2015;61:1696-1707)
C1 [Stueck, Ashley E.; Wanless, Ian R.] Queen Elizabeth 2 Hlth Sci Ctr, Dept Pathol, Halifax, NS B3H 1V8, Canada.
C3 Queen Elizabeth II Health Sciences Centre
RP Wanless, IR (corresponding author), Queen Elizabeth 2 Hlth Sci Ctr, Dept Pathol, 5788 Univ Ave, Halifax, NS B3H 1V8, Canada.
EM iwanless@eastlink.ca
OI Stueck, Ashley/0000-0002-0328-6687
FU Capital Health Research Fund
FX Supported by the Capital Health Research Fund.
CR [Anonymous], 2012, MacSween's Pathology of the Liver, DOI 10.1016/B978-0-7020-3398-8.00012-X
   Arnason T, 2013, HISTOPATHOLOGY, V62, P458, DOI 10.1111/his.12032
   Bioulac-Sage P, 2008, COMP HEPATOL, V7, P1
   Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743
   Brunt EM, 2010, J PEDIATR GASTR NUTR, V51, P626, DOI 10.1097/MPG.0b013e3181e7ff55
   D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606
   Delladetsima J, 2010, VIRCHOWS ARCH, V457, P457, DOI 10.1007/s00428-010-0957-x
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Fleming KE, 2013, LIVER INT, V33, P525, DOI 10.1111/liv.12099
   GRISHAM JW, 1962, CANCER RES, V22, P842
   Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753
   Kim SU, 2012, J HEPATOL, V57, P556, DOI 10.1016/j.jhep.2012.04.029
   Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218
   Libbrecht L, 2000, J PATHOL, V192, P373, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH700&gt;3.0.CO;2-5
   Lin WR, 2010, HEPATOLOGY, V51, P1017, DOI 10.1002/hep.23483
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sohrabpour AA, 2012, ALIMENT PHARM THER, V36, P824, DOI 10.1111/apt.12044
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614
   Theise ND, 2013, GASTROENTEROLOGY, V145, P253, DOI 10.1053/j.gastro.2013.02.052
   Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599
   Wanless IR, 2002, BLOOD, V100, P1566, DOI 10.1182/blood-2002-01-0306
   WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1016/0270-9139(95)90043-8
   Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706
   Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122
NR 31
TC 69
Z9 78
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD MAY
PY 2015
VL 61
IS 5
BP 1696
EP 1707
DI 10.1002/hep.27706
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CG4DR
UT WOS:000353233500028
PM 25644399
DA 2024-02-19
ER

PT J
AU Garcia-Llorens, G
   Martinez-Sena, T
   Pareja, E
   Tolosa, L
   Castell, JV
   Bort, R
AF Garcia-Llorens, Guillem
   Martinez-Sena, Teresa
   Pareja, Eugenia
   Tolosa, Laia
   Castell, Jose V.
   Bort, Roque
TI A robust reprogramming strategy for generating hepatocyte-like cells
   usable in pharmaco-toxicological studies
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Hepatocyte-like cells; Direct reprogramming; Hepatocyte;
   Pharmaco-toxicology; Inborn errors of metabolism; iHEP; HLC
ID HUMAN SOMATIC-CELLS; MASS-SPECTROMETRY; HUMAN FIBROBLASTS; LIFE-SPAN;
   TELOMERASE; EXPRESSION; GENE; GROWTH; ALIGNMENT; REVEALS
AB BackgroundHigh-throughput pharmaco-toxicological testing frequently relies on the use of established liver-derived cell lines, such as HepG2 cells. However, these cells often display limited hepatic phenotype and features of neoplastic transformation that may bias the interpretation of the results. Alternate models based on primary cultures or differentiated pluripotent stem cells are costly to handle and difficult to implement in high-throughput screening platforms. Thus, cells without malignant traits, optimal differentiation pattern, producible in large and homogeneous amounts and with patient-specific phenotypes would be desirable.MethodsWe have designed and implemented a novel and robust approach to obtain hepatocytes from individuals by direct reprogramming, which is based on a combination of a single doxycycline-inducible polycistronic vector system expressing HNF4A, HNF1A and FOXA3, introduced in human fibroblasts previously transduced with human telomerase reverse transcriptase (hTERT). These cells can be maintained in fibroblast culture media, under standard cell culture conditions.ResultsClonal hTERT-transduced human fibroblast cell lines can be expanded at least to 110 population doublings without signs of transformation or senescence. They can be easily differentiated at any cell passage number to hepatocyte-like cells with the simple addition of doxycycline to culture media. Acquisition of a hepatocyte phenotype is achieved in just 10 days and requires a simple and non-expensive cell culture media and standard 2D culture conditions. Hepatocytes reprogrammed from low and high passage hTERT-transduced fibroblasts display very similar transcriptomic profiles, biotransformation activities and show analogous pattern behavior in toxicometabolomic studies. Results indicate that this cell model outperforms HepG2 in toxicological screening. The procedure also allows generation of hepatocyte-like cells from patients with given pathological phenotypes. In fact, we succeeded in generating hepatocyte-like cells from a patient with alpha-1 antitrypsin deficiency, which recapitulated accumulation of intracellular alpha-1 antitrypsin polymers and deregulation of unfolded protein response and inflammatory networks.ConclusionOur strategy allows the generation of an unlimited source of clonal, homogeneous, non-transformed induced hepatocyte-like cells, capable of performing typical hepatic functions and suitable for pharmaco-toxicological high-throughput testing. Moreover, as far as hepatocyte-like cells derived from fibroblasts isolated from patients suffering hepatic dysfunctions, retain the disease traits, as demonstrated for alpha-1-antitrypsin deficiency, this strategy can be applied to the study of other cases of anomalous hepatocyte functionality.
C1 [Garcia-Llorens, Guillem; Martinez-Sena, Teresa; Pareja, Eugenia; Tolosa, Laia; Castell, Jose V.; Bort, Roque] Hosp Univ & Politecn La Fe, Unidad Hepatol Expt & Trasplante Hepat, Inst Invest Sanitaria La Fe, Torre A Lab 6-08,Avda Fernando Abril Martorell 106, Valencia 46026, Spain.
   [Garcia-Llorens, Guillem; Pareja, Eugenia; Castell, Jose V.; Bort, Roque] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.
   [Garcia-Llorens, Guillem; Castell, Jose V.] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain.
   [Pareja, Eugenia] Hosp Univ Dr Peset, Serv Cirugia Gen & Aparato Digest, Valencia, Spain.
   [Tolosa, Laia] Inst Salud Carlos III, Ctr Invest Biomed Red Bioingn Biomat & Nanomed CIB, Madrid, Spain.
C3 Hospital Universitari i Politecnic La Fe; Instituto de Salud Carlos III;
   CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University
   of Valencia; Instituto de Salud Carlos III
RP Bort, R (corresponding author), Hosp Univ & Politecn La Fe, Unidad Hepatol Expt & Trasplante Hepat, Inst Invest Sanitaria La Fe, Torre A Lab 6-08,Avda Fernando Abril Martorell 106, Valencia 46026, Spain.; Bort, R (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.
EM bort_ber@gva.es
OI Bort, Roque/0000-0002-7285-0536
CR Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2
   An  P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16092-0
   Araujo AM, 2021, METABOLITES, V11, DOI 10.3390/metabo11100692
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001
   Ballester M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54357-x
   Ballester M, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1416-5
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Burkard A, 2012, XENOBIOTICA, V42, P939, DOI 10.3109/00498254.2012.675093
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183
   Cayo MA, 2017, CELL STEM CELL, V20, P478, DOI 10.1016/j.stem.2017.01.011
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377
   da Silva KM, 2021, METABOLITES, V11, DOI 10.3390/metabo11090635
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Donato MT, 2008, CELL TRANSPLANT, V17, P1211, DOI 10.3727/096368908787236620
   Dove A, 2014, SCIENCE, V346, P1013, DOI 10.1126/science.346.6212.1013
   Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008
   FALANGA V, 1993, J CELL PHYSIOL, V157, P408, DOI 10.1002/jcp.1041570225
   Gao YM, 2017, STEM CELL REP, V9, P1813, DOI 10.1016/j.stemcr.2017.10.019
   Garcia-Llorens G, 2022, J PERS MED, V12, DOI 10.3390/jpm12071111
   Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4
   Gieseck RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086372
   Gomez-Lechon MJ, 2010, TOXICOL IN VITRO, V24
   Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11
   Hayer A, 2016, NAT CELL BIOL, V18, P1311, DOI 10.1038/ncb3438
   Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014
   Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003
   Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116
   Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38
   Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056
   Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109
   KAPLOWITZ N, 1981, YALE J BIOL MED, V54, P497
   Kogiso T, 2013, HEPATOL INT, V7, P937, DOI 10.1007/s12072-013-9432-5
   Kuligowski J, 2015, ANALYST, V140, P7810, DOI 10.1039/c5an01638j
   Lahoz A, 2007, TOXICOL IN VITRO, V21, P1247, DOI 10.1016/j.tiv.2007.03.022
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   MacKenzie KL, 2000, EXP CELL RES, V259, P336, DOI 10.1006/excr.2000.4982
   Marfil V, 2015, ONCOGENE, V34, P3011, DOI 10.1038/onc.2014.240
   Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650
   MIYAZAKI M, 1993, EXP CELL RES, V206, P27, DOI 10.1006/excr.1993.1116
   Mondello C, 2003, BIOCHEM BIOPH RES CO, V308, P914, DOI 10.1016/S0006-291X(03)01484-0
   Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063
   Moreno-Torres M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01652-1
   Rombaut M, 2021, J HEPATOL, V75, P690, DOI 10.1016/j.jhep.2021.04.048
   Santamaria R, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-06184-w
   Segeritz CP, 2018, J HEPATOL, V69, P851, DOI 10.1016/j.jhep.2018.05.028
   Serrano F, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0349-5
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tolosa L, 2012, TOXICOL SCI, V127, P187, DOI 10.1093/toxsci/kfs083
   Tricot T, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11030442
   Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511
   Vaziri H, 1999, MOL CELL BIOL, V19, P2373
   Vinken M, 2014, ARCH TOXICOL, V88, P199, DOI 10.1007/s00204-013-1123-4
   Xie BQ, 2019, CELL RES, V29, P696, DOI 10.1038/s41422-019-0196-x
   Zabulica M, 2019, STEM CELLS DEV, V28, P907, DOI 10.1089/scd.2019.0064
   Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140
NR 60
TC 0
Z9 0
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD APR 18
PY 2023
VL 14
IS 1
AR 94
DI 10.1186/s13287-023-03311-w
PG 19
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA E3KU8
UT WOS:000974573900001
PM 37072803
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kamat, A
   Ghosh, PM
   Glover, RL
   Zhu, B
   Yeh, CK
   Choudhury, GG
   Katz, MS
AF Kamat, Amrita
   Ghosh, Paramita M.
   Glover, Renee L.
   Zhu, Bing
   Yeh, Chih-Ko
   Choudhury, Goutam Ghosh
   Katz, Michael S.
TI Reduced expression of epidermal growth factor receptors in rat liver
   during aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE extracellular signal-regulated kinase; hepatocytes; receptor
   dimerization; receptor tyrosine kinase
ID AGE-RELATED DECLINE; EGF RECEPTOR; DNA-SYNTHESIS; TYROSINE KINASE;
   THYROID-HORMONE; LIGAND-BINDING; HEPATOCYTES; ACTIVATION; TRANSCRIPTION;
   REGENERATION
AB Proliferative responsiveness of hepatocytes to epidermal growth factor (EGF) declines during aging. The role of EGF receptors in mediating age-dependent changes of EGF-induced mitogenic signaling in liver remains incompletely understood. We assessed EGF receptor expression levels in whole liver specimens as well as in freshly isolated and cultured hepatocytes from young adult and senescent Fischer 344 male rats. Hepatic EGF receptor messenger RNA and protein levels, and the number of high- and low-affinity receptor binding sites, decreased with aging. Ligand-induced EGF receptor activation, determined by receptor dimerization and tyrosine phosphorylation, was reduced in old animals in parallel with the age-related decline in receptor expression. Stimulation of the extracellular signal-regulated kinase pathway by EGF was also attenuated in hepatocytes from old animals. Our results implicate decreased expression of EGF receptors as a key determinant of reduced mitogenic signaling responsive to EGF stimulation of liver during aging.
C1 S Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.
   [Kamat, Amrita; Glover, Renee L.; Choudhury, Goutam Ghosh; Katz, Michael S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.
   [Ghosh, Paramita M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA.
   [Zhu, Bing; Yeh, Chih-Ko] Univ Texas Hlth Sci Ctr San Antonio, Dept Dent Diagnost Sci, San Antonio, TX 78229 USA.
C3 Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy
   Memorial Veterans Hospital; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio
RP Kamat, A (corresponding author), S Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr 182, San Antonio, TX 78229 USA.
EM kamat@uthscsa.edu
OI Yeh, Chih-Ko/0000-0001-6611-9942
FU NCI NIH HHS [R21 CA109057] Funding Source: Medline; NIDDK NIH HHS [R01
   DK 50190, R01 DK050190] Funding Source: Medline; BLRD VA [I01 BX000926]
   Funding Source: Medline
CR ATADJA PW, 1994, MOL CELL BIOL, V14, P4991, DOI 10.1128/MCB.14.7.4991
   BALZER AG, 1994, MOL CELL BIOL, V14, P5192
   Berasain C, 2005, GASTROENTEROLOGY, V128, P424, DOI 10.1053/j.gastro.2004.11.006
   DE BK, 1991, AM J PHYSIOL, V260, pG290, DOI 10.1152/ajpgi.1991.260.2.G290
   DeCicco LA, 1996, BIOCHEM BIOPH RES CO, V228, P69, DOI 10.1006/bbrc.1996.1617
   EARP HS, 1981, J CLIN INVEST, V67, P1580, DOI 10.1172/JCI110190
   GLADHAUG IP, 1989, FEBS LETT, V243, P21, DOI 10.1016/0014-5793(89)81209-8
   GLADHAUG IP, 1988, CANCER RES, V48, P6560
   HOU XY, 1994, CELL GROWTH DIFFER, V5, P801
   Hubbard SR, 2006, CELL, V125, P1029, DOI 10.1016/j.cell.2006.05.028
   HUDSON LG, 1990, CELL, V62, P1165, DOI 10.1016/0092-8674(90)90393-S
   Hutter D, 2000, J GERONTOL A-BIOL, V55, pB125, DOI 10.1093/gerona/55.3.B125
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200
   Kim-Kaneyama JR, 2000, J BIOL CHEM, V275, P20685, DOI 10.1074/jbc.M908723199
   Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586
   MARTI U, 1993, HEPATOLOGY, V18, P1432, DOI 10.1002/hep.1840180623
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3
   MUKKU VR, 1984, J BIOL CHEM, V259, P6543
   MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1
   Nishi H, 2002, CANCER RES, V62, P827
   OCONNORMCCOURT M, 1986, BIOCHEM CELL BIOL, V64, P803, DOI 10.1139/o86-108
   OGUEY D, 1992, EUR J CELL BIOL, V59, P187
   OHTAKE Y, 2007, J HEPATOL
   Palmer HJ, 1999, J BIOL CHEM, V274, P11424, DOI 10.1074/jbc.274.16.11424
   Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184
   RIABOWOL K, 1992, P NATL ACAD SCI USA, V89, P157, DOI 10.1073/pnas.89.1.157
   Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536
   Scheving LA, 2007, AM J PHYSIOL-GASTR L, V293, pG552, DOI 10.1152/ajpgi.00140.2007
   Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2
   Skarpen E, 2005, J CELL PHYSIOL, V202, P707, DOI 10.1002/jcp.20171
   SOROKIN A, 1994, J BIOL CHEM, V269, P9752
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200
   Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   WOLLENBERG GK, 1989, LAB INVEST, V60, P254
   Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013
NR 43
TC 9
Z9 10
U1 0
U2 2
PU GERONTOLOGICAL SOC AMER
PI WASHINGTON
PA 1030 15TH ST NW, STE 250, WASHINGTON, DC 20005202-842 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUL
PY 2008
VL 63
IS 7
BP 683
EP 692
DI 10.1093/gerona/63.7.683
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 336UE
UT WOS:000258389300005
PM 18693222
OA Bronze, Green Submitted, Green Accepted
DA 2024-02-19
ER

PT J
AU Chi, C
   Fu, H
   Li, YH
   Zhang, GY
   Zeng, FY
   Ji, QX
   Shen, QR
   Wang, XJ
   Li, ZC
   Zhou, CC
   Sun, DY
   Fu, JT
   Wu, WB
   Zhang, PP
   Zhang, JB
   Liu, J
   Shen, FM
   Li, DJ
   Wang, P
AF Chi, Chen
   Fu, Hui
   Li, Yong-Hua
   Zhang, Guo-Yan
   Zeng, Fei-Yan
   Ji, Qing-Xin
   Shen, Qi-Rui
   Wang, Xu-Jie
   Li, Zi-Chen
   Zhou, Can-Can
   Sun, Di-Yang
   Fu, Jiang-Tao
   Wu, Wen-Bin
   Zhang, Ping-Ping
   Zhang, Jia-Bao
   Liu, Jian
   Shen, Fu-Ming
   Li, Dong-Jie
   Wang, Pei
TI Exerkine fibronectin type-III domain-containing protein
   5/irisin-enriched extracellular vesicles delay vascular ageing by
   increasing SIRT6 stability
SO EUROPEAN HEART JOURNAL
LA English
DT Article; Early Access
DE Vascular ageing; Senescence; Exercise; Extracellular vesicles; FNDC5;
   SIRT6
ID PHYSICAL-ACTIVITY; IRISIN; CELLS; SENESCENCE; HEART; INFLAMMATION;
   REGULATOR; PRESSURE; MYOKINE; DISEASE
AB Aims Exercise confers protection against cardiovascular ageing, but the mechanisms remain largely unknown. This study sought to investigate the role of fibronectin type-III domain-containing protein 5 (FNDC5)/irisin, an exercise-associated hormone, in vascular ageing. Moreover, the existence of FNDC5/irisin in circulating extracellular vesicles (EVs) and their biological functions was explored. Methods and results FNDC5/irisin was reduced in natural ageing, senescence, and angiotensin II (Ang II)-treated conditions. The deletion of FNDC5 shortened lifespan in mice. Additionally, FNDC5 deficiency aggravated vascular stiffness, senescence, oxidative stress, inflammation, and endothelial dysfunction in 24-month-old naturally aged and Ang II-treated mice. Conversely, treatment of recombinant irisin alleviated Ang II-induced vascular stiffness and senescence in mice and vascular smooth muscle cells. FNDC5 was triggered by exercise, while FNDC5 knockout abrogated exercise-induced protection against Ang II-induced vascular stiffness and senescence. Intriguingly, FNDC5 was detected in human and mouse blood-derived EVs, and exercise-induced FNDC5/irisin-enriched EVs showed potent anti-stiffness and anti-senescence effects in vivo and in vitro. Adeno-associated virus-mediated rescue of FNDC5 specifically in muscle but not liver in FNDC5 knockout mice, promoted the release of FNDC5/irisin-enriched EVs into circulation in response to exercise, which ameliorated vascular stiffness, senescence, and inflammation. Mechanistically, irisin activated DnaJb3/Hsp40 chaperone system to stabilize SIRT6 protein in an Hsp70-dependent manner. Finally, plasma irisin concentrations were positively associated with exercise time but negatively associated with arterial stiffness in a proof-of-concept human study. Conclusion FNDC5/irisin-enriched EVs contribute to exercise-induced protection against vascular ageing. These findings indicate that the exerkine FNDC5/irisin may be a potential target for ageing-related vascular comorbidities.
C1 [Chi, Chen; Fu, Hui; Zhang, Guo-Yan; Zeng, Fei-Yan; Ji, Qing-Xin; Wang, Xu-Jie; Li, Zi-Chen; Zhou, Can-Can; Shen, Fu-Ming; Li, Dong-Jie] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Pharm, Shanghai, Peoples R China.
   [Chi, Chen] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Cardiol, Shanghai, Peoples R China.
   [Li, Yong-Hua] Second Mil Med Univ, Naval Med Univ, Changzheng Hosp, Dept Anesthesiol, Shanghai, Peoples R China.
   [Shen, Qi-Rui] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China.
   [Sun, Di-Yang; Fu, Jiang-Tao; Wu, Wen-Bin; Zhang, Ping-Ping; Zhang, Jia-Bao; Wang, Pei] Second Mil Med Univ, Naval Med Univ, Coll Pharm, Dept Pharmacol, Shanghai, Peoples R China.
   [Liu, Jian] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China.
C3 Tongji University; Tongji University; Naval Medical University; Wenzhou
   Medical University; Naval Medical University; Naval Medical University
RP Shen, FM; Li, DJ (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Pharm, Shanghai, Peoples R China.; Wang, P (corresponding author), Second Mil Med Univ, Naval Med Univ, Coll Pharm, Dept Pharmacol, Shanghai, Peoples R China.
EM fumingshen@tongji.edu.cn; djli@tongji.edu.cn; Pwang@smmu.edu.cn
RI zhang, lin/IZQ-4870-2023; Li, Dong-Jie/AAQ-5991-2020
OI WANG, PEI/0000-0002-1650-3353; Li, Dong-Jie/0000-0002-7119-9374
FU China MOST National Key RD Programme [2018YFA0108301]; National Natural
   Science Foundation of China [81773719, 81973312, 91849135, 81971306,
   81873945, 82073915]; Shanghai Science and Technology Commission
   [21XD1424900, 21S11901200, 2019CXJQ03]; Shanghai Talent Development Fund
   [2020091]; Shanghai Shuguang Program [19SG32]; Shanghai Rising Stars of
   Medical Talent Development Program-Clinical Pharmacist Project
   [SHWRS(2020)_087]
FX This work was supported by grants from the China MOST National Key R&D
   Programme (2018YFA0108301), the National Natural Science Foundation of
   China (81773719, 81973312, 91849135, 81971306, 81873945 and 82073915),
   Shanghai Science and Technology Commission Grants (21XD1424900,
   21S11901200, and 2019CXJQ03), Shanghai Talent Development Fund
   (2020091), Shanghai Shuguang Program (19SG32), and Shanghai Rising Stars
   of Medical Talent Development Program-Clinical Pharmacist Project
   (SHWRS(2020)_087).
CR Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703
   Bi JB, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136277
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352
   Chi C, 2017, J CLIN HYPERTENS, V19, P1269, DOI 10.1111/jch.13110
   Chow LS, 2022, NAT REV ENDOCRINOL, V18, P273, DOI 10.1038/s41574-022-00641-2
   Davidson SM, 2023, CARDIOVASC RES, V119, P45, DOI 10.1093/cvr/cvac031
   Diaz-Canestro C, 2022, CARDIOVASC RES, V118, P2385, DOI 10.1093/cvr/cvab300
   Du Bois P, 2015, CIRC RES, V117, P424, DOI 10.1161/CIRCRESAHA.114.305393
   El Harane N, 2018, EUR HEART J, V39, P1835, DOI 10.1093/eurheartj/ehy012
   Faust O, 2020, NATURE, V587, P489, DOI 10.1038/s41586-020-2906-4
   Fu JJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003433
   Grootaert MOJ, 2021, CIRC RES, V128, P474, DOI 10.1161/CIRCRESAHA.120.318353
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Holtermann A, 2021, EUR HEART J, V42, P1499, DOI 10.1093/eurheartj/ehab087
   Hooshmand-Moghadam B, 2020, EXP GERONTOL, V141, DOI 10.1016/j.exger.2020.111090
   Hou ZX, 2019, CIRC RES, V124, P1386, DOI 10.1161/CIRCRESAHA.118.314635
   Hu SQ, 2021, NAT BIOMED ENG, V5, P1174, DOI 10.1038/s41551-021-00705-0
   Ikeda G, 2021, J AM COLL CARDIOL, V77, P1073, DOI 10.1016/j.jacc.2020.12.060
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Islam MR, 2021, NAT METAB, V3, P1058, DOI 10.1038/s42255-021-00438-z
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kim H, 2018, CELL, V175, P1756, DOI 10.1016/j.cell.2018.10.025
   Kim K, 2020, EUR HEART J, V41, P1490, DOI 10.1093/eurheartj/ehz768
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606
   Lecker SH, 2012, CIRC-HEART FAIL, V5, P812, DOI 10.1161/CIRCHEARTFAILURE.112.969543
   Li DJ, 2021, THERANOSTICS, V11, P4381, DOI 10.7150/thno.53652
   Li WX, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI150051
   Liberale L, 2020, EUR HEART J, V41, P1575, DOI 10.1093/eurheartj/ehz712
   Liberale L, 2020, EUR HEART J, V41, P2974, DOI 10.1093/eurheartj/ehz961
   Lin YN, 2021, EUR HEART J, V42, P3558, DOI 10.1093/eurheartj/ehab419
   Liu SX, 2019, MOL THER-NUCL ACIDS, V18, P34, DOI 10.1016/j.omtn.2019.08.002
   Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4
   Maak S, 2021, ENDOCR REV, V42, P436, DOI 10.1210/endrev/bnab003
   McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037
   Nayor M, 2021, EUR HEART J, V42, P4565, DOI 10.1093/eurheartj/ehab580
   Niu YL, 2021, MOL MED, V27, DOI 10.1186/s10020-020-00258-z
   Otaka N, 2018, CIRC RES, V123, P1326, DOI 10.1161/CIRCRESAHA.118.313777
   Premilovac D, 2019, CARDIOVASC RES, V115, P590, DOI 10.1093/cvr/cvy225
   Rai R, 2017, CELL REP, V21, P1471, DOI 10.1016/j.celrep.2017.10.057
   Rana KS, 2014, AGE, V36, P995, DOI 10.1007/s11357-014-9620-9
   Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4
   Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641
   Stojanovic SD, 2020, EUR HEART J, V41, P2983, DOI 10.1093/eurheartj/ehz919
   Tabony AM, 2011, HYPERTENSION, V58, P643, DOI 10.1161/HYPERTENSIONAHA.111.174839
   Tian X, 2019, CELL, V177, P622, DOI 10.1016/j.cell.2019.03.043
   Ungvari Z, 2018, CIRC RES, V123, P849, DOI 10.1161/CIRCRESAHA.118.311378
   Vinel C, 2018, NAT MED, V24, P1360, DOI 10.1038/s41591-018-0131-6
   Visseren Frank L J, 2021, Eur Heart J, V42, P3227, DOI 10.1093/eurheartj/ehab484
   Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005
   Whitham M, 2018, CELL METAB, V27, P237, DOI 10.1016/j.cmet.2017.12.001
   Zhang X, 2020, CELL DEATH DIFFER, V27, P540, DOI 10.1038/s41418-019-0372-z
   Zhang ZZ, 2017, HYPERTENSION, V70, P1165, DOI 10.1161/HYPERTENSIONAHA.117.10156
   Zietzer A, 2022, EUR HEART J, V43, P95, DOI 10.1093/eurheartj/ehab334
NR 56
TC 21
Z9 24
U1 8
U2 45
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
EI 1522-9645
J9 EUR HEART J
JI Eur. Heart J.
PD 2022 NOV 14
PY 2022
VL 43
IS 43
SI SI
BP 4579
EP +
DI 10.1093/eurheartj/ehac431
EA AUG 2022
PG 18
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 6H4QT
UT WOS:000836340300001
PM 35929617
DA 2024-02-19
ER

PT J
AU Rocha-Rodrigues, S
   Santos-Alves, E
   Coxito, PM
   Marques-Aleixo, I
   Passos, E
   Guimaraes, JT
   Martins, MJ
   Oliveira, PJ
   Magalhaes, J
   Ascensao, A
AF Rocha-Rodrigues, Silvia
   Santos-Alves, Estela
   Coxito, Pedro M.
   Marques-Aleixo, Ines
   Passos, Emanuel
   Guimaraes, Joao T.
   Martins, Maria J.
   Oliveira, Paulo J.
   Magalhaes, Jose
   Ascensao, Antonio
TI Combined effects of aging and in vitro non-steroid anti-inflammatory
   drugs on kidney and liver mitochondrial physiology
SO LIFE SCIENCES
LA English
DT Article
DE Elderly; Renal and hepatic toxicity; Bioenergetics; Anti-inflammatory
   drugs
ID PERMEABILITY TRANSITION PORE; INDUCED HEPATOCYTE INJURY; AGE-RELATED
   DECLINE; OXIDATIVE STRESS; DICLOFENAC; SALICYLATE; PHOSPHORYLATION;
   BIOENERGETICS; DYSFUNCTION; RESPIRATION
AB Aims: Aging and drug-induced side effects may contribute to deteriorate mitochondrial bioenergetics in many tissues, including kidney and liver. One possibility is that the combination of both aging and drug toxicity accelerates the process of mitochondria( degradation, leading to progressive bioenergetic disruption. We therefore analyzed in vitro kidney (KM) and liver (LM) mitochondrial response to salicylate and diclofenac in old and adult animals.
   Main methods: Male-Wistar adult (19-wks) and aged (106-wks) rats were used. In vitro endpoints of oxygen consumption and membrane potential were evaluated in non-treated conditions (vehicle) and in the presence of salicylate (0.5 mM) and diclofenac (50 mu M). The susceptibility to calcium-induced permeability transition pore (MPTP) was assessed. Aconitase and C, -SH and MDA contents were measured. Apoptotic signaling was followed by measuring caspase 3, 8 and 9 activities, Box, Bcl2 and CypD expression. ANT content was semi-quantified.
   Key findings: In general, animal age alone compromised KM state 3 and LM ADP lag phase while resulting in decreased resistance to the MPTP. Aging decreased LM CypD and increased Mn-SOD. Kidney caspase 9-like activity was lower in aged group. Salicylate and diclofenac induced KM and LM dysfunction. ADP lag phase in KM was further increased in the aged group in the presence of diclofenac. No further impairments were observed regarding drug toxicity adding to the aging process.
   Significance: Aging impaired KM and LM function despite no detected alterations on oxidative stress and apoptosis. However, aging did not further exacerbate KM and LM frailty induced by salicylate and diclofenac. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Rocha-Rodrigues, Silvia; Santos-Alves, Estela; Coxito, Pedro M.; Marques-Aleixo, Ines; Magalhaes, Jose; Ascensao, Antonio] Univ Porto, Fac Sport, CIAFEL Res Ctr Phys Act Hlth & Leisure, P-4200450 Oporto, Portugal.
   [Oliveira, Paulo J.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal.
   [Passos, Emanuel; Guimaraes, Joao T.; Martins, Maria J.] Univ Porto, Fac Med, Dept Biochem U38 FCT, P-4200450 Oporto, Portugal.
   [Guimaraes, Joao T.] Hosp Sao Joao, Dept Clin Pathol, Oporto, Portugal.
C3 Universidade do Porto; Universidade de Coimbra; Universidade do Porto;
   Sao Joao Hospital
RP Ascensao, A (corresponding author), Univ Porto, Fac Sport Sci, Res Ctr Phys Act Hlth & Leisure, Rua Dr Placido Costa 91, P-4200450 Oporto, Portugal.
EM aascensao@fade.up.pt
RI Guimarães, João Tiago/T-3079-2017; Magalhães, José/B-6991-2009; Martins,
   Maria João/ABC-8271-2021; Oliveira, Paulo J./AAQ-8943-2020; Oliveira,
   Paulo J./H-1980-2011; Santos-Alves, Estela/AAY-1349-2021; Alves,
   Estela/AAX-1575-2020; Marques-Aleixo, Inês/ABE-8088-2021;
   Marques-Aleixo, Inês/M-2550-2017; Ascensao, Antonio A/I-6171-2013; ,
   Maria Joao Martins/ABQ-4920-2022; Rocha-Rodrigues, Sílvia/J-2055-2019;
   Martins, Maria/IQT-0561-2023
OI Guimarães, João Tiago/0000-0003-4836-6311; Magalhães,
   José/0000-0003-4808-8374; Martins, Maria João/0000-0002-3560-3261;
   Oliveira, Paulo J./0000-0002-5201-9948; Oliveira, Paulo
   J./0000-0002-5201-9948; Santos-Alves, Estela/0000-0001-8084-0859; Alves,
   Estela/0000-0001-8084-0859; Marques-Aleixo, Inês/0000-0003-3438-0868;
   Marques-Aleixo, Inês/0000-0003-3438-0868; Ascensao, Antonio
   A/0000-0001-5269-0857; , Maria Joao Martins/0000-0002-3560-3261;
   Rocha-Rodrigues, Silvia/0000-0003-3724-1417; Coxito,
   Pedro/0000-0003-0573-7418
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/89807/2012, SFRH/BD36626/2007, SFRH/BD/61889/2009,
   SFRH/BD/71149/2010, SFRH/BPD/66935/2009, SFRH/BPD/4225/2007]; FCT
   [PTDC/DES/113580/2009-FCOMP-01-0124-FEDER-014705]; IJUP [70, 71/2010];
   Research Centre in Physical Activity, Health and Leisure (CIAFEL) ID
   Unit [PEst-OE/SAU/UI0617/2011]; Fundação para a Ciência e a Tecnologia
   [SFRH/BD/71149/2010, SFRH/BD/61889/2009] Funding Source: FCT
FX SRR (SFRH/BD/89807/2012), PC (SFRH/BD36626/2007), IMA
   (SFRH/BD/61889/2009), EP (SFRH/BD/71149/2010), JM (SFRH/BPD/66935/2009),
   AA (SFRH/BPD/4225/2007) are supported by grants from the Portuguese
   Foundation for Science and Technology (FCT). The present work was
   supported by a research grant from the FCT
   (PTDC/DES/113580/2009-FCOMP-01-0124-FEDER-014705) and from IJUP (70 and
   71/2010) to Antonio Ascensao and Jose Magalhaes, respectively; and from
   the Research Centre in Physical Activity, Health and Leisure (CIAFEL)
   I&D Unit (PEst-OE/SAU/UI0617/2011).
CR Abraham NS, 2008, ALIMENT PHARM THER, V28, P97, DOI 10.1111/j.1365-2036.2008.03706.x
   Al-Nasser IA, 1999, TOXICOL LETT, V105, P1, DOI 10.1016/S0378-4274(98)00373-7
   Ascensao A, 2005, AM J PHYSIOL-HEART C, V289, pH722, DOI 10.1152/ajpheart.01249.2004
   Ascensao A, 2011, CLIN SCI, V120, P37, DOI 10.1042/CS20100254
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Bardou M, 2010, JOINT BONE SPINE, V77, P6, DOI 10.1016/j.jbspin.2009.11.008
   Battaglia V, 2005, J BIOL CHEM, V280, P33864, DOI 10.1074/jbc.M502391200
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826
   Buege J A, 1978, Methods Enzymol, V52, P302
   Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   Ferreira FM, 2003, J BIOCHEM MOL TOXIC, V17, P214, DOI 10.1002/jbt.10081
   Ferreira FML, 1999, ACTA DIABETOL, V36, P173, DOI 10.1007/s005920050163
   Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006
   Gómez-Lechón MJ, 2003, BIOCHEM PHARMACOL, V66, P2155, DOI 10.1016/j.bcp.2003.08.003
   Goodell S, 1998, MECH AGEING DEV, V101, P245, DOI 10.1016/S0047-6374(97)00182-6
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hu M.-L., 1990, METHOD ENZYMOL, P380
   KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lal N, 2009, ARCH BIOCHEM BIOPHYS, V490, P1, DOI 10.1016/j.abb.2009.07.005
   Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009
   LOCKE M, 1990, AM J PHYSIOL, V258, pC723, DOI 10.1152/ajpcell.1990.258.4.C723
   Lumini-Oliveira J, 2011, MITOCHONDRION, V11, P54, DOI 10.1016/j.mito.2010.07.005
   Mahesh R, 2009, CELL BIOCHEM FUNCT, V27, P358, DOI 10.1002/cbf.1581
   Marques-Aleixo I, 2012, TOXICOLOGY, V302, P51, DOI 10.1016/j.tox.2012.07.018
   Masubuchi Y, 1999, BIOCHEM PHARMACOL, V58, P861, DOI 10.1016/S0006-2952(99)00163-X
   Masubuchi Y, 2002, HEPATOLOGY, V35, P544, DOI 10.1053/jhep.2002.31871
   Matas J, 2009, J MOL CELL CARDIOL, V46, P420, DOI 10.1016/j.yjmcc.2008.10.020
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   McCommis KS, 2011, AM J PHYSIOL-REG I, V301, pR1250, DOI 10.1152/ajpregu.00841.2010
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Mingatto FE, 1996, ARCH BIOCHEM BIOPHYS, V334, P303, DOI 10.1006/abbi.1996.0459
   Nadanaciva S, 2011, CURR DRUG TARGETS, V12, P774, DOI 10.2174/138945011795528985
   Ng LE, 2006, BIOCHEM BIOPH RES CO, V348, P494, DOI 10.1016/j.bbrc.2006.07.089
   Nulton-Persson AC, 2004, J CARDIOVASC PHARM, V44, P591, DOI 10.1097/00005344-200411000-00012
   O'Toole JF, 2010, BIOCHEM J, V427, P105, DOI 10.1042/BJ20091373
   Oliveira PJ, 2011, CURR DRUG TARGETS, V12, P761
   Pereira CV, 2012, EXPERT OPIN DRUG MET, V8, P219, DOI 10.1517/17425255.2012.645536
   Petrescu I, 1997, BBA-BIOENERGETICS, V1318, P385, DOI 10.1016/S0005-2728(96)00109-0
   Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008
   Pigoso AA, 1998, INT J BIOCHEM CELL B, V30, P961, DOI 10.1016/S1357-2725(98)00030-2
   Sanz Alberto, 2008, Curr Aging Sci, V1, P10
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Satoh M, 2011, LAB INVEST, V91, P190, DOI 10.1038/labinvest.2010.175
   Schmitt R, 2008, AM J PHYSIOL-RENAL, V294, pF1265, DOI 10.1152/ajprenal.00543.2007
   Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x
   Serviddio G, 2007, REDOX REP, V12, P91, DOI 10.1179/135100007X162112
   Siu WP, 2008, TOXICOL APPL PHARM, V227, P451, DOI 10.1016/j.taap.2007.11.030
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Suski J, 2011, CURR DRUG TARGETS, V12, P827, DOI 10.2174/138945011795529029
   Trost LC, 1997, TOXICOL APPL PHARM, V147, P431, DOI 10.1006/taap.1997.8313
   Trost LC, 1996, J PHARMACOL EXP THER, V278, P1000
   Uyemura SA, 1997, ARCH BIOCHEM BIOPHYS, V342, P231, DOI 10.1006/abbi.1997.9985
   VLESSIS AA, 1987, MOL PHARMACOL, V31, P643
   Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006
NR 64
TC 8
Z9 10
U1 0
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD SEP 3
PY 2013
VL 93
IS 8
BP 329
EP 337
DI 10.1016/j.lfs.2013.07.004
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 204YL
UT WOS:000323407100004
PM 23872100
DA 2024-02-19
ER

PT J
AU Pinto, AP
   Muñoz, VR
   Tavares, MEA
   dos Santos, JR
   Rebelo, MA
   Alberici, LC
   Simabuco, FM
   Teixeira, GR
   Pauli, JR
   de Moura, LP
   Cintra, DE
   Ropelle, ER
   Freitas, EC
   Rivas, DA
   da Silva, ASR
AF Pinto, Ana P.
   Munoz, Vitor R.
   Tavares, Maria Eduarda A.
   dos Santos, Jonathas R.
   Rebelo, Macario A.
   Alberici, Luciane C.
   Simabuco, Fernando M.
   Teixeira, Giovana R.
   Pauli, Jose R.
   de Moura, Leandro P.
   Cintra, Dennys E.
   Ropelle, Eduardo R.
   Freitas, Ellen C.
   Rivas, Donato A.
   da Silva, Adelino S. R.
TI Combined physical exercise reverses the reduced expression of<i>
   Bmal1</i> in the liver of aged mice
SO LIFE SCIENCES
LA English
DT Article; Early Access
DE Senescence; Combined exercise; Transcriptome; Rev-erb ?; Liver
ID MITOCHONDRIAL BIOGENESIS; SYSTEM; PHYSIOLOGY; AUTOPHAGY; GLUCOSE; ALPHA;
   STATE; LEADS
AB Aging can modify the morphology and function of the liver, such as generating a decrease in the mitochondria content, autophagy, and cell senescence. Although exercise training has several beneficial effects on hepatic metabolism, its actions on autophagy processes, mitochondrial function, and cellular senescence need to be more widely explored. The present study verified the effects of aging and exercise on hepatic circadian markers, autophagy, and mitochondria activity in 24-month-old mice with a combined exercise training protocol. In addition, we used public datasets from human livers in several conditions and BMAL1 knockout mice. C57BL/6 mice were distributed into Control (CT, young, 6-month-old mice), sedentary old (Old Sed, sedentary, 24-month -old mice), and exercised old (Old Ex, 24-month-old mice submitted to a combined exercise training protocol). The exercise training protocol consisted of three days of endurance exercise - treadmill running, and two days of resistance exercise - climbing a ladder, for three weeks. At the end of the protocol, the liver was removed and prepared for histological analysis, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), immunoblotting technique, and oxygen consumption. Heatmaps were built using a human dataset and Bmal1 knockout samples. In summary, the Old Sed had reduced strength, coordination, and balance, as well as a decrease in Bmal1 expression and the presence of degenerated liver cells. Still, this group upregulated the transcription factors related to mitochondrial biogenesis. The Old Ex group had increased strength, coordination, and balance, improved glucose sensitivity, as well as restored Bmal1 expression and the mitochondrial tran-scription factors. The human datasets indicated that mitochondrial markers and autophagy strongly correlate with specific liver diseases but not aging. We can speculate that mitochondrial and autophagy molecular markers alterations may depend on long-term training.
C1 [Pinto, Ana P.; Munoz, Vitor R.; Freitas, Ellen C.; da Silva, Adelino S. R.] Univ Sao Paulo, Sch Phys Educ & Sport Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Tavares, Maria Eduarda A.; Teixeira, Giovana R.] Sao Paulo State Univ UNESP, Sch Dent Aracatuba, Multicentr Program Postgrad Physiol Sci, Aracatuba, SP, Brazil.
   [dos Santos, Jonathas R.; Alberici, Luciane C.] Univ Sao Paulo FCFRP USP, Sch Pharmaceut Sci Ribeirao Preto, Dept Biomol Sci, Ribeirao Preto, SP, Brazil.
   [Rebelo, Macario A.] Univ Estadual Campinas, State Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil.
   [Simabuco, Fernando M.; Pauli, Jose R.; de Moura, Leandro P.; Cintra, Dennys E.; Ropelle, Eduardo R.] Univ Campinas UNICAMP, Sch Appl Sci, Lab Mol Biol Exercise LaBMEx, Limeira, SP, Brazil.
   [Teixeira, Giovana R.] State Univ Sao Paulo UNESP, Dept Phys Educ, Presidente Prudente, SP, Brazil.
   [Freitas, Ellen C.] Univ Sao Paulo, Med Sch, Dept Hlth Sci, Ribeirao Preto, SP, Brazil.
   [Rivas, Donato A.] Tufts Univ, Nutr Exercise Physiol & Sarcopenia Lab, Boston, MA 02111 USA.
   [da Silva, Adelino S. R.] Univ Sao Paulo, Ribeirao Preto Med Sch, Postgrad Program Rehabil & Funct Performance, Ribeirao Preto, SP, Brazil.
   [Simabuco, Fernando M.] Fed Univ Sao Paulo UNIFESP, Dept Biochem, Vila Clementino, SP, Brazil.
C3 Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade
   de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual
   de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo;
   Tufts University; Universidade de Sao Paulo; Universidade Federal de Sao
   Paulo (UNIFESP)
RP da Silva, ASR (corresponding author), Ave Bandeirantes,3900,Monte Alegre, BR-14040907 Ribeirao Preto, SP, Brazil.
EM adelinosanchez@usp.br
RI Teixeira, Giovana R/C-1342-2012; Freitas, Ellen Cristini/C-4497-2012;
   Alberici, Luciane C/J-3013-2015; Cintra, Dennys E/N-7758-2017; Ropelle,
   Eduardo R/C-3977-2012; Pinto, Ana Paula/P-7026-2017; Santos, Jonathas
   Rodrigo/JWO-8894-2024; Tavares, Maria Eduarda Almeida/D-4578-2018;
   Rivas, Donato A/IAR-6803-2023; Rebelo, Macario Arosti/HTQ-3508-2023;
   Pauli, José Rdrigo/AAD-2763-2021; Rivas, Donato/N-6613-2017
OI Teixeira, Giovana R/0000-0002-0044-2939; Freitas, Ellen
   Cristini/0000-0002-7343-2002; Alberici, Luciane C/0000-0002-7464-9385;
   Cintra, Dennys E/0000-0002-7954-5630; Ropelle, Eduardo
   R/0000-0003-1655-9557; Pinto, Ana Paula/0000-0002-9139-6746; Santos,
   Jonathas Rodrigo/0000-0001-5384-3966; Tavares, Maria Eduarda
   Almeida/0000-0002-3552-2840; Pauli, José Rdrigo/0000-0002-6129-1521;
   Rebelo, Macario Arosti/0000-0003-4491-9660; Rivas,
   Donato/0000-0002-4500-6233
FU Sao Paulo Research Foundation (FAPESP) [2019/11820-5, 2020/13443-1,
   2021/06291-3, 2021/08692-5, 2021/08693-1]; National Council for
   Scientific and Technological Development (CNPq) [301279/2019-5];
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   [001]
FX The present work received financial support from the Sao Paulo Research
   Foundation (FAPESP; process numbers 2019/11820-5, 2020/13443-1,
   2021/06291-3, 2021/08692-5, and 2021/08693-1) , National Council for
   Scientific and Technological Development (CNPq; process number
   301279/2019-5) , and the Coordination for the Improvement of Higher
   Education Personnel (CAPES; finance code 001) .
CR Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008
   Bhullar KS, 2021, J AGR FOOD CHEM, V69, P1555, DOI 10.1021/acs.jafc.0c07831
   Chen CCW, 2018, AM J PHYSIOL-ENDOC M, V315, pE404, DOI 10.1152/ajpendo.00391.2017
   Chimienti G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102601
   Coqueiro RD, 2019, CLIN NUTR ESPEN, V29, P203, DOI 10.1016/j.clnesp.2018.10.003
   Da Rocha AL, 2016, J CELL PHYSIOL, V231, P1045, DOI 10.1002/jcp.25197
   da Rocha AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140020
   de Cavanagh EMV, 2008, EXP GERONTOL, V43, P919, DOI 10.1016/j.exger.2008.08.007
   de Melo DG, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10688-w
   Fan ZH, 2017, NUCLEIC ACIDS RES, V45, P5720, DOI 10.1093/nar/gkx156
   Faraci C, 2018, REPRODUCTION, V156, P185, DOI 10.1530/REP-18-0061
   Ferraro E, 2016, J CACHEXIA SARCOPENI, V7, P449, DOI 10.1002/jcsm.12097
   Freer CL, 2022, BMJ OPEN DIAB RES CA, V10, DOI 10.1136/bmjdrc-2022-002950
   Graupera I, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100482
   Halle JP, 1997, EUR J CELL BIOL, V74, P281
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hubbard WB, 2021, Clin Bioenerg, P385
   Hunter AL, 2020, P NATL ACAD SCI USA, V117, P25869, DOI 10.1073/pnas.2005330117
   Janice GL-DaCAT-RaSA-P Victor RPaVBP, 2020, AGING, P37
   Johnston HE, 2022, NUTRIENTS, V14, DOI 10.3390/nu14163365
   Komatsu M, 2012, J BIOCHEM, V152, P5, DOI 10.1093/jb/mvs059
   Kristensen CM, 2017, EXP GERONTOL, V98, P124, DOI 10.1016/j.exger.2017.08.006
   Kurosaki R, 2003, NEUROBIOL AGING, V24, P315, DOI 10.1016/S0197-4580(02)00085-4
   Le Minh K, 2009, CRIT CARE MED, V37, P215, DOI 10.1097/CCM.0b013e31819260ae
   Lee KM, 2017, AGING-US, V9, P880, DOI 10.18632/aging.101198
   Liu J, 2019, J CELL BIOCHEM, V120, P16408, DOI 10.1002/jcb.28587
   Liu QX, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00622-4
   Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042
   Mann A, 2015, MOVEMENT DISORDERS: GENETICS AND MODELS, 2ND EDITION, P139, DOI 10.1016/B978-0-12-405195-9.00008-1
   Modi HR, 2008, J MEMBRANE BIOL, V221, P51, DOI 10.1007/s00232-007-9086-0
   Mulvey L, 2017, MOL CELL ENDOCRINOL, V455, P41, DOI 10.1016/j.mce.2016.09.001
   Nahata M, 2021, NPJ AGING MECH DIS, V7, DOI 10.1038/s41514-021-00065-8
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002
   Pereira BC, 2015, NEUROSCIENCE, V311, P231, DOI 10.1016/j.neuroscience.2015.10.027
   Pereira BC, 2015, INT J SPORTS MED, V36, P378, DOI 10.1055/s-0034-1395589
   Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Quan Y, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9423593
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schreiter T, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13122009
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Toledo M, 2018, CELL METAB, V28, P268, DOI 10.1016/j.cmet.2018.05.023
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185
   Vasileiou PVS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070686
   Vinué A, 2015, METHODS MOL BIOL, V1339, P247, DOI 10.1007/978-1-4939-2929-0_17
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23
   Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213
   Yan SH, 2018, ENVIRON POLLUT, V243, P480, DOI 10.1016/j.envpol.2018.09.009
   Yang GR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3305
   Yao K, 2018, EXP GERONTOL, V111, P86, DOI 10.1016/j.exger.2018.07.010
   Yasuda T, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11091389
   Zhang DQ, 2018, HEPATOLOGY, V68, P883, DOI 10.1002/hep.29878
   Zhang DQ, 2014, J BIOL CHEM, V289, P25925, DOI 10.1074/jbc.M114.567628
   Zuccolotto-dos-Reis FH, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13574
NR 60
TC 1
Z9 1
U1 2
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD 2023 JAN 1
PY 2023
VL 312
AR 121175
DI 10.1016/j.lfs.2022.121175
EA NOV 2022
PG 12
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 6S5HT
UT WOS:000893018700005
PM 36414092
OA hybrid
DA 2024-02-19
ER

PT J
AU McCullough, KD
   Coleman, WB
   Smith, GJ
   Grisham, JW
AF McCullough, KD
   Coleman, WB
   Smith, GJ
   Grisham, JW
TI Age-dependent induction of hepatic tumor regression by the tissue
   microenvironment after transplantation of neoplastically transformed rat
   liver epithelial cells into the liver
SO CANCER RESEARCH
LA English
DT Article
ID STEM-LIKE CELLS; BREAST-CANCER; DEATH; APOPTOSIS; CARCINOMA; GROWTH;
   CARCINOGENESIS; PROLIFERATION; RESTRICTION; LYMPHOCYTES
AB Age is the biggest risk factor associated with the development of cancer. Whereas the incidence of neoplastic disease increases dramatically in aging humans and experimental animals, the effects of aging on tumorigenesis are poorly understood. Using a rodent model, we have previously shown that the microenvironment of the hepatic parenchyma regulates hepatic tumor formation from transplanted neoplastic cells in an age-dependent manner. In the current study, we have investigated the mechanistic basis for the age-dependent suppression of tumor formation by transplanted BAG2-GN6TF rat liver epithelial tumor cells. Examination of liver tissue at 7 and 14 days after transplantation of liver tumor cells revealed the presence of injection-site tumors in both young and old animals. With time, these tumors spontaneously regressed from young adult livers, leaving no tumor remnant and without evidence of injury to the parenchyma. In contrast, tumors detected in old animals at early time points after transplantation persisted for the remainder of the life of the host. Reduced cell proliferation and increased apoptotic cell death were detected in hepatic tumors in young rats relative to hepatic tumors in old rats. These observations suggest that the regression of hepatic tumors from young rats was the direct result of an increased ratio of cell death to cell birth, whereas the persistence and expansion of hepatic tumors in old rats was related to increased cell proliferation relative to cell death. Because young adult rats developed persistent (nonregressing) tumors after transplantation of BAG2-GN6TP cells to extrahepatic sites, the consistent regression of BAG2-GN6TF tumors from livers of young rats seemed to be largely a result of interactions between tumor cells and factors specific to the liver microenvironment. These data indicate that the hepatic microenviromnent of young rats can negatively regulate the growth of transformed liver epithelial cells, but with increasing age, the ability of the hepatic microenviromnent to suppress the growth of neoplastic tissue deteriorates. Age-associated alterations in tissue microenvironments may thus permit the development of tumors late in life.
C1 UNIV N CAROLINA,SCH MED,CURRICULUM TOXICOL,DEPT PATHOL & LAB MED,CHAPEL HILL,NC 27599.
C3 University of North Carolina School of Medicine; University of North
   Carolina; University of North Carolina Chapel Hill
FU NCI NIH HHS [CA29323, CA64340] Funding Source: Medline; NIEHS NIH HHS
   [T32 ES07126] Funding Source: Medline
CR ALBRIGHT JW, 1985, MECH AGEING DEV, V31, P295, DOI 10.1016/0047-6374(85)90096-X
   BAIRD MB, 1971, GERONTOLOGY, V17, P105, DOI 10.1159/000211813
   BERGES R, 1993, CLIN CHEM, V39, P356
   BURSCH W, 1990, CARCINOGENESIS, V11, P847, DOI 10.1093/carcin/11.5.847
   BURSCH W, 1992, TRENDS PHARMACOL SCI, V13, P245, DOI 10.1016/0165-6147(92)90077-J
   CAIGNARD A, 1985, INT J CANCER, V36, P273, DOI 10.1002/ijc.2910360221
   CHALLIS GB, 1990, ACTA ONCOL, V29, P545, DOI 10.3109/02841869009090048
   COHEN HJ, 1994, CANCER, V74, P2092, DOI 10.1002/1097-0142(19941001)74:7+<2092::AID-CNCR2820741717>3.0.CO;2-G
   COLEMAN WB, 1993, AM J PATHOL, V142, P1373
   FOLEY JF, 1991, J HISTOTECHNOL, V14, P237, DOI 10.1179/his.1991.14.4.237
   FUKI H, 1987, J LEUKOCYTE BIOL, V41, P130
   GOLDSWORTHY TL, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431843
   GRASLKRAUPP B, 1994, P NATL ACAD SCI USA, V91, P9995, DOI 10.1073/pnas.91.21.9995
   GRISHAM JW, 1993, P SOC EXP BIOL MED, V204, P270
   GRISHAM JW, 1990, PATHOBIOLOGY, V58, P3, DOI 10.1159/000163560
   GRIST SA, 1992, MUTAT RES, V266, P189, DOI 10.1016/0027-5107(92)90186-6
   HAAG JD, 1992, CANCER RES, V52, P4021
   HALLIDAY GM, 1995, WORLD J SURG, V19, P352, DOI 10.1007/BF00299157
   HUNT MJ, 1994, BRIT J DERMATOL, V130, P1, DOI 10.1111/j.1365-2133.1994.tb06873.x
   HURWITZ PJ, 1991, ANN PLAS SURG, V26, P403, DOI 10.1097/00000637-199104000-00016
   ISAACS JT, 1992, J ANDROL, V13, P457
   ISHIZU H, 1994, J PEDIATR SURG, V29, P155, DOI 10.1016/0022-3468(94)90310-7
   KANEDA K, 1989, ARCH HISTOL CYTOL, V52, P447, DOI 10.1679/aohc.52.447
   KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J
   KHAR A, 1986, JNCI-J NATL CANCER I, V76, P871
   KREIDER JW, 1985, J NATL CANCER I, V75, P141
   KRIPKE ML, 1977, CANCER RES, V37, P1395
   KRUCK PA, 1995, P NATL ACAD SCI USA, V92, P258
   KYPRIANOU N, 1990, CANCER RES, V50, P3748
   KYPRIANOU N, 1991, CANCER RES, V51, P162
   LEE LW, 1991, CANCER RES, V51, P5238
   LOCHTER A, 1995, SEMIN CANCER BIOL, V6, P165, DOI 10.1006/scbi.1995.0017
   MARITIN F, 1983, INT J CANCER, V32, P623
   MCCULLOUGH KD, 1994, CANCER RES, V54, P3668
   MILLER RA, 1991, CANCER, V68, P2496, DOI 10.1002/1097-0142(19911201)68:11+<2496::AID-CNCR2820681503>3.0.CO;2-B
   MONTI D, 1992, AM J CLIN NUTR, V55, P1208, DOI 10.1093/ajcn/55.6.1208S
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   NEWELL GR, 1989, SEMIN ONCOL, V16, P3
   Noda K, 1996, ALCOHOL CLIN EXP RES, V20, pA95, DOI 10.1111/j.1530-0277.1996.tb01739.x
   PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156
   RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0
   REIS LAG, 1991, NIH PUBL
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   RUBIN H, 1985, CANCER RES, V45, P2935
   SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x
   SCHULTEHERMANN R, 1994, INT ARCH ALLERGY IMM, V105, P363, DOI 10.1159/000236784
   SCHULTEHERMANN R, 1992, TOXICOL LETT, V64-5, P569, DOI 10.1016/0378-4274(92)90233-A
   SCHWAB R, 1989, SEMIN ONCOL, V16, P20
   SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656
   SZENDE B, 1989, P NATL ACAD SCI USA, V86, P1643, DOI 10.1073/pnas.86.5.1643
   TAKEICHI N, 1990, CANCER IMMUNOL IMMUN, V31, P81, DOI 10.1007/BF01742370
   TOMEI LD, 1994, APOPTOSIS, V2, P377
   TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9
   TSAO MS, 1987, CANCER RES, V47, P1282
   VANDENBRINK MRM, 1991, CANCER RES, V51, P4931
   WERAARCHAKUL N, 1989, EXP CELL RES, V181, P197, DOI 10.1016/0014-4827(89)90193-6
   WINNOCK M, 1993, SEMIN LIVER DIS, V13, P81, DOI 10.1055/s-2007-1007340
   YANO M, 1993, GUT S S3, V3, pS16
   ZHANG WH, 1993, J SURG RES, V55, P140, DOI 10.1006/jsre.1993.1121
NR 59
TC 62
Z9 67
U1 0
U2 3
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W.,
   PHILADELPHIA, PA 19106
SN 0008-5472
J9 CANCER RES
JI Cancer Res.
PD MAY 1
PY 1997
VL 57
IS 9
BP 1807
EP 1813
PG 7
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA WW569
UT WOS:A1997WW56900032
PM 9135026
DA 2024-02-19
ER

PT J
AU Gonçalves, S
   Yin, K
   Ito, Y
   Chan, A
   Olan, I
   Gough, S
   Cassidy, L
   Serrao, E
   Smith, S
   Young, A
   Narita, M
   Hoare, M
AF Goncalves, Susana
   Yin, Kelvin
   Ito, Yoko
   Chan, Adelyne
   Olan, Ioana
   Gough, Sarah
   Cassidy, Liam
   Serrao, Eva
   Smith, Stephen
   Young, Andrew
   Narita, Masashi
   Hoare, Matthew
TI COX2 regulates senescence secretome composition and senescence
   surveillance through PGE<sub>2</sub>
SO CELL REPORTS
LA English
DT Article; Early Access
ID NF-KAPPA-B; IMMUNE-RESPONSES; TUMOR; CANCER; PHENOTYPE; DISEASE; CELLS
AB Senescent cells trigger their own immune-mediated destruction, termed senescence surveillance. This is dependent on the inflammatory senescence-associated secretory phenotype (SASP), which includes COX2, an enzyme with complex roles in cancer. The role COX2 plays during senescence surveillance is unknown. Here, we show that during RAS-induced senescence (RIS), COX2 is a critical regulator of SASP composition and senescence surveillance in vivo. COX2 regulates the expression of multiple inflammatory SASP components through an autocrine feedback loop involving its downstream product, prostaglandin E-2 (PGE(2)), binding to EP4. During in vivo hepatocyte RIS, Cox2 is critical to tumor suppression, Cxcl1 expression, and immune-mediated senescence surveillance, partially through PGE(2). Loss of Cox2 in RIS dysregulates the intrahepatic immune microenvironment, with enrichment of immunosuppressive immature myeloid cells and CD4(+) regulatory T lymphocytes. Therefore, COX2 and PGE(2) play a critical role in senescence, shaping SASP composition, promoting senescence surveillance and tumor suppression in the earliest stages of tumorigenesis.
C1 [Goncalves, Susana; Yin, Kelvin; Ito, Yoko; Chan, Adelyne; Olan, Ioana; Gough, Sarah; Cassidy, Liam; Serrao, Eva; Young, Andrew; Narita, Masashi; Hoare, Matthew] Univ Cambridge, CRUK Cambridge Inst, Cambridge CB2 0RE, England.
   [Smith, Stephen] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England.
   [Narita, Masashi] Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Yokohama, Kanagawa 2260026, Japan.
   [Hoare, Matthew] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England.
C3 University of Cambridge; CRUK Cambridge Institute; University of
   Cambridge; Tokyo Institute of Technology; University of Cambridge
RP Hoare, M (corresponding author), Univ Cambridge, CRUK Cambridge Inst, Cambridge CB2 0RE, England.; Hoare, M (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England.
EM mwh20@cam.ac.uk
RI Gonçalves, Susana A B/B-4663-2015; Smith, Stephen Paul/J-2885-2019
OI Gonçalves, Susana A B/0000-0002-8025-2624; Smith, Stephen
   Paul/0000-0001-7744-3238; Yin, Kelvin/0000-0003-2993-6374; Cassidy,
   Liam/0000-0002-9312-6256; Chan, Adelyne Sue Li/0000-0003-2214-0306;
   Narita, Masashi/0000-0001-7764-577X; Hoare, Matthew/0000-0001-5990-9604;
   Gough, Sarah/0000-0001-8697-9659; Ito, Yoko/0000-0003-4578-6126
FU CRUK Advanced Clinician Scientist Fellowship [C52489/A19924]; Cancer
   Research UK Cambridge Institute core grant [C9545/A29580]; Medical
   Research Council [MR/R010013/1]; Biotechnology and Biological Sciences
   Research Council [BB/S013466/1]; MRC [MR/R010013/1] Funding Source: UKRI
FX We thank all members of the Narita laboratory for helpful discussions
   and staff of the Cancer Research UK Cambridge Institute core facilities
   for technical support. We are grateful to Garret FitzGerald for the
   Ptgs2fl/fl mice and Jesus Gil for the ESF cell line. This work was
   supported by a CRUK Advanced Clinician Scientist Fellowship to M.H.
   (C52489/A19924) and a Cancer Research UK Cambridge Institute core grant
   (C9545/A29580) to M.N. M.H. and M.N. are also supported by a Medical
   Research Council project grant (MR/R010013/1); M.N. is also supported by
   the Biotechnology and Biological Sciences Research Council
   (BB/S013466/1).
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Böttcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004
   Bonavita E, 2020, IMMUNITY, V53, P1215, DOI 10.1016/j.immuni.2020.10.020
   Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Dagouassat M, 2013, AM J RESP CRIT CARE, V187, P703, DOI 10.1164/rccm.201208-1361OC
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Gallois C, 1998, J BIOL CHEM, V273, P23183, DOI 10.1074/jbc.273.36.23183
   Goradel NH, 2019, J CELL PHYSIOL, V234, P5683, DOI 10.1002/jcp.27411
   Hari P, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw0254
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X
   Hoare M, 2018, ANNU REV CANC BIOL, V2, P175, DOI 10.1146/annurev-cancerbio-030617-050352
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Kabir TD, 2016, AGING-US, V8, P1608, DOI 10.18632/aging.100987
   Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Lun ATL, 2017, NAT METHODS, V14, P707, DOI 10.1038/nmeth.4295
   Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Na YR, 2015, EUR J IMMUNOL, V45, P2661, DOI 10.1002/eji.201545471
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258
   Parry AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04283-9
   Richard AC, 2018, NAT IMMUNOL, V19, P849, DOI 10.1038/s41590-018-0160-9
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206
   Serrao EM, 2016, GUT, V65, P465, DOI 10.1136/gutjnl-2015-310114
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   van der Maaten L, 2014, J MACH LEARN RES, V15, P3221
   Wang DR, 2009, P NATL ACAD SCI USA, V106, P7548, DOI 10.1073/pnas.0805806106
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3
   Zdanov S, 2007, EXP CELL RES, V313, P3046, DOI 10.1016/j.yexcr.2007.04.033
   Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015
NR 47
TC 29
Z9 30
U1 0
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD 2021 MAR 16
PY 2021
VL 34
IS 11
AR 108860
DI 10.1016/j.celrep.2021.108860
EA MAR 2021
PG 19
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA QX9HX
UT WOS:000629653900018
PM 33730589
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zakhidov, ST
   Gordeeva, OF
   Marshak, TL
AF Zakhidov, ST
   Gordeeva, OF
   Marshak, TL
TI A biological model of accelerated senescence. 1. The rate of the
   spontaneous mutation process in spermatogenesis of
   senescence-accelerated mice
SO BIOLOGY BULLETIN
LA English
DT Article
ID CHROMOSOME-ABERRATIONS; MOUSE SAM; SOMATIC MUTATIONS; LIVER-CELLS;
   GERM-CELLS; MICRONUCLEUS ANALYSIS; SPERM MORPHOLOGY; AGING PROCESS;
   MURINE MODEL; AGE
AB We studied the dynamics of age-related cytogenetic chances in the developing male germ cells of mice prone to accelerated senescence (strain SAMPI) and mice resistant to accelerated senescence (strain SAMPI) by counting the spermatogonial and meiotic micronuclei and testing the defects of the spermatozoon head shape. In these animals, the accumulation of germinative mutations has a nonlinear pattern. During the entire ontogenesis of SAMPI mice, the frequency of circular spermatids with micronuclei corresponded to the level observed upon induced mutagenesis.
C1 Moscow MV Lomonosov State Univ, Biol Fac, Moscow 119899, Russia.
   Russian Acad Sci, Inst Dev Biol, Moscow 117808, Russia.
C3 Lomonosov Moscow State University; Russian Academy of Sciences; Koltzov
   Institute of Developmental Biology of the Russian Academy of Sciences
RP Zakhidov, ST (corresponding author), Moscow MV Lomonosov State Univ, Biol Fac, Moscow 119899, Russia.
RI Gordeeva, Olga/H-5413-2017
OI Gordeeva, Olga/0000-0001-5279-9342
CR Allen JW, 1996, MUTAT RES-DNAGING G, V316, P261, DOI 10.1016/S0921-8734(96)90008-9
   ALLEN JW, 1994, MUTAT RES, V323, P81, DOI 10.1016/0165-7992(94)90049-3
   ALLEN JW, 1985, CYTOBIOS, V43, P225
   BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T
   Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674
   Calvo A, 1997, REPROD NUTR DEV, V37, P661, DOI 10.1051/rnd:19970605
   CROWLEY C, 1963, P NATL ACAD SCI USA, V49, P626, DOI 10.1073/pnas.49.5.626
   CURTIS HJ, 1963, SCIENCE, V141, P686, DOI 10.1126/science.141.3582.686
   CURTIS HJ, 1971, J GERONTOL, V26, P292, DOI 10.1093/geronj/26.3.292
   CURTIS HJ, 1966, J GERONTOL, V21, P268, DOI 10.1093/geronj/21.2.268
   FABRICANT JD, 1982, J REPROD FERTIL, V66, P485, DOI 10.1530/jrf.0.0660485
   GOSDEN RG, 1982, J REPROD FERTIL, V64, P127, DOI 10.1530/jrf.0.0640127
   HACKERKLOM UB, 1995, Z NATURFORSCH C, V50, P303, DOI 10.1515/znc-1995-3-421
   HE PM, 1994, MECH AGEING DEV, V76, P43, DOI 10.1016/0047-6374(94)90006-X
   Higuchi K, 1997, EXP GERONTOL, V32, P129, DOI 10.1016/S0531-5565(96)00060-5
   HOLSTEIN AF, 1986, ANDROLOGIA, V8, P5
   HONDO JC, 1994, CHROMOSOMA, V103, P186
   Hosokawa M, 1997, EXP GERONTOL, V32, P111, DOI 10.1016/S0531-5565(96)00078-2
   Hosokawa M, 1997, EXP GERONTOL, V32, P197, DOI 10.1016/S0531-5565(96)00069-1
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Johnson TE, 1997, EXP GERONTOL, V32, P11, DOI 10.1016/S0531-5565(96)00079-4
   KIRKWOOD TBL, 1982, HUM GENET, V60, P101, DOI 10.1007/BF00569695
   KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958
   LEE W, 1994, SAM MODEL SENESCENCE, P129
   LEONARD A, 1975, EXP GERONTOL, V10, P309, DOI 10.1016/0531-5565(75)90019-4
   LEONARD A, 1978, CR SOC BIOL, V172, P1029
   LOWE X, 1995, MUTAT RES-DNAGING G, V338, P59, DOI 10.1016/0921-8734(95)00012-U
   MARTUS HJ, 1995, MUTAT RES-DNAGING G, V338, P203, DOI 10.1016/0921-8734(95)00025-2
   MIETHING A, 1993, ANDROLOGIA, V25, P317
   Muller W., 1994, ADV MUTAGENESIS RES, P4, DOI [10.1007/978-3-642-78193-3_1, DOI 10.1007/978-3-642-78193-3_1]
   NATH J, 1995, CHROMOSOMA, V103, P725, DOI 10.1007/s004120050085
   NISITANI S, 1990, MUTAT RES, V237, P221, DOI 10.1016/0921-8734(90)90003-A
   Odagiri Y, 1998, NAT GENET, V19, P116, DOI 10.1038/468
   RAPOPORT IA, 1965, MIKROGENETIKA
   RAPOPORT IA, 1972, MODEL FORMIROVANIYA, P13
   RICHARD F, 1994, MUTAT RES, V316, P1, DOI 10.1016/0921-8734(94)90002-7
   ROSENBUSCH B, 1992, FERTIL STERIL, V58, P1071
   ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075
   SLAGBOOM PE, 1990, MUTAT RES, V237, P183, DOI 10.1016/0921-8734(90)90024-L
   STONE JF, 1995, MUTAT RES-DNAGING G, V338, P107, DOI 10.1016/0921-8734(95)00016-Y
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   TAKEDA T, 1994, INT CONGR SER, V1062, P15
   TOBITA M, 1995, SAM MODEL SENESCENCE, P125
   Uryvaeva IV, 1999, DOKL AKAD NAUK+, V368, P703
   URYVAEVA IV, 1995, MUTAT RES-ENVIR MUTA, V334, P71, DOI 10.1016/0165-1161(95)90032-2
   Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015
   Xia C, 1999, MAMM GENOME, V10, P235, DOI 10.1007/s003359900979
   Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074
   ZAKHIDOV ST, 1993, THESIS MOSCOW STATE
   ZAKHIDOV ST, 1999, GENETICHESKAYA TEORI, P185
   1997, BIOKHIMIYA, V62
NR 54
TC 1
Z9 1
U1 0
U2 0
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1062-3590
J9 BIOL BULL+
JI Biol. Bull
PD JAN-FEB
PY 2001
VL 28
IS 1
BP 18
EP 24
DI 10.1023/A:1026650519457
PG 7
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 528EE
UT WOS:000174230800003
DA 2024-02-19
ER

PT J
AU Piscaglia, F
   Gaiani, S
   Calderoni, D
   Donati, G
   Celli, N
   Gramantieri, L
   Crespi, C
   Bolondi, L
AF Piscaglia, F
   Gaiani, S
   Calderoni, D
   Donati, G
   Celli, N
   Gramantieri, L
   Crespi, C
   Bolondi, L
TI Influence of liver fibrosis on hepatic artery Doppler resistance index
   in chronic hepatitis of viral origin
SO SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE chronic hepatitis; Doppler sonography; liver fibrosis; portal velocity;
   resistance index
ID PORTAL-VEIN; IMPEDANCE INDEXES; CIRRHOSIS; DISEASE; HEMODYNAMICS;
   CIRCULATION; SEVERITY; MEAL; TRANSPLANTATION; HYPERTENSION
AB Background: Hepatic arterial Doppler sonography is increasingly being used in liver diagnostics. The determinants of the elevation of hepatic artery impedance indexes in chronic liver disease, however, have still not been fully clarified. The aim of the present study was to investigate the relationship between histological alterations and liver circulation in chronic hepatitis. Methods: Hepatic artery resistance index and portal flow velocity were measured using Doppler sonography in 47 patients with chronic hepatitis of viral origin diagnosed at histopathology. The patients were divided into two groups, those with mild and those with severe alterations. in accordance with the various histological parameters of the Knodell scoring system. Results: Hepatic artery resistance index and age were higher in patients with more severe liver fibrosis (respectively 0.638 +/- 0.083 and 39.0 +/- 10.9 (years) in mild fibrosis versus 0.687 +/- 0.060 and 49.4 +/- 14.3 (years) in severe fibrosis, P +/- 0.05 for both), whereas no difference between the two groups was found for the other histological features (degeneration, inflammation and necrosis), nor for portal how velocity. Conclusions: The increase in hepatic artery resistance index appears to be influenced by the extent of fibrous tissue deposition in the liver, determined by chronic inflammation and repair and, secondly, by ageing.
C1 Univ Bologna, Azienda Osped S Orsola Malpighi, Dept Internal Med & Gastroenterol, Div Internal Med, Bologna, Italy.
C3 University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di
   Bologna
RP Bolondi, L (corresponding author), Div Med Interna, Via Albertoni 15, IT-40138 Bologna, Italy.
RI Gramantieri, Laura/K-8603-2016; Piscaglia, Fabio/AAC-6899-2022;
   Gramantieri, Laura/J-3862-2019; Piscaglia, Fabio/GRY-4468-2022
OI Gramantieri, Laura/0000-0002-5187-9559; Piscaglia,
   Fabio/0000-0001-8264-1845; Piscaglia, Fabio/0000-0001-8264-1845
CR Bolognesi M, 1998, HEPATOLOGY, V27, P674, DOI 10.1002/hep.510270306
   Bolognesi M, 1996, HEPATOLOGY, V23, P1035
   Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5
   BURNS PN, 1995, CLIN APPL DOPPLER UL, P90
   Colli A, 1998, HEPATOLOGY, V28, P1182, DOI 10.1002/hep.510280503
   Ekataksin W, 2000, HEPATOLOGY, V31, P269, DOI 10.1002/hep.510310203
   Gaiani S, 1997, J HEPATOL, V27, P979, DOI 10.1016/S0168-8278(97)80140-7
   GAIANI S, 1991, GASTROENTEROLOGY, V100, P160, DOI 10.1016/0016-5085(91)90596-D
   GAIANI S, 1989, HEPATOLOGY, V9, P815, DOI 10.1002/hep.1840090604
   Gramantieri L, 1999, CLIN EXP IMMUNOL, V115, P515
   GROSZMANN RJ, 1994, HEPATOLOGY, V20, P1359, DOI 10.1002/hep.1840200538
   Iwao T, 1997, AM J GASTROENTEROL, V92, P1012
   Iwao T, 1998, GUT, V43, P843, DOI 10.1136/gut.43.6.843
   JOYNT LK, 1995, RADIOLOGY, V196, P489, DOI 10.1148/radiology.196.2.7617865
   KASSISSIA I, 1993, HEPATOLOGY, V18, P1189
   KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511
   Koda M, 1996, HEPATO-GASTROENTEROL, V43, P199
   LAFORTUNE M, 1993, RADIOLOGY, V187, P391, DOI 10.1148/radiology.187.2.8475279
   MORIYASU F, 1984, Gastroenterologia Japonica, V19, P529
   MORIYASU F, 1986, AM J ROENTGENOL, V146, P735, DOI 10.2214/ajr.146.4.735
   MOSTBECK GH, 1990, RADIOLOGY, V175, P511, DOI 10.1148/radiology.175.2.2183288
   OHNISHI K, 1985, RADIOLOGY, V155, P757, DOI 10.1148/radiology.155.3.3890004
   Piscaglia F, 1998, AM J GASTROENTEROL, V93, P1925
   Piscaglia F, 1997, ULTRASOUND MED BIOL, V23, P675, DOI 10.1016/S0301-5629(97)00012-4
   Piscaglia F, 1999, HEPATOLOGY, V30, P58, DOI 10.1002/hep.510300112
   SABBA C, 1995, HEPATOLOGY, V21, P428, DOI 10.1016/0270-9139(95)90103-5
   SACERDOTI D, 1995, GASTROENTEROLOGY, V108, P1152, DOI 10.1016/0016-5085(95)90214-7
   SACERDOTI D, 1997, J HEPATOL, V27, P989
   SAKAI Y, 1996, HEPATOLOGY, V25, P421
   Schneider AW, 1999, J HEPATOL, V30, P876, DOI 10.1016/S0168-8278(99)80142-1
   SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532
   SIRINGO S, 1994, HEPATOLOGY, V20, P66, DOI 10.1016/0270-9139(94)90135-X
   SKIDMORE R, 1980, ULTRASOUND MED BIOL, V6, P227, DOI 10.1016/0301-5629(80)90017-4
   Taourel P, 1998, HEPATOLOGY, V28, P932, DOI 10.1002/hep.510280406
   TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202
   VASSILIADES VG, 1993, ABDOM IMAGING, V18, P61, DOI 10.1007/BF00201704
NR 36
TC 25
Z9 30
U1 0
U2 1
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0036-5521
J9 SCAND J GASTROENTERO
JI Scand. J. Gastroenterol.
PD JUN
PY 2001
VL 36
IS 6
BP 647
EP 652
DI 10.1080/003655201750163178
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 432AY
UT WOS:000168665100015
PM 11424325
DA 2024-02-19
ER

PT J
AU Muscogiuri, G
   Kamat, A
   Balas, B
   Giaccari, A
   DeFronzo, RA
   Musi, N
   Katz, MS
AF Muscogiuri, Giovanna
   Kamat, Amrita
   Balas, Bogdan
   Giaccari, Andrea
   DeFronzo, Ralph A.
   Musi, Nicolas
   Katz, Michael S.
TI β-Adrenergic Responsive Induction of Insulin Resistance in Liver of
   Aging Rats
SO ENDOCRINE RESEARCH
LA English
DT Article
DE Glucose production; Catecholamines; beta-Adrenergic receptor
ID ADENYLATE-CYCLASE; GLUCOSE-PRODUCTION; DIABETIC RATS; HUMAN TISSUES;
   AGE; GLYCOGENOLYSIS; EPINEPHRINE; EXPRESSION; RECEPTORS; STRESS
AB Introduction. We previously demonstrated increases in beta-adrenergic receptor (beta-AR) density in rat liver, in association with increased beta-AR-mediated stimulation of glucose output in rat hepatocytes, during senescent aging. We therefore hypothesized that pharmacologic beta-adrenergic stimulation might induce insulin resistance and glucose output in liver of aging rats in vivo. Methods. In this study, pancreatic clamps were performed on young adult (4-month-old) and senescent (24-month-old) Fischer 344 male rats by infusing somatostatin (3 mu g/kg/min) at time 0 to inhibit insulin secretion, and then infusing insulin (1 mU/kg/min) to replace basal insulin concentrations. At time 0 rats also received either the beta-AR agonist isoproterenol (100 ng/kg/min) or saline (control). After 120 min the insulin infusion rate was increased to 4 mU/kg/min for an additional 120 min. Tritiated glucose was infused throughout the study to measure glucose turnover rates. Results and Conclusion. The results of the pancreatic clamp studies demonstrated that under saline control conditions hepatic glucose production (HGP) was suppressed during hyper-insulinemia in both young and old rats, with a trend toward reduced insulin sensitivity in the older animals. Isoproterenol infusion impaired insulin-induced suppression of HGP in both age groups. The results suggest that beta-AR stimulation by isoproterenol increases HGP and acutely induces hepatic insulin resistance in both young and old rats. A similar role for beta-adrenergic-mediated hepatic insulin resistance in aging humans would suggest a novel therapeutic target for the treatment or prevention of glucose dysregulation and diabetes developing with advancing age.
C1 [Kamat, Amrita; Katz, Michael S.] S Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.
   [Muscogiuri, Giovanna; Kamat, Amrita; Balas, Bogdan; DeFronzo, Ralph A.; Musi, Nicolas; Katz, Michael S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.
   [Kamat, Amrita; DeFronzo, Ralph A.; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Giaccari, Andrea] Catholic Univ, Rome & Don Gnocchi Fdn, Dept Endocrinol, Milan, Italy.
   [Katz, Michael S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Dent Diagnost Sci, San Antonio, TX 78229 USA.
C3 Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy
   Memorial Veterans Hospital; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; Catholic
   University of the Sacred Heart; University of Texas System; University
   of Texas Health Science Center at San Antonio
RP Kamat, A (corresponding author), S Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr 182, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.
EM kamat@uthscsa.edu
RI Muscogiuri, Giovanna/K-5817-2016; Giaccari, Andrea/AAA-7824-2022;
   Giaccari, Andrea/ACI-3719-2022; Giaccari, Andrea/J-1889-2012
OI Giaccari, Andrea/0000-0002-7462-7792; Giaccari,
   Andrea/0000-0002-7462-7792; Muscogiuri, Giovanna/0000-0002-8809-4931
FU Department of Veterans Affairs; American Heart Association; Kronos
   Longevity Research Institute
FX This work was supported by a VISN 17 Award from the Department of
   Veterans Affairs (AK), a Grant-in-Aid American Heart Association Award
   (AK), and a research grant from the Kronos Longevity Research Institute
   (MSK).
CR ARNER P, 1990, J CLIN ENDOCR METAB, V71, P1119, DOI 10.1210/jcem-71-5-1119
   Barzilai N, 1996, AM J PHYSIOL-ENDOC M, V270, pE930, DOI 10.1152/ajpendo.1996.270.6.E930
   Cardani R, 2001, HISTOCHEM CELL BIOL, V116, P441, DOI 10.1007/s00418-001-0340-8
   CIZZA G, 1995, J CLIN INVEST, V95, P1217, DOI 10.1172/JCI117771
   COURTNEY CH, 2006, ENDOCRINOLOGY, P1093
   Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   DEIBERT DC, 1980, J CLIN INVEST, V65, P717, DOI 10.1172/JCI109718
   Dinneen SF, 1998, DIABETES CARE, V21, P1408, DOI 10.2337/diacare.21.9.1408
   Elahi D, 2000, EUR J CLIN NUTR, V54, pS112, DOI 10.1038/sj.ejcn.1601032
   Erraji-Benchekroun L, 2005, AM J PHYSIOL-ENDOC M, V288, pE715, DOI 10.1152/ajpendo.00113.2004
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   GIACCARI A, 1992, J CLIN INVEST, V89, P36, DOI 10.1172/JCI115583
   GIACCARI A, 1990, J CLIN INVEST, V85, P1785
   GRAF RJ, 1978, DIABETES, V27, P834, DOI 10.2337/diabetes.27.8.834
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   Gruenewald DA, 2009, HAZZARDS GERIATRIC M, P1267
   Hellgren I, 2000, BIOL PHARM BULL, V23, P700
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Podolin DA, 1996, AM J PHYSIOL-REG I, V270, pR365, DOI 10.1152/ajpregu.1996.270.2.R365
   RIZZA RA, 1980, J CLIN INVEST, V65, P682, DOI 10.1172/JCI109714
   ROSSETTI L, 1993, J CLIN INVEST, V92, P2963, DOI 10.1172/JCI116919
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   SANO M, 1993, LIFE SCI, V52, P1063, DOI 10.1016/0024-3205(93)90199-D
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   Sumida KD, 2003, J APPL PHYSIOL, V95, P712, DOI 10.1152/japplphysiol.01125.2002
   Vidal-Puig A, 2001, NATURE, V413, P125, DOI 10.1038/35093198
   Xiao RP, 1998, J CLIN INVEST, V101, P1273, DOI 10.1172/JCI1335
   Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013
NR 35
TC 8
Z9 8
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0743-5800
EI 1532-4206
J9 ENDOCR RES
JI Endocr. Res.
PY 2011
VL 36
IS 2
BP 74
EP 82
DI 10.3109/07435800.2010.539993
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 758KK
UT WOS:000290163400004
PM 21438725
DA 2024-02-19
ER

PT J
AU Tordella, L
   Khan, S
   Hohmeyer, A
   Banito, A
   Klotz, S
   Raguz, S
   Martin, N
   Dhamarlingam, G
   Carroll, T
   Meljem, JMG
   Deswal, S
   Martínez-Barbera, JP
   García-Escudero, R
   Zuber, J
   Zender, L
   Gil, J
AF Tordella, Luca
   Khan, Sadaf
   Hohmeyer, Anja
   Banito, Ana
   Klotz, Sabrina
   Raguz, Selina
   Martin, Nadine
   Dhamarlingam, Gopuraja
   Carroll, Thomas
   Meljem, Jose Mario Gonzalez
   Deswal, Sumit
   Martinez-Barbera, Juan Pedro
   Garcia-Escudero, Ramon
   Zuber, Johannes
   Zender, Lars
   Gil, Jesus
TI SWI/SNF regulates a transcriptional program that induces senescence to
   prevent liver cancer
SO GENES & DEVELOPMENT
LA English
DT Article
DE senescence; ARID1B; SWI/SNF; p53; ENTPD7; dNTP metabolism; cancer
ID TUMOR-SUPPRESSOR; MUTATIONS; COMPLEX; PATTERNS; ARID1A; CELLS; P53;
   P16(INK4A); ACTIVATION; INTERACTS
AB Oncogene-induced senescence (OIS) is a potent tumor suppressor mechanism. To identify senescence regulators relevant to cancer, we screened an shRNA library targeting genes deleted in hepatocellular carcinoma (HCC). Here, we describe how knockdown of the SWI/SNF component ARID1B prevents OIS and cooperates with RAS to induce liver tumors. ARID1B controls p16(INK4a) and p21(CIP1a) transcription but also regulates DNA damage, oxidative stress, and p53 induction, suggesting that SWI/SNF uses additional mechanisms to regulate senescence. To systematically identify SWI/SNF targets regulating senescence, we carried out a focused shRNA screen. We discovered several new senescence regulators, including ENTPD7, an enzyme that hydrolyses nucleotides. ENTPD7 affects oxidative stress, DNA damage, and senescence. Importantly, expression of ENTPD7 or inhibition of nucleotide synthesis in ARID1B-depleted cells results in re-establishment of senescence. Our results identify novel mechanisms by which epigenetic regulators can affect tumor progression and suggest that prosenescence therapies could be employed against SWI/SNF-mutated cancers.
C1 [Tordella, Luca; Khan, Sadaf; Banito, Ana; Raguz, Selina; Martin, Nadine; Dhamarlingam, Gopuraja; Carroll, Thomas; Gil, Jesus] CSC, MRC, London W12 0NN, England.
   [Tordella, Luca; Khan, Sadaf; Banito, Ana; Raguz, Selina; Martin, Nadine; Dhamarlingam, Gopuraja; Carroll, Thomas; Gil, Jesus] Imperial Coll London, Fac Med, ICS, London W12 0NN, England.
   [Hohmeyer, Anja; Klotz, Sabrina; Zender, Lars] Univ Tubingen, Div Mol Oncol Solid Tumours, Dept Internal Med 1, D-72076 Tubingen, Germany.
   [Meljem, Jose Mario Gonzalez; Martinez-Barbera, Juan Pedro] UCL, Birth Defects Res Ctr, Dev Biol & Canc Programme, Inst Child Hlth, London WC1N 1EH, England.
   [Deswal, Sumit; Zuber, Johannes] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.
   [Garcia-Escudero, Ramon] Ctr Invest Energet Medioambientales & Tecnol CIEM, Mol Oncol Unit, Madrid 28040, Spain.
   [Garcia-Escudero, Ramon] Univ Hosp 12 Octubre, Biomed Res Inst I 12, Madrid 28041, Spain.
   [Martin, Nadine] Ctr Rech Canc Lyon, Senescence Escape Mech Lab, UMR 1052, UMR 5286,CNRS,INSERM, F-69373 Lyon 08, France.
C3 Imperial College London; Eberhard Karls University of Tubingen;
   University of London; University College London; Vienna Biocenter (VBC);
   Research Institute of Molecular Pathology (IMP); Centro de
   Investigaciones Energeticas, Medioambientales Tecnologicas; Hospital
   Universitario 12 de Octubre; Universite Claude Bernard Lyon 1; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Centre
   National de la Recherche Scientifique (CNRS)
RP Gil, J (corresponding author), CSC, MRC, London W12 0NN, England.; Gil, J (corresponding author), Imperial Coll London, Fac Med, ICS, London W12 0NN, England.
EM jesus.gil@csc.mrc.ac.uk
RI Martinez-Barbera, Juan Pedro/AAE-9284-2020; Banito, Ana/P-6168-2017;
   Zuber, Johannes/E-7517-2011; Garcia-Escudero, Ramon/A-2735-2012; Gil,
   Jesus/C-7739-2012; Gonzalez-Meljem, Jose Mario/AAF-9305-2020
OI Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Zuber,
   Johannes/0000-0001-8810-6835; Garcia-Escudero,
   Ramon/0000-0001-5640-6542; Gil, Jesus/0000-0002-4303-6260; Martin,
   Nadine/0000-0002-4806-2388; Banito, Ana/0000-0003-2188-0003; Tordella,
   Luca/0000-0002-0542-7834; Gonzalez-Meljem, Jose
   Mario/0000-0002-1554-0363
FU Medical Research Council Centenary Award; Instituto de Salud Carlos
   III-Redes Tematicas de Investigation Cooperativa en Salud grant
   [RD12/0036/0009]; Medical Research Council [MC-A652-5PZ00,
   MC_U120085810]; Children with Cancer UK [15-190] Funding Source:
   researchfish; Great Ormond Street Hospital Childrens Charity [W1055]
   Funding Source: researchfish; Medical Research Council [MR/M000125/1,
   MC_U120085810] Funding Source: researchfish; MRC [MC_U120085810,
   MR/M000125/1] Funding Source: UKRI
FX We are grateful to S. Lowe and all members of J.G.'s laboratory for
   reagents, helpful comments, and contributions to this project. This
   project was supported in part by a Medical Research Council Centenary
   Award. R.G.-E. was funded by Instituto de Salud Carlos III-Redes
   Tematicas de Investigation Cooperativa en Salud grant RD12/0036/0009.
   Core support from the Medical Research Council (grants MC-A652-5PZ00 and
   MC_U120085810) funded the research in J.G.'s laboratory.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004
   Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609
   BARCLAY RK, 1962, CANCER RES, V22, P809
   Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109
   Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799
   Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107
   Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896
   Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038
   Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010
   Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020
   Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291
   Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018
   Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480
   Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111
   Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583
   Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Khursheed M, 2013, BRIT J CANCER, V108, P2056, DOI 10.1038/bjc.2013.200
   Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07
   Kondoh H, 2005, CANCER RES, V65, P177
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200
   Lee JJ, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0091-3
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920
   Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200
   Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554
   Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5
   Samartzis EP, 2014, ONCOTARGET, V5, P5295, DOI 10.18632/oncotarget.2092
   Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493
   Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119
   Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849
   Shi JD, 2001, J BIOL CHEM, V276, P17474, DOI 10.1074/jbc.M011569200
   Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268
   Wang J, 2009, BIOCHEMISTRY-US, V48, P11612, DOI 10.1021/bi901588z
   Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539
   Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068
   Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061
NR 45
TC 40
Z9 46
U1 0
U2 14
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD OCT 1
PY 2016
VL 30
IS 19
BP 2187
EP 2198
DI 10.1101/gad.286112.116
PG 12
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA EA3YJ
UT WOS:000386544900005
PM 27737960
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Schneider, JL
   Villarroya, J
   Diaz-Carretero, A
   Patel, B
   Urbanska, AM
   Thi, MM
   Villarroya, F
   Santambrogio, L
   Cuervo, AM
AF Schneider, Jaime L.
   Villarroya, Joan
   Diaz-Carretero, Antonio
   Patel, Bindi
   Urbanska, Aleksandra M.
   Thi, Mia M.
   Villarroya, Francesc
   Santambrogio, Laura
   Cuervo, Ana Maria
TI Loss of hepatic chaperone-mediated autophagy accelerates proteostasis
   failure in aging
SO AGING CELL
LA English
DT Article
DE autophagy; lysosomal protein degradation; macroautophagy; oxidative
   stress; proteotoxicity; protein aggregation; ubiquitin-proteasome system
ID SELECTIVE UPTAKE; RAT-LIVER; DEGRADATION; ACTIVATION; RECEPTOR;
   METABOLISM; PROTEINS; LYSOSOMES; PATHWAY; DIETARY
AB Chaperone-mediated autophagy (CMA), a cellular process that contributes to protein quality control through targeting of a subset of cytosolic proteins to lysosomes for degradation, undergoes a functional decline with age. We have used a mouse model with liver-specific defective CMA to identify changes in proteostasis attributable to reduced CMA activity in this organ with age. We have found that other proteolytic systems compensate for CMA loss in young mice which helps to preserve proteostasis. However, these compensatory responses are not sufficient for protection against proteotoxicity induced by stress (oxidative stress, lipid challenges) or associated with aging. Livers from old mice with CMA blockage exhibit altered protein homeostasis, enhanced susceptibility to oxidative stress and hepatic dysfunction manifested by a diminished ability to metabolize drugs, and a worsening of the metabolic dysregulation identified in young mice. Our study reveals that while the regulatory function of CMA cannot be compensated for in young organisms, its contribution to protein homeostasis can be handled by other proteolytic systems. However, the decline in the compensatory ability identified with age explains the more severe consequences of CMA impairment in older organisms and the contribution of CMA malfunction to the gradual decline in proteostasis and stress resistance observed during aging.
C1 [Schneider, Jaime L.; Villarroya, Joan; Diaz-Carretero, Antonio; Patel, Bindi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.
   [Schneider, Jaime L.; Villarroya, Joan; Diaz-Carretero, Antonio; Patel, Bindi; Santambrogio, Laura; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA.
   [Villarroya, Joan] Hosp Santa Creu & Sant Pau, Barcelona 08025, Spain.
   [Urbanska, Aleksandra M.; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA.
   [Thi, Mia M.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA.
   [Villarroya, Francesc] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain.
   [Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Spain.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Hospital of Santa Creu
   i Sant Pau; Yeshiva University; Albert Einstein College of Medicine;
   Yeshiva University; Albert Einstein College of Medicine; University of
   Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN
RP Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM ana-maria.cuervo@einstein.yu.edu
RI Schneider, Jaime/ISA-3518-2023; Villarroya, Francesc/K-4357-2014;
   Villarroya, Joan/W-4066-2018; Thi, Mia Mia/K-8772-2019
OI Schneider, Jaime/0000-0003-2591-2279; Villarroya,
   Joan/0000-0002-7859-1109; Villarroya, Francesc/0000-0003-1266-9142;
   Cuervo, Ana Maria/0000-0002-0771-700X
FU National Institutes of Health [AG21904, AG038072, DK098408, AG031782];
   MINECO (Spain) [SAF2011-23636]; NIH/NIA [T32-GM007288, F30AG046109]
FX This work was supported by grants from the National Institutes of Health
   AG21904, AG038072 and DK098408 to AMC, AG031782 to AMC and LS and
   SAF2011-23636 from MINECO (Spain) to FV. JLS was supported by NIH/NIA
   T32-GM007288 and F30AG046109.
CR Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   Aniento F, 1996, FEBS LETT, V390, P47, DOI 10.1016/0014-5793(96)00625-4
   Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07
   Chen WD, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25766
   CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738
   Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606
   CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x
   CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200
   Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501
   Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003
   DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8
   Hanada S, 2012, J HISTOCHEM CYTOCHEM, V60, P475, DOI 10.1369/0022155412441478
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771
   Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200
   Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155
   Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073
   Kim KM, 2012, EXP CELL RES, V318, P152, DOI 10.1016/j.yexcr.2011.10.013
   Koga H, 2011, J NEUROSCI, V31, P18492, DOI 10.1523/JNEUROSCI.3219-11.2011
   Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393
   Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519
   Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021
   Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109
   Scharf B, 2013, CHEM BIOL, V20, P922, DOI 10.1016/j.chembiol.2013.06.006
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009
   Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718
   Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   STORRIE B, 1990, METHOD ENZYMOL, V182, P203
   Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211
   Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697
   Vakifahmetoglu-Norberg H, 2013, GENE DEV, V27, P1718, DOI 10.1101/gad.220897.113
   Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
NR 42
TC 125
Z9 134
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR
PY 2015
VL 14
IS 2
BP 249
EP 264
DI 10.1111/acel.12310
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA CC9AN
UT WOS:000350659900011
PM 25620427
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Cheluvappa, R
   Hilmer, SN
   Kwun, SY
   Jamieson, HA
   O'Reilly, JN
   Muller, M
   Cogger, VC
   Le Couteur, DG
AF Cheluvappa, Rajkumar
   Hilmer, Sarah N.
   Kwun, Sun Young
   Jamieson, Hamish A.
   O'Reilly, Jennifer N.
   Muller, Michael
   Cogger, Victoria C.
   Le Couteur, David G.
TI The effect of old age on liver oxygenation and the hepatic expression of
   VEGF and VEGFR2
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE liver; pimonidazole; hypoxia; vascular endothelial growth factor;
   vascular endothelial growth factor-receptor 2; aging; poloxamer 407
ID ENDOTHELIAL GROWTH-FACTOR; PERFUSED-RAT-LIVER; FAT-STORING CELLS;
   DRUG-METABOLISM; OXIDATIVE STRESS; SINUSOIDAL WALL; HYPOXIA;
   ANGIOGENESIS; RECEPTORS; PSEUDOCAPILLARIZATION
AB In old age, the liver contains less ATP and hypoxia-responsive genes are upregulated. Age-related changes in hepatic perfusion and the liver sinusoidal endothelial cell (LSEC) could contribute to this altered hepatic oxygen-dependent metabolism by causing intrahepatocytic hypoxia. Furthermore, age-related changes in the LSEC ('pseudocapillarization') have been partially induced by ATP depletion. To investigate whether there is intracellular hypoxia in the old rat liver, pimonidazole immunohistochemistry in intact livers and ATP levels in isolated LSECs were studied from young and old rats. There were no age-related changes. To determine whether defenestration of the LSEC could impair oxygen diffusion, pimonidazole immunohistochemistry was performed in rats treated with poloxamer 407. Despite defenestration. there was no change in pimonidazole staining. Immunohistochemistry was then performed to determine whether there are age-related changes in VEGF and VEGFR2. VEGF staining was not associated with age. However, there was an increase in perisinusoidal VEGFR2 expression with increasing age. In conclusion, liver hypoxia does not occur in old age and LSEC pseudocapillarization does not constitute an oxygen-diffusion barrier. There are no age-related changes in VEGF expression but an increase in perisinusoidal VEGFR2 expression, which has implications for the effects of aging on the hepatic sinusoid. (C) 2007 Elsevier Inc. All rights reserved.
C1 Univ Sydney, Concord RG Hosp, Ctr Educ Res Ageing, ANZAC Res Inst, Sydney, NSW 2006, Australia.
   Royal N Shore Hosp, Dept Age Care & Clin Pharmacol, St Leonards, NSW 2065, Australia.
   Concord RG Hosp, Dept Anat Pathol, Concord, NSW 2139, Australia.
C3 Concord Repatriation General Hospital; University of Sydney; ANZAC
   Research Institute; Royal North Shore Hospital; Concord Repatriation
   General Hospital
RP Cheluvappa, R (corresponding author), Univ Sydney, Concord RG Hosp, Ctr Educ Res Ageing, ANZAC Res Inst, Sydney, NSW 2006, Australia.
EM rcheluvappa@med.usyd.edu.au
RI Research Institute, ANZAC/CAE-9030-2022; Hilmer, Sarah/AAW-8554-2020;
   Ekanayake, Kanchana/P-8817-2016
OI Hilmer, Sarah/0000-0002-5970-1501; Cheluvappa,
   Rajkumar/0000-0002-3472-9591; Le Couteur, David/0000-0002-4227-5817
CR Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122
   Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x
   ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429
   Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422
   Arteel GE, 1996, AM J PHYSIOL-GASTR L, V271, pG494, DOI 10.1152/ajpgi.1996.271.3.G494
   BOUWENS L, 1992, ENZYME, V46, P155, DOI 10.1159/000468782
   Braet F, 2003, HEPATOLOGY, V38, P394, DOI 10.1053/jhep.2003.50347
   BRAET F, 1994, LAB INVEST, V70, P944
   Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902
   Cho CSL, 2001, AM J PHYSIOL-HEART C, V280, pH1802, DOI 10.1152/ajpheart.2001.280.4.H1802
   Cogger VC, 2001, PHARMACOL TOXICOL, V89, P306, DOI 10.1034/j.1600-0773.2001.d01-165.x
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524
   DANIELS CK, 1987, P SOC EXP BIOL MED, V186, P246
   Di Giulio C, 2005, RESP PHYSIOL NEUROBI, V147, P31, DOI 10.1016/j.resp.2005.01.006
   Donahower B, 2006, AM J PHYSIOL-GASTR L, V291, pG102, DOI 10.1152/ajpgi.00575.2005
   Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264
   Froomes PR, 2003, NUCL MED BIOL, V30, P93, DOI 10.1016/S0969-8051(02)00386-4
   Funyu J, 2001, BIOCHEM BIOPH RES CO, V280, P481, DOI 10.1006/bbrc.2000.4148
   Gerber HP, 1999, DEVELOPMENT, V126, P1149
   GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422
   Herrlinger C, 2001, BEST PRACT RES CL GA, V15, P897, DOI 10.1053/bega.2001.0249
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Ishikawa K, 1999, BIOCHEM BIOPH RES CO, V254, P587, DOI 10.1006/bbrc.1998.9984
   Kang MJ, 2005, BIOGERONTOLOGY, V6, P27, DOI 10.1007/s10522-004-7381-z
   KASSISSIA I, 1992, HEPATOLOGY, V16, P763, DOI 10.1002/hep.1840160324
   Katschinski DM, 2006, EXP GERONTOL, V41, P482, DOI 10.1016/j.exger.2005.12.003
   Kinirons MT, 2004, BRIT J CLIN PHARMACO, V57, P540, DOI 10.1111/j.1365-2125.2004.02096.x
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Le Couteur DG, 1999, AM J PHYSIOL-GASTR L, V277, pG725, DOI 10.1152/ajpgi.1999.277.3.G725
   LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562
   Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834
   MCLEAN AJ, 1991, CLIN PHARMACOKINET, V21, P42, DOI 10.2165/00003088-199121010-00004
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Neves D, 2006, ANN NY ACAD SCI, V1067, P164, DOI 10.1196/annals.1354.020
   Nyska A, 2002, TOXICOL APPL PHARM, V184, P153, DOI 10.1006/taap.2002.9485
   Picciotti P, 2004, EXP GERONTOL, V39, P1253, DOI 10.1016/j.exger.2004.06.003
   QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533
   ROSE CP, 1985, CIRC RES, V56, P57, DOI 10.1161/01.RES.56.1.57
   Rosmorduc O, 1999, AM J PATHOL, V155, P1065, DOI 10.1016/S0002-9440(10)65209-1
   Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   SMEDSROD B, 1985, CELL TISSUE RES, V241, P639
   Tanaka T, 2006, J GERONTOL A-BIOL, V61, P795, DOI 10.1093/gerona/61.8.795
   TANUMA Y, 1978, ARCH HISTOL JAPON, V41, P1
   Turley H, 1998, J PATHOL, V186, P313
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114
   Yamaguchi R, 2000, ONCOL REP, V7, P725
   YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425
   Yokomori H, 2003, LIVER INT, V23, P467, DOI 10.1111/j.1478-3231.2003.00880.x
   Zhong Z, 2001, J PHARMACOL EXP THER, V299, P858
NR 59
TC 16
Z9 17
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT
PY 2007
VL 42
IS 10
BP 1012
EP 1019
DI 10.1016/j.exger.2007.06.001
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 220XM
UT WOS:000250190600011
PM 17658234
DA 2024-02-19
ER

PT J
AU Le Couteur, DG
   Cogger, VC
   Markus, AMA
   Harvey, PJ
   Yin, ZL
   Ansselin, AD
   McLean, AJ
AF Le Couteur, DG
   Cogger, VC
   Markus, AMA
   Harvey, PJ
   Yin, ZL
   Ansselin, AD
   McLean, AJ
TI Pseudocapillarization and associated energy limitation in the aged rat
   liver
SO HEPATOLOGY
LA English
DT Article
ID SINUSOIDAL ENDOTHELIAL-CELLS; HEPATIC-ARTERY FLOW; DRUG-METABOLISM;
   OXYGEN SUPPLEMENTATION; HUMAN CIRRHOSIS; TREATED RATS; HEPATOCYTES;
   CLEARANCE; HYPOXIA; DEFENESTRATION
AB Age-related impairment of drug metabolism by the liver is consistent with hepatocyte hypoxia, suggestive of the development of a diffusional barrier to oxygen supply. Because the effects of aging; on the diffusional pathway (sinusoidal endothelium and space of Disse) have not been described, we performed comparative studies on the livers of Fischer F344 rats aged 4 to 7, 12 to 15, and 24 to 27 months. Light-microscopic examination revealed no evidence of fibrosis, cirrhosis, or other specific pathology. In contrast, scanning and transmission electron-microscopic examination revealed that aging is associated with pseudocapillarization of the sinusoidal endothelium, indicated by defenestration with reduced porosity, thickening of the endothelium, infrequent development of basal lamina, and only minor collagen deposits in the space of Disse, Furthermore, immunohistochemistry studies showed strong expression of collagen IV, moderate expression of factor VIII-related antigen, and weak expression of collagen I along the sinusoids of livers from old rats (P < .0001), In vitro P-31 magnetic resonance spectroscopy analysis showed that aging is associated with changes in high-energy phosphate and other metabolites, consistent with hepatocyte hypoxia. Aging in the liver is associated with changes in the sinusoidal endothelium and space of Disse that may restrict the availability of oxygen and other substrates.
C1 Univ Sydney, Canberra Clin Sch, Garran, ACT, Australia.
   John Curtin Sch Med Res, Acton, Australia.
   Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia.
   Univ Sydney, Electron Microscope Unit, Sydney, NSW 2006, Australia.
C3 University of Sydney; Australian National University; John Curtin School
   of Medical Research; University of Sydney; University of Sydney
RP McLean, AJ (corresponding author), Canberra Hosp, Dept Geriatr Med, Garran, ACT 2605, Australia.
RI harvey, peta/D-2048-2017
OI harvey, peta/0000-0003-4735-6242; Le Couteur, David/0000-0002-4227-5817
CR Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122
   Brauer M, 1997, J STUD ALCOHOL, V58, P119, DOI 10.15288/jsa.1997.58.119
   BURT AD, 1993, J PATHOL, V170, P105, DOI 10.1002/path.1711700203
   CHO CS, 2001, IN PRESS AM J PHYSL
   DELEEUW AM, 1990, J ELECTRON MICR TECH, V14, P218
   DOBBS BR, 1994, LIVER, V14, P230
   ENGELMANN GL, 1981, MECH AGEING DEV, V16, P385, DOI 10.1016/0047-6374(81)90023-3
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Froomes PRA, 1999, GASTROENTEROLOGY, V116, P915, DOI 10.1016/S0016-5085(99)70075-2
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harvey PJ, 1999, NMR BIOMED, V12, P395, DOI 10.1002/(SICI)1099-1492(199910)12:6<395::AID-NBM568>3.0.CO;2-M
   Harvey PJ, 2000, J PHARMACOL EXP THER, V293, P641
   Hoppeler H, 2000, ACTA PHYSIOL SCAND, V168, P445, DOI 10.1046/j.1365-201x.2000.00696.x
   HORN T, 1987, HEPATOLOGY, V7, P77, DOI 10.1002/hep.1840070117
   JONES DP, 1981, BIOCHEM PHARMACOL, V30, P1019, DOI 10.1016/0006-2952(81)90436-6
   KASSISSIA I, 1992, HEPATOLOGY, V16, P763, DOI 10.1002/hep.1840160324
   Le Couteur DG, 1999, BIOMED PHARMACOTHER, V53, P122, DOI 10.1016/S0753-3322(99)80077-8
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 1999, J PHARMACOL EXP THER, V289, P1553
   Le Couteur DG, 1999, LANCET, V353, P71, DOI 10.1016/S0140-6736(05)74834-0
   Le Couteur DG, 1999, AM J PHYSIOL-GASTR L, V277, pG725, DOI 10.1152/ajpgi.1999.277.3.G725
   MARTIN G, 1992, CLIN EXP PHARMACOL P, V19, P537, DOI 10.1111/j.1440-1681.1992.tb00501.x
   MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603
   McLean AJ, 1999, GASTROENTEROLOGY, V117, P1257, DOI 10.1016/S0016-5085(99)70427-0
   MCLEAN AJ, 1991, CLIN PHARMACOKINET, V21, P43
   MORGAN DJ, 1991, HEPATOLOGY, V14, P1280, DOI 10.1002/hep.1840140650
   MORI T, 1994, ALCOHOL ALCOHOLISM, V29, P67
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   POPPER H, 1952, AM J CLIN PATHOL, V22, P717
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   POPPER H, 1985, HEPATOLOGY, V5, P1244
   ROSE CP, 1985, CIRC RES, V56, P57, DOI 10.1161/01.RES.56.1.57
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239
   SCHMUCKER DL, 1977, SCIENCE, V197, P1005, DOI 10.1126/science.887935
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VESTAL RE, 1989, HEPATOLOGY, V9, P331, DOI 10.1002/hep.1840090228
   WEIBEL ER, 1989, J MICROSC-OXFORD, V155, P393, DOI 10.1111/j.1365-2818.1989.tb02898.x
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
NR 44
TC 151
Z9 160
U1 1
U2 4
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD MAR
PY 2001
VL 33
IS 3
BP 537
EP 543
DI 10.1053/jhep.2001.22754
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 407LZ
UT WOS:000167274200007
PM 11230732
OA Bronze
DA 2024-02-19
ER

PT J
AU Torres-Mendoza, CE
   Albert, A
   Arriaga, MJD
AF Torres-Mendoza, CE
   Albert, A
   Arriaga, MJD
TI Molecular study of the rat liver NADH:: Cytochrome <i>c</i>
   oxidoreductase complex during development and ageing
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE ageing; mitochondria; complex I-III
ID BOVINE HEART-MITOCHONDRIA; UBIQUINONE OXIDOREDUCTASE; PROTEIN;
   SUBCOMPLEXES; SENESCENCE; SUBUNITS; DECLINE; ENZYME; ASSAY
AB The mechanisms involved in ageing are yet to be fully understood but it is thought that changes produced in energy transfer pathways occurring in the mitochondria may be responsible for the lack of energy typical of the later stages of life. The aim of the present investigation was to determine the enzymatic activity of the liver NADH cytochrome c oxidorectuctase complex (Complex I-III) in mitochondria isolated from the liver of rats of 3 different age groups: lactating, animals (15-17 days), adult females (3-5 months) and old animals (26-30 months). The activities of the unbound Complexes I and III were also determined.
   An increase in Complex I-III activity was detected during development (142 +/- 10 vs. 447 +/- 23 mu mol cyt. c/mg/min, p < 0.001) ang ageing (447 +/- 23 vs. 713 +/- 45 mu mol cyt. c/mg//min, p < 0.001). However, unbound Complex I showed a reduction in activity during the ageing period whilst Complex III activity moderately increased. Immunological studies indicated only a moderate increase in the amount of Complex I-III and studies on the purified complex suggested that the increase in activity was due to effects other than an increase in enzyme quantity. The analysis of protein bands and the quantification of prosthetic groups showed particular reductions in the relative concentrations of Complex I subunits including the 51 kDa unit, which binds FMN, confirmed by a similar reduction in levels of the nucleotide. In contrast, 4 of the 5 subunits which increased during the lifetime of the animals corresponded to those of Complex III. These subunits are responsible for the binding of catalytic groups. The results suggest that, in addition to the increase in the amount of enzyme, binding factors between Complexes I and III may also play an important role in the observed increase in Complex I-III activity.
C1 Univ Complutense, Fac Med, Dept Biochem & Mol Biol, E-28040 Madrid, Spain.
   Inst Quim Fis Rocasolano, Dept Crystallog, Madrid, Spain.
C3 Complutense University of Madrid; Consejo Superior de Investigaciones
   Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)
RP Arriaga, MJD (corresponding author), Univ Complutense, Fac Med, Dept Biochem & Mol Biol, Ciudad Univ S-N, E-28040 Madrid, Spain.
RI Albert, Armando/J-2373-2012
OI Albert, Armando/0000-0002-0026-6816
CR ALEMANY J, 1988, EXP GERONTOL, V23, P25, DOI 10.1016/0531-5565(88)90017-4
   [Anonymous], 1979, MEMBRANE BIOCH LAB M
   BARLETT GR, 1959, J BIOL CHEM, V234, P466
   BERRY EA, 1991, J BIOL CHEM, V266, P9064
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   BOOKELMAN H, 1978, BIOCHEM MED METAB B, V19, P366, DOI 10.1016/0006-2944(78)90037-6
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   COOPER JM, 1992, BIOCHIM BIOPHYS ACTA, V1101, P198, DOI 10.1016/S0005-2728(05)80019-2
   DELACRUZ J, 1990, INT J BIOCHEM, V22, P729, DOI 10.1016/0020-711X(90)90008-Q
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DUPUIS A, 1991, BIOCHEMISTRY-US, V30, P2954, DOI 10.1021/bi00225a032
   ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X
   FINEL M, 1992, BIOCHEMISTRY-US, V31, P11425, DOI 10.1021/bi00161a022
   GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   Hatefi Y, 1967, METHOD ENZYMOL, P235
   HATEFI Y, 1967, METHOD ENZYMOL, V10, P255
   HERON C, 1979, BIOCHEM J, V181, P435, DOI 10.1042/bj1810435
   KING TE, 1964, BIOCHEM BIOPH RES CO, V16, P511, DOI 10.1016/0006-291X(64)90184-6
   KIRKLAND JL, 1992, CLIN BIOCHEM, V25, P61, DOI 10.1016/0009-9120(92)80047-K
   LENAZ G, 1995, FEBS LETT, V366, P119, DOI 10.1016/0014-5793(95)00508-7
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   MULLERHOCKER J, 1992, BRAIN PATHOL, V2, P149, DOI 10.1111/j.1750-3639.1992.tb00683.x
   OCHOA S, 1955, METHOD ENZYMOL, V1, P735, DOI 10.1016/0076-6879(55)01128-2
   Rieske J.S., 1967, Methods in Enzymology, V10, P239
   RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3
   SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224
   SOHAL RS, 1992, MUTAT RES, V275, P295, DOI 10.1016/0921-8734(92)90033-L
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   STORNELL E, 1992, FEBS LETT, V311, P107
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   Tisdale HDBT-M, 1967, Oxidation and phosphorylation, P213, DOI [10.1016/0076-6879(67)10042-6, DOI 10.1016/0076-6879(67)10042-6]
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   VANBELZEN R, 1992, EUR J BIOCHEM, V209, P1019, DOI 10.1111/j.1432-1033.1992.tb17377.x
   WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   YAMAGUCHI M, 1993, BIOCHEMISTRY-US, V32, P1935, DOI 10.1021/bi00059a008
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   ZIEGLER DM, 1962, ARCH BIOCHEM BIOPHYS, V97, P41, DOI 10.1016/0003-9861(62)90042-5
NR 42
TC 11
Z9 12
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0300-8177
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD MAY
PY 1999
VL 195
IS 1-2
BP 133
EP 142
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 203LV
UT WOS:000080709900015
PM 10395077
DA 2024-02-19
ER

PT J
AU Svistounov, D
   Oteiza, A
   Zykova, SN
   Sorensen, KK
   McCourt, P
   McLachlan, AJ
   McCuskey, RS
   Smedsrod, B
AF Svistounov, Dmitri
   Oteiza, Ana
   Zykova, Svetlana N.
   Sorensen, Karen Kristine
   McCourt, Peter
   McLachlan, Andrew J.
   McCuskey, Robert S.
   Smedsrod, Bard
TI Hepatic disposal of advanced glycation end products during maturation
   and aging
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Scavenger cell; Liver; Lysosome; AGE accumulation; AGE disposal
ID ENDOTHELIAL-CELLS; RAT-LIVER; LYSOSOME MEMBRANE; KUPFFER CELLS; HUMAN
   TISSUES; DENSE BODIES; ACCUMULATION; ENDOCYTOSIS; AGE; EXOCYTOSIS
AB Aging is characterized by progressive loss of metabolic and biochemical functions and accumulation of metabolic by-products, including advanced glycation end products (AGEs), which are observed in several pathological conditions. A number of waste macromolecules, including AGEs are taken up from the circulation by endocytosis mainly into liver sinusoidal endothelial cells (LSECs) and Kupffer cells (KCs). However, AGEs still accumulate in different tissues with aging, despite the presence of this clearance mechanism. The aim of the present study was to determine whether the efficiency of LSECs and KCs for disposal of AGEs changes through aging.
   Results: After intravenous administration of C-14-AGE-albumin in pre-pubertal, young adult, middle aged and old mice, more than 90% of total recovered C-14-AGE was liver associated, irrespective of age. LSECs and KCs represented the main site of uptake. A fraction of the C-14-AGE degradation products (C-14-AGE-DPs) was stored for months in the lysosomes of these cells after uptake. The overall rate of elimination of C-14-AGE-DPs from the liver was markedly faster in pre-pubertal than in all post-pubertal age groups. The ability to eliminate C-14-AGE-DPs decreased to similar extents after puberty in LSECs and KCs. A rapid early removal phase was characteristic for all age groups except the old group, where this phase was absent.
   Conclusions: Removal of AGE-DPs from the liver scavenger cells is a very slow process that changes with age. The ability of these cells to dispose of AGEs declines after puberty. Decreased AGE removal efficiency early in life may lead to AGE accumulation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Svistounov, Dmitri; Oteiza, Ana; Sorensen, Karen Kristine; McCourt, Peter; Smedsrod, Bard] Univ Tromso, Dept Med Biol, Tromso, Norway.
   [Zykova, Svetlana N.] Univ Hosp Northern Norway, Dept Nephrol, Tromso, Norway.
   [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.
   [McCuskey, Robert S.] Univ Arizona, Coll Med, Dept Cellular & Mol Med, Tucson, AZ USA.
C3 UiT The Arctic University of Tromso; UiT The Arctic University of
   Tromso; University Hospital of North Norway; University of Sydney;
   University of Arizona
RP Svistounov, D (corresponding author), Univ Tromso, Dept Med Biol, Tromso, Norway.
EM d.svistounov@gmail.com
RI McCourt, Peter/B-3043-2009; McLachlan, Andrew J/AFN-2474-2022
OI McCourt, Peter/0000-0001-5072-4590; McLachlan, Andrew
   J/0000-0003-4674-0242; Oteiza, Ana/0009-0007-2246-6927; Smedsrod,
   Bard/0000-0002-3308-8948; Sorensen, Karen Kristine/0000-0002-7570-186X
FU National Institute of Health (NIH), USA [1.R21AG026582-01A1]; Norwegian
   Research Council [153483/V50]; Tromso Research Foundation; Basque
   Government, Spain [BFI 05.525]
FX The work was supported by the National Institute of Health (NIH), USA,
   (grant no. 1.R21AG026582-01A1); the Norwegian Research Council (grant
   no. 153483/V50); the Tromso Research Foundation; and the Basque
   Government, Spain (grant no. BFI 05.525).
CR ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373
   Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1
   DEBRUYN PPH, 1986, AM J ANAT, V177, P35, DOI 10.1002/aja.1001770105
   DELEEUW AM, 1983, HEPATOLOGY, V3, P497
   DELEEUW AM, 1990, J ELECTRON MICR TECH, V14, P218
   DEPRIESTER W, 1984, MECH AGEING DEV, V26, P205, DOI 10.1016/0047-6374(84)90094-0
   DUNN JA, 1991, BIOCHEMISTRY-US, V30, P1205, DOI 10.1021/bi00219a007
   FORSTER S, 1988, BIOCHIM BIOPHYS ACTA, V947, P465, DOI 10.1016/0304-4157(88)90004-4
   GIACOMELLI F, 1980, CLIN BIOCHEM, V13, P227, DOI 10.1016/S0009-9120(80)80027-0
   Graham J. M., 1997, SUBCELLULAR FRACTION
   Hammes HP, 1999, INVEST OPHTH VIS SCI, V40, P1855
   Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855
   He CJ, 1999, DIABETES, V48, P1308, DOI 10.2337/diabetes.48.6.1308
   Horie K, 1997, BIOCHEM BIOPH RES CO, V236, P327, DOI 10.1006/bbrc.1997.6944
   IVESON GP, 1989, BIOCHEM J, V261, P451, DOI 10.1042/bj2610451
   JAHRAUS A, 1994, J CELL SCI, V107, P145
   KJEKEN R, 1995, EXP CELL RES, V216, P290, DOI 10.1006/excr.1995.1037
   Ling X, 1998, LAB INVEST, V78, P1591
   MAKITA Z, 1994, LANCET, V343, P1519, DOI 10.1016/S0140-6736(94)92935-1
   Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016
   Miyata S, 1997, J BIOL CHEM, V272, P4037, DOI 10.1074/jbc.272.7.4037
   Niwa T, 2006, MASS SPECTROM REV, V25, P713, DOI 10.1002/mas.20089
   NIXON RA, 1993, ANN NY ACAD SCI, V679, P87, DOI 10.1111/j.1749-6632.1993.tb18291.x
   ROEDERER M, 1989, EUR J CELL BIOL, V48, P37
   ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7
   Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Sell DR, 1997, J GERONTOL A-BIOL, V52, pB277, DOI 10.1093/gerona/52A.5.B277
   Sell DR, 1996, P NATL ACAD SCI USA, V93, P485, DOI 10.1073/pnas.93.1.485
   SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011
   Svistounov DN, 2003, BIOCHEM BIOPH RES CO, V309, P786, DOI 10.1016/j.bbrc.2003.08.080
   Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053
   WATTIAUX R, 1993, BIOCHEM BIOPH RES CO, V190, P808, DOI 10.1006/bbrc.1993.1121
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
NR 36
TC 17
Z9 18
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN
PY 2013
VL 48
IS 6
BP 549
EP 556
DI 10.1016/j.exger.2013.03.005
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 139WX
UT WOS:000318616800003
PM 23531498
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU UEJIMA, Y
   FUKUCHI, Y
   TERAMOTO, S
   TABATA, R
   ORIMO, H
AF UEJIMA, Y
   FUKUCHI, Y
   TERAMOTO, S
   TABATA, R
   ORIMO, H
TI AGE-CHANGES IN VISCERAL CONTENT OF GLUTATHIONE IN THE SENESCENCE
   ACCELERATED MOUSE (SAM)
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; FREE RADICAL; GLUTATHIONE; SENESCENCE ACCELERATED MOUSE
ID LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; DEPENDENT PROTECTION; RATS;
   TISSUES; LIVER
AB Free radical formation is known to play a role in the aging processes. However, it is still disputable whether the scavengers of free radicals including glutathione (GSH) decrease during aging. The senescence accelerated mice (SAM) are known to show age-related disorders. Some of these syndromes were thought to be closely associated with oxidative damages. Using the two strains of SAM, SAM-R/1 and SAM-P/2, we examined age-related changes in GSH content in the tissues and its oxidation. In the eye, GSH levels were significantly decreased at the age of 16 months in SAM-P/2 and female SAM-R/1. The ratio of oxidized glutathione to total GSH increased, indicating GSH may play an important role in the eyes. But there were no remarkable age-related changes in GSH contents of other tissues such as liver, kidney and lung in both SAM-R/1 and SAM-P/2. These data suggest that the GSH level of the tissues in general can not be a proper indicator for senescence.
C1 UNIV TOKYO, SCH MED, DEPT GERIATR, TOKYO 113, JAPAN.
C3 University of Tokyo
RI Teramoto, Shinji/ABF-5781-2020
CR CALVIN HI, 1986, SCIENCE, V233, P553, DOI 10.1126/science.3726547
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CANTIN AM, 1989, AM REV RESPIR DIS, V139, P370, DOI 10.1164/ajrccm/139.2.370
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   HOSOKAWA M, 1988, EXP EYE RES, V47, P629, DOI 10.1016/0014-4835(88)90100-5
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   LAMMIKEEFE CJ, 1984, GERONTOLOGY, V30, P153, DOI 10.1159/000212623
   MATSUSHITA M, 1986, AM J PATHOL, V125, P276
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   NIKI E, 1990, METHOD ENZYMOL, V186, P330
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705
   PEREZ R, 1991, FREE RADICAL BIO MED, V10, P35, DOI 10.1016/0891-5849(91)90019-Y
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   ROSS D, 1988, PHARMACOL THERAPEUT, V37, P231, DOI 10.1016/0163-7258(88)90027-7
   SHAN XQ, 1990, PHARMACOL THERAPEUT, V47, P61, DOI 10.1016/0163-7258(90)90045-4
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
   UEJIMA Y, 1991, MECH AGEING DEV, V61, P223, DOI 10.1016/0047-6374(91)90057-7
   UEJIMA Y, 1990, EUR RESPIR J, V3, P1029
   VIDELA LA, 1987, CELL BIOCHEM FUNCT, V5, P273, DOI 10.1002/cbf.290050406
   YAGI K, 1986, BIOCHEM INT, V13, P1051
   1989, NUTR REV, V47, P330
NR 28
TC 15
Z9 15
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB
PY 1993
VL 67
IS 1-2
BP 129
EP 139
DI 10.1016/0047-6374(93)90117-A
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA KT333
UT WOS:A1993KT33300011
PM 8385727
DA 2024-02-19
ER

PT J
AU Bjursell, M
   Wedin, M
   Admyre, T
   Hermansson, M
   Böttcher, G
   Göransson, M
   Lindén, D
   Bamberg, K
   Oscarsson, J
   Bohlooly-Y, M
AF Bjursell, Mikael
   Wedin, Marianne
   Admyre, Therese
   Hermansson, Majlis
   Bottcher, Gerhard
   Goransson, Melker
   Linden, Daniel
   Bamberg, Krister
   Oscarsson, Jan
   Bohlooly-Y, Mohammad
TI Ageing <i>Fxr</i> Deficient Mice Develop Increased Energy Expenditure,
   Improved Glucose Control and Liver Damage Resembling NASH
SO PLOS ONE
LA English
DT Article
ID FARNESOID-X-RECEPTOR; FAMILIAL INTRAHEPATIC CHOLESTASIS;
   BILE-ACID-HOMEOSTASIS; HIGH-FAT DIET; NUCLEAR RECEPTOR; NONALCOHOLIC
   STEATOHEPATITIS; INSULIN SENSITIVITY; GENE-EXPRESSION; KNOCKOUT MICE;
   PPAR-ALPHA
AB Nuclear receptor subfamily 1, group H, member 4 (Nr1h4, FXR) is a bile acid activated nuclear receptor mainly expressed in the liver, intestine, kidney and adrenal glands. Upon activation, the primary function is to suppress cholesterol 7 alpha-hydroxylase (Cyp7a1), the rate-limiting enzyme in the classic or neutral bile acid synthesis pathway. In the present study, a novel Fxr deficient mouse line was created and studied with respect to metabolism and liver function in ageing mice fed chow diet. The Fxr deficient mice were similar to wild type mice in terms of body weight, body composition, energy intake and expenditure as well as behaviours at a young age. However, from 15 weeks of age and onwards, the Fxr deficient mice had almost no body weight increase up to 39 weeks of age mainly because of lower body fat mass. The lower body weight gain was associated with increased energy expenditure that was not compensated by increased food intake. Fasting levels of glucose and insulin were lower and glucose tolerance was improved in old and lean Fxr deficient mice. However, the Fxr deficient mice displayed significantly increased liver weight, steatosis, hepatocyte ballooning degeneration and lobular inflammation together with elevated plasma levels of ALT, bilirubin and bile acids, findings compatible with non-alcoholic steatohepatitis (NASH) and cholestasis. In conclusion, ageing Fxr deficient mice display late onset leanness associated with elevated energy expenditure and improved glucose control but develop severe NASH-like liver pathology.
C1 [Bjursell, Mikael; Wedin, Marianne; Admyre, Therese; Hermansson, Majlis; Bottcher, Gerhard; Goransson, Melker; Linden, Daniel; Bamberg, Krister; Oscarsson, Jan; Bohlooly-Y, Mohammad] AstraZeneca R&D, Molndal, Sweden.
C3 AstraZeneca
RP Bjursell, M (corresponding author), AstraZeneca R&D, Molndal, Sweden.
EM mikael.bjursell@astrazeneca.com
FU AstraZeneca
FX This study was funded by AstraZeneca, the employer of Mikael Bjursell,
   Marianne Wedin, Therese Admyre, Majlis Hermansson, Gerhard Bottcher,
   Melker Goransson, Daniel Linden, Krister Bamberg, Jan Oscarsson,
   Mohammad Bohlooly-Y. There are no patents, products in development or
   marketed products to declare. This does not alter the authors' adherence
   to all the PLOS ONE policies on sharing data and materials, as detailed
   online in the guide for authors.
CR Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046
   Bjursell M, 2005, BIOCHEM BIOPH RES CO, V326, P759, DOI 10.1016/j.bbrc.2004.11.116
   Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432
   Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010
   Boufker HI, 2011, BONE, V49, P1219, DOI 10.1016/j.bone.2011.08.013
   Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033
   Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200
   Chen F, 2004, GASTROENTEROLOGY, V126, P756, DOI 10.1053/j.gastro.2003.12.013
   Düfer M, 2012, DIABETES, V61, P1479, DOI 10.2337/db11-0815
   Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200
   Figge A, 2004, J BIOL CHEM, V279, P2790, DOI 10.1074/jbc.M307363200
   FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8
   Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510
   Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583
   Hashidume T, 2011, BIOSCI BIOTECH BIOCH, V75, P1702, DOI 10.1271/bbb.110224
   Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435
   Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001
   Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103
   Inoue M, 2011, J CLIN BIOCHEM NUTR, V48, P161, DOI 10.3164/jcbn.09-122GFR
   Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200
   Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200
   Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600
   Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200
   Lian F, 2011, BIOCHEM J, V438, P315, DOI 10.1042/BJ20102096
   Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604
   Malaguarnera L, 2005, J HEPATOL, V42, P585, DOI 10.1016/j.jhep.2004.11.040
   Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409
   Meng ZP, 2010, MOL ENDOCRINOL, V24, P886, DOI 10.1210/me.2009-0286
   Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030
   Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y
   Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034
   Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300
   Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007
   van Dijk TH, 2009, J BIOL CHEM, V284, P10315, DOI 10.1074/jbc.M807317200
   Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019
   Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330
   Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078
   Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269
   Zhang YQ, 2006, ARTERIOSCL THROM VAS, V26, P2316, DOI 10.1161/01.ATV.0000235697.35431.05
   Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157
   Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103
NR 49
TC 54
Z9 62
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 20
PY 2013
VL 8
IS 6
AR e64721
DI 10.1371/journal.pone.0064721
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 158JQ
UT WOS:000319966400064
PM 23700488
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU JENA, BS
   PATNAIK, BK
AF JENA, BS
   PATNAIK, BK
TI CHANGES IN CATALASE ACTIVITY AND ITS THERMOLABILITY IN LIVER AND KIDNEYS
   OF AGING MALE GARDEN LIZARD
SO GERONTOLOGY
LA English
DT Article
DE LIZARD; CATALASE; THERMOLABILITY
ID LIFE-SPAN; THERMAL INACTIVATION; MUSCA-DOMESTICA; DIFFERENT AGES;
   GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; RESPONSES; STRESS; MICE
AB Catalase activity in liver and kidneys of male garden lizards remained unchanged during maturation, but showed an increase during ageing. Instead of inactivating catalase, thermal treatment at 60 +/- 1-degrees-C caused a marginal increase in enzyme activity in the liver of middle-aged and kidneys of young lizards with no significant effect in old counterparts. Increase in basal enzyme activity during ageing and the maintenance of resistance against thermal inactivation of the enzyme throughout the life-span support the contention that catalase molecules in lizard tissues are not altered as a function of age, a deviation from the predictions of Orgel's error catastrophe hypothesis.
C1 BERHAMPUR UNIV, DEPT ZOOL, BERHAMPUR 760007, ORISSA, INDIA.
C3 Berhampur University
CR [Anonymous], AGE PIGMENTS
   BAIRD MB, 1971, GERONTOLOGY, V17, P105, DOI 10.1159/000211813
   BAIRD MB, 1975, GERONTOLOGY, V21, P240, DOI 10.1159/000212051
   BAIRD MB, 1975, GERONTOLOGY, V21, P57, DOI 10.1159/000212031
   BAIRD MB, 1974, GERONTOLOGY, V20, P169, DOI 10.1159/000212011
   BAIRD MB, 1976, EXP GERONTOL, V11, P167, DOI 10.1016/0531-5565(76)90029-2
   Bergmeyer H. U., 1974, METHODS ENZYMATIC AN
   CHANCE B, 1968, BIOCHEMISTS HDB, P383
   DARNELL J, 1986, MOL CELL BIOL, P938
   FARMER KJ, 1987, EXP GERONTOL, V22, P59, DOI 10.1016/0531-5565(87)90015-5
   GARG SK, 1990, GERONTOLOGY, V36, P126, DOI 10.1159/000213187
   HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1
   HELFMAN PM, 1974, EXP GERONTOL, V9, P209, DOI 10.1016/0531-5565(74)90014-X
   IMRE S, 1987, MECH AGEING DEV, V38, P259, DOI 10.1016/0047-6374(87)90094-7
   JENA BS, 1990, GERONTOLOGY, V36, P12
   JENA BS, 1991, GERONTOLOGY, V37, P299
   JENA BS, 1990, GERONTOLOGY, V36, P262
   KARA TC, 1981, GERONTOLOGY, V27, P187, DOI 10.1159/000212472
   KRISHNAKANTHA TP, 1972, BIOCHEM J, V130, P167, DOI 10.1042/bj1300167
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASSIE HR, 1976, MECH AGEING DEV, V5, P39, DOI 10.1016/0047-6374(76)90006-3
   NICOLOSI RJ, 1973, EXP GERONTOL, V8, P101, DOI 10.1016/0531-5565(73)90020-X
   NOHL H, 1979, MECH AGEING DEV, V11, P145, DOI 10.1016/0047-6374(79)90050-2
   OLIVIERA RJ, 1973, EXP GERONTOL, V8, P189
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   ORGEL LE, 1973, NATURE, V244, P441, DOI 10.1038/243441a0
   SCHOFIELD JD, 1978, EXP GERONTOL, V13, P147, DOI 10.1016/0531-5565(78)90007-4
   SOHAL RS, 1984, MECH AGEING DEV, V24, P185, DOI 10.1016/0047-6374(84)90070-8
   SOHAL RS, 1985, MECH AGEING DEV, V31, P329, DOI 10.1016/0047-6374(85)90098-3
   YAGIL G, 1976, EXP GERONTOL, V11, P73, DOI 10.1016/0531-5565(76)90016-4
NR 30
TC 9
Z9 9
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PD SEP-OCT
PY 1992
VL 38
IS 5
BP 252
EP 257
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA JV304
UT WOS:A1992JV30400002
PM 1427123
DA 2024-02-19
ER

PT J
AU ALTMAN, DF
AF ALTMAN, DF
TI CHANGES IN GASTROINTESTINAL, PANCREATIC, BILIARY, AND HEPATIC-FUNCTION
   WITH AGING
SO GASTROENTEROLOGY CLINICS OF NORTH AMERICA
LA English
DT Article
C1 UNIV CALIF SAN FRANCISCO,FRESNO CENT SAN JOAQUIN VALLEY MED EDUC PROGRAM,FRESNO,CA.
C3 University of California System; University of California San Francisco;
   University of California San Francisco at Fresno
RP ALTMAN, DF (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,2615 E CLINTON AVE,FRESNO,CA 93703, USA.
CR ANAND BS, 1989, GASTROINTEST ENDOSC, V35, P210, DOI 10.1016/S0016-5107(89)72760-7
   ANURAS S, 1984, GASTROENTEROLOGY, V86, P1016
   ARORA S, 1989, GASTROENTEROLOGY, V96, P1560, DOI 10.1016/0016-5085(89)90527-1
   BANNISTER JJ, 1987, GUT, V28, P353, DOI 10.1136/gut.28.3.353
   BIRD T, 1977, GERONTOLOGY, V23, P309, DOI 10.1159/000212201
   BROCKLEHURST JC, 1983, GERONTOLOGY, V29, P181, DOI 10.1159/000213112
   CARRERE J, 1987, J GERONTOL, V42, P315, DOI 10.1093/geronj/42.3.315
   CITI S, 1964, G Gerontol, V12, P123
   CLEMENS TL, 1986, J CLIN ENDOCR METAB, V63, P656, DOI 10.1210/jcem-63-3-656
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   FEIBUSCH J, 1979, AM J CLIN NUTR, V32, P942
   GROSSMAN MI, 1963, GASTROENTEROLOGY, V45, P14
   GULLO L, 1986, J AM GERIATR SOC, V34, P790, DOI 10.1111/j.1532-5415.1986.tb03983.x
   HOLLIS JB, 1974, ANN INTERN MED, V80, P371, DOI 10.7326/0003-4819-80-3-371
   HOLT PR, 1984, J GERONTOL, V39, P642, DOI 10.1093/geronj/39.6.642
   Holt PR, 1983, AGING GUT MASSON PUB, P33
   IHRE T, 1974, SCAND J GASTROEN S25, V9, P5
   KEANE P, 1986, SURG GYNECOL OBSTET, V163, P555
   KIMURA K, 1972, GASTROENTEROLOGY, V63, P584
   KITANI K, 1986, HEPATOLOGY, V6, P316, DOI 10.1002/hep.1840060227
   KREEL L, 1973, GUT, V14, P962, DOI 10.1136/gut.14.12.962
   LANGIER R, 1985, CLIN GASTROENTEROL, V14, P749
   MALONEY AG, 1986, HEPATOLOGY, V6, P282, DOI 10.1002/hep.1840060221
   MCCALLUM RW, 1981, GASTROENTEROLOGY, V80, P1151
   MCHUGH SM, 1987, DIGEST DIS SCI, V32, P726, DOI 10.1007/BF01296139
   MOORE JG, 1983, DIGEST DIS SCI, V28, P340, DOI 10.1007/BF01324951
   PIAGET F, 1959, J MED LYON, V40, P961
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   SAMLOFF IM, 1975, GASTROENTEROLOGY, V69, P83
   SCHMUCKER DL, 1986, J AM GERIATR SOC, V34, P377, DOI 10.1111/j.1532-5415.1986.tb04321.x
   SCHNEIDER EL, 1986, ANN INTERN MED, V104, P432, DOI 10.7326/0003-4819-104-3-432
   VALDIVIESO V, 1978, GASTROENTEROLOGY, V74, P871
   Vanzant FR, 1932, ARCH INTERN MED, V49, P345, DOI 10.1001/archinte.1932.00150100002001
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1988, AGE AGEING, V17, P401, DOI 10.1093/ageing/17.6.401
NR 35
TC 21
Z9 22
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0889-8553
J9 GASTROENTEROL CLIN N
JI Gastroenterol. Clin. North Am.
PD JUN
PY 1990
VL 19
IS 2
BP 227
EP 234
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DF360
UT WOS:A1990DF36000002
PM 2194943
DA 2024-02-19
ER

PT J
AU HE, PM
   YAMAOKAKOSEKI, S
   YASUMOTO, K
AF HE, PM
   YAMAOKAKOSEKI, S
   YASUMOTO, K
TI EFFECT OF PARAQUAT ADMINISTRATION ON ANTIOXIDATIVE ENZYME-ACTIVITIES AND
   OXIDATIVE DAMAGE IN THE BLOOD AND LIVER OF SENESCENCE-ACCELERATED MICE
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
ID MIXED-FUNCTION OXIDATION; SUPEROXIDE-DISMUTASE; GLUTATHIONE-PEROXIDASE;
   METHYL VIOLOGEN; MURINE MODEL; OXYGEN; RATS; INDUCTION; TOXICITY;
   SELENIUM
AB The effect was assessed of paraquat administration on the antioxidative defense mechanism in blood and liver. Ten-week-old senescence-accelerated mice were fed with either a 20% casein diet or the same diet supplemented with 200 ppm paraquat for 12 weeks. About 0.2 ml of blood withdrawn periodically from the supraorbital vein was assayed for the activities of antioxidative enzymes and oxidative damage. Blood and liver collected after decapitating the mice were equivalently treated at the end of the experimental period. Paraquat ingestion depressed the antioxidative enzyme activities, and increased the level of oxidized protein in erythrocytes and the thiobarbituric acid-reactive substance (TBARS) value in plasma. Similar changes were observed for the plasma and liver in the antioxidative enzyme activites, and in the level of oxidized protein and the TBARS value. These changes produced by paraquat administration were closely associated with accelerated aging leading to cell death. We discuss the effect of paraquat on senescence in mice, in relation to the oxidative damage caused.
C1 KYOTO UNIV, FOOD SCI RES INST, UJI, KYOTO 611, JAPAN.
C3 Kyoto University
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   [Anonymous], BIOCH MECH PARAQUAT
   BOWEN SW, 1988, J BIOL CHEM, V263, P14808
   BULLIVANT CM, 1966, BMJ-BRIT MED J, V1, P1272, DOI 10.1136/bmj.1.5498.1272
   BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Halliwell Barry, 1993, American Journal of Clinical Nutrition, V57, p715S, DOI 10.1093/ajcn/57.5.715S
   HASSAN HM, 1977, J BIOL CHEM, V252, P7667
   He P., 1990, Nippon Eiyo Shokuryo Gakkaishi = Journal of the Japanese Society of Nutrition and Food Science, V43, P121
   HE PM, 1992, J NUTR SCI VITAMINOL, V38, P57, DOI 10.3177/jnsv.38.57
   KIMBROUGH RD, 1970, TOXICOL APPL PHARM, V17, P679, DOI 10.1016/0041-008X(70)90042-6
   LEVINE RL, 1984, METHOD ENZYMOL, V107, P370
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   NICOTERA TM, 1989, CANCER RES, V49, P5239
   OLIVER CN, 1987, J AM GERIATR SOC, V35, P947, DOI 10.1111/j.1532-5415.1987.tb02297.x
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   SMITH PJ, 1974, NATURE, V247, P392, DOI 10.1038/247392a0
   STARKE PE, 1987, FASEB J, V1, P36, DOI 10.1096/fasebj.1.1.2886388
   STEVENS JB, 1977, J BIOL CHEM, V252, P3509
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   YAGI K, 1984, METHOD ENZYMOL, V105, P328
   YOSHIDA M, 1981, AGR BIOL CHEM TOKYO, V45, P1681, DOI 10.1080/00021369.1981.10864764
NR 25
TC 5
Z9 5
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD JAN
PY 1994
VL 58
IS 1
BP 146
EP 150
DI 10.1271/bbb.58.146
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA MU668
UT WOS:A1994MU66800031
PM 27315713
DA 2024-02-19
ER

PT J
AU LIU, JK
   MORI, A
AF LIU, JK
   MORI, A
TI AGE-ASSOCIATED CHANGES IN SUPEROXIDE-DISMUTASE ACTIVITY, THIOBARBITURIC
   ACID REACTIVITY AND REDUCED GLUTATHIONE LEVEL IN THE BRAIN AND LIVER IN
   SENESCENCE-ACCELERATED MICE (SAM) - A COMPARISON WITH DDY MICE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE SENESCENCE ACCELERATED MICE (SAM); THIOBARBITURIC ACID (TBA) REACTIVITY;
   SUPEROXIDE DISMUTASE (SOD) ACTIVITY; REDUCED GLUTATHIONE (GSH);
   ANTIOXIDANT DEFENSE
ID MOUSE SAM; RAT-BRAIN; ANTIOXIDANTS; TISSUES; DAMAGE
AB The antioxidant defense alteration in young and old senescence accelerated mice (SAM) was studied by examining superoxide dismutase (SOD) activity, thiobarbituric acid (TBA) reactivity, and reduced glutathione (GSH) level in brain and liver tissues. The changes were compared with those in age-paired ddY mice, a strain exhibiting normal aging. SAM mice showed an age-dependent increase in SOD activity in liver, and an age-dependent increase in TBA reactivity in both the brain and the liver; they also showed an age-dependent decrease in the GSH level in the brain and the liver. When compared with ddY mice, SAM mice showed a higher SOD activity in the brain (at both 3 and 11 months old), a lower GSH level in the liver (at 3 months old), and a higher TBA reactivity in the liver (at 3 months old). These findings suggest that the mechanism of senescence acceleration in SAM mice is to some extent related to free radical damage.
C1 OKAYAMA UNIV, SCH MED,INST MOLEC & CELLULAR MED,DEPT NEUROSCI, 2-5-1 SHIKATACHO, OKAYAMA 700, JAPAN.
C3 Okayama University
RI Liu, Jiankang/A-1610-2011
CR CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   DE AK, 1991, MECH AGEING DEV, V59, P123, DOI 10.1016/0047-6374(91)90078-E
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   Emerit I., 1992, FREE RADICALS AGING
   GEREMIA E, 1990, NEUROCHEM RES, V15, P719, DOI 10.1007/BF00973653
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   GUTTERIDGE JMC, 1982, INT J BIOCHEM, V14, P649, DOI 10.1016/0020-711X(82)90050-7
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   HAZELTON GA, 1978, FED PROC, V37, P3501
   HIGUCHI K, 1983, LAB INVEST, V48, P231
   HIGUCHI K, 1983, J EXP MED, V158, P1600, DOI 10.1084/jem.158.5.1600
   HIRAMATSU M, 1992, J NEUROCHEM, V58, P1160, DOI 10.1111/j.1471-4159.1992.tb09375.x
   HIRAMATSU M, 1992, FREE RADICALS AGING, P213
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   HOSOKAWA M, 1984, EXP EYE RES, V38, P105, DOI 10.1016/0014-4835(84)90095-2
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   MAVELLI I, 1978, J NEUROCHEM, V31, P363, DOI 10.1111/j.1471-4159.1978.tb12472.x
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   Moldeus P, 1983, FUNCTIONS GLUTATHION, P99
   MUNDAY R, 1989, BIOCHEM PHARMACOL, V38, P4349, DOI 10.1016/0006-2952(89)90641-2
   NISSIN PJ, 1976, ANAL BIOCHEM, V74, P214
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   ROCKSTEIN M, 1974, THEORETICAL ASPECTS
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKESHITA S, 1985, AM J PATHOL, V121, P455
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
   TAPPEL AL, 1975, PATHOBIOLOGY CELL ME, P145
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
   VIANI P, 1991, J NEUROCHEM, V56, P253, DOI 10.1111/j.1471-4159.1991.tb02589.x
   Warner HR., 1987, MODERN BIOL THEORIES
NR 31
TC 92
Z9 108
U1 1
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD OCT 1
PY 1993
VL 71
IS 1-2
BP 23
EP 30
DI 10.1016/0047-6374(93)90032-M
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA MD032
UT WOS:A1993MD03200003
PM 8309281
DA 2024-02-19
ER

PT J
AU Honma, T
   Tsuduki, T
   Sugawara, S
   Kitano, Y
   Ito, J
   Kijima, R
   Tsubata, M
   Nakagawa, K
   Miyazawa, T
AF Honma, Taro
   Tsuduki, Tsuyoshi
   Sugawara, Soko
   Kitano, Yasuna
   Ito, Junya
   Kijima, Ryo
   Tsubata, Mari
   Nakagawa, Kiyotaka
   Miyazawa, Teruo
TI Aging decreases antioxidant effects and increases lipid peroxidation in
   the Apolipoprotein E deficient mouse
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE aging; apolipoprotein E; lipid peroxidation; senescence; TBARS
ID CONJUGATED TRIENE SYSTEM; LINOLENIC ACID ISOMER;
   HIGH-DENSITY-LIPOPROTEIN; ALPHA-ELEOSTEARIC-ACID; ADIPOSE-TISSUE; SAMP10
   MOUSE; BLOOD-PLASMA; LIFE-SPAN; IN-VITRO; HIGH-FAT
AB In this study, to study the effect of aging and Apolipoprotein E (ApoE) deficiency on antioxidant ability in mice, we examined whether lipid peroxidation is promoted by aging in ApoE deficient (ApoE(-/-)) mice, which have a shorter lifespan than normal mice. The levels of thiobarbituric acid-reactive substances (TBARS), a biomarker of lipid peroxidation, were measured in plasma and liver in ApoE(-/-) mice aged 12 weeks (young) and 52 weeks (early stage of senescence). TBARS in plasma and liver were significantly increased by aging. Next, we examined the reasons why lipid peroxidation was promoted by aging, based on measurement of protein and mRNA levels for antioxidant enzymes (superoxide dismutase, catalase, and glutathione peroxidase) in liver in ApoE(-/-) mice aged 12 and 52 weeks. The levels of superoxide dismutase 1 and 2 in liver were significantly decreased by aging. The mRNA level of catalase was also significantly decreased and the mRNA levels of superoxide dismutase 1, superoxide dismutase 2 and glutathione peroxidase 1 all showed a tendency to decrease with age. These results suggest that lipid peroxidation is caused by reduction of antioxidant activity with aging and that this promotes senescence and shortens lifespan in ApoE(-/-) mice.
C1 [Honma, Taro; Tsuduki, Tsuyoshi; Sugawara, Soko; Kitano, Yasuna; Ito, Junya; Kijima, Ryo; Tsubata, Mari] Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Sendai, Miyagi 9818555, Japan.
   [Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr, Food & Biodynam Chem Lab, Sendai, Miyagi 9818555, Japan.
C3 Tohoku University; Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Sendai, Miyagi 9818555, Japan.
EM tsuzukit@biochem.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/C-2254-2016; Tsuduki, Tsuyoshi/T-2697-2019
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528
FU Japan Society for the Promotion of Science [20157639]
FX This study was supported by a Grant-in-aid for Scientific Research from
   Japan Society for the Promotion of Science (No.20157639).
CR Ang LS, 2008, EXP GERONTOL, V43, P615, DOI 10.1016/j.exger.2008.03.010
   Arukwe A, 2011, COMP BIOCHEM PHYS C, V154, P288, DOI 10.1016/j.cbpc.2011.06.012
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bowman TA, 2010, ENDOCRINOLOGY, V151, P5157, DOI 10.1210/en.2010-0176
   BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316
   Buttini M, 2002, J NEUROSCI, V22, P10539
   Csiszar A, 2007, AGING CELL, V6, P783, DOI 10.1111/j.1474-9726.2007.00339.x
   Ferré N, 2001, MOL CELL BIOCHEM, V218, P165, DOI 10.1023/A:1007296919243
   HAYEK T, 1994, BIOCHEM BIOPH RES CO, V201, P1567, DOI 10.1006/bbrc.1994.1883
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Hosokawa M, 2002, MECH AGEING DEV, V123, P1553, DOI 10.1016/S0047-6374(02)00091-X
   Hurtado I, 1996, ATHEROSCLEROSIS, V125, P39, DOI 10.1016/0021-9150(96)05840-6
   Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103
   Karavia EA, 2011, FEBS J, V278, P3119, DOI 10.1111/j.1742-4658.2011.08238.x
   Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659
   Kojima T, 2012, AM J PATHOL, V180, P1879, DOI 10.1016/j.ajpath.2012.01.019
   Kosinska W, 2011, ENVIRON MOL MUTAGEN, V52, P502, DOI 10.1002/em.20648
   Kumar M, 2012, BRIT J NUTR, V107, P1006, DOI 10.1017/S0007114511003953
   Maizel J, 2009, CIRCULATION, V119, P306, DOI 10.1161/CIRCULATIONAHA.108.797407
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   Mendoza-Nunez Victor Manuel, 2009, BMC Geriatr, V9, P40, DOI 10.1186/1471-2318-9-40
   Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Navarro A, 2005, AM J PHYSIOL-REG I, V289, pR1392, DOI 10.1152/ajpregu.00834.2004
   Ohashi M, 2006, ARTERIOSCL THROM VAS, V26, P2331, DOI 10.1161/01.ATV.0000238347.77590.c9
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ohmura H, 1999, ATHEROSCLEROSIS, V142, P179, DOI 10.1016/S0021-9150(98)00235-4
   Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386
   Pedersen WA, 2000, J NEUROCHEM, V74, P1426, DOI 10.1046/j.1471-4159.2000.0741426.x
   Qi XP, 2007, MOL VIS, V13, P1
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316
   Shannon J, 2007, PUBLIC HEALTH NUTR, V10, P810, DOI 10.1017/S1368980007258604
   Shinohara N, 2012, BBA-MOL CELL BIOL L, V1821, P980, DOI 10.1016/j.bbalip.2012.04.001
   Singh SP, 2010, J GERONTOL A-BIOL, V65, P14, DOI 10.1093/gerona/glp165
   Tsuduki T, 2011, NUTRITION, V27, P334, DOI 10.1016/j.nut.2010.05.017
   Tsuzuki T, 2005, LIPIDS, V40, P1117, DOI 10.1007/s11745-005-1475-0
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298
   Tsuzuki T, 2007, BBA-MOL CELL BIOL L, V1771, P20, DOI 10.1016/j.bbalip.2006.11.006
   Tsuzuki T, 2006, J NUTR BIOCHEM, V17, P518, DOI 10.1016/j.jnutbio.2005.09.006
   Um HC, 2011, NITRIC OXIDE-BIOL CH, V25, P161, DOI 10.1016/j.niox.2011.06.001
   Viani P, 1996, BBA-MOL BASIS DIS, V1315, P78, DOI 10.1016/0925-4439(95)00094-1
   Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974
   YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1
   Yanaka M, 2011, BIOSCI BIOTECH BIOCH, V75, P1098, DOI 10.1271/bbb.100909
   ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543
NR 47
TC 18
Z9 21
U1 0
U2 5
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD MAY 1
PY 2013
VL 52
IS 3
BP 234
EP 240
DI 10.3164/jcbn.12-85
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 295WI
UT WOS:000330146700008
PM 23704813
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Park, JH
   Chung, HY
   Kim, M
   Lee, JH
   Jung, M
   Ha, H
AF Park, Jong Hee
   Chung, Hae Young
   Kim, Minkyu
   Lee, Jung Hwa
   Jung, Mankil
   Ha, Hunjoo
TI Daumone fed late in life improves survival and reduces hepatic
   inflammation and fibrosis in mice
SO AGING CELL
LA English
DT Article
DE aging; inflammation; insulin resistance; liver; longevity; pheromones
ID ANTIOXIDANT ENZYMES; INSULIN-RESISTANCE; LIVER FIBROSIS; CALORIE;
   RESVERATROL; SPAN; RESTRICTION; ACTIVATION; RAPAMYCIN; DAUER
AB The liver is one of the most susceptible organs to aging, and hepatic inflammation and fibrosis increase with age. Chronic inflammation has been proposed as the major molecular mechanism underlying aging and age-related diseases, whereas calorie restriction has been shown to be the most effective in extending mammalian lifespan and to have anti-aging effects through its anti-inflammatory action. Thus, it is necessary to develop effective calorie restriction mimetics. Daumone [(2)-(6R)-(3,5-dihydroxy-6-methyltetrahydropyran-2-yloxy) heptanoic acid], a pheromone secreted by Caenorhabditis elegans, forces them to enter the dauer stage when facing inadequate conditions. Because Caenorhabditis elegans live longer during the dauer stage under energy deprivation, it was hypothesized that daumone may improve survival in mammals by mimicking calorie restriction. Daumone (2 mg kg(-1) day(-1)) was administered orally for 5 months to 24-month-old male C57BL/6J mice. Daumone was found to reduce the risk of death by 48% compared with age-matched control mice, and the increased plasma insulin normally presented in old mice was significantly reduced by daumone. The increased hepatic hypertrophy, senescence-associated beta-galactosidase activity, insulin resistance, lipid accumulation, inflammation, oxidative stress, and fibrosis in old mice were significantly attenuated by daumone. From a mechanistic view, daumone reduced the phosphorylation of the I kappa B alpha and upregulation of Rela and Nfkbia mRNA in the livers of old mice. The anti-inflammatory effect of daumone was confirmed in lipopolysaccharide-induced liver injury model. Oral administration of daumone improves survival in mice and delivers anti-aging effects to the aged liver by modulating chronic inflammation, indicating that daumone could be developed as an anti-aging compound.
C1 [Park, Jong Hee; Lee, Jung Hwa; Ha, Hunjoo] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Global Top Res Program 5, Seoul 120750, South Korea.
   [Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Dept Pharm, Aging Tissue Bank, Pusan, South Korea.
   [Kim, Minkyu; Jung, Mankil] Yonsei Univ, Dept Chem, Seoul 120749, South Korea.
C3 Ewha Womans University; Pusan National University; Yonsei University
RP Ha, H (corresponding author), Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, 52 Ewhayoedae Gil, Seoul 120750, South Korea.
EM mjung@yonsei.ac.kr; hha@ewha.ac.kr
RI Kim, Minkyu/J-3783-2016
OI Ha, Hunjoo/0000-0002-5601-1265
FU NRF - Korean Government (MEST) [NRF-2012R1A2A1A03006092]; Ministry of
   Health and Welfare, the Republic of Korea [A121443]
FX This study was supported by NRF-2012R1A2A1A03006092 from an NRF grant
   funded by the Korean Government (MEST) and by a grant of the Korean
   Health Technology R&D Project, the Ministry of Health and Welfare, the
   Republic of Korea (Project No. A121443).
CR Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fan RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020443
   Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0
   Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017
   Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Haga S, 2010, LAB INVEST, V90, P1718, DOI 10.1038/labinvest.2010.119
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   Helenius M, 2001, ANTIOXID REDOX SIGN, V3, P147, DOI 10.1089/152308601750100669
   Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324
   Hu Patrick J, 2007, WormBook, P1
   Iwasa M, 2010, HEPATOL RES, V40, P1188, DOI 10.1111/j.1872-034X.2010.00724.x
   Jeon BT, 2012, DIABETES, V61, P1444, DOI 10.2337/db11-1498
   Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162
   Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201
   Le Couteur DG, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P191, DOI 10.1007/978-90-481-8556-6_11
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Michael J Morgan, 2011, Cell Research, V21, P103
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070
   Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   Noh K, 2012, BIOMED CHROMATOGR, V26, P152, DOI 10.1002/bmc.1649
   Noh K, 2011, J PHARMACEUT BIOMED, V56, P114, DOI 10.1016/j.jpba.2011.04.008
   Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Rahman MM, 2009, OXID MED CELL LONGEV, V2, P307, DOI 10.4161/oxim.2.5.9579
   Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005
   Rikans LE, 1999, MECH AGEING DEV, V108, P173, DOI 10.1016/S0047-6374(99)00012-3
   Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x
   Song KH, 2013, DIABETOLOGIA, V56, P1661, DOI 10.1007/s00125-013-2907-z
   Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711
   Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620
   Zwaal RR, 1997, GENETICS, V145, P715
NR 44
TC 15
Z9 16
U1 1
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2014
VL 13
IS 4
BP 709
EP 718
DI 10.1111/acel.12224
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AN2LQ
UT WOS:000340417100015
PM 24796965
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU HENDERSON, GI
   SPEEG, KV
   ROBERTS, RK
   PEREZ, A
   SCHENKER, S
AF HENDERSON, GI
   SPEEG, KV
   ROBERTS, RK
   PEREZ, A
   SCHENKER, S
TI EFFECT OF AGING ON HEPATIC ELIMINATION OF CIMETIDINE AND SUBSEQUENT
   INTERACTION OF AGING AND CIMETIDINE ON AMINOPYRINE METABOLISM
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
C1 UNIV TEXAS,HLTH SCI CTR,DEPT MED,DIV GASTROENTEROL & NUTR,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284.
   AUDIE L MURPHY MEM VET HOSP,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Audie L. Murphy Memorial Veterans Hospital
CR CASTLEDEN CM, 1977, BRIT MED J, V1, P10, DOI 10.1136/bmj.1.6052.10
   DESMOND PV, 1980, LIFE SCI, V26, P1261, DOI 10.1016/0024-3205(80)90071-5
   DIVOLL M, 1982, Clinical Pharmacology and Therapeutics, V31, P218
   DRAYER DE, 1981, CLIN PHARMACOL THER, V31, P45
   DUGGLEBY RG, 1980, ANAL BIOCHEM, V110, P9
   FEELY J, 1984, BRIT J CLIN PHARMACO, V17, P77, DOI 10.1111/j.1365-2125.1984.tb05002.x
   FRANKLIN MR, 1971, ARCH BIOCHEM BIOPHYS, V143, P318, DOI 10.1016/0003-9861(71)90213-X
   FUJITA S, 1982, LIVER AGING 1982, P55
   GERBER MC, 1985, PHARMACOL THERAPEUT, V27, P353, DOI 10.1016/0163-7258(85)90075-0
   GREENBLATT DJ, 1978, BRIT J CLIN PHARMACO, V5, P407, DOI 10.1111/j.1365-2125.1978.tb01646.x
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   HENDERSON G, 1986, DEV PHARMACOL THERAP, V9, P201, DOI 10.1159/000457093
   HEYROVSKY A, 1956, CLIN CHIM ACTA, V1, P470, DOI 10.1016/0009-8981(56)90020-1
   HURWITZ N, 1969, BRIT MED J, V1, P536, DOI 10.1136/bmj.1.5643.536
   JICK H, 1968, NEW ENGL J MED, V279, P284, DOI 10.1056/NEJM196808082790603
   KANATAKI T, 1985, J PHARM EXP THER, V233, P222
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   KELLY J F, 1982, Clinical Pharmacology and Therapeutics, V31, P238
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KLEIN U, 1976, INT J CLIN PHARM BI, V13, P187
   KLINGER W, 1969, ARCH INT PHARMACOD T, V180, P309
   KLOTZ U, 1982, LIVER AGING, P289
   KNODELL RG, 1982, GASTROENTEROLOGY, V82, P84
   LAWSON DH, 1974, Q J MED, V43, P433
   LENNARD MS, 1984, XENOBIOTICA, V14, P885, DOI 10.3109/00498258409151487
   LOCKWOOD GF, 1979, J PHARM PHARMACOL, V31, P787, DOI 10.1111/j.2042-7158.1979.tb13661.x
   LORENZO B, 1981, J LAB CLIN MED, V97, P545
   MORGAN K, 1982, LANCET, V1, P516
   OMALLEY K, 1982, LIVER AGING, P303
   POLAND AP, 1973, J PHARMACOL EXP THER, V184, P269
   RANDOLPH WC, 1977, J PHARM SCI, V66, P1148, DOI 10.1002/jps.2600660825
   REIDENBERG MM, 1978, CLIN PHARMACOL THER, V23, P371
   REIDENBERG MM, 1980, CLIN PHARMACOL THER, V28, P732, DOI 10.1038/clpt.1980.228
   RICHEY DP, 1977, ANNU REV PHARMACOL, V17, P49, DOI 10.1146/annurev.pa.17.040177.000405
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   SPEEG KV, 1982, GASTROENTEROLOGY, V82, P89
   STEVENSON IH, 1979, DRUGS ELDERLY, P51
   TAYLOR DC, 1978, DRUG METAB DISPOS, V6, P21
   WEINER IM, 1981, J PHARMACOL EXP THER, V216, P516
   1981, DRUGS, V22, P279
NR 40
TC 5
Z9 6
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD JUL 1
PY 1988
VL 37
IS 13
BP 2667
EP 2673
DI 10.1016/0006-2952(88)90261-4
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA P1354
UT WOS:A1988P135400026
PM 3390226
DA 2024-02-19
ER

PT J
AU Mansouri, A
   Fromenty, B
   Berson, A
   Robin, MA
   Grimbert, S
   Beaugrand, M
   Erlinger, S
   Pessayre, D
AF Mansouri, A
   Fromenty, B
   Berson, A
   Robin, MA
   Grimbert, S
   Beaugrand, M
   Erlinger, S
   Pessayre, D
TI Multiple hepatic mitochondrial DNA deletions suggest premature oxidative
   aging in alcoholic patients
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE aging; alcoholism; DNA; mitochondria; mutations; steatosis
ID CHRONIC ETHANOL-CONSUMPTION; RAT-LIVER; ACCUMULATION; GENOME; CELLS
AB Background/Aims: A 4977-base pair deletion has been detected in the hepatic mitochondrial DNA of alcoholic patients with microvesicular steatosis, a lesion ascribed to impaired mitochondrial beta-oxidation. However, only a single deletion had been looked for in this previous study, and it could not be determined whether the deletion was preexisting or acquired, Alcohol abuse increases the formation of reactive oxygen species in hepatic mitochondria. If this effect accelerates the oxidative aging of mitochondrial DNA, several other mutations would be expected.
   Methods: The mtDNA region extending from nucleotide 8167 to nucleotide 14246 was screened for the presence of large mitochondrial DNA deletions in 58 alcoholic patients and 67 age-matched non-alcoholic controls. Hepatic DNA was subjected to polymerase chain reactions that amplified non-deleted and deleted mitochondrial DNA, respectively, and the boundaries of the mitochondrial DNA deletions were sequenced.
   Results: Only 3% of the non-alcoholic controls carried a mitochondrial DNA deletion, whereas 24% of all alcoholic patients and 85% of the 13 alcoholic patients with microvesicular steatosis exhibited either single or multiple 4977, 5385, 5039 and 5556-base pair mitochondrial DNA deletions. No deletion(s) were observed, however, in 13 patients with microvesicular steatosis due to other causes.
   Conclusions: Diverse mitochondrial DNA rearrangements are observed in alcoholic patients with micro vesicular steatosis. We suggest that alcohol abuse leads to premature oxidative aging of mitochondrial DNA. Hypothetically, oxidative damage to mitochondrial constituents (DNA, proteins and lipids) may favor microvesicular fat deposition.
C1 HOP BEAUJON,INSERM,U24,F-92118 CLICHY,FRANCE.
   HOP BEAUJON,CTR RECH PHYSIOPATHOL HEPAT,ASSOC CLAUDE BERNARD,F-92118 CLICHY,FRANCE.
   HOP JEAN VERDIER,SERV HEPATOGASTROENTEROL,BONDY,FRANCE.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Beaujon - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Beaujon - APHP;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Jean-Verdier - APHP
RI Fromenty, Bernard/Y-8621-2019; Fromenty, Bernard/E-5052-2016; Abdellah,
   Mansouri/B-3002-2017
OI Fromenty, Bernard/0000-0003-2994-5465; Abdellah,
   Mansouri/0000-0003-3856-5771
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARAI M, 1984, HEPATOLOGY, V4, P165, DOI 10.1002/hep.1840040201
   BALLARDINI G, 1994, J HEPATOL, V20, P218, DOI 10.1016/S0168-8278(05)80061-3
   BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991
   COLEMAN WB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P142, DOI 10.1016/0005-2728(90)90136-R
   CORTOPASSI G, 1995, BBA-MOL BASIS DIS, V1271, P171, DOI 10.1016/0925-4439(95)00025-Y
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   FERNANDEZCHECA JC, 1991, J CLIN INVEST, V87, P397, DOI 10.1172/JCI115010
   FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6
   FROMENTY B, 1995, GASTROENTEROLOGY, V108, P193, DOI 10.1016/0016-5085(95)90024-1
   GROSOVSKY AJ, 1988, P NATL ACAD SCI USA, V85, P185, DOI 10.1073/pnas.85.1.185
   Harada S, 1996, ALCOHOL CLIN EXP RES, V20, pA293
   KUKIELKA E, 1994, ARCH BIOCHEM BIOPHYS, V309, P377, DOI 10.1006/abbi.1994.1127
   MONTGOMERY RI, 1987, J BIOL CHEM, V262, P13285
   NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K
   SCHON EA, 1996, CELLULAR AGING CELL, P19
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   THAYER WS, 1981, J BIOL CHEM, V256, P6090
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WIELAND P, 1995, BIOCHEM BIOPH RES CO, V213, P815, DOI 10.1006/bbrc.1995.2202
NR 20
TC 119
Z9 127
U1 0
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0168-8278
J9 J HEPATOL
JI J. Hepatol.
PD JUL
PY 1997
VL 27
IS 1
BP 96
EP 102
DI 10.1016/S0168-8278(97)80286-3
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA XK449
UT WOS:A1997XK44900015
PM 9252080
DA 2024-02-19
ER

PT J
AU Hanada, S
   Harada, M
   Abe, M
   Akiba, J
   Sakata, M
   Kwan, R
   Taniguchi, E
   Kawaguchi, T
   Koga, H
   Nagata, E
   Ueno, T
   Sata, M
AF Hanada, Shinichiro
   Harada, Masaru
   Abe, Mitsuhiko
   Akiba, Jun
   Sakata, Masahiro
   Kwan, Raymond
   Taniguchi, Eitaro
   Kawaguchi, Takumi
   Koga, Hironori
   Nagata, Eisuke
   Ueno, Takato
   Sata, Michio
TI Aging Modulates Susceptibility to Mouse Liver Mallory-Denk Body
   Formation
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE Mallory-Denk body; aging; oxidative stress; proteasome activity;
   autophagy; endoplasmic reticulum stress
ID SIMPLE EPITHELIAL KERATINS; OXIDATIVE STRESS; PROTEASOME INHIBITOR;
   AGGRESOME FORMATION; INCLUSION FORMATION; DISEASE; AUTOPHAGY; CELLS;
   MICE; BODIES
AB Mallory-Denk bodies (MDBs) are hepatocyte cytoplasmic inclusions found in several liver diseases and consist primarily of the cytoskeletal proteins, keratins 8 and 18 (K8/K18). Recent evidence indicates that the extent of stress-induced protein misfolding, a K8 > K18 overexpression state, and transglutaminase-2 activation promote MDB formation. In addition, the genetic background and gender play an important role in mouse MDB formation, but the effect of aging on this process is unknown. Given that oxidative stress increases with aging, the authors hypothesized that aging predisposes to MDB formation. They used an established mouse MDB model-namely, feeding non-transgenic male FVB/N mice (1, 3, and 8 months old) with 3,5 diethoxycarbonyl-1,4-dihydrocollidine for 2 months. MDB formation was assessed using immunofluorescence staining and biochemically by demonstrating keratin and ubiquitin-containing crosslinks generated by transglutaminase-2. Immunofluorescence staining showed that old mice had a significant increase in MDB formation compared with young mice. MDB formation paralleled the generation of high molecular weight ubiquitinated keratin-containing complexes and induction of p62. Old mouse livers had increased oxidative stress. In addition, 20S proteasome activity and autophagy were decreased, and endoplasmic reticulum stress was increased in older livers. Therefore, aging predisposes to experimental MDB formation, possibly by decreased activity of protein degradation machinery. (J Histochem Cytochem 60:475-483, 2012)
C1 [Hanada, Shinichiro; Abe, Mitsuhiko; Sakata, Masahiro; Taniguchi, Eitaro; Kawaguchi, Takumi; Koga, Hironori; Ueno, Takato; Sata, Michio] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka 8300011, Japan.
   [Akiba, Jun] Kurume Univ, Sch Med, Dept Pathol, Div Gastroenterol, Kurume, Fukuoka 8300011, Japan.
   [Kawaguchi, Takumi; Sata, Michio] Kurume Univ, Sch Med, Dept Digest Dis Informat & Res, Div Gastroenterol, Kurume, Fukuoka 8300011, Japan.
   [Hanada, Shinichiro; Abe, Mitsuhiko; Sakata, Masahiro; Taniguchi, Eitaro; Koga, Hironori; Ueno, Takato; Sata, Michio] Kurume Univ, Liver Canc Div, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan.
   [Hanada, Shinichiro; Nagata, Eisuke] Nagata Hosp, Yanagawa, Japan.
   [Harada, Masaru] Univ Occupat & Environm Hlth, Dept Internal Med 3, Japan Sch Med, Kitakyushu, Fukuoka 807, Japan.
   [Kwan, Raymond] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA.
C3 Kurume University; Kurume University; Kurume University; Kurume
   University; University of Occupational & Environmental Health - Japan;
   University of Michigan System; University of Michigan
RP Hanada, S (corresponding author), Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka 8300011, Japan.
EM hanadas@med.kurume-u.ac.jp
CR Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087
   Bardag-Gorce F, 2004, EXP MOL PATHOL, V76, P9, DOI 10.1016/j.yexmp.2003.08.006
   Barshop NJ, 2008, ALIMENT PHARM THER, V28, P13, DOI 10.1111/j.1365-2036.2008.03703.x
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21
   Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Donohue TM, 2004, ALCOHOL CLIN EXP RES, V28, P1257, DOI 10.1097/01.ALC.0000134233.89896.19
   Forman HJ, 2008, ARCH BIOCHEM BIOPHYS, V477, P183, DOI 10.1016/j.abb.2008.06.011
   French BA, 2001, EXP MOL PATHOL, V71, P241, DOI 10.1006/exmp.2001.2401
   Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X
   Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   Hanada S, 2008, HEPATOLOGY, V48, P943, DOI 10.1002/hep.22436
   Hanada S, 2007, J HEPATOL, V47, P93, DOI 10.1016/j.jhep.2007.01.039
   Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Harada M, 2003, EXP CELL RES, V288, P60, DOI 10.1016/S0014-4827(03)00162-9
   Harada M, 2008, HEPATOLOGY, V47, P2026, DOI 10.1002/hep.22294
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146
   Ku NO, 2004, METHOD CELL BIOL, V78, P489
   Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441
   Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600
   Nakamichi I, 2005, J CELL BIOL, V171, P931, DOI 10.1083/jcb.200507093
   Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762
   Soti C, 2002, CELL STRESS CHAPERON, V7, P186, DOI 10.1379/1466-1268(2002)007<0186:CCOA>2.0.CO;2
   Strnad P, 2007, GASTROENTEROLOGY, V132, P1515, DOI 10.1053/j.gastro.2007.02.020
   Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674
   Stumptner C, 2007, HEPATOLOGY, V46, P851, DOI 10.1002/hep.21744
   Tanikawa K, 2006, MED MOL MORPHOL, V39, P22, DOI 10.1007/s00795-006-0313-z
   Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024
NR 36
TC 13
Z9 16
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0022-1554
EI 1551-5044
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD JUN
PY 2012
VL 60
IS 6
BP 475
EP 483
DI 10.1369/0022155412441478
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 950QJ
UT WOS:000304663500006
PM 22473941
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Le Couteur, DG
   Warren, A
   Cogger, VC
   Smedsrod, B
   Sorensen, KK
   De Cabo, R
   Fraser, R
   Mccuskey, RS
AF Le Couteur, David G.
   Warren, Alessandra
   Cogger, Victoria C.
   Smedsrod, Bard
   Sorensen, Karen K.
   De Cabo, Rafael
   Fraser, Robin
   Mccuskey, Robert S.
TI Old age and the hepatic sinusoid
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Article
DE liver; aging; liver sinusoidal endothelial cell; chylomicron remnant;
   endocytosis; microcirculation; stellate cell; Kupffer cell; caloric
   restriction
ID LOW-DENSITY-LIPOPROTEIN; LIVER ENDOTHELIAL-CELLS; GLYCATION
   END-PRODUCTS; PERFUSED-RAT-LIVER; KUPFFER CELLS; BLOOD-FLOW; IN-VIVO;
   DRUG-METABOLISM; T-CELLS; PSEUDOCAPILLARIZATION
AB Morphological changes in the hepatic sinusoid with old age are increasingly recognized. These include thickening and defenestration of the liver sinusoidal endothelial cell, sporadic deposition of collagen and basal lamina in the extracellular space of Disse, and increased numbers of fat engorged, nonactivated stellate cells. In addition, there is endothelial upregulation of von Willebrand factor and ICAM-1 with reduced expression of caveolin-1. These changes have been termed age-related pseudocapillarization. The effects of old age on Kupffer cells are inconsistent, but impaired responsiveness is likely. There are functional implications of these aging changes in the hepatic sinusoid. There is reduced sinusoidal perfusion, which will impair the hepatic clearance of highly extracted substrates. Blood clearance of a variety of waste macromolecules takes place in liver sinusoidal endothelial cells (LSECs). Previous studies indicated either that aging had no effect, or reduced the endocytic capacity of LSECs. However, a recent study in mice showed reduced endocytosis in pericentral regions of the liver lobules. Reduced endocytosis may increase systemic exposure to potential harmful waste macromolecules such as advanced glycation end products Loss of fenestrations leads to impaired transfer of lipoproteins from blood to hepatocytes. This provides a mechanism for impaired chylomicron remnant clearance and postprandial hyperlipidemia associated with old age. Given the extensive range of substrates metabolized by the liver, age-related changes in the hepatic sinusoid and microcirculation have important systemic implications for aging and age-related diseases.
C1 [Le Couteur, David G.; Warren, Alessandra; Cogger, Victoria C.] Univ Sydney, Ctr Educ & Res Aging, Sydney, NSW 2139, Australia.
   [Le Couteur, David G.; Warren, Alessandra; Cogger, Victoria C.] Concord RG Hosp, Sydney, NSW 2139, Australia.
   [Smedsrod, Bard; Sorensen, Karen K.; Mccuskey, Robert S.] Univ Tromso, Inst Med Biol, Dept Cell Biol & Histol, Tromso, Norway.
   [De Cabo, Rafael] NIA, Lab Expt Gerontol, Baltimore, MD 21224 USA.
   [Fraser, Robin] Univ Otago, Christchurch Sch Med, Christchurch, New Zealand.
   [Mccuskey, Robert S.] Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ USA.
C3 University of Sydney; Concord Repatriation General Hospital; UiT The
   Arctic University of Tromso; National Institutes of Health (NIH) - USA;
   NIH National Institute on Aging (NIA); University of Otago; University
   of Arizona
RP Le Couteur, DG (corresponding author), Univ Sydney, Ctr Educ & Res Aging, Sydney, NSW 2139, Australia.
EM dlecouteur@med.usyd.edu.au
RI de Cabo, Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo,
   Rafael/0000-0002-3354-2442; Smedsrod, Bard/0000-0002-3308-8948; Le
   Couteur, David/0000-0002-4227-5817
FU NIA NIH HHS [R21 AG-02582] Funding Source: Medline
CR Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   BLOMHOFF R, 1984, J BIOL CHEM, V259, P8898
   Borel P, 1998, J GERONTOL A-BIOL, V53, pB133, DOI 10.1093/gerona/53A.2.B133
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   CAPERNA TJ, 1982, MECH AGEING DEV, V20, P205, DOI 10.1016/0047-6374(82)90088-4
   Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   DELEEUW AM, 1983, HEPATOLOGY, V3, P497
   DELEEUW AM, 1990, J ELECTRON MICR TECH, V14, P218
   DURHAM SK, 1990, J PATHOL, V162, P341, DOI 10.1002/path.1711620412
   Enomoto Katsuhiko, 2004, Medical Electron Microscopy, V37, P208, DOI 10.1007/s00795-004-0261-4
   ERIKSSON S, 1983, EXP CELL RES, V144, P223, DOI 10.1016/0014-4827(83)90458-5
   Everitt AV, 2005, AGE, V27, P39, DOI 10.1007/s11357-005-3284-4
   FINDOR J, 1973, ACTA HEPATO-GASTRO, V20, P200
   FLOREN CH, 1984, SCAND J GASTROENTERO, V19, P473, DOI 10.1080/00365521.1984.12005755
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   FRASER R, 1978, ATHEROSCLEROSIS, V29, P113, DOI 10.1016/0021-9150(78)90001-1
   Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055
   FUJITA H, 1983, VIRCHOWS ARCH B, V42, P33, DOI 10.1007/BF02890368
   Grizzi F, 2003, TOXICOL PATHOL, V31, P173, DOI 10.1080/01926230390183643
   HARDONK MJ, 1985, HISTOCHEMISTRY, V83, P473, DOI 10.1007/BF00509211
   HEIL MF, 1984, MECH AGEING DEV, V26, P327, DOI 10.1016/0047-6374(84)90104-0
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   HINTON DE, 1968, J GERONTOL, V23, P205, DOI 10.1093/geronj/23.2.205
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   JAMES OFW, 1985, J HEPATOL, V1, P431, DOI 10.1016/S0168-8278(85)80780-7
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006
   Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x
   Karrar A, 2007, GUT, V56, P243, DOI 10.1136/gut.2006.093906
   Katz SC, 2004, J IMMUNOL, V173, P230, DOI 10.4049/jimmunol.173.1.230
   Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x
   KNOOK DL, 1976, MECH AGEING DEV, V5, P389, DOI 10.1016/0047-6374(76)90036-1
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Le Couteur DG, 2006, NEW RES ATHEROSCLERO, P19
   LECOUTEUR D, 1992, BIOCHEM PHARMACOL, V43, P913, DOI 10.1016/0006-2952(92)90264-J
   Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639
   MARTIN G, 1994, MECH AGEING DEV, V73, P157, DOI 10.1016/0047-6374(94)90048-5
   MARTIN G, 1992, CLIN EXP PHARMACOL P, V19, P537, DOI 10.1111/j.1440-1681.1992.tb00501.x
   Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020
   McCuskey RS, 2000, LIVER, V20, P3, DOI 10.1034/j.1600-0676.2000.020001003.x
   MCCUSKEY RS, 1993, SEMIN LIVER DIS, V13, P1, DOI 10.1055/s-2007-1007333
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   NAGELKERKE JF, 1983, J BIOL CHEM, V258, P2221
   NAITO M, 1978, CELL TISSUE RES, V190, P371
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060
   Romero EL, 1999, FEBS LETT, V448, P193, DOI 10.1016/S0014-5793(99)00364-6
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHAFFNER F, 1959, AM J DIG DIS, V4, P389, DOI 10.1007/BF02231171
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Seternes T, 2002, P NATL ACAD SCI USA, V99, P7594, DOI 10.1073/pnas.102173299
   Simons LA, 2001, ATHEROSCLEROSIS, V159, P201, DOI 10.1016/S0021-9150(01)00495-6
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   SKOGH T, 1985, IMMUNOLOGY, V55, P585
   SMEDSROD B, 1984, BIOCHEM J, V223, P617, DOI 10.1042/bj2230617
   SMEDSROD B, 1990, BIOCHEM J, V266, P313, DOI 10.1042/bj2660313
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509
   Smedsrod Bard, 2004, Comp Hepatol, V3 Suppl 1, pS22, DOI 10.1186/1476-5926-2-S1-S22
   Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X
   Sun WB, 1998, WORLD J GASTROENTERO, V4, P77
   VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282
   Videla LA, 2001, REDOX REP, V6, P155, DOI 10.1179/135100001101536265
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   VOMEL T, 1981, FORTSCHR MED, V99, P1511
   VOMEL T, 1984, Z GERONTOL, V17, P69
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Warren A, 2007, J HEPATOL, V46, P239, DOI 10.1016/j.jhep.2006.08.022
   Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378
   Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001
   WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4
   Wisse E, 1997, SEMIN LIVER DIS, V17, P265, DOI 10.1055/s-2007-1007204
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, BRIT J CLIN PHARMACO, V30, P634, DOI 10.1111/j.1365-2125.1990.tb03826.x
   Yamano T, 2000, TOXICOL APPL PHARM, V162, P68, DOI 10.1006/taap.1999.8833
   Yokomori H, 2001, LIVER, V21, P198, DOI 10.1034/j.1600-0676.2001.021003198.x
   Yu KCW, 2001, FRONT BIOSCI-LANDMRK, V6, pD332, DOI 10.2741/Yu
NR 93
TC 124
Z9 135
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
EI 1932-8494
J9 ANAT REC
JI Anat. Rec.
PD JUN
PY 2008
VL 291
IS 6
BP 672
EP 683
DI 10.1002/ar.20661
PG 12
WC Anatomy & Morphology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology
GA 313CN
UT WOS:000256718800008
PM 18484614
OA Bronze
DA 2024-02-19
ER

PT J
AU Yang, X
   Zong, C
   Feng, C
   Zhang, CA
   Smirnov, A
   Sun, GQ
   Shao, CC
   Zhang, LY
   Hou, XJ
   Liu, WT
   Meng, Y
   Zhang, LY
   Shao, CS
   Wei, LX
   Melino, G
   Shi, YF
AF Yang, Xue
   Zong, Chen
   Feng, Chao
   Zhang, Cangang
   Smirnov, Artem
   Sun, Gangqi
   Shao, Changchun
   Zhang, Luyao
   Hou, Xiaojuan
   Liu, Wenting
   Meng, Yan
   Zhang, Liying
   Shao, Changshun
   Wei, Lixin
   Melino, Gerry
   Shi, Yufang
TI Hippo Pathway Activation in Aged Mesenchymal Stem Cells Contributes to
   the Dysregulation of Hepatic Inflammation in Aged Mice
SO ADVANCED SCIENCE
LA English
DT Article; Early Access
DE aging-associated hepatic inflammation; hippo pathway; immunosuppression;
   mesenchymal stem cells
ID CONCANAVALIN-A MODEL; LEPTIN-RECEPTOR; INTERFERON-GAMMA; INNATE
   IMMUNITY; STROMAL CELLS; LIVER; MECHANISMS; RECRUITMENT; SENESCENCE;
   IMMUNOSUPPRESSION
AB Aging is always accompanied by chronic diseases which probably attribute to long-term chronic inflammation in the aging body. Whereas, the mechanism of chronic inflammation in aging body is still obscure. Mesenchymal stem cells (MSCs) are capable of local chemotaxis to sites of inflammation and play a powerful role in immune regulation. Whether degeneration of MSCs in the aging body is associated with unbalanced inflammation is still not clear. In this study, immunosuppressive properties of aged MSCs are found to be repressed. The impaired immunosuppressive function of aged MSCs is associated with lower expression of the Hippo effector Yes-associated protein 1 (YAP1) and its target gene signal transducer and activator of transcription 1 (STAT1). YAP1 regulates the transcription of STAT1 through binding with its promoter. In conclusion, a novel YAP1/STAT1 axis maintaining immunosuppressive function of MSCs is revealed and impairment of this signal pathway in aged MSCs probably resulted in higher inflammation in aged mice liver.
C1 [Yang, Xue; Zong, Chen; Zhang, Luyao; Shao, Changshun; Shi, Yufang] Soochow Univ, Affiliated Hosp 3, Med Coll, Inst Translat Med,State Key Lab Radiat Med & Prote, Suzhou 215000, Peoples R China.
   [Yang, Xue; Feng, Chao; Smirnov, Artem; Melino, Gerry] Univ Roma Tor Vergata, Dept Expt Med, TOR, I-00133 Rome, Italy.
   [Yang, Xue; Zong, Chen; Hou, Xiaojuan; Liu, Wenting; Meng, Yan; Wei, Lixin] Naval Med Univ, Affiliated Hosp 3, Dept Tumor Immunol, Shanghai 200438, Peoples R China.
   [Yang, Xue; Zong, Chen; Hou, Xiaojuan; Liu, Wenting; Meng, Yan; Wei, Lixin] Naval Med Univ, Affiliated Hosp 3, Gene Therapy Ctr, Shanghai 200438, Peoples R China.
   [Yang, Xue; Zong, Chen; Hou, Xiaojuan; Liu, Wenting; Meng, Yan; Wei, Lixin] Natl Ctr Liver Canc, Dept immunol & Metab, Shanghai 201805, Peoples R China.
   [Zhang, Cangang] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pathogen Microbiol & Immunol, Xian 710061, Shaanxi, Peoples R China.
   [Sun, Gangqi; Zhang, Luyao] Anhui Med Univ, Hosp 2, Dept Clin Pharmacol, Hefei 230601, Peoples R China.
   [Shao, Changshun] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei 230022, Anhui, Peoples R China.
C3 Soochow University - China; University of Rome Tor Vergata; Naval
   Medical University; Naval Medical University; Xi'an Jiaotong University;
   Anhui Medical University; Anhui Medical University
RP Shi, YF (corresponding author), Soochow Univ, Affiliated Hosp 3, Med Coll, Inst Translat Med,State Key Lab Radiat Med & Prote, Suzhou 215000, Peoples R China.; Melino, G (corresponding author), Univ Roma Tor Vergata, Dept Expt Med, TOR, I-00133 Rome, Italy.; Wei, LX (corresponding author), Naval Med Univ, Affiliated Hosp 3, Dept Tumor Immunol, Shanghai 200438, Peoples R China.; Wei, LX (corresponding author), Naval Med Univ, Affiliated Hosp 3, Gene Therapy Ctr, Shanghai 200438, Peoples R China.; Wei, LX (corresponding author), Natl Ctr Liver Canc, Dept immunol & Metab, Shanghai 201805, Peoples R China.
EM lixinwei@smmu.edu.cn; melino@uniroma2.it; yfshi@suda.edu.cn
RI Zhang, Cangang/AAG-2860-2021; Shi, Yufang/AAE-4431-2020; Smirnov,
   Artem/AAB-3496-2020
OI Zhang, Cangang/0000-0001-6443-7023; Shi, Yufang/0000-0001-8964-319X;
   Smirnov, Artem/0000-0002-1575-8725; Yang, Xue/0000-0003-1965-0399
FU National Natural Science Foundation of China [82173276, 81930085,
   82073032, 82073037, 81972599]; Jiangsu Province International Joint
   Laboratory for Regenerative Medicine Fund, Suzhou Foreign Academician
   Workstation Fund [SWY202202]; Shanghai Municipal Health Bureau
   [20214Y0013]; Associazione Italiana per la Ricerca contro il Cancro
   (AIRC); MUR-PNRR M4C2I1.3 PE6 project;  [27366];  [PE00000019];  [CUP:
   E83C22004670001]
FX & nbsp;The authors were grateful to Dr. Zhaocai Zhou (Fudan University,
   China) for Yap1 FL/FL mice. This project was supported by the National
   Natural Science Foundation of China (Grant NO. 82173276, 81930085,
   82073032, 82073037, 81972599); Jiangsu Province International Joint
   Laboratory for Regenerative Medicine Fund, Suzhou Foreign Academician
   Workstation Fund (SWY202202); Shanghai Municipal Health Bureau (Grant
   NO. 20214Y0013); MUR-PNRR M4C2I1.3 PE6 project PE00000019 Heal Italia
   (CUP: E83C22004670001) to GM; and by Associazione Italiana per la
   Ricerca contro il Cancro (AIRC) to GM (IG 2022 ID 27366; 2023-2027).
CR Agarwal P, 2019, CELL STEM CELL, V24, P769, DOI 10.1016/j.stem.2019.02.018
   Aihara A, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101779
   Andersen MH, 2014, LEUKEMIA, V28, P1784, DOI 10.1038/leu.2014.108
   Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y
   Ballegeer M., 2016, J GASTROENTEROL HEPA, V1
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Bektas A, 2018, EXP GERONTOL, V105, P10, DOI 10.1016/j.exger.2017.12.015
   Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45
   Callihan P, 2011, PHARMACOL THERAPEUT, V129, P290, DOI 10.1016/j.pharmthera.2010.10.007
   Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051
   Chapat L, 2004, EUR J IMMUNOL, V34, P2520, DOI 10.1002/eji.200425139
   Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x
   Cho E, 2019, IN VIVO, V33, P1411, DOI 10.21873/invivo.11618
   Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8
   Cottini F, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.970055
   Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562
   Dara L, 2016, J CLIN INVEST, V126, P4068, DOI 10.1172/JCI90830
   Decker M, 2017, NAT CELL BIOL, V19, P677, DOI 10.1038/ncb3530
   Elster D, 2020, MECH AGEING DEV, V189, DOI 10.1016/j.mad.2020.111280
   Floreani A, 2009, BEST PRACT RES CL GA, V23, P909, DOI 10.1016/j.bpg.2009.10.005
   Fougère B, 2017, J GERONTOL A-BIOL, V72, P1218, DOI 10.1093/gerona/glw240
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Fu LN, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000201
   Han L, 2020, CANCER RES, V80, P3383, DOI 10.1158/0008-5472.CAN-20-0506
   Han X, 2014, CELL DEATH DIFFER, V21, P1758, DOI 10.1038/cdd.2014.85
   Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178
   Heymann F, 2015, LAB ANIM-UK, V49, P12, DOI 10.1177/0023677215572841
   Hirose K, 2003, J CLIN ENDOCR METAB, V88, P2573, DOI 10.1210/jc.2002-021511
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hong LX, 2018, CELL MOL IMMUNOL, V15, P1003, DOI 10.1038/s41423-018-0007-1
   Horimoto Y, 2012, CELL ADHES MIGR, V6, P193, DOI 10.4161/cam.20631
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Jing YY, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-98
   Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161
   Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488
   Kim MK, 2018, BMB REP, V51, P126, DOI 10.5483/BMBRep.2018.51.3.015
   Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030
   Koyama A, 2013, J GERONTOL A-BIOL, V68, P433, DOI 10.1093/gerona/gls187
   Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213
   Leist M, 1996, J HEPATOL, V25, P948, DOI 10.1016/S0168-8278(96)80301-1
   Li Y, 2017, INT J MOL MED, V39, P775, DOI 10.3892/ijmm.2017.2912
   Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009
   Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029
   Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17762
   Liu Y, 2022, OPEN LIFE SCI, V17, P91, DOI 10.1515/biol-2022-0013
   Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   Matsuzaki Y, 2014, CELL STEM CELL, V15, P112, DOI 10.1016/j.stem.2014.07.001
   Méndez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Miyagi T, 2004, HEPATOLOGY, V40, P1190, DOI 10.1002/hep.20447
   Mohar I, 2015, METHODS MOL BIOL, V1325, P3, DOI 10.1007/978-1-4939-2815-6_1
   Morsiani C, 2019, AGEING RES REV, V51, P24, DOI 10.1016/j.arr.2019.02.002
   Moya IM, 2016, CURR OPIN CELL BIOL, V43, P62, DOI 10.1016/j.ceb.2016.08.004
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011
   Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813
   Pineault KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11100-4
   Ramjee V, 2017, J CLIN INVEST, V127, P899, DOI 10.1172/JCI88759
   Rashid U, 2021, BMC VET RES, V17, DOI 10.1186/s12917-021-03100-8
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Santos-Otte P, 2019, COMPUT STRUCT BIOTEC, V17, P1265, DOI 10.1016/j.csbj.2019.08.005
   Sarkar S, 2017, GENE DEV, V31, P1109, DOI 10.1101/gad.296640.117
   Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221
   Shi Z, 2017, ONCOGENE, V36, P4362, DOI 10.1038/onc.2017.24
   Stampouloglou E, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000591
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979
   Thomas HE, 2010, CELL DEATH DIFFER, V17, P577, DOI 10.1038/cdd.2009.165
   Wallin R, 2001, MED RES REV, V21, P274, DOI 10.1002/med.1010
   Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119
   Wang H, 2019, MOL MED REP, V20, P4883, DOI 10.3892/mmr.2019.10750
   Wangler S, 2019, OSTEOARTHR CARTILAGE, V27, P1094, DOI 10.1016/j.joca.2019.04.002
   WEINBAUM DL, 1980, NATURE, V286, P725, DOI 10.1038/286725a0
   Wiley JA, 2001, AM J PATHOL, V158, P119, DOI 10.1016/S0002-9440(10)63950-8
   Wu YO, 2019, GENE, V692, P79, DOI 10.1016/j.gene.2018.12.063
   Xie L, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/762098
   Yamauchi T, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050398
   Yan S, 2012, IMMUNOL CELL BIOL, V90, P421, DOI 10.1038/icb.2011.59
   Yang X, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00480-6
   Ye XJ, 2022, INT IMMUNOPHARMACOL, V102, DOI 10.1016/j.intimp.2021.108380
   Yen YT, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02175-1
   Yeung YT, 2019, PHARMACOL RES, V143, P151, DOI 10.1016/j.phrs.2019.03.018
   Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044
   Yu FX, 2012, CELL CYCLE, V11, P4097, DOI 10.4161/cc.22322
   Zhang CG, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002809
   Zhang C, 2022, GENOM PROTEOM BIOINF, V20, P70, DOI 10.1016/j.gpb.2022.01.005
   Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408
   Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008
   Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x
   Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238
NR 91
TC 0
Z9 0
U1 12
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2198-3844
J9 ADV SCI
JI Adv. Sci.
PD 2023 SEP 26
PY 2023
VL 10
IS 27
DI 10.1002/advs.202300424
EA AUG 2023
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AE4Z5
UT WOS:001042901100001
PM 37544916
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Yang, F
   Zhang, F
   Ji, XY
   Jiang, X
   Xue, MJ
   Yu, HY
   Hu, XN
   Bao, ZJ
AF Yang, Fan
   Zhang, Fan
   Ji, Xueying
   Jiang, Xin
   Xue, Mengjuan
   Yu, Huiyuan
   Hu, Xiaona
   Bao, Zhijun
TI Secretory galectin-3 induced by glucocorticoid stress triggers stemness
   exhaustion of hepatic progenitor cells
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Cell senescence; galectin-3; protein interaction; stemness exhaustion;
   liver injury; cellular senescence; galectin; stem cells; glycoprotein;
   protein-protein interaction; cell cycle; proliferation; AMP-activated
   kinase (AMPK); quiescence
ID HEMATOPOIETIC STEM; SELF-RENEWAL; LIVER; GROWTH; PROMOTE; NICHE; AMPK
AB Adult progenitor cell populations typically exist in a quiescent state within a controlled niche environment. However, various stresses or forms of damage can disrupt this state, which often leads to dysfunction and aging. We built a glucocorticoid (GC)-induced liver damage model of mice, found that GC stress induced liver damage, leading to consequences for progenitor cells expansion. However, the mechanisms by which niche factors cause progenitor cells proliferation are largely unknown. We demonstrate that, within the liver progenitor cells niche, Galectin-3 (Gal-3) is responsible for driving a subset of progenitor cells to break quiescence. We show that GC stress causes aging of the niche, which induces the up-regulation of Gal-3. The increased Gal-3 population increasingly interacts with the progenitor cell marker CD133, which triggers focal adhesion kinase (FAK)/AMP-activated kinase (AMPK) signaling. This results in the loss of quiescence and leads to the eventual stemness exhaustion of progenitor cells. Conversely, blocking Gal-3 with the inhibitor TD139 prevents the loss of stemness and improves liver function. These experiments identify a stress-dependent change in progenitor cell niche that directly influence liver progenitor cell quiescence and function.
C1 [Yang, Fan; Zhang, Fan; Ji, Xueying; Jiang, Xin; Xue, Mengjuan; Yu, Huiyuan; Hu, Xiaona; Bao, Zhijun] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Dept Geriatr Med, Shanghai, Peoples R China.
   [Yang, Fan; Zhang, Fan; Ji, Xueying; Jiang, Xin; Xue, Mengjuan; Yu, Huiyuan; Hu, Xiaona; Bao, Zhijun] Shanghai Key Lab Clin Geriatr Med, Shanghai, Peoples R China.
   [Yang, Fan; Zhang, Fan; Ji, Xueying; Jiang, Xin; Xue, Mengjuan; Yu, Huiyuan; Hu, Xiaona; Bao, Zhijun] Fudan Univ, Res Ctr Aging & Med, Shanghai, Peoples R China.
C3 Fudan University; Fudan University
RP Bao, ZJ (corresponding author), Fudan Univ, Shanghai Med Coll, Huadong Hosp, Dept Geriatr Med, Shanghai, Peoples R China.; Bao, ZJ (corresponding author), Shanghai Key Lab Clin Geriatr Med, Shanghai, Peoples R China.; Bao, ZJ (corresponding author), Fudan Univ, Res Ctr Aging & Med, Shanghai, Peoples R China.
EM zhijunbao@fudan.edu.cn
RI Ji, Xueying/HRA-8284-2023
OI Yang, Fan/0000-0002-9805-9099
FU National Key Research and Development Program of China [2018YFC2002000];
   National Natural Science Foundation of China [81901408, 81701374];
   Shanghai Sailing program [19YF1414500, 17YF1405200]; Shanghai Municipal
   Science and Technology Committee Program [YDZX20173100004026]; Shanghai
   Medical Leadership Training Program [2019LJ09]; Young Excellent Medical
   Talents Training Program of Health Department of Shanghai Municipal
   Government [2018YQ58]
FX The work was supported by National Key Research and Development Program
   of China Grant 2018YFC2002000, National Natural Science Foundation of
   China Grants 81901408 and 81701374, Shanghai Sailing program Grants
   19YF1414500 and 17YF1405200, Shanghai Municipal Science and Technology
   Committee Program Grant YDZX20173100004026, Shanghai Medical Leadership
   Training Program Grant 2019LJ09, and the Young Excellent Medical Talents
   Training Program of Health Department of Shanghai Municipal Government
   Grant 2018YQ58.
CR Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Chen QF, 2013, STEM CELLS, V31, P1160, DOI 10.1002/stem.1359
   de Celis MFR, 2016, MOL PSYCHIATR, V21, P590, DOI 10.1038/mp.2015.230
   Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022
   Engel M, 2018, NEURON, V99, P389, DOI 10.1016/j.neuron.2018.07.009
   Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001
   Ferro F, 2019, STEM CELLS, V37, P813, DOI 10.1002/stem.2998
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Fukumori T, 2003, CANCER RES, V63, P8302
   Galluzzi L, 2019, TRENDS CELL BIOL, V29, P447, DOI 10.1016/j.tcb.2019.03.005
   Hall JE, 2019, NAT REV NEPHROL, V15, P367, DOI 10.1038/s41581-019-0145-4
   Hantsoo L, 2019, BIOL PSYCHIAT, V85, P97, DOI 10.1016/j.biopsych.2018.08.018
   Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020
   Kalamakis G, 2019, CELL, V176, P1407, DOI 10.1016/j.cell.2019.01.040
   Kertser A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4111
   Kimura A, 2012, EXP DERMATOL, V21, P515, DOI 10.1111/j.1600-0625.2012.01515.x
   Kostopoulou ON, 2018, INT J CANCER, V142, P1266, DOI 10.1002/ijc.31132
   Laberge RM, 2012, AGING CELL, V11, P569, DOI 10.1111/j.1474-9726.2012.00818.x
   Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010
   Mavrogonatou E, 2020, SEMIN CANCER BIOL, V62, P182, DOI 10.1016/j.semcancer.2019.06.018
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509
   Oster H, 2017, ENDOCR REV, V38, P3, DOI 10.1210/er.2015-1080
   Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3
   Pitter KL, 2016, BRAIN, V139, P1458, DOI 10.1093/brain/aww046
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Saksida T, 2013, J CELL PHYSIOL, V228, P1568, DOI 10.1002/jcp.24318
   Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592
   Shen SN, 2019, J CACHEXIA SARCOPENI, V10, P429, DOI 10.1002/jcsm.12393
   Siwicki M, 2016, CELL METAB, V24, P655, DOI 10.1016/j.cmet.2016.10.014
   Vaz-Silva J, 2018, EMBO J, V37, DOI 10.15252/embj.201899084
   Volarevic V, 2015, EUR J IMMUNOL, V45, P531, DOI 10.1002/eji.201444849
   Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338
   Yang F, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00024-18
   Yang H, 2019, NAT MED, V25, P1428, DOI 10.1038/s41591-019-0566-4
   Ye H, 2019, FASEB J, V33, P12135, DOI 10.1096/fj.201900788RR
   Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012
   Yong KSM, 2016, CELL MOL IMMUNOL, V13, P605, DOI 10.1038/cmi.2015.40
   Zannas AS, 2017, MOL PSYCHIATR, V22, P640, DOI 10.1038/mp.2017.35
   Zannas AS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0828-5
   Zhao HX, 2019, NAT CELL BIOL, V21, P476, DOI 10.1038/s41556-019-0296-3
NR 42
TC 8
Z9 8
U1 1
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 4
PY 2020
VL 295
IS 49
BP 16852
EP 16862
DI 10.1074/jbc.RA120.012974
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA PE7BW
UT WOS:000598518600030
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU SCHUMER, W
   KUTTNER, RE
AF SCHUMER, W
   KUTTNER, RE
TI EFFECT OF AGING ON HEPATIC CARBOHYDRATE-METABOLISM IN SEPTIC RATS
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
C1 VET ADM MED CTR,SURG RES LAB,N CHICAGO,IL 60064.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA)
RP SCHUMER, W (corresponding author), UNIV HLTH SCI CHICAGO MED SCH,DEPT SURG,3333 GREEN BAY RD,N CHICAGO,IL 60064, USA.
CR Apantaku F O, 1981, Adv Shock Res, V5, P113
   BERGMEYER HU, 1974, METHODS ENZYMATIC AN, V3
   BERKMAN P, 1985, J AM GERIATRIC SOC, V14, P644
   DOBROSIELSKIVERGONA K, 1984, AGE, V7, P67, DOI 10.1007/BF02432203
   GARRISON RN, 1982, ANN SURG, V196, P43, DOI 10.1097/00000658-198207000-00010
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   GRINNA LS, 1975, EXP GERONTOL, V10, P319, DOI 10.1016/0531-5565(75)90021-2
   HOLLOWAY WA, 1984, GERIATRICS, V39, P48
   HOLTZMAN S, 1974, CIRC SHOCK, V1, P99
   Kuttner R E, 1983, Adv Shock Res, V10, P175
   Kuttner R E, 1980, Adv Shock Res, V4, P73
   KUTTNER RE, 1985, CIRC SHOCK, V16, P41
   KUTTNER RE, 1982, J SURG RES, V33, P123, DOI 10.1016/0022-4804(82)90017-8
   LINN BS, 1983, ARCH SURG-CHICAGO, V118, P405
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCGOWAN JE, 1975, J INFECT DIS, V132, P316, DOI 10.1093/infdis/132.3.316
   MILLER SI, 1980, AM J MED, V68, P649, DOI 10.1016/0002-9343(80)90250-8
   NARIMIYA M, 1984, AM J PHYSIOL, V246, pE397, DOI 10.1152/ajpendo.1984.246.5.E397
   NOUEL O, 1981, ARCH INTERN MED, V141, P1477, DOI 10.1001/archinte.141.11.1477
   SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7
   SCHMUCKER DL, 1980, EXP GERONTOL, V15, P7, DOI 10.1016/0531-5565(80)90018-2
   SCHULER JJ, 1976, ANN SURG, V183, P345, DOI 10.1097/00000658-197604000-00003
   SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011
   WOLFE RR, 1978, AM J PHYSIOL, V235, pR219, DOI 10.1152/ajpregu.1978.235.5.R219
   Yates A J, 1980, Adv Shock Res, V4, P63
   YU BP, 1984, MECH AGEING DEV, V24, P67
NR 26
TC 3
Z9 3
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD SEP
PY 1987
VL 42
IS 5
BP 487
EP 490
DI 10.1093/geronj/42.5.487
PG 4
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA K0735
UT WOS:A1987K073500007
PM 3040852
DA 2024-02-19
ER

PT J
AU Vougioukalaki, M
   Demmers, J
   Vermeij, WP
   Baar, M
   Bruens, S
   Magaraki, A
   Kuijk, E
   Jager, M
   Merzouk, S
   Brandt, RMC
   Kouwenberg, J
   van Boxtel, R
   Cuppen, E
   Pothof, J
   Hoeijmakers, JHJ
AF Vougioukalaki, Maria
   Demmers, Joris
   Vermeij, Wilbert P.
   Baar, Marjolein
   Bruens, Serena
   Magaraki, Aristea
   Kuijk, Ewart
   Jager, Myrthe
   Merzouk, Sarra
   Brandt, Renata M. C.
   Kouwenberg, Janneke
   van Boxtel, Ruben
   Cuppen, Edwin
   Pothof, Joris
   Hoeijmakers, Jan H. J.
TI Different responses to DNA damage determine ageing differences between
   organs
SO AGING CELL
LA English
DT Article; Early Access
DE adult stem cells; DNA damage response; ERCC1; genome maintenance; liver;
   nucleotide excision repair; organoids; small intestine
ID HEMATOPOIETIC STEM-CELLS; MOUSE MODEL; NUCLEAR ABNORMALITIES;
   SMALL-INTESTINE; IN-VITRO; REPAIR; LIVER; MECHANISMS; DEFICIENT;
   ERCC1-XPF
AB Organs age differently, causing wide heterogeneity in multimorbidity, but underlying mechanisms are largely elusive. To investigate the basis of organ-specific ageing, we utilized progeroid repair-deficient Ercc1(Delta)(/-) mouse mutants and systematically compared at the tissue, stem cell and organoid level two organs representing ageing extremes. Ercc1(Delta)(/-) intestine shows hardly any accelerated ageing. Nevertheless, we found apoptosis and reduced numbers of intestinal stem cells (ISCs), but cell loss appears compensated by over-proliferation. ISCs retain their organoid-forming capacity, but organoids perform poorly in culture, compared with WT. Conversely, liver ages dramatically, even causing early death in Ercc1-KO mice. Apoptosis, p21, polyploidization and proliferation of various (stem) cells were prominently elevated in Ercc1(Delta)(/-) liver and stem cell populations were either largely unaffected (Sox9+), or expanding (Lgr5+), but were functionally exhausted in organoid formation and development in vitro. Paradoxically, while intestine displays less ageing, repair in WT ISCs appears inferior to liver as shown by enhanced sensitivity to various DNA-damaging agents, and lower lesion removal. Our findings reveal organ-specific anti-ageing strategies. Intestine, with short lifespan limiting time for damage accumulation and repair, favours apoptosis of damaged cells relying on ISC plasticity. Liver with low renewal rates depends more on repair pathways specifically protecting the transcribed compartment of the genome to promote sustained functionality and cell preservation. As shown before, the hematopoietic system with intermediate self-renewal mainly invokes replication-linked mechanisms, apoptosis and senescence. Hence, organs employ different genome maintenance strategies, explaining heterogeneity in organ ageing and the segmental nature of DNA-repair-deficient progerias.
C1 [Vougioukalaki, Maria; Demmers, Joris; Bruens, Serena; Brandt, Renata M. C.; Kouwenberg, Janneke; Pothof, Joris; Hoeijmakers, Jan H. J.] Erasmus MC, Dept Mol Genet, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
   [Vermeij, Wilbert P.; van Boxtel, Ruben; Hoeijmakers, Jan H. J.] Princess Maxima Ctr Pediat Oncol, Oncode Inst, Utrecht, Netherlands.
   [Baar, Marjolein] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.
   [Magaraki, Aristea; Merzouk, Sarra] Oncode Inst, Dept Dev Biol, Rotterdam, Netherlands.
   [Kuijk, Ewart; Cuppen, Edwin] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med & Canc Genom Netherlands, Div Biomed Genet, Utrecht, Netherlands.
   [Jager, Myrthe] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, Utrecht, Netherlands.
   [Cuppen, Edwin] Hartwig Med Fdn, Amsterdam, Netherlands.
   [Hoeijmakers, Jan H. J.] Univ Hosp Cologne, Inst Genome Stabil Ageing & Dis, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
C3 Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht
   University Medical Center; Utrecht University; Utrecht University
   Medical Center; Utrecht University; Utrecht University Medical Center;
   University of Cologne
RP Hoeijmakers, JHJ (corresponding author), Erasmus MC, Dept Mol Genet, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
EM j.hoeijmakers@erasmusmc.nl
RI Hoeijmakers, Jan/AAX-6972-2021; Kuijk, Ewart/I-2569-2019; Cuppen,
   Edwin/H-2389-2016
OI Kuijk, Ewart/0000-0002-1385-6516; Cuppen, Edwin/0000-0002-0400-9542;
   Vermeij, Wilbert/0000-0002-9690-1385; Brandt, Renata M.
   C./0000-0003-0514-5623; Jager, Myrthe/0000-0002-1406-1715
FU European Commission; Deutsche Forschungsgemeinschaft [73111208 - SFB
   829]; European Joint Programme on Rare Diseases; Royal Academy of Arts
   and Sciences of the Netherlands; National Institute of Health
   (NIH)/National Institute of Ageing (NIA) [PO1 AG017242]; European
   Research Council; KWF Kankerbestrijding [5030]; Oncode
FX European Commission; Deutsche Forschungsgemeinschaft, Grant/Award
   Number: 73111208 - SFB 829; KWF Kankerbestrijding, Grant/Award Number:
   5030; European Joint Programme on Rare Diseases; Royal Academy of Arts
   and Sciences of the Netherlands; National Institute of Health
   (NIH)/National Institute of Ageing (NIA), Grant/Award Number: PO1
   AG017242; European Research Council; Oncode
CR Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08
   Alyodawi K, 2019, J CACHEXIA SARCOPENI, V10, P662, DOI 10.1002/jcsm.12404
   Andressoo JO, 2006, CANCER CELL, V10, P121, DOI 10.1016/j.ccr.2006.05.027
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196
   Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721
   Barnhoorn S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004686
   Barriga FM, 2017, CELL STEM CELL, V20, P801, DOI 10.1016/j.stem.2017.02.007
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426
   Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002
   Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097
   Cho JS, 2013, STEM CELLS, V31, P511, DOI 10.1002/stem.1261
   de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174
   de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619
   Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z
   Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866
   Gehart H, 2015, TRENDS GENET, V31, P344, DOI 10.1016/j.tig.2015.04.005
   Gilgenkrantz H, 2018, AM J PATHOL, V188, P1316, DOI 10.1016/j.ajpath.2018.03.008
   Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Jager M, 2019, GENOME RES, V29, P1067, DOI 10.1101/gr.246223.118
   Jaspers NGJ, 2002, DNA REPAIR, V1, P1027, DOI 10.1016/S1568-7864(02)00166-0
   Kim DE, 2020, AGING CELL, V19, DOI 10.1111/acel.13072
   Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200
   Lans H, 2019, NAT REV MOL CELL BIO, V20, P766, DOI 10.1038/s41580-019-0169-4
   Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   Martin K, 1998, EXP CELL RES, V241, P316, DOI 10.1006/excr.1998.4001
   Matsumura H, 2016, SCIENCE, V351, DOI 10.1126/science.aad4395
   McNeely T, 2020, HUM GENET, V139, P309, DOI 10.1007/s00439-019-02047-z
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   Milanese C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12640-5
   Muradian K, 2001, Z GERONTOL GERIATR, V34, P441, DOI 10.1007/s003910170015
   Naipal KAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126029
   Nalapareddy K, 2017, CELL REP, V18, P2608, DOI 10.1016/j.celrep.2017.02.056
   Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Niedernhofer LJ, 2018, ANNU REV BIOCHEM, V87, P295, DOI 10.1146/annurev-biochem-062917-012239
   Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x
   Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542
   Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rübe CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Schumacher B, 2021, NATURE, V592, P695, DOI 10.1038/s41586-021-03307-7
   Shivdasani RA, 2014, CELL STEM CELL, V14, P135, DOI 10.1016/j.stem.2014.01.015
   Sperka T, 2012, NAT CELL BIOL, V14, P73, DOI 10.1038/ncb2388
   Steegenga WT, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600141
   Tetteh PW, 2016, CELL STEM CELL, V18, P203, DOI 10.1016/j.stem.2016.01.001
   Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316
   Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131
   Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Yousefzadeh M, 2021, ELIFE, V10, DOI 10.7554/eLife.62852
   Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094
NR 69
TC 11
Z9 12
U1 3
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 APR
PY 2022
VL 21
IS 4
AR e13562
DI 10.1111/acel.13562
EA MAR 2022
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 1X1UP
UT WOS:000765001200001
PM 35246937
OA Green Published
DA 2024-02-19
ER

PT J
AU Wang, CF
   Maddick, M
   Miwa, S
   Jurk, D
   Czapiewski, R
   Saretzki, G
   Langie, SAS
   Godschalk, RWL
   Cameron, K
   von Zglinicki, T
AF Wang, Chunfang
   Maddick, Mandy
   Miwa, Satomi
   Jurk, Diana
   Czapiewski, Rafal
   Saretzki, Gabriele
   Langie, Sabine A. S.
   Godschalk, Roger W. L.
   Cameron, Kerry
   von Zglinicki, Thomas
TI Adult-onset, short-term dietary restriction reduces cell senescence in
   mice
SO AGING-US
LA English
DT Article
DE Dietary restriction; caloric restriction; mice; senescence; telomeres;
   ageing
ID OXIDATIVE DNA-DAMAGE; LIFE-SPAN EXTENSION; CALORIC RESTRICTION;
   IN-VITRO; LIPOFUSCIN ACCUMULATION; MIDDLE-AGE; CANCER; STRESS;
   INDUCTION; LONGEVITY
AB Dietary restriction (DR) extends the lifespan of a wide variety of species and reduces the incidence of major age-related diseases. Cell senescence has been proposed as one causal mechanism for tissue and organism ageing. We show for the first time that adult-onset, short-term DR reduced frequencies of senescent cells in the small intestinal epithelium and liver of mice, which are tissues known to accumulate increased numbers of senescent cells with advancing age. This reduction was associated with improved telomere maintenance without increased telomerase activity. We also found a decrease in cumulative oxidative stress markers in the same compartments despite absence of significant changes in steady-state oxidative stress markers at the whole tissue level. The data suggest the possibility that reduction of cell senescence may be a primary consequence of DR which in turn may explain known effects of DR such as improved mitochondrial function and reduced production of reactive oxygen species.
C1 [Wang, Chunfang; Maddick, Mandy; Miwa, Satomi; Jurk, Diana; Cameron, Kerry; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Czapiewski, Rafal; Saretzki, Gabriele] Newcastle Univ, Inst Ageing & Hlth, Crucible Lab, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Langie, Sabine A. S.] Newcastle Univ, Inst Ageing & Hlth, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Langie, Sabine A. S.] Newcastle Univ, Inst Ageing & Hlth, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Godschalk, Roger W. L.] Maastricht Univ, Dept Hlth Risk Anal & Toxicol, Nutr & Toxicol Res Inst Maastricht NUTRIM, Maastricht, Netherlands.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle University - UK; Maastricht University
RP von Zglinicki, T (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM t.vonzglinicki@ncl.ac.uk
RI Langie, Sabine A/Q-2917-2017; Czapiewski, Rafal/JGM-6152-2023; Saretzki,
   Gabriele Christine/I-7175-2019
OI Langie, Sabine A/0000-0003-3288-7331; Saretzki, Gabriele
   Christine/0000-0003-2100-8223; Miwa, Satomi/0000-0002-1239-1198; von
   Zglinicki, Thomas/0000-0002-5939-0248; Jurk, Diana/0000-0003-4486-0857;
   Czapiewski, Rafal/0000-0003-0211-8435
FU BBSRC; EPSRC (CISBAN); MRC; ESRC; Centre for Brain Ageing and Vitality;
   MRC [G0700718, G0900686, G0601333] Funding Source: UKRI; Medical
   Research Council [G0900686, G0700718, G0601333] Funding Source:
   researchfish
FX We thank Adele Kitching and Julie Wallace for technical support with the
   mice; Dr Glyn Nelson for his technical support in the nitrotyrosine
   measurement and Lou M. Maas for his technical support in the 8-oxodG
   analysis. This work was funded by BBSRC and EPSRC (CISBAN). Part of the
   work was subsidized by the Centre for Brain Ageing and Vitality, which
   is funded through the Lifelong Health and Wellbeing cross council
   initiative by the MRC, BBSRC, EPSRC and ESRC.
CR Anderson Rozalyn M., 2007, V35, P18
   Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476
   Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Campisi J, 2009, J GERONTOL A-BIOL, V64, P164, DOI 10.1093/gerona/gln073
   Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   Collins AR, 2000, FREE RADICAL RES, V32, P333, DOI 10.1080/10715760000300331
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
   DEKOK TMCM, 1994, CARCINOGENESIS, V15, P1399, DOI 10.1093/carcin/15.7.1399
   Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008
   Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x
   Godschalk RWL, 1998, CARCINOGENESIS, V19, P819, DOI 10.1093/carcin/19.5.819
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Guo ZM, 2001, MECH AGEING DEV, V122, P1771, DOI 10.1016/S0047-6374(01)00298-6
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721
   Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x
   Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   KUBO C, 1984, J NUTR, V114, P1884, DOI 10.1093/jn/114.10.1884
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166
   LAWLESS C, 2010, EXP GERONTOL
   Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x
   LIPMAN RD, 1995, AGING-CLIN EXP RES, V7, P136, DOI 10.1007/BF03324303
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Masoro EJ, 2001, AGING-CLIN EXP RES, V13, P261
   MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9
   Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x
   Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103
   Messaoudi I, 2008, AGING CELL, V7, P908, DOI 10.1111/j.1474-9726.2008.00440.x
   Miller RA, 1997, MECH AGEING DEV, V96, P181, DOI 10.1016/S0047-6374(97)01893-9
   Panda S, 2008, MECH AGEING DEV, V129, P332, DOI 10.1016/j.mad.2008.02.014
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pendergrass WR, 1999, J CELL PHYSIOL, V180, P123, DOI 10.1002/(SICI)1097-4652(199907)180:1<123::AID-JCP14>3.0.CO;2-W
   PENDERGRASS WR, 1995, EXP CELL RES, V217, P309, DOI 10.1006/excr.1995.1091
   Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x
   Pugh TD, 1999, CANCER RES, V59, P1642
   Racette SB, 2006, J GERONTOL A-BIOL, V61, P943, DOI 10.1093/gerona/61.9.943
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   ROWLATT C, 1976, Laboratory Animals (London), V10, P419, DOI 10.1258/002367776780956917
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Sitte N, 2001, EXP GERONTOL, V36, P475, DOI 10.1016/S0531-5565(00)00253-9
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1989, FREE RADICAL BIO MED, V6, P23, DOI 10.1016/0891-5849(89)90155-X
   Spaulding CC, 1997, MECH AGEING DEV, V93, P25, DOI 10.1016/S0047-6374(96)01808-8
   Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   TCHKONIA T, 2010, AGING CELL
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   VOLK MJ, 1994, CANCER RES, V54, P3054
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   WOLF NS, 1995, EXP CELL RES, V217, P317, DOI 10.1006/excr.1995.1092
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
   Zhang H, 2000, EXP CELL RES, V259, P284, DOI 10.1006/excr.2000.4965
   Zhuo L, 2009, MECH AGEING DEV, V130, P700, DOI 10.1016/j.mad.2009.08.005
NR 76
TC 100
Z9 107
U1 0
U2 8
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP
PY 2010
VL 2
IS 9
BP 555
EP 566
DI 10.18632/aging.100196
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 657VR
UT WOS:000282447100007
PM 20844316
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Melis, JPM
   Jonker, MJ
   Vijg, J
   Hoeijmakers, JHJ
   Breit, TM
   van Steeg, H
AF Melis, Joost P. M.
   Jonker, Martijs J.
   Vijg, Jan
   Hoeijmakers, Jan H. J.
   Breit, Timo M.
   van Steeg, Harry
TI Aging on a different scale - chronological versus pathology-related
   aging
SO AGING-US
LA English
DT Article
DE aging; senescence; diseases; signaling pathways; metabolism; lipofuscin
ID NUCLEOTIDE EXCISION-REPAIR; GENE-EXPRESSION PROFILES; OXIDATIVE
   DNA-DAMAGE; LIFE-SPAN; CALORIC RESTRICTION; XERODERMA-PIGMENTOSUM;
   CELLULAR SENESCENCE; SOMATIC MUTATIONS; COCKAYNE-SYNDROME;
   INSULIN-RECEPTOR
AB In the next decades the elderly population will increase dramatically, demanding appropriate solutions in health care and aging research focusing on healthy aging to prevent high burdens and costs in health care. For this, research targeting tissue-specific and individual aging is paramount to make the necessary progression in aging research. In a recently published study we have attempted to make a step interpreting aging data on chronological as well as pathological scale. For this, we sampled five major tissues at regular time intervals during the entire C57BL/6J murine lifespan from a controlled in vivo aging study, measured the whole transcriptome and incorporated temporal as well as physical health aspects into the analyses. In total, we used 18 different age-related pathological parameters and transcriptomic profiles of liver, kidney, spleen, lung and brain and created a database that can now be used for a broad systems biology approach. In our study, we focused on the dynamics of biological processes during chronological aging and the comparison between chronological and pathology-related aging.
C1 [Melis, Joost P. M.; van Steeg, Harry] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands.
   [Melis, Joost P. M.; van Steeg, Harry] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands.
   [Jonker, Martijs J.; Breit, Timo M.] Univ Amsterdam, MicroArray Dept, Amsterdam, Netherlands.
   [Jonker, Martijs J.; Breit, Timo M.] Fac Sci FNWI, Integrat Bioinformat Unit MAD IBU, SILS, Amsterdam, Netherlands.
   [Jonker, Martijs J.; Breit, Timo M.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands.
   [Vijg, Jan] Albert Einstein Coll Med, Dept Genet, New York, NY USA.
   [Hoeijmakers, Jan H. J.] Erasmus Univ, Med Ctr, CGC Dept Genet, Rotterdam, Netherlands.
C3 Netherlands National Institute for Public Health & the Environment;
   Leiden University; Leiden University Medical Center (LUMC); Leiden
   University - Excl LUMC; University of Amsterdam; Vrije Universiteit
   Amsterdam; Yeshiva University; Erasmus University Rotterdam; Erasmus MC
RP van Steeg, H (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands.
EM harry.van.steeg@rivm.nl
RI Hoeijmakers, Jan/AAX-6972-2021
FU IOP Genomics [IGE03009]; NIH/NIA [3PO1 AG017242]; STW [STW-LGC.6935];
   Netherlands Bioinformatics Center (NBIC) [BioRange II - BR4.1]; Markage
   [FP7-Health-2008-200880]; LifeSpan [LSHG-CT-2007-036894]; European
   Research Council (ERC)
FX The work presented here was in part financially supported by IOP
   Genomics IGE03009, NIH/NIA (3PO1 AG017242), STW Grant STW-LGC.6935 and
   Netherlands Bioinformatics Center (NBIC) BioRange II - BR4.1. Support
   was also obtained from Markage (FP7-Health-2008-200880), LifeSpan
   (LSHG-CT-2007-036894), European Research Council (ERC advanced scientist
   grant JHJH).
CR Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6
   Beltrami E, 2013, AGING CELL, V12, P177, DOI 10.1111/acel.12036
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Bucholtz N, 2013, DNA REPAIR
   Busuttil R, 2007, NEUROSCIENCE, V145, P1341, DOI 10.1016/j.neuroscience.2006.09.060
   Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x
   Canugovi C, 2013, DNA REPAIR, V12, P578, DOI 10.1016/j.dnarep.2013.04.010
   Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x
   Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Diderich K, 2011, DNA REPAIR, V10, P772, DOI 10.1016/j.dnarep.2011.04.025
   Dollé MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403
   Dröge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006
   Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   Giese H, 1999, ONCOGENE, V18, P1257, DOI 10.1038/sj.onc.1202404
   Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75
   Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021
   GOEL SK, 1986, CANCER RES, V46, P1324
   Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x
   Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   HOLLANDER CF, 1984, MECH AGEING DEV, V28, P249, DOI 10.1016/0047-6374(84)90025-3
   Holly AC, 2013, AGING CELL, V12, P324, DOI 10.1111/acel.12044
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Huang T, 2011, OMICS, V15, P665, DOI 10.1089/omi.2011.0034
   Jackaman C, 2013, AGING CELL, V12, P345, DOI 10.1111/acel.12062
   Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x
   Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248
   Kim J, 2010, TRENDS CELL BIOL, V20, P311, DOI 10.1016/j.tcb.2010.03.003
   Komarova EA, 2012, AGING-US, V4, P709, DOI 10.18632/aging.100498
   Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020
   Kurz T, 2010, ANTIOXID REDOX SIGN, V13, P511, DOI 10.1089/ars.2009.3005
   Kyng KJ, 2005, ONCOGENE, V24, P5026, DOI 10.1038/sj.onc.1208692
   Labunskyy VM, 2013, ANTIOXID REDOX SIGN, V19, P1362, DOI 10.1089/ars.2012.4891
   Lenaz G, 2006, ANTIOXID REDOX SIGN, V8, P417, DOI 10.1089/ars.2006.8.417
   Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x
   Liu BH, 2013, AGING CELL, V12, P316, DOI 10.1111/acel.12035
   Liu DP, 2011, ANTIOXID REDOX SIGN, V15, P1669, DOI 10.1089/ars.2010.3644
   Ludlow AT, 2012, J GERONTOL A-BIOL, V67, P911, DOI 10.1093/gerona/gls002
   Maslov AY, 2013, AGING CELL, V12, P467, DOI 10.1111/acel.12071
   Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949
   Melis JPM, 2008, CANCER RES, V68, P1347, DOI 10.1158/0008-5472.CAN-07-6067
   Melis JPM, 2013, ANTIOXID REDOX SIGN, V18, P2409, DOI 10.1089/ars.2012.5036
   Melis JPM, 2013, TOXICOL APPL PHARM, V266, P289, DOI 10.1016/j.taap.2012.11.004
   Melis JPM, 2011, MUTAT RES-REV MUTAT, V728, P107, DOI 10.1016/j.mrrev.2011.07.001
   Melis JP, 2013, DNA REPAIR IN PRESS
   Melis JPM., 2012, NUCLEOTIDE EXCISION, P158
   Melis JPM, 2011, DNA REPAIR HUMAN HLT, P121
   Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x
   Moreira PI, 2007, ANTIOXID REDOX SIGN, V9, P1621, DOI 10.1089/ars.2007.1703
   Moriya K, 2001, CANCER RES, V61, P4365
   ONO T, 1995, MUTAT RES-DNAGING G, V338, P183, DOI 10.1016/0921-8734(95)00023-Y
   Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x
   Perse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059638
   Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228
   Pulliam DA, 2012, ANTIOXIDANTS REDOX S
   Qian F, 2012, AGING CELL, V11, P104, DOI 10.1111/j.1474-9726.2011.00759.x
   Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x
   Rufini A, 2013, ONCOGENE
   Scialo F, 2012, ANTIOXIDANTS REDOX S
   Seo K, 2013, AGING CELL IN PRESS
   Sepe S, 2013, DNA REPAIR, V12, P568, DOI 10.1016/j.dnarep.2013.04.009
   Seviour EG, 2010, AGING-US, V2, P900, DOI 10.18632/aging.100248
   Sheedfar F, 2013, AGING CELL IN PRESS
   Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978
   Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776
   Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296
   Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994
   Suh Y, 2006, ANTIOXID REDOX SIGN, V8, P559, DOI 10.1089/ars.2006.8.559
   Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353
   Swindell WR, 2008, MECH AGEING DEV, V129, P138, DOI 10.1016/j.mad.2007.11.003
   Swindell WR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01215
   Swindell WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033204
   Swindell WR, 2012, AGEING RES REV, V11, P254, DOI 10.1016/j.arr.2011.12.006
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Tomás-Loba A, 2013, AGING CELL, V12, P93, DOI 10.1111/acel.12025
   Vijg J, 2005, ANN NY ACAD SCI, V1055, P35, DOI 10.1196/annals.1323.007
   Vijg J., 2007, AGING GENOME DUAL RO
   Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x
   Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
   Zeng N, 2013, AGING CELL IN PRESS
   Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607
NR 98
TC 18
Z9 18
U1 0
U2 17
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD OCT
PY 2013
VL 5
IS 10
BP 782
EP 788
DI 10.18632/aging.100606
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 258RX
UT WOS:000327477500009
PM 24131799
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Yoshimoto, S
   Loo, TM
   Atarashi, K
   Kanda, H
   Sato, S
   Oyadomari, S
   Iwakura, Y
   Oshima, K
   Morita, H
   Hattori, M
   Honda, K
   Ishikawa, Y
   Hara, E
   Ohtani, N
AF Yoshimoto, Shin
   Loo, Tze Mun
   Atarashi, Koji
   Kanda, Hiroaki
   Sato, Seidai
   Oyadomari, Seiichi
   Iwakura, Yoichiro
   Oshima, Kenshiro
   Morita, Hidetoshi
   Hattori, Masahisa
   Honda, Kenya
   Ishikawa, Yuichi
   Hara, Eiji
   Ohtani, Naoko
TI Obesity-induced gut microbial metabolite promotes liver cancer through
   senescence secretome
SO NATURE
LA English
DT Article
ID HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; MECHANISMS;
   CLOSTRIDIUM; EXPRESSION; ACID; INFLAMMATION; PHENOTYPE; BACTERIUM;
   STRESS
AB Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer(1). As the worldwide obesity epidemic has shown no signs of abating(2), better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer1,3, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP)(4,5) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage(6). The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs)(7), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer(8) or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis(3), indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
C1 [Yoshimoto, Shin; Loo, Tze Mun; Sato, Seidai; Hara, Eiji; Ohtani, Naoko] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan.
   [Yoshimoto, Shin; Loo, Tze Mun; Sato, Seidai; Honda, Kenya; Hara, Eiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan.
   [Loo, Tze Mun] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan.
   [Atarashi, Koji; Honda, Kenya] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan.
   [Atarashi, Koji; Ohtani, Naoko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan.
   [Kanda, Hiroaki; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Koto Ku, Tokyo 1358550, Japan.
   [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan.
   [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2788510, Japan.
   [Oshima, Kenshiro; Hattori, Masahisa] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan.
   [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2298501, Japan.
C3 Japanese Foundation for Cancer Research; Japan Science & Technology
   Agency (JST); Tokyo University of Science; RIKEN; Japan Science &
   Technology Agency (JST); Japanese Foundation for Cancer Research;
   Tokushima University; Tokyo University of Science; University of Tokyo;
   Azabu University
RP Hara, E (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan.
EM eiji.hara@jfcr.or.jp
RI Honda, Kenya/N-5297-2015; Ohtani, Naoko/AAB-1891-2021; Yoshimoto,
   Shin/ACD-1941-2022; Oyadomari, Seiichi/GZA-7157-2022; Oyadomari,
   Seiichi/GZA-7072-2022; Iwakura, Yoichiro/E-5457-2011; Atarashi,
   Koji/I-5363-2014
OI Ohtani, Naoko/0000-0001-8934-0797; Yoshimoto, Shin/0000-0001-8405-0301;
   Iwakura, Yoichiro/0000-0002-9934-5775; Atarashi,
   Koji/0000-0001-5422-0736; Loo, Tze Mun/0000-0001-5725-1423; Honda,
   Kenya/0000-0001-8937-9835
FU Japan Science and Technology Agency (JST); Ministry of Education,
   Culture, Sports, Science and Technology of Japan (MEXT); Ministry of
   Health, Labour and Welfare of Japan (MHLW); Uehara Memorial Foundation;
   Takeda Science Foundation; Japan Society for Promotion of Science
   (JSPS); Ajinomoto Scholarship Foundation; Grants-in-Aid for Scientific
   Research [23300343, 221S0001, 25293080, 24650625, 23300352] Funding
   Source: KAKEN
FX The authors thank M. Oshima for suggestions in antibiotics treatment and
   members of the Hara laboratory for discussion during the preparation of
   this manuscript. This work was supported by grants from Japan Science
   and Technology Agency (JST), Ministry of Education, Culture, Sports,
   Science and Technology of Japan (MEXT), Ministry of Health, Labour and
   Welfare of Japan (MHLW), Uehara Memorial Foundation and Takeda Science
   Foundation. S.Y. was partly supported by a postdoctoral fellowship from
   the Japan Society for Promotion of Science (JSPS). T. M. L. was partly
   supported by an international scholarship from the Ajinomoto Scholarship
   Foundation.
CR Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469
   Beuers U, 2006, NAT CLIN PRACT GASTR, V3, P318, DOI 10.1038/ncpgasthep0521
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174
   KITAZAWA S, 1990, CARCINOGENESIS, V11, P1323, DOI 10.1093/carcin/11.8.1323
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98
   Minamida K, 2006, BIOSCI BIOTECH BIOCH, V70, P332, DOI 10.1271/bbb.70.332
   Muto A, 2012, J CHROMATOGR B, V900, P24, DOI 10.1016/j.jchromb.2012.05.023
   Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028
   Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104
   Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139
   RAFTER JJ, 1987, AM J CLIN NUTR, V45, P559, DOI 10.1093/ajcn/45.3.559
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Ridlon JM, 2012, J LIPID RES, V53, P66, DOI 10.1194/jlr.M020313
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Sekiya Y, 2011, J CELL PHYSIOL, V226, P2535, DOI 10.1002/jcp.22598
   Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X
   Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004
   Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Takuma Y, 2010, WORLD J GASTROENTERO, V16, P1436, DOI 10.3748/wjg.v16.i12.1436
   Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105
NR 39
TC 1468
Z9 1632
U1 22
U2 471
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD JUL 4
PY 2013
VL 499
IS 7456
BP 97
EP +
DI 10.1038/nature12347
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 176ED
UT WOS:000321285600041
PM 23803760
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Yoon, G
   Kim, HJ
   Yoon, YS
   Cho, H
   Lim, IK
   Lee, JH
AF Yoon, G
   Kim, HJ
   Yoon, YS
   Cho, H
   Lim, IK
   Lee, JH
TI Iron chelation-induced senescence-like growth arrest in hepatocyte cell
   lines:: association of transforming growth factor β1 (TGF-β1)-mediated
   p27<SUP>Kip1</SUP> expression
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE desferroxamine mesylate; Chang cells; G(1) arrest; p53
ID POLY(ADP-RIBOSE) POLYMERASE; HEPATOCELLULAR-CARCINOMA; IN-VITRO; G1
   PHASE; INHIBITION; CYCLE; DEFEROXAMINE; STRESS; P53; PROLIFERATION
AB Iron is essential for cellular proliferation in all organisms. When deprived of iron, the growth of cells is invariably inhibited. However, the mechanism involved remains largely unclear. In the present study, we have observed that subcytotoxic concentrations of desferroxamine mesylate (DFO), an iron chelator, specifically inhibited the transition from G(1) to S-phase of Chang cells, a hepatocyte cell line. This was accompanied by the appearance of senescent biomarkers, such as enlarged and flattened cell morphology, senescence-associated beta-galactosidase activity and reduced expression of poly(ADP-ribose) polymerase. Concomitantly, p27(Kip1) (where Kip is kinase-inhibitory protein) was induced markedly, whereas other negative cell-cycle regulators, such as p21(Cip1) (where Cip is cyclin-dependent kinase-interacting protein), p15(INK4B) and p16(INK4A) (Where INK is inhibitors of cyclin-dependent kinase 4), were not, implying its association in the G(1) arrest. Furthermore, the induction of p27(Kip1) was accompanied by an increased level of transforming growth factor beta1 (TGF-beta1) mRNA. When neutralized with an anti-(TGF-beta1) antibody, p27(Kip1) induction was completely abolished, indicating that TGF-beta1 is the major inducer of p27(Kip1). Finally, DFO-induced senescence-like arrest was found to be independent of p53, since cell-cycle arrest was still observed with two p53-negative cell lines, Huh7 and Hep3B cells. In conclusion, DFO induced senescence-like G, arrest in hepatocyte cell lines and this was associated with the induction of p27(Kip1) through TGF-beta1, but was independent of p53.
C1 Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 442749, South Korea.
C3 Ajou University
RP Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Wonchon Dong, Suwon 442749, South Korea.
EM ypeace@madang.ajou.ac.kr
OI Lim, In Kyoung/0000-0002-2399-607X; Cho, Hyeseong/0000-0002-4672-8887
CR Adams Paul C., 1998, Journal of Hepatology, V28, P19, DOI 10.1016/S0168-8278(98)80370-X
   Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000
   Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7
   Boldt DH, 1999, AM J MED SCI, V318, P207, DOI 10.1097/00000441-199910000-00001
   Bonkovsky H L, 2000, Clin Liver Dis, V4, P409, DOI 10.1016/S1089-3261(05)70116-1
   BRODIE C, 1993, CANCER RES, V53, P3968
   Burkle A, 1998, EXP GERONTOL, V33, P519, DOI 10.1016/S0531-5565(98)00036-9
   Caspari T, 2000, CURR BIOL, V10, pR315, DOI 10.1016/S0960-9822(00)00439-5
   Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543
   Chenoufi N, 1998, LIVER, V18, P60
   Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200
   DELLORCO RT, 1991, J CELL PHYSIOL, V146, P216, DOI 10.1002/jcp.1041460205
   Deugnier Y, 2001, J GASTROEN HEPATOL, V16, P491, DOI 10.1046/j.1440-1746.2001.02430.x
   Deugnier Yves, 1998, Journal of Hepatology, V28, P21, DOI 10.1016/S0168-8278(98)80371-1
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Erickson S, 1998, ONCOGENE, V17, P595, DOI 10.1038/sj.onc.1201965
   Fan LJ, 2001, CANCER RES, V61, P1073
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200
   HANN HWL, 1990, HEPATOLOGY, V11, P566, DOI 10.1002/hep.1840110407
   HANN HWL, 1992, CANCER, V70, P2051, DOI 10.1002/1097-0142(19921015)70:8<2051::AID-CNCR2820700806>3.0.CO;2-1
   HOYES KP, 1992, CANCER RES, V52, P4591
   Hulleman E, 2001, CELL MOL LIFE SCI, V58, P80, DOI 10.1007/PL00000780
   Ito K, 1999, RADIOLOGY, V212, P235, DOI 10.1148/radiology.212.1.r99jl41235
   Katakura Y, 1999, BIOCHEM BIOPH RES CO, V255, P110, DOI 10.1006/bbrc.1999.0129
   KONTOGHIORGHES GJ, 1986, HEMATOL ONCOL, V4, P195, DOI 10.1002/hon.2900040303
   LEDERMAN HM, 1984, BLOOD, V64, P748
   LUCAS JJ, 1995, BLOOD, V86, P2268, DOI 10.1182/blood.V86.6.2268.bloodjournal8662268
   McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X
   NYHOLM S, 1993, J BIOL CHEM, V268, P26200
   Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2
   Park JI, 2000, J CANCER RES CLIN, V126, P455, DOI 10.1007/s004320050013
   Pietrangelo Antonello, 1998, Journal of Hepatology, V28, P8, DOI 10.1016/S0168-8278(98)80368-1
   POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9
   Reddel RR, 2000, CARCINOGENESIS, V21, P477, DOI 10.1093/carcin/21.3.477
   Renton FJ, 1996, BIOCHEM PHARMACOL, V51, P1553, DOI 10.1016/0006-2952(96)00099-8
   REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831
   ROBBINS E, 1970, P NATL ACAD SCI USA, V66, P1244, DOI 10.1073/pnas.66.4.1244
   Sakaida I, 1999, DIGEST DIS SCI, V44, P560, DOI 10.1023/A:1026661508553
   Salminen A, 1997, BIOCHEM BIOPH RES CO, V238, P712, DOI 10.1006/bbrc.1997.7371
   Sambrook J, 2001, MOL CLONING
   Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648
   Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805
   Vogt M, 1998, CELL GROWTH DIFFER, V9, P139
   Xiao HY, 1997, BIOCHEM BIOPH RES CO, V237, P457, DOI 10.1006/bbrc.1997.7158
   Yeo EJ, 2000, EXP GERONTOL, V35, P553, DOI 10.1016/S0531-5565(00)00108-X
NR 46
TC 62
Z9 65
U1 1
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD SEP 1
PY 2002
VL 366
BP 613
EP 621
DI 10.1042/BJ20011445
PN 2
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 593DE
UT WOS:000177975500025
PM 11945174
OA Green Published
DA 2024-02-19
ER

PT J
AU Jiang, Y
   Xiang, C
   Zhong, F
   Zhang, Y
   Wang, LY
   Zhao, YY
   Wang, JC
   Ding, C
   Jin, L
   He, FC
   Wang, HJ
AF Jiang, Yan
   Xiang, Chan
   Zhong, Fan
   Zhang, Yang
   Wang, Liyan
   Zhao, Yuanyuan
   Wang, Jiucun
   Ding, Chen
   Jin, Li
   He, Fuchu
   Wang, Haijian
TI Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate
   hepatic stellate cells activation and liver fibrosis
SO THERANOSTICS
LA English
DT Article
DE liver fibrosis; HSC; EZH2; JMJD3; epigenetics
ID CARBON-TETRACHLORIDE; GENE POLYMORPHISMS; PPAR-GAMMA; INHIBITION;
   INTERLEUKIN-10; EXPRESSION; THERAPY; TISSUE; FIBROGENESIS; PROGRESSION
AB Rationale: As the central hallmark of liver fibrosis, transdifferentiation of hepatic stellate cells (HSCs), the predominant contributor to fibrogenic hepatic myofibroblast responsible for extracellular matrix (ECM) deposition, is characterized with transcriptional and epigenetic remodeling. We aimed to characterize the roles of H3K27 methyltransferase EZH2 and demethylase JMJD3 and identify their effective pathways and novel target genes in HSCs activation and liver fibrosis.
   Methods: In primary HSCs, we analyzed effects of pharmacological inhibitions and genetic manipulations of EZH2 and JMJD3 on HSCs activation. In HSCs cell lines, we evaluated effects of EZH2 inhibition by DZNep on proliferation, cell cycling, senescence and apoptosis. In CCI4 and BDL murine models of liver fibrosis, we assessed in vivo effects of DZNep administration and Ezh2 silencing. We profiled rat primary HSCs transcriptomes with RNA-seq, screened the pathways and genes associated with DZNep treatment, analyzed EZH2 and JMJD3 regulation towards target genes by ChIP-qPCR.
   Results: EZH2 inhibition by DZNep resulted in retarded growth, lowered cell viability, cell cycle arrest in S and G2 phases, strengthened senescence, and enhanced apoptosis of HSCs, decreased hepatic collagen deposition and rescued the elevated serum ALT and AST activities of diseased mice, and downregulated cellular and hepatic expressions of H3K27me3, EZH2, alpha-SMA and COL1A. Ezh2 silencing by RNA interference in vitro and in vivo showed similar effects. JMJD3 inhibition by GSK-J4 and overexpression of wild-type but not mutant Jmjd3 enhanced or repressed HSCs activation respectively. EZH2 inhibition by DZNep transcriptionally inactivated TGF-beta 1 pathway, cell cycle pathways and vast ECM components in primary HSCs. EZH2 inhibition decreased H3K27me3 recruitment at target genes encoding TGF-beta 1 pseudoreceptor BAMBI, anti-inflammatory cytokine IL10 and cell cycle regulators CDKN1A, GADD45A and GADD45B, and increased their expressions, while Jmjd3 overexpression manifested alike effects.
   Conclusions: EZH2 and JMJD3 antagonistically modulate HSCs activation. The therapeutic effects of DZNep as epigenetic drug in liver fibrosis are associated with the regulation of EZH2 towards direct target genes encoding TGF-I31 pseudoreceptor BAMBI, anti-inflammatory cytokine IL10 and cell cycle regulators CDKN1A, GADD45A and GADD45B, which are also regulated by JMJD3. Our present study provides new mechanistic insight into the epigenetic modulation of EZH2 and JMJD3 in HSCs biology and hepatic fibrogenesis.
C1 [Jiang, Yan; Zhong, Fan; Zhang, Yang; He, Fuchu] Fudan Univ, Shanghai Peoples Hosp 5, Shanghai Key Lab Med Epigenet,Inst Biomed Sci,Sha, Minist Sci & Technol,Int Colab Med Epigenet & Met, Shanghai, Peoples R China.
   [Xiang, Chan; Wang, Liyan; Zhao, Yuanyuan; Wang, Haijian] Fudan Univ, Shanghai Pudong Hosp, Ctr Med Res & Innovat, Shanghai, Peoples R China.
   [Xiang, Chan; Wang, Liyan; Zhao, Yuanyuan; Wang, Haijian] Fudan Univ, Shanghai Med Coll, Pudong Med Ctr, Shanghai, Peoples R China.
   [Wang, Liyan; Zhao, Yuanyuan; Wang, Jiucun; Ding, Chen; Jin, Li; Wang, Haijian] Fudan Univ, State Key Lab Genet Engn, Shanghai, Peoples R China.
   [Wang, Liyan; Zhao, Yuanyuan; Wang, Jiucun; Ding, Chen; Jin, Li; Wang, Haijian] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Minist Educ, Key Lab Contemporary Anthropol, Shanghai, Peoples R China.
   [Wang, Liyan; Zhao, Yuanyuan; Wang, Jiucun; Ding, Chen; Jin, Li; Wang, Haijian] Fudan Univ, Dept Anthropol & Human Genet, Sch Life Sci, Shanghai, Peoples R China.
   [He, Fuchu] Beijing Inst Life, Natl Ctr Prot Sci, Beijing Prote Res Ctr, State Key Lab Prote, Beijing, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Fudan University;
   Fudan University; Fudan University
RP Wang, HJ (corresponding author), Fudan Univ, Shanghai Pudong Hosp, Shanghai, Peoples R China.; Wang, HJ (corresponding author), Fudan Univ, Sch Life Sci, Shanghai, Peoples R China.; He, FC (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.
EM hefc@nic.bmi.ac.cn; haijianwang@fudan.edu.cn
RI Wang, Jiucun/J-8744-2012; jin, li/IWU-4648-2023; LI,
   Wenhui/JCD-9947-2023; li, jian/IAQ-2794-2023; Li, Juan/JEO-6872-2023;
   yang, zhou/JKI-3744-2023
OI Jin, Li/0000-0001-9201-2321
FU National Key Research and Development Program of China [2018YFC0910701,
   2016YFC0901903]; National Natural Science Foundation of China [31970827,
   81572404, 31301050]
FX This work was supported by the National Key Research and Development
   Program of China (2018YFC0910701 and 2016YFC0901903) and the National
   Natural Science Foundation of China (31970827, 81572404 and 31301050).
CR Aravinthan A, 2014, CELL CYCLE, V13, P1489, DOI 10.4161/cc.28471
   Bae MA, 2010, ARCH PHARM RES, V33, P433, DOI 10.1007/s12272-010-0313-3
   Bergmann C, 2018, ANN RHEUM DIS, V77, P150, DOI 10.1136/annrheumdis-2017-211501
   Byun S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14384-z
   Chen X, 2020, THERANOSTICS, V10, P4851, DOI 10.7150/thno.42423
   Coward WR, 2018, AM J RESP CELL MOL, V58, P449, DOI 10.1165/rcmb.2017-0286OC
   Coward WR, 2014, FASEB J, V28, P3183, DOI 10.1096/fj.13-241760
   Cribbs A, 2018, J BIOL CHEM, V293, P2422, DOI 10.1074/jbc.RA117.000698
   Dong FY, 2019, EBIOMEDICINE, V39, P472, DOI 10.1016/j.ebiom.2018.11.055
   ELIAS JA, 1994, J IMMUNOL, V152, P2421
   Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Fujita T, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0005-6
   Guo PF, 2015, INFECT GENET EVOL, V30, P89, DOI 10.1016/j.meegid.2014.12.011
   Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716
   Hong L, 2016, WORLD J GASTROENTERO, V22, P2779, DOI 10.3748/wjg.v22.i9.2779
   Jiang Y, 2019, HUM GENE THER, V30, P179, DOI 10.1089/hum.2018.047
   Jiang Y, 2015, FASEB J, V29, P1830, DOI 10.1096/fj.14-251751
   Kattenhorn LM, 2016, HUM GENE THER, V27, P947, DOI 10.1089/hum.2016.160
   Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948
   Korthagen NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030442
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262
   Lai JY, 2019, BBA-MOL BASIS DIS, V1865, P2403, DOI 10.1016/j.bbadis.2019.05.008
   Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401
   Lindahl GE, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-80
   Liu C, 2014, J BIOL CHEM, V289, P7082, DOI 10.1074/jbc.M113.543769
   Long F, 2020, BIOCHEM BIOPH RES CO, V528, P671, DOI 10.1016/j.bbrc.2020.05.115
   Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621
   Lua I, 2016, J HEPATOL, V64, P1137, DOI 10.1016/j.jhep.2016.01.010
   Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002
   Martin-Mateos R, 2019, CELL MOL GASTROENTER, V7, P197, DOI 10.1016/j.jcmgh.2018.09.005
   McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049
   Mimura I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22180-5
   Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013
   Nelson DR, 2000, GASTROENTEROLOGY, V118, P655, DOI 10.1016/S0016-5085(00)70134-X
   Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794
   Park KC, 2014, BRIT J PHARMACOL, V171, P4820, DOI 10.1111/bph.12590
   Pediconi N, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1755-2
   Perugorria MJ, 2012, HEPATOLOGY, V56, P1129, DOI 10.1002/hep.25754
   Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062
   Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508
   Sha MQ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.383
   Song S, 2019, J MOL CELL CARDIOL, V135, P119, DOI 10.1016/j.yjmcc.2019.08.003
   Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026
   Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107
   Tanaka N, 2017, BBA-MOL BASIS DIS, V1863, P3170, DOI 10.1016/j.bbadis.2017.08.017
   Tao L, 2018, ARCH TOXICOL, V92, P2935, DOI 10.1007/s00204-018-2278-9
   Teratani T, 2012, GASTROENTEROLOGY, V142, P152, DOI 10.1053/j.gastro.2011.09.049
   Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620
   Thompson KC, 1998, HEPATOLOGY, V28, P1518, DOI 10.1002/hep.510280611
   Tsou PS, 2019, P NATL ACAD SCI USA, V116, P3695, DOI 10.1073/pnas.1813006116
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107
   Wang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03137-6
   Wight TN, 2017, MATRIX BIOL, V60-61, P38, DOI 10.1016/j.matbio.2016.12.001
   Wree A, 2018, HEPATOLOGY, V67, P736, DOI 10.1002/hep.29523
   Xiao X, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12915
   Yan JL, 2016, BLOOD, V128, P948, DOI 10.1182/blood-2016-01-690701
   Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304
   Zeybel M, 2017, MOL THER, V25, P218, DOI 10.1016/j.ymthe.2016.10.004
   Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893
   Zhang F, 2018, THERANOSTICS, V8, P610, DOI 10.7150/thno.22237
   Zhang K, 2019, THERANOSTICS, V9, P3622, DOI 10.7150/thno.32935
   Zhang XX, 2019, PROTEIN CELL, V10, P864, DOI 10.1007/s13238-019-0653-9
   Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006
   Zhao Y, 2019, EMBO J, V38, DOI 10.15252/embj.201899599
   Zheng JJ, 2015, FEBS J, V282, P4810, DOI 10.1111/febs.13544
   Zhou X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1012-0
   Zhou XX, 2018, FASEB J, V32, P5976, DOI 10.1096/fj.201800237R
   Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457
NR 75
TC 45
Z9 50
U1 3
U2 52
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2021
VL 11
IS 1
BP 361
EP 378
DI 10.7150/thno.46360
PG 18
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA OI0DJ
UT WOS:000582957500024
PM 33391480
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Yang, MK
   Kim, YG
AF Yang, MK
   Kim, YG
TI Protective role of germanium-132 against paraquat-induced oxidative
   stress in the livers of senescence-accelerated mice
SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A
LA English
DT Article
ID CELLS; MACROPHAGES; SUPPLEMENTS; SUPEROXIDE; COMPOUND; GE-132
AB The effects of the synthetic antioxidant germanium (Ge-132) were studied on liver oxidant damage induced by paraquat (PQ) in senescence-accelerated mice (SAM). PQ administered intravenously to SAM-P/8 (susceptible) or SAM-R/1 (resistant) mice increased liver DNA strand breakage and malondialdehyde (MDA) levels, indicators of oxidant damage. Ge-132 effectively blocked the PQ-induced effects on liver DNA strand breaks and MDA levels. In addition, Ge-132 significantly elevated the activities of hepatic superoxide dismutase (SOD) and catalase following PQ pretreatment. Histopathologically, Ge-132 inhibited PQ-induced hepatic mitochondrial injury in both strains, but more effectively in the susceptible strain. Data suggest that Ge-132 may be useful as an antioxidant in view of its ability to prevent PQ-induced hepatic oxidant injury.
C1 Chosun Univ, Coll Nat Sci, Dept Biol Sci, Dong Ku, Kwangju 501759, South Korea.
C3 Chosun University
RP Kim, YG (corresponding author), Chosun Univ, Coll Nat Sci, Dept Biol Sci, Dong Ku, 375 Seosuk Dong, Kwangju 501759, South Korea.
CR [Anonymous], 1989, MOL CLONING LAB MANU
   ARIMORI S, 1981, IMMUNOMODULATION MIC, P1
   ASO H, 1985, MICROBIOL IMMUNOL, V29, P65, DOI 10.1111/j.1348-0421.1985.tb00803.x
   BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BIRNBOIM HC, 1981, CANCER RES, V41, P1889
   Chen Y Q, 1992, Yao Xue Xue Bao, V27, P481
   Dusinská M, 1998, CARCINOGENESIS, V19, P809, DOI 10.1093/carcin/19.5.809
   FABISIAK JP, 1997, AM J PHYSIOL, V272, P6675
   HALIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501
   HARA S, 1990, Z NATURFORSCH C, V45, P1250
   HO CC, 1990, PHARMACOLOGY, V41, P286, DOI 10.1159/000138736
   Iijima M, 1990, No To Shinkei, V42, P851
   IKEMOTO K, 1996, EXPERIENTIA, V15, P159
   JAO SW, 1990, DIS COLON RECTUM, V33, P99, DOI 10.1007/BF02055535
   Kim YG, 1997, FREE RADICAL RES, V26, P1, DOI 10.3109/10715769709097779
   MCCORD JM, 1982, CAN J PHYSIOL PHARM, V60, P1346, DOI 10.1139/y82-201
   MCCORD JM, 1969, J BIOL CHEM, V244, P1024
   MING X, 1996, CHUNG HUA WAI KO TSA, V34, P221
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   Okawa H., 1979, ANAL BIOCHEM, V95, P351
   Park HY, 1998, J MICROBIOL, V36, P171
   Park Young Soon, 1993, Korean Biochemical Journal, V26, P184
   SUZUKI F, 1985, BRIT J CANCER, V52, P757, DOI 10.1038/bjc.1985.254
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tao SH, 1997, REGUL TOXICOL PHARM, V25, P211, DOI 10.1006/rtph.1997.1098
   TSUTSUI M, 1976, J AM CHEM SOC, V98, P8287, DOI 10.1021/ja00441a081
   VANDERSPOEL JI, 1990, LANCET, V336, P117, DOI 10.1016/0140-6736(90)91632-K
   XIN XH, 1996, CHUNG HUA YU FANG I, V30, P221
   Yokochi S, 1998, SCAND J IMMUNOL, V48, P183
NR 30
TC 22
Z9 25
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI LONDON
PA ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND
SN 0098-4108
J9 J TOXICOL ENV HEAL A
JI J. TOXICOL. ENV. HEALTH PT A
PD NOV 12
PY 1999
VL 58
IS 5
BP 289
EP 297
DI 10.1080/009841099157250
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 253HL
UT WOS:000083550900003
PM 10598954
DA 2024-02-19
ER

PT J
AU Lee, YN
   Wang, HH
   Su, CH
   Lee, HI
   Chou, YH
   Hsieh, CL
   Liu, WT
   Shu, KT
   Chang, KT
   Yeh, HI
   Wu, YJ
AF Lee, Yi-Nan
   Wang, Hsueh-Hsiao
   Su, Cheng-Huang
   Lee, Hsin-, I
   Chou, Yen-Hung
   Hsieh, Chin-Ling
   Liu, Wen-Ting
   Shu, Kuo-Tung
   Chang, Kai-Ting
   Yeh, Hung-, I
   Wu, Yih-Jer
TI Deferoxamine accelerates endothelial progenitor cell senescence and
   compromises angiogenesis
SO AGING-US
LA English
DT Article
DE senescence; deferoxamine; angiogenesis; endothelial progenitor cell
ID LIFE-SPAN; GROWTH ARREST; RISK-FACTORS; G1 PHASE; IRON; PROLIFERATION;
   DESFERRIOXAMINE; ACCUMULATION; ANTIOXIDANT; HEPATOCYTE
AB Senescence reduces the circulating number and angiogenic activity of endothelial progenitor cells (EPCs), and is associated with aging-related vascular diseases. However, it is very time-consuming to obtain aged cells ((similar to)1 month of repeated replication) or animals ((similar to)2 years) for senescence studies. Here, we established an accelerated senescence model by treating EPCs with deferoxamine (DFO), an FDA-approved iron chelator. Four days of low-dose (3 mu M) DFO induced senescent phenotypes in EPCs, including a senescent pattern of protein expression, impaired mitochondrial bioenergetics, altered mitochondrial protein levels and compromised angiogenic activity. DFO-treated early EPCs from young and old donors (35 vs. 70 years old) displayed similar senescent phenotypes, including elevated senescence-associated beta-galactosidase activity and reduced relative telomere lengths, colony-forming units and adenosine triphosphate levels. To validate this accelerated senescence model in vivo, we intraperitoneally injected Sprague-Dawley rats with DFO for 4 weeks. Early EPCs from DFO-treated rats displayed profoundly senescent phenotypes compared to those from control rats. Additionally, in hind-limb ischemic mice, DFO pretreatment compromised EPC angiogenesis by reducing both blood perfusion and capillary density. DFO thus accelerates EPC senescence and appears to hasten model development for cellular senescence studies.
C1 [Lee, Yi-Nan; Su, Cheng-Huang; Hsieh, Chin-Ling; Liu, Wen-Ting; Shu, Kuo-Tung; Chang, Kai-Ting; Yeh, Hung-, I; Wu, Yih-Jer] MacKay Mem Hosp, Cardiovasc Ctr, Dept Internal Med, Taipei 10449, Taiwan.
   [Lee, Yi-Nan; Su, Cheng-Huang; Hsieh, Chin-Ling; Liu, Wen-Ting; Shu, Kuo-Tung; Chang, Kai-Ting; Yeh, Hung-, I; Wu, Yih-Jer] MacKay Mem Hosp, Dept Med Res, Taipei 10449, Taiwan.
   [Wang, Hsueh-Hsiao; Su, Cheng-Huang; Lee, Hsin-, I; Chou, Yen-Hung; Yeh, Hung-, I; Wu, Yih-Jer] MacKay Med Coll, Dept Med, New Taipei 25245, Taiwan.
   [Chou, Yen-Hung; Wu, Yih-Jer] MacKay Med Coll, Inst Biomed Sci, New Taipei 25245, Taiwan.
C3 Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical
   College; Mackay Medical College
RP Wu, YJ (corresponding author), MacKay Mem Hosp, Cardiovasc Ctr, Dept Internal Med, Taipei 10449, Taiwan.; Wu, YJ (corresponding author), MacKay Mem Hosp, Dept Med Res, Taipei 10449, Taiwan.; Wu, YJ (corresponding author), MacKay Med Coll, Dept Med, New Taipei 25245, Taiwan.; Wu, YJ (corresponding author), MacKay Med Coll, Inst Biomed Sci, New Taipei 25245, Taiwan.
EM jacobyjwu@gmail.com
FU Ministry of Science and Technology of Taiwan [101-2314-B-715-001-MY2];
   Mackay Memorial Hospital [MMH-E-103-03]
FX This work was supported by grants from the Ministry of Science and
   Technology of Taiwan (101-2314-B-715-001-MY2) and Mackay Memorial
   Hospital (MMH-E-103-03) .
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Bajbouj K, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818764470
   BRODIE C, 1993, CANCER RES, V53, P3968
   Cañuelo A, 2012, MOL CELL BIOCHEM, V363, P101, DOI 10.1007/s11010-011-1162-1
   Chekanov VS, 2003, VASC MED, V8, P157, DOI 10.1191/1358863x03vm491oa
   Chekanov VS, 2003, ANN THORAC SURG, V75, P184, DOI 10.1016/S0003-4975(02)04122-X
   Chen CL, 2019, ONCOTARGETS THER, V12, P4359, DOI 10.2147/OTT.S193507
   Chenoufi N, 1998, LIVER, V18, P60
   Donneys A, 2013, BONE, V52, P318, DOI 10.1016/j.bone.2012.10.014
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Garcia V, 2020, P NATL ACAD SCI USA, V117, P9497, DOI 10.1073/pnas.1918761117
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARTLEY A, 1990, FEBS LETT, V264, P145, DOI 10.1016/0014-5793(90)80786-I
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Holden P, 2019, TISSUE ENG PART B-RE, V25, P461, DOI [10.1089/ten.TEB.2019.0111, 10.1089/ten.teb.2019.0111]
   Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009
   Imanishi T, 2004, CLIN EXP PHARMACOL P, V31, P407, DOI 10.1111/j.1440-1681.2004.04022.x
   Jie KE, 2009, ATHEROSCLEROSIS, V202, P345, DOI 10.1016/j.atherosclerosis.2008.05.012
   Kong LC, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-020-02074-y
   Li JY, 2011, ARTERIOSCL THROM VAS, V31, P2518, DOI 10.1161/ATVBAHA.111.235143
   LUCAS JJ, 1995, BLOOD, V86, P2268, DOI 10.1182/blood.V86.6.2268.bloodjournal8662268
   MARZABADI MR, 1988, MECH AGEING DEV, V46, P145, DOI 10.1016/0047-6374(88)90122-4
   Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837
   Min KS, 2015, BIOL PHARM BULL, V38, P1557, DOI 10.1248/bpb.b15-00341
   Mockett RJ, 2010, FREE RADICAL BIO MED, V49, P2028, DOI 10.1016/j.freeradbiomed.2010.09.029
   Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008
   Parvar M, 2014, CHINESE CHEM LETT, V25, P630, DOI 10.1016/j.cclet.2014.01.022
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Pourcelot E, 2015, BBA-MOL CELL RES, V1853, P1596, DOI 10.1016/j.bbamcr.2015.03.009
   Stiban J, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1066, DOI 10.1134/S0006297916100059
   Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93
   Uehara M, 1998, J NUTR SCI VITAMINOL, V44, P705, DOI 10.3177/jnsv.44.705
   Umemura T, 2008, AM J HYPERTENS, V21, P1203, DOI 10.1038/ajh.2008.278
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   Wang HH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63716-y
   Wang HH, 2019, ANGIOGENESIS, V22, P569, DOI 10.1007/s10456-019-09680-2
   Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007
   Xue FL, 2022, CELL TISSUE BANK, V23, P185, DOI 10.1007/s10561-021-09932-w
   Yoon G, 2002, BIOCHEM J, V366, P613, DOI 10.1042/BJ20011445
   Yoon YS, 2004, ANN NY ACAD SCI, V1011, P123, DOI 10.1196/annals.1293.013
   Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010
   Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816
NR 43
TC 3
Z9 4
U1 0
U2 3
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP 15
PY 2021
VL 13
IS 17
BP 21364
EP 21384
PG 21
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA WC6XE
UT WOS:000704398100009
PM 34508614
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Min, F
   Sun, HQ
   Wang, B
   Ahmad, N
   Guo, H
   Gao, HT
   Gao, YY
   Liu, X
   Li, HY
AF Min, Fei
   Sun, Hequn
   Wang, Bo
   Ahmad, Naveed
   Guo, Hao
   Gao, Hongtao
   Gao, Yanyan
   Liu, Xin
   Li, Haiyan
TI Hepatoprotective effects of hydroxysafflor yellow A in
   D-galactose-treated aging mice
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Hydroxysafflor yellow A; D-galactose; Oxidative stress; Replicative
   senescence; p16
ID CELL-CYCLE; INK4A-ARF LOCUS; PROTEINS; RB
AB Hydroxysafflor yellow A (HSYA) is an effective chemical component isolated from Chinese herb Carthamus tinctorius L. In present study, we aimed to evaluate the effects of HSYA on D-galactose- (D-gal-) induced aging in mice, and to elucidate the underlying mechanism. Male C57BL/6 mice were intraperitoneal injection of D-gal and HSYA for 8 weeks. The body weight gain, spleen and thymus coefficients were determined. Levels of super dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) in serum and liver were measured using commercial kits. Pathological changes and the SA-5-Gal activity in liver tissues were detected by hematoxylin and eosin and SA-5-Gal staining. The expression levels of p16, CDK4, CDK6 and phosphorylation levels of Retinoblastoma (Rb) were detected by immunohistochemistry and western blot analysis. mRNA levels of genes regulated by p16-Rb pathway were determined by quantitative real-time PCR. In vivo, HSYA improved the aging changes including body weight, organ index and antioxidant status such as activities of SOD, CAT, GSH-Px and MDA in D-gal treated aging mice. HSYA also dramatically attenuated pathologic changes of aging liver tissues induced by D-gal. Furthermore, HSYA significantly decreased the mRNA and protein level of cyclin-dependent kinase inhibitor p16, followed by increasing CDK4/6 protein expression and decreasing the phosphorylation of Retinoblastoma (pRb) which up-regulated the expression of downstream genes CCNE1, CCNA2, P107 and MCM4. Collectively, these data indicated that HSYA could ameliorate aging, especially hepatic replicative senescence resulting from D-gal, the mechanism could be associated with the suppression of p16-Rb pathway.
C1 [Min, Fei; Sun, Hequn; Wang, Bo; Ahmad, Naveed; Guo, Hao; Gao, Hongtao; Gao, Yanyan; Liu, Xin; Li, Haiyan] Jilin Agr Univ, Coll Life Sci, Engn Res Ctr, Chinese Minist Educ Bioreactor & Pharmaceut Dev, Changchun 130118, Peoples R China.
C3 Jilin Agricultural University
RP Liu, X; Li, HY (corresponding author), Jilin Agr Univ, Coll Life Sci, Engn Res Ctr, Chinese Minist Educ Bioreactor & Pharmaceut Dev, Changchun 130118, Peoples R China.
EM xinl111@163.com; hyli99@163.com
RI Ahmad, Naveed/ISV-0081-2023; Ahmad, Naveed/HJG-9755-2022; jiang,
   lei/IWE-1124-2023
OI Ahmad, Naveed/0000-0003-2038-2838; Ahmad, Naveed/0000-0003-2038-2838; 
FU Special Program for Research of Transgenic Plants [2016ZX08010-002];
   National Key Research and Development Program [2016YFD0101005]; Research
   foundation of Jilin Agricultural University [201710]
FX This research was supported by the Special Program for Research of
   Transgenic Plants (2016ZX08010-002), the National Key Research and
   Development Program (2016YFD0101005), and the Research foundation of
   Jilin Agricultural University (201710).
CR Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809
   Ahlemeyer B, 2003, CELL MOL LIFE SCI, V60, P1779, DOI 10.1007/s00018-003-3080-1
   Akçay NI, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015500079
   Ao H, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8259280
   Bai YH, 2012, MOLECULES, V17, P14918, DOI 10.3390/molecules171214918
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bastianetto S, 2002, NEUROBIOL AGING, V23, P891, DOI 10.1016/S0197-4580(02)00024-6
   Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507
   Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615
   Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077
   Giorgi C, 2018, INT REV CEL MOL BIO, V340, P209, DOI 10.1016/bs.ircmb.2018.05.006
   Jin KL, 2019, AGING DIS, V10, P676, DOI 10.14336/AD.2019.0315
   Jin KL, 2015, AGING DIS, V6, P1, DOI 10.14336/AD.2014.1210
   Jin M., 2018, CLUSTER COMPUT, P1
   Kong SZ, 2013, REJUV RES, V16, P404, DOI 10.1089/rej.2013.1433
   Li CY, 2015, J ETHNOPHARMACOL, V162, P225, DOI 10.1016/j.jep.2014.12.068
   Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002
   Maciejczyk M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4393460
   Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602
   Massagué J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094
   Premoli A, 2009, Minerva Gastroenterol Dietol, V55, P71
   Qian MX, 2018, ADV EXP MED BIOL, V1086, P235, DOI 10.1007/978-981-13-1117-8_15
   Ramagiri Sruthi, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P1, DOI 10.1515/jbcpp-2015-0021
   Reinheckel T, 1999, PHOTOCHEM PHOTOBIOL, V69, P566, DOI 10.1111/j.1751-1097.1999.tb03328.x
   Ruan QW, 2014, GERONTOLOGY, V60, P424, DOI 10.1159/000358235
   Sun KY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7108604
   TAUCHI H, 1994, ARCH GERONTOL GERIAT, V19, P135, DOI 10.1016/0167-4943(94)90035-3
   Xu RA, 2014, J ETHNOPHARMACOL, V151, P1141, DOI 10.1016/j.jep.2013.12.025
   Yu L, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00371
   Zhang JY, 2019, BIOMED PHARMACOTHER, V109, P806, DOI 10.1016/j.biopha.2018.09.086
   Zhao L, 2015, CELL DEATH DIFFER, V22, P1630, DOI 10.1038/cdd.2015.6
NR 36
TC 21
Z9 23
U1 3
U2 28
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD AUG 15
PY 2020
VL 881
AR 173214
DI 10.1016/j.ejphar.2020.173214
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA NI9ME
UT WOS:000565669000001
PM 32454116
DA 2024-02-19
ER

PT J
AU Inomata, K
   Tajima, K
   Yagi, H
   Higashi, H
   Shimoda, H
   Matsubara, K
   Hibi, T
   Abe, Y
   Tsujikawa, H
   Kitago, M
   Shinoda, M
   Obara, H
   Itano, O
   Soto-Gutierrez, A
   Kitagawa, Y
AF Inomata, Kenta
   Tajima, Kazuki
   Yagi, Hiroshi
   Higashi, Hisanobu
   Shimoda, Hirofumi
   Matsubara, Kentaro
   Hibi, Taizo
   Abe, Yuta
   Tsujikawa, Hanako
   Kitago, Minoru
   Shinoda, Masahiro
   Obara, Hideaki
   Itano, Osamu
   Soto-Gutierrez, Alejandro
   Kitagawa, Yuko
TI A Pre-Clinical Large Animal Model of Sustained Liver Injury and
   Regeneration Stimulus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FULMINANT HEPATIC-FAILURE; PARTIAL-HEPATECTOMY; HEPATOCYTE
   PROLIFERATION; PORCINE MODEL; PIG MODEL; RETRORSINE; CELLS;
   TRANSPLANTATION; RATS; SENESCENCE
AB A feasible large animal model to evaluate regenerative medicine techniques is vital for developing clinical applications. One such appropriate model could be to use retrorsine (RS) together with partial hepatectomy (PH). Here, we have developed the first porcine model using RS and PH. RS or saline control was administered intraperitoneally to Gottingen miniature pigs twice, two weeks apart. Four weeks after the second dose, animals underwent PH. Initially, we tested different doses of RS and resection of different amounts of liver, and selected 50 mg/kg RS with 60% hepatectomy as our model for further testing. Treated animals were sacrificed 3, 10, 17 or 28 days after PH. Blood samples and resected liver were collected. Serum and liver RS content was determined by Liquid Chromatograph-tandem Mass Spectrometer. Blood analyses demonstrated liver dysfunction after PH. Liver regeneration was significantly inhibited 10 and 17 days after PH in RS-treated animals, to the extent of 20%. Histological examination indicated hepatic injury and regenerative responses after PH. Immunohistochemical staining demonstrated accumulation of Cyclin D1 and suppression of Ki-67 and PCNA in RS-treated animals. We report the development of the first large animal model of sustained liver injury with suppression of hepatic regeneration.
C1 [Inomata, Kenta; Tajima, Kazuki; Yagi, Hiroshi; Higashi, Hisanobu; Shimoda, Hirofumi; Matsubara, Kentaro; Hibi, Taizo; Abe, Yuta; Kitago, Minoru; Shinoda, Masahiro; Obara, Hideaki; Itano, Osamu; Kitagawa, Yuko] Keio Univ, Dept Surg, Tokyo, Japan.
   [Tsujikawa, Hanako] Keio Univ, Dept Pathol, Tokyo, Japan.
   [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA.
C3 Keio University; Keio University; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh
RP Yagi, H (corresponding author), Keio Univ, Dept Surg, Tokyo, Japan.
EM h_yagi@a3.keio.jp
OI Tsujikawa, Hanako/0000-0002-6389-430X
FU Japan Agency for Medical Research and Development (AMED), Research
   Center Network for Realization of Regenerative Medicine Projects
FX This work was supported by Japan Agency for Medical Research and
   Development (AMED), Research Center Network for Realization of
   Regenerative Medicine Projects to H. Yagi and Y. Kitagawa. The authors
   wish to acknowledge Dr. Shingo Akimoto, Specially-Appointed Associate
   Professor, Keio University School of Medicine, for his technical help in
   performing the Western blotting for this study.
CR Arkadopoulos N, 2011, J SURG RES, V170, pE233, DOI 10.1016/j.jss.2011.06.006
   Assy N, 1998, J LAB CLIN MED, V131, P251, DOI 10.1016/S0022-2143(98)90097-X
   Benoist S, 2000, J SURG RES, V88, P63, DOI 10.1006/jsre.1999.5778
   Court FG, 2004, J SURG RES, V116, P181, DOI 10.1016/j.jss.2003.08.007
   Farantos C, 2008, EUR SURG RES, V40, P347, DOI 10.1159/000118031
   Fondevila C, 2010, LIVER TRANSPLANT, V16, P364, DOI 10.1002/lt.21989
   Gordon GJ, 2000, AM J PATHOL, V156, P607, DOI 10.1016/S0002-9440(10)64765-7
   Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135
   Hansel Marc C, 2016, Curr Protoc Toxicol, V67, DOI 10.1002/0471140856.tx1413s67
   Hayashi H, 2005, LIVER INT, V25, P162, DOI 10.1111/j.1478-3231.2005.01029.x
   Hickey RD, 2014, STEM CELL RES, V13, P144, DOI 10.1016/j.scr.2014.05.003
   Hickey RD, 2011, HEPATOLOGY, V54, P1351, DOI 10.1002/hep.24490
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hua Z, 2012, J ELECTRON MICROSC, V61, P179, DOI 10.1093/jmicro/dfs035
   Kalpana K, 1999, J SURG RES, V82, P121, DOI 10.1006/jsre.1998.5420
   Kelly DM, 2004, LIVER TRANSPLANT, V10, P253, DOI 10.1002/lt.20073
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   Lee KCL, 2013, LIVER INT, V33, P544, DOI 10.1111/liv.12042
   Matsubara K, 2015, PROTOC EXCH, DOI [10.1038/protex.2015.121, DOI 10.1038/PROTEX.2015.121]
   Mese H, 2000, CANCER CHEMOTH PHARM, V46, P241, DOI 10.1007/s002800000145
   MONNET D, 1985, J CLIN CHEM CLIN BIO, V23, P249
   Newsome PN, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-34
   Newsome PN, 2000, LIVER TRANSPLANT, V6, P21, DOI 10.1016/S1527-6465(00)80029-5
   OCHIAI A, 1994, BIOCHEM BIOPH RES CO, V205, P73, DOI 10.1006/bbrc.1994.2631
   OKAJIMA A, 1990, EUR J BIOCHEM, V193, P375, DOI 10.1111/j.1432-1033.1990.tb19349.x
   Pagano D, 2012, TRANSPL P, V44, P2029, DOI 10.1016/j.transproceed.2012.06.009
   Pitzalis S, 2005, J HEPATOL, V43, P485, DOI 10.1016/j.jhep.2005.03.029
   Rahman TM, 2000, INT J EXP PATHOL, V81, P145
   Serra MP, 2012, HEPATOLOGY, V56, P760, DOI 10.1002/hep.25698
   SIELAFF TD, 1995, HEPATOLOGY, V21, P796, DOI 10.1016/0270-9139(95)90534-0
   Spronk HMH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113979
   Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takayama K, 2014, P NATL ACAD SCI USA, V111, P16772, DOI 10.1073/pnas.1413481111
   Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029
   Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465
   Zentai C, 2014, J SURG RES, V187, P616, DOI 10.1016/j.jss.2013.11.007
   Zhang JJ, 2009, EUR SURG RES, V42, P35, DOI 10.1159/000167855
   Zhou XF, 2006, WORLD J GASTROENTERO, V12, P1439, DOI 10.3748/wjg.v12.i9.1439
NR 39
TC 8
Z9 8
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 9
PY 2018
VL 8
AR 14987
DI 10.1038/s41598-018-32889-y
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GW3LA
UT WOS:000446802600001
PM 30301901
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Gokarn, R
   Solon-Biet, SM
   Cogger, VC
   Cooney, GJ
   Wahl, D
   McMahon, AC
   Mitchell, JR
   Mitchell, SJ
   Hine, C
   de Cabo, R
   Raubenheimer, D
   Simpson, SJ
   Le Couteur, DG
AF Gokarn, Rahul
   Solon-Biet, Samantha M.
   Cogger, Victoria C.
   Cooney, Gregory J.
   Wahl, Devin
   McMahon, Aisling C.
   Mitchell, James R.
   Mitchell, Sarah J.
   Hine, Christopher
   de Cabo, Rafael
   Raubenheimer, David
   Simpson, Stephen J.
   Le Couteur, David G.
TI Long-term Dietary Macronutrients and Hepatic Gene Expression in Aging
   Mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Geometric Framework; Liver; Nutrition; Life span
ID CALORIC RESTRICTION; LIFE-SPAN; PROTEIN; HEALTH; METAANALYSIS;
   RESPONSES; SURVIVAL; BENEFITS; RODENTS; GROWTH
AB Nutrition influences both hepatic function and aging, but mechanisms are poorly understood. Here, the effects of lifelong, ad libitum-fed diets varying in macronutrients and energy on hepatic gene expression were studied. Gene expression was measured using Affymetrix mouse arrays in livers of 46 mice aged 15 months fed one of 25 diets varying in protein, carbohydrates, fat, and energy density from 3 weeks of age. Gene expression was almost entirely influenced by protein intake. Carbohydrate and fat intake had few effects on gene expression compared with protein. Pathways and processes associated with protein intake included those involved with mitochondrial function, metabolic signaling (PI3K-Akt, AMPK, mTOR) and metabolism of protein and amino acids. Protein intake had variable effects on genes associated with regulation of longevity and influenced by caloric restriction. Among the genes of interest with expression that were significantly associated with protein intake are Cth, Gls2, Igf1, and Nnmt, which were increased with higher protein intake, and Igf2bp2, Fgf21, Prkab2, and Mtor, which were increased with lower protein intake. Dietary protein has a powerful impact on hepatic gene expression in older mice, with some overlap with genes previously reported to be involved with regulation of longevity or caloric restriction.
C1 [Gokarn, Rahul; Solon-Biet, Samantha M.; Cogger, Victoria C.; Cooney, Gregory J.; Wahl, Devin; Raubenheimer, David; Simpson, Stephen J.; Le Couteur, David G.] Univ Sydney, Charles Perkins Ctr, Univ Pl, Sydney, NSW 2006, Australia.
   [Gokarn, Rahul; Solon-Biet, Samantha M.; Cogger, Victoria C.; Wahl, Devin; McMahon, Aisling C.; Le Couteur, David G.] Concord Hosp, Aging & Alzheimers Inst AAAI, Concord, NSW, Australia.
   [Gokarn, Rahul; Solon-Biet, Samantha M.; Cogger, Victoria C.; Wahl, Devin; McMahon, Aisling C.; Le Couteur, David G.] Concord Hosp, CERA, Concord, NSW, Australia.
   [Gokarn, Rahul; Solon-Biet, Samantha M.; Cogger, Victoria C.; Wahl, Devin; McMahon, Aisling C.; Le Couteur, David G.] Concord Hosp, ANZAC Res Inst, Concord, NSW, Australia.
   [Mitchell, James R.; Mitchell, Sarah J.; Hine, Christopher] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA.
   [de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
C3 University of Sydney; Concord Repatriation General Hospital; Concord
   Repatriation General Hospital; Concord Repatriation General Hospital;
   University of Sydney; ANZAC Research Institute; Harvard University;
   Harvard T.H. Chan School of Public Health; National Institutes of Health
   (NIH) - USA; NIH National Institute on Aging (NIA)
RP Le Couteur, DG (corresponding author), Univ Sydney, Charles Perkins Ctr, Univ Pl, Sydney, NSW 2006, Australia.
EM david.lecouteur@sydney.edu.au
RI Wahl, Devin/R-9621-2018; Ekanayake, Kanchana/P-8817-2016; de Cabo,
   Rafael Carlos/E-7996-2010; Research Institute, ANZAC/CAE-9030-2022;
   Solon-Biet, Samantha/R-6551-2017
OI Wahl, Devin/0000-0003-2794-0185; de Cabo, Rafael
   Carlos/0000-0003-2830-5693; Raubenheimer, David/0000-0001-9050-1447;
   Hine, Christopher/0000-0003-1926-7939; Simpson, Stephen
   J./0000-0003-0256-7687; Solon-Biet, Samantha/0000-0003-0608-958X
FU Australian National Health and Medical Research Council [571328,
   1084267, 1101913]; NHMRC Peter Doherty Biomedical Fellowship; Ageing and
   Alzheimers Institute; Sydney Medical School Foundation; National Health
   and Medical Research Council of Australia [1084267, 1101913] Funding
   Source: NHMRC
FX The study was supported by the Australian National Health and Medical
   Research Council (Project grants 571328, 1084267, and 1101913 to D.L.C.,
   S.J.S., D.R.), NHMRC Peter Doherty Biomedical Fellowship (SSB), the
   Ageing and Alzheimers Institute, and the Sydney Medical School
   Foundation.
CR Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188
   Caraballo SCG, 2017, BBA-MOL BASIS DIS, V1863, P1789, DOI 10.1016/j.bbadis.2017.04.022
   Derous D, 2017, AGING-US, V9, P1770, DOI 10.18632/aging.101269
   Díaz-Rúa R, 2017, J NUTR BIOCHEM, V46, P39, DOI 10.1016/j.jnutbio.2017.04.008
   Endo Y, 2002, J NUTR, V132, P3632, DOI 10.1093/jn/132.12.3632
   Gaddam RR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160521
   Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048
   Ingram DK, 2017, AGEING RES REV, V39, P15, DOI 10.1016/j.arr.2017.05.008
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Le Couteur DG, 2016, CELL MOL LIFE SCI, V73, P1237, DOI 10.1007/s00018-015-2120-y
   Le Couteur DG, 2012, J GERONTOL A-BIOL, V67, P168, DOI 10.1093/gerona/glr095
   Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91
   Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105
   MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Osada J, 2013, ISRN NUTR, V2013, DOI 10.5402/2013/403792
   Plank M, 2012, MOL BIOSYST, V8, P1339, DOI 10.1039/c2mb05255e
   Predmore BL, 2010, AGE, V32, P467, DOI 10.1007/s11357-010-9150-z
   Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047303
   Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x
   Simpson SJ, 2007, J GERONTOL A-BIOL, V62, P707, DOI 10.1093/gerona/62.7.707
   Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033
   Simpson SJ, 2014, NATURE, V508, pS66, DOI 10.1038/508S66a
   Solon-Biet SM, 2016, CELL METAB, V24, P555, DOI 10.1016/j.cmet.2016.09.001
   Solon-Biet SM, 2015, J ENDOCRINOL, V226, pR17, DOI 10.1530/JOE-15-0173
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Song SX, 2016, MOL NUTR FOOD RES, V60, P1199, DOI 10.1002/mnfr.201500789
   Speakman JR, 2016, EXP GERONTOL, V86, P28, DOI 10.1016/j.exger.2016.03.011
   Swindell WR, 2008, MECH AGEING DEV, V129, P138, DOI 10.1016/j.mad.2007.11.003
   Swindell WR, 2012, AGEING RES REV, V11, P254, DOI 10.1016/j.arr.2011.12.006
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Velázquez-Villegas LA, 2016, J NUTR, V146, P1634, DOI 10.3945/jn.116.232868
NR 36
TC 14
Z9 14
U1 2
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD DEC
PY 2018
VL 73
IS 12
BP 1618
EP 1625
DI 10.1093/gerona/gly065
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA HI8EF
UT WOS:000456687400006
PM 29688281
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Bello, RI
   Gómez-Díaz, C
   Burón, MI
   Navas, P
   Villalba, JM
AF Bello, Rosario I.
   Gomez-Diaz, Consuelo
   Buron, Maria I.
   Navas, Placido
   Villalba, Jose M.
TI Differential regulation of hepatic apoptotic pathways by dietary olive
   and sunflower oils in the aging rat
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; apoptosis; Bax; Bcl-2; cancer; caspases; dietary oil; liver;
   neutral sphingomyelinase
ID TERM CALORIC RESTRICTION; LIVER PLASMA-MEMBRANE; AGE-RELATED-CHANGES;
   DOUBLE-STRAND-BREAKS; COENZYME-Q; CELL-DEATH; FAT TYPE; CERAMIDE; MICE;
   SPHINGOMYELINASE
AB In this work we have studied how dietary fat affects aging-related changes in a number of factors that regulate rat hepatic apoptosis. Animals were fed lifelong with two experimental diets containing either virgin olive oil or sunflower oil as dietary fat. Caspases of the intrinsic and extrinsic pathways of apoptosis, Bcl-2 and Bax polypeptide levels, and plasma membrane neutral sphingomyelinase activity were determined at 6, 12, and 24 months of age. Caspase-8/10 activity (a marker of the extrinsic pathway) was not affected by either aging or dietary fat, but activities of both caspase-9 (a marker of the intrinsic pathway) and caspase-3 (an executioner caspase) were significantly depressed in liver from animals fed on a sunflower oil-based diet. These decreases were not observed in animals fed with a diet based on virgin olive oil, which also resulted in significantly lower Bcl-2/Bax ratios. On the other hand, in comparison with sunflower, dietary olive oil decreased oxidative stress in liver from aged rats, resulting in lower levels of membrane hydroperoxides and higher coenzyme Q levels in plasma membrane. Plasma membrane Mg2+-dependent neutral sphingomyelinase was strongly activated in aged rats fed on the sunflower oil diet, but no aging-related increase was observed in animals fed on the olive oil diet. Our results support that dietary oil can alter significantly the susceptibility of hepatocytes to different apoptotic stimuli by altering both pro- and anti-apoptotic mediators, which reinforces the importance of the diet in aging studies. Because virgin olive oil may increase susceptibility of hepatocytes to apoptosis induced through the intrinsic pathway under conditions of decreased oxidative stress, our results may have important implications to understand the potential beneficial effects of that edible oil against liver carcinogenesis during aging. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Cordoba, Fac Ciencias, Dept Biol Celular, Cordoba 14014, Spain.
   Univ Pablo Olavide, CSIC, CABD, Seville, Spain.
C3 Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas
   (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for
   Developmental Biology (CABD)
RP Villalba, JM (corresponding author), Univ Cordoba, Fac Ciencias, Dept Biol Celular, Cordoba 14014, Spain.
EM bclvimoj@uco.es
RI NAVAS, PLACIDO/R-5943-2019
OI NAVAS, PLACIDO/0000-0002-4115-7966; Villalba Montoro, Jose
   Manuel/0000-0001-8554-3802
CR ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294
   Arroyo A, 1998, PROTOPLASMA, V205, P107, DOI 10.1007/BF01279300
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Barroso MP, 1997, J BIOENERG BIOMEMBR, V29, P259, DOI 10.1023/A:1022462111175
   Bello RI, 2005, EXP GERONTOL, V40, P694, DOI 10.1016/j.exger.2005.07.003
   Bello RI, 2003, J BIOENERG BIOMEMBR, V35, P169, DOI 10.1023/A:1023702321148
   BURON MI, 1987, EPITHELIA, V1, P295
   Della Ragione F, 2000, BIOCHEM BIOPH RES CO, V278, P733, DOI 10.1006/bbrc.2000.3875
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Fabiani R, 2006, J NUTR, V136, P614, DOI 10.1093/jn/136.3.614
   GRASLKRAUPP B, 1994, P NATL ACAD SCI USA, V91, P9995, DOI 10.1073/pnas.91.21.9995
   Higami Y, 1997, AM J PATHOL, V151, P659
   Higami Y, 1996, MUTAT RES-FUND MOL M, V357, P225, DOI 10.1016/0027-5107(96)00127-3
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   JAMES SJ, 1994, CANCER RES, V54, P5508
   James WPT, 1998, EXP CLIN ENDOCR DIAB, V106, P1
   JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Liu B, 1997, SEMIN CELL DEV BIOL, V8, P311, DOI 10.1006/scdb.1997.0153
   López-Lluch G, 1999, BIOFACTORS, V9, P171, DOI 10.1002/biof.5520090212
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Martín SF, 2002, BIOCHEM BIOPH RES CO, V297, P581, DOI 10.1016/S0006-291X(02)02222-2
   Martín SF, 2001, J BIOENERG BIOMEMBR, V33, P143, DOI 10.1023/A:1010704715979
   Mataix J, 1998, FREE RADICAL BIO MED, V24, P511, DOI 10.1016/S0891-5849(97)00288-8
   Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184
   Miskin R, 2005, MECH AGEING DEV, V126, P255, DOI 10.1016/j.mad.2004.08.018
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   Navas P, 2004, METHOD ENZYMOL, V378, P200
   Navas P, 2002, FREE RADICAL RES, V36, P369, DOI 10.1080/10715760290021207
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Perez-Jimenez F, 2005, EUR J CLIN INVEST, V35, P421, DOI 10.1111/j.1365-2362.2005.01516.x
   PETKOVA DH, 1988, EXP GERONTOL, V23, P19, DOI 10.1016/0531-5565(88)90016-2
   Puertollano MA, 2004, CURR MICROBIOL, V48, P373, DOI 10.1007/s00284-003-4197-z
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Rodriguez I, 1996, J EXP MED, V183, P1031, DOI 10.1084/jem.183.3.1031
   SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719
   Selman C, 2003, EXP GERONTOL, V38, P897, DOI 10.1016/S0531-5565(03)00091-3
   Selman C, 2003, BIOGERONTOLOGY, V4, P141, DOI 10.1023/A:1024149923693
   STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Suh Y, 2002, MECH AGEING DEV, V123, P881, DOI 10.1016/S0047-6374(02)00025-8
   Tirosh O, 2003, EXP GERONTOL, V38, P955, DOI 10.1016/S0531-5565(03)00151-7
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0
   Warner HR, 1997, J AM GERIATR SOC, V45, P1140, DOI 10.1111/j.1532-5415.1997.tb05981.x
   Warner HR, 1997, CURR TOP CELL REGUL, V35, P107, DOI 10.1016/S0070-2137(97)80004-0
   Youssef JA, 2003, MECH AGEING DEV, V124, P333, DOI 10.1016/S0047-6374(02)00189-6
   Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X
   METHOD ENZYMOL
NR 54
TC 14
Z9 14
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD NOV
PY 2006
VL 41
IS 11
BP 1174
EP 1184
DI 10.1016/j.exger.2006.08.012
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 122IN
UT WOS:000243219500011
PM 17049786
DA 2024-02-19
ER

PT J
AU Tewari, D
   Józwik, A
   Lysek-Gladysinska, M
   Grzybek, W
   Adamus-Bialek, W
   Bicki, J
   Strzalkowska, N
   Kaminska, A
   Horbanczuk, OK
   Atanasov, AG
AF Tewari, Devesh
   Jozwik, Artur
   Lysek-Gladysinska, Malgorzata
   Grzybek, Weronika
   Adamus-Bialek, Wioletta
   Bicki, Jacek
   Strzalkowska, Nina
   Kaminska, Agnieszka
   Horbanczuk, Olaf K.
   Atanasov, Atanas G.
TI Fenugreek (<i>Trigonella foenum-graecum</i>L.) Seeds Dietary
   Supplementation Regulates Liver Antioxidant Defense Systems in Aging
   Mice
SO NUTRIENTS
LA English
DT Article
DE fenugreek; aging; liver; antioxidants; mice
ID OXIDATIVE STRESS; L.
AB Fenugreek seeds are widely used in Asia and other places of the world for their nutritive and medicinal properties. In Asia, fenugreek seeds are also recommended for geriatric populations. Here, we evaluated for the first time the effect of fenugreek seed feed supplementation on the liver antioxidant defense systems in aging mice. The study was conducted on 12-months aged mice which were given fenugreek seed dietary supplement. We evaluated the activities of various antioxidant defense enzymes such as superoxide dismutase (SOD), glutathione reductase (GR), and glutathione peroxidase (GPx), and also estimated the phenolics and free radical scavenging properties in mice liver upon fenugreek supplementation. The estimation of SOD, GPx, and GR activities in aged mice liver revealed a significant (p< 0.01) difference among all the liver enzymes. Overall, this study reveals that fenugreek seed dietary supplementation has a positive effect on the activities of the hepatic antioxidant defense enzymes in the aged mice.
C1 [Tewari, Devesh] Lovely Profess Univ, Sch Pharmaceut Sci, Dept Pharmacognosy, Phagwara 144411, Punjab, India.
   [Tewari, Devesh; Jozwik, Artur; Grzybek, Weronika; Strzalkowska, Nina; Atanasov, Atanas G.] Polish Acad Sci, Inst Genet & Anim Biotechnol, PL-05552 Magdalenka, Poland.
   [Lysek-Gladysinska, Malgorzata] Jan Kochanowski Univ, Inst Biol, Div Med Biol, Uniwersytecka 7, PL-25406 Kielce, Poland.
   [Adamus-Bialek, Wioletta; Bicki, Jacek] Jan Kochanowski Univ, Coll Med, Dept Surg Med, Lab Med Genet, Al IX Wiekow Kielc 19A, PL-25317 Kielce, Poland.
   [Kaminska, Agnieszka] Cardinal Stefan Wyszynski Univ, Coll Med, Fac Med, PL-01815 Warsaw, Poland.
   [Horbanczuk, Olaf K.] Warsaw Univ Life Sci WULS SGGW, Dept Tech & Food Prod Dev, 159c Nowoursynowska, PL-02776 Warsaw, Poland.
   [Atanasov, Atanas G.] Bulgarian Acad Sci, Inst Neurobiol, 23 Acad G Bonchev Str, BU-1113 Sofia, Bulgaria.
   [Atanasov, Atanas G.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria.
   [Atanasov, Atanas G.] Med Univ Vienna, Ludwig Boltzmann Inst Digital Hlth & Patient Safe, Spitalgasse 23, A-1090 Vienna, Austria.
C3 Lovely Professional University; Polish Academy of Sciences; Jan
   Kochanowski University; Jan Kochanowski University; Cardinal Stefan
   Wyszynski University in Warsaw; Warsaw University of Life Sciences;
   Bulgarian Academy of Sciences; University of Vienna; Medical University
   of Vienna
RP Józwik, A; Atanasov, AG (corresponding author), Polish Acad Sci, Inst Genet & Anim Biotechnol, PL-05552 Magdalenka, Poland.; Atanasov, AG (corresponding author), Bulgarian Acad Sci, Inst Neurobiol, 23 Acad G Bonchev Str, BU-1113 Sofia, Bulgaria.; Atanasov, AG (corresponding author), Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria.; Atanasov, AG (corresponding author), Med Univ Vienna, Ludwig Boltzmann Inst Digital Hlth & Patient Safe, Spitalgasse 23, A-1090 Vienna, Austria.
EM dtewari3@gmail.com; aa.jozwik@ighz.pl;
   malgorzata.lysek-gladysinska@ujk.edu.pl; w.grzybek@ighz.pl;
   wioletta.adamus-bialek@ujk.edu.pl; jacek.bicki@ujk.edu.pl;
   n.strzalkowska@ighz.pl; agnieszka.kaminska73@wp.pl;
   olaf_horbanczuk@sggw.pl; a.atanasov@ighz.pl
RI Jozwik, Artur/HJY-6775-2023; Atanasov, Atanas G./C-5535-2013;
   Adamus-Białek, Wioletta/AAQ-9631-2021; Tewari, Devesh/P-9954-2019;
   Kaminska, Agnieszka/HJG-6446-2022
OI Jozwik, Artur/0000-0001-5546-9891; Atanasov, Atanas
   G./0000-0003-2545-0967; Adamus-Białek, Wioletta/0000-0001-6129-0492;
   Tewari, Devesh/0000-0002-5125-3791; Kaminska,
   Agnieszka/0000-0001-6977-6411; Lysek-Gladysinska,
   Malgorzata/0000-0002-0327-3202; Bicki, Jacek/0000-0003-3031-0985;
   Horbanczuk, Olaf/0000-0002-1746-9134
FU Polish KNOW (Leading National Research Centre) Scientific Consortium
   "Healthy Animal-Safe Food," decision of Ministry of Science and Higher
   Education [05-1/KNOW2/2015]; European Union under the European Regional
   Development Fund [Homing/2017-4/41]
FX Devesh Tewari, Artur Jozwik and Atanas G. Atanasov acknowledge the
   support by the Polish KNOW (Leading National Research Centre) Scientific
   Consortium "Healthy Animal-Safe Food," decision of Ministry of Science
   and Higher Education No. 05-1/KNOW2/2015 and the European Union under
   the European Regional Development Fund (Homing/2017-4/41).
CR Abdel-Daim MM, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1309175
   Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331
   Asard H., 2003, VITAMIN C ITS FUNCTI
   Basch Ethan, 2003, Altern Med Rev, V8, P20
   Benayad Z, 2014, J FOOD COMPOS ANAL, V35, P21, DOI 10.1016/j.jfca.2014.04.002
   BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25
   Caetano Aline C., 2013, BMC Physiology, V13, P3, DOI 10.1186/1472-6793-13-3
   Colantoni A, 2001, J AM AGING ASSOC, V24, P51, DOI 10.1007/s11357-001-0007-3
   De la Fuente M, 2002, EUR J CLIN NUTR, V56, pS5, DOI 10.1038/sj.ejcn.1601476
   Delire B, 2017, AGING-US, V9, P112, DOI 10.18632/aging.101124
   Dixit P, 2005, PHYTOTHER RES, V19, P977, DOI 10.1002/ptr.1769
   Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028
   García-Ruiz C, 2018, HEPATOL COMMUN, V2, P1425, DOI 10.1002/hep4.1271
   Grizzi F, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-9
   Grover AK, 2016, NUTR J, V15, DOI 10.1186/s12937-015-0115-z
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   He YF, 2015, J LIQ CHROMATOGR R T, V38, P29, DOI 10.1080/10826076.2013.864981
   Heemels MT, 2010, NATURE, V464, P503, DOI 10.1038/464503a
   Junaidi O, 2007, CLIN GERIATR MED, V23, P889, DOI 10.1016/j.cger.2007.06.006
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   López-Alarcón C, 2013, ANAL CHIM ACTA, V763, P1, DOI 10.1016/j.aca.2012.11.051
   Luan GX, 2018, J AGR FOOD CHEM, V66, P3169, DOI 10.1021/acs.jafc.8b00179
   Luceri C, 2018, TOXICOL REP, V5, P141, DOI 10.1016/j.toxrep.2017.12.017
   Man SM, 2019, J FOOD QUALITY, DOI 10.1155/2019/8635806
   Moradi N., 2013, GLOB J MED PLANT RES, V1, P199
   Naidu MM, 2011, LWT-FOOD SCI TECHNOL, V44, P451, DOI 10.1016/j.lwt.2010.08.013
   Nelson ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14689
   Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027
   Pandey H, 2015, J FOOD SCI TECH MYS, V52, P1054, DOI 10.1007/s13197-013-1057-0
   Pibiri Monica, 2018, Aging (Albany NY), V10, P1801, DOI 10.18632/aging.101524
   Sánchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520
   Skerget M, 2005, FOOD CHEM, V89, P191, DOI 10.1016/j.foodchem.2004.02.025
   Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639
   Sowmya P, 1999, PLANT FOOD HUM NUTR, V53, P359, DOI 10.1023/A:1008021618733
   Srichamroen A, 2008, J CLIN BIOCHEM NUTR, V43, P167, DOI 10.3164/jcbn.2008060
   Srinivasan K, 2019, NONVITAMIN AND NONMINERAL NUTRITIONAL SUPPLEMENTS, P217, DOI 10.1016/B978-0-12-812491-8.00031-X
   Tauler P, 2002, PFLUG ARCH EUR J PHY, V443, P791, DOI 10.1007/s00424-001-0770-0
   Tavakoly R, 2018, EUR J INTEGR MED, V18, P13, DOI 10.1016/j.eujim.2018.01.005
   Tewari D., 2015, J Biol Act Prod from Nat, V5, P120, DOI [DOI 10.1080/22311866.2015.1044703, 10.1080/22311866.2015.1044703]
   Thirunavukkarasu V, 2003, PHYTOTHER RES, V17, P737, DOI 10.1002/ptr.1198
   Toda S., 2011, Chinese Medicine, V2, P29, DOI 10.4236/cm.2011.21005
   Venkata KCN, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600950
   Wani S. A., 2018, Journal of the Saudi Society of Agricultural Sciences, V17, P97, DOI 10.1016/j.jssas.2016.01.007
   Yuan FF, 2019, MOLECULES, V24, DOI 10.3390/molecules24193517
NR 44
TC 16
Z9 18
U1 5
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2020
VL 12
IS 9
AR 2552
DI 10.3390/nu12092552
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA OE1ID
UT WOS:000580292300001
PM 32846876
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Columbano, A
   Simbula, M
   Pibiri, M
   Perra, A
   Deidda, M
   Locker, J
   Pisanu, A
   Uccheddu, A
   Ledda-Columbano, GM
AF Columbano, A.
   Simbula, M.
   Pibiri, M.
   Perra, A.
   Deidda, M.
   Locker, J.
   Pisanu, A.
   Uccheddu, A.
   Ledda-Columbano, G. M.
TI Triiodothyronine stimulates hepatocyte proliferation in two models of
   impaired liver regeneration
SO CELL PROLIFERATION
LA English
DT Article
ID RAT-LIVER; CELL-PROLIFERATION; ALPHA; MICE; PROTEIN; AGE; DNA
AB Objectives: Liver regeneration is attenuated in old age and is substantially slower after 90% than after 70% partial hepatectomy (PH). We have previously demonstrated that the proliferative response to a primary mitogen is intact in aged mice, indicating that impaired liver regeneration is not due to loss of proliferative capacity. Here, we have investigated whether mitogenic effects of triiodothyronine (T3) could reverse the impaired regeneration of ageing or 90% hepatectomy, in the rat. Materials and methods: T3 (20 mu g/100 g body weight) was administered to 14-month-old rats subjected to 70% PH or to young rats subjected to 90% PH. Cell-proliferative capacity was determined by bromodeoxyuridine incorporation and microscopy and changes of cell cycle-related proteins were analysed by Western blot analysis. Results: Treatment of old intact rats with T3 increased cyclin D-1 expression that was followed by an enhanced proliferative response, the labelling index (LI), being 7.8% versus 1.3% of controls. T3 given before 70% PH stimulated regenerative response (LI was 10.8% versus 2.28%), and expression of cyclin D-1 and proliferating cell nuclear antigen (PCNA) 24 h after PH. Pre-treatment with T3 also improved the regenerative response of the liver after 90% hepatectomy (LI was 27.9% versus 14.2%). Conclusions: These findings show in principle that mitogen-induced hyperplasia could be applied to human therapy in patients with reduced regenerative capacity or massive loss of hepatocytes.
C1 [Columbano, A.] Dipartimento Tossicol, Sezione Oncol & Patol Mol, Oncol & Patol Mol Unit, I-09124 Cagliari, Italy.
   [Pisanu, A.; Uccheddu, A.] Univ Cagliari, Dept Surg, Cagliari, Italy.
   [Locker, J.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY USA.
C3 University of Cagliari; Yeshiva University; Albert Einstein College of
   Medicine
RP Columbano, A (corresponding author), Dipartimento Tossicol, Sezione Oncol & Patol Mol, Oncol & Patol Mol Unit, Via Porcell 4, I-09124 Cagliari, Italy.
EM columbano@unica.it
RI Columbano, Amedeo/C-7463-2011; simbula, michela/P-6171-2018
OI Columbano, Amedeo/0000-0002-6956-9030; simbula,
   michela/0000-0002-7473-5494; Locker, Joseph/0000-0002-4190-188X; PIBIRI,
   MONICA/0000-0002-9660-9616
FU NCI NIH HHS [R01 CA104292, R01-CA104292-01] Funding Source: Medline;
   Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom
CR AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Columbano A, 2003, CELL DEATH DIFFER, V10, pS19, DOI 10.1038/sj.cdd.4401113
   Columbano A, 1996, FASEB J, V10, P1118, DOI 10.1096/fasebj.10.10.8751714
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   GAUB J, 1984, HEPATOLOGY, V4, P902, DOI 10.1002/hep.1840040519
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Ledda-Columbano GM, 2000, AM J PATHOL, V156, P91, DOI 10.1016/S0002-9440(10)64709-8
   Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403
   Ledda-Columbano GM, 2000, CANCER RES, V60, P603
   Ledda-Columbano GM, 1998, ONCOGENE, V17, P1039, DOI 10.1038/sj.onc.1202018
   Malik R, 2005, AM J TRANSPLANT, V5, P1801, DOI 10.1111/j.1600-6143.2005.00949.x
   Malik R, 2003, HEPATOLOGY, V37, P79, DOI 10.1053/jhep.2003.50001
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com
   Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899
   Redaelli CA, 2002, WORLD J SURG, V26, P1126, DOI 10.1007/s00268-002-6321-9
   Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400
   Stocker E, 1971, Beitr Pathol, V144, P400
   Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441
   ZIEVE L, 1985, J LAB CLIN MED, V105, P331
NR 26
TC 27
Z9 36
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7722
EI 1365-2184
J9 CELL PROLIFERAT
JI Cell Prolif.
PD JUN
PY 2008
VL 41
IS 3
BP 521
EP 531
DI 10.1111/j.1365-2184.2008.00532.x
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 301SV
UT WOS:000255916800010
PM 18422700
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU MARTIN, G
   SEWELL, RB
   YEOMANS, ND
   MORGAN, DJ
   SMALLWOOD, RA
AF MARTIN, G
   SEWELL, RB
   YEOMANS, ND
   MORGAN, DJ
   SMALLWOOD, RA
TI HEPATIC KUPFFER CELL-FUNCTION - THE EFFICIENCY OF UPTAKE AND
   INTRACELLULAR DEGRADATION OF C-14-LABELED MITOCHONDRIA IS REDUCED IN
   AGED RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; LIVER; KUPFFER CELLS; PHAGOCYTOSIS
ID LIVER KUPFFER; HEPATOCYTES; ENDOCYTOSIS
AB Uptake from the circulation and subsequent intracellular degradation of foreign and potentially harmful substances are key functions of hepatic Kupffer cells. While ageing is generally associated with decreased clearance by the reticulo-endothelial system, the effect of ageing on specific Kupffer cell functions is poorly understood. This study measured the ability of Kupffer cells of isolated perfused rat livers from young and old rats to both phagocytose and subsequently degrade exogenous radiolabelled mitochondria. Using electron microscopy and stereological techniques it was determined that there was no change in the volume density of Kupffer cells between 2 and 24 months, implying that the size of the Kupffer cell population increased (along with the total liver size) with age. However, despite this increase size there was no parallel increase in the capacity of the liver to take up or degrade radiolabelled mitochondria, implying that, in aged rats; Kupffer cell uptake and intracellular degradation was less efficient.
C1 AUSTIN HOSP,DEPT MED,HEIDELBERG,VIC 3084,AUSTRALIA.
   WESTERN HOSP,DEPT MED,MELBOURNE,VIC,AUSTRALIA.
   VICTORIAN COLL PHARM,MELBOURNE,VIC,AUSTRALIA.
   HEIDELBERG REPATRIAT HOSP,DEPT MED,HEIDELBERG,VIC,AUSTRALIA.
C3 Austin Research Institute; Florey Institute of Neuroscience & Mental
   Health; Western Hospital; Florey Institute of Neuroscience & Mental
   Health
OI Yeomans, Neville/0000-0001-9870-832X
CR BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441
   BROUWER A, 1983, MECH AGEING DEV, V21, P205, DOI 10.1016/0047-6374(83)90042-8
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   Chalkley HW, 1943, J NATL CANCER I, V4, P47
   DAN C, 1985, EXP CELL RES, V158, P75, DOI 10.1016/0014-4827(85)90432-X
   DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251
   DELEEUW AM, 1983, HEPATOLOGY, V3, P497
   DICE JF, 1982, J BIOL CHEM, V257, P4624
   GLAUMANN H, 1981, LAB INVEST, V45, P479
   GLAUMANN H, 1975, LAB INVEST, V33, P262
   HEIDRICK ML, 1972, GERONTOLOGIST, V12, pA28
   HENDRIKS HFJ, 1987, MECH AGEING DEV, V41, P241, DOI 10.1016/0047-6374(87)90044-3
   HORAN MA, 1984, MECH AGEING DEV, V26, P165, DOI 10.1016/0047-6374(84)90091-5
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   JONES EA, 1985, SEMIN LIVER DIS, V5, P157, DOI 10.1055/s-2008-1063920
   KNOOK DL, 1980, BIOCHEM BIOPH RES CO, V96, P250, DOI 10.1016/0006-291X(80)91207-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NASHAT KH, 1985, J HEPATOL, V1, P153, DOI 10.1016/S0168-8278(85)80763-7
   SEWELL RB, 1988, GASTROENTEROLOGY, V95, P1088, DOI 10.1016/0016-5085(88)90187-4
   SIMPSON DP, 1975, J BIOL CHEM, V250, P8148
   SLEYSTER EC, 1980, MECH AGEING DEV, V14, P443, DOI 10.1016/0047-6374(80)90015-9
   VANDALEN DPP, 1982, SINUSOIDAL LIVER CEL, P271
   VANMANEN R, 1983, MECH AGEING DEV, V22, P159, DOI 10.1016/0047-6374(83)90109-4
   WILSON PD, 1982, GERONTOLOGY, V28, P32, DOI 10.1159/000212509
   WISSE E, 1974, J ULTRA MOL STRUCT R, V46, P393, DOI 10.1016/S0022-5320(74)90064-1
   WISSE E, 1974, J ULTRA MOL STRUCT R, V46, P499, DOI 10.1016/S0022-5320(74)90070-7
   WISSE E, 1972, J ULTRA MOL STRUCT R, V38, P528, DOI 10.1016/0022-5320(72)90089-5
NR 28
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAR
PY 1994
VL 73
IS 3
BP 157
EP 168
DI 10.1016/0047-6374(94)90048-5
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NH975
UT WOS:A1994NH97500001
PM 8057687
DA 2024-02-19
ER

PT J
AU Lew, LC
   Hor, YY
   Jaafar, MH
   Lau, ASY
   Lee, BK
   Chuah, LO
   Yap, KP
   Azlan, A
   Azzam, G
   Choi, SB
   Liong, MT
AF Lew, Lee-Ching
   Hor, Yan-Yan
   Jaafar, Mohamad-Hafis
   Lau, Amy-Sie-Yik
   Lee, Boon-Kiat
   Chuah, Li-Oon
   Yap, Kien-Pong
   Azlan, Azali
   Azzam, Ghows
   Choi, Sy-Bing
   Liong, Min-Tze
TI <i>Lactobacillus</i>Strains Alleviated Hyperlipidemia and Liver
   Steatosis in Aging Rats via Activation of AMPK
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE triglyceride; immune; AMPK; Lactobacillus; NAFLD; SCD1
ID COA DESATURASE; PROTEIN-KINASE; CHOLESTEROL; BIFIDOBACTERIA;
   TRIGLYCERIDES; INFLAMMATION; INHIBITION; EXPRESSION; RECEPTOR; WOMEN
AB In this study, we hypothesized that different strains ofLactobacilluscan alleviate hyperlipidemia and liver steatosis via activation of 5 ' adenosine monophosphate-activated protein kinase (AMPK), an enzyme that is involved in cellular energy homeostasis, in aged rats. Male rats were fed with a high-fat diet (HFD) and injected with D-galactose daily over 12 weeks to induce aging. Treatments included (n= 6) (i) normal diet (ND), (ii) HFD, (iii) HFD-statin (lovastatin 2 mg/kg/day), (iv) HFD-Lactobacillus fermentumDR9 (10 log CFU/day), (v) HFD-Lactobacillus plantarumDR7 (10 log CFU/day), and (vi) HFD-Lactobacillus reuteri8513d (10 log CFU/day). Rats administered with statin, DR9, and 8513d reduced serum total cholesterol levels after eight weeks (p< 0.05), while the administration of DR7 reduced serum triglycerides level after 12 weeks (p< 0.05) as compared to the HFD control. A more prominent effect was observed from the administration of DR7, where positive effects were observed, ranging from hepatic gene expressions to liver histology as compared to the control (p< 0.05); downregulation of hepatic lipid synthesis and beta-oxidation gene stearoyl-CoA desaturase 1 (SCD1), upregulation of hepatic sterol excretion genes of ATP-binding cassette subfamily G member 5 and 8 (ABCG5andABCG8), lesser degree of liver steatosis, and upregulation of hepatic energy metabolisms genesAMPK alpha 1andAMPK alpha 2. Taken altogether, this study illustrated that the administration of selectedLactobacillusstrains led to improved lipid profiles via activation of energy and lipid metabolisms, suggesting the potentials ofLactobacillusas a promising natural intervention for alleviation of cardiovascular and liver diseases.
C1 [Lew, Lee-Ching; Hor, Yan-Yan; Jaafar, Mohamad-Hafis; Lau, Amy-Sie-Yik; Lee, Boon-Kiat; Chuah, Li-Oon; Liong, Min-Tze] Univ Sains Malaysia, Sch Ind Technol, George Town 11800, Malaysia.
   [Lew, Lee-Ching; Hor, Yan-Yan; Jaafar, Mohamad-Hafis; Azzam, Ghows; Liong, Min-Tze] Univ Sains Malaysia, USM RIKEN Int Ctr Ageing Sci URICAS, George Town 11800, Malaysia.
   [Yap, Kien-Pong] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.
   [Azlan, Azali; Azzam, Ghows] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia.
   [Choi, Sy-Bing] Perdana Univ, Sch Data Sci, MARDI Complex, Serdang 43400, Selangor, Malaysia.
C3 Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Malaya;
   Universiti Sains Malaysia; Perdana University
RP Liong, MT (corresponding author), Univ Sains Malaysia, Sch Ind Technol, George Town 11800, Malaysia.; Liong, MT (corresponding author), Univ Sains Malaysia, USM RIKEN Int Ctr Ageing Sci URICAS, George Town 11800, Malaysia.; Choi, SB (corresponding author), Perdana Univ, Sch Data Sci, MARDI Complex, Serdang 43400, Selangor, Malaysia.
EM leechinglew719@gmail.com; yyhor877@gmail.com; jaafarhafis2733@gmail.com;
   sieyikamy226@gmail.com; boonkiatlee92@gmail.com; lioonchuah88@gmail.com;
   kianpengyap88@gmail.com; azaliazlan89@gmail.com; azzamghows85@gmail.com;
   sybing.choi@perdanauniversity.edu.my; mintze.liong@usm.my
RI YAP, KIEN-PONG/G-3002-2014; Choi, Sy Bing/AGZ-6475-2022; Liong,
   Min-Tze/GVT-7267-2022; Hor, YY/ACW-4325-2022
OI Liong, Min-Tze/0000-0002-4471-8271; Choi, Sy Bing/0000-0003-3189-904X
FU URICAS grant [1001/PTEKIND/870030]; MyBrain Scholarship by Ministry of
   Higher Education Malaysia; Clinical Nutrition Intl (M) Sdn. Bhd.
FX This work was supported by the URICAS grant [1001/PTEKIND/870030]; and
   the MyBrain Scholarship provided by Ministry of Higher Education
   Malaysia; and funding by Clinical Nutrition Intl (M) Sdn. Bhd.
CR Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200
   Ben Salah R, 2013, ANAEROBE, V23, P55, DOI 10.1016/j.anaerobe.2013.07.003
   Bendali F, 2017, BENEF MICROBES, V8, P271, DOI 10.3920/BM2016.0121
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chen SCC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04631-7
   Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101
   Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19
   ENOCH HG, 1976, J BIOL CHEM, V251, P5095
   Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799
   Foretz M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092826
   Frisdal E, 2011, J BIOL CHEM, V286, P30926, DOI 10.1074/jbc.M111.264325
   Fung WY, 2010, LWT-FOOD SCI TECHNOL, V43, P563, DOI 10.1016/j.lwt.2009.10.004
   Ganesan LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20646
   Gierens H, 2000, ARTERIOSCL THROM VAS, V20, P1777, DOI 10.1161/01.ATV.20.7.1777
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879
   Hong YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154302
   Hor YY, 2014, DERMATOL SIN, V32, P141, DOI 10.1016/j.dsi.2014.03.001
   Hu X, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-67
   Ji MS, 2017, EXP THER MED, V14, P5881, DOI 10.3892/etm.2017.5327
   Kim E, 2011, EUR J PHARMACOL, V672, P38, DOI 10.1016/j.ejphar.2011.09.172
   Lee MS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1031-2
   Lew LC, 2018, KOREAN J FOOD SCI AN, V38, P350, DOI 10.5851/kosfa.2018.38.2.350
   Lian ZQ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-67
   Lye HS, 2017, J BIOTECHNOL, V262, P75, DOI 10.1016/j.jbiotec.2017.09.007
   Lye HS, 2010, INT DAIRY J, V20, P169, DOI 10.1016/j.idairyj.2009.10.003
   Matsushita Makoto, 2015, Rinsho Byori, V63, P543
   McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926
   Michael DR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02889-5
   Michael DR, 2016, BENEF MICROBES, V7, P443, DOI 10.3920/BM2015.0146
   Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200
   Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003
   Njoku DB, 2010, EXPERT OPIN DRUG MET, V6, P519, DOI 10.1517/17425251003601979
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Oliveira MC, 2013, OBESITY, V21, pE396, DOI [10.1002/oby.20230, 10.1038/oby.20230]
   Rerksuppaphol S, 2015, J CLIN DIAGN RES, V9, pKC01, DOI 10.7860/JCDR/2015/11867.5728
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Seki R., 2017, BIOMED RES CLIN PRAC, V2, P1, DOI [10.15761/BRCP.1000141, DOI 10.15761/BRCP.1000141]
   Singh Shiv Vardan, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P121, DOI 10.1515/jbcpp-2015-0017
   Storey BC, 2018, KIDNEY INT, V93, P1000, DOI [10.1016/j.kint.2017.09.011, 10.1016/j.kint.2017.11.020]
   Tham CSC, 2012, ANN MICROBIOL, V62, P1079, DOI 10.1007/s13213-011-0349-8
   Tomizawa M, 2014, BIOMED REP, V2, P633, DOI [10.3892/br.2014.309, 10.3892/br.2015.487]
   Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05
   Trapani Laura, 2010, Curr Gerontol Geriatr Res, P420139, DOI 10.1155/2010/420139
   van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738
   Voloshyna I, 2011, PROG LIPID RES, V50, P213, DOI 10.1016/j.plipres.2011.02.001
   Wadhera RK, 2016, J CLIN LIPIDOL, V10, P472, DOI 10.1016/j.jacl.2015.11.010
   Wu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178868
   Xie N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-53
   Yoon HS, 2011, PROBIOTICS ANTIMICRO, V3, P194, DOI 10.1007/s12602-011-9086-3
   Zavisic G, 2012, BRAZ J MICROBIOL, V43, P418, DOI [10.1590/S1517-83822012000100050, 10.1590/S1517-838220120001000050]
   Zhou YJ, 2017, EXPERT REV GASTROENT, V11, P269, DOI 10.1080/17474124.2017.1283984
NR 53
TC 21
Z9 21
U1 2
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2020
VL 21
IS 16
AR 5872
DI 10.3390/ijms21165872
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA NI0TJ
UT WOS:000565071500001
PM 32824277
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bayram, B
   Nikolai, S
   Huebbe, P
   Ozcelik, B
   Grimm, S
   Grune, T
   Frank, J
   Rimbach, G
AF Bayram, Banu
   Nikolai, Sibylle
   Huebbe, Patricia
   Ozcelik, Beraat
   Grimm, Stefanie
   Grune, Tilman
   Frank, Jan
   Rimbach, Gerald
TI Biomarkers of oxidative stress, antioxidant defence and inflammation are
   altered in the senescence-accelerated mouse prone 8
SO AGE
LA English
DT Article
DE SAMP8; Accelerated ageing; Stress response; Proteasomal activity;
   Ascorbic acid; Tocopherol
ID VITAMIN-E; ALPHA-TOCOPHEROL; HUMAN LONGEVITY; BRAIN; LIVER; MICE;
   PEROXIDATION; MELATONIN; GENE; AGE
AB In this study we compared biomarkers of oxidative stress, stress response, antioxidant defence and inflammation between mice (n = 10 per group, female, 7 months old) with an accelerated (SAMP8) and a normal ageing phenotype (SAMR1). As compared to SAMR1 mice, SAMP8 mice exhibited higher levels of lipid peroxides and protein carbonyls as well as a lower activity of the proteasomal subunit beta-5. Furthermore, heme oxygenase-1 and paraoxonase-1 (PON-1) status was lower in SAMP8 mice indicating impaired stress response. Biomarkers of inflammation such as C-reactive protein and serum amyloid P were elevated in SAMP8 mice. Interestingly, impaired stress response and increased inflammation in SAMP8 mice were associated with elevated concentrations of ascorbic acid and alpha-tocopherol in the liver. An age-dependent increase in hepatic vitamin E and a decline in PON-1 gene expression were also observed in aged compared to young C57BL/6 mice.
C1 [Bayram, Banu; Nikolai, Sibylle; Huebbe, Patricia; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, D-24098 Kiel, Germany.
   [Bayram, Banu; Ozcelik, Beraat] Istanbul Tech Univ, Dept Food Engn, TR-34469 Istanbul, Turkey.
   [Grimm, Stefanie; Grune, Tilman] Univ Jena, Dept Nutr Toxicol, Inst Nutr, D-07743 Jena, Germany.
   [Frank, Jan] Univ Hohenheim, Inst Biol Chem & Nutr, D-70599 Stuttgart, Germany.
C3 University of Kiel; Istanbul Technical University; Friedrich Schiller
   University of Jena; University Hohenheim
RP Rimbach, G (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Hermann Rodewald Str 6, D-24098 Kiel, Germany.
EM rimbach@foodsci.uni-kiel.de
RI Rimbach, Gerald/A-7178-2011; Ozcelik, Beraat/E-8446-2010; Frank,
   Jan/A-1763-2009; Bayram, Banu/HJI-7100-2023
OI Ozcelik, Beraat/0000-0002-1810-8154; Frank, Jan/0000-0002-7548-5829;
   Rimbach, Gerald/0000-0001-7888-4684; Grune, Tilman/0000-0003-4775-9973
FU TUBITAK (The Scientific and Technological Research Council of Turkey);
   German Research Foundation (DFG) [FR 2478/4-1]; German Federal Ministry
   of Education and Research (BMBF) [0315679A]; DFG Cluster of Excellence
   "Inflammation at Interfaces"
FX BB is supported by TUBITAK (The Scientific and Technological Research
   Council of Turkey). JF is supported by grant no. FR 2478/4-1 from the
   German Research Foundation (DFG) and grant no. 0315679A from the German
   Federal Ministry of Education and Research (BMBF). GR is supported by
   the BMBF and the DFG Cluster of Excellence "Inflammation at Interfaces".
CR Alvarez-García O, 2006, BIOGERONTOLOGY, V7, P43, DOI 10.1007/s10522-005-6041-2
   Amano A, 2010, ARCH BIOCHEM BIOPHYS, V496, P38, DOI 10.1016/j.abb.2010.01.012
   Azzi A, 2003, MOL ASPECTS MED, V24, P325, DOI 10.1016/S0098-2997(03)00028-1
   Breusing N, 2009, MECH AGEING DEV, V130, P748, DOI 10.1016/j.mad.2009.09.004
   Brigelius-Flohé R, 2004, ANN NY ACAD SCI, V1031, P40, DOI 10.1196/annals.1331.004
   Brigelius-Flohé R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145
   BURTON GW, 1982, LANCET, V2, P327
   Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4
   Caliebe A, 2010, AGEING RES REV, V9, P238, DOI 10.1016/j.arr.2010.03.003
   Carretero M, 2009, J PINEAL RES, V47, P192, DOI 10.1111/j.1600-079X.2009.00700.x
   CHATTERJEE I, 1961, NATURE, V192, P163, DOI 10.1038/192163a0
   Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   CONSTANTINESCU A, 1993, J BIOL CHEM, V268, P10906
   Cuesta S, 2013, AGE, V35, P659, DOI 10.1007/s11357-012-9397-7
   Cuesta S, 2010, EXP GERONTOL, V45, P950, DOI 10.1016/j.exger.2010.08.016
   Dullaart RPF, 2009, CLIN ENDOCRINOL, V70, P221, DOI 10.1111/j.1365-2265.2008.03306.x
   Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103
   Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x
   Fenton M, 2004, EXP GERONTOL, V39, P115, DOI 10.1016/j.exger.2003.10.004
   Forman K, 2010, J PINEAL RES, V49, P312, DOI 10.1111/j.1600-079X.2010.00800.x
   Frank J, 2006, J LIPID RES, V47, P2718, DOI 10.1194/jlr.M600291-JLR200
   Fuhrman B, 2006, NUTRITION, V22, P922, DOI 10.1016/j.nut.2006.04.012
   Gaedicke S, 2008, FEBS LETT, V582, P3542, DOI 10.1016/j.febslet.2008.09.032
   Gong YS, 2008, BEHAV BRAIN RES, V194, P100, DOI 10.1016/j.bbr.2008.06.029
   Han SN, 2004, ANN NY ACAD SCI, V1031, P96, DOI 10.1196/annals.1331.010
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Idriss NK, 2008, J AM COLL CARDIOL, V52, P971, DOI 10.1016/j.jacc.2008.06.019
   Jula A, 2002, JAMA-J AM MED ASSOC, V287, P598, DOI 10.1001/jama.287.5.598
   Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162
   Kunes JP, 2009, NUTR RES, V29, P114, DOI 10.1016/j.nutres.2009.01.003
   Liu YS, 2008, MOL CELL PROTEOMICS, V7, P1737, DOI 10.1074/mcp.M800109-MCP200
   Mármol F, 2010, PHYSIOL RES, V59, P553, DOI 10.33549/physiolres.931768
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   MOREL DW, 1983, J LIPID RES, V24, P1070
   Muller PY, 2005, J PLANT PHYSIOL, V162, P811, DOI 10.1016/j.jplph.2005.04.015
   Packer L, 2001, J NUTR, V131, p369S, DOI 10.1093/jn/131.2.369S
   Petursdottir AL, 2007, NEUROBIOL AGING, V28, P1170, DOI 10.1016/j.neurobiolaging.2006.05.033
   Radák Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje
   Rebrin I, 2005, FREE RADICAL BIO MED, V39, P549, DOI 10.1016/j.freeradbiomed.2005.04.008
   Rimbach G, 2002, P NUTR SOC, V61, P415, DOI 10.1079/PNS2002183
   Rimbach G, 2010, MOLECULES, V15, P1746, DOI 10.3390/molecules15031746
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   Sato E, 1996, MECH AGEING DEV, V86, P105, DOI 10.1016/0047-6374(95)01681-3
   Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102
   Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7
   SCARPA M, 1984, BIOCHIM BIOPHYS ACTA, V801, P215, DOI 10.1016/0304-4165(84)90070-9
   Schiborr C, 2010, CURR PHARM BIOTECHNO, V11, P861, DOI 10.2174/138920110793262006
   Schrader C, 2011, CURR MED CHEM, V18, P5624, DOI 10.2174/092986711798347216
   Sun LY, 2011, FASEB J, V25, P398, DOI 10.1096/fj.10-164376
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   Tan QH, 2006, GENETICS, V172, P1821, DOI 10.1534/genetics.105.050914
   Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3
   Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017
   Tsakiris S, 2009, EUR J CLIN NUTR, V63, P215, DOI 10.1038/sj.ejcn.1602918
   Wagner AE, 2010, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-1
   Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931
   Yuan M, 2005, REPROD FERT DEVELOP, V17, P507, DOI 10.1071/RD04099
NR 58
TC 20
Z9 20
U1 0
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD AUG
PY 2013
VL 35
IS 4
BP 1205
EP 1217
DI 10.1007/s11357-012-9448-0
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 179UQ
UT WOS:000321547300015
PM 22767392
OA Green Published
DA 2024-02-19
ER

PT J
AU Zhang, YKJ
   Saupe, KW
   Klaassen, CD
AF Zhang, Yu-Kun Jennifer
   Saupe, Kurt W.
   Klaassen, Curtis D.
TI Energy Restriction Does Not Compensate for the Reduced Expression of
   Hepatic Drug-Processing Genes in Mice with Aging
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID MICROSOMAL-ENZYME INDUCERS; CONSTITUTIVE ANDROSTANE RECEPTOR; CALORIC
   RESTRICTION; METABOLIZING ENZYMES; TISSUE DISTRIBUTION; NUCLEAR
   RECEPTORS; SULFOTRANSFERASE ENZYMES; DIETARY RESTRICTION;
   ACTIVATED-RECEPTOR; FISCHER-344 RAT
AB Liver is the major organ that eliminates xenobiotics from the body, a process that is accomplished by a series of drug-processing genes (DPGs). These genes encode transporters on both basolateral and apical membranes of hepatocytes, as well as phase I and II enzymes. The current study compares the expression of hepatic DPGs in adult and aged mouse livers and explores the potential effects of energy restriction (ER) on these genes during aging. Of 79 quantified hepatic DPGs, 52 were expressed lower in 24-monthold aged mice than in 12-month-old adult mice. Furthermore, the mRNA expression of multiple xenobiotic-activated transcription factors also decreased with age. Six-month ER exerted less of an effect on the hepatic DPGs than did aging. ER increased the mRNAs of two and decreased the mRNAs of nine DPGs in adult mice. In aged mice, ER increased the mRNAs of 10 and decreased the mRNAs of 5 DPGs. The only mRNA that was increased by both ER and aging was Gstm3. ER increased the mRNAs of Cyp2b10, Ugt1a9, Gsta1, and Oatp1a4 only in adult mice and decreased the mRNAs of Aldh6a1, Pon3, Ugt1a1, Sult1a1, and Atp8b1 only in aged mice. In summary, the reduced mRNA expression of hepatic DPGs in aged mice indicates decreased drug-processing capability, whereas ER did not compensate for the global reduction of hepatic DPG expression in aged mice. The hepatic transcription factors are likely to mediate the changes in hepatic DPG expression during aging and ER.
C1 [Zhang, Yu-Kun Jennifer; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.
   [Saupe, Kurt W.] Univ Wisconsin, Dept Med, Madison, WI USA.
   [Saupe, Kurt W.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA.
C3 University of Kansas; University of Kansas Medical Center; University of
   Wisconsin System; University of Wisconsin Madison; University of
   Wisconsin System; University of Wisconsin Madison
RP Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.
EM cklaasse@kumc.edu
FU National Institutes of Health National Institute of Diabetes and
   Digestive and Kidney Diseases [DK-081461]; National Institutes of Health
   National Institute of Environmental Health Sciences [ES-009716,
   ES-009649, ES-013714]; National Institutes of Health National Center for
   Research Resources [RR-021940]; National Institutes of Health National
   Institute on Aging [AG-00908]; University of Wisconsin Comprehensive
   Cancer Center
FX This work was supported in part by the National Institutes of Health
   National Institute of Diabetes and Digestive and Kidney Diseases [Grant
   DK-081461]; National Institutes of Health National Institute of
   Environmental Health Sciences [Grants ES-009716, ES-009649, ES-013714];
   National Institutes of Health National Center for Research Resources
   [Grant RR-021940]; National Institutes of Health National Institute on
   Aging [Grant AG-00908]; and the University of Wisconsin Comprehensive
   Cancer Center.
CR Agrawal AK, 2003, DRUG METAB DISPOS, V31, P612, DOI 10.1124/dmd.31.5.612
   Alnouti Y, 2006, DRUG METAB DISPOS, V34, P477, DOI 10.1121/dmd.105.006932
   Alnouti Y, 2008, J PHARMACOL EXP THER, V324, P612, DOI 10.1124/jpet.107.129650
   Alnouti Y, 2008, TOXICOL SCI, V101, P51, DOI 10.1093/toxsci/kfm280
   Alnouti Y, 2006, TOXICOL SCI, V93, P242, DOI 10.1093/toxsci/kfl050
   Anderson Rozalyn M., 2007, V35, P18
   Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476
   Assem M, 2004, J BIOL CHEM, V279, P22250, DOI 10.1074/jbc.M314111200
   Barbier O, 2004, TRENDS ENDOCRIN MET, V15, P324, DOI 10.1016/j.tem.2004.07.007
   Brtko Julius, 2007, Biomedical Papers (Olomouc), V151, P187
   Buckley DB, 2007, DRUG METAB DISPOS, V35, P121, DOI 10.1124/dmd.106.012070
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Cheng XG, 2005, DRUG METAB DISPOS, V33, P1276, DOI 10.1124/dmd.105.003988
   Cheng XG, 2009, DRUG METAB DISPOS, V37, P2178, DOI 10.1124/dmd.109.027177
   Chiang JYL, 2009, EXPERT OPIN DRUG MET, V5, P137, DOI [10.1517/17425250802707342, 10.1517/17425250802707342 ]
   Colman RJ, 2007, J NUTR, V137, P2247, DOI 10.1093/jn/137.10.2247
   Corton JC, 2004, J BIOL CHEM, V279, P46204, DOI 10.1074/jbc.M406739200
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Howroyd P, 2004, TOXICOL PATHOL, V32, P591, DOI 10.1080/01926230490515283
   HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Klaassen CD, 2005, CURR DRUG METAB, V6, P309, DOI 10.2174/1389200054633826
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Kodama S, 2006, DRUG METAB REV, V38, P75, DOI 10.1080/03602530600569851
   Kusuhara H, 2009, DRUG METAB PHARMACOK, V24, P37, DOI 10.2133/dmpk.24.37
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200
   Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200
   Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229
   Ramaiah SK, 2001, DRUG METAB DISPOS, V29, P1088
   Ramaiah SK, 1998, TOXICOL APPL PHARM, V150, P12, DOI 10.1006/taap.1998.8365
   REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174
NR 39
TC 17
Z9 20
U1 0
U2 3
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD JUL
PY 2010
VL 38
IS 7
BP 1122
EP 1131
DI 10.1124/dmd.110.032599
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 631WU
UT WOS:000280382100015
PM 20382754
OA Green Published
DA 2024-02-19
ER

PT J
AU Hess, S
   Kendall, TJ
   Pena, M
   Yamane, K
   Soong, D
   Adams, L
   Truman, R
   Rambukkana, A
AF Hess, Samuel
   Kendall, Timothy J.
   Pena, Maria
   Yamane, Keitaro
   Soong, Daniel
   Adams, Linda
   Truman, Richard
   Rambukkana, Anura
TI <i>In</i><i> vivo</i> partial reprogramming by bacteria promotes adult
   liver organ growth without fibrosis and tumorigenesis
SO CELL REPORTS MEDICINE
LA English
DT Article; Early Access
ID LEPRAE TURNS BACK; CELL-LIKE CELLS; MYCOBACTERIUM-LEPRAE; REGENERATION;
   LEPROSY; EXPRESSION; ARMADILLO; RECONSTRUCTION; TRANSCRIPTOME;
   DEMYELINATION
AB Ideal therapies for regenerative medicine or healthy aging require healthy organ growth and rejuvenation, but no organ-level approach is currently available. Using Mycobacterium leprae (ML) with natural partial cellular reprogramming capacity and its animal host nine-banded armadillos, we present an evolutionarily refined model of adult liver growth and regeneration. In infected armadillos, ML reprogram the entire liver and significantly increase total liver/body weight ratio by increasing healthy liver lobules, including hepatocyte proliferation and proportionate expansion of vasculature, and biliary systems. ML-infected livers are micro -architecturally and functionally normal without damage, fibrosis, or tumorigenesis. Bacteria-induced reprog-ramming reactivates liver progenitor/developmental/fetal genes and upregulates growth-, metabolism-, and anti-aging-associated markers with minimal change in senescence and tumorigenic genes, suggesting bac-terial hijacking of homeostatic, regeneration pathways to promote de novo organogenesis. This may facilitate the unraveling of endogenous pathways that effectively and safely re-engage liver organ growth, with broad therapeutic implications including organ regeneration and rejuvenation.
C1 [Hess, Samuel; Kendall, Timothy J.; Yamane, Keitaro; Rambukkana, Anura] Univ Edinburgh, Inst Regenerat & Repair, Edinburgh, Scotland.
   [Hess, Samuel; Yamane, Keitaro; Rambukkana, Anura] Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Scotland.
   [Kendall, Timothy J.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Scotland.
   [Kendall, Timothy J.] Univ Edinburgh, Edinburgh Pathol, Edinburgh, Scotland.
   [Pena, Maria; Adams, Linda; Truman, Richard] US Dept HHS, Hlth Resources & Serv Adm, Healthcare Syst Bur, Natl Hansens Dis Program, Baton Rouge, LA USA.
   [Soong, Daniel] Univ Edinburgh, Med Res Council, Ctr Reprod Hlth, Edinburgh, Scotland.
   [Truman, Richard] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA USA.
   [Rambukkana, Anura] Univ Edinburgh, Edinburgh Infect Dis, Edinburgh, Scotland.
   [Rambukkana, Anura] Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh, Scotland.
C3 University of Edinburgh; University of Edinburgh; University of
   Edinburgh; University of Edinburgh; United States Health Resources &
   Service Administration (HRSA); UK Research & Innovation (UKRI); Medical
   Research Council UK (MRC); University of Edinburgh; Louisiana State
   University School of Veterinary Medicine; Louisiana State University
   System; Louisiana State University; University of Edinburgh; University
   of Edinburgh
RP Rambukkana, A (corresponding author), Univ Edinburgh, Inst Regenerat & Repair, Edinburgh, Scotland.; Rambukkana, A (corresponding author), Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Scotland.; Rambukkana, A (corresponding author), Univ Edinburgh, Edinburgh Infect Dis, Edinburgh, Scotland.; Rambukkana, A (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh, Scotland.
EM a.rambuka@ed.ac.uk
RI Kendall, Tim/H-2698-2019
OI Kendall, Tim/0000-0002-4174-2786; rambukkana, anura/0000-0002-6286-9145
FU Medical Research Council UK [MR/P011292/1]; National Institutes of
   Health, National Institute of Allergy and Infectious Diseases
   [AAI15006]; National Hansen's Disease Program; Wellcome Trust
   [095898/Z/11/Z]; Wellcome Trust [095898/Z/11/Z] Funding Source: Wellcome
   Trust
FX We acknowledge Roena Stevenson, Judith Wiles, Rachel Walley, and Gregory
   McCormick for animal studies, and Lyndsey Boswell, Melanie McMillan, and
   Michael Millar (SuRF@Little France) for histology and imaging. We thank
   Yanggu Shi and the bioinformatics team at Arraystar (Rockville, MD,
   USA), Jaminson McCorrison and John Glass (J Craig Venter Institute, CA,
   USA), and Rahul Sharma (National Hansen's Disease Program [NHDP]) for
   sequencing assistance, and David Hay and Luke Boulter (University of
   Edinburgh) for antibodies. We acknowledge Julia Martina-Rambukkana for
   generating illustrations from up-to-date literature. This work was
   supported by the Medical Research Council UK (MR/P011292/1 to A.R.) and
   the National Institutes of Health, National Institute of Allergy and
   Infectious Diseases through Interagency Agreement AAI15006 with the
   Health Resources and Services Administration, Healthcare Systems Bureau,
   and National Hansen's Disease Program (R.T. and L.A.). T.J.K. was
   supported by a Wellcome Trust Intermediate Clinical Fellowship
   (095898/Z/11/Z).
CR Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586
   Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2
   Allaire M, 2020, CLIN RES HEPATOL GAS, V44, P6, DOI 10.1016/j.clinre.2019.07.011
   Andrews S., 2012, FASTQC
   [Anonymous], 2016, R LANG ENV STAT COMP
   [Anonymous], CELL, V154, P257
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005
   Avelar RA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01990-9
   Baddeley A, 2016, CHAP HALL CRC INTERD, P1
   Balamayooran G, 2015, CLIN DERMATOL, V33, P108, DOI 10.1016/j.clindermatol.2014.07.001
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Chen YP, 2021, SCIENCE, V373, P1537, DOI 10.1126/science.abg5159
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Colak D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61826-1
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Cordero-Espinoza L, 2018, J CLIN INVEST, V128, P85, DOI 10.1172/JCI93562
   David R, 2013, NAT REV MOL CELL BIO, V14, P130, DOI 10.1038/nrm3526
   David R, 2013, NAT REV MICROBIOL, V11, P145, DOI 10.1038/nrmicro2975
   Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92
   Dhanasekaran R, 2021, NAT REV CLIN ONCOL, DOI 10.1038/s41571-021-00549-2
   Donation G.O. and Transplantation, 2016, ORGAN DONATION TRANS
   Ebenezer GJ, 2022, EXP NEUROL, V352, DOI 10.1016/j.expneurol.2022.114053
   Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97
   Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Gill D, 2022, ELIFE, V11, DOI 10.7554/eLife.71624
   Hazbón MH, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty042
   He LJ, 2021, SCIENCE, V371, P905, DOI 10.1126/science.abc4346
   Hess S, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.BAI-0020-2019
   Hess S, 2015, CURR OPIN MICROBIOL, V23, P179, DOI 10.1016/j.mib.2014.11.021
   Hishida T, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110730
   Job CK, 2000, INT J LEPROSY, V68, P18
   Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043
   Kendall TJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74691-9
   Kendall TJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12701-9
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693
   Lara-Diaz VJ, 2017, J PHYSIOL BIOCHEM, V73, P245, DOI 10.1007/s13105-016-0545-x
   Le Lay J, 2010, PHYSIOL REV, V90, P1, DOI 10.1152/physrev.00018.2009
   Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Lu YC, 2020, NATURE, V588, P124, DOI 10.1038/s41586-020-2975-4
   MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7
   Marsee A, 2021, CELL STEM CELL, V28, P816, DOI 10.1016/j.stem.2021.04.005
   Martin M., 2011, EMBnet. J., V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]
   Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988
   Morsiani C, 2019, AGEING RES REV, V51, P24, DOI 10.1016/j.arr.2019.02.002
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2
   Noon Luke A, 2005, Sci STKE, V2005, ppe52, DOI 10.1126/stke.3092005pe52
   Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047
   Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122
   Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337
   Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3
   Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631
   Rambukkana A, 2010, PROG NEUROBIOL, V91, P102, DOI 10.1016/j.pneurobio.2009.12.002
   Reizel Y, 2020, GENE DEV, V34, P1039, DOI 10.1101/gad.337691.120
   Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z
   Rustad KC, 2010, ORGANOGENESIS, V6, P151, DOI 10.4161/org.6.3.12139
   Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Segal JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11266-x
   Sharma R, 2018, INFECT GENET EVOL, V62, P20, DOI 10.1016/j.meegid.2018.04.017
   Sterratt D.C., 2015, RIMAGEJROI READ IMAG
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takahashi Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071447
   Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102
   Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433
   Teutsch HF, 1999, HEPATOLOGY, V29, P494, DOI 10.1002/hep.510290243
   Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039
   Truman RW, 2014, ILAR J, V54, P304, DOI 10.1093/ilar/ilt050
   Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536
   Truman RW, 2001, INT J LEPROSY, V69, P1
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263
   Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300
   Wang C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23353-z
   Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006
   Wei YL, 2021, SCIENCE, V371, P906, DOI 10.1126/science.abb1625
   Wells JM, 2018, NATURE, V557, P322, DOI 10.1038/s41586-018-0073-7
   Wuebben EL, 2017, ONCOTARGET, V8, P44917, DOI 10.18632/oncotarget.16570
   Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144
   2014, bioRxiv, DOI [10.1101/003665, 10.1101/003665, DOI 10.1101/003665]
NR 91
TC 4
Z9 4
U1 2
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2666-3791
J9 CELL REP MED
JI Cell Rep. Med.
PD 2022 NOV 15
PY 2022
VL 3
IS 11
AR 100820
DI 10.1016/j.xcrm.2022.100820
EA NOV 2022
PG 30
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 6R8EF
UT WOS:000892529300025
PM 36384103
OA Green Accepted, Green Published, gold
DA 2024-02-19
ER

PT J
AU LUPA, VA
   PODOLIN, DA
   ROTH, DA
   MAZZEO, RS
AF LUPA, VA
   PODOLIN, DA
   ROTH, DA
   MAZZEO, RS
TI INFLUENCE OF AGING AND ENDURANCE TRAINING ON LACTATE-DEHYDROGENASE IN
   LIVER AND SKELETAL-MUSCLE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE LDH ACTIVITY; ISOZYME; GLUCONEOGENESIS; SKELETAL MUSCLE
ID GLUCONEOGENESIS-INHIBITED RATS; LDH ACTIVITY; ADAPTATIONS; EXERCISE;
   ISOZYME; FIBER; METABOLISM; CLEARANCE; WOMEN; AGE
AB The purpose of this investigation was to determine the effects of aging and endurance training on lactate dehydrogenase (LDH) activity and isozyme pattern in liver and skeletal muscle. Male Fischer 344 rats (n = 30) of three different age groups (young, 4 months; middle-aged, 12 months and old, 22 months) were trained on a treadmill at 75% running capacity for 1 h/day, five times per week for 10 weeks. Age-matched sedentary controls (n = 36) were used for comparison. Total LDH enzyme activity was measured spectrophotometrically; LDH isozymes were separated by native 5.5% polyacrylamide gel electrophoresis and quantified densitometrically. With increasing age, hepatic LDH activity decreased 28%. Old sedentary animals displayed significantly less (22%) hepatic LDH 5 than young and middle-aged animals, and significantly more (40%) hepatic LDH 4 than middle-aged animals. Training resulted in a significant decrease (38%) in total hepatic LDH activity in young rats only. Young animals displayed a significant increase in hepatic LDH 3 (28%), whereas middle-aged animals exhibited a significant decrease in hepatic LDH 3 (40%) with training. No change in total hepatic LDH activity was exhibited in middle-aged or old rats with training. Neither aging or training had a significant effect on LDH activity or isozyme pattern in extensor digitorum longus (EDL). Similarly, LDH activity was maintained in soleus with age, and isozyme pattern was only negligibly affected. We conclude that with age there is a decline in hepatic LDH activity and a decrease in the LDH 5 isozyme. Endurance training induced significant decreases in hepatic LDH activity of young animals. However, these decreases were not a result of shifts in isozymal pattern. Further, LDH activity was maintained in EDL and soleus muscle with age. Finally, endurance training did not have a significant effect on LDH activity or isozymal pattern of EDL or soleus.
C1 UNIV COLORADO,DEPT KINESIOL,EXERCISE BIOCHEM LAB,BOULDER,CO 80309.
C3 University of Colorado System; University of Colorado Boulder
FU NIA NIH HHS [AG-07180] Funding Source: Medline
CR APPLE FS, 1989, J APPL PHYSIOL, V66, P2717, DOI 10.1152/jappl.1989.66.6.2717
   APPLE FS, 1986, J APPL PHYSIOL, V61, P477, DOI 10.1152/jappl.1986.61.2.477
   BERG T, 1973, NATURE-NEW BIOL, V245, P239, DOI 10.1038/newbio245239a0
   BOLLAG DM, 1991, PROTEIN METHODS, P145
   COGGAN AR, 1992, J APPL PHYSIOL, V72, P1780, DOI 10.1152/jappl.1992.72.5.1780
   DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929
   DIETZ AA, 1967, ANAL BIOCHEM, V20, P246, DOI 10.1016/0003-2697(67)90030-9
   DONOVAN CM, 1989, AM J PHYSIOL, V257, pE782, DOI 10.1152/ajpendo.1989.257.5.E782
   DONOVAN CM, 1983, AM J PHYSIOL, V244, pE83, DOI 10.1152/ajpendo.1983.244.1.E83
   DONOVAN CM, 1990, AM J PHYSIOL, V258, pR770, DOI 10.1152/ajpregu.1990.258.3.R770
   EDDINGER TJ, 1985, J HISTOCHEM CYTOCHEM, V33, P1033, DOI 10.1177/33.10.2931475
   EDGERTON VR, 1969, J HISTOCHEM CYTOCHEM, V17, P828, DOI 10.1177/17.12.828
   ESSENGUSTAVSSON B, 1986, ACTA PHYSIOL SCAND, V126, P107, DOI 10.1111/j.1748-1716.1986.tb07793.x
   Frisch F., 1993, Medicine and Science in Sports and Exercise, V25, pS142, DOI 10.1249/00005768-199305001-00797
   GABRIEL O, 1971, METHOD ENZYMOL, V22, P564
   GILLESPIE AC, 1982, MED SCI SPORT EXER, V14, P461, DOI 10.1249/00005768-198206000-00010
   HICKSON RC, 1975, J APPL PHYSIOL, V40, P868
   JOHNALDER HB, 1986, AM J PHYSIOL, V251, pR137, DOI 10.1152/ajpregu.1986.251.1.R137
   KLITGAARD H, 1989, J APPL PHYSIOL, V67, P1409, DOI 10.1152/jappl.1989.67.4.1409
   MAZZEO RS, 1984, J APPL PHYSIOL, V57, P1369, DOI 10.1152/jappl.1984.57.5.1369
   MHROVA O, 1972, COR ET VASA, V20, P142
   ORLANDER J, 1980, ACTA PHYSIOL SCAND, V109, P149, DOI 10.1111/j.1748-1716.1980.tb06580.x
   PODOLIN DA, 1992, PHYSIOLOGIST, V35, P191
   ROGERS MA, 1993, EXERCISE SPORTS SCI, P65
   SANCHEZ J, 1983, EUR J APPL PHYSIOL O, V52, P69, DOI 10.1007/BF00429028
   SCHMUKLE.M, 1966, J GERONTOL, V21, P109, DOI 10.1093/geronj/21.1.109
   SINGH SN, 1968, J BIOL CHEM, V243, P4526
   SJODIN B, 1976, ACTA PHYSIOL SCAND, V97, P150, DOI 10.1111/j.1748-1716.1976.tb10247.x
   SOMERO GN, 1980, PHYSIOL ZOOL, V53, P322, DOI 10.1086/physzool.53.3.30155794
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   SUMIDA KD, 1993, J APPL PHYSIOL, V74, P782, DOI 10.1152/jappl.1993.74.2.782
   TESCH P, 1978, ACTA PHYSIOL SCAND, V103, P40, DOI 10.1111/j.1748-1716.1978.tb06188.x
   TURCOTTE LP, 1990, J APPL PHYSIOL, V68, P944, DOI 10.1152/jappl.1990.68.3.944
   TURCOTTE LP, 1990, AM J PHYSIOL, V258, pE203, DOI 10.1152/ajpendo.1990.258.1.E203
   WASSERMAN DH, 1987, J APPL PHYSIOL, V63, P2411, DOI 10.1152/jappl.1987.63.6.2411
   WINDER WW, 1985, EXERCISE SPORT SCI R, P1
NR 36
TC 13
Z9 13
U1 0
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP
PY 1994
VL 75
IS 3
BP 191
EP 204
DI 10.1016/0047-6374(94)90009-4
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PK319
UT WOS:A1994PK31900002
PM 7845053
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   MOORE, DR
AF RIKANS, LE
   MOORE, DR
TI INFLUENCE OF AGING ON RAT-LIVER ENZYMES INVOLVED IN GLUTATHIONE
   SYNTHESIS AND DEGRADATION
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE GLUTATHIONE; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE;
   GAMMA-GLUTAMYL-TRANSFERASE; GLUTATHIONE REDUCTASE; GLUCOSE-6-PHOSPHATE
   DEHYDROGENASE; RAT LIVER
ID DRUG-METABOLIZING-ENZYMES; AGE-RELATED-CHANGES; HEPATIC GLUTATHIONE;
   TURNOVER; TISSUES; MOUSE; DEHYDROGENASE; ANTIOXIDANTS; ALCOHOL; KIDNEY
AB The purpose of this study was to determine the effects of aging on the activities of rat liver enzymes involved in the synthesis and degradation of glutathione, as well as those important for maintaining glutathione in its reduced form. Gamma-glutamylcysteine synthetase, gamma-glutamyltransferase, glutathione reductase, and glucose-6-phosphate dehydrogenase activities were measured in liver fractions prepared from male and female Fischer-344 rats at the ages of 4, 14, and 29 months. The activity of gamma-glutamylcysteine synthetase, the rate-limiting enzyme in GSH synthesis, and overall rates of glutathione synthesis were unaffected by aging. In contrast, the activity of gamma-glutamyltransferase, the key enzyme in glutathione degradation, was markedly influenced by animal age; activity increased with age in male rats and decreased with age in female rats. Age-associated alterations also were observed in activities of hepatic enzymes needed to maintain glutathione in its reduced form. Glutathione reductase activity was greater in old female rats and glucose-6-phosphate dehydrogenase activity was greater in old male rats than in young and middle-aged rats of the same sex. Age-dependent changes in glutathione metabolizing enzymes could have important toxicological implications.
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA,HLTH SCI CTR,DEPT PHARMACOL,POB 26901,OKLAHOMA CITY,OK 73190, USA.
CR BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   BORGHOFF SJ, 1986, DRUG METAB DISPOS, V14, P417
   DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   KRAUPPGRASL B, 1991, CANCER RES, V51, P666
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAUTERBURG BH, 1981, J CLIN INVEST, V67, P1415, DOI 10.1172/JCI110170
   LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402
   LOHR GW, 1974, METHOD ENZYMAT AN, P636
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   MORTON S, 1985, BIOCHEM PHARMACOL, V34, P1559, DOI 10.1016/0006-2952(85)90699-9
   NEUSCHWANDERTETRI BA, 1989, ANAL BIOCHEM, V179, P236, DOI 10.1016/0003-2697(89)90121-8
   Reed DJ, 1980, REV BIOCHEM TOXICOL, V2, P213
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   RIKANS LE, 1989, LIFE SCI, V45, P1373, DOI 10.1016/0024-3205(89)90024-6
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   RIKANS LE, 1987, ALCOHOL CLIN EXP RES, V11, P562, DOI 10.1111/j.1530-0277.1987.tb00175.x
   SAWAKI M, 1990, CARCINOGENESIS, V11, P1857, DOI 10.1093/carcin/11.10.1857
   SCHULTEHERMANN R, 1983, CANCER RES, V43, P839
   SEELIG GF, 1985, METHOD ENZYMOL, V113, P379
   SOHAL RS, 1987, ARCH GERONTOL GERIAT, V6, P95, DOI 10.1016/0167-4943(87)90001-X
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   TATE SS, 1985, METHOD ENZYMOL, V113, P400
   WANG RKJ, 1977, EXP GERONTOL, V12, P117, DOI 10.1016/0531-5565(77)90019-5
   WILSON PD, 1972, GERONTOLOGY, V18, P36, DOI 10.1159/000211918
   WULF JH, 1975, EXP GERONTOL, V10, P101, DOI 10.1016/0531-5565(75)90040-6
NR 33
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD NOV-DEC
PY 1991
VL 13
IS 3
BP 263
EP 270
DI 10.1016/0167-4943(91)90048-U
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GU885
UT WOS:A1991GU88500006
PM 15374419
DA 2024-02-19
ER

PT J
AU Lai, PF
   Baskaran, R
   Kuo, CH
   Day, CH
   Chen, RJ
   Ho, TJ
   Yeh, YL
   Padma, VV
   Lai, CH
   Huang, CY
AF Lai, Pei-Fang
   Baskaran, Rathinasamy
   Kuo, Chia-Hua
   Day, Cecilia Hsuan
   Chen, Ray-Jade
   Ho, Tsung-Jung
   Yeh, Yu-Lan
   Padma, Viswanadha Vijaya
   Lai, Chin-Hu
   Huang, Chih-Yang
TI Bioactive dipeptide from potato protein hydrolysate combined with
   swimming exercise prevents high fat diet induced hepatocyte apoptosis by
   activating PI3K/Akt in SAMP8 mouse
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article; Early Access
DE Aging; Apoptosis; Bioactive peptide; High fat diet; Obesity
ID LIPOLYSIS-STIMULATING PEPTIDES; NONALCOHOLIC STEATOHEPATITIS;
   LIVER-DISEASE; LIPOTOXICITY; INFLAMMATION; INCREASES; FIBROSIS; RISK;
   RATS
AB Obesity in aged population have surges the occurrence of various metabolic disorders including Nonalcoholic fatty liver disease (NAFLD). Apoptosis in the liver is one of the causative factors for NAFLD-induced liver damage. Plants derived bioactive peptides have been shown as an alternative treatment approach for the treating NAFLD due to its less toxicity. Moderate exercise has been reported to improve cellular physiological function prevent age associated metabolic disorders. In the present study, we evaluate the effects of bioactive dipeptide (IF) derived from alcalase potato-protein hydrolysates and swimming exercise in preventing High Fat Diet (HFD)-induced liver damage in senescence accelerated mouse-prone 8 (SAMP8) mice model. Mouse were fed with HFD for 6 weeks followed by oral IF administration or swimming exercise and both for 8 weeks. HFD induces significant structural changes in liver of HFD fed SAMP8 mouse. Both IF administration and exercise prevent the structural abnormalities induced by HFD, however, combined IF treatment and exercise offer better protection. Combined IF treatment and exercise activate PI3K/Akt cell survival protein and effectively inhibit Fas-FADD-induced apoptosis in HFD fed aged mouse. Oral supplementation of bioactive peptide IF combined with moderate swimming exercise effectively alleviate HFD-induced hepatic injury in aged mice.
C1 [Lai, Pei-Fang] Tzu Chi Univ, Hualien Tzu Chi Hosp, Dept Emergency Med, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan.
   [Lai, Pei-Fang] Tzu Chi Univ, Hualien Tzu Chi Hosp, Dept Med, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan.
   [Baskaran, Rathinasamy] Asia Univ, Dept Bioinformat & Med Engn, Taichung 41354, Taiwan.
   [Kuo, Chia-Hua] Univ Taipei, Dept Sports Sci, Taibei, Taiwan.
   [Day, Cecilia Hsuan] Meiho Univ, Dept Nursing, Pingtung, Taiwan.
   [Chen, Ray-Jade] Taipei Med Univ, Sch Med, Dept Surg, Coll Med, Taipei, Taiwan.
   [Ho, Tsung-Jung] Tzu Chi Univ, Hualien Tzu Chi Hosp, Dept Chinese Med, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan.
   [Yeh, Yu-Lan] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan.
   [Yeh, Yu-Lan] Jen Teh Jr Coll Med Nursing & Management, Miaoli, Taiwan.
   [Padma, Viswanadha Vijaya] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India.
   [Lai, Chin-Hu; Huang, Chih-Yang] Taichung Armed Force Gen Hosp, Div Cardiovasc Surg, Dept Surg, Taichung 41152, Taiwan.
   [Huang, Chih-Yang] Tzu Chi Univ Sci & Technol, Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Cardiovasc & Mitochondrial Related Dis Res Ctr, Hualien, Taiwan.
   [Huang, Chih-Yang] Tzu Chi Univ Sci & Technol, Buddhist Tzu Chi Med Fdn, Ctr Gen Educ, Hualien, Taiwan.
   [Huang, Chih-Yang] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.
   [Huang, Chih-Yang] Asia Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.
C3 Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi
   University; Tzu Chi University; Buddhist Tzu Chi General Hospital;
   Hualien Tzu Chi Hospital; Asia University Taiwan; Taipei Medical
   University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital;
   Tzu Chi University; Changhua Christian Hospital; Bharathiar University;
   Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi
   University of Science & Technology; Tzu Chi University of Science &
   Technology; China Medical University Taiwan; China Medical University
   Hospital - Taiwan; Asia University Taiwan
RP Huang, CY (corresponding author), Taichung Armed Force Gen Hosp, Div Cardiovasc Surg, Dept Surg, Taichung 41152, Taiwan.; Huang, CY (corresponding author), Tzu Chi Univ Sci & Technol, Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Cardiovasc & Mitochondrial Related Dis Res Ctr, Hualien, Taiwan.; Huang, CY (corresponding author), Tzu Chi Univ Sci & Technol, Buddhist Tzu Chi Med Fdn, Ctr Gen Educ, Hualien, Taiwan.; Huang, CY (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Huang, CY (corresponding author), Asia Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.
EM cyhuang@mail.cmu.edu.tw
RI Baskaran, Rathinasamy/I-3345-2019; Chen, Ray/GRJ-6736-2022
OI Baskaran, Rathinasamy/0000-0002-2676-7379; lai, jin
   hu/0000-0003-2400-9459; Huang, Chih-Yang/0000-0003-2347-0411
FU China Medical University [CMU107-TC-01]
FX This research was funded by China Medical University, Grant No.
   CMU107-TC-01.
CR Asokan SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040779
   Barcelos RP, 2017, FREE RADICAL RES, V51, P222, DOI 10.1080/10715762.2017.1291942
   Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004
   Chiang WD, 1999, FOOD CHEM, V65, P189, DOI 10.1016/S0308-8146(98)00193-9
   Chiang WD, 2016, FOOD NUTR RES, V60, DOI [10.3402/fnr.v60.30511, 10.3402/fnr.v60.31417]
   Chuang HL, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13525
   Cipolla MJ, 2018, J CEREBR BLOOD F MET, V38, P755, DOI 10.1177/0271678X17705567
   Ding Q, 2012, J NUTR BIOCHEM, V23, P867, DOI 10.1016/j.jnutbio.2011.04.011
   Egnatchik RA, 2019, J BIOL CHEM, V294, P3081, DOI 10.1074/jbc.RA118.004869
   Hajighasem A, 2018, PEERJ, V6, DOI 10.7717/peerj.5522
   Hsu CS, 2017, EXPERT REV GASTROENT, V11, P759, DOI 10.1080/17474124.2017.1342535
   Hu WS, 2015, INT J MOL SCI, V16, P10158, DOI 10.3390/ijms160510158
   Huang CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/275431
   Huang CY, 2015, J FUNCT FOODS, V12, P389, DOI 10.1016/j.jff.2014.11.027
   Keating SE, 2012, J HEPATOL, V57, P157, DOI 10.1016/j.jhep.2012.02.023
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kwon I, 2020, ANN HEPATOL, V19, P69, DOI 10.1016/j.aohep.2019.08.010
   Lin CC, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12902
   Lin JY, 2020, AGING-US, V12, P6852, DOI 10.18632/aging.103046
   Linden MA, 2015, MED SCI SPORT EXER, V47, P556, DOI 10.1249/MSS.0000000000000430
   Liu B, 2020, J ALZHEIMERS DIS, V75, P385, DOI 10.3233/JAD-200063
   Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055
   Piguet AC, 2019, HEPATOL RES, V49, P637, DOI 10.1111/hepr.13323
   Ryan Alice S, 2010, Aging health, V6, P551, DOI 10.2217/ahe.10.46
   Stine JG, 2020, CONT CLIN TRIAL COMM, V18, DOI 10.1016/j.conctc.2020.100560
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Takeda T., 2013, SENESCENCE ACCELERAT
   Tsai BCK, 2020, FOOD RES INT, V129, DOI 10.1016/j.foodres.2019.108862
   Tsou MJ, 2013, FOOD CHEM, V138, P1454, DOI 10.1016/j.foodchem.2012.10.149
   Tsou MJ, 2010, FOOD CHEM, V122, P243, DOI 10.1016/j.foodchem.2010.02.070
   Wu KM, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0356-5
NR 33
TC 9
Z9 10
U1 3
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD 2021 MAR
PY 2021
VL 48
IS 3
BP 2629
EP 2637
DI 10.1007/s11033-021-06317-w
EA MAR 2021
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA RQ2VW
UT WOS:000635504500003
PM 33791907
DA 2024-02-19
ER

PT J
AU Nakanishi, Y
   Yasumoto, K
AF Nakanishi, Y
   Yasumoto, K
TI Induction after administering paraquat of heme oxygenase-1 and heat
   shock protein 70 in the liver of senescence-accelerated mice
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE age; senescence-accelerated mouse; heat shock protein 70; heme
   oxygenase; stress
ID AGE-DEPENDENT RESPONSE; OXIDATIVE STRESS; GENE-EXPRESSION;
   MESSENGER-RNAS; MURINE MODEL; CADMIUM IONS; LIFE-SPAN; MOUSE SAM; RAT;
   HYPERTHERMIA
AB Age-associated changes in the induction of heme oxygenase (HO-1) and heat shock protein 70 (HSP70) after the administration of paraquat were investigated in the liver of senescence-accelerated mice (SAMs). The extent of HO-1 and HSP70 induced in response to paraquat decreased significantly with age, and the level of oxidized proteins increased with age, Moreover, the extent of induced HSP70 was lower in mice that were prone to accelerated senescence (SAMP1//Fky) than in mice that were resistant to accelerated senescence (SAMR1/Fky) of the same age, These results suggest that an age-associated decline in the levels of HO-1 and HSP70 enhanced oxidative damage during the aging process, Age-dependent changes in HO-1 and in the levels of oxidized proteins were examined in SAMP1//Fky, The accumulation of oxidized proteins was suppressed when HO-1 was induced, but increased markedly after the induction of HO-1 decreased, Free iron, the residuum from heme degradation, might mediate free radical production, The role of HO-1 is discussed in relation to the oxidative damage associated with age.
C1 KYOTO UNIV, FOOD SCI RES INST, UJI, KYOTO 611, JAPAN.
C3 Kyoto University
CR BLAKE MJ, 1990, J BIOL CHEM, V265, P15275
   BLAKE MJ, 1991, P NATL ACAD SCI USA, V88, P9873, DOI 10.1073/pnas.88.21.9873
   CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391
   CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364
   CURRIE RW, 1983, CAN J BIOCHEM CELL B, V61, P438, DOI 10.1139/o83-059
   ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   FUJIO N, 1987, J BIOCHEM-TOKYO, V101, P181, DOI 10.1093/oxfordjournals.jbchem.a121889
   HE P, 1994, INT CONGR SER, V1062, P133
   HE PM, 1994, MECH AGEING DEV, V76, P43, DOI 10.1016/0047-6374(94)90006-X
   HE PM, 1994, BIOSCI BIOTECH BIOCH, V58, P146, DOI 10.1271/bbb.58.146
   HE PM, 1994, BIOSCI BIOTECH BIOCH, V58, P1037, DOI 10.1271/bbb.58.1037
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   KITADO H, 1994, J GERONTOL, V49, pB247, DOI 10.1093/geronj/49.6.B247
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LINCOLN BC, 1988, BIOCHEM J, V250, P189, DOI 10.1042/bj2500189
   LINCOLN BC, 1989, BIOCHIM BIOPHYS ACTA, V992, P49, DOI 10.1016/0304-4165(89)90049-4
   LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540
   LIU AYC, 1989, J BIOL CHEM, V264, P12037
   LLESUY SF, 1994, BBA-MOL CELL RES, V1223, P9, DOI 10.1016/0167-4889(94)90067-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU D, 1993, BIOCHEM BIOPH RES CO, V192, P808, DOI 10.1006/bbrc.1993.1486
   MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025
   MAINES MD, 1986, J BIOL CHEM, V261, P411
   MATZ JM, 1994, FASEB J, V8, P97, DOI 10.1096/fasebj.8.1.8299895
   MCCOUBREY WK, 1992, ARCH BIOCHEM BIOPHYS, V295, P13, DOI 10.1016/0003-9861(92)90481-B
   MITANI K, 1993, BIOCHEM J, V290, P819, DOI 10.1042/bj2900819
   NUTTER LM, 1994, J LAB CLIN MED, V123, P506
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   RAJU VS, 1994, BBA-GENE STRUCT EXPR, V1217, P273, DOI 10.1016/0167-4781(94)90286-0
   SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKETANI S, 1989, FEBS LETT, V245, P173, DOI 10.1016/0014-5793(89)80215-7
   TAKETANI S, 1991, BIOCHEM INT, V23, P625
   TAKETANI S, 1988, BIOCHEM INT, V17, P665
   TRAKSHEL GM, 1989, J BIOL CHEM, V264, P1323
   UDELSMAN R, 1993, J CLIN INVEST, V91, P465, DOI 10.1172/JCI116224
   WALL SR, 1993, MOL CELL BIOCHEM, V129, P187, DOI 10.1007/BF00926367
   Welch WS, 1993, SCI AM, V268, P34
   WU B, 1993, J GERONTOL, V48, pB50, DOI 10.1093/geronj/48.2.B50
   YAMAGUCHI T, 1995, BIOCHEM BIOPH RES CO, V214, P11, DOI 10.1006/bbrc.1995.2250
NR 45
TC 17
Z9 17
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD AUG
PY 1997
VL 61
IS 8
BP 1302
EP 1306
DI 10.1271/bbb.61.1302
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA XT919
UT WOS:A1997XT91900013
PM 9301111
OA Bronze
DA 2024-02-19
ER

PT J
AU Thomas, RP
   Guigneaux, M
   Wood, T
   Evers, BM
AF Thomas, RP
   Guigneaux, M
   Wood, T
   Evers, BM
TI Age-associated changes in gene expression patterns in the liver
SO JOURNAL OF GASTROINTESTINAL SURGERY
LA English
DT Article; Proceedings Paper
CT 42nd Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract
CY MAY 19-23, 2001
CL ATLANTA, GA
SP Soc Surg Alimentary Tract
DE aging; gene expression; liver; gene array
ID SUPEROXIDE-DISMUTASE; FREE-RADICALS; OXIDATIVE DAMAGE; CATALASE;
   ENZYMES; STEP
AB Aging is one of the least clearly understood biological processes. Alteration of oxidation/reduction (redox) enzymes has been demonstrated with aging; however, a systematic analysis of expression patterns has not been performed. The liver plays a key role in homeostasis and detoxification; therefore alteration of hepatic gene expression with aging may affect outcome after surgery. The purpose of our study was to assess changes in gene expression patterns in aged livers from both rats and humans using gene array analysis. Total RNA was extracted from young (2-month-old) and aged (2-year-old) rat livers, as well as young (1-year-old) and aged (78-year-old) human livers. Gene expression patterns were compared using Affymetrix GeneChip arrays. The expression pattern of selected genes was confirmed by reverse transcription-polymerase chain reaction. A threefold or greater change in gene expression was noted in 582 genes in the aged rat livers and 192 genes in the aged human livers. Comparison of the genes that were increased with aging demonstrated some similar patterns of expression in the rat and human livers, particularly in members of the antioxidant family and the cytochrome P-450 genes. Our findings demonstrate changes in the expression pattern of genes in the liver with aging. Concomitant increases in the expression of important antioxidant and detoxifying genes were noted in the livers of both rats and humans. This induction pattern suggests a complex link between changing hepatic detoxification/redox capability and senescence.
C1 Univ Texas, Med Branch, Dept Surg, Galveston, TX 77555 USA.
   Univ Texas, Med Branch, Mol Genom Core Lab, Galveston, TX 77555 USA.
C3 University of Texas System; University of Texas Medical Branch
   Galveston; University of Texas System; University of Texas Medical
   Branch Galveston
RP Evers, BM (corresponding author), Univ Texas, Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.
EM mevers@utmb.edu
RI Wood, Thomas/GWZ-2481-2022; Wood, Thomas G/B-6172-2012
OI Wood, Thomas/0000-0001-8962-8571; Cullen, Joseph/0000-0002-2222-1328
FU NIA NIH HHS [R01 AG10885] Funding Source: Medline; NIDDK NIH HHS [T32
   DK07639, P01 DK35608] Funding Source: Medline
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Amicarelli F, 1997, MECH AGEING DEV, V97, P215, DOI 10.1016/S0047-6374(97)00061-4
   BENGTON VL, 1999, HDB THEORIES AGING
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   Carrillo MC, 2001, EXP GERONTOL, V36, P255, DOI 10.1016/S0531-5565(00)00209-6
   CEBALLOSPICOT I, 1992, CLIN CHEM, V38, P66
   CHESKY J A, 1976, Experimental Aging Research, V2, P399, DOI 10.1080/03610737608257998
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Day J.C., 1993, CURRENT POPULATION R, P25
   Ehlers RA, 2000, ANN SURG, V231, P838, DOI 10.1097/00000658-200006000-00008
   EVERS BM, 1994, SURG CLIN N AM, V74, P23
   GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243
   GRANT DM, 1991, J INHERIT METAB DIS, V14, P421, DOI 10.1007/BF01797915
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Han ES, 2000, MECH AGEING DEV, V115, P157, DOI 10.1016/S0047-6374(00)00119-6
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   KENSLER TW, 1986, ADV FREE RADICAL BIO, V2, P347, DOI 10.1016/S8755-9668(86)80019-9
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Powers JH., 1968, SURG AGED DEBILITATE
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   ROSENTHAL RA, 2001, SABISTON TXB SURG, P226
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Villalba JM, 2000, ANTIOXID REDOX SIGN, V2, P213, DOI 10.1089/ars.2000.2.2-213
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   Zenilman M E, 1998, Curr Probl Surg, V35, P99, DOI 10.1016/S0011-3840(98)80003-8
   1998, 301 CDCD
NR 37
TC 34
Z9 36
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1091-255X
EI 1873-4626
J9 J GASTROINTEST SURG
JI J. Gastrointest. Surg.
PD MAY-JUN
PY 2002
VL 6
IS 3
BP 445
EP 453
AR PII S1091-255X(01)00010-5
DI 10.1016/S1091-255X(01)00010-5
PG 9
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Gastroenterology & Hepatology; Surgery
GA 627EN
UT WOS:000179920400041
PM 12022999
DA 2024-02-19
ER

PT J
AU Wu, H
   Wade, M
   Krall, L
   Grisham, J
   Xiong, Y
   VanDyke, T
AF Wu, H
   Wade, M
   Krall, L
   Grisham, J
   Xiong, Y
   VanDyke, T
TI Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21
   halts hepatocyte cell-cycle progression, postnatal liver development,
   and regeneration
SO GENES & DEVELOPMENT
LA English
DT Article
DE cell cycle; liver development; liver regeneration; CDK inhibitor; p21
   growth arrest; transgenic mice; cell specificity
ID TRANSGENIC MICE; MESSENGER-RNA; OVAL CELLS; RAT-LIVER; TRANSTHYRETIN;
   TRANSFORMATION; ALBUMIN
AB The CDK inhibitor p21 (WAE-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G(1) arrest, as well as in physiological processes, such as cell differentiation and senescence, that do not involve p53 function. To determine the impact of p21 on normal development and cell-cycle regulation in vivo, we have generated transgenic mice that abundantly express p21 specifically in hepatocytes. During postnatal liver development, when transgenic p21 protein becomes detectable, hepatocyte proliferation is inhibited dramatically. This disturbance causes a reduction in the overall number of adult hepatocytes, resulting in aberrant tissue organization, runted liver and body growth, and increased mortality. The transgenic p21 protein is associated with most, if not all, of the cyclin D1-CDK4 in liver but not significantly with other cyclin/CDK proteins, indicating the importance of cyclin D1-CDK4 function in normal liver development. The appearance of large polyploid nuclei in some hepatocytes indicates that p21 may also cause arrest during the G(2) phase of the cell cycle. Significantly, partial hepatectomy failed to stimulate hepatocytes to proliferate in p21 transgenic animals. These results provide the first in vivo evidence that appropriate p21 levels are critical in normal development and further implicate p21 in the control of multiple cell-cycle phases.
C1 UNIV N CAROLINA, DEPT BIOPHYS & BIOCHEM, CHAPEL HILL, NC 27599 USA.
   UNIV N CAROLINA, DEPT PATHOL, CHAPEL HILL, NC 27599 USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill
FU NCI NIH HHS [CA65572, CA46283] Funding Source: Medline; NIDDK NIH HHS
   [DK42910] Funding Source: Medline
CR ALBRECHT JH, 1993, AM J PHYSIOL, V265, pG857, DOI 10.1152/ajpgi.1993.265.5.G857
   APRELIKOVA O, 1995, J BIOL CHEM, V270, P18195, DOI 10.1074/jbc.270.31.18195
   BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0
   COSTA RH, 1986, MOL CELL BIOL, V6, P4697, DOI 10.1128/MCB.6.12.4697
   COSTA RH, 1988, P NATL ACAD SCI USA, V85, P3840, DOI 10.1073/pnas.85.11.3840
   DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545
   DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X
   DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4
   ELBENDARY A, 1994, CELL GROWTH DIFFER, V5, P1301
   ELDEIRY WS, 1994, CANCER RES, V54, P1169
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   EVARTS RP, 1989, CANCER RES, V49, P1541
   EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737
   FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364
   Fausto N, 1990, CURR OPIN CELL BIOL, V2, P1036, DOI 10.1016/0955-0674(90)90153-6
   FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GRISHAM JW, 1962, CANCER RES, V22, P842
   GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939
   GUAN KL, 1996, IN PRESS MOL BIOL CE
   GUMUCIO JJ, 1989, RBC-CELL BIOL REV, V19, P1
   GUO K, 1995, MOL CELL BIOL, V15, P3823
   HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327
   HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0
   HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387
   HARPER JW, 1993, CELL, V75, P805
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HIRAI H, 1995, MOL CELL BIOL, V15, P2672
   HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897
   HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6
   HUPPI K, 1994, ONCOGENE, V9, P3017
   JENKINS CW, 1995, CELL CYCLE MAT METHO, P250
   JIANG HP, 1994, ONCOGENE, V9, P3397
   JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004
   KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634
   KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7
   KOCH KS, 1994, BIOCHEM BIOPH RES CO, V204, P91, DOI 10.1006/bbrc.1994.2430
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639
   LI CY, 1995, J BIOL CHEM, V270, P4971, DOI 10.1074/jbc.270.10.4971
   LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0
   LOYER P, 1994, J BIOL CHEM, V269, P2491
   LU XP, 1992, J BIOL CHEM, V267, P2841
   LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0
   MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650
   MICHIELI P, 1994, CANCER RES, V54, P3391
   MING FK, 1995, MOL CELL BIOL, V15, P2682
   MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451
   MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0
   NISHIDA N, 1994, CANCER RES, V54, P3107
   NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   NOGUCHI S, 1991, J ENDOCRINOL, V128, P425, DOI 10.1677/joe.0.1280425
   PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329
   POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X
   SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6
   SEGAL SS, 1992, AM J PHYSIOL, V263, pH1, DOI 10.1152/ajpheart.1992.263.1.H1
   SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0
   SHAW P, 1994, P NATL ACAD SCI USA, V89, P551
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1
   SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781
   SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9
   SOLOMON MJ, 1994, TRENDS BIOCHEM SCI, V19, P496, DOI 10.1016/0968-0004(94)90137-6
   STEINMAN RA, 1994, ONCOGENE, V9, P3389
   SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7
   SYMONDS HS, 1993, MOL CELL BIOL, V13, P3255, DOI 10.1128/MCB.13.6.3255
   TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8
   VASSY J, 1993, MOL CELL BIOL LIVER, P265
   WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0
   XIONG Y, 1993, GENE DEV, V7, P1572, DOI 10.1101/gad.7.8.1572
   XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0
   YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x
   YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0
   ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750
NR 77
TC 209
Z9 222
U1 0
U2 8
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD FEB 1
PY 1996
VL 10
IS 3
BP 245
EP 260
DI 10.1101/gad.10.3.245
PG 16
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA TV711
UT WOS:A1996TV71100001
PM 8595876
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Schafer, MJ
   Miller, JD
   LeBrasseur, NK
AF Schafer, Marissa J.
   Miller, Jordan D.
   LeBrasseur, Nathan K.
TI Cellular senescence: Implications for metabolic disease
SO MOLECULAR AND CELLULAR ENDOCRINOLOGY
LA English
DT Article
DE Aging; Obesity; Diabetes; Exercise; Senolytics; Inflammation
ID GENOME-WIDE ASSOCIATION; ENDOPLASMIC-RETICULUM STRESS; INCREASED
   OXIDATIVE STRESS; ADIPOSE-TISSUE; SKELETAL-MUSCLE; SECRETORY PHENOTYPE;
   INSULIN-RESISTANCE; TELOMERE LENGTH; IN-VIVO; ENDOTHELIAL-CELLS
AB The growing burden of obesity- and aging-related diseases has hastened the search for governing biological processes. Cellular senescence is a stress-induced state of stable growth arrest strongly associated with aging that is aberrantly activated by obesity. The transition of a cell to a senescent state is demarcated by an array of phenotypic markers, and leveraging their context-dependent presentation is essential for determining the influence of senescent cells on tissue pathogenesis. Biomarkers of senescent cells have been identified in tissues that contribute to metabolic disease, including fat, liver, skeletal muscle, pancreata, and cardiovascular tissue, suggesting that pharmacological and behavioral interventions that alter their abundance and/or behavior may be a novel therapeutic strategy. However, contradictory findings with regard to a protective versus deleterious role of senescent cells in certain contexts emphasize the need for additional studies to uncover the complex interplay that defines multi organ disease processes associated with obesity and aging. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Schafer, Marissa J.; Miller, Jordan D.; LeBrasseur, Nathan K.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA.
   [Schafer, Marissa J.; LeBrasseur, Nathan K.] Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.
   [Miller, Jordan D.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA.
   [Miller, Jordan D.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic
RP LeBrasseur, NK (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.
EM lebrasseur.nathan@mayo.edu
OI LeBrasseur, Nathan/0000-0002-2002-0418; Miller,
   Jordan/0000-0002-9868-4097
FU Glenn Foundation for Medical Research; NIH/NIA [AG041122, AG053832,
   HL111121, TR000954, AG49182, AG13925]
FX The authors acknowledge the support of the Glenn Foundation for Medical
   Research and NIH/NIA grants AG041122, AG053832, HL111121, TR000954,
   AG49182, and AG13925. We thank Matthew Moore, Mayo Clinic Center for
   Innovation, for generating figures.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020
   Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004
   Al-Aubaidy HA, 2011, EUR J ENDOCRINOL, V164, P899, DOI 10.1530/EJE-11-0053
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213
   [Anonymous], 2014, 65+ in the United States: 2010
   [Anonymous], 2010, PREVALENCE OVERWEIGH
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382
   BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Berkenkamp B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088071
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Böni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543
   Böni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396
   Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010
   Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602
   Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429
   Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606
   Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Dietze D, 2002, DIABETES, V51, P2369, DOI 10.2337/diabetes.51.8.2369
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dörr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437
   Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   GEPTS W, 1978, DIABETES, V27, P251, DOI 10.2337/diab.27.1.S251
   GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619
   Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x
   Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585
   Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842
   Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054
   Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Katunga LA, 2015, MOL METAB, V4, P493, DOI 10.1016/j.molmet.2015.04.001
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   LeBrasseur NK, 2011, AM J PHYSIOL-ENDOC M, V300, pE3, DOI 10.1152/ajpendo.00512.2010
   Lee R, 2012, CURR MED CHEM, V19, P2504, DOI 10.2174/092986712800493057
   Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561
   Li HJ, 2016, CELL HOST MICROBE, V19, P240, DOI 10.1016/j.chom.2016.01.008
   Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x
   Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027
   Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010
   McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447
   Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369
   Merched AJ, 2004, CIRCULATION, V110, P3830, DOI 10.1161/01.CIR.0000148681.01282.89
   Meyer K, 2016, J AM COLL CARDIOL, V67, P2018, DOI 10.1016/j.jacc.2016.02.047
   Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P1345, DOI 10.1038/ijo.2010.49
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Ning YC, 2013, MECH AGEING DEV, V134, P570, DOI 10.1016/j.mad.2013.11.006
   Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x
   Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509
   Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Roos C. M., 2016, AGING CELL, P1
   Roos CM, 2013, AM J PHYSIOL-HEART C, V305, pH1428, DOI 10.1152/ajpheart.00735.2012
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382
   Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969
   Sell H, 2008, AM J PHYSIOL-ENDOC M, V294, pE1070, DOI 10.1152/ajpendo.00529.2007
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Stout MB, 2014, AGING-US, V6, P575, DOI 10.18632/aging.100681
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003
   Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557
   Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651
   Tsutsui T, 1999, MOL CELL BIOL, V19, P7011
   TZANKOFF SP, 1978, J APPL PHYSIOL, V45, P536, DOI 10.1152/jappl.1978.45.4.536
   Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037
   Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014
   van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425
   Vasile E, 2001, FASEB J, V15, P458, DOI 10.1096/fj.00-0051com
   Villaret A, 2010, DIABETES, V59, P2755, DOI 10.2337/db10-0398
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   Wei FJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11900
   Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x
   Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005
   White TA, 2014, GERONTOLOGY, V60, P289, DOI 10.1159/000356740
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Xu M, 2015, ELIFE, P4
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zannolli R, 2008, ACTA PAEDIATR, V97, P952, DOI 10.1111/j.1651-2227.2008.00783.x
   Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364
   Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011
   Zhang XY, 2011, J NUTR, V141, P1254, DOI 10.3945/jn.111.139576
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
   Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207
NR 134
TC 53
Z9 55
U1 1
U2 29
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0303-7207
J9 MOL CELL ENDOCRINOL
JI Mol. Cell. Endocrinol.
PD NOV 5
PY 2017
VL 455
IS C
SI SI
BP 93
EP 102
DI 10.1016/j.mce.2016.08.047
PG 10
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA FI8LG
UT WOS:000412253500011
PM 27591120
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Jiang, JX
   Fish, SR
   Tomilov, A
   Li, Y
   Fan, WG
   Dehnad, A
   Gae, D
   Das, S
   Mozes, G
   Charville, GW
   Ramsey, J
   Cortopassi, G
   Török, NJ
AF Jiang, Joy X.
   Fish, Sarah R.
   Tomilov, Alexey
   Li, Yuan
   Fan, Weiguo
   Dehnad, Ali
   Gae, David
   Das, Suvarthi
   Mozes, Gergely
   Charville, Gregory W.
   Ramsey, Jon
   Cortopassi, Gino
   Torok, Natalie J.
TI Nonphagocytic Activation of NOX2 Is Implicated in Progressive
   Nonalcoholic Steatohepatitis During Aging
SO HEPATOLOGY
LA English
DT Article; Early Access
ID FATTY LIVER-DISEASE; LIFE-SPAN; SENESCENCE; FIBROSIS; SIRT1; MICE
AB Background and Aims Older patients with obesity/type II diabetes mellitus frequently present with advanced NASH. Whether this is due to specific molecular pathways that accelerate fibrosis during aging is unknown. Activation of the Src homology 2 domain-containing collagen-related (Shc) proteins and redox stress have been recognized in aging; however, their link to NASH has not been explored. Approach and Results Shc expression increased in livers of older patients with NASH, as assessed by real time quantitative PCR (RT-qPCR) or western blots. Fibrosis, Shc expression, markers of senescence, and nicotinamide adenine dinucleotide phosphate, reduced form oxidases (NOXs) were studied in young/old mice on fast food diet (FFD). To inhibit Shc in old mice, lentiviral (LV)-short hairpin Shc versus control-LV were used during FFD. For hepatocyte-specific effects, floxed (fl/fl) Shc mice on FFD were injected with adeno-associated virus 8-thyroxine-binding globulin-Cre-recombinase versus control. Fibrosis was accelerated in older mice on FFD, and Shc inhibition by LV in older mice or hepatocyte-specific deletion resulted in significantly improved inflammation, reduction in senescence markers in older mice, lipid peroxidation, and fibrosis. To study NOX2 activation, the interaction of p47(phox)(NOX2 regulatory subunit) and p52Shc was evaluated by proximity ligation and coimmunoprecipitations. Palmitate-induced p52Shc binding to p47(phox), activating the NOX2 complex, more so at an older age. Kinetics of binding were assessed in Src homology 2 domain (SH2) or phosphotyrosine-binding (PTB) domain deletion mutants by biolayer interferometry, revealing the role of SH2 and the PTB domains. Lastly, anin silicomodel of p52Shc/p47(phox)interaction using RosettaDock was generated. Conclusions Accelerated fibrosis in the aged is modulated by p52Shc/NOX2. We show a pathway for direct activation of the phagocytic NOX2 in hepatocytes by p52Shc binding and activating the p47(phox)subunit that results in redox stress and accelerated fibrosis in the aged.
C1 [Jiang, Joy X.; Fish, Sarah R.] Univ Calif Davis, Med Ctr, Gastroenterol & Hepatol, Sacramento, CA USA.
   [Tomilov, Alexey; Ramsey, Jon; Cortopassi, Gino] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA USA.
   [Li, Yuan; Fan, Weiguo; Dehnad, Ali; Das, Suvarthi; Mozes, Gergely; Torok, Natalie J.] Stanford Univ, Gastroenterol & Hepatol, 300 Pasteur Dr, Stanford, CA 94304 USA.
   [Gae, David] Univ Calif San Francisco, Sch Med, Dept Surg, San Francisco, CA 94143 USA.
   [Charville, Gregory W.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.
   [Torok, Natalie J.] VA Palo Alto, Palo Alto, CA USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Davis;
   Stanford University; University of California System; University of
   California San Francisco; Stanford University; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care
   System
RP Török, NJ (corresponding author), Stanford Univ, Gastroenterol & Hepatol, 300 Pasteur Dr, Stanford, CA 94304 USA.
EM ntorok@stanford.edu
RI Li, Yuan/J-7786-2019
OI Li, Yuan/0000-0002-3171-8053; Fan, Weiguo/0000-0002-2382-5473; Mozes,
   Gergely/0000-0001-8567-6496
FU National Institute of Diabetes and Digestive and Kidney Diseases [R01
   DK083283]; National Institute on Aging (NIA) [1RO1AG060726, I01
   BX002418, PO1 AG025532]; SPARK Program, Stanford University, Weston
   Havens Foundation
FX This research was supported by funding from the National Institute of
   Diabetes and Digestive and Kidney Diseases R01 DK083283 (N.J. T.),
   National Institute on Aging (NIA) 1RO1AG060726 (G.C and N.J.T.), I01
   BX002418 (N.J.T.), SPARK Program, Stanford University, Weston Havens
   Foundation (N.J. T.), and NIA PO1 AG025532 (J.R. and G.C.).
CR Angulo P, 2015, SEMIN LIVER DIS, V35, P132, DOI 10.1055/s-0035-1550065
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bettaieb A, 2015, GASTROENTEROLOGY, V149, P468, DOI 10.1053/j.gastro.2015.04.009
   Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011
   Fusco S, 2012, CELL CYCLE, V11, P4135, DOI 10.4161/cc.22074
   Hagopian Kevork, 2016, Biochem Biophys Rep, V7, P273, DOI 10.1016/j.bbrep.2016.06.021
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Pibiri M, 2018, AGING-US, V10, P1801, DOI 10.18632/aging/101524
   Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107
   Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200
   Shaw PX, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/569146
   SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9
   Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622
   Tomilov A, 2016, J BIOL CHEM, V291, P12575, DOI 10.1074/jbc.M115.695577
   Tomilov A, 2014, AGING CELL, V13, P1049, DOI 10.1111/acel.12267
   Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Xu F, 2014, AGING CELL, V13, P185, DOI 10.1111/acel.12176
   Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008
   ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0
NR 24
TC 9
Z9 10
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2020 OCT
PY 2020
VL 72
IS 4
BP 1204
EP 1218
DI 10.1002/hep.31118
EA OCT 2020
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA OA2QV
UT WOS:000579619900001
PM 31950520
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Hu, B
   An, HM
   Shen, KP
   Xu, L
   Du, Q
   Deng, S
   Wu, Y
AF Hu, Bing
   An, Hong-Mei
   Shen, Ke-Ping
   Xu, Ling
   Du, Qin
   Deng, Shan
   Wu, Yang
TI Liver Yin deficiency tonifying herbal extract induces apoptosis and cell
   senescence in Bel-7402 human hepatocarcinoma cells
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE hepatocarcinoma; Chinese herbal formula; apoptosis; cell senescence
ID TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; IN-VITRO;
   HEPATOCELLULAR-CARCINOMA; ACCELERATED SENESCENCE; DEATH PATHWAYS;
   TUMOR-CELLS; CANCER; THERAPY; RESVERATROL; AUTOPHAGY
AB Liver cancer ranks as the fifth most prevalent malignancy of all cancers worldwide. According to the principles of traditional Chinese medicine, liver Yin deficiency is a common clinical syndrome of liver cancer, and tonifying liver Yin is a common treatment method for liver cancer. However, no hepatocarcinoma-specific liver Yin tonifying formula has yet been established. In the present study, we established a liver cancer-specific combination of herbs, which we term liver Yin tonifying formula (LYTF). We found that LYTF inhibits the proliferation of Bel-7402 cells in a dose- and time-dependent manner. LYTF induces apoptosis in Bel-7402 cells, which is accompanied by activation of caspases-8, -9 and -3. Pan-caspase blocking completely abrogates LYTF-induced apoptosis and partially abrogates LYTF-induced proliferation inhibition. LYTF also induces cell senescence, as indicated by a large and flattened morphology, senescence-activated beta-galactosidase-positive staining and G0/G1 cell cycle arrest, accompanied by the up-regulation of p16 and p21 and the down-regulation of retinoblastoma protein phosphorylation. These findings suggest that LYTF is effective in inhibiting the growth and survival of hepatocarcinoma cells through the induction of apoptosis and cell senescence. Our study also provides insight into traditional Chinese medicine methods used for the treatment of liver cancer.
C1 [Hu, Bing; Shen, Ke-Ping; Xu, Ling; Du, Qin; Deng, Shan] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Oncol, Shanghai 200032, Peoples R China.
   [Hu, Bing; Shen, Ke-Ping; Xu, Ling; Du, Qin; Deng, Shan] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Tradit Chinese Med Oncol, Shanghai 200032, Peoples R China.
   [An, Hong-Mei] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Sci & Technol, Shanghai 200032, Peoples R China.
   [Wu, Yang] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.
   [Wu, Yang] Sichuan Univ, W China Med Sch, W China Hosp, Ctr Canc, Chengdu, Sichuan, Peoples R China.
C3 Shanghai University of Traditional Chinese Medicine; Shanghai University
   of Traditional Chinese Medicine; Shanghai University of Traditional
   Chinese Medicine; Sichuan University; Sichuan University
RP Hu, B (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Oncol, 725 S Wanping Rd, Shanghai 200032, Peoples R China.
EM beearhu@hotmail.com
OI An, Hong-Mei/0000-0001-6656-9409
FU Science and Technology Commission of Shanghai Municipality
   [09JC1413600]; State Clinical Research Center of TCM [LYTD-04]; Key
   Discipline of State Administration of Traditional Chinese Medicine
   (Traditional Chinese Medicine in Oncology); Shanghai Shen Kang Platform
   [SHDC12007206]
FX This study was partially supported by the Key Basic Research Program
   from the Science and Technology Commission of Shanghai Municipality
   (09JC1413600), the Program for Long-Yi Scholars and Research Team in
   State Clinical Research Center of TCM (LYTD-04), the Key Discipline of
   State Administration of Traditional Chinese Medicine (Traditional
   Chinese Medicine in Oncology) and the Shanghai Shen Kang Platform Grant
   (SHDC12007206). The authors would also like to thank the Shanghai Key
   Laboratory of Tissue Engineering for providing technical assistance.
CR [Anonymous], SHANXI COLL TRADIT C
   [Anonymous], WORLD J INTEGR TRADI
   Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560
   Chang UM, 2006, LIFE SCI, V79, P1129, DOI 10.1016/j.lfs.2006.03.027
   Chiantore MV, 2009, CURR MED CHEM, V16, P287, DOI 10.2174/092986709787002691
   Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708
   Di X, 2009, BIOCHEM PHARMACOL, V77, P1139, DOI 10.1016/j.bcp.2008.12.016
   Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Feng Lei, 2006, Zhong Yao Cai, V29, P689
   Gao Z, 2011, BIOCHEM BIOPH RES CO, V407, P271, DOI 10.1016/j.bbrc.2011.02.008
   Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024
   Hagymasi Krisztina, 2008, Orvosi Hetilap, V149, P541, DOI 10.1556/OH.2008.28313
   Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200
   Hou FG, 2005, SHANGHAI J TRADIT CH, V9, P22
   Hsu YL, 2008, J GASTROEN HEPATOL, V23, pE290, DOI 10.1111/j.1440-1746.2008.05390.x
   Hu B, 2011, CANCER BIOTHER RADIO, V26, P97, DOI 10.1089/cbr.2010.0853
   Hu Bing, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P1048, DOI 10.3736/jcim20101108
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0
   Li Lin, 2008, Zhongguo Yaolixue Tongbao, V24, P1619
   Liu Qing, 2005, Zhong Xi Yi Jie He Xue Bao, V3, P260
   Lodygin D, 2002, J CLIN INVEST, V110, P1717, DOI 10.1172/JCI200216588
   Lord R, 2011, INT J CLIN PRACT, V65, P182, DOI 10.1111/j.1742-1241.2010.02545.x
   Meier P, 2007, MOL CELL, V28, P746, DOI 10.1016/j.molcel.2007.11.016
   Meng MB, 2008, J ALTERN COMPLEM MED, V14, P1027, DOI 10.1089/acm.2008.0060
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Oliveri RS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004787.pub2
   Pan MQ, 2003, CHINESE ARCH TRADIT, V1, P1641
   Rampone B, 2010, CURR ONCOL REP, V12, P186, DOI 10.1007/s11912-010-0094-3
   Roninson IB, 2003, CANCER RES, V63, P2705
   Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005
   Shu Xiaojuan, 2005, Integr Cancer Ther, V4, P219, DOI 10.1177/1534735405279927
   te Poele RH, 2002, CANCER RES, V62, P1876
   Wysocki PJ, 2010, EXPERT OPIN INV DRUG, V19, P265, DOI 10.1517/13543780903514110
   Xiang M, 2002, JIANGSU MED J CLIN R, V0, P13
   Xing R, 2011, GUT             0614
   Yan SL, 2010, TOXICOL IN VITRO, V24, P842, DOI 10.1016/j.tiv.2009.12.008
   [杨建文 Yang Jianwen], 2004, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V13, P156
   Yu Y, 2009, CANCER-AM CANCER SOC, V115, P5132, DOI 10.1002/cncr.24567
   杜琴, 2010, [中药材, Journal of Chinese Medicinal Materials], V33, P1512
NR 41
TC 9
Z9 10
U1 0
U2 11
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD JAN
PY 2012
VL 3
IS 1
BP 80
EP 86
DI 10.3892/etm.2011.364
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 862WN
UT WOS:000298124900015
PM 22969849
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Cen, YL
   Qi, JJ
   Chen, L
   Xia, CX
   Zheng, M
   Liu, YN
   Lou, GH
AF Cen, Yelei
   Qi, Jinjin
   Chen, Liang
   Xia, Caixia
   Zheng, Min
   Liu, Yanning
   Lou, Guohua
TI Decreased miR-17-92 cluster correlates with senescence features,
   disrupted oxidative homeostasis, and impaired therapeutic efficacy of
   mesenchymal stem cells
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE acute liver failure; adipose tissue-derived mesenchymal stem cells;
   MiR-17-92 cluster; oxidative homeostasis; senescence
ID SURVIVAL; STRESS
AB Aging and replicative cellular senescence are associated with the reduced therapeutic potential of mesenchymal stem cells (MSCs) on a variety of diseases. This study aimed to determine the mechanism in MSC senescence and further explore a modification strategy to reverse senescence-associated cell dysfunction to improve the therapeutic efficacy of MSCs on acute liver failure (ALF). We found that the adipose tissue-derived MSCs from old mice (oAMSCs) exhibited senescence phenotypes and showed reduced therapeutic efficacy in lipopolysaccharide and D-galactosamine-induced ALF, as shown by the increased hepatic necrosis, liver histology activity index scores, serum liver function indicator levels, and inflammatory cytokine levels. The expression of miR-17-92 cluster members, especially miR-17 and miR-20a, was obviously decreased in oAMSCs and replicatively senescent AMSCs, and was consistent with the decreased oncogene c-Myc level during AMSC senescence and may mediate c-Myc stemness addiction. Further experiments revealed that c-Myc-regulated miR-17-92 expression contributed to increased p21 expression and redox system dysregulation during AMSC senescence. Furthermore, modification of AMSCs with the two key miRNAs in the miR-17-92 cluster mentioned above reversed the senescence features of oAMSCs and restored the therapeutic effect of senescent AMSCs on ALF. In conclusion, the cellular miR-17-92 cluster level is correlated with AMSC senescence and can be used both as an index for evaluating and as a modification target for improving the therapeutic potential of AMSCs.
   NEW & NOTEWORTHY We reported for the first time that c-Myc-regulated miR-17-92 contributed to increased p21 expression and redox system dysregulation during AMSC senescence and was associated with the reduced therapeutic effects of senescent AMSCs on ALF. Moreover, modifying the expression of the miR-17-92 cluster members, especially miR-17 and/or miR-20a, could reverse AMSC senescence. Thus, miR-17-92 cluster can be used both as an index for evaluating and as a modification strategy for improving the therapeutic potential of AMSCs.
C1 [Cen, Yelei; Qi, Jinjin; Xia, Caixia; Zheng, Min; Liu, Yanning; Lou, Guohua] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Dis, State Key Lab Diag & Treatment Infect Dis, Natl Clin Res Ctr Infect Dis,Affiliated Hosp 1,Col, Hangzhou, Peoples R China.
   [Chen, Liang] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Thyroid Dis Diag & Treatment Ctr, Hangzhou, Peoples R China.
   [Xia, Caixia] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Infect Dis, Sch Med, Hangzhou, Peoples R China.
C3 Collaborative Innovation Center for Diagnosis & Treatment of Infectious
   Diseases; Zhejiang University; Zhejiang University; Zhejiang University
RP Zheng, M; Liu, YN; Lou, GH (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Dis, State Key Lab Diag & Treatment Infect Dis, Natl Clin Res Ctr Infect Dis,Affiliated Hosp 1,Col, Hangzhou, Peoples R China.
EM minzheng@zju.edu.cn; liuyanning@zju.edu.cn; louguohua@zju.edu.cn
FU National Natural Science Foundation of China [81870428, 82270624];
   Ten-Thousands Talents Program of Zhejiang Province [2020R52010];
   Fundamental Research Funds for the Central Universities [2021FZZX001-41,
   K20210183]; Independent Task of State Key Laboratory for Diagnosis and
   Treatment of Infectious Diseases [zz202314, 2022zz20]
FX This study was supported by the National Natural Science Foundation of
   China (81870428 and 82270624), the Ten-Thousands Talents Program of
   Zhejiang Province (2020R52010),the Fundamental Research Funds for the
   Central Universities(2021FZZX001-41 and K20210183), and the Independent
   Task of State Key Laboratory for Diagnosis and Treatment of Infectious
   Diseases (zz202314 and 2022zz20).
CR Auler M, 2021, J INVEST DERMATOL, V141, P1076, DOI 10.1016/j.jid.2020.11.011
   Balsera M, 2019, FREE RADICAL BIO MED, V140, P28, DOI 10.1016/j.freeradbiomed.2019.03.003
   Block TJ, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0688-x
   Sepúlveda JC, 2014, STEM CELLS, V32, P1865, DOI 10.1002/stem.1654
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   Dai ZT, 2021, INT J BIOL SCI, V17, P2278, DOI 10.7150/ijbs.57338
   Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986
   Gnani D, 2019, AGING CELL, V18, DOI 10.1111/acel.12933
   Horiguchi M, 2021, J CELL MOL MED, V25, P4298, DOI 10.1111/jcmm.16484
   Hou XH, 2019, AM J PHYSIOL-CELL PH, V316, pC104, DOI 10.1152/ajpcell.00313.2018
   Kanzaki H, 2011, PROTEOMICS, V11, P3531, DOI 10.1002/pmic.201000501
   Kim YJ, 2012, STEM CELLS DEV, V21, P1749, DOI 10.1089/scd.2011.0429
   Kornicka K, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/309169
   Lee JH, 2020, AGING CELL, V19, DOI 10.1111/acel.13111
   Li YL, 2014, CANCER CELL, V26, P262, DOI 10.1016/j.ccr.2014.06.014
   Liao NS, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1404-9
   Liu WJ, 2015, AGING-US, V7, P205, DOI 10.18632/aging.100728
   Liu YN, 2018, EBIOMEDICINE, V36, P140, DOI 10.1016/j.ebiom.2018.08.054
   Lou GH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-019-1512-5
   Lou GH, 2017, J CELL MOL MED, V21, P2963, DOI 10.1111/jcmm.13208
   Ma XJ, 2020, MECH AGEING DEV, V189, DOI 10.1016/j.mad.2020.111264
   Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125
   Oberacker T, 2018, FEBS LETT, V592, P2297, DOI 10.1002/1873-3468.13156
   Patel P, 2018, CLIN LIVER DIS, V22, P419, DOI 10.1016/j.cld.2018.01.011
   Rossi M, 2020, TRENDS MOL MED, V26, P422, DOI 10.1016/j.molmed.2020.01.010
   Saleh M, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00433-z
   Stravitz RT, 2019, LANCET, V394, P869, DOI 10.1016/S0140-6736(19)31894-X
   Tomé M, 2014, STEM CELLS, V32, P2229, DOI 10.1002/stem.1699
   Urtasun R, 2016, ONCOGENE, V35, P4719, DOI 10.1038/onc.2015.517
   Vaira V, 2020, CLIN SCI, V134, P1151, DOI 10.1042/CS20200032
   van den Brand FF, 2021, EUR J INTERN MED, V90, P30, DOI 10.1016/j.ejim.2021.03.024
   Vono R, 2018, ANTIOXID REDOX SIGN, V29, P864, DOI 10.1089/ars.2017.7294
   Ye D, 2018, J CELL MOL MED, V22, P6167, DOI 10.1111/jcmm.13902
   Zhu ED, 2018, J MOL ENDOCRINOL, V60, P225, DOI 10.1530/JME-17-0183
   Zhuang YT, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.631835
NR 35
TC 3
Z9 3
U1 2
U2 3
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0363-6143
EI 1522-1563
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD AUG 1
PY 2023
VL 325
IS 2
BP C443
EP C455
DI 10.1152/ajpcell.00515.2022
PG 13
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA R5CW3
UT WOS:001064537700001
PM 37366574
DA 2024-02-19
ER

PT J
AU Ma, JX
   Hu, XP
   Liao, CH
   Xiao, HT
   Zhu, QC
   Li, Y
   Liu, ZG
   Tao, AJ
   He, ZD
   Xu, CS
   Zheng, K
AF Ma, Jingxin
   Hu, Xiaopeng
   Liao, Chenghui
   Xiao, Haitao
   Zhu, Qinchang
   Li, Ying
   Liu, Zhigang
   Tao, Anjin
   He, Zhendan
   Xu, Chenshu
   Zheng, Kai
TI Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells
   by Inducing Senescence
SO MOLECULES
LA English
DT Article
DE gypenoside L; senescence; NF-B signaling; MAPK; cell cycle arrest;
   chemoresistance
ID NATURAL-PRODUCTS; GYNOSTEMMA-PENTAPHYLLUM; DEATH; APOPTOSIS; AUTOPHAGY;
   ACTIVATION; PROSTATE; PATHWAY; KINASE; HEPG2
AB Senescence is an irreversible state of cell cycle arrest that can be triggered by multiple stimuli, such as oxygen reactive species and DNA damage. Growing evidence has proven that senescence is a tumor-suppressive approach in cancer treatment. Therefore, developing novel agents that modulate senescence may be an alternative strategy against cancer. In our study, we investigated the inhibitory effect of gypenoside L (Gyp-L), a saponin isolated from Gynostemma pentaphyllum, on cancer cell growth. We found that Gyp-L increased the SA--galactosidase activity, promoted the production of senescence-associated secretory cytokines, and inhibited cell proliferation of human liver and esophageal cancer cells. Moreover, Gyp-L caused cell cycle arrest at S phase, and activated senescence-related cell cycle inhibitor proteins (p21 and p27) and their upstream regulators. In addition, Gyp-L activated p38 and ERK MAPK pathways and NF-B pathway to induce senescence. Consistently, adding chemical inhibitors efficiently counteracted the Gyp-L-mediated senescence, growth inhibition, and cell cycle arrest in cancer cells. Furthermore, treatment with Gyp-L, enhanced the cytotoxicity of clinic therapeutic drugs, including 5-fluorouracil and cisplatin, on cancer cells. Overall, these results indicate that Gyp-L inhibits proliferation of cancer cells by inducing senescence and renders cancer cells more sensitive to chemotherapy.
C1 [Ma, Jingxin; Hu, Xiaopeng; Liao, Chenghui; Xiao, Haitao; Zhu, Qinchang; Li, Ying; Liu, Zhigang; He, Zhendan; Xu, Chenshu; Zheng, Kai] Shenzhen Univ, Sch Pharmaceut Sci, Shenzhen Key Lab Novel Nat Hlth Care Prod,Hlth Sc, Engn Lab Shenzhen Nat Small Mol Innovat Drugs Hlt, Shenzhen 518060, Peoples R China.
   [Tao, Anjin] Hybio Pharmaceut Co Ltd, Shenzhen 518057, Peoples R China.
   [He, Zhendan] Shenzhen Univ, Guangdong Key Lab Genome Stabil & Human Dis Preve, Hlth Sci Ctr, Shenzhen 518060, Peoples R China.
C3 Shenzhen University; Shenzhen University
RP Xu, CS; Zheng, K (corresponding author), Shenzhen Univ, Sch Pharmaceut Sci, Shenzhen Key Lab Novel Nat Hlth Care Prod,Hlth Sc, Engn Lab Shenzhen Nat Small Mol Innovat Drugs Hlt, Shenzhen 518060, Peoples R China.
EM 18565811720@163.com; hu54398@2008.sina.com; liao.chenghui66@gmail.com;
   Xhaitao@szu.edu.cn; Zhuqc@szu.edu.cn; li.ying@szu.edu.cn;
   lzg@szu.edu.cn; taoanjin@hybio.com.cn; hezhendan@szu.edu.cn;
   cshuxu@szu.edu.cn; zhengk@szu.edu.cn
RI Li, Ying/AAC-1331-2021; Zheng, Kai/AAT-8994-2021; Zheng,
   Kai/AFE-1969-2022; Hu, Xiaoyu/JPK-8482-2023
OI Zheng, Kai/0000-0001-9275-1239; Zheng, Kai/0000-0001-9275-1239; 
FU National Key R & D Program of China [2017YFA053900]; National Natural
   Science Foundation of China [81603341, U1702286, 31670360]; Guangdong
   Science and Technology Project [2017B090901016]; Shenzhen Science and
   Technology Project [JCYJ20170818141722713]; New Teacher Natural Science
   Research Project of Shenzhen University [2018021]
FX This research was funded by the National Key R & D Program of China (No.
   2017YFA053900), the National Natural Science Foundation of China (No.
   81603341, U1702286, 31670360), the Guangdong Science and Technology
   Project (2017B090901016), the Shenzhen Science and Technology Project
   (JCYJ20170818141722713), and the New Teacher Natural Science Research
   Project of Shenzhen University (No. 2018021).
CR Alcántara-Flores E, 2015, MOLECULES, V20, P21125, DOI 10.3390/molecules201219757
   Brandsma I, 2017, EXPERT OPIN INV DRUG, V26, P1341, DOI 10.1080/13543784.2017.1389895
   Butera G, 2018, SEMIN CELL DEV BIOL, V78, P3, DOI 10.1016/j.semcdb.2017.07.019
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005
   Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005
   Chang UM, 2006, LIFE SCI, V79, P1129, DOI 10.1016/j.lfs.2006.03.027
   Cheng TC, 2011, J AGR FOOD CHEM, V59, P11319, DOI 10.1021/jf2018758
   Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890
   Cragg GM, 2016, MED PRIN PRACT, V25, P41, DOI 10.1159/000443404
   Gao J, 2019, CHEM-BIOL INTERACT, V297, P50, DOI 10.1016/j.cbi.2018.10.014
   Grossi V, 2014, WORLD J GASTROENTERO, V20, P9744, DOI 10.3748/wjg.v20.i29.9744
   Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4
   Jiang YL, 2017, ONCOL REP, V38, P3668, DOI 10.3892/or.2017.6035
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   Liao CH, 2016, ONCOTARGET, V7, P47387, DOI 10.18632/oncotarget.10159
   Lin JF, 2017, DRUG DES DEV THER, V11, P1517, DOI 10.2147/DDDT.S126464
   Liu JS, 2015, J CELL MOL MED, V19, P1697, DOI 10.1111/jcmm.12546
   Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065
   Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038
   Osorio FG, 2016, INT REV CEL MOL BIO, V326, P133, DOI 10.1016/bs.ircmb.2016.04.003
   Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213
   Sanders K, 2016, SEMIN ONCOL NURS, V32, P215, DOI 10.1016/j.soncn.2016.06.001
   Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518
   Shi L, 2015, CHEM-BIOL INTERACT, V238, P48, DOI 10.1016/j.cbi.2015.06.004
   Xie ZH, 2010, J AGR FOOD CHEM, V58, P11243, DOI 10.1021/jf1026372
   Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004
   Yan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095609
   Yuan RYK, 2017, ANN NY ACAD SCI, V1401, P19, DOI 10.1111/nyas.13387
   Zdanov S, 2006, FEBS LETT, V580, P6455, DOI 10.1016/j.febslet.2006.10.064
   Zhao JH, 2016, PHARMACOL THERAPEUT, V160, P145, DOI 10.1016/j.pharmthera.2016.02.008
   Zheng K, 2019, THERANOSTICS, V9, P104, DOI 10.7150/thno.30308
   Zheng K, 2017, J AGR FOOD CHEM, V65, P6625, DOI 10.1021/acs.jafc.7b02296
   Zheng K, 2016, AUTOPHAGY, V12, P1593, DOI 10.1080/15548627.2016.1192751
   Zheng K, 2016, J AGR FOOD CHEM, V64, P1702, DOI 10.1021/acs.jafc.5b05668
NR 36
TC 22
Z9 23
U1 0
U2 21
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD MAR 2
PY 2019
VL 24
IS 6
AR 1054
DI 10.3390/molecules24061054
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA HU8AD
UT WOS:000465503800030
PM 30889805
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Ishizuka, K
   Kon, K
   Lee-Okada, HC
   Arai, K
   Uchiyama, A
   Yamashina, S
   Yokomizo, T
   Ikejima, K
AF Ishizuka, Kei
   Kon, Kazuyoshi
   Lee-Okada, Hyeon-Cheol
   Arai, Kumiko
   Uchiyama, Akira
   Yamashina, Shunhei
   Yokomizo, Takehiko
   Ikejima, Kenichi
TI Aging exacerbates high-fat diet-induced steatohepatitis through
   alteration in hepatic lipid metabolism in mice
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Early Access
DE aging; fatty acid metabolism; lipidomics; lipotoxicity; non-alcoholic
   steatohepatitis
ID OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; MOLECULAR-MECHANISMS;
   LIVER-DISEASE; PPAR-ALPHA; ACID; STEATOSIS; SIRT1; LIPOTOXICITY;
   PREVALENCE
AB Background and Aim Aging is an independent risk factor for the progression of non-alcoholic steatohepatitis. Here, we investigated the role of age-related alterations in fatty acid metabolism in dietary steatohepatitis using lipidomics analysis.
   Methods Male 8-week and 55-week-old C57BL/6 J mice were fed a high-fat diet (HFD) for 8 weeks. The quality and quantity of lipid molecular species in the liver were evaluated using the lipidomics approach.
   Results Elder mice fed an HFD developed more severe steatohepatitis than young mice. Oxidative stress and inflammatory cytokines in the liver were exacerbated following HFD feeding in elder mice compared with young mice. In elder mice, de novo fatty acid synthesis was promoted, whereas beta oxidation was blunted following HFD feeding, and lipid secretion from the liver was reduced. The expression of sirtuin 1 was not only reduced with age as expected but also significantly decreased due to intake of HFD. In the lipidomics analysis, the concentrations of diacylglycerol and TAG molecular species containing monounsaturated fatty acids were markedly increased following HFD feeding in elder mice compared with young mice. In contrast, the concentration of phosphatidylethanolamine and phosphatidylcholine molecular species containing polyunsaturated fatty acids were remarkably decreased following HFD feeding in elder mice compared with young mice, and the expression of fatty acid desaturase was blunted.
   Conclusions Aging-dependent alterations in lipid metabolism under excessive lipid supply most likely enhance hepatic lipotoxicity, thereby exacerbating metabolic steatohepatitis in elderly.
C1 [Ishizuka, Kei; Kon, Kazuyoshi; Arai, Kumiko; Uchiyama, Akira; Yamashina, Shunhei; Ikejima, Kenichi] Juntendo Univ, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.
   [Lee-Okada, Hyeon-Cheol; Yokomizo, Takehiko] Juntendo Univ, Grad Sch Med, Dept Biochem, Tokyo, Japan.
C3 Juntendo University; Juntendo University
RP Kon, K (corresponding author), Juntendo Univ, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.
EM kazukon@juntendo.ac.jp
RI Yokomizo, Takehiko/P-5673-2016; Lee-Okada, Hyeon-Cheol/AAQ-4520-2021;
   Kon, Kazuyoshi/AAV-7832-2020
OI Yokomizo, Takehiko/0000-0002-5219-1553; Lee-Okada,
   Hyeon-Cheol/0000-0002-5493-8112; Kon, Kazuyoshi/0000-0002-1127-2218;
   Uchiyama, Akira/0000-0003-3814-2760; Ikejima,
   Kenichi/0000-0002-2657-0840
FU JSPS KAKENHI [17K09440, 15K09023]; Grants-in-Aid for Scientific Research
   [17K09440, 15K09023] Funding Source: KAKEN
FX This work was supported in part by JSPS KAKENHI (17K09440 to K.K. and
   15K09023 to K.I.)
CR Alwayn IPJ, 2005, PEDIATR RES, V57, P445, DOI 10.1203/01.PDR.0000153672.43030.75
   Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2
   Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001
   Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604
   Bharat D, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700601
   Byrdwell WC, 2002, LIPIDS, V37, P1087, DOI 10.1007/s11745-002-1004-1
   Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003
   de Mello-Coelho V, 2017, MECH AGEING DEV, V167, P46, DOI 10.1016/j.mad.2017.08.015
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Drew JE, 2016, J NUTR BIOCHEM, V37, P20, DOI 10.1016/j.jnutbio.2016.07.013
   El-Badry AM, 2007, J HEPATOL, V47, P718, DOI 10.1016/j.jhep.2007.08.005
   Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514
   Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009
   Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199
   Hirsova P, 2016, J LIPID RES, V57, P1758, DOI 10.1194/jlr.R066357
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200
   Ikeda I, 2014, BIOSCI BIOTECH BIOCH, V78, P1584, DOI 10.1080/09168451.2014.923297
   Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005
   Kawanishi N, 2018, AM J PHYSIOL-REG I, V314, pR892, DOI 10.1152/ajpregu.00371.2017
   Kon K, 2017, HEPATOL RES, V47, pE44, DOI 10.1111/hepr.12720
   Kusama H, 2017, J GASTROENTEROL, V52, P611, DOI 10.1007/s00535-016-1256-3
   Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004
   Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Matsuzaka T, 2002, J LIPID RES, V43, P107
   Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018
   Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376
   Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763
   Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Ralston JC, 2017, ANNU REV NUTR, V37, P77, DOI 10.1146/annurev-nutr-071816-064836
   Salie MJ, 2016, BBA-MOL CELL BIOL L, V1861, P1207, DOI 10.1016/j.bbalip.2016.04.004
   Sanyal AJ, 2014, GASTROENTEROLOGY, V147, P377, DOI 10.1053/j.gastro.2014.04.046
   Shih LM, 2018, MOLECULES, V23, DOI 10.3390/molecules23112862
   Suzuki M, 2019, ALCOHOL CLIN EXP RES, V43, P617, DOI 10.1111/acer.13982
   Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001
   Watanabe S, 2015, HEPATOL RES, V45, P363, DOI 10.1111/hepr.12511
   Wu MT, 2014, MAR DRUGS, V12, P964, DOI 10.3390/md12020964
   Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200
NR 43
TC 11
Z9 11
U1 3
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD 2020 AUG
PY 2020
VL 35
IS 8
BP 1437
EP 1448
DI 10.1111/jgh.15006
EA FEB 2020
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA MT4YS
UT WOS:000513758500001
PM 32030821
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Kriss, CL
   Duro, N
   Nadeau, OW
   Guergues, J
   Chavez-Chiang, O
   Culver-Cochran, AE
   Chaput, D
   Varma, S
   Stevens, SM
AF Kriss, Crystina L.
   Duro, Nalvi
   Nadeau, Owen W.
   Guergues, Jennifer
   Chavez-Chiang, Omar
   Culver-Cochran, Ashley E.
   Chaput, Dale
   Varma, Sameer
   Stevens, Stanley M., Jr.
TI Site-specific identification and validation of hepatic histone nitration
   in vivo: Implications for alcohol-induced liver injury
SO JOURNAL OF MASS SPECTROMETRY
LA English
DT Article
DE alcohol; histone; liver; nitration; oxidative and nitrative stress
ID MODULATES TYROSINE PHOSPHORYLATION; PROTEIN NITRATION; NITRIC-OXIDE;
   PEROXYNITRITE; NEURODEGENERATION; PARTICLE
AB Oxidative and nitrative stress have been implicated in the molecular mechanisms underlying a variety of biological processes and disease states including cancer, aging, cardiovascular disease, neurological disorders, diabetes, and alcohol-induced liver injury. One marker of nitrative stress is the formation of 3-nitrotyrosine, or protein tyrosine nitration (PTN), which has been observed during inflammation and tissue injury; however, the role of PTN in the progression or possibly the pathogenesis of disease is still unclear. We show in a model of alcohol-induced liver injury that an increase in PTN occurs in hepatocyte nuclei within the liver of wild-type male C57BL/6J mice following chronic ethanol exposure (28 days). High-resolution mass spectrometric analysis of isolated hepatic nuclei revealed several novel sites of tyrosine nitration on histone proteins. Histone nitration sites were validated by tandem mass spectrometry (MS/MS) analysis of representative synthetic nitropeptides equivalent in sequence to the respective nitrotyrosine sites identified in vivo. We further investigated the potential structural impact of the novel histone H3 Tyr41 (H3Y41) nitration site identified using molecular dynamics (MD) simulations. MD simulations of the nitrated and non-nitrated forms of histone H3Y41 showed significant structural changes at the DNA interface upon H3Y41 nitration. The results from this study suggest that, in addition to other known post-translational modifications that occur on histone proteins (e.g., acetylation and methylation), PTN could induce chromatin structural changes, possibly affecting gene transcription processes associated with the development of alcohol-induced liver injury.
C1 [Kriss, Crystina L.; Duro, Nalvi; Chavez-Chiang, Omar; Culver-Cochran, Ashley E.; Chaput, Dale; Varma, Sameer; Stevens, Stanley M., Jr.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, 4202 E Fowler Ave, Tampa, FL 33620 USA.
   [Kriss, Crystina L.] Houston Method Res Inst, Dept Cardiovasc Regenerat, 6607 Bertner Ave, Houston, TX 77030 USA.
   [Nadeau, Owen W.; Guergues, Jennifer] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 261 Mt View Dr, Colchester, VT 05446 USA.
   [Guergues, Jennifer] Vanderbilt Univ, MSRC Prote Core Lab, Med Res Bldg 3, Nashville, TN 37232 USA.
   [Chavez-Chiang, Omar] H Lee Moffitt Canc Ctr Res Inst, Dept Tumor Biol, 12902 Magnolia Dr, Tampa, FL 33612 USA.
   [Culver-Cochran, Ashley E.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.
C3 State University System of Florida; University of South Florida; Albany
   College of Pharmacy & Health Sciences; Vanderbilt University; H Lee
   Moffitt Cancer Center & Research Institute; Cincinnati Children's
   Hospital Medical Center
RP Stevens, SM (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, 4202 E Fowler Ave, Tampa, FL 33620 USA.
EM smstevens@usf.edu
RI Kriss, Crystina L/E-7800-2013; Stevens, Stanley M./E-4120-2013
OI Stevens, Stanley/0000-0002-1399-0256; Kriss,
   Crystina/0000-0002-8951-5291
FU NIAAA NIH HHS [AA022185] Funding Source: Medline
CR Abdelmegeed MA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/149627
   Bartesaghi S, 2018, REDOX BIOL, V14, P618, DOI 10.1016/j.redox.2017.09.009
   Basnet H, 2014, NATURE, V516, P267, DOI 10.1038/nature13736
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Calingasan NY, 2000, ANN NY ACAD SCI, V903, P353, DOI 10.1111/j.1749-6632.2000.tb06386.x
   Connelly KE, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700427
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8
   Dawson MA, 2009, NATURE, V461, P819, DOI 10.1038/nature08448
   Di Stasi AMM, 1999, J NEUROCHEM, V73, P727
   Dixit K, 2010, INT J BIOL MACROMOL, V46, P20, DOI 10.1016/j.ijbiomac.2009.10.009
   Duncan MW, 2003, AMINO ACIDS, V25, P351, DOI 10.1007/s00726-003-0022-z
   Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985
   Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006
   Halliwell B, 1999, FREE RADICAL RES, V31, P651, DOI 10.1080/10715769900301221
   Haqqani AS, 2002, J BIOL CHEM, V277, P3614, DOI 10.1074/jbc.M105730200
   Hart-Smith G, 2016, MOL CELL PROTEOMICS, V15, P989, DOI 10.1074/mcp.M115.055384
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638
   Khan MA, 2016, INT J BIOL MACROMOL, V82, P31, DOI 10.1016/j.ijbiomac.2015.10.085
   Khan MA, 2017, BIOCHIMIE, V140, P1, DOI 10.1016/j.biochi.2017.06.006
   Kong SK, 1996, P NATL ACAD SCI USA, V93, P3377, DOI 10.1073/pnas.93.8.3377
   Li XH, 1998, BIOCHEM J, V331, P599, DOI 10.1042/bj3310599
   LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   MacMillan-Crow LA, 2001, FREE RADICAL BIO MED, V31, P1603, DOI 10.1016/S0891-5849(01)00750-X
   McKim SE, 2003, GASTROENTEROLOGY, V125, P1834, DOI 10.1053/j.gastro.2003.08.030
   Moran-Salvador E, 2017, CELL MOL GASTROENTER, V4, P125, DOI 10.1016/j.jcmgh.2017.04.007
   Myung Y, 2010, B KOREAN CHEM SOC, V31, P2581, DOI 10.5012/bkcs.2010.31.9.2581
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200
   Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c
   Ren BB, 2019, CURR GENET, V65, P829, DOI 10.1007/s00294-019-00962-2
   Sacksteder CA, 2006, BIOCHEMISTRY-US, V45, P8009, DOI 10.1021/bi060474w
   Seeley KW, 2014, INT J MOL SCI, V15, P6265, DOI 10.3390/ijms15046265
   Seeley KW, 2012, J PROTEOMICS, V75, P1691, DOI 10.1016/j.jprot.2011.11.025
   Shaytan AK, 2016, J MOL BIOL, V428, P221, DOI 10.1016/j.jmb.2015.12.004
   Shi WQ, 2007, REGUL PEPTIDES, V144, P1, DOI 10.1016/j.regpep.2007.06.011
   Souza JM, 2008, FREE RADICAL BIO MED, V45, P357, DOI 10.1016/j.freeradbiomed.2008.04.010
   Stevens SM, 2008, MOL CELL PROTEOMICS, V7, P2442, DOI 10.1074/mcp.M800065-MCP200
   Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006
NR 45
TC 4
Z9 4
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1076-5174
EI 1096-9888
J9 J MASS SPECTROM
JI J. Mass Spectrom.
PD JUN
PY 2021
VL 56
IS 6
AR e4713
DI 10.1002/jms.4713
PG 12
WC Biochemical Research Methods; Chemistry, Analytical; Spectroscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Spectroscopy
GA SP5VI
UT WOS:000659736600003
PM 33942435
DA 2024-02-19
ER

PT J
AU Agrawal, AK
   Shapiro, BH
AF Agrawal, AK
   Shapiro, BH
TI Constitutive and inducible hepatic cytochrome P450 isoforms in senescent
   male and female rats and response to low-dose phenobarbital
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID GROWTH-HORMONE PROFILES; DRUG-METABOLISM; GENDER DIFFERENCES;
   LIVER-MICROSOMES; GENE-EXPRESSION; MESSENGER-RNAS; INDUCTION; AGE;
   RESPONSIVENESS; PURIFICATION
AB Numerous studies, usually limited to male rodents, have reported an inverse relationship between the age of the animal and the activities of various multi-cytochrome P450-dependent drug-metabolizing enzymes. It has been suggested that the aging-induced decline in hepatic drug-metabolizing capacity is solely a male phenomenon. That is, whereas the levels of male-specific isoforms of P450 decline with senescence, the female-dependent isoforms remain unchanged in females and even increase in male liver. In addition to their baseline activities, induction levels of hepatic monooxygenases have also been reported to decrease with aging. To examine aging- and sex-dependent effects on drug metabolism at a more molecular level, we measured the expression (mRNA, protein, and/or catalytic activity) of a near dozen constitutive and inducible isoforms of P450 in 5- and 23-month-old male and female Sprague-Dawley rats. Moreover, we investigated the induction effects of low concentrations of phenobarbital known to reveal gender differences and the threshold sensitivities of both constitutive and inducible isoforms. With the exception of male-specific CYP2C11 (whose expression declined similar to70% in aged male rats), we observed little senescence-associated reduction in either preinduction or induction levels of CYP2B1, CYP2B2, CYP3A1, CYP3A2, CYP2C6, CYP2C7, CYP2C12, and CYP2C13 in either male or female rats. Moreover, the sexually dimorphic expression levels apparent at 5 months of age persisted in the old rats.
C1 Univ Penn, Sch Vet Med, Labs Biochem, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania
RP Shapiro, BH (corresponding author), Univ Penn, Sch Vet Med, Labs Biochem, Philadelphia, PA 19104 USA.
EM shapirob@vet.upenn.edu
FU NICHD NIH HHS [HD16358] Funding Source: Medline; NIGMS NIH HHS [GM45758]
   Funding Source: Medline
CR ABRAHAM NG, 1985, EXP GERONTOL, V20, P277, DOI 10.1016/0531-5565(85)90053-1
   ADELMAN RC, 1971, EXP GERONTOL, V6, P75, DOI 10.1016/0531-5565(71)90051-9
   AGRAWAL AK, 1991, TOXICOL APPL PHARM, V108, P96, DOI 10.1016/0041-008X(91)90272-G
   Agrawal AK, 2001, MOL CELL ENDOCRINOL, V173, P167, DOI 10.1016/S0303-7207(00)00401-9
   AGRAWAL AK, 1995, ANAL BIOCHEM, V224, P455, DOI 10.1006/abio.1995.1071
   Agrawal AK, 1996, MOL PHARMACOL, V49, P523
   Agrawal AK, 2000, J PHARMACOL EXP THER, V292, P228
   BANDIERA S, 1992, ARCH BIOCHEM BIOPHYS, V296, P286, DOI 10.1016/0003-9861(92)90574-G
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   BITAR MS, 1987, MECH AGEING DEV, V38, P189, DOI 10.1016/0047-6374(87)90078-9
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   Dhir RN, 2002, DRUG METAB DISPOS, V30, P141, DOI 10.1124/dmd.30.2.141
   FUJITA S, 1991, YAKUGAKU ZASSHI, V111, P627, DOI 10.1248/yakushi1947.111.11_627
   GEMZIK B, 1992, J BIOCHEM TOXICOL, V7, P43, DOI 10.1002/jbt.2570070109
   HORBACH GJMJ, 1990, BIOCHEM PHARMACOL, V40, P529, DOI 10.1016/0006-2952(90)90552-V
   HORBACH GJMJ, 1992, XENOBIOTICA, V22, P515, DOI 10.3109/00498259209053114
   HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KAO J, 1980, BIOCHEM PHARMACOL, V29, P1191, DOI 10.1016/0006-2952(80)90417-7
   KATO R, 1968, JPN J PHARMACOL, V18, P389, DOI 10.1254/jjp.18.389
   MACGEOCH C, 1984, J BIOL CHEM, V259, P5433
   MCMARTIN DN, 1980, TOXICOL APPL PHARM, V54, P411, DOI 10.1016/0041-008X(80)90168-4
   MORGAN ET, 1985, J BIOL CHEM, V260, P1895
   OMIECINSKI CJ, 1985, J BIOL CHEM, V260, P3247
   Pampori NA, 2000, ENDOCRINOLOGY, V141, P4100, DOI 10.1210/en.141.11.4100
   Pampori NA, 1999, ENDOCRINOLOGY, V140, P1245, DOI 10.1210/en.140.3.1245
   PAMPORI NA, 1991, BIOCHEM PHARMACOL, V41, P1299, DOI 10.1016/0006-2952(91)90101-A
   PAMPORI NA, 1995, BIOTECHNIQUES, V18, P588
   RAM PA, 1991, MOL ENDOCRINOL, V5, P13, DOI 10.1210/mend-5-1-13
   RAMSDEN R, 1993, J BIOL CHEM, V268, P21722
   RYAN DE, 1990, PHARMACOL THERAPEUT, V45, P153, DOI 10.1016/0163-7258(90)90029-2
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SCHMUCKER DL, 1987, REV BIOL RES AGING, V3, P509
   SCHUETZ EG, 1990, J BIOL CHEM, V265, P1188
   SHAPIRO BH, 1986, BIOCHEM PHARMACOL, V35, P1766, DOI 10.1016/0006-2952(86)90340-0
   SHAPIRO BH, 1984, BRIT J PHARMACOL, V81, P49, DOI 10.1111/j.1476-5381.1984.tb10742.x
   SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5
   SHAPIRO BH, 1994, ARCH BIOCHEM BIOPHYS, V312, P234, DOI 10.1006/abbi.1994.1304
   SHIMADA M, 1989, ARCH BIOCHEM BIOPHYS, V270, P578, DOI 10.1016/0003-9861(89)90540-7
   SUWA Y, 1985, J BIOL CHEM, V260, P7980
   VANBEZOOIJEN RL, 1994, EXP GERONTOL, V29, P187, DOI 10.1016/0531-5565(94)90050-7
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   WAXMAN DJ, 1991, METHOD ENZYMOL, V206, P249
   WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292
   Xu XW, 1996, TRENDS ENDOCRIN MET, V7, P145, DOI 10.1016/1043-2760(96)00043-4
NR 46
TC 36
Z9 39
U1 0
U2 4
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD MAY
PY 2003
VL 31
IS 5
BP 612
EP 619
DI 10.1124/dmd.31.5.612
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 667NN
UT WOS:000182238700015
PM 12695350
DA 2024-02-19
ER

PT J
AU Zhang, XY
   Strakovsky, R
   Zhou, D
   Zhang, YK
   Pan, YX
AF Zhang, Xiyuan
   Strakovsky, Rita
   Zhou, Dan
   Zhang, Yukun
   Pan, Yuan-Xiang
TI A Maternal High-Fat Diet Represses the Expression of Antioxidant Defense
   Genes and Induces the Cellular Senescence Pathway in the Liver of Male
   Offspring Rats
SO JOURNAL OF NUTRITION
LA English
DT Article
ID OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; PREGNANCY; LACTATION; ACID;
   MICE; STEATOHEPATITIS; PARAOXONASE-1; LIPOGENESIS; METABOLISM
AB Maternal high-fat (HF) diet feeding is associated with increased risk of developing metabolism-related diseases in adult offspring, including chronic liver disease. The present study tested the hypothesis that maternal HF diet leads to a decreased antioxidant defense capacity and causes cellular senescence in liver of adult offspring rats, which might increase risk of developing chronic liver disease. Timed-pregnant Sprague Dawley rats were fed a HF diet (45% of energy from fat) or a control (C) diet (16% of energy from fat) during gestation and lactation. The resulting offspring were fed a C diet after weaning to generate 2 offspring groups: C diet-fed offspring of dams fed C diet (C/C) and C diet-fed offspring of dams fed a HF diet (HF/C). At 12 wk of age, male rats were killed and samples were collected for analysis. Maternal HF diet significantly increased plasma TG and hepatic TBARS concentrations and the size of hepatic lipid droplets in offspring rats. The expression of antioxidant defense genes, such as glutathione peroxidase-1, Cu/Zn superoxide dismutase (Sod1), paraoxonase enzymes (Pon1, Pon2, and Pon3), were significantly lower in the liver of HF/C pups than in C/C pups. The expression of Inhibitor of cyclin dependent Kinase 4a (p16INK4a), a marker of cellular senescence, and cyclooxygenase-2 (Cox2), a proinflammatory marker, was significantly higher in the HF/C offspring group than in the C/C offspring group. Western-blot analysis shows that cyclin D1 and phosphorylated retinoblastoma protein were significantly lower in HF/C offspring than in C/C offspring. The results provide the first evidence to our knowledge that maternal HF diet might alter antioxidant defense capacity and program the p16INK4a-dependent cellular senescence in the liver of adult offspring. J. Nutr. 141: 1254-1259, 2011.
C1 [Zhang, Xiyuan; Zhou, Dan; Zhang, Yukun; Pan, Yuan-Xiang] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [Strakovsky, Rita; Pan, Yuan-Xiang] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
RP Pan, YX (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
EM yxpan@illinois.edu
RI Pan, Yuan-Xiang/C-6576-2019
OI Pan, Yuan-Xiang/0000-0003-3219-4367
FU USDA Cooperative State Research, Education and Extension Service
   [ILLU-698-374]
FX Supported in part by the USDA Cooperative State Research, Education and
   Extension Service, Hatch project no. ILLU-698-374.
CR Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030
   Barker DJP, 1997, BRIT MED BULL, V53, P96
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Camps J, 2009, WORLD J GASTROENTERO, V15, P1929, DOI 10.3748/wjg.15.1929
   Chapman C, 2000, J NUTR, V130, P146, DOI 10.1093/jn/130.2.146
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281
   Delhaye M, 1999, J HEPATOL, V30, P461, DOI 10.1016/S0168-8278(99)80106-8
   Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245
   Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X
   Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Ghebremeskel K, 1999, BRIT J NUTR, V81, P395, DOI 10.1017/S0007114599000689
   GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4
   HIGHAM FC, 1984, J DEV PHYSIOL, V6, P153
   Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919
   Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674
   Hu KQ, 2003, PROSTAG LEUKOTR ESS, V69, P329, DOI 10.1016/j.plefa.2003.07.001
   INNIS SM, 1988, J NUTR, V118, P1177, DOI 10.1093/jn/118.10.1177
   Karrasch S, 2008, RESP MED, V102, P1215, DOI 10.1016/j.rmed.2008.04.013
   Kniss DA, 1999, J SOC GYNECOL INVEST, V6, P285, DOI 10.1177/107155769900600602
   Koukkou E, 1998, CIRCULATION, V98, P2899, DOI 10.1161/01.CIR.98.25.2899
   Li B, 2009, J SURG RES, V157, P43, DOI 10.1016/j.jss.2008.12.020
   LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774
   Luyckx VA, 2009, AM J PHYSIOL-RENAL, V297, pF1697, DOI 10.1152/ajprenal.00462.2009
   McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661
   Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9
   Odaka Y, 2010, OBESITY, V18, P1688, DOI 10.1038/oby.2009.513
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Rajia S, 2010, J NEUROENDOCRINOL, V22, P905, DOI 10.1111/j.1365-2826.2010.02005.x
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0
   Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017
   SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1
   Shin EJ, 2008, NEUROCHEM INT, V52, P1134, DOI 10.1016/j.neuint.2007.12.003
   Strakovsky RS, 2010, J NUTR, V140, P2116, DOI 10.3945/jn.110.127803
   Stringer DM, 2010, BBA-MOL CELL BIOL L, V1801, P1375, DOI 10.1016/j.bbalip.2010.08.011
   Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796
   Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108
   Zhang J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-62
NR 43
TC 44
Z9 50
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JUL
PY 2011
VL 141
IS 7
BP 1254
EP 1259
DI 10.3945/jn.111.139576
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 783DL
UT WOS:000292061600005
PM 21562236
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Nishimura, N
   De Battista, D
   McGivern, DR
   Engle, RE
   Tice, A
   Fares-Gusmao, R
   Kabat, J
   Pomerenke, A
   Nguyen, H
   Sato, S
   Bock, KW
   Moore, IN
   Kleiner, DE
   Zamboni, F
   Alter, HJ
   Govindarajan, S
   Farci, P
AF Nishimura, Norihisa
   De Battista, Davide
   McGivern, David R.
   Engle, Ronald E.
   Tice, Ashley
   Fares-Gusmao, Rafaelle
   Kabat, Juraj
   Pomerenke, Anna
   Nguyen, Hanh
   Sato, Shinya
   Bock, Kevin W.
   Moore, Ian N.
   Kleiner, David E.
   Zamboni, Fausto
   Alter, Harvey J.
   Govindarajan, Sugantha
   Farci, Patrizia
TI Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging
   liver and in patients with liver cirrhosis
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE CHI3L1; aging; liver fibrosis; cirrhosis
ID SERUM FIBROSIS MARKERS; HEPATITIS-C VIRUS; NATURAL-HISTORY; B-VIRUS;
   YKL-40; PROGRESSION; TISSUE; GENE; AGE; INFLAMMATION
AB Older age at the time of infection with hepatitis viruses is associated with an increased risk of liver fibrosis progression. We hypothesized that the pace of fibrosis progression may reflect changes in gene expression within the aging liver. We compared gene expression in liver specimens from 54 adult donors without evidence of fibrosis, including 36 over 40 y old and 18 between 18 and 40 y old. Chitinase 3-like 1 (CHI3L1), which encodes chitinase-like protein YKL-40/CHI3L1, was identified as the gene with the greatest agedependent increase in expression in liver tissue. We investigated the cellular source of CHI3L1 in the liver and its function using liver tissue specimens and in vitro models. CHI3L1 expression was significantly higher in livers of patients with cirrhosis of diverse etiologies compared with controls represented by patients who underwent liver resection for hemangioma. The highest intrahepatic CHI3L1 expression was observed in cirrhosis due to hepatitis D virus, followed by hepatitis C virus, hepatitis B virus, and alcohol-induced cirrhosis. In situ hybridization of CHI3L1 messenger RNA (mRNA) identified hepatocytes as the major producers of CHI3L1 in normal liver and in cirrhotic tissue, wherein hepatocytes adjacent to fibrous septa showed higher CHI3L1 expression than did those in more distal areas. In vitro studies showed that recombinant CHI3L1 promotes proliferation and activation of primary human hepatic stellate cells (HSCs), the major drivers of liver fibrosis. These findings collectively demonstrate that CHI3L1 promotes liver fibrogenesis through a direct effect on HSCs and support a role for CHI3L1 in the increased susceptibility of aging livers to fibrosis progression.
C1 [Nishimura, Norihisa; De Battista, Davide; Engle, Ronald E.; Tice, Ashley; Pomerenke, Anna; Nguyen, Hanh; Sato, Shinya; Farci, Patrizia] NIAID, Hepat Pathogenesis Sect, Lab Infect Dis, NIH, Bethesda, MD 20892 USA.
   [McGivern, David R.; Fares-Gusmao, Rafaelle] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
   [Kabat, Juraj] NIAID, Biol Imaging Facil, Res Technol Branch, NIH, Bethesda, MD 20892 USA.
   [Bock, Kevin W.; Moore, Ian N.] NIAID, Infect Dis Pathogenesis Sect, NIH, Bethesda, MD 20892 USA.
   [Kleiner, David E.] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA.
   [Zamboni, Fausto] Azienda Osped Brotzu, Liver Transplantat Ctr, I-09134 Cagliari, Italy.
   [Alter, Harvey J.] NIH, Dept Transfus Med, Clin Ctr, Bethesda, MD 20892 USA.
   [Govindarajan, Sugantha] Univ Southern Calif, Rancho Los Amigos Hosp, Dept Pathol, Los Angeles, CA 90242 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Allergy & Infectious Diseases (NIAID); US Food & Drug Administration
   (FDA); National Institutes of Health (NIH) - USA; NIH National Institute
   of Allergy & Infectious Diseases (NIAID); National Institutes of Health
   (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases
   (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer
   Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical
   Center (CC); University of Southern California
RP Farci, P (corresponding author), NIAID, Hepat Pathogenesis Sect, Lab Infect Dis, NIH, Bethesda, MD 20892 USA.; Alter, HJ (corresponding author), NIH, Dept Transfus Med, Clin Ctr, Bethesda, MD 20892 USA.
EM halter@dtm.cc.nih.gov; patrizia.farci@nih.gov
RI De Battista, Davide/GWM-5590-2022; Engle, Ronald/AAK-9594-2021
OI De Battista, Davide/0000-0002-0087-7676; Engle,
   Ronald/0000-0003-4174-1983; Nguyen, Hanh/0000-0002-0080-8312; McGivern,
   David/0000-0003-3497-5087; Nishimura, Norihisa/0000-0002-6295-3283
FU Intramural Research Program of the National Institute of Allergy and
   Infectious Diseases; National Cancer Institute, NIH; Center for
   Biologics Evaluation and Research, US Food and Drug Administration
FX This work was supported by the Intramural Research Program of the
   National Institute of Allergy and Infectious Diseases and the National
   Cancer Institute, NIH, and by intramural funds from the Center for
   Biologics Evaluation and Research, US Food and Drug Administration. We
   thank the Microscopy and Core Imaging Facility of the Center for
   Biologics Evaluation and Research.
CR Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9
   Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505
   Boccato S, 2006, J VIRAL HEPATITIS, V13, P297, DOI 10.1111/j.1365-2893.2005.00683.x
   Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016
   Bojesen SE, 2011, CLIN CHIM ACTA, V412, P709, DOI 10.1016/j.cca.2011.01.022
   Chen ZC, 2018, P NATL ACAD SCI USA, V115, pE11369, DOI 10.1073/pnas.1809028115
   Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600
   Diaz G, 2018, MOL CANCER RES, V16, P1406, DOI 10.1158/1541-7786.MCR-18-0012
   Dor Y, 2018, LANCET, V392, P777, DOI 10.1016/S0140-6736(18)31268-6
   Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101
   Esmat G, 2007, J HEPATOL, V46, P620, DOI 10.1016/j.jhep.2006.12.010
   Farci P, 2012, SEMIN LIVER DIS, V32, P228, DOI 10.1055/s-0032-1323628
   Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]
   Fontana RJ, 2010, GUT, V59, P1401, DOI 10.1136/gut.2010.207423
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Geng B, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0876-2
   Harouaka D, 2016, P NATL ACAD SCI USA, V113, P1375, DOI 10.1073/pnas.1516879113
   He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032
   Ignat SR, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020461
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1
   Johansen JS, 2006, DAN MED BULL, V53, P172
   Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020
   Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025
   Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948
   Kjaergaard AD, 2016, CRIT REV CL LAB SCI, V53, P396, DOI 10.1080/10408363.2016.1190683
   Knudsen LS, 2006, SCAND J RHEUMATOL, V35, P489, DOI 10.1080/03009740600904300
   Kumagai E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35282
   Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250
   Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1
   Li LT, 2015, MOL MED REP, V11, P1566, DOI 10.3892/mmr.2014.2914
   Melis M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0230-1
   Montgomery TA, 2017, J AM SOC NEPHROL, V28, P3217, DOI 10.1681/ASN.2017010110
   Nojgaard C, 2003, J HEPATOL, V39, P179, DOI 10.1016/S0168-8278(03)00184-3
   PINZANI M, 1991, AM J PHYSIOL, V260, pC485, DOI 10.1152/ajpcell.1991.260.3.C485
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778
   Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Simon R, 2007, CANCER INFORM, V3, P11
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248
   Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546
   Yan LL, 2018, INFECTION, V46, P385, DOI 10.1007/s15010-018-1136-2
   Zhou Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007096
NR 49
TC 13
Z9 13
U1 0
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 27
PY 2021
VL 118
IS 17
AR e2019633118
DI 10.1073/pnas.2019633118
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA RY3DT
UT WOS:000647796500012
PM 33888584
OA Green Published
DA 2024-02-19
ER

PT J
AU Della Torre, S
   Benedusi, V
   Pepe, G
   Meda, C
   Rizzi, N
   Uhlenhaut, NH
   Maggi, A
AF Della Torre, Sara
   Benedusi, Valeria
   Pepe, Giovanna
   Meda, Clara
   Rizzi, Nicoletta
   Uhlenhaut, Nina Henriette
   Maggi, Adriana
TI Dietary essential amino acids restore liver metabolism in ovariectomized
   mice <i>via</i> hepatic estrogen receptor α
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SEX-DIFFERENCES; FATTY LIVER; ER-ALPHA; EXPRESSION; INSULIN; ACTIVATION;
   SURVIVAL
AB In female mammals, the cessation of ovarian functions is associated with significant metabolic alterations, weight gain, and increased susceptibility to a number of pathologies associated with ageing. The molecular mechanisms triggering these systemic events are unknown because most tissues are responsive to lowered circulating sex steroids. As it has been demonstrated that isoform alpha of the estrogen receptor (ER alpha) may be activated by both estrogens and amino acids, we test the metabolic effects of a diet enriched in specific amino acids in ovariectomized (OVX) mice. This diet is able to block the OVX-induced weight gain and fat deposition in the liver. The use of liver-specific ER alpha KO mice demonstrates that the hepatic ER alpha, through the control of liver lipid metabolism, has a key role in the systemic response to OVX. The study suggests that the liver ER alpha might be a valuable target for dietary treatments for the post-menopause.
   Menopause is associated with metabolic changes and an increased risk of a number of chronic diseases. Here, the authors show in a mouse model of menopause that an amino acid-enriched diet rescues liver lipid metabolism and prevents weight gain in a manner dependent on hepatic ER alpha.
C1 [Della Torre, Sara; Benedusi, Valeria; Pepe, Giovanna; Maggi, Adriana] Univ Milan, Dept Pharmaceut Sci, Milan, Italy.
   [Della Torre, Sara; Benedusi, Valeria; Pepe, Giovanna; Maggi, Adriana] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy.
   [Meda, Clara] Univ Milan, Dept Hlth Sci, Milan, Italy.
   [Rizzi, Nicoletta] Univ Milan, Res Serv Management Off, Milan, Italy.
   [Uhlenhaut, Nina Henriette] Helmholtz Diabet Ctr HMGU, Inst Diabet & Canc IDC, Helmholz Zentrum Munich, Mol Endocrinol, Munich, Germany.
   [Uhlenhaut, Nina Henriette] TUM Sch Life Sci Weihenstephan, Metab Programming, Freising Weihenstephan, Germany.
C3 University of Milan; University of Milan; University of Milan;
   University of Milan; Helmholtz Association; Helmholtz-Center Munich -
   German Research Center for Environmental Health; Technical University of
   Munich
RP Della Torre, S; Maggi, A (corresponding author), Univ Milan, Dept Pharmaceut Sci, Milan, Italy.; Della Torre, S; Maggi, A (corresponding author), Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy.
EM sara.dellatori@unimi.it; adriana.maggi@unimi.it
RI Meda, Clara/G-8680-2013; Uhlenhaut, Henriette/AFR-1141-2022
OI Meda, Clara/0000-0003-3524-2010; Della Torre, Sara/0000-0001-9498-5266;
   Uhlenhaut, Henriette/0000-0002-4220-4779; Pepe,
   Giovanna/0000-0003-4752-4349; Benedusi, Valeria/0000-0003-4791-4806
FU Cariplo Foundation [2013-0786]; European Community (ERC-Advanced Grant
   Ways) [322977]; Department of Pharmaceutical Sciences (DISFARM,
   University of Milan); European Research Council (ERC) [322977] Funding
   Source: European Research Council (ERC)
FX We are grateful to Prof. Enzo Nisoli (DEMETRA, University of Milan) for
   the helpful discussion on the setting of the dietary experimental
   protocol; to Prof. Rocco Piazza (University of Milan-Bicocca) for
   bioinformatic support; to Prof. Graziella Messina (DBS, University of
   Milan) and to Prof. Elisabetta Vegeto (DISFARM, University of Milan) for
   the critical discussion and comments that greatly improved the
   manuscript. This work was supported by Cariplo Foundation (Grant
   2013-0786) and European Community (ERC-Advanced Grant Ways 322977).
   Authors acknowledge financial support from Department of Pharmaceutical
   Sciences (DISFARM, University of Milan).
CR Alayev A, 2016, ONCOGENE, V35, P3535, DOI 10.1038/onc.2015.414
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708
   Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Borugian MJ, 2004, CANCER EPIDEM BIOMAR, V13, P1163
   Cignarella A, 2010, TRENDS PHARMACOL SCI, V31, P183, DOI 10.1016/j.tips.2010.01.001
   Costa R, 2019, CELL REP, V28, P1949, DOI 10.1016/j.celrep.2019.07.050
   Della Torre S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.572490
   Della Torre S, 2018, CELL METAB, V28, P256, DOI 10.1016/j.cmet.2018.05.021
   Della Torre S, 2017, CELL METAB, V25, P499, DOI 10.1016/j.cmet.2017.01.006
   Della Torre S, 2016, CELL REP, V15, P360, DOI 10.1016/j.celrep.2016.03.019
   Della Torre S, 2014, NAT REV ENDOCRINOL, V10, P13, DOI 10.1038/nrendo.2013.203
   Della Torre S, 2011, ENDOCRINOLOGY, V152, P2256, DOI 10.1210/en.2011-0173
   Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002
   Della Torre Sara, 2021, RNA SEQ MOUSE LIVER
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Faltas CL, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa030
   Gaggini M, 2018, HEPATOLOGY, V67, P145, DOI 10.1002/hep.29465
   Goossens GH, 2021, NAT REV ENDOCRINOL, V17, P47, DOI 10.1038/s41574-020-00431-8
   Hodson L, 2019, NAT REV ENDOCRINOL, V15, P689, DOI 10.1038/s41574-019-0256-9
   Holecek M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0271-1
   Holmes MD, 2017, J CLIN ONCOL, V35, P325, DOI 10.1200/JCO.2016.68.3292
   Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415
   Khomtchouk BB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176334
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9
   Leeners B, 2017, HUM REPROD UPDATE, V23, P300, DOI 10.1093/humupd/dmw045
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y
   Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249
   Lobo RA, 2017, NAT REV ENDOCRINOL, V13, P220, DOI 10.1038/nrendo.2016.164
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maggi A, 2018, MOL METAB, V15, P3, DOI 10.1016/j.molmet.2018.02.012
   Maggi A, 2011, BBA-MOL BASIS DIS, V1812, P1054, DOI 10.1016/j.bbadis.2011.05.001
   Mauvais-Jarvis F, 2017, ADV EXP MED BIOL, V1043, P217, DOI 10.1007/978-3-319-70178-3_11
   McNeil M, 2017, JAMA-J AM MED ASSOC, V318, P911, DOI 10.1001/jama.2017.11462
   Meda C, 2020, MOL METAB, V32, P97, DOI 10.1016/j.molmet.2019.12.009
   Miyamoto I, 2019, BIOCHEM BIOPH RES CO, V510, P629, DOI 10.1016/j.bbrc.2019.02.010
   Morselli E, 2017, NAT REV ENDOCRINOL, V13, P352, DOI 10.1038/nrendo.2017.12
   Osman B, 2009, CELL SIGNAL, V21, P1806, DOI 10.1016/j.cellsig.2009.07.016
   Palmisano BT, 2017, ADV EXP MED BIOL, V1043, P227, DOI 10.1007/978-3-319-70178-3_12
   Paquette A, 2008, MENOPAUSE, V15, P1169, DOI 10.1097/gme.0b013e31817b8159
   ROHAN TE, 1993, NUTR CANCER, V20, P167, DOI 10.1080/01635589309514283
   ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866
   Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019
   Villa A, 2012, P NATL ACAD SCI USA, V109, P11806, DOI 10.1073/pnas.1205797109
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506
   Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7
   Zhu L, 2018, MOL METAB, V8, P106, DOI 10.1016/j.molmet.2017.12.012
   Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718
NR 57
TC 16
Z9 16
U1 0
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 25
PY 2021
VL 12
IS 1
AR 6883
DI 10.1038/s41467-021-27272-x
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA XD7EG
UT WOS:000722866700017
PM 34824281
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Lavery, WL
   Goyns, MH
AF Lavery, WL
   Goyns, MH
TI Increased expression of the S25 ribosomal protein gene occurs during
   ageing of the rat liver
SO GERONTOLOGY
LA English
DT Article
DE ribosomal protein; gene expression; liver, rat; ageing
ID DIFFERENTIAL DISPLAY ANALYSIS; NON-HODGKINS-LYMPHOMAS; MESSENGER-RNA
   LEVELS; AGING BRAIN; PATTERNS; FIBROBLASTS; PROFILE; CELLS; YOUNG
AB Background. It appears that consistent changes in the levels of activity of a small cohort of genes (probably <1% of all active genes) occur in all mammalian cells during ageing. Identification of such genes could provide valuable insights into the ageing process. Objective: We have studied age-related changes in gene expression profiles in the rat liver. One of the genes which exhibited clear and consistent increases in expression is characterised. Methods: Analysis of the gene expression profile was carried out using a combination of an optimised form of differential display and single-strand conformational polymorphism (SSCP) gel analysis. Gene expression levels were quantified by Northern blot analysis. The gene's identity was determined by comparing its nucleotide sequence to DNA databases. Results: During this investigation we observed one gene which exhibited an increase in expression in livers from young adult (6 months) to old adult (24 months) rats. The differential expression of this gene was confirmed by SSCP gel analysis and Northern blotting. Densitometry of the latter indicated that expression increased by 165% with age. Characterisation of the isolated polymerase chain reaction fragment demonstrated it to code for the ribosomal protein S25 (RPS25). Conclusion: This increase in RPS25 expression is further evidence that the composition of ribosomes may alter with age and as a result could have significant effects on protein synthesis. Copyright (C) 2002 S. Karger AG, Basel.
C1 Univ Sunderland, Sch Sci, Sunderland SR1 3SD, England.
C3 University of Sunderland
RP Goyns, MH (corresponding author), Univ Sunderland, Sch Sci, Fleming Bldg,Wharncliffe St, Sunderland SR1 3SD, England.
CR AUSBEL F, 1993, CURRENT PROTOCOLS MO
   BURNS DK, 1984, MOL CELL BIOL, V12, P2643
   Carter D, 1999, LEUKEMIA LYMPHOMA, V33, P343, DOI 10.3109/10428199909058434
   Charlton MA, 1999, CANCER LETT, V143, P45, DOI 10.1016/S0304-3835(99)00173-1
   DAHLBERG AE, 1989, CELL, V57, P525, DOI 10.1016/0092-8674(89)90122-0
   Goyns MH, 1998, MECH AGEING DEV, V101, P73, DOI 10.1016/S0047-6374(97)00166-8
   Grierson AJ, 1996, LEUKEMIA LYMPHOMA, V23, P353, DOI 10.3109/10428199609054839
   Holliday R, 1984, Monogr Dev Biol, V17, P221
   KIRKLAND JL, 1993, EXP GERONTOL, V28, P557, DOI 10.1016/0531-5565(93)90044-E
   Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   LI ML, 1991, GENE, V107, P329, DOI 10.1016/0378-1119(91)90335-9
   LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244
   LUCE MC, 1989, EXP GERONTOL, V24, P113, DOI 10.1016/0531-5565(89)90022-3
   MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6
   MERRY BJ, 1994, PHYSL BASIS AGING GE, P285
   Mueller PP, 1998, J BIOL CHEM, V273, P32870, DOI 10.1074/jbc.273.49.32870
   PAPACONSTANTINO.J, 1995, HDB BIOL AGING
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   ROSENBERGER RF, 1991, MUTAT RES, V256, P243
   Salehi M, 1996, EXPERIENTIA, V52, P888, DOI 10.1007/BF01938876
   Salehi M, 1999, MECH AGEING DEV, V107, P61, DOI 10.1016/S0047-6374(98)00137-7
   Sheerin A, 2001, MECH AGEING DEV, V122, P1813, DOI 10.1016/S0047-6374(01)00319-0
   SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WARNER JR, 1982, MOL BIOL YEAST SACCH, P529
NR 27
TC 6
Z9 6
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD NOV-DEC
PY 2002
VL 48
IS 6
BP 369
EP 373
DI 10.1159/000065505
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 613QL
UT WOS:000179142900004
PM 12393952
DA 2024-02-19
ER

PT J
AU Araki, C
   Takemoto, D
   Kitagawa, Y
   Tateishi, N
   Rogi, T
   Izumo, T
   Kawamoto, S
   Shibata, H
   Hara, E
   Nakai, M
AF Araki, Chie
   Takemoto, Daisuke
   Kitagawa, Yoshinori
   Tateishi, Norifumi
   Rogi, Tomohiro
   Izumo, Takayuki
   Kawamoto, Shimpei
   Shibata, Hiroshi
   Hara, Eiji
   Nakai, Masaaki
TI Sesamin Metabolites Suppress the Induction of Cellular Senescence
SO NUTRIENTS
LA English
DT Article
DE sesamin; episesamin; SC1; EC1-2; cellular senescence; mitochondria
ID ANTIOXIDATIVE METABOLITES; MITOCHONDRIAL-FUNCTION; PREMATURE SENESCENCE;
   CELLS; EXPRESSION; LIVER; INHIBITION; EPISESAMIN; P16(INK4A); GENERATION
AB Cellular senescence induces inflammation and is now considered one of the causes of organismal aging. Accumulating evidence indicates that age-related deterioration of mitochondrial function leads to an increase in reactive oxygen species (ROS) and DNA damage, which in turn causes cellular senescence. Thus, it is important to maintain mitochondrial function and suppress oxidative stress in order to inhibit the accumulation of senescent cells. Sesamin and its isomer episesamin are types of lignans found in sesame oil, and after being metabolized in the liver, their metabolites have been reported to exhibit antioxidant properties. However, their effects on cellular senescence remain unknown. In this study, the effects of sesamin, episesamin, and their metabolites SC1 and EC1-2 on replicative senescence were evaluated using human diploid lung fibroblasts, and TIG-3 cells. The results showed that sesamin and episesamin treatment had no effect on proliferative capacity compared to the untreated late passage group, whereas SC1 and EC1-2 treatment improved proliferative capacity and mitigated DNA damage of TIG-3 cells. Furthermore, other cellular senescence markers, such as senescence-associated secretory phenotype (SASP), mitochondria-derived ROS, and mitochondrial function (ROS/ATP ratio) were also reduced by SC1 and EC1-2 treatment. These results suggest that SC1 and EC1-2 can maintain proper mitochondrial function and suppress the induction of cellular senescence.
C1 [Araki, Chie; Takemoto, Daisuke; Kitagawa, Yoshinori; Tateishi, Norifumi; Rogi, Tomohiro; Izumo, Takayuki; Shibata, Hiroshi; Nakai, Masaaki] Suntory Wellness Ltd, Inst Hlth Care Sci, Kyoto 6190284, Japan.
   [Kawamoto, Shimpei; Hara, Eiji] Osaka Univ, Res Inst Microbial Dis, Dept Mol Microbiol, Osaka 5650871, Japan.
C3 Suntory Holdings Ltd; Osaka University
RP Takemoto, D (corresponding author), Suntory Wellness Ltd, Inst Hlth Care Sci, Kyoto 6190284, Japan.
EM daisuke_takemoto@suntory.co.jp
OI rogi, tomohiro/0000-0001-8665-8337; Takemoto,
   Daisuke/0000-0003-3465-0581
CR Abdul-Ghani MA, 2009, DIABETOLOGIA, V52, P574, DOI 10.1007/s00125-009-1264-4
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dang Y, 2020, AGING CELL, V19, DOI 10.1111/acel.13060
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Deesrisak K, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2020.12293
   Fujita Y, 2022, EXP GERONTOL, V165, DOI 10.1016/j.exger.2022.111866
   Gil L, 2006, FREE RADICAL RES, V40, P495, DOI 10.1080/10715760600592962
   Hara E, 1996, MOL CELL BIOL, V16, P859
   Hara H, 2013, AM J PHYSIOL-LUNG C, V305, pL737, DOI 10.1152/ajplung.00146.2013
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Ichiba M, 2007, HEPATO-GASTROENTEROL, V54, P1736
   Ikeda T, 2003, INT J SPORTS MED, V24, P530
   Ito S, 2015, AUTOPHAGY, V11, P547, DOI 10.1080/15548627.2015.1017190
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Kim SJ, 2018, AGING-US, V10, P1239, DOI 10.18632/aging.101463
   König J, 2017, REDOX BIOL, V11, P673, DOI 10.1016/j.redox.2017.01.017
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Le TD, 2019, EUR REV MED PHARMACO, V23, P1826, DOI 10.26355/eurrev_201902_17146
   Le TD, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060924
   Lei H, 2013, J SCI FOOD AGR, V93, P1833, DOI 10.1002/jsfa.5974
   Lin HQ, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00550
   Liu XF, 2014, INFLAMMATION, V37, P1486, DOI 10.1007/s10753-014-9874-5
   Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x
   Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896
   McConnell BB, 1999, MOL CELL BIOL, V19, P1981
   Mistry Y, 2013, REDOX BIOL, V1, P411, DOI 10.1016/j.redox.2013.08.004
   Nakai M, 2003, J AGR FOOD CHEM, V51, P1666, DOI 10.1021/jf0258961
   Nakai M, 2006, BIOSCI BIOTECH BIOCH, V70, P1273, DOI 10.1271/bbb.70.1273
   Nollet E, 2017, ATHEROSCLEROSIS, V260, P138, DOI 10.1016/j.atherosclerosis.2017.03.023
   Omori S, 2020, CELL METAB, V32, P814, DOI 10.1016/j.cmet.2020.09.006
   Ren XC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4175353
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Roussel D, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.196188
   Salazar G, 2017, FREE RADICAL BIO MED, V108, P225, DOI 10.1016/j.freeradbiomed.2017.03.032
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Stöckl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009
   Takada S, 2015, EXP PHYSIOL, V100, P1319, DOI 10.1113/EP085251
   Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8
   Tomimori N, 2012, BIOL PHARM BULL, V35, P709, DOI 10.1248/bpb.35.709
   Urata H, 2008, CHEM PHARM BULL, V56, P1611, DOI 10.1248/cpb.56.1611
   Watanabe S, 2017, CANCER SCI, V108, P563, DOI 10.1111/cas.13184
   Yasuda K, 2012, DRUG METAB DISPOS, V40, P1917, DOI 10.1124/dmd.112.045906
   Yuan HT, 1996, EXP GERONTOL, V31, P465, DOI 10.1016/0531-5565(96)00001-0
NR 48
TC 0
Z9 0
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR
PY 2023
VL 15
IS 7
AR 1627
DI 10.3390/nu15071627
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA D7DT0
UT WOS:000970301900001
PM 37049468
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Dawson, HD
   Yamamoto, Y
   Zolfaghari, R
   Rosales, FJ
   Dietz, J
   Shimada, T
   Li, NQ
   Ross, AC
AF Dawson, HD
   Yamamoto, Y
   Zolfaghari, R
   Rosales, FJ
   Dietz, J
   Shimada, T
   Li, NQ
   Ross, AC
TI Regulation of hepatic vitamin A storage in a rat model of controlled
   vitamin A status during aging
SO JOURNAL OF NUTRITION
LA English
DT Article
DE aging; vitamin A; lecithin; retinol acyltransferase; cellular
   retinol-binding protein; retinyl esters; rats
ID RETINOL-BINDING PROTEIN; MAMMARY-GLAND MICROSOMES; MESSENGER-RNA LEVELS;
   ACYLTRANSFERASE ACTIVITY; A STATUS; PLASMA RETINOL; ACYL-COA;
   SUBCELLULAR-LOCALIZATION; ESTER HYDROLASE; SMALL-INTESTINE
AB It is currently unknown whether the capacity of the liver to esterify and store vitamin A (VA) changes as a function of long-term VA intake or age. The objective of this study was to investigate whether age and/or VA status are factors for the hepatic expression of cellular retinol-binding protein (CRBP), the esterification of retinol by lecithin:retinol acyltransferase (LRAT) and the accumulation of VA and lipids in liver, Two factors, VA intake and age, were studied in a 3 x 3 design. Diets denoted as VA-marginal, control and supplemented contained 0.35, 4 and 25 mg retinol equivalents/kg diet, respectively; male Lewis rats were fed these diets from weaning until the ages of 2-3 mo (young), 8-10 mo (middle-aged) and 18-20 mo told) (n = 6/group, Liver CRBP mRNA differed two-way ANOVA) with dietary VA (P < 0.0001) and age (P < 0.05), Hepatic LRAT activity increased with dietary VA (P < 0.0001). Age was not a factor (P = 0.47) although there was an interaction of age and dietary VA (P < 0.0001). Hepatic LRAT activity was correlated (r = 0.633, P < 0.0001) with plasma retinol at physiologic concentrations. In VA-supplemented rats of all ages, the plasma molar ratio of total retinol:retinol-binding protein (RBP) exceeded 1, and liver VA and total lipid concentrations were elevated. However, tests of liver function had previously been shown to be within normal values. Thus, the capacity of the liver for retinol esterification by LRAT was not diminished by age or the accumulation of VA and other lipids. We conclude the following: 1) hepatic LRAT activity is regulated across a broad, physiologic range of dietary VA; 2) LRAT activity is regulated throughout life; and 3) the capacity for hepatic VA storage is high throughout life.
C1 Penn State Univ, Grad Program Nutr, University Pk, PA 16802 USA.
   Penn State Univ, Dept Nutr, University Pk, PA 16802 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park
RP Ross, AC (corresponding author), Penn State Univ, Grad Program Nutr, University Pk, PA 16802 USA.
RI Dawson, Harry/H-8242-2013; Dawson, Harry/ABG-2734-2021
OI Dawson, Harry/0000-0002-7648-9952
FU NIA NIH HHS [AG-09839] Funding Source: Medline
CR BLANER WS, 1994, RETINOIDS BIOL CHEM, V2, P229
   BLOMHOFF R, 1992, ANNU REV NUTR, V12, P37, DOI 10.1146/annurev.nu.12.070192.000345
   Cartmel B, 1999, AM J CLIN NUTR, V69, P937
   Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176
   Dawson HD, 1999, J NUTR, V129, P1510, DOI 10.1093/jn/129.8.1510
   Dawson HD, 1999, J NUTR, V129, P1782, DOI 10.1093/jn/129.10.1782
   GARDNER EM, 1993, J NUTR, V123, P1435
   GARRY PJ, 1987, AM J CLIN NUTR, V46, P989, DOI 10.1093/ajcn/46.6.989
   Gaziano J. Michael, 1995, Annals of Epidemiology, V5, P255, DOI 10.1016/1047-2797(94)00090-G
   HARRISON EH, 1987, J LIPID RES, V28, P973
   HARRISON EH, 1993, BIOCHIM BIOPHYS ACTA, V1170, P99, DOI 10.1016/0005-2760(93)90058-H
   HARTZ SC, 1988, J AM COLL NUTR, V7, P119, DOI 10.1080/07315724.1988.10720228
   KATO M, 1985, J BIOL CHEM, V260, P4832
   KENT G, 1976, P NATL ACAD SCI USA, V73, P3719, DOI 10.1073/pnas.73.10.3719
   KIM I, 1993, AM J PUBLIC HEALTH, V83, P546, DOI 10.2105/AJPH.83.4.546
   KOWALSKI TE, 1994, AM J MED, V97, P523, DOI 10.1016/0002-9343(94)90347-6
   KRASINSKI SD, 1989, AM J CLIN NUTR, V49, P112, DOI 10.1093/ajcn/49.1.112
   LEVIN MS, 1988, J BIOL CHEM, V263, P17715
   *LIF SCI RES OFF, 1985, ASS VIT A NUTR STAT
   MACDONALD PN, 1988, BIOCHEM BIOPH RES CO, V156, P157, DOI 10.1016/S0006-291X(88)80818-0
   MACDONALD PN, 1988, J BIOL CHEM, V263, P12478
   MALLIA A K, 1975, Journal of Lipid Research, V16, P180
   MATSUURA T, 1993, ARCH BIOCHEM BIOPHYS, V301, P221, DOI 10.1006/abbi.1993.1137
   Matsuura T, 1996, J NUTR, V126, P2474, DOI 10.1093/jn/126.10.2474
   Matsuura T, 1997, J NUTR, V127, P218, DOI 10.1093/jn/127.2.218
   Ong David E., 1994, P283
   ONG DE, 1987, J BIOL CHEM, V262, P2729
   ONG DE, 1988, J BIOL CHEM, V263, P5789
   PARK YK, 1991, AM J CLIN NUTR, V54, P750, DOI 10.1093/ajcn/54.4.750
   RAJAN N, 1990, J LIPID RES, V31, P821
   RANDOLPH RK, 1991, J BIOL CHEM, V266, P16453
   RANDOLPH RK, 1991, ARCH BIOCHEM BIOPHYS, V288, P500, DOI 10.1016/0003-9861(91)90227-A
   Redlich CA, 1999, ATHEROSCLEROSIS, V143, P427, DOI 10.1016/S0021-9150(98)00303-7
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   ROSS AC, 1986, METHOD ENZYMOL, V123, P68, DOI 10.1016/S0076-6879(86)23010-4
   ROSS AC, 1982, J LIPID RES, V23, P133
   SAARI JC, 1989, J BIOL CHEM, V264, P8636
   SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9647, DOI 10.1021/bi00451a016
   Sibulesky L, 1999, AM J CLIN NUTR, V69, P656
   SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503
   SMITH JE, 1975, J LIPID RES, V16, P318
   SOMMER A, 1996, VITAMIN A DEFICIENCY
   Soprano Dianne Robert, 1994, P257
   SOPRANO DR, 1986, J LIPID RES, V27, P166
   STAUBER PM, 1991, AM J CLIN NUTR, V54, P878, DOI 10.1093/ajcn/54.5.878
   West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570
   WOLFORD ST, 1986, J TOXICOL ENV HEALTH, V18, P161, DOI 10.1080/15287398609530859
   ZOLFAGHARI R, 1993, J BIOL CHEM, V268, P13532
   ZOLFAGHARI R, 1993, CLIN CHEM, V39, P1408
NR 49
TC 26
Z9 31
U1 0
U2 2
PU AMER INST NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3166
J9 J NUTR
JI J. Nutr.
PD MAY
PY 2000
VL 130
IS 5
BP 1280
EP 1286
DI 10.1093/jn/130.5.1280
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 311FC
UT WOS:000086873200032
PM 10801930
OA hybrid
DA 2024-02-19
ER

PT J
AU Yudoh, K
   Shi, YQ
   Karasawa, R
AF Yudoh, Kazuo
   Shi, Yeqing
   Karasawa, Rie
TI Angiogenic growth factors inhibit chondrocyte ageing in osteoarthritis:
   potential involvement of catabolic stress-induced overexpression of
   caveolin-1 in cellular ageing
SO INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
LA English
DT Article
DE ageing; angiogenic growth factor; caveolin-1; chondrocyte
ID ACTIVATED PROTEIN-KINASE; MAP-KINASE; SIGNAL-TRANSDUCTION;
   DOWN-REGULATION; ARTICULAR-CARTILAGE; SENESCENCE; EXPRESSION; CELLS;
   PATHOGENESIS; PATHWAYS
AB Objective: Recently, attention has been attracted by the finding that overexpression of caveolin-1 induces cellular senescence in age-related diseases. We aimed to ascertain whether angiogenic growth factors (AGFs) can inhibit interleukin (IL)-1 beta-induced senescence in human chondrocytes by downregulation of caveolin-1.
   Methods: We investigated the intracellular signalling pathways involved in chondrocyte ageing. Human chondrocytes were isolated from the articular cartilage of patients undergoing arthroplastic knee surgery in osteoarthritis (OA). Chondrocytes were stimulated with or without IL-1 beta (10 ng/mL) in the presence or absence of vascular endothelial growth factor, basic fibroblast growth factor or hepatocyte growth factor (20 ng/mL). After 72-h incubation, we observed the expression of caveolin-1 in human chondrocytes by immunohistochemistry, and analysed the protein levels of caveolin-1 by Western blot. We examined the time-course of phosphorylation patterns of mammalian mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3-K) by Western blot, and used several specific protein kinase inhibitors to evaluate the involvement of the intracellular signalling pathways. Also, chondrocyte replicative lifespan was analyzed in the presence or absence of AGFs.
   Results: Treatment with AGFs inhibited IL-1 beta-induced overexpression of caveolin-1 in human OA chondrocytes. Treatment with AGFs all down-regulated protein levels of IL-1 beta-accelarated expression of caveolin-1 in chondrocytes. IL-1 beta significantly decreased the cellular replicative lifespan in chondrocytes. Treatment with AGFs prevented the IL-1 beta-induced shortening of chondrocyte replicative lifespan. The specific inhibitors for MAPK/extracellular signal-regulated kinase and PI3-K cancelled the AGF-induced downregulation of overexpression of caveolin-1.
   Conclusion: Our results suggest that AGFs downregulated IL-1 beta-induced chondrocyte ageing and overexpression of caveolin-1 in human chondrocytes, which is mediated by kinase cascades involving the p42/44 MAP kinase and PI3-K/Akt signalling pathways.
C1 [Yudoh, Kazuo; Shi, Yeqing; Karasawa, Rie] St Marianna Univ, Sch Med, Dept Frontier Med, Inst Med Sci, Kawasaki, Kanagawa, Japan.
   [Shi, Yeqing] Second Mil Med Univ, Changhai Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China.
C3 Saint Marianna University; Naval Medical University
RP Yudoh, K (corresponding author), St Marianna Univ, Sch Med, Dept Frontier Med, Inst Med Sci, Kawasaki, Kanagawa, Japan.
EM yudo@marianna-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Ministry of Health, Labour and Welfare of Japan
FX This Study was Supported by grants from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan, The Ministry of
   Health, Labour and Welfare of Japan.
CR Aigner T, 2002, CURR OPIN RHEUMATOL, V14, P578, DOI 10.1097/00002281-200209000-00018
   Cho KA, 2005, MECH AGEING DEV, V126, P105, DOI 10.1016/j.mad.2004.09.029
   Cho KA, 2003, J BIOL CHEM, V278, P27789, DOI 10.1074/jbc.M208105200
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   Dai SM, 2006, ARTHRITIS RHEUM-US, V54, P818, DOI 10.1002/art.21639
   Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0
   Enomoto H, 2003, AM J PATHOL, V162, P171, DOI 10.1016/S0002-9440(10)63808-4
   Fox T, 1998, PROTEIN SCI, V7, P2249, DOI 10.1002/pro.5560071102
   Fujimoto T, 2000, J CELL SCI, V113, P3509
   Fujita Y, 2004, KIDNEY INT, V66, P1794, DOI 10.1111/j.1523-1755.2004.00954.x
   Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633
   Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467
   Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144
   JEFFREY AE, 1999, J BIOL CHEM, V274, P32333
   Krajewska WM, 2004, CELL MOL BIOL LETT, V9, P195
   KRASILNIKOV MA, 2000, BIOKHIMIYA, V65, P68
   Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1
   Lentzsch S, 2004, LEUKEMIA, V18, P1883, DOI 10.1038/sj.leu.2403486
   Liu J, 2002, J BIOL CHEM, V277, P10661, DOI 10.1074/jbc.M110354200
   Liu J, 1999, J BIOL CHEM, V274, P15781, DOI 10.1074/jbc.274.22.15781
   Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200
   Martin J A, 2001, Iowa Orthop J, V21, P1
   Martin JA, 1997, J ORTHOP RES, V15, P491, DOI 10.1002/jor.1100150403
   Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014
   Martin JA, 2002, BIORHEOLOGY, V39, P145
   MASKAZU N, 2001, J RHEUMATOL, V28, P1772
   ORNA H, 2004, EXP CELL RES, V297, P224
   Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199
   Pfander D, 1999, OSTEOARTHR CARTILAGE, V7, P548, DOI 10.1053/joca.1999.0259
   Pfander D, 2001, ANN RHEUM DIS, V60, P1070, DOI 10.1136/ard.60.11.1070
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x
   Reboul P, 2001, ARTHRITIS RHEUM, V44, P73, DOI 10.1002/1529-0131(200101)44:1<73::AID-ANR11>3.0.CO;2-E
   Régina A, 2004, J NEUROSCI RES, V75, P291, DOI 10.1002/jnr.10865
   Riera MF, 2003, J MOL ENDOCRINOL, V31, P279, DOI 10.1677/jme.0.0310279
   SCHERER PE, 1995, J BIOL CHEM, V270, P15781
   Schwab W, 2000, HISTOCHEM CELL BIOL, V113, P221, DOI 10.1007/s004180050441
   Schwab W, 1999, HISTOCHEM CELL BIOL, V112, P41, DOI 10.1007/s004180050390
   Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734
   Smart EJ, 1999, MOL CELL BIOL, V19, P7289
   Squires GR, 2003, ARTHRITIS RHEUM-US, V48, P1261, DOI 10.1002/art.10976
   Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X
   Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166
   Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007
   Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje
   VOLONTE D, 2002, MOL BIOL CELL, V277, P41295
   Wakitani S, 1997, ACTA ORTHOP SCAND, V68, P474, DOI 10.3109/17453679708996266
   Yeo EJ, 2002, MECH AGEING DEV, V123, P1563, DOI 10.1016/S0047-6374(02)00092-1
   Yoo SA, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/129873
   Yoo SA, 2009, ARTHRITIS RHEUM-US, V60, P345, DOI 10.1002/art.24289
NR 50
TC 15
Z9 16
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1756-1841
EI 1756-185X
J9 INT J RHEUM DIS
JI Int. J. Rheum. Dis.
PY 2009
VL 12
IS 2
BP 90
EP 99
DI 10.1111/j.1756-185X.2009.01390.x
PG 10
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA 476BA
UT WOS:000268410500003
PM 20374325
DA 2024-02-19
ER

PT J
AU Sijens, PE
   Smit, GP
   Borgdorff, MAJ
   Kappert, P
   Oudkerk, M
AF Sijens, Paul E.
   Smit, G. Peter
   Borgdorff, Marinus A. J.
   Kappert, Peter
   Oudkerk, Matthijs
TI Multiple voxel <SUP>1</SUP>H MR spectroscopy of phosphorylase-b kinase
   deficient patients (GSD IXa) showing an accumulation of fat in the liver
   that resolves with aging
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE glycogen storage disease; hepatomegaly; lipid metabolism; magnetic
   resonance spectroscopy
ID GLYCOGEN-STORAGE-DISEASE; MAGNETIC-RESONANCE-SPECTROSCOPY; HEPATIC
   TRIGLYCERIDE CONTENT; INSULIN-RESISTANCE; QUANTIFICATION; PREVALENCE;
   CRITERIA; TYPE-1
AB Background/Aims: Phosphorylase-b deficient patients suffer from glycogen storage disease (GSD IXa) leading to liver enlargement which usually resolves during puberty and adolescence. This pathology has not yet been documented by H-1 MR spectroscopy (MRS) investigation.
   Methods: MRS of eight GSD IXa patients was performed in this study to assess whether or not liver fat content is elevated in GSD IXa and decreases with aging. An improvement in our MRS method compared with previous liver fat MRS studies is that we measured a plane of liver voxels at once rather than a single MRS voxel, yielding a reliable determination of liver fat content.
   Results:Fat contents of 3.4-10% were observed in young GSD IXa patients, as compared with 0.5-0.9% in controls, these dropped to control levels in patients past age 40 (r = -0.82; P < 0.01).
   Conclusions: Liver fat content is increased in glycogen storage disease (GSD IXa) and normalizes with ageing. Assessing liver fat levels in this population is a novel and interesting concept. This could potentially enhance the understanding of liver function in that 20% of the population who has increased liver fat. (c) 2006 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 Univ Groningen, Med Ctr, NL-9713 GZ Groningen, Netherlands.
C3 University of Groningen
RP Sijens, PE (corresponding author), Univ Groningen, Med Ctr, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands.
EM p.e.sijens@rad.umcg.nl
OI Oudkerk, Matthijs/0000-0003-2800-4110
CR Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z
   Bandsma RHJ, 2002, EUR J PEDIATR, V161, pS65, DOI 10.1007/s00431-002-1007-8
   Bandsma RHJ, 2002, J PEDIATR-US, V140, P256, DOI 10.1067/mpd.2002.121382
   Behrman RE, 2000, NELSON TXB PEDIAT
   Burwinkel B, 1998, HUM GENET, V102, P423, DOI 10.1007/s004390050715
   Chang S, 1998, HUM MOL GENET, V7, P865, DOI 10.1093/hmg/7.5.865
   Fernandes J, 2001, INHERITED METABOLIC, P85
   Hendrickx J, 1998, EUR J PEDIATR, V157, P919, DOI 10.1007/s004310050967
   Ishii M, 2005, TOHOKU J EXP MED, V206, P23, DOI 10.1620/tjem.206.23
   JEVON GP, 1994, PEDIATR PATHOL, V14, P709, DOI 10.3109/15513819409023343
   KAGALWALLA AF, 1995, J PEDIATR-US, V127, P602, DOI 10.1016/S0022-3476(95)70123-0
   Kawamitsu Hideaki, 2003, Magn Reson Med Sci, V2, P47, DOI 10.2463/mrms.2.47
   Kuhlmann J, 2003, DIABETES, V52, P138, DOI 10.2337/diabetes.52.1.138
   LABRUNE P, 1992, J INHERIT METAB DIS, V15, P723, DOI 10.1007/BF01800013
   Lee S, 2006, SCAND J GASTROENTERO, V41, P566, DOI 10.1080/00365520500319591
   LONGO R, 1993, INVEST RADIOL, V28, P297, DOI 10.1097/00004424-199304000-00006
   MCADAMS AJ, 1974, HUM PATHOL, V5, P463, DOI 10.1016/S0046-8177(74)80024-9
   MCKUSICK V, ONLINE MENDELIAN INH
   NAGAI T, 1988, ACTA PAEDIATR SCAND, V77, P460, DOI 10.1111/j.1651-2227.1988.tb10681.x
   NAKAI A, 1994, EUR J PEDIATR, V153, P581
   Roser W, 1996, MAGN RESON IMAGING, V14, P1217, DOI 10.1016/S0730-725X(96)00243-3
   Schippers HM, 2003, J INHERIT METAB DIS, V26, P43, DOI 10.1023/A:1024071328772
   Schwab KO, 2006, DIABETES CARE, V29, P218, DOI 10.2337/diacare.29.02.06.dc05-0724
   SCRIVER CR, 2000, METABOLIC MOL BASES, P151
   SIJENS PE, 1995, MAGN RESON IMAGING, V13, P621, DOI 10.1016/0730-725X(95)00005-2
   Sijens PE, 1998, MAGN RESON IMAGING, V16, P205, DOI 10.1016/S0730-725X(97)00246-4
   Sijens PE, 1997, MAGN RESON MED, V37, P222, DOI 10.1002/mrm.1910370214
   Stefan N, 2005, HORM RES, V64, P38, DOI 10.1159/000089316
   Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004
   Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566
   THOMSEN C, 1994, MAGN RESON IMAGING, V12, P487, DOI 10.1016/0730-725X(94)92543-7
   Tiikkainen M, 2003, DIABETES, V52, P701, DOI 10.2337/diabetes.52.3.701
   TUCHMAN M, 1986, METABOLISM, V35, P627, DOI 10.1016/0026-0495(86)90169-1
   WILLEMS PJ, 1990, EUR J PEDIATR, V149, P268, DOI 10.1007/BF02106291
NR 34
TC 13
Z9 14
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
J9 J HEPATOL
JI J. Hepatol.
PD DEC
PY 2006
VL 45
IS 6
BP 851
EP 855
DI 10.1016/j.jhep.2006.06.021
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 111VX
UT WOS:000242484600011
PM 17005290
DA 2024-02-19
ER

PT J
AU Xu, Q
   Li, YY
   Gao, X
   Kang, K
   Williams, JG
   Tong, LF
   Liu, J
   Ji, M
   Deterding, LJ
   Tong, XM
   Locasale, JW
   Li, LP
   Shats, I
   Li, XL
AF Xu, Qing
   Li, Yuanyuan
   Gao, Xia
   Kang, Kai
   Williams, Jason G.
   Tong, Lingfeng
   Liu, Juan
   Ji, Ming
   Deterding, Leesa J.
   Tong, Xuemei
   Locasale, Jason W.
   Li, Leping
   Shats, Igor
   Li, Xiaoling
TI HNF4α regulates sulfur amino acid metabolism and confers sensitivity to
   methionine restriction in liver cancer
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NUCLEAR FACTOR 4-ALPHA; HEPATOCELLULAR-CARCINOMA; HYDROGEN-SULFIDE;
   LIFE-SPAN; METHYLATION; EXPRESSION; GLUCOSE; METTL16; SERINE
AB Methionine restriction, a dietary regimen that protects against metabolic diseases and aging, represses cancer growth and improves cancer therapy. However, the response of different cancer cells to this nutritional manipulation is highly variable, and the molecular determinants of this heterogeneity remain poorly understood. Here we report that hepatocyte nuclear factor 4 alpha (HNF4 alpha) dictates the sensitivity of liver cancer to methionine restriction. We show that hepatic sulfur amino acid (SAA) metabolism is under transcriptional control of HNF4 alpha. Knocking down HNF4 alpha or SAA enzymes in HNF4 alpha -positive epithelial liver cancer lines impairs SAA metabolism, increases resistance to methionine restriction or sorafenib, promotes epithelial-mesenchymal transition, and induces cell migration. Conversely, genetic or metabolic restoration of the transsulfuration pathway in SAA metabolism significantly alleviates the outcomes induced by HNF4 alpha deficiency in liver cancer cells. Our study identifies HNF4 alpha as a regulator of hepatic SAA metabolism that regulates the sensitivity of liver cancer to methionine restriction. The molecular determinants of differential responses of different cancer cells to methionine restriction are poorly understood. Here the authors show that hepatocyte nuclear factor 4 alpha regulates sulfur amino acid metabolism and dictates the sensitivity of liver cancer to this dietary manipulation.
C1 [Xu, Qing; Ji, Ming; Shats, Igor; Li, Xiaoling] NIEHS, Signal Transduct Lab, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Li, Yuanyuan; Kang, Kai; Li, Leping] NIEHS, Biostat & Computat Biol Branch, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Gao, Xia; Liu, Juan; Locasale, Jason W.] Duke Univ, Dept Pharmacol & Canc Biol, Sch Med, Durham, NC 27710 USA.
   [Williams, Jason G.; Deterding, Leesa J.] NIEHS, Mass Spectrometry Res & Support Grp, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Tong, Lingfeng; Tong, Xuemei] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol,Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200001, Peoples R China.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS); Duke University; National Institutes of Health (NIH) - USA; NIH
   National Institute of Environmental Health Sciences (NIEHS); Shanghai
   Jiao Tong University
RP Shats, I; Li, XL (corresponding author), NIEHS, Signal Transduct Lab, POB 12233, Res Triangle Pk, NC 27709 USA.
EM igor.shats@nih.gov; lix3@niehs.nih.gov
RI Wang, Jin/GYA-2019-2022; Locasale, Jason W/ABE-6505-2020; Gao,
   Xia/CAF-4717-2022
OI Locasale, Jason W/0000-0002-7766-3502; Gao, Xia/0000-0003-0979-9990; Ji,
   Ming/0009-0008-4763-850X
FU Intramural Research Program of National Institute of Environmental
   Health Sciences of the NIH [Z01 ES102205]; Comparative Medicine Branch
   of National Institute of Environmental Health Sciences; NATIONAL
   INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES103005, ZIAES102205]
   Funding Source: NIH RePORTER
FX We thank Drs. Paul Wade and Stephen Shears and members of the Li
   laboratory for critical reading of the manuscript. We also thank the
   Comparative Medicine Branch of National Institute of Environmental
   Health Sciences for support with animal experiments and Drs. Masahiko
   Negishi and Muluneh Fashe for providing normal human hepatocytes. This
   research was supported by the Intramural Research Program of National
   Institute of Environmental Health Sciences of the NIH to X.L. (Z01
   ES102205).
CR Ables GP, 2017, EXP GERONTOL, V94, P83, DOI 10.1016/j.exger.2017.01.012
   Ables GP, 2016, ANN NY ACAD SCI, V1363, P68, DOI 10.1111/nyas.13014
   Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055
   [Anonymous], 2018, JCI INSIGHT, DOI DOI 10.1172/JCI.INSIGHT.120360
   [Anonymous], 2017, BIO PROTOCOL, DOI DOI 10.21769/BIOPROTOC.2382
   Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1
   Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103
   Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599
   Cao X, 2019, ANTIOXID REDOX SIGN, V31, P1, DOI 10.1089/ars.2017.7058
   Chen H, 2019, HEPATOLOGY, V70, P1011, DOI 10.1002/hep.30500
   Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200
   Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86
   Ding XX, 2017, ONCOTARGET, V8, P55715, DOI 10.18632/oncotarget.18382
   Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523
   Frau M, 2012, HEPATOLOGY, V56, P165, DOI 10.1002/hep.25643
   Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3
   Gomes AR, 2015, CLIN MOL HEPATOL, V21, P257, DOI 10.3350/cmh.2015.21.3.257
   Gravel SP, 2014, CANCER RES, V74, P7521, DOI 10.1158/0008-5472.CAN-14-2643-T
   GUO HY, 1993, CANCER RES, V53, P5676
   Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043
   Hens JR, 2016, BMC CANC, V16
   Hsieh MH, 2019, CELL REP, V28, P1860, DOI 10.1016/j.celrep.2019.07.027
   Jin B, 2016, TUMOR BIOL, V37, P5911, DOI 10.1007/s13277-015-4443-6
   Kanarek N, 2018, NATURE, V559, P632, DOI 10.1038/s41586-018-0316-7
   Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891
   Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145
   Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309
   Knott SRV, 2018, NATURE, V554, P378, DOI 10.1038/nature25465
   Komninou D, 2006, NUTR CANCER, V54, P202, DOI 10.1207/s15327914nc5402_6
   Lau HH, 2018, J HEPATOL, V68, P1033, DOI 10.1016/j.jhep.2017.11.026
   Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]
   Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056
   Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743
   Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438
   Mato JM, 2013, ANN HEPATOL, V12, P183, DOI 10.1016/S1665-2681(19)31355-9
   Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824
   NISHIZAKI T, 1995, NUTR CANCER, V23, P85, DOI 10.1080/01635589509514364
   Nwosu ZC, 2017, CELL MOL GASTROENTER, V4, P303, DOI 10.1016/j.jcmgh.2017.05.004
   ORENTREICH N, 1993, J NUTR, V123, P269
   Pascale RM, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2018.06.04
   Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003
   Perridon BW, 2016, AGING-US, V8, P2264, DOI 10.18632/aging.101026
   PoirsonBichat F, 1997, BRIT J CANCER, V75, P1605, DOI 10.1038/bjc.1997.274
   Qiu ZX, 2019, CANCER CELL, V36, P179, DOI 10.1016/j.ccell.2019.07.001
   Sanderson SM, 2019, NAT REV CANCER, V19, P625, DOI 10.1038/s41568-019-0187-8
   Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]
   Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44
   Shima H, 2017, CELL REP, V21, P3354, DOI 10.1016/j.celrep.2017.11.092
   Shimbo T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004028
   Sinha R, 2014, PROSTATE, V74, P1663, DOI 10.1002/pros.22884
   Sladek F. M., 2001, NUCL RECEPT GENET DI, V9, P309
   SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
   STERN PH, 1984, J CELL PHYSIOL, V119, P29, DOI 10.1002/jcp.1041190106
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263
   Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251
   Wang SSS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.18
   Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5
   Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014
   Yang Z. Q., 2012, INTECH, DOI [10.5772/52301, DOI 10.5772/52301]
   Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183
   Zhang Y, 2013, MOL CELL BIOL, V33, P1104, DOI 10.1128/MCB.01215-12
   Zhang ZH, 2018, ONCOL LETT, V15, P1503, DOI 10.3892/ol.2017.7521
   Zhu HR, 2018, BIOMED RES INT-UK, V2018, DOI 10.1155/2018/3205125
   Zhu JJ, 2019, CELL METAB, V30, P865, DOI 10.1016/j.cmet.2019.09.009
NR 70
TC 45
Z9 51
U1 0
U2 19
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 7
PY 2020
VL 11
IS 1
AR 3978
DI 10.1038/s41467-020-17818-w
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NC3ET
UT WOS:000561098400031
PM 32770044
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Deevska, G
   Sunkara, M
   Karakashian, C
   Peppers, B
   Morris, AJ
   Nikolova-Karakashian, MN
AF Deevska, Gergana
   Sunkara, Manjula
   Karakashian, Claudia
   Peppers, Benjamin
   Morris, Andrew J.
   Nikolova-Karakashian, Mariana N.
TI Effect of Procysteine on aging-associated changes in hepatic GSH and
   SMase: evidence for transcriptional regulation of <i>smpd3</i>
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE sphingomyelinase; ceramide; reduced glutathione supplementation; aging;
   diet; oxidative stress
ID NECROSIS-FACTOR-ALPHA; AGE-RELATED-CHANGES; ACETAMINOPHEN-INDUCED
   HEPATOTOXICITY; NEUTRAL SPHINGOMYELINASE 2;
   L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID; GLUTATHIONE METABOLISM; CYSTEINE
   PRODRUG; N-ACETYLCYSTEINE; OXIDATIVE STRESS; ANTIOXIDANT ENZYMES
AB In hepatocytes, aging-associated decline in GSH has been linked to activation of neutral SMase (nSMase), accumulation of bioactive ceramide, and inflammation. In this study, we seek to test whether dietary supplementation with the cysteine precursor, L-2-oxothiazolidine-4-carboxylic acid (OTC), would correct the aging-associated differences in hepatic GSH, nSMase, and ceramide. Young and aged mice were placed on a diet that either lacked sulfur-containing amino acids (SAAs) or had 0.5% OTC for 4 weeks. Mice fed standard chow were used as an additional control. SAA-deficient mice exhibited significant aging-associated differences in hepatic GSH, GSH/GSSG, ceramide, and nSMase. C24:1 ceramide, the major ceramide species in liver, was affected the most by aging, followed by the less abundant C16:0 ceramide. OTC supplementation eliminated the aging-associated differences in hepatic GSH and GSH/GSSG ratio. Surprisingly, however, instead of decreasing, the nSMase activity and ceramide increased in the OTC-fed mice irrespective of their age. These effects were due to elevated nSMase-2 mRNA and protein and appeared to be direct. Similar increases were seen in HepG2 cells following treatment with OTC. The OTC-fed aged mice also exhibited hepatic steatosis and triacylglyceride accumulation. These results suggest that OTC is a potent stimulant of nSMase-2 expression and that there may be unanticipated complications of OTC supplementation.
C1 [Deevska, Gergana; Karakashian, Claudia; Peppers, Benjamin; Nikolova-Karakashian, Mariana N.] Univ Kentucky, Albert B Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA.
   [Sunkara, Manjula; Morris, Andrew J.] Lexington Vet Affairs Med Ctr, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40536 USA.
C3 University of Kentucky; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Lexington VA Medical Center
RP Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA.
EM mnikolo@uky.edu
RI sunkara, Manjula/H-7944-2016
OI sunkara, Manjula/0000-0001-6151-1929
FU National Institutes of Health [AG019223, AG026711, GM50388, P20RR021954]
FX This work was supported by National Institutes of Health Grants AG019223
   and AG026711 (to M.N.K.), and GM50388, P20RR021954 for LC-MS/MS analyses
   (to A.J.M.).
CR Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010
   Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033
   BANKS MF, 1994, J NUTR, V124, P378, DOI 10.1093/jn/124.3.378
   Barditch-Crovo P, 1998, J CLIN PHARMACOL, V38, P357, DOI 10.1002/j.1552-4604.1998.tb04435.x
   Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164
   BRODEUR J, 1987, CAN J PHYSIOL PHARM, V65, P816, DOI 10.1139/y87-131
   Cacciatore I, 2010, MOLECULES, V15, P1242, DOI 10.3390/molecules15031242
   Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313
   CHATTERJEE S, 1994, J BIOL CHEM, V269, P879
   Choi J, 2013, MOLECULES, V18, P3467, DOI 10.3390/molecules18033467
   Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794
   Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250
   Crankshaw DL, 2002, J BIOCHEM MOL TOXIC, V16, P235, DOI 10.1002/jbt.10044
   Deaciuc IV, 2000, ALCOHOL CLIN EXP RES, V24, P1557, DOI 10.1111/j.1530-0277.2000.tb04575.x
   Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200
   DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048
   Erden-Inal M, 2002, CELL BIOCHEM FUNCT, V20, P61, DOI 10.1002/cbf.937
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   Filosto S, 2012, J BIOL CHEM, V287, P514, DOI 10.1074/jbc.M111.315481
   Gerard-Monnier D, 1993, Clin Physiol Biochem, V10, P36
   Gwilt PR, 1998, J CLIN PHARMACOL, V38, P945, DOI 10.1002/j.1552-4604.1998.tb04391.x
   Hagen TM, 2000, ANTIOXID REDOX SIGN, V2, P473, DOI 10.1089/15230860050192251
   Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359
   Hoang MH, 2012, MOL NUTR FOOD RES, V56, P900, DOI 10.1002/mnfr.201100611
   Iimuro Y, 2000, HEPATOLOGY, V31, P391, DOI 10.1002/hep.510310219
   Ito H, 2012, J BIOCHEM, V151, P599, DOI 10.1093/jb/mvs037
   JAIN A, 1995, J NUTR, V125, P851
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   JURIMAROMET M, 1992, BIOCHEM PHARMACOL, V44, P1803, DOI 10.1016/0006-2952(92)90075-T
   KALAYJIAN RC, 1994, J ACQ IMMUN DEF SYND, V7, P369
   Kim IH, 2012, BMB REP, V45, P348, DOI 10.5483/BMBRep.2012.45.6.276
   Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255
   LANG CA, 1992, J LAB CLIN MED, V120, P720
   Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013
   Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281
   Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313
   Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169
   Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005
   Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200
   Meyers-Needham M, 2012, MOL CANCER THER, V11, P1092, DOI 10.1158/1535-7163.MCT-11-0705
   Moberly JB, 1998, J AM SOC NEPHROL, V9, P1093
   Molano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047650
   Monette JS, 2011, PHARMACOL RES, V63, P23, DOI 10.1016/j.phrs.2010.09.007
   Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X
   Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18
   NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718
   NISHINA H, 1987, PHYSIOL CHEM PHYS M, V19, P9
   Paasche G, 1998, OPHTHALMIC RES, V30, P351, DOI 10.1159/000055495
   Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   PORTA P, 1991, J PHARMACOL EXP THER, V257, P331
   Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   Rivas DA, 2012, J APPL PHYSIOL, V113, P1727, DOI 10.1152/japplphysiol.00412.2012
   Robciuc A, 2012, J LIPID RES, V53, P2286, DOI 10.1194/jlr.M026732
   Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200
   Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777
   Ruvolo PP, 2001, J BIOL CHEM, V276, P11754, DOI 10.1074/jbc.M011400200
   Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4
   Sasaki T, 2001, NUCL MED BIOL, V28, P25, DOI 10.1016/S0969-8051(00)00180-3
   Scheid MP, 1999, BLOOD, V93, P217, DOI 10.1182/blood.V93.1.217.401k16_217_225
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   TAKAHASHI S, 1982, ARCH BIOCHEM BIOPHYS, V214, P260, DOI 10.1016/0003-9861(82)90029-7
   Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0
   VERICEL E, 1994, MOL CELL BIOCHEM, V132, P25, DOI 10.1007/BF00925671
   Wang H, 2003, EXP GERONTOL, V38, P507, DOI 10.1016/S0531-5565(03)00036-6
   WILLIAMSON JM, 1982, P NATL ACAD SCI-BIOL, V79, P6246, DOI 10.1073/pnas.79.20.6246
   YAMADA S, 1995, AMINO ACIDS, V8, P37, DOI 10.1007/BF00806542
   Yan F, 2001, CANCER RES, V61, P963
   Zhu YG, 2006, BRAIN RES, V1090, P35, DOI 10.1016/j.brainres.2006.03.063
NR 70
TC 13
Z9 14
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD OCT
PY 2014
VL 55
IS 10
BP 2041
EP 2052
DI 10.1194/jlr.M048223
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AQ6MA
UT WOS:000342925400008
PM 25047167
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Ahsan, MK
   Mehal, WZ
AF Ahsan, Md. Kaimul
   Mehal, Wajahat Z.
TI Activation of adenosine receptor A<sub>2A</sub> increases HSC
   proliferation and inhibits death and senescence by down-regulation of
   p53 and Rb
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE liver fibrosis; hepatic stellate cells; adenosine receptors; apoptosis;
   senescence
ID HEPATIC STELLATE CELLS; ONCOGENE-INDUCED SENESCENCE; CELLULAR
   SENESCENCE; GROWTH-FACTOR; TUMOR-SUPPRESSION; LIVER FIBROSIS;
   CHEMOTAXIS; APOPTOSIS; CONTRACTION; EXPRESSION
AB Background and Aims: During fibrosis hepatic stellate cells (HSC) undergo activation, proliferation, and senescence but the regulation of these important processes is poorly understood. The adenosine A(2A) receptor (A(2A)) is known to be present on HSC, and its activation results in liver fibrosis. In this study, we tested if A(2A) has a role in the regulation of HSC proliferation, apoptosis, senescence, and the relevant molecular mechanism.
   Methods: The ability of adenosine to regulate p53 and Rb protein levels, proliferation, apoptosis and senescence was tested in the human HSC cell line LX-2 and rat primary HSC.
   Results: Adenosine receptor activation down-regulates p53 and Rb protein levels, increases BrdU incorporation and increases cell survival in LX-2 cells and in primary rat HSC. These effects of NECA were reproduced by an adenosine A(2A) receptor specific agonist (CGS21680) and blocked by a specific antagonist (ZM241385). By day twenty-one of culture primary rat HSC entered senescence and expressed beta-gal which was significantly inhibited by NECA. Furthermore, NECA induced down regulation of p53 and Rb and Rac1, and decreased phosphorylation of p44-42 MAP Kinase in LX-2 cells and primary rat HSC. These effects were reproduced by the cAMP analog 8-Bromo-cAMP and the adenylyl cyclase activator forskolin, and were blocked by PKA inhibitors.
   Conclusions: These results demonstrate that A(2A) receptor regulates a number of HSC fate decisions and induces greater HSC proliferation, reduces apoptosis and senescence by decreasing p53 and Rb through cAMP-PKA/Rac1/p38 MAPK pathway. This provides a mechanism for adenosine induced HSC regulation and liver fibrosis.
C1 [Ahsan, Md. Kaimul; Mehal, Wajahat Z.] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA.
C3 Yale University
RP Mehal, WZ (corresponding author), Yale Univ, Dept Internal Med, Sect Digest Dis, 333 Cedar St,1080 LMP,POB 208019, New Haven, CT 06520 USA.
EM wajahat.mehal@yale.edu
RI Masutani, Hiroshi/B-5114-2014
FU National Institutes of Health (NIAAA/NIH) [UO1 AA021912-01]; NIH
   [2R56DK076674-06]; Veterans Administration Merit Award; Yale Liver
   Center [P30 DK034989/DK/NIDDK NIH]
FX This work was supported by National Institutes of Health Grant UO1
   AA021912-01 (NIAAA/NIH), NIH 2R56DK076674-06, Veterans Administration
   Merit Award, and the Yale Liver Center (P30 DK034989/DK/NIDDK NIH).
CR Abriss B, 2003, J HEPATOL, V38, P169, DOI 10.1016/S0168-8278(02)00361-6
   Bataller R, 2005, ANTIOXID REDOX SIGN, V7, P1346, DOI 10.1089/ars.2005.7.1346
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005
   Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812
   Chan ESL, 2010, MOD RHEUMATOL, V20, P114, DOI 10.1007/s10165-009-0251-4
   Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760
   Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Cronstein Bruce N, 2004, ScientificWorldJournal, V4, P1
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Feoktistov Igor, 2009, Handb Exp Pharmacol, P383, DOI 10.1007/978-3-540-89615-9_13
   Fischer R, 2002, GASTROENTEROLOGY, V123, P845, DOI 10.1053/gast.2002.35384
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   Gao ZG, 2007, EXPERT OPIN EMERG DR, V12, P479, DOI 10.1517/14728214.12.3.479
   Grant MB, 1999, CIRC RES, V85, P699, DOI 10.1161/01.RES.85.8.699
   Grant MB, 2001, INVEST OPHTH VIS SCI, V42, P2068
   Hashmi AZ, 2007, AM J PHYSIOL-GASTR L, V292, pG395, DOI 10.1152/ajpgi.00208.2006
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Houglum K, 1997, J CLIN INVEST, V99, P1322, DOI 10.1172/JCI119291
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557
   KAWADA N, 1992, BIOCHEM J, V285, P367, DOI 10.1042/bj2850367
   Kinnman N, 2001, LAB INVEST, V81, P1709, DOI 10.1038/labinvest.3780384
   Knittel T, 1997, J HEPATOL, V27, P1067, DOI 10.1016/S0168-8278(97)80151-1
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Mohamadnejad M, 2010, HEPATOLOGY, V51, P963, DOI 10.1002/hep.23389
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Reinehr R, 2008, GASTROENTEROLOGY, V134, P1494, DOI 10.1053/j.gastro.2008.02.021
   ROCKEY DC, 1995, BIOCHEM BIOPH RES CO, V207, P725, DOI 10.1006/bbrc.1995.1247
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589
   Soon RK, 2008, CLIN LIVER DIS, V12, P791, DOI 10.1016/j.cld.2008.07.004
   Wang RB, 2007, COGN NEURODYNAMICS, V1, P1, DOI 10.1007/s11571-006-9010-9
   Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002
   Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
NR 48
TC 31
Z9 32
U1 2
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD APR 10
PY 2014
VL 5
AR 69
DI 10.3389/fphar.2014.00069
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA AX7AT
UT WOS:000347069900001
PM 24782773
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, S
   Kim, J
   Lee, C
   Oh, D
   Han, J
   Kim, TJ
   Kim, SW
   Seo, YS
   Oh, SH
   Jung, Y
AF Wang, Sihyung
   Kim, Jieun
   Lee, Chanbin
   Oh, Dayoung
   Han, Jinsol
   Kim, Tae-Jin
   Kim, Sang-Woo
   Seo, Young-Su
   Oh, Seh-hoon
   Jung, Youngmi
TI Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells
   into stem-like cells, which ameliorates liver damage in mouse
SO BIOMATERIALS
LA English
DT Article
DE TSG-6; Reprogramming; HSC; Organoid; Liver regeneration
ID TGF-BETA; HIPPO PATHWAY; SELF-RENEWAL; ADULT LIVER; ORGAN SIZE;
   FIBROSIS; FATE; REGENERATION; SENESCENCE; PROGRESSION
AB Liver fibrosis is a major characteristic of liver disease. When the liver is damaged, quiescent hepatic stellate cells (HSCs) transdifferentiate into proliferative myofibroblastic/activated HSCs, which are the main contributors to liver fibrosis. Hence, a strategy for regulating HSC activation is important in the treatment of liver disease. Tumor necrosis factor-inducible gene 6 protein (TSG-6), a cytokine released from mesenchymal stem cells (MSCs), influences MSC sternness. Therefore, we investigated the biological effect of TSG-6 on HSCs. Human primary HSCs treated with TSG-6 showed significant downregulation of HSC activation markers and upregulation of senescence markers. TSG-6 promoted these cells to express stem cell markers and form spherical organoids, which exhibited elevated expression of stemness-related genes. These organoids differentiated into functional hepatocytic cells under specific culture conditions. Organoids derived from TSG-6-treated HSCs improved livers in organoid transplant mice subjected to CCl4 treatment (which induces liver fibrosis). Furthermore, HSC transdifferentiation by TSG-6 was mediated by Yes-associated protein 1. These findings demonstrate that TSG-6 induces the conversion of HSCs into stem cell-like cells in vitro and that organoids derived from TSG-6-treated HSCs can restore fibrotic liver, suggesting that direct reprogramming of HSCs by TSG-6 can be a useful strategy to control liver disease.
C1 [Wang, Sihyung; Kim, Jieun; Lee, Chanbin; Oh, Dayoung; Han, Jinsol; Kim, Tae-Jin; Kim, Sang-Woo; Seo, Young-Su; Jung, Youngmi] Dept Integrated Biol Sci, Pusan 46241, South Korea.
   [Kim, Tae-Jin; Kim, Sang-Woo; Jung, Youngmi] Dept Biol Sci, Pusan 46241, South Korea.
   [Seo, Young-Su] Pusan Natl Univ, Dept Microbiol, Pusan 46241, South Korea.
   [Oh, Seh-hoon] Duke Univ, Div Gastroenterol, Dept Med, Durham, NC 27707 USA.
C3 Pusan National University; Duke University
RP Jung, Y (corresponding author), Pusan Natl Univ, Dept Biol Sci, 63-2 Pusandaehak Ro, Pusan 609735, South Korea.
EM s.wang@pusan.ac.kr; jieun@pusan.ac.kr; lcb102@pusan.ac.kr;
   odyon3@pusan.ac.kr; wlsthf1408@pusan.ac.kr; tjkim77@pusan.ac.kr;
   kimsw@pusan.ac.kr; yseo2011@pusan.ac.kr; seh.hoon.oh@duke.edu;
   y.jung@pusan.ac.kr
RI Kim, Tae-Jin/AEQ-9847-2022
OI Kim, Tae-Jin/0000-0001-7678-0478
FU National Research Foundation of Korea (NRF) - Korea government (MSIT,
   Ministry of Science and ICT) [2016R1A2B2007922]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIT, Ministry of Science
   and ICT) (No. 2016R1A2B2007922) to YJ. The biospecimens and data used
   for this study were provided by the Biobank of Pusan National University
   Hospital, a member of the Korea Biobank Network.
CR Bagasra O, 2007, NAT PROTOC, V2, P2782, DOI 10.1038/nprot.2007.395
   Barra F, 2019, EXPERT OPIN BIOL TH, V19, P343, DOI 10.1080/14712598.2019.1581761
   Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021
   Bora-Singhal N, 2015, STEM CELLS, V33, P1705, DOI 10.1002/stem.1993
   Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097
   Carelli S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010267
   Chaudhari P, 2016, EXP BIOL MED, V241, P1653, DOI 10.1177/1535370216657901
   Chi JY, 2015, ONCOTARGET, V6, P23987, DOI 10.18632/oncotarget.4364
   Dollé L, 2015, AM J PHYSIOL-GASTR L, V308, pG233, DOI 10.1152/ajpgi.00069.2014
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gaça MDA, 1999, J HEPATOL, V30, P850, DOI 10.1016/S0168-8278(99)80139-1
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Hyun J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10993
   Jho E, 2018, J THORAC DIS, V10, pS3895, DOI 10.21037/jtd.2018.10.70
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354
   Kim J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03782-x
   Kim J, 2016, CELL PHYSIOL BIOCHEM, V40, P263, DOI 10.1159/000452543
   Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029
   Kordes C, 2014, J CLIN INVEST, V124, P5503, DOI 10.1172/JCI74119
   Kordes C, 2013, CELL PHYSIOL BIOCHEM, V31, P290, DOI 10.1159/000343368
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Leali D, 2012, ARTERIOSCL THROM VAS, V32, P696, DOI 10.1161/ATVBAHA.111.243998
   Lee DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11961
   Lee RH, 2014, P NATL ACAD SCI USA, V111, P16766, DOI 10.1073/pnas.1416121111
   Leite SB, 2016, BIOMATERIALS, V78, P1, DOI 10.1016/j.biomaterials.2015.11.026
   Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310
   Liu Y, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/7652359
   Machado MV, 2016, GASTROENTEROLOGY, V150, P1769, DOI 10.1053/j.gastro.2016.02.066
   Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407
   Miyamura N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms16017
   Miyata E, 2008, BLOOD, V111, P2427, DOI 10.1182/blood-2007-07-101261
   Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728
   Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392
   Murrow LM, 2017, DEVELOPMENT, V144, P998, DOI 10.1242/dev.140905
   Ni X, 2016, SCI REP-UK, V6, DOI 10.1038/srep38694
   Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113
   Oh SH, 2004, LAB INVEST, V84, P607, DOI 10.1038/labinvest.3700074
   Ou CL, 2017, ONCOTARGET, V8, P75727, DOI 10.18632/oncotarget.20155
   Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047
   Rangwala F, 2011, J PATHOL, V224, P401, DOI 10.1002/path.2888
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029
   Shi HF, 2014, NEURAL REGEN RES, V9, P931, DOI 10.4103/1673-5374.133135
   Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V291, pG575, DOI 10.1152/ajpgi.00102.2006
   Suh YG, 2012, HEPATOLOGY, V56, P1902, DOI 10.1002/hep.25817
   Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542
   Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998
   Thomas C, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4674
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wang H, 2014, CANCER METAST REV, V33, P173, DOI 10.1007/s10555-013-9463-3
   Wang S, 2018, CELL PHYSIOL BIOCHEM, V48, P1215, DOI 10.1159/000491987
   Wang S, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.140
   Wang S, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0019-z
   Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034
   Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115
   Yi HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127946
   Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Zhang X., 2018, INT J MOL SCI, P1912
   Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303
NR 66
TC 19
Z9 19
U1 2
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2019
VL 219
AR 119375
DI 10.1016/j.biomaterials.2019.119375
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Materials Science
GA IW0JN
UT WOS:000484648300009
PM 31374480
DA 2024-02-19
ER

PT J
AU Zhang, C
   Cuervo, AM
AF Zhang, Cong
   Cuervo, Ana Maria
TI Restoration of chaperone-mediated autophagy in aging liver improves
   cellular maintenance and hepatic function
SO NATURE MEDICINE
LA English
DT Article
ID AGE; DEGRADATION; PROTEIN; LYSOSOMES; DISEASE; HEPATOCYTES; RECEPTOR
AB Chaperone-mediated autophagy (CMA), a selective mechanism for degradation of cytosolic proteins in lysosomes, contributes to the removal of altered proteins as part of the cellular quality-control systems(1,2). We have previously found that CMA activity declines in aged organisms and have proposed that this failure in cellular clearance could contribute to the accumulation of altered proteins, the abnormal cellular homeostasis and, eventually, the functional loss characteristic of aged organisms. To determine whether these negative features of aging can be prevented by maintaining efficient autophagic activity until late in life, in this work we have corrected the CMA defect in aged rodents. We have generated a double transgenic mouse model in which the amount of the lysosomal receptor for CMA, previously shown to decrease in abundance with age(3), can be modulated. We have analyzed in this model the consequences of preventing the age-dependent decrease in receptor abundance in aged rodents at the cellular and organ levels. We show here that CMA activity is maintained until advanced ages if the decrease in the receptor abundance is prevented and that preservation of autophagic activity is associated with lower intracellular accumulation of damaged proteins, better ability to handle protein damage and improved organ function.
C1 [Cuervo, Ana Maria] Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA.
   Marion Bessin Liver Res Ctr, Dept Anat & Struct Biol, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine
RP Cuervo, AM (corresponding author), Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM amcuervo@aecom.yu.edu
RI Zhang, Cong/A-1616-2013
OI Zhang, Cong/0000-0002-6074-9836; Cuervo, Ana Maria/0000-0002-0771-700X
FU US National Institutes of Health National Institute on Aging [AG021904,
   AG19834]; National Institute of Diabetes and Digestive and Kidney
   Diseases [DK041918]
FX We are grateful to S. Kaushik and A. C. Massey for assistance in the
   preparation of this manuscript. The pUHD10-3 plasmid and the Alb-tTA
   mice were generous gifts from H. Bujard (University of Heidelberg) and
   the antibody to the asialoglycoprotein receptor was kindly supplied by
   A. Wolkoff (Albert Einstein College of Medicine). This work was
   supported in part by US National Institutes of Health National Institute
   on Aging grants AG021904 and AG19834, National Institute of Diabetes and
   Digestive and Kidney Diseases DK041918, an Ellison Medical Foundation
   Award and a Glenn Foundation Award.
CR Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825
   BARRET A, 1998, HDB PROTEOLYTIC ENZY, P850
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Cavallini G, 2007, AUTOPHAGY, V3, P26, DOI 10.4161/auto.3268
   CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738
   Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002
   Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144
   Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200
   Higami Y, 1997, AM J PATHOL, V151, P659
   JENTOFT N, 1983, METHOD ENZYMOL, V91, P570
   Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152
   Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103
   Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Pappas P, 1998, EUR J DRUG METAB PH, V23, P461, DOI 10.1007/BF03189996
   Salvador N, 2000, J BIOL CHEM, V275, P27447
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   TANAKA K, 1988, DIABETES RES CLIN PR, V5, P71, DOI 10.1016/S0168-8227(88)80081-0
   Terman A, 1995, GERONTOLOGY, V41, P319
   WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349
   METHOD ENZYMOL
NR 27
TC 398
Z9 457
U1 1
U2 27
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD SEP
PY 2008
VL 14
IS 9
BP 959
EP 965
DI 10.1038/nm.1851
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 345IB
UT WOS:000258988600029
PM 18690243
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Aramaki, T
   Katsuta, Y
   Sekiyama, T
   Tsutsui, H
   Kome-ichi, H
   Ohsuga, M
   Satomura, K
   Yoshimura, M
AF Aramaki, T
   Katsuta, Y
   Sekiyama, T
   Tsutsui, H
   Kome-ichi, H
   Ohsuga, M
   Satomura, K
   Yoshimura, M
TI Effects of aging and liver disease upon the pharmacokinetics of
   nipradilol
SO CLINICAL DRUG INVESTIGATION
LA English
DT Article
ID PORTAL-HYPERTENSION; ESOPHAGEAL-VARICES; PROPRANOLOL; CIRRHOSIS
AB Objective: The effects of aging and liver disease on the pharmacokinetics of nipradilol were studied after a single oral dose of 6mg.
   Study Participants: Nipradilol was administered to three groups of subjects: younger healthy volunteers with a mean age of 33.2 years (group I, n = 6), older subjects without hepatic dysfunction with a mean age of 55.5 years (group II, n = 6), and patients with histologically confirmed cirrhosis of the liver with a mean age of 55.4 years (group III, n = 8).
   Results: When compared with younger subjects (group I), the older subjects (group II) had a significantly longer time to maximum concentration, a greater area under the plasma concentration-time curve (AUC), a greater bioavailability (F), and a greater 24-hour urinary excretion of nipradilol. There was also a tendency towards a longer half-life in group II compared with group I. Cirrhotic subjects (group III) showed the same differences relative to group I. In addition, F was significantly larger and the plasma clearance was significantly decreased in group III compared with group II. Nearly identical results were demonstrated for the pharmacokinetics of denitrated nipradilol, one of the major metabolites of the test drug. A significant correlation was demonstrated between the AUC of nipradilol and age when groups I and II were combined.
   Conclusion: It was concluded that the pharmacokinetics of nipradilol may be altered with aging and hepatic dysfunction, and that changes in metabolism are likely to be a major factor.
C1 Nippon Med Sch, Dept Internal Med 1, Bunkyo Ku, Tokyo 1138603, Japan.
   Kowa Co, Tokyo Res Lab, Tokyo, Japan.
C3 Nippon Medical School; Kowa Company, Ltd.
RP Aramaki, T (corresponding author), Nippon Med Sch, Dept Internal Med 1, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.
CR ARAMAKI T, 1992, J HEPATOL, V15, P48, DOI 10.1016/0168-8278(92)90010-M
   FEELY J, 1981, NEW ENGL J MED, V304, P692, DOI 10.1056/NEJM198103193041202
   FUZII M, 1986, JPN HEART J, V27, P233
   GREENBLATT DJ, 1982, J AM GERIATR SOC, V30, pS6, DOI 10.1111/j.1532-5415.1982.tb01350.x
   KLOTZ U, 1975, J CLIN INVEST, V55, P347, DOI 10.1172/JCI107938
   KOBAYASHI A, 1991, JPN J MED, V30, P318
   MONTAMAT SC, 1989, NEW ENGL J MED, V321, P303
   OHSUGA M, 1993, J HEPATOL, V17, P236, DOI 10.1016/S0168-8278(05)80044-3
   OKAMURA H, 1994, ARZNEIMITTEL-FORSCH, V44, P1250
   PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
   TATEISHI T, 1993, JPN J CLIN PHARM THE, V24, P419
   UCHIDA Y, 1983, ARCH INT PHARMACOD T, V262, P132
   UCHIDA Y, 1987, NEW CARDIOVASCULAR D, P95
   YONEDA M, 1985, IYAKUHIN KENKYU, V16, P1100
   YOSHIMURA M, 1985, J PHARMACOBIO-DYNAM, V8, P738
   YOSHIMURA M, 1985, JPN J CLIN PHARM THE, V16, P679
NR 16
TC 1
Z9 2
U1 0
U2 0
PU ADIS INTERNATIONAL LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW
   ZEALAND
SN 1173-2563
J9 CLIN DRUG INVEST
JI Clin. Drug Invest.
PD SEP
PY 1998
VL 16
IS 3
BP 251
EP 257
DI 10.2165/00044011-199816030-00009
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 128DT
UT WOS:000076390500009
PM 18370546
DA 2024-02-19
ER

PT J
AU Seki, E
   Brenner, DA
AF Seki, Ekihiro
   Brenner, David A.
TI Recent advancement of molecular mechanisms of liver fibrosis
SO JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
LA English
DT Article
DE Alcoholic liver disease; Angiogenesis; Autophagy; Hepatic stellate
   cells; IL-17; IL-22; IL-33; Liver cirrhosis; Reversal; Senescence
ID HEPATIC STELLATE CELLS; ENDOTHELIAL GROWTH-FACTOR; B-VIRUS INFECTION;
   HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; INTESTINAL MICROBIOME;
   MICE; INTERLEUKIN-22; INJURY; MYOFIBROBLASTS
AB Liver fibrosis occurs in response to any etiology of chronic liver injury including hepatitis B and C, alcohol consumption, fatty liver disease, cholestasis, and autoimmune hepatitis. Hepatic stellate cells (HSCs) are the primary source of activated myofibroblasts that produce extracellular matrix (ECM) in the liver. Various inflammatory and fibrogenic pathways contribute to the activation of HSCs. Recent studies also discovered that liver fibrosis is reversible and activated HSCs can revert to quiescent HSCs when causative agents are removed. Although the basic research for liver fibrosis has progressed remarkably, sensitive and specific biomarkers as non-invasive diagnostic tools, and effective anti-fibrotic agents have not been developed yet. This review highlights the recent advances in cellular and molecular mechanisms of liver fibrosis, especially focusing on origin of myofibroblasts, inflammatory signaling, autophagy, cellular senescence, HSC inactivation, angiogenesis, and reversibility of liver fibrosis.
C1 [Seki, Ekihiro] Cedars Sinai Med Ctr, Dept Med, Div Gastroenterol, Los Angeles, CA 90048 USA.
   [Brenner, David A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.
C3 Cedars Sinai Medical Center; University of California System; University
   of California San Diego
RP Seki, E (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Gastroenterol, 8700 Beverly Blvd,Suite D2099, Los Angeles, CA 90048 USA.
EM Ekihiro.Seki@cshs.org
RI Seki, Ekihiro/K-2481-2016
OI Seki, Ekihiro/0000-0002-9472-6085; Brenner, David/0000-0003-2573-525X
FU NIH [R01AA02017204, R01DK085252, P42ES010337]
FX This manuscript was supported by NIH grants R01AA02017204, R01DK085252
   and P42ES010337.
CR Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206
   Cobleigh MA, 2013, AM J PATHOL, V182, P21, DOI 10.1016/j.ajpath.2012.08.043
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   DeMinicis S, 2014, HEPATOLOGY, V59, P1738, DOI 10.1002/hep.26695
   Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681
   Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028
   Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y
   Feng DC, 2014, J IMMUNOL, V193, P2512, DOI 10.4049/jimmunol.1400588
   Feng DC, 2012, GASTROENTEROLOGY, V143, P188, DOI 10.1053/j.gastro.2012.03.044
   Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019
   Guillot A, 2014, HEPATOLOGY, V59, P296, DOI 10.1002/hep.26598
   Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803
   Hartmann P, 2012, GASTROENTEROLOGY, V143, P1330, DOI 10.1053/j.gastro.2012.07.099
   Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282
   Hernández-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354
   Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111
   Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486
   Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297
   Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kronenberger B, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-102
   Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742
   Li YC, 2013, P NATL ACAD SCI USA, V110, P2324, DOI 10.1073/pnas.1214136110
   Liu C, 2014, J BIOL CHEM, V289, P7082, DOI 10.1074/jbc.M113.543769
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Mazagova M, 2015, FASEB J, V29, P1043, DOI 10.1096/fj.14-259515
   Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Meng F, 2012, GASTROENTEROLOGY, V143
   Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4
   Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551
   Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020
   Scholten D, 2011, HEPATOLOGY, V53, P1048, DOI 10.1002/hep.24191
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332
   Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691
   She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200
   Brenner David A, 2013, Gastroenterol Hepatol (N Y), V9, P737, DOI 10.1016/j.clinre.2015.06.015
   Sun YQ, 2014, TOHOKU J EXP MED, V234, P255, DOI 10.1620/tjem.234.255
   Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065
   Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806
   Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304
   Yang L, 2014, GASTROENTEROLOGY, V146, P1339, DOI 10.1053/j.gastro.2014.01.061
   Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang Y, 2011, GASTROENTEROLOGY, V141, P1897, DOI 10.1053/j.gastro.2011.06.051
   Zhao JJ, 2014, HEPATOLOGY, V59, P1331, DOI 10.1002/hep.26916
   Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013
NR 62
TC 226
Z9 260
U1 13
U2 74
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1868-6974
EI 1868-6982
J9 J HEPATO-BIL-PAN SCI
JI J. Hepato-Biliary-Pancreat. Sci.
PD JUL
PY 2015
VL 22
IS 7
BP 512
EP 518
DI 10.1002/jhbp.245
PG 7
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA CL2XP
UT WOS:000356811400003
PM 25869468
OA Green Published, Green Accepted, Bronze
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Kawano, Y
   Ishikawa, N
   Aida, J
   Sanada, Y
   Izumiyama-Shimomura, N
   Nakamura, K
   Poon, SSS
   Matsumoto, K
   Mizuta, K
   Uchida, E
   Tajiri, T
   Kawarasaki, H
   Takubo, K
AF Kawano, Youichi
   Ishikawa, Naoshi
   Aida, Junko
   Sanada, Yukihiro
   Izumiyama-Shimomura, Naotaka
   Nakamura, Ken-ichi
   Poon, Steven S. S.
   Matsumoto, Koshi
   Mizuta, Koichi
   Uchida, Eiji
   Tajiri, Takashi
   Kawarasaki, Hideo
   Takubo, Kaiyo
TI Q-FISH Measurement of Hepatocyte Telomere Lengths in Donor Liver and
   Graft after Pediatric Living-Donor Liver Transplantation: Donor Age
   Affects Telomere Length Sustainability
SO PLOS ONE
LA English
DT Article
ID IN-SITU HYBRIDIZATION; REPLICATIVE SENESCENCE; CHROMOSOMAL INSTABILITY;
   CELLULAR SENESCENCE; LINGUAL EPITHELIUM; HUMAN FIBROBLASTS; ALLOGRAFTS;
   OUTCOMES; CELLS; LIFE
AB Along with the increasing need for living-donor liver transplantation (LDLT), the issue of organ shortage has become a serious problem. Therefore, the use of organs from elderly donors has been increasing. While the short-term results of LDLT have greatly improved, problems affecting the long-term outcome of transplant patients remain unsolved. Furthermore, since contradictory data have been reported with regard to the relationship between donor age and LT/LDLT outcome, the question of whether the use of elderly donors influences the long-term outcome of a graft after LT/LDLT remains unsettled. To address whether hepatocyte telomere length reflects the outcome of LDLT, we analyzed the telomere lengths of hepatocytes in informative biopsy samples from 12 paired donors and recipients (grafts) of pediatric LDLT more than 5 years after adult-to-child LDLT because of primary biliary atresia, using quantitative fluorescence in situ hybridization (Q-FISH). The telomere lengths in the paired samples showed a robust relationship between the donor and grafted hepatocytes (r = 0.765, p = 0.0038), demonstrating the feasibility of our Q-FISH method for cell-specific evaluation. While 8 pairs showed no significant difference between the telomere lengths for the donor and the recipient, the other 4 pairs showed significantly shorter telomeres in the recipient than in the donor. Multiple regression analysis revealed that the donors in the latter group were older than those in the former (p = 0.001). Despite the small number of subjects, this pilot study indicates that donor age is a crucial factor affecting telomere length sustainability in hepatocytes after pediatric LDLT, and that the telomeres in grafted livers may be elongated somewhat longer when the grafts are immunologically well controlled.
C1 [Kawano, Youichi; Uchida, Eiji; Tajiri, Takashi] Nippon Med Sch, Dept Surg, Tokyo 113, Japan.
   [Kawano, Youichi; Ishikawa, Naoshi; Aida, Junko; Izumiyama-Shimomura, Naotaka; Nakamura, Ken-ichi; Takubo, Kaiyo] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan.
   [Sanada, Yukihiro; Mizuta, Koichi; Kawarasaki, Hideo] Jichi Med Univ, Dept Transplant Surg, Shimotsuke, Tochigi, Japan.
   [Poon, Steven S. S.] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.
   [Matsumoto, Koshi] Ebina Gen Hosp, Dept Clin Pathol, Ebina, Kanagawa, Japan.
C3 Nippon Medical School; Tokyo Metropolitan Institute of Gerontology;
   Jichi Medical University; British Columbia Cancer Agency
RP Kawano, Y (corresponding author), Nippon Med Sch, Dept Surg, 1-1-5 Sendagi, Tokyo 113, Japan.
EM y-kawano@nms.ac.jp; naoshi@tmig.or.jp
RI Aida, Junko/Q-5697-2019
OI Aida, Junko/0000-0003-4923-5540
FU Japan Society for the Promotion of Science (JSPS) KAKENHI [19790926,
   24592013, 24590468]; Grants-in-Aid for Scientific Research [24592013,
   19790926, 24590468, 23659193] Funding Source: KAKEN
FX This work was supported by Japan Society for the Promotion of Science
   (JSPS) KAKENHI, 19790926 and 24592013 (to Y.K.), 24590468 (to N.I.). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abbasoglu O, 2008, WORLD J GASTROENTERO, V14, P3117, DOI 10.3748/wjg.14.3117
   Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001
   Aida J, 2011, J PATHOL, V223, P410, DOI 10.1002/path.2817
   Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Aini W, 2012, TRANSPL INT, V25, P956, DOI 10.1111/j.1432-2277.2012.01523.x
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Attia M, 2008, TRANSPL INT, V21, P713, DOI 10.1111/j.1432-2277.2008.00696.x
   Baerlocher GM, 2009, BLOOD, V114, P219, DOI 10.1182/blood-2009-03-209833
   Barber K, 2007, GUT, V56, P279, DOI 10.1136/gut.2006.093195
   Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500
   Borchert D, 2005, TRANSPL INT, V18, P709, DOI 10.1111/j.1432-2277.2005.00128.x
   CALNE RY, 1979, LANCET, V2, P1033
   Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8
   Chkhotua A, 2002, TRANSPL IMMUNOL, V9, P165, DOI 10.1016/S0966-3274(02)00003-5
   Cowles RA, 2008, J PEDIATR SURG, V43, P1605, DOI 10.1016/j.jpedsurg.2008.04.012
   Demetris AJ, 2006, HEPATOLOGY, V44, P489, DOI 10.1002/hep.21280
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Evans HM, 2006, HEPATOLOGY, V43, P1109, DOI 10.1002/hep.21152
   Ferlicot S, 2003, J PATHOL, V200, P661, DOI 10.1002/path.1392
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hornsby PJ, 2002, J GERONTOL A-BIOL, V57, pB251, DOI 10.1093/gerona/57.7.B251
   Ishikawa N, 2012, AGE, V34, P795, DOI 10.1007/s11357-011-9280-y
   Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004
   Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685
   MARKUS BH, 1988, TRANSPLANTATION, V46, P372
   McDiarmid SV, 2004, LIVER TRANSPLANT, V10, pS23, DOI 10.1002/lt.20272
   Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9
   Mehrabi A, 2008, LANGENBECK ARCH SURG, V393, P245, DOI 10.1007/s00423-007-0262-6
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakamura KI, 2002, J INVEST DERMATOL, V119, P1014, DOI 10.1046/j.1523-1747.2002.19523.x
   Navarro V, 2006, LIVER TRANSPLANT, V12, P652, DOI 10.1002/lt.20680
   Nobori S, 2006, P NATL ACAD SCI USA, V103, P19081, DOI 10.1073/pnas.0605159103
   O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989
   Ohe H, 2011, TRANSPLANTATION, V91, P808, DOI 10.1097/TP.0b013e31820f07de
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Sanada Y, 2014, TRANSPL INT, V27, P383, DOI 10.1111/tri.12273
   Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z
   Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x
   Singhal A, 2010, EXP CLIN TRANSPLANT, V8, P196
   STARZL TE, 1989, LANCET, V2, P1000
   STARZL TE, 1968, ANN SURG, V168, P392, DOI 10.1097/00000658-196809000-00009
   STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507
   STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5
   Sugawara Y, 1999, J Hepatobiliary Pancreat Surg, V6, P245, DOI 10.1007/s005340050114
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2
   Takubo K, 2010, MECH AGEING DEV, V131, P614, DOI 10.1016/j.mad.2010.08.007
   Takubo K, 2010, J PATHOL, V221, P201, DOI 10.1002/path.2704
   Veldhuis JD, 2008, AGEING RES REV, V7, P189, DOI 10.1016/j.arr.2007.12.005
   Wege Henning, 2007, Curr Stem Cell Res Ther, V2, P31, DOI 10.2174/157488807779317062
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yoshiya S, 2012, TRANSPLANTATION, V94, P947, DOI 10.1097/TP.0b013e31826969e6
NR 54
TC 12
Z9 14
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 11
PY 2014
VL 9
IS 4
AR e93749
DI 10.1371/journal.pone.0093749
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AI3CI
UT WOS:000336736200024
PM 24727734
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU JACKSON, RA
   HAWA, MI
   ROSHANIA, RD
   SIM, BM
   DISILVIO, L
   JASPAN, JB
AF JACKSON, RA
   HAWA, MI
   ROSHANIA, RD
   SIM, BM
   DISILVIO, L
   JASPAN, JB
TI INFLUENCE OF AGING ON HEPATIC AND PERIPHERAL GLUCOSE-METABOLISM IN
   HUMANS
SO DIABETES
LA English
DT Article
C1 UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637.
C3 University of Chicago
RP JACKSON, RA (corresponding author), MIDDLESEX HOSP,COBBOLD LABS,LONDON W1N 8AA,ENGLAND.
RI Jackson, Robert Adam/G-6236-2011
OI Jackson, Robert Adam/0000-0002-1163-6421
FU NIADDK NIH HHS [AM-25913] Funding Source: Medline
CR Abramson DI, 1940, AM HEART J, V19, P541, DOI 10.1016/S0002-8703(40)90195-8
   ADELMAN RC, 1972, ENDOCRINOLOGY, V90, P1551, DOI 10.1210/endo-90-6-1551
   ANDRES R, 1956, J CLIN INVEST, V35, P671, DOI 10.1172/JCI103324
   ANDRES R, 1962, J CLIN INVEST, V41, P108, DOI 10.1172/JCI104452
   ANDRES R, 1971, MED CLIN N AM, V55, P835, DOI 10.1016/S0025-7125(16)32479-8
   AZHAR S, 1983, METABOLISM, V32, P1019, DOI 10.1016/0026-0495(83)90070-7
   BERRY MN, 1985, METABOLISM, V34, P141, DOI 10.1016/0026-0495(85)90123-4
   CASTENFORS H, 1961, SCAND J CLIN LAB INV, V13, P512, DOI 10.3109/00365516109137316
   CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13
   COMROE JH, 1965, PHYSL RESPIRATION, P161
   COOPER KE, 1955, J PHYSIOL-LONDON, V128, P258, DOI 10.1113/jphysiol.1955.sp005304
   DAGENAIS GR, 1976, J CLIN INVEST, V58, P421, DOI 10.1172/JCI108486
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEBODO RC, 1963, RECENT PROG HORM RES, V19, P445
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DILLON RS, 1965, DIABETES, V14, P672, DOI 10.2337/diab.14.10.672
   DRAZNIN B, 1985, DIABETES, V34, P1168, DOI 10.2337/diabetes.34.11.1168
   EDELMAN IS, 1952, AM J PHYSIOL, V171, P279, DOI 10.1152/ajplegacy.1952.171.2.279
   ELAHI D, 1984, DIABETES, V33, P950, DOI 10.2337/diabetes.33.10.950
   FEIBUSCH JM, 1982, DIGEST DIS SCI, V27, P1095, DOI 10.1007/BF01391447
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FINK RI, 1986, J CLIN INVEST, V77, P2034, DOI 10.1172/JCI112533
   FINK RI, 1984, J CLIN ENDOCR METAB, V58, P721, DOI 10.1210/jcem-58-4-721
   GAFNI A, 1984, CURR TOP CELL REGUL, V24, P273
   GOLAY A, 1983, J AM GERIATR SOC, V31, P144, DOI 10.1111/j.1532-5415.1983.tb04853.x
   GOLAY A, 1982, DIABETES, V31, P1023, DOI 10.2337/diacare.31.11.1023
   GREGERMAN RI, 1981, TXB ENDOCRINOLOGY, P1192
   GUTH PH, 1968, AM J DIG DIS, V13, P565, DOI 10.1007/BF02233071
   HOGAN D B, 1984, Journal of Clinical and Experimental Gerontology, V6, P145
   HULTMAN E, 1961, SCAND J CLIN LAB INV, V13, P503, DOI 10.3109/00365516109137315
   HUTTON JJ, 1972, ANAL BIOCHEM, V45, P577, DOI 10.1016/0003-2697(72)90219-9
   INSEL PA, 1975, J CLIN INVEST, V55, P1057, DOI 10.1172/JCI108006
   JACKSON RA, 1984, J CLIN ENDOCR METAB, V59, P857, DOI 10.1210/jcem-59-5-857
   JACKSON RA, 1982, J CLIN ENDOCR METAB, V55, P840, DOI 10.1210/jcem-55-5-840
   JACKSON RA, 1986, J CLIN ENDOCR METAB, V63, P541, DOI 10.1210/jcem-63-3-541
   JACKSON RA, 1973, DIABETES, V22, P442, DOI 10.2337/diab.22.6.442
   JACKSON RA, 1987, METABOLISM, V36, P144, DOI 10.1016/0026-0495(87)90008-4
   KAISER FE, 1983, METABOLISM, V32, P838, DOI 10.1016/0026-0495(83)90116-6
   KENDALL MJ, 1979, GUT, V11, P498
   LENTNER C, 1981, GEIGY SCI TABLES, V1, P219
   LILJENQUIST JE, 1979, DIABETOLOGIA, V17, P139, DOI 10.1007/BF01219739
   LILJENQUIST JE, 1979, J CLIN ENDOCR METAB, V49, P937, DOI 10.1210/jcem-49-6-937
   LLOYD B, 1978, CLIN CHEM, V24, P1724
   MEISTAS MT, 1985, DIABETES, V34, P960, DOI 10.2337/diabetes.34.10.960
   MEYER HU, 1980, DIABETES, V29, P752, DOI 10.2337/diabetes.29.9.752
   MINAKER KL, 1982, DIABETES, V31, P851, DOI 10.2337/diabetes.31.10.851
   MONTGOMERY RD, 1978, Q J MED, V47, P197
   MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115
   MOTTRAM RF, 1955, J PHYSIOL-LONDON, V128, P268, DOI 10.1113/jphysiol.1955.sp005305
   PAGANO G, 1981, METABOLISM, V30, P46, DOI 10.1016/0026-0495(81)90217-1
   PAGANO G, 1984, METABOLISM, V33, P976, DOI 10.1016/0026-0495(84)90223-3
   PALMER JP, 1975, J CLIN ENDOCR METAB, V41, P498, DOI 10.1210/jcem-41-3-498
   POLONSKY K, 1986, DIABETES, V35, P379, DOI 10.2337/diabetes.35.4.379
   POLONSKY K, 1981, DIABETES, V30, P664, DOI 10.2337/diab.30.8.664
   RADZIUK J, 1978, AM J PHYSIOL, V234, pE84, DOI 10.1152/ajpendo.1978.234.1.E84
   RADZIUK J, 1978, METABOLISM, V27, P657, DOI 10.1016/0026-0495(78)90003-3
   REAVEN GM, 1982, DIABETES, V31, P670, DOI 10.2337/diabetes.31.8.670
   REICHARD GA, 1963, J BIOL CHEM, V238, P495
   ROBERT JJ, 1982, DIABETES, V31, P203, DOI 10.2337/diabetes.31.3.203
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   SACCA L, 1979, J CLIN INVEST, V63, P849, DOI 10.1172/JCI109384
   SIMONSON DC, 1983, DIABETOLOGIA, V25, P1
   SPENCE JC, 1920, Q J MED, V14, P314
   WAHREN J, 1966, ACTA PHYSL SCAND S, V269, P5
   WEBSTER SGP, 1975, GUT, V16, P109, DOI 10.1136/gut.16.2.109
NR 66
TC 79
Z9 83
U1 0
U2 0
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1660 DUKE ST, ALEXANDRIA, VA 22314
SN 0012-1797
J9 DIABETES
JI Diabetes
PD JAN
PY 1988
VL 37
IS 1
BP 119
EP 129
DI 10.2337/diabetes.37.1.119
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA L5429
UT WOS:A1988L542900020
PM 3275553
DA 2024-02-19
ER

PT J
AU MOONEY, H
   ROBERTS, R
   COOKSLEY, WGE
   HALLIDAY, JW
   POWELL, LW
AF MOONEY, H
   ROBERTS, R
   COOKSLEY, WGE
   HALLIDAY, JW
   POWELL, LW
TI ALTERATIONS IN THE LIVER WITH AGING
SO CLINICS IN GASTROENTEROLOGY
LA English
DT Article
C1 ROYAL BRISBANE HOSP,BRISBANE,QLD 4029,AUSTRALIA.
C3 Royal Brisbane & Women's Hospital
RP MOONEY, H (corresponding author), UNIV QUEENSLAND,SCH MED,BRISBANE,QLD 4006,AUSTRALIA.
RI cooksley, william ge/G-7742-2011
CR [Anonymous], LIVER AGING
   BENDER AD, 1964, J AM GERIATR SOC, V12, P114, DOI 10.1111/j.1532-5415.1964.tb00344.x
   BENDER DA, 1965, J AM GERIATR SOC, V13, P192
   BRADBEAR RA, 1985, J NATIONAL CANCER I
   BRANDFONBRENER M, 1955, CIRCULATION, V12, P557, DOI 10.1161/01.CIR.12.4.557
   BRANDT LJ, 1984, GASTROINTESTINAL DIS, P489
   CASTLEDEN CM, 1977, BRIT MED J, V1, P10, DOI 10.1136/bmj.1.6052.10
   CHENG AHR, 1978, AM J CLIN NUTR, V31, P12, DOI 10.1093/ajcn/31.1.12
   COHEN R, 1960, GERIATRICS, V15, P824
   CROOKS J, 1976, Clinical Pharmacokinetics, V1, P280
   DIVOLL M, 1981, J PHARM SCI, V70, P1104, DOI 10.1002/jps.2600701004
   DUNN GD, 1973, AM J MED SCI, V265, P175, DOI 10.1097/00000441-197303000-00001
   DUSHEIKO GM, 1981, NONA NONB HEPATITIS, P251
   ELDOMEIRI AA, 1971, CANCER-AM CANCER SOC, V27, P7, DOI 10.1002/1097-0142(197101)27:1<7::AID-CNCR2820270103>3.0.CO;2-Q
   FARAH F, 1977, BRIT MED J, V2, P155, DOI 10.1136/bmj.2.6080.155
   FENSTER LF, 1965, GASTROENTEROLOGY, V49, P262
   FISHER CH, 1974, INVEST RADIOL, V9, P456, DOI 10.1097/00004424-197411000-00006
   GIBSON PR, 1984, AUSTR NZ J MED, V14, P812
   GITLIN N, 1984, VIRAL HEPATITIS LIVE, P115
   GOODSON JD, 1982, ARCH INTERN MED, V142, P1485, DOI 10.1001/archinte.142.8.1485
   GREENBLATT DJ, 1981, BRIT J CLIN PHARMACO, V12, P631, DOI 10.1111/j.1365-2125.1981.tb01281.x
   GREENBLATT DJ, 1979, CLIN PHARMACOL THER, V26, P103
   GREENBLATT DJ, 1983, BRIT J CLIN PHARMACO, V15, P303, DOI 10.1111/j.1365-2125.1983.tb01503.x
   GREENBLATT DJ, 1982, J PHARMACOL EXP THER, V220, P120
   GREENBLATT DJ, 1980, J PHARMACOL EXP THER, V215, P86
   GREENBLATT RB, 1979, J AM GERIATR SOC, V27, P481, DOI 10.1111/j.1532-5415.1979.tb01734.x
   HALE WE, 1983, AGE AGEING, V12, P275, DOI 10.1093/ageing/12.4.275
   HAYES MJ, 1975, BRIT J CLIN PHARMACO, V2, P69, DOI 10.1111/j.1365-2125.1975.tb00474.x
   HAYES MJ, 1975, BRIT J CLIN PHARMACO, V2, P73, DOI 10.1111/j.1365-2125.1975.tb00475.x
   Hislop W S, 1982, Age Ageing, V11, P153, DOI 10.1093/ageing/11.3.153
   HURWITZ N, 1969, BRIT MED J, V1, P536, DOI 10.1136/bmj.1.5643.536
   HURWITZ N, 1969, BMJ-BRIT MED J, V1, P531, DOI 10.1136/bmj.1.5643.531
   IRVINE RE, 1974, BRIT J CLIN PHARMACO, V1, P41, DOI 10.1111/j.1365-2125.1974.tb00204.x
   JAMES OFW, 1983, CLIN GASTROENTEROL, V12, P671
   KAMPMANN JP, 1975, GERIATRICS, V30, P91
   KLOTZ U, 1975, J CLIN INVEST, V55, P347, DOI 10.1172/JCI107938
   KLOTZ U, 1982, LIVER AGING 1982, P287
   KRAUS JW, 1978, CLIN PHARMACOL THER, V24, P411
   Landowne M, 1960, AGING SOME SOCIAL BI, P159
   LEHMANN AB, 1985, GERONTOLOGY, V31, P186, DOI 10.1159/000212701
   LUDWIG J, 1970, J GERONTOL, V25, P244, DOI 10.1093/geronj/25.3.244
   MACKLON AF, 1980, CLIN SCI, V59, P479, DOI 10.1042/cs0590479
   MUNRO HN, 1978, POSTGRAD MED, V63, P143, DOI 10.1080/00325481.1978.11714785
   MURRAY TG, 1981, CLIN PHARMACOL THER, V30, P805, DOI 10.1038/clpt.1981.241
   NOUL O, 1980, DIGESTIVE DISEASES S, V25, P49
   OCHS HR, 1981, PHARMACOLOGY, V23, P24, DOI 10.1159/000137524
   OMALLEY K, 1971, BMJ-BRIT MED J, V3, P607, DOI 10.1136/bmj.3.5775.607
   POWELL LW, 1985, LIVER BILIARY DISEAS, P963
   PURTILO DT, 1973, CANCER, V32, P458, DOI 10.1002/1097-0142(197308)32:2<458::AID-CNCR2820320225>3.0.CO;2-B
   RICHEY DP, 1977, ANNU REV PHARMACOL, V17, P49, DOI 10.1146/annurev.pa.17.040177.000405
   RICHMAN SM, 1961, AM J MED, V30, P211, DOI 10.1016/0002-9343(61)90093-6
   ROBERTS RK, 1978, GASTROENTEROLOGY, V75, P479
   RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203
   RUBIN RH, 1974, AM J MED, V57, P601, DOI 10.1016/0002-9343(74)90012-6
   SAINT E G, 1952, Med J Aust, V2, P613
   SALEM S A M, 1978, Age and Ageing, V7, P68, DOI 10.1093/ageing/7.2.68
   SANDFORD NL, 1984, AUST NZ J MED, V14, P597, DOI 10.1111/j.1445-5994.1984.tb05006.x
   SCHAFFNER F, 1959, AM J DIG DIS, V4, P389, DOI 10.1007/BF02231171
   SCHMUCKER DL, 1976, J GERONTOL, V31, P135, DOI 10.1093/geronj/31.2.135
   SEELEY TT, 1972, HUM PATHOL, V3, P265, DOI 10.1016/S0046-8177(72)80080-7
   SHERLOCK S, 1951, BRIT HEART J, V13, P273
   SHULL HJ, 1976, ANN INTERN MED, V84, P420, DOI 10.7326/0003-4819-84-4-420
   STEVENS RG, 1984, INT J CANCER, V33, P453, DOI 10.1002/ijc.2910330406
   STEVENSON IH, 1977, BRIT J CLIN PHARMACO, V4, P261, DOI 10.1111/j.1365-2125.1977.tb00710.x
   SZMUNESS W, 1976, NEW ENGL J MED, V295, P755, DOI 10.1056/NEJM197609302951404
   TAUCHI H, 1961, Nagoya J Med Sci, V24, P97
   TAUCHI H, 1975, MECH AGEING DEV, V4, P71, DOI 10.1016/0047-6374(75)90008-1
   VESTAL RE, 1975, CLIN PHARMACOL THER, V18, P425
   VESTAL RE, 1977, CLIN PHARMACOL THER, V21, P343
   VESTAL RE, 1980, CLIN PHARMACOKINET, V5, P309, DOI 10.2165/00003088-198005040-00001
   VESTAL RE, 1978, DRUGS, V16, P358, DOI 10.2165/00003495-197816040-00004
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   WILLIAMSON J, 1980, AGE AGEING, V9, P73, DOI 10.1093/ageing/9.2.73
   WOOD AJJ, 1979, CLIN PHARMACOL THER, V26, P16
   WOODHOUSE KW, 1985, AGE AGEING, V14, P113, DOI 10.1093/ageing/14.2.113
   WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328
   ZIMBERG S, 1974, GERONTOLOGIST, V14, P221, DOI 10.1093/geront/14.3.221
   ZURCHER C, 1982, LIVER AGING 1982, P19
NR 78
TC 43
Z9 43
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0300-5089
J9 CLIN GASTROENTEROL
PY 1985
VL 14
IS 4
BP 757
EP 771
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AUT53
UT WOS:A1985AUT5300007
PM 3910308
DA 2024-02-19
ER

PT J
AU VARELAMOREIRAS, G
   PEREZOLLEROS, L
   GARCIACUEVAS, M
   RUIZROSO, B
AF VARELAMOREIRAS, G
   PEREZOLLEROS, L
   GARCIACUEVAS, M
   RUIZROSO, B
TI EFFECTS OF AGING ON FOLATE METABOLISM IN RATS FED A LONG-TERM FOLATE
   DEFICIENT DIET
SO INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
LA English
DT Article
DE TISSUE FOLATES; AGING; FOLATE DEFICIENCY; S-ADENOSYLMETHIONINE;
   S-ADENOSYLHOMOCYSTEINE; RAT
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; AFFINITY; TISSUES
AB The present study was focused on the effects of feeding to young (2 mo. old) and aged (30 mo. old) mts either a folate repleted or a folate deficient diet for seven weeks on several markers of folate metabolism. Serum and liver folate contents were determined, and hepatic distribution of folates based on glutamic acid chain length and pteridine ring was obtained. Irt addition, liver s-adenosylmethionine (Ado Met) and s-adenosylhomocysteine (AdoHcy) concentrations, as well as serum homocysteine concentration have been also determined. Ageing itself seems not to be associated with lower hepatic folate content, but in serum a 50% decrease was observed Feeding the folate deficient diet did result in significant lower (p<0.001) liver folate content in both age groups, and in marked decreases in serum folates. These quantitative changes in the folate deficient groups were associated with an elongation of the glutamate chain length, mostly represented by a significant decrease in the proportion of pentaglutamyl derivatives, an increase of hexaglutamyl, and appearance of hepta and octaglutamyl folate derivatives. However there were no important modifications in the pteridine ring distribution regardless of the age and level of dietary folate.
   In the present study, ageing seems to be associated with a significantly lower AdoMet/AdoHc ratio (65% decrease, p<0.05), irrespective of the folic acid included in the diet. The induced folate deficiency did result in marked increases of AdoHcy concentrations, and concomitant decreases of AdoMet and AdoMet/AdoHcy ratios. The effect of ageing was without significance on serum homocysteine concentrations, although the folate deficiency caused significant elevations (p<0.05) either in young or aged animals.
C1 UNIV COMPLUTENSE MADRID,FAC FARM,DEPT NUTR 1,E-28040 MADRID,SPAIN.
C3 Complutense University of Madrid
RI Pérez-Olleros, Lourdes/K-6724-2014
OI Pérez-Olleros, Lourdes/0000-0003-1345-4231; VARELA-MOREIRAS,
   GREGORIO/0000-0001-5158-4999
CR ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3
   BAKER H, 1978, J AM GERIATR SOC, V26, P218, DOI 10.1111/j.1532-5415.1978.tb01962.x
   BAYLEY LB, 1984, J NUTR, V114, P1770
   BAYLEY LB, 1979, AM J CLIN NUTR, V32, P2346
   FELL D, 1985, J CHROMATOGR, V345, P150, DOI 10.1016/0378-4347(85)80146-8
   FOO SK, 1982, J BIOL CHEM, V87, P13587
   HOFFMAN DR, 1979, CAN J BIOCHEM CELL B, V57, P56, DOI 10.1139/o79-007
   HORNE DW, 1989, AM J CLIN NUTR, V50, P359, DOI 10.1093/ajcn/50.2.359
   HURDIE ADF, 1965, BRIT MED J, V2, P843
   JENKS DA, 1987, J BIOL CHEM, V262, P2485
   KESAVAN V, 1983, AM J CLIN NUTR, V37, P262, DOI 10.1093/ajcn/37.2.262
   KRUMDIECK C L, 1986, P447
   RAN JY, 1985, CLIN RES, V33, pA760
   SELHUB J, 1989, ANAL BIOCHEM, V182, P84, DOI 10.1016/0003-2697(89)90722-7
   SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693
   SELHUB J, 1991, AM J CLIN NUTR, V55, P131
   Tamura T, 1990, FOLIC ACID METABOLIS, P121
   VARELAMOREIRAS G, 1991, J NUTR BIOCHEM, V2, P44, DOI 10.1016/0955-2863(91)90049-B
   VARELAMOREIRAS G, 1992, J NUTR, V122, P986, DOI 10.1093/jn/122.4.986
   VARELAMOREIRAS G, 1994, INT J VITAM NUTR RES, V64, P41
   Wagner P. A., 1981, Nutrition Research, V1, P565, DOI 10.1016/S0271-5317(81)80086-3
   WARTANOWICZ M, 1984, ACTA PHYSL POL, V34, P338
   WEBSTER SGP, 1978, J AM GERIATR SOC, V27, P451
NR 23
TC 19
Z9 19
U1 0
U2 2
PU VERLAG HANS HUBER
PI BERN 9
PA LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND
SN 0300-9831
J9 INT J VITAM NUTR RES
JI Int. J. Vitam. Nutr. Res.
PY 1994
VL 64
IS 4
BP 294
EP 299
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA PX896
UT WOS:A1994PX89600009
PM 7883468
DA 2024-02-19
ER

PT J
AU Tanimizu, N
   Ichinohe, N
   Suzuki, H
   Mitaka, T
AF Tanimizu, Naoki
   Ichinohe, Norihisa
   Suzuki, Hiromu
   Mitaka, Toshihiro
TI Prolonged oxidative stress and delayed tissue repair exacerbate
   acetaminophen-induced liver injury in aged mice
SO AGING-US
LA English
DT Article
DE acetaminophen; drug-induced liver injury; aging; oxidative stress;
   necrosis
ID CELL-CYCLE ARREST; IFN-GAMMA; PROLIFERATION DEFECTS; DNA; SENESCENCE;
   REGENERATION; HEPATOCYTES; HEPATECTOMY; PARACETAMOL; ALPHA
AB The liver gradually loses its regenerative capabilities with aging. However, it remains unknown whether aging affects drug-induced liver injury. Here, we used acetaminophen induced acute liver injury model to compare tissue injury and regeneration of aged mice (>80 weeks old) with young ones (8-10 weeks old). The mortality of aged mice after acetaminophen injury was higher than that of young mice. Transient increase of serum GOT and decrease of reduced glutathione (GSH) were not returned to original levels in aged mice even at 48 hours. In addition, Foxm1b and its targets Ccnd1 and Cdk1 were upregulated in young but not in aged mice after 48 hours. Moreover, an apoptosis-related gene, Cidea, was upregulated specifically in aged livers, which was consistent with increased number of TUNEL+ hepatocytes. Unexpectedly, damaged hepatocytes were retained in aged liver tissue, which may be caused by impaired recruitment of macrophages to the damaged area, without increases in Ccl2 after acetaminophen injury. Collectively, prolonged oxidative stress due to delayed recovery of GSH and the retention of damaged hepatocytes may suppress tissue repair and hepatocyte proliferation, resulting in exacerbation of acetaminophen injury in aged mice. Thus, aging is a risk factor conferring susceptibility against drug-induced liver injury.
C1 [Tanimizu, Naoki; Ichinohe, Norihisa; Mitaka, Toshihiro] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Dev & Regenerat,Chuo Ku, Sapporo, Hokkaido 0608556, Japan.
   [Suzuki, Hiromu] Sapporo Med Univ, Sch Med, Dept Mol Biol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan.
C3 Sapporo Medical University; Sapporo Medical University
RP Tanimizu, N (corresponding author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Dev & Regenerat,Chuo Ku, Sapporo, Hokkaido 0608556, Japan.
EM tanimizu@sapmed.ac.jp
OI Ichinohe, Norihisa/0000-0003-3723-7418
FU Japan Society for the Science Promotion [20K05843, 17H05653, 18H02873,
   17K19703]; Grants-in-Aid for Scientific Research [17H05653, 18H02873,
   17K19703, 20K05843] Funding Source: KAKEN
FX NT is supported by Japan Society for the Science Promotion,
   Grants-in-Aid for Scientific Research (C) for N. Tanimizu (20K05843),
   Grants-in-Aid for Scientific Research on Innovative Areas "Stem Cell
   Aging and Disease" for N. Tanimizu (17H05653). TM is supported by
   Grants-in-Aid for Scientific Research (B) (18H02873), and Grants-in-Aid
   for Exploratory Research (17K19703).
CR Baker DJ, 2008, CELL CYCLE, V7, P2795, DOI 10.4161/cc.7.18.6687
   Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Bhatia-Dey N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00013
   Bhushan B, 2019, AM J PATHOL, V189, P719, DOI 10.1016/j.ajpath.2018.12.006
   Bhushan B, 2014, AM J PATHOL, V184, P3013, DOI 10.1016/j.ajpath.2014.07.019
   Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004
   Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5
   Borude P, 2018, AM J PATHOL, V188, P1406, DOI 10.1016/j.ajpath.2018.03.006
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   García-Román R, 2020, CLIN PHARMACOL THER, V107, P1068, DOI 10.1002/cpt.1701
   Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Józwiak-Bebenista M, 2014, ACTA POL PHARM, V71, P11
   Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276
   Kano A, 1997, J BIOCHEM-TOKYO, V121, P677
   Liukas A, 2011, CLIN PHARMACOKINET, V50, P121, DOI 10.2165/11537240-000000000-00000
   Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089
   Manyike PT, 2000, CLIN PHARMACOL THER, V67, P275, DOI 10.1067/mcp.2000.104736
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   MITAKA T, 1993, CANCER RES, V53, P3145
   Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8
   MOOLTEN FL, 1970, CANCER RES, V30, P2353
   Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682
   Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006
   Pibiri M, 2018, AGING-US, V10, P1801, DOI 10.18632/aging/101524
   Stahl EC, 2020, AM J PATHOL, V190, P372, DOI 10.1016/j.ajpath.2019.10.016
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Tura BJ, 2001, INT J EXP PATHOL, V82, P317, DOI 10.1046/j.1365-2613.2001.00207.x
   Vaquero J, 2007, GASTROENTEROLOGY, V132, P372, DOI 10.1053/j.gastro.2006.11.025
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Yang WT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09046-8
   Zhu CZ, 2014, J GASTROEN HEPATOL, V29, P1102, DOI 10.1111/jgh.12468
NR 42
TC 6
Z9 7
U1 1
U2 6
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD OCT 15
PY 2020
VL 12
IS 19
BP 18907
EP 18927
DI 10.18632/aging.103973
PG 21
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA OF3EF
UT WOS:000581094800013
PM 33001859
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Eguchi, S
   Takatsuki, M
   Hidaka, M
   Soyama, A
   Muraoka, I
   Tomonaga, T
   Shimokawa, I
   Kanematsu, T
AF Eguchi, Susumu
   Takatsuki, Mitsuhisa
   Hidaka, Masaaki
   Soyama, Akihiko
   Muraoka, Izumi
   Tomonaga, Tetsuo
   Shimokawa, Isao
   Kanematsu, Takashi
TI Lack of Grafted Liver Rejuvenation in Adult-to-Pediatric Liver
   Transplantation
SO DIGESTIVE DISEASES AND SCIENCES
LA English
DT Article
DE Living donor liver transplantation; Senescence marker protein-30;
   Rejuvenation; Pediatric; Graft
ID SENESCENCE MARKER PROTEIN-30; HEP G2 CELLS; KNOCKOUT MICE; VITAMIN-C;
   RAT-LIVER; AGE; SMP30; BIOSYNTHESIS; APOPTOSIS; SURVIVAL
AB A grafted donor liver should grow and survive under the different conditions presented by a liver transplantation recipient. It has remained unclear, however, whether the age of a grafted liver can be modulated by recipient factors.
   This study investigated whether a grafted aged donor liver can be rejuvenated in a pediatric recipient.
   Of 119 living donor liver transplants, ten pairs were adult-to-pediatric combinations. Senescence marker protein-30 (SMP-30), which is a protein that is remarkably reduced upon aging, was used as a senescence marker. Immunohistochemical staining for SMP-30 was performed in biopsy specimen after living donor liver transplantation (LDLT). Re-expression of SMP-30 was investigated in a biopsied adult liver (n = 6) that had been transplanted in a pediatric recipient.
   A remarkable expression of SMP-30 was seen in a control pediatric normal liver in comparison with that in an aged adult donor biopsy. Re-expression or an increase in SMP-30 was not observed in the liver of any pediatric recipient who had received an adult liver.
   An adult grafted liver does not appear to rejuvenate in a pediatric recipient.
C1 [Eguchi, Susumu; Takatsuki, Mitsuhisa; Hidaka, Masaaki; Soyama, Akihiko; Muraoka, Izumi; Tomonaga, Tetsuo; Kanematsu, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan.
   [Shimokawa, Isao] Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Nagasaki 8528501, Japan.
C3 Nagasaki University; Nagasaki University
RP Eguchi, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
EM sueguchi@net.nagasaki-u.ac.jp
RI Hidaka, Masaaki/AAE-5826-2020
OI Hidaka, Masaaki/0000-0001-8191-6405; Shimokawa,
   Isao/0000-0001-8901-1029; Soyama, Akihiko/0000-0003-2932-4300
FU Grants-in-Aid for Scientific Research [23591868] Funding Source: KAKEN
CR BUCHER NL, 1964, CANCER RES, V241, P509
   CASTLEDEN CM, 1979, BRIT J CLIN PHARMACO, V7, P49, DOI 10.1111/j.1365-2125.1979.tb00896.x
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Cuende N, 2005, TRANSPLANTATION, V79, P1445, DOI 10.1097/01.TP.0000158877.74629.AA
   Eguchi S, 2008, SURG TODAY, V38, P795, DOI 10.1007/s00595-007-3729-8
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Furusawa H, 2008, BIOL PHARM BULL, V31, P1673, DOI 10.1248/bpb.31.1673
   Garcia C E, 2004, Exp Clin Transplant, V2, P183
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   HYAMS DE, 1974, BRIT MED J, V1, P150, DOI 10.1136/bmj.1.5899.150
   Jeong DH, 2008, J RADIAT RES, V49, P653, DOI 10.1269/jrr.08042
   Kashio A, 2009, BIOCHEM BIOPH RES CO, V390, P394, DOI 10.1016/j.bbrc.2009.09.003
   Koike K, 2010, AM J PHYSIOL-LUNG C, V298, pL784, DOI 10.1152/ajplung.00256.2009
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Lv S, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-17
   MACLENNAN WJ, 1977, GERONTOLOGY, V23, P360, DOI 10.1159/000212209
   Maruyama N, 2004, ANN NY ACAD SCI, V1019, P383, DOI 10.1196/annals.1297.068
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161
   Park JK, 2008, TOXICOLOGY, V246, P132, DOI 10.1016/j.tox.2008.01.006
   Sakai Y, 1997, HEPATOLOGY, V25, P421
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   SAWADA N, 1988, CANCER RES, V48, P1618
   Selzner M, 2009, LIVER TRANSPLANT, V15, P1594, DOI 10.1002/lt.21864
   Tanno M, 1996, MECH AGEING DEV, V92, P53, DOI 10.1016/S0047-6374(96)01802-7
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Yoshizumi T, 2008, LIVER TRANSPLANT, V14, P1007, DOI 10.1002/lt.21462
NR 27
TC 12
Z9 12
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0163-2116
J9 DIGEST DIS SCI
JI Dig. Dis. Sci.
PD MAY
PY 2011
VL 56
IS 5
BP 1542
EP 1547
DI 10.1007/s10620-010-1445-5
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 755AO
UT WOS:000289899200039
PM 20936349
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Wang, JY
   Zhang, W
   Liu, XQ
   Kim, M
   Zhang, K
   Tsai, RYL
AF Wang, Junying
   Zhang, Wen
   Liu, Xiaoqin
   Kim, Minjee
   Zhang, Ke
   Tsai, Robert Y. L.
TI Epigenome-wide analysis of aging effects on liver regeneration
SO BMC BIOLOGY
LA English
DT Article
DE DNA methylation; Epigenetic; Tissue repair; WGBS
ID C/EBP-ALPHA; PROGENITOR CELLS; AGED MICE; OLD MICE; PROLIFERATION;
   HEPATOCYTES; INHIBITION; TRANSCRIPTION; NUCLEOSTEMIN; EXPRESSION
AB BackgroundAging is known to exert an effect on liver regeneration, with the ability of liver to regenerate displaying a significant decline over time. Liver physiological parameters such as liver volume, blood flow, and metabolism, as well as the ability to regenerate after injury have all been shown to decrease at old age in humans and model systems, with a number of molecular mechanisms proposed to be involved, including DNA methylation-dependent genome remodeling. To address how changes in DNA methylation mediate the adverse aging effect on liver regeneration, we searched for differentially methylated genomic regions (DMRs) in mouse livers co-regulated by aging and regeneration and determined their associated genes and enriched pathways.ResultsDMRs were identified using whole-genome bisulfite sequencing (WGBS). Pathway analysis of aging DMR-mapped genes revealed two distinct phases of aging, 2-to-8 and 8-to-16 months old (m/o). Regenerative DMR-mapped differentially expressed genes (DEGs) were enriched in pathways controlling cell proliferation and differentiation. Most DMRs shared by both aging and regeneration changed in the same methylation direction between 2 and 8 m/o but in the opposite direction between 8 and 16 m/o. Regenerative DMRs inversely affected by aging during 8-to-16 m/o were found in the promoter/gene regions of 12 genes. Four regenerative DEGs were synchronously regulated by early aging and inversely regulated by mid-to-late aging DMRs. Lead DMR-mapped genes were validated by their expression profiles in liver aging and regeneration.ConclusionsOur study has uncovered new DMRs and gene targets inversely affected by liver aging and regeneration to explain the adverse aging effect on liver regeneration. These findings will be of fundamental importance to understand the epigenomic changes underlying the biology of aging on liver regeneration.
C1 [Wang, Junying; Zhang, Wen; Liu, Xiaoqin; Kim, Minjee; Zhang, Ke; Tsai, Robert Y. L.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.
   [Zhang, Ke; Tsai, Robert Y. L.] Texas A&M Hlth Sci Ctr, Dept Translat Med Sci, 2121 W Holcombe Blvd, Houston, TX 77030 USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M Health Science Center; Texas A&M University System; Texas A&M
   University College Station; Texas A&M Health Science Center
RP Tsai, RYL (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.; Tsai, RYL (corresponding author), Texas A&M Hlth Sci Ctr, Dept Translat Med Sci, 2121 W Holcombe Blvd, Houston, TX 77030 USA.
EM robtsai@tamu.edu
RI Wang, Jiacheng/ABE-5948-2020; li, bai/JNE-1502-2023
OI Wang, Jiacheng/0000-0003-4327-1508; Kim, Minjee/0000-0002-2001-2442
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Arechederra M, 2020, SEMIN CELL DEV BIOL, V97, P38, DOI 10.1016/j.semcdb.2019.03.004
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Chen H, 2019, HEPATOLOGY, V70, P1011, DOI 10.1002/hep.30500
   Choi KM, 2021, J CELL PHYSIOL, V236, P7759, DOI 10.1002/jcp.30459
   Cole JJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1185-3
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Cuadrado A, 2005, OBES SURG, V15, P442, DOI 10.1381/0960892053576596
   de Magalhaes JP, 2012, FASEB J, V26, P4821, DOI 10.1096/fj.12-210872
   El'chaninov AV, 2016, B EXP BIOL MED+, V161, P155, DOI 10.1007/s10517-016-3367-5
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Gujar H, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020172
   Haga S, 2010, LAB INVEST, V90, P1718, DOI 10.1038/labinvest.2010.119
   Hahn O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1187-1
   Han XM, 2019, STEM CELL REP, V12, P624, DOI 10.1016/j.stemcr.2019.01.010
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Huang G, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.60
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Lin T, 2014, J CELL SCI, V127, P2302, DOI 10.1242/jcs.143842
   Lin T, 2013, HEPATOLOGY, V58, P2176, DOI 10.1002/hep.26600
   Ling QX, 2014, AM J CANCER RES, V4, P508
   Meer MV, 2018, ELIFE, V7, DOI 10.7554/eLife.40675
   Morsiani C, 2019, AGEING RES REV, V51, P24, DOI 10.1016/j.arr.2019.02.002
   NELSON JF, 1990, ANN NY ACAD SCI, V592, P8
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Prada MP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18947-y
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428
   SAWADA N, 1989, EXP CELL RES, V181, P584, DOI 10.1016/0014-4827(89)90115-8
   Seale K, 2022, NAT REV GENET, V23, P585, DOI 10.1038/s41576-022-00477-6
   Selzner M, 2009, LIVER TRANSPLANT, V15, P1288, DOI 10.1002/lt.21828
   Slieker RC, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0191-3
   Stocker E, 1971, Beitr Pathol, V144, P400
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38
   Takasugi M, 2011, MECH AGEING DEV, V132, P65, DOI 10.1016/j.mad.2010.12.003
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005
   Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   Wang S, 2019, DEV CELL, V50, P43, DOI 10.1016/j.devcel.2019.05.034
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Washburn WK, 1996, TRANSPLANTATION, V61, P1062, DOI 10.1097/00007890-199604150-00013
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Zheng H, 2017, ONCOTARGET, V8, P18872, DOI 10.18632/oncotarget.14770
NR 57
TC 0
Z9 0
U1 3
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD FEB 13
PY 2023
VL 21
IS 1
AR 30
DI 10.1186/s12915-023-01533-1
PG 20
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 8Z3KU
UT WOS:000933282400002
PM 36782243
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sato, R
   Maesawa, C
   Fujisawa, K
   Wada, K
   Oikawa, K
   Takikawa, Y
   Suzuki, K
   Oikawa, H
   Ishikawa, K
   Masuda, T
AF Sato, R
   Maesawa, C
   Fujisawa, K
   Wada, K
   Oikawa, K
   Takikawa, Y
   Suzuki, K
   Oikawa, H
   Ishikawa, K
   Masuda, T
TI Prevention of critical telomere shortening by oestradiol in human normal
   hepatic cultured cells and carbon tetrachloride induced rat liver
   fibrosis
SO GUT
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; STELLATE CELLS; SERUM TESTOSTERONE;
   ESTROGEN-RECEPTOR; HUMAN ENDOMETRIUM; RISK-FACTORS; IN-VIVO; CIRRHOSIS;
   EXPRESSION; ACTIVATION
AB Background and aim: Significant telomere shortening of hepatocytes is associated with replicative senescence and a non-dividing state in chronic liver disease, resulting in end stage liver failure and/or development of hepatocellular carcinoma. To prevent critical telomere shortening in hepatocytes, we have focused on oestrogen dependent transactivation of the human telomerase reverse transcriptase ( hTERT) gene as a form of telomerase therapy in chronic liver disease.
   Methods: We examined expression of hTERT mRNA and its protein, and telomerase activity ( TA) in three human normal hepatic cell lines (Hc-cells, h-Nheps, and WRL-68) before and after treatment with 17beta-oestradiol. The effects of exogenous oestradiol administration were examined in a carbon tetrachloride (CCl4) induced model of liver fibrosis in rats.
   Results: Expression of hTERT mRNA and its protein was upregulated by oestradiol treatment. Telomere length decreased in Hc-cells and h-Nheps with accumulated passages whereas with long term oestradiol exposure it was greater than without oestradiol. The incidence of beta-galactosidase positive cells, indicating a state of senescence, decreased significantly in oestradiol treated cells in comparison with non-treated cells (p< 0.05). TA in both male and female rats with CCl4 induced liver fibrosis was significantly higher with oestradiol administration than without (p< 0.05). Long term oestradiol administration markedly rescued the hepatic telomere from extensive shortening in both male and female rats.
   Conclusion: These results suggest that oestradiol acts as a positive modulator of the hTERT gene in the liver. Oestrogen dependent transactivation of the hTERT gene is a new strategy for slowing the progression of chronic liver disease.
C1 Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate 0208505, Japan.
   Iwate Med Univ, Sch Med, Dept Internal Med 1, Morioka, Iwate 0208505, Japan.
   Iwate Prefectural Univ, Dept Nursing, Takizawa, Iwate 0200173, Japan.
C3 Iwate Medical University; Iwate Medical University; Iwate Prefectural
   University
RP Maesawa, C (corresponding author), Iwate Med Univ, Sch Med, Dept Pathol, Uchimaru 19-1, Morioka, Iwate 0208505, Japan.
EM chihaya@iwate-med.ac.jp
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Alcolado R, 1997, CLIN SCI, V92, P103, DOI 10.1042/cs0920103
   Arthur MJP, 1998, DIGESTION, V59, P376, DOI 10.1159/000007492
   Bednarek AK, 1998, ONCOGENE, V16, P381, DOI 10.1038/sj.onc.1201553
   BEDOSSA P, 1995, HEPATOLOGY, V21, P760, DOI 10.1002/hep.1840210325
   Berger A, 2000, BRIT MED J, V320, P536
   Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051
   Dai WJ, 2001, WORLD J GASTROENTERO, V7, P1
   de Lange T, 1999, SCIENCE, V283, P947, DOI 10.1126/science.283.5404.947
   De Maria N, 2002, MOL CELL ENDOCRINOL, V193, P59
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   FAUSTO N, 1991, CIBA F SYMP, V157, P165
   Friedman SL, 1998, DIGESTION, V59, P368, DOI 10.1159/000007517
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   Hagmann M, 2000, SCIENCE, V287, P1185, DOI 10.1126/science.287.5456.1185
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HIYAMA K, 1995, J IMMUNOL, V155, P3711
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kyo S, 1997, CANCER RES, V57, P610
   Kyo S, 1999, CANCER RES, V59, P5917
   LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304
   Maesawa C, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng004
   MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P77, DOI 10.1007/BF01606580
   Meeker AK, 1996, ENDOCRINOLOGY, V137, P5743, DOI 10.1210/en.137.12.5743
   Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444
   MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049
   MILANI S, 1991, AM J PATHOL, V139, P1221
   Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9
   PORTER LE, 1983, GASTROENTEROLOGY, V84, P704
   ROSSINI GP, 1989, GASTROENTEROLOGY, V96, P1102, DOI 10.1016/0016-5085(89)91629-6
   Roulot D, 1999, HEPATOLOGY, V29, P1730, DOI 10.1002/hep.510290622
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   RUDOLPH KL, 2001, LIVER BIOL PATHOBIOL, P1000
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426
   Schuppan D, 1999, CURR TOPICS PATHOL, V93, P205
   Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127
   Tanaka K, 2000, CANCER RES, V60, P5106
   Tanaka M, 1998, AM J PATHOL, V153, P1985, DOI 10.1016/S0002-9440(10)65712-4
   Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811
   Urabe Y, 1996, LIVER, V16, P293
   VILLA E, 1988, CANCER-AM CANCER SOC, V62, P611, DOI 10.1002/1097-0142(19880801)62:3<611::AID-CNCR2820620328>3.0.CO;2-0
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Williams CD, 2001, J CLIN ENDOCR METAB, V86, P3912, DOI 10.1210/jc.86.8.3912
   Williams EJ, 1998, POSTGRAD MED J, V74, P193, DOI 10.1136/pgmj.74.870.193
   Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883
   YAGER JD, 1980, CANCER RES, V40, P3680
   Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307
   YU MW, 1993, CANCER RES, V53, P790
   ZAMAN SN, 1985, LANCET, V1, P1357
NR 54
TC 38
Z9 49
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD JUL
PY 2004
VL 53
IS 7
BP 1001
EP 1009
DI 10.1136/gut.2003.027516
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 829CS
UT WOS:000222021800019
PM 15194652
OA Green Published, Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Tomás-Zapico, C
   Alvarez-García, O
   Sierra, V
   Vega-Naredo, I
   Caballero, B
   García, JJ
   Acuña-Castroviejo, D
   Rodríguez, MI
   Tolivia, D
   Rodríguez-Colunga, MJ
   Coto-Montes, A
AF Tomas-Zapico, Cristina
   Alvarez-Garcia, Oscar
   Sierra, Veronica
   Vega-Naredo, Ignacio
   Caballero, Beatriz
   Garcia, Jose Joaquin
   Acuna-Castroviejo, Dario
   Rodriguez, Maria Isabel
   Tolivia, Delio
   Rodriguez-Colunga, Maria Josefa
   Coto-Montes, Ana
TI Oxidative damage in the livers of senescence-accelerated mice:: a
   gender-related response
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE senescence-accelerated model mouse (SAM); aging; oxidative stress; liver
   damage
ID GLUTATHIONE REDOX STATE; AGE-RELATED-CHANGES; FREE-RADICAL THEORY;
   DROSOPHILA-MELANOGASTER; SUPEROXIDE-DISMUTASE; PROTEIN OXIDATION;
   OXIDANT STRESS; MOUSE SAM; BRAIN; DNA
AB The prevalence of liver diseases emphasizes the need of animal models to research on the mechanism of disease pathogenesis. Furthermore, most of the liver pathologies have the oxidative stress as an important component. The senescence-accelerated mouse strain SAMP8 was proposed as a valuable animal model for the study of liver diseases. To gain a better understanding of the mechanisms underlying degenerative processes in SAMP8 mice livers, we studied the oxidative-induced damage in 5-month-old SAMP8 mice and SAMR1, senescence-accelerated-resistant mice. We found profound differences in the antioxidant response to aging between sexes, with males displaying lowest levels of main antioxidant enzymes superoxide dismutase (SOD), catalase (CAT), and glutathione reductase (GR) in SAMP8; whereas females had no difference in their activities, except for GR, when compared with their SAMR1 controls. The results obtained show the binomial SOD/CAT as an important factor for counteracting reactive oxygen species-dependent damage. There were not pathological differences at the morphological level between both strains, although the decay in protection against free radicals had an immediate response by increasing lipid and protein oxidative damage in SAMP8 mice liver. At 5 months, both male and female SAMP8 mice confront the oxidative stress challenge to different extents. Indeed, proteins seem to be the most vulnerable biomolecule in SAMP8 male mice.
C1 Univ Oviedo, Dept Morphol & Cellular Biol, Fac Med, E-33006 Oviedo, Spain.
   Univ Zaragoza, Fac Med, Dept Physiol & Pharmacol, E-50009 Zaragoza, Spain.
   Univ Granada, Fac Med, Inst Biotechnol, Dept Physiol, E-18071 Granada, Spain.
C3 University of Oviedo; University of Zaragoza; University of Granada
RP Coto-Montes, A (corresponding author), Univ Oviedo, Dept Morphol & Cellular Biol, Fac Med, E-33006 Oviedo, Spain.
EM acoto@uniovi.es
RI Garcia, Javier/JWP-0036-2024; Vega-Naredo, Ignacio/A-4245-2009;
   Tomas-Zapico, Cristina/M-5399-2019; Lara, María Isabel
   Rodríguez/A-1961-2017; Acuña-Castroviejo, Dario/N-7456-2016; Sierra,
   3479/J-9274-2012; Caballero-Garcia, Beatriz/AAC-2636-2020; coto-montes,
   ana/D-2544-2016
OI Tomas-Zapico, Cristina/0000-0001-7823-0410; Lara, María Isabel
   Rodríguez/0000-0002-2270-0070; Acuña-Castroviejo,
   Dario/0000-0002-9680-1560; Caballero-Garcia,
   Beatriz/0000-0003-0242-9620; coto-montes, ana/0000-0002-6609-6258;
   Sierra, Veronica/0000-0002-7491-3588; Vega-Naredo,
   Ignacio/0000-0003-1993-6725; Garcia Garcia, Jose
   Joaquin/0000-0001-9507-6478
CR *AM LIV FDN, 2002, CIRR MUCH CAUS
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674
   Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562
   Coto-Montes A, 1999, J PINEAL RES, V27, P154, DOI 10.1111/j.1600-079X.1999.tb00610.x
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4
   FLOYD RA, 1993, TOXICOL IND HEALTH, V9, P197, DOI 10.1177/0748233793009001-214
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   JABERABOANSARI A, 1989, MECH AGEING DEV, V50, P257, DOI 10.1016/0047-6374(89)90104-8
   Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149
   Kasper M, 2001, ARCH GERONTOL GERIAT, V32, P233, DOI 10.1016/S0167-4943(01)00103-0
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   Kovacs EJ, 2002, ALCOHOL RES HEALTH, V26, P257
   LEE KT, 1975, CLIN CHIM ACTA, V58, P101, DOI 10.1016/S0009-8981(75)80002-7
   Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   LUBINSKY S, 1979, GENETICS, V91, P723
   MARTIN JP, 1987, ARCH BIOCHEM BIOPHYS, V255, P329, DOI 10.1016/0003-9861(87)90400-0
   Maser RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134991
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   MULLAART E, 1989, MECH AGEING DEV, V47, P253, DOI 10.1016/0047-6374(89)90037-7
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   Okatani Y, 2003, INT J BIOCHEM CELL B, V35, P367, DOI 10.1016/S1357-2725(02)00260-1
   Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8
   Pemberton PW, 2004, BBA-MOL BASIS DIS, V1689, P182, DOI 10.1016/j.bbadis.2004.01.005
   Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2
   Rebrin I, 2004, EXP GERONTOL, V39, P1513, DOI 10.1016/j.exger.2004.08.014
   Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5
   Rebrin I, 2005, FREE RADICAL BIO MED, V39, P549, DOI 10.1016/j.freeradbiomed.2005.04.008
   Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506
   REED DJ, 1986, BIOCHEM PHARMACOL, V35, P7, DOI 10.1016/0006-2952(86)90545-9
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   Rojkind M, 2002, CELL MOL LIFE SCI, V59, P1872, DOI 10.1007/PL00012511
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   SIES H, 1991, KLIN WOCHENSCHR, V69, P965, DOI 10.1007/BF01645140
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Wang H, 2003, EXP GERONTOL, V38, P507, DOI 10.1016/S0531-5565(03)00036-6
   Yasui F, 2002, NEUROSCI LETT, V334, P177, DOI 10.1016/S0304-3940(02)01127-8
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Zahn RK, 2000, MECH AGEING DEV, V119, P101, DOI 10.1016/S0047-6374(00)00170-6
   Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje
NR 54
TC 17
Z9 21
U1 0
U2 10
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD FEB
PY 2006
VL 84
IS 2
BP 213
EP 220
DI 10.1139/Y05-111
PG 8
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA 049YE
UT WOS:000238052900008
PM 16900947
DA 2024-02-19
ER

PT J
AU Vats, R
   Kaminski, TW
   Ju, EM
   Brozska, T
   Tutuncuoglu, E
   Tejero, J
   Novelli, EM
   Sundd, P
   Pradhan-Sundd, T
AF Vats, Ravi
   Kaminski, Tomasz W.
   Ju, Eun-Mi
   Brozska, Tomasz
   Tutuncuoglu, Egemen
   Tejero, Jesus
   Novelli, Enrico M.
   Sundd, Prithu
   Pradhan-Sundd, Tirthadipa
TI P-selectin deficiency promotes liver senescence in sickle cell disease
   mice
SO BLOOD
LA English
DT Article
ID ADHESION; PATHOPHYSIOLOGY; ERYTHROCYTES; FLOW
AB Sickle cell disease (SCD) is caused by a homozygous mutation in the beta-globin gene, which leads to erythrocyte sickling, vasoocclusion, and intense hemolysis. P-selectin inhibition has been shown to prevent vasoocclusive events in patients with SCD; however, the chronic effect of P-selectin inhibition in SCD remains to be determined. Here, we used quantitative liver intravital microscopy in our recently generated P-selectin-deficient SCD mice to show that chronic P-selectin deficiency attenuates liver ischemia but fails to prevent hepatobiliary injury. Remarkably, we find that this failure in resolution of hepatobiliary injury in P-selectin-deficient SCD mice is associated with the increase in cellular senescence and reduced epithelial cell proliferation in the liver. These findings highlight the importance of investigating the long-term effects of chronic P-selectin inhibition therapy on liver pathophysiology in patients with SCD.
C1 [Vats, Ravi; Kaminski, Tomasz W.; Ju, Eun-Mi; Brozska, Tomasz; Tutuncuoglu, Egemen; Tejero, Jesus; Novelli, Enrico M.; Sundd, Prithu; Pradhan-Sundd, Tirthadipa] Univ Pittsburgh, Sch Med, Pittsburgh Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA 15261 USA.
   [Vats, Ravi; Sundd, Prithu] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Brozska, Tomasz; Novelli, Enrico M.; Pradhan-Sundd, Tirthadipa] Univ Pittsburgh, Sch Med, Div Hematol Oncol, Pittsburgh, PA 15261 USA.
   [Tejero, Jesus; Sundd, Prithu] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA.
   [Novelli, Enrico M.; Sundd, Prithu; Pradhan-Sundd, Tirthadipa] Univ Pittsburgh, Sickle Cell Ctr Excellence, Sch Med, Pittsburgh, PA 15261 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP Pradhan-Sundd, T (corresponding author), Univ Pittsburgh, Div Hematol Oncol, Dept Med, Sch Med, E1225 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.; Sundd, P (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Dept Med,Vasc Med Inst, E1225 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.
EM prs51@pitt.edu; tip9@pitt.edu
RI Vats, Ravi/IUO-5437-2023; Novelli, Enrico/ACZ-2466-2022; Tejero,
   Jesus/G-3953-2017
OI Vats, Ravi/0009-0009-9987-8828; Novelli, Enrico/0000-0003-3010-8285;
   Tejero, Jesus/0000-0003-3245-9978; Pradhan-Sundd,
   Tirthadipa/0000-0002-8763-4844; Kaminski, Tomasz/0000-0002-8688-4171
FU National Institutes of Health (NIH)/National Institute of Diabetes and
   Digestive and Kidney Diseases grant [1K01DK125617-01]; NIH/National
   Heart, Lung, and Blood Institute [1R01HL128297, 1R01HL141080];
   Hemophilia Center of Western Pennsylvania; American Heart Association
   [19PRE34430188]; Vitalant
FX This work was supported, in part, by the National Institutes of Health
   (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases
   grant 1K01DK125617-01 (T.P.-S.) and NIH/National Heart, Lung, and Blood
   Institute grants 1R01HL128297 (P.S.) and 1R01HL141080 (P.S.). This work
   was also supported, in part, by funds from the Hemophilia Center of
   Western Pennsylvania (P.S., T.P.-S.) and Vitalant (P.S.), and by
   American Heart Association award 19PRE34430188 (R.V.).
CR Ataga KI, 2017, NEW ENGL J MED, V376, P429, DOI 10.1056/NEJMoa1611770
   Ballesteros I, 2020, CELL, V183, P1282, DOI 10.1016/j.cell.2020.10.003
   Bennewitz M.F., 2014, Intravital, V3, pe29748, DOI 10.4161/intv.29748
   Bennewitz MF, 2020, BLOOD ADV, V4, P266, DOI 10.1182/bloodadvances.2019000603
   Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713
   Guillot A, 2019, HEPATOL COMMUN, V3, P730, DOI 10.1002/hep4.1356
   Karkoska K, 2020, AM J HEMATOL, V95, pE338, DOI 10.1002/ajh.26002
   Kato GJ, 2017, J CLIN INVEST, V127, P750, DOI 10.1172/JCI89741
   Kutlar A, 2014, HEMATOL ONCOL CLIN N, V28, P323, DOI 10.1016/j.hoc.2013.11.007
   Liu YF, 2019, BLOOD, V134, P579, DOI 10.1182/blood.2019000172
   Matsui NM, 2002, BLOOD, V100, P3790, DOI 10.1182/blood-2002-02-0626
   Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955
   Ortega-Gómez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Perkins LA, 2020, BLOOD ADV, V4, P4102, DOI 10.1182/bloodadvances.2020002642
   Pradhan-Sundd T, 2018, GASTROENTEROLOGY, V155, P1218, DOI 10.1053/j.gastro.2018.06.048
   Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X
   Saijou E, 2018, HEPATOL COMMUN, V2, P703, DOI 10.1002/hep4.1178
   Schett G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05800-6
   Sundd P, 2019, ANNU REV PATHOL-MECH, V14, P263, DOI 10.1146/annurev-pathmechdis-012418-012838
   Vats R, 2020, HEPATOLOGY, V72, P2165, DOI 10.1002/hep.31239
   Vats R, 2020, AM J RESP CRIT CARE, V201, P33, DOI 10.1164/rccm.201807-1370OC
   Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804
   Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367
NR 24
TC 12
Z9 12
U1 1
U2 5
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD MAY 13
PY 2021
VL 137
IS 19
BP 2676
EP 2680
DI 10.1182/blood.2020009779
PG 5
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA SE9UL
UT WOS:000652412000018
PM 33619560
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Rikans, LE
   Hornbrook, KR
AF Rikans, LE
   Hornbrook, KR
TI Thiol-disulfide exchange systems in the liver of aging Fischer 344 rats
SO GERONTOLOGY
LA English
DT Article
DE thiol-disulfide exchange; thioltransferase; protein disulfide isomerase;
   thioredoxin reductase; glutathione reductase; protein sulfhydryls; rat
   liver
ID DEHYDROASCORBATE REDUCTASE; ANTIOXIDANT DEFENSES; FOOD RESTRICTION;
   ISOMERASE; THIOLTRANSFERASE; GLUTATHIONE; PURIFICATION; ENZYMES; AGE;
   OXIDOREDUCTASES
AB The purpose of this study was to determine whether the major thiol-disulfide oxidoreductase activities of the rat liver were altered as a consequence of aging, and whether the alterations had any consequences in terms of hepatic thiol concentrations. Liver fractions were prepared from male and female Fischer 344 rats at ages representing young adulthood (5 months), middle age (15 months) and old age (24-29 months), and the activities of the major thioldisulfide exchange enzymes, together with protein and nonprotein sulfhydryl contents, were measured using spectrophotometric procedures. Thioltransferase, protein disulfide isomerase and thioredoxin reductase activities in livers of male and female rats were unchanged with aging, while glutathione disulfide (GSSG) reductase activity remained the same (in male livers) or increased (in female livers) as a consequence of aging. Both protein and nonprotein sulfhydryl concentrations were well maintained in old age. The absence of age-dependent alterations in the thiol-protein disulfide exchange enzymes and the lack of compromise in the glutathione GSSG reductase system suggest that aged livers retain their capacity to regulate their thiol-disulfide redox balance under normal physiological conditions.
C1 Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmacol & Toxicol, Oklahoma City, OK 73190 USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP Rikans, LE (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmacol & Toxicol, POB 26901, Oklahoma City, OK 73190 USA.
EM lora-rikans@uokhsc.edu
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   BORGHOFF SJ, 1986, DRUG METAB DISPOS, V14, P417
   CHEN LH, 1992, ARCH GERONTOL GERIAT, V14, P17, DOI 10.1016/0167-4943(92)90003-M
   DE AK, 1991, MECH AGEING DEV, V59, P123, DOI 10.1016/0047-6374(91)90078-E
   DELBELLO B, 1994, BIOCHEM J, V304, P385, DOI 10.1042/bj3040385
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   FREEDMAN RB, 1984, BIOCHEM SOC T, V12, P929, DOI 10.1042/bst0120929
   GAN ZR, 1986, J BIOL CHEM, V261, P996
   Gilbert H. F., 1990, ADV ENZYMOLOGY, V63, P69
   GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HILLSON DA, 1984, METHOD ENZYMOL, V107, P281
   IBBETSON AL, 1976, BIOCHEM J, V159, P377, DOI 10.1042/bj1590377
   KEHRER JP, 1994, FREE RADICAL BIO MED, V17, P65, DOI 10.1016/0891-5849(94)90008-6
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAMBERT N, 1983, BIOCHEM J, V213, P235, DOI 10.1042/bj2130235
   LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003
   MANNERVIK B, 1980, BIOCHEM J, V190, P125, DOI 10.1042/bj1900125
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   Matsuo M., 1993, FREE RADICALS AGING, P143
   POWIS G, 1995, PHARMACOL THERAPEUT, V68, P149, DOI 10.1016/0163-7258(95)02004-7
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   RIKANS LE, 1989, LIFE SCI, V45, P1373, DOI 10.1016/0024-3205(89)90024-6
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   RIKANS LE, 1987, DRUG METAB DISPOS, V15, P356
   RIKANS LE, IN PRESS MECH AGEING
   SASTRE J, 1992, MECH AGEING DEV, V62, P181, DOI 10.1016/0047-6374(92)90054-H
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1987, MECH AGEING DEV, V40, P171, DOI 10.1016/0047-6374(87)90016-9
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   WELLS WW, 1995, METHOD ENZYMOL, V252, P30
   WELLS WW, 1990, J BIOL CHEM, V265, P15361
   Yu B.P., 1993, FREE RADICALS AGING, P57
NR 35
TC 13
Z9 15
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PD MAR-APR
PY 1998
VL 44
IS 2
BP 72
EP 77
DI 10.1159/000021987
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA YZ298
UT WOS:000072240400003
PM 9523217
DA 2024-02-19
ER

PT J
AU Armeni, T
   Tomasetti, M
   Baroni, SS
   Saccucci, F
   Marra, M
   Pieri, C
   Littarru, GP
   Principato, G
   Battino, M
AF Armeni, T
   Tomasetti, M
   Baroni, SS
   Saccucci, F
   Marra, M
   Pieri, C
   Littarru, GP
   Principato, G
   Battino, M
TI Dietary restriction affects antioxidant levels in rat liver mitochondria
   during ageing
SO MOLECULAR ASPECTS OF MEDICINE
LA English
DT Article; Proceedings Paper
CT 9th International Symposium on Biomedical and Clinical Aspects of
   Coenzyme Q
CY MAY, 1996
CL ANCONA, ITALY
DE coenzyme Q; rat liver mitochondria; glutathione; dietary restriction
ID NONSYNAPTIC MITOCHONDRIA; BRAIN-REGIONS
AB Six experimental groups of young (7-month-old) and aged (24-32-month-old) rats, underwent different dietary manipulations (i.e. dietary restriction and/or a vitamin E-depleted diet), and their liver mitochondria were assayed for several antioxidants and peroxidation markers. Glutathione levels were affected both by age and dietary treatment. Coenzyme Q(9) and CoQ(10) showed the highest levels in the oldest rats where ageing, as well as other oxidative stresses, could induce ubiquinone biosynthesis. (C) 1997 Elsevier Science Ltd.
C1 UNIV ANCONA,INST BIOL & GENET,ANCONA,ITALY.
   UNIV ANCONA,INST BIOCHEM,I-60131 ANCONA,ITALY.
   INRCA ANCONA,GERONTOL RES DEPT,CYTOL CTR,ANCONA,ITALY.
C3 Marche Polytechnic University; Marche Polytechnic University; IRCCS
   INRCA
RI Svegliati, Silvia/L-2614-2016; Battino, Maurizio/E-6103-2012; Armeni,
   Tatiana/J-8228-2013
OI Svegliati, Silvia/0000-0001-6863-2600; Battino,
   Maurizio/0000-0002-7250-1782; Armeni, Tatiana/0000-0003-0931-1342;
   PRINCIPATO, Giovanni/0000-0001-8800-0301; Saccucci,
   Franca/0000-0002-8407-2516
CR Akerboom T P, 1981, Methods Enzymol, V77, P373
   BATTINO M, 1991, J BIOENERG BIOMEMBR, V23, P345, DOI 10.1007/BF00762227
   BATTINO M, 1995, MECH AGEING DEV, V78, P173, DOI 10.1016/0047-6374(94)01535-T
   JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATSURA T, 1991, BIOCHIM BIOPHYS ACTA, V1083, P277, DOI 10.1016/0005-2760(91)90083-T
   PANFILI E, 1991, FEBS LETT, V290, P35, DOI 10.1016/0014-5793(91)81219-X
NR 8
TC 13
Z9 13
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0098-2997
J9 MOL ASPECTS MED
JI Mol. Asp. Med.
PY 1997
VL 18
SU S
BP S247
EP S250
PG 4
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA XR183
UT WOS:A1997XR18300032
PM 9266530
DA 2024-02-19
ER

PT J
AU PARADIES, G
   RUGGIERO, FM
AF PARADIES, G
   RUGGIERO, FM
TI EFFECT OF AGING ON THE ACTIVITY OF THE PHOSPHATE CARRIER AND ON THE
   LIPID-COMPOSITION IN RAT-LIVER MITOCHONDRIA
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
ID ADENINE-NUCLEOTIDE TRANSLOCASE; AGE-RELATED-CHANGES; HEART-MITOCHONDRIA;
   PYRUVATE TRANSLOCATOR; HEPATIC MITOCHONDRIA; ENERGY-REQUIREMENTS;
   MOLECULAR ASPECTS; ANION MOVEMENT; KEY ROLE; TRANSPORT
C1 CNR,STUDY MITOCHONDRIA & BIOENERGET UNIT,I-70126 BARI,ITALY.
C3 Consiglio Nazionale delle Ricerche (CNR)
RP PARADIES, G (corresponding author), UNIV BARI,DIPARTMENTO BIOCHIM & BIOL MOLEC,VIA AMENDOLA 165-A,I-70126 BARI,ITALY.
CR CHENEVAL D, 1983, FEBS LETT, V159, P123, DOI 10.1016/0014-5793(83)80429-3
   COTY WA, 1975, MOL CELL BIOCHEM, V9, P109, DOI 10.1007/BF01732202
   COTY WA, 1974, J BIOL CHEM, V249, P2593
   Ernster L, 1977, STRUCTURE FUNCTION E, P209
   FONYO A, 1980, J BIOENERG BIOMEMBR, V12, P137, DOI 10.1007/BF00744679
   FONYO A, 1978, J BIOENERG BIOMEMBR, V10, P171, DOI 10.1007/BF00743106
   FONYO A, 1979, PHARMACOL THERAPEUT, V7, P627, DOI 10.1016/0163-7258(79)90045-7
   FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1
   FRY M, 1981, J BIOL CHEM, V256, P2874
   GOORMAGHTIGH E, 1980, BIOCHIM BIOPHYS ACTA, V597, P1, DOI 10.1016/0005-2736(80)90145-5
   GRINNA LS, 1977, MECH AGEING DEV, V6, P197, DOI 10.1016/0047-6374(77)90021-5
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HANSFORD RG, 1982, MECH AGEING DEV, V19, P5, DOI 10.1016/0047-6374(82)90044-6
   HANSFORD RG, 1978, BIOCHEM J, V170, P285, DOI 10.1042/bj1700285
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HOEK JB, 1971, BIOCHIM BIOPHYS ACTA, V226, P297, DOI 10.1016/0005-2728(71)90096-X
   KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5
   KIM JH, 1988, MECH AGEING DEV, V46, P263
   KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4
   LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255
   LEHNINGER AL, 1974, P NATL ACAD SCI USA, V71, P1520, DOI 10.1073/pnas.71.4.1520
   LEWIN MB, 1984, MECH AGEING DEV, V24, P343, DOI 10.1016/0047-6374(84)90119-2
   LIGETI E, 1984, BIOCHEMISTRY-US, V24, P4423
   MAK IT, 1983, BIOCHIM BIOPHYS ACTA, V722, P302, DOI 10.1016/0005-2728(83)90077-4
   MCGIVAN JD, 1971, EUR J BIOCHEM, V20, P392, DOI 10.1111/j.1432-1033.1971.tb01405.x
   MENDE P, 1982, EUR J BIOCHEM, V128, P91
   MERTENSSTRIJTHAGEN J, 1989, ARCH BIOCHEM BIOPHYS, V274, P37, DOI 10.1016/0003-9861(89)90412-8
   MITCHELL P, 1969, EUR J BIOCHEM, V9, P149, DOI 10.1111/j.1432-1033.1969.tb00588.x
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   NOHL H, 1980, MECH AGEING DEV, V14, P137, DOI 10.1016/0047-6374(80)90112-8
   Palmieri F, 1979, Methods Enzymol, V56, P279
   PAPA S, 1974, EUR J BIOCHEM, V49, P265, DOI 10.1111/j.1432-1033.1974.tb03831.x
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   PARADIES G, 1977, BIOCHIM BIOPHYS ACTA, V462, P333, DOI 10.1016/0005-2728(77)90132-3
   PARADIES G, 1990, ARCH BIOCHEM BIOPHYS, V278, P425, DOI 10.1016/0003-9861(90)90280-C
   PARADIES G, 1989, ARCH BIOCHEM BIOPHYS, V269, P595, DOI 10.1016/0003-9861(89)90145-8
   REED KC, 1975, EUR J BIOCHEM, V55, P497, DOI 10.1111/j.1432-1033.1975.tb02187.x
   ROBINSON NC, 1980, BIOCHEMISTRY-US, V19, P3656, DOI 10.1021/bi00557a003
   RUGGIERO FM, 1984, LIPIDS, V19, P171, DOI 10.1007/BF02534794
   VORBECK ML, 1982, ARCH BIOCHEM BIOPHYS, V217, P351, DOI 10.1016/0003-9861(82)90511-2
   WAHLER BE, 1958, BIOCHEM Z, V329, P508
   WEINDRUCH R, 1980, MECH AGEING DEV, V14, P375
   WOHLRAB H, 1984, BIOCHEMISTRY-US, V23, P1057, DOI 10.1021/bi00301a004
   WOHLRAB H, 1986, BIOCHIM BIOPHYS ACTA, V853, P115, DOI 10.1016/0304-4173(86)90007-8
   YECHIEL E, 1985, J BIOL CHEM, V260, P9123
NR 45
TC 69
Z9 74
U1 0
U2 5
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 1991
VL 284
IS 2
BP 332
EP 337
DI 10.1016/0003-9861(91)90304-2
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA ET071
UT WOS:A1991ET07100016
PM 1989517
DA 2024-02-19
ER

PT J
AU Kong, JY
   Yeon, SC
   Lee, HJ
   Kan, C
   Park, JK
   Jeong, KS
   Hong, IH
AF Kong, Joo-Yeon
   Yeon, Seong-Chan
   Lee, Hu Jang
   Kan, Changkeun
   Park, Jin-Kyu
   Jeong, Kyu-Shik
   Hong, Il-Hwa
TI Protective Effects of Nutria Bile against Thioacetamide-Induced Liver
   Injury in Mice
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID URSODEOXYCHOLIC ACID; 7-KETOLITHOCHOLIC ACID; GENE; EXPRESSION;
   MODULATION; MYOCASTOR; SPREAD
AB Several eradication programs have been developed and executed to curb alien invasive species that tend to damage the ecological environments they colonize; however, only few studies have evaluated the utilization of carcasses of these species after eradication. Nutria (Myocastor coypus) is an invasive rodent species targeted by eradication programs in many countries. We noted that nutria produce large amounts of ursodeoxycholic acid (UDCA) in their bile. UDCA is a unique component responsible for the anti-inflammatory and hepatoprotective effects exerted by bear bile. Therefore, we sought to examine the medicinal utility of nutria carcasses by investigating the hepatoprotective effect of their bile in mice. C57BL/6 mice were injected with thioacetamide (TAA), which induced liver damage by increasing Kupffer cell infiltration. Administration of nutria bile reduced hepatic inflammation, improved hepatic function, and increased the levels of senescence marker protein 30 (an indicator of hepatocyte viability). Our results show that nutria bile exerts protective effects against TAA-induced liver injury in mice, suggesting that nutria carcasses may be used for the treatment of liver injuries.
C1 [Kong, Joo-Yeon; Hong, Il-Hwa] Gyeongsang Natl Univ, Coll Vet Med, Dept Pathol, Jinju, South Korea.
   [Yeon, Seong-Chan] Seoul Natl Univ, Coll Vet Med, Dept Vet Clin Sci, Seoul, South Korea.
   [Yeon, Seong-Chan] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Seoul, South Korea.
   [Lee, Hu Jang; Kan, Changkeun; Hong, Il-Hwa] Gyeongsang Natl Univ, Inst Anim Med, Jinju, South Korea.
   [Park, Jin-Kyu; Jeong, Kyu-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Vet Pathol, Daegu, South Korea.
C3 Gyeongsang National University; Seoul National University (SNU); Seoul
   National University (SNU); Gyeongsang National University; Kyungpook
   National University
RP Hong, IH (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Dept Pathol, Jinju, South Korea.; Hong, IH (corresponding author), Gyeongsang Natl Univ, Inst Anim Med, Jinju, South Korea.
EM ihhong@gnu.ac.kr
OI Lee, Hu-Jang/0000-0002-7552-6416; Hong, Il-Hwa/0000-0002-2991-2690
FU National Research Foundation of Korea [NRF-2015R1C1A1A01055527]
FX This work was supported by the National Research Foundation of Korea
   [grant numbers NRF-2015R1C1A1A01055527].
CR Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46
   Bardi DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109424
   Bavle Radhika M, 2014, J Oral Maxillofac Pathol, V18, P2, DOI 10.4103/0973-029X.131880
   Carter J, 2002, WILDLIFE SOC B, V30, P162
   Chiang J. Y., 2002, ENDOCR REV, P23443
   Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228
   Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151
   Davi, 2010, 1252930037 STN US DE
   Fiorucci S, 2011, MINI-REV MED CHEM, V11, P753, DOI 10.2174/138955711796355258
   Fountoulakis M, 2002, TOXICOL APPL PHARM, V183, P71, DOI 10.1006/taap.2002.9460
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   HAGEY LR, 1993, J LIPID RES, V34, P1911
   HOFMANN AF, 1994, SCAND J GASTROENTERO, V29, P1, DOI 10.3109/00365529409103618
   Hong IH, 2016, J VET MED SCI, V78, P1887, DOI 10.1292/jvms.16-0174
   Hong IH, 2014, J BIOL CHEM, V289, P1106, DOI 10.1074/jbc.M113.526780
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   IUCN Invasive Species Specialist Group, 2000, IUCN GUID PREV BIOD
   Jones JD, 1997, COMP BIOCHEM PHYS C, V118, P387, DOI 10.1016/S0742-8413(97)00176-X
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886
   Lazaridis KN, 2001, J HEPATOL, V35, P134, DOI 10.1016/S0168-8278(01)00092-7
   Lee D. H., 2013, KOREAN J ENV ECOLOGY, V27, P316
   Li S, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/4305074
   LI YW, 1995, J ETHNOPHARMACOL, V47, P27, DOI 10.1016/0378-8741(95)01249-D
   Lowe S., 2000, 100 WORLDS WORST INV
   Pares Albert, 2014, Clin Liver Dis (Hoboken), V3, P29, DOI 10.1002/cld.311
   Pimentel M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0017-2013
   Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548
   SALEN G, 1982, GASTROENTEROLOGY, V83, P341
   Sar P, 2007, MOL CELL BIOCHEM, V303, P239, DOI 10.1007/s11010-007-9462-1
   Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177
   TINT GS, 1986, GASTROENTEROLOGY, V90, P702, DOI 10.1016/0016-5085(86)91126-1
   VEITCH CR, 2002, P INT C ER ISL INV
   Wang ME, 2012, J NUTR BIOCHEM, V23, P1352, DOI 10.1016/j.jnutbio.2011.08.004
   Watanabe S, 2012, J TOXICOL SCI, V37, P105, DOI 10.2131/jts.37.105
   Xie Y, 2012, DRUG METAB DISPOS, V40, P796, DOI 10.1124/dmd.111.043539
NR 36
TC 3
Z9 4
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2019
VL 2019
AR 6059317
DI 10.1155/2019/6059317
PG 10
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA IH5IC
UT WOS:000474526700001
PM 31341496
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Roizen, JD
   Casella, A
   Lai, MZ
   Long, CL
   Tara, Z
   Caplan, I
   O'Lear, L
   Levine, MA
AF Roizen, Jeffrey D.
   Casella, Alex
   Lai, Meizan
   Long, Caela
   Tara, Zahra
   Caplan, Ilana
   O'Lear, Lauren
   Levine, Michael A.
TI Decreased Serum 25-Hydroxyvitamin D in Aging Male Mice Is Associated
   With Reduced Hepatic <i>Cyp2r1</i> Abundance
SO ENDOCRINOLOGY
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; VITAMIN-D STATUS; SUPPLEMENTATION;
   CHOLECALCIFEROL; YOUNG
AB The prevalence of vitamin D deficiency, as determined by circulating levels of 25-hydroxycalciferol [25(OH)D], is greater in older individuals compared with the young. To examine the hypothesis that altered production or inactivation of 25(OH)D contributes to lower circulating levels of 25(OH)D, we measured the serum levels of parent vitamin D3 (cholecalciferol) and 25(OH)D. We also determined the relative abundance of transcripts encoding hepatic CYP2R1 and CYP27B1, the principal 25hydroxylases, transcripts encoding enzymes that degrade 25(OH)D in the liver (Cyp3A11) and kidney (Cyp24A1) and transcripts encoding megalin and cubilin, proteins critical to vitamin D resorption in the kidney in mice at three different ages. We observed a significant decline in the relative abundance of Cyp2R1 in the liver with aging (one-way ANOVA, P = 0.0077). Concurrent with the decrease in mRNA, a significant decline in hepatic CYP2R1 protein (one-way ANOVA for trend, P = 0.007) and 25(OH)D (one-way ANOVA for trend, P = 0.002) and in the ratio of 25(OH)D3 to cholecalciferol (one-way ANOVA, P = 0.0003). By contrast, levels of the transcripts encoding Cyp3a11, Cyp24a1, and Cyp27b1 megalin and cubilin were unchanged with aging. A significant positive correlation was found between Cyp2r1 mRNA and 25(OH)D, and a stronger correlation was found between Cyp2r1 mRNA and the ratio of 25(OH)D3 to cholecalciferol. These results indicate that decreased expression of CYP2R1 contributes to the reduced serum levels of 25(OH)D in aging.
C1 [Roizen, Jeffrey D.; Casella, Alex; Lai, Meizan; Long, Caela; Tara, Zahra; Caplan, Ilana; O'Lear, Lauren; Levine, Michael A.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.
   [Roizen, Jeffrey D.; Casella, Alex; Lai, Meizan; Long, Caela; Tara, Zahra; Caplan, Ilana; O'Lear, Lauren; Levine, Michael A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania
RP Roizen, JD (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Perelman Sch Med, 3401 Civ Ctr Blvd,11 Northwest, Philadelphia, PA 19104 USA.
EM roizenj@chop.edu
RI Levine, Michael/JED-8261-2023; Wion, Didier/M-7045-2018; Roizen,
   Jeffrey/J-5050-2012
OI Wion, Didier/0000-0001-7144-6470; Roizen, Jeffrey/0000-0002-3384-6200;
   Levine, Michael/0000-0003-0036-7809
FU NIH [K08-HD087964-01]
FX The project described was supported by NIH Grant K08-HD087964-01 (to
   J.D.R.). The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the NIH.
CR Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155
   Anderson D, 2014, GENES IMMUN, V15, P578, DOI 10.1038/gene.2014.52
   ANDERSSON S, 1983, J BIOL CHEM, V258, P6777
   BAKER MR, 1980, AGE AGEING, V9, P249, DOI 10.1093/ageing/9.4.249
   Barnes MS, 2011, J NUTR, V141, P476, DOI 10.3945/jn.110.131516
   Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101
   Dreyfus M, 2015, CANCER-AM CANCER SOC, V121, P3362, DOI 10.1002/cncr.29451
   Forsythe LK, 2012, BRIT J NUTR, V107, P126, DOI 10.1017/S0007114511002662
   Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001
   HOLT PR, 1981, DIGEST DIS SCI, V26, P1109, DOI 10.1007/BF01295977
   Hysinger EB, 2016, J ALLERGY CLIN IMMUN, V138, P1747, DOI 10.1016/j.jaci.2016.06.056
   Ilahi M, 2008, AM J CLIN NUTR, V87, P688, DOI 10.1093/ajcn/87.3.688
   MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134
   Mazahery H, 2015, NUTRIENTS, V7, P5111, DOI 10.3390/nu7075111
   Michaud J, 2010, J AM SOC NEPHROL, V21, P1488, DOI 10.1681/ASN.2009080815
   Pasquali M, 2015, BBA CLIN, V3, P251, DOI 10.1016/j.bbacli.2015.03.004
   Pérez-López FR, 2011, MATURITAS, V69, P27, DOI 10.1016/j.maturitas.2011.02.014
   Stubbs JR, 2014, CLIN J AM SOC NEPHRO, V9, P1965, DOI 10.2215/CJN.03130314
   Thacher TD, 2015, J CLIN ENDOCR METAB, V100, pE1005, DOI 10.1210/jc.2015-1746
   Vaes AMM, 2018, CLIN NUTR, V37, P808, DOI 10.1016/j.clnu.2017.03.029
   Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0
NR 21
TC 12
Z9 14
U1 1
U2 7
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD AUG
PY 2018
VL 159
IS 8
BP 3083
EP 3089
DI 10.1210/en.2017-03028
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA GR8CE
UT WOS:000442933700023
PM 29955863
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Kim, KH
   Cheng, NY
   Lau, LF
AF Kim, Ki-Hyun
   Cheng, Naiyuan
   Lau, Lester F.
TI Cellular communication network factor 1-stimulated liver macrophage
   efferocytosis drives hepatic stellate cell activation and liver fibrosis
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article; Early Access
ID BINDING-SITE; TGF-BETA; SENESCENCE; INJURY; MODEL; IDENTIFICATION;
   PROLIFERATION; HETEROGENEITY; MECHANISMS; REGRESSION
AB Following inflammatory injury in the liver, neutrophils quickly infiltrate the injured tissue to defend against microbes and initiate the repair process; these neutrophils are short lived and rapidly undergo apoptosis. Hepatic stellate cells (HSCs) are the principal precursor cells that transdifferentiate into myofibroblast-like cells, which produce a large amount of extracellular matrix that promotes repair but can also lead to fibrosis if the injury becomes chronic. The matricellular protein cellular communication network factor 1 (CCN1) acts as a bridging molecule by binding phosphatidylserine in apoptotic cells and integrin alpha(v)beta(3) in phagocytes, thereby triggering efferocytosis or phagocytic clearance of the apoptotic cells. Here, we show that CCN1 induces liver macrophage efferocytosis of apoptotic neutrophils in carbon tetrachloride (CCl4)-induced liver injury, leading to the production of activated transforming growth factor (TGF)-beta 1, which in turn induces HSC transdifferentiation into myofibroblast-like cells that promote fibrosis development. Consequently, knock-in mice expressing a single amino acid substitution in CCN1 rendering it unable to bind alpha(v)beta(3) or induce efferocytosis are impaired in neutrophil clearance, production of activated TGF-beta 1, and HSC transdifferentiation, resulting in greatly diminished liver fibrosis following exposure to CCl4. Conclusion: These results reveal the crucial role of CCN1 in stimulating liver macrophage clearance of apoptotic neutrophils, a process that drives HSC transdifferentiation into myofibroblastic cells and underlies fibrogenesis in chronic liver injury.
C1 [Kim, Ki-Hyun; Cheng, Naiyuan; Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Lau, LF (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.
EM lflau@uic.edu
OI Kim, Ki-Hyun/0000-0001-8265-6609; Lau, Lester/0000-0002-4364-2914
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases
   [AR061791]; National Institute of Diabetes and Digestive and Kidney
   Diseases [DK108994]; National Institute of General Medical Sciences
   [GM78492]; National Institutes of Health [R01GM78492, R01DK108994,
   R01AR061791]
FX National Institute of Arthritis and Musculoskeletal and Skin Diseases,
   Grant/Award Number: AR061791; National Institute of Diabetes and
   Digestive and Kidney Diseases, Grant/Award Number: DK108994; National
   Institute of General Medical Sciences, Grant/Award Number: GM78492;
   National Institutes of Health, Grant/Award Number: R01GM78492,
   R01DK108994 and R01AR061791
CR Borkham-Kamphorst E, 2016, CYTOKINE GROWTH F R, V28, P53, DOI 10.1016/j.cytogfr.2015.10.002
   Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340
   Calvente CJ, 2019, J CLIN INVEST, V129, P4091, DOI 10.1172/JCI122258
   Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472
   Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200
   Choi JS, 2015, MUCOSAL IMMUNOL, V8, P1285, DOI 10.1038/mi.2015.19
   Constandinou C, 2005, METH MOLEC MED, V117, P237
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y
   Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Fabre T, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar7754
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   Feng T, 2019, CIRCULATION, V139, P2495, DOI 10.1161/CIRCULATIONAHA.119.039530
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007
   Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638
   Hviid CVB, 2014, SHOCK, V41, P233, DOI 10.1097/SHK.0000000000000105
   Jelnes P, 2007, HEPATOLOGY, V45, P1462, DOI 10.1002/hep.21569
   Jun JI, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-15075, 10.1038/s41467-020-15075-5]
   Jun JI, 2018, J CLIN INVEST, V128, P97, DOI 10.1172/JCI93563
   Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386
   Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950
   Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948
   Kliment CR, 2011, INT J CLIN EXP PATHO, V4, P349
   KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200
   Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621
   Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100
   Preisegger KH, 1999, LAB INVEST, V79, P103
   Pulli B, 2015, ANTIOXID REDOX SIGN, V23, P1255, DOI 10.1089/ars.2014.6108
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Saijou E, 2018, HEPATOL COMMUN, V2, P703, DOI 10.1002/hep4.1178
   Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Weiskirchen R, 2005, METH MOLEC MED, V117, P99
   Wen YK, 2021, CELL MOL IMMUNOL, V18, P45, DOI 10.1038/s41423-020-00558-8
   Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015
   Yang WT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09046-8
   Yang W, 2021, HEPATOLOGY, V74, P2774, DOI 10.1002/hep.31987
   Yu Q, 2000, GENE DEV, V14, P163
   Zhou Z, 2018, CELL MOL GASTROENTER, V5, P399, DOI 10.1016/j.jcmgh.2018.01.003
NR 48
TC 7
Z9 7
U1 1
U2 1
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD 2022 OCT
PY 2022
VL 6
IS 10
BP 2798
EP 2811
DI 10.1002/hep4.2057
EA AUG 2022
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 4V0ZE
UT WOS:000836308500001
PM 35929736
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Makino, Y
   Hikita, H
   Fukumoto, K
   Sung, JH
   Sakano, Y
   Murai, K
   Sakane, S
   Kodama, T
   Sakamori, R
   Kondo, J
   Kobayashi, S
   Tatsumi, T
   Takehara, T
AF Makino, Yuki
   Hikita, Hayato
   Fukumoto, Kenji
   Sung, Ji Hyun
   Sakano, Yoshihiro
   Murai, Kazuhiro
   Sakane, Sadatsugu
   Kodama, Takahiro
   Sakamori, Ryotaro
   Kondo, Jumpei
   Kobayashi, Shogo
   Tatsumi, Tomohide
   Takehara, Tetsuo
TI Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes
   Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis
SO CANCER RESEARCH
LA English
DT Article
ID POSTTRANSLATIONAL MODIFICATION; MOUSE MODEL; EXPRESSION; CANCER; ORIGIN;
   MDM2; RAS
AB In chronic liver diseases (CLD), p53 is constitutively activated in hepatocytes due to various etiologies as viral infection, ethanol exposure, or lipid accumulation. This study was aimed to clarify the significance of p53 activation on the pathophys-iology of CLDs. In Kras-mutant liver cancer model, murine double minute 2 (Mdm2), a negative regulator of p53, was specifically deleted in hepatocytes [Alb-Cre KrasLSL-G12D Mdm2(fl/fl) (LiKM; Kras(G12D) mutation and Mdm2 loss in the liver)]. Accumulation of p53 and upregulation of its down-stream genes were observed in hepatocytes in LiKM mice. LiKM mice showed liver inflammation accompanied by hepatocyte apoptosis, senescence-associated secretory phenotype (SASP), and the emergence of hepatic progenitor cells (HPC). More importantly, Mdm2 deletion promoted non-cell autonomous development of liver tumors. Organoids generated from HPCs harbored tumor-formation ability when subcutaneously inocu-lated into NOD/Shi-scid/IL2Ry (null) mice. Treatment with acyclic retinoid suppressed growth of HPCs in vitro and inhibited tumorigenesis in LiKM mice. All of the phenotypes in LiKM mice, including accelerated liver tumorigenesis, were negated by further deletion of p53 in hepatocytes (Alb-Cre KrasLSL-G12D Mdm2(fl/fl )p53(fl/fl)). Activation of hepatic p53 was noted in liver biopsy samples obtained from 182 patients with CLD, in com-parison with 23 normal liver samples without background liver diseases. In patients with CLD, activity of hepatic p53 was positively correlated with the expression of apoptosis, SASP, HPC-associated genes and tumor incidence in the liver after biopsy. In conclusion, activation of hepatocyte p53 creates a microenvironment prone to tumor formation from HPCs. Optimization of p53 activity in hepatocytes is important to prevent patients with CLD from hepatocarcinogenesis. Significance: This study reveals that activation of p53 in hepa-tocytes promotes liver carcinogenesis derived from HPCs, which elucidates a paradoxical aspect of a tumor suppressor p53 and novel mechanism of liver carcinogenesis.
C1 [Makino, Yuki; Hikita, Hayato; Fukumoto, Kenji; Sung, Ji Hyun; Murai, Kazuhiro; Sakane, Sadatsugu; Kodama, Takahiro; Sakamori, Ryotaro; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Osaka, Japan.
   [Sakano, Yoshihiro; Kobayashi, Shogo] Osaka Univ, Dept Gastroenterol Surg, Grad Sch Med, Osaka, Japan.
   [Kondo, Jumpei] Osaka Univ, Dept Mol Biochem & Clin Invest, Grad Sch Med, Osaka, Japan.
   [Takehara, Tetsuo] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2 2 Yamadaoka, Suita, Osaka 5650871, Japan.
C3 Osaka University; Osaka University; Osaka University; Osaka University
RP Takehara, T (corresponding author), Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2 2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM takehara@gh.med.osaka-u.ac.jp
RI Sakamori, Ryotaro/B-4406-2014; Murai, Kazuhiro/ADY-0970-2022; Sakano,
   Yoshihiro/JTV-4679-2023
OI Sakamori, Ryotaro/0000-0002-1580-607X; Murai,
   Kazuhiro/0000-0001-8634-2922; Sakano, Yoshihiro/0000-0002-7633-6657;
   Kodama, Takahiro/0000-0002-6250-1324; Sakane,
   Sadatsugu/0000-0002-6306-4621
FU Kowa; NGS core facility of the Genome Information Research Center at the
   Research Institute for Microbial Diseases of Osaka University [19K17432,
   21K08005]; Ministry of Education, Culture, Sports, Science, and
   Technology, Japan [21K08005]; Japan Agency for Medical Research and
   Development [JP21H02903, 22fk0310512]; Osaka Cancer Society [19K17432,
   21K08005];  [JP21fk0210064]
FX The authors would like to acknowledge Dr. Hiroshi Suemizu (Department of
   Laboratory Animal Research, Central Institute for Experimental Animals,
   Kana-gawa, Japan) for offering NOG mice. The authors also thank Kowa for
   kindly providing ACR. They are grateful to Prof. Hidetoshi Eguchi
   (Department of Gastroenterological Surgery, Osaka University Graduate
   School of Medicine, Osaka, Japan) for providing surgically resected
   human liver samples. The authors also thank Miyuki Imai (Department of
   Gastroenterology and Hepatology, Osaka University Graduate School of
   Medicine, Osaka, Japan) for technical support. They acknowledge the NGS
   core facility of the Genome Information Research Center at the Research
   Institute for Microbial Diseases of Osaka University for the support
   with RNA-seq and data analysis. This work was partially supported by a
   Grant-in-Aid for Early-Career Scientists (to Y. Makino, 19K17432) , a
   Grant-in-Aid for Scientific Research (C) (to Y. Makino, 21K08005) , a
   research grant from the Osaka Cancer Society (to Y. Makino) ,
   Grants-in-Aid for Scientific Research (B) (to T. Takehara, JP21H02903)
   from the Ministry of Education, Culture, Sports, Science, and
   Technology, Japan, and a Grant-in-Aid for Research Program on Hepatitis
   from the Japan Agency for Medical Research and Development (22fk0310512
   and JP21fk0210064 to T. Takehara) .
CR Akyol G, 1999, PATHOL INT, V49, P214, DOI 10.1046/j.1440-1827.1999.00849.x
   Baudoin NC, 2021, GENES-BASEL, V12, DOI 10.3390/genes12040558
   Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455
   Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097
   Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006
   Charni M, 2014, J MOL MED, V92, P1229, DOI 10.1007/s00109-014-1223-5
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015
   Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007
   Dollé L, 2010, J HEPATOL, V52, P117, DOI 10.1016/j.jhep.2009.10.009
   Erker L, 2008, STEM CELL RES, V1, P90, DOI 10.1016/j.scr.2008.01.002
   Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006
   Guan HB, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0046-9
   Hamarsheh S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19288-6
   Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207
   Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409
   Jing YY, 2018, CANCER LETT, V434, P22, DOI 10.1016/j.canlet.2018.07.001
   Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747
   Kao CF, 2004, ONCOGENE, V23, P2472, DOI 10.1038/sj.onc.1207368
   Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957
   Köhn-Gaone J, 2016, AM J PHYSIOL-GASTR L, V310, pG143, DOI 10.1152/ajpgi.00215.2015
   LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0
   Li XF, 2017, HEPATOLOGY, V66, P1934, DOI 10.1002/hep.29372
   Loguercio C, 2003, J VIRAL HEPATITIS, V10, P266, DOI 10.1046/j.1365-2893.2003.00432.x
   Lu W, 1999, VIROLOGY, V264, P134, DOI 10.1006/viro.1999.9979
   Makino Y, 2018, CANCER RES, V78, P4902, DOI 10.1158/0008-5472.CAN-17-3844
   Marquardt JU, 2015, NAT REV CANCER, V15, P653, DOI 10.1038/nrc4017
   Meng X, 2014, CANCER RES, V74, P7161, DOI 10.1158/0008-5472.CAN-14-1446
   Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106
   Shahnazari P, 2014, IRAN J MED SCI, V39, P446
   Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048
   Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303
   Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126
   Viebahn CS, 2006, EUR J CELL BIOL, V85, P1265, DOI 10.1016/j.ejcb.2006.08.006
   Viebahn CS, 2010, J HEPATOL, V53, P500, DOI 10.1016/j.jhep.2010.04.010
   Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430
   Yahagi N, 2004, J BIOL CHEM, V279, P20571, DOI 10.1074/jbc.M400884200
   YOSHIMURA H, 1983, AM J PATHOL, V110, P322
   Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726
   Zhang AB, 2010, STEM CELLS DEV, V19, P1277, DOI 10.1089/scd.2009.0304
   Zheng YW, 2014, STEM CELLS DEV, V23, P2237, DOI 10.1089/scd.2013.0577
   Ziol M, 2010, GASTROENTEROLOGY, V139, P335, DOI 10.1053/j.gastro.2010.04.012
NR 42
TC 18
Z9 19
U1 3
U2 9
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD AUG 15
PY 2022
VL 82
IS 16
DI 10.1158/0008-5472.CAN-21-4390
PG 14
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 3Z4KY
UT WOS:000844386000001
PM 35696550
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Dongiovanni, P
   Romeo, S
   Valenti, L
AF Dongiovanni, Paola
   Romeo, Stefano
   Valenti, Luca
TI Hepatocellular carcinoma in nonalcoholic fatty liver: Role of
   environmental and genetic factors
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Nonalcoholic fatty liver disease; Steatosis; Hepatocellular carcinoma;
   Cirrhosis; Fibrogenesis; Liver disease; Genetics; Single nucleotide
   polymorphism; Patatin-like phospholipase domain-containing 3
ID GREATER-THAN-G; GENOME-WIDE ASSOCIATION; HEPATITIS-C-VIRUS; METABOLIC
   SYNDROME; PNPLA3 RS738409; RISK-FACTORS; INSULIN-RESISTANCE;
   UNITED-STATES; CRYPTOGENIC CIRRHOSIS; SUSCEPTIBILITY LOCUS
AB Hepatocellular carcinoma (HCC) is the fourth cause of cancer related mortality, and its incidence is rapidly increasing. Viral hepatitis, alcohol abuse, and exposure to hepatotoxins are major risk factors, but nonalcoholic fatty liver disease (NAFLD) associated with obesity, insulin resistance, and type 2 diabetes, is an increasingly recognized trigger, especially in developed countries. Older age, severity of insulin resistance and diabetes, and iron overload have been reported to predispose to HCC in this context. Remarkably, HCCs have been reported in non-cirrhotic livers in a higher proportion of cases in NAFLD patients than in other etiologies. Inherited factors have also been implicated to explain the different individual susceptibility to develop HCC, and their role seems magnified in fatty liver, where only a minority of affected subjects progresses to cancer. In particular, the common I148M variant of the PNPLA3 gene influencing hepatic lipid metabolism influences HCC risk independently of its effect on the progression of liver fibrosis. Recently, rare loss-of-function mutations in Apolipoprotein B resulting in very low density lipoproteins hepatic retention and in Telomerase reverse transcriptase influencing cellular senescence have also been linked to HCC in NAFLD. Indeed, hepatic stellate cells senescence has been suggested to bridge tissue aging with alterations of the intestinal microbiota in the pathogenesis of obesity-related HCC. A deeper understanding of the mechanisms mediating hepatic carcinogenesis during insulin resistance, and the identification of its genetic determinants will hopefully provide new diagnostic and therapeutic tools.
C1 [Dongiovanni, Paola; Valenti, Luca] Osped Policlin, Fdn IRCCS Ca Granda, I-20122 Milan, Italy.
   [Dongiovanni, Paola; Valenti, Luca] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.
   [Romeo, Stefano] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, S-40530 Gothenburg, Sweden.
   [Romeo, Stefano] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Clin Nutr Unit, I-88100 Catanzaro, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan;
   University of Gothenburg; Magna Graecia University of Catanzaro
RP Valenti, L (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Pad Granelli Via F Sforza 35, I-20122 Milan, Italy.
EM luca.valenti@unimi.it
RI Romeo, Stefano/L-6861-2015; Valenti, Luca/B-3695-2009; Dongiovanni,
   Paola/AAC-9965-2019
OI Romeo, Stefano/0000-0001-9168-4898; Valenti, Luca/0000-0001-8909-0345;
   Dongiovanni, Paola/0000-0003-4343-7213
FU Novo Nordisk Fonden [NNF14OC0009321] Funding Source: researchfish
CR Alexander J, 2013, J GASTROEN HEPATOL, V28, P848, DOI 10.1111/jgh.12116
   Alla V, 2005, SEMIN LIVER DIS, V25, P461, DOI 10.1055/s-2005-923317
   Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527
   Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027
   Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005
   Bonnefont-Rousselot D, 2009, EUR J GASTROEN HEPAT, V21, P104, DOI 10.1097/MEG.0b013e3282ffd9f8
   Bugianesi E, 2004, HEPATOLOGY, V39, P179, DOI 10.1002/hep.20023
   Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168
   Burza MA, 2012, DIGEST LIVER DIS, V44, P1037, DOI 10.1016/j.dld.2012.05.006
   Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173
   Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408
   Carthew P, 1997, CARCINOGENESIS, V18, P599, DOI 10.1093/carcin/18.3.599
   Cefalù AB, 2013, ARTERIOSCL THROM VAS, V33, P2021, DOI 10.1161/ATVBAHA.112.301101
   Chaiteerakij R, 2011, HEPATOLOGY, V53, P1430, DOI 10.1002/hep.24304
   Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Corradini SG, 2011, HEPATOLOGY, V53, P1776, DOI 10.1002/hep.24244
   Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095
   Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167
   Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017
   Devkota S, 2013, NATURE, V499, P37, DOI 10.1038/nature12404
   Dongiovanni P, 2013, CURR PHARM DESIGN, V19, P5219, DOI 10.2174/13816128113199990381
   Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019
   Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008
   Dongiovanni P, 2010, AM J PATHOL, V176, P1006, DOI 10.2353/ajpath.2010.090249
   Dwyer J, 2007, ANN NY ACAD SCI, V1114, P36, DOI 10.1196/annals.1396.022
   Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011
   El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065
   El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2462, DOI 10.1111/j.1572-0241.2001.04054.x
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001
   Falleti E, 2011, LIVER INT, V31, P1137, DOI 10.1111/j.1478-3231.2011.02534.x
   Fargion S, 2001, AM J GASTROENTEROL, V96, P2448, DOI 10.1111/j.1572-0241.2001.04052.x
   Fracanzani AL, 2005, BLOOD CELL MOL DIS, V35, P27, DOI 10.1016/j.bcmd.2005.03.007
   Fracanzani AL, 2010, HEPATOLOGY, V51, P501, DOI 10.1002/hep.23333
   Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231
   Guyot E, 2013, J HEPATOL, V58, P312, DOI 10.1016/j.jhep.2012.09.036
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hassan MM, 2013, MOL CARCINOGEN, V52, P139, DOI 10.1002/mc.22057
   Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982
   He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501
   Houglum K, 1997, HEPATOLOGY, V26, P605, DOI 10.1053/jhep.1997.v26.pm0009303489
   Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107
   Jinjuvadia R, 2014, J CLIN GASTROENTEROL, V48, P172, DOI 10.1097/MCG.0b013e3182a030c4
   Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110
   Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809
   Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384
   Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932
   Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448
   Lee SS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-335
   Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005
   Liang J, 2006, HAEMATOLOGICA, V91, P656
   Liu YL, 2014, J HEPATOL, V61, P75, DOI 10.1016/j.jhep.2014.02.030
   Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014
   Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001
   Lonardo A, 1998, DIGEST DIS SCI, V43, P2489, DOI 10.1023/A:1026646618643
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494
   Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5
   Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844
   Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046
   Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005
   Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939
   Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4
   Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Miki D, 2011, NAT GENET, V43, P797, DOI 10.1038/ng.876
   Mori S, 2004, J GASTROENTEROL, V39, P391, DOI 10.1007/s00535-003-1308-3
   Nahon P, 2012, J HEPATOL, V57, P663, DOI 10.1016/j.jhep.2012.02.035
   Nair S, 2002, HEPATOLOGY, V35, P105, DOI 10.1053/jhep.2002.30318
   Nischalke HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027087
   Nkontchou G, 2011, J VIRAL HEPATITIS, V18, pE516, DOI 10.1111/j.1365-2893.2011.01441.x
   Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Pekow JR, 2007, CANCER-AM CANCER SOC, V109, P2490, DOI 10.1002/cncr.22701
   Pirazzi C, 2012, J HEPATOL, V57, P1276, DOI 10.1016/j.jhep.2012.07.030
   Rahman R, 2013, WORLD J GASTRO ONCOL, V5, P186, DOI 10.4251/wjgo.v5.i9.186
   Regimbeau Jean M, 2004, Liver Transpl, V10, pS69, DOI 10.1002/lt.20033
   Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257
   Rudnick DA, 2005, HEPATOLOGY, V42, P514, DOI 10.1002/hep.20815
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Salomao M, 2010, AM J SURG PATHOL, V34, P1630, DOI 10.1097/PAS.0b013e3181f31caa
   Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Shimada M, 2002, J HEPATOL, V37, P154, DOI 10.1016/S0168-8278(02)00099-5
   Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687
   Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283
   Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011
   STAL P, 1995, HEPATOLOGY, V21, P521, DOI 10.1016/0270-9139(95)90115-9
   Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017
   Stickel F, 2010, GUT, V59, P1303, DOI 10.1136/gut.2009.199661
   Takuma Y, 2010, WORLD J GASTROENTERO, V16, P1436, DOI 10.3748/wjg.v16.i12.1436
   Tanaka A, 2007, WORLD J GASTROENTERO, V13, P5180, DOI 10.3748/wjg.v13.i39.5180
   TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7
   Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488
   Trépo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767
   Trepo E, 2012, HEPATOLOGY, V55, P1307, DOI 10.1002/hep.25518
   Trépo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350
   Trichopoulos D, 2011, JNCI-J NATL CANCER I, V103, P1686, DOI 10.1093/jnci/djr395
   Turati F, 2013, BRIT J CANCER, V108, P222, DOI 10.1038/bjc.2012.492
   Turati F, 2012, HEPATOLOGY, V55, P1416, DOI 10.1002/hep.24794
   Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x
   Valenti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075982
   Valenti L, 2013, DIGEST LIVER DIS, V45, P619, DOI 10.1016/j.dld.2012.12.006
   Valenti L, 2013, J HEPATOL, V58, P399, DOI 10.1016/j.jhep.2012.09.011
   Valenti L, 2012, J HEPATOL, V57, P1319, DOI 10.1016/j.jhep.2012.07.041
   Valenti L, 2012, WORLD J GASTROENTERO, V18, P2813, DOI 10.3748/wjg.v18.i22.2813
   Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123
   Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622
   Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013
   Valenti L, 2009, SEMIN IMMUNOPATHOL, V31, P359, DOI 10.1007/s00281-009-0152-9
   Viganò M, 2013, HEPATOLOGY, V58, P1245, DOI 10.1002/hep.26445
   Vinciguerra M, 2009, J HEPATOL, V50, P1132, DOI 10.1016/j.jhep.2009.01.027
   Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160
   Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036
   Yasui K, 2011, CLIN GASTROENTEROL H, V9, P428, DOI 10.1016/j.cgh.2011.01.023
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012
   Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638
NR 120
TC 96
Z9 108
U1 0
U2 26
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD SEP 28
PY 2014
VL 20
IS 36
BP 12945
EP 12955
DI 10.3748/wjg.v20.i36.12945
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AR9GK
UT WOS:000343880900018
PM 25278690
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Heckenbach, I
   Mkrtchyan, GV
   Ezra, MB
   Bakula, D
   Madsen, JS
   Nielsen, MH
   Oro, D
   Osborne, B
   Covarrubias, AJ
   Idda, ML
   Gorospe, M
   Mortensen, L
   Verdin, E
   Westendorp, R
   Scheibye-Knudsen, M
AF Heckenbach, Indra
   Mkrtchyan, Garik V.
   Ezra, Michael Ben
   Bakula, Daniela
   Madsen, Jakob Sture
   Nielsen, Malte Hasle
   Oro, Denise
   Osborne, Brenna
   Covarrubias, Anthony J.
   Idda, M. Laura
   Gorospe, Myriam
   Mortensen, Laust
   Verdin, Eric
   Westendorp, Rudi
   Scheibye-Knudsen, Morten
TI Nuclear morphology is a deep learning biomarker of cellular senescence
SO NATURE AGING
LA English
DT Article
ID DNA-DAMAGE; CELLS; CANCER; DISEASES; PATHWAY; TARGET
AB Senescent cells are typically identified by a combination of senescence-associated markers, and the phenotype is heterogeneous. Here, using deep neural networks, Heckenbach et al. show that nuclear morphology can be used to predict cellular senescence in images of tissues and cell cultures.
   Cellular senescence is an important factor in aging and many age-related diseases, but understanding its role in health is challenging due to the lack of exclusive or universal markers. Using neural networks, we predict senescence from the nuclear morphology of human fibroblasts with up to 95% accuracy, and investigate murine astrocytes, murine neurons, and fibroblasts with premature aging in culture. After generalizing our approach, the predictor recognizes higher rates of senescence in p21-positive and ethynyl-2'-deoxyuridine (EdU)-negative nuclei in tissues and shows an increasing rate of senescent cells with age in H&E-stained murine liver tissue and human dermal biopsies. Evaluating medical records reveals that higher rates of senescent cells correspond to decreased rates of malignant neoplasms and increased rates of osteoporosis, osteoarthritis, hypertension and cerebral infarction. In sum, we show that morphological alterations of the nucleus can serve as a deep learning predictor of senescence that is applicable across tissues and species and is associated with health outcomes in humans.
C1 [Heckenbach, Indra; Mkrtchyan, Garik V.; Ezra, Michael Ben; Bakula, Daniela; Madsen, Jakob Sture; Osborne, Brenna; Scheibye-Knudsen, Morten] Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, Copenhagen, Denmark.
   [Heckenbach, Indra; Verdin, Eric] Buck Inst Res Aging, Novato, CA USA.
   [Heckenbach, Indra; Scheibye-Knudsen, Morten] Tracked bio, Copenhagen, Denmark.
   [Ezra, Michael Ben; Mortensen, Laust; Westendorp, Rudi] Methods & Anal Stat Denmark, Copenhagen, Denmark.
   [Nielsen, Malte Hasle; Oro, Denise] Gubra, Horsholm, Denmark.
   [Covarrubias, Anthony J.] David Geffen Sch Med UCLA, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA.
   [Covarrubias, Anthony J.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA.
   [Idda, M. Laura; Gorospe, Myriam] Natl Inst Aging Intramural Res Program, Lab Genet & Genom, NIH, Baltimore, MD USA.
   [Idda, M. Laura] CNR, Ist Ric Genet & Biomed, Sassari, Italy.
   [Mortensen, Laust; Westendorp, Rudi] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.
C3 University of Copenhagen; Buck Institute for Research on Aging;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA); Consiglio Nazionale delle Ricerche
   (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University
   of Copenhagen
RP Scheibye-Knudsen, M (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, Copenhagen, Denmark.; Scheibye-Knudsen, M (corresponding author), Tracked bio, Copenhagen, Denmark.
EM mscheibye@sund.ku.dk
RI Osborne, Brenna/F-5950-2018
OI Osborne, Brenna/0000-0002-0197-3010; Nielsen, Malte
   Hasle/0000-0002-2348-5747; Madsen, Jakob Sture/0000-0002-2841-7284
FU Novo Nordisk Foundation Challenge Programme [NNF17OC0027812]; Nordea
   Foundation [02-2017-1749]; Neye Foundation; Lundbeck Foundation
   [R324-2019-1492]; Ministry of Higher Education and Science
   [0238-00003B]; National Institutes of Health [U54 AG075932]; National
   Institute on Aging Intramural Research Program, National Institutes of
   Health; VitaDAO; Insilico Medicine
FX This research was supported by the Novo Nordisk Foundation Challenge
   Programme (NNF17OC0027812), the Nordea Foundation (02-2017-1749), the
   Neye Foundation, the Lundbeck Foundation (R324-2019-1492), the Ministry
   of Higher Education and Science (0238-00003B), VitaDAO, Insilico
   Medicine and the U54 AG075932 grant from the National Institutes of
   Health. M.L.I. and M.G. were supported by the National Institute on
   Aging Intramural Research Program, National Institutes of Health. The
   funders had no role in study design, data collection and analysis,
   decision to publish or preparation of the manuscript.
CR Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387
   Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010
   Burton DGA, 2014, CELL MOL LIFE SCI, V71, P4373, DOI 10.1007/s00018-014-1691-3
   Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005
   Chen JH, 2006, FEBS LETT, V580, P6669, DOI 10.1016/j.febslet.2006.11.023
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Covarrubias AJ, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00305-3
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Filippi-Chiela EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042522
   Fort S, 2020, Arxiv, DOI [arXiv:1912.02757, 10.48550/arXiv.1912.02757]
   Gal Y, 2016, Arxiv, DOI [arXiv:1506.02142, 10.48550/ARXIV.1506.02142, DOI 10.48550/ARXIV.1506.02142]
   Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134
   Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Hudgins AD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00059
   Idda ML, 2020, AGING-US, V12, P4052, DOI 10.18632/aging.102903
   Imai Y, 2014, CELL REP, V7, P194, DOI 10.1016/j.celrep.2014.03.006
   Imanishi T, 2005, J HYPERTENS, V23, P1831, DOI 10.1097/01.hjh.0000183524.73746.1b
   Kassani SH, 2019, I C INF COMM TECH CO, P519, DOI 10.1109/ictc46691.2019.8939878
   Keijzers G, 2017, NEW ENGL J MED, V377, P1868, DOI 10.1056/NEJMra1703366
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Kusumoto D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20213-0
   Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2
   Leontieva OV, 2014, P NATL ACAD SCI USA, V111, P8832, DOI 10.1073/pnas.1405723111
   Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197
   Martins F, 2020, AGING CELL, V19, DOI 10.1111/acel.13143
   Matjusaitis M, 2016, AGEING RES REV, V29, P1, DOI 10.1016/j.arr.2016.05.003
   MITSUI Y, 1976, EXP CELL RES, V100, P147, DOI 10.1016/0014-4827(76)90336-0
   Moreno-Blas D, 2019, AGING-US, V11, P6175, DOI 10.18632/aging.102181
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nelson DM, 2014, AGE, V36, P1049, DOI 10.1007/s11357-014-9637-0
   Neri Francesco, 2021, Curr Protoc, V1, pe32, DOI 10.1002/cpz1.32
   Ogrodnik M, 2021, AGING CELL, V20, DOI 10.1111/acel.13338
   Pathak RU, 2021, AGEING RES REV, V67, DOI 10.1016/j.arr.2021.101264
   Petr MA, 2020, TRENDS CELL BIOL, V30, P117, DOI 10.1016/j.tcb.2019.12.001
   Ronneberger O., 2015, MED IMAGE COMPUTIN 3, P234, DOI 10.1007/978-3-319-24574-4_28
   Schafer MJ, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133668
   Tomita H, 2021, CANCERS, V13, DOI 10.3390/cancers13040600
   von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034
   Wang BS, 2021, NATURE AGING, V1, P962, DOI 10.1038/s43587-021-00107-6
   Wang BS, 2020, AGING CELL, V19, DOI 10.1111/acel.13106
   Wang BS, 2020, TRENDS CANCER, V6, P838, DOI 10.1016/j.trecan.2020.05.004
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wen YM, 2018, Arxiv, DOI [arXiv:1803.04386, 10.48550/arXiv.1803.04386, DOI 10.48550/ARXIV.1803.04386]
   Xu M, 2017, J GERONTOL A-BIOL, V72, P780, DOI 10.1093/gerona/glw154
   Yamazaki Y, 2016, STROKE, V47, P1068, DOI 10.1161/STROKEAHA.115.010835
   Young Andrew R J, 2013, Methods Mol Biol, V965, P1, DOI 10.1007/978-1-62703-239-1_1
   Zhao Hong, 2013, Methods Mol Biol, V965, P83, DOI 10.1007/978-1-62703-239-1_5
NR 57
TC 28
Z9 30
U1 1
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD AUG
PY 2022
VL 2
IS 8
BP 742
EP +
DI 10.1038/s43587-022-00263-3
PG 25
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA 7D1HX
UT WOS:000900251600011
PM 37118134
OA Green Published, hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Gerovska, D
   Garcia-Gallastegi, P
   Crende, O
   Márquez, J
   Larrinaga, G
   Unzurrunzaga, M
   Araúzo-Bravo, MJ
   Badiola, I
AF Gerovska, Daniela
   Garcia-Gallastegi, Patricia
   Crende, Olatz
   Marquez, Joana
   Larrinaga, Gorka
   Unzurrunzaga, Maite
   Arauzo-Bravo, Marcos J.
   Badiola, Iker
TI GeromiRs Are Downregulated in the Tumor Microenvironment during Colon
   Cancer Colonization of the Liver in a Murine Metastasis Model
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE colorectal cancer; liver metastasis; miRNA; tumor microenvironment;
   geromiRs; histone modifications
ID MICRORNAS; CELLS; CARCINOGENESIS; CONTRIBUTES; ACTIVATION; SENESCENCE;
   MIRNAS
AB Cancer is a phenomenon broadly related to ageing in various ways such as cell cycle deregulation, metabolic defects or telomerases dysfunction as principal processes. Although the tumor cell is the main actor in cancer progression, it is not the only element of the disease. Cells and the matrix surrounding the tumor, called the tumor microenvironment (TME), play key roles in cancer progression. Phenotypic changes of the TME are indispensable for disease progression and a few of these transformations are produced by epigenetic changes including miRNA dysregulation. In this study, we found that a specific group of miRNAs in the liver TME produced by colon cancer called geromiRs, which are miRNAs related to the ageing process, are significantly downregulated. The three principal cell types involved in the liver TME, namely, liver sinusoidal endothelial cells, hepatic stellate (Ito) cells and Kupffer cells, were isolated from a murine hepatic metastasis model, and the miRNA and gene expression profiles were studied. From the 115 geromiRs and their associated hallmarks of aging, which we compiled from the literature, 75 were represented in the used microarrays, 26 out of them were downregulated in the TME cells during colon cancer colonization of the liver, and none of them were upregulated. The histone modification hallmark of the downregulated geromiRs is significantly enriched with the geromiRs miR-15a, miR-16, miR-26a, miR-29a, miR-29b and miR-29c. We built a network of all of the geromiRs downregulated in the TME cells and their gene targets from the MirTarBase database, and we analyzed the expression of these geromiR gene targets in the TME. We found that Cercam and Spsb4, identified as prognostic markers in a few cancer types, are associated with downregulated geromiRs and are upregulated in the TME cells.
C1 [Gerovska, Daniela; Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Computat Biol & Syst Biomed Grp, C Doctor Beguiristain S-N, San Sebastian 20014, Spain.
   [Gerovska, Daniela; Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Computat Biomed Data Anal Platform, C Doctor Beguiristain S-N, San Sebastian 20014, Spain.
   [Garcia-Gallastegi, Patricia; Crende, Olatz; Marquez, Joana; Badiola, Iker] Univ Basque Country UPV EHU, Fac Med & Nursing, Dept Cell Biol & Histol, Leioa 48940, Spain.
   [Larrinaga, Gorka] Univ Basque Country UPV EHU, Fac Med & Nursing, Dept Nursing 1, Leioa 48940, Spain.
   [Larrinaga, Gorka] Univ Basque Country UPV EHU, Fac Med & Nursing, Dept Physiol, Leioa 48940, Spain.
   [Larrinaga, Gorka] BioCruces Hlth Res Inst, Baracaldo 48903, Spain.
   [Unzurrunzaga, Maite] Ctr Salud Legazpi OSI Goierri Urola Garaia Osakid, Legazpia 20230, Spain.
   [Arauzo-Bravo, Marcos J.] Basque Fdn Sci, IKERBASQUE, C Maria Diaz Harokoa 3, Bilbao 48013, Spain.
   [Arauzo-Bravo, Marcos J.] CIBER Frailty & Hlth Aging CIBERfes, Madrid 28029, Spain.
   [Arauzo-Bravo, Marcos J.] Barcelona Supercomp Ctr, TransBioNet Themat Network Excellence Transit Bio, Barcelona 08034, Spain.
   [Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Computat Biol & Bioinformat Grp, Rontgenstr 20, D-48149 Munster, Germany.
   [Badiola, Iker] Nanokide Therapeut SL, B Sarriena Sn, Leioa 48940, Spain.
C3 Instituto de Investigacion Sanitaria Biodonostia; Instituto de
   Investigacion Sanitaria Biodonostia; University of Basque Country;
   University of Basque Country; University of Basque Country; Basque
   Foundation for Science; CIBER - Centro de Investigacion Biomedica en
   Red; CIBERFES; Universitat Politecnica de Catalunya; Barcelona
   Supercomputer Center (BSC-CNS); Max Planck Society
RP Araúzo-Bravo, MJ (corresponding author), Biodonostia Hlth Res Inst, Computat Biol & Syst Biomed Grp, C Doctor Beguiristain S-N, San Sebastian 20014, Spain.; Araúzo-Bravo, MJ (corresponding author), Biodonostia Hlth Res Inst, Computat Biomed Data Anal Platform, C Doctor Beguiristain S-N, San Sebastian 20014, Spain.; Badiola, I (corresponding author), Univ Basque Country UPV EHU, Fac Med & Nursing, Dept Cell Biol & Histol, Leioa 48940, Spain.; Araúzo-Bravo, MJ (corresponding author), Basque Fdn Sci, IKERBASQUE, C Maria Diaz Harokoa 3, Bilbao 48013, Spain.; Araúzo-Bravo, MJ (corresponding author), CIBER Frailty & Hlth Aging CIBERfes, Madrid 28029, Spain.; Araúzo-Bravo, MJ (corresponding author), Barcelona Supercomp Ctr, TransBioNet Themat Network Excellence Transit Bio, Barcelona 08034, Spain.; Araúzo-Bravo, MJ (corresponding author), Max Planck Inst Mol Biomed, Computat Biol & Bioinformat Grp, Rontgenstr 20, D-48149 Munster, Germany.; Badiola, I (corresponding author), Nanokide Therapeut SL, B Sarriena Sn, Leioa 48940, Spain.
EM daniela.gerovska@biodonostia.org; patricia.garcia@ehu.eus;
   olatz.crende@ehu.eus; joana.marquez@ehu.eus; gorka.larrinaga@ehu.eus;
   maite.unzurrunzagaaltube@osakidetza.eus; mararabra@yahoo.co.uk;
   iker.badiola@ehu.eus
RI Gerovska, Daniela/ABD-3615-2020; Marcos, Arauzo-Bravo/A-1706-2011
OI Gerovska, Daniela/0000-0003-0671-4277; Marcos,
   Arauzo-Bravo/0000-0002-3264-464X; BADIOLA, IKER/0000-0003-2392-2537;
   MARQUEZ CLAVIJO, JOANA/0000-0002-6429-615X; GARCIA GALLASTEGI,
   PATRICIA/0000-0002-5140-3390; CRENDE ARRUABARRENA,
   OLATZ/0000-0002-3245-9575
FU Instituto de Salud Carlos III [AC17/00012]; Diputacion Foral de
   Gipuzkoa; Department of Economic Development and Infrastructures of the
   Basque Government [DFG109/20]; Department of Economic Development and
   Infrastructures of the Basque Government (DFG109/Grants Health
   Department of the Basque Government (Spain)) [2020333039, 2020333001.
   20]; European Union project (ERA-Net program EracoSysMed) [JTC-2 2017];
   European Union project (H2020FETOPEN, Circular Vision) [899417]
FX This work was supported by grants from Instituto de Salud Carlos III
   (AC17/00012), cofounded by the European Union projects (European
   Regional Development Fund/European Science Foundation, Investing in your
   future), (ERA-Net program EracoSysMed, JTC-2 2017) and (H2020FETOPEN,
   Circular Vision, Project 899417); Diputacion Foral de Gipuzkoa and the
   Department of Economic Development and Infrastructures of the Basque
   Government (DFG109/20) and the Department of Economic Development and
   Infrastructures of the Basque Government (DFG109/Grants Health
   Department of the Basque Government (Spain), RIS3 call, Exp. No.
   2020333039 and 2020333001. 20).
CR Acunzo Mario, 2015, Adv Biol Regul, V57, P1, DOI 10.1016/j.jbior.2014.09.013
   Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167
   Akhtar M, 2019, ADV ANAT PATHOL, V26, P69, DOI 10.1097/PAP.0000000000000219
   ALPINI G, 1994, HEPATOLOGY, V20, P494, DOI 10.1002/hep.1840200231
   American Cancer Society, 2021, KEY STAT CERV CANC
   Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69
   Bauer KM, 2012, J PROTEOME RES, V11, P4744, DOI 10.1021/pr300600r
   Bayraktar R, 2017, MOL ONCOL, V11, P1673, DOI 10.1002/1878-0261.12144
   Bourassa MW, 2014, NEUROCHEM INT, V77, P33, DOI 10.1016/j.neuint.2014.03.012
   Caravia XM, 2017, MECH AGEING DEV, V168, P10, DOI 10.1016/j.mad.2017.05.003
   Caravia XM, 2015, ADV EXP MED BIOL, V887, P213, DOI 10.1007/978-3-319-22380-3_11
   Chang L, 2020, NUCLEIC ACIDS RES, V48, pW244, DOI 10.1093/nar/gkaa467
   Charpin C, 1997, J PATHOL, V181, P294
   Chen J, 2016, TUMOR BIOL, V37, P7095, DOI 10.1007/s13277-016-5017-y
   Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840
   Fibbi G, 2001, GROWTH FACTORS, V19, P87, DOI 10.3109/08977190109001078
   Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000
   Gerovska D, 2020, CANCERS, V12, DOI 10.3390/cancers12092380
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He ZJ, 2018, BIOCHEM BIOPH RES CO, V504, P820, DOI 10.1016/j.bbrc.2018.09.059
   Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032
   Hu YB, 2018, CELL PHYSIOL BIOCHEM, V51, P2111, DOI 10.1159/000495829
   Hu Y, 2019, FASEB J, V33, P2314, DOI 10.1096/fj.201801390R
   Huang TH, 2020, ONCOL REP, V43, P1906, DOI 10.3892/or.2020.7547
   Jiang M, 2020, AGING-US, V12, P20835, DOI 10.18632/aging.104102
   Jin LT, 2018, CANCER BIOL THER, V19, P858, DOI 10.1080/15384047.2018.1456599
   Liu T, 2019, J CELL PHYSIOL, V234, P5496, DOI 10.1002/jcp.27342
   Liu XM, 2019, GLIA, V67, P101, DOI 10.1002/glia.23530
   Liu ZL, 2013, MOL CELL BIOCHEM, V372, P35, DOI 10.1007/s11010-012-1443-3
   Liu ZJ, 2018, ONCOL LETT, V16, P6598, DOI 10.3892/ol.2018.9415
   Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x
   Long LM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-275
   Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P1347, DOI 10.3390/ijms13021347
   Ma LC, 2019, CANCER CELL, V36, P418, DOI 10.1016/j.ccell.2019.08.007
   Marquez J, 2018, INT J CANCER, V143, P709, DOI 10.1002/ijc.31343
   MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722
   Papadimitriou MNB, 1999, CLIN EXP METASTAS, V17, P669, DOI 10.1023/A:1006747106885
   Putteeraj M, 2017, CNS NEUROL DISORD-DR, V16, P1000, DOI 10.2174/1871527316666170807142311
   Saliminejad K, 2019, J CELL PHYSIOL, V234, P5451, DOI 10.1002/jcp.27486
   Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632
   Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518
   Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5
   Shinjo K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233782
   Simanovich E, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01931
   Su YH, 2016, ONCOTARGET, V7, P33246, DOI 10.18632/oncotarget.8910
   Sun X, 2014, MOL CELL BIOCHEM, V388, P11, DOI 10.1007/s11010-013-1895-0
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Ugalde A.P., 2014, EMERGENCE GEROMIRS G
   Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507
   Valcárcell M, 2014, J INVEST DERMATOL, V134, P470, DOI 10.1038/jid.2013.342
   Wang Lijun, 2020, Liver Res, V4, P74, DOI 10.1016/j.livres.2020.06.001
   Wang SM, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.553714
   Wei R., 2020, FRONT GENET, V1-1, P17
   Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065
   Wojciechowska A, 2017, ADV CLIN EXP MED, V26, P865, DOI 10.17219/acem/62915
   Wright WE, 1996, DEV GENET, V18, P173
   Xia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047863
   Xu KW, 2014, ONCOTARGETS THER, V7, DOI 10.2147/OTT.S59364
   Yin HL, 2020, THERANOSTICS, V10, P8494, DOI 10.7150/thno.44849
   Zhang ZC, 2014, MOL CANCER THER, V13, P1942, DOI 10.1158/1535-7163.MCT-13-1000
   Zhao HJ, 2014, THERANOSTICS, V4, P1193, DOI 10.7150/thno.8712
   Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131
NR 66
TC 4
Z9 5
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2021
VL 22
IS 9
AR 4819
DI 10.3390/ijms22094819
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA SC0RX
UT WOS:000650391100001
PM 34062897
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sodhi, K
   Nichols, A
   Mallick, A
   Klug, RL
   Liu, J
   Wang, XL
   Srikanthan, K
   Goguet-Rubio, P
   Nawab, A
   Pratt, R
   Lilly, MN
   Sanabria, JR
   Xie, ZJ
   Abraham, NG
   Shapiro, JI
AF Sodhi, Komal
   Nichols, Alexandra
   Mallick, Amrita
   Klug, Rebecca L.
   Liu, Jiang
   Wang, Xiaoliang
   Srikanthan, Krithika
   Goguet-Rubio, Perrine
   Nawab, Athar
   Pratt, Rebecca
   Lilly, Megan N.
   Sanabria, Juan R.
   Xie, Zijian
   Abraham, Nader G.
   Shapiro, Joseph, I
TI RETRACTED: The Na/K-ATPase Oxidant Amplification Loop Regulates Aging
   (Retracted article. See vol. 12, 2022)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID HIGH-FAT DIET; CELLULAR SENESCENCE; OXIDATIVE STRESS; DNA-DAMAGE;
   PREMATURE SENESCENCE; HEPATIC INFLAMMATION; SIGNAL-TRANSDUCTION; DERMAL
   FIBROBLASTS; HYDROGEN-PEROXIDE; GENE-EXPRESSION
AB As aging involves oxidant injury, we examined the role of the recently described Na/K-ATPase oxidant amplification loop (NKAL). First, C57B16 old mice were given a western diet to stimulate oxidant injury or pNaKtide to antagonize the NKAL. The western diet accelerated functional and morphological evidence for aging whereas pNaKtide attenuated these changes. Next, human dermal fibroblasts (HDFs) were exposed to different types of oxidant stress in vitro each of which increased expression of senescence markers, cell-injury, and apoptosis as well as stimulated the NKAL. Further stimulation of the NKAL with ouabain augmented cellular senescence whereas treatment with pNaKtide attenuated it. Although N-Acetyl Cysteine and Vitamin E also ameliorated overall oxidant stress to a similar degree as pNaKtide, the pNaKtide produced protection against senescence that was substantially greater than that seen with either antioxidant. In particular, pNaKtide appeared to specifically ameliorate nuclear oxidant stress to a greater degree. These data demonstrate that the NKAL is intimately involved in the aging process and may serve as a target for anti-aging interventions.
C1 [Sodhi, Komal; Nichols, Alexandra; Mallick, Amrita; Klug, Rebecca L.; Liu, Jiang; Wang, Xiaoliang; Srikanthan, Krithika; Goguet-Rubio, Perrine; Nawab, Athar; Pratt, Rebecca; Lilly, Megan N.; Sanabria, Juan R.; Xie, Zijian; Abraham, Nader G.; Shapiro, Joseph, I] Marshall Univ, Joan C Edwards Sch Med, Dept Med, Huntington, WV 25755 USA.
   [Sodhi, Komal; Nichols, Alexandra; Mallick, Amrita; Klug, Rebecca L.; Liu, Jiang; Wang, Xiaoliang; Srikanthan, Krithika; Goguet-Rubio, Perrine; Nawab, Athar; Pratt, Rebecca; Lilly, Megan N.; Sanabria, Juan R.; Xie, Zijian; Abraham, Nader G.; Shapiro, Joseph, I] Marshall Univ, Joan C Edwards Sch Med, Dept Surg, Huntington, WV 25755 USA.
   [Sodhi, Komal; Nichols, Alexandra; Mallick, Amrita; Klug, Rebecca L.; Liu, Jiang; Wang, Xiaoliang; Srikanthan, Krithika; Goguet-Rubio, Perrine; Nawab, Athar; Pratt, Rebecca; Lilly, Megan N.; Sanabria, Juan R.; Xie, Zijian; Abraham, Nader G.; Shapiro, Joseph, I] Marshall Univ, Joan C Edwards Sch Med, Dept Biomed Sci, Huntington, WV 25755 USA.
   [Abraham, Nader G.] New York Med Coll, Dept Med & Pharmacol, Valhalla, NY 10595 USA.
C3 Marshall University; Marshall University; Marshall University; New York
   Medical College
RP Shapiro, JI (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Med, Huntington, WV 25755 USA.; Shapiro, JI (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Surg, Huntington, WV 25755 USA.; Shapiro, JI (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Biomed Sci, Huntington, WV 25755 USA.
EM shapiroj@marshall.edu
RI WANG, XIAOLIANG/AAO-4274-2021
OI Liu, Jiang/0000-0002-0654-707X
FU National Institutes of Health [HL109015, HL071556, HL105649, HL55601,
   DK106666-01, HL34300]; Brickstreet Foundation; Huntington Foundation,
   Inc.
FX This work was supported by National Institutes of Health Grants HL109015
   (to J.I.S. and Z.X.), HL071556 and HL105649 (to J.I.S.), HL55601,
   DK106666-01 (J.L.), and HL34300 (to N.G.A.), by the Brickstreet
   Foundation (to J.I.S. and N.G.A.) and by the Huntington Foundation, Inc.
   We acknowledged David Neff from the Molecular and Biological Imaging
   Center, at Marshall University, for his contribution to the confocal
   imaging. We also acknowledged Jung Han Kim from Department of Biomedical
   Sciences, for her contribution in the measurement of oxygen consumption
   and energy expenditure in the mice.
CR Abdollahi M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/876834
   Al-Zuhir N, 2012, EUR J VASC ENDOVASC, V43, P662, DOI 10.1016/j.ejvs.2012.02.031
   Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Baylin SB, 1998, ADV CANCER RES, V72, P141
   Bennett MR, 2001, CIRC RES, V88, P648, DOI 10.1161/hh0701.089955
   Bruey JM, 2010, LEUKEMIA RES, V34, P1320, DOI 10.1016/j.leukres.2010.03.010
   Butt H, 2017, LIFE SCI, V184, P1, DOI 10.1016/j.lfs.2017.07.002
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cerella C, 2016, CURR DRUG TARGETS, V17, P405, DOI 10.2174/1389450116666150202155915
   Chen HP, 2013, METHODS MOL BIOL, V1048, P1, DOI 10.1007/978-1-62703-556-9_1
   Chen J, 2006, J GERONTOL A-BIOL, V61, P20, DOI 10.1093/gerona/61.1.20
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Chen QM, 2000, ANN NY ACAD SCI, V908, P111
   Das A, 2018, CELL, V173, P74, DOI 10.1016/j.cell.2018.02.008
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Davidovic M, 1999, MED HYPOTHESES, V53, P329, DOI 10.1054/mehy.1998.0767
   Dial L, 2014, CURR CLIN PHARMACOL, V9, P298, DOI 10.2174/1574884708666131111204031
   Foyouzi N, 2004, FERTIL STERIL, V82, P1019, DOI 10.1016/j.fertnstert.2004.02.133
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259
   Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200
   Haller ST, 2012, AM J HYPERTENS, V25, P690, DOI 10.1038/ajh.2012.17
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hemnani T, 1998, Indian J Physiol Pharmacol, V42, P440
   Hollingworth R, 2017, J VIROL, V91, DOI 10.1128/JVI.00930-17
   Jena NR, 2012, J BIOSCIENCES, V37, P503, DOI 10.1007/s12038-012-9218-2
   Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008
   Jun JI, 2017, J CELL COMMUN SIGNAL, V11, P15, DOI 10.1007/s12079-016-0359-1
   Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007
   Kim H, 2009, TOXICOL LETT, V184, P13, DOI 10.1016/j.toxlet.2008.10.006
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   KUMAZAKI T, 1991, EXP CELL RES, V195, P13, DOI 10.1016/0014-4827(91)90494-F
   Kuo LJ, 2008, IN VIVO, V22, P305
   Kyrylkova Kateryna, 2012, Methods Mol Biol, V887, P41, DOI 10.1007/978-1-61779-860-3_5
   La Fata G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/563247
   Lai FF, 2013, J BIOL CHEM, V288, P13295, DOI 10.1074/jbc.M113.467381
   Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507
   Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597
   Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Liu DP, 2011, ANTIOXID REDOX SIGN, V15, P1669, DOI 10.1089/ars.2010.3644
   Liu J, 2002, KIDNEY INT, V62, P2118, DOI 10.1046/j.1523-1755.2002.00672.x
   Liu J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6010018
   Liu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34592
   Liu J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/381320
   Loo AEK, 2012, BIOCHEM BIOPH RES CO, V423, P253, DOI 10.1016/j.bbrc.2012.05.100
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu H, 2017, INT J MOL MED, V39, P208, DOI 10.3892/ijmm.2016.2806
   Marthandan S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0035-y
   Matos L, 2012, AGE, V34, P783, DOI 10.1007/s11357-011-9276-7
   Nguyen ANT, 2011, AM J PHYSIOL-RENAL, V301, pF897, DOI 10.1152/ajprenal.00095.2011
   Petropoulou C, 2001, FEBS LETT, V509, P287, DOI 10.1016/S0014-5793(01)03150-7
   Quan CJ, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0167-6
   Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Sebastián C, 2009, J IMMUNOL, V183, P2356, DOI 10.4049/jimmunol.0901131
   Shibutani M, 2000, LAB INVEST, V80, P199, DOI 10.1038/labinvest.3780023
   Singh SP, 2016, PROSTAG OTH LIPID M, V125, P8, DOI 10.1016/j.prostaglandins.2016.07.004
   Sodhi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00306-5
   Sodhi K, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500781
   Soto-Gamez A, 2017, DRUG DISCOV TODAY, V22, P786, DOI 10.1016/j.drudis.2017.01.004
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738
   van Raalte Heather, 2015, Open J Obstet Gynecol, V5, P505
   VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703
   Wang JS, 2016, MOL MED REP, V14, P4063, DOI 10.3892/mmr.2016.5743
   Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363
   Würstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013
   Yan YL, 2013, J BIOL CHEM, V288, P34249, DOI 10.1074/jbc.M113.461020
   Yan YL, 2012, MOL CELL BIOCHEM, V367, P175, DOI 10.1007/s11010-012-1331-x
   Yao HW, 2012, AM J PHYSIOL-LUNG C, V303, pL557, DOI 10.1152/ajplung.00175.2012
   Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005
   Zeng JP, 2014, J DERMATOL SCI, V73, P49, DOI 10.1016/j.jdermsci.2013.08.013
   Zheng JZ, 2010, J NEUROSCI RES, V88, P3376, DOI 10.1002/jnr.22488
NR 78
TC 27
Z9 31
U1 0
U2 5
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 26
PY 2018
VL 8
AR 9721
DI 10.1038/s41598-018-26768-9
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GK5RM
UT WOS:000436234300003
PM 29946187
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kawabata, T
   Kinoshita, M
   Inatsu, A
   Habu, Y
   Nakashima, H
   Shinomiya, N
   Seki, S
AF Kawabata, Toshinobu
   Kinoshita, Manabu
   Inatsu, Akihito
   Habu, Yoshiko
   Nakashima, Hiroyuki
   Shinomiya, Nariyoshi
   Seki, Shuhji
TI Functional Alterations of Liver Innate Immunity of Mice with Aging in
   Response to CpG-Oligodeoxynucleotide
SO HEPATOLOGY
LA English
DT Article
ID LIGAND-MEDIATED FUNCTION; NECROSIS-FACTOR-ALPHA; BETA T-CELLS;
   BACTERIAL-DNA; IN-VITRO; SHWARTZMAN REACTION; INTERFERON-GAMMA; SEPTIC
   SHOCK; AGED MICE; NK CELLS
AB Immune functions of liver natural killer T (NKT) cells induced by the synthetic ligand a-galactosylceramide enhanced age-dependently; hepatic injury and multiorgan dysfunction syndrome (MODS) induced by ligand-activated NKT cells were also enhanced. This study investigated how aging affects liver innate immunity after common bacteria DNA stimulation. Young (6 weeks) and old (50-60 weeks) C57BL/6 mice were injected with CpG oligodeoxynucleotides (CpG-ODN), and the functions of liver leukocytes were assessed. A CpG-ODN injection into the old mice remarkably increased tumor necrosis factor (TNF) production in Kupffer cells, and MODS and lethal shock were induced, both of which are rarely seen in young mice. Old Kupffer cells showed increased Toll-like receptor-9 expression, and CpG-ODN challenge augmented TNF receptor and Fas-L expression in liver NKT cells. Experiments using mice depleted of natural killer (NK) cells by anti-asialoGM1 antibody (Ab), perforin knockout mice, and mice pretreated with neutralizing interferon (IFN)-gamma Ab demonstrated the important role of liver NK cells in antitumor immunity. The production capacities of old mice for IFN-gamma, IFN-alpha, and perforin were much lower than those of young mice, and the CpG-induced antitumor cytotoxicity of liver NK cells lessened. Lethal shock and MODS greatly decreased in old mice depleted/deficient in TNF, FasL, or NKT cells. However, depletion of NK cells also decreased serum TNF levels and FasL expression of NKT cells, which resulted in improved hepatic injury and survival, suggesting that NK cells are indirectly involved in MODS/lethal shock induced by NKT cells. Neutralization of TNF did not reduce the CpG-induced antitumor effect in the liver. Conclusion: Hepatic injury and MODS mediated by NKT cells via the TNF and FasL-mediated pathway after CpG injection increased, but the antitumor activity of liver NK cells decreased with aging. (HEPATOLOGY 2008;48:1586-1597.)
C1 [Kawabata, Toshinobu; Kinoshita, Manabu; Habu, Yoshiko; Nakashima, Hiroyuki; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 3598513, Japan.
   [Inatsu, Akihito] Natl Def Med Coll, Dept Lab Med, Tokorozawa, Saitama 3598513, Japan.
   [Shinomiya, Nariyoshi] Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, Tokorozawa, Saitama 3598513, Japan.
C3 National Defense Medical College - Japan; National Defense Medical
   College - Japan; National Defense Medical College - Japan
RP Seki, S (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
EM btraums@ndmc.ac.jp
RI Shinomiya, Nariyoshi/I-9666-2014
OI Nakashima, Hiroyuki/0000-0001-6066-3031
FU National Defense Medical College
FX Supported in part by a grant-in-aid for Special Research Program (Host
   Stress Responses to Internal and External Factors) from the National
   Defense Medical College (to N.S. and S.S.).
CR Ballas ZK, 1996, J IMMUNOL, V157, P1840
   Cowdery J, 1996, J IMMUNOL, V156, P4570
   Elkins KL, 1999, J IMMUNOL, V162, P2291
   FUJIO H, 1995, MECH AGEING DEV, V81, P97, DOI 10.1016/0047-6374(95)01588-Q
   Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461
   Habu Y, 2004, IMMUNOLOGY, V113, P35, DOI 10.1111/j.1365-2567.2004.01932.x
   Hafner M, 2001, CANCER RES, V61, P5523
   Halpern MD, 1996, CELL IMMUNOL, V167, P72, DOI 10.1006/cimm.1996.0009
   HASHIMOTO W, 1995, J IMMUNOL, V154, P4333
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Heumann Didier, 1995, Journal of Inflammation, V47, P173
   Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027
   Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127
   Ishii KJ, 2003, CLIN CANCER RES, V9, P6516
   Kaser A, 1999, CLIN EXP IMMUNOL, V118, P71
   Kinoshita M, 2005, SHOCK, V23, P65, DOI 10.1097/01.shk.0000144423.40270.96
   KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0
   Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   Lu F, 2001, CELL RES, V11, P217, DOI 10.1038/sj.cr.7290089
   Mason KA, 2005, CLIN CANCER RES, V11, P361
   Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2
   MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221
   Motegi A, 2006, J LEUKOCYTE BIOL, V79, P463, DOI 10.1189/jlb.0705396
   Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578
   Nakashima H, 2006, GASTROENTEROLOGY, V131, P1573, DOI 10.1053/j.gastro.2006.08.028
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Razin A, 1981, Prog Nucleic Acid Res Mol Biol, V25, P33, DOI 10.1016/S0079-6603(08)60482-1
   Roman M, 1997, NAT MED, V3, P849, DOI 10.1038/nm0897-849
   Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777
   Sato K, 2005, EUR J IMMUNOL, V35, P593, DOI 10.1002/eji.200425520
   Schlosser SF, 2000, HEPATOLOGY, V32, P779, DOI 10.1053/jhep.2000.18422
   Seki S, 1997, IMMUNOLOGY, V92, P561, DOI 10.1046/j.1365-2567.1997.00383.x
   Seki S, 1998, INFECT IMMUN, V66, P5286, DOI 10.1128/IAI.66.11.5286-5294.1998
   Sparwasser T, 1997, NATURE, V386, P336, DOI 10.1038/386336a0
   Takeda K, 1996, J IMMUNOL, V156, P3366
   TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O
   TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0
   Yamamoto K, 2002, AM J PATHOL, V161, P1805, DOI 10.1016/S0002-9440(10)64457-4
   Zimmermann S, 1998, J IMMUNOL, V160, P3627
NR 40
TC 35
Z9 37
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD NOV
PY 2008
VL 48
IS 5
BP 1586
EP 1597
DI 10.1002/hep.22489
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 368BP
UT WOS:000260596600028
PM 18925636
OA Bronze
DA 2024-02-19
ER

PT J
AU Yasui, F
   Ishibashi, M
   Matsugo, S
   Kojo, S
   Oomura, Y
   Sasaki, K
AF Yasui, F
   Ishibashi, M
   Matsugo, S
   Kojo, S
   Oomura, Y
   Sasaki, K
TI Brain lipid hydroperoxide level increases in senescence-accelerated mice
   at an early age
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE aging; senescence-accelerated mice; oxidative stress; lipid
   hydroperoxide level; brain; liver
ID ALZHEIMERS-DISEASE; OXIDATIVE STRESS; MOUSE SAM; PROTEIN; DNA;
   PARKINSONS; DAMAGE; MEMORY; MODEL
AB We previously reported that the levels of lipid hydroperoxides, one of oxidative stress markers, in the brain and peripheral organs such as liver, heart, and lung are significantly higher in senescence accelerated-prone 8 mice (SAMP8) than in their controls, senescence accelerated-resistant mice (SAMR1), at 3, 6, and/or 9 months of age. To ascertain the exact age at which the lipid hydroperoxide levels increase in SAMP8, we measured them in the brain and liver of SAMP8 and SAMR1 at both 1 and 2 months of age. At 1 month of age, there was no significant inter-strain difference in the levels in brain or liver. However, in SAMP8 both levels were significantly greater at 2 months of age than at I month of age, but no such difference was detected for SAMR1. The present results suggest that SAMP8 are exposed to elevated levels of oxidative stress from an early age (2 months old), and that this may be a cause of the senescence-related impairments and degeneration in the brain and peripheral tissues (such as liver, heart, and lung) seen in this strain. (C) 2003 Published by Elsevier Ireland Ltd.
C1 Toyama Univ, Fac Engn, Div Bioinformat Engn, Toyama 9308555, Japan.
   Yamanashi Univ, Interdisciplinary Grad Sch Med & Engn, Div Biotechnol, Kofu, Yamanashi 4008511, Japan.
   Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308263, Japan.
   Kyushu Univ, Fac Med, Dept Physiol, Fukuoka 8128582, Japan.
C3 University of Toyama; University of Yamanashi; Nara Womens University;
   Kyushu University
RP Sasaki, K (corresponding author), Toyama Univ, Fac Engn, Div Bioinformat Engn, 3190 Gofuku, Toyama 9308555, Japan.
RI Kojo, Shosuke/GNP-0971-2022
CR Alam ZI, 1997, J NEUROCHEM, V69, P1326
   Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2
   Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x
   Fujibayashi Y, 1998, NEUROSCI LETT, V254, P109, DOI 10.1016/S0304-3940(98)00667-3
   HALLIWELL B, 1992, FREE RADICAL RES COM, V16, P75, DOI 10.3109/10715769209049161
   Korolainen MA, 2002, ELECTROPHORESIS, V23, P3428, DOI 10.1002/1522-2683(200210)23:19<3428::AID-ELPS3428>3.0.CO;2-5
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Lyras L, 1998, J NEUROCHEM, V71, P302
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   Minamoto H, 2001, COGNITIVE BRAIN RES, V11, P23, DOI 10.1016/S0926-6410(00)00060-4
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P48
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   PALMER AM, 1994, BRAIN RES, V645, P338, DOI 10.1016/0006-8993(94)91670-5
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Yasui F, 2002, NEUROSCI LETT, V334, P177, DOI 10.1016/S0304-3940(02)01127-8
NR 15
TC 46
Z9 53
U1 0
U2 6
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD OCT 16
PY 2003
VL 350
IS 1
BP 66
EP 68
DI 10.1016/S0304-3940(03)00827-9
PG 3
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 720ZU
UT WOS:000185293200016
PM 12962918
DA 2024-02-19
ER

PT J
AU Bochkis, IM
   Shin, S
   Kaestner, KH
AF Bochkis, Irina Mikhailovna
   Shin, Soona
   Kaestner, Klaus Hermann
TI Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the
   liver leads to activation of mTOR and age-onset obesity
SO MOLECULAR METABOLISM
LA English
DT Article
DE Bile acids; Aging; Winged helix transcription factors; mTOR pathway;
   Hepatic lip genesis; Foxa proteins
ID NF-KAPPA-B; GROWTH-HORMONE; X-RECEPTOR; TRANSCRIPTIONAL RESPONSE;
   MAMMALIAN TARGET; BODY GROWTH; PATHWAY; HEPATOCYTE; GLUCOSE; STAT5B
AB Cytokine signaling has been connected to regulation of metabolism and energy balance. Numerous cytokine gene expression changes are stimulated by accumulation of bile acids in livers of young Foxa2 liver-conditional null mice. We hypothesized that bile acid-induced inflammation in young Foxa2 mutants, once chronic, affects metabolic homeostasis. We found that loss of Foxa2 in the liver results in a premature aging phenotype, including significant weight gain, reduced food intake, and decreased energy expenditure. We show that Foxa2 antagonizes the mammalian target of rapamycin (mTOR) pathway, resulting in increased hepatic lipogenesis and adiposity. While much prior work has focused on adipose tissue in obesity, we discovered a novel age-onset obesity phenotype in a model where gene deletion occurs only in the liver, underscoring the importance of the role hepatic lipogenesis plays in the development of obesity. (C) 2013 The Authors. Published by Elsevier GmbH. All rights reserved.
C1 [Kaestner, Klaus Hermann] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; University of Pennsylvania
RP Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.
EM kaestner@mail.med.upenn.edu
RI Shin, Soona/AAV-1049-2021; Bochkis, Irina/AAR-8865-2020
OI Bochkis, Irina/0000-0001-8073-8408; Shin, Soona/0000-0001-5696-9505
FU NIH [DK-P01-049210]
FX We thank M. Wan, K. Leavens, and M. Bimbaum for advice on insulin
   injections and critical reading of the manuscript; J.A. Whittsett
   (Cincinnati Children's Hospital Medical Center and The University of
   Cincinnati College of Medicine) for providing rabbit polyclonal
   antibodies to Foxa2; V. Kameswaran, R. Dhir, J. Millar, and H. Collins
   for contributions to this project. This work was supported by NIH Grant
   DK-P01-049210 to K.H.K. We thank the Mouse Phenotyping, Physiology and
   Metabolism Core and Functional Genomics Core of the Penn Diabetes
   Research Center (P30-DK19525), for experimental assistance.
CR Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026
   Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x
   Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006
   Blaas L, 2010, HEPATOLOGY, V51, P1319, DOI 10.1002/hep.23469
   Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853
   Bochkis IM, 2009, PHYSIOL GENOMICS, V38, P186, DOI 10.1152/physiolgenomics.90376.2008
   Cabana VG, 1996, J LIPID RES, V37, P2662
   Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008
   Chen C, 2010, J CLIN INVEST, V120, P4091, DOI 10.1172/JCI43873
   Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101
   Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489
   Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005
   Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200
   Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x
   Dhir RN, 2003, P NATL ACAD SCI USA, V100, P15224, DOI 10.1073/pnas.2434273100
   Durazzo M, 2009, J GASTROENTEROL, V44, P476, DOI 10.1007/s00535-009-0023-0
   Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453
   Gebert CA, 1999, MOL ENDOCRINOL, V13, P38, DOI 10.1210/me.13.1.38
   Hays NP, 2006, PHYSIOL BEHAV, V88, P257, DOI 10.1016/j.physbeh.2006.05.029
   Honsawek S, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-16
   Hosui A, 2008, PHYSIOL GENOMICS, V34, P135, DOI 10.1152/physiolgenomics.00048.2008
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435
   Hui Alex Y., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005684
   Hwahng SH, 2009, HEPATOLOGY, V49, P1913, DOI 10.1002/hep.22887
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100
   LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006
   Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004
   Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058
   Lee SS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001307
   Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107
   Lichanska AM, 2008, TRENDS GENET, V24, P41, DOI 10.1016/j.tig.2007.10.006
   Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018
   Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604
   Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002
   Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013
   Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026
   Osorio FG, 2012, AGING-US, V4, P726, DOI 10.18632/aging.100502
   Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Rodriguez A, 2007, J CLIN ENDOCR METAB, V92, P3568, DOI 10.1210/jc.2006-2764
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948
   Salman TA, 2010, HEPATOL INT, V4, P767, DOI 10.1007/s12072-010-9216-0
   Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097
   Summers SA, 1999, J BIOL CHEM, V274, P23858, DOI 10.1074/jbc.274.34.23858
   Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887
   Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744
   Tschöp MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]
   Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536
   Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239
   Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008
   Vidarsdottir S, 2006, J CLIN ENDOCR METAB, V91, P3482, DOI 10.1210/jc.2006-0368
   Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025
   Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330
   White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362
   Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222
   Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002
   Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11
   Zollner G, 2005, AM J PHYSIOL-GASTR L, V289, pG798, DOI 10.1152/ajpgi.00319.2004
NR 64
TC 19
Z9 21
U1 1
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-8778
J9 MOL METAB
JI Mol. Metab.
PD NOV
PY 2013
VL 2
IS 4
BP 447
EP 456
DI 10.1016/j.molmet.2013.08.005
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA V42UE
UT WOS:000209637900014
PM 24327960
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Verma, S
   Tachtatzis, P
   Penrhyn-Lowe, S
   Scarpini, C
   Jurk, D
   Von Zglinicki, T
   Coleman, N
   Alexander, GJM
AF Verma, Suman
   Tachtatzis, Phaedra
   Penrhyn-Lowe, Sue
   Scarpini, Cinzia
   Jurk, Diana
   Von Zglinicki, Thomas
   Coleman, Nick
   Alexander, Graeme J. M.
TI Sustained telomere length in hepatocytes and cholangiocytes with
   increasing age in normal liver
SO HEPATOLOGY
LA English
DT Article
ID DOMINO HEPATIC TRANSPLANTATION; EARLY RENAL-FAILURE; PRIMARY
   HYPEROXALURIA; KUPFFER CELLS; HEPATOCELLULAR-CARCINOMA; HUMAN
   FIBROBLASTS; VIRUS-INFECTION; STELLATE CELLS; DISEASE; PATIENT
AB Telomeres, a validated biomarker of aging, comprise multiple nucleotide repeats capping chromosomes that shorten with each cell cycle until a critical length is achieved, precipitating cell senescence. Only two previous studies focused on the effect of aging in normal liver tissue, but these studies were compromised by small sample size, limited age range, tissue derived from individuals with an increased risk of senescence, and the use of liver homogenates. We developed a robust large-volume, four-color quantitative fluorescent in situ hybridization technique to measure telomere length in large numbers of hepatocytes, Kupffer cells, hepatic stellate cells, CD4-positive and CD8-positive lymphocytes, and cholangiocytes. Following validation against the gold standard (Southern blotting), the technique was applied to normal archived paraffin-embedded liver tissue obtained following reperfusion of implanted donor liver. We studied 73 highly selected donors aged 5-79 years with a short medical illness preceding death and no history of liver disease, reperfusion injury, or steatosis and normal graft function 1-year posttransplantation. Cholangiocytes had significantly longer telomeres compared with all other intrahepatic lineages over a wide age range (P < 0.05). Age-related telomere attrition was restricted to sinusoidal cells (i.e., Kupffer cells [P = 0.0054] and stellate cells [P = 0.0001]). Cholangiocytes and hepatocytes showed no age-related telomere shortening. Conclusion: In normal liver and over a broad age range, cholangiocytes have longer telomeres than all other intrahepatic lineages. Age-related telomere length decline is restricted to Kupffer cells and stellate cells. (HEPATOLOGY 2012)
C1 [Verma, Suman; Tachtatzis, Phaedra; Alexander, Graeme J. M.] Cambridge Univ Hosp NHS Fdn Trust, Univ Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England.
   [Penrhyn-Lowe, Sue; Scarpini, Cinzia; Coleman, Nick] Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge, England.
   [Jurk, Diana; Von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 University of Cambridge; Newcastle University - UK
RP Alexander, GJM (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Univ Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England.
EM gja1000@doctors.org.uk
OI von Zglinicki, Thomas/0000-0002-5939-0248; Jurk,
   Diana/0000-0003-4486-0857; Scarpini, Cinzia G./0000-0003-4730-5197
FU Addenbrooke's Hepatology Endowment Fund; Medical Research Council
   [G0900686] Funding Source: researchfish; MRC [G0900686] Funding Source:
   UKRI
FX Supported by Addenbrooke's Hepatology Endowment Fund.
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Aviv A, 2002, HYPERTENSION, V40, P229, DOI 10.1161/01.HYP.0000027280.91984.1B
   Aziz S, 2005, J ULTRAS MED, V24, P1449, DOI 10.7863/jum.2005.24.10.1449
   Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012
   Bastani B, 1999, AM J NEPHROL, V19, P64, DOI 10.1159/000013428
   Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080
   Casas-Melley AT, 2002, PEDIATR TRANSPLANT, V6, P249, DOI 10.1034/j.1399-3046.2002.01083.x
   CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1
   Dhiman RK, 2007, LIVER TRANSPLANT, V13, P814, DOI 10.1002/lt.21050
   Donckier V, 2001, TRANSPLANTATION, V71, P1346, DOI 10.1097/00007890-200105150-00030
   Farese S, 2005, NEPHROL DIAL TRANSPL, V20, P2557, DOI 10.1093/ndt/gfi019
   Ferlicot S, 2003, J PATHOL, V200, P661, DOI 10.1002/path.1392
   FORBES A, 1990, BRIT MED BULL, V46, P303, DOI 10.1093/oxfordjournals.bmb.a072400
   FORBES A, 1988, J ROY COLL PHYS LOND, V22, P237
   Franchello A, 2005, AM J TRANSPLANT, V5, P2324, DOI 10.1111/j.1600-6143.2005.01014.x
   GALE RP, 1978, SCIENCE, V201, P937, DOI 10.1126/science.356266
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   HEIL MF, 1984, MECH AGEING DEV, V26, P327, DOI 10.1016/0047-6374(84)90104-0
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380
   LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7
   Miyata E, 2008, BLOOD, V111, P2427, DOI 10.1182/blood-2007-07-101261
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2004, BIOCHEM BIOPH RES CO, V325, P1131, DOI 10.1016/j.bbrc.2004.10.152
   Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104
   O'Sullivan Jacintha N, 2005, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1206s33
   OGAWA K, 1973, TOHOKU J EXP MED, V111, P253, DOI 10.1620/tjem.111.253
   Popper H, 1986, AGING LIVER
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036
   Saini N, 2009, LIVER INT, V29, P1162, DOI 10.1111/j.1478-3231.2009.02082.x
   Saner FH, 2010, TRANSPLANTATION, V90, P782, DOI 10.1097/TP.0b013e3181eefe1f
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Takeishi T, 1999, ARCH HISTOL CYTOL, V62, P413, DOI 10.1679/aohc.62.413
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614
   von Figura G, 2009, J MOL MED, V87, P1165, DOI 10.1007/s00109-009-0509-5
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Younossi ZM, 2010, CLIN GASTROENTEROL H, V8, P718, DOI 10.1016/j.cgh.2010.04.017
   Zhang Y, 2007, CANCER INVEST, V25, P668, DOI 10.1080/07357900701561024
   Zoll M IT, 1989, GERONTOLOGY, V35, P61
NR 49
TC 49
Z9 60
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2012
VL 56
IS 4
BP 1510
EP 1520
DI 10.1002/hep.25787
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 018PJ
UT WOS:000309673500035
PM 22504828
OA Bronze
DA 2024-02-19
ER

PT J
AU Jia, KX
   Zhang, YH
   Luo, RY
   Liu, RP
   Li, YJ
   Wu, JZ
   Xie, KH
   Liu, J
   Li, S
   Zhou, F
   Li, XJY
AF Jia, Kexin
   Zhang, Yinhao
   Luo, Ranyi
   Liu, Runping
   Li, Yajing
   Wu, Jianzhi
   Xie, Kaihong
   Liu, Jia
   Li, Shuo
   Zhou, Fei
   Li, Xiaojiaoyang
TI Acteoside ameliorates hepatic ischemia-reperfusion injury via reversing
   the senescent fate of liver sinusoidal endothelial cells and restoring
   compromised sinusoidal networks
SO INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE hepatic ischemia-reperfusion injury; liver sinusoidal endothelial cell;
   senescence-associated secretory phenotype; acteoside; high mobility
   group protein 1
ID EXPRESSION; HMGB1
AB Hepatic ischemia-reperfusion injury (HIRI), a common two-phase intersocietal reaction in liver surgery, typically leading to sustained liver dysfunction. During this process, liver sinusoidal endothelial cells (LSECs) are vulnerable to damage and exert senescence-associated secretory phenotype (SASP). However, how these SASP-LSECs secreted damage-associated molecular patterns (DAMPs) to impact the whole HIRI microenvironment and whether it can be reversed by therapeutics remains unknown. Here, we found that either HIRI surgery or hypoxia and reoxygenation (HR) stimulation forced LSECs into SASP and expressed HMGB1-dominated DAMPs, which were dramatically improved by acteoside (ACT). Additionally, hypoxic hepatocytes released excessive HMGB1 to LSECs and synergistically aggravated their SASP state. Mechanistically, HMGB1 bound with TLR3/TLR4 on LSECs, promoted the nuclear translocation of IRF1 and subsequent transcription of cxcl1 and Hmgb1, leading to the chemotaxis of neutrophils and accelerating immune damage in a vicious circle. Notably, ACT or HMGB1 siRNA effectively disrupted HMGB1-TLR3/4 interaction, leading to IRF1 inhibition and repairing LSEC functions, which was largely reversed by HMGB1 stimulation and IRF1-overexpressed liposomes with LSECs-targeted hyaluronic acid-derivative conjugated in mice. Collectively, ACT reversed the senescent fate of LSECs and restored sinusoidal networks by targeting HMGB1-TLR3/4-IRF1 signaling, thus providing protection against HIRI and offering the potential for new therapeutics development.
C1 [Jia, Kexin; Zhang, Yinhao; Luo, Ranyi; Li, Yajing; Wu, Jianzhi; Xie, Kaihong; Liu, Jia; Zhou, Fei; Li, Xiaojiaoyang] Beijing Univ Chinese Med, Sch Life Sci, Beijing 100029, Peoples R China.
   [Liu, Runping; Li, Shuo] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 100029, Peoples R China.
C3 Beijing University of Chinese Medicine; Beijing University of Chinese
   Medicine
RP Li, XJY (corresponding author), Beijing Univ Chinese Med, Sch Life Sci, Beijing 100029, Peoples R China.
EM xiaojiaoyang.li@bucm.edu.cn
OI Li, Xiaojiaoyang/0000-0003-0291-5856
FU National Natural Science Foundation of China [82274186]; National Key
   Research and Development Program on Modernization of Traditional Chinese
   Medicine [2022YFC3502100]; Fundamental Research Funds for the Central
   Universities [2023-JYB-JBZD-046]; National High-Level Talents Special
   Support Program; Standardized study of mouse liver ischemia-reperfusion
   injury model suitable for efficacy evaluation of traditional Chinese
   medicine;  [90011451310048]
FX This work was supported by the National Natural Science Foundation of
   China (Grant NO. 82274186 to XL); National Key Research and Development
   Program on Modernization of Traditional Chinese Medicine (Grant NO.
   2022YFC3502100 to XL); Fundamental Research Funds for the Central
   Universities (Grant NO. 2023-JYB-JBZD-046 to XL); National High-Level
   Talents Special Support Program to XL; Standardized study of mouse liver
   ischemia-reperfusion injury model suitable for efficacy evaluation of
   traditional Chinese medicine (Grant NO. 90011451310048 to JL).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Cannistrà M, 2016, INT J SURG, V33, pS57, DOI 10.1016/j.ijsu.2016.05.050
   Chen CH, 2009, J AGR FOOD CHEM, V57, P8852, DOI 10.1021/jf9028333
   Chen JQ, 2016, CLIN REV ALLERG IMMU, V50, P1, DOI 10.1007/s12016-015-8473-z
   Chen S, 2023, J HEPATOL, V78, P543, DOI 10.1016/j.jhep.2022.10.028
   Chiou WF, 2004, J PHARM PHARMACOL, V56, P743, DOI 10.1211/0022357023501
   Chun SK, 2018, AGING CELL, V17, DOI 10.1111/acel.12761
   Dar WA, 2019, LIVER INT, V39, DOI 10.1111/liv.14091
   Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006
   Gracia-Sancho J, 2021, NAT REV GASTRO HEPAT, V18, P411, DOI 10.1038/s41575-020-00411-3
   Hirao H, 2022, NAT REV GASTRO HEPAT, V19, P239, DOI 10.1038/s41575-021-00549-8
   Hofmann J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093132
   Huang H, 2015, HEPATOLOGY, V62, P600, DOI 10.1002/hep.27841
   Kaltenmeier C, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11142222
   Khullar M, 2019, INT IMMUNOPHARMACOL, V69, P109, DOI 10.1016/j.intimp.2019.01.020
   Lassailly G, 2019, J HEPATOL, V70, P1159, DOI 10.1016/j.jhep.2019.01.019
   Lei J, 2021, AGING-US, V13, P12086, DOI 10.18632/aging.202915
   Li WB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00229
   Li XJY, 2021, ACTA PHARM SIN B, V11, P3527, DOI 10.1016/j.apsb.2021.03.018
   Li  YJ, 2022, ACTA PHARMACOL SIN, V43, P2026, DOI 10.1038/s41401-021-00843-w
   Lu HX, 2019, CYTOKINE GROWTH F R, V47, P74, DOI 10.1016/j.cytogfr.2019.05.009
   Lu TY, 2022, BIOMATERIALS, V284, DOI 10.1016/j.biomaterials.2022.121486
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Miao H, 2022, J NUTR BIOCHEM, V106, DOI 10.1016/j.jnutbio.2022.109020
   Mou JF, 2021, PHYTOTHER RES, V35, P4555, DOI 10.1002/ptr.7159
   Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318
   Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Salvoza N, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23073562
   Seo ES, 2013, MOL CELLS, V35, P348
   Seo YS, 2013, AM J PHYSIOL-GASTR L, V305, pG838, DOI 10.1152/ajpgi.00151.2013
   Sofiadis K, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.20209760
   Sorensen KK, 1998, J EXP BIOL, V201, P1707
   Sosa RA, 2021, HEPATOLOGY, V73, P1158, DOI 10.1002/hep.31324
   Tam WY, 2002, J NAT PROD, V65, P990, DOI 10.1021/np010454p
   Vacchelli E, 2016, CANCER RES, V76, P3122, DOI 10.1158/0008-5472.CAN-16-0294
   Wang FX, 2022, ACTA PHARM SIN B, V12, P3618, DOI 10.1016/j.apsb.2022.03.014
   Wang XD, 2020, HEPATOLOGY, V72, P1771, DOI 10.1002/hep.31179
   Wang YB, 2020, ACCOUNTS CHEM RES, V53, P1046, DOI 10.1021/acs.accounts.9b00631
   Winkler M, 2021, J HEPATOL, V74, DOI 10.1016/j.jhep.2020.08.033
   Wu DD, 2016, SHOCK, V46, P329, DOI 10.1097/SHK.0000000000000595
   Xiao YS, 2022, BIOMED PHARMACOTHER, V153, DOI 10.1016/j.biopha.2022.113296
   Xiong QB, 1999, LIFE SCI, V65, P421, DOI 10.1016/S0024-3205(99)00263-5
   Yamada Y, 2013, J PHARM SCI-US, V102, P3119, DOI 10.1002/jps.23480
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
   Yang H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00484
   Yazdani HO, 2017, J Hepatol
   Zhang HF, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6670579
   Zhou W, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03493-2
NR 49
TC 0
Z9 1
U1 1
U2 1
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-2288
J9 INT J BIOL SCI
JI Int. J. Biol. Sci.
PY 2023
VL 19
IS 15
BP 4967
EP 4988
DI 10.7150/ijbs.87332
PG 22
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA Z5MW7
UT WOS:001112524900016
PM 37781526
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU SIERRA, F
   WALTER, R
   VAUTRAVERS, P
   GUIGOZ, Y
AF SIERRA, F
   WALTER, R
   VAUTRAVERS, P
   GUIGOZ, Y
TI IDENTIFICATION OF SEVERAL ISOFORMS OF T-KININOGEN EXPRESSED IN THE LIVER
   OF AGING RATS
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE KININOGENS; AGING; CYSTEINE PROTEINASE INHIBITORS; ALLELES; CDNA
   SEQUENCE; LIVER
ID ACUTE PHASE PROTEIN; HEPATOCYTE-STIMULATING FACTOR; PHENOL-CHLOROFORM
   EXTRACTION; MOLECULAR-WEIGHT KININOGEN; SINGLE-STEP METHOD;
   MESSENGER-RNAS; PLASMA; KALLIKREIN; PURIFICATION; INHIBITORS
AB We have previously shown that senescent Sprague-Dawley rats have significantly increased levels of kininogen (KG) mRNA and protein, when compared with younger counterparts. In the rat, five different isoforms of kininogen have been identified: high-molecular-weight K-kininogen, low-molecular-weight K-kininogen, and T1 alpha, T1 beta, and T2 kininogens. Several of these isoforms have been shown to differ in their biological properties. It was therefore considered relevant to establish which of these isoforms are expressed in the liver of old rats. To this end, we have isolated and sequenced nine independent cDNA clones from a library constructed using liver mRNA from healthy senescent rats. Predicted protein sequences indicate the presence of T-kininogens only. The relative lack of induction of K-kininogens during aging was further confirmed by RNA hybridization experiments. The nucleotide sequences reveal a microheterogeneity of silent polymorphisms, suggesting the presence and expression of several different alleles of the genes. From our data we conclude that (i) Several isoforms of TKG are expressed in the liver of senescent Sprague-Dawley rats and (ii) T1 kininogens appear to be the most highly represented T-KG mRNA species in old rat livers. (C) 1995 Academic Press, Inc.
C1 HAHNEMANN UNIV, PHILADELPHIA, PA 19129 USA.
   NESTEC LTD, NESTLE RES CTR, CH-1000 LAUSANNE 26, SWITZERLAND.
C3 Drexel University; Nestle SA
RP SIERRA, F (corresponding author), MED COLL PENN, CTR GERONTOL RES, 2900 QUEEN LANE, PHILADELPHIA, PA 19129 USA.
FU NIA NIH HHS [AG 00532] Funding Source: Medline
CR ANDERSON KP, 1985, J BIOL CHEM, V260, P2065
   ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465
   BARLAS A, 1985, BIOCHEM BIOPH RES CO, V129, P280, DOI 10.1016/0006-291X(85)91434-2
   BAUMANN H, 1989, J BIOL CHEM, V264, P8046
   BERG T, 1991, BIOCHEM J, V280, P19, DOI 10.1042/bj2800019
   CHAGAS JR, 1992, BIOCHEMISTRY-US, V31, P4969, DOI 10.1021/bi00136a008
   CHAO S, 1989, BIOCHIM BIOPHYS ACTA, V991, P477, DOI 10.1016/0304-4165(89)90076-7
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   COLE T, 1985, FEBS LETT, V182, P57, DOI 10.1016/0014-5793(85)81153-4
   ENJYOJI K, 1988, J BIOL CHEM, V263, P973
   FURUTOKATO S, 1985, J BIOL CHEM, V260, P2054
   GAGINELLA TS, 1989, AM J PHYSIOL, V256, pG1, DOI 10.1152/ajpgi.1989.256.1.G1
   GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251
   GREENBAUM LM, 1988, METHOD ENZYMOL, V163, P272
   GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5
   GUTMAN N, 1988, EUR J BIOCHEM, V171, P577, DOI 10.1111/j.1432-1033.1988.tb13827.x
   KAGEYAMA R, 1985, J BIOL CHEM, V260, P2060
   KAKIZUKA A, 1988, J BIOL CHEM, V263, P3884
   KITAGAWA H, 1987, J BIOL CHEM, V262, P2190
   KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x
   LENARCIC B, 1991, FEBS LETT, V280, P211, DOI 10.1016/0014-5793(91)80295-E
   MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835
   MOREAU T, 1988, EUR J BIOCHEM, V173, P185, DOI 10.1111/j.1432-1033.1988.tb13983.x
   OHKUBO I, 1984, BIOCHEMISTRY-US, V23, P5691, DOI 10.1021/bi00319a005
   OKAMOTO H, 1983, BIOCHEM BIOPH RES CO, V112, P701, DOI 10.1016/0006-291X(83)91519-X
   PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
   SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHACHTER M, 1979, PHARMACOL REV, V31, P1
   SIERRA F, 1992, J BIOL CHEM, V267, P10665
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   SUEYOSHI T, 1985, FEBS LETT, V182, P193, DOI 10.1016/0014-5793(85)81182-0
   TAIT JF, 1987, J BIOL CHEM, V262, P11651
   XIONG W, 1990, J BIOL CHEM, V265, P2822
NR 34
TC 3
Z9 4
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 1995
VL 322
IS 2
BP 333
EP 338
DI 10.1006/abbi.1995.1472
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA RY950
UT WOS:A1995RY95000006
PM 7574705
DA 2024-02-19
ER

PT J
AU Yamamoto, K
   Shuang, E
   Hatakeyama, Y
   Sakamoto, Y
   Tsuduki, T
AF Yamamoto, Kazushi
   Shuang, E.
   Hatakeyama, Yu
   Sakamoto, Yu
   Tsuduki, Tsuyoshi
TI High-fat diet intake from senescence inhibits the attenuation of cell
   functions and the degeneration of villi with aging in the small
   intestine, and inhibits the attenuation of lipid absorption ability in
   SAMP8 mice
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE aging; high fat diet; lipid absorption; SAMP8; small intestine
ID OXIDATIVE STRESS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MURINE MODEL;
   ACID; ACCUMULATION; INCREASES; EXPRESSION; LIVER; UNDERNUTRITION
AB We examined the effect of a high-fat diet from senescence as a means of preventing malnutrition among the elderly. The senescence-accelerated mouse P8 was used and divided into three groups. The 6C group was given a normal diet until 6 months old. The 12N group was given a normal diet until 12 months old. The 12F group was given a normal diet until 6 months old and then a high-fat diet until 12 months old. In the oral fat tolerance test, there was a decrease in area under the curve for serum triacylglycerol level in the 12N group and a significant increase in the 12F group, suggesting that the attenuation of lipid absorption ability with aging was delayed by a high-fat diet from senescence. To examine this mechanism, histological analysis in the small intestine was performed. As a result, the degeneration of villi with aging was inhibited by the high-fat diet. There was also a significant decrease in length of villus in the small intestine in the 12N group and a significant increase in the 12F group. The high-fat diet from senescence inhibited the degeneration of villi with aging in the small intestine, and inhibited the attenuation of lipid absorption ability.
C1 [Yamamoto, Kazushi; Shuang, E.; Hatakeyama, Yu; Sakamoto, Yu; Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan.
C3 Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan.
EM tsudukit@m.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/C-2254-2016; Tsuduki, Tsuyoshi/T-2697-2019
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528
FU Integration research for agriculture and interdisciplinary fields for
   Bio-oriented Technology Research Advancement Institution (BRAIN), Japan
FX This study was supported by Integration research for agriculture and
   interdisciplinary fields for Bio-oriented Technology Research
   Advancement Institution (BRAIN), Japan.
CR Benkovic V, 2014, CLIN NUTR, V33, P689, DOI 10.1016/j.clnu.2013.09.006
   Breen DM, 2013, DIABETES, V62, P3005, DOI 10.2337/db13-0523
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choudhery MS, 2012, CELL BIOL INT, V36, P747, DOI 10.1042/CBI20110183
   CLEMENT G, 1964, J PHYSIOLOGY PARIS, V56, P111
   Cuesta S, 2013, AGE, V35, P659, DOI 10.1007/s11357-012-9397-7
   DARMON N, 1993, J NUTR, V123, P1068
   Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P7578, DOI 10.3748/wjg.v12.i47.7578
   Schoffen JPF, 2014, EXP GERONTOL, V51, P54, DOI 10.1016/j.exger.2014.01.001
   Gottardo L, 2008, OBESITY, V16, P205, DOI 10.1038/oby.2007.28
   Honma T, 2013, J JPN SOC FOOD SCI, V60, P541, DOI 10.3136/nskkk.60.541
   Honma T, 2013, J CLIN BIOCHEM NUTR, V52, P234, DOI 10.3164/jcbn.12-85
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Kaynar L, 2012, AFR J TRADIT COMPLEM, V9, P412, DOI 10.4314/ajtcam.v9i3.17
   Lee N, 2014, PROTEOMICS, V14, P1610, DOI 10.1002/pmic.201400001
   Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001
   Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003
   Murashita K, 2013, COMP BIOCHEM PHYS A, V166, P361, DOI 10.1016/j.cbpa.2013.07.015
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Okamoto M, 2011, J MED CHEM, V54, P6295, DOI 10.1021/jm200662c
   Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200
   Powell DR, 2013, J PHARMACOL EXP THER, V345, P250, DOI 10.1124/jpet.113.203364
   Ray MA, 2010, J AM ASSOC LAB ANIM, V49, P282
   Ren JK, 2011, J NUTR BIOCHEM, V22, P691, DOI 10.1016/j.jnutbio.2010.06.002
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316
   Saha P, 2015, BBA-BIOMEMBRANES, V1848, P702, DOI 10.1016/j.bbamem.2014.11.005
   Schramm DD, 2003, LIFE SCI, V73, P857, DOI 10.1016/S0024-3205(03)00373-4
   Shibata A, 2008, BIOCHEM PHARMACOL, V76, P330, DOI 10.1016/j.bcp.2008.05.017
   Shibata H, 2013, OLEOSCIENCE, V13, P17
   Shinohara N, 2012, BBA-MOL CELL BIOL L, V1821, P980, DOI 10.1016/j.bbalip.2012.04.001
   Shuang E, 2014, EXP GERONTOL, V55, P63, DOI 10.1016/j.exger.2014.03.025
   Sugawara S, 2013, J CLIN BIOCHEM NUTR, V52, P139, DOI 10.3164/jcbn.12-88
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tanabe N, 2010, CIRC J, V74, P1346, DOI 10.1253/circj.CJ-09-0861
   Tsuduki T, 2013, J OLEO SCI, V62, P825, DOI 10.5650/jos.62.825
   Tsuduki T, 2013, FOOD CHEM, V139, P16, DOI 10.1016/j.foodchem.2013.02.025
   Tsuduki T, 2011, NUTRITION, V27, P334, DOI 10.1016/j.nut.2010.05.017
   Tsuzuki T, 2005, LIPIDS, V40, P1117, DOI 10.1007/s11745-005-1475-0
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298
   Tsuzuki T, 2007, BBA-MOL CELL BIOL L, V1771, P20, DOI 10.1016/j.bbalip.2006.11.006
   Tsuzuki T, 2006, J NUTR BIOCHEM, V17, P518, DOI 10.1016/j.jnutbio.2005.09.006
   Uchida A, 2013, METHOD CELL BIOL, V116, P151, DOI 10.1016/B978-0-12-408051-5.00014-0
   Vargas-Robles H, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/467471
   Venold FF, 2013, COMP BIOCHEM PHYS A, V164, P229, DOI 10.1016/j.cbpa.2012.09.009
   Villeneuve NF, 2009, CELL CYCLE, V8, P3255, DOI 10.4161/cc.8.20.9565
   WATSON TDG, 1995, RES VET SCI, V58, P256, DOI 10.1016/0034-5288(95)90113-2
   Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3
   Wijnhoven HAH, 2012, CLIN NUTR, V31, P351, DOI 10.1016/j.clnu.2011.10.013
   Winter TA, 2007, NUTRITION, V23, P29, DOI 10.1016/j.nut.2006.10.005
   Wu D, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-11
   Yamamoto K, 2014, BIOGERONTOLOGY, V15, P463, DOI 10.1007/s10522-014-9512-5
   Zhang LS, 2015, LIPIDS, V50, P371, DOI 10.1007/s11745-015-3995-y
   Zhang YQ, 2015, ARCH BIOCHEM BIOPHYS, V576, P39, DOI 10.1016/j.abb.2014.12.018
   Zhou Y, 2014, ARCH GERONTOL GERIAT, V58, P293, DOI 10.1016/j.archger.2013.10.005
NR 59
TC 19
Z9 21
U1 1
U2 20
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD NOV 1
PY 2015
VL 57
IS 3
BP 204
EP 211
DI 10.3164/jcbn.15-60
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CX2XN
UT WOS:000365560200005
PM 26566305
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Maji, RK
   Czepukojc, B
   Scherer, M
   Tierling, S
   Cadenas, C
   Gianmoena, K
   Gasparoni, N
   Nordström, K
   Gasparoni, G
   Laggai, S
   Yang, XY
   Sinha, A
   Ebert, P
   Falk-Paulsen, M
   Kinkley, S
   Hoppstädter, J
   Chung, HR
   Rosenstiel, P
   Hengstler, JG
   Walter, J
   Schulz, MH
   Kessler, SM
   Kiemer, AK
AF Maji, Ranjan Kumar
   Czepukojc, Beate
   Scherer, Michael
   Tierling, Sascha
   Cadenas, Cristina
   Gianmoena, Kathrin
   Gasparoni, Nina
   Nordstroem, Karl
   Gasparoni, Gilles
   Laggai, Stephan
   Yang, Xinyi
   Sinha, Anupam
   Ebert, Peter
   Falk-Paulsen, Maren
   Kinkley, Sarah
   Hoppstaedter, Jessica
   Chung, Ho-Ryun
   Rosenstiel, Philip
   Hengstler, Jan G.
   Walter, Joern
   Schulz, Marcel H.
   Kessler, Sonja M.
   Kiemer, Alexandra K.
TI Alterations in the hepatocyte epigenetic landscape in steatosis
SO EPIGENETICS & CHROMATIN
LA English
DT Article
ID DNA METHYLATION; LIVER; CHROMATIN; AGE; STEATOHEPATITIS; ACCUMULATION;
   METHYLOME; DISCOVERY
AB Fatty liver disease or the accumulation of fat in the liver, has been reported to affect the global population. This comes with an increased risk for the development of fibrosis, cirrhosis, and hepatocellular carcinoma. Yet, little is known about the effects of a diet containing high fat and alcohol towards epigenetic aging, with respect to changes in transcriptional and epigenomic profiles. In this study, we took up a multi-omics approach and integrated gene expression, methylation signals, and chromatin signals to study the epigenomic effects of a high-fat and alcohol-containing diet on mouse hepatocytes. We identified four relevant gene network clusters that were associated with relevant pathways that promote steatosis. Using a machine learning approach, we predict specific transcription factors that might be responsible to modulate the functionally relevant clusters. Finally, we discover four additional CpG loci and validate aging-related differential CpG methylation. Differential CpG methylation linked to aging showed minimal overlap with altered methylation in steatosis.
C1 [Maji, Ranjan Kumar; Schulz, Marcel H.] Goethe Univ, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.
   [Maji, Ranjan Kumar; Schulz, Marcel H.] German Ctr Cardiovasc Res DZHK, Partner Site Rhine Main, D-60590 Frankfurt, Germany.
   [Czepukojc, Beate; Laggai, Stephan; Hoppstaedter, Jessica; Kessler, Sonja M.; Kiemer, Alexandra K.] Saarland Univ, Dept Pharm, Pharmaceut Biol, D-66123 Saarbrucken, Germany.
   [Scherer, Michael] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona 08003, Spain.
   [Tierling, Sascha; Gasparoni, Nina; Nordstroem, Karl; Gasparoni, Gilles; Walter, Joern] Saarland Univ, Dept Genet, D-66123 Saarbrucken, Germany.
   [Cadenas, Cristina; Gianmoena, Kathrin; Hengstler, Jan G.] IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany.
   [Kinkley, Sarah] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany.
   [Yang, Xinyi; Chung, Ho-Ryun] Philipps Univ Marburg, Inst Med Bioinformat & Biostat, D-35032 Marburg, Germany.
   [Sinha, Anupam; Falk-Paulsen, Maren; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.
   [Ebert, Peter] Heinrich Heine Univ, Med Fac, Core Unit Bioinformat, D-40225 Dusseldorf, Germany.
   [Ebert, Peter; Schulz, Marcel H.] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, D-66123 Saarbrucken, Germany.
   [Schulz, Marcel H.] Saarland Univ, Excellence Cluster Multimodal Comp & Interact, D-66123 Saarbrucken, Germany.
   [Kessler, Sonja M.] Martin Luther Univ Halle Wittenberg, Inst Pharm, Expt Pharmacol Nat Sci, Halle, Germany.
   [Kessler, Sonja M.] Halle Res Ctr Drug Therapy HRCDT, Halle, Germany.
C3 Goethe University Frankfurt; German Centre for Cardiovascular Research;
   Saarland University; Barcelona Institute of Science & Technology; Pompeu
   Fabra University; Centre de Regulacio Genomica (CRG); Saarland
   University; Dortmund University of Technology; Leibniz Institut for
   Arbeitsforschung an der TU Dortmund (IFADO); Max Planck Society;
   Philipps University Marburg; University of Kiel; Heinrich Heine
   University Dusseldorf; Max Planck Society; Saarland University; Martin
   Luther University Halle Wittenberg
RP Schulz, MH (corresponding author), Goethe Univ, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.; Schulz, MH (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Rhine Main, D-60590 Frankfurt, Germany.; Kessler, SM; Kiemer, AK (corresponding author), Saarland Univ, Dept Pharm, Pharmaceut Biol, D-66123 Saarbrucken, Germany.; Schulz, MH (corresponding author), Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, D-66123 Saarbrucken, Germany.; Schulz, MH (corresponding author), Saarland Univ, Excellence Cluster Multimodal Comp & Interact, D-66123 Saarbrucken, Germany.; Kessler, SM (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Pharm, Expt Pharmacol Nat Sci, Halle, Germany.; Kessler, SM (corresponding author), Halle Res Ctr Drug Therapy HRCDT, Halle, Germany.
EM marcel.schulz@em.uni-frankfurt.de; sonja.kessler@pharmazie.uni-halle.de;
   pharm.bio.kiemer@mx.uni-saarland.de
RI Scherer, Michael/T-8354-2019; Rosenstiel, Philip/A-5137-2009
OI Scherer, Michael/0000-0001-7990-6179; Rosenstiel,
   Philip/0000-0002-9692-8828
FU Projekt DEAL; Federal Ministry of Education and Research [O1KU1216F];
   Deutsche Forschungsgemeinschaft [KI702]; DZHK (German Centre for
   Cardiovascular Research) [81Z0200101]; DFG Cardio-Pulmonary Institute
   (CPI) [390649896]; Walter Benjamin Fellowship - Deutsche
   Forschungsgemeinschaft (DFG, German Research Foundation) [493935791];
   Hessian Ministry within the LOEWE Research Initiative ACLF-I
FX Open Access funding enabled and organized by Projekt DEAL to
   Goethe-University. The results upon which this publication is based were
   partly funded by the Federal Ministry of Education and Research under
   the Project Number (O1KU1216F to AKK, PR, JGH, JW, HRC) and the Deutsche
   Forschungsgemeinschaft (KI702) (to AKK). RKM and MHS are supported
   through DZHK (German Centre for Cardiovascular Research)
   grant-81Z0200101 and the DFG Cardio-Pulmonary Institute (CPI) [EXC 2026]
   ID: 390649896. MS was supported through the Walter Benjamin Fellowship
   funded by Deutsche Forschungsgemeinschaft (DFG, German Research
   Foundation)-493935791. MHS was supported by the Hessian Ministry within
   the LOEWE Research Initiative ACLF-I.
CR Abderrahmani A, 2018, DIABETES, V67, P1310, DOI 10.2337/db17-1539
   Ajoolabady A, 2022, MED RES REV, V42, P1463, DOI 10.1002/med.21881
   Arrigoni L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1495
   Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419
   Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]
   Bu F., 2022, JUNB EGFR AXIS IS CR, DOI [10.2139/ssrn.4089491, DOI 10.2139/SSRN.4089491]
   Bysani M, 2017, EPIGENOMICS-UK, V9, P105, DOI 10.2217/epi-2016-0087
   Casagrande V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06439-x
   Cevenini E, 2010, CURR PHARM DESIGN, V16, P609, DOI 10.2174/138161210790883840
   Chen CC, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010256
   Chen X, 2018, FASEB J, V32, P2722, DOI 10.1096/fj.201700875R
   Chen XY, 2022, INT J MOL MED, V50, DOI 10.3892/ijmm.2022.5169
   Ebert P, 2021, BIOINFORMATICS, V37, P1198, DOI 10.1093/bioinformatics/btaa960
   Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109
   Ernst J, 2017, NAT PROTOC, V12, P2478, DOI 10.1038/nprot.2017.124
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frankish A, 2021, NUCLEIC ACIDS RES, V49, pD916, DOI 10.1093/nar/gkaa1087
   Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406
   Gianmoena K, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109526
   Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5
   hindawi, MECH IMPL AG REL CHA
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Hung YH, 2022, bioRxiv, DOI [10.1101/2021.08.20.457162, 10.1101/2021.08.20.457162, DOI 10.1101/2021.08.20.457162]
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Kang G, 2017, METABOLISM, V77, P13, DOI 10.1016/j.metabol.2017.08.007
   Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249
   Kirchner H, 2016, MOL METAB, V5, P171, DOI 10.1016/j.molmet.2015.12.004
   Köhler N, 2022, BBA-MOL BASIS DIS, V1868, DOI 10.1016/j.bbadis.2022.166398
   Kulakovskiy IV, 2013, NUCLEIC ACIDS RES, V41, pD195, DOI 10.1093/nar/gks1089
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Li P, 2014, IMMUNOL REV, V261, P141, DOI 10.1111/imr.12199
   Liu YL, 2020, AGING-US, V12, P204, DOI 10.18632/aging.102610
   Loomba R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96685
   Lou Y, 2017, CELL PHYSIOL BIOCHEM, V41, P239, DOI 10.1159/000456061
   Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176
   Müller F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1664-9
   Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047
   Nassir F, 2014, WORLD J GASTROENTERO, V20, P2136, DOI 10.3748/wjg.v20.i9.2136
   Nilsson E, 2015, J CLIN ENDOCR METAB, V100, pE1491, DOI 10.1210/jc.2015-3204
   Odena G, 2016, SCI REP-UK, V6, DOI 10.1038/srep35610
   Page A, 2015, J HEPATOL, V62, P388, DOI 10.1016/j.jhep.2014.09.033
   Park PH, 2005, AM J PHYSIOL-GASTR L, V289, pG1124, DOI 10.1152/ajpgi.00091.2005
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Prasun P, 2021, TRANSL GASTROENT HEP, V6, DOI 10.21037/tgh-20-125
   Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47
   Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rodriguez-Sanabria JS, 2022, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.770504
   Salameh Y, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00171
   Schmidt F, 2019, BIOINFORMATICS, V35, P1608, DOI 10.1093/bioinformatics/bty856
   Schmidt F, 2017, NUCLEIC ACIDS RES, V45, P54, DOI 10.1093/nar/gkw1061
   sciencedirect, LIV FIBR ACT TRANSCR
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sookoian S, 2016, J PATHOL, V240, P437, DOI 10.1002/path.4803
   Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098
   Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018
   Vinciguerra M, 2013, HEPATOLOGY, V58, P830, DOI 10.1002/hep.26212
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Wiesenthal AA, 2023, BIOLOGY-BASEL, V12, DOI 10.3390/biology12040530
   Yang MC, 2020, FASEB J, V34, P13533, DOI 10.1096/fj.201903292RR
   Zeybel M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0056-6
   Zhao ZC, 2020, J HEPATOL, V73, P664, DOI 10.1016/j.jhep.2020.04.009
NR 68
TC 0
Z9 0
U1 3
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1756-8935
J9 EPIGENET CHROMATIN
JI Epigenetics Chromatin
PD JUL 6
PY 2023
VL 16
IS 1
AR 30
DI 10.1186/s13072-023-00504-8
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA L8ZP4
UT WOS:001026094500002
PM 37415213
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU MIYAZAKI, M
   GOHDA, E
   MIHARA, K
   TSUBOI, S
   KAJI, K
   YAMAMOTO, I
   NAMBA, M
AF MIYAZAKI, M
   GOHDA, E
   MIHARA, K
   TSUBOI, S
   KAJI, K
   YAMAMOTO, I
   NAMBA, M
TI INCREASE IN PRODUCTION OF HEPATOCYTE GROWTH-FACTOR BY HUMAN EMBRYONIC
   LUNG FIBROBLASTS IN THE PROCESS OF AGING IN CULTURE
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
ID FULMINANT HEPATIC-FAILURE; ADULT-RAT HEPATOCYTES; HUMAN-SKIN
   FIBROBLASTS; TUMOR CYTOTOXIC FACTOR; DNA-SYNTHESIS; PARTIAL-HEPATECTOMY;
   LIVER-REGENERATION; MESSENGER-RNA; SCATTER FACTOR; CARBON-TETRACHLORIDE
AB It was determined whether human hepatocyte growth factor (hHGF)-producing ability would change in the human embryonic lung fibroblast cell strains (MRC-B and IMR-90) until the cells senesced in culture. The effects of phorbol 12-myristate 13-acetate (PMA), dexamethasone, and transforming growth factor-beta(1) (TGF-beta 1) on hHGF production were also studied in these cell strains. For stimulation of DNA synthesis of adult rat hepatocytes in primary culture, hHGF secreted by MRC-5 cells at 39.9 and 69.8 population doubling levels (PDLs) showed almost the same activity as recombinant hHGF. Secretion of hHGF by MRC-5 cells increased about threefold between 37.3 and 67.8 PDLs. IMR-90 cells also showed about a threefold increase in hHGF secretion with increased passage from 37.8 to 66.0 PDL. Both cell strains showed almost the same ratio of hHGF amount in the cell extracts to that secreted into the medium around 40 and 70 PDLs. Northern blot analysis showed that the transcriptional level of the hHGF gene in MRC-5 cells increased about threefold from 42.0 to 73.6 PDL in culture. These findings indicated that hHGF production increased in both cell strains with aging in culture. Production of hHGF in both cell strains was remarkably stimulated by treatment with 10 nM PMA. On the other hand, hHGF production in both cell strains was slightly suppressed by treatment with 1 mu M dexamethasone. TGF-beta at a concentration of 5 ng/ml prominently inhibited hHGF production in both cell strains. The response of both cell strains to these regulators for hHGF production was almost the same around 40 and 70 PDLs in culture. (C) 1994 Academic Press, Inc.
C1 OKAYAMA UNIV,FAC PHARMACEUT SCI,DEPT IMMUNOCHEM,OKAYAMA 700,JAPAN.
   TOKYO METROPOLITAN GERIATR HOSP & INST GERENTOL,TOKYO 173,JAPAN.
C3 Okayama University
RP MIYAZAKI, M (corresponding author), OKAYAMA UNIV,SCH MED,INST MOLEC & CELLULAR BIOL,DEPT CELL BIOL,2-5-1 SHIKATA CHO,OKAYAMA 700,JAPAN.
RI Gohda, Eiichi/B-1629-2011
CR ASAMI O, 1991, J BIOCHEM-TOKYO, V109, P8
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   CARR BI, 1986, CANCER RES, V46, P2330
   CASTAGNA M, 1982, J BIOL CHEM, V257, P7847
   DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6
   FRANCAVILLA A, 1991, HEPATOLOGY, V14, P665, DOI 10.1002/hep.1840140415
   GHERARDI E, 1990, NATURE, V346, P228, DOI 10.1038/346228b0
   GOHDA E, 1990, LIFE SCI, V46, P1801
   GOHDA E, 1990, BIOCHIM BIOPHYS ACTA, V1053, P21, DOI 10.1016/0167-4889(90)90020-E
   GOHDA E, 1992, FEBS LETT, V301, P107, DOI 10.1016/0014-5793(92)80220-B
   GOHDA E, 1992, CELL BIOL INT REP, V16, P917, DOI 10.1016/S0309-1651(06)80171-2
   GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334
   GOHDA E, 1992, J PHARMACOBIO-DYNAM, V15, P131, DOI 10.1248/bpb1978.15.131
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HIGASHIO K, 1990, BIOCHEM BIOPH RES CO, V170, P397, DOI 10.1016/0006-291X(90)91287-3
   HIGUCHI O, 1991, BIOCHEM BIOPH RES CO, V176, P599, DOI 10.1016/S0006-291X(05)80226-8
   ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6
   JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0
   KAN M, 1991, BIOCHEM BIOPH RES CO, V174, P331, DOI 10.1016/0006-291X(91)90524-B
   KINOSHITA T, 1991, BIOCHEM BIOPH RES CO, V177, P330, DOI 10.1016/0006-291X(91)91987-N
   KLEINSEK DA, 1989, AGE, V12, P55, DOI 10.1007/BF02432636
   KUMAR S, 1992, P NATL ACAD SCI USA, V89, P4683, DOI 10.1073/pnas.89.10.4683
   LINDROOS PM, 1991, HEPATOLOGY, V13, P743, DOI 10.1016/0270-9139(91)92574-R
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407
   Maciag T, 1990, Important Adv Oncol, P85
   MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8
   MATSUMOTO K, 1992, P NATL ACAD SCI USA, V89, P3800, DOI 10.1073/pnas.89.9.3800
   MIYAZAKI M, 1992, EXP CELL RES, V200, P404, DOI 10.1016/0014-4827(92)90188-E
   MIYAZAKI M, 1985, EXP CELL RES, V159, P176, DOI 10.1016/S0014-4827(85)80047-1
   MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4
   MIYAZAWA K, 1991, EUR J BIOCHEM, V197, P15, DOI 10.1111/j.1432-1033.1991.tb15876.x
   MURANO S, 1991, MOL CELL BIOL, V11, P3905, DOI 10.1128/MCB.11.8.3905
   NAKAMURA T, 1985, BIOCHEM BIOPH RES CO, V133, P1042, DOI 10.1016/0006-291X(85)91241-0
   NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0
   NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1
   NAKAYAMA H, 1985, BIOMED RES-TOKYO, V6, P231
   NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339
   NISHINO T, 1991, BIOCHEM BIOPH RES CO, V181, P323, DOI 10.1016/S0006-291X(05)81421-4
   OKAJIMA A, 1990, EUR J BIOCHEM, V193, P375, DOI 10.1111/j.1432-1033.1990.tb19349.x
   OWEN TA, 1990, J CELL PHYSIOL, V142, P137, DOI 10.1002/jcp.1041420117
   RAMADORI G, 1992, BIOCHEM BIOPH RES CO, V183, P739, DOI 10.1016/0006-291X(92)90545-V
   RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2
   ROSEN EM, 1989, IN VITRO CELL DEV B, V25, P163
   RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415
   RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126
   SAKON M, 1992, LANCET, V339, P818, DOI 10.1016/0140-6736(92)91953-6
   Sambrook J., 1989, MOL CLONING LABORATO, V2nd
   SELDEN C, 1990, FEBS LETT, V270, P81, DOI 10.1016/0014-5793(90)81239-K
   SELDEN C, 1986, BIOCHEM BIOPH RES CO, V139, P361
   SHIMA N, 1991, BIOCHEM BIOPH RES CO, V180, P1151, DOI 10.1016/S0006-291X(05)81187-8
   STEPP MA, 1986, J BIOL CHEM, V261, P6542
   STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0
   STRAIN AJ, 1991, J CLIN INVEST, V87, P1853, DOI 10.1172/JCI115207
   TAMURA M, 1993, J BIOL CHEM, V268, P8140
   TSUBOUCHI H, 1989, HEPATOLOGY, V9, P875, DOI 10.1002/hep.1840090615
   TSUBOUCHI H, 1991, HEPATOLOGY, V13, P1
   VINTERMYR OK, 1989, J CELL PHYSIOL, V138, P29, DOI 10.1002/jcp.1041380106
   WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001
   YAMATO K, 1989, J CELL PHYSIOL, V139, P610, DOI 10.1002/jcp.1041390322
   YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802, DOI 10.1016/0006-291X(92)91803-X
   ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K
   ZARNEGAR R, 1989, CANCER RES, V49, P3314
NR 66
TC 11
Z9 11
U1 0
U2 3
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0014-4827
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAY
PY 1994
VL 212
IS 1
BP 22
EP 29
DI 10.1006/excr.1994.1113
PG 8
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA NL213
UT WOS:A1994NL21300003
PM 8174639
DA 2024-02-19
ER

PT J
AU Junaidi, O
   Di Bisceglie, AM
AF Junaidi, Omer
   Di Bisceglie, Adrian M.
TI Aging liver and hepatitis
SO CLINICS IN GERIATRIC MEDICINE
LA English
DT Article
ID C VIRUS-INFECTION; CHRONIC ACTIVE HEPATITIS; AGE-RELATED-CHANGES;
   AUTOIMMUNE HEPATITIS; UNITED-STATES; INTERFERON THERAPY; ANTIVIRAL
   THERAPY; VIRAL-HEPATITIS; PLUS RIBAVIRIN; NURSING-HOME
AB Chronic liver disease and cirrhosis are the tenth leading causes of death in the United States and results in approximately 25,000 deaths annually. As life expectancy in developed countries has increased, so has the number of elderly patients who have liver disease. With an aging population and chronic liver disease becoming an increasingly significant cause of morbidity and mortality, the various causes for hepatitis will need to be evaluated and available treatments considered, even in elderly population. Common causes for hepatitis in elderly individuals include viral, autoimmune, and drug-induced hepatitis, but evidence for treatment of this population is limited. This article reviews the likely causes of hepatitis in elderly individuals and discusses evidence for treating this population.
C1 St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.
   St Louis Univ, Sch Med, Dept Gastroenterol & Hepatol, St Louis, MO 63110 USA.
C3 Saint Louis University; Saint Louis University
RP Junaidi, O (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, 3635 Vista Ave, St Louis, MO 63110 USA.
EM junaidio@slu.edu
CR Al-Chalabi T, 2006, J HEPATOL, V45, P575, DOI 10.1016/j.jhep.2006.04.007
   Alessi Nunziata, 2003, Infez Med, V11, P208
   Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711
   Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   [Anonymous], NATL VITAL STAT REPO
   Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1
   Bacosi M, 2002, HEPATOL RES, V22, P231, DOI 10.1016/S1386-6346(01)00140-1
   Brind AM, 1996, QJM-INT J MED, V89, P291
   Brown GR, 2002, SOUTH MED J, V95, P826, DOI 10.1097/00007611-200295080-00010
   *CDC, 1999, MMWR-MORBID MORTAL W, V45, P1
   Chalasani N, 2004, GASTROENTEROLOGY, V126, P1287, DOI 10.1053/j.gastro.2004.02.015
   Chien NT, 1999, J AM GERIATR SOC, V47, P1110, DOI 10.1111/j.1532-5415.1999.tb05236.x
   de Franchis R, 2003, J HEPATOL, V39, pS3, DOI 10.1016/S0168-8278(03)00378-7
   DONALDSON PT, 1991, HEPATOLOGY, V13, P701, DOI 10.1016/0270-9139(91)92567-R
   FLOREANI A, 1992, GERONTOLOGY, V38, P214
   FORBES A, 1990, BRIT MED BULL, V46, P303, DOI 10.1093/oxfordjournals.bmb.a072400
   FORBES A, 1988, J ROY COLL PHYS LOND, V22, P237
   Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Galan MV, 2005, J CLIN GASTROENTEROL, V39, P64
   GORDON SC, 1993, HEPATOLOGY, V18, P1338, DOI 10.1016/0270-9139(93)90221-8
   Graham DJ, 2003, AM J GASTROENTEROL, V98, P175
   Hey-Hadavi Judith H, 2006, Am J Geriatr Pharmacother, V4, P112, DOI 10.1016/j.amjopharm.2006.06.001
   HORIIKE N, 1995, J GASTROEN HEPATOL, V10, P246, DOI 10.1111/j.1440-1746.1995.tb01088.x
   Imai Y, 2004, J GASTROENTEROL, V39, P1069, DOI 10.1007/s00535-004-1448-0
   Kaplowitz N, 2001, HEPATOLOGY, V33, P308, DOI 10.1053/jhep.2001.21083
   Khorashadi S, 2006, CLIN GASTROENTEROL H, V4, P902, DOI 10.1016/j.cgh.2006.03.014
   Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734
   KONDO Y, 1993, HEPATOLOGY, V18, P768, DOI 10.1002/hep.1840180404
   KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991
   KUNKEL HG, 1951, J CLIN INVEST, V30, P654
   Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LEBOVICS E, 1985, DIGEST DIS SCI, V30, P824, DOI 10.1007/BF01309511
   Li YH, 2006, CANCER-AM CANCER SOC, V106, P1320, DOI 10.1002/cncr.21701
   Liaw YF, 2003, J GASTROEN HEPATOL, V18, P239, DOI 10.1046/j.1440-1746.2003.03037.x
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110
   MACKAY IR, 1956, LANCET, V271, P1323
   MADDREY WC, 1981, SEMIN LIVER DIS, V1, P77
   MADDREY WC, 2002, DRUG INDUCED LIVER D, P227
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Marcus EL, 1997, J AM GERIATR SOC, V45, P755, DOI 10.1111/j.1532-5415.1997.tb01484.x
   McFarlane IG, 1998, GUT, V42, P599, DOI 10.1136/gut.42.5.599
   Monica F, 1998, J VIRAL HEPATITIS, V5, P345, DOI 10.1046/j.1365-2893.1998.00112.x
   Nagasaka S, 2002, DIABETIC MED, V19, P347, DOI 10.1046/j.1464-5491.2002.00712_4.x
   Newton JL, 1997, AGE AGEING, V26, P441, DOI 10.1093/ageing/26.6.441
   Nudo CG, 2006, CAN J GASTROENTEROL, V20, P589, DOI 10.1155/2006/357259
   Parker DR, 1997, QJM-MON J ASSOC PHYS, V90, P289, DOI 10.1093/qjmed/90.4.289
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   RoudotThoraval F, 1997, HEPATOLOGY, V26, P485, DOI 10.1002/hep.510260233
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Schramm C, 2001, AM J GASTROENTEROL, V96, P1587
   SELBY CD, 1986, AGE AGEING, V15, P350, DOI 10.1093/ageing/15.6.350
   Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009
   Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119
   Strader DB, 2002, HEPATOLOGY, V36, pS226, DOI 10.1053/jhep.2002.36991
   Strassburg CP, 2002, SEMIN LIVER DIS, V22, P339, DOI 10.1055/s-2002-35704
   Sugauchi F, 2000, J MED VIROL, V62, P456, DOI 10.1002/1096-9071(200012)62:4&lt;456::AID-JMV10&gt;3.0.CO;2-3
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   Toda G, 1997, J HEPATOL, V26, P1207, DOI 10.1016/S0168-8278(97)80453-9
   Tolman KG, 2002, AM J CARDIOL, V89, P1374, DOI 10.1016/S0002-9149(02)02355-X
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   WALDENSTROM J, 1950, DTSCH GES VERDAU STO, V15, P113, DOI DOI 10.1016/S0168-8278(02)00408-7
   *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341
   Williams D, 1996, AGE AGEING, V25, P377, DOI 10.1093/ageing/25.5.377
   Willner IR, 1998, ANN INTERN MED, V128, P111, DOI 10.7326/0003-4819-128-2-199801150-00006
   WYNNE H, 1987, AGE AGEING, V16, P153, DOI 10.1093/ageing/16.3.153
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   WYNNE HA, 1993, AGE AGEING, V22, P354, DOI 10.1093/ageing/22.5.354
   YANO M, 1993, GUT, V34, pS13, DOI 10.1136/gut.34.2_Suppl.S13
   Yarze JC, 1996, NEW ENGL J MED, V334, P923
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 81
TC 18
Z9 18
U1 0
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-0690
EI 1879-8853
J9 CLIN GERIATR MED
JI Clin. Geriatr. Med.
PD NOV
PY 2007
VL 23
IS 4
BP 889
EP +
DI 10.1016/j.cger.2007.06.006
PG 16
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 228QM
UT WOS:000250744600012
PM 17923344
DA 2024-02-19
ER

PT J
AU Thadathil, N
   Selvarani, R
   Mohammed, S
   Nicklas, EH
   Tran, AL
   Kamal, M
   Luo, WY
   Brown, JL
   Lawrence, MM
   Borowik, AK
   Miller, BF
   Van Remmen, H
   Richardson, A
   Deepa, SS
AF Thadathil, Nidheesh
   Selvarani, Ramasamy
   Mohammed, Sabira
   Nicklas, Evan H.
   Tran, Albert L.
   Kamal, Maria
   Luo, Wenyi
   Brown, Jacob L.
   Lawrence, Marcus M.
   Borowik, Agnieszka K.
   Miller, Benjamin F.
   Van Remmen, Holly
   Richardson, Arlan
   Deepa, Sathyaseelan S.
TI Senolytic treatment reduces cell senescence and necroptosis in Sod1
   knockout mice that is associated with reduced inflammation and
   hepatocellular carcinoma
SO AGING CELL
LA English
DT Article; Early Access
DE cell senescence; Cu; Zn superoxide dismutase; hepatocellular carcinoma;
   inflammation; necroptosis; senolytics
ID CU/ZN SUPEROXIDE-DISMUTASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS;
   ACCELERATED AGING PHENOTYPE; AGE-RELATED DYSREGULATION; OXIDATIVE
   STRESS; LIVER; PROTEIN; LEADS; RISK; ACCUMULATION
AB The goal of this study was to test the role cellular senescence plays in the increased inflammation, chronic liver disease, and hepatocellular carcinoma seen in mice null for Cu/Zn-Superoxide dismutase (Sod1KO). To inhibit senescence, wildtype (WT) and Sod1KO mice were given the senolytics, dasatinib, and quercetin (D + Q) at 6 months of age when the Sod1KO mice begin exhibiting signs of accelerated aging. Seven months of D + Q treatment reduced the expression of p16 in the livers of Sod1KO mice to WT levels and the expression of several senescence-associated secretory phenotype factors (IL-6, IL-1 beta, CXCL-1, and GDF-15). D + Q treatment also reduced markers of inflammation in livers of the Sod1KO mice, for example, cytokines, chemokines, macrophage levels, and Kupffer cell clusters. D + Q treatment had no effect on various markers of liver fibrosis in the Sod1KO mice but reduced the expression of genes involved in liver cancer and dramatically reduced the incidence of hepatocellular carcinoma. Surprisingly, D + Q also reduced markers of necroptosis (phosphorylated and oligomerized MLKL) in the Sod1KO mice to WT levels. We also found that inhibiting necroptosis in the Sod1KO mice with necrostatin-1s reduced the markers of cellular senescence (p16, p21, and p53). Our study suggests that an interaction occurs between cellular senescence and necroptosis in the liver of Sod1KO mice. We propose that these two cell fates interact through a positive feedback loop resulting in a cycle amplifying both cellular senescence and necroptosis leading to inflammaging and age-associated pathology in the Sod1KO mice.
C1 [Thadathil, Nidheesh; Selvarani, Ramasamy; Mohammed, Sabira; Nicklas, Evan H.; Tran, Albert L.; Richardson, Arlan; Deepa, Sathyaseelan S.] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, 975 NE 10th St,BRC 1374A, Oklahoma City, OK 73104 USA.
   [Mohammed, Sabira; Richardson, Arlan; Deepa, Sathyaseelan S.] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA.
   [Kamal, Maria; Luo, Wenyi] Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK USA.
   [Brown, Jacob L.; Lawrence, Marcus M.; Borowik, Agnieszka K.; Miller, Benjamin F.; Van Remmen, Holly] Oklahoma Med Res Fdn, Aging & Metab Program, Oklahoma City, OK USA.
   [Brown, Jacob L.; Miller, Benjamin F.; Van Remmen, Holly; Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK USA.
   [Lawrence, Marcus M.] Southern Utah Univ, Dept Kinesiol & Outdoor Recreat, Cedar, UT USA.
   [Van Remmen, Holly; Richardson, Arlan; Deepa, Sathyaseelan S.] Univ Oklahoma, Ctr Gerosci & Hlth Brain Aging, Hlth Sci Ctr, Oklahoma City, OK USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; University of Oklahoma System; University of Oklahoma
   Health Sciences Center; Oklahoma Medical Research Foundation; University
   of Oklahoma System; University of Oklahoma Health Sciences Center; Utah
   System of Higher Education; Southern Utah University; University of
   Oklahoma System; University of Oklahoma Health Sciences Center
RP Richardson, A; Deepa, SS (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, 975 NE 10th St,BRC 1374A, Oklahoma City, OK 73104 USA.
EM arlan-richardson@ouhsc.edu; deepa-sathyaseelan@ouhsc.edu
RI Thadathil, Nidheesh/IWE-4992-2023; Kamal, Maria/HGT-9385-2022
OI T, Nidheesh/0000-0003-2168-8337
FU National Institute on Aging [T32AG052363]; U.S. Department of Veterans
   Affairs [1IK6 BX005234, 1IK6BX005238, I01 BX004453, I01BX004538];
   American Physiological Society; University of Oklahoma Health Sciences
   Center; Presbyterian Health Foundation Seed; GeroOncology Pilot Grant;
   NIH [R01AG064951, R01AG057424, R01AG059718]
FX National Institute on Aging, Grant/Award Number: T32AG052363; U.S.
   Department of Veterans Affairs, Grant/Award Number: 1IK6 BX005234,
   1IK6BX005238, I01 BX004453 and I01BX004538; American Physiological
   Society; University of Oklahoma Health Sciences Center; Presbyterian
   Health Foundation Seed; GeroOncology Pilot Grant; NIH, Grant/Award
   Number: R01AG064951, R01AG057424 and R01AG059718
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016
   Borghesan M, 2019, CELL REP, V27, P3956, DOI 10.1016/j.celrep.2019.05.095
   Brubaker AL, 2011, AGING DIS, V2, P346
   Chang AY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-267
   Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006
   Deepa SS, 2017, GEROSCIENCE, V39, P187, DOI 10.1007/s11357-017-9975-9
   Didier ES, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-25
   Duval F, 2015, INT J INFLAMM, V2015, DOI 10.1155/2015/943497
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Guido M, 1996, J HEPATOL, V24, P301, DOI 10.1016/S0168-8278(96)80008-0
   Huang DL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00497-16
   Iuchi Y, 2010, MOL CELL BIOCHEM, V341, P181, DOI 10.1007/s11010-010-0449-y
   Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104
   Kataoka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104741
   Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kim SJ, 2012, BIOMATERIALS, V33, P2154, DOI 10.1016/j.biomaterials.2011.11.084
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Liu C, 2021, ACTA BIOCH BIOPH SIN, V53, P823, DOI 10.1093/abbs/gmab061
   Liu S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/290182
   Logan S, 2019, GEROSCIENCE, V41, P591, DOI 10.1007/s11357-019-00105-y
   Masternak MM, 2012, PATHOBIOL AGING AGE, V2, DOI 10.3402/pba.v2i0.17293
   Miyata T, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.140180
   Mohammed S, 2021, AGING CELL, V20, DOI 10.1111/acel.13512
   Mohammed S, 2021, FREE RADICAL BIO MED, V164, P315, DOI 10.1016/j.freeradbiomed.2020.12.449
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Okado-Matsumoto A, 2001, ANAL BIOCHEM, V298, P337, DOI 10.1006/abio.2001.5385
   Olivieri F, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9076485
   Olofsson EM, 2007, FREE RADICAL BIO MED, V42, P1098, DOI 10.1016/j.freeradbiomed.2007.01.012
   Pang Q, 2017, ONCOTARGETS THER, V10, P4645, DOI 10.2147/OTT.S143154
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191
   Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43
   Richardson A, 2015, EXP GERONTOL, V68, P51, DOI 10.1016/j.exger.2014.12.002
   Sahasrabuddhe VV, 2012, JNCI-J NATL CANCER I, V104, P1808, DOI 10.1093/jnci/djs452
   Sakiyama H, 2016, FREE RADICAL RES, V50, P666, DOI 10.3109/10715762.2016.1164856
   Smith LR, 2016, MUSCLE NERVE, V54, P71, DOI 10.1002/mus.24998
   Snider TA, 2018, GEROSCIENCE, V40, P97, DOI 10.1007/s11357-018-0008-0
   Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6
   Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176
   Tao YQ, 2018, CANCER MANAG RES, V10, P2695, DOI 10.2147/CMAR.S167560
   Thadathil N, 2021, J NEUROIMMUNE PHARM, V16, P667, DOI 10.1007/s11481-020-09972-1
   Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200
   Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111
   Villanueva Augusto, 2016, Clin Liver Dis (Hoboken), V8, P89, DOI 10.1002/cld.578
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Woltman A.M., 2014, Macrophages: Biology and Role in the Pathology of Diseases, P217, DOI [DOI 10.1007/978-1-4939-1311-4_10, 10.1007/978-1-4939-1311-4_10]
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001
   Yu LX, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0048-z
   Zhang M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.556532
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang YQ, 2017, REDOX BIOL, V11, P30, DOI 10.1016/j.redox.2016.10.014
   Zhang YQ, 2016, MECH AGEING DEV, V154, P1, DOI 10.1016/j.mad.2016.01.005
   Zhang YQ, 2013, FREE RADICAL BIO MED, V60, P300, DOI 10.1016/j.freeradbiomed.2013.02.026
   Zhao YJ, 2013, MOL CLIN ONCOL, V1, P593, DOI 10.3892/mco.2013.119
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 64
TC 21
Z9 20
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 AUG
PY 2022
VL 21
IS 8
DI 10.1111/acel.13676
EA JUL 2022
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 3U6QQ
UT WOS:000829049900001
PM 35869934
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Peng, DY
   Song, H
   Liu, LB
AF Peng, Dan-yue
   Song, Hui
   Liu, Ling-bo
TI Resveratrol-downregulated phosphorylated liver kinase B1 is involved in
   senescence of acute myeloid leukemia stem cells
SO JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL
   SCIENCES
LA English
DT Article
DE phosphorylated liver kinase B1 (pLKB1); Sirtuin 1 (SIRT1); resveratrol;
   acute myeloid leukemia (AML); leukemia stem cells (LSCs); cellular
   senescence
ID GROWTH ARREST; LKB1; CANCER; INHIBITION; MUTATIONS; INDUCTION; SENSOR;
   GENE
AB Senescence is an important obstacle to cancer development. Engaging a senescent response may be an effective way to cure acute myeloid leukemia (AML). The aim of this study was to examine the effect of resveratrol-downregulated phosphorylated liver kinase B1 (pLKB1) on the senescence of acute myeloid leukemia (AML) stem cells. The protein expressions of pLKB1 and Sirtuin 1 (SIRT1), a regulator of pLKB1, were measured in CD34(+)CD38(-) KG1a cells treated with resveratrol (40 mu mol/L) or not by Western blotting. Senescence-related factors were examined, including p21 mRNA tested by real-time PCR, cell morphology by senescence-associated beta-galactosidase (SA-beta-gal) staining, cell proliferation by MTT assay and cell cycle by flow cytometry. Besides, apoptosis was flow cytometrically determined. The results showed that pLKB1 was highly expressed in CD34(+)CD38(-) KG1a cells, and resveratrol, which could downregulate pLKB1 through activation of SIRT1, induced senescence and apoptosis of CD34(+)CD38(-) KG1a cells. It was concluded that resveratrol-downregulated pLKB1 is involved in the senescence of AML stem cells.
C1 [Peng, Dan-yue; Song, Hui; Liu, Ling-bo] Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
C3 Huazhong University of Science & Technology
RP Liu, LB (corresponding author), Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
EM 962040850@qq.com; 420520081@qq.com; 1723037335@qq.com
FU National Natural Science Foundation of China [81370660, 81170524]
FX This project was supported by grants from the National Natural Science
   Foundation of China (Nos. 81370660, 81170524).
CR Ablain J, 2014, NAT MED, V20, P167, DOI 10.1038/nm.3441
   Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702
   Bourdeau V, 2014, NAT MED, V20, P123, DOI 10.1038/nm.3469
   Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595
   Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572
   Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38
   Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1
   Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904
   Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055
   Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571
   Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049
   Rowan A, 1999, J INVEST DERMATOL, V112, P509, DOI 10.1046/j.1523-1747.1999.00551.x
   Styczynski J, 2007, ACTA BIOCHIM POL, V54, P717, DOI 10.18388/abp.2007_3140
   Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497
   Wang Y, 2011, RADIAT RES, V176, P743, DOI 10.1667/RR2727.1
   Wang Y, 2011, STEM CELLS DEV, V20, P1143, DOI 10.1089/scd.2010.0413
   Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005
   Xiao Y, 2013, LEUKEMIA RES, V37, P333, DOI 10.1016/j.leukres.2012.11.006
   Zou J, 2012, ANN HEMATOL, V91, P813, DOI 10.1007/s00277-011-1397-7
   Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483
   王建祥, 2011, [中华血液学杂志, Chinese Journal of Hematology], V32, P361
NR 26
TC 20
Z9 21
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1672-0733
EI 1993-1352
J9 J HUAZHONG U SCI-MED
JI J. Huazhong Univ. Sci. Tech.-Med.
PD AUG
PY 2015
VL 35
IS 4
BP 485
EP 489
DI 10.1007/s11596-015-1457-7
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA CN9JC
UT WOS:000358762100003
PM 26223914
DA 2024-02-19
ER

PT J
AU BRILL, S
   HOLST, P
   SIGAL, S
   ZVIBEL, I
   FIORINO, A
   OCHS, A
   SOMASUNDARAN, U
   REID, LM
AF BRILL, S
   HOLST, P
   SIGAL, S
   ZVIBEL, I
   FIORINO, A
   OCHS, A
   SOMASUNDARAN, U
   REID, LM
TI HEPATIC PROGENITOR POPULATIONS IN EMBRYONIC, NEONATAL, AND ADULT LIVER
SO PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
ID OVAL CELLS; STEM-CELL; RAT-LIVER; HEPATOCYTES; DIFFERENTIATION;
   TRANSPLANTATION; CULTURE; SYSTEM
AB Oval cells, small cells with oval-shaped nuclei, are induced to proliferate in the livers of animals treated with carcinogens and are thought to be related to liver stem cells and/or committed liver progenitor cell-populations. We have developed protocols for identifying and isolating antigenically related cell populations present in normal tissues using monoclonal antibodies to oval cell antigens and fluorescence-activated cell sorting. We have isolated oval cell-antigen-positive (OCAP) cells from embryonic, neonatal, and adult rat livers and have identified culture conditions permitting their growth in culture.(5-7) The requirements for growth of the OCAP cells included substrata of type IV collagen mixed with laminin, basal medium with complex lipids and low calcium, specific growth factors (most potently, insulin-like growth factor II and granulocyte-macrophage colony-stimulating factor), and co-cultures of embryonic, liver-specific stroma, strongly suggesting paracrine signaling between hepatic and hemopoietic precursor cells.(5-7) The growing OCAP cultures proved to be uniformly expressing oval cell markers but were nevertheless a mixture of hepatic and hemopoietic precursor cells.
   To separate the hepatic and hemopoietic subpopulations of OCAP cells, we surveyed known antibodies and found ones that uniquely identify either hepatic or hemopoietic cells. Several of these antibodies were used in panning procedures and fluorescence-activated cell sorting to eliminate contaminant cell populations, particularly hemopoietic and endothelial cells.(8) Using specific flow cytometric parameters, three cellular subpopulations could be isolated separately that were identified by immuno-chemistry and molecular hybridization assays as probable: (i) committed progenitors to hepatocytes; (ii) committed progenitors to bile ducts; or (iii) a mixed population of hemopoietic cells that contained a small percentage of hepatic blasts that are possibly pluripotent.(8,9) The hepatic precursor cells have been characterized using immunochemistry, flow cytometry, and molecular hybridization assays. The hepatic blasts are small (7-10 mu m) cells with high nuclear to cytoplasmic ratios and with minimal complexity of the cytoplasm. Cultures of the committed progenitors were found to differentiate into cells with recognizable parenchymal cell fates.
   We discuss our studies in the context of our model of the liver as stem cell and lineage system and suggest that a slow, unidirectional, terminal differentiation process, paralleling more rapid ones in the skin or gut, occurs at all times in the liver and is thought to vary primarily in kinetics during quiescent versus regenerative states. Aging is hypothesized to result in gradual reduction in the liver's regenerative potential due to loss of stem cells. The known zonal distribution in tissue-specific gene expression is interpreted to be a lineage-position-dependent process regulated by gradients of hormones or growth factors, soluble and insoluble matrix signals, and/or maturation-dependent changes in chromatin.
C1 ALBERT EINSTEIN COLL MED, CTR LIVER, BRONX, NY 10461 USA.
   ALBERT EINSTEIN COLL MED, CTR CANC, BRONX, NY 10461 USA.
   ALBERT EINSTEIN COLL MED, DEPT IMMUNOL & MICROBIOL, BRONX, NY 10461 USA.
   ALBERT EINSTEIN COLL MED, DEPT GERIATR, BRONX, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine
RP BRILL, S (corresponding author), ALBERT EINSTEIN COLL MED, DEPT MOLEC PHARMACOL, BRONX, NY 10461 USA.
FU NCI NIH HHS [P30-CA13330] Funding Source: Medline; NIADDK NIH HHS
   [AM17702] Funding Source: Medline; NIDDK NIH HHS [DK44266] Funding
   Source: Medline
CR [Anonymous], 1993, EXTRACELLULAR MATRIX
   ARBER N, 1988, LIVER, V8, P80
   BENNETT AL, 1987, J CELL BIOL, V105, P1073, DOI 10.1083/jcb.105.3.1073
   BRILL S, IN PRESS LIVER BIOL
   EVARTS RP, 1989, CANCER RES, V49, P1541
   FARIS RA, 1991, CANCER RES, V51, P1308
   GEBHARDT R, 1988, SCAND J GASTROENTERO, V23, P8, DOI 10.3109/00365528809095909
   GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5
   GERMAIN L, 1988, CANCER RES, V48, P368
   Grisham J W, 1980, Ann N Y Acad Sci, V349, P128, DOI 10.1111/j.1749-6632.1980.tb29521.x
   HIXSON DC, 1990, PATHOBIOLOGY, V58, P65, DOI 10.1159/000163565
   KRAFT A, 1992, CONTRIB ONCOL, V44, P203
   KUO FC, 1991, MOL CELL BIOL, V11, P6050, DOI 10.1128/MCB.11.12.6050
   MARTINEZHERNAND.A, 1993, EXTRACELLULAR MATRIX, P255
   PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217
   POTTER VR, 1981, ONCODEV BIOL MED, V2, P243
   Reid LM, 1990, CURR OPIN CELL BIOL, V2, P121, DOI 10.1016/S0955-0674(05)80042-0
   REID LM, 1992, HEPATOLOGY, V15, P1198, DOI 10.1002/hep.1840150635
   ROSENBERG E, 1992, EUR J CELL BIOL, V59, P21
   SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6
   SELL S, 1990, CANCER RES, V50, P3811
   SELL S, 1990, CURR OPIN CELL BIOL, V2, P1036
   SIGAL S, 1993, EXTRACELLULAR MATRIX, P507
   SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139
   SIRICA AE, 1990, PATHOBIOLOGY, V58, P44, DOI 10.1159/000163564
   WILSON JW, 1958, J PATHOL BACTERIOL, V76, P441, DOI 10.1002/path.1700760213
NR 26
TC 76
Z9 85
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0037-9727
J9 P SOC EXP BIOL MED
JI Proc. Soc. Exp. Biol. Med.
PD DEC
PY 1993
VL 204
IS 3
BP 261
EP 269
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA PC073
UT WOS:A1993PC07300004
PM 8234369
DA 2024-02-19
ER

PT J
AU Gao, Y
   Zhang, W
   Zeng, LQ
   Bai, H
   Li, J
   Zhou, J
   Zhou, GY
   Fang, CW
   Wang, F
   Qin, XJ
AF Gao, Yu
   Zhang, Wei
   Zeng, Li-Qin
   Bai, Hua
   Li, Jia
   Zhou, Jian
   Zhou, Geng-Yao
   Fang, Cong-Wen
   Wang, Feng
   Qin, Xu-Jun
TI Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD
   and liver aging by inducing lipophagy
SO REDOX BIOLOGY
LA English
DT Article
DE Nonalcoholic fatty liver disease (NAFLD); Lipophagy; FGF21; Exercise;
   Aging
ID OXIDATIVE STRESS; SKELETAL-MUSCLE; LIPID-ACCUMULATION;
   INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; AUTOPHAGY; FGF21; DISEASE;
   METABOLISM; OBESITY
AB Exercise and dietary intervention are currently available strategies to treat nonalcoholic fatty liver disease (NAFLD), while the underlying mechanism remains controversial. Emerging evidence shows that lipophagy is involved in the inhibition of the lipid droplets accumulation. However, it is still unclear if exercise and dietary intervention improve NAFLD through regulating lipophagy, and how exercise of skeletal muscle can modulate lipid metabolism in liver. Moreover, NAFLD is associated with aging, and little is known about the effect of lipid accumulation on aging process. Here in vivo and in vitro models, we found that exercise and dietary intervention reduced lipid droplets formation, decreased hepatic triglyceride in the liver induced by high-fat diet. Exercise and dietary intervention enhanced the lipophagy by activating AMPK/ULK1 and inhibiting Akt/mTOR/ULK1 pathways respectively. Furthermore, exercise stimulated FGF21 production in the muscle, followed by secretion to the circulation to promote the lipophagy in the liver via an AMPK-dependent pathway. Importantly, for the first time, we demonstrated that lipid accumulation exacerbated liver aging, which was ameliorated by exercise and dietary intervention through inducing lipophagy. Our findings suggested a new mechanism of exercise and dietary intervention to improve NAFLD through promoting lipophagy. The study also provided evidence to support that muscle exercise is beneficial to other metabolic organs such as liver. The FGF21-mediated AMPK dependent lipophagy might be a potential drug target for NAFLD and aging caused by lipid metabolic dysfunction.
C1 [Gao, Yu; Zhou, Jian; Zhou, Geng-Yao; Fang, Cong-Wen; Wang, Feng; Qin, Xu-Jun] Fourth Mil Med Univ, Sch Prevent Med, Dept Nutr & Food Hyg, 169 Changle West Rd, Xian 710032, Peoples R China.
   [Zhang, Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiovasc Dis, Xian 710032, Peoples R China.
   [Zeng, Li-Qin] Fourth Mil Med Univ, Xijing Hosp, Dept Ultrasound, Xian 710032, Peoples R China.
   [Bai, Hua] Fourth Mil Med Univ, Sch Prevent Med, Dept Toxicol, Xian 710032, Peoples R China.
   [Li, Jia] Fourth Mil Med Univ, Dept Aerosp Med, Xian 710032, Peoples R China.
C3 Air Force Military Medical University; Air Force Military Medical
   University; Air Force Military Medical University; Air Force Military
   Medical University; Air Force Military Medical University
RP Wang, F; Qin, XJ (corresponding author), Fourth Mil Med Univ, Sch Prevent Med, Dept Nutr & Food Hyg, 169 Changle West Rd, Xian 710032, Peoples R China.
EM wfeng@fmmu.edu.cn; qinxujun@hotmail.com
FU National Natural Science Foundation of China [31670863, 81270417,
   81573127, 81470537]; Natural Science Foundation of Shaanxi Province
   [2016JZ027, 2019JM-130]; Ministry of Education Key Lab of Hazard
   Assessment and Control in Special Operational Environment; Shaanxi Key
   Laboratory of Free Radical Biology and Medicine; State Key Laboratory of
   Cancer Biology
FX This work was supported by National Natural Science Foundation of China
   (31670863, 81270417, 81573127, 81470537) and Natural Science Foundation
   of Shaanxi Province (2016JZ027, 2019JM-130). This work was also
   supported by the Ministry of Education Key Lab of Hazard Assessment and
   Control in Special Operational Environment, Shaanxi Key Laboratory of
   Free Radical Biology and Medicine, and State Key Laboratory of Cancer
   Biology.
CR Akoumi A, 2017, EXP CELL RES, V354, P85, DOI 10.1016/j.yexcr.2017.03.032
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025
   Cho Jinkyung, 2014, J Exerc Nutrition Biochem, V18, P339, DOI 10.5717/jenb.2014.18.4.339
   Christian P, 2013, BBA-MOL CELL BIOL L, V1831, P819, DOI 10.1016/j.bbalip.2012.12.009
   Chun SK, 2017, EXERC SPORT SCI REV, V45, P181, DOI 10.1249/JES.0000000000000116
   Codogno P, 2010, CELL METAB, V11, P449, DOI 10.1016/j.cmet.2010.05.006
   Cox KL, 2003, METABOLISM, V52, P107, DOI 10.1053/meta.2003.50017
   Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022
   Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x
   Dong HQ, 2011, TRENDS ENDOCRIN MET, V22, P234, DOI 10.1016/j.tem.2011.02.003
   Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006
   Farzanegi P, 2019, EUR J SPORT SCI, V19, P994, DOI 10.1080/17461391.2019.1571114
   Fatouros IG, 2018, CLIN CHEM LAB MED, V56, P525, DOI 10.1515/cclm-2017-0674
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fletcher JA, 2016, AM J PHYSIOL-GASTR L, V310, pG832, DOI 10.1152/ajpgi.00355.2015
   Fu TT, 2018, CELL REP, V23, P1357, DOI 10.1016/j.celrep.2018.03.127
   Giralt M, 2015, MOL CELL ENDOCRINOL, V418, P66, DOI 10.1016/j.mce.2015.09.018
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   González-Rodríguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162
   Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P237, DOI 10.3748/wjg.v18.i3.237
   He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021
   Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166
   Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Kirkwood L, 2007, INT J FOOD SCI NUTR, V58, P383, DOI 10.1080/09637480701252336
   Kwanten WJ, 2014, WORLD J GASTROENTERO, V20, P7325, DOI 10.3748/wjg.v20.i23.7325
   Lam T, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.61
   Laurens C, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00091
   Leal LG, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01307
   Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004
   Lewis JE, 2019, TRENDS ENDOCRIN MET, V30, P491, DOI 10.1016/j.tem.2019.05.007
   Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513
   Linden MA, 2014, AM J PHYSIOL-ENDOC M, V306, pE300, DOI 10.1152/ajpendo.00427.2013
   Luo Yongde, 2013, Front Endocrinol (Lausanne), V4, P194, DOI 10.3389/fendo.2013.00194
   Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Moller AB, 2015, J APPL PHYSIOL
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ost M, 2016, FREE RADICAL BIO MED, V98, P78, DOI 10.1016/j.freeradbiomed.2016.02.018
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Proenca CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068357
   Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Romero-Gómez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016
   Sabaratnam R, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13723
   Salminen A, 2017, J MOL MED, V95, P123, DOI 10.1007/s00109-016-1477-1
   Savitha S, 2007, EUR J PHARMACOL, V574, P61, DOI 10.1016/j.ejphar.2007.07.016
   Schlein C, 2016, CELL METAB, V23, P441, DOI 10.1016/j.cmet.2016.01.006
   Schulze RJ, 2017, HEPATOL COMMUN, V1, P359, DOI 10.1002/hep4.1056
   Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736
   Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895
   Severinsen MCK, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa016
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Singh K, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-70
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   So B, 2014, INTEGR MED RES, V3, P172, DOI 10.1016/j.imr.2014.09.007
   So WY, 2016, INT J BIOCHEM CELL B, V78, P237, DOI 10.1016/j.biocel.2016.07.022
   Straub L, 2015, MOL METAB, V4, P605, DOI 10.1016/j.molmet.2015.06.008
   Takagi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18944
   Tang H, 2016, EBIOMEDICINE, V6, P139, DOI 10.1016/j.ebiom.2016.02.041
   Tanimura Y, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12828
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Valentine RJ, 2014, ARCH BIOCHEM BIOPHYS, V562, P62, DOI 10.1016/j.abb.2014.08.013
   Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057
   Zhao L, 2014, EXP GERONTOL, V56, P3, DOI 10.1016/j.exger.2014.02.001
   Zhao Y, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0648-1
NR 77
TC 92
Z9 108
U1 15
U2 86
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD SEP
PY 2020
VL 36
AR 101635
DI 10.1016/j.redox.2020.101635
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA NQ7ZX
UT WOS:000571089100002
PM 32863214
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wang, DX
   Wang, TT
   Li, ZM
   Guo, YX
   Granato, D
AF Wang, Dongxu
   Wang, Taotao
   Li, Zhanming
   Guo, Yuanxin
   Granato, Daniel
TI Green Tea Polyphenols Upregulate the Nrf2 Signaling Pathway and Suppress
   Oxidative Stress and Inflammation Markers in D-Galactose-Induced Liver
   Aging in Mice
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE green tea polyphenols (GTPs); aging; antioxidants; D-galactose;
   inflammatory cytokines; Nrf2 signaling pathway
ID ANTIOXIDANT ENZYMES; INJURY; DISEASES; EXPRESSION; APOPTOSIS; PRODUCTS;
   PROTECTS; PI3K/AKT; CELLS
AB The beneficial effects of green tea polyphenols (GTPs) on D-galactose (D-Gal)-induced liver aging in male Kunming mice were investigated. For this purpose, 40 adult male Kunming mice were divided into four groups. All animals, except for the normal control and GTPs control, were intraperitoneally injected with D-galactose (D-Gal; 300 mg/kg/day for 5 days a week) for 12 consecutive weeks, and the D-Gal-treated mice were allowed free access to 0.05% GTPs (w/w) diet or normal diet for 12 consecutive weeks. Results showed that GTP administration improved the liver index and decreased transaminases and total bilirubin levels. Furthermore, GTPs significantly increased hepatic glutathione and total antioxidant levels, and the activities of superoxide dismutase, catalase, and glutathione S-transferase (GST). Furthermore, GTPs downregulated 8-hydroxy-2-deoxyguanosine, advanced glycation end products, and hepatic oxidative stress markers, such as malondialdehyde and nitric oxide. Additionally, GTPs abrogated dysregulation in hepatic Kelch-like ECH-associated protein 1 and nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream target gene expression [heme oxygenase 1, NAD(P)H:quinone oxidoreductase 1, and GST] and inhibited tumor necrosis factor-alpha, transforming growth factor-beta, and interleukin (IL)-1 beta and IL-6 in the liver of treated mice. Finally, GTPs effectively attenuated D-Gal-induced edema, vacuole formation, and inflammatory cell infiltration. In conclusion, GTPs showed antioxidant and anti-inflammatory properties in D-Gal-induced aging mice, and may be considered a natural alternative to the effects of hepatic aging.
C1 [Wang, Dongxu; Li, Zhanming; Guo, Yuanxin] Jiangsu Univ Sci & Technol, Sch Grain Sci & Technol, Zhenjiang, Jiangsu, Peoples R China.
   [Wang, Taotao] Jiangsu Univ, Dept Clin Nutr, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China.
   [Granato, Daniel] Univ Limerick, Fac Sci & Engn, Dept Biol Sci, Limerick, Ireland.
C3 Jiangsu University of Science & Technology; Jiangsu University;
   University of Limerick
RP Wang, DX (corresponding author), Jiangsu Univ Sci & Technol, Sch Grain Sci & Technol, Zhenjiang, Jiangsu, Peoples R China.
EM wdx@just.edu.cn
RI Li, Zhanming/Q-9510-2019; wang, tao/HLG-5649-2023; Li,
   Zhanming/AFS-6484-2022; Granato, Daniel/AAC-6151-2019
OI Li, Zhanming/0000-0003-0872-3310; Li, Zhanming/0000-0003-0872-3310;
   Granato, Daniel/0000-0002-4533-1597
FU Natural Science Foundation of Jiangsu Province [BK20210881]; Jiangsu
   University of Science and Technology
FX Funding This research was supported by the Natural Science Foundation of
   Jiangsu Province (BK20210881) and a talent fund from the Jiangsu
   University of Science and Technology.
CR Arruda HS, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104203
   Boland BS, 2014, J CLIN EXP HEPATOL, V4, P1, DOI 10.1016/j.jceh.2014.01.003
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   El-Beshbishy Hesham A, 2011, Pathophysiology, V18, P125, DOI 10.1016/j.pathophys.2010.08.002
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Granato D, 2020, TRENDS FOOD SCI TECH, V98, P162, DOI 10.1016/j.tifs.2020.01.010
   Hirsch N, 2016, MOL NUTR FOOD RES, V60, P2542, DOI 10.1002/mnfr.201600221
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Hu SJ, 2019, WORLD J CLIN CASES, V7, P691, DOI 10.12998/wjcc.v7.i6.691
   Iranshahy M, 2018, FOOD CHEM TOXICOL, V120, P261, DOI 10.1016/j.fct.2018.07.024
   Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kucera O, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/476180
   Li J, 2019, J AGR FOOD CHEM, V67, P7832, DOI 10.1021/acs.jafc.9b02567
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lord SR, 2018, HAND CLINIC, V159, P157, DOI 10.1016/B978-0-444-63916-5.00010-0
   Miyagawa C, 1997, BIOSCI BIOTECH BIOCH, V61, P1901, DOI 10.1271/bbb.61.1901
   Moldogazieva NT, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3085756
   Mu XY, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3508907
   Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006
   Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016
   Oz HS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060561
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   Ramos-Tovar E, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9121279
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Shanware NP, 2013, ANNU REV PHARMACOL, V53, P89, DOI 10.1146/annurev-pharmtox-010611-134717
   Sharma R, 2019, EUR J NUTR, V58, P2943, DOI 10.1007/s00394-018-01890-6
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Tian WH, 2021, J FOOD SCI, V86, P2736, DOI 10.1111/1750-3841.15744
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014
   Wang DX, 2020, FOOD CHEM TOXICOL, V144, DOI 10.1016/j.fct.2020.111576
   Wang DX, 2019, FOOD FUNCT, V10, P3898, DOI [10.1039/C9FO00572B, 10.1039/c9fo00572b]
   Wang DX, 2017, FOOD FUNCT, V8, P3165, DOI 10.1039/c7fo00791d
   Wang DX, 2015, TOXICOL APPL PHARM, V283, P65, DOI 10.1016/j.taap.2014.12.018
   Wang XX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54691-0
   Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.10.2783S
   Xia HM, 2019, INT J MOL MED, V44, P1523, DOI 10.3892/ijmm.2019.4285
   Xiao Y, 2018, FOOD CHEM TOXICOL, V119, P141, DOI 10.1016/j.fct.2018.05.017
   Xing LJ, 2019, J AGR FOOD CHEM, V67, P1029, DOI 10.1021/acs.jafc.8b06146
   Xu L, 2016, INT J HYPERTHER, V32, P465, DOI 10.3109/02656736.2016.1155762
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yin XS, 2015, J CARDIOVASC PHARM T, V20, P428, DOI 10.1177/1074248414568196
   Zhang Y, 2015, FOOD FUNCT, V6, P927, DOI [10.1039/c4fo01051e, 10.1039/C4FO01051E]
   Zhang ZF, 2010, FOOD CHEM TOXICOL, V48, P2500, DOI 10.1016/j.fct.2010.06.023
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
NR 51
TC 9
Z9 9
U1 7
U2 31
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD FEB 23
PY 2022
VL 9
AR 836112
DI 10.3389/fnut.2022.836112
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 2B8BX
UT WOS:000810408700001
PM 35284456
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Piscaglia, F
   Gaiani, S
   Zironi, G
   Gramantieri, L
   Casali, A
   Siringo, S
   Serra, C
   Bolondi, L
AF Piscaglia, F
   Gaiani, S
   Zironi, G
   Gramantieri, L
   Casali, A
   Siringo, S
   Serra, C
   Bolondi, L
TI Intra- and extrahepatic arterial resistances in chronic hepatitis and
   liver cirrhosis
SO ULTRASOUND IN MEDICINE AND BIOLOGY
LA English
DT Article; Proceedings Paper
CT 31st EASL Meeting
CY AUG, 1995
CL COPENHAGEN, DENMARK
SP EASL, Minist Univ Ricerca Sci & Tecnol
DE ageing; chronic hepatitis; Doppler effect; hepatic artery; liver
   cirrhosis; portal hypertension; ultrasound
ID PORTAL-VEIN THROMBOSIS; VARICEAL HEMORRHAGE; DOPPLER; ENDOSCOPY;
   HYPERTENSION; HEMODYNAMICS; FLOWMETRY; DISEASE; RATS
AB Thirty patients with chronic hepatitis (CH), 84 with liver cirrhosis (LC) and 42 controls, underwent noninvasive measurement of hepatic artery resistance index (RI) by means of Doppler ultrasound (US), at the porta hepatis and in the intrahepatic branches, in order to investigate possible changes related to: (a) the liver disease; (b) the site of measurement; and (c) ageing, The intrahepatic RI differed among LC, CH and controls (0.731, 0.690 and 0.633, p < 0.05), whereas the RI at the porta hepatis did not (0.754, 0.748 and 0.729, respectively), Intrahepatic RI correlated with age in LC (r=0,51,p < 0.0001) and in controls (r = 0.49, p < 0.001), In LC, it correlated also with the presence and size of esophageal varices (r = 0.32, p < 0.05), In conclusion, an increase of hepatic artery RI in chronic liver diseases can be demonstrated when assessed in the intraparenchymal branches, The increase of hepatic artery RI with ageing should be considered in future studies, (C) 1997 World Federation for Ultrasound in Medicine and Biology.
C1 UNIV BOLOGNA,DIPARTIMENTO MED INTERNA & GASTROENTEROL,I-40138 BOLOGNA,ITALY.
C3 University of Bologna
RI Gramantieri, Laura/K-8603-2016; Gramantieri, Laura/J-3862-2019;
   Piscaglia, Fabio/AAC-6899-2022; Piscaglia, Fabio/GRY-4468-2022
OI Gramantieri, Laura/0000-0002-5187-9559; Piscaglia,
   Fabio/0000-0001-8264-1845; Piscaglia, Fabio/0000-0001-8264-1845
CR ALPERN MB, 1987, RADIOLOGY, V162, P53, DOI 10.1148/radiology.162.1.3538152
   BARBARA L, 1990, Journal of Hepatology, V10, P353, DOI 10.1016/0168-8278(90)90146-I
   BEPPU K, 1981, GASTROINTEST ENDOSC, V27, P213, DOI 10.1016/S0016-5107(81)73224-3
   Bolognesi M, 1996, HEPATOLOGY, V23, P1035
   Ekataksin W., 1995, Hepatology, V22, p159A, DOI 10.1016/0270-9139(95)94359-5
   FERNANDEZMUNOZ D, 1985, AM J PHYSIOL, V249, pG316, DOI 10.1152/ajpgi.1985.249.3.G316
   GOSLING RG, 1971, ANGIOLOGY, V22, P52, DOI 10.1177/000331977102200109
   JAMES OFW, 1990, LIVER AGING 1990, P210
   JOYNT LK, 1995, RADIOLOGY, V196, P489, DOI 10.1148/radiology.196.2.7617865
   KASSISSIA I, 1993, HEPATOLOGY, V18, P1189
   LEE SS, 1987, GASTROENTEROLOGY, V93, P157, DOI 10.1016/0016-5085(87)90328-3
   MORIYASU F, 1986, GASTROENTEROLOGY, V90, P710, DOI 10.1016/0016-5085(86)91127-3
   PIERCE M E, 1990, Australasian Radiology, V34, P331, DOI 10.1111/j.1440-1673.1990.tb02667.x
   PLATT JF, 1995, RADIOLOGY, V196, P95, DOI 10.1148/radiology.196.1.7784597
   PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
   RIGSBY CM, 1987, RADIOLOGY, V162, P39, DOI 10.1148/radiology.162.1.3538151
   SABBA C, 1995, HEPATOLOGY, V21, P428, DOI 10.1016/0270-9139(95)90103-5
   SACERDOTI D, 1995, GASTROENTEROLOGY, V108, P1152, DOI 10.1016/0016-5085(95)90214-7
   SACERDOTI D, 1993, HEPATOLOGY, V17, P219, DOI 10.1002/hep.1840170210
   SCHENK WG, 1962, ANN SURG, V156, P463, DOI 10.1097/00000658-196209000-00013
   SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532
   SIRINGO S, 1994, HEPATOLOGY, V20, P66, DOI 10.1016/0270-9139(94)90135-X
   SIRINGO S, 1994, J HEPATOL, V20, P11, DOI 10.1016/S0168-8278(05)80461-1
   SKIDMORE R, 1980, ULTRASOUND MED BIOL, V6, P227, DOI 10.1016/0301-5629(80)90017-4
   TERRY JD, 1992, J ULTRAS MED, V11, P647
   TONI R, 1985, J CLIN ULTRASOUND, V13, P611
   VASSILIADES VG, 1993, ABDOM IMAGING, V18, P61, DOI 10.1007/BF00201704
   VOROBIOFF J, 1984, GASTROENTEROLOGY, V87, P1120
   WATANABE Y, 1994, HEPATOLOGY, V19, P1198, DOI 10.1016/0270-9139(94)90867-2
   ZIRONI G, 1994, EUR J ULTRASOUND, V1, P51
   ZOLI M, 1993, J HEPATOL, V17, P56, DOI 10.1016/S0168-8278(05)80521-5
NR 31
TC 44
Z9 44
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0301-5629
J9 ULTRASOUND MED BIOL
JI Ultrasound Med. Biol.
PY 1997
VL 23
IS 5
BP 675
EP 682
DI 10.1016/S0301-5629(97)00012-4
PG 8
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA XJ933
UT WOS:A1997XJ93300004
PM 9253815
DA 2024-02-19
ER

PT J
AU Amin, B
   Ford, KI
   Robinson, RAS
AF Amin, Bushra
   Ford, Katarena, I
   Robinson, Rena A. S.
TI Quantitative proteomics to study aging in rabbit liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE cPILOT; Enhanced multiplexing; Aging; Liver; Rabbit; Metabolism;
   Proteomics; Oryctolagus cuniculus
ID AGE-RELATED-CHANGES; GENE-EXPRESSION; ATP SYNTHASE; RIBOSOMAL-PROTEINS;
   ISCHEMIC-STROKE; MOUSE MODELS; REVEALS AGE; CYTOCHROME-P450; PROFILES;
   DISEASE
AB Aging globally effects cellular and organismal metabolism across a range of mammalian species, including humans and rabbits. Rabbits (Oryctolagus cuniculus are an attractive model system of aging due to their genetic similarity with humans and their short lifespans. This model can be used to understand metabolic changes in aging especially in major organs such as liver where we detected pronounced variations in fat metabolism, mitochondrial dysfunction, and protein degradation. Such changes in the liver are consistent across several mammalian species however in rabbits the downstream effects of these changes have not yet been explored. We have applied proteomics to study changes in the liver proteins from young, middle, and old age rabbits using a multiplexing cPILOT strategy. This resulted in the identification of 2,586 liver proteins, among which 45 proteins had significant p< 0.05) changes with aging. Seven proteins were differentially-expressed at all ages and include fatty acid binding protein, aldehyde dehydrogenase, enoyl-CoA hydratase, 3-hydroxyacyl CoA dehydrogenase, apolipoprotein C3, peroxisomal sarcosine oxidase, adhesion G-protein coupled receptor, and glutamate ionotropic receptor kinate. Insights to how alterations in metabolism affect protein expression in liver have been gained and demonstrate the utility of rabbit as a model of aging.
C1 [Amin, Bushra; Ford, Katarena, I; Robinson, Rena A. S.] Vanderbilt Univ, Dept Chem, 5423 Stevenson Ctr, Nashville, TN 37235 USA.
   [Ford, Katarena, I; Robinson, Rena A. S.] Vanderbilt Univ, Dept Neurol, Med Ctr, Nashville, TN 37232 USA.
   [Ford, Katarena, I; Robinson, Rena A. S.] Vanderbilt Memory & Alzheimers Ctr, Nashville, TN 37212 USA.
   [Ford, Katarena, I; Robinson, Rena A. S.] Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.
   [Ford, Katarena, I; Robinson, Rena A. S.] Vanderbilt Brain Inst, Nashville, TN 37232 USA.
C3 Vanderbilt University; Vanderbilt University; Vanderbilt University;
   Vanderbilt University
RP Robinson, RAS (corresponding author), Vanderbilt Univ, Dept Chem, 5423 Stevenson Ctr, Nashville, TN 37235 USA.
EM rena.as.robinson@vanderbilt.edu
FU 2017 American Society of Mass Spectrometry Career Development Award;
   Vanderbilt University Start -up funds; NIH, NIGMS [R01GM117191]; NCI/NIH
   Cancer Center Support Grant [5P30 CA68485-19]; Vanderbilt Mouse
   Metabolic Phenotyping Center Grant [2 U24 DK059637-16]
FX The authors acknowledge Prof. Dr. Nam Vo, University of Pittsburgh for
   rabbit tissues and a 2017 American Society of Mass Spectrometry Career
   Development Award to BA. This study was supported by Vanderbilt
   University Start -up funds and NIH, NIGMS (R01GM117191) funds to RASR.
   The authors acknowledge the Translational Pathology Shared Resource
   supported by NCI/NIH Cancer Center Support Grant5P30 CA68485-19 and the
   Vanderbilt Mouse Metabolic Phenotyping Center Grant2 U24 DK059637-16.
CR Abdollahi Hamed, 2017, Gastroenterol Hepatol Bed Bench, V10, pS146
   Alfoeldi Jessica, 2009, P129, DOI 10.1007/978-90-481-2227-1_11
   Amelina H, 2011, J CHROMATOGR B, V879, P3393, DOI 10.1016/j.jchromb.2011.08.044
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   Armand-Ugon M, 2017, CURR ALZHEIMER RES, V14, P1327, DOI 10.2174/1567205014666170505095921
   Au A, 2017, ATHEROSCLEROSIS, V265, P60, DOI 10.1016/j.atherosclerosis.2017.08.003
   Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319
   Aumailley L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193170
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Basisty N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700108
   Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025
   Boberg M, 2017, DRUG METAB DISPOS, V45, P216, DOI 10.1124/dmd.116.072652
   Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029
   Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714
   Cha MY, 2015, HUM MOL GENET, V24, P6492, DOI 10.1093/hmg/ddv358
   Chakravarti Bulbul, 2017, Curr Aging Sci, V10, P246, DOI 10.2174/1874609810666170315112634
   Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562
   CHOOI WY, 1981, MOL GEN GENET, V184, P342, DOI 10.1007/BF00352502
   Cizkova K, 2014, ORGANOGENESIS, V10, P53, DOI 10.4161/org.27911
   Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003
   Doran P, 2006, BBA-PROTEINS PROTEOM, V1764, P773, DOI 10.1016/j.bbapap.2006.01.007
   Du B, 2014, INT J MOL MED, V34, P578, DOI 10.3892/ijmm.2014.1806
   Durani LW, 2017, BIOCHEM BIOPH RES CO, V493, P1356, DOI 10.1016/j.bbrc.2017.09.164
   Emahazion T, 1998, CYTOGENET CELL GENET, V82, P114, DOI 10.1159/000015081
   Evans AR, 2015, PROTEOM CLIN APPL, V9, P872, DOI 10.1002/prca.201400149
   Evans AR, 2013, PROTEOMICS, V13, P3267, DOI 10.1002/pmic.201300198
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Frost DC, 2018, ANAL CHEM, V90, P10664, DOI 10.1021/acs.analchem.8b01301
   Frost DC, 2016, METHODS MOL BIOL, V1410, P169, DOI 10.1007/978-1-4939-3524-6_10
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Govindaraj V, 2018, GEN COMP ENDOCR, V266, P126, DOI 10.1016/j.ygcen.2018.05.005
   Gurkar AU, 2015, EXP GERONTOL, V68, P43, DOI 10.1016/j.exger.2015.01.045
   Han SJ, 2013, J ORTHOP SCI, V18, P885, DOI 10.1007/s00776-013-0444-8
   Hartl FU, 2016, ANNU REV BIOCHEM, V85, P1, DOI 10.1146/annurev-biochem-011116-110806
   Hasenan SM, 2018, EXP GERONTOL, V113, P1, DOI 10.1016/j.exger.2018.09.001
   Havlícková V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009
   Hirschey MD, 2011, AGING-US, V3, P635, DOI 10.18632/aging.100339
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Holper L, 2019, NEUROPSYCHOPHARMACOL, V44, P837, DOI 10.1038/s41386-018-0090-0
   Hu LT, 2017, BIOCHEM BIOPH RES CO, V486, P492, DOI 10.1016/j.bbrc.2017.03.069
   Hu SX, 2013, POULTRY SCI, V92, P1283, DOI 10.3382/ps.2012-02911
   Janus Jeffrey R, 2018, BMC Res Notes, V11, P666, DOI 10.1186/s13104-018-3750-6
   Jun GR, 2017, ALZHEIMERS DEMENT, V13, P727, DOI 10.1016/j.jalz.2016.12.012
   Kawai Y, 2013, AM J PHYSIOL-CELL PH, V305, pC1139, DOI 10.1152/ajpcell.00199.2013
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   Khatir DS, 2017, SCAND J CLIN LAB INV, V77, P549, DOI 10.1080/00365513.2017.1355561
   Kim Y, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700240
   King CD, 2018, J PROTEOMICS, V181, P92, DOI 10.1016/j.jprot.2018.04.006
   Kinirons MT, 2004, BRIT J CLIN PHARMACO, V57, P540, DOI 10.1111/j.1365-2125.2004.02096.x
   Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001
   Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001
   KVANNES J, 1994, BBA-GEN SUBJECTS, V1201, P203, DOI 10.1016/0304-4165(94)90042-6
   Lavery WL, 2002, GERONTOLOGY, V48, P369, DOI 10.1159/000065505
   Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006
   Li B, 2011, PROTEOMICS, V11, P3359, DOI 10.1002/pmic.201100001
   Li DG, 2018, AGING-US, V10, P1192, DOI 10.18632/aging.101460
   Li FH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3269405
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Liu XL, 2008, MOL VIS, V14, P2404
   Liu Y, 2018, J PROTEOME RES, V17, P2318, DOI 10.1021/acs.jproteome.8b00012
   Liu YS, 2008, MOL CELL PROTEOMICS, V7, P1737, DOI 10.1074/mcp.M800109-MCP200
   Liu Y, 2017, EXP EYE RES, V154, P53, DOI 10.1016/j.exer.2016.11.001
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lv P, 2018, INT J MOL MED, V41, P61, DOI 10.3892/ijmm.2017.3216
   Marchais-Oberwinkler S, 2011, J STEROID BIOCHEM, V125, P66, DOI 10.1016/j.jsbmb.2010.12.013
   Martin GG, 2008, J NUTR, V138, P1859, DOI 10.1093/jn/138.10.1859
   Martin GG, 2018, LIPIDS, V53, P27, DOI 10.1002/lipd.12008
   MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6
   Hurtado-López LM, 2015, MED SCI MONITOR, V21, P1745, DOI 10.12659/MSM.893597
   Mc Auley MT, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160177
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Mi J, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-19
   Mi J, 2007, PROTEOMICS, V7, P1916, DOI 10.1002/pmic.200600638
   Miller I, 2014, CURR PROTEIN PEPT SC, V15, P134, DOI 10.2174/1389203715666140221115135
   Miura Y, 2018, BBA-GEN SUBJECTS, V1862, P1462, DOI 10.1016/j.bbagen.2018.03.025
   Miyahara H, 2018, J PROTEOMICS, V172, P111, DOI 10.1016/j.jprot.2017.10.003
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Mu WC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070918
   Olona A, 2018, MOL METAB, V11, P18, DOI 10.1016/j.molmet.2018.03.003
   Pascovici D, 2016, PROTEOMICS, V16, P2448, DOI 10.1002/pmic.201600044
   Paulo JA, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700475
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524
   Plumel MI, 2016, J PROTEOMICS, V135, P181, DOI 10.1016/j.jprot.2015.09.008
   Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844
   Reams RR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/132981
   Robinson RAS, 2012, ANAL CHEM, V84, P4677, DOI 10.1021/ac202000v
   Sahasrabuddhe NA, 2014, J PROTEOMICS, V108, P306, DOI 10.1016/j.jprot.2014.04.027
   Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200
   Sowell RA, 2007, J PROTEOME RES, V6, P3637, DOI 10.1021/pr070224h
   Sun MZ, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0614-3
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Takada H, 2015, CELL MOL LIFE SCI, V72, P4015, DOI 10.1007/s00018-015-1984-1
   Tanaka T, 2018, AGING CELL, V17, DOI 10.1111/acel.12799
   Vilà-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044
   Wang PW, 2017, ONCOTARGET, V8, P88951, DOI 10.18632/oncotarget.21627
   Wang W, 2017, DRUG DISCOV TODAY, V22, P912, DOI 10.1016/j.drudis.2016.12.006
   Wang YZ, 2017, J INT MED RES, V45, P2042, DOI 10.1177/0300060517713517
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Williams EG, 2018, MOL CELL PROTEOMICS, V17, P1766, DOI 10.1074/mcp.RA118.000554
   Woudstra TD, 2004, LIPIDS, V39, P603, DOI 10.1007/s11745-004-1272-9
   Wulff AB, 2018, ARTERIOSCL THROM VAS, V38, P660, DOI 10.1161/ATVBAHA.117.310473
   Yao L, 2018, CELL PHYSIOL BIOCHEM, V45, P984, DOI 10.1159/000487293
   Yousefzadeh MJ, 2019, METHODS MOL BIOL, V1896, P203, DOI 10.1007/978-1-4939-8931-7_17
   Zhang DJ, 2018, J AGR FOOD CHEM, V66, P5510, DOI 10.1021/acs.jafc.8b00446
   Zhang SJ, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2018.01.013
   Zhou L, 2013, PROTEOMICS, V13, P2469, DOI 10.1002/pmic.201200230
   Zhou L, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay075
NR 114
TC 9
Z9 10
U1 0
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD APR
PY 2020
VL 187
AR 111227
DI 10.1016/j.mad.2020.111227
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LG5TY
UT WOS:000528164000004
PM 32126221
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Sheedfar, F
   Sung, MMY
   Aparicio-Vergara, M
   Kloosterhuis, NJ
   Miquilena-Colina, ME
   Vargas-Castrillón, J
   Febbraio, M
   Jacobs, RL
   de Bruin, A
   Vinciguerra, M
   García-Monzón, C
   Hofker, MH
   Dyck, JRB
   Koonen, DPY
AF Sheedfar, Fareeba
   Sung, Miranda M. Y.
   Aparicio-Vergara, Marcela
   Kloosterhuis, Niels J.
   Eugenia Miquilena-Colina, Maria
   Vargas-Castrillon, Javier
   Febbraio, Maria
   Jacobs, Rene L.
   de Bruin, Alain
   Vinciguerra, Manlio
   Garcia-Monzon, Carmelo
   Hofker, Marten H.
   Dyck, Jason R. B.
   Koonen, Debby P. Y.
TI Increased hepatic CD36 expression with age is associated with enhanced
   susceptibility to nonalcoholic fatty liver disease
SO AGING-US
LA English
DT Article
DE CD36; aging; liver; steatosis; inflammation; obesity; NAFLD; NASH
ID ACID TRANSPORT; SKELETAL-MUSCLE; CARDIAC MYOCYTES; PLASMA-MEMBRANE;
   INCREASED RATES; INSULIN; MICE; STEATOHEPATITIS; TRANSLOCATION;
   ACCUMULATION
AB CD36 has been associated with obesity and diabetes in human liver diseases, however, its role in age-associated nonalcoholic fatty liver disease (NAFLD) is unknown. Therefore, liver biopsies were collected from individuals with histologically normal livers (n=30), and from patients diagnosed with simple steatosis (NAS; n=26). Patients were divided into two groups according to age and liver biopsy samples were immunostained for CD36. NAFLD parameters were examined in young (12-week) and middle-aged (52-week) C57BL/6J mice, some fed with chow-diet and some fed with low-fat (LFD; 10% kcal fat) or high-fat diet (HFD; 60% kcal fat) for 12-weeks. CD36 expression was positively associated with age in individuals with normal livers but not in NAS patients. However, CD36 was predominantly located at the plasma membrane of hepatocytes in aged NAS patients as compared to young. In chow-fed mice, aging, despite an increase in hepatic CD36 expression, was not associated with the development of NAFLD. However, middle-aged mice did exhibit the development of HFD-induced NAFLD, mediated by an increase of CD36 on the membrane. Enhanced CD36-mediated hepatic fat uptake may contribute to an accelerated progression of NAFLD in mice and humans. Therapies to prevent the increase in CD36 expression and/or CD36 from anchoring at the membrane may prevent the development of NAFLD.
C1 [Sheedfar, Fareeba; Aparicio-Vergara, Marcela; Kloosterhuis, Niels J.; Hofker, Marten H.; Koonen, Debby P. Y.] Univ Groningen, Univ Med Ctr Groningen, Mol Genet, Groningen, Netherlands.
   [Sung, Miranda M. Y.; Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Ctr, Dept Pediat, Edmonton, AB, Canada.
   [Eugenia Miquilena-Colina, Maria; Vargas-Castrillon, Javier; Garcia-Monzon, Carmelo] Univ Hosp Santa Cristina, CIBERehd, Inst Invest Sanitaria Princesa, Liver Res Unit, Madrid, Spain.
   [Febbraio, Maria] Univ Alberta, Dept Dent, Edmonton, AB, Canada.
   [Jacobs, Rene L.] Univ Alberta, Dept Food & Nutrit Sci, Edmonton, AB, Canada.
   [de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dutch Mol Pathol Ctr, Dept Pathobiol, Utrecht, Netherlands.
   [Vinciguerra, Manlio] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy.
   [Vinciguerra, Manlio] UCL, Royal Free Hosp, Inst Liver & Digest Hlth, London, England.
C3 University of Groningen; University of Alberta; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEREHD; University of Alberta;
   University of Alberta; Utrecht University; IRCCS Casa Sollievo Della
   Sofferenza; University of London; University College London; Royal Free
   London NHS Foundation Trust; UCL Medical School
RP Koonen, DPY (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Mol Genet, Groningen, Netherlands.
EM d.p.y.koonen@umcg.nl
RI Vinciguerra, Manlio/N-1309-2015; de Bruin, Alain/AAL-9195-2020
OI Vinciguerra, Manlio/0000-0002-1768-3894; , Fareeba/0000-0002-1315-1903;
   Jacobs, Rene/0000-0002-5525-1355; de Bruin, Alain/0000-0001-8579-2649;
   Dyck, Jason/0000-0002-7045-2884
FU Graduate School for Drug Exploration (GUIDE), University of Groningen;
   Center for Translational Molecular Medicine (CTMM) project PREDICCt
   [01C-104]; Dutch Heart Foundation, Dutch Diabetes Research Foundation
   and Dutch Kidney Foundation (PREDICCt); Instituto de Salud Carlos III
   [PI10/00067, PI13/01299]; Canadian Institutes of Health Research (CIHR)
   [MOP125973]; Canadian Diabetes Association (CDA) [OG-3-13-4155];
   MFAG-AIRC grant of the Associazione Italiana per la Ricerca sul Cancro;
   Natural Sciences and Engineering Research Council of Canada [386652]
FX FS and MA-V are supported by a PhD scholarship from the Graduate School
   for Drug Exploration (GUIDE), University of Groningen. MHH and DPYK are
   supported by the Center for Translational Molecular Medicine (CTMM)
   project PREDICCt (grant 01C-104) and Dutch Heart Foundation, Dutch
   Diabetes Research Foundation and Dutch Kidney Foundation (PREDICCt).
   Further support was obtained by grants from Instituto de Salud Carlos
   III (PI10/00067 and PI13/01299) to CG-M; the Canadian Institutes of
   Health Research (CIHR, MOP125973) and the Canadian Diabetes Association
   (CDA, OG-3-13-4155) to JRBD; a MFAG-AIRC grant of the Associazione
   Italiana per la Ricerca sul Cancro to MV; the Natural Sciences and
   Engineering Research Council of Canada (386652) and a New Investigator
   Award from the Canadian Institutes of Health Research (CIHR) to RLJ.
CR [Anonymous], 2009, 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases: prevent and control cardiovascular diseases, cancers, chronic respiratory diseases and diabetes
   Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051
   Blagosklonny MV, 2012, AGING-US, V4, P861, DOI 10.18632/aging.100525
   Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje
   Bonen A, 2003, ACTA PHYSIOL SCAND, V178, P347, DOI 10.1046/j.1365-201X.2003.01157.x
   Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Buqué X, 2012, AM J PHYSIOL-ENDOC M, V303, pE504, DOI 10.1152/ajpendo.00653.2011
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002
   Choo YS, 2012, HUM MOL GENET, V21, P2514, DOI 10.1093/hmg/dds070
   Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007
   Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655
   Ehehalt R, 2006, MOL CELL BIOCHEM, V284, P135, DOI 10.1007/s11010-005-9034-1
   Erickson SK, 2009, J LIPID RES, V50, pS412, DOI 10.1194/jlr.R800089-JLR200
   Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712
   Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406
   Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200
   Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009
   Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901
   Koonen DPY, 2010, DIABETES, V59, P1366, DOI 10.2337/db09-1142
   Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018
   Liang CP, 2004, J CLIN INVEST, V113, P764, DOI 10.1172/JCI19528
   Lin Y, 2012, LAB INVEST, V92, P265, DOI 10.1038/labinvest.2011.159
   Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113
   Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Memon RA, 1998, AM J PHYSIOL-ENDOC M, V274, pE210, DOI 10.1152/ajpendo.1998.274.2.E210
   Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Schwenk RW, 2008, CARDIOVASC RES, V79, P249, DOI 10.1093/cvr/cvn116
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200
   Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4
   World Health Organization (WHO), 2011, WHAT AR PUBL HLTH IM
   Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037
NR 46
TC 75
Z9 83
U1 1
U2 18
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD APR
PY 2014
VL 6
IS 4
BP 281
EP 295
DI 10.18632/aging.100652
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AI0IY
UT WOS:000336531900004
PM 24751397
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Torres-Hernandez, A
   Wang, W
   Nikiforov, Y
   Tejada, K
   Torres, L
   Kalabin, A
   Wu, Y
   Ul Haq, MI
   Khan, MY
   Zhao, Z
   Su, WY
   Camargo, J
   Hundeyin, M
   Diskin, B
   Adam, S
   Rossi, JAK
   Kurz, E
   Aykut, B
   Shadaloey, SAA
   Leinwand, J
   Miller, G
AF Torres-Hernandez, Alejandro
   Wang, Wei
   Nikiforov, Yuri
   Tejada, Karla
   Torres, Luisana
   Kalabin, Aleksandr
   Wu, Yue
   Ul Haq, Muhammad Israr
   Khan, Mohammed Y.
   Zhao, Zhen
   Su, Wenyu
   Camargo, Jimmy
   Hundeyin, Mautin
   Diskin, Brian
   Adam, Salma
   Rossi, Juan A. Kochen
   Kurz, Emma
   Aykut, Berk
   Shadaloey, Sorin A. A.
   Leinwand, Joshua
   Miller, George
TI Targeting SYK signaling in myeloid cells protects against liver fibrosis
   and hepatocarcinogenesis
SO ONCOGENE
LA English
DT Article
ID HEPATIC STELLATE CELLS; TYROSINE KINASE; RECEPTOR 4; INFLAMMATION;
   INHIBITION; INJURY; NK
AB Liver fibrosis and fibrosis-associated hepatocarcinogenesis are driven by chronic inflammation and are leading causes of morbidity and death worldwide. SYK signaling regulates critical processes in innate and adaptive immunity, as well as parenchymal cells. We discovered high SYK expression in the parenchymal hepatocyte, hepatic stellate cell (HSC), and the inflammatory compartments in the fibrotic liver. We postulated that targeting SYK would mitigate hepatic fibrosis and oncogenic progression. We found that inhibition of SYK with the selective small molecule inhibitors Piceatannol and PRT062607 markedly protected against toxin-induced hepatic fibrosis, associated hepatocellular injury and intra-hepatic inflammation, and hepatocarcinogenesis. SYK inhibition resulted in increased intra-tumoral expression of the p16 and p53 but decreased expression of Bcl-xL and SMAD4. Further, hepatic expression of genes regulating angiogenesis, apoptosis, cell cycle regulation, and cellular senescence were affected by targeting SYK. We found that SYK inhibition mitigated both HSC trans-differentiation and acquisition of an inflammatory phenotype in T cells, B cells, and myeloid cells. However, in vivo experiments employing selective targeted deletion of SYK indicated that only SYK deletion in the myeloid compartment was sufficient to confer protection against fibrogenic progression. Targeting SYK promoted myeloid cell differentiation into hepato-protective TNF alpha(low) CD206(hi) phenotype downregulating mTOR, IL-8 signaling and oxidative phosphorylation. Collectively, these data suggest that SYK is an attractive target for experimental therapeutics in treating hepatic fibrosis and oncogenesis.
C1 [Torres-Hernandez, Alejandro; Wang, Wei; Nikiforov, Yuri; Tejada, Karla; Torres, Luisana; Kalabin, Aleksandr; Wu, Yue; Ul Haq, Muhammad Israr; Khan, Mohammed Y.; Zhao, Zhen; Su, Wenyu; Camargo, Jimmy; Hundeyin, Mautin; Diskin, Brian; Adam, Salma; Rossi, Juan A. Kochen; Kurz, Emma; Aykut, Berk; Shadaloey, Sorin A. A.; Leinwand, Joshua; Miller, George] NYU, Sch Med, Dept Surg, SA Localio Lab, 450 East 29th St, New York, NY 10016 USA.
   [Miller, George] NYU, Sch Med, Dept Cell Biol, 450 East 29th St, New York, NY 10016 USA.
C3 New York University; New York University
RP Miller, G (corresponding author), NYU, Sch Med, Dept Surg, SA Localio Lab, 450 East 29th St, New York, NY 10016 USA.; Miller, G (corresponding author), NYU, Sch Med, Dept Cell Biol, 450 East 29th St, New York, NY 10016 USA.
EM george.miller@nyumc.org
RI Hundeyin, Mautin/AAU-6792-2020
OI Kurz, Emma/0000-0001-8251-5224; Kalabin, Aleksandr/0000-0003-4133-6267
FU Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer
   Center [P30CA016087]; NYU Cancer Institute Center Support Grant [NIH/NCI
   5 P30CA16087]; NCI [CA168611, CA155649, CA193111]; Society of University
   Surgeons-Ethicon Resident Research Award; American Liver
   Foundation-Thomas F. Nealon, III Postdoctoral Research Fellowship
   Honoring Zachery Rue; American Liver Foundation Postdoctoral Research
   Fellowship; NYU Physician-Scientist Training Program
FX We thank the NYU Langone Health Genome Technology Center (GTC) for
   expert library preparation and sequencing; the GTC is partially
   supported by the Cancer Center Support Grant P30CA016087 at the Laura
   and Isaac Perlmutter Cancer Center. We thank the NYU Langone Health
   Experimental Pathology Research Laboratory, which is partially funded by
   NYU Cancer Institute Center Support Grant NIH/NCI 5 P30CA16087, for
   expert tissue processing and equipment support. This work was supported
   by NCI CA168611 (GM), CA155649 (GM), CA193111 (ATH, BD), Society of
   University Surgeons-Ethicon Resident Research Award (ATH), American
   Liver Foundation-Thomas F. Nealon, III Postdoctoral Research Fellowship
   Honoring Zachery Rue (ATH), American Liver Foundation Postdoctoral
   Research Fellowship (WW), NYU Physician-Scientist Training Program
   (ATH).
CR Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1
   Coffey G, 2017, J CLIN PHARMACOL, V57, P194, DOI 10.1002/jcph.794
   Cornall RJ, 2000, P NATL ACAD SCI USA, V97, P1713, DOI 10.1073/pnas.97.4.1713
   Daley D, 2017, J EXP MED, V214, P1711, DOI 10.1084/jem.20161707
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   de Rosamel L, 2017, EXPERT OPIN EMERG DR, V22, P175, DOI 10.1080/14728214.2017.1336538
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21
   Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5
   Iñarrairaegui M, 2018, CLIN CANCER RES, V24, P1518, DOI 10.1158/1078-0432.CCR-17-0289
   Kant R, 2014, J MED MICROBIOL, V63, P293, DOI 10.1099/jmm.0.064220-0
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Kurniawan DW, 2018, J CONTROL RELEASE, V288, P227, DOI 10.1016/j.jconrel.2018.09.004
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Marcus A, 2014, ADV IMMUNOL, V122, P91, DOI 10.1016/B978-0-12-800267-4.00003-1
   Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025
   Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x
   Mócsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765
   Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008
   Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798
   O'Neill LAJ, 2016, CELL REP, V17, P625, DOI 10.1016/j.celrep.2016.09.085
   Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706
   Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0
   Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429
   Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353
   Qu C, 2018, HEPATOLOGY, V68, P1125, DOI 10.1002/hep.29881
   Seifert L, 2015, CELL REP, V13, P1909, DOI 10.1016/j.celrep.2015.10.058
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Thapa M, 2015, HEPATOLOGY, V61, P2067, DOI 10.1002/hep.27761
   Uehara T., 2014, CURR PROTOC PHARM, V66, P11
   Wang W, 2017, HEPATOLOGY, V66, P108, DOI 10.1002/hep.29129
   Weiskirchen Ralf, 2014, Hepatobiliary Surg Nutr, V3, P344, DOI 10.3978/j.issn.2304-3881.2014.11.03
   Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001
   Yang J, 2015, J HEPATOCELL CARCINO, V2, P11, DOI 10.2147/JHC.S44515
   Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138
   Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162
   Zhou Z, 2018, CELL MOL GASTROENTER, V5, P399, DOI 10.1016/j.jcmgh.2018.01.003
NR 41
TC 23
Z9 24
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD JUN 6
PY 2019
VL 38
IS 23
BP 4512
EP 4526
DI 10.1038/s41388-019-0734-5
PG 15
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA IB4KM
UT WOS:000470240300006
PM 30742098
DA 2024-02-19
ER

PT J
AU SHADDOCK, JG
   FEUERS, RJ
   CHOU, MW
   PEGRAM, RA
   CASCIANO, DA
AF SHADDOCK, JG
   FEUERS, RJ
   CHOU, MW
   PEGRAM, RA
   CASCIANO, DA
TI EFFECTS OF AGING AND CALORIC RESTRICTION ON THE GENOTOXICITY OF 4
   CARCINOGENS IN THE INVITRO RAT HEPATOCYTE DNA-REPAIR ASSAY
SO MUTATION RESEARCH
LA English
DT Article
DE CALORIC RESTRICTION; DNA REPAIR; HEPATOCYTES, RAT; 2-AAF; AFB1; DMBA;
   DMN; CYTOCHROME-P450 ENZYMES
ID DRUG-METABOLIZING-ENZYMES; LIFE-SPAN; CHEMICAL CARCINOGENS; DIETARY
   RESTRICTION; LIVER-MICROSOMES; FOOD RESTRICTION; EXCISION-REPAIR;
   FISCHER-344 RAT; AGE; CYTOCHROME-P-450
AB The effects of aging and chronic caloric restriction (CR) on the genotoxicity of four carcinogens, representing four different classes of chemicals, in the in vitro rat hepatocyte/DNA repair assay were investigated. Hepatocyte cultures were isolated from young, middle-aged, and old male Fischer (F344) rats which were maintained on either an ad libitum (AL) or a CR diet (60% of AL). Hepatocyte cultures from old AL rats, treated with 2-acetylaminofluorene (2-AAF), aflatoxin B1 (AFB1), 7,12-dimethylbenz[a]anthracene (DMBA) and dimethylnitrosamine (DMN), exhibited age-related decreases in DNA repair as compared to young AL rats. By contrast, cultures from young CR rats exhibited significant diet-related decreases in DNA repair with 2-AAF, AFB1, DMBA and DMN, when compared to results from young AL diet-fed rats. Old CR F344 rat derived cultures exhibited no significant age-related dose-dependent decrease in the DNA repair response with any of the chemicals tested. However, in cultures from old CR rats 10.0 muM AFB1 produced an age-related decrease in DNA repair from the response observed in young CR rats. When hepatocytes were isolated from Aroclor 1254-induced rats, increases in DNA repair were observed. These data indicate an age- and diet-related decrease in DNA repair and/or DNA damage and suggest that this decrease is due to a decrease in metabolic activation of these carcinogens to genotoxic species.
C1 NATL CTR TOXICOL RES,DIV COMPARAT TOXICOL,JEFFERSON,AR 72079.
   UNIV ARKANSAS MED SCI HOSP,DEPT BIOCHEM & MOLEC BIOL,LITTLE ROCK,AR 72205.
   UNIV ARKANSAS MED SCI HOSP,DEPT TOXICOL,LITTLE ROCK,AR 72205.
C3 US Food & Drug Administration (FDA); University of Arkansas System;
   University of Arkansas Medical Sciences; University of Arkansas System;
   University of Arkansas Medical Sciences
RP SHADDOCK, JG (corresponding author), NATL CTR TOXICOL RES,DIV GENET TOXICOL,HFT 120,NCTR DR,JEFFERSON,AR 72079, USA.
CR BELAND FA, 1990, HDB EXPT PHARM, P280
   BUDROE JD, 1984, MUTAT RES, V135, P131, DOI 10.1016/0165-1218(84)90166-6
   Casciano D A, 1990, SAAS Bull Biochem Biotechnol, V3, P102
   CASCIANO DA, 1983, MUTAT RES, V122, P81, DOI 10.1016/0165-7992(83)90146-X
   CASCIANO DA, 1984, ENV MUTAGEN, V6, P49
   CHOU MW, 1990, BIOL EFFECTS DIETARY, P42
   COLLIER IE, 1982, MECH AGEING DEV, V19, P141, DOI 10.1016/0047-6374(82)90005-7
   FUJITA S, 1982, LIVER AGING 1982, P55
   GUENGERICH FP, 1982, XENOBIOTICA, V12, P701, DOI 10.3109/00498258209038945
   HALL KY, 1984, MECH AGEING DEV, V24, P163, DOI 10.1016/0047-6374(84)90068-X
   HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169
   HOWARD PC, 1981, CARCINOGENESIS, V2, P97, DOI 10.1093/carcin/2.2.97
   IOANNIDES C, 1990, DRUG METAB REV, V22, P1, DOI 10.3109/03602539008991444
   JAYARAJ A, 1981, MECH AGEING DEV, V17, P163, DOI 10.1016/0047-6374(81)90082-8
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO H, 1980, JPN J GENET, V55, P99, DOI 10.1266/jjg.55.99
   KRITCHEVSKY D, 1987, AM J CLIN NUTR, V45, P236, DOI 10.1093/ajcn/45.1.236
   LAGOPOULOS L, 1987, CARCINOGENESIS, V8, P33, DOI 10.1093/carcin/8.1.33
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LEAKEY JEA, 1991, BIOL EFFECTS DIETARY, P207
   LICASTRO F, 1988, AGE, V11, P48, DOI 10.1007/BF02431772
   LIPMAN JM, 1989, MECH AGEING DEV, V48, P135, DOI 10.1016/0047-6374(89)90045-6
   MASLANSKY CJ, 1985, MECH AGEING DEV, V24, P283
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   McCay CM, 1939, J NUTR, V18, P15, DOI 10.1093/jn/18.1.15
   MCMILLAN JM, 1991, MUTAT RES, V249, P81, DOI 10.1016/0027-5107(91)90134-A
   MILLER EC, 1981, CANCER-AM CANCER SOC, V47, P2327, DOI 10.1002/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO;2-Z
   MITCHELL AD, 1983, MUTAT RES, V123, P363, DOI 10.1016/0165-1110(83)90029-5
   NEWBERNE PM, 1986, DIET NUTRITION CANCE, P205
   Oldham J.W., 1979, TCA MANUAL, V5, P1047
   PARIZA MW, 1987, AM J CLIN NUTR, V45, P151, DOI 10.1093/ajcn/45.1.151
   PASHKO LL, 1983, J GERONTOL, V38, P8, DOI 10.1093/geronj/38.1.8
   PEGRAM RA, 1989, MECH AGEING DEV, V48, P167, DOI 10.1016/0047-6374(89)90048-1
   PLESKO MM, 1984, BIOCHEM BIOPH RES CO, V118, P730, DOI 10.1016/0006-291X(84)91455-4
   PROBST GS, 1987, CELL BIOL TOXICOL, V3, P113, DOI 10.1007/BF00058451
   ROBERTSON T. BRAILSFORD, 1934, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V12, P33, DOI 10.1038/icb.1934.6
   ROSS MH, 1961, J NUTR, V75, P197, DOI 10.1093/jn/75.2.197
   SACHAN DS, 1982, J NUTR, V112, P2301, DOI 10.1093/jn/112.12.2301
   SACHAN DS, 1982, BIOCHEM BIOPH RES CO, V104, P984, DOI 10.1016/0006-291X(82)91346-8
   SHADDOCK JG, 1989, ENVIRON MOL MUTAGEN, V13, P281, DOI 10.1002/em.2850130402
   SHADDOCK JG, 1990, MUTAGENESIS, V4, P387
   SHIMADA T, 1987, TOXICOL APPL PHARM, V91, P13, DOI 10.1016/0041-008X(87)90189-X
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   TANNENBAUM A., 1940, Amer. F. Cancer, V38, P335
   Tannenbaum A, 1940, ARCH PATHOL, V30, P509
   TICE RR, 1986, HDB BIOL AGING
   TRETON JA, 1982, CELL BIOL INT REP, V6, P253, DOI 10.1016/0309-1651(82)90077-7
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   WERAARCHAKUL N, 1989, EXP CELL RES, V166, P497
   WILLIAMS G, 1985, REG TOXICOL PHARM, V5, P123
   WILLIAMS GM, 1982, MUTAT RES, V97, P359, DOI 10.1016/0165-1161(82)90003-6
   WILLIAMS GM, 1978, CANCER LETT, V4, P69, DOI 10.1016/S0304-3835(78)93522-X
   WILLIAMS GM, 1977, CANCER RES, V37, P1845
   WILLIAMS JR, 1976, ADV RADIAT BIOL, V6, P161
   YANG CS, 1990, DRUG METAB REV, V22, P147, DOI 10.3109/03602539009041082
NR 56
TC 20
Z9 20
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD JAN
PY 1993
VL 295
IS 1
BP 19
EP 30
DI 10.1016/0921-8734(93)90008-Q
PG 12
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA JZ619
UT WOS:A1993JZ61900003
PM 7677926
DA 2024-02-19
ER

PT J
AU Zou, YF
   Yan, H
   Li, CY
   Wen, F
   Jize, X
   Zhang, CW
   Liu, SQ
   Zhao, YZ
   Fu, YP
   Li, LX
   Liu, F
   Chen, J
   Li, R
   Chen, XF
   Tian, ML
AF Zou, Yuanfeng
   Yan, Hong
   Li, Cenyu
   Wen, Fang
   Jize, Xiaoping
   Zhang, Chaowen
   Liu, Siqi
   Zhao, Yuzhe
   Fu, Yuping
   Li, Lixia
   Liu, Fan
   Chen, Ji
   Li, Rui
   Chen, Xingfu
   Tian, Mengliang
TI A Pectic Polysaccharide from <i>Codonopsis pilosula</i> Alleviates
   Inflammatory Response and Oxidative Stress of Aging Mice via Modulating
   Intestinal Microbiota-Related Gut-Liver Axis
SO ANTIOXIDANTS
LA English
DT Article
DE polysaccharide; aging; inflammation; oxidative stress; intestinal
   microbiota; gut-liver axis
ID HIGH-FAT; DEGRADATION; HOMEOSTASIS; PROBIOTICS; METFORMIN
AB Aging is a biological process that leads to the progressive deterioration and loss of physiological functions in the human body and results in an increase in morbidity and mortality, and aging-related disease is a major global problem that poses a serious threat to public health. Polysaccharides have been shown to delay aging by reducing oxidative damage, suppressing inflammatory responses, and modulating intestinal microbiota. Our previous studies have shown that polysaccharide CPP-1 extracted from the root of Codonopsis pilosula possesses noticeable anti-oxidant activity in vitro. Thus, in our study, we tested the anti-aging effect of CPP-1 in naturally aging mice (in vivo). Eighteen C57/BL mice (48-week-old, male) were divided into a control group, high-dose CPP-1 group (20 mg/mL), and low-dose CPP-1 group (10 mg/mL). We discovered that CPP-1 can exert a reparative effect on aging stress in the intestine and liver, including alleviating inflammation and oxidative damage. We revealed that CPP-1 supplementation improved the intestinal microbiota composition and repaired the intestinal barrier in the gut. Furthermore, CPP-1 was proved to modulate lipid metabolism and repair hepatocyte injury in the liver by influencing the enterohepatic axis associated with the intestinal microbiota. Therefore, we concluded that CPP-1 prevents and alleviates oxidative stress and inflammatory responses in the intestine and liver of aging mice by modulating the intestinal microbiota-related gut-liver axis to delay aging.
C1 [Zou, Yuanfeng; Yan, Hong; Li, Cenyu; Wen, Fang; Jize, Xiaoping; Zhang, Chaowen; Liu, Siqi; Zhao, Yuzhe; Fu, Yuping; Li, Lixia] Sichuan Agr Univ, Coll Vet Med, Nat Med Res Ctr, Chengdu 611130, Peoples R China.
   [Liu, Fan; Chen, Ji; Li, Rui; Chen, Xingfu; Tian, Mengliang] Sichuan Agr Univ, Coll Agron, Chengdu 611130, Peoples R China.
C3 Sichuan Agricultural University; Sichuan Agricultural University
RP Zou, YF (corresponding author), Sichuan Agr Univ, Coll Vet Med, Nat Med Res Ctr, Chengdu 611130, Peoples R China.; Tian, ML (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu 611130, Peoples R China.
EM yuanfengzou@sicau.edu.cn; lixiali@sicau.edu.cn; liufantl2006@163.com;
   secondat@sicau.edu.cn
OI Zou, Yuan-Feng/0000-0002-3116-1478
FU Genuine Traditional Chinese Medicine Group of Sichuan Innovation Team of
   National Modern Agricultural Industry Technology System
   [SCCXTD-2023-19]; Featured Medicinal Plants Sharing and Service Platform
   of Sichuan Province
FX This work was supported in part by the Genuine Traditional Chinese
   Medicine Group of Sichuan Innovation Team of National Modern
   Agricultural Industry Technology System (SCCXTD-2023-19) and Featured
   Medicinal Plants Sharing and Service Platform of Sichuan Province
CR Allen JM, 2018, MED SCI SPORT EXER, V50, P747, DOI [10.1249/MSS.0000000000001495, 10.1249/mss.0000000000001495]
   Arnold JW, 2021, MICROBIOME, V9, DOI 10.1186/s40168-020-00980-0
   Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4
   Baiocchi L, 2021, HEPATOL COMMUN, V5, P1125, DOI 10.1002/hep4.1725
   Cao L, 2020, MAR DRUGS, V18, DOI 10.3390/md18110564
   Carter EA, 2011, SPECTROCHIM ACTA A, V80, P1, DOI 10.1016/j.saa.2011.07.066
   Chinese Pharmacopoeia Commission, 2020, National Commission of Chinese Pharmacopoeia
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Cockburn DW, 2016, J MOL BIOL, V428, P3230, DOI 10.1016/j.jmb.2016.06.021
   Cui L, 2021, INT J BIOL MACROMOL, V166, P1035, DOI 10.1016/j.ijbiomac.2020.10.259
   de Gonzalo-Calvo D, 2010, FREE RADICAL BIO MED, V49, P733, DOI 10.1016/j.freeradbiomed.2010.05.019
   de Kreutzenberg SV, 2015, NUTR METAB CARDIOVAS, V25, P686, DOI 10.1016/j.numecd.2015.03.007
   De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055
   den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213
   Fang X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.792746
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Gao XP, 2022, FRONT BIOSCI-LANDMRK, V27, DOI 10.31083/j.fbl2711315
   Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637
   He L, 2017, CELL PHYSIOL BIOCHEM, V44, P532, DOI 10.1159/000485089
   Huang C, 2021, FOOD FUNCT, V12, P10828, DOI [10.1039/d1fo02354c, 10.1039/D1FO02354C]
   Jiang N, 2022, CELL CYCLE, V21, P1519, DOI 10.1080/15384101.2022.2055252
   Jing HJ, 2018, INT J BIOL MACROMOL, V106, P1270, DOI 10.1016/j.ijbiomac.2017.08.138
   Kang YB, 2019, INT J OBESITY, V43, P1631, DOI 10.1038/s41366-018-0187-x
   Kim Minhoo, 2020, Transl Med Aging, V4, P103
   Kirjavainen PV, 2019, NAT MED, V25, P1089, DOI 10.1038/s41591-019-0469-4
   Kong C, 2019, NUTRITION, V60, P175, DOI 10.1016/j.nut.2018.10.002
   Kraig E, 2018, EXP GERONTOL, V105, P53, DOI 10.1016/j.exger.2017.12.026
   Kuo WT, 2022, ANN NY ACAD SCI, V1514, P21, DOI 10.1111/nyas.14798
   Lan Y, 2022, FOOD FUNCT, V13, P2925, DOI [10.1039/D1FO03147C, 10.1039/d1fo03147c]
   Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001
   Li SY, 2021, ECOTOX ENVIRON SAFE, V207, DOI 10.1016/j.ecoenv.2020.111501
   Liu AL, 2020, J GERONTOL A-BIOL, V75, P1284, DOI 10.1093/gerona/glz263
   Liu K.H., 2017, Chin. J. Anim. Vet. Sci, V48, P1349
   Liu Y, 2020, INT J BIOL MACROMOL, V164, P884, DOI 10.1016/j.ijbiomac.2020.07.191
   Ma YX, 2021, WORLD J HEPATOL, V13, P1512, DOI 10.4254/wjh.v13.i11.1512
   Marshall JC, 1998, CAN J PHYSIOL PHARM, V76, P479, DOI 10.1139/cjpp-76-5-479
   Meng Y, 2020, INT J BIOL MACROMOL, V163, P1677, DOI 10.1016/j.ijbiomac.2020.09.117
   Pabst O, 2023, NAT REV GASTRO HEPAT, V20, P447, DOI 10.1038/s41575-023-00771-6
   Parker BJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00906
   Reisinger N, 2020, TOXINS, V12, DOI 10.3390/toxins12100622
   Ren WK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00503
   SALYERS AA, 1978, AM J CLIN NUTR, V31, pS128, DOI 10.1093/ajcn/31.10.S128
   Schoeler M, 2019, REV ENDOCR METAB DIS, V20, P461, DOI 10.1007/s11154-019-09512-0
   Shintouo CM, 2020, EXP GERONTOL, V141, DOI 10.1016/j.exger.2020.111079
   Skalska J, 2016, FOOD CHEM TOXICOL, V97, P307, DOI 10.1016/j.fct.2016.09.026
   Soenen S, 2016, CURR OPIN CLIN NUTR, V19, P12, DOI 10.1097/MCO.0000000000000238
   Soukas AA, 2019, TRENDS ENDOCRIN MET, V30, P745, DOI 10.1016/j.tem.2019.07.015
   Sun YX, 2008, INT J BIOL MACROMOL, V43, P279, DOI 10.1016/j.ijbiomac.2008.06.009
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Tian SY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0290-9
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Vatner SF, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101194
   Vemuri R, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091255
   Walrath T, 2021, J LEUKOCYTE BIOL, V109, P1045, DOI 10.1002/JLB.3RI0620-405RR
   Wang ZQ, 2015, METAB ENG, V27, P46, DOI 10.1016/j.ymben.2014.10.005
   Wassenaar TM, 2018, EUR J MICROBIOL IMMU, V8, P63, DOI 10.1556/1886.2018.00017
   [伍春 Wu Chun], 2014, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V30, P92
   Xin T, 2012, INT J BIOL MACROMOL, V51, P788, DOI 10.1016/j.ijbiomac.2012.07.019
   Xu W, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/4362479
   Yang XW, 2013, FOOD CHEM TOXICOL, V55, P297, DOI 10.1016/j.fct.2012.12.039
   Yu Y, 2018, CARBOHYD POLYM, V183, P91, DOI 10.1016/j.carbpol.2017.12.009
   Zafar H, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2020.1848158
   Zhang LD, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.965180
   Zhao HJ, 2016, CARBOHYD POLYM, V151, P1227, DOI 10.1016/j.carbpol.2016.06.058
   Zhao JC, 2018, FOOD FUNCT, V9, P917, DOI [10.1039/c7fo01574g, 10.1039/C7FO01574G]
   Zou YF, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.786141
   Zou YF, 2021, J SCI FOOD AGR, V101, P6043, DOI 10.1002/jsfa.11261
   Zou YF, 2019, MOLECULES, V24, DOI 10.3390/molecules24203632
NR 68
TC 0
Z9 0
U1 17
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD SEP
PY 2023
VL 12
IS 9
AR 1781
DI 10.3390/antiox12091781
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA T9BX1
UT WOS:001080875000001
PM 37760084
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU McLean, AJ
   Cogger, VC
   Chong, GC
   Warren, A
   Markus, AMA
   Dahlstrom, JE
   Le Couteur, DG
AF McLean, AJ
   Cogger, VC
   Chong, GC
   Warren, A
   Markus, AMA
   Dahlstrom, JE
   Le Couteur, DG
TI Age-related pseudocapillarization of the human liver
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE ageing; liver; pseudocapillarization; defenestration; electron
   microscopy; immunohistochemistry; hepatic sinusoid
ID ATHEROSCLEROSIS; METABOLISM; FLOW
AB Age-related changes in liver function are important because they may promote susceptibility to adverse drug reactions, neurotoxicity, atherosclerosis, and other important diseases in older people. Age-related changes in the rat hepatic sinusoidal endothelium, termed pseudocapillarization, have been described recently and these may contribute to hepatic impairment. The present study has examined surgical and post-mortem specimens with immunohistochemistry and transmission electron microscopy to determine whether pseudocapillarization also occurs in older humans. The age of the subject, independent of systemic disease or hepatic pathology in surgical and post-mortem samples of human liver, was associated with increased peri-sinusoidal expression of von Willebrand's factor, collagen I, collagen IV, and staining with Masson's trichrome. Electron microscopy revealed significant age-related thickening of the sinusoidal endothelium (young 165 +/- 17 mn, middle age 222 +/- 11 nm, older 289 +/- 9 nm, p < 0.001) with loss of fenestrations (young 7.7 +/- 0.7 per 10 mu m, middle age 3.6 +/- 0.5 per 10 mu m, older 1.5 +/- 0.4 per 10 mu m, p < 0.001), and age-related deposition of basal lamina and collagen. In conclusion, ageing in humans is associated with morphological changes in the sinusoidal endothelium and space of Disse which are presumptively related to the ageing process and potentially represent an important link between the ageing process and disease susceptibility. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Natl Ageing Res Inst, Parkville, Vic 3052, Australia.
   Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia.
   Royal Melbourne Hosp, Parkville, Vic 3050, Australia.
   Univ Sydney, Canberra Hosp, Garran, Australia.
   Univ Sydney, Canberra Clin Sch, Garran, Australia.
   Univ Sydney, Ctr Educ & Res Ageing, Concord, Australia.
   Univ Sydney, ANZAC Res Inst, Concord, Australia.
   Concord RG Hosp, Concord, Australia.
C3 National Ageing Research Institute; University of Melbourne; Royal
   Melbourne Hospital; University of Sydney; Australian National
   University; Canberra Hospital; University of Sydney; University of
   Sydney; University of Sydney; ANZAC Research Institute; Concord
   Repatriation General Hospital
RP McLean, AJ (corresponding author), Natl Ageing Res Inst, POB 31, Parkville, Vic 3052, Australia.
EM a.mclean@nari.unimelb.edu.au
RI Research Institute, ANZAC/CAE-9030-2022; Dahlstrom, Jane/E-4683-2018
OI Dahlstrom, Jane/0000-0001-5608-693X; Le Couteur,
   David/0000-0002-4227-5817
CR FENYVES D, 1993, HEPATOLOGY, V17, P301, DOI 10.1002/hep.1840170222
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Harvey PJ, 1999, GASTROENTEROLOGY, V117, P1025, DOI 10.1016/S0016-5085(99)70370-7
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Le Couteur David G, 2002, Rev Environ Health, V17, P51
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 1999, J PHARMACOL EXP THER, V289, P1553
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Lipman RD, 1999, J GERONTOL A-BIOL, V54, pB466, DOI 10.1093/gerona/54.11.B466
   MCLEAN AJ, 1991, CLIN PHARMACOKINET, V21, P42, DOI 10.2165/00003088-199121010-00004
   Müller AM, 2002, EXP GERONTOL, V37, P713, DOI 10.1016/S0531-5565(02)00010-4
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yang MC, 2002, PHARMACOL TOXICOL, V90, P203, DOI 10.1034/j.1600-0773.2002.900406.x
NR 15
TC 119
Z9 130
U1 3
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD MAY
PY 2003
VL 200
IS 1
BP 112
EP 117
DI 10.1002/path.1328
PG 6
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA 676KG
UT WOS:000182750300016
PM 12692849
DA 2024-02-19
ER

PT J
AU Cheng, YJ
   Wang, B
   Zhou, H
   Dang, SP
   Jin, M
   Shi, YF
   Hao, L
   Yang, ZX
   Zhang, YY
AF Cheng, Yiji
   Wang, Bei
   Zhou, Hong
   Dang, Shipeng
   Jin, Min
   Shi, Yufang
   Hao, Li
   Yang, Zhenxi
   Zhang, Yanyun
TI Autophagy is Required for the Maintenance of Liver Progenitor Cell
   Functionality
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Autophagy; Self-renewal; Hepatic differentiation; Cellular senescence
ID MESENCHYMAL STEM-CELLS; OVAL CELLS; LIFE-SPAN; IN-VIVO; SENESCENCE;
   MOUSE; MICE; DIFFERENTIATION; PROLIFERATION; REPOPULATION
AB Background: Liver progenitor cells (LPCs) are bipotent stem cells existing in the adult liver, which could be activated upon massive liver injury and contribute to liver regeneration. However, mechanisms of maintenance of LPC functionality remain poorly understood. Previous studies found that autophagy was required for the self-renewal and differentiation of several tissue stem cells. Methods: The study compared the level of autophagic activity in LPCs and differentiated hepatocytes. Then, autophagic activity was inhibited in LPCs by lentivirus-mediated autophagy-related gene 5 or Beclin 1 knockdown. Clonogenic assay, cell viability assays, hepatic differentiation assay, and senescence analysis were conducted to assess the role of autophagy in regulating self-renewal, hepatic differentiation and senescence of LPCs. Results: We observed high autophagic activity in LPCs compared with differentiated hepatocytes. We found that inhibition of autophagy impaired the self-renewal, proliferation, and hepatic differentiation capability of LPCs under normal cultural condition, but had little impact on cell viability. Interestingly, while wild-type LPCs remained rarely affected by the toxin, etoposide, inhibition of autophagy induced the senescent phenotype of LPCs. Overexpression of Beclin 1 in Beclin 1-knockdown LPCs restored the functionality of stem cells. Conclusion: Our findings indicate that autophagy may function as a critical regulator of LPC functionality under both physiological and pathological condition. Copyright (C) 2015 S. Karger AG, Basel
C1 [Cheng, Yiji; Zhou, Hong; Dang, Shipeng; Jin, Min; Shi, Yufang; Zhang, Yanyun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200031, Peoples R China.
   [Cheng, Yiji; Zhou, Hong; Dang, Shipeng; Jin, Min; Shi, Yufang; Zhang, Yanyun] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200031, Peoples R China.
   [Wang, Bei] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai 200030, Peoples R China.
   [Hao, Li] Anhui Med Univ, Affiliated Hosp 1, Clin Lab, Hefei, Peoples R China.
   [Yang, Zhenxi] Shanghai Seventh Peoples Hosp, Dept Surg, Shanghai, Peoples R China.
C3 Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai
   Jiao Tong University; Anhui Medical University
RP Zhang, YY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Scie, Inst Hlth Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.
EM zhenxi_yang@126.com; yyzhang@sibs.ac.cn
RI Shi, Yufang/AAE-4431-2020
OI Shi, Yufang/0000-0001-8964-319X
FU Strategic Priority Research Program of the Chinese Academy of Sciences
   [XDA01040000]; Ministry of Science and Technology of China
   [2011CB966200, 2014CB943300]; National Natural Science Foundation of
   China [81130057, 81071748, 81373164, 81190133, 31300708]; Program of
   Science and Technology Commission of Shanghai Municipality [12ZR1415900,
   13ZR1423200, 14ZR1446300]
FX This work was supported by Strategic Priority Research Program of the
   Chinese Academy of Sciences (XDA01040000), the Ministry of Science and
   Technology of China (2011CB966200, 2014CB943300), National Natural
   Science Foundation of China (81130057, 81071748, 81373164, 81190133,
   31300708), the Program of Science and Technology Commission of Shanghai
   Municipality (12ZR1415900, 13ZR1423200, 14ZR1446300).
CR Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751
   Bi Y, 2014, CELL PHYSIOL BIOCHEM, V34, P1318, DOI 10.1159/000366340
   Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010
   Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788
   Brown NE, 2012, CANCER RES, V72, P6477, DOI 10.1158/0008-5472.CAN-11-4139
   Cai JL, 2004, EXP HEMATOL, V32, P585, DOI 10.1016/j.exphem.2004.03.013
   Dang SP, 2014, AUTOPHAGY, V10, P1301, DOI 10.4161/auto.28771
   Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6
   Feng DC, 2012, GASTROENTEROLOGY, V143, P188, DOI 10.1053/j.gastro.2012.03.044
   Grompe M, 1999, SEMIN LIVER DIS, V19, P7, DOI 10.1055/s-2007-1007093
   Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132
   Hou J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.338
   Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584
   Li WL, 2006, STEM CELLS, V24, P322, DOI 10.1634/stemcells.2005-0108
   Lowes KN, 2003, GUT, V52, P1327, DOI 10.1136/gut.52.9.1327
   Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200
   Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811
   te Poele RH, 2002, CANCER RES, V62, P1876
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Wang X, 2014, GUT, P1
   Xu CF, 2011, FASEB J, V25, P2700, DOI 10.1096/fj.10-167676
   Zhao F, 2011, BLOOD, V117, P1723, DOI 10.1182/blood-2010-04-281659
NR 32
TC 25
Z9 25
U1 2
U2 18
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PY 2015
VL 36
IS 3
BP 1163
EP 1174
DI 10.1159/000430287
PG 12
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA CM6WZ
UT WOS:000357833400029
PM 26111576
OA gold
DA 2024-02-19
ER

PT J
AU Seo, E
   Kang, H
   Choi, H
   Choi, W
   Jun, HS
AF Seo, Eunhui
   Kang, Hwansu
   Choi, Hojung
   Choi, Woohyuk
   Jun, Hee-Sook
TI Reactive oxygen species-induced changes in glucose and lipid metabolism
   contribute to the accumulation of cholesterol in the liver during aging
SO AGING CELL
LA English
DT Article
DE aging; cholesterol; lipid metabolism; liver; reactive oxygen species
ID OXIDATIVE STRESS; HEPATIC STEATOSIS; DISEASE; PREVALENCE; GENES
AB Aging is a major risk factor for many chronic diseases due to increased vulnerability to external stress and susceptibility to disease. Aging is associated with metabolic liver disease such as nonalcoholic fatty liver. In this study, we investigated changes in lipid metabolism during aging in mice and the mechanisms involved. Lipid accumulation was increased in liver tissues of aged mice, particularly cholesterol. Increased uptake of both cholesterol and glucose was observed in hepatocytes of aged mice as compared with younger mice. The mRNA expression of GLUT2, GK, SREBP2, HMGCR, and HMGCS, genes for cholesterol synthesis, was gradually increased in liver tissues during aging. Reactive oxygen species (ROS) increase with aging and are closely related to various aging-related diseases. When we treated HepG2 cells and primary hepatocytes with the ROS inducer, H2O2, lipid accumulation increased significantly compared to the case for untreated HepG2 cells. H2O2 treatment significantly increased glucose uptake and acetyl-CoA production, which results in glycolysis and lipid synthesis. Treatment with H2O2 significantly increased the expression of mRNA for genes related to cholesterol synthesis and uptake. These results suggest that ROS play an important role in altering cholesterol metabolism and consequently contribute to the accumulation of cholesterol in the liver during the aging process.
C1 [Seo, Eunhui; Kang, Hwansu; Choi, Hojung; Jun, Hee-Sook] Gachon Univ, Coll Pharm, Incheon, South Korea.
   [Seo, Eunhui; Kang, Hwansu; Choi, Hojung; Jun, Hee-Sook] Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea.
   [Seo, Eunhui; Kang, Hwansu; Choi, Hojung; Choi, Woohyuk; Jun, Hee-Sook] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon, South Korea.
   [Choi, Woohyuk] Korea Univ, Div Life Sci, Seoul, South Korea.
   [Jun, Hee-Sook] Gil Hosp, Gachon Med Res Inst, Incheon, South Korea.
C3 Gachon University; Gachon University; Gachon University; Korea
   University
RP Jun, HS (corresponding author), Gachon Univ, Coll Pharm, Incheon, South Korea.; Jun, HS (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea.
EM hsjun@gachon.ac.kr
RI Choi, Hojung/ABI-1959-2020
OI Choi, Hojung/0000-0001-9235-5500; seo, eunhui/0000-0001-6418-2198
FU Korea Health Industry Development Institute [HI14C1135]; National
   Research Foundation of Korea [NRF-2016R1A6A3A11930857]
FX Korea Health Industry Development Institute, Grant/Award Number:
   HI14C1135; National Research Foundation of Korea, Grant/Award Number:
   NRF-2016R1A6A3A11930857
CR Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005
   Chia YY, 2012, EUR J PHARMACOL, V677, P197, DOI 10.1016/j.ejphar.2011.12.037
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   Cogger Victoria C, 2011, Curr Gerontol Geriatr Res, V2011, P150364, DOI 10.1155/2011/150364
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   FOLCH J, 1951, J BIOL CHEM, V191, P833
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Guan LL, 2013, EXP GERONTOL, V48, P1387, DOI 10.1016/j.exger.2013.09.001
   Hassan W, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/313602
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411
   Mc Auley MT, 2015, COMPUT STRUCT BIOTEC, V13, P38, DOI 10.1016/j.csbj.2014.11.006
   Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026
   Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0
   Salmon Adam B, 2012, Longev Healthspan, V1, P7, DOI 10.1186/2046-2395-1-7
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Silva M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/272617
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   Vock C, 2008, CELL PHYSIOL BIOCHEM, V22, P515, DOI 10.1159/000185525
   von Wilamowitz-Moellendorff A, 2013, DIABETES, V62, P4070, DOI 10.2337/db13-0880
   Wafa K, 2015, BIOMED ENVIRON SCI, V28, P829, DOI [10.3967/bes2015.115, 10.1016/S0895-3988(15)30114-8]
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Yamamoto N., 2016, CURRENT PROTOCOLS PR, V85
NR 37
TC 79
Z9 81
U1 2
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR
PY 2019
VL 18
IS 2
AR e12895
DI 10.1111/acel.12895
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HO5JY
UT WOS:000460963500003
PM 30609251
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU SHIH, AP
   ZBUZEK, VK
   SAUCHELLI, FC
   WU, WH
AF SHIH, AP
   ZBUZEK, VK
   SAUCHELLI, FC
   WU, WH
TI EFFECT OF AGING ON HEPATIC-CLEARANCE OF VASOPRESSIN IN FISCHER-344 RATS
SO GERONTOLOGY
LA English
DT Article
C1 UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT ANESTHESIOL,185 S ORANGE AVE,NEWARK,NJ 07103.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers
   University Biomedical & Health Sciences
FU NIA NIH HHS [R01 AGO2778] Funding Source: Medline
CR AFIFI AA, 1984, COMPUTER AIDED MULTI, P103
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   CORT JH, 1975, KIDNEY INT, V8, P292, DOI 10.1038/ki.1975.116
   DORSA DM, 1982, BRAIN RES, V242, P151, DOI 10.1016/0006-8993(82)90505-4
   ENGEL PA, 1984, AM J PHYSIOL, V246, P202
   FINDLEY T, 1949, AM J MED, V7, P70, DOI 10.1016/0002-9343(49)90484-2
   GINSBURG M, 1953, J ENDOCRINOL, V9, P283, DOI 10.1677/joe.0.0090283
   LANDFIELD PW, 1980, PEPTIDES, V1, P185, DOI 10.1016/0196-9781(80)90116-3
   LI CH, 1984, ACTA ENDOCRINOL-COP, V105, P314, DOI 10.1530/acta.0.1050314
   RABKIN R, 1980, ENDOCRINOLOGY, V106, P930, DOI 10.1210/endo-106-3-930
   SCHIMASSEK H, 1963, BIOCHEM Z, V336, P460
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SLADEK CD, 1981, NEUROBIOL AGING, V2, P293, DOI 10.1016/0197-4580(81)90038-5
   SPROTT RL, 1986, FASEB J, V45, P42
   TURKINGTON M, 1976, HYPOTHALAMUS PITUITA, P123
   WU WH, 1969, BIOCHEMISTRY-US, V8, P2719, DOI 10.1021/bi00835a005
   ZBUZEK V, 1984, NEUROENDOCRINOLOGY, V39, P538, DOI 10.1159/000124035
   ZBUZEK VK, 1982, EXP GERONTOL, V17, P133, DOI 10.1016/0531-5565(82)90047-X
   ZBUZEK VK, 1983, EXP GERONTOL, V18, P305, DOI 10.1016/0531-5565(83)90042-6
   ZBUZEK VK, 1987, EXP GERONTOL, V22, P113, DOI 10.1016/0531-5565(87)90046-5
   ZBUZEK VK, 1986, J GERONTOL, V41, P140, DOI 10.1093/geronj/41.2.140
NR 21
TC 1
Z9 1
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD SEP-DEC
PY 1988
VL 34
IS 5-6
BP 257
EP 263
DI 10.1159/000212964
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA T1203
UT WOS:A1988T120300006
PM 3220261
DA 2024-02-19
ER

PT J
AU Mach, J
   Huizer-Pajkos, A
   Kane, A
   Jones, B
   McKenzie, C
   Mitchell, SJ
   de Cabo, R
   Cogger, VC
   Le Couteur, DG
   Hilmer, SN
AF Mach, John
   Huizer-Pajkos, Aniko
   Kane, Alice
   Jones, Brett
   McKenzie, Catriona
   Mitchell, Sarah J.
   de Cabo, Rafael
   Cogger, Victoria C.
   Le Couteur, David G.
   Hilmer, Sarah N.
TI The effect of aging on mitochondrial and cytosolic hepatic intrinsic
   death pathway and apoptosis associated proteins in Fischer 344 rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Liver; Apoptosis; Mitochondria; Intrinsic death pathway
ID LIVER-DISEASE; CYTOCHROME-C; CELL-DEATH; BCL-2; BAX; MECHANISMS;
   BCL-X(L); FAMILY; INJURY
AB Apoptosis is increased in the liver in old age and is a common pathological feature of liver disease. The mitochondria play a key role in regulating apoptosis via the intrinsic death pathway. As the effect of aging on this pathway is unclear, we aimed to characterize the impact of aging on the hepatic intrinsic death pathway and apoptosis. Livers from young adult (6.6 +/- 0.3 months, n = 9) and old (25.4 +/- 0.7 months, n = 9) male Fischer 344 rats were extracted for cellular fractionation and immunobloting. In old age there were lower mitochondrial protein levels of pro-apoptotic BAK, BID, tBID and VDAC1 (p < 0.05) and of anti-apoptotic Bcl-2. Compared to young, old rats had lower cytosolic protein levels of pro-apoptotic BAX, BAK, BID, tBID and anti-apoptotic Bcl-xL (p < 0.05). BAK, Bcl-2 and Bcl-xL were found in the cytosol. Furthermore with old age, cytosolic protein levels of cytochrome C, AIF and cleaved caspase-9 did not change but activation of caspase-3, -6 and -7 increased (p < 0.05) and DNA fragmentation trended to increase. Our results suggest an age-related decline in the levels of a number of proteins involved in the intrinsic death pathway, an uncoupling of intermediate apoptosis signaling and increased cellular apoptosis in the liver in old age. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Mach, John; Huizer-Pajkos, Aniko; Kane, Alice; Jones, Brett; Hilmer, Sarah N.] Kolling Inst Med Res, Lab Ageing & Pharmacol, Sydney, NSW, Australia.
   [Mach, John; Huizer-Pajkos, Aniko; Kane, Alice; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia.
   [Mach, John; Huizer-Pajkos, Aniko; Kane, Alice; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia.
   [Mach, John; Kane, Alice; Jones, Brett; Cogger, Victoria C.; Le Couteur, David G.; Hilmer, Sarah N.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Jones, Brett] Royal N Shore Hosp, Dept Gastroenterol, Sydney, NSW, Australia.
   [McKenzie, Catriona] Royal Prince Alfred Hosp, Dept Pathol, Sydney, NSW, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Concord Hosp, Ageing & Alzheimers Inst, Concord, NSW, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Concord Hosp, Ctr Educ & Res Ageing, Concord, NSW, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Univ Sydney, Sydney, NSW 2006, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Concord Hosp, ANZAC Res Inst, Concord, NSW, Australia.
   [Mitchell, Sarah J.; de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
C3 University of Sydney; Kolling Institute of Medical Research; Royal North
   Shore Hospital; University of Sydney; University of Sydney; Royal North
   Shore Hospital; University of Sydney; Royal North Shore Hospital;
   University of Sydney; University of Sydney; NSW Health; Royal Prince
   Alfred Hospital; Concord Repatriation General Hospital; Concord
   Repatriation General Hospital; University of Sydney; Concord
   Repatriation General Hospital; University of Sydney; ANZAC Research
   Institute; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA)
RP Hilmer, SN (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, Lab Ageing & Pharmacol, Room 612027,Level 12, St Leonards, NSW 2065, Australia.
EM sarah.hilmer@sydney.edu.au
RI Hilmer, Sarah/AAW-8554-2020; Research Institute, ANZAC/CAE-9030-2022; de
   Cabo, Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI Hilmer, Sarah/0000-0002-5970-1501; de Cabo, Rafael
   Carlos/0000-0003-2830-5693; Le Couteur, David/0000-0002-4227-5817; Kane,
   Alice/0000-0002-4303-0491; Mckenzie, Catriona/0000-0002-6452-4976; de
   Cabo, Rafael/0000-0002-3354-2442
FU National Health and Medical Research Council of Australia [570968];
   Geoff and Elaine Penney Ageing Research Unit; Royal North Shore
   Hospital, Australia; Intramural Research Program of the National
   Institute on Aging, National Institutes of Health
FX The work was supported by the National Health and Medical Research
   Council of Australia (project grant number #570968), the Geoff and
   Elaine Penney Ageing Research Unit, Royal North Shore Hospital,
   Australia, and the Intramural Research Program of the National Institute
   on Aging. RdC and SJM are supported by the Intramural Research Program
   of the National Institute on Aging, National Institutes of Health.
CR López-Domínguez JA, 2015, J GERONTOL A-BIOL, V70, P399, DOI 10.1093/gerona/glu045
   Bai Li, 2004, Chin J Dig Dis, V5, P175, DOI 10.1111/j.1443-9573.2004.00178.x
   Candé C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400
   Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59
   El-Hassan H, 2003, TOXICOL APPL PHARM, V191, P118, DOI 10.1016/S0041-008X(03)00240-0
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Ferreira DMS, 2011, DIABETOLOGIA, V54, P1788, DOI 10.1007/s00125-011-2130-8
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hilmer Sarah N, 2005, Ther Clin Risk Manag, V1, P151, DOI 10.2147/tcrm.1.2.151.62914
   Honig LS, 2000, AM J MED, V108, P317, DOI 10.1016/S0002-9343(00)00291-6
   Ishigami F, 2001, TRANSPLANTATION, V72, P1803, DOI 10.1097/00007890-200112150-00016
   Kam PCA, 2000, ANAESTHESIA, V55, P1081, DOI 10.1046/j.1365-2044.2000.01554.x
   Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084
   Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10
   Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200
   KRAJEWSKI S, 1993, CANCER RES, V53, P4701
   Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007
   Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017
   Mach J, 2014, J GERONTOL A-BIOL, V69, P387, DOI 10.1093/gerona/glt095
   MILLER LL, 1951, J EXP MED, V94, P431, DOI 10.1084/jem.94.5.431
   Miyoshi N, 2006, P NATL ACAD SCI USA, V103, P1727, DOI 10.1073/pnas.0510346103
   Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687
   MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x
   PaLMS, 2013, LIV FUNCT TESTS PLAS
   Peixoto PM, 2011, AM J PATHOL, V178, P48, DOI 10.1016/j.ajpath.2010.11.014
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Raddatz D, 2007, Z GASTROENTEROL, V45, P51, DOI 10.1055/s-2006-927394
   Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036
   Schneider E., 2012, HDB BIOL AGING
   Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019
   Todt F, 2015, EMBO J, V34, P67, DOI 10.15252/embj.201488806
   Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009
   Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499
   Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108
   Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X
NR 44
TC 9
Z9 10
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL
PY 2015
VL 67
BP 54
EP 61
DI 10.1016/j.exger.2015.04.009
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CI6MV
UT WOS:000354874700007
PM 25910621
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Quiles, JL
   Martínez, E
   Ibáñez, S
   Ochoa, JJ
   Martín, Y
   López-Frías, M
   Huertas, JR
   Mataix, J
AF Quiles, JL
   Martínez, E
   Ibáñez, S
   Ochoa, JJ
   Martín, Y
   López-Frías, M
   Huertas, JR
   Mataix, J
TI Ageing-related tissue-specific alterations in mitochondrial composition
   and function are modulated by dietary fat type in the rat
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE ageing; olive oil; sunflower oil; cytochrome c oxidase; cytochromes;
   coenzyme Q; liver, heart, and skeletal muscle
ID RESPIRATORY-CHAIN; LIPID-PEROXIDATION; OLIVE OIL; LIVER; EXERCISE;
   ACIDS; METABOLISM; SENESCENCE; OXIDASE; MOUSE
AB This study investigated the way in which feeding rats with two fat sources (olive or sunflower oils) affected electron-transport components and function of mitotic (liver) and postmitotic (heart and skeletal muscle) tissues during ageing. Rats adapted the mitochondrial-membrane-lipid profile to dietary fat throughout the study, suggesting that the benefits to eat either of the two fats might be maintained lifelong. Liver was more resistant to dietary changes and ageing than heart and skeletal muscle, which showed higher levels of coenzyme Q, cytochrome b, and cytochrome a + a(3) with ageing and lower cytochrome c oxidase and complex IV turnover. Dietary fat differentially modulated the response of tissues during ageing, with sunflower oil leading to the highest levels of coenzyme Q and cytochromes b and a + a(3). Since high levels of cytochrome b have been related to increased age, it could be hypothesized that olive oil could lead to less aged mitochondria.
C1 Univ Granada, Inst Nutr & Food Technol, Dept Physiol, E-18071 Granada, Spain.
C3 University of Granada
RP Quiles, JL (corresponding author), Univ Granada, Inst Nutr & Food Technol, Dept Physiol, C Ramon & Cajal 4, E-18071 Granada, Spain.
EM jlquiles@goliat.ugr.es
RI /AAB-6832-2019; Huertas, Jesus Francisco Rodriguez/G-8188-2015; Quiles,
   José L./C-6911-2013; Ochoa, Julio/L-8733-2014
OI /0000-0002-8479-4658; Huertas, Jesus Francisco
   Rodriguez/0000-0002-7446-0857; Quiles, José L./0000-0002-9048-9086;
   Ochoa, Julio/0000-0001-8976-6296
CR BATTINO M, 1986, FEBS LETT, V199, P155, DOI 10.1016/0014-5793(86)80470-7
   BATTINO M, 2002, J BIOENERG BIOMEMBR
   Cairns CB, 1998, AM J PHYSIOL-REG I, V274, pR1376, DOI 10.1152/ajpregu.1998.274.5.R1376
   CAPALDI RA, 1988, J BIOENERG BIOMEMBR, V20, P291, DOI 10.1007/BF00769634
   CHARNOCK JS, 1992, MOL CELL BIOCHEM, V116, P19, DOI 10.1007/BF01270564
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   ESPOSTI MD, 1982, BIOCHIM BIOPHYS ACTA, V682, P189, DOI 10.1016/0005-2728(82)90098-6
   Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340
   Fleischer S, 1979, Methods Enzymol, V55, P32
   Gabbita SP, 1997, FREE RADICAL BIO MED, V23, P191, DOI 10.1016/S0891-5849(97)00043-9
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9
   HUERTAS JR, 1991, FEBS LETT, V287, P89, DOI 10.1016/0014-5793(91)80022-U
   Kipling D, 2001, MATURITAS, V38, P25, DOI 10.1016/S0378-5122(00)00189-4
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Kumar VB, 1999, LIFE SCI, V65, P1657, DOI 10.1016/S0024-3205(99)00414-2
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   LEPAGE G, 1986, J LIPID RES, V27, P114
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lutz M, 1999, LIPIDS, V34, pS119, DOI 10.1007/BF02562256
   Mataix J, 1998, FREE RADICAL BIO MED, V24, P511, DOI 10.1016/S0891-5849(97)00288-8
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   MIQUEL J, 1995, EUR J PHARM-ENVIRON, V292, P333, DOI 10.1016/0926-6917(95)90041-1
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   NICHOLLS P, 1976, BIOCHIM BIOPHYS ACTA, V430, P30, DOI 10.1016/0005-2728(76)90219-X
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Quiles JL, 1999, BRIT J NUTR, V81, P21, DOI 10.1017/S0007114599000094
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   VANNESTE WH, 1966, BIOCHIM BIOPHYS ACTA, V113, P175, DOI 10.1016/S0926-6593(66)80132-7
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   YAMAOKA S, 1988, J NUTR, V118, P290, DOI 10.1093/jn/118.3.290
NR 34
TC 44
Z9 48
U1 0
U2 8
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD DEC
PY 2002
VL 34
IS 6
BP 517
EP 524
DI 10.1023/A:1022530512096
PG 8
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA 649JH
UT WOS:000181204000012
PM 12678443
DA 2024-02-19
ER

PT J
AU Pasciu, D
   Montisci, S
   Greco, M
   Doratiotto, S
   Pitzalis, S
   Pani, P
   Laconi, S
   Laconi, E
AF Pasciu, Daniela
   Montisci, Stefania
   Greco, Marianna
   Doratiotto, Silvia
   Pitzalis, Sabrina
   Pani, Paolo
   Laconi, Sergio
   Laconi, Ezio
TI Aging is associated with increased clonogenic potential in rat liver
   <i>in vivo</i>
SO AGING CELL
LA English
DT Article
DE aging; cancer; cell transplantation; clonal growth
ID REPLICATIVE SENESCENCE; TUMOR SUPPRESSION; CANCER; GROWTH; REPOPULATION;
   HEPATOCYTES; TRANSPLANTATION; REGENERATION; HEPATECTOMY; REPLACEMENT
AB Cancer increases with age and often arises from the selective clonal growth of altered cells. Thus, any environment favoring clonal growth per se poses a higher risk for cancer development. Using a genetically tagged animal model, we investigated whether aging is associated with increased clonogenic potential. Groups of 4-, 12-, 18-, and 24-month-old Fischer 344 rats were infused (via the portal vein) with 2 x 10(6) hepatocytes isolated from a normal syngenic 2-month-old donor. Animals deficient in dipeptidyl-peptidase type IV (DPP-IV-) enzyme were used as recipients, allowing for the histochemical detection of injected DPP-IV+ cells. Groups of animals were sacrificed at various times thereafter. No growth of DPP-IV+ transplanted hepatocytes was present after either 2 or 6 months in the liver of rats transplanted at young age, as expected. In striking contrast, significant expansion of donor-derived cells was seen in animals transplanted at the age of 18 months: clusters comprising 7-10 DPP-IV+ hepatocytes/cross-section were present after 2 months and were markedly enlarged after 6 months (mean of 88 +/- 35 cells/cluster/cross-section). These results indicate that the microenvironment of the aged liver supports the clonal expansion of transplanted normal hepatocytes. Such clonogenic environments can foster the selective growth of pre-existing altered cells, thereby increasing the overall risk for cancer development associated with aging.
C1 Univ Cagliari, Dept Biomed Sci & Biotechnol, Expt Pathol Sect, I-09125 Cagliari, Italy.
C3 University of Cagliari
RP Laconi, E (corresponding author), Univ Cagliari, Dept Biomed Sci & Biotechnol, Expt Pathol Sect, Via Porcell 4, I-09125 Cagliari, Italy.
EM elaconi@unica.it
RI Pani, Paolo/AAG-3902-2021; GRECO, MARIANNA/IAR-6364-2023; Pitzalis,
   Sabrina/AAA-9406-2019
OI Pani, Paolo/0000-0003-4443-1761; 
CR AIHARA T, 1994, GASTROENTEROLOGY, V107, P1805, DOI 10.1016/0016-5085(94)90824-9
   Antebi A, 2005, SCIENCE, V310, P1911, DOI 10.1126/science.1122816
   Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   CHIJIIWA K, 1994, SURGERY, V116, P544
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO;2-1
   Grompe M, 1999, SEMIN LIVER DIS, V19, P7, DOI 10.1055/s-2007-1007093
   GUPTA S, 1991, HEPATOLOGY, V14, P144, DOI 10.1002/hep.1840140124
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Laconi E, 2000, Lancet Oncol, V1, P235, DOI 10.1016/S1470-2045(00)00154-6
   Laconi E, 2002, SEMIN CELL DEV BIOL, V13, P433, DOI 10.1016/S1084952102001313
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   Laconi E, 2000, AM J PATHOL, V156, P389, DOI 10.1016/S0002-9440(10)64741-4
   Laconi S, 2001, P NATL ACAD SCI USA, V98, P7806, DOI 10.1073/pnas.131210498
   Laconi S, 2001, AM J PATHOL, V158, P771, DOI 10.1016/S0002-9440(10)64019-9
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   OGAWA K, 1985, JPN J CANCER RES, V76, P779
   PETO R, 1975, BRIT J CANCER, V32, P411, DOI 10.1038/bjc.1975.242
   Ries LAG, 2003, ONCOLOGIST, V8, P541
   Rubin H, 2001, ADV CANCER RES, V83, P159, DOI 10.1016/S0065-230X(01)83006-2
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   THOMPSON NL, 1991, BIOCHEM J, V273, P497, DOI 10.1042/bj2730497
   Vineis P, 2003, CARCINOGENESIS, V24, P1, DOI 10.1093/carcin/24.1.1
   Weibel ER, 1979, PRACTICAL METHODS BI
NR 32
TC 35
Z9 36
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2006
VL 5
IS 5
BP 373
EP 377
DI 10.1111/j.1474-9726.2006.00230.x
PG 5
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 080ZQ
UT WOS:000240287400003
PM 16911563
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Raouf, S
   Weston, C
   Yucel, N
AF Raouf, Samrrah
   Weston, Claire
   Yucel, Nora
CA Reproducibility Project Canc Biolo
TI Registered report: Senescence surveillance of pre-malignant hepatocytes
   limits liver cancer development
SO ELIFE
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; TUMORS; RAS; CARCINOGENESIS; TUMORIGENESIS;
   PROGRAM
AB The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from 'Senescence surveillance of pre-malignant hepatocytes limits liver cancer development' by Kang et al. (2011), published in Nature in 2011. The experiments that will be replicated are those reported in Figures 3B, 3C, 3E, and 4A. In these experiments, Kang et al. (2011) demonstrate the phenomenon of oncogene-induced cellular senescence and immune-mediated clearance of senescent cells after intrahepatic injection of NRAS (Figures 2I, 3B, 3C, and 3E). Additionally, Kang et al. (2011) show the specific necessity of CD4+ T cells for immunoclearance of senescent cells (Figure 4A). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.
C1 [Raouf, Samrrah] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA.
   [Weston, Claire] Reveal Biosci, San Diego, CA USA.
   [Yucel, Nora] Stanford Univ, Stanford, CA 94305 USA.
C3 University of California System; University of California Davis;
   Stanford University
RP Raouf, S (corresponding author), Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA.
OI Errington, Tim/0000-0002-4959-5143
FU Laura and John Arnold Foundation
FX Laura and John Arnold Foundation Reproducibility Project: Cancer
   Biology; The Reproducibility Project: Cancer Biology is funded by the
   Laura and John Arnold Foundation, provided to the Center for Open
   Science in collaboration with Science Exchange. The funder had no role
   in study design or the decision to submit the work for publication.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471
   Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Brinkhoff B, 2014, EUR J IMMUNOL, V44, P1213, DOI 10.1002/eji.201343794
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020
   Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863
   Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920
   QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0
   Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002
   Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405
   Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 17
TC 9
Z9 9
U1 0
U2 7
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JAN 26
PY 2015
VL 4
AR e04105
DI 10.7554/eLife.04105
PG 14
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA AZ6UO
UT WOS:000348356200003
PM 25621566
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Fraile-Ramos, J
   Garrit, A
   Reig-Vilallonga, J
   Giménez-Llort, L
AF Fraile-Ramos, Juan
   Garrit, Anna
   Reig-Vilallonga, Josep
   Gimenez-Llort, Lydia
TI Hepatic Oxi-Inflammation and Neophobia as Potential Liver-Brain Axis
   Targets for Alzheimer's Disease and Aging, with Strong Sensitivity to
   Sex, Isolation, and Obesity
SO CELLS
LA English
DT Article
DE Alzheimer's disease; 3xTg-AD; liver-brain axis; obesity; HPA axis;
   corticosterone; oxidative stress; social isolation; amyloidosis;
   steatosis
ID TRIPLE-TRANSGENIC MICE; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS;
   QUANTITATIVE-DETERMINATION; IMMUNE-SYSTEM; 3XTG-AD MICE; REDOX STATUS;
   MOUSE MODEL; HPA AXIS; GLUTATHIONE
AB Research on Alzheimer's disease (AD) has classically focused on alterations that occur in the brain and their intra- and extracellular neuropathological hallmarks. However, the oxi-inflammation hypothesis of aging may also play a role in neuroimmunoendocrine dysregulation and the disease's pathophysiology, where the liver emerges as a target organ due to its implication in regulating metabolism and supporting the immune system. In the present work, we demonstrate organ (hepatomegaly), tissue (histopathological amyloidosis), and cellular oxidative stress (decreased glutathione peroxidase and increased glutathione reductase enzymatic activities) and inflammation (increased IL-6 and TNF??) as hallmarks of hepatic dysfunction in 16-month-old male and female 3xTg-AD mice at advanced stages of the disease, and as compared to age- and sex-matched non-transgenic (NTg) counterparts. Moreover, liver-brain axis alterations were found through behavioral (increased neophobia) and HPA axis correlations that were enhanced under forced isolation. In all cases, sex (male) and isolation (naturalistic and forced) were determinants of worse hepatomegaly, oxidative stress, and inflammation progression. In addition, obesity in old male NTg mice was translated into a worse steatosis grade. Further research is underway determine whether these alterations could correlate with a worse disease prognosis and to establish potential integrative system targets for AD research.
C1 [Fraile-Ramos, Juan; Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona 08193, Spain.
   [Fraile-Ramos, Juan; Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Sch Med, Dept Psychiat & Forens Med, Barcelona 08193, Spain.
   [Garrit, Anna; Reig-Vilallonga, Josep] Univ Autonoma Barcelona, Sch Med, Dept Anat, Barcelona 08193, Spain.
C3 Autonomous University of Barcelona; Autonomous University of Barcelona;
   Autonomous University of Barcelona
RP Giménez-Llort, L (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Barcelona 08193, Spain.; Giménez-Llort, L (corresponding author), Univ Autonoma Barcelona, Sch Med, Dept Psychiat & Forens Med, Barcelona 08193, Spain.
EM lidia.gimenez@uab.cat
OI Gimenez-Llort, Lydia/0000-0002-4091-489X; Fraile-Ramos,
   Juan/0000-0002-4475-4360
FU AGAUR; Generalitat de Catalunya [2017-SGR-1468]; Universitat Autonoma de
   Barcelona [UAB-GE-260408]; European Union [Fet-OPEN-1-2016-2017-737390];
   Memorial Mercedes Llort Sender [2021/80/09241941.8]
FX This work was funded by AGAUR, Generalitat de Catalunya, 2017-SGR-1468
   and Universitat Autonoma de Barcelona, UAB-GE-260408 to L.G.-L. The
   colony of 3xTg-AD mice is sustained by ArrestAD H2020,
   Fet-OPEN-1-2016-2017-737390, European Union's Horizon 2020 research and
   innovation program under grant agreement No 737390 to L.G.-L. It also
   received financial support from Memorial Mercedes Llort Sender,
   2021/80/09241941.8.
CR Ahmad MH, 2018, NEUROPSYCHOBIOLOGY, V77, P197, DOI 10.1159/000495521
   Alvarado C, 2006, DEV COMP IMMUNOL, V30, P1168, DOI 10.1016/j.dci.2006.03.004
   Angiulli F, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11091525
   [Anonymous], 2021, ALZHEIMERS DEMENT, V17, P327, DOI 10.1002/alz.12328
   Baeta-Corral R, 2023, BEHAV BRAIN RES, V438, DOI 10.1016/j.bbr.2022.114189
   Baeta-Corral R, 2015, BEHAV NEUROSCI, V129, P129, DOI 10.1037/bne0000027
   Baeza I, 2010, J NEUROIMMUNOL, V219, P90, DOI 10.1016/j.jneuroim.2009.12.008
   Baliño P, 2019, ALCOHOL CLIN EXP RES, V43, P1672, DOI 10.1111/acer.14133
   Battaglia S, 2022, PSYCHOPHYSIOLOGY, V59, DOI 10.1111/psyp.14122
   Battaglia S, 2022, TRENDS NEUROSCI, V45, P504, DOI 10.1016/j.tins.2022.04.003
   Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4
   Blázquez G, 2014, BEHAV BRAIN RES, V268, P185, DOI 10.1016/j.bbr.2014.04.008
   Canet G, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00269
   Cheng Y, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00195-1
   Clement CG, 2014, HUM PATHOL, V45, P1766, DOI 10.1016/j.humpath.2014.04.016
   Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S
   De la Fuente M, 2012, FREE RADICAL BIO MED, V53, pS165, DOI 10.1016/j.freeradbiomed.2012.08.346
   De la Fuente M, 2010, NEUROIMMUNOMODULAT, V17, P213, DOI 10.1159/000258727
   Esmaeili MH, 2018, BRAIN RES BULL, V137, P265, DOI 10.1016/j.brainresbull.2018.01.001
   Estrada LD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00174
   Feng Y, 2020, CELL STRESS CHAPERON, V25, P47, DOI 10.1007/s12192-019-01034-7
   Ferré N, 2006, MINI-REV MED CHEM, V6, P1321, DOI 10.2174/138955706778993049
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   García-Mesa Y, 2016, J GERONTOL A-BIOL, V71, P40, DOI 10.1093/gerona/glv005
   Gibson GE, 2005, NEUROBIOL AGING, V26, P575, DOI 10.1016/j.neurobiolaging.2004.07.017
   Giménez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007
   Gimenez-Llort L., 2009, ALZHEIMERS DEMENT, V5, pP502, DOI [10.1016/j.jalz.2009.04.711, DOI 10.1016/J.JALZ.2009.04.711]
   Gimenez-Llort L, 2021, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.611384
   Giménez-Llort L, 2012, ANN NY ACAD SCI, V1262, P74, DOI 10.1111/j.1749-6632.2012.06639.x
   Giménez-Llort L, 2008, NEUROIMMUNOMODULAT, V15, P331, DOI 10.1159/000156475
   Gioeva Z, 2009, PATHOLOGE, V30, P240, DOI 10.1007/s00292-009-1133-4
   Gonzalez-Marrero I, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00017
   Villagarcía HG, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/7838290
   Han D, 2006, AM J PHYSIOL-GASTR L, V291, pG1, DOI 10.1152/ajpgi.00001.2006
   Hasegawa M, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020024
   Hernanz A., 2014, ALZHEIMERS DEMENT, V10, pP492, DOI [10.1016/j.jalz.2014.05.737, DOI 10.1016/J.JALZ.2014.05.737]
   Huang ZH, 2022, NUTRIENTS, V14, DOI 10.3390/nu14204298
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062
   Ke ZL, 2020, J NUTR BIOCHEM, V83, DOI 10.1016/j.jnutbio.2020.108426
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kosel F, 2020, NEUROSCI BIOBEHAV R, V112, P634, DOI 10.1016/j.neubiorev.2020.02.012
   Lackner C, 2011, EXPERT REV GASTROENT, V5, P223, DOI [10.1586/egh.11.8, 10.1586/EGH.11.8]
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Li JL, 2020, EXP ANIM TOKYO, V69, P326, DOI 10.1538/expanim.19-0148
   Li S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4234061
   LIAO JF, 1995, AM J PHYSIOL-REG I, V268, pR699, DOI 10.1152/ajpregu.1995.268.3.R699
   Lyketsos Constantine G, 2011, Alzheimers Dement, V7, P532, DOI 10.1016/j.jalz.2011.05.2410
   Machado MV, 2011, EXPERT REV GASTROENT, V5, P213, DOI [10.1586/EGH.11.16, 10.1586/egh.11.16]
   Marchese M, 2014, J ALZHEIMERS DIS, V39, P191, DOI 10.3233/JAD-131490
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   Maté I, 2015, J ALZHEIMERS DIS, V43, P213, DOI 10.3233/JAD-140861
   Morris G, 2019, MOL NEUROBIOL, V56, P406, DOI 10.1007/s12035-018-1092-y
   Muchtar E, 2021, J INTERN MED, V289, P268, DOI 10.1111/joim.13169
   Muntsant A, 2022, FRONT AGING NEUROSCI, V14, DOI 10.3389/fnagi.2022.969381
   Muntsant A, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9070715
   Muntsant A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.572583
   Nguyen ET, 2020, HORM BEHAV, V126, DOI 10.1016/j.yhbeh.2020.104852
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Presnell CE, 2013, CURR NEUROVASC RES, V10, P185
   Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017
   Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060
   Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378
   Sarkar S.R., 2020, ARC J NEUROSCI, V4, P20, DOI [10.20431/2456-057x.0403003, DOI 10.20431/2456-057X.0403003]
   Sarkar S, 2020, METAB BRAIN DIS, V35, P1371, DOI 10.1007/s11011-020-00608-0
   Scheltens P, 2021, LANCET, V397, P1577, DOI 10.1016/S0140-6736(20)32205-4
   Sentellas S, 2014, TOXICOL IN VITRO, V28, P1006, DOI 10.1016/j.tiv.2014.04.017
   Shen LX, 2021, J ALZHEIMERS DIS, V80, P665, DOI 10.3233/JAD-201442
   Sie YD, 2015, FASEB J, V29
   Siersbæk MS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70765-w
   Simon G, 2020, LEGAL MED-TOKYO, V47, DOI 10.1016/j.legalmed.2020.101781
   Tao WJ, 2019, MAR DRUGS, V17, DOI 10.3390/md17110645
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   Tiwari S, 2019, INT J NANOMED, V14, P5541, DOI 10.2147/IJN.S200490
   Torres-Lista V, 2017, J ALZHEIMERS DIS REP, V1, P47, DOI 10.3233/ADR-170011
   Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019
   Vida C, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01974
   Wieckowska-Gacek A, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.654509
   Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.10.2783S
   Xie XX, 2020, J STEROID BIOCHEM, V200, DOI 10.1016/j.jsbmb.2020.105607
   Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931
NR 82
TC 2
Z9 2
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAY 30
PY 2023
VL 12
IS 11
AR 1517
DI 10.3390/cells12111517
PG 20
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA I7OX4
UT WOS:001004654500001
PM 37296638
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Fujita, T
   Shirasawa, T
   Maruyama, N
AF Fujita, T
   Shirasawa, T
   Maruyama, N
TI Isolation and characterization of genomic and cDNA clones encoding mouse
   senescence marker protein-30 (SMP30)
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
LA English
DT Article
DE aging; calcium binding protein; 5' flanking sequence; genomic DNA;
   senescence marker protein-30 (SMP30); transcription initiation site;
   (mouse liver)
ID ANDROGEN RECEPTOR GENE; BINDING-PROTEIN; 5'-FLANKING REGION; RAT-LIVER;
   EXPRESSION; AGE; CLONING; CELLS
AB We isolated and characterized genomic and cDNA clones encoding mouse senescence marker protein-30 (SMP30), the protein amounts of which are known to decrease with aging in the livers of rats. This decrease in the expression of SMP30 is independent of androgen. SMP30 is a calcium binding protein also called regucalcin. The expression of SMP30 in aged mouse liver and 5' flanking sequence of the genome were also characterized. The cDNA contained an open reading frame encoding 299 amino acids with a calculated molecular weight of 33 404. The amino acid sequence of mouse SMP30 showed 94% similarity to rat SMP30 and 89% to human SMP30. Northern blot analysis specifically detected mouse SMP30 transcript in the liver and also confirmed its significant decrease with aging. Analysis of the murine genomic clone revealed that SMP30 was organized by seven exons and six introns, spanning approx. 17.5 kb. Primer extension analysis revealed that two major transcription initiation sites were localized at 101 bp and 102 bp upstream from ATG translation initiation codon. The nucleotide (nt) sequence of 5' flanking region showed a TATA-like sequence, a CAAT box, and SP-1 sites at nt -29, -72 and -169 in the promoter region, respectively. Interestingly, we found two classes of C/EBP sites which are highly and constantly expressed in the liver, in addition to AP-2, AP-1, GATA-1, AP-1/GRE and GAGA sites. These results provide important clues for understanding the regulatory mechanism of SMP30 gene expression and its relationship to aging.
C1 TOKYO METROPOLITAN INST GERONTOL,DEPT MOL PATHOL,TOKYO 173,JAPAN.
C3 Tokyo Metropolitan Institute of Gerontology
RP Fujita, T (corresponding author), TOKYO METROPOLITAN INST GERONTOL,DEPT MOL BIOL,ITABASHI KU,35-2 SAKAECHO,TOKYO 173,JAPAN.
CR AMMENDOLA R, 1992, J BIOL CHEM, V267, P17944
   [Anonymous], 1989, MOL CLONING LAB MANU
   AUSUBEL FM, 1992, CURRENT PROTOCOLS S, V20
   BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771
   IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078
   ICHIHARA J, 1995, BBA-GENE STRUCT EXPR, V1260, P365, DOI 10.1016/0167-4781(94)00226-S
   KOZAK M, 1986, CELL, V46, P659
   LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933
   MILLER RT, 1991, J BIOL CHEM, V266, P10813
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   VASSEUR S, 1995, BBA-GENE STRUCT EXPR, V1261, P272, DOI 10.1016/0167-4781(95)00020-H
   Yamaguchi M. A., 1992, CALCIUM INHIBITION, P19
   YU CW, 1995, BBA-GENE STRUCT EXPR, V1262, P150, DOI 10.1016/0167-4781(95)00070-W
NR 20
TC 38
Z9 52
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4781
J9 BBA-GENE STRUCT EXPR
JI Biochim. Biophys. Acta-Gene Struct. Expression
PD JUL 31
PY 1996
VL 1308
IS 1
BP 49
EP 57
DI 10.1016/0167-4781(96)00064-4
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA VB035
UT WOS:A1996VB03500010
PM 8765750
DA 2024-02-19
ER

PT J
AU Morgan, AE
   Mc Auley, MT
AF Morgan, Amy Elizabeth
   Mc Auley, Mark Tomas
TI Cholesterol Homeostasis: An In Silico Investigation into How Aging
   Disrupts Its Key Hepatic Regulatory Mechanisms
SO BIOLOGY-BASEL
LA English
DT Article
DE aging; cholesterol biosynthesis; reactive oxygen species; mathematical
   model; systems biology
ID AGE-RELATED-CHANGES; ALL-CAUSE MORTALITY; MATHEMATICAL-MODEL;
   LDL-CHOLESTEROL; SYSTEMS BIOLOGY; CARDIOVASCULAR-DISEASE; REDUCTASE
   DEREGULATION; LIPOPROTEIN METABOLISM; LIPID-METABOLISM; ACETYL-COA
AB Simple Summary
   Cardiovascular disease is the leading cause of death worldwide. High blood cholesterol levels are associated with an increased risk of this condition. How high levels of blood cholesterol result in cardiovascular disease during aging is a difficult question to answer. Computational models have been used over the years to help understand this problem, as they are capable of representing complex systems such as this. The aim of this work was to use a computational model of cholesterol metabolism to better understand why, in certain studies involving the oldest old (persons >= 85 years), high blood cholesterol levels have been associated with a decreased risk of death. Using our computational model, we found that key age-associated changes to how cholesterol is processed in the liver could be responsible for this observation. The findings from our work contribute to our understanding of cholesterol metabolism in older people and how treatments could be developed in the future to promote healthy aging.
   The dysregulation of intracellular cholesterol homeostasis is associated with several age-related diseases, most notably cardiovascular disease (CVD). Research in this area has benefitted from using computational modelling to study the inherent complexity associated with the regulation of this system. In addition to facilitating hypothesis exploration, the utility of modelling lies in its ability to represent an array of rate limiting enzymatic reactions, together with multiple feedback loops, which collectively define the dynamics of cholesterol homeostasis. However, to date no model has specifically investigated the effects aging has on this system. This work addresses this shortcoming by explicitly focusing on the impact of aging on hepatic intracellular cholesterol homeostasis. The model was used to investigate the experimental findings that reactive oxygen species induce the total activation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGCR). Moreover, the model explored the impact of an age-related decrease in hepatic acetyl-CoA acetyltransferase 2 (ACAT2). The model suggested that an increase in the activity of HMGCR does not have as significant an impact on cholesterol homeostasis as a decrease in hepatic ACAT2 activity. According to the model, a decrease in the activity of hepatic ACAT2 raises free cholesterol (FC) and decreases low-density lipoprotein cholesterol (LDL-C) levels. Increased acetyl CoA synthesis resulted in a reduction in the number of hepatic low-density lipoprotein receptors, and increased LDL-C, FC, and cholesterol esters. The rise in LDL-C was restricted by elevated hepatic FC accumulation. Taken together these findings have important implications for healthspan. This is because emerging clinical data suggest hepatic FC accumulation is relevant to the pathogenesis of non-alcoholic fatty liver disease (NAFLD), which is associated with an increased risk of CVD. These pathophysiological changes could, in part, help to explain the phenomenon of increased mortality associated with low levels of LDL-C which have been observed in certain studies involving the oldest old (>= 85 years).
C1 [Morgan, Amy Elizabeth; Mc Auley, Mark Tomas] Univ Chester, Fac Sci & Engn, Thornton Sci Pk, Chester CH2 4NU, Cheshire, England.
C3 University of Chester
RP Mc Auley, MT (corresponding author), Univ Chester, Fac Sci & Engn, Thornton Sci Pk, Chester CH2 4NU, Cheshire, England.
EM amy.morgan@chester.ac.uk; m.mcauley@chester.ac.uk
OI Morgan, Amy/0000-0001-7557-6651
FU British Society for Research on Ageing
FX This work was supported in part by publication funds provided by the
   British Society for Research on Ageing.
CR Al-Mallah MH, 2009, CARDIOL J, V16, P227
   [Anonymous], 2005, BMC BIOINFORMATICS, V6
   August E, 2007, B MATH BIOL, V69, P1233, DOI 10.1007/s11538-006-9132-6
   AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
   Bekkar A, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay031
   Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06
   Benson HE, 2017, BRIT J PHARMACOL, V174, P4362, DOI 10.1111/bph.14037
   Berrougui H, 2009, REJUV RES, V12, P117, DOI 10.1089/rej.2008.0840
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   Bhattacharya BS, 2014, J THEOR BIOL, V349, P150, DOI 10.1016/j.jtbi.2014.01.013
   Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016
   Bourgin M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01121
   Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852
   Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773
   Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M
   Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008
   Chaudhary R, 2017, WORLD J CARDIOL, V9, P76, DOI 10.4330/wjc.v9.i2.76
   Czauderna T, 2010, BIOINFORMATICS, V26, P2340, DOI 10.1093/bioinformatics/btq407
   Duncan MS, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011433
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   Fajemiroye JO, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7156435
   Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7
   Félix-Redondo FJ, 2013, AGING DIS, V4, P154
   Fell D., 1997, UNDERSTANDING CONTRO, V2
   Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144
   Ferrara A, 1997, CIRCULATION, V96, P37
   GARRY PJ, 1992, AM J CLIN NUTR, V55, P682, DOI 10.1093/ajcn/55.3.682
   Goldberg IJ, 1996, J LIPID RES, V37, P693
   Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564
   Gomez-Cabrero D, 2011, INTERFACE FOCUS, V1, P438, DOI 10.1098/rsfs.2011.0015
   Hagström H, 2019, LIVER INT, V39, P197, DOI 10.1111/liv.13973
   Han RL, 2010, MICROBIOL IMMUNOL, V54, P246, DOI 10.1111/j.1348-0421.2010.00203.x
   Holzer M, 2013, BBA-MOL CELL BIOL L, V1831, P1442, DOI 10.1016/j.bbalip.2013.06.004
   Homan R, 1997, CURR PHARM DESIGN, V3, P29
   Ioannou GN, 2016, TRENDS ENDOCRIN MET, V27, P84, DOI 10.1016/j.tem.2015.11.008
   JAVITT NB, 1994, FASEB J, V8, P1308, DOI 10.1096/fasebj.8.15.8001744
   Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   Johnston TP, 1997, PHARMACOTHERAPY, V17, P342
   Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Kervizic G, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-99
   Kilner J, 2016, MOL BIOSYST, V12, P93, DOI 10.1039/c5mb00211g
   KREISBERG RA, 1987, AM J MED, V82, P54, DOI 10.1016/0002-9343(87)90272-5
   Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114
   Le Novère N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558
   Lebeau PF, 2019, J BIOL CHEM, V294, P9037, DOI 10.1074/jbc.RA119.008094
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liu HH, 2015, AGEING RES REV, V19, P43, DOI 10.1016/j.arr.2014.12.001
   Lu J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003509
   Lv YB, 2015, ATHEROSCLEROSIS, V239, P137, DOI 10.1016/j.atherosclerosis.2015.01.002
   Mazein A, 2013, BIOCHEM PHARMACOL, V86, P56, DOI 10.1016/j.bcp.2013.03.021
   Mc Auley M.T., 2019, COMPUTER MODELLING N, P63
   Mc Auley M, 2018, CONN'S HANDBOOK OF MODELS FOR HUMAN AGING, 2ND EDITION, P79, DOI 10.1016/B978-0-12-811353-0.00007-5
   Mc Auley MT, 2017, MED HYPOTHESES, V104, P15, DOI 10.1016/j.mehy.2017.05.013
   Mc Auley MT, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160177
   Mc Auley MT, 2014, EXPERT REV ENDOCRINO, V9, P357, DOI 10.1586/17446651.2014.921569
   Mc Auley MT, 2015, METABOLITES, V5, P232, DOI 10.3390/metabo5020232
   Mc Auley MT, 2015, COMPUT STRUCT BIOTEC, V13, P38, DOI 10.1016/j.csbj.2014.11.006
   Mc Auley MT, 2015, INTERD T GERONT GERI, V40, P35, DOI 10.1159/000364928
   Mc Auley MT, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-130
   Mc Auley MT, 2018, SUBCELL BIOCHEM, V90, P99, DOI 10.1007/978-981-13-2835-0_4
   Mc Auley MT., 2015, ADV TOXICOL, V2015, P575403, DOI 10.1155/2015/575403
   McAuley MT, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-26
   Mooney K.M., 2016, J INTEGRATIVE CARDIO, V1, P76, DOI 10.15761/JIC.1000122
   Mooney KM, 2016, WIRES SYST BIOL MED, V8, P123, DOI 10.1002/wsbm.1328
   Morgan AE, 2017, P NUTR SOC, V76, P378, DOI 10.1017/S0029665116002822
   Morgan AE, 2016, BIOSYSTEMS, V145, P19, DOI 10.1016/j.biosystems.2016.05.001
   Morgan AE, 2016, AGEING RES REV, V27, P108, DOI 10.1016/j.arr.2016.03.008
   Mulas MF, 2005, MECH AGEING DEV, V126, P648, DOI 10.1016/j.mad.2004.11.010
   NEUMANN SJ, 1990, B MATH BIOL, V52, P711, DOI 10.1016/S0092-8240(05)80381-7
   O'Donnel CJ, 2008, REV ESP CARDIOL, V61, P299, DOI 10.1016/S1885-5857(08)60118-8
   Ostaszewski M, 2019, BRIEF BIOINFORM, V20, P659, DOI 10.1093/bib/bby024
   Pallottini V, 2006, J HEPATOL, V44, P368, DOI 10.1016/j.jhep.2005.06.011
   Pallottini V, 2005, MECH AGEING DEV, V126, P845, DOI 10.1016/j.mad.2005.02.009
   Pallottini V, 2007, MECH AGEING DEV, V128, P688, DOI 10.1016/j.mad.2007.10.001
   Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Parton A, 2019, BIOINFORMATICS, V35, P2449, DOI 10.1093/bioinformatics/bty980
   Parton A, 2016, BRIEF BIOINFORM, V17, P562, DOI 10.1093/bib/bbv081
   Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030
   Pedersen TR, 2016, CIRC RES, V118, P721, DOI 10.1161/CIRCRESAHA.115.306297
   Perry RJ, 2017, CELL METAB, V25, P749, DOI 10.1016/j.cmet.2016.12.017
   Pool F, 2018, PROCESSES, V6, DOI 10.3390/pr6080134
   Pool F, 2018, J THEOR BIOL, V443, P157, DOI 10.1016/j.jtbi.2017.12.023
   Postmus I, 2015, INT J EPIDEMIOL, V44, P604, DOI 10.1093/ije/dyv031
   Proctor C. J., 2013, J COMPUT SCI SYST BI, V6, P271, DOI DOI 10.4172/JCSB.1000122
   Ravnskov U, 2003, QJM-INT J MED, V96, P927, DOI 10.1093/qjmed/hcg150
   Ravnskov U, 2018, EXPERT REV CLIN PHAR, V11, P959, DOI 10.1080/17512433.2018.1519391
   Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401
   Reiss AB, 2018, CLIN SCI, V132, P1135, DOI 10.1042/CS20180190
   Saqi M, 2016, METHODS MOL BIOL, V1386, P43, DOI 10.1007/978-1-4939-3283-2_3
   Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895
   Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003
   Shiomi M, 2000, METABOLISM, V49, P552, DOI 10.1016/S0026-0495(00)80025-6
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200
   Tindall MJ, 2009, J THEOR BIOL, V257, P371, DOI 10.1016/j.jtbi.2008.11.016
   Tirosh O, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2548154
   Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471
   Toroghi MK, 2019, COMPUT CHEM ENG, V130, DOI 10.1016/j.compchemeng.2019.06.032
   Trapani Laura, 2010, Curr Gerontol Geriatr Res, P420139, DOI 10.1155/2010/420139
   Trapani L, 2010, EXP GERONTOL, V45, P119, DOI 10.1016/j.exger.2009.10.014
   UCHIDA K, 1978, J LIPID RES, V19, P544
   van der Wulp MYM, 2013, MOL CELL ENDOCRINOL, V368, P1, DOI 10.1016/j.mce.2012.06.007
   Wang MJ, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1000-0
   Watterson S, 2013, BIOCHIMIE, V95, P613, DOI 10.1016/j.biochi.2012.05.024
   Weverling-Rijnsburger AWE, 2003, ARCH INTERN MED, V163, P1549, DOI 10.1001/archinte.163.13.1549
   WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9
   Wildermuth MC, 2000, GENOME BIOL, V1
NR 113
TC 12
Z9 13
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD OCT
PY 2020
VL 9
IS 10
AR 314
DI 10.3390/biology9100314
PG 18
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA OJ8DZ
UT WOS:000584186000001
PM 33007859
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU FISMAN, M
AF FISMAN, M
TI HEPATIC AGING AS AN ETIOLOGIC FACTOR IN THE DEVELOPMENT OF
   ALZHEIMERS-DISEASE
SO MEDICAL HYPOTHESES
LA English
DT Article
RP FISMAN, M (corresponding author), VICTORIA HOSP,DEPT PSYCHIAT,LONDON N6A 4G5,ONTARIO,CANADA.
CR ALDRICH MS, 1987, ANN NEUROL, V21, P149, DOI 10.1002/ana.410210207
   CALLOWAY NO, 1965, J AM GERIATR SOC, V13, P20, DOI 10.1111/j.1532-5415.1965.tb00569.x
   CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682
   DANIELS CK, 1985, J IMMUNOL, V134, P3855
   DICE JF, 1988, LIVER BIOL PATHOBIOL, P1245
   DONOHUE TM, 1987, ANN NY ACAD SCI, V492, P253, DOI 10.1111/j.1749-6632.1987.tb48677.x
   FISMAN M, 1985, AM J PSYCHIAT, V142, P71
   FREEMAN H, 1984, CLIN BIOCH ELDERLY
   GUMERLOCK MK, 1989, IMPLICATIONS BLOOD B, P495
   HAUSSINGER D, 1986, REGULATION HEPATIC M, P253
   HAXBY JV, 1986, ARCH NEUROL-CHICAGO, V43, P882, DOI 10.1001/archneur.1986.00520090022010
   HENDERSON AS, 1988, ACTA PSYCHIAT SCAND, V78, P257, DOI 10.1111/j.1600-0447.1988.tb06336.x
   JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x
   MARCHESINI G, 1988, ADV AMMONIA METABOLI
   MULLERHILL B, 1989, ANNU REV BIOCHEM, V58, P287
   RASKIND MA, 1989, GERIATRIC PSYCHIATRY, P313
   RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203
   SCHUBERT D, 1988, SCIENCE, V241, P223, DOI 10.1126/science.2968652
   SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P463, DOI 10.1146/annurev.neuro.12.1.463
   SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341
   SNOW AD, 1987, HUM PATHOL, V18, P506, DOI 10.1016/S0046-8177(87)80036-9
   STERNLIEB I, 1984, LYSOSOM BIOL PATHOL, P185
   TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367
   WHARTON SA, 1984, LYSOSOMES BIOL PATHO
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   ZIMMERMANN K, 1988, EMBO J, V7, P367, DOI 10.1002/j.1460-2075.1988.tb02822.x
NR 26
TC 3
Z9 3
U1 0
U2 1
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PD NOV
PY 1990
VL 33
IS 3
BP 163
EP 167
DI 10.1016/0306-9877(90)90168-E
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA EJ085
UT WOS:A1990EJ08500005
PM 2292979
DA 2024-02-19
ER

PT J
AU Liu, HY
   Pei, XL
   Wang, J
   Zhou, Y
   Wang, LM
   Qi, B
AF Liu, Haiying
   Pei, Xinli
   Wang, Jing
   Zhou, Yang
   Wang, Limei
   Qi, Bin
TI Effect of loach paste on the liver and immune organs of
   D-galactose-induced ageing mice
SO FOOD AND AGRICULTURAL IMMUNOLOGY
LA English
DT Article
DE Loach paste; oxidation resistance; liver damage; gene expression
ID OXIDATIVE STRESS; ANTIOXIDANT MECHANISM; COGNITIVE IMPAIRMENT; HSP70;
   ACTIVATION; INJURY; DAMAGE; MODEL; RATS
AB We examined the effects of loach paste (LP) on liver and immune organs of d-galactose (DG)-induced aging mice. The results showed that LP can alleviate the atrophy of spleen and thymus, and restore the blood glucose levels. LP was particularly beneficial to liver. Liver indices and activities of aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase reduced with high doses of LP. Moreover, LP can improve the antioxidant system in liver by increasing the activities of total superoxide dismutase, glutathione peroxidase, and catalase, reducing malondialdehyde concentration. Furthermore, LP can improve immunity and reduce the inflammation of liver. The swelling of liver cells was alleviated and the cell arrangement returned to normal in the LP group. In addition, gene expressions of HSP70 and tumour necrosis factor- (TNF-) in liver which can promote inflammatory cytokine decreased significantly. Thus, regular LP intake effectively relieved DG-induced oxidative stress and alleviated liver and immune organs damage.
C1 [Liu, Haiying] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
   [Liu, Haiying; Pei, Xinli; Wang, Jing; Zhou, Yang] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
   [Pei, Xinli] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Jiangsu, Peoples R China.
   [Wang, Jing] Jiangnan Univ, Natl Engn Res Ctr Funct Food, Wuxi, Jiangsu, Peoples R China.
   [Wang, Limei; Qi, Bin] Changshu Inst Technol, Sch Biotechnol & Food Engn, Changshu, Jiangsu, Peoples R China.
C3 Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan
   University; Changshu Institute of Technology
RP Liu, HY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.; Liu, HY (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
EM liuhaiying@jiangnan.edu.cn
FU Fundamental Research Funds for the Central Universities [JUSRP1603XNC];
   Ministry of Finance, China [201513003-8]; Primary Research & Development
   Plan of Jiangsu Province [BE2017316, BE2017326]
FX This study was financially supported by the Fundamental Research Funds
   for the Central Universities [no. JUSRP1603XNC]; the non-profit industry
   Scientific Research Special Fund Agreement [no. 201513003-8] from the
   Ministry of Finance, China and Primary Research & Development Plan of
   Jiangsu Province (no. BE2017316 and no. BE2017326).
CR Arunachalam K, 2011, FOOD AGR IMMUNOL, V22, P161, DOI 10.1080/09540105.2010.549211
   Castro-Alférez M, 2017, CHEM ENG J, V318, P214, DOI 10.1016/j.cej.2016.06.093
   Chen J, 2012, FOOD AGR IMMUNOL, V23, P352, DOI 10.1080/09540105.2011.634378
   Chowdhury MI, 2017, J TRACE ELEM MED BIO, V39, P162, DOI 10.1016/j.jtemb.2016.09.012
   Gong YS, 2016, EXP GERONTOL, V74, P21, DOI 10.1016/j.exger.2015.11.020
   Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002
   Huang QF, 2012, FOOD CHEM TOXICOL, V50, P713, DOI 10.1016/j.fct.2011.12.009
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Jiang JL, 2012, COMP BIOCHEM PHYS C, V155, P483, DOI 10.1016/j.cbpc.2011.12.008
   Kasote DM, 2015, INT J BIOL SCI, V11, P982, DOI 10.7150/ijbs.12096
   Kumar A, 2011, J ASIAN NAT PROD RES, V13, P42, DOI 10.1080/10286020.2010.544253
   Kunnen S, 2012, J LIPID RES, V53, P1783, DOI 10.1194/jlr.R024513
   Labat-Robert J, 2014, PATHOL BIOL, V62, P61, DOI 10.1016/j.patbio.2014.02.009
   Liu X, 2017, FOOD AGR IMMUNOL, V28, P859, DOI 10.1080/09540105.2017.1318834
   Narne P, 2017, MOL CELL NEUROSCI, V82, P176, DOI 10.1016/j.mcn.2017.05.008
   Nia B. H., 2017, CANADIAN J DIABETES, V82, P176
   Peng XY, 2014, INT DAIRY J, V34, P80, DOI 10.1016/j.idairyj.2013.08.004
   Salehpour F, 2017, NEUROBIOL AGING, V58, P140, DOI 10.1016/j.neurobiolaging.2017.06.025
   Szeto YT, 2014, FOOD AGR IMMUNOL, V25, P332, DOI 10.1080/09540105.2013.794202
   Vimala B, 2012, FOOD AGR IMMUNOL, V23, P303, DOI 10.1080/09540105.2011.625494
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wooton AK, 2017, JNP-J NURSE PRACT, V13, P222, DOI 10.1016/j.nurpra.2016.08.035
   You LJ, 2011, J AGR FOOD CHEM, V59, P7948, DOI 10.1021/jf2016368
   You LJ, 2010, FOOD RES INT, V43, P1167, DOI 10.1016/j.foodres.2010.02.009
   You LJ, 2010, FOOD CHEM, V120, P810, DOI 10.1016/j.foodchem.2009.11.018
   Zhang CN, 2015, FISH PHYSIOL BIOCHEM, V41, P203, DOI 10.1007/s10695-014-0017-6
   Zhang S, 2014, FOOD AGR IMMUNOL, V25, P386, DOI 10.1080/09540105.2013.810709
   Zhang TT, 2017, ECOTOX ENVIRON SAFE, V143, P46, DOI 10.1016/j.ecoenv.2017.04.058
   Zhang ZF, 2010, FOOD CHEM TOXICOL, V48, P2500, DOI 10.1016/j.fct.2010.06.023
   Zhao XY, 2017, ENVIRON TOXICOL PHAR, V52, P221, DOI 10.1016/j.etap.2017.04.008
   Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931
NR 31
TC 12
Z9 13
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0954-0105
EI 1465-3443
J9 FOOD AGR IMMUNOL
JI Food Agric. Immunol.
PY 2018
VL 29
IS 1
BP 316
EP 331
DI 10.1080/09540105.2017.1376037
PG 16
WC Chemistry, Applied; Food Science & Technology; Immunology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Immunology; Toxicology
GA GK1ZX
UT WOS:000435924800001
OA gold
DA 2024-02-19
ER

PT J
AU Gatineau, E
   Capel, F
   Dardevet, D
   David, J
   Pouyet, C
   Polakof, S
   Mosoni, L
AF Gatineau, Eva
   Capel, Frederic
   Dardevet, Dominique
   David, Jeremie
   Pouyet, Corinne
   Polakof, Sergio
   Mosoni, Laurent
TI Effect of high chronic intake of sucrose on liver metabolism in aging
   rats. Modulation by rutin and micronutrients
SO JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Fructose; Polyphenols; Protein synthesis; Lipids; Triglycerides
ID PEROXISOMAL BETA-OXIDATION; HIGH-FAT DIET; INSULIN-RESISTANCE; HEPATIC
   STEATOSIS; LIPID-ACCUMULATION; HIGH-CARBOHYDRATE; FRUCTOSE; STRESS;
   LIPOGENESIS; GLUCOSE
AB High-sugar intake and senescence share common deleterious effects, in particular in liver, but combination of these two factors was little studied. Our aims were to examine the effect of a high-sucrose diet in liver of old rats and also the potential benefices of a polyphenol/micronutrient supplementation. Four groups of 22-month-old male rats fed during 5months with a diet containing either 13 or 62% sucrose, supplemented or not with rutin, vitamin E, A, D, selenium, and zinc were compared. We measured liver macronutrient composition, glycation/oxidative stress, enzyme activities (lipogenesis, -oxidation, fructokinase), gene expression (enzymes and transcription factors), in vivo protein synthesis rates and plasma parameters. Sucrose induced an increase in plasma and liver lipid content, and a stimulation of liver protein synthesis rates. Gene expression was little changed by sucrose, with lower levels for LXR- and LXR-. Polyphenol/micronutrient supplementation tended to limit liver triglyceride infiltration through variations in fatty acid synthase, acyl coA oxidase, and possibly ATP-citrate lyase activities. In conclusion, despite differences in enzymatic regulations, and blunted responses of gene expression, high-sucrose diet was still able to induce a marked increase in liver lipid content in old animals. However, it probably attenuated the positive impact of polyphenol/micronutrients.
C1 [Gatineau, Eva; Capel, Frederic; Dardevet, Dominique; David, Jeremie; Pouyet, Corinne; Polakof, Sergio; Mosoni, Laurent] Univ Clermont Auvergne, INRA, CRNH Auvergne, UNH,Unite Nutr Humaine,PFEM,MetaboHUB Clermont, F-63122 Clermont Ferrand, Theix, France.
C3 INRAE; Universite Clermont Auvergne (UCA)
RP Mosoni, L (corresponding author), Univ Clermont Auvergne, INRA, CRNH Auvergne, UNH,Unite Nutr Humaine,PFEM,MetaboHUB Clermont, F-63122 Clermont Ferrand, Theix, France.
EM laurent.mosoni@clermont.inra.fr
RI Capel, Frederic/AAW-8838-2020; Dardevet, Dominique/IAM-3666-2023;
   Gatineau, Eva/S-7508-2018
OI Capel, Frederic/0000-0002-0133-0277; Gatineau, Eva/0000-0001-7354-0049;
   Dardevet, Dominique/0000-0001-7320-9970; Mosoni,
   Laurent/0000-0002-5409-6760
FU Institut National de la Recherche Agronomique (INRA), France
FX This work was supported by Institut National de la Recherche Agronomique
   (INRA), France. Similar results as those of this study were published in
   a preliminary form in the result section of Gatineau Eva thesis on the
   following website:
   https://tel.archives-ouvertes.fr/tel-01491088/document.
CR Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Chuffa LGA, 2014, INDIAN J BIOCHEM BIO, V51, P215
   Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144
   Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010
   Dong B, 2013, J LIPID RES, V54, P1241, DOI 10.1194/jlr.M032599
   Eliades M, 2015, WORLD J GASTROENTERO, V21, P1718, DOI 10.3748/wjg.v21.i6.1718
   Faure P, 2007, J TRACE ELEM MED BIO, V21, P113, DOI 10.1016/j.jtemb.2006.12.005
   Ferramosca A, 2014, EUR J NUTR, V53, P1103, DOI 10.1007/s00394-013-0613-8
   Giris M, 2014, J PHYSIOL BIOCHEM, V70, P385, DOI 10.1007/s13105-014-0314-7
   Hagopian K, 2005, BBA-GEN SUBJECTS, V1721, P37, DOI 10.1016/j.bbagen.2004.10.001
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Hu QH, 2012, BIOCHEM PHARMACOL, V84, P113, DOI 10.1016/j.bcp.2012.03.005
   Jensen-Urstad APL, 2012, BBA-MOL CELL BIOL L, V1821, P747, DOI 10.1016/j.bbalip.2011.09.017
   Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899
   Lustig RH, 2013, ADV NUTR, V4, P226, DOI 10.3945/an.112.002998
   Mayot G., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P410
   Mosoni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109098
   Odbayar TO, 2006, J AGR FOOD CHEM, V54, P8261, DOI 10.1021/jf061135c
   Pagliassotti MJ, 1996, AM J PHYSIOL-REG I, V271, pR1319, DOI 10.1152/ajpregu.1996.271.5.R1319
   Panchal SK, 2011, J NUTR, V141, P1062, DOI 10.3945/jn.111.137877
   Park SY, 2006, LIFE SCI, V79, P2228, DOI 10.1016/j.lfs.2006.07.014
   Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508
   Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034
   Polakof S, 2016, J PROTEOME RES, V15, P1862, DOI 10.1021/acs.jproteome.6b00043
   Prakash P, 2014, EUR J PHARMACOL, V727, P15, DOI 10.1016/j.ejphar.2014.01.038
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   SHAFRIR E, 1984, COMP BIOCHEM PHYS B, V78, P493, DOI 10.1016/0305-0491(84)90064-6
   She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443
   Tappy L, 2012, CLIN RES HEPATOL GAS, V36, P554, DOI 10.1016/j.clinre.2012.06.005
   Vilà L, 2011, TOXICOL APPL PHARM, V251, P32, DOI 10.1016/j.taap.2010.11.011
   VITORICA J, 1981, ENZYME, V26, P144
   Wu CH, 2011, J FOOD SCI, V76, pT65, DOI 10.1111/j.1750-3841.2010.02033.x
   Yang L, 2014, NEUROL SCI, V35, P289, DOI 10.1007/s10072-013-1509-3
   Zhang Y, 2014, EUR J NUTR, V53, P221, DOI 10.1007/s00394-013-0519-5
   Zhao S, 2012, BIOCHEM CELL BIOL, V90, P142, DOI [10.1139/o11-079, 10.1139/O11-079]
NR 36
TC 3
Z9 4
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1138-7548
EI 1877-8755
J9 J PHYSIOL BIOCHEM
JI J. Physiol. Biochem.
PD NOV
PY 2018
VL 74
IS 4
SI SI
BP 569
EP 577
DI 10.1007/s13105-018-0628-y
PG 9
WC Biochemistry & Molecular Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology
GA HC8IN
UT WOS:000452046200008
PM 29637446
DA 2024-02-19
ER

PT J
AU Takeda, R
   Tabuchi, A
   Nonaka, Y
   Kano, R
   Sudo, M
   Kano, Y
   Hoshino, D
AF Takeda, Reo
   Tabuchi, Ayaka
   Nonaka, Yudai
   Kano, Ryotaro
   Sudo, Mizuki
   Kano, Yutaka
   Hoshino, Daisuke
TI Cmah deficiency blunts cellular senescence in adipose tissues and
   improves whole-body glucose metabolism in aged mice
SO GERIATRICS & GERONTOLOGY INTERNATIONAL
LA English
DT Article; Early Access
DE adipose tissue; aging; cellular senescence; Cmah; glucose metabolism
ID N-GLYCOLYLNEURAMINIC ACID; INSULIN-RESISTANCE; FATTY LIVER;
   INFLAMMATION; EXERCISE; OBESITY; P53
AB Aim: Cytidine monophosphate-N-acetylneuraminic acid (Neu5Ac) hydroxylase (Cmah) is an enzyme, which converts Neu5Ac to the sialic acid Neu5Gc. Neu5Gc is thought to increase inflammatory cytokines, which are, in part, produced in senescent cells of adipose tissues. Cellular senescence in adipose tissues induces whole-body aging and impaired glucose metabolism. Therefore, we hypothesized that Cmah deficiency would prevent cellular senescence in adipose tissues and impaired glucose metabolism. Methods: Wild-type (WT) and Cmah knockout (KO) mice aged 24-25 months were used. Whole-body metabolism was assessed using a metabolic gas analysis system. We measured blood glucose and insulin concentrations after oral glucose administration. The size of the lipid droplets in the liver was quantified. Markers of cellular senescence and senescence-associated secretory phenotypes were measured in adipose tissues. Results: Cmah KO had significantly increased VO2 and energy expenditure (P < 0.01). Unlike glucose, the insulin concentration after oral glucose administration was significantly lower in the Cmah KO group than in the WT group (P < 0.001). Lipid droplets in the liver were significantly lower in the Cmah KO group than in the WT group (P < 0.05). The markers of cellular senescence and senescence-associated secretory phenotypes in the adipose tissues were significantly lower in the Cmah KO group than in the WT group (P < 0.05). Conclusions: Cmah deficiency blunted cellular senescence in adipose tissues and improved whole-body glucose metabolism. These characteristics in aged Cmah KO mice might be associated with higher energy expenditure.
C1 [Takeda, Reo; Tabuchi, Ayaka; Kano, Ryotaro; Kano, Yutaka; Hoshino, Daisuke] Univ Electrocommun, Dept Engn Sci, Tokyo, Japan.
   [Takeda, Reo; Kano, Ryotaro] Japan Soc Promot Sci, Tokyo, Japan.
   [Nonaka, Yudai] Kanazawa Univ, Inst Liberal Arts & Sci, Kanazawa, Ishikawa, Japan.
   [Sudo, Mizuki] Meiji Yasuda Life Fdn Hlth & Welf, Phys Fitness Res Inst, Tokyo, Japan.
   [Kano, Yutaka; Hoshino, Daisuke] Univ Electrocommun, Ctr Neurosci & Biomed Engn, Tokyo, Japan.
   [Hoshino, Daisuke] Univ Electrocommun, Dept Engn Sci, Biosci & Technol Program, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.
C3 University of Electro-Communications - Japan; Japan Society for the
   Promotion of Science; Kanazawa University; University of
   Electro-Communications - Japan; University of Electro-Communications -
   Japan
RP Hoshino, D (corresponding author), Univ Electrocommun, Dept Engn Sci, Biosci & Technol Program, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.
EM dhoshino@uec.ac.jp
OI Kano, Ryotaro/0000-0001-9541-2486
FU This work was supported by the JSPS KAKENHI (22J15314). We thank Dr
   Hiromu Takematsu (Graduate School of Health Sciences, Fujita Health
   University) for providing Cmah knockout mice. [22J15314]; JSPS KAKENHI
FX This work was supported by the JSPS KAKENHI (22J15314). We thank Dr
   Hiromu Takematsu (Graduate School of Health Sciences, Fujita Health
   University) for providing Cmah knockout mice.
CR Amano Y, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14540
   Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011
   Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692
   Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83
   Fuchs A, 2021, GASTROENTEROLOGY, V161, P968, DOI 10.1053/j.gastro.2021.05.008
   Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198
   Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866
   Kale A, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00187-9
   Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Kavaler S, 2011, FASEB J, V25, P1887, DOI 10.1096/fj.10-175281
   Kawanishi K, 2019, P NATL ACAD SCI USA, V116, P16036, DOI 10.1073/pnas.1902902116
   Kimura M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010264
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Kwon DN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/830315
   Kwon DN, 2015, AGING-US, V7, P579, DOI 10.18632/aging.100800
   Lusk G, 1924, J BIOL CHEM, V59, P41
   Martin PT, 2021, AM J PATHOL, V191, P1474, DOI 10.1016/j.ajpath.2021.04.015
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06
   Narasimhan A, 2022, CURR DIABETES REP, V22, P537, DOI 10.1007/s11892-022-01493-w
   Okerblom J, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1656
   Okerblom JJ, 2017, J IMMUNOL, V198, P2366, DOI 10.4049/jimmunol.1601471
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Schefer V, 1996, EXP GERONTOL, V31, P387, DOI 10.1016/0531-5565(95)02032-2
   Schosserer M, 2018, GERONTOLOGY, V64, P229, DOI 10.1159/000485183
   Shi J, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00703
   Spinelli R, 2020, J ENDOCRINOL INVEST, V43, P1373, DOI 10.1007/s40618-020-01255-z
   Takeda R, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05593-1
   Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Uhm M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5085
   Wang LC, 2022, CELL METAB, V34, P75, DOI 10.1016/j.cmet.2021.11.002
NR 38
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1444-1586
EI 1447-0594
J9 GERIATR GERONTOL INT
JI Geriatr. Gerontol. Int.
PD 2023 DEC
PY 2023
VL 23
IS 12
BP 958
EP 964
DI 10.1111/ggi.14732
EA NOV 2023
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AU1X9
UT WOS:001105206500001
PM 37968438
DA 2024-02-19
ER

PT J
AU HORNE, DW
   PATTERSON, D
   SAID, HM
AF HORNE, DW
   PATTERSON, D
   SAID, HM
TI AGING - EFFECT ON HEPATIC-METABOLISM AND TRANSPORT OF FOLATE IN THE RAT
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
C1 VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232.
   VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT GASTROENTEROL,NASHVILLE,TN 37232.
   VANDERBILT UNIV,MED CTR,SCH MED,DEPT MOLEC PHYSIOL & BIOPHYS,NASHVILLE,TN 37232.
C3 Vanderbilt University; Vanderbilt University; Vanderbilt University
RP HORNE, DW (corresponding author), VET ADM MED CTR,DIV BIOCHEM,RES SERV 151,1310 24TH AVE S,NASHVILLE,TN 37212, USA.
FU NIADDK NIH HHS [AM26657] Funding Source: Medline; NIDDK NIH HHS
   [DK39501, DK32189] Funding Source: Medline
CR ANTONY AC, 1987, J CLIN INVEST, V80, P711, DOI 10.1172/JCI113126
   BAILEY LB, 1979, AM J CLIN NUTR, V32, P2346, DOI 10.1093/ajcn/32.11.2346
   BAILEY LB, 1984, J NUTR, V114, P1770, DOI 10.1093/jn/114.10.1770
   BAKER H, 1978, J AM GERIATR SOC, V26, P218, DOI 10.1111/j.1532-5415.1978.tb01962.x
   HALSTED CH, 1980, ANNU REV MED, V31, P79, DOI 10.1146/annurev.me.31.020180.000455
   HORNE DW, 1981, ANAL BIOCHEM, V116, P393, DOI 10.1016/0003-2697(81)90378-X
   HORNE DW, 1976, BIOCHEM BIOPH RES CO, V68, P70, DOI 10.1016/0006-291X(76)90011-5
   HORNE DW, 1977, ANAL BIOCHEM, V83, P615, DOI 10.1016/0003-2697(77)90065-3
   HORNE DW, 1978, J BIOL CHEM, V253, P3529
   HURDLE ADF, 1966, BRIT MED J, V3, P202
   IWAMOTO K, 1986, BIOCHEM PHARMACOL, V35, P2677
   KALISH MI, 1977, BIOCHIM BIOPHYS ACTA, V483, P452, DOI 10.1016/0005-2744(77)90073-0
   KATO R, 1968, JPN J PHARMACOL, V18, P381, DOI 10.1254/jjp.18.381
   KESAVAN V, 1983, AM J CLIN NUTR, V37, P262, DOI 10.1093/ajcn/37.2.262
   OBROIN JD, 1975, AM J CLIN NUTR, V28, P438, DOI 10.1093/ajcn/28.5.438
   OMALLEY K, 1971, BMJ-BRIT MED J, V3, P607, DOI 10.1136/bmj.3.5775.607
   READ AE, 1965, BMJ-BRIT MED J, V2, P843, DOI 10.1136/bmj.2.5466.843
   SAID HM, 1984, DIGESTION, V30, P231, DOI 10.1159/000199113
   TAMURA T, 1972, ANAL BIOCHEM, V49, P517, DOI 10.1016/0003-2697(72)90456-3
   Wagner P. A., 1981, Nutrition Research, V1, P565, DOI 10.1016/S0271-5317(81)80086-3
   WARTANOWICZ M, 1984, ACTA PHYSL POL, V34, P338
   WEBSTER SGP, 1979, J AM GERIATR SOC, V27, P451, DOI 10.1111/j.1532-5415.1979.tb01725.x
   WILSON SD, 1984, ANAL BIOCHEM, V142, P529, DOI 10.1016/0003-2697(84)90502-5
   WILSON SD, 1982, CLIN CHEM, V28, P1198
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
NR 25
TC 8
Z9 8
U1 0
U2 1
PU AMER SOC CLINICAL NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, SUBSCRIPTIONS, RM L-2310, BETHESDA, MD 20814-3998
SN 0002-9165
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD AUG
PY 1989
VL 50
IS 2
BP 359
EP 363
DI 10.1093/ajcn/50.2.359
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AK118
UT WOS:A1989AK11800023
PM 2756923
OA Bronze
DA 2024-02-19
ER

PT J
AU Nidadavolu, LS
   Niedernhofer, LJ
   Khan, SA
AF Nidadavolu, Lolita S.
   Niedernhofer, Laura J.
   Khan, Saleem A.
TI Identification of microRNAs dysregulated in cellular senescence driven
   by endogenous genotoxic stress
SO AGING-US
LA English
DT Article
DE MicroRNA; aging; cellular senescence; DNA repair; mouse embryonic
   fibroblasts
ID REPLICATIVE LIFE-SPAN; DNA-DAMAGE RESPONSE; HUMAN FIBROBLASTS; MOUSE
   MODEL; TUMOR-SUPPRESSOR; DOWN-REGULATION; GROWTH ARREST; AGING PROCESS;
   CELLS; REPAIR
AB XFE progeroid syndrome, a disease of accelerated aging caused by deficiency in the DNA repair endonuclease XPF-ERCC1, is modeled by Ercc1 knockout and hypomorphic mice. Tissues and primary cells from these mice senesce prematurely, offering a unique opportunity to identify factors that regulate senescence and aging. We compared microRNA (miRNA) expression in Ercc1(-/-) primary mouse embryonic fibroblasts (MEFs) and wild-type (WT) MEFs in different growth conditions to identify miRNAs that drive cellular senescence. Microarray analysis showed three differentially expressed miRNAs in passage 7 (P7) Ercc1(-/-) MEFs grown at 20% O-2 compared to Ercc1(-/-) MEFs grown at 3% O-2. Thirty-six differentially expressed miRNAs were identified in Ercc1(-/-) MEFs at P7 compared to early passage (P3) in 3% O-2. Eight of these miRNAs (miR-449a, miR-455*, miR-128, miR-497, miR-543, miR-450b-3p, miR-872 and miR-10b) were similarly downregulated in the liver of progeroid Ercc1(-/Delta) and old WT mice compared to adult WT mice, a tissue that senesces with aging. Three miRNAs (miR-449a, miR-455* and miR-128) were also downregulated in Ercc1(-/Delta) and WT old mice kidneys compared to young WT mice. We also discovered that the miRNA expression regulator Dicer is significantly downregulated in tissues of old mice and late passage cells compared to young controls. Collectively these results support the conclusion that the miRNAs identified may play an important role in staving off cellular senescence and their altered expression could be indicative of aging.
C1 [Nidadavolu, Lolita S.; Niedernhofer, Laura J.; Khan, Saleem A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh
RP Khan, SA (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
EM khan@pitt.edu
OI Nidadavolu, Lolita/0000-0003-2433-0728
FU University of Pittsburgh Cancer Institute; National Institutes of Health
   [T32AG021885, ES016114]
FX We would like to thank Kusum Pandit, PhD and Naftali Kaminski, MD, PhD
   for their expertise regarding the Agilent microRNA microarray system and
   for providing access to microarray instrumentation. We would also like
   to acknowledge Siobhan Gregg, PhD, and Andria Robinson, PhD for
   providing cell stocks and tissues, as well as technical assistance. This
   work was supported by a pilot grant to SAK from the University of
   Pittsburgh Cancer Institute. LJN was supported by NIH (ES016114). LSN
   was supported by the training grant T32AG021885 from the National
   Institutes of Health.
CR Abdelmohsen K, 2012, MOL CELL BIOL, V32, P2530, DOI 10.1128/MCB.00510-12
   Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y
   Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08
   [Anonymous], 2011, J CELL BIOL
   [Anonymous], 2011, BROAD SEGMENTAL PROG
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bates DJ, 2010, AGING CELL, V9, P1, DOI 10.1111/j.1474-9726.2009.00529.x
   Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09
   Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042
   Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573
   Dallaire A, 2012, AGING-US, V4, P636, DOI 10.18632/aging.100489
   Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069
   Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Donzelli S, 2012, CELL DEATH DIFFER, V19, P1038, DOI 10.1038/cdd.2011.190
   ElSharawy A, 2012, AGING CELL, V11, P607, DOI 10.1111/j.1474-9726.2012.00824.x
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568
   Gombar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-353
   Goss JR, 2011, MECH AGEING DEV, V132, P437, DOI 10.1016/j.mad.2011.04.010
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Guidi M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-95
   Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214
   Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761
   Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043
   Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028
   Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001
   Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276
   Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611
   Lawrence NJ, 2008, DNA REPAIR, V7, P281, DOI 10.1016/j.dnarep.2007.10.005
   Leontieva OV, 2012, CELL CYCLE, V11, P4642, DOI 10.4161/cc.22937
   Li XL, 2011, AGING-US, V3, P985, DOI 10.18632/aging.100371
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lizé M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181
   LUCIBELLO FC, 1993, J CELL SCI, V105, P123
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Mancini M, 2012, AGING-US, V4, P843, DOI 10.18632/aging.100508
   Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823
   Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177
   Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017
   Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167
   Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380
   Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Pospelova TV, 2009, CELL CYCLE, V8, P4112, DOI 10.4161/cc.8.24.10215
   Ramamoorthy A, 2012, DRUG METAB DISPOS, V40, P726, DOI 10.1124/dmd.111.040329
   Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918
   Rizzo M, 2011, AGING-US, V3, P665, DOI 10.18632/aging.100353
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025
   Sheinerman KS, 2012, AGING-US, V4, P590, DOI 10.18632/aging.100486
   Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124
   Vo N, 2010, J ORTHOP RES, V28, P1600, DOI 10.1002/jor.21153
   Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010
   Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100
   Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531
   Zheng DL, 2012, FEBS LETT, V586, P4165, DOI 10.1016/j.febslet.2012.10.014
   Zhu YH, 2011, CLIN CANCER RES, V17, P7105, DOI 10.1158/1078-0432.CCR-11-0071
NR 76
TC 38
Z9 43
U1 0
U2 5
PU IMPACT JOURNALS LLC
PI ALBANY
PA 6211 TIPTON HOUSE, STE 6, ALBANY, NY 12203 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN
PY 2013
VL 5
IS 6
BP 460
EP 473
DI 10.18632/aging.100571
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 195CS
UT WOS:000322679600009
PM 23852002
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Fang, J
   Liang, WL
AF Fang, Jia
   Liang, Wulong
TI ASCs-derived exosomes loaded with vitamin A and quercetin inhibit rapid
   senescence-like response after acute liver injury
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article; Early Access
DE Adipose mesenchymal stem cells; Exosome; Quercetin; Acute liver injury;
   Senescence-like response
ID FIBROSIS
AB Acute liver injury is a short-term burst of liver cell damage, which has many causes and complex mechanisms. Despite the unique ability of the liver to heal itself, there is still no effective treatment except liver transplantation for chronic liver injury or even liver failure caused by acute liver injury. Stem cell-derived exosomes are ideal drug carriers due to their unique immunomodulatory effects and structural characteristics. In this study, quercetin and vitamin A loaded adipose mesenchymal stem cells (ASCs)-derived exosomes were constructed and used to treat acute liver injury induced by CCl4 in mice. Quercetin enhances the therapeutic efficacy of exosomes, while vitamin A enhances the liver targeting of exosomes, and it was found that quercetin and vitamin A loaded mesenchymal stem cell exosomes reduce rapid senescence-like response induced by acute liver injury. (c) 2021 Elsevier Inc. All rights reserved.
C1 [Fang, Jia] Henan Univ Peoples Hosp, Zhengzhou Univ Peoples Hosp, Henan Prov Peoples Hosp, Clin Res Serv Ctr, Zhengzhou 450000, Henan, Peoples R China.
   [Liang, Wulong] Zhengzhou Univ, Affiliated Hosp 5, Zhengzhou 450000, Henan, Peoples R China.
C3 Zhengzhou University; Zhengzhou University
RP Fang, J (corresponding author), Henan Univ Peoples Hosp, Zhengzhou Univ Peoples Hosp, Henan Prov Peoples Hosp, Clin Res Serv Ctr, Zhengzhou 450000, Henan, Peoples R China.; Liang, WL (corresponding author), Zhengzhou Univ, Affiliated Hosp 5, Zhengzhou 450000, Henan, Peoples R China.
EM fangjiatg@163.com; Liang_Wulong@163.com
FU National Natural Science Foundation of China [32000511]; Medical Science
   and Technology Joint Construction Program of Henan Province, China
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 32000511) and the Medical Science and Technology Joint
   Construction Program of Henan Province, China (No.LHGJ20200032) .
CR Andrade L, 2018, CELL TRANSPLANT, V27, P739, DOI 10.1177/0963689717743512
   Basile DP, 2016, J AM SOC NEPHROL, V27, P687, DOI 10.1681/ASN.2015030309
   Chiabotto G, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.594794
   Chu XG, 2020, AGING CELL, V19, DOI 10.1111/acel.13201
   He CJ, 2018, THERANOSTICS, V8, P237, DOI 10.7150/thno.21945
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Kabirifar R, 2017, HEPATOB PANCREAT DIS, V16, P88, DOI 10.1016/S1499-3872(16)60164-9
   Khadrawy SM, 2021, ENVIRON SCI POLLUT R, V28, P2019, DOI 10.1007/s11356-020-10637-y
   Kohli J, 2021, EMBO REP, V22, DOI 10.15252/embr.202052243
   Li SP, 2018, ACTA PHARMACOL SIN, V39, P542, DOI 10.1038/aps.2017.178
   Li X, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00072
   Li Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030167
   Lou GH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.63
   Luo XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1670-6
   Ma XY, 2020, AM J PHYSIOL-ENDOC M, V318, pE817, DOI 10.1152/ajpendo.00427.2019
   Magar RT, 2020, J MICROBIOL BIOTECHN, V30, P11, DOI 10.4014/jmb.1907.07003
   Miltonprabu S, 2017, FOOD CHEM TOXICOL, V108, P365, DOI 10.1016/j.fct.2016.08.034
   Mohi-ud-din R, 2019, CURR DRUG METAB, V20, P867, DOI 10.2174/1389200220666191105121653
   Pechanova O, 2020, MOLECULES, V25, DOI 10.3390/molecules25153322
   Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170
   Reyes-Farias M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133177
   Sharma A, 2018, INT J CANCER, V142, P1086, DOI 10.1002/ijc.31089
   Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105
   Vinayak M, 2019, ANTI-CANCER AGENT ME, V19, P1560, DOI 10.2174/1871520619666190705150214
   Wang W, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00635-0
   Wei WM, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.590470
   Wortzel I, 2019, DEV CELL, V49, P347, DOI 10.1016/j.devcel.2019.04.011
   Xu D, 2019, MOLECULES, V24, DOI 10.3390/molecules24061123
   Yosef R, 2017, EMBO J, V36, P2280, DOI 10.15252/embj.201695553
   Yzydorczyk C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11756-2
NR 30
TC 15
Z9 15
U1 5
U2 29
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD 2021 OCT 1
PY 2021
VL 572
BP 125
EP 130
DI 10.1016/j.bbrc.2021.07.059
EA AUG 2021
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA TX3MU
UT WOS:000682995200005
PM 34364291
DA 2024-02-19
ER

PT J
AU RUTHERFORD, MS
   BAEHLER, CS
   RICHARDSON, A
AF RUTHERFORD, MS
   BAEHLER, CS
   RICHARDSON, A
TI GENETIC EXPRESSION OF COMPLEMENT FACTORS AND ALPHA-1-ACID GLYCOPROTEIN
   BY LIVER-TISSUE DURING SENESCENCE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 ILLINOIS STATE UNIV, DEPT CHEM, NORMAL, IL 61761 USA.
C3 Illinois State University
FU NIA NIH HHS [AG 04520, AG 04091] Funding Source: Medline
CR ABERNETHY DR, 1984, J AM GERIATR SOC, V32, P705, DOI 10.1111/j.1532-5415.1984.tb04167.x
   BIRCHENALLSPARKS MC, 1985, MECH AGEING DEV, V32, P99, DOI 10.1016/0047-6374(85)90039-9
   CAMPBELL RD, 1983, P NATL ACAD SCI-BIOL, V80, P4464, DOI 10.1073/pnas.80.14.4464
   CHAPLIN DD, 1983, P NATL ACAD SCI-BIOL, V80, P6947, DOI 10.1073/pnas.80.22.6947
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CLEWELL DB, 1972, J BACTERIOL, V110, P1135, DOI 10.1128/JB.110.3.1135-1146.1972
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   DILELLA AG, 1982, MECH AGEING DEV, V19, P113, DOI 10.1016/0047-6374(82)90003-3
   DOMDEY H, 1982, P NATL ACAD SCI-BIOL, V79, P7619, DOI 10.1073/pnas.79.24.7619
   FINKELSTEIN MS, 1982, GERIATRICS, V37, P65
   GARVEY JS, 1980, MECH AGEING DEV, V12, P287, DOI 10.1016/0047-6374(80)90052-4
   GOOD RA, 1974, FED PROC, V33, P2040
   GUIGOZ Y, 1983, PHARM MORPHOLOGICAL, P25
   HEIL MF, 1982, J RETICULOENDOTH SOC, V32, P287
   HORBACH GJMJ, 1984, BIOCHIM BIOPHYS ACTA, V783, P60, DOI 10.1016/0167-4781(84)90078-2
   Hugli T E, 1978, Adv Immunol, V26, P1, DOI 10.1016/S0065-2776(08)60228-X
   KATSURADA A, 1982, BIOCHEM BIOPH RES CO, V109, P250, DOI 10.1016/0006-291X(82)91592-3
   Kiessling R, 1978, Contemp Top Immunobiol, V8, P171
   Makinodan T, 1980, Adv Immunol, V29, P287, DOI 10.1016/S0065-2776(08)60047-4
   MANIATIS T, 1982, MOL CLONING LABORATO, P452
   MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835
   NEWELL SL, 1983, J IMMUNOL, V130, P834
   NONAKA M, 1984, P NATL ACAD SCI-BIOL, V81, P6822, DOI 10.1073/pnas.81.21.6822
   PALMBLAD J, 1978, GERONTOLOGY, V24, P381, DOI 10.1159/000212275
   RICCA GA, 1981, J BIOL CHEM, V256, P362
   RICHARDSON A, 1983, REV BIOL RES AGING, V1, P225
   RICHARDSON A, 1985, REV BIOL RES AGING, V2, P395
   RICHARDSON A, 1985, MOL BIOL AGING GENE, P229
   RICHARDSON A, CLIN PHARM AGING
   Roitt I.M., 1998, IMMUNOLOGY, V5
   ROY AK, 1983, J BIOL CHEM, V258, P123
   RUTHERFORD B, 1983, J IMMUNOL, V130, P874
   Schmid K., 1975, PLASMA PROTEINS, P183
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   Walford RL, 1969, IMMUNOLOGIC THEORY A
   WEBSTER GC, 1984, MECH AGEING DEV, V24, P335, DOI 10.1016/0047-6374(84)90118-0
NR 37
TC 7
Z9 7
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG
PY 1986
VL 35
IS 3
BP 245
EP 254
DI 10.1016/0047-6374(86)90127-2
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA E1801
UT WOS:A1986E180100004
PM 3640187
DA 2024-02-19
ER

PT J
AU ENESCO, HE
   SHIMOKAWA, I
   YU, BP
AF ENESCO, HE
   SHIMOKAWA, I
   YU, BP
TI EFFECT OF DIETARY RESTRICTION AND AGING ON POLYPLOIDY IN RAT-LIVER
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE DIETARY RESTRICTION; LIVER POLYPLOIDY; AGING
ID HEPATIC METABOLIC CHARACTERISTICS; CALORIC RESTRICTION; FOOD
   RESTRICTION; FISCHER-344 RAT; EXPERIMENTAL MANIPULATION; CELL
   POLYPLOIDY; AGE-CHANGES; HEPATOCYTES; GROWTH; PLOIDY
AB Liver polyploidy levels were compared as a function of age and diet in male Fischer 344 rats between 1 and 24 months of age. Dietary restriction was imposed on one group by reducing their food intake to 60% of ad libitum food intake. Histological sections of the livers of animals at each age and diet were examined. Diploid, tetraploid and octaploid nuclei were observed, and their size and frequency established. There were no differences in the diameter or volume of these size classes as a function of age or diet. An age-related decline in the percentage of diploid nuclei, coupled with an increase in the percentage of tetraploid and octaploid nuclei was observed in both groups. The major difference between the two groups was that the adult level of liver polyploidy was attained more slowly in the animals on dietary restriction as compared to the ad libitum fed controls. Polyploid cell formation in the liver is under the control of growth hormone, thyroid hormone and thymus, all of which might be influenced by dietary restriction.
C1 UNIV TEXAS, HLTH SCI CTR, DEPT PHYSIOL, SAN ANTONIO, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP ENESCO, HE (corresponding author), CONCORDIA UNIV, DEPT BIOL, 1455 DE MAISONNEUVE BLVD W, MONTREAL H3G 1M8, QUEBEC, CANADA.
OI Shimokawa, Isao/0000-0001-8901-1029
CR ALFERT M, 1958, EXP CELL RES, V15, P230, DOI 10.1016/0014-4827(58)90079-X
   [Anonymous], 1981, Statistical Tables
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   Carriere R, 1969, Int Rev Cytol, V25, P201, DOI 10.1016/S0074-7696(08)60204-1
   CARRIERE R, 1962, ENDOCRINOLOGY, V70, P761, DOI 10.1210/endo-70-6-761
   ENESCO HE, 1981, EXP GERONTOL, V16, P357, DOI 10.1016/0531-5565(81)90056-5
   ENESCO HE, 1983, EXP GERONTOL, V18, P79, DOI 10.1016/0531-5565(83)90054-2
   ENESCO M, 1962, J EMBRYOL EXP MORPH, V10, P530
   EPSTEIN CJ, 1967, P NATL ACAD SCI USA, V57, P327, DOI 10.1073/pnas.57.2.327
   EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0
   EVERITT AV, 1971, GERONTOLOGY, V17, P98, DOI 10.1159/000211812
   FABRIS N, 1988, ANN NY ACAD SCI, V521, P72, DOI 10.1111/j.1749-6632.1988.tb35266.x
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   FUJIMOTO Y, 1989, JPN J CANCER RES, V80, P45, DOI 10.1111/j.1349-7006.1989.tb02243.x
   GAHAN PB, 1977, EXP GERONTOL, V12, P133, DOI 10.1016/0531-5565(77)90021-3
   GAHAN PB, 1982, COMP BIOCHEM PHYS A, V71, P345, DOI 10.1016/0300-9629(82)90414-5
   GAHAN PB, P GERONTOLOGY 2000
   GARRISON JC, 1990, FUND APPL TOXICOL, V14, P346, DOI 10.1016/0272-0590(90)90214-5
   GARRISON JC, 1981, FUND APPL TOXICOL, V49, P249
   GAUB J, 1981, EUR J CLIN INVEST, V11, P235, DOI 10.1111/j.1365-2362.1981.tb01846.x
   HELWIGLARSEN H, 1952, ACTA PATHOL SCAND S, V92
   HERLIHY JT, 1990, MECH AGEING DEV, V53, P9, DOI 10.1016/0047-6374(90)90030-J
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   IWASAKI K, 1988, ACTA PATHOL JAPON, V38, P1119
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LERUMEUR E, 1981, BIOCHEM BIOPH RES CO, V101, P1038
   LEUCHTENBERGER C, 1954, LAB INVEST, V3, P245
   MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   McCarter R J, 1989, Aging (Milano), V1, P71
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MEDVEDEV ZA, 1986, EXP GERONTOL, V21, P277, DOI 10.1016/0531-5565(86)90037-9
   MERRY BJ, 1985, MOL BIOL AGING, P117
   MIDDLETON J, 1982, EXP GERONTOL, V17, P267, DOI 10.1016/0531-5565(82)90015-8
   NAKANO M, 1989, MECH AGEING DEV, V49, P271, DOI 10.1016/0047-6374(89)90077-8
   NANDAL C, 1966, EXP CELL RES, V42, P117
   NAORA H, 1957, J BIOPHYS BIOCHEM CY, V3, P949, DOI 10.1083/jcb.3.6.949
   PIERI C, 1980, MECH AGEING DEV, V13, P275, DOI 10.1016/0047-6374(80)90040-8
   PIERI C, 1982, EXPERIENTIA, V38, P680, DOI 10.1007/BF01964092
   ROMAGNA F, 1981, EXP CELL BIOL, V49, P294
   SCHLATTERER B, 1974, ACTA ANAT, V90, P563
   SCHOOLEY RA, 1966, ENDOCRINOLOGY, V79, P1053, DOI 10.1210/endo-79-6-1053
   SHIMA A, 1976, EXP GERONTOL, V11, P193, DOI 10.1016/0531-5565(76)90033-4
   SPINDLER SR, 1982, J BIOL CHEM, V257, P1627
   URYVAEVA IV, 1981, J THEOR BIOL, V89, P557, DOI 10.1016/0022-5193(81)90028-X
   VANBEZOOIJEN CFA, 1983, PHARM MORPHOLOGICAL, P115
   Weindruch R. H., 1988, RETARDATION AGEING D
   WEINDRUCH RH, 1979, FED PROC, V38, P2007
   WEINDRUCH RH, 1980, J GERONTOL, V35, P525, DOI 10.1093/geronj/35.4.525
   WINICK M, 1966, J NUTR, V89, P300, DOI 10.1093/jn/89.3.300
   YU BP, 1984, MECH AGEING DEV, V24, P67
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1989, GERIATRICS, V44, P87
NR 55
TC 14
Z9 15
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN 14
PY 1991
VL 59
IS 1-2
BP 69
EP 78
DI 10.1016/0047-6374(91)90074-A
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FR468
UT WOS:A1991FR46800006
PM 1890887
DA 2024-02-19
ER

PT J
AU KUMAR, R
   CHIERO, L
   RODRIGUEZ, D
AF KUMAR, R
   CHIERO, L
   RODRIGUEZ, D
TI PROTEIN PHOSPHOTRANSFERASES FROM LIVER OF AGING RATS
SO GERONTOLOGY
LA English
DT Article
C1 UNIV ILLINOIS,DEPT BIOL CHEM,CHICAGO,IL 60680.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP KUMAR, R (corresponding author), UNIV ILLINOIS,DEPT DERMATOL,CHICAGO,IL 60680, USA.
CR Benesch R E, 1974, Adv Protein Chem, V28, P211, DOI 10.1016/S0065-3233(08)60231-4
   BEUNE R, 1978, P NATN ACAD SCI US, V75, P108
   BILEZIKIAN JP, 1977, MOL PHARMACOL, V13, P775
   BOIVIN P, 1979, BIOCHEM BIOPH RES CO, V89, P7, DOI 10.1016/0006-291X(79)90936-7
   BYLUND DB, 1977, LIFE SCI, V21, P403, DOI 10.1016/0024-3205(77)90521-5
   CLARI G, 1981, BIOCHIM BIOPHYS ACTA, V677, P403, DOI 10.1016/0304-4165(81)90253-1
   ERICSON E, 1975, MECH AGE DEV, V1
   HATHAWAY GM, 1979, J BIOL CHEM, V254, P762
   HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038
   HOSEY MM, 1977, CURR TOP MEMBR TRANS, V9, P233
   KLEINSMITH LJ, 1975, J CELL PHYSIOL, V85, P459, DOI 10.1002/jcp.1040850412
   KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423
   KUMAR R, 1975, BIOCHIM BIOPHYS ACTA, V410, P87, DOI 10.1016/0005-2744(75)90209-0
   KUMAR R, 1973, BIOCHIM BIOPHYS ACTA, V315, P66, DOI 10.1016/0005-2744(73)90130-7
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARTIN RG, 1960, J BIOL CHEM, V236, P1043
   PFEFFER SR, 1976, ARCH BIOCHEM BIOPHYS, V177, P117, DOI 10.1016/0003-9861(76)90421-5
   PIAU JP, 1978, BIOCHIM BIOPHYS ACTA, V544, P482, DOI 10.1016/0304-4165(78)90322-7
   REICHLMEIER K, 1978, Z PHYSL CHEM, V359, P308
   REICHLMEIER KD, 1976, J NEUROCHEM, V27, P1249, DOI 10.1111/j.1471-4159.1976.tb00336.x
   REIMANN EM, 1971, J BIOL CHEM, V246, P1986
   ROSE KM, 1981, J BIOL CHEM, V256, P7468
   ROTHSTEIN M, 1977, MECH AGEING DEV, V6, P241, DOI 10.1016/0047-6374(77)90025-2
   SCHMIDT MJ, 1979, J NEUROCHEM, V32, P335, DOI 10.1111/j.1471-4159.1979.tb00356.x
   SCHROCKEN DD, 1977, NATURE LONDON, V267, P856
   SIMKOWSKI KW, 1980, J BIOL CHEM, V255, P6456
   THORNBURG W, 1978, J BIOL CHEM, V253, P4638
   TRAUGH JA, 1974, J BIOL CHEM, V249, P1207
   WILLIAMS RH, 1973, P SOC EXP BIOL MED, V143, P382
   WILSON PD, 1973, GERONTOLOGY, V19, P79, DOI 10.1159/000211964
   ZIMMERMAN I, 1974, MECH AGEING DEV, V3, P33, DOI 10.1016/0047-6374(74)90003-7
   ZIMMERMAN ID, 1975, MECH AGEING DEV, V4, P89, DOI 10.1016/0047-6374(75)90010-X
NR 32
TC 4
Z9 4
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PY 1984
VL 30
IS 1
BP 37
EP 48
DI 10.1159/000212605
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA RY297
UT WOS:A1984RY29700007
PM 6321300
DA 2024-02-19
ER

PT J
AU Barash, H
   Gross, ER
   Edrei, Y
   Ella, E
   Israel, A
   Cohen, I
   Corchia, N
   Ben-Moshe, T
   Pappo, O
   Pikarsky, E
   Goldenberg, D
   Shiloh, Y
   Galun, E
   Abramovitch, R
AF Barash, Hila
   Gross, Eitan R.
   Edrei, Yifat
   Ella, Ezra
   Israel, Ariel
   Cohen, Irit
   Corchia, Nathalie
   Ben-Moshe, Tehila
   Pappo, Orit
   Pikarsky, Eli
   Goldenberg, Daniel
   Shiloh, Yosef
   Galun, Eithan
   Abramovitch, Rinat
TI Accelerated carcinogenesis following liver regeneration is associated
   with chronic inflammation-induced double-strand DNA breaks
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE hepatocellular carcinoma; MRI; MDR2(-/-) mice; genomic instability
ID NF-KAPPA-B; PARTIAL-HEPATECTOMY; HEPATOCELLULAR-CARCINOMA; TUMOR-GROWTH;
   CANCER DEVELOPMENT; DAMAGE RESPONSE; CHROMOSOMAL INSTABILITY;
   MDR2-KNOCKOUT MICE; MITOTIC RATE; ATM
AB Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide and is considered to be the outcome of chronic liver inflammation. Currently, the main treatment for HCC is surgical resection. However, survival rates are suboptimal partially because of tumor recurrence in the remaining liver. Our aim was to understand the molecular mechanisms linking liver regeneration under chronic inflammation to hepatic tumorigenesis. Mdr2-KO mice, a model of inflammation-associated cancer, underwent partial hepatectomy (PHx), which led to enhanced hepatocarcinogenesis. Moreover, liver regeneration in these mice was severely attenuated. We demonstrate the activation of the DNA damage-response machinery and increased genomic instability during early liver inflammatory stages resulting in hepatocyte apoptosis, cell-cycle arrest, and senescence and suggest their involvement in tumor growth acceleration subsequent to PHx. We propose that under the regenerative proliferative stress induced by liver resection, the genomic unstable hepatocytes generated during chronic inflammation escape senescence and apoptosis and reenter the cell cycle, triggering the enhanced tumorigenesis. Thus, we clarify the immediate and long-term contributions of the DNA damage response to HCC development and recurrence.
C1 [Barash, Hila; Edrei, Yifat; Ella, Ezra; Israel, Ariel; Cohen, Irit; Corchia, Nathalie; Ben-Moshe, Tehila; Goldenberg, Daniel; Galun, Eithan; Abramovitch, Rinat] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel.
   [Barash, Hila; Edrei, Yifat; Corchia, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ, Med Ctr, Magnet Resonance Imaging Magnet Resonance Spect L, Human Biol Res Ctr, IL-91120 Jerusalem, Israel.
   [Gross, Eitan R.] Hadassah Hebrew Univ, Med Ctr, Dept Pediat Surg, IL-91120 Jerusalem, Israel.
   [Pappo, Orit; Pikarsky, Eli] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel.
   [Shiloh, Yosef] Tel Aviv Univ, Sackler Sch Med, David & Inez Myers Lab Canc Res, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Sackler Faculty of Medicine
RP Abramovitch, R (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, POB 12000, IL-91120 Jerusalem, Israel.
EM rinat@hadassah.org.il
RI pikarsky, eli/GXV-7099-2022; Galun, Eithan/AAD-9117-2022; Israel,
   Ariel/AFL-8794-2022
OI Galun, Eithan/0000-0002-6243-6702; pikarsky, eli/0000-0003-4186-7105
FU Israel Science Foundation [728/05]; Israeli Ministry of Science
   [LSHB-CT-2004-512034, LSHB-CT-2005-018961]; FP7 program
   [LSHB-CT-2008-223317]; Kamea Scientific Foundation of the Israeli
   Government; Lille and Alfy Nathan, Barbara Fox Miller, and Wolfson
   Foundations; Horwitz Foundation; Israeli Ministry of Science, Culture,
   and Sport
FX We thank Mery Clausen for assisting in manuscript editing and Reba
   Condiotti for assisting in DNA extraction for CGH analysis. This
   research was supported in part by Grant 728/05 from the Israel Science
   Foundation (to R. A.); the Israeli Science Foundation (E. G.); the
   Israeli Ministry of Science through a grant from the National Gene
   Therapy Knowledge Center and through Grants LSHB-CT-2004-512034
   (MOLEDA), LSHB-CT-2005-018961 (INTHER), and the FP7 program
   LSHB-CT-2008-223317 (LIV-ES) (to E. G.); and the Kamea Scientific
   Foundation of the Israeli Government (D. G.). Additional support was
   provided through grants from the Lille and Alfy Nathan, Barbara Fox
   Miller, and Wolfson Foundations (to E. G.); by the Horwitz Foundation
   through the Center for Complexity Science (E. G., R. A., H. B., and Y.
   E.); and by the Israeli Ministry of Science, Culture, and Sport (Eshkol
   Scholarship to H. B.).
CR Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268
   ASAGA T, 1991, JPN J SURG, V21, P669, DOI 10.1007/BF02471053
   Barasli H, 2008, HEPATOLOGY, V48, P1232, DOI 10.1002/hep.22394
   Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130
   Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x
   Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344
   Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002
   Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861
   Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1
   Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   DE JONG KP, 1995, HEPATOLOGY, V22, P1263
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y
   Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072
   Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424
   Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735
   HANIGAN MH, 1990, CARCINOGENESIS, V11, P589, DOI 10.1093/carcin/11.4.589
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868
   Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703
   Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937
   Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172
   Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002
   Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880
   LLANOS JME, 1986, VIRCHOWS ARCH B, V51, P17, DOI 10.1007/BF02899012
   LLANOS JME, 1986, VIRCHOWS ARCH B, V52, P67
   Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198
   Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3
   LOIZIDOU MC, 1991, CLIN EXP METASTAS, V9, P335, DOI 10.1007/BF01769354
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   MAUAD TH, 1994, AM J PATHOL, V145, P1237
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017
   Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108
   O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028
   RIZVI TA, 1989, VIRCHOWS ARCH B, V56, P345
   Sarraf-Yazdi S, 2008, EJSO-EUR J SURG ONC, V34, P476, DOI 10.1016/j.ejso.2007.06.001
   Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005
   Schwartz M, 2007, NAT CLIN PRACT ONCOL, V4, P424, DOI 10.1038/ncponc0844
   Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011
   Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004
   SOLT DB, 1983, CANCER RES, V43, P188
   Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436
   Teoh NC, 2008, HEPATOLOGY, V47, P2078, DOI 10.1002/hep.22194
   Umeda T, 2002, ONCOLOGY-BASEL, V62, P38, DOI 10.1159/000048274
   van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049
   Zimmermann Artur, 2002, Med Sci Monit, V8, pRA53
   Zindy P, 2005, FEBS LETT, V579, P95, DOI 10.1016/j.febslet.2004.09.092
NR 55
TC 103
Z9 117
U1 0
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 2
PY 2010
VL 107
IS 5
BP 2207
EP 2212
DI 10.1073/pnas.0908867107
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 552MV
UT WOS:000274296300073
PM 20133864
OA Green Published
DA 2024-02-19
ER

PT J
AU Liu, JF
   Wu, Y
   Yang, YH
   Wu, SF
   Liu, S
   Xu, P
   Yang, JT
AF Liu, Jiang-Feng
   Wu, Yue
   Yang, Ye-Hong
   Wu, Song-Feng
   Liu, Shu
   Xu, Ping
   Yang, Jun-Tao
TI Phosphoproteome profiling of mouse liver during normal aging
SO PROTEOME SCIENCE
LA English
DT Article
DE Normal aging; Mouse; Liver; Phosphoproteome; Label free
ID HALLMARKS; ENRICHMENT; METABOLISM; METFORMIN; PATHWAYS; PLATFORM;
   DISEASE; LIFE
AB Background Aging is a complex biological process accompanied by a time-dependent functional decline that affects most living organisms. Omics studies help to comprehensively understand the mechanism of aging and discover potential intervention methods. Old mice are frequently obese with a fatty liver. Methods We applied mass spectrometry-based phosphoproteomics to obtain a global phosphorylation profile of the liver in mice aged 2 or 18 months. MaxQuant was used for quantitative analysis and PCA was used for unsupervised clustering. Results Through phosphoproteome analysis, a total of 5,685 phosphosites in 2,335 proteins were filtered for quantitative analysis. PCA analysis of both the phosphoproteome and transcriptome data could distinguish young and old mice. However, from kinase prediction, kinase-substrate interaction analysis, and KEGG functional enrichment analysis done with phosphoproteome data, we observed high phosphorylation of fatty acid biosynthesis, beta-oxidation, and potential secretory processes, together with low phosphorylation of the Egfr-Sos1-Araf/Braf-Map2k1-Mapk1 pathway and Ctnnb1 during aging. Proteins with differentially expressed phosphosites seemed more directly related to the aging-associated fatty liver phenotype than the differentially expressed transcripts. The phosphoproteome may reveal distinctive biological functions that are lost in the transcriptome. Conclusions In summary, we constructed a phosphorylation-associated network in the mouse liver during normal aging, which may help to discover novel antiaging strategies.
C1 [Liu, Jiang-Feng; Wu, Yue; Yang, Ye-Hong; Yang, Jun-Tao] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Med Mol Biol, Dept Biochem & Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.
   [Wu, Yue] Nankai Univ, Sch Stat & Data Sci, Tianjin 300071, Peoples R China.
   [Wu, Song-Feng; Liu, Shu; Xu, Ping] Chinese Acad Med Sci, State Key Lab Prote, Res Unit Prote & ResearchDev New Drug, Inst Life,Beijing Proteome Res Ctr,Natl Ctr Prot, Beijing 102206, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Peking Union Medical College; Nankai University; Chinese Academy of
   Medical Sciences - Peking Union Medical College
RP Yang, JT (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Med Mol Biol, Dept Biochem & Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.; Xu, P (corresponding author), Chinese Acad Med Sci, State Key Lab Prote, Res Unit Prote & ResearchDev New Drug, Inst Life,Beijing Proteome Res Ctr,Natl Ctr Prot, Beijing 102206, Peoples R China.
EM xuping@ncpsb.org.cn; yangjt@pumc.edu.cn
RI zhang, xu/JXX-7692-2024; LI, Xiang/JBJ-8387-2023; Li,
   Shuyao/JRY-8603-2023; lin, qing/JTU-4293-2023; liu,
   kaiyuan/JHU-0258-2023
FU Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
   [CIFMS2017-I2M-1-008, CIFMS2019-I2M-1-004, CIFMS2021-I2M-1-057]
FX This work was supported by grants from the Chinese Academy of Medical
   Sciences Innovation Fund for Medical Sciences (CIFMS2017-I2M-1-008,
   CIFMS2019-I2M-1-004, CIFMS2021-I2M-1-057).
CR Amirthalingam M, 2021, AGEING RES REV, V71, DOI 10.1016/j.arr.2021.101443
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011
   Benayoun BA, 2019, GENOME RES, V29, P697, DOI 10.1101/gr.240093.118
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Cano M, 2017, CURR PHARM DESIGN, V23, P4351, DOI 10.2174/1381612823666170714143426
   Chakravarti D, 2021, CELL, V184, P306, DOI 10.1016/j.cell.2020.12.028
   Chartier M, 2013, PEERJ, V1, DOI 10.7717/peerj.126
   Cheng A, 2019, BIOINFORMATICS, V35, P2774, DOI 10.1093/bioinformatics/bty1058
   Han H, 2018, NUCLEIC ACIDS RES, V46, pD380, DOI 10.1093/nar/gkx1013
   He D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13911-x
   Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968
   Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Jian CS, 2020, CELL METAB, V31, P892, DOI 10.1016/j.cmet.2020.04.011
   Johnson AA, 2020, AGEING RES REV, V60, DOI 10.1016/j.arr.2020.101070
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kim Y, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700240
   Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001
   Lee JS, 2019, P NATL ACAD SCI USA, V116, P13311, DOI 10.1073/pnas.1903847116
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Moaddel R, 2021, AGING CELL, V20, DOI 10.1111/acel.13325
   Morsiani C, 2019, AGEING RES REV, V51, P24, DOI 10.1016/j.arr.2019.02.002
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Park JW, 2009, EXP MOL MED, V41, P772, DOI 10.3858/emm.2009.41.11.083
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   Ren LL, 2018, MOL CELL PROTEOMICS, V17, P1067, DOI 10.1074/mcp.RA117.000421
   Rivero-Segura NA, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101164
   Robles MS, 2017, CELL METAB, V25, P118, DOI 10.1016/j.cmet.2016.10.004
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Srivastava A, 2020, GENOM PROTEOM BIOINF, V18, P430, DOI 10.1016/j.gpb.2020.12.001
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tian MM, 2015, INT J MOL SCI, V16, P4209, DOI 10.3390/ijms16024209
   Tornesello ML, 2013, GENOMICS, V102, P74, DOI 10.1016/j.ygeno.2013.04.001
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]
   Wattacheril J, 2017, HEPATOL RES, V47, P1469, DOI 10.1111/hepr.12885
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010
NR 43
TC 4
Z9 4
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1477-5956
J9 PROTEOME SCI
JI Proteome Sci.
PD AUG 5
PY 2022
VL 20
IS 1
AR 12
DI 10.1186/s12953-022-00194-2
PG 12
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 3O1PP
UT WOS:000836612100001
PM 35932011
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Campisi, J
   Sedivy, J
AF Campisi, Judith
   Sedivy, John
TI How Does Proliferative Homeostasis Change With Age? What Causes It and
   How Does It Contribute to Aging?
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article; Proceedings Paper
CT Biology of Aging Summit
CY SEP, 2008
CL Gaithersburg, MD
SP Natl Inst Aging, Div Aging Biol
DE Proliferative homeostasis; Aging
ID SENESCENCE; CANCER; CELLS; LIVER; LIFE
AB The notion that there might be a cellular basis for aging stems from research that began several decades ago and was proposed to explain the loss of proliferative homeostasis, which is a hallmark of complex animals. Recent years have seen growing support for the idea that two cell fates-apoptosis and cellular senescence, both now well-established tumor suppressor mechanisms-may be important drivers of aging phenotypes and age-related disease. However, there remain many unanswered questions, some quite basic, about how these processes change with age and how they might contribute to aging. It is now clear that failures in apoptosis or senescence can result in hyperproliferative diseases such as cancer. Less is known about whether and how increased apoptosis or senescence can cause tissue degeneration and aging. In addition, there is now a growing recognition that cellular senescence can have cell-nonautonomous effects within tissues. New molecular tools and model organisms, some already on the horizon, will need to be developed to better understand the roles of apoptosis and cellular senescence in age-associated changes in proliferative homeostasis.
C1 [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.
   [Campisi, Judith] Buck Inst Age Res, Novato, CA USA.
   [Sedivy, John] Brown Univ, Dept Mol & Cell Biol & Biochem, Providence, RI 02912 USA.
C3 University of California System; University of California Berkeley;
   United States Department of Energy (DOE); Lawrence Berkeley National
   Laboratory; Buck Institute for Research on Aging; Brown University
RP Campisi, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.
EM jcampisi@buckinstitute.org
CR Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2009, J GERONTOL A-BIOL, V64, P175, DOI 10.1093/gerona/gln065
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Collins CJ, 2003, AGING CELL, V2, P145, DOI 10.1046/j.1474-9728.2003.00048.x
   Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7
   Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x
   Sharpless NE, 2009, J GERONTOL A-BIOL, V64, P202, DOI 10.1093/gerona/gln070
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030
NR 20
TC 31
Z9 32
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD FEB
PY 2009
VL 64
IS 2
BP 164
EP 166
DI 10.1093/gerona/gln073
PG 3
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Geriatrics & Gerontology
GA 419AB
UT WOS:000264190400004
PM 19228778
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Liu, HW
   Chan, YC
   Wei, CC
   Chen, YA
   Wang, MF
   Chang, SJ
AF Liu, Hung-Wen
   Chan, Yin-Ching
   Wei, Chu-Chun
   Chen, Yun-An
   Wang, Ming-Fu
   Chang, Sue-Joan
TI An alternative model for studying age-associated metabolic
   complications: Senescence-accelerated mouse prone 8
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Senescence-accelerated mouse prone 8; Aging; Insulin resistance; Ectopic
   lipid accumulation; Adipocyte hypertrophy
ID MUSCLE INSULIN-RESISTANCE; VISCERAL ADIPOSE-TISSUE; PPAR-GAMMA;
   FATTY-ACIDS; LIVER; DISEASE; INFLAMMATION; MICE; SUPPLEMENTATION;
   MECHANISMS
AB Rodent animal models take at least 18 months to develop aging phenotypes for researchers to investigate the mechanism of age-related metabolic complications. Senescence-accelerated mouse prone 8 (SAMP8) shortens the process of aging and may facilitate an alternative model for studying age-related insulin resistance. The short-lived strain SAMP8 and two long-lived strains SAM resistant 1 (SAMR1) mice and C57BL/6 mice at 12 (young) and 40 weeks old (old) were used in the present study. Glucose tolerance test, histology and signaling pathways involved in lipid metabolism in adipose tissue and liver and key components of insulin signaling pathway in the skeletal muscle were determined in these three strains. We found that short-lived SAMP8 mice developed symptoms of insulin resistance including hyperglycemia, hyperinsulinemia, and impaired glucose tolerance in association with adipocyte hypertrophy and ectopic lipid accumulation in liver and muscle at 40-wk.-old. Significantly increased serum IL-6, leptin, and resistin levels and adipogenic transcription factor PPAR gamma and macrophage marker F4/80 mRNA expression in adipose tissues were observed in old SAMP8 mice, compared with that in young SAMP8 mice. Marked increases in SREBP1 and PPAR. and a decrease in PPARa at mRNA level in accordance with activation of mTOR/Akt pathway were contributed to hepatic lipid accumulation in old SAMP8 mice. Down-regulation of insulin signaling pathway including IR beta, IRS1, and AS160 at protein level in skeletal muscle was observed in old SAMP8 mice. At 40-wk.-old, both long-lived SAMR1 and C57BL/6 mice have not been fully developed age-related metabolic disorders including insulin resistance and visceral fat expansion in line with fewer defects in lipid metabolism and skeletal muscle insulin signaling pathway. In conclusion, our data suggest the suitability of the SAMP8 mice as a model for studying age-related metabolic complications.
C1 [Liu, Hung-Wen; Wei, Chu-Chun; Chen, Yun-An; Chang, Sue-Joan] Natl Cheng Kung Univ, Dept Life Sci, 1 Univ Rd, Tainan, Taiwan.
   [Liu, Hung-Wen] Natl Taiwan Normal Univ, Dept Phys Educ, Taipei, Taiwan.
   [Chan, Yin-Ching; Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung, Taiwan.
C3 National Cheng Kung University; National Taiwan Normal University;
   Providence University - Taiwan
RP Chang, SJ (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, 1 Univ Rd, Tainan, Taiwan.
EM sjchang@mail.ncku.edu.tw
RI Wang, Yin/HCI-9352-2022; wang, ming/HPC-6329-2023
OI Liu, Hung-Wen/0000-0001-6735-8507; Chan, Yin Ching/0000-0001-9602-0775
FU Ministry of Science and Technology, Taiwan [102-2628-B-006-012-MY3,
   104-2320-B-006-023-MY3]
FX This research was supported by grants from Ministry of Science and
   Technology, Taiwan granted to SJC (102-2628-B-006-012-MY3;
   104-2320-B-006-023-MY3).
CR Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003
   Cuesta S, 2013, AGE, V35, P659, DOI 10.1007/s11357-012-9397-7
   DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302
   Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90
   Gupte AA, 2008, J APPL PHYSIOL, V105, P839, DOI 10.1152/japplphysiol.00148.2008
   Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Jacobson L, 2002, AM J PHYSIOL-ENDOC M, V282, pE786, DOI 10.1152/ajpendo.00495.2001
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107
   Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322
   Liu HW, 2015, J AGR FOOD CHEM, V63, P8407, DOI 10.1021/acs.jafc.5b02501
   Liu YS, 2008, MOL CELL PROTEOMICS, V7, P1737, DOI 10.1074/mcp.M800109-MCP200
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Meng QY, 2008, REJUV RES, V11, P649, DOI 10.1089/rej.2007.0645
   Miard S, 2009, AGING CELL, V8, P449, DOI 10.1111/j.1474-9726.2009.00490.x
   Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Palmer AK, 2016, EXP GERONTOL, V86, P97, DOI 10.1016/j.exger.2016.02.013
   Pararasa C, 2015, BIOGERONTOLOGY, V16, P235, DOI 10.1007/s10522-014-9536-x
   Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59
   Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251
   Siersbæk R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010
   Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Xie B., 2016, DIABETES
NR 30
TC 12
Z9 14
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC 1
PY 2017
VL 99
BP 61
EP 68
DI 10.1016/j.exger.2017.08.023
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FM9LQ
UT WOS:000415591300008
PM 28843510
DA 2024-02-19
ER

PT J
AU Bingöl, SA
   Deprem, T
   Tasçi, SK
   Kocamis, H
AF Bingol, Seyit Ali
   Deprem, Turgay
   Tasci, Serap Koral
   Kocamis, Hakan
TI Immunohistochemical Localization of Catalase in Geese (<i>Anser
   anser</i>) Liver
SO KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI
LA English
DT Article
DE Catalase; Immunohistochemistry; Liver; Geese
ID OXIDATIVE STRESS; PEROXISOMES
AB The aim of the present study was to investigate immunohistochemical localization of catalase (CAT) in geese liver as well as its histological structure. Six healthy female geese (Anser anser, aging between 10-12 months and weighing 2-3 kg), were used in this study. Tissues were fixed in Bouin solution for histological and immunohistochemical examinations and embedded in paraffin. Serial cross-sections were taken from paraffin blocks and then stained whit Crossman's triple stain (Triple stain), Hematoxylin and Eosin (HE) and Periodic Acid Schiff (PAS) for histological examinations. After incubation cross section with for 1 hr, 1: 3000 diluted anti-CAT Avidin-Biotin-Peroxidase Complex (ABC) method was applied for immunohistochemical staining. It was histologically observed that hepatocytes formed hepatic cords (also called Remark cords) mostly surrounding the central vein of goose liver. Globuler glycogen deposits were observed in some of the hepatocytes. Catalase immunoreactivity was diffusely observed in hepatocyte cytoplasms. Furthermore, some of hepatocyte nuclei were positively stained for catalase immunoreactivity. In addition, primary antibody was prepared against bovine liver catalase was immunoreactived in geese liver was detected. As a result, antioxidant defense system was carried out especially by the hepatocytes in geese liver and this study was thought to contribute to studies about antioxidant in poultry.
C1 [Bingol, Seyit Ali] Kafkas Univ, Ataturk Hlth Serv Vocat Sch, TR-36040 Kars, Turkey.
   [Deprem, Turgay; Tasci, Serap Koral; Kocamis, Hakan] Kafkas Univ, Fac Vet Med, Dept Histol Embryol, TR-36040 Kars, Turkey.
C3 Kafkas University; Kafkas University
RP Bingöl, SA (corresponding author), Kafkas Univ, Ataturk Hlth Serv Vocat Sch, TR-36040 Kars, Turkey.
EM seyitali@kafkas.edu.tr
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217
   Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025
   Comelekoglu Ulku, 2000, Turkish Journal of Biology, V24, P483
   Gulmez N, 2008, VET OZEL HISTOLOJI, P185
   Guven A., 2005, Kafkas Universitesi Veteriner Fakultesi Dergisi, V11, P113
   Halliwell B., 1989, Free radicals in biology and medicine, V2nd
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   Junqueira LC, 2006, BASIC HISTOLOGY, P332
   Klotz MG, 1997, MOL BIOL EVOL, V14, P951, DOI 10.1093/oxfordjournals.molbev.a025838
   Luna L.G., 1968, Manual of histologic staining methods of armed forces institute of pathology, V3
   Memisogullari R, 2003, CELL BIOCHEM FUNCT, V21, P291, DOI 10.1002/cbf.1025
   MORIKAWA S, 1969, J HISTOCHEM CYTOCHEM, V17, P30, DOI 10.1177/17.1.30
   Ozguner M, 2002, J ANKARA MED SCH, V24, P49
   Özkaya A, 2010, KAFKAS UNIV VET FAK, V16, P263
   Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119
   ROELS F, 1979, J HISTOCHEM CYTOCHEM, V27, P1471, DOI 10.1177/27.11.92501
   Saglam M, 2001, GENEL HISTOLOJI
   Sumner JB, 1937, J BIOL CHEM, V121, P417
   VOLKL A, 1988, J HISTOCHEM CYTOCHEM, V36, P329, DOI 10.1177/36.4.3346536
   Zik B, 2007, VET EMBRIYOLOJI, P243
NR 21
TC 3
Z9 3
U1 0
U2 3
PU KAFKAS UNIV, VETERINER FAKULTESI DERGISI
PI KARS
PA KAFKAS UNIV, VETERINER FAKULTESI DERGISI, KARS, 36040, TURKEY
SN 1300-6045
J9 KAFKAS UNIV VET FAK
JI Kafkas Univ. Vet. Fak. Derg.
PY 2011
VL 17
IS 1
BP 77
EP 81
PG 5
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 696FP
UT WOS:000285427600014
DA 2024-02-19
ER

PT J
AU KITANI, K
AF KITANI, K
TI NEUROHUMORAL CONTROL OF LIVER FUNCTIONS DURING AGING
SO GERONTOLOGY
LA English
DT Article
RP KITANI, K (corresponding author), TOKYO METROPOLITAN INST GERONTOL,CLIN PHYSIOL LAB 1,35-2 SAKAECHO,ITABASHI KU,TOKYO 173,JAPAN.
CR CARRILLO MC, 1986, HEPATOLOGY, V6, P786
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   CUTLER RG, 1984, FREE RADICALS MOL BI, P235
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P3891, DOI 10.1016/0006-2952(85)90440-X
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   FUJITA S, 1986, LIVER AGING 1986, P103
   FUJITA S, 1982, LIVER AGING 1982, P55
   GREENBLATT DJ, 1980, CLIN PHARMACOL THER, V27, P301, DOI 10.1038/clpt.1980.40
   GUSTAFSSON JA, 1976, P NATL ACAD SCI USA, V73, P1462
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KITANI K, 1985, LIFE SCI, V36, P657, DOI 10.1016/0024-3205(85)90170-5
   KITANI K, 1986, HEPATOLOGY, V6, P316, DOI 10.1002/hep.1840060227
   KITANI K, 1986, HEPATOLOGY, V6, P786
   KITANI K, 1984, PHARM MORPHOLOGICAL, P105
   KITANI K, 1984, FOREIGN COMPOUND MET, P12
   KLOTZ U, 1975, J CLIN INVEST, V55, P347, DOI 10.1172/JCI107938
   KLOTZ U, 1982, LIVER AGING 1982, P287
   MACGEOCH M, 1985, HORMONAL REGULATION, P235
   MALONEY AG, 1986, HEPATOLOGY, V6, P282, DOI 10.1002/hep.1840060221
   MODE A, 1981, ENDOCRINOLOGY, V108, P2103, DOI 10.1210/endo-108-6-2103
   NOKUBO M, 1986, LIFE SCI, V38, P1999
   SHADER RI, 1981, PSYCHOPHARMACOLOGY, V75, P193, DOI 10.1007/BF00432186
   SHAFFER G, 1976, ENDOCRINOLOGY, V98, P562
   SHIMAZU T, 1986, LIVER AGING, P171
   SHIMAZU T, 1978, LIVER AGING 1978, P263
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   SUTTER MA, 1985, BIOCHEM PHARMACOL, V34, P2983, DOI 10.1016/0006-2952(85)90025-5
   VESTAL RE, 1978, LIVER AGING 1978, P343
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
NR 30
TC 10
Z9 10
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD JAN-APR
PY 1988
VL 34
IS 1-2
BP 55
EP 63
DI 10.1159/000212931
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA N4927
UT WOS:A1988N492700009
PM 2898420
DA 2024-02-19
ER

PT J
AU Barogi, S
   Baracca, A
   Cavazzoni, M
   Castelli, GP
   Lenaz, G
AF Barogi, S
   Baracca, A
   Cavazzoni, M
   Castelli, GP
   Lenaz, G
TI Effect of the oxidative stress induced by adriamycin on rat hepatocyte
   bioenergetics during ageing
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE hepatocytes; oxidative stress; adriamycin; mitochondria; respiratory
   chain; mitochondrial ATPase
ID FLOW CYTOMETRIC ANALYSIS; BEEF-HEART MITOCHONDRIA; F0F1 ATP SYNTHASE;
   COENZYME-Q; HYDROGEN-PEROXIDE; COMPLEX-I; SKELETAL-MUSCLE; SUPEROXIDE
   GENERATION; NADH DEHYDROGENASE; DEPENDENT CHANGES
AB We have investigated the effect of ageing and of adriamycin treatment on the bioenergetics of isolated rat hepatocytes. Ageing per se, whilst being associated with a striking increase of hydrogen peroxide in the cells, induces only minor changes on mitochondrial functions. The adriamycin treatment induces a decrease of the mitochondrial membrane potential in situ and a consistent increase of the superoxide anion cellular content independently of the donor's age, whilst the hydrogen peroxide is significantly higher in aged than in adult rat hepatocytes. Kinetic studies in isolated mitochondria show that the mitochondrial respiratory chain activity (NADH --> O-2) of 50 mu M adriamycin-treated hepatocytes is lowered both in adult and aged rats. The same adriamycin concentration induces a slight decrease of the maximal rate of ATP hydrolysis in both young and aged rats, without affecting the K-m for the substrate. However, at drug concentrations lower than 50 mu M, both ATPase and NADH oxidation activities decrease significantly in aged rats only. The results suggest that free radicals increase during ageing in rat hepatocytes but are unable: to induce major modifications of mitochondrial bioenergetics. This contrasts with the damaging effect of adriamycin, suggesting that some effects of the drug may be due to other reasons besides oxidative stress. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Bologna, Dipartimento Biochim, I-40126 Bologna, Italy.
C3 University of Bologna
RP Lenaz, G (corresponding author), Univ Bologna, Dipartimento Biochim, Via Irnerio 48, I-40126 Bologna, Italy.
EM lenaz@biocfarm.unibo.it
RI Lenaz, Giorgio/B-5751-2013
OI BARACCA, ALESSANDRA/0000-0002-0490-1776
CR AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   ANDREE P, 1998, OXYGEN SPECIES REACT
   APPELKVIST EL, 1991, BIOMEDICAL CLIN ASPE, P141
   Barogi S, 1995, MECH AGEING DEV, V84, P139, DOI 10.1016/0047-6374(95)01640-6
   BASS DA, 1983, J IMMUNOL, V130, P1910
   BATTINO M, 1990, MEMBRANE BIOCHEM, V9, P179, DOI 10.3109/09687689009025839
   Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2
   BEYER RE, 1985, MECH AGEING DEV, V32, P267, DOI 10.1016/0047-6374(85)90085-5
   BEYER RE, 1994, J BIOENERG BIOMEMBR, V26, P349, DOI 10.1007/BF00762775
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   BLACK KA, 1993, CYTOMETRY, V14, P334, DOI 10.1002/cyto.990140314
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0
   BYRNE E, 1991, REV NEUROL, V147, P532
   CASTELLUCCIO C, 1994, MECH AGEING DEV, V76, P73, DOI 10.1016/0047-6374(94)91583-0
   CEBALLOSPICOT I, 1991, BRAIN RES, V552, P198, DOI 10.1016/0006-8993(91)90084-9
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CROFT S, 1992, FREE RADICAL RES COM, V17, P21, DOI 10.3109/10715769209061086
   CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9
   DARZYNKIEWICZ Z, 1982, CANCER RES, V42, P799
   DAVIES KJA, 1986, J BIOL CHEM, V261, P3060
   DICE JF, 1989, EXP GERONTOL, V24, P451
   DIPLOCK AT, 1994, MOL ASPECTS MED, V15, P293, DOI 10.1016/0098-2997(94)90005-1
   ERNSTER L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P1
   ESPOSTI MD, 1982, BIOCHIM BIOPHYS ACTA, V682, P189, DOI 10.1016/0005-2728(82)90098-6
   ESTORNELL E, 1992, FEBS LETT, V311, P107, DOI 10.1016/0014-5793(92)81378-Y
   FLORENCE TM, 1984, J INORG BIOCHEM, V22, P221, DOI 10.1016/0162-0134(84)85007-2
   FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61
   GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0
   GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105
   Genova ML, 1997, FEBS LETT, V410, P467
   GENOVA ML, 1994, MOL ASPECTS MED, V15, P47
   GLUCK MR, 1994, J BIOL CHEM, V269, P3167
   GOODMAN J, 1977, BIOCHEM BIOPH RES CO, V77, P797, DOI 10.1016/S0006-291X(77)80048-X
   GOORMAGHTIGH E, 1982, BIOCHIM BIOPHYS ACTA, V685, P137, DOI 10.1016/0005-2736(82)90090-6
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8
   GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093
   GUERRIERI F, 1994, BIOCHEM MOL BIOL INT, V33, P117
   GUERRIERI F, 1992, ARCH GERONTOL GERIAT, V14, P299, DOI 10.1016/0167-4943(92)90029-4
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N
   JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526
   JOHNSON LV, 1980, CELL BIOL, V2, P990
   JUAN G, 1994, CYTOMETRY, V15, P335, DOI 10.1002/cyto.990150409
   KONSTANTINOV AA, 1987, BIOCHIM BIOPHYS ACTA, V894, P1, DOI 10.1016/0005-2728(87)90206-4
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   LENAZ G, 1994, MOL ASPECTS MED, V15, P29, DOI 10.1016/0098-2997(94)90010-8
   Lenaz G, 1998, BIOFACTORS, V8, P195, DOI 10.1002/biof.5520080305
   Lenaz G, 1998, BBA-BIOENERGETICS, V1364, P207, DOI 10.1016/S0005-2728(98)00028-0
   LENAZ G, 1988, J MEMBRANE BIOL, V104, P193, DOI 10.1007/BF01872322
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LIPPE G, 1993, BIOCHEM MOL BIOL INT, V30, P1061
   MACLENNAN DH, 1966, J BIOL CHEM, V241, P5251
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MIQUEL J, 1984, EXP GERONTOL, V19, P31, DOI 10.1016/0531-5565(84)90029-9
   MULLERHOECKER J, 1993, J NEUROL SCI, V106, P14
   NAGINO M, 1989, CANCER RES, V49, P4913
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   RICEEVANS C, 1992, MOL ASPECTS MED, V13, P1
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   ROMERO FJ, 1983, BIOCHEM EDUC, V11, P135, DOI 10.1016/0307-4412(83)90093-6
   ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440
   SAKAGUCHI Y, 1994, CANCER CHEMOTH PHARM, V33, P371, DOI 10.1007/BF00686265
   SCHON EA, 1996, CELLULAR AGING CELL, P19
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SHIMOMURA Y, 1985, J BIOL CHEM, V260, P5075
   SIMIC MG, 1989, MUTAT RES, V214, P3, DOI 10.1016/0027-5107(89)90192-9
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   SOHAL RS, 1991, MECH AGEING DEV, V60, P189, DOI 10.1016/0047-6374(91)90130-R
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   SOLAINI G, 1993, EUR J BIOCHEM, V214, P729, DOI 10.1111/j.1432-1033.1993.tb17974.x
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   TSAI AL, 1985, ANAL BIOCHEM, V151, P131, DOI 10.1016/0003-2697(85)90062-4
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633
   Wainio W. W., 1970, MAMMALIAN MITOCHONDR
   WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X
   WELLS WW, 1987, METHOD ENZYMOL, V141, P92
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zucchini C, 1995, BIOCHEM MOL BIOL INT, V37, P607
NR 91
TC 22
Z9 23
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN 24
PY 2000
VL 113
IS 1
BP 1
EP 21
DI 10.1016/S0047-6374(99)00089-5
PG 21
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 283TJ
UT WOS:000085291600001
PM 10708246
DA 2024-02-19
ER

PT J
AU Bloomer, SA
   Han, O
   Kregel, KC
   Brown, KE
AF Bloomer, Steven A.
   Han, Okhee
   Kregel, Kevin C.
   Brown, Kyle E.
TI Altered expression of iron regulatory proteins with aging is associated
   with transient hepatic iron accumulation after environmental heat stress
SO BLOOD CELLS MOLECULES AND DISEASES
LA English
DT Article
DE TFR1; Ferroportin; Hyperthermia; Deferoxamine; Aging; DMT1
ID OXIDATIVE STRESS; RAT-LIVER; OLD RATS; FERROPORTIN-1; MACROPHAGES;
   TRANSPORTER; HEPCIDIN; MUSCLE; DMT1; ERYTHROPHAGOCYTOSIS
AB An increasing body of evidence suggests that dysregulation of iron metabolism contributes to age-related pathologies. We have previously observed increased hepatic iron with aging, and that environmental heat stress stimulates a further increase in iron and oxidative liver injury in old rats. The purpose of this study was to determine a mechanism for the increase in hepatic iron in old rats after heat stress. Young (6 mo) and old (24 mo) Fischer 344 rats were exposed to two heating bouts separated by 24 h. Livers were harvested after the second heat stress, and protein levels of the iron import protein, transferrin receptor-1 (TFR1), and the iron export protein, ferroportin (Fpn) were determined by immunoblot. In the nonheated condition, old rats had lower TFR1 expression, and higher Fpn expression. After heat stress, TFR1 declined in the old rats, and iron chelation studies demonstrated that this decline was dependent on a hyperthermia-induced increase in iron. TFR1 did not change in the young rats after heat stress. Since TFR1 is inversely regulated by iron, our results suggest that the increase in intracellular iron with aging and heat stress lower TFR1 expression. Fpn expression increased in both age groups after heat stress, but this response was delayed in old rats. This delay in the induction of an iron exporter suggests a mechanism for the increase in hepatic iron and oxidative injury after heat stress in aged organisms. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Bloomer, Steven A.] Penn State Abington Coll, Div Sci & Engn, Abington, PA 19001 USA.
   [Han, Okhee] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.
   [Kregel, Kevin C.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA.
   [Brown, Kyle E.] Iowa City Vet Adm Med Ctr, Iowa City, IA 52242 USA.
   [Brown, Kyle E.] Univ Iowa, Div Gastroenterol Hepatol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.
   [Kregel, Kevin C.; Brown, Kyle E.] Univ Iowa, Program Free Rad & Radiat Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); Pennsylvania State University; Pennsylvania
   State University - University Park; University of Iowa; University of
   Iowa; University of Iowa
RP Bloomer, SA (corresponding author), Penn State Abington Coll, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
EM sab320@psu.edu
OI Brown, Kyle/0000-0002-8206-036X
FU Penn State Abington; Veterans' Administration; NIH [AG12350]
FX SAB was supported by start-up funds from Penn State Abington. KEB was
   supported by a Merit Grant from the Veterans' Administration. KCK was
   supported by the NIH grant AG12350.
CR Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200
   Argaud L, 2007, ARCH INTERN MED, V167, P2177, DOI 10.1001/archinte.167.20.ioi70147
   Bloomer SA, 2008, AM J PHYSIOL-REG I, V294, pR1165, DOI 10.1152/ajpregu.00719.2007
   Bloomer SA, 2009, J GERONTOL A-BIOL, V64, P419, DOI 10.1093/gerona/gln056
   Brown KE, 2007, TOXICOL APPL PHARM, V223, P180, DOI 10.1016/j.taap.2007.05.011
   Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Cook J., 1973, BR J HAEMATOL, V25
   Dongiovanni P, 2010, AM J PATHOL, V176, P1006, DOI 10.2353/ajpath.2010.090249
   Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596
   Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003
   Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072
   Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343
   Haak JL, 2009, AM J PHYSIOL-REG I, V296, pR812, DOI 10.1152/ajpregu.90708.2008
   Hall DM, 1999, AM J PHYSIOL-GASTR L, V276, pG1195, DOI 10.1152/ajpgi.1999.276.5.G1195
   Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509
   Han O, 2007, J CELL BIOCHEM, V101, P1000, DOI 10.1002/jcb.21392
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007
   Jung SH, 2008, EXP PHYSIOL, V93, P407, DOI 10.1113/expphysiol.2007.039453
   KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4
   Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102
   Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250
   Layoun A, 2012, AM J PATHOL, V180, P2340, DOI 10.1016/j.ajpath.2012.01.046
   Lymboussaki A, 2003, J HEPATOL, V39, P710, DOI 10.1016/S0168-8278(03)00408-2
   Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123
   McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6
   Minson CT, 1998, J APPL PHYSIOL, V84, P1323, DOI 10.1152/jappl.1998.84.4.1323
   Mysliwska J, 1998, MECH AGEING DEV, V100, P313, DOI 10.1016/S0047-6374(97)00154-1
   Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314
   Naz N, 2012, LAB INVEST, V92, P842, DOI 10.1038/labinvest.2012.52
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873
   Oliveira SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006618
   Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107
   Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7
   ROWELL LB, 1969, J APPL PHYSIOL, V27, P673, DOI 10.1152/jappl.1969.27.5.673
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0
   Starzynski RR, 2013, BIOCHEM J, V449, P69, DOI 10.1042/BJ20121139
   Stauss HM, 1997, AM J PHYSIOL-HEART C, V272, pH776, DOI 10.1152/ajpheart.1997.272.2.H776
   Sukumaran A, 2012, BLOOD CELL MOL DIS, V49, P11, DOI 10.1016/j.bcmd.2012.03.002
   Tacchini L, 2002, HEPATOLOGY, V36, P103, DOI 10.1053/jhep.2002.33997
   Torrance JD, 1980, Methods in Hematology: Iron, V1, P90
   Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200
   Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270
   Viatte L, 2006, BLOOD, V107, P2952, DOI 10.1182/blood-2005-10-4071
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
   Xu JZ, 2012, INT J MOL SCI, V13, P2368, DOI 10.3390/ijms13022368
   Xu JZ, 2012, EXP GERONTOL, V47, P100, DOI 10.1016/j.exger.2011.10.011
   Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
NR 52
TC 11
Z9 11
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1079-9796
EI 1096-0961
J9 BLOOD CELL MOL DIS
JI Blood Cells Mol. Dis.
PD JAN
PY 2014
VL 52
IS 1
BP 19
EP 26
DI 10.1016/j.bcmd.2013.07.002
PG 8
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 265AP
UT WOS:000327922400004
PM 23900040
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Baumann, A
   Hernández-Arriaga, A
   Brandt, A
   Sánchez, V
   Nier, A
   Jung, F
   Kehm, R
   Höhn, A
   Grune, T
   Frahm, C
   Witte, OW
   Camarinha-Silva, A
   Bergheim, I
AF Baumann, Anja
   Hernandez-Arriaga, Angelica
   Brandt, Annette
   Sanchez, Victor
   Nier, Anika
   Jung, Finn
   Kehm, Richard
   Hoehn, Annika
   Grune, Tilman
   Frahm, Christiane
   Witte, Otto Wilhelm
   Camarinha-Silva, Amelia
   Bergheim, Ina
TI Microbiota profiling in aging-associated inflammation and liver
   degeneration
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article; Early Access
DE Aging; Defensins; Intestinal permeability; Microbiota; NOx; Toll-like
   receptors
ID GUT MICROBIOTA; I-FABP; BARRIER; PROGRESSION; IMMUNITY; DISEASE; SHIFTS;
   MICE
AB Background: The number of people above the age of 60 years is raising world-wide being associated with an increase in the prevalence of aging-associated impairments and even diseases. Recent studies suggest that aging is associated with alterations in bacterial endotoxin levels and that these changes may add to low-grade inflammation, the so-called 'inflammaging', and aging-associated liver degeneration. However, mechanisms involved, and especially, the interaction of intestinal microbiota and barrier in the development of aging-associated inflammation and liver degeneration have not been fully understood.
   Objective: The aim of the present study was to determine if intestinal microbiota composition changes with age and if these alterations are associated with changes of markers of intestinal barrier function and the development of inflammation and liver degeneration.
   Methods: Blood, liver, small and large intestinal tissue of male 2-, 15-, 24- and 30-months old C57BL/6 mice fed standard chow were obtained. Intestinal microbiota composition, expression levels of antimicrobial peptides in small intestine and markers of intestinal barrier function were measured. Furthermore, indices of liver damage, inflammation and expression levels of lipopolysaccharide binding protein (Lbp) as well as of toll-like receptors (Tlr) 1-9 in liver tissue were assessed.
   Results: Pairwise comparisons of the microbial community in the small intestine showed differences between 2- and 24-, 15- and 24-, as well as 15- and 30-months old animals while Shannon's diversity, species richness and evenness indexes did not differ in both small and large intestine, respectively, between age groups. Concentrations of nitric oxide were significantly lower in small intestine of 15-, 24- and 30-months old mice compared to 2-months old mice while mRNA expression of the antimicrobial peptides defensin alpha 1 and lysozyme 1 was unchanged. In contrast, in liver tissue, older age of animals was associated with increasing inflammation and the development of fibrosis in 24- and 30-months old mice. Numbers of inflammatory foci and neutrophils in livers of 24- and 30-months old mice were significantly higher compared to 2-months old mice. These alterations were also associated with higher endotoxin levels in plasma as well as an increased mRNA expression of Lbp and Tlr1, Tlr2, Tlr4, Tlr6 and Tlr9 in livers in older mice.
   Conclusion: Despite no consistent and robust changes of microbiota composition in small and/or large intestine of mice of different age were observed, our data suggest that alterations of markers of intestinal barrier function in small intestine are associated with an induction of several Tlrs and beginning hepatic inflammation in older mice and increase with age.
C1 [Baumann, Anja; Brandt, Annette; Sanchez, Victor; Nier, Anika; Jung, Finn; Bergheim, Ina] Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Althanstr 14 UZA 2, A-1090 Vienna, Austria.
   [Hernandez-Arriaga, Angelica; Camarinha-Silva, Amelia] Univ Hohenheim, Inst Anim Sci, Emil Wolff Str 8, D-70599 Stuttgart, Germany.
   [Kehm, Richard; Hoehn, Annika; Grune, Tilman] German Inst Human Nutr Potsdam Rehbrucke DIfE, Nuthetal, Germany.
   [Grune, Tilman] German Ctr Diabet Res DZD, Munich, Germany.
   [Grune, Tilman] Univ Vienna, Dept Physiol Chem, Vienna, Austria.
   [Frahm, Christiane; Witte, Otto Wilhelm] Univ Hosp Jena, Hans Berger Dept Neurol, Jena, Germany.
C3 University of Vienna; University Hohenheim; Deutsches Institut fur
   Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Vienna;
   Friedrich Schiller University of Jena
RP Bergheim, I (corresponding author), Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Althanstr 14 UZA 2, A-1090 Vienna, Austria.; Camarinha-Silva, A (corresponding author), Univ Hohenheim, Inst Anim Sci, Emil Wolff Str 8, D-70599 Stuttgart, Germany.
EM amelia.silva@uni-hohenheim.de; ina.bergheim@univie.ac.at
RI Brandt, Annette/HNC-3045-2023; Sánchez, Victor/KAM-5057-2024
OI Nier, Anika/0000-0003-3772-2261; Hernandez-Arriaga,
   Angelica/0000-0002-9980-4695; Sanchez Juarez, Victor
   Manuel/0000-0003-0878-7744; Brandt, Annette/0000-0002-3934-747X
FU Deutsche Forschungsgemeinschaft (DFG) [SPP1656, BE2376/8-1, CA1708/1-1];
   European Union's Horizon 2020 research and innovation programme under
   the Marie Sklodowska-Curie grant [859890]; Marie Curie Actions (MSCA)
   [859890] Funding Source: Marie Curie Actions (MSCA)
FX The research was funded by the Deutsche Forschungsgemeinschaft (DFG)
   within the Priority Programm SPP1656 (BE2376/8-1 to I.B. and CA1708/1-1
   to A.C-S.) and by the European Union's Horizon 2020 research and
   innovation programme under the Marie Sklodowska-Curie grant agreement
   no. 859890 (SmartAge).
CR Brandt A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43228-0
   Buford TW, 2018, GEROSCIENCE, V40, P257, DOI 10.1007/s11357-018-0026-y
   Chen XL, 2019, EBIOMEDICINE, V40, P135, DOI 10.1016/j.ebiom.2018.12.016
   Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004
   CORAZZA GR, 1986, GERONTOLOGY, V32, P60, DOI 10.1159/000212766
   Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0
   DeVeale B, 2004, AGING CELL, V3, P195, DOI 10.1111/j.1474-9728.2004.00106.x
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016
   Gustot T, 2006, HEPATOLOGY, V43, P989, DOI 10.1002/hep.21138
   Hernández-Arriaga A, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090283
   Jeong JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39848
   Jin CJ, 2020, AM J PHYSIOL-GASTR L, V318, pG736, DOI 10.1152/ajpgi.00345.2018
   Kain V, 2019, FASEB J, V33, P6456, DOI 10.1096/fj.201802477R
   Kim JH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062212
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13
   Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9
   Lau E, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0089-7
   Liang S, 2009, MECH AGEING DEV, V130, P538, DOI 10.1016/j.mad.2009.06.006
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188
   Miani M, 2018, CELL METAB, V28, P557, DOI 10.1016/j.cmet.2018.06.012
   Mu KW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071755
   Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030
   NEDADELGADO JC, 2013, CLIN IMMUNOL, V148, P198
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Pence B.D., 2020, AGING MED MILTON, V4, P47
   Qi YF, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.05.018
   Rausch P, 2016, INT J MED MICROBIOL, V306, P343, DOI 10.1016/j.ijmm.2016.03.004
   SALZMAN AL, 1995, AM J PHYSIOL-GASTR L, V268, pG361, DOI 10.1152/ajpgi.1995.268.2.G361
   Santi-Rampazzo A.Pd., 2015, EVID-BASED COMPL ALT
   Sellmann C, 2017, J NUTR, V147, P2041, DOI 10.3945/jn.117.253815
   Singh PP, 2019, CELL, V177, P200, DOI 10.1016/j.cell.2019.02.038
   Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002
   Sovran B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35228-3
   Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75
   Steegenga WT, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-38
   Steele AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097171
   Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x
   Tanaka T, 2018, AGING CELL, V17, DOI 10.1111/acel.12799
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Valentini L, 2014, PHYSIOL REP, V2, DOI [10.14814/phy2.281, 10.1002/phy2.281]
   Vaughan DE, 2017, ARTERIOSCL THROM VAS, V37, P1446, DOI 10.1161/ATVBAHA.117.309451
   Wagnerberger S, 2012, BRIT J NUTR, V107, P1727, DOI 10.1017/S0007114511004983
   Wang J, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01065
   Wilms E., SCI REP-UK, V10, P1
   Xu CM, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1616-2
   Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330
   Zong X, 2020, ANIM NUTR, V6, P389, DOI 10.1016/j.aninu.2020.09.002
NR 52
TC 10
Z9 10
U1 0
U2 6
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 1438-4221
EI 1618-0607
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD 2021 MAY
PY 2021
VL 311
IS 4
AR 151500
DI 10.1016/j.ijmm.2021.151500
EA APR 2021
PG 11
WC Microbiology; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology; Virology
GA SK3MV
UT WOS:000656123700003
PM 33813306
OA gold
DA 2024-02-19
ER

PT J
AU Wu, W
   Hou, CL
   Mu, XP
   Sun, C
   Zhu, YC
   Wang, MJ
   Lv, QZ
AF Wu, Wei
   Hou, Cui-Lan
   Mu, Xue-Pan
   Sun, Chen
   Zhu, Yi-Chun
   Wang, Ming-Jie
   Lv, Qian-Zhou
TI H<sub>2</sub>S Donor NaHS Changes the Production of Endogenous
   H<sub>2</sub>S and NO in D-Galactose-Induced Accelerated Ageing
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID HYDROGEN-SULFIDE PROTECTS; NITRIC-OXIDE; CELLULAR SENESCENCE; LIFE-SPAN;
   OVEREXPRESSION; ENZYME; CELLS; SOD
AB Aims. The study was designed to explore whether hydrogen sulphide (H2S) and nitric oxide (NO) generation changed in Dgalactose- (D-gal-) induced ageing, the possible effects of exogenous H2S supplementation, and related mechanisms. Results. In D-gal-induced senescent mice, both H2S and NO levels in the heart, liver, and kidney tissues were decreased significantly. A similar trend was observed in D-gal-challenged human umbilical vein endothelial cells (HUVECs). Sustained H2S donor (NaHS) treatment for 2 months elevated H2S and NO levels in these mice, and during this period, the D-gal-induced senescent phenotype was reversed. The protective effect of NaHS is associated with a decrease in reactive oxygen species levels and an increase in antioxidants, such as glutathione, and superoxide dismutase and glutathione peroxidase activities. Increased expression of the H2S-producing enzymes cystathionine.-lyase (CSE) and cystathionine-beta-synthase (CBS) in the heart, liver, and kidney tissues was observed in the NaHS-treated groups. NaHS supplementation also significantly postponed D-gal-induced HUVEC senescence. Conclusions. Endogenous hydrogen sulphide production in both ageing mice and endothelial cells is insufficient. Exogenous H2S can partially rescue ageing-related dysfunction by inducing endogenous H2S and NO production and reducing oxidative stress. Restoring endogenous H2S production may contribute to healthy ageing, and H2S may have antiageing effects.
C1 [Wu, Wei; Lv, Qian-Zhou] Fudan Univ, Zhongshan Hosp, Dept Pharm, Shanghai 200032, Peoples R China.
   [Hou, Cui-Lan; Mu, Xue-Pan; Sun, Chen; Zhu, Yi-Chun; Wang, Ming-Jie] Fudan Univ, Shanghai Key Lab Clin Geriatr Med, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai 200032, Peoples R China.
C3 Fudan University; Fudan University
RP Lv, QZ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Pharm, Shanghai 200032, Peoples R China.; Wang, MJ (corresponding author), Fudan Univ, Shanghai Key Lab Clin Geriatr Med, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai 200032, Peoples R China.
EM mjwang@shmu.edu.cn; lvqianzhou_1975@163.com
RI wang, ming/HPC-6329-2023
OI wu, wei/0000-0002-3538-9437
FU National Natural Science Foundation of China (NSFC) [81230003, 81670248,
   81402917]; Ministry of Education [20110071130009]; Shanghai Pujiang
   Program [15PJ1400700]; Key Laboratory Program of the Education
   Commission of Shanghai Municipality [ZDSYS14005]
FX The authors thank Bo Tan for his excellent technical assistance in
   H<INF>2</INF>S measurements. This study was supported by the National
   Natural Science Foundation of China (NSFC) (no. 81230003 to Yi-Chun Zhu,
   81670248 to Ming-Jie Wang, and 81402917 to Bo Tan), the Ministry of
   Education (20110071130009 to Yi-Chun Zhu), the Shanghai Pujiang Program
   (15PJ1400700 to Ming-Jie Wang), and a Key Laboratory Program of the
   Education Commission of Shanghai Municipality (ZDSYS14005 to Yi-Chun
   Zhu).
CR Altaany Z, 2013, J CELL MOL MED, V17, P879, DOI 10.1111/jcmm.12077
   Assady M, 2011, IRAN J PARASITOL, V6, P17
   Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200
   Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Castro JP, 2013, J PROTEOMICS, V92, P171, DOI 10.1016/j.jprot.2013.05.006
   Chang L, 2014, J MED FOOD, V17, P357, DOI 10.1089/jmf.2013.2830
   Chang YM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040466
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Duan XC, 2015, AM J HYPERTENS, V28, P1106, DOI 10.1093/ajh/hpu299
   Farrugia G, 2014, GASTROENTEROLOGY, V147, P303, DOI 10.1053/j.gastro.2014.04.041
   Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007
   He M, 2009, BIOL PHARM BULL, V32, P55, DOI 10.1248/bpb.32.55
   Höhn A, 2017, REDOX BIOL, V11, P482, DOI 10.1016/j.redox.2016.12.001
   Hou C.-L., 2016, OXIDATIVE MED CELLUL, V2016, P13, DOI DOI 10.1155/2016/7570489
   Jin S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/758358
   Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001
   Kumar Anil, 2011, Int J Alzheimers Dis, V2011, P347569, DOI 10.4061/2011/347569
   Li N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6492469
   Liu YY, 2013, NEUROCHEM INT, V62, P603, DOI 10.1016/j.neuint.2012.12.010
   Meng GL, 2015, BRIT J PHARMACOL, V172, P5501, DOI 10.1111/bph.12900
   Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104
   Nagpure BV, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6904327
   Nam SM, 2014, NEUROCHEM RES, V39, P1702, DOI 10.1007/s11064-014-1362-7
   Newgard CB, 2013, J CLIN INVEST, V123, P946, DOI 10.1172/JCI68833
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Pascual I, 2010, EXP EYE RES, V90, P420, DOI 10.1016/j.exer.2009.12.003
   Pazdro R., 2012, EXP DIABETES RES, V2012, P8
   Qabazard B, 2015, HANDB EXP PHARMACOL, V230, P269, DOI 10.1007/978-3-319-18144-8_14
   Qiao Wei-Li, 2014, Shengli Xuebao, V66, P276
   Shen XG, 2011, FREE RADICAL BIO MED, V50, P1021, DOI 10.1016/j.freeradbiomed.2011.01.025
   Uddin MN, 2010, J IMMUNOTOXICOL, V7, P165, DOI 10.3109/15476910903510806
   Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
   Wei YH, 2016, P NATL ACAD SCI USA, V113, pE2832, DOI 10.1073/pnas.1524727113
   Xie ZZ, 2014, ANTIOXID REDOX SIGN, V21, P2531, DOI 10.1089/ars.2013.5604
   Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645
   Zhang D., 2015, OXID MED CELL LONGEV, V2015, P10
   Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004
NR 39
TC 46
Z9 48
U1 4
U2 27
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2017
VL 2017
AR 5707830
DI 10.1155/2017/5707830
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA ES9UE
UT WOS:000399906100001
PM 28512525
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Winkler, S
   Hempel, M
   Hsu, MJ
   Gericke, M
   Kühne, H
   Brückner, S
   Erler, S
   Burkhardt, R
   Christ, B
AF Winkler, Sandra
   Hempel, Madlen
   Hsu, Mei-Ju
   Gericke, Martin
   Kuehne, Hagen
   Brueckner, Sandra
   Erler, Silvio
   Burkhardt, Ralph
   Christ, Bruno
TI Immune-Deficient Pfp/Rag2<SUP>-/-</SUP> Mice Featured Higher Adipose
   Tissue Mass and Liver Lipid Accumulation with Growing Age than Wildtype
   C57BL/6N Mice
SO CELLS
LA English
DT Article
DE hepatosteatosis; innate immune system; aging; liver; adipose tissue;
   hepatocyte
ID FATTY-ACID-METABOLISM; OBESITY; INFLAMMATION; ZONATION; ADIPOCYTE;
   GLUCOSE; LINKS; NASH; DIET; RISK
AB Aging is a risk factor for adipose tissue dysfunction, which is associated with inflammatory innate immune mechanisms. Since the adipose tissue/liver axis contributes to hepatosteatosis, we sought to determine age-related adipose tissue dysfunction in the context of the activation of the innate immune system fostering fatty liver phenotypes. Using wildtype and immune-deficient mice, we compared visceral adipose tissue and liver mass as well as hepatic lipid storage in young (ca. 14 weeks) and adult (ca. 30 weeks) mice. Adipocyte size was determined as an indicator of adipocyte function and liver steatosis was quantified by hepatic lipid content. Further, lipid storage was investigated under normal and steatosis-inducing culture conditions in isolated hepatocytes. The physiological age-related increase in body weight was associated with a disproportionate increase in adipose tissue mass in immune-deficient mice, which coincided with higher triglyceride storage in the liver. Lipid storage was similar in isolated hepatocytes from wildtype and immune-deficient mice under normal culture conditions but was significantly higher in immune-deficient than in wildtype hepatocytes under steatosis-inducing culture conditions. Immune-deficient mice also displayed increased inflammatory, adipogenic, and lipogenic markers in serum and adipose tissue. Thus, the age-related increase in body weight coincided with an increase in adipose tissue mass and hepatic steatosis. In association with a (pro-)inflammatory milieu, aging thus promotes hepatosteatosis, especially in immune-deficient mice.
C1 [Winkler, Sandra; Hempel, Madlen; Hsu, Mei-Ju; Kuehne, Hagen; Brueckner, Sandra; Christ, Bruno] Univ Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, Div Appl Mol Hepatol, D-04103 Leipzig, Germany.
   [Gericke, Martin] Martin Luther Univ Halle Wittenberg, Inst Anat & Cell Biol, D-06108 Halle, Saale, Germany.
   [Erler, Silvio] Martin Luther Univ Halle Wittenberg, Inst Biol, Anim Ecol, D-06099 Halle, Germany.
   [Burkhardt, Ralph] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany.
   [Burkhardt, Ralph] Univ Hosp Regensburg, Dept Clin Chem & Lab Med, D-93042 Regensburg, Germany.
C3 Leipzig University; Martin Luther University Halle Wittenberg; Martin
   Luther University Halle Wittenberg; Leipzig University; University of
   Regensburg
RP Christ, B (corresponding author), Univ Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, Div Appl Mol Hepatol, D-04103 Leipzig, Germany.
EM bruno.christ@medizin.uni-leipzig.de
RI Burkhardt, Ralph/F-5221-2013; Gericke, Martin/AAI-8637-2020; Erler,
   Silvio/B-4162-2012; Brückner, Sandra/F-4982-2013
OI Erler, Silvio/0000-0002-9425-8103; Burkhardt, Ralph/0000-0003-1924-1202
FU DFG, German Research Foundation [CH109/22-1]; Ministry of Science and
   Technology, Taiwan [105-2917-I-564-071]; German Research Foundation
   (DFG); Leipzig University
FX This work was supported by the DFG, German Research Foundation, to B. C.
   (CH109/22-1). M.-J. H. was supported by the Ministry of Science and
   Technology, Taiwan Postdoctoral Research Abroad Program
   (105-2917-I-564-071). We acknowledge support from the German Research
   Foundation (DFG) and Leipzig University within the program of Open
   Access Publishing.
CR Adolph TE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081649
   Ande SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23608
   Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x
   Boonchaya-Anant P, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0441-1
   Braune J, 2017, DIABETOLOGIA, V60, P889, DOI 10.1007/s00125-017-4223-5
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Buch SC, 2008, HEPATOL INT, V2, P95, DOI 10.1007/s12072-007-9041-2
   Burkhardt R, 2011, ARTERIOSCL THROM VAS, V31, P775, DOI 10.1161/ATVBAHA.110.213843
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Cautivo KM, 2016, EUR J IMMUNOL, V46, P1315, DOI 10.1002/eji.201545562
   Chi X, 2017, MOL METAB, V6, P1137, DOI 10.1016/j.molmet.2017.06.014
   Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Daigo K, 2016, IMMUNOL REV, V274, P202, DOI 10.1111/imr.12476
   du Plessis J, 2015, GASTROENTEROLOGY, V149, P635, DOI 10.1053/j.gastro.2015.05.044
   Dyar KA, 2018, CELL, V174, P1571, DOI 10.1016/j.cell.2018.08.042
   Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12
   Fried SK, 2015, OBESITY, V23, P1345, DOI 10.1002/oby.21133
   Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   GORSKY LD, 1984, J BIOL CHEM, V259, P6812
   Graffy PM, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20151024
   Guillory B, 2018, AGING CELL, V17, DOI 10.1111/acel.12688
   GUZMAN M, 1989, BIOCHEM J, V264, P107, DOI 10.1042/bj2640107
   Hempel M, 2015, CELL MOL LIFE SCI, V72, P2599, DOI 10.1007/s00018-015-1861-y
   Hesse D, 2018, GROWTH FACTORS, V36, P78, DOI 10.1080/08977194.2018.1497621
   Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007
   Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074
   Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x
   INGELMANSUNDBERG M, 1984, J BIOL CHEM, V259, P6447
   Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x
   Kang YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154003
   Kapetanovic R, 2015, AGEING RES REV, V24, P40, DOI 10.1016/j.arr.2015.02.005
   Kietzmann T, 2017, REDOX BIOL, V11, P622, DOI 10.1016/j.redox.2017.01.012
   Kim SN, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0121-7
   Klöting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0
   Koenig S, 2007, HISTOCHEM CELL BIOL, V128, P105, DOI 10.1007/s00418-007-0301-y
   Kumari M, 2018, SEMIN IMMUNOPATHOL, V40, P189, DOI 10.1007/s00281-017-0668-3
   Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007
   Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897
   Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814
   Lee YH, 2016, ONCOTARGET, V7, P46959, DOI 10.18632/oncotarget.10506
   López-Lluch G, 2017, MECH AGEING DEV, V162, P108, DOI 10.1016/j.mad.2016.12.005
   Maurizi G, 2018, J CELL PHYSIOL, V233, P88, DOI 10.1002/jcp.25855
   McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867
   McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1
   Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56
   Meir AY, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2888
   Munukka E, 2014, J HEPATOL, V61, P132, DOI 10.1016/j.jhep.2014.02.020
   NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x
   Navarro E, 2015, MOL NUTR FOOD RES, V59, P75, DOI 10.1002/mnfr.201400521
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008
   Parker R, 2018, NAT REV GASTRO HEPAT, V15, P50, DOI 10.1038/nrgastro.2017.116
   Pelz S, 2012, EXP CELL RES, V318, P276, DOI 10.1016/j.yexcr.2011.11.005
   Pérez LM, 2016, J PHYSIOL-LONDON, V594, P3187, DOI 10.1113/JP271691
   Peverill W, 2014, INT J MOL SCI, V15, P8591, DOI 10.3390/ijms15058591
   Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200
   Ramseyer VD, 2016, ADIPOCYTE, V5, P119, DOI 10.1080/21623945.2016.1145846
   RAUCY JL, 1991, MOL PHARMACOL, V39, P275
   Rodríguez A, 2015, AM J PHYSIOL-ENDOC M, V309, pE691, DOI 10.1152/ajpendo.00297.2015
   Sakamoto K, 2008, CIRC J, V72, P844, DOI 10.1253/circj.72.844
   Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Schleicher J, 2015, BBA-MOL CELL BIOL L, V1851, P641, DOI 10.1016/j.bbalip.2015.02.004
   Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547
   Siegel R. L., 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.213322-s2.0-84954400636, DOI 10.3322/CAAC.21332]
   Stengel A, 2014, PEPTIDES, V61, P75, DOI 10.1016/j.peptides.2014.09.006
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Stout MB, 2017, PHYSIOLOGY, V32, P9, DOI 10.1152/physiol.00012.2016
   Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026
   Tal Y, 2019, CELL MOL LIFE SCI, V76, P1795, DOI 10.1007/s00018-019-03023-6
   Tikka A, 2016, ENDOCRINE, V52, P187, DOI 10.1007/s12020-015-0838-9
   Tilg H, 2014, BEST PRACT RES CL GA, V28, P599, DOI 10.1016/j.bpg.2014.07.006
   Tomas TC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00360
   Trim W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00169
   Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033
   van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350
   van Zutphen T, 2016, J HEPATOL, V65, P1198, DOI 10.1016/j.jhep.2016.05.046
   Vegiopoulos A, 2017, EMBO J, V36, P1999, DOI 10.15252/embj.201696206
   Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502
   Winkler S, 2015, ACTA PHYSIOL, V215, P89, DOI 10.1111/apha.12560
   Yeh YT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/290575
   You TJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE741, DOI 10.1152/ajpendo.00419.2004
NR 84
TC 5
Z9 5
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD AUG
PY 2019
VL 8
IS 8
AR 775
DI 10.3390/cells8080775
PG 22
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA IV8TI
UT WOS:000484537500008
PM 31349725
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Sarkar, M
   Dodge, JL
   Greenblatt, RM
   Kuniholm, MH
   DeHovitz, J
   Plankey, M
   Kovacs, A
   French, AL
   Seaberg, EC
   Ofotokun, I
   Fischl, M
   Overton, E
   Kelly, E
   Bacchetti, P
   Peters, MG
AF Sarkar, Monika
   Dodge, Jennifer L.
   Greenblatt, Ruth M.
   Kuniholm, Mark H.
   DeHovitz, Jack
   Plankey, Michael
   Kovacs, Andrea
   French, Audrey L.
   Seaberg, Eric C.
   Ofotokun, Igho
   Fischl, Margaret
   Overton, Edgar
   Kelly, Erin
   Bacchetti, Peter
   Peters, Marion G.
CA Women's Interagency HIV Study
TI Reproductive Aging and Hepatic Fibrosis Progression in Human
   Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE menopause; hormones; fibrosis markers; anti-mullerian hormone; hepatic
   scarring
ID ANTI-MULLERIAN HORMONE; SIMPLE NONINVASIVE INDEX; LIVER FIBROSIS;
   OVARIAN RESERVE; NONALCOHOLIC STEATOHEPATITIS; VIRAL-HEPATITIS;
   INTERAGENCY HIV; INFECTION; BIOPSY; MENOPAUSE
AB Background. Severity of hepatic fibrosis is greater in postmenopausal than in premenopausal women, perhaps owing to protective effects of estrogens. However, prior studies of estrogen and liver fibrosis lack serial fibrosis measures, adjustment for age, or longitudinal observations in coinfected populations.
   Methods. In a longitudinal cohort of women coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), we assessed fibrosis progression across reproductive age, using validated serum fibrosis markers, aminotransferase platelet ratio index (APRI) and fibrosis 4 (FIB-4). Fibrosis rate was evaluated within each woman as she transitioned from pre-to postmenopause, defined by a biomarker of ovarian function.
   Results. The median follow-up (n = 405) was 9.1 years (interquartile range, 5.0-15.2 years), with a median menopausal age of 49 years (47-52 years). When fully controlled for chronologic aging, the fibrosis progression rate was accelerated during perimenopause, as shown using FIB-4 (0.12 units per year faster than during premenopause; 95% confidence interval [CI],.02-.21; P =.01) and APRI (0.05 units per year faster; -. 002 to.09; P =.06). Accelerated fibrosis was also observed during postmenopause compared with premenopause, for FIB-4 (0.14 units per year faster; 95% CI, -. 01 to.29; P =.07) and APRI (0.07 units per year faster; -. 003 to.15; P =.06). Accelerated fibrosis in perimenopause persisted after adjustment for Hispanic ethnicity, antiretroviral use, and alcohol (0.10 FIB-4 units per year faster than during premenopause; 95% CI,.008-. 20; P =.03).
   Conclusions. In HIV/HCV-coinfected women, hepatic fibrosis accelerates with reproductive aging. Accelerated fibrosis begins in perimenopause, highlighting a previously unrecognized group of women at increased risk for advanced fibrosis and associated complications. Longitudinal analyses of fibrosis rates across reproductive age should be conducted in non-HCV-related liver diseases, given potential implications in a broader spectrum of women.
C1 [Sarkar, Monika; Peters, Marion G.] Univ Calif San Francisco, Div GI Hepatol, San Francisco, CA 94143 USA.
   [Dodge, Jennifer L.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.
   [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Pharm, San Francisco, CA 94143 USA.
   [Kuniholm, Mark H.] SUNY Albany, Dept Epidemiol & Biostat, Albany, NY 12222 USA.
   [DeHovitz, Jack] SUNY Downstate, Div Infect Dis, Brooklyn, NY USA.
   [Plankey, Michael] Georgetown Univ, Div Infect Dis, Washington, DC USA.
   [Kovacs, Andrea] Univ Southern Calif, Div Infect Dis, Los Angeles, CA USA.
   [French, Audrey L.] Cook Cty Hosp, Div Infect Dis, Chicago, IL USA.
   [Seaberg, Eric C.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Ofotokun, Igho] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA.
   [Fischl, Margaret] Univ Miami, Div Infect Dis, Coral Gables, FL 33124 USA.
   [Overton, Edgar] Univ Alabama Birmingham, Infect Dis, Birmingham, AL USA.
   [Kelly, Erin] Univ Ottawa, Div GI Hepatol, Ottawa, ON, Canada.
   [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   State University of New York (SUNY) System; State University of New York
   (SUNY) Albany; State University of New York (SUNY) System; State
   University of New York (SUNY) Downstate Medical Center; Georgetown
   University; University of Southern California; John H Stroger Junior
   Hospital Cook County; Johns Hopkins University; Johns Hopkins Bloomberg
   School of Public Health; Emory University; University of Miami;
   University of Alabama System; University of Alabama Birmingham;
   University of Ottawa; University of California System; University of
   California San Francisco
RP Sarkar, M (corresponding author), Univ Calif San Francisco, Div Gastroenterol & Hepatol, 513 Parnassus Ave,Room S-357, San Francisco, CA 94143 USA.
EM monika.sarkar@ucsf.edu
RI Dodge, Jennifer/AAY-2530-2020; DeHovitz, Joan P/C-2129-2018
OI DeHovitz, Joan P/0000-0003-0835-1983; Overton,
   Edgar/0000-0002-4013-536X; DeHovitz, Jack/0000-0001-7307-0614
FU National Institute of Allergy and Infectious Diseases; University of
   Alabama, Birmingham; University of Mississippi Medical Center (UABUMMC)
   WIHS [U01-AI-103401]; Atlanta WIHS [U01-AI-103408]; Bronx WIHS
   [U01-AI-035004]; Brooklyn WIHS [U01-AI-031834]; Chicago WIHS
   [U01-AI-034993]; Metropolitan Washington WIHS [U01-AI-034994]; Miami
   WIHS [U01-AI-103397]; UNC WIHS [U01-AI-103390]; Connie Wofsy Women's HIV
   Study, Northern California [U01-AI-034989]; WIHS Data Management and
   Analysis Center [U01-AI-042590]; Southern California WIHS
   [U01-HD-032632]; Eunice Kennedy Shriver National Institute of Child
   Health and Human Development; National Cancer Institute; National
   Institute on Drug Abuse; National Institute on Mental Health; National
   Institute of Dental and Craniofacial Research; National Institute on
   Alcohol Abuse and Alcoholism; National Institute on Deafness and other
   Communication Disorders; NIH Office of Research on Women's Health;
   University of California, San Francisco; Clinical and Translational
   Research Awards (CTRA) [UL1-TR000004]; Atlanta CTRA [UL1-TR000454];
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
   [DK111944]; NIDDK [A1088351]
FX The WIHS is funded primarily by the National Institute of Allergy and
   Infectious Diseases, by site as follows: University of Alabama,
   Birmingham and University of Mississippi Medical Center (UABUMMC) WIHS
   (principal investigators, Michael Saag, Mirjam-Colette Kempf, and
   Deborah Konkle- Parker; grant U01-AI-103401; Atlanta WIHS (I. O. and
   Gina Wingood; grant U01-AI-103408; Bronx WIHS (Kathryn Anastos; grant
   U01-AI-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson;
   grant U01-AI-031834; Chicago WIHS (Mardge Cohen and A. L. F.; grant
   U01-AI-034993; Metropolitan Washington WIHS (Seble Kassaye; grant
   U01-AI-034994; Miami WIHS (M. F. and Lisa Metsch; grant U01-AI-103397;
   UNC WIHS (Adaora Adimora; grant U01-AI-103390; Connie Wofsy Women's HIV
   Study, Northern California (R. M. G., Bradley Aouizerat, and Phyllis
   Tien; grant U01-AI-034989; WIHS Data Management and Analysis Center
   (Stephen Gange and Elizabeth Golub; grant U01-AI-042590; and Southern
   California WIHS (Joel Milam; grant U01-HD-032632 (WIHS I-WIHS IV). The
   WIHS receives additional cofunding from the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development, the National
   Cancer Institute, the National Institute on Drug Abuse, and the National
   Institute on Mental Health. Targeted supplemental funding for specific
   projects is provided by the National Institute of Dental and
   Craniofacial Research, the National Institute on Alcohol Abuse and
   Alcoholism, the National Institute on Deafness and other Communication
   Disorders, and the NIH Office of Research on Women's Health. WIHS data
   collection is supported by the University of California, San Francisco,
   Clinical and Translational Research Awards (CTRA) (grant UL1-TR000004)
   and Atlanta CTRA (grant UL1-TR000454). This work is also supported by
   the National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK) (K23 grant DK111944 to M. S.) and NIDDK (R21 grant A1088351 to
   M. P.).
CR Al-Mohri H, 2005, HIV MED, V6, P375, DOI 10.1111/j.1468-1293.2005.00330.x
   Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004
   Amanvermez R, 2016, INT J FERTIL STERIL, V9, P411
   Bacchetti P, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-145
   Bacchetti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020104
   Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005
   Bambha K, 2012, AIDS, V26, P599, DOI 10.1097/QAD.0b013e32834fa121
   Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004
   Bressler LH, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.07.012
   Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020
   Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320
   Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005
   Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931
   Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0
   Di Martino V, 2004, HEPATOLOGY, V40, P1426, DOI 10.1002/hep.20463
   Ditah I, 2014, J HEPATOL, V60, P691, DOI 10.1016/j.jhep.2013.11.014
   Ezechi OC, 2010, J OBSTET GYNAECOL RE, V36, P1053, DOI 10.1111/j.1447-0756.2010.01253.x
   Gruijters MJG, 2003, MOL CELL ENDOCRINOL, V211, P85, DOI 10.1016/j.mce.2003.09.024
   Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141
   Jung S, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.02.105
   Kelly EM, 2016, CLIN INFECT DIS, V63, P512, DOI 10.1093/cid/ciw350
   Klair JS, 2016, HEPATOLOGY, V64, P85, DOI 10.1002/hep.28514
   Kline J, 2016, MATURITAS, V92, P115, DOI 10.1016/j.maturitas.2016.07.010
   Konerman MA, 2014, HEPATOLOGY, V59, P767, DOI 10.1002/hep.26741
   Kucera R, 2016, GYNECOL ENDOCRINOL, V32, P383, DOI 10.3109/09513590.2015.1121981
   Leite Andrea G B, 2015, J Int Assoc Provid AIDS Care, V14, P463, DOI 10.1177/2325957415587571
   Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105
   Lynch SM, 2016, J CLIN TRANSL HEPATO, V4, P310, DOI 10.14218/JCTH.2016.00027
   Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x
   Scherzer R, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.048
   Sherman KE, 2011, HEPATOLOGY, V54, P2245, DOI 10.1002/hep.24651
   Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3478, DOI 10.1210/jc.2008-0567
   Stepanova M, 2015, DIGEST DIS SCI, V60, P3248, DOI 10.1007/s10620-015-3709-6
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Sulkowski MS, 2016, LIVER INT, V36, P43, DOI 10.1111/liv.13021
   Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375
   Tsepelidis S, 2007, HUM REPROD, V22, P1837, DOI 10.1093/humrep/dem101
   Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669
   van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065
   Villa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044624
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   Yang JD, 2017, CLIN GASTROENTEROL H, V15, P127, DOI 10.1016/j.cgh.2016.07.034
   Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761
   Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307
NR 44
TC 4
Z9 5
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2017
VL 65
IS 10
BP 1695
EP 1702
DI 10.1093/cid/cix643
PG 8
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA FL3NI
UT WOS:000414129400017
PM 29020239
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Lv, S
   Wang, JH
   Liu, F
   Gao, Y
   Fei, R
   Du, SC
   Wei, L
AF Lv, Sa
   Wang, Jiang-Hua
   Liu, Feng
   Gao, Yan
   Fei, Ran
   Du, Shao-Cai
   Wei, Lai
TI Senescence marker protein 30 in acute liver failure: validation of a
   mass spectrometry proteomics assay
SO BMC GASTROENTEROLOGY
LA English
DT Article
ID HEPATOMA H4-II-E CELLS; DEOXYRIBONUCLEIC-ACID SYNTHESIS; REGENERATING
   RAT-LIVER; HEP G2 CELLS; ENDOGENOUS REGUCALCIN; CARBON-TETRACHLORIDE;
   SMP30; PROLIFERATION; SERUM; OVEREXPRESSION
AB Background: Our previous proteomic study showed that the senescence marker protein (SMP30) is selectively present in the plasma of a murine model of acute liver failure (ALF). The aim of this study was to validate this SMP30 expression in the plasma and liver tissues of mice and humans with ALF.
   Methods: After the proteomic analysis of plasma from a murine model of D-galactosamine/ lipopolysaccharide (GalN/LPS)-induced ALF by two-dimensional electrophoresis (2-DE) and mass spectrometry, the expression levels of SMP30 in the plasma and liver tissues were validated by western blot and RT-PCR analyses. These results were then confirmed in plasma samples from humans.
   Results: These data validate the results of 2-DE, and western blot showed that SMP30 protein levels were only elevated in the plasma of ALF mice. Further analysis revealed that GalN/LPS induced the downregulation of SMP30 protein levels in liver tissues (by approximately 25% and 16% in the GalN/LPS-treated mice and in the treated mice that survived, respectively; P < 0.01). Hepatic SMP30 mRNA levels decreased by about 90% only in the mice that survived the GalN/LPS treatment. Importantly, plasma obtained from patients with ALF also contained higher levels of SMP30, about (3.65 +/- 0.34) times those observed in healthy volunteers.
   Conclusion: This study shows that SMP30 is not only a potential biomarker for the diagnosis and even prognosis of ALF. It also plays a very important role in a self-protective mechanism in survival and participates in the pathophysiological processes of ALF.
C1 [Lv, Sa; Wang, Jiang-Hua; Liu, Feng; Gao, Yan; Fei, Ran; Du, Shao-Cai; Wei, Lai] Peking Univ, Inst Hepatol, Peking Univ Peoples Hosp, Beijing 100044, Peoples R China.
C3 Peking University
RP Wei, L (corresponding author), Peking Univ, Inst Hepatol, Peking Univ Peoples Hosp, Beijing 100044, Peoples R China.
EM lvsa@sina.com; to_wjh@163.com; liu1116m@sina.com; gaoyan6384@163.com;
   lawpha@sina.com; dushaocai@sina.com; weilai@pkuph.edu.cn
RI wei, lai/JCO-0672-2023
CR Feng JT, 2006, ONCOGENE, V25, P3810, DOI 10.1038/sj.onc.1209551
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   He QY, 2003, PROTEOMICS, V3, P666, DOI 10.1002/pmic.200300394
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   ISOGAI M, 1994, MOL CELL BIOCHEM, V136, P85, DOI 10.1007/BF00931609
   ISOGAI M, 1994, MOL CELL BIOCHEM, V131, P173, DOI 10.1007/BF00925954
   Izumi T, 2004, J CELL BIOCHEM, V92, P296, DOI 10.1002/jcb.20056
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Low TY, 2004, PROTEOMICS, V4, P3960, DOI 10.1002/pmic.200400852
   Lv S, 2007, J PROTEOME RES, V6, P2746, DOI 10.1021/pr0701759
   Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161
   Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274
   Parent R, 2005, J HEPATOL, V43, P177, DOI 10.1016/j.jhep.2005.04.001
   Tsurusaki Y, 2002, J CELL BIOCHEM, V87, P450, DOI 10.1002/jcb.10325
   Tsurusaki Y, 2002, J CELL BIOCHEM, V85, P516, DOI 10.1002/jcb.10153
   Yamaguchi M, 2005, J CELL BIOCHEM, V95, P1169, DOI 10.1002/jcb.20490
   Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085
NR 20
TC 13
Z9 19
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-230X
J9 BMC GASTROENTEROL
JI BMC Gastroenterol.
PD MAY 28
PY 2008
VL 8
AR 17
DI 10.1186/1471-230X-8-17
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 321ZK
UT WOS:000257344800001
PM 18507831
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Grune, T
   Merker, K
   Jung, T
   Sitte, N
   Davies, KJA
AF Grune, T
   Merker, K
   Jung, T
   Sitte, N
   Davies, KJA
TI Protein oxidation and degradation during postmitotic senescence
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE protein oxidation; fibroblasts; proteasome; postmitotic senescence;
   aging; free radicals
ID HUMAN BJ FIBROBLASTS; OXYGEN RADICALS; OXIDIZED PROTEINS; LIPOFUSCIN
   PIGMENTS; CELLULAR SENESCENCE; PROTEASOME ACTIVITY; PROTEOLYSIS; AGE;
   LIVER; COMPLEX
AB Oxidized and cross-linked proteinacious materials (lipofuscin, age pigments, ceroid, etc.) have long been known to accumulate in aging and in age-related diseases, and some studies have suggested that age-dependent inhibition of the proteasome and/or lysosomal proteases may contribute to this phenomenon. Cell culture studies trying to model these aging effects have almost all been performed with proliferating (divisionally competent) cell lines. There is little information on nondividing (postmitotic) cells; yet age-related accumulation of oxidized and cross-linked protein aggregates is most marked in postmitotic tissues such as brain, heart, and skeletal muscles. The present investigation was undertaken to test whether oxidized and cross-linked proteins generally accumulate in nondividing, IMR-90 and MRC-5, human cell lines, and whether such accumulation is associated with diminished proteolytic capacities. Since both protein oxidation and declining proteolytic activities might play major roles in the age-associated accumulation of intracellular oxidized materials, we tested for protein carbonyl formation, proteasomal activities, and lysosomal cathepsin activities. For these studies, confluent, postmitotic IMR-90 and MRC-5 fibroblasts (at various population doubling levels) were cultured under hyperoxic conditions to facilitate age-related oxidative senescence. Our results reveal marked decreases in the activity of both the proteasomal system and the lysosomal proteases during senescence of nondividing fibroblasts, but the peptidyl-glutamyl-hydrolyzing activity of the proteasome was particularly inhibited. This decline in proteolytic capacity was accompanied by an increased accumulation of oxidized proteins. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.
   Univ So Calif, Div Mol & Computat Biol, Los Angeles, CA 90089 USA.
   Humboldt Univ, Fac Med Charite, Neurosci Res Ctr, D-10098 Berlin, Germany.
   Univ Dusseldorf, Inst Environm Hlth Res, D-4000 Dusseldorf, Germany.
C3 University of Southern California; University of Southern California;
   Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf
RP Davies, KJA (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, 3715 McClintock Ave, Los Angeles, CA 90089 USA.
EM Kclvin@usc.edu
OI Jung, Tobias/0000-0002-9159-8444; Davies, Kelvin/0000-0001-7790-3003;
   Grune, Tilman/0000-0003-4775-9973
FU NIEHS NIH HHS [ES 03598] Funding Source: Medline
CR AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8
   Andersen JK, 1996, J NEUROCHEM, V67, P2164
   Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4
   CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347
   CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P195, DOI 10.1006/abbi.1995.1359
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CATALDO AM, 1994, BRAIN RES, V640, P68, DOI 10.1016/0006-8993(94)91858-9
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Davidoff F, 2002, QUAL SAF HEALTH CARE, V11, P2, DOI 10.1136/qhc.11.1.2
   DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   DAVIES KJA, 1987, J BIOL CHEM, V262, P8220
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9908
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9914
   DAVIES KJA, 1987, J BIOL CHEM, V262, P8227
   Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje
   FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   Gieche J, 2001, BBA-MOL CELL RES, V1538, P321, DOI 10.1016/S0167-4889(01)00083-0
   GIULIVI C, 1994, ARCH BIOCHEM BIOPHYS, V311, P329, DOI 10.1006/abbi.1994.1245
   GIULIVI C, 1990, J BIOL CHEM, V265, P19453
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857
   Grune T, 2001, FREE RADICAL BIO MED, V30, P1243, DOI 10.1016/S0891-5849(01)00515-9
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HEINECKE JW, 1993, J BIOL CHEM, V268, P4069
   Horie K, 1997, BIOCHEM BIOPH RES CO, V236, P327, DOI 10.1006/bbrc.1997.6944
   Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010
   INUBUSHI T, 1994, J BIOCHEM-TOKYO, V116, P282, DOI 10.1093/oxfordjournals.jbchem.a124520
   Kato Y, 1998, FEBS LETT, V439, P231, DOI 10.1016/S0014-5793(98)01372-6
   Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   Keller JN, 2004, INT J BIOCHEM CELL B, V36, P2376, DOI 10.1016/j.biocel.2004.05.003
   Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200
   Mehlhase J, 2000, IUBMB LIFE, V50, P331, DOI 10.1080/15216540051081137
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   PACIFICI RE, 1993, J BIOL CHEM, V268, P15405
   PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2
   PACIFICI RE, 1990, METHOD ENZYMOL, V186, P485
   ROMERO MT, 1994, NEUROSCIENCE, V58, P217, DOI 10.1016/0306-4522(94)90169-4
   Rudeck M, 2000, IUBMB LIFE, V49, P451
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490
   Sitte N, 2000, FASEB J, V14, P2503, DOI 10.1096/fj.00-0210com
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Sitte N, 1998, FEBS LETT, V440, P399, DOI 10.1016/S0014-5793(98)01495-1
   SITTE N, 1996, FREE RADIC BIOL MED, V28, P701
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   Stadtman E R, 1992, EXS, V62, P64
   Szweda PA, 2002, FREE RADICAL BIO MED, V33, P29, DOI 10.1016/S0891-5849(02)00837-7
   Terman A, 2004, EXP GERONTOL, V39, P701, DOI 10.1016/j.exger.2004.01.005
   Terman A, 1995, GERONTOLOGY, V41, P319
   Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x
   Viteri G, 2004, ARCH BIOCHEM BIOPHYS, V427, P197, DOI 10.1016/j.abb.2004.05.006
   vonZglinicki T, 1995, GERONTOLOGY, V41, P95
   WEIH M, IN PRESS J CEREB BLO
   WHILMARK U, 1997, FREE RADIC BIOL MED, V1229, P1229
   Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X
NR 63
TC 84
Z9 94
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD NOV 1
PY 2005
VL 39
IS 9
BP 1208
EP 1215
DI 10.1016/j.freeradbiomed.2005.06.009
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 978JZ
UT WOS:000232870700009
PM 16214036
DA 2024-02-19
ER

PT J
AU Chondrogianni, N
   Fragoulis, EG
   Gonos, ES
AF Chondrogianni, N
   Fragoulis, EG
   Gonos, ES
TI Protein degradation during aging: the lysosome-, the calpain- and the
   proteasome-dependent cellular proteolytic systems
SO BIOGERONTOLOGY
LA English
DT Article; Proceedings Paper
CT International Conference on Biotechnology the Genome and Human Ageing
CY MAR 19-22, 2001
CL MELBOURNE, AUSTRALIA
SP Australian Soc Cellular Molec Gerontol (ASCMG)
DE aging; calpains; lysosomes; proteasome; protein oxidation; proteolysis;
   senescence
ID AGE-RELATED DECLINE; MECHANISMS; CELLS; CENTENARIANS; FIBROBLASTS;
   SENESCENCE; OXIDATION; INCREASE; LIVER; 20S
AB Aging is a natural process determined by both genetic and environmental factors. Aging is accompanied by the imbalance of the function of several cellular homeostatic mechanisms, which results, among others, in the accumulation of abnormal (i.e. oxidized, cross-linked, unfolded) proteins. It has been proposed that the increased failure of homeostasis during aging is due to the impaired function of the major cellular proteolytic mechanisms mediated by the lysosome, the calpains and the proteasome. This article will address the issue of the function of these cellular proteolytic systems during aging.
C1 Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Athens 11635, Greece.
   Univ Athens, Sch Biol Sci, Dept Biochem & Mol Biol, Indiana, PA 15701 USA.
C3 National Hellenic Research Foundation
RP Gonos, ES (corresponding author), Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, 48 Vas Constantinou Ave, Athens 11635, Greece.
CR BAUDRY M, 1986, NEUROBIOL AGING, V7, P255, DOI 10.1016/0197-4580(86)90004-7
   Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9
   Friguet B, 2000, ANN NY ACAD SCI, V908, P143
   Gonos ES, 1998, EXP CELL RES, V240, P66, DOI 10.1006/excr.1998.3948
   Gonos ES, 2000, EXP GERONTOL, V35, P15, DOI 10.1016/S0531-5565(99)00075-3
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   HOLLIDAY R, 1996, UNDERSTANDING AGEING
   IBRAHIM M, 1994, MOL CELL BIOCHEM, V131, P49, DOI 10.1007/BF01075724
   KARLSSON JO, 1995, NEUROBIOL AGING, V16, P901, DOI 10.1016/0197-4580(95)02004-7
   Merker K, 2000, ARCH BIOCHEM BIOPHYS, V375, P50, DOI 10.1006/abbi.1999.1657
   NAKAMURA Y, 1999, NEUROSCI LETT, V13, P215
   Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220
   Petropoulou C, 2000, ANN NY ACAD SCI, V908, P133
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x
NR 20
TC 44
Z9 44
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2002
VL 3
IS 1-2
BP 121
EP 123
DI 10.1023/A:1015236203379
PG 3
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 541LT
UT WOS:000174986600023
PM 12014830
DA 2024-02-19
ER

PT J
AU Dong, BN
   Lee, JS
   Park, YY
   Yang, F
   Xu, GY
   Huang, WD
   Finegold, MJ
   Moore, DD
AF Dong, Bingning
   Lee, Ju-Seog
   Park, Yun-Yong
   Yang, Feng
   Xu, Ganyu
   Huang, Wendong
   Finegold, Milton J.
   Moore, David D.
TI Activating CAR and β-catenin induces uncontrolled liver growth and
   tumorigenesis
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CONSTITUTIVE ANDROSTANE RECEPTOR; HEPATOCELLULAR-CARCINOMA; TUMOR
   PROMOTION; MOUSE-LIVER; TRANSCRIPTION FACTOR; INDUCED SENESCENCE;
   NUCLEAR RECEPTOR; UBIQUITIN LIGASE; C-MYC; MICE
AB Aberrant beta-catenin activation contributes to a third or more of human hepatocellular carcinoma (HCC), but beta-catenin activation alone is not sufficient to induce liver cancer in mice. Differentiated hepatocytes proliferate upon acute activation of either beta-catenin or the nuclear xenobiotic receptor CAR. These responses are strictly limited and are tightly linked, since beta-catenin is activated in nearly all of the CAR-dependent tumours generated by the tumour promoter phenobarbital. Here, we show that full activation of beta-catenin in the liver induces senescence and growth arrest, which is overcome by combined CAR activation, resulting in uncontrolled hepatocyte proliferation, hepatomegaly and rapid lethality despite maintenance of normal liver function. Combining CAR activation with limited beta-catenin activation induces tumorigenesis, and the tumours share a conserved gene expression signature with beta-catenin-positive human HCC. These results reveal an unexpected route for hepatocyte proliferation and define a murine model of hepatocarcinogenesis with direct relevance to human HCC.
C1 [Dong, Bingning; Yang, Feng; Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
   [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA.
   [Park, Yun-Yong] Univ Ulsan, Coll Med, Dept Med, ASAN Inst Life Sci,ASAN Med Ctr, Seoul 138736, South Korea.
   [Xu, Ganyu; Huang, Wendong] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA.
   [Finegold, Milton J.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
C3 Baylor College of Medicine; University of Texas System; UTMD Anderson
   Cancer Center; University of Ulsan; City of Hope; Beckman Research
   Institute of City of Hope; Baylor College of Medicine
RP Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.
EM moore@bcm.edu
RI Lee, Ju-Seog/X-1786-2018; Moore, David Dudley/JQI-9927-2023
OI Lee, Ju-Seog/0000-0002-5666-9753; 
FU NIH [R01 DK46546]; R.P. Doherty Jr-Welch Chair in Science [Q-0022]; MD
   Anderson Cancer Center Sister Institute Fund; NIDDK-sponsored Cellular
   and Molecular Core laboratory of the Texas Medical Center Digestive
   Diseases Center [DK 56388]
FX This work was supported by NIH R01 DK46546 and the R.P. Doherty Jr-Welch
   Chair in Science Q-0022 (D.D.M.), the MD Anderson Cancer Center Sister
   Institute Fund (J.-S.L.) and the NIDDK-sponsored Cellular and Molecular
   Core laboratory of the Texas Medical Center Digestive Diseases Center
   (DK 56388). We also acknowledge joint participation by Diana Helis Henry
   Medical Research Foundation through its direct engagement in the
   continuous active conduct of medical research in conjunction with Baylor
   College of Medicine and the Targeting CAR to prevent liver cancer
   project for the Cancer Program.
CR Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001
   Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937
   Aydinlik H, 2001, ONCOGENE, V20, P7812, DOI 10.1038/sj.onc.1204982
   Basu S, 2011, P NATL ACAD SCI USA, V108, P6805, DOI 10.1073/pnas.1015269108
   Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2
   Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475
   Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200
   Braeuning A, 2011, TOXICOL SCI, V123, P113, DOI 10.1093/toxsci/kfr166
   Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179
   Cadoret A, 2001, CANCER RES, V61, P3245
   Calvisi DF, 2004, CARCINOGENESIS, V25, P901, DOI 10.1093/carcin/bgh083
   Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023
   Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012
   Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883
   Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912
   de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
   DRAGANI TA, 1985, CARCINOGENESIS, V6, P225, DOI 10.1093/carcin/6.2.225
   El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673
   Ganzenberg K, 2013, TOXICOLOGY, V308, P113, DOI 10.1016/j.tox.2013.03.019
   Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924
   Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527
   Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123
   Harada N, 2002, CANCER RES, V62, P1971
   He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509
   Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520
   Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704
   Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017
   Kim SM, 2012, HEPATOLOGY, V55, P1443, DOI 10.1002/hep.24813
   La Vecchia C, 2014, EUR J CANCER PREV, V23, P1, DOI 10.1097/CEJ.0b013e32836014c8
   Lamminpää A, 2002, EUR J CLIN PHARMACOL, V58, P137, DOI 10.1007/s00228-002-0429-6
   Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547
   Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   Loeppen S, 2002, CANCER RES, V62, P5685
   Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010
   Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47
   Miyoshi H, 2009, CANCER SCI, V100, P2046, DOI 10.1111/j.1349-7006.2009.01284.x
   Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001
   Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5
   Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538
   Qu K, 2013, CANCER LETT, V331, P105, DOI 10.1016/j.canlet.2012.12.008
   Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344
   Rignall B, 2011, CARCINOGENESIS, V32, P52, DOI 10.1093/carcin/bgq226
   Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026
   Schreiber S, 2011, J MOL HISTOL, V42, P393, DOI 10.1007/s10735-011-9342-6
   Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522
   Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005
   Wei BR, 2008, TOXICOL PATHOL, V36, P972, DOI 10.1177/0192623308327120
   White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001
   Wu QF, 2010, ACTA PHARMACOL SIN, V31, P361, DOI 10.1038/aps.2010.4
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459
   Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200
   Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108
   Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397
NR 57
TC 68
Z9 79
U1 0
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB
PY 2015
VL 6
AR 5944
DI 10.1038/ncomms6944
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CC0OJ
UT WOS:000350035000001
PM 25661872
OA Green Submitted, Green Accepted, gold
DA 2024-02-19
ER

PT S
AU Kim, JH
   Choy, HE
   Nam, KH
   Park, SC
AF Kim, JH
   Choy, HE
   Nam, KH
   Park, SC
BE Park, SC
   Hwang, ES
   Kim, HS
   Park, WY
TI Transglutaminase-mediated crosslinking of specific core histone subunits
   and cellular senescence
SO HEALTHY AGING FOR FUNCTIONAL LONGEVITY: MOLECULAR AND CELLULAR
   INTERACTIONS IN SENESCENCE
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Healthy Aging for Functional Longevity
CY FEB, 2000
CL KYONGJU, SOUTH KOREA
SP Federat Korean Gerontol Soc, Int Assoc BioMed Gerontol, Korea Sci & Engn Fdn, Korea Res Fdn, Korea Res Fdn Hlth Sci, Seoul Natl Univ
DE transglutaminase; macromolecular crosslinking; histones
ID TISSUE TRANSGLUTAMINASE; RAT-LIVER; EXPRESSION; APOPTOSIS
AB We observed that the transglutaminase (tTGase) level and activity increased in aged rats and senescent primary fibroblasts, suggesting that the tTGase-mediated macromolecule crosslinking may play a mechanistic role during aging. Although preliminary, our in vitro experiment suggests that the target of tTGase is core histones: H2A:H2B and H3:H4 are specifically crosslinked by tTGase. On the basis of these data, we postulate that the changes of DNA metabolism in association with cellular aging may be ascribed primarily to the crosslinking of core histone subunits. Further speculation awaits substantive data showing increased histone crosslinking in senescent cells and also what crosslinked histones in various DNA metabolisms may imply. At the moment, present data are sufficient to propose that tTGase is a senescence marker and it may be primarily responsible for the phenotypes associated with cellular senescence.
C1 Seoul Natl Univ, Coll Med, Dept Biochem, Aging & Phys Culture Res Inst, Seoul 110799, South Korea.
C3 Seoul National University (SNU)
RP Park, SC (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem, Aging & Phys Culture Res Inst, Seoul 110799, South Korea.
CR BJORKSTEN J, 1968, J AM GERIATR SOC, V16, P408, DOI 10.1111/j.1532-5415.1968.tb02821.x
   DUDEK SM, 1993, J NEUROCHEM, V61, P1159, DOI 10.1111/j.1471-4159.1993.tb03636.x
   Han JA, 1999, J CANCER RES CLIN, V125, P89, DOI 10.1007/s004320050247
   KNIGHT RL, 1993, EUR J CELL BIOL, V60, P210
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   LU S, 1995, J BIOL CHEM, V270, P9748, DOI 10.1074/jbc.270.17.9748
   MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584
   MOZZHUKHINA TG, 1991, GERONTOLOGY, V37, P181
   Park Sang-Chul, 1994, Journal of Korean Medical Science, V9, P490
   Park SC, 1999, J GERONTOL A-BIOL, V54, pB78, DOI 10.1093/gerona/54.2.B78
   PARK WY, 2000, IN PRESS J BIOL CHEM
   Shimizu T, 1997, BIOCHEMISTRY-US, V36, P12071, DOI 10.1021/bi970922n
NR 12
TC 22
Z9 23
U1 0
U2 2
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-285-1
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2001
VL 928
BP 65
EP 70
PG 6
WC Biochemistry & Molecular Biology; Geriatrics & Gerontology;
   Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Geriatrics & Gerontology; Science &
   Technology - Other Topics
GA BT10T
UT WOS:000171969700006
PM 11795529
DA 2024-02-19
ER

PT J
AU COECKE, S
   VANDENBERGHE, Y
   CALLAERTS, A
   SONCK, W
   VERLEYE, G
   VANBEZOOIJEN, CFA
   VERCRUYSSE, A
   ROGIERS, V
AF COECKE, S
   VANDENBERGHE, Y
   CALLAERTS, A
   SONCK, W
   VERLEYE, G
   VANBEZOOIJEN, CFA
   VERCRUYSSE, A
   ROGIERS, V
TI HEPATIC CYTOSOLIC GLUTATHIONE-S-TRANSFERASE ACTIVITIES IN AGING BROWN
   NORWAY RATS - IMPORTANCE OF SEX-DIFFERENCES AND PHENOBARBITAL TREATMENT
   FOR STUDIES OF AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 VRIJE UNIV BRUSSELS,CTR STAT OPERAT ONDERZOEK,B-1090 BRUSSELS,BELGIUM.
   TNO,INST EXPTL GERONTOL,2280 HV RIJSWIJK,NETHERLANDS.
C3 Vrije Universiteit Brussel; Netherlands Organization Applied Science
   Research
RP COECKE, S (corresponding author), VRIJE UNIV BRUSSELS,DIENST TOXICOL,LAARBEEKLAAN 103,B-1090 BRUSSELS,BELGIUM.
OI Rogiers, Vera/0000-0003-0635-7740
CR ADESNIK M, 1981, J BIOL CHEM, V256, P340
   BAARS AJ, 1980, ANN BIOL CLIN-PARIS, V38, P49
   BIRNBAUM L, 1978, EXP GERONTOL, P244
   BIRNBAUM LS, 1979, CHEM-BIOL INTERACT, V26, P254
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARNE T, 1979, BIOCHEM J, V177, P433, DOI 10.1042/bj1770433
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1225, DOI 10.3109/00498258809042246
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   DEPIERRE JW, 1984, XENOBIOTICA, V14, P295, DOI 10.3109/00498258409151415
   FUJITA S, 1982, LIVER AGEING, P287
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P579
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HALES BF, 1977, BIOCHEM PHARMACOL, V26, P555, DOI 10.1016/0006-2952(77)90337-9
   HALES BF, 1976, BIOCHEM J, V160, P223, DOI 10.1042/bj1600223
   HATAYAMA I, 1986, BIOCHEM BIOPH RES CO, V140, P581, DOI 10.1016/0006-291X(86)90771-0
   HOLLANDER CF, 1986, LAB ANIM SCI, V26, P320
   IGARASHI T, 1987, XENOBIOTICA, V17, P127, DOI 10.3109/00498258709043923
   JAKOBY WB, 1984, BIOCHEM PHARMACOL, V33, P2539, DOI 10.1016/0006-2952(84)90621-X
   JAYARAJ A, 1985, J NATL CANCER I, V74, P95
   KATO R, 1968, J BIOCHEM-TOKYO, V63, P406
   KITAGAWA H, 1985, BIOL PHARMACOL, V34, P287
   KITAHARA A, 1982, LIVER AGING 1982, P135
   Kitani K, 1982, Arch Gerontol Geriatr, V1, P43, DOI 10.1016/0167-4943(82)90005-X
   Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357
   MANNERVIK B, 1988, CRIT REV BIOCHEM MOL, V23, P238
   NORUSIS MJ, 1986, SPSS PC PLUS ADV STA, pB152
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PEMBLE S, 1986, BIOCHEM J, V238, P375
   POPPER H, 1987, MODERN BIOL THEORIES, P219
   Sipes IG, 1986, CASARETT DOULLS TOXI, P64
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   TREVOR AJ, 1984, BASIC CLIN PHARM, P247
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VANDENBERGHE Y, 1988, IN VITRO CELL DEV B, V24, P281
NR 34
TC 13
Z9 13
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD AUG
PY 1990
VL 55
IS 2
BP 189
EP 198
DI 10.1016/0047-6374(90)90026-C
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DX652
UT WOS:A1990DX65200008
PM 2232911
DA 2024-02-19
ER

PT J
AU CovielloMcLaughlin, GM
   Prowse, KR
AF CovielloMcLaughlin, GM
   Prowse, KR
TI Telomere length regulation during postnatal development and ageing in
   Mus spretus
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID HUMAN FIBROBLASTS; MOUSE TELOMERASE; IMMORTAL CELLS; MITOTIC CLOCK; DNA;
   TISSUES; IDENTIFICATION; PROLIFERATION; LYMPHOCYTES; SENESCENCE
AB Telomere shortening has been causally implicated in replicative senescence in humans, To examine the relationship between telomere length and ageing in mice, we have utilized Mus spretus as a model species because it has telomere lengths of approximately the same length as humans, Telomere length and telomerase were analyzed from liver, kidney, spleen, brain and testis from >180 M.spretus male and female mice of different ages, Although telomere lengths for each tissue were heterogeneous, significant changes in telomere lengths were found in spleen and brain, but not in liver, testis or kidney, Telomerase activity was abundant in liver and testis, but weak to non-detectable in spleen, kidney and brain. Gender differences in mean terminal restriction fragment length were discovered in tissues from M.spretus and from M.spretus x C57BL/6 F1 mice, in which a M.spretus-sized telomeric smear could be measured. The comparison of the rank order of tissue telomere lengths within individual M.spretus showed that certain tissues tended to be longer than the others, and this ranking also extended to tissues of the M.spretus x C57BL/6 F1 mice, These data suggest that telomere lengths within individual tissues are regulated independently and are genetically controlled.
C1 GERON CORP,MENLO PK,CA 94025.
C3 Geron Corporation
CR ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213
   BACCHETTI S, 1995, INT J ONCOL, V7, P423
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492
   Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200
   Broccoli D, 1997, HUM MOL GENET, V6, P69, DOI 10.1093/hmg/6.1.69
   CHADENEAU C, 1995, ONCOGENE, V11, P893
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994
   DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x
   DELONE G V, 1987, Ontogenez, V18, P304
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   FORNI L, 1988, ANN INST PASTEUR IMM, V139, P257, DOI 10.1016/0769-2625(88)90139-0
   GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   GREIDER CW, 1996, CELLULAR AGING CELL, P123
   HANAI T, 1993, CELL MOL BIOL, V39, P81
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7
   Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HIROSE F, 1989, EXP CELL RES, V181, P169, DOI 10.1016/0014-4827(89)90191-2
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   KIPLING D, 1997, IN PRESS EUR J CANC
   MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049
   Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7
   OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7
   PROWSE KR, 1993, P NATL ACAD SCI USA, V90, P1493, DOI 10.1073/pnas.90.4.1493
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   REZNIKOV KY, 1991, ADV ANAT EMBRYOL CEL, V122, P1
   SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0
   STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881
   VAZIRI H, 1993, AM J HUM GENET, V52, P661
   VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0
   WHITTINGHAM DG, 1982, KREPROD PHYSL, P139
   WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2
   YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0
NR 43
TC 117
Z9 126
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD AUG 1
PY 1997
VL 25
IS 15
BP 3051
EP 3058
DI 10.1093/nar/25.15.3051
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA XP995
UT WOS:A1997XP99500014
PM 9224604
OA Green Published, Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Xu, GQ
   Zhang, L
   Ma, AH
   Qian, Y
   Ding, Q
   Liu, Y
   Wang, BS
   Yang, ZJ
   Liu, YZ
AF Xu, Guiqin
   Zhang, Li
   Ma, Aihui
   Qian, Yu
   Ding, Qi
   Liu, Yun
   Wang, Boshi
   Yang, Zhaojuan
   Liu, Yongzhong
TI SIP1 is a downstream effector of GADD45G in senescence induction and
   growth inhibition of liver tumor cells
SO ONCOTARGET
LA English
DT Article
DE GADD45G; SIP1; cell senescence; hepatocellular carcinoma
ID EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA CELLS;
   NEGATIVE BREAST-CANCER; CELLULAR SENESCENCE; PREMATURE SENESCENCE;
   KINASE PATHWAYS; TRANSCRIPTION; STRESS; ARREST; JNK
AB Cellular senescence evasion caused by the inactivation of tumor suppressive programs is implicated in tumor initiation and therapeutic resistance. Our previous study has shown that the downregulation of growth arrest and DNA damage 45G (GADD45G) contributes to senescence bypass in hepatocellular carcinoma (HCC). Here, we report that the Smad-interacting protein-1 (SIP1) is transcriptionally activated and functions critically in the GADD45G-induced tumor cell senescence. Knockdown of SIP1 significantly abrogates the suppressive effects of GADD45G on the growth of xenografted liver tumor in vivo. The essential role of SIP1 in GADD45G activities is further validated in the model of the proteasome inhibitor MG132-induced cell senescence. We further show that JNK but not p38 MAPK activation is involved in the GADD45G-mediated SIP1 upregulation, and that JNK inhibition counteracts the GADD45G-induced cellular senescence. More importantly, we show that GADD45G and SIP1 expression are coincidently downregulated in primary human HCC tissues. Together, our results establish that the dowregulation of GADD45G-SIP1 axis may contribute to cellular senescence evasion and HCC development.
C1 [Xu, Guiqin; Zhang, Li; Ma, Aihui; Qian, Yu; Ding, Qi; Liu, Yun; Wang, Boshi; Yang, Zhaojuan; Liu, Yongzhong] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China.
C3 Shanghai Jiao Tong University
RP Liu, YZ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China.
EM liuyzg@shsci.org
RI Liu, Yun/IRZ-5739-2023; wang, yixuan/JGM-3893-2023; Ma,
   Xiaodong/JAN-7473-2023; yang, yun/IZE-1092-2023
OI Qian, Yu/0000-0003-4759-4697
FU National Science Foundation of China [81201542, 81301716, 81402348];
   Natural Science Foundation of Shanghai [12ZR1430100, 14YF1413900]; State
   Key Laboratory of Oncogenes and Related Genes [91-14-10, 91-13-04];
   Chinese National Key Project [2013ZX1000201-02]; Key Discipline and
   Specialty Foundation of Shanghai Municipal Commission of Health and
   Family Planning
FX This work was supported by grants from The National Science Foundation
   of China (81201542, 81301716 and 81402348), Natural Science Foundation
   of Shanghai (12ZR1430100 and 14YF1413900), the State Key Laboratory of
   Oncogenes and Related Genes (91-14-10 and 91-13-04), the Chinese
   National Key Project (2013ZX1000201-02) and Key Discipline and Specialty
   Foundation of Shanghai Municipal Commission of Health and Family
   Planning.
CR Acun T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-223
   Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449
   Blagosklonny MV, 2012, AGING-US, V4, P159, DOI 10.18632/aging.100443
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173
   Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108
   Cretu Alexandra, 2009, Cancer Ther, V7, P268
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   Leontieva OV, 2015, ONCOTARGET, V6, P23238, DOI 10.18632/oncotarget.4836
   Leontieva OV, 2012, P NATL ACAD SCI USA, V109, P13314, DOI 10.1073/pnas.1205690109
   Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129
   Lim JS, 2012, CANCER LETT, V321, P154, DOI 10.1016/j.canlet.2012.01.044
   Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815
   Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6
   Liu J, 2015, NAT CELL BIOL, V17, P856, DOI 10.1038/ncb3193
   Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8
   Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406
   Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103
   Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473
   Qi M, 2013, EUR J PHARMACOL, V715, P76, DOI 10.1016/j.ejphar.2013.05.051
   Qiao YC, 2015, ONCOTARGET, V6, P7804, DOI 10.18632/oncotarget.3158
   Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073
   Roninson IB, 2003, CANCER RES, V63, P2705
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619
   Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056
   Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2
   Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Xu XS, 2015, ONCOTARGET, V6, P3988, DOI 10.18632/oncotarget.2905
   Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094443
   Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267
   Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059
   Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030
   Zhang L, 2014, EXP BIOL MED, V239, P773, DOI 10.1177/1535370214531879
   Zhang L, 2014, HEPATOLOGY, V59, P178, DOI 10.1002/hep.26628
   Zhao CY, 2014, CANCER RES, V74, P3983, DOI 10.1158/0008-5472.CAN-13-3396
   Zhu N, 2009, MOL BIOL REP, V36, P2075, DOI 10.1007/s11033-008-9419-9
   Zhu XM, 2014, BIOCHEM BIOPH RES CO, V450, P1261, DOI 10.1016/j.bbrc.2014.06.112
NR 42
TC 14
Z9 16
U1 0
U2 17
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD OCT 20
PY 2015
VL 6
IS 32
BP 33636
EP 33647
DI 10.18632/oncotarget.5602
PG 12
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA CU0DQ
UT WOS:000363186600115
PM 26378039
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wei, DQ
   Li, YZ
   Che, M
   Li, CW
   Wu, Q
   Sun, C
AF Wei, Dongqin
   Li, Yizhou
   Che, Meng
   Li, Chaowei
   Wu, Qiong
   Sun, Chao
TI Melatonin relieves hepatic lipid dysmetabolism caused by aging via
   modifying the secondary bile acid pattern of gut microbes
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Article
DE Melatonin; Lipid metabolism; Gut microbiota; Bile acids; FXR
ID TRIMETHYLAMINE-N-OXIDE; CAMPYLOBACTER-JEJUNI; OXIDATIVE STRESS; SALT
   HYDROLASE; L-CARNITINE; METABOLISM; MECHANISM; TMAO; EXPRESSION; MICE
AB It has been reported that aging-generated gut microecosystem may promote host hepatic lipid dysmetabolism through shaping the pattern of secondary bile acids (BAs). Then as an oral drug, melatonin (Mel)-mediated beneficial efforts on the communication between gut microbiota and aging host are still not clearly. Here, we show that aging significantly shapes the pattern of gut microbiota and BAs, whereas Mel treatment reverses these phenotypes (P < 0.05), which is identified to depend on the existence of gut microbiota. Mechanistically, aging-triggered high-level expression of ileac farnesoid X receptor (FXR) is significantly decreased through Mel-mediated inhibition on Campylobacter jejuni (C. jejuni)-induced deconjugation of tauroursodeoxycholic acid (TUDCA) and glycoursodeoxycholic acid (GUDCA) (P < 0.05). The aging-induced high-level of serum taurine chenodeoxycholic acid (TCDCA) activate trimethylamine-N-oxide (TMAO)-triggered activating transcriptional factor 4 (ATF4) signaling via hepatic FXR, which further regulates hepatic BAs metabolism, whereas TUDCA inhibits aging-triggered high-level of hepatic ATF4. Overall, Mel reduces C. jejuni-mediated deconjugation of TUDCA to inhibit aging-triggered high-level expression of hepatic FXR, which further decreases hepatic TMAO production, to relieve hepatic lipid dysmetabolism.
C1 [Wei, Dongqin; Li, Yizhou; Che, Meng; Li, Chaowei; Wu, Qiong; Sun, Chao] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.
C3 Northwest A&F University - China
RP Sun, C (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.
EM sunchao2775@163.com
OI Sun, Chao/0000-0001-7222-4028
FU National Key Research and Development Program of China [2021YF1000602];
   Key Research and Development Projects in Shaanxi province [2021NY-020];
   Natural Science Foundation of China [U1804106]; Qinghai Fundamental
   Scientific and Technological Research Plan [2018-ZJ-721]; Scientific
   Research Guiding Plan Topic of Qinghai Hygiene Department
   [2018-wjzdx-131]
FX This work was supported by the grants from the National Key Research and
   Development Program of China (2021YF1000602) and the Key Research and
   Development Projects in Shaanxi province(2021NY-020) and Natural Science
   Foundation of China (U1804106) and Qinghai Fundamental Scientific and
   Technological Research Plan (2018-ZJ-721) and the Scientific Research
   Guiding Plan Topic of Qinghai Hygiene Department (2018-wjzdx-131).
CR Bana B, 2019, ANNU REV GENET, V53, P239, DOI 10.1146/annurev-genet-112618-043650
   Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011
   Binyamin D, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00784-9
   Burnham PM, 2018, NAT REV MICROBIOL, V16, P551, DOI 10.1038/s41579-018-0037-9
   Camell CD, 2019, CELL METAB, V30, P1024, DOI 10.1016/j.cmet.2019.10.006
   Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15
   Chen SF, 2019, CELL METAB, V30, P1141, DOI 10.1016/j.cmet.2019.08.021
   Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032
   González-Rodríguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162
   GRAD BR, 1993, PSYCHONEUROENDOCRINO, V18, P283, DOI 10.1016/0306-4530(93)90025-G
   Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x
   Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119
   Jia W, 2018, NAT REV GASTRO HEPAT, V15, DOI 10.1038/nrgastro.2018.24
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159
   Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012
   Kim J, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0680-z
   Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763
   Koeth RA, 2019, J CLIN INVEST, V129, P373, DOI 10.1172/JCI94601
   Koeth RA, 2014, CELL METAB, V20, P799, DOI 10.1016/j.cmet.2014.10.006
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kong B, 2018, HEPATOLOGY, V68, P1961, DOI 10.1002/hep.30041
   Kong B, 2012, HEPATOLOGY, V56, P1034, DOI 10.1002/hep.25740
   Koubaa-Ghorbel F, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13160
   Lee JY., 2020, BIOCH BIOPHYS ACTA, V1865
   Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008
   Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384
   Li L, 2019, AGING-US, V11, P9348, DOI 10.18632/aging.102376
   Lv WJ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1241894
   Ma JL, 2020, GUT MICROBES, V11, P1450, DOI 10.1080/19490976.2020.1763770
   Mannino G, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12598
   Masanta WO, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201800083
   Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004
   Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Pan SJ, 2022, BBA-MOL BASIS DIS, V1868, DOI 10.1016/j.bbadis.2021.166281
   Parséus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283
   Perino A, 2021, PHYSIOL REV, V101, P683, DOI 10.1152/physrev.00049.2019
   PIERPAOLI W, 1994, P NATL ACAD SCI USA, V91, P787, DOI 10.1073/pnas.91.2.787
   Rao A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4823
   Roberts AB, 2018, NAT MED, V24, P1407, DOI 10.1038/s41591-018-0128-1
   Romano KA, 2017, CELL HOST MICROBE, V22, P279, DOI 10.1016/j.chom.2017.07.021
   Rong B., 2020, MELATONIN RES, V3, P58, DOI [10.32794/mr11250048, DOI 10.32794/MR11250048]
   Rong BH, 2021, CELL MOL GASTROENTER, V12, P1643, DOI 10.1016/j.jcmgh.2021.06.024
   Rong BH, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12561
   Rong BH, 2019, J NUTR BIOCHEM, V64, P206, DOI 10.1016/j.jnutbio.2018.10.020
   Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003
   Sistrunk JR, 2016, CLIN MICROBIOL REV, V29, P819, DOI 10.1128/CMR.00031-16
   Song ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0628-3
   Stahl EC, 2020, AM J PATHOL, V190, P372, DOI 10.1016/j.ajpath.2019.10.016
   Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4
   Sun XL, 2018, GASTROENTEROLOGY, V154, P1751, DOI 10.1053/j.gastro.2018.01.042
   Taheri N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35409-0
   Takahashi S, 2016, J LIPID RES, V57, P2130, DOI 10.1194/jlr.M071183
   Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360
   Troseid M, 2016, METAB SYNDR RELAT D, V14, P197, DOI 10.1089/met.2015.0120
   Violi F, 2017, ANTIOXID REDOX SIGN, V27, P1083, DOI 10.1089/ars.2016.6963
   Volt H, 2016, J PINEAL RES, V60, P193, DOI 10.1111/jpi.12303
   Wahlström A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005
   Wang Q, 2018, BIOL PHARM BULL, V41, P985, DOI 10.1248/bpb.b17-00724
   Wang ZN, 2019, EUR HEART J, V40, P583, DOI [10.109, 10.1093/eurheartj/ehy799]
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Wang Z, 2012, APPL ENVIRON MICROB, V78, P8795, DOI 10.1128/AEM.02519-12
   Xu PF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12399
   Yin J, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00002-20
   Yin J, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12524
   Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718
   Zhang YJ, 2019, BRIT J PHARMACOL, V176, P2848, DOI 10.1111/bph.14705
   Zhou H, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12450
NR 70
TC 5
Z9 5
U1 8
U2 28
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1420-682X
EI 1420-9071
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD OCT
PY 2022
VL 79
IS 10
AR 527
DI 10.1007/s00018-022-04412-0
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 4W0JE
UT WOS:000859853200001
PM 36151409
DA 2024-02-19
ER

PT J
AU Herranz, D
   Muñoz-Martin, M
   Cañamero, M
   Mulero, F
   Martinez-Pastor, B
   Fernandez-Capetillo, O
   Serrano, M
AF Herranz, Daniel
   Munoz-Martin, Maribel
   Canamero, Marta
   Mulero, Francisca
   Martinez-Pastor, Barbara
   Fernandez-Capetillo, Oscar
   Serrano, Manuel
TI Sirt1 improves healthy ageing and protects from metabolic
   syndrome-associated cancer
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SMALL-MOLECULE ACTIVATORS; CALORIC RESTRICTION; LIFE-SPAN; RESVERATROL;
   TUMORIGENESIS; SURVIVAL; MICE; EXPRESSION; SIRTUINS; DIET
AB Genetic overexpression of protein deacetylase Sir2 increases longevity in a variety of lower organisms, and this has prompted interest in the effects of its closest mammalian homologue, Sirt1, on ageing and cancer. We have generated transgenic mice moderately overexpressing Sirt1 under its own regulatory elements (Sirt1-tg). Old Sirt1-tg mice present lower levels of DNA damage, decreased expression of the ageing-associated gene p16 Ink4a, a better general health and fewer spontaneous carcinomas and sarcomas. These effects, however, were not sufficiently potent to affect longevity. To further extend these observations, we developed a metabolic syndrome-associated liver cancer model in which wild-type mice develop multiple carcinomas. Sirt1-tg mice show a reduced susceptibility to liver cancer and exhibit improved hepatic protection from both DNA damage and metabolic damage. Together, these results provide direct proof of the anti-ageing activity of Sirt1 in mammals and of its tumour suppression activity in ageing-and metabolic syndrome-associated cancer.
C1 [Herranz, Daniel; Munoz-Martin, Maribel; Serrano, Manuel] Spanish Natl Canc Res Ctr, Tumor Suppress Grp, E-28029 Madrid, Spain.
   [Canamero, Marta] Spanish Natl Canc Res Ctr, Comparat Pathol Unit, E-28029 Madrid, Spain.
   [Mulero, Francisca] Spanish Natl Canc Res Ctr, Mol Imaging Unit, E-28029 Madrid, Spain.
   [Martinez-Pastor, Barbara; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr, Genom Instabil Grp, E-28029 Madrid, Spain.
C3 Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional
   de Investigaciones Oncologicas (CNIO); Centro Nacional de
   Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones
   Oncologicas (CNIO)
RP Serrano, M (corresponding author), Spanish Natl Canc Res Ctr, Tumor Suppress Grp, 3 Melchor Fernandez Almagro St, E-28029 Madrid, Spain.
EM mserrano@cnio.es
RI Mulero, Francisca/R-2387-2019; Fernandez-Capetillo, Oscar/H-3508-2015;
   Martinez, Barbara/HKO-6749-2023; Herranz, Daniel/L-6986-2017; Mulero,
   Francisca M/M-3289-2014; /AAI-3238-2021; Herranz, Daniel/D-8121-2011;
   Serrano, Manuel/H-2634-2015
OI Mulero, Francisca/0000-0001-9584-4211; Fernandez-Capetillo,
   Oscar/0000-0002-2690-6885; Martinez, Barbara/0000-0003-0960-1737;
   Herranz, Daniel/0000-0003-1768-5969; Mulero, Francisca
   M/0000-0001-9584-4211; Serrano, Manuel/0000-0001-7177-9312
FU Spanish Ministry of Health; 'Francisco Cobos' Foundation; CNIO; Spanish
   Ministry of Science; Regional Government of Madrid; European Union;
   European Research Council (ERC); 'Marcelino Botin' Foundation
FX We are indebted to Gema Iglesias for excellent mouse handling. We thank
   Felipe Sierra, Antonio Maraver and Pablo J. Fernandez-Marcos for helpful
   discussions. D.H. is supported by a predoctoral fellowship from the
   Spanish Ministry of Health and by the 'Francisco Cobos' Foundation. Work
   in the laboratory of M.S. is funded by the CNIO and by grants from the
   Spanish Ministry of Science (SAF and CONSOLIDER), the Regional
   Government of Madrid (GsSTEM), the European Union (PROTEOMAGE), the
   European Research Council (ERC Advanced Grant) and by the 'Marcelino
   Botin' Foundation. The sponsors had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   paper.
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P403, DOI 10.1517/13543770902762893
   Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x
   Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188
   Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759
   Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954
   Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357
   Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147
   Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319
   Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020
   FREEMAN JE, 1992, BIOCHEM J, V281, P689, DOI 10.1042/bj2810689
   Garber K, 2008, NAT BIOTECHNOL, V26, P371, DOI 10.1038/nbt0408-371
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Hempenstall S, 2010, MECH AGEING DEV, V131, P111, DOI 10.1016/j.mad.2009.12.008
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   LUCHSINGER JA, 2006, SCI AGING KNOWLEDGE, pPE19
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025
   Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007
   Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750
   Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Sun D, 2008, MOL CARCINOGEN, V47, P47, DOI 10.1002/mc.20360
   Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001
   Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
NR 42
TC 453
Z9 511
U1 1
U2 52
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR
PY 2010
VL 1
AR 3
DI 10.1038/ncomms1001
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 649OJ
UT WOS:000281781400003
PM 20975665
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Ruggiero, AD
   Davis, MA
   Davis, AT
   DeStephanis, D
   Williams, AG
   Vemuri, R
   Fanning, KM
   Sherrill, C
   Cline, JM
   Caudell, DL
   Kavanagh, K
AF Ruggiero, Alistaire D.
   Davis, Matthew A.
   Davis, Ashley T.
   DeStephanis, Darla
   Williams, Abigail G.
   Vemuri, Ravichandra
   Fanning, Katherine M.
   Sherrill, Chrissy
   Cline, J. Mark
   Caudell, David L.
   Kavanagh, Kylie
TI Delayed effects of radiation in adipose tissue reflect progenitor damage
   and not cellular senescence
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Radiation; Senescence; Adipose; Liver; Adipose progenitors
ID INSULIN-RESISTANCE; SKELETAL-MUSCLE; BRAIN-INJURY; IRRADIATION;
   EXPOSURE; GAMMA; DYSFUNCTION; EXPRESSION; BIOMARKER; DISEASE
AB The pathogenesis of many age-related diseases is linked to cellular senescence, a state of inflammation-inducing, irreversible cell cycle arrest. The consequences and mechanisms of age-associated cellular senescence are often studied using in vivo models of radiation exposure. However, it is unknown whether radiation induces persistent senescence, like that observed in ageing. We performed analogous studies in mice and monkeys, where young mice and rhesus macaques received sub-lethal doses of ionizing radiation and were observed for similar to 15% of their expected lifespan. Assessments of 8-hydroxy-2' - deoxyguanosine (8-OHdG), senescence-associated beta-galactosidase (SA beta-gal), and p16(Ink4)(a) and p21 were performed on mitotic and post-mitotic tissues - liver and adipose tissue - 6 months and 3 years post-exposure for the mice and monkeys, respectively. No elevations in 8-OHdG, SA-beta gal staining, or p16(Ink4a) or p21 gene or protein expression were found in mouse and monkey liver or adipose tissue compared to control animals. Despite no evidence of senescence, progenitor cell dysfunction persisted after radiation exposure, as indicated by lower in situ CD34(+) adipose cells (p = 0 .03) , and deficient adipose stromal vascular cell proliferation (p <0.05) and differentiation (p = 0.04) ex vivo. Our investigation cautions that employing radiation to study senescence-related processes should be limited to the acute post-exposure period and that stem cell damage likely underpins the dysfunction associated with delayed effects of radiation.
C1 [Ruggiero, Alistaire D.; Davis, Ashley T.; DeStephanis, Darla; Williams, Abigail G.; Vemuri, Ravichandra; Fanning, Katherine M.; Sherrill, Chrissy; Cline, J. Mark; Caudell, David L.; Kavanagh, Kylie] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, 575 N Patterson Ave, Winston Salem, NC 27101 USA.
   [Davis, Matthew A.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA.
   [Kavanagh, Kylie] Univ Tasmania, Coll Hlth & Med, Hobart, Tas, Australia.
C3 Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest
   University; Wake Forest Baptist Medical Center; University of Tasmania
RP Kavanagh, K (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, 575 N Patterson Ave, Winston Salem, NC 27101 USA.
EM kkavanag@wakehealth.edu
FU Department of Defense [W81XWH-15-1-0574]; National Institutes of Health
   [T32OD010957]
FX This work was supported by the following awards: Department of Defense
   W81XWH-15-1-0574 and National Institutes of Health T32OD010957.
CR Abernathy LM, 2015, J THORAC ONCOL, V10, P1703, DOI 10.1097/JTO.0000000000000677
   Ambele MA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124283
   Andrews RN, 2017, RADIAT RES, V187, P599, DOI 10.1667/RR14616.1
   [Anonymous], 2015, World population prospects: The 2015 revision, V33, P1, DOI DOI 10.1007/S13398-014-0173-7.2
   Bacarella N, 2020, INT J RADIAT ONCOL, V106, P878, DOI 10.1016/j.ijrobp.2019.11.034
   Campisi J, 2001, ADV CELL AGING GERON, V4, P1
   Chen ZT, 2019, ONCOL REP, V42, P883, DOI 10.3892/or.2019.7209
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Chiou KL, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0612
   Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807
   Colman RJ, 2018, BBA-MOL BASIS DIS, V1864, P2733, DOI 10.1016/j.bbadis.2017.07.008
   Daya S, 2007, DIFFERENTIATION, V75, P360, DOI 10.1111/j.1432-0436.2006.00146.x
   Debo RJ, 2016, RADIAT RES, V186, P55, DOI 10.1667/RR14357.1
   Delanian S, 2012, RADIOTHER ONCOL, V105, P273, DOI 10.1016/j.radonc.2012.10.012
   Diaz MF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79278-y
   Fanning KM, 2017, AM J PHYSIOL-REG I, V313, pR290, DOI 10.1152/ajpregu.00108.2017
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Graber TG, 2015, AGE, V37, DOI 10.1007/s11357-015-9773-1
   Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505
   Gujral DM, 2016, HEART, V102, P269, DOI 10.1136/heartjnl-2015-308765
   Hall BM, 2017, AGING-US, V9, P1867, DOI 10.18632/aging.101268
   Hatzmann FM, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020214
   Heidenreich PA, 2009, HEART, V95, P252, DOI 10.1136/hrt.2008.149088
   Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074
   Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hotta K, 1999, J GERONTOL A-BIOL, V54, pB183, DOI 10.1093/gerona/54.5.B183
   Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052
   Kamal NSM, 2020, EUR J CELL BIOL, V99, DOI 10.1016/j.ejcb.2020.151108
   Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9
   Kang C, 2019, MOL CELLS, V42, P821, DOI 10.14348/molcells.2019.0298
   Kavanagh K, 2021, GEROSCIENCE, V43, P343, DOI 10.1007/s11357-020-00230-z
   Kavanagh K, 2010, NUTR RES, V30, P418, DOI 10.1016/j.nutres.2010.06.006
   Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x
   Le ONL, 2010, AGING CELL, V9, P398, DOI 10.1111/j.1474-9726.2010.00567.x
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152179
   Mattison JA, 2017, EXP GERONTOL, V94, P41, DOI 10.1016/j.exger.2016.12.005
   Milan G, 2021, TRENDS ENDOCRIN MET, V32, P994, DOI 10.1016/j.tem.2021.09.001
   Miró C, 2002, LANCET, V360, P1429, DOI 10.1016/S0140-6736(02)11387-0
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nylander V, 2016, DIABETES, V65, P3573, DOI 10.2337/db16-0364
   Orr JS, 2013, JOVE-J VIS EXP, DOI 10.3791/50707
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588
   Park HR, 2011, CELL IMMUNOL, V267, P1, DOI 10.1016/j.cellimm.2010.10.004
   Plett PA, 2012, HEALTH PHYS, V103, P343, DOI 10.1097/HP.0b013e3182667309
   Prado C, 2017, RADIAT RES, V188, P615, DOI 10.1667/RR14804.1
   Prieto LI, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040954
   Raghunathan D, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0658-x
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Ross MD, 2018, AM J PHYSIOL-HEART C, V314, pH392, DOI 10.1152/ajpheart.00592.2017
   Sabin Rebecca J, 2011, Genome Integr, V2, P7, DOI 10.1186/2041-9414-2-7
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Schwab N, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.742632
   Stout MB, 2017, PHYSIOLOGY, V32, P9, DOI 10.1152/physiol.00012.2016
   Sundar IK, 2018, AM J RESP CELL MOL, V59, P189, DOI 10.1165/rcmb.2017-0390OC
   Sundgren PC, 2009, J MAGN RESON IMAGING, V29, P291, DOI 10.1002/jmri.21657
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Thrall KD, 2015, HEALTH PHYS, V109, P502, DOI 10.1097/HP.0000000000000339
   Turnquist C, 2019, NEURO-ONCOLOGY, V21, P474, DOI 10.1093/neuonc/noz001
   Uckun FM, 1997, CLIN CANCER RES, V3, P325
   Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684
   van Nimwegen FA, 2014, J CLIN ONCOL, V32, P3257, DOI 10.1200/JCO.2013.54.4379
   von Zglinicki T, 2021, ANTIOXID REDOX SIGN, V34, P308, DOI 10.1089/ars.2020.8048
   Vujaskovic Z, 2000, INT J RADIAT BIOL, V76, P511, DOI 10.1080/095530000138510
   Wang Y, 2021, BIOMED PHARMACOTHER, V135, DOI 10.1016/j.biopha.2020.111191
   Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000
   Xu MQ, 2015, ECS ELECTROCHEM LETT, V4, DOI 10.1149/2.0021508eel
   Xu P, 2021, MOL MED REP, V24, DOI 10.3892/mmr.2021.12482
   Zhang Y, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1275-0
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 74
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 FEB
PY 2023
VL 45
IS 1
SI SI
BP 507
EP 521
DI 10.1007/s11357-022-00660-x
EA SEP 2022
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 8R9OV
UT WOS:000856603400001
PM 36136223
OA Green Published
DA 2024-02-19
ER

PT J
AU Maeso-Díaz, R
   Dalton, GD
   Oh, S
   Du, K
   Tang, LD
   Chen, TY
   Dutta, RK
   Hartman, JH
   Meyer, JN
   Diehl, AM
AF Maeso-Diaz, Raquel
   Dalton, George D.
   Oh, Sehhoon
   Du, Kuo
   Tang, Linda
   Chen, Tianyi
   Dutta, Rajesh K.
   Hartman, Jessica H.
   Meyer, Joel N.
   Diehl, Anna Mae
TI Aging reduces liver resiliency by dysregulating Hedgehog signaling
SO AGING CELL
LA English
DT Article; Early Access
DE aging; Hedgehog; hepatocytes; liver regeneration; resiliency; smoothened
ID PARTIAL-HEPATECTOMY; REGENERATION; CELLS; HALLMARKS; MICE
AB Older age is a major risk factor for damage to many tissues, including liver. Aging undermines resiliency and impairs liver regeneration. The mechanisms whereby aging reduces resiliency are poorly understood. Hedgehog is a signaling pathway with critical mitogenic and morphogenic functions during development. Recent studies indicate that Hedgehog regulates metabolic homeostasis in adult liver. The present study evaluates the hypothesis that Hedgehog signaling becomes dysregulated in hepatocytes during aging, resulting in decreased resiliency and therefore, impaired regeneration and enhanced vulnerability to damage. Partial hepatectomy (PH) was performed on young and old wild-type mice and Smoothened (Smo)-floxed mice treated with viral vectors to conditionally delete Smo and disrupt Hedgehog signaling specifically in hepatocytes. Changes in signaling were correlated with changes in regenerative responses and compared among groups. Old livers had fewer hepatocytes proliferating after PH. RNA sequencing identified Hedgehog as a top downregulated pathway in old hepatocytes before and after the regenerative challenge. Deleting Smo in young hepatocytes before PH prevented Hedgehog pathway activation after PH and inhibited regeneration. Gene Ontogeny analysis demonstrated that both old and Smo-deleted young hepatocytes had activation of pathways involved in innate immune responses and suppression of several signaling pathways that control liver growth and metabolism. Hedgehog inhibition promoted telomere shortening and mitochondrial dysfunction in hepatocytes, consequences of aging that promote inflammation and impair tissue growth and metabolic homeostasis. Hedgehog signaling is dysregulated in old hepatocytes. This accelerates aging, resulting in decreased resiliency and therefore, impaired liver regeneration and enhanced vulnerability to damage.
C1 [Maeso-Diaz, Raquel; Dalton, George D.; Oh, Sehhoon; Du, Kuo; Tang, Linda; Chen, Tianyi; Dutta, Rajesh K.; Diehl, Anna Mae] Duke Univ Hlth Syst, Div Gastroenterol, Dept Med, 905 S LaSalle St,GSRB 1,Suite 1073, Durham, NC 27710 USA.
   [Hartman, Jessica H.; Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.
C3 Duke University; Duke University
RP Diehl, AM (corresponding author), Duke Univ Hlth Syst, Div Gastroenterol, Dept Med, 905 S LaSalle St,GSRB 1,Suite 1073, Durham, NC 27710 USA.
EM annamae.diehl@duke.edu
RI Dutta, Rajesh Kumar/J-7790-2019; Meyer, Joel/G-9836-2017
OI Dutta, Rajesh Kumar/0000-0002-1394-0961; Tang,
   Linda/0000-0003-2865-5378; Meyer, Joel/0000-0003-1219-0983
FU NIH [RO1 DK 077794]; Florence McAlister Professorship of Medicine;
   Pilot/Exploratory Study project grant by the Duke Claude D. Pepper Older
   Americans Independence Center (OAIC) NIA [P30AG028716, K99ES029552]
FX This work was supported by NIH grants RO1 DK 077794, the Florence
   McAlister Professorship of Medicine to AMD, a Pilot/Exploratory Study
   project grant by the Duke Claude D. Pepper Older Americans Independence
   Center (OAIC) NIA P30AG028716 and K99ES029552 to JHH
CR Adamek A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051308
   Barnes RP, 2019, MECH AGEING DEV, V177, P37, DOI 10.1016/j.mad.2018.03.013
   Chakravarti D, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024853118
   Chakravarti D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18420-w
   Chan IS, 2014, ALCOHOL CLIN EXP RES, V38, P787, DOI 10.1111/acer.12279
   Desbois-Mouthon C, 2006, FASEB J, V20, P773, DOI 10.1096/fj.05-4704fje
   Donthamsetty S, 2014, CELL CYCLE, V13, P2056, DOI 10.4161/cc.29061
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Jung YM, 2007, HEPATOLOGY, V45, P1091, DOI 10.1002/hep.21660
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Khiati S, 2015, P NATL ACAD SCI USA, V112, P11282, DOI 10.1073/pnas.1511016112
   LEONG GF, 1964, CANCER RES, V24, P1496
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Machado MV, 2018, CRIT REV BIOCHEM MOL, V53, P264, DOI 10.1080/10409238.2018.1448752
   MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7
   Maeso-Diaz Raquel, 2020, Semin Liver Dis, V40, P373, DOI 10.1055/s-0040-1715446
   Matz-Soja M, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-11
   Mazumdar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075253
   Nevzorova YA, 2015, LAB ANIM-UK, V49, P81, DOI 10.1177/0023677215572000
   Ochoa B, 2010, HEPATOLOGY, V51, P1712, DOI 10.1002/hep.23525
   Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008
   Pibiri Monica, 2018, Aging (Albany NY), V10, P1801, DOI 10.18632/aging.101524
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Rallis A, 2020, CELL REP, V30, P2627, DOI 10.1016/j.celrep.2020.02.006
   Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3
   Sato R, 2004, GUT, V53, P1001, DOI 10.1136/gut.2003.027516
   Scheffold A, 2020, LEUKEMIA, V34, P1125, DOI 10.1038/s41375-019-0641-3
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Stine Jonathan G, 2013, Curr Gastroenterol Rep, V15, P299, DOI 10.1007/s11894-012-0299-8
   Swiderska-Syn M, 2014, GUT, V63, P1333, DOI 10.1136/gutjnl-2013-305962
   Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   van Horssen J, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.050
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Xiang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.230
   Xu XH, 2013, J HEPATOL, V59, P308, DOI 10.1016/j.jhep.2013.03.037
   Zhang MJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62293
NR 43
TC 8
Z9 9
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 FEB
PY 2022
VL 21
IS 2
AR e13530
DI 10.1111/acel.13530
EA JAN 2022
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA YY9JH
UT WOS:000738567900001
PM 34984806
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Fishelson, L
   Becker, K
AF Fishelson, L
   Becker, K
TI Development and aging of the liver and pancreas in the domestic carp,
   <i>Cyprinus carpio</i>:: From embryogenesis to 15-year-old fish
SO ENVIRONMENTAL BIOLOGY OF FISHES
LA English
DT Article
DE cytology; development; aging
ID TROUT SALMO-GAIRDNERI; RAINBOW-TROUT; BRACHYDANIO-RERIO; BROWN TROUT;
   ULTRASTRUCTURE; ZEBRAFISH; TRUTTA; MACROPHAGES; RICHARDSON; MORPHOLOGY
AB The cytology of development and aging of the liver and pancreas in domestic carp was studied in a large sample of EM and LM sections from larvae juveniles 1-10 year old adults and 15 year old experimentally stunted fish weighing 20 g and of 110-120 mm TL. The primordium of the two glands appears in embryos 3-4 days after fertilization as buds from the gut wall. Formation of the hepatic tubules is first seen in larvae 10 days after fertilization. Two types of hepatocytes are discernable: one with a pale cytoplasm and the other with a dense opaque cytoplasm; both extend microvilli into the sinusoidal space of Disse and bear intracellular bile canaliculi. With maturation and branching of the hepatic tubules a complicated hepatic muralium is formed. The pancreatic cells develop in 5-6 mm TL embryos primarily along the blood capillaries and in 10-11 day old larvae exocrine A and B cells are seen prominent by their zymogen granules and spires and stacks of rough endoplasmic reticulum. Ripening of the Islets of Langerhans begin in larvae of 10 mm TL. By 16 mm TL two types of endocrine cells are visible. With aging three processes are recognizable in the liver: (1) increased branching of the blood net displaces the hepatic units and complicates the structure of the liver parenchyma; (2) a gradual increase in lipid vacuoles and debris deposition in secretory cells takes place; and (3) the number of melano-macrophage cells and melano-macrophage centers gradually increases. In 15-year-old experimentally stunted fish (110-120 mm TL) the liver and pancreas resemble those of juvenile fish appearing much healthier than those of 8-10 year old large carp from commercial ponds. These findings provide evidence that aging is not a simple time-dependent mechanism but is also strongly modulated by environmental factors.
C1 Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.
   Univ Hohenheim, Inst Anim Prod Trop & Subtrop, D-7000 Stuttgart, Germany.
C3 Tel Aviv University; University Hohenheim
RP Fishelson, L (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.
CR Bond CE, 1996, BIOL FISHES
   BOULHIC M, 1992, AQUACULTURE, V102, P373, DOI 10.1016/0044-8486(92)90190-V
   BRAUNBECK T, 1990, ARCH ENVIRON CON TOX, V19, P405, DOI 10.1007/BF01054986
   BRINN J E JR, 1973, American Zoologist, V13, P653
   CHAPMAN GB, 1981, J FISH BIOL, V18, P553, DOI 10.1111/j.1095-8649.1981.tb03796.x
   CRAIG JF, 1977, J ANIM ECOL, V46, P617, DOI 10.2307/3834
   EURELL JA, 1982, J FISH BIOL, V21, P113, DOI 10.1111/j.1095-8649.1982.tb02829.x
   FISHELSON L, 1995, J MORPHOL, V223, P175, DOI 10.1002/jmor.1052230206
   FISHELSON L., 1966, BAMIDGEH, V18, P67
   Fishelson L., 1966, Zoologische Jahrbuecher (Anatomie), V83, P571
   Fishelson L, 1996, J MORPHOL, V229, P1, DOI 10.1002/(SICI)1097-4687(199607)229:1<1::AID-JMOR1>3.0.CO;2-7
   FUJITA H, 1986, CELL TISSUE RES, V244, P63
   HACKING MA, 1978, CAN J ZOOL, V56, P477, DOI 10.1139/z78-068
   HAMPTON JA, 1987, ANAT RECORD, V219, P338, DOI 10.1002/ar.1092190403
   HAMPTON JA, 1989, AM J ANAT, V185, P58, DOI 10.1002/aja.1001850107
   Hinton D.E., 1990, P17
   HINTON DE, 1972, J FISH RES BOARD CAN, V29, P531, DOI 10.1139/f72-089
   HINTON DE, 1976, J FISH BIOL, V8, P209, DOI 10.1111/j.1095-8649.1976.tb03944.x
   Marlasca MJ, 1998, HISTOL HISTOPATHOL, V13, P703, DOI 10.14670/HH-13.703
   MESEGUER J, 1994, CELL TISSUE RES, V277, P1
   NAKAMURA M, 1971, ENTWICKLUNGSGESCHICH, V134, P61
   NEPANITAYA W, 1979, CELL TISSUE RES, V196, P249
   PEUTE J, 1985, CELL TISSUE RES, V242, P377, DOI 10.1007/BF00214551
   PEUTE J, 1978, CELL TISSUE RES, V186, P297, DOI 10.1007/BF00225539
   ROBERTSON JC, 1992, J MORPHOL, V211, P41, DOI 10.1002/jmor.1052110106
   ROCHA E, 1994, J ANAT, V185, P241
   Rocha E, 1996, J SUBMICR CYTOL PATH, V28, P357
   Schramm M, 1998, BIOMARKERS, V3, P93, DOI 10.1080/135475098231264
   SIDON EW, 1985, J MORPHOL, V178, P225
   Smallwood WM, 1933, J MORPHOL, V55, P15, DOI 10.1002/jmor.1050550103
   SPELLBERG L, 1994, ANAT REC, V240, P291
   TELFORD I, 1995, INTRO FUNCTIONAL HIS
   TITELBACH M, 1966, Z MIKROSKOP ANAT FOR, V75, P185
   VOGELBEIN WK, 1987, J FISH BIOL, V31, P145, DOI 10.1111/j.1095-8649.1987.tb05306.x
   WILLIAMS DW, 1982, J ANAT, V135, P173
   Wolke R. E., 1992, Annual Review of Fish Diseases, V2, P91, DOI 10.1016/0959-8030(92)90058-6
   WOODHEAD AD, 1977, EXP GERONTOL, V13, P37
   YAMAMOTO T, 1965, Z ZELLFORSCH, P319
NR 38
TC 13
Z9 16
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0378-1909
J9 ENVIRON BIOL FISH
JI Environ. Biol. Fishes
PY 2001
VL 61
IS 1
BP 85
EP 97
DI 10.1023/A:1011076722505
PG 13
WC Ecology; Marine & Freshwater Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA 417BZ
UT WOS:000167816700011
DA 2024-02-19
ER

PT J
AU Gallego, P
   Castejón-Vega, B
   del Campo, JA
   Cordero, MD
AF Gallego, Paloma
   Castejon-Vega, Beatriz
   del Campo, Jose A.
   Cordero, Mario D.
TI The Absence of NLRP3-inflammasome Modulates Hepatic Fibrosis
   Progression, Lipid Metabolism, and Inflammation in KO NLRP3 Mice during
   Aging
SO CELLS
LA English
DT Article
DE non-alcoholic fatty liver disease; oxidative stress; liver damage;
   inflammation; NLRP3-inflammasome complex
ID FATTY LIVER-DISEASE; INNATE IMMUNITY; ACTIVATION
AB Aging is associated with metabolic changes and low-grade inflammation in several organs, which may be due to NLRP3 inflammasome activation. Methods: Here, we asked whether age-related liver changes such as lipid metabolism and fibrosis are reduced in aged mice lacking the NLRP3 inflammasome. We report reduced protein levels of lipid markers (MTP, FASN, DGAT1), SOD activity, oxidative stress marker PTPRG, and the fibrotic markers TPM2 beta, COL1-alpha 1 associated with increased GATA4, in NLRP3 deficient mice. Fibrotic, lipid, and oxidative reduction in liver tissues of mice was more pronounced in those old KO NLRP3 mice than in the younger ones, despite their greater liver damage. These results suggest that absence of the NLRP3 inflammasome attenuates age-related liver fibrotic pathology in mice, suggesting that pharmacological targeting may be beneficial.
C1 [Gallego, Paloma] Valme Univ Hosp, Unit Clin Management Digest Dis & CIBERehd, Seville 41014, Spain.
   [Castejon-Vega, Beatriz] Univ Seville, Dept Oral Med, Res Lab, Seville 41009, Spain.
   [del Campo, Jose A.] AlgaEnergy SA, Ada Europa 19, Madrid 28108, Spain.
   [Cordero, Mario D.] Univ Europea Atlantico UNEATLANTICO, Fdn Univ Iberoamer FUNIBER, Catedra Reprod & Genet Humana Inst El Estudio Bio, Seville 41001, Spain.
C3 Hospital Valme; CIBER - Centro de Investigacion Biomedica en Red;
   CIBEREHD; University of Sevilla
RP del Campo, JA (corresponding author), AlgaEnergy SA, Ada Europa 19, Madrid 28108, Spain.; Cordero, MD (corresponding author), Univ Europea Atlantico UNEATLANTICO, Fdn Univ Iberoamer FUNIBER, Catedra Reprod & Genet Humana Inst El Estudio Bio, Seville 41001, Spain.
EM palgalyer@alum.us.es; beacastej92@outlook.es;
   joseantonio.delcampo@gmail.com; mdcormor@ugr.es
RI Cordero, Mario D./L-8006-2014
OI Cordero, Mario D./0000-0003-0151-3644; Castejon Vega,
   Beatriz/0000-0003-0286-2395
FU Nicolas Monardes Program from Servicio Andaluz de Salud (SAS)
FX This work was supported by Nicolas Monardes Program from Servicio
   Andaluz de Salud (SAS).
CR Arrese M, 2016, DIGEST DIS SCI, V61, P1294, DOI 10.1007/s10620-016-4049-x
   Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012
   Cannito S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172575
   Cheng YJ, 2017, AGING-US, V9, P1359, DOI 10.18632/aging.101232
   Conte M, 2016, TRENDS ENDOCRIN MET, V27, P893, DOI 10.1016/j.tem.2016.09.001
   Del Campo JA, 2018, WORLD J HEPATOL, V10, P1, DOI 10.4254/wjh.v10.i1.1
   HUSSAIN MM, 2012, NUTR METAB, V9
   Inzaugarat M.E., NLRP3 INFLAMMASOME A
   Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y
   Li J, 2019, WORLD J HEPATOL, V11, P412, DOI 10.4254/wjh.v11.i5.412
   Liu BQ, 2019, DIABETES METAB SYNDR, V12, P801, DOI 10.2147/DMSO.S206558
   Luo DS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00926
   Maeso-Díaz R, 2019, AGING DIS, V10, P684, DOI 10.14336/AD.2019.0127
   Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399
   Marín-Aguilar F, 2020, AGING CELL, V19, DOI 10.1111/acel.13050
   Ozaki E, 2015, J INFLAMM RES, V8, P15, DOI 10.2147/JIR.S51250
   Rhee EJ, 2019, ENDOCRINOL METAB, V34, P226
   Schild Michael H, 2018, Surg Pathol Clin, V11, P267, DOI 10.1016/j.path.2018.02.013
   Streeper RS, 2012, AGING-US, V4, P13, DOI 10.18632/aging.100424
   Wan XY, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/6489012
   Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1
   Yang JCZ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040872
NR 22
TC 19
Z9 20
U1 3
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD OCT
PY 2020
VL 9
IS 10
AR 2148
DI 10.3390/cells9102148
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA OJ8FC
UT WOS:000584188900001
PM 32977490
OA gold, Green Accepted, Green Published
DA 2024-02-19
ER

PT J
AU López-Domínguez, JA
   Khraiwesh, H
   González-Reyes, JA
   López-Lluch, G
   Navas, P
   Ramsey, JJ
   de Cabo, R
   Burón, MI
   Villalba, JM
AF Alberto Lopez-Dominguez, Jose
   Khraiwesh, Husam
   Antonio Gonzalez-Reyes, Jose
   Lopez-Lluch, Guillermo
   Navas, Placido
   Ramsey, Jon Jay
   de Cabo, Rafael
   Isabel Buron, Maria
   Manuel Villalba, Jose
TI Dietary Fat and Aging Modulate Apoptotic Signaling in Liver of
   Calorie-Restricted Mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Apoptosis; Calorie restriction; Dietary fat; Liver
ID NF-KAPPA-B; OXIDATIVE STRESS; PEROXIDE PRODUCTION; LIPID COMPOSITION;
   ACID-COMPOSITION; SKELETAL-MUSCLE; SHORT-TERM; RAT-LIVER; EXPRESSION;
   AGE
AB Imbalance between proliferation and cell death accounts for several age-linked diseases. Aging, calorie restriction (CR), and fat source are all factors that may influence apoptotic signaling in liver, an organ that plays a central metabolic role in the organism. Here, we have studied the combined effect of these factors on a number of apoptosis regulators and effectors. For this purpose, animals were fed diets containing different fat sources (lard, soybean oil, or fish oil) under CR for 6 or 18 months. An age-linked increase in the mitochondrial apoptotic pathway was detected with CR, including a decrease in Bcl-2/Bax ratio, an enhanced release of cytochrome c to the cytosol and higher caspase-9 activity. However, these changes were not fully transmitted to the effectors apoptosis-inducing factor and caspase-3. CR (which abated aging-related inflammatory responses) and dietary fat altered the activities of caspases-8, -9, and -3. Apoptotic index (DNA fragmentation) and mean nuclear area were increased in aged animals with the exception of calorie-restricted mice fed a lard-based fat source. These results suggest possible protective changes in hepatic homeostasis with aging in the calorie-restricted lard group.
C1 [Alberto Lopez-Dominguez, Jose; Khraiwesh, Husam; Antonio Gonzalez-Reyes, Jose; Isabel Buron, Maria; Manuel Villalba, Jose] Univ Cordoba, Dept Biol Celular Fisiol & Inmunol, CeiA3, Cordoba, Spain.
   [Lopez-Lluch, Guillermo; Navas, Placido] Univ Pablo Olavide, CSIC, CABD, Seville, Spain.
   [Lopez-Lluch, Guillermo; Navas, Placido] Inst Salud Carlos III, CIBERER, Seville, Spain.
   [Ramsey, Jon Jay] Univ Calif Davis, VM Mol Biosci, Davis, CA 95616 USA.
   [de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
C3 Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas
   (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for
   Developmental Biology (CABD); Instituto de Salud Carlos III; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERER; University of
   California System; University of California Davis; National Institutes
   of Health (NIH) - USA; NIH National Institute on Aging (NIA)
RP Villalba, JM (corresponding author), CeiA3, Dept Biol Celular Fisiol & Inmunol, Campus Rabanales,Edificio Severo Ochoa,3a Planta, Cordoba 14014, Spain.
EM jmvillalba@uco.es
RI de Cabo, Rafael Carlos/E-7996-2010; López-Domínguez, José
   Alberto/AAA-9275-2020; González-Reyes, José A/K-1367-2014; NAVAS,
   PLACIDO/R-5943-2019; Lopez-Lluch, Guillermo/N-4742-2014; de Cabo,
   Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; López-Domínguez, José
   Alberto/0000-0001-8733-3294; González-Reyes, José A/0000-0003-1918-5490;
   NAVAS, PLACIDO/0000-0002-4115-7966; Lopez-Lluch,
   Guillermo/0000-0001-9830-8502; Villalba Montoro, Jose
   Manuel/0000-0001-8554-3802; de Cabo, Rafael/0000-0002-3354-2442
FU National Institutes of Health [1R01AG028125-01A1]; Ministerio de
   Economia y Competitividad [BFU2011-23578]; Junta de Andalucia Proyectos
   de Excelencia [P09-CVI-4887]; Junta de Andalucia Proyectos
   Internacionales grant; Junta de Andalucia [BIO-276]; University of
   Cordoba; Spanish Ministerio de Educacion; Agencia Espanola de
   Cooperacion Internacional al Desarrollo
FX Supported by National Institutes of Health grant 1R01AG028125-01A1 (to
   J.J.R., P.N., and J.M.V.), Ministerio de Economia y Competitividad
   BFU2011-23578 (to J.M.V.), Junta de Andalucia Proyectos de Excelencia
   grant P09-CVI-4887 (to J.M.V.), Junta de Andalucia Proyectos
   Internacionales grant (to J.M.V.), and BIO-276 (Junta de Andalucia and
   the University of Cordoba to J.M.V.). J.A.L.-D. was funded by a
   predoctoral fellowship of the Spanish Ministerio de Educacion and
   BIO-276. H.K. was funded by a predoctoral fellowship of the Agencia
   Espanola de Cooperacion Internacional al Desarrollo and BIO-276.
CR Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220
   López-Domínguez JA, 2013, AGE, V35, P2027, DOI 10.1007/s11357-012-9492-9
   Ando K, 2002, MICROSC RES TECHNIQ, V59, P293, DOI 10.1002/jemt.10207
   Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071
   Bello RI, 2003, J BIOENERG BIOMEMBR, V35, P169, DOI 10.1023/A:1023702321148
   Bello RI, 2006, EXP GERONTOL, V41, P1174, DOI 10.1016/j.exger.2006.08.012
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   Calder PC, 2002, EUR J CLIN NUTR, V56, pS14, DOI 10.1038/sj.ejcn.1601478
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chen YN, 2013, BIOSCIENCE REP, V33, P83, DOI 10.1042/BSR20120060
   Chen YN, 2012, J GERONTOL A-BIOL, V67, P1121, DOI 10.1093/gerona/gls113
   Chen ZY, 2000, PROSTAG LEUKOTR ESS, V63, P301, DOI 10.1054/plef.2000.0218
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317
   FujikawaYamamoto K, 1997, CELL STRUCT FUNCT, V22, P399, DOI 10.1247/csf.22.399
   Garcia-Fernandez M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-123
   Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430
   Gorla GR, 2001, J CELL SCI, V114, P2943
   GRASLKRAUPP B, 1994, P NATL ACAD SCI USA, V91, P9995, DOI 10.1073/pnas.91.21.9995
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Hagopian K, 2005, AM J PHYSIOL-ENDOC M, V288, pE674, DOI 10.1152/ajpendo.00382.2004
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Higami Y, 1997, AM J PATHOL, V151, P659
   Higami Y, 2000, CELL TISSUE RES, V299, P363, DOI 10.1007/s004410050034
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   Hikita H, 2012, J HEPATOL, V57, P92, DOI 10.1016/j.jhep.2012.01.027
   Honig LS, 2000, AM J MED, V108, P317, DOI 10.1016/S0002-9343(00)00291-6
   Itzhaki O, 2003, MECH AGEING DEV, V124, P999, DOI 10.1016/S0047-6374(03)00171-4
   Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229
   Kanzler S, 2000, SEMIN CANCER BIOL, V10, P173, DOI 10.1006/scbi.2000.0318
   Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121
   Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   Nakatani T, 1997, EXP CELL RES, V236, P137, DOI 10.1006/excr.1997.3715
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426
   Puche JE, 2008, ENDOCRINOLOGY, V149, P2620, DOI 10.1210/en.2007-1563
   Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2
   Rusyn I, 1999, CARCINOGENESIS, V20, P2095, DOI 10.1093/carcin/20.11.2095
   Selman C, 2003, EXP GERONTOL, V38, P897, DOI 10.1016/S0531-5565(03)00091-3
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6
   Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Suh Y, 2002, MECH AGEING DEV, V123, P881, DOI 10.1016/S0047-6374(02)00025-8
   TAHIN QS, 1981, EUR J BIOCHEM, V121, P5, DOI 10.1111/j.1432-1033.1981.tb06421.x
   Talarmin H, 1999, MOL CELL BIOL, V19, P6003
   Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005
   Tresguerres JAF, 2008, J STEROID BIOCHEM, V108, P318, DOI 10.1016/j.jsbmb.2007.09.010
   Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479
   Yu BP, 2002, J NUTR SCI VITAMINOL, V48, P257, DOI 10.3177/jnsv.48.257
   Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X
NR 62
TC 11
Z9 11
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2015
VL 70
IS 4
BP 399
EP 409
DI 10.1093/gerona/glu045
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA CH2ZW
UT WOS:000353896100001
PM 24691092
OA Green Published
DA 2024-02-19
ER

PT J
AU Maniyadath, B
   Chattopadhyay, T
   Verma, S
   Kumari, S
   Kulkarni, P
   Banerjee, K
   Lazarus, A
   Kokane, SS
   Shetty, T
   Anamika, K
   Kolthur-Seetharam, U
AF Maniyadath, Babukrishna
   Chattopadhyay, Tandrika
   Verma, Srikant
   Kumari, Sujata
   Kulkarni, Prineeta
   Banerjee, Kushal
   Lazarus, Asmitha
   Kokane, Saurabh S.
   Shetty, Trupti
   Anamika, Krishanpal
   Kolthur-Seetharam, Ullas
TI Loss of Hepatic Oscillatory Fed microRNAs Abrogates Refed Transition and
   Causes Liver Dysfunctions
SO CELL REPORTS
LA English
DT Article
ID FATTY-ACID OXIDATION; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL CONTROL;
   GLUCOSE-METABOLISM; TARGET PREDICTION; ENERGY-METABOLISM; SIRT1;
   PGC-1-ALPHA; COACTIVATOR; GLUCONEOGENESIS
AB Inability to mediate fed-fast transitions in the liver is known to cause metabolic dysfunctions and diseases. Intuitively, a failure to inhibit futile translation of state-specific transcripts during fed-fast cycles would abrogate dynamic physiological transitions. Here, we have discovered hepatic fed microRNAs that target fasting-induced genes and are essential for a refed transition. Our findings highlight the role of these fed microRNAs in orchestrating system-level control over liver physiology and whole-body energetics. By targeting SIRT1, PGC1 alpha, and their down-stream genes, fed microRNAs regulate metabolic and mitochondrial pathways. MicroRNA expression, processing, and RISC loading oscillate during these cycles and possibly constitute an anticipatory mechanism. Fed-microRNA oscillations are deregulated during aging. Scavenging of hepatic fed microRNAs causes uncontrolled gluconeogenesis and failure in the catabolic-to-anabolic switching upon feeding, which are hallmarks of metabolic diseases. Besides identifying mechanisms that enable efficient physio-logical toggling, our study highlights fed microRNAs as candidate therapeutic targets.
C1 [Maniyadath, Babukrishna; Chattopadhyay, Tandrika; Kumari, Sujata; Kulkarni, Prineeta; Banerjee, Kushal; Lazarus, Asmitha; Kokane, Saurabh S.; Shetty, Trupti; Kolthur-Seetharam, Ullas] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai, Maharashtra, India.
   [Verma, Srikant; Anamika, Krishanpal] Aryabhata Pingala, LABS, Persistent Syst, Pune, Maharashtra, India.
C3 Tata Institute of Fundamental Research (TIFR)
RP Kolthur-Seetharam, U (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Mumbai, Maharashtra, India.
EM ullas@tifr.res.in
OI Kokane, Saurabh/0000-0003-2813-9525; verma, srikant/0000-0001-8484-1453;
   Maniyadath, Babukrishna/0000-0002-5634-5388
FU DAE-TIFR (Government of India) [12P-0122]; Department of Biotechnology
   (DBT, India) [BT/PR4972/AGR/36/714/2012]
FX We acknowledge the following funding sources: DAE-TIFR (Government of
   India) (12P-0122) and the Department of Biotechnology (DBT, India)
   (BT/PR4972/AGR/36/714/2012) to U.K.-S. We thank the Centre for Cellular
   and Molecular Platforms (C-CAMP), Bangalore, for small RNA sequencing
   services. We acknowledge Dr. Kalidas Kohale, Dr. Shital Suryavanshi, Dr.
   Sachin Atole, Dr. Sagar Tarate, and Ms. Ritika Gupta for the help with
   animal experiments.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072
   Banerjee KK, 2012, CELL REP, V2, P1485, DOI 10.1016/j.celrep.2012.11.013
   Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018
   Cantó C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   CHEN C, 1992, HORM METAB RES, V24, P161, DOI 10.1055/s-2007-1003285
   Choi SE, 2013, MOL CELLS, V36, P385, DOI 10.1007/s10059-013-0297-1
   Dumortier O, 2013, CELL METAB, V18, P312, DOI 10.1016/j.cmet.2013.06.004
   Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783
   Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1
   Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Fu XH, 2015, J CLIN INVEST, V125, P2497, DOI 10.1172/JCI75438
   Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247
   Han HS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01878-6
   Hashimoto T, 2009, BIOINFORMATICS, V25, P2613, DOI 10.1093/bioinformatics/btp438
   Hatting M, 2017, CELL METAB, V25, P428, DOI 10.1016/j.cmet.2016.12.007
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Horton TJ, 2001, J APPL PHYSIOL, V90, P155, DOI 10.1152/jappl.2001.90.1.155
   Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021
   Jansen BJH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-330
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Jin X, 2016, ONCOTARGET, V7, P66455, DOI 10.18632/oncotarget.12186
   Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001
   Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001
   Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711
   Martin M., 2011, EMBnet. J., V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]
   MEZEY E, 1978, GASTROENTEROLOGY, V74, P770
   Naïmi M, 2010, TRENDS ENDOCRIN MET, V21, P75, DOI 10.1016/j.tem.2009.09.003
   Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007
   Du NH, 2014, ELIFE, V3, DOI 10.7554/eLife.02510
   Nguyen D, 2013, AGING CELL, V12, P415, DOI 10.1111/acel.12073
   Niu BL, 2018, MOL MED REP, V18, P1609, DOI 10.3892/mmr.2018.9088
   Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Sharabi K, 2017, CELL, V169, P148, DOI 10.1016/j.cell.2017.03.001
   Soeters MR, 2012, AM J PHYSIOL-ENDOC M, V303, pE1397, DOI 10.1152/ajpendo.00397.2012
   Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   Stanga Z, 2008, EUR J CLIN NUTR, V62, P687, DOI 10.1038/sj.ejcn.1602854
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365
   Titchenell PM, 2017, TRENDS ENDOCRIN MET, V28, P497, DOI 10.1016/j.tem.2017.03.003
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098
   Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753
   Yang ZH, 2015, ACTA PHARM SIN B, V5, P145, DOI 10.1016/j.apsb.2015.01.002
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553
   Zhang LH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-290
   Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8
NR 83
TC 15
Z9 16
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 19
PY 2019
VL 26
IS 8
BP 2212
EP +
DI 10.1016/j.celrep.2019.01.087
PG 22
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HL9DA
UT WOS:000459041600020
PM 30784600
OA gold
DA 2024-02-19
ER

PT J
AU Gupta, G
   Cases, JA
   She, L
   Ma, XH
   Yang, XM
   Hu, MZ
   Wu, J
   Rossetti, L
   Barzilai, N
AF Gupta, G
   Cases, JA
   She, L
   Ma, XH
   Yang, XM
   Hu, MZ
   Wu, J
   Rossetti, L
   Barzilai, N
TI Ability of insulin to modulate hepatic glucose production in aging rats
   is impaired by fat accumulation
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE obesity; caloric restriction
ID VISCERAL FAT; CALORIC RESTRICTION; COMPUTED-TOMOGRAPHY; FOOD
   RESTRICTION; CONSCIOUS RATS; IN-VIVO; LIVER; RESISTANCE; AGE;
   GLUCOSE-6-PHOSPHATASE
AB Increased total fat mass (FM) and visceral fat (VF) may account in part for age-associated decrease in hepatic insulin action. This study determined whether preventing the changes in body fat distribution abolished this defect throughout aging. We studied the F-1 hybrid of Brown Norway-Fischer 344 rats (n = 29), which we assigned to caloric restriction (CR) or fed ad libitum (AL). CR (55% of the calories consumed by AL) was initiated and used at 2 mo to prevent age-dependent increases in FM and VF. AL rats were studied at 2, 8, and 20 mo; CR rats were studied at 8 and 20 mo. VF and FM remained unchanged throughout aging in CR rats. AL-fed rats at 8 and 20 mo had over fourfold higher FM and VF compared with both CR groups. Insulin clamp studies (3 mU . kg(-1) . min(-1) with somatostatin) were performed to assess hepatic insulin sensitivity. Prevention of fat accretion resulted in a marked improvement in insulin action in the suppression of hepatic glucose production (HGP) (6.3 +/- 0.3 and 7.2 +/- 1.2 mg . kg(-1) . min(-1) in 8- and 20-mo CR rats vs. 8.3 +/- 0.5 and 10.8 +/- 0.9 mg . kg(-1) . min(-1) in 8- and 20-mo AL rats, respectively). The rate of gluconeogenesis (by enrichment of hepatic uridine diphosphate glucose and phosphoenolpyruvate pools by [C-14]lactate) was unchanged in all groups. The improvement in hepatic insulin action in the CR group was mostly due to effective suppression of glycogenolysis (4.4 +/- 0.3 and 4.9 +/- 0.3 mU . kg(-1) . min(-1) in 8- and 20-mo CR rats vs. 5.8 +/- 0.6 and 8.2 +/- 1.0 mg . kg(-1) . min(-1) in 8- and 20-mo AL rats, respectively). The results demonstrated the preservation of hepatic insulin action in aging CR rats. Therefore, body fat and its distribution are major determinants of age-associated hepatic insulin resistance.
C1 Albert Einstein Coll Med, Dept Med, Div Geriatr, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine
RP Barzilai, N (corresponding author), Albert Einstein Coll Med, Dept Med, Div Geriatr, Belfer Bldg 701,1300 Morris Pk Ave, Bronx, NY 10461 USA.
RI xin, li/JCO-3925-2023; sun, bo/JFA-9978-2023
FU NIA NIH HHS [K08 AG-00636, R29 AG-16003] Funding Source: Medline; NIDDK
   NIH HHS [R01 DK-45024] Funding Source: Medline
CR Armeni T, 1998, MECH AGEING DEV, V101, P101, DOI 10.1016/S0047-6374(97)00167-X
   Barzilai N, 1999, J GERONTOL A-BIOL, V54, pB89, DOI 10.1093/gerona/54.3.B89
   Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291
   BARZILAI N, 1989, AGE, V12, P13, DOI 10.1007/BF02432513
   Barzilai N, 1996, AM J PHYSIOL-ENDOC M, V270, pE930, DOI 10.1152/ajpendo.1996.270.6.E930
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94
   BARZILAI N, 1993, J BIOL CHEM, V268, P25019
   BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Massillon D, 1998, J BIOL CHEM, V273, P228, DOI 10.1074/jbc.273.1.228
   Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871
   Mittelman SD, 1997, J CLIN INVEST, V100, P3121, DOI 10.1172/JCI119867
   NEESE RA, 1995, J BIOL CHEM, V270, P14452, DOI 10.1074/jbc.270.24.14452
   OSHAUGHNESSY IM, 1995, HYPERTENSION, V26, P186, DOI 10.1161/01.HYP.26.1.186
   Pallet V, 1997, MECH AGEING DEV, V99, P123, DOI 10.1016/S0047-6374(97)00098-5
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681
   ROSSETTI L, 1993, J CLIN INVEST, V92, P2963, DOI 10.1172/JCI116919
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   SHIMOKATA H, 1989, J GERONTOL, V44, P66
   VANERMEN A, 1994, J GERONTOL, V49, pB12, DOI 10.1093/geronj/49.1.B12
   Walter R, 1998, J GERONTOL A-BIOL, V53, pB102, DOI 10.1093/gerona/53A.2.B102
NR 31
TC 53
Z9 55
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JUN
PY 2000
VL 278
IS 6
BP E985
EP E991
DI 10.1152/ajpendo.2000.278.6.E985
PG 7
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 323NH
UT WOS:000087571200003
PM 10826999
DA 2024-02-19
ER

PT J
AU Naiini, MR
   Shahouzehi, B
   Khaksari, M
   Azizi, S
   Naghibi, N
   Nazari-Robati, M
AF Naiini, Mahdis Rahimi
   Shahouzehi, Beydolah
   Khaksari, Mohammad
   Azizi, Shahrzad
   Naghibi, Niloufar
   Nazari-Robati, Mahdieh
TI Ellagic acid reduces hepatic lipid contents through regulation of SIRT1
   and AMPK in old rats
SO ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article; Early Access
DE Ellagic acid; ageing; liver; lipid metabolism; SIRT1; AMPK; PPAR-alpha;
   SREBP-1c
ID LIVER; INSULIN; TISSUE
AB Objective: Ellagic acid is used in traditional medicine for the treatment of lipid disorders. In this study, the effects of ellagic acid on key regulators of lipid metabolism, and histopathological alterations in aged liver were examined.Methods: A total of 21 male Wistar rats were divided into three groups, including young control, old control, and old ellagic acid. After one month of treatment with ellagic acid, the expression levels of hepatic SIRT1, AMPK, SREBP-1c, PPAR-alpha, and phosphorylated AMPK (p-AMPK) were evaluated. The levels of several serum biochemical factors, and hepatic triglyceride, and cholesterol contents were assessed.Results: Ellagic acid elevated the levels of SIRT1, p-AMPK, and PPAR-alpha and reduced SREBP-1c level in the liver of old rats. It decreased triglyceride and cholesterol contents in the aged liver and improved histopathological changes.Conclusions: The results demonstrated that ellagic acid can exert protective effects against hepatic lipid metabolism disorders induced by ageing.
C1 [Naiini, Mahdis Rahimi] Kerman Univ Med Sci, Inst Neuropharmacol, Pharmaceut Res Ctr, Kerman, Iran.
   [Shahouzehi, Beydolah] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Cardiovasc Res Ctr, Kerman, Iran.
   [Khaksari, Mohammad] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran.
   [Azizi, Shahrzad] Shahid Bahonar Univ Kerman, Fac Vet Med, Dept Pathobiol, Kerman, Iran.
   [Naghibi, Niloufar; Nazari-Robati, Mahdieh] Kerman Univ Med Sci, Fac Med, Dept Clin Biochem, Kerman, Iran.
C3 Kerman University of Medical Sciences; Kerman University of Medical
   Sciences; Kerman University of Medical Sciences; Shahid Bahonar
   University of Kerman (SBUK); Kerman University of Medical Sciences
RP Nazari-Robati, M (corresponding author), Kerman Univ Med Sci, Fac Med, Dept Clin Biochem, Kerman, Iran.
EM mnazari@kmu.ac.ir
OI Azizi, Shahrzad/0000-0003-3746-9593; Khaksari,
   Mohammad/0000-0003-0770-4281
FU Kerman University of Medical Sciences [400000647]
FX This study was funded by Kerman University of Medical Sciences (Grant
   No. 400000647).
CR Ahad A, 2014, CHEM-BIOL INTERACT, V219, P64, DOI 10.1016/j.cbi.2014.05.011
   ALTamimi JZ, 2022, PHARM BIOL, V60, P25, DOI 10.1080/13880209.2021.1990969
   Amin MM, 2017, APPL PHYSIOL NUTR ME, V42, P181, DOI 10.1139/apnm-2016-0429
   Antunes LC, 2016, ARCH ENDOCRIN METAB, V60, P138
   Bahri F, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13931
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chung KW, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040880
   DiNicolantonio JJ, 2022, OPEN HEART, V9, DOI 10.1136/openhrt-2021-001801
   Dubrac S, 2011, DERM-ENDOCRINOL, V3, P23, DOI 10.4161/derm.3.1.14615
   Fan J, 2022, ANIMALS-BASEL, V12, DOI 10.3390/ani12131692
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164
   HAUG A, 1987, J NUTR, V117, P1011, DOI 10.1093/jn/117.6.1011
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Kang I, 2016, ADV NUTR, V7, P961, DOI 10.3945/an.116.012575
   Kang I, 2016, MOL NUTR FOOD RES, V60, P1129, DOI 10.1002/mnfr.201500796
   Karimi MY, 2020, J DIET SUPPL, V17, P651, DOI 10.1080/19390211.2019.1634175
   Kim YM, 2010, J BIOL CHEM, V285, P29069, DOI 10.1074/jbc.M110.120386
   Kohjima M, 2008, INT J MOL MED, V21, P507
   Lee KH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030610
   Li Y, 2022, AGING DIS, V13, P1239, DOI 10.14336/AD.2022.0318
   Liu Run, 2015, Acta Nutrimenta Sinica, V37, P399
   Mehrzadi S, 2018, PHARMACOL REP, V70, P712, DOI 10.1016/j.pharep.2018.02.007
   Mutlu AS, 2021, DEV CELL, V56, P1394, DOI 10.1016/j.devcel.2021.03.034
   Naghibi N, 2023, BMC COMPLEMENT MED, V23, DOI 10.1186/s12906-023-03907-y
   Okla M, 2015, J NUTR BIOCHEM, V26, P82, DOI 10.1016/j.jnutbio.2014.09.010
   Papsdorf K, 2019, TRENDS CELL BIOL, V29, P97, DOI 10.1016/j.tcb.2018.09.004
   Polce SA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050531
   García-Niño WR, 2015, PHARMACOL RES, V97, P84, DOI 10.1016/j.phrs.2015.04.008
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210
   Wan J, 2020, AGING CELL, V19, DOI 10.1111/acel.13238
   Xu QY, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.751501
NR 37
TC 0
Z9 0
U1 4
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1381-3455
EI 1744-4160
J9 ARCH PHYSIOL BIOCHEM
JI Arch. Physiol. Biochem.
PD 2023 OCT 9
PY 2023
DI 10.1080/13813455.2023.2262165
EA OCT 2023
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
GA U5CU5
UT WOS:001084984200001
PM 37814948
DA 2024-02-19
ER

PT J
AU Oh, BK
   Lee, CH
   Park, C
   Park, YN
AF Oh, BK
   Lee, CH
   Park, C
   Park, YN
TI Telomerase regulation and progressive telomere shortening of rat hepatic
   stem-like epithelial cells during in vitro aging
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE rat hepatic stein-like epithelial cell; telomerase; telomere;
   transformation; in vitro aging
ID OVAL CELLS; CENTRIFUGAL ELUTRIATION; CHROMOSOME INSTABILITY; IMMORTAL
   CELLS; LIVER; EXPRESSION; RNA; DNA; IDENTIFICATION; ACTIVATION
AB Rat hepatic stein-like epithelial cells, LE/2, LE/6, and WB-F344, share some phenotypic properties with oval cells, observed in the early stages of hepatocarcinogenesis. Here, we describe regulations of telomerase and telomere length during in vitro aging of LEs and WB-F344. These cells displayed no apparent aging phenotypes for over 140 passages. Telomerase activity and telomere length of these cells progressively decreased with the passages, and at the late passages, telomere shortening appeared to be reduced as telomerase activity increased. Regulation of TERT and TR, key components of telomerase, was similar to that of the telomerase activity. LEs possessed weak telomerase activity with a slow rate of proliferation compared to WB-F344, and were not tumorigenic, whereas WB-F344 was transformed in vitro from intermediate passage. In conclusion, LEs and WB-F344 have different biochemical properties, and telomerase activation and short telomeres are unlikely necessary for the transformation of WB-F344. TERT and TR seem to be the regulators of the telomerase activity. The relationship between telomere length and telomerase activity suggests that telomerase contributes to the regulation of telomere length in these cells. Our findings provide a better understanding of mechanisms in neoplastic transformation of rat hepatic stem-like epithelial cells. (C) 2004 Elsevier Inc. All rights reserved.
C1 Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Dept Pathol, Seoul 120749, South Korea.
   Yonsei Univ, Coll Med, Brain Korea 21 Project Med Sci, Seoul 120749, South Korea.
   Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul 120749, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University Health System; Yonsei University; Yonsei University
   Health System
RP Park, YN (corresponding author), Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Dept Pathol, CPO Box 8044, Seoul 120749, South Korea.
EM young0608@yumc.yonsei.ac.kr
RI Park, Jun Yong/H-7127-2019
OI Park, Young Nyun/0000-0003-0357-7967
CR ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5
   BRAUN L, 1987, CANCER RES, V47, P4116
   Broccoli D, 1996, MOL CELL BIOL, V16, P3765
   CHADENEAU C, 1995, ONCOGENE, V11, P893
   Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080
   Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902
   Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6
   FAUSTO N, 1987, CELL SEPARATION METH, V4, P45
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   Ford LP, 2002, ONCOGENE, V21, P580, DOI 10.1038/sj.onc.1205086
   Gammaitoni L, 2004, BLOOD, V103, P4440, DOI 10.1182/blood-2003-09-3079
   GERMAIN L, 1985, CANCER RES, V45, P673
   Golubovskaya VM, 1999, MOL CARCINOGEN, V24, P209, DOI 10.1002/(SICI)1098-2744(199903)24:3<209::AID-MC7>3.0.CO;2-F
   Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625
   GRISHAM JW, 1993, P SOC EXP BIOL MED, V204, P270
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HAYNER NT, 1984, CANCER RES, V44, P332
   Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474
   Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964
   HIXSON DC, 1990, PATHOBIOLOGY, V58, P65, DOI 10.1159/000163565
   Holt SE, 1996, MOL CELL BIOL, V16, P2932
   Hooth MJ, 1998, AM J PATHOL, V153, P1913, DOI 10.1016/S0002-9440(10)65705-7
   Kaufmann WK, 2001, CARCINOGENESIS, V22, P1257, DOI 10.1093/carcin/22.8.1257
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   Liao C, 2000, HEPATOLOGY, V32, P721, DOI 10.1053/jhep.2000.17967
   Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7
   Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X
   Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9
   Newbold RF, 2002, MUTAGENESIS, V17, P539, DOI 10.1093/mutage/17.6.539
   Oh BK, 2003, J HEPATOL, V39, P786, DOI 10.1016/S0168-8278(03)00395-7
   Oh BK, 2002, CANCER LETT, V186, P93, DOI 10.1016/S0304-3835(02)00320-8
   Petitot F, 2003, EXP CELL RES, V286, P30, DOI 10.1016/S0014-4827(03)00103-4
   PETROPOULOS CJ, 1985, CANCER RES, V45, P5762
   PLENAT F, 1988, AM J PATHOL, V130, P91
   PROWSE KR, 1993, P NATL ACAD SCI USA, V90, P1493, DOI 10.1073/pnas.90.4.1493
   Ramakrishnan S, 1998, CANCER RES, V58, P622
   Sambrook J., 2001, MOL CLONING LAB MANU
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   STEINBERG P, 1994, LAB INVEST, V71, P700
   Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038
   TSAO MS, 1987, AM J PATHOL, V127, P168
   TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9
   Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232
   YASWEN P, 1985, AM J PATHOL, V121, P505
   YASWEN P, 1984, CANCER RES, V44, P324
   Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4
NR 50
TC 9
Z9 13
U1 0
U2 2
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD AUG 15
PY 2004
VL 298
IS 2
BP 445
EP 454
DI 10.1016/j.yexcr.2004.04.032
PG 10
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA 842EF
UT WOS:000222985300011
PM 15265692
DA 2024-02-19
ER

PT J
AU Singer, SS
   Henkels, K
   Deucher, A
   Barker, M
   Singer, J
   Trulzsch, DV
AF Singer, SS
   Henkels, K
   Deucher, A
   Barker, M
   Singer, J
   Trulzsch, DV
TI Growth hormone and aging change rat liver fatty acid binding protein
   levels
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE aging; rat liver; growth hormone; hypophysectomy; fatty acid binding
   protein
ID ENZYMATIC SULFATION; BODY-COMPOSITION; SULFOTRANSFERASE; LIGANDIN;
   STEROIDS; TISSUES; THERAPY; DRUGS; OLD
AB Objective: Rat liver fatty acid binding protein (FABP) is believed relevant to understanding of homeostasis in lipid metabolism and lipid related diseases. Relatively little is known about endocrine control of FABP production. Thus, we examined endocrine effects on its hepatic content.
   Methods/Results: Hypophysectomy of 300-325 g males caused statistically significant drops of FABP levels averaging 62.2% and 67.0%, expressed g/liver or 100 g/body weight, 30-52 days after surgery. Cortisol administration (3.8 mg/kg, daily, 32-36 days) did not significantly alter this effect of hypophysectomy. Recombinant human growth hormone (GH, 2.0 U/kg, b.i.d, 17-20 days) greatly decreased the effect of hypophysectomy on FABP but had no effect in intact males. Supporting the control of FABP content by GH, FABP levels decreased significantly in 12-13 and 16-22 month old males, but not in growing, 4-6 or 10-11 month old males. FABP levels in 12-13.5 month old females also dropped significantly compared to 4-6 month old females.
   Discussion: The importance of the data to metabolism, growth, and aging is discussed.
C1 WRIGHT STATE UNIV, VET ADM MED CTR, DEPT MED, DAYTON, OH 45435 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   University System of Ohio; Wright State University Dayton
RP Singer, SS (corresponding author), UNIV DAYTON, DEPT CHEM, 300 COLL PK, DAYTON, OH 45428 USA.
CR ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BERRY SA, 1993, J AM COLL NUTR, V12, P638
   BIERICH JR, 1989, HORM RES, V32, P153, DOI 10.1159/000181282
   FLEISCHNER G, 1975, BIOCHEM BIOPH RES CO, V67, P1401, DOI 10.1016/0006-291X(75)90182-5
   GALINSKY RE, 1990, J PHARMACOL EXP THER, V255, P577
   MISHKIN S, 1972, BIOCHEM BIOPH RES CO, V47, P997, DOI 10.1016/0006-291X(72)90931-X
   OCKNER RK, 1982, J BIOL CHEM, V257, P7872
   OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56
   REYES H, 1971, J CLIN INVEST, V50, P2242, DOI 10.1172/JCI106721
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   RUDMAN D, 1985, J AM GERIATR SOC, V33, P800, DOI 10.1111/j.1532-5415.1985.tb04195.x
   SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605
   SHULMAN DI, 1992, J PEDIATR GASTR NUTR, V14, P3, DOI 10.1097/00005176-199201000-00002
   SINGER SS, 1976, ENDOCRINOLOGY, V98, P963, DOI 10.1210/endo-98-4-963
   SINGER SS, 1992, BIOCHEM INT, V27, P373
   SINGER SS, 1982, BIOCHIM BIOPHYS ACTA, V700, P110, DOI 10.1016/0167-4838(82)90298-9
   STEEL RDG, 1960, PRINCIPLES STAT
   STEIN LB, 1976, AM J PHYSIOL, V231, P1371, DOI 10.1152/ajplegacy.1976.231.5.1371
   VEERKAMP JH, 1993, PROSTAG LEUKOTR ESS, V49, P887, DOI 10.1016/0952-3278(93)90174-U
   YAMAZOE Y, 1989, MOL PHARMACOL, V35, P707
NR 20
TC 8
Z9 8
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD APR
PY 1996
VL 15
IS 2
BP 169
EP 174
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA UE788
UT WOS:A1996UE78800012
PM 8778148
DA 2024-02-19
ER

PT J
AU Schnabl, B
   Purbeck, CA
   Choi, YH
   Hagedorn, CH
   Brenner, DA
AF Schnabl, B
   Purbeck, CA
   Choi, YH
   Hagedorn, CH
   Brenner, DA
TI Replicative senescence of activated human hepatic stellate cells is
   accompanied by a pronounced inflammatory but less fibrogenic phenotype
SO HEPATOLOGY
LA English
DT Article
ID TUMOR-SUPPRESSOR P53; CYTOCHROME-C; IN-VIVO; TELOMERASE EXPRESSION;
   ISOLATED-MITOCHONDRIA; HUMAN FIBROBLASTS; LIVER FIBROSIS; TISSUE-REPAIR;
   MESSENGER-RNA; RAT-LIVER
AB Limited proliferative capacity is a characteristic of most normal human cells and results in a growth-arrested state, called replicative senescence. Functional expression of the telomerase catalytic subunit (human telomerase reverse transcriptase; hTERT) in human activated hepatic stellate cells (HSCs) rescues them from death with immortalization and maintains an activated HSC phenotype. The aim of this study was to evaluate alterations in gene and protein expression of in vitro aged human activated HSCs and to define the pathway by which senescent-activated HSCs are eliminated in culture. Altered patterns of gene expression in senescent human HSCs were assessed using DNA microarray analysis and compared with early passage HSCs or hTERT immortalized HSCs. Senescent HSCs showed higher expression of inflammation and stress-associated genes as compared with early passage HSCs. Senescent HSCs expressed reduced levels of extracellular matrix proteins, including collagens, tenascin, and fibronectin. TUNEL staining of senescent HSCs showed approximately 21% positive cells, indicating DNA fragmentation and apoptosis. Apoptosis involved the mitochondrial pathway with decreased levels of Bcl-2 and Bcl-x(L) protein, release of cytochrome C, and increased caspase-3 activity. In contrast, 4% to 5% of early activated HSCs or telomerase positive HSCs were TUNEL positive. In conclusion, cultured human HSCs undergo a switch from a fibrogenic to an inflammatory phenotype, suggesting that senescent human HSCs might modulate chronic wound heating processes. Maintenance of telomere length represents an important survival factor for activated human HSCs.
C1 Univ N Carolina, Dept Med, Div Digest Dis & Nutr, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.
   Emory Univ, Sch Med, Dept Med, Atlanta, GA USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   Emory University
RP Brenner, DA (corresponding author), Univ N Carolina, Dept Med, Div Digest Dis & Nutr, CB 7038,Glaxo Res Bldg,Rm 156, Chapel Hill, NC 27599 USA.
OI Brenner, David/0000-0003-2573-525X
FU NIAAA NIH HHS [AA11605] Funding Source: Medline; NIDDK NIH HHS [DK34987]
   Funding Source: Medline; NIGMS NIH HHS [GM41804] Funding Source: Medline
CR ABDELAZIZ G, 1990, AM J PATHOL, V137, P1333
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Burns TF, 1999, J CELL PHYSIOL, V181, P231, DOI 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006
   Dufour JF, 1998, DIGEST DIS SCI, V43, P2573, DOI 10.1023/A:1026601904609
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Funk WD, 2000, EXP CELL RES, V258, P270, DOI 10.1006/excr.2000.4945
   Gong WR, 1998, HEPATOLOGY, V28, P492, DOI 10.1002/hep.510280229
   GREENWEL P, 1993, LAB INVEST, V69, P210
   Hellerbrand C, 1998, HEPATOLOGY, V27, P1285, DOI 10.1002/hep.510270514
   Hellerbrand C, 1996, HEPATOLOGY, V24, P670
   Holt SE, 1999, MOL CARCINOGEN, V25, P241, DOI 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.3.CO;2-0
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Iwamoto H, 1999, J LAB CLIN MED, V134, P83, DOI 10.1016/S0022-2143(99)90057-4
   Jürgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997
   Kaplan MM, 1997, ANN INTERN MED, V126, P682, DOI 10.7326/0003-4819-126-9-199705010-00002
   Knittel T, 1999, AM J PATHOL, V154, P153, DOI 10.1016/S0002-9440(10)65262-5
   Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123
   Kweon YO, 2001, J HEPATOL, V35, P749, DOI 10.1016/S0168-8278(01)00218-5
   Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1
   Maher JJ, 1998, AM J PHYSIOL-GASTR L, V275, pG847, DOI 10.1152/ajpgi.1998.275.4.G847
   MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886
   MIYASHITA T, 1995, CELL, V80, P293
   MIYASHITA T, 1994, ONCOGENE, V9, P1799
   Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681
   Natsume M, 1999, J LEUKOCYTE BIOL, V66, P601, DOI 10.1002/jlb.66.4.601
   OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O
   Saile B, 1997, AM J PATHOL, V151, P1265
   Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426
   Schnabl B, 2001, HEPATOLOGY, V34, P953, DOI 10.1053/jhep.2001.28790
   Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349
   Schwabe RF, 2001, J IMMUNOL, V166, P6812, DOI 10.4049/jimmunol.166.11.6812
   Senoo H, 1996, CELL BIOL INT, V20, P501, DOI 10.1006/cbir.1996.0065
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   SHERON N, 1993, HEPATOLOGY, V18, P41, DOI 10.1002/hep.1840180108
   Stefanovic B, 1999, MOL CELL BIOL, V19, P4334
   Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201
   Stefanovic B, 2003, J BIOL CHEM, V278, P927, DOI 10.1074/jbc.M209175200
   Stefanovic B, 2002, J BIOL CHEM, V277, P18229, DOI 10.1074/jbc.M108065200
   Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   Walz A, 1997, J LEUKOCYTE BIOL, V62, P604, DOI 10.1002/jlb.62.5.604
   Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2
   WU CY, 1995, J CELL SCI, V108, P2511
   YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
NR 52
TC 159
Z9 174
U1 0
U2 20
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD MAR
PY 2003
VL 37
IS 3
BP 653
EP 664
DI 10.1053/jhep.2003.50097
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 650RJ
UT WOS:000181276800021
PM 12601363
OA Bronze
DA 2024-02-19
ER

PT J
AU Rastogi, A
   Maiwall, R
   Bihari, C
   Trehanpati, N
   Pamecha, V
   Sarin, SK
AF Rastogi, Archana
   Maiwall, Rakhi
   Bihari, Chhagan
   Trehanpati, Nirupma
   Pamecha, Viniyendra
   Sarin, Shiv Kumar
TI Two-tier regenerative response in liver failure in humans
SO VIRCHOWS ARCHIV
LA English
DT Article
DE Hepatic progenitor cells; Proliferating hepatocytes; ACLF; ALF; CHD
ID HEPATIC STEM-CELLS; PROGENITOR CELLS; DUCTULAR REACTIONS; CIRRHOSIS;
   NICHE; DISEASES; ACTIVATION; CONSENSUS; INVOLVEMENT; SENESCENCE
AB Acute and chronic liver failure is associated with high mortality. The enormous regenerative potential of the liver has generated a lot of attention. We undertook this work to assess the two-tier regenerative response in liver failure by immunohistochemistry and to correlate such response with liver histology in acute liver failure (ALF), acute-on-chronic liver failure (ACLF), and decompensated cirrhosis (CHD). Histological examination and immunohistochemical analysis of proliferating hepatocytes and activated hepatic progenitor cells (HPCs) were performed on the liver tissue of patients with ALF (25), ACLF (70), and CHD (70). Comparative analysis of regenerative markers and correlation with histological parameters were done in ALF, ACLF, and CHD. Hepatocytes proliferated significantly more in ALF in comparison to ACLF (p < 0.001) and CHD (p < 0.001). HPC proliferation was significantly higher in ACLF (p < 0.001) and CHD (p < 0.001) than in ALF. ACLF patients showed the highest HPC proliferation and differentiation. Significantly more intermediate hepatocytes were found in ACLF than in ALF and CHD (p < 0.001). Marked parenchymal replacement by fibrosis and/or necrosis correlated significantly with activation of HPC in ACLF (p = 0.01, odds ratio (OR) 4.95) and in CHD (p = 0.05, OR 4.19). The study of liver regeneration in human acute and chronic liver failure suggests that hepatocyte proliferation, providing the first line of regeneration response, is most active in ALF whereas HPC activation, the second line of defense, is more prominent in ACLF. More HPC differentiate to hepatocytes in ACLF than in CHD, reflecting better regenerative potential in ACLF.
C1 [Rastogi, Archana; Bihari, Chhagan] Inst Liver & Biliary Sci, Dept Pathol, New Delhi 110070, India.
   [Maiwall, Rakhi; Sarin, Shiv Kumar] Inst Liver & Biliary Sci, Dept Hepatol, New Delhi 110070, India.
   [Trehanpati, Nirupma] Inst Liver & Biliary Sci, Dept Res, New Delhi 110070, India.
   [Pamecha, Viniyendra] Inst Liver & Biliary Sci, Dept Hepatopancreaticobiliary Surg, New Delhi 110070, India.
C3 Institute of Liver & Biliary Sciences (ILBS); Institute of Liver &
   Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS);
   Institute of Liver & Biliary Sciences (ILBS)
RP Rastogi, A (corresponding author), Inst Liver & Biliary Sci, Dept Pathol, D-1 Vasant Kunj, New Delhi 110070, India.
EM drarchanarastogi@gmail.com
RI Bihari, Chhagan/AAY-4443-2020
OI Sarin, Shiv Kumar/0000-0002-0544-5610
CR ANTHONY PP, 1978, J CLIN PATHOL, V31, P395, DOI 10.1136/jcp.31.5.395
   Bird TG, 2008, CELL TISSUE RES, V331, P283, DOI 10.1007/s00441-007-0542-z
   Bisgaard HC, 2002, AM J PATHOL, V161, P1187, DOI 10.1016/S0002-9440(10)64395-7
   D'Amico G, 2001, P 3 BAV INT CONS WOR, P36
   de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009
   Dollé L, 2010, J HEPATOL, V52, P117, DOI 10.1016/j.jhep.2009.10.009
   Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044
   Erker L, 2008, STEM CELL RES, V1, P90, DOI 10.1016/j.scr.2008.01.002
   Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   Forbes S, 2002, J PATHOL, V197, P510, DOI 10.1002/path.1163
   Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x
   Katoonizadeh A, 2010, GUT, V59, P1561, DOI 10.1136/gut.2009.189639
   Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218
   Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177
   Libbrecht L, 2000, J PATHOL, V192, P373, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH700&gt;3.0.CO;2-5
   Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6
   Naveiras O, 2006, CELL MOL LIFE SCI, V63, P760, DOI 10.1007/s00018-005-5469-5
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Petersen B, 2008, HEPATOLOGY, V47, P1810, DOI 10.1002/hep.22333
   Rastogi A, 2013, HISTOPATHOLOGY, V62, P731, DOI 10.1111/his.12070
   Rastogi A, 2012, VIRCHOWS ARCH, V461, P393, DOI 10.1007/s00428-012-1291-2
   Rastogi A, 2011, VIRCHOWS ARCH, V459, P121, DOI 10.1007/s00428-011-1115-9
   Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x
   Roskams T, 2006, J HEPATOL, V45, P1, DOI 10.1016/j.jhep.2006.05.002
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Roskams T, 2003, J HEPATOL, V39, P431, DOI 10.1016/S0168-8278(03)00333-7
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Roskams TA, 2003, SEMIN LIVER DIS, V23, P385
   Roskams T, 2008, CLIN LIVER DIS, V12, P853, DOI 10.1016/j.cld.2008.07.014
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Santoni-Rugiu E, 2005, APMIS, V113, P876, DOI 10.1111/j.1600-0463.2005.apm_386.x
   Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x
   Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367
   Swenson ES, 2008, LIVER INT, V28, P308, DOI 10.1111/j.1478-3231.2007.01659.x
   Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001
   Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614
   THORGEIRSSON SS, 1993, AM J PATHOL, V142, P1331
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516
NR 40
TC 15
Z9 15
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
EI 1432-2307
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD MAY
PY 2014
VL 464
IS 5
BP 565
EP 573
DI 10.1007/s00428-014-1547-0
PG 9
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA AG8MW
UT WOS:000335673700006
PM 24590583
DA 2024-02-19
ER

PT J
AU Golubovskaya, VM
   Presnell, SC
   Hooth, MJ
   Smith, GJ
   Kaufmann, WK
AF Golubovskaya, VM
   Presnell, SC
   Hooth, MJ
   Smith, GJ
   Kaufmann, WK
TI Expression of telomerase in normal and malignant rat hepatic epithelia
SO ONCOGENE
LA English
DT Article
DE telomerase; rat liver; hepatocyte; stem cell; hepatocarcinogenesis
ID STEM-LIKE CELLS; IMMORTAL CELLS; RNA COMPONENT; CANCER; LIVER; TISSUES;
   HEPATOCARCINOGENESIS; DIFFERENTIATION; PROLIFERATION; PROGRESSION
AB Telomerase is a ribonucleoprotein that synthesizes telomeric DNA repeats onto the ends of chromosomes. More than 85% of human cancers express telomerase activity and a large proportion of human hepatocellular carcinomas are positive, To study the role of telomerase expression in rat hepatocarcinogenesis, telomerase activity was assayed in various rat tissues and in two types of liver epithelial cells: hepatocytes and hepatic epithelial stem-like cells. In the present study, we demonstrate that telomerase activity in rats is tissue-specific and stable with animal aging. Liver and testis were found to be telomerase positive, spleen had low or no activity, and kidney was negative, Telomerase activity did not change significantly in 18 month-old rats compared to 2 month-old rats, but was moderately (twofold) increased during liver regeneration induced by a 2/3's partial hepatectomy. Telomerase activity was detected in isolated rat hepatocytes and low passage hepatic epithelial stem-like cells (WB-F344). Telomerase activity displayed significant variations in a propagable clone of WB-F344 cells. At low passage levels after establishment in vitro (passages 4-9) non-tumorigenic WB-F344 cells expressed telomerase activity. During further in vitro passaging these cells lost expression of telomerase. Expression of telomerase in the tumor-derived lines of WB-F344 cells but not in the selectively cycled, parental lineages of these cells suggests that there may be a role for telomerase in hepatocarcinogenesis.
C1 UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599.
   UNIV N CAROLINA,DEPT PATHOL & LAB MED,CHAPEL HILL,NC 27599.
   UNIV N CAROLINA,CURRICULUM TOXICOL,CHAPEL HILL,NC 27599.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill
FU NCI NIH HHS [CA 59495, CA 59486, CA 64340] Funding Source: Medline
CR BACCHETTI S, 1995, INT J ONCOL, V7, P423
   BIESSMANN H, 1992, ADV GENET, V30, P185, DOI 10.1016/S0065-2660(08)60321-1
   BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492
   BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082
   Broccoli D, 1996, MOL CELL BIOL, V16, P3765
   BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x
   CAYAMA E, 1978, NATURE, V275, P60, DOI 10.1038/275060a0
   CHADENEAU C, 1995, ONCOGENE, V11, P893
   CHIAO C, 1995, AM J PATHOL, V146, P1248
   COLEMAN WB, 1993, AM J PATHOL, V142, P1373
   COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   Gilley D, 1996, MOL CELL BIOL, V16, P66
   Greaves M, 1996, TRENDS GENET, V12, P127, DOI 10.1016/0168-9525(96)30016-4
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   GRISHAM JW, 1993, P SOC EXP BIOL MED, V204, P270
   HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476
   HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HEALY KC, 1995, ONCOL RES, V7, P121
   HUFF J, 1991, ENVIRON HEALTH PERSP, V93, P247, DOI 10.2307/3431195
   Kaufmann WK, 1996, FASEB J, V10, P238, DOI 10.1096/fasebj.10.2.8641557
   KAUFMANN WK, 1981, CANCER RES, V41, P4653
   KAUFMANN WK, 1986, CARCINOGENESIS, V7, P669, DOI 10.1093/carcin/7.4.669
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201
   Kyo S, 1997, CANCER RES, V57, P610
   LEE LW, 1989, AM J PATHOL, V135, P63
   LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K
   MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P
   McClintock B, 1941, GENETICS, V26, P234
   OLOVNIKOV A M, 1971, Doklady Biochemistry, V201, P394
   PROWSE K, 1995, P NATL ACAD SCI USA, V201, P4818
   Shay JW, 1996, TRENDS GENET, V12, P129, DOI 10.1016/0168-9525(96)30018-8
   SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955
   Strahl C, 1996, MOL CELL BIOL, V16, P53
   TAHARA H, 1995, CANCER RES, V55, P2734
   TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9
   WANG SS, 1990, NATURE, V345, P456, DOI 10.1038/345456a0
   Yoshimi N, 1996, MOL CARCINOGEN, V16, P1, DOI 10.1002/(SICI)1098-2744(199605)16:1<1::AID-MC1>3.0.CO;2-N
   ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601
   ZHANG Y, 1995, LIVER REGENERATION C, P179
NR 45
TC 19
Z9 20
U1 0
U2 0
PU STOCKTON PRESS
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS
SN 0950-9232
J9 ONCOGENE
JI Oncogene
PD SEP 4
PY 1997
VL 15
IS 10
BP 1233
EP 1240
DI 10.1038/sj.onc.1201278
PG 8
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA XU991
UT WOS:A1997XU99100013
PM 9294617
DA 2024-02-19
ER

PT J
AU Leontieva, OV
   Paszkiewicz, GM
   Blagosklonny, MV
AF Leontieva, Olga V.
   Paszkiewicz, Geraldine M.
   Blagosklonny, Mikhail V.
TI Fasting levels of hepatic p-S6 are increased in old mice
SO CELL CYCLE
LA English
DT Article
DE aging; mTOR; rapalogs; rapamycin; senescence
ID EXTENDS LIFE-SPAN; GENETICALLY HETEROGENEOUS MICE; CELL-CYCLE ARREST;
   CALORIC RESTRICTION; DIETARY RESTRICTION; MAMMALIAN TARGET;
   GROWTH-CONTROL; RAPAMYCIN; SENESCENCE; MTOR
AB TOR is involved in aging in a wide range of species from yeast to mammals. Here we show that, after overnight fasting, mTOR activity is higher in the livers of 28 months old female mice compared with middle-aged mice. Taken together with previous reports, our data predict that the life-extending effect of calorie restriction (CR) may be diminished, if CR is started in very old age. In contrast, rapamycin is known to be effective, even when started late in life.
C1 [Leontieva, Olga V.; Paszkiewicz, Geraldine M.; Blagosklonny, Mikhail V.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA.
C3 Roswell Park Comprehensive Cancer Center
RP Blagosklonny, MV (corresponding author), Roswell Pk Canc Inst, Buffalo, NY 14263 USA.
EM Blagosklonny@oncotarget.com
CR Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486
   Blagosklonny MV, 2012, AM J PATHOL, V181, P1142, DOI 10.1016/j.ajpath.2012.06.024
   Blagosklonny MV, 2012, AGING-US, V4, P159, DOI 10.18632/aging.100443
   Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766
   Blagosklonny MV, 2009, CELL CYCLE, V8, P4055, DOI 10.4161/cc.8.24.10310
   Blagosklonny MV, 2009, AGING-US, V1, P357, DOI 10.18632/aging.100040
   Blagosklonny MV, 2009, CELL CYCLE, V8, P1883, DOI 10.4161/cc.8.12.8815
   Cava E, 2013, AGING-US, V5, P507, DOI 10.18632/aging.100581
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   Cho S, 2012, MOL CELLS, V33, P597, DOI 10.1007/s10059-012-0042-1
   D'Antona G, 2010, INTERD T GERONT GERI, V37, P115, DOI 10.1159/000319998
   Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107
   Dulic Vjekoslav, 2013, Methods Mol Biol, V965, P15, DOI 10.1007/978-1-62703-239-1_2
   Emran S, 2014, AGING-US, V6, P390, DOI 10.18632/aging.100665
   Fok WC, 2013, PLOS ONE, V9
   Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11
   Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Hinojosa CA, 2012, EXP GERONTOL, V47, P958, DOI 10.1016/j.exger.2012.08.013
   Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kaeberlein Matt, 2013, F1000Prime Rep, V5, P5, DOI 10.12703/P5-5
   Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x
   Kaeberlein M, 2009, NATURE, V460, P331, DOI 10.1038/460331a
   Kolesnichenko M, 2012, CELL CYCLE, V11, P2391, DOI 10.4161/cc.20683
   Leontieva OV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.178
   Leontieva OV, 2013, CELL DEATH DIFFER, V20, P1241, DOI 10.1038/cdd.2013.86
   Leontieva OV, 2014, AGING CELL, V13, P616, DOI 10.1111/acel.12211
   Leontieva OV, 2014, P NATL ACAD SCI USA, V111, P8832, DOI 10.1073/pnas.1405723111
   Leontieva OV, 2014, CELL CYCLE, V13, P509, DOI 10.4161/cc.27973
   Leontieva OV, 2013, CELL CYCLE, V12, P3063, DOI 10.4161/cc.26130
   Leontieva OV, 2012, AGING-US, V4, P899, DOI 10.18632/aging.100528
   Leontieva OV, 2012, P NATL ACAD SCI USA, V109, P13314, DOI 10.1073/pnas.1205690109
   Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363
   Mehta R, 2010, ADV EXP MED BIOL, V694, P14
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x
   Popovich IG, 2014, CANCER BIOL THER, V15, P586, DOI 10.4161/cbt.28164
   Pospelova TV, 2009, CELL CYCLE, V8, P4112, DOI 10.4161/cc.8.24.10215
   Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802
   Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9
   Selman C, 2012, CELL CYCLE, V11, P17, DOI 10.4161/cc.11.1.18736
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026
   Serrano M, 2012, CELL CYCLE, V11, P2231, DOI 10.4161/cc.21065
   Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078
   Spong A, 2012, CELL CYCLE, V11, P845, DOI 10.4161/cc.11.5.19607
   Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Zhang YQ, 2014, J GERONTOL A-BIOL, V69, P119, DOI 10.1093/gerona/glt056
NR 57
TC 17
Z9 19
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD SEP 1
PY 2014
VL 13
IS 17
BP 2656
EP 2659
DI 10.4161/15384101.2014.949150
PG 4
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA AZ6JE
UT WOS:000348325300009
PM 25486351
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Kakarla, P
   Vadluri, G
   Kesireddy, SR
AF Kakarla, P
   Vadluri, G
   Kesireddy, SR
TI Response of hepatic antioxidant system to exercise training in aging
   female rat
SO JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL AND INTEGRATIVE
   PHYSIOLOGY
LA English
DT Article
ID INDUCED OXIDATIVE STRESS; GLUTATHIONE-REDUCTASE; LIPID-PEROXIDATION;
   ENZYMES; AGE; CATALASE; INJURY; LIVER; HEART
AB This study was undertaken to investigate the effect of exercise training on aging in the hepatic oxidative status and antioxidant defense of female albino rat. Two age groups of 3 months and 12 months old Wistar strain female albino rats were given chronic exercise training for a period of 12 weeks. The antioxidant enzyme assays were carried out by the standard methods. Lower (P <0.01) activities of the antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) and glutathione reductase (GR) by 21%, 44% and 63% respectively was observed in the older rats when compared to younger rats. Also, glutathione (GSH) levels were 42% lower (P <0.01) in older than younger animals. Exercise training to the 12 months aged rats significantly (P <0.01) elevated these antioxidant enzyme activities and GSH content, when compared to older control rats. These levels are almost equal to the values observed in the younger control rats. The levels of lipid peroxidation end product, malondialdehyde (MDA) the major indicator of oxidative stress, was found to increase with age (11%) and exercise training caused further elevation (28% of control). The present findings imply that the reactive oxygen species that are generated due to aging process were detoxified by the exercise induced antioxidant system in the liver tissue. These findings are also in agreement with similar changes in male animals, which clearly envisage no gender difference in the amelioration of the antioxidant enzyme system in older age due to exercise. In conclusion, it can be stated that twelve weeks treadmill exercise training has beneficial effect in improving antioxidant defense capacity by augmenting SOD, CAT and GR activities and GSH levels of older rats, thereby preventing oxidative damage to the liver tissue. (C) 2005 Wiley-Liss, Inc.
C1 Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India.
C3 Sri Venkateswara University
RP Kesireddy, SR (corresponding author), Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India.
EM sathyakreddy@rediffmail.com
CR ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010
   BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8
   BRUCE AF, 1982, LAB INVEST, V47, P412
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   CHANCE B, 1979, PHYSIOL REV, V59, P72
   CHANCE B, 1955, METHODS ENZYMOL PHYS, V59, P527
   Chevion S, 2003, P NATL ACAD SCI USA, V100, P5119, DOI 10.1073/pnas.0831097100
   CHOUDHARY AK, 1994, SCIENCE, V265, P1580
   EVELO CTA, 1992, EUR J APPL PHYSIOL O, V64, P354, DOI 10.1007/BF00636224
   FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051
   Ginsburg GS, 2001, CLIN CHIM ACTA, V305, P131, DOI 10.1016/S0009-8981(00)00427-7
   GUOHUA C, 1995, ARCH BIOCH BIOPHY, V320, P195
   Hiroshi O, 1979, ANAL BIOCHEM, V95, P351
   Husain K, 2002, MOL CELL BIOCHEM, V231, P129, DOI 10.1023/A:1014416915643
   Husain K, 2002, BBA-MOL BASIS DIS, V1587, P75, DOI 10.1016/S0925-4439(02)00070-4
   Husain K., 1997, PATHOPHYSIOLOGY, V4, P69
   Jang IS, 2001, MECH AGEING DEV, V122, P561, DOI 10.1016/S0047-6374(01)00236-6
   Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x
   Ji LL, 2001, ANN NY ACAD SCI, V928, P236
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   JI LL, 1992, J APPL PHYSIOL, V73, P1854, DOI 10.1152/jappl.1992.73.5.1854
   KHAJURIA A, 1997, EVERYMANS SCI, V3, P109
   KONO Y, 1982, J BIOL CHEM, V257, P5751
   LEW H, 1991, EUR J DRUG METAB PH, V16, P21
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   Meijer EP, 2002, J AM GERIATR SOC, V50, P349, DOI 10.1046/j.1532-5415.2002.50069.x
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   NELSON DL, 2001, LEHNINGER PRINCIPLES, P873
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   Schröder H, 2001, EUR J NUTR, V40, P178, DOI 10.1007/s003940170006
   SEMESEI I, 1991, MECH AGEING DEV, V58, P13
   SOHAL RS, 1987, REV BIOL RES AGING, V3, P385
   Somani Satu M., 1995, Indian Journal of Physiology and Pharmacology, V39, P323
   Somani Satu M., 1996, Indian Journal of Physiology and Pharmacology, V40, P205
   SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V51, P627, DOI 10.1016/0091-3057(94)00427-K
   SOMANI SM, 1997, OXIDANTS ANTIOXIDANT, P125
   Sriram KI, 2001, CURR SCI INDIA, V80, P921
   THEODORUS P, 1981, METHOD ENZYMOL, V77, P373
   Toshinai K, 1997, RES COMMUN MOL PATH, V95, P259
   VENKATAIAH A, 1995, THESIS S V U TIRUPAT
   Yu BP, 1993, FREE RADICALS AGING
NR 42
TC 44
Z9 54
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2471-5646
J9 J EXP ZOOL PART A
JI J. Exp. Zool. Part A-Ecol. Integr. Physiol.
PD MAR 1
PY 2005
VL 303A
IS 3
BP 203
EP 208
DI 10.1002/jez.a.149
PG 6
WC Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Zoology
GA 902QY
UT WOS:000227372800004
PM 15726629
DA 2024-02-19
ER

PT J
AU Meng, SS
   Gu, HW
   Zhang, T
   Li, YS
   Tang, HB
AF Meng, Sha-Sha
   Gu, Hong-Wei
   Zhang, Ting
   Li, Yu-Sang
   Tang, He-Bin
TI Gradual deterioration of fatty liver disease to liver cancer <i>via</i>
   inhibition of AMPK signaling pathways involved in energy-dependent
   disorders, cellular aging, and chronic inflammation
SO FRONTIERS IN ONCOLOGY
LA English
DT Article
DE fatty Liver; AMPK; inflammation; hypoxia; aging; tumor microenvironment;
   liver cancer
ID SENESCENCE; KINASE; GLUCOSE
AB IntroductionHepatocellular carcinoma (HCC) is the most prevalent primary liver cancer kind. According to recent research, a fatty liver increases the risk of hepatocellular cancer. Nevertheless, the AMPK signaling pathway is crucial. In addition, 5'-AMP-activated protein kinase (AMPK) is strongly linked to alterations in the tumor microenvironment, such as inflammation, hypoxia, and aging. The objective of this study is to evaluate the impact of the AMPK signaling pathway on the progression of fatty liver to HCC. MethodsIn this study, we established a mouse liver cancer model using high-fat diets and nano-nitrosamines (nano-DEN). In addition, we employed a transcriptomic technique to identify all mRNAs detected in liver samples at the 25th weekexpression of proteins linked with the LKB1-AMPK-mTOR signaling pathway, inflammation, aging, and hypoxia was studied in microarrays of liver cancer tissues from mice and humans. These proteins included p-AMPK, LKB1, mTOR, COX-2, beta-catenin, HMGB1, p16, and HIF-1 alpha. ResultsData were collected at different times in the liver as well as in cancerous and paracancerous regions and analyzed by a multispectral imaging system. The results showed that most of the genes in the AMPK signaling pathway were downregulated. Prakk1 expression was upregulated compared to control group but downregulated in the cancerous regions compared to the paracancerous regions. Stk11 expression was downregulated in the cancerous regions. Mtor expression was upregulated in the cancerous regions. During liver cancer formation, deletion of LKB1 in the LKB1-AMPK-mTOR signaling pathway reduces phosphorylation of AMPK. It contributed to the upregulation of mTOR, which further led to the upregulation of HIF1 alpha. In addition, the expression of beta-catenin, COX-2, and HMGB1 were upregulated, as well as the expression of p16 was downregulated. DiscussionThese findings suggest that changes in the AMPK signaling pathway exacerbate the deterioration of disrupted energy metabolism, chronic inflammation, hypoxia, and cellular aging in the tumor microenvironment, promoting the development of fatty liver into liver cancer.
C1 [Meng, Sha-Sha; Zhang, Ting; Li, Yu-Sang; Tang, He-Bin] South Cent Minzu Univ, Sch Pharmaceut Sci, Lab Hepatopharmacol & Ethnopharmacol, Wuhan, Peoples R China.
   [Gu, Hong-Wei] Wuhan Mental Hlth Ctr, Dept Pharm, Wuhan, Peoples R China.
C3 South Central Minzu University
RP Li, YS; Tang, HB (corresponding author), South Cent Minzu Univ, Sch Pharmaceut Sci, Lab Hepatopharmacol & Ethnopharmacol, Wuhan, Peoples R China.
EM liys2006@mail.scuec.edu.cn; hbtang2006@mail.scuec.edu.cn
RI LI, XIAO/JCE-6169-2023; zhou, yang/JED-3951-2023; zheng,
   yan/JKJ-3632-2023; cheng, chen/JHS-9462-2023
FU National Natural Science Foundation of China [82174110, 81673711,
   81573887]
FX Funding This work was supported by the National Natural Science
   Foundation of China (82174110, 81673711 and 81573887).
CR Bi L, 2021, CANCER RES, V81, P2015, DOI 10.1158/0008-5472.CAN-20-3044
   Delgado TC, 2019, J HEPATOCELL CARCINO, V6, P85, DOI 10.2147/JHC.S169585
   Cataldo I, 2021, PATHOLOGICA, V113, P194, DOI 10.32074/1591-951X-242
   Chen Fengzhen, 2020, Yichuan, V42, P799, DOI 10.16288/j.yczz.20-080
   Chen XZ, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/6934809
   Chen YC, 2022, J EXP CLIN CANC RES, V41, DOI 10.1186/s13046-022-02252-1
   Chyau CC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010360
   Ciccarese F, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8730816
   Fang CQ, 2022, FRONT PHYSIOL, V13, DOI 10.3389/fphys.2022.970292
   Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001
   Greten TF, 2017, HEPAT ONCOL, V4, P123, DOI 10.2217/hep-2017-0011
   Guo XQ, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa055
   He S, 2020, BIOMED PHARMACOTHER, V132, DOI 10.1016/j.biopha.2020.110851
   Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6
   Jung TY, 2020, EXP MOL MED, V52, P1831, DOI 10.1038/s12276-020-00525-3
   Kottakis F, 2012, CELL RES, V22, P1617, DOI 10.1038/cr.2012.108
   Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06
   LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350
   Li XJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01487
   Li YS, 2016, TOXICOL RES-UK, V5, P210, DOI 10.1039/c5tx00317b
   Liang XY, 2014, MOL MED REP, V9, P1019, DOI 10.3892/mmr.2014.1916
   Liang XY, 2010, CANCER BIOL THER, V9, P156, DOI 10.4161/cbt.9.2.10452
   Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009
   Liu G, 2019, FASEB J, V33, P10089, DOI 10.1096/fj.201802619RR
   Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832
   Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008
   Matter MS, 2016, HEPATOLOGY, V63, P1888, DOI 10.1002/hep.28487
   Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031
   Moldogazieva NT, 2020, CANCERS, V12, DOI 10.3390/cancers12040862
   Park SY, 2019, ONCOL LETT, V17, P2695, DOI 10.3892/ol.2019.9892
   Park SY, 2016, ONCOL REP, V35, P1566, DOI 10.3892/or.2015.4519
   Powell EE, 2021, LANCET, V397, P2212, DOI 10.1016/S0140-6736(20)32511-3
   Qin QF, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01247
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Seo J, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01367-5
   Serra S, 2018, J CLIN PATHOL, V71, P853, DOI 10.1136/jclinpath-2018-205216
   Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100
   Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016
   Sung H., 2021, CA Cancer J. Clin, V71, P209, DOI DOI 10.3322/caac.21660
   Wang G, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2509-x
   Wang H, 2021, CELL MOL IMMUNOL, V18, P73, DOI 10.1038/s41423-020-00579-3
   Wang MJ, 2021, J HEPATOCELL CARCINO, V8, P685, DOI 10.2147/JHC.S296234
   Wang Q, 2018, BIOL PHARM BULL, V41, P985, DOI 10.1248/bpb.b17-00724
   Wang ZH, 2021, EBIOMEDICINE, V73, DOI 10.1016/j.ebiom.2021.103627
   Wen Y, 2019, ONCOGENE, V38, P1845, DOI 10.1038/s41388-018-0552-1
   Xu CR, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI154515
   Xu C, 2021, MOL CANCER RES, V19, P1441, DOI 10.1158/1541-7786.MCR-21-0027
   Yang HR, 2021, INT J BIOL SCI, V17, P4207, DOI 10.7150/ijbs.64714
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang BH, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02492-9
   Zhang T, 2022, J ETHNOPHARMACOL, V285, DOI 10.1016/j.jep.2021.114917
NR 51
TC 3
Z9 3
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2234-943X
J9 FRONT ONCOL
JI Front. Oncol.
PD MAR 2
PY 2023
VL 13
AR 1099624
DI 10.3389/fonc.2023.1099624
PG 13
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 9W5UA
UT WOS:000949141800001
PM 36937390
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Factor, VM
   Jensen, MR
   Thorgeirsson, SS
AF Factor, VM
   Jensen, MR
   Thorgeirsson, SS
TI Coexpression of c-myc and transforming growth factor alfa in the liver
   promotes early replicative senescence and diminishes regenerative
   capacity after partial hepatectomy in transgenic mice
SO HEPATOLOGY
LA English
DT Article
ID UNSCHEDULED DNA-SYNTHESIS; FACTOR-ALPHA; CELL-CYCLE; MOLECULAR
   MECHANISMS; SIGNAL-TRANSDUCTION; DIETARY RESTRICTION; HEPATOCYTE GROWTH;
   MESSENGER-RNA; MAMMARY-GLAND; FACTOR-BETA
AB We have recently shown that overexpression of c-myc and transforming growth factor alpha (TGF-alpha) in the liver of double-transgenic mice results in severe DNA damage, aberrant hepatic growth, and development of tumors at a much younger age than that observed in c-myc single-transgenic mice. We now report that double-transgenic TGF-alpha/c-myc hepatocytes rapidly lose their ability to proliferate upon mitogenic stimulation following partial hepatectomy (PH). At 4 weeks of age, the overall rate of bromodeoxyuridine (BrdU) incorporation following PH was comparable in c-myc and TGF-alpha/c-myc livers and exceeded that seen in wild-type (WT) mice, However, by 10 weeks of age, c-myc single-transgenic hepatocytes showed proliferative advantages over the WT cells, whereas TGF-alpha/c-myc double-transgenic hepatocytes had a decreased capacity to proliferate upon mitogenic stimulation. This decreased proliferative response was accompanied by a reduction in the total fraction of proliferating hepatocytes, as well as by a decline in the induction of cyclin A, cyclin B, and cdc2 gene expression, These data show that constitutive coexpression of c-myc and TGF-alpha accelerates age-related loss in the regenerative potential following PH, and suggest that early replicative senescence of differentiated hepatocytes may have a role in providing a selective growth advantage to initiated cell populations in this model.
C1 NCI, EXPT CARCINOGENESIS LAB, DBS, NIH, BETHESDA, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI)
RI Jensen, Michael R/E-9677-2011
CR ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294
   ALBRECHT JH, 1993, AM J PHYSIOL, V265, pG857, DOI 10.1152/ajpgi.1993.265.5.G857
   ALEXANDROW MG, 1995, CANCER RES, V55, P1452
   AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J
   AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737
   ANATSKAYA OV, 1994, J THEOR BIOL, V168, P191, DOI 10.1006/jtbi.1994.1098
   ASAKURA S, 1994, MUTAT RES-GENET TOX, V322, P257, DOI 10.1016/0165-1218(94)90101-5
   BARBASON H, 1983, BRIT J CANCER, V47, P517, DOI 10.1038/bjc.1983.82
   Bisgaard HC, 1996, HEPATOLOGY, V23, P62, DOI 10.1053/jhep.1996.v23.pm0008550050
   BRODSKY VY, 1985, GENOME MULTIPLICATIO, P305
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   Campisi Judith, 1996, P121
   Carriere R, 1969, Int Rev Cytol, V25, P201, DOI 10.1016/S0074-7696(08)60204-1
   CHOU MW, 1995, CANCER LETT, V91, P191, DOI 10.1016/0304-3835(95)03750-Q
   CORNELL RP, 1990, HEPATOLOGY, V11, P916, DOI 10.1002/hep.1840110603
   CURTIS HJ, 1963, SCIENCE, V141, P686, DOI 10.1126/science.141.3582.686
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555
   DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034
   EDWARDS JL, 1961, AM J PATHOL, V38, P437
   FABRIKANT JI, 1969, EXP CELL RES, V55, P277, DOI 10.1016/0014-4827(69)90493-5
   FACTOR VM, 1997, P AM ASSOC CANC RES, V38, pA585
   Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831
   FRANCAVILLA A, 1993, J SURG ONCOL, P1
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x
   GERLYNG P, 1992, CARCINOGENESIS, V13, P1795, DOI 10.1093/carcin/13.10.1795
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HIMENO Y, 1992, P NATL ACAD SCI USA, V89, P5497, DOI 10.1073/pnas.89.12.5497
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q
   JIRTLE RL, 1991, DIGEST DIS SCI, V36, P659, DOI 10.1007/BF01297035
   Kao CY, 1996, BIOCHEM BIOPH RES CO, V222, P64, DOI 10.1006/bbrc.1996.0698
   Kaufmann WK, 1996, FASEB J, V10, P238, DOI 10.1096/fasebj.10.2.8641557
   LEE GH, 1992, CANCER RES, V52, P5162
   Liu P, 1997, HEPATOLOGY, V25, P874, DOI 10.1002/hep.510250415
   LOYER P, 1994, J BIOL CHEM, V269, P2491
   Luetteke N C, 1990, Semin Cancer Biol, V1, P265
   MACDONALD RA, 1961, ARCH INTERN MED, V107, P79
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   MEAD JE, 1990, CANCER RES, V50, P7023
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819
   MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293
   MULLAART E, 1990, MUTAT RES, V237, P189, DOI 10.1016/0921-8734(90)90001-8
   MURAKAMI H, 1993, CANCER RES, V53, P1719
   Norwood TH, 1996, EXP GERONTOL, V31, P61, DOI 10.1016/0531-5565(95)02020-9
   OHKUBO Y, 1994, EXP CELL RES, V214, P270, DOI 10.1006/excr.1994.1258
   PENDERGRASS WR, 1993, J CELL PHYSIOL, V156, P96, DOI 10.1002/jcp.1041560114
   RABES HM, 1976, CELL TISSUE KINET, V9, P517
   ROSENBERGER RF, 1991, J THEOR BIOL, V148, P383, DOI 10.1016/S0022-5193(05)80243-7
   Sakata H, 1996, CELL GROWTH DIFFER, V7, P1513
   Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416
   SANDGREN EP, 1995, CANCER RES, V55, P3915
   SANDGREN EP, 1989, ONCOGENE, V4, P715
   SANDGREN EP, 1993, MOL CELL BIOL, V13, P320, DOI 10.1128/MCB.13.1.320
   SantoniRugiu E, 1996, AM J PATHOL, V149, P407
   Sargent LM, 1996, CANCER RES, V56, P2137
   SAWADA N, 1988, CANCER RES, V48, P1618
   SCHWEIZER J, 1980, EUR J BIOCHEM, V112, P243, DOI 10.1111/j.1432-1033.1980.tb07200.x
   SHIOTA G, 1994, HEPATOLOGY, V19, P962, DOI 10.1002/hep.1840190423
   SHIOTA G, 1995, RES COMMUN MOL PATH, V89, P259
   SMITH GH, 1995, AM J PATHOL, V147, P1081
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012
   STOCKER E, 1972, Z ZELLFORSCH MIK ANA, V125, P306, DOI 10.1007/BF00306629
   STOCKER E, 1968, VERH DTSCH GES PATH, V50, P53
   TAKAGI H, 1992, CANCER RES, V52, P5171
   Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340
   TONJES RR, 1995, ONCOGENE, V10, P765
   URYVAEVA IV, 1981, J THEOR BIOL, V89, P557, DOI 10.1016/0022-5193(81)90028-X
   URYVAEVA IV, 1975, SOVIET J DEV BIOL, V6, P396
   WEBBER EM, 1994, AM J PATHOL, V145, P398
   WEBBER EM, 1994, HEPATOLOGY, V19, P489
NR 77
TC 36
Z9 38
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD DEC
PY 1997
VL 26
IS 6
BP 1434
EP 1443
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA YK772
UT WOS:A1997YK77200011
PM 9397983
DA 2024-02-19
ER

PT J
AU Silva, MG
   Nunes, P
   Oliveira, P
   Ferreira, R
   Fardilha, M
   Moreira-Gonçalves, D
   Duarte, JA
   Oliveira, MM
   Peixoto, F
AF Silva, Monica Garcia
   Nunes, Paulo
   Oliveira, Paula
   Ferreira, Rita
   Fardilha, Margarida
   Moreira-Goncalves, Daniel
   Duarte, Jose Alberto
   Oliveira, Maria Manuel
   Peixoto, Francisco
TI Long-Term Aerobic Training Improves Mitochondrial and Antioxidant
   Function in the Liver of Wistar Rats Preventing Hepatic Age-Related
   Function Decline
SO BIOLOGY-BASEL
LA English
DT Article
DE biochemistry; aerobic training; mitochondria; antioxidant enzymes;
   oxidative stress; ageing; liver
ID REDUCES OXIDATIVE STRESS; SKELETAL-MUSCLE; MODERATE EXERCISE;
   PHYSICAL-EXERCISE; ENZYME-ACTIVITY; MAJOR ORGANS; GLUTATHIONE;
   INCREASES; ACID; EXPRESSION
AB Simple Summary This study shows the lifelong benefits of aerobic exercise in preventing early age-related consequences on mitochondrial liver function and antioxidant activity. Although exercise intensity is often cited as crucial for developing adaptive responses in the body, we demonstrated that the duration of the training protocol might be more critical for the adaptive response. Thus, physical exercise prescribers should promote the awareness of physical exercise practitioners about the importance of performing this practice regularly, as the benefits go far beyond those already known in cardiac and skeletal muscle. Most studies on the effects of physical exercise have focused on its influence on muscle tissue, forgetting its interference in liver function. Ageing leads to the progressive impairment of hepatic functions. Several biochemical and bioenergetics parameters were determined to test the impact of a lifelong aerobic training program in the hepatic age-related and the development of an adaptative response. Liver samples were collected from 28 male Wistar rats (4-week-old, 159.4 +/- 11.9 g at the beginning of the protocol), randomly distributed into two groups: non-exercised or exercised and submitted to a treadmill exercise program (60 min/day, 5 days/week, at 70% of maximal running speed), for 24 (n = 9) or 54 weeks (n = 10). A maximal running speed test was performed to determine the training speed. Antioxidant enzyme activity, cellular redox status, oxidative stress, mitochondrial respiratory chain enzymes and respiratory activity were performed in liver samples. Lifelong exercise decreased the age-associated decline in mitochondrial dysfunction, increasing the respiratory rate in state 2 (mitochondrial respiration stimulated by the substrate in the absence of added ADP) (p = 0.03) and citrate synthase enzymatic activity (p = 0.007). Complex II (p < 0.0001) and IV (p < 0.001) showed a decrease in enzymatic activity. Ageing-related oxidative stress was also attenuated by physical exercise, as showed by the increase in first-line defense antioxidant enzymes (superoxide dismutase (p = 0.07) and catalase (p = 0.03)), decreased lipid peroxidation levels (p = 0.864 for total fraction, p = 0,27 for mitochondrial fraction) and higher glutathione reduced/oxidized ratio (p = 0.02). According to our results, the regular practice of exercise can prevent the liver's mitochondrial dysfunction and loss of antioxidant system efficacy that may arise from ageing, highlighting the benefit of lifelong aerobic exercise in preventing age-related hepatic impairment and associated diseases.
C1 [Silva, Monica Garcia; Nunes, Paulo; Oliveira, Maria Manuel] Univ Tras Os Montes & Alto Douro, Ctr Quim Vila Real CQVR, Chem Dept, P-5000801 Vila Real, Portugal.
   [Oliveira, Paula] Univ Tras Os Montes & Alto Douro, Ctr Invest & Tecnol Agroambientais & Biol CITAB, Inst Inovacao Capacitacao & Sustentabilidade Prod, Dept Vet Sci, P-5000801 Vila Real, Portugal.
   [Ferreira, Rita] Univ Aveiro, Dept Chem, Lab Associado Quim Verde Rede Quim & Tecnol LAQV, P-3810193 Aveiro, Portugal.
   [Fardilha, Margarida] Univ Aveiro, Inst Res Biomed, Med Sci Dept, Lab Signal Transduct, P-5000801 Vila Real, Portugal.
   [Moreira-Goncalves, Daniel; Duarte, Jose Alberto] Univ Porto, Fac Sports, Ctr Invest Atividade Fis Saude & Lazer CIAFEL, P-4099002 Porto, Portugal.
   [Peixoto, Francisco] Univ Tras Os Montes & Alto Douro, Ctr Quim Vila Real CQVR, Biol & Environm Dept, P-5000801 Vila Real, Portugal.
C3 University of Tras-os-Montes & Alto Douro; University of Tras-os-Montes
   & Alto Douro; Universidade de Aveiro; Universidade de Aveiro;
   Universidade do Porto; University of Tras-os-Montes & Alto Douro
RP Oliveira, MM (corresponding author), Univ Tras Os Montes & Alto Douro, Ctr Quim Vila Real CQVR, Chem Dept, P-5000801 Vila Real, Portugal.; Peixoto, F (corresponding author), Univ Tras Os Montes & Alto Douro, Ctr Quim Vila Real CQVR, Biol & Environm Dept, P-5000801 Vila Real, Portugal.
EM mmso@utad.pt; fpeixoto@utad.pt
RI Gonçalves, Daniel/Q-8138-2018; Oliveira, Paula/F-2510-2013; Duarte, Jose
   Alberto/F-1443-2013; Fardilha, Margarida/G-3182-2010; Ferreira,
   Rita/C-4020-2014
OI Gonçalves, Daniel/0000-0002-7404-7405; Oliveira,
   Paula/0000-0001-9519-4044; Duarte, Jose Alberto/0000-0003-4756-5917;
   Fardilha, Margarida/0000-0001-7459-9173; Oliveira,
   Maria/0000-0001-5834-5253; Peixoto, Francisco/0000-0001-9729-7477; G.
   Silva, Monica/0000-0003-0775-4457; Ferreira, Rita/0000-0002-6872-4051
CR Alessio HM, 2000, MED SCI SPORT EXER, V32, P1576
   [Anonymous], 1996, GUIDE CARE USE LAB A
   Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012
   Calbet JAL, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101478
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   Chae CH, 2008, NUTR RES, V28, P399, DOI 10.1016/j.nutres.2008.02.010
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P996, DOI 10.1111/ggi.12192
   Del Valle LG., 2011, BIOMED AGING PATHOL, V1, P1, DOI [DOI 10.1016/J.BIOMAG.2011.03.001, 10.1016/J.BIOMAG.2011.03.001]
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   DELRIO LA, 1977, ANAL BIOCHEM, V80, P409, DOI 10.1016/0003-2697(77)90662-5
   Dominiak K, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020896
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422
   Félix LM, 2017, EUR J PHARMACOL, V803, P48, DOI 10.1016/j.ejphar.2017.03.044
   Finaud J, 2006, SPORTS MED, V36, P327, DOI 10.2165/00007256-200636040-00004
   Fletcher JA, 2014, MED SCI SPORT EXER, V46, P1089, DOI 10.1249/MSS.0000000000000223
   Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001
   Gonçalves IO, 2014, MITOCHONDRION, V15, P40, DOI 10.1016/j.mito.2014.03.012
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Gusdon AM, 2017, EXP GERONTOL, V90, P1, DOI 10.1016/j.exger.2017.01.013
   Han GS, 2013, J PHYS THER SCI, V25, P1317, DOI 10.1589/jpts.25.1317
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Jayakumar T, 2007, EXP GERONTOL, V42, P183, DOI 10.1016/j.exger.2006.10.006
   Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006
   Kacerovsky-Bielesz G, 2009, DIABETES, V58, P1333, DOI 10.2337/db08-1240
   Kakarla P, 2008, FREE RADICAL RES, V42, P428, DOI 10.1080/10715760802069462
   Kvam S, 2016, J AFFECT DISORDERS, V202, P67, DOI 10.1016/j.jad.2016.03.063
   Leek BT, 2001, AM J PHYSIOL-REG I, V280, pR441, DOI 10.1152/ajpregu.2001.280.2.R441
   Lundby C, 2016, EXP PHYSIOL, V101, P17, DOI 10.1113/EP085319
   Mallikarjuna K, 2009, ALCOHOL, V43, P59, DOI 10.1016/j.alcohol.2008.09.003
   MANNERVIK B, 1985, METHOD ENZYMOL, V113, P490
   Marmett B, 2018, REDOX REP, V23, P146, DOI 10.1080/13510002.2018.1475993
   Marosi K, 2012, NEUROSCIENCE, V226, P21, DOI 10.1016/j.neuroscience.2012.09.001
   Marshall RN, 2022, PHYSIOL REP, V10, DOI 10.14814/phy2.15345
   Meng QY, 2007, MECH AGEING DEV, V128, P286, DOI 10.1016/j.mad.2006.12.008
   Merry TL, 2016, FREE RADICAL BIO MED, V98, P123, DOI 10.1016/j.freeradbiomed.2015.11.032
   Nakanishi K, 2021, EXP NEUROL, V337, DOI 10.1016/j.expneurol.2020.113590
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Oh S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43029
   Oliveira AN, 2019, SPORTS MED HLTH SCI, V1, P11, DOI 10.1016/j.smhs.2019.08.008
   Oliveira MM, 2013, J APPL TOXICOL, V33, P434, DOI 10.1002/jat.1763
   OTTOLENGHI A, 1959, ARCH BIOCHEM BIOPHYS, V79, P355, DOI 10.1016/0003-9861(59)90414-X
   PAYA M, 1992, BIOCHEM PHARMACOL, V44, P205, DOI 10.1016/0006-2952(92)90002-Z
   Peake JM, 2015, J APPL PHYSIOL, V119, P172, DOI 10.1152/japplphysiol.01055.2014
   Peixoto F, 2004, TOXICOL IN VITRO, V18, P733, DOI 10.1016/j.tiv.2004.02.009
   Peixoto F, 2002, J BIOCHEM MOL TOXIC, V16, P220, DOI 10.1002/jbt.10042
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009
   Radák Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje
   Radák Z, 2000, ARCH BIOCHEM BIOPHYS, V383, P114, DOI 10.1006/abbi.2000.2042
   Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004
   Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498
   Santos-Alves E, 2015, LIFE SCI, V135, P124, DOI 10.1016/j.lfs.2015.06.007
   Siu PM, 2003, J APPL PHYSIOL, V94, P555, DOI 10.1152/japplphysiol.00821.2002
   Srividhya R, 2009, INT J DEV NEUROSCI, V27, P223, DOI 10.1016/j.ijdevneu.2009.01.003
   Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011
   Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003
   Trefts E, 2015, PROG MOL BIOL TRANSL, V135, P203, DOI 10.1016/bs.pmbts.2015.07.010
   Tzimou A, 2020, BIOGERONTOLOGY, V21, P577, DOI 10.1007/s10522-020-09871-1
   Wiklund P, 2016, J SPORT HEALTH SCI, V5, P151, DOI 10.1016/j.jshs.2016.04.001
   Yoon GA, 2014, NUTR RES PRACT, V8, P618, DOI 10.4162/nrp.2014.8.6.618
NR 63
TC 5
Z9 5
U1 3
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD DEC
PY 2022
VL 11
IS 12
AR 1750
DI 10.3390/biology11121750
PG 18
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 7D4UQ
UT WOS:000900487600001
PM 36552260
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Stacchiotti, A
   Lavazza, A
   Ferroni, M
   Sberveglieri, G
   Bianchi, R
   Rezzani, R
   Rodella, LF
AF Stacchiotti, Alessandra
   Lavazza, Antonio
   Ferroni, Matteo
   Sberveglieri, Giorgio
   Bianchi, Rossella
   Rezzani, Rita
   Rodella, Luigi Fabrizio
TI Effects of aluminium sulphate in the mouse liver: Similarities to the
   aging process
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE liver; aluminium; aging; fibrosis; ultrastructure; microanalysis
ID AGE-RELATED-CHANGES; RAT-LIVER; ALZHEIMERS-DISEASE; OXIDATIVE STRESS;
   IN-VIVO; IRON; MICE; PSEUDOCAPILLARIZATION; EXPRESSION; MORPHOLOGY
AB Aluminium (Al) is a ubiquitous metal that is potentially toxic to the brain. Its effects on other fundamental organs are not completely understood. This morphological in vivo study sought to compare sublethal hepatotoxic changes and Al deposition in adult mice that orally ingested Al sulphate daily for 10 months, in age matched control mice that drank tap water and in senescent mice (24 months old). Livers were examined for collagen deposition using Sirius red and Masson, for iron accumulation using Perls' stain. Light, electron microscopy and morphometry were used to assess fibrosis and vascular changes. Scanning transmission electron microscopy and EDX microanalysis were used to detect in situ elemental Al. Iron deposition, transferrin receptor expression were significantly altered following Al exposure and in the aged liver but were unaffected in age matched control mice. In Al treated mice as in senescent mice, endothelial thickness was increased and porosity was decreased like perisinusoidal actin. Furthermore, Al stimulated the deposition of collagen and laminin, mainly in acinar zones 1 and 3. Pseudocapillarization and periportal laminin in senescent mice were similar to Al treated adult liver. In conclusion, prolonged Al sulphate intake accelerates features of senescence in the adult mice liver. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Stacchiotti, Alessandra; Rezzani, Rita; Rodella, Luigi Fabrizio] Univ Brescia, Dept Biomed Sci & Biotechnol, Div Human Anat, I-25123 Brescia, Italy.
   [Lavazza, Antonio] Ist Zooprofilatt Sperimentale Lombardia & Emilia, I-25124 Brescia, Italy.
   [Ferroni, Matteo; Sberveglieri, Giorgio] Univ Brescia, INFM, CNR, I-25123 Brescia, Italy.
   [Ferroni, Matteo] Univ Brescia, Dept Chem & Phys, I-25123 Brescia, Italy.
   [Bianchi, Rossella] Univ Milan, Dept Human Morphol, I-20133 Milan, Italy.
C3 University of Brescia; IZS Lombardia e Emilia; University of Brescia;
   Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la
   Fisica della Materia (INFM-CNR); University of Brescia; University of
   Milan
RP Stacchiotti, A (corresponding author), Univ Brescia, Dept Biomed Sci & Biotechnol, Div Human Anat, Vle Europa 11, I-25123 Brescia, Italy.
EM stacchio@med.unibs.it
RI Ferroni, Matteo/F-5133-2010; LAVAZZA, ANTONIO/G-8182-2011; Rezzani,
   Rita/E-9528-2010; Ferroni, Matteo/AAK-3021-2021; Stacchiotti,
   Alessandra/AAL-7239-2021; Stacchiotti, Alessandra/E-8706-2010;
   Sberveglieri, Giorgio/A-5030-2010; Stacchiotti,
   Alessandra/AAA-2193-2019; Rodella, Luigi Fabrizio/F-1079-2010
OI Ferroni, Matteo/0000-0002-4231-9162; LAVAZZA,
   ANTONIO/0000-0002-7646-3592; Ferroni, Matteo/0000-0002-4231-9162;
   Sberveglieri, Giorgio/0000-0003-0080-8117; Rodella, Luigi
   Fabrizio/0000-0002-9497-4708; stacchiotti,
   alessandra/0000-0002-6767-6617
CR Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Cogger VC, 2001, PHARMACOL TOXICOL, V89, P306, DOI 10.1034/j.1600-0773.2001.d01-165.x
   Deloncle R, 2001, EXP GERONTOL, V36, P231, DOI 10.1016/S0531-5565(00)00214-X
   DEVOTO E, 1994, ENVIRON HEALTH PERSP, V102, P940, DOI 10.2307/3431916
   Exley C, 2004, FREE RADICAL BIO MED, V36, P380, DOI 10.1016/j.freeradbiomed.2003.11.017
   Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2
   Gonzalez MA, 2007, BIOL TRACE ELEM RES, V116, P329, DOI 10.1007/BF02698017
   Hermenegildo C, 1999, NEUROCHEM INT, V34, P245, DOI 10.1016/S0197-0186(99)00010-8
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Kametani K, 2006, MED MOL MORPHOL, V39, P97, DOI 10.1007/s00795-006-0316-9
   Kim Y, 2007, TOXICOL APPL PHARM, V220, P349, DOI 10.1016/j.taap.2007.02.001
   Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001
   Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Miu AC, 2004, J ALZHEIMERS DIS, V6, P315
   Nayak P, 2002, ENVIRON RES, V89, P101, DOI 10.1006/enrs.2002.4352
   Ohtsuki Y, 2008, HISTOL HISTOPATHOL, V23, P137, DOI 10.14670/HH-23.137
   Pérez G, 2005, BBA-MOL CELL RES, V1745, P124, DOI 10.1016/j.bbamcr.2004.12.002
   Platt B, 2006, J ALZHEIMERS DIS, V10, P203
   Rimon E, 2002, ARCH INTERN MED, V162, P445, DOI 10.1001/archinte.162.4.445
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   SCIOT R, 1990, HEPATOLOGY, V11, P416, DOI 10.1002/hep.1840110313
   Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006
   Senoo Haruki, 2004, Medical Electron Microscopy, V37, P3, DOI 10.1007/s00795-003-0230-3
   Stacchiotti A, 2006, HISTOL HISTOPATHOL, V21, P131, DOI 10.14670/HH-21.131
   Stacchiotti A, 2006, J HISTOCHEM CYTOCHEM, V54, P1149, DOI 10.1369/jhc.6A6932.2006
   Turgut G, 2004, YONSEI MED J, V45, P135, DOI 10.3349/ymj.2004.45.1.135
   Vieira VLP, 2000, TOXICOL LETT, V117, P45, DOI 10.1016/S0378-4274(00)00233-2
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   Walton JR, 2007, NEUROSCI LETT, V412, P29, DOI 10.1016/j.neulet.2006.08.093
   Ward RJ, 2001, J INORG BIOCHEM, V87, P9, DOI 10.1016/S0162-0134(01)00308-7
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
NR 36
TC 16
Z9 16
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2008
VL 43
IS 4
BP 330
EP 338
DI 10.1016/j.exger.2008.01.009
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 292KS
UT WOS:000255265500009
PM 18337038
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Chen, JN
   Wei, Y
   Chen, XY
   Jiao, JJ
   Zhang, Y
AF Chen, Jingnan
   Wei, Yan
   Chen, Xinyu
   Jiao, Jingjing
   Zhang, Yu
TI Polyunsaturated fatty acids ameliorate aging <i>via</i>
   redox-telomere-antioncogene axis
SO ONCOTARGET
LA English
DT Article
DE polyunsaturated fatty acids; anti-aging; redox; telomere protection;
   antioncogene; Gerotarget
ID OXIDATIVE STRESS; FISH-OIL; DOCOSAHEXAENOIC ACID; CELLULAR SENESCENCE;
   PROTEIN EXPRESSION; MESSENGER-RNA; CANCER-CELLS; D-GALACTOSE; LIFE-SPAN;
   MICE
AB Polyunsaturated fatty acids (PUFA), a group of nourishing and health-promoting nutrients, ameliorate age-related chronic diseases. However, how PUFA especially n-3 PUFA exert anti-aging functions remains poorly understood. Here we link fish oil, docosahexaenoic acid (DHA) and arachidonic acid (AA) to the aging etiology via a redox-telomere-antioncogene axis based on D-galactose-induced aging mice. Both fish oil and PUFA enhanced hepatic superoxide dismutase (SOD) and catalase activities and cardiac SOD activities within the range of 18%-46%, 26%-65% and 19%-58%, respectively, whereas reduced cerebral monoamine oxidase activity, plasma F-2-isoprostane level and cerebral lipid peroxidation level by 56%-90%, 20%-79% and 16%-54%, respectively. Thus, PUFA improve the in vivo redox and oxidative stress induced aging process, which however does not exhibit a dose-dependent manner. Notably, both PUFA and fish oil effectively inactivated testicular telomerase and inhibited c-Myc-mediated telomerase reverse transcriptase expression, whereas n-3 PUFA rather than n-6 PUFA protected liver and testes against telomere shortening within the range of 13%-25% and 25%-27%, respectively. Therefore, n-3 PUFA may be better at inhibiting the DNA damage induced aging process. Surprisingly, only DHA significantly suppressed cellular senescence pathway evidenced by testicular antioncogene p16 and p53 expression. This work provides evident support for the crosstalk between PUFA especially n-3 PUFA and the aging process via maintaining the in vivo redox homeostasis, rescuing age-related telomere attrition and down-regulating the antioncogene expression.
C1 [Chen, Jingnan; Wei, Yan; Chen, Xinyu; Zhang, Yu] Zhejiang Univ, Dept Food Sci & Nutr, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.
   [Jiao, Jingjing] Zhejiang Univ, Sch Publ Hlth, Dept Nutr, Sch Med, Hangzhou, Zhejiang, Peoples R China.
C3 Zhejiang University; Zhejiang University
RP Zhang, Y (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.; Jiao, JJ (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Nutr, Sch Med, Hangzhou, Zhejiang, Peoples R China.
EM jingjingjiao@zju.edu.cn; y_zhang@zju.edu.cn
RI chen, xinyu/HNR-2708-2023
FU National Natural Science Foundation of China [31401659, 31201307];
   Zhejiang Provincial Natural Science Foundation of China [LY14C200008]
FX We gratefully thank the financial support from the National Natural
   Science Foundation of China (Grant No. 31401659 and 31201307) and the
   Zhejiang Provincial Natural Science Foundation of China (Grant No.
   LY14C200008).
CR Aubert G, 2014, PROG MOL BIOL TRANSL, V125, P89, DOI 10.1016/B978-0-12-397898-1.00004-9
   de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866
   Bhatia B, 2008, J BIOL CHEM, V283, P27957, DOI 10.1074/jbc.M803467200
   Bhattacharya A, 2007, J NUTR BIOCHEM, V18, P372, DOI 10.1016/j.jnutbio.2006.07.002
   Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389
   Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598
   Borghetti G, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0098-y
   Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002
   Budni J, 2016, BEHAV BRAIN RES, V302, P35, DOI 10.1016/j.bbr.2015.12.041
   Calviello G, 2006, CURR SIGNAL TRANSD T, V1, P255, DOI 10.2174/157436206778226923
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952
   Dasilva G, 2015, J NUTR BIOCHEM, V26, P1385, DOI 10.1016/j.jnutbio.2015.07.007
   Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039
   Eitsuka T, 2004, BIOFACTORS, V21, P19, DOI 10.1002/biof.552210105
   Fan C, 2008, BBA-MOL BASIS DIS, V1782, P642, DOI 10.1016/j.bbadis.2008.08.009
   Fan CN, 2013, CURR OPIN CLIN NUTR, V16, P124, DOI 10.1097/MCO.0b013e32835c02c8
   Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008
   Franke C, 2010, BRIT J NUTR, V103, P1648, DOI 10.1017/S0007114509993746
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Ghasemifard S, 2014, PROG LIPID RES, V56, P92, DOI 10.1016/j.plipres.2014.09.001
   Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x
   Halade GV, 2013, EXP BIOL MED, V238, P610, DOI 10.1177/1535370213489485
   Harada H, 2003, MOL CANCER RES, V1, P729
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658
   Kiecolt-Glaser JK, 2013, BRAIN BEHAV IMMUN, V28, P16, DOI 10.1016/j.bbi.2012.09.004
   LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350
   Li YJ, 2016, ONCOTARGET, V7, P17393, DOI 10.18632/oncotarget.8165
   Liu DP, 2011, ANTIOXID REDOX SIGN, V15, P1669, DOI 10.1089/ars.2010.3644
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mallajosyula JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001616
   Manzhulo IV, 2015, ACTA HISTOCHEM, V117, P659, DOI 10.1016/j.acthis.2015.07.001
   McLaughlin-Drubin ME, 2013, P NATL ACAD SCI USA, V110, P16175, DOI 10.1073/pnas.1310432110
   Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev
   O'Callaghan N, 2014, NUTRITION, V30, P489, DOI 10.1016/j.nut.2013.09.013
   Park H, 2016, ONCOTARGET, V7, P9634, DOI 10.18632/oncotarget.7457
   Perales S, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-70
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Saada HN, 2014, INT J RADIAT BIOL, V90, P1179, DOI 10.3109/09553002.2014.934928
   Sanchez JR, 2015, EXP GERONTOL, V71, P27, DOI 10.1016/j.exger.2015.08.017
   Sommerfeld HJ, 1996, CANCER RES, V56, P218
   Sun XH, 2014, BIOTECHNOL APPL BIOC, V61, P691, DOI 10.1002/bab.1219
   Suram A, 2014, AGING CELL, V13, P780, DOI 10.1111/acel.12246
   Tang X, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-70
   Ubeda N, 2012, BRIT J NUTR, V107, pS137, DOI 10.1017/S0007114512001535
   VENKATRAMAN JT, 1994, LIPIDS, V29, P561, DOI 10.1007/BF02536628
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035
   Wan XH, 2016, NUTR CANCER, V68, P320, DOI 10.1080/01635581.2016.1142581
   Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010
   Yamagata K, 2016, PROSTAG LEUKOTR ESS, V104, P11, DOI 10.1016/j.plefa.2015.10.006
   Yessoufou A, 2006, INT J OBESITY, V30, P739, DOI 10.1038/sj.ijo.0803211
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Yokoyama Y, 2000, BIOCHEM BIOPH RES CO, V273, P316, DOI 10.1006/bbrc.2000.2939
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
NR 56
TC 25
Z9 28
U1 1
U2 28
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD JAN 31
PY 2017
VL 8
IS 5
BP 7301
EP 7314
DI 10.18632/oncotarget.14236
PG 14
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA EJ5YP
UT WOS:000393295500014
PM 28038469
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Miyazaki, M
   Gohda, E
   Kaji, K
   Namba, M
AF Miyazaki, M
   Gohda, E
   Kaji, K
   Namba, M
TI Increased hepatocyte growth factor production by aging human fibroblasts
   mainly due to autocrine stimulation by interleukin-1
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID MESSENGER-RNA; CELL-LINE; EXPRESSION; CULTURE; GENE; RECEPTOR; CLONING;
   ALPHA; WAF1
AB Hepatocyte growth factor (HGF), also known as scatter factor is a pleiotropic factor that is mainly produced by mesenchymal cells and acts on cells of epithelial origin which express the HGF receptor c-Met. Here we demonstrate that production of HGF by human embryonic lung fibroblasts increased sharply after about 70% completion of their lifespan in culture, which is regulated at the transcriptional level. In addition, human skin fibroblasts from old donors, over 80 years, also produced more HGF than cells from young and middle-aged donors. The increased production of HGF by aging fibroblasts from human embryonic lung tissue is mainly due to autocrine stimulation by interleukin-1. (C) 1998 Academic Press.
C1 Okayama Univ, Sch Med, Dept Cell Biol, Inst Mol & Cellular Biol, Okayama 7008558, Japan.
   Okayama Univ, Fac Pharmaceut Sci, Dept Immunochem, Okayama 7008530, Japan.
   Univ Shizuoka, Grad Sch Nutr & Environm Sci, Dept Food Sci & Nutr, Lab Cellular & Mol Biol Aging, Shizuoka 4228529, Japan.
C3 Okayama University; Okayama University; University of Shizuoka
RP Miyazaki, M (corresponding author), Okayama Univ, Sch Med, Dept Cell Biol, Inst Mol & Cellular Biol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
RI Gohda, Eiichi/B-1629-2011
CR BOCCACCIO C, 1994, J BIOL CHEM, V269, P12846
   COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0
   COZZOLINO F, 1990, P NATL ACAD SCI USA, V87, P6487, DOI 10.1073/pnas.87.17.6487
   DEJUAN C, 1994, BIOCHEM BIOPH RES CO, V204, P1364, DOI 10.1006/bbrc.1994.2614
   DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   GOHDA E, 1995, LEUKEMIA LYMPHOMA, V19, P197
   GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787
   KUMAR S, 1992, P NATL ACAD SCI USA, V89, P4683, DOI 10.1073/pnas.89.10.4683
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499
   MATSUNAGA T, 1994, EXP CELL RES, V210, P326, DOI 10.1006/excr.1994.1045
   MIYAZAKI M, 1994, EXP CELL RES, V212, P22, DOI 10.1006/excr.1994.1113
   MIYAZAWA K, 1991, EUR J BIOCHEM, V197, P15, DOI 10.1111/j.1432-1033.1991.tb15876.x
   MURANO S, 1991, MOL CELL BIOL, V11, P3905, DOI 10.1128/MCB.11.8.3905
   NISHIDA T, 1987, BIOCHEM BIOPH RES CO, V143, P345, DOI 10.1016/0006-291X(87)90671-1
   OSAWA Y, 1995, BIOCHEM BIOPH RES CO, V216, P429, DOI 10.1006/bbrc.1995.2641
   PALMER JN, 1995, J CLIN INVEST, V95, P2555, DOI 10.1172/JCI117956
   RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5
   TAMURA M, 1993, J BIOL CHEM, V268, P8140
   TSUBOUCHI H, 1991, HEPATOLOGY, V13, P1
   YAMAMOTO K, 1991, EXP GERONTOL, V26, P525, DOI 10.1016/0531-5565(91)90071-S
   ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177
NR 23
TC 15
Z9 15
U1 1
U2 2
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 8
PY 1998
VL 246
IS 1
BP 255
EP 260
DI 10.1006/bbrc.1998.8593
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA ZP868
UT WOS:000073796700046
PM 9600102
DA 2024-02-19
ER

PT J
AU Denk, H
   Pabst, D
   Abuja, PM
   Reihs, R
   Tessaro, B
   Zatloukal, K
   Lackner, C
AF Denk, Helmut
   Pabst, Daniela
   Abuja, Peter M.
   Reihs, Robert
   Tessaro, Brigitte
   Zatloukal, Kurt
   Lackner, Carolin
TI Senescence markers in focal nodular hyperplasia of the liver: pathogenic
   considerations on the basis of immunohistochemical results
SO MODERN PATHOLOGY
LA English
DT Article; Early Access
ID BILE DUCTULAR CELLS; PROGENITOR CELLS; HEPATOCYTES; PROGRESSION;
   EXPRESSION; CHOLANGIOCYTES; CYTOKERATIN-7; PROLIFERATION; EPITHELIUM;
   FIBROSIS
AB Focal nodular hyperplasia (FNH) is a polyclonal tumour-like hepatic lesion characterised by parenchymal nodules, connective tissue septa without interlobular bile ducts, pronounced ductular reaction and inflammation. It may represent a response to local arterial hyperperfusion and hyperoxygenation resulting in oxidative stress. We aimed at obtaining closer insight into the pathogenesis of FNH with its characteristic morphologic features. Immunohistochemistry and immunofluorescence microscopy was performed on FNH specimens using antibodies against keratins (K) 7 and 19, neural cell adhesion molecule (NCAM), lamin B1, senescence markers (CDK inhibitor 1/p21(Cip1), CDK inhibitor /p16(Ink4a), senescence-associated (SA) beta- galactosidase activity), proliferation markers (Ki-67, proliferating-cell nuclear antigen (PCNA)), and the abnormally phosphorylated histone gamma-H2AX, indicating DNA double strand breaks; moreover SA beta- galactosidase activity was determined histochemically. Ductular metaplasia of hepatocytes indicated by K7 expression in the absence of K19 plays a major role in the development of ductular reaction in FNH. Moreover, the expression of senescence markers (p21(Cip1), p16(Ink4a), gamma-H2AX, SA beta-galactosidase activity) in hepatocytes and cholangiocytes suggests that stress-induced cellular senescence contributes to fibrosis and inflammation via production of components of the senescence-associated secretory phenotype. Expression of proliferation markers (Ki-67, PCNA) was not enhanced in hepatocytes and biliary cells. Senescence and ductular metaplasia of hepatocytes may thus be involved in inflammation, fibrosis and apoptosis resistance. Hence, fibrosis, inflammation and reduced apoptotic cell death, rather than proliferation (hyperplasia) may be responsible for increased tissue mass and tumour-like appearance of FNH.
C1 [Denk, Helmut; Pabst, Daniela; Abuja, Peter M.; Reihs, Robert; Tessaro, Brigitte; Zatloukal, Kurt; Lackner, Carolin] Med Univ Graz, Inst Pathol, Diagnost & Res Ctr Mol Biomed, Graz, Austria.
C3 Medical University of Graz
RP Denk, H (corresponding author), Med Univ Graz, Inst Pathol, Diagnost & Res Ctr Mol Biomed, Graz, Austria.
EM helmut.denk@medunigraz.at
OI Zatloukal, Kurt/0000-0001-5299-7218; Abuja, Peter
   Michael/0000-0003-1957-4066
CR Aguilar-Bravo B, 2019, HEPATOLOGY, V69, P2180, DOI 10.1002/hep.30472
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Balabaud C, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/268625
   Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5
   Chiba M, 2011, J CLIN PATHOL, V64, P564, DOI 10.1136/jcp.2011.090175
   Delladetsima I, 2016, HISTOL HISTOPATHOL, V31, P1089, DOI 10.14670/HH-11-738
   Desmet VJ, 2011, VIRCHOWS ARCH, V458, P251, DOI 10.1007/s00428-011-1048-3
   Desmet VJ, 2009, HEPATOLOGY, V50, P333, DOI 10.1002/hep.23152
   Fischer H P, 1995, Verh Dtsch Ges Pathol, V79, P36
   Fischer HP, 2006, PATHOLOGE, V27, P273, DOI 10.1007/s00292-006-0839-9
   FISCHER HP, 1991, VIRCHOWS ARCH B, V60, P373, DOI 10.1007/BF02899569
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Goodman Z. D., 2007, MACSWEENS PATHOLOGY
   Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613
   Guicciardi ME, 2020, HEPATOLOGY, V71, P741, DOI 10.1002/hep.31067
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Ishak K. G., 1999, ATLAS TUMOR PATHOL, P30
   Iyer A, 2008, HUM PATHOL, V39, P1370, DOI 10.1016/j.humpath.2008.01.015
   JORGENSEN M, 1973, ACTA PATH MICRO IM A, VA 81, P663
   Michalopoulos GK, 2002, HEPATOLOGY, V36, P278, DOI 10.1053/jhep.2002.34858
   Nagahama Y, 2014, AM J PATHOL, V184, P3001, DOI 10.1016/j.ajpath.2014.07.005
   Nolte M, 1998, J CLIN PATHOL, V51, P47, DOI 10.1136/jcp.51.1.47
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Paradis V, 2003, GASTROENTEROLOGY, V124, P651, DOI 10.1053/gast.2003.50104
   R Core Team, 2021, A language and environment for statistical computing
   Rebouissou S, 2008, J HEPATOL, V48, P163, DOI [10.1016/j.jhep.2007.10.003, 10.1016/j.jhep.2008.02.001]
   Ren CL, 2003, J HEPATOL, V38, P770, DOI 10.1016/S0168-8278(03)00144-2
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Rókusz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176518
   Roncalli M, 2016, CLIN MOL HEPATOL, V22, P199, DOI 10.3350/cmh.2016.0101
   Roskams T, 1996, HISTOPATHOLOGY, V28, P291, DOI 10.1046/j.1365-2559.1996.d01-438.x
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   SASAKI M, 2010, AM J CLIN PATHOL, V133, P212
   Sato K., 2018, J Exp Res Human Growth Aging, V1, P1
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Sato Y, 2009, HUM PATHOL, V40, P181, DOI 10.1016/j.humpath.2008.04.024
   Schaub JR, 2018, NATURE, V557, P247, DOI 10.1038/s41586-018-0075-5
   Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Strazzabosco M, 2012, J HEPATOL, V56, P1159, DOI 10.1016/j.jhep.2011.09.022
   Stueck AE, 2015, HEPATOLOGY, V61, P1696, DOI 10.1002/hep.27706
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   VANEYKEN P, 1989, LIVER, V9, P372
   WANLESS IR, 1985, HEPATOLOGY, V5, P1194, DOI 10.1002/hep.1840050622
   Yabushita K, 2001, LIVER, V21, P50, DOI 10.1034/j.1600-0676.2001.210108.x
NR 47
TC 4
Z9 5
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0893-3952
EI 1530-0285
J9 MODERN PATHOL
JI Mod. Pathol.
PD 2022 JAN
PY 2022
VL 35
IS 1
BP 87
EP 95
DI 10.1038/s41379-021-00940-5
EA OCT 2021
PG 9
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA XT9WE
UT WOS:000706906500002
PM 34645984
OA hybrid
DA 2024-02-19
ER

PT J
AU Mori, T
   Ishigami, A
   Seyama, K
   Onai, R
   Kubo, S
   Shimizu, K
   Maruyama, N
   Fukuchi, Y
AF Mori, T
   Ishigami, A
   Seyama, K
   Onai, R
   Kubo, S
   Shimizu, K
   Maruyama, N
   Fukuchi, Y
TI Senescence marker protein-30 knockout mouse as a novel murine model of
   senile lung
SO PATHOLOGY INTERNATIONAL
LA English
DT Article
DE aging; knockout mice; real time reverse transcription-polymerase chain
   reaction; senescence marker protein-30; senile lung
ID NECROSIS-FACTOR-ALPHA; OBSTRUCTIVE PULMONARY-DISEASE; EMPHYSEMATOUS
   LUNGS; SMP30; APOPTOSIS; LYMPHOCYTE; SMOKERS; LIVER; AGE; SAM
AB Senescence marker protein-30 (SMP30) was originally identified as a novel protein of which expression decreases in an androgen-independent manner with aging in the rat liver and functions to protect cells from apoptosis. By reverse transcription-polymerase chain reaction analysis, SMP30 mRNA transcripts were found in the mouse lung, liver, kidney, testis and cerebrum. We examined SMP30 expression in the mouse liver, kidney and lung during aging and a distinct temporal profile of SMP30 expression was found in each tissue; the SMP30 mRNA level peaked at 1-3 months of age and decreased thereafter in the liver (the highest at 1 month of age followed by a rapid decline and consistently low thereafter in the kidney), and peaked at 12 months of age in the lung. To investigate the physiological role of SMP30 in the lung, immunohistochemical studies of wild-type (SMP30Y/+) mice and histopathological examinations of SMP30 knockout (SMP30Y/-) mice were performed. Immunoreactivity against anti-SMP30 antibody was mainly detected in bronchial epithelial cells and strongly detected at 6-12 months of age. Morphometric analysis was performed to measure the mean linear intercept and destructive index, and found peripheral airspace enlargement without alveolar destruction in SMP30Y/- mice at 1, 3 and 6 months of age compared with the SMP30Y/+ mice. Our results strongly suggest that SMP30Y/- mice could be a novel model for a senile lung and further examinations of SMP30Y/- mice may offer clues to elucidate the mechanisms of the development of pulmonary diseases in the elderly.
C1 Tokyo Metropolitan Inst Gerontol, Organ Disorder & Agine Res Grp, Itabashi Ku, Tokyo 1730015, Japan.
   Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 113, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Juntendo University
RP Maruyama, N (corresponding author), Tokyo Metropolitan Inst Gerontol, Organ Disorder & Agine Res Grp, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM maruyama@tmig.or.jp
OI Ishigami, Akihito/0000-0001-7875-7482
CR Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407
   Churg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259
   Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092
   KUROZUMI M, 1994, AM J RESP CRIT CARE, V149, P776, DOI 10.1164/ajrccm.149.3.8118649
   Kuschner WG, 1996, EUR RESPIR J, V9, P1989, DOI 10.1183/09031936.96.09101989
   Majo J, 2001, EUR RESPIR J, V17, P946, DOI 10.1183/09031936.01.17509460
   SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8
   SAETTA M, 1985, AM REV RESPIR DIS, V131, P764
   TERAMOTO S, 1994, AM J RESP CRIT CARE, V150, P238, DOI 10.1164/ajrccm.150.1.8025756
   THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P765
   THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752
   VERBEKEN EK, 1992, CHEST, V101, P793, DOI 10.1378/chest.101.3.793
   VERBEKEN EK, 1992, CHEST, V101, P800, DOI 10.1378/chest.101.3.800
NR 22
TC 51
Z9 66
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1320-5463
EI 1440-1827
J9 PATHOL INT
JI Pathol. Int.
PD MAR
PY 2004
VL 54
IS 3
BP 167
EP 173
DI 10.1111/j.1440-1827.2003.01603.x
PG 7
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 775CN
UT WOS:000189023300004
PM 14989739
DA 2024-02-19
ER

PT J
AU MA, HJ
   NAGATA, TS
AF MA, HJ
   NAGATA, TS
TI STUDY ON RNA-SYNTHESIS IN THE LIVERS OF AGING MICE BY MEANS OF
   ELECTRON-MICROSCOPIC AUTORADIOGRAPHY
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE MOUSE LIVER; ELECTRON MICROSCOPIC AUTORADIOGRAPHY; RNA SYNTHESIS; AGING
ID PROTEIN; YOUNG; AUTORADIOGRAPHY; URIDINE-H-3; METABOLISM; OOCYTES; RATS
AB The application of H-3-uridine radioautography results in labeling of the liver cells in which RNA is synthesized at various ages of the mouse.  Quantitative changes of RNA synthesis in the hepatocytes of aging mice were studied by electron microscopic radioautography.  The silver grains were mainly located in the nucleoli and nuclei and a few in the mitochondria and rough surfaced endoplasmic reticulum of almost all of the cell populations at various ages.  The number of silver grains in the hepatocyte gradually increased after birth, reached the maximum at 14 days of postnatal age, then decreased to 24 months with aging.  The number of silver grains of the euchromatin was more than those of the heterochromatin of the hepatocyte nuclei at various ages.  The number of silver grains of the granular components was more than those of the fibrillar components of the hepatocyte nucleoli at various ages.  However, the ratio of silver grains among euchromatin, heterochromatin, granular components and fibrillar components remained approximately constant.
RP MA, HJ (corresponding author), SHINSHU UNIV,SCH MED,DEPT ANAT & CELL BIOL,MATSUMOTO,NAGANO 390,JAPAN.
CR ADENUGA GA, 1988, EXP GERONTOL, V23, P35, DOI 10.1016/0531-5565(88)90018-6
   ANGELIER N, 1979, J CELL BIOL, V80, P277, DOI 10.1083/jcb.80.2.277
   CARLSSON J, 1979, GROWTH, V43, P105
   FERIOLI ME, 1980, J CELL PHYSIOL, V103, P121, DOI 10.1002/jcp.1041030117
   GRANBOUL.N, 1965, EXP CELL RES, V38, P604, DOI 10.1016/0014-4827(65)90384-8
   KUMAR D, 1981, EXPERIENTIA, V37, P37, DOI 10.1007/BF01965555
   MA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P335
   MA H, 1988, Acta Anatomica Nipponica, V63, P137
   MA HJ, 1990, CELL MOL BIOL, V36, P73
   MAGALHAES MC, 1988, CELL BIOL INT REP, V12, P109, DOI 10.1016/0309-1651(88)90124-5
   MARES V, 1987, PHYSIOL BOHEMOSLOV, V36, P225
   Matsumoto K, 1987, No To Shinkei, V39, P855
   MAZZOCCHI G, 1978, VIRCHOWS ARCH B, V28, P97
   MOTLIK J, 1984, BIOL CELL, V50, P229, DOI 10.1111/j.1768-322X.1984.tb00270.x
   MURATA F, 1979, ACTA HISTOCHEM CYTOC, V12, P443, DOI 10.1267/ahc.12.443
   NAGATA T, 1972, Acta Histochemica et Cytochemica, V5, P201
   NAGATA T, 1972, HISTOCHEMISTRY, V32, P163, DOI 10.1007/BF00303731
   NAGATA T, 1976, 5TH P INT C HIST CYT, P242
   NAGATA TETSUJI, 1966, MED J SHINSHU UNIV, V11, P49
   NOORDUYN NJ, 1966, J CELL BIOL, V30, P655, DOI 10.1083/jcb.30.3.655
   PERRY RP, 1963, EXP CELL RES, V29, P400, DOI 10.1016/S0014-4827(63)80003-8
   PUVIONDUTILLEUL F, 1980, J CELL SCI, V242, P305
   RICCA GA, 1978, J CELL PHYSIOL, V97, P137, DOI 10.1002/jcp.1040970202
   SCHULTZ LD, 1981, CHROMOSOMA, V82, P171, DOI 10.1007/BF00286102
   SERENI F, 1967, ARCH BIOCHEM BIOPHYS, V121, P251, DOI 10.1016/0003-9861(67)90074-4
   SORIERO AA, 1980, J GERONTOL, V35, P167, DOI 10.1093/geronj/35.2.167
   UNUMA T, 1968, EXP CELL RES, V52, P429, DOI 10.1016/0014-4827(68)90484-9
   WHITE FP, 1981, BRAIN RES, V229, P43, DOI 10.1016/0006-8993(81)90744-7
   WINICK M, 1965, DEV BIOL, V12, P451, DOI 10.1016/0012-1606(65)90009-6
   YOSHIDA K, 1978, HISTOCHEMISTRY, V57, P93, DOI 10.1007/BF00507359
NR 30
TC 28
Z9 31
U1 0
U2 0
PU CELLULAR & MOLECULAR BIOLOGY
PI NOISY-LE-GRAND
PA PROF R WEGMANN RESIDENCE HAUSSMANN 1 AVENUE DU PAVE NEUF, 93160
   NOISY-LE-GRAND, FRANCE
SN 0145-5680
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PY 1990
VL 36
IS 5
BP 589
EP 600
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA EP848
UT WOS:A1990EP84800013
PM 1705865
DA 2024-02-19
ER

PT J
AU Kim, DH
   Lee, B
   Lee, J
   Kim, ME
   Lee, JS
   Chung, JH
   Yu, BP
   Dong, HH
   Chung, HY
AF Kim, Dae Hyun
   Lee, Bonggi
   Lee, Jaewon
   Kim, Mi Eun
   Lee, Jun Sik
   Chung, Jae Heun
   Yu, Byung Pal
   Dong, H. Henry
   Chung, Hae Young
TI FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related
   inflammation <i>via</i> the TF/PAR2 pathway in aging and diabetic mice
SO REDOX BIOLOGY
LA English
DT Article
DE FoxO6; IL-1 beta; TF/PAR2 signaling; Aging; Inflammation; Insulin
   resistance
ID ACTIVATED RECEPTOR 2; DIET-INDUCED OBESITY; NF-KAPPA-B; EXPRESSION;
   CELLS; GLUCONEOGENESIS; MECHANISMS; IL-8; AP-1
AB FoxO has been proposed to play a role in the promotion of insulin resistance, and inflammation. FoxO is a pro-inflammatory transcription factor that is a key mediator of generation of inflammatory cytokines such as IL-1 beta in the liver. However, the detailed association of FoxO6 with insulin resistance and age-related inflammation has not been fully documented. Here, we showed that FoxO6 was elevated in the livers of aging rats and obese mice that exhibited insulin resistance. In addition, virus-mediated FoxO6 activation led to insulin resistance in mice with a notable increase in PAR2 and inflammatory signaling in the liver. On the other hand, FoxO6-KO mice showed reduced PAR2 signaling with a decrease in inflammatory cytokine expression and elevated insulin signaling. Because FoxO6 is closely associated with abnormal production of IL-1 beta in the liver, we focused on the FoxO6/IL-1 beta/PAR2 axis to further examine mechanisms underlying FoxO6-mediated insulin resistance and inflammation in the liver. In vitro experiments showed that FoxO6 directly binds to and elevates IL-15 expression. In turn, IL-1 beta treatment elevated the protein levels of PAR2 with a significant decrease in hepatic insulin signaling, whereas PAR2-siRNA treatment abolished these effects. However, PAR2-siRNA treatment had no effect on IL-1 beta expression induced by FoxO6, indicating that IL-1 beta may not be downstream of PAR2. Taken together, we assume that FoxO6-mediated IL-1 beta is involved in hepatic inflammation and insulin resistance via TF/PAR2 pathway in the liver.
C1 [Kim, Dae Hyun; Lee, Jaewon; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Dept Pharm, 2 Busandaehak Ro 63Beon Gi, Busan 46241, South Korea.
   [Lee, Bonggi] KIOM, Korean Med KM Applicat Ctr, Daegu 41062, South Korea.
   [Kim, Mi Eun; Lee, Jun Sik] Chosun Univ, Coll Nat Sci, Dept Biol, Gwangju 501759, South Korea.
   [Chung, Jae Heun] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan 50612, South Korea.
   [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
   [Dong, H. Henry] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh UPMC, Dept Pediat, Pittsburgh, PA 15224 USA.
C3 Pusan National University; Korea Institute of Oriental Medicine (KIOM);
   Chosun University; Pusan National University; Pusan National University
   Hospital; University of Texas System; University of Texas Health Science
   Center at San Antonio; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); University of Pittsburgh
RP Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Pharm, 2 Busandaehak Ro 63Beon Gi, Busan 46241, South Korea.
EM hyjung@pusan.ac.kr
RI Chung, Jae Heun/AAH-2853-2021; Lee, Jaewon/N-9064-2013
OI Dong, H. Henry/0000-0003-0279-5241; Lee, Jaewon/0000-0003-3203-2130
FU National Research Foundation (NRF) - Korean government
   [MSIT-2018R1A2A3075425, MSIP-2009-0083538]; Basic Science Research
   Program through the National Research Foundation of Korea (NRF) -
   Ministry of Education [NRF-2018R1A6A3A11046180]
FX This work was supported by a National Research Foundation (NRF) grant
   funded by the Korean government (MSIT-2018R1A2A3075425;
   MSIP-2009-0083538). In addition, this research was supported by the
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF) funded by the Ministry of Education
   (NRF-2018R1A6A3A11046180). We also take this opportunity to thank the
   Aging Tissue Bank (Busan, Korea) for supplying aged tissue.
CR Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0
   Affò S, 2014, GUT, V63, P1782, DOI 10.1136/gutjnl-2013-306098
   Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461
   Bartneck M, 2016, HEPATOLOGY, V63, P1310, DOI 10.1002/hep.28418
   Calabuig-Navarro V, 2015, J BIOL CHEM, V290, P15581, DOI 10.1074/jbc.M115.650994
   Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Chung KW, 2015, AGING CELL, V14, P524, DOI 10.1111/acel.12305
   Jin YJ, 2012, CELL SIGNAL, V24, P1485, DOI 10.1016/j.cellsig.2012.03.014
   Johansson U, 2005, J LEUKOCYTE BIOL, V78, P967, DOI 10.1189/jlb.0704422
   Jung E, 2013, MOLECULES, V18, P15724, DOI 10.3390/molecules181215724
   Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034
   Kanke T, 2009, BRIT J PHARMACOL, V158, P361, DOI 10.1111/j.1476-5381.2009.00342.x
   Karger S, 2009, ENDOCR-RELAT CANCER, V16, P189, DOI 10.1677/ERC-07-0283
   Kelso EB, 2007, ARTHRITIS RHEUM, V56, P765, DOI 10.1002/art.22423
   Kim SR, 2014, ARCH PHARM RES, V37, P539, DOI 10.1007/s12272-013-0211-6
   Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784
   Lim JX, 2013, FASEB J, V27, P4757, DOI 10.1096/fj.13-232702
   Looby E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-190
   Maruyama K, 2017, CAN J PHYSIOL PHARM, V95, P356, DOI 10.1139/cjpp-2016-0298
   Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403
   Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1
   Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708
   Shearer AM, 2016, J BIOL CHEM, V291, P23188, DOI 10.1074/jbc.M116.732743
   Srinivasan R, 2011, J THROMB HAEMOST, V9, P2087, DOI 10.1111/j.1538-7836.2011.04454.x
   Su DM, 2009, DIABETES, V58, P2624, DOI 10.2337/db09-0232
   van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167
   Wang J, 2015, AM J PATHOL, V185, P524, DOI 10.1016/j.ajpath.2014.10.008
NR 30
TC 30
Z9 32
U1 1
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD JUN
PY 2019
VL 24
AR 101184
DI 10.1016/j.redox.2019.101184
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA IC8TS
UT WOS:000471255400020
PM 30974318
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Cheng, ZR
   Ferris, C
   Crowe, MA
   Ingvartsen, KL
   Grelet, C
   Vanlierde, A
   Foldager, L
   Becker, F
   Wathes, DC
AF Cheng, Zhangrui
   Ferris, Conrad A.
   Crowe, Mark L.
   Ingvartsen, Klaus
   Grelet, Clement
   Vanlierde, Amelie
   Foldager, Leslie
   Becker, Frank
   Wathes, D. Claire
TI Hepatic Global Transcriptomic Profiles of Holstein Cows According to
   Parity Reveal Age-Related Changes in Early Lactation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE liver; ageing; cellular senescence; transcriptome; immunity; metabolism;
   lactation; age; cows
ID NEGATIVE-ENERGY BALANCE; DAIRY-COWS; GENE-EXPRESSION; STELLATE CELLS;
   LATE-GESTATION; KUPFFER CELLS; T-CELLS; LIVER; TRANSITION; GROWTH
AB Cows can live for over 20 years, but their productive lifespan averages only around 3 years after first calving. Liver dysfunction can reduce lifespan by increasing the risk of metabolic and infectious disease. This study investigated the changes in hepatic global transcriptomic profiles in early lactation Holstein cows in different lactations. Cows from five herds were grouped as primiparous (lactation number 1, PP, 534.7 & PLUSMN; 6.9 kg, n = 41), or multiparous with lactation numbers 2-3 (MP2-3, 634.5 & PLUSMN; 7.5 kg, n = 87) or 4-7 (MP4-7, 686.6 & PLUSMN; 11.4 kg, n = 40). Liver biopsies were collected at around 14 days after calving for RNA sequencing. Blood metabolites and milk yields were measured, and energy balance was calculated. There were extensive differences in hepatic gene expression between MP and PP cows, with 568 differentially expressed genes (DEGs) between MP2-3 and PP cows, and 719 DEGs between MP4-7 and PP cows, with downregulated DEGs predominating in MP cows. The differences between the two age groups of MP cows were moderate (82 DEGs). The gene expression differences suggested that MP cows had reduced immune functions compared with the PP cows. MP cows had increased gluconeogenesis but also evidence of impaired liver functionality. The MP cows had dysregulated protein synthesis and glycerophospholipid metabolism, and impaired genome and RNA stability and nutrient transport (22 differentially expressed solute carrier transporters). The genes associated with cell cycle arrest, apoptosis, and the production of antimicrobial peptides were upregulated. More surprisingly, evidence of hepatic inflammation leading to fibrosis was present in the primiparous cows as they started their first lactation. This study has therefore shown that the ageing process in the livers of dairy cows is accelerated by successive lactations and increasing milk yields. This was associated with evidence of metabolic and immune disorders together with hepatic dysfunction. These problems are likely to increase involuntary culling, thus reducing the average longevity in dairy herds.
C1 [Cheng, Zhangrui; Wathes, D. Claire] Royal Vet Coll, Dept Pathobiol & Populat Sci, Hawkshead Lane, North Mymms, Hatfield AL9 7TA, England.
   [Ferris, Conrad A.] Agrifood & Biosci Inst, Newforge Lane, Upper Malone Rd, Belfast BT9 5PX, North Ireland.
   [Crowe, Mark L.] Univ Coll Dublin, Sch Vet Med, Dublin D04V1W8, Ireland.
   [Ingvartsen, Klaus; Foldager, Leslie] Aarhus Univ, Dept Anim & Vet Sci, Blichers 20, DK-8830 Tjele, Denmark.
   [Grelet, Clement; Vanlierde, Amelie] Walloon Agr Res Ctr, Valorisat Agr Prod Dept, B-5030 Gembloux, Belgium.
   [Foldager, Leslie] Aarhus Univ, Res Ctr 6Bioinformat, Universitetsbyen 81, DK-8000 Aarhus, Denmark.
   [Becker, Frank] Res Inst Farm Anim Biol, Wilhelm-Stahl-Allee 2, D-18196 Dummerstorf, Germany.
C3 University of London; University of London Royal Veterinary College;
   Agri-Food & Biosciences Institute; University College Dublin; Aarhus
   University; Aarhus University; Forschungsinstitut fur Nutztierbiologie
   (FBN)
RP Cheng, ZR (corresponding author), Royal Vet Coll, Dept Pathobiol & Populat Sci, Hawkshead Lane, North Mymms, Hatfield AL9 7TA, England.
EM zcheng@rvc.ac.uk; Conrad.Ferris@afbini.gov.uk; mark.crowe@ucd.ie;
   kli@anivet.au.dk; c.grelet@cra.wallonie.be; a.vanlierde@cra.wallonie.be;
   eslie@anivet.au.dk; becker@fbn-dummerstorf.de; cwathes@rvc.ac.uk
RI Foldager, Leslie/AAA-7100-2021; Grelet, Clément/ACK-9444-2022; Crowe,
   Mark/B-8496-2008
OI Foldager, Leslie/0000-0002-2639-826X; Becker, Frank/0000-0001-9832-3091;
   krogh, mogens/0000-0003-0731-6676; Crowe, Mark/0000-0003-1999-815X;
   Rousing, Tine/0000-0001-8619-6996; Ferris, Conrad/0000-0001-8623-5983;
   Wathes, D Claire/0000-0002-8206-6091; Grelet,
   Clement/0000-0003-3313-485X
FU European Union [613689]
FX This project received funding from the European Union's Seventh
   Framework Programme (Brussels, Belgium) for research, technological
   development, and demonstration under grant agreement no. 613689. The
   views expressed in this publication are the sole responsibility of the
   authors and do not necessarily reflect the views of the European
   Commission.
CR Alegre F, 2017, SEMIN LIVER DIS, V37, P119, DOI 10.1055/s-0037-1601350
   Arfuso F, 2016, ARCH ANIM BREED, V59, P429, DOI 10.5194/aab-59-429-2016
   Barchetta I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113302
   Bell MJ, 2010, VET REC, V167, P238, DOI 10.1136/vr.c4267
   Beltman ME, 2010, REPROD FERT DEVELOP, V22, P987, DOI 10.1071/RD09302
   Bernard David, 2015, Oncoscience, V2, P741
   Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x
   Blankley S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0427
   Boulton AC, 2017, ANIMAL, V11, P1372, DOI 10.1017/S1751731117000064
   Buggiotti L, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07977-5
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Capelletti MM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144908
   Carroll B, 2018, FEBS J, V285, P1948, DOI 10.1111/febs.14400
   Chagas LM, 2007, J DAIRY SCI, V90, P4022, DOI 10.3168/jds.2006-852
   Cheng Z, 2021, J DAIRY SCI, V104, P10059, DOI 10.3168/jds.2021-20136
   Cheng Z., 2023, J DAIRY SCI
   Cheng ZR, 2022, ANIMALS-BASEL, V12, DOI 10.3390/ani12162146
   Cheng ZR, 2021, MOL BIOL REP, V48, P4611, DOI 10.1007/s11033-021-06494-8
   Cieslak KP, 2016, HPB, V18, P691, DOI 10.1016/j.hpb.2016.05.011
   Coffey MP, 2006, J DAIRY SCI, V89, P322, DOI 10.3168/jds.S0022-0302(06)72097-5
   Conroy KP, 2016, CELL TISSUE RES, V365, P511, DOI 10.1007/s00441-016-2407-9
   Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629
   Dai N, 2020, TRENDS ENDOCRIN MET, V31, P670, DOI 10.1016/j.tem.2020.05.007
   Dallago GM, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11030808
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   De Vries A, 2020, ANIMAL, V14, pS155, DOI 10.1017/S1751731119003264
   De Vries A, 2017, J DAIRY SCI, V100, P4184, DOI 10.3168/jds.2016-11847
   De Vries A, 2020, J DAIRY SCI, V103, P3838, DOI 10.3168/jds.2019-17361
   Ding L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21061960
   Doherty DG, 1999, J IMMUNOL, V163, P2314
   Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3
   EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0
   Esslemont RJ, 1997, VET REC, V140, P36, DOI 10.1136/vr.140.2.36
   Ezhilarasan D, 2021, HEPATOB PANCREAT DIS, V20, P315, DOI 10.1016/j.hbpd.2021.04.010
   Fenwick MA, 2008, DOMEST ANIM ENDOCRIN, V34, P31, DOI 10.1016/j.domaniend.2006.10.002
   Ferraboschi P, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10121534
   FERRARIS RP, 1993, J NUTR, V123, P502, DOI 10.1093/jn/123.3.502
   Fierbinteanu-Braticevici C, 2010, WORLD J GASTROENTERO, V16, P4784, DOI 10.3748/wjg.v16.i38.4784
   Fiore E, 2017, ANIM PROD SCI, V57, P1007, DOI 10.1071/AN15376
   Frenk S, 2018, BIOGERONTOLOGY, V19, P547, DOI 10.1007/s10522-018-9750-z
   Gao ST, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-020-07332-0
   Gaudio E, 2006, WORLD J GASTROENTERO, V12, P3546, DOI 10.3748/wjg.v12.i22.3546
   Geisler CE, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109298
   González-Gualda E, 2021, FEBS J, V288, P56, DOI 10.1111/febs.15570
   Govindan JA, 2019, P NATL ACAD SCI USA, V116, P21651, DOI 10.1073/pnas.1912628116
   Grandl F, 2019, ANIMAL, V13, P198, DOI 10.1017/S175173111800112X
   Grossmann M, 2019, ENDOCR REV, V40, P417, DOI 10.1210/er.2018-00158
   Habel J, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10061028
   Halaby MJ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.695238
   Hamsanathan S, 2022, FRONT PHYSIOL, V13, DOI 10.3389/fphys.2022.796850
   Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317
   Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Idda ML, 2020, AGING-US, V12, P4052, DOI 10.18632/aging.102903
   Ingvartsen KL, 2013, ANIMAL, V7, P112, DOI 10.1017/S175173111200170X
   Kenna T, 2003, J IMMUNOL, V171, P1775, DOI 10.4049/jimmunol.171.4.1775
   Kenna T, 2004, CLIN IMMUNOL, V113, P56, DOI 10.1016/j.clim.2004.05.003
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kessler EC, 2014, J DAIRY SCI, V97, P5481, DOI 10.3168/jds.2014-7926
   Kieler M, 2021, FEBS J, V288, P3694, DOI 10.1111/febs.15715
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Knolle PA, 2016, CELL MOL IMMUNOL, V13, P347, DOI 10.1038/cmi.2016.5
   Kobayashi Y, 1999, ENDOCRINOLOGY, V140, P3947, DOI 10.1210/en.140.9.3947
   Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200
   Krogh MA, 2020, ANIMAL, V14, P1067, DOI 10.1017/S1751731119002659
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Lacasse P, 2018, RES VET SCI, V116, P40, DOI 10.1016/j.rvsc.2017.06.020
   Lai RW, 2019, BMB REP, V52, P86
   Lallet-Daher H, 2013, CANCER RES, V73, P5253, DOI 10.1158/0008-5472.CAN-12-3690
   LeBlanc SJ, 2014, ANIMAL, V8, P54, DOI 10.1017/S1751731114000524
   Little MW, 2019, ANIMAL, V13, P799, DOI 10.1017/S1751731118001891
   Lizardo DY, 2017, MOL BIOSYST, V13, P498, DOI 10.1039/c6mb00842a
   Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903
   LOMAX MA, 1983, BRIT J NUTR, V49, P481, DOI 10.1079/BJN19830057
   Loor JJ, 2006, PHYSIOL GENOMICS, V27, P29, DOI 10.1152/physiolgenomics.00036.2006
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   MACFARLANE WM, 1994, BIOCHEM J, V303, P625, DOI 10.1042/bj3030625
   Magalhaes S, 2018, CURR MOL MED, V18, P178, DOI 10.2174/1566524018666180907162955
   McFadden JW, 2020, ANIMAL, V14, pS165, DOI 10.1017/S1751731119003185
   Miglior F, 2017, J DAIRY SCI, V100, P10251, DOI 10.3168/jds.2017-12968
   Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049
   Moskalev AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45714-x
   Moyes KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157480
   Moyes KM, 2009, J DAIRY SCI, V92, P5419, DOI 10.3168/jds.2009-2088
   Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
   Ortiz Cristina, 2021, Curr Tissue Microenviron Rep, V2, P41, DOI 10.1007/s43152-021-00030-3
   Palmisano BT, 2017, ADV EXP MED BIOL, V1043, P227, DOI 10.1007/978-3-319-70178-3_12
   Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002
   Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695
   Piñeyrúa JTM, 2018, ANIM REPROD SCI, V191, P9, DOI 10.1016/j.anireprosci.2018.01.017
   Pritchard T, 2013, J DAIRY SCI, V96, P3296, DOI 10.3168/jds.2012-6219
   Prysyazhnyuk V, 2021, WORLD J HEPATOL, V13, P620, DOI 10.4254/wjh.v13.i6.620
   RAO TS, 1994, INFLAMMATION, V18, P187, DOI 10.1007/BF01534559
   Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7
   Reynolds CK, 2004, J DAIRY SCI, V87, P961, DOI 10.3168/jds.S0022-0302(04)73240-3
   Rezazadeh H, 2021, BIOMED PHARMACOTHER, V138, DOI 10.1016/j.biopha.2021.111440
   Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3
   Russo LC, 2020, CELL CYCLE, V19, P1545, DOI 10.1080/15384101.2020.1762043
   Salminen A, 2021, AGEING RES REV, V67, DOI 10.1016/j.arr.2021.101280
   Sebastiani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008210
   Shavlakadze T, 2019, CELL REP, V28, P3263, DOI 10.1016/j.celrep.2019.08.043
   Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021
   Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002
   Silveira MAD, 2023, J BIOL CHEM, V299, DOI 10.1016/j.jbc.2023.102872
   Sojka DR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50840-7
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Sun F, 2021, INT IMMUNOPHARMACOL, V98, DOI 10.1016/j.intimp.2021.107906
   Tarkhov AE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43075-z
   Taylor VJ, 2004, VET REC, V155, P583, DOI 10.1136/vr.155.19.583
   Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008
   Uetsuka K, 2007, J VET MED SCI, V69, P767, DOI 10.1292/jvms.69.767
   Vels L, 2009, J DAIRY SCI, V92, P922, DOI 10.3168/jds.2008-1209
   Walker CG, 2016, J DAIRY SCI, V99, P5820, DOI 10.3168/jds.2015-10331
   Walsh SW, 2011, ANIM REPROD SCI, V123, P127, DOI 10.1016/j.anireprosci.2010.12.001
   Wang L, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.538778
   Wang S, 2018, CELL PHYSIOL BIOCHEM, V48, P1215, DOI 10.1159/000491987
   Wathes DC, 2007, THERIOGENOLOGY, V68, pS232, DOI 10.1016/j.theriogenology.2007.04.006
   Wathes DC, 2007, DOMEST ANIM ENDOCRIN, V33, P203, DOI 10.1016/j.domaniend.2006.05.004
   Wathes D. C., 2021, Ruminants, V1, P147, DOI 10.3390/ruminants1020012
   Wathes DC, 2021, J DAIRY SCI, V104, P3596, DOI 10.3168/jds.2020-19165
   Wathes D. C., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138041
   Wathes DC, 2009, PHYSIOL GENOMICS, V39, P1, DOI 10.1152/physiolgenomics.00064.2009
   Weiskirchen R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111429
   Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Yang Z, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01714-8
   Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97
NR 130
TC 0
Z9 1
U1 8
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2023
VL 24
IS 12
AR 9906
DI 10.3390/ijms24129906
PG 32
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA K6DM2
UT WOS:001017324900001
PM 37373054
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Flannery, C
   Dufour, S
   Rabol, R
   Shulman, GI
   Petersen, KF
AF Flannery, Clare
   Dufour, Sylvie
   Rabol, Rasmus
   Shulman, Gerald I.
   Petersen, Kitt Falk
TI Skeletal Muscle Insulin Resistance Promotes Increased Hepatic De Novo
   Lipogenesis, Hyperlipidemia, and Hepatic Steatosis in the Elderly
SO DIABETES
LA English
DT Article
ID FATTY LIVER-DISEASE; METABOLIC SYNDROME; DENSITY-LIPOPROTEIN;
   ACTIVATION; GLYCOGENOLYSIS; PREVALENCE; EXERCISE; RECEPTOR; PROTEIN;
   HUMANS
AB Aging is closely associated with muscle insulin resistance, hyperlipidemia, nonalcoholic fatty liver disease (NAFLD), and type 2 diabetes. We examined the hypothesis that muscle insulin resistance in healthy aging promotes increased hepatic de novo lipogenesis (DNL) and hyperlipidemia by altering the distribution pattern of postprandial energy storage. Healthy, normal weight, sedentary elderly subjects pair-matched to young subjects were given two high-carbohydrate meals followed by C-13/H-1 magnetic resonance spectroscopy measurements of postprandial changes in muscle and liver glycogen and lipid content, and assessment of DNL using (H2O)-H-2. Net muscle glycogen synthesis was reduced by 45% (P < 0.007) in the elderly subjects compared with the young, reflecting severe muscle insulin resistance. Net liver glycogen synthesis was similar between groups (elderly, 143 +/- 23 mmol/L vs. young, 138 +/- 13 mmol/L; P = NS). Hepatic DNL was more than twofold higher in the elderly than in the young subjects (elderly, 14.5 +/- 1.4% vs. young, 6.9 +/- 0.7%; P = 0.00015) and was associated with approximately threefold higher postprandial hepatic triglyceride (TG) content (P < 0.005) and increased fasting plasma TGs (elderly, 1.19 +/- 0.18 mmol/L vs. young, 0.74 +/- 0.11 mmol/L; P = 0.02). These results strongly support the hypothesis that muscle insulin resistance in aging promotes hyperlipidemia and NAFLD by altering the pattern of postprandial carbohydrate storage away from muscle glycogen and into hepatic DNL. Diabetes 61:2711-2717, 2012
C1 [Flannery, Clare; Rabol, Rasmus; Shulman, Gerald I.; Petersen, Kitt Falk] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
   [Dufour, Sylvie; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.
   [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.
C3 Yale University; Yale University; Howard Hughes Medical Institute; Yale
   University
RP Petersen, KF (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
EM kitt.petersen@yale.edu
RI Flannery, Clare/AAB-5302-2022
OI Flannery, Clare/0000-0002-0219-0907
FU U.S. Public Health Service [R01-AG-23686, R01-DK-49230, R24-DK-085638,
   UL-RR-024139]; American Diabetes Association
FX This work was supported by grants from the U.S. Public Health Service
   (R01-AG-23686, R01-DK-49230, R24-DK-085638, and UL-RR-024139). G.I.S. is
   an investigator of the Howard Hughes Medical Institute. K.F.P. is the
   recipient of a Distinguished Clinical Scientist Award from the American
   Diabetes Association.
CR BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
   Berrougui H, 2009, REJUV RES, V12, P117, DOI 10.1089/rej.2008.0840
   Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197
   Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101
   Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Dumortier M, 2005, INT J OBESITY, V29, P966, DOI 10.1038/sj.ijo.0802991
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270
   Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220
   Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2
   Krauss RM, 2004, ENDOCRIN METAB CLIN, V33, P405, DOI 10.1016/j.ecl.2004.03.016
   LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Petersen KF, 1996, AM J PHYSIOL-ENDOC M, V270, pE186, DOI 10.1152/ajpendo.1996.270.1.E186
   Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104
   Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103
   Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295
   Previs SF, 1996, J MASS SPECTROM, V31, P639, DOI 10.1002/(SICI)1096-9888(199606)31:6<639::AID-JMS336>3.0.CO;2-S
   Rabol R, 2011, P NATL ACAD SCI USA, V108, P13705, DOI 10.1073/pnas.1110105108
   Rodriguez A, 2007, J CLIN ENDOCR METAB, V92, P3568, DOI 10.1210/jc.2006-2764
   ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033
   Shen J, 1997, J MAGN RESON, V127, P229, DOI 10.1006/jmre.1997.1205
   Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248
   Shimano H, 2009, FEBS J, V276, P615, DOI 10.1111/j.1742-4658.2008.06805.x
   Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200
NR 27
TC 110
Z9 120
U1 0
U2 24
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
J9 DIABETES
JI Diabetes
PD NOV
PY 2012
VL 61
IS 11
BP 2711
EP 2717
DI 10.2337/db12-0206
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 050GQ
UT WOS:000312041600008
PM 22829450
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Warren, A
   Bertolino, P
   Cogger, VC
   McLean, AJ
   Fraser, R
   Le Couteur, DG
AF Warren, A
   Bertolino, P
   Cogger, VC
   McLean, AJ
   Fraser, R
   Le Couteur, DG
TI Hepatic pseudocapillarization in aged mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE liver; aging; pseudocapillarization; mouse; liver sinusoidal endothelial
   cell; fenestration
ID RAT-LIVER; ATHEROSCLEROSIS; CLEARANCE; SIEVE; LIFE
AB Age-related changes in the hepatic sinusoid of the rat, human and baboons called pseudocapillarization have been discovered and are important because they are considered to be implicated in the pathogenesis of some age-related diseases. In this study, we investigated whether similar changes occur in the livers of old mice. Livers of young (3-4 months) and old (20-24 months) mice were perfusion-fixed and studied using electron microscopy and immunohistochemistry. The thickness of the sinusoidal endothelium was increased in old mice (154 +/- 4 versus 244 +/- 8 nm, P < 0.001). There was a reduction in fenestrations within the endothelium (porosity decreased from 4.1 +/- 0.3 to 2.2 +/- 0.2%, P < 0.001). There was perisinusoidal staining with Sirius red in old mice, however, expression of laminin and von Willebrands factor was similar in young and old mice. Novel perisinusoidal fat-engorged stellate cells were found extensively in the old mice. This study confirmed that pseudocapillarization is a widespread aging change in the liver, now documented in several species including the mouse. Mice are an appropriate animal model for studying aging and the hepatic sinusoid. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Sydney, Ctr Educ & Res Aging, Concord RG Hosp, Sydney, NSW 2006, Australia.
   Univ Sydney, ANZAC Res Inst, Concord RG Hosp, Sydney, NSW 2006, Australia.
   AW Morrow Liver Ctr, Sydney, NSW, Australia.
   Univ Sydney, Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2006, Australia.
   Univ Melbourne, Natl Ageing Res Inst, Parkville, Vic 3052, Australia.
   Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand.
C3 University of Sydney; Concord Repatriation General Hospital; University
   of Sydney; ANZAC Research Institute; Concord Repatriation General
   Hospital; University of Sydney; Centenary Institute; National Ageing
   Research Institute; University of Melbourne; University of Otago
RP Le Couteur, DG (corresponding author), Univ Sydney, Ctr Educ & Res Aging, Concord RG Hosp, Sydney, NSW 2006, Australia.
EM dlecouteur@med.usyd.edu.au
RI Ekanayake, Kanchana/P-8817-2016; Research Institute,
   ANZAC/CAE-9030-2022; Bertolino, Patrick/JQI-3345-2023
OI Bertolino, Patrick/0000-0001-8244-7057; Le Couteur,
   David/0000-0002-4227-5817
CR AKAMATSU K, 1993, ALCOHOL ALCOHOLISM, V28, P53, DOI 10.1093/alcalc/28.Supplement_1A.53
   CHERKASOV AN, 1990, J MEMBRANE SCI, V50, P109, DOI 10.1016/S0376-7388(00)80310-5
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cotreau MM, 2005, CLIN PHARMACOKINET, V44, P33, DOI 10.2165/00003088-200544010-00002
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LECOUTEUR D, 1992, BIOCHEM PHARMACOL, V43, P913, DOI 10.1016/0006-2952(92)90264-J
   Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
NR 14
TC 51
Z9 53
U1 2
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT
PY 2005
VL 40
IS 10
BP 807
EP 812
DI 10.1016/j.exger.2005.06.012
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 979AZ
UT WOS:000232915800007
PM 16125353
DA 2024-02-19
ER

PT J
AU Luo, DS
   Li, JB
   Chen, KC
   Yin, YF
   Fang, ZY
   Pang, HT
   Rong, XL
   Guo, J
AF Luo, Duosheng
   Li, Jingbiao
   Chen, Kechun
   Yin, Yifan
   Fang, Zhaoyan
   Pang, Huiting
   Rong, Xianglu
   Guo, Jiao
TI Study on Metabolic Trajectory of Liver Aging and the Effect of Fufang
   Zhenzhu Tiaozhi on Aging Mice
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE Fufang Zhenzhu Tiaozhi; metabolomics; liver aging; ultra-performance
   liquid chromatography; mass spectrometry
ID BILE-ACID; INFLAMMATION; EXPRESSION; DISEASE; SYSTEM; CYP7A1; SERUM;
   RATS; UPLC; AGE
AB The aim of this study was to investigate the metabolic trajectory of liver aging, the effect of FTZ against liver aging in aging mice, and its mechanism using ultraperformance liquid chromatography/quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF/MS).
   Methods: A total of 80 C57BL/6J Narl mice were randomly divided into five groups: 3-month-old group, 9-month-old group, 14-month-old group, 20-month-old group, and FTZ treatment group (20 months old). The mice in the treatment group received a therapeutic dose of oral FTZ extract (1.0 g/kg, on raw material weight basis) once daily during the experiment. The other groups received the corresponding volume of oral normal saline solution. Liver samples of all five groups were collected after 12 weeks, and UPLC-Q-TOF/MS was used to analyze metabolic changes. Orthogonal partial least squares-discriminant analysis (OPLS-DA) was used to analyze the resulting data. Additionally, cholesterol (TC), triglyceride (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), secretion levels of TNF-alpha, IL-6, 5-LOX, and COX-2, as well as their relative mRNA expression in the liver were determined.
   Results: The levels of TC, TG, AST, and ALT were increased, and liver tissue structure was damaged. The secretion levels of TNF-alpha, IL-6, 5-LOX, and COX-2, as well as their relative mRNA expression in the liver also increased with aging. FTZ administration reduced the symptoms of liver aging. The OPLS-DA score plot illustrated the effect of FTZ against liver aging, with N-acetyl-leukotriene E4, 20-hydroxy-leukotriene E4, leukotriene E4, and arachidonic acid among the key biomarkers. The pivotal pathways revealed by pathway analysis included arachidonic acid metabolism and biosynthesis of unsaturated fatty acids. The mechanism by which FTZ reduces the symptoms of liver aging in mice might be related to disorders of the abovementioned pathways.
   Conclusion: A metabolomic approach based on UPLC-Q-TOF/MS and multivariate statistical analysis was successfully applied to investigate the metabolic trajectory of liver aging. FTZ has a protective effect against liver aging, which may be mediated via interference with the metabolism of arachidonic acid, biosynthesis of unsaturated fatty acids, and downregulation of pro-inflammatory factors in the liver in mice in vivo.
C1 [Luo, Duosheng; Li, Jingbiao; Chen, Kechun; Yin, Yifan; Fang, Zhaoyan; Pang, Huiting; Rong, Xianglu; Guo, Jiao] Guangdong Pharmaceut Univ, SATCM, Key Unit Modulating Liver Treat Hyperlipemia, Guangzhou, Guangdong, Peoples R China.
   [Luo, Duosheng; Li, Jingbiao; Chen, Kechun; Yin, Yifan; Fang, Zhaoyan; Pang, Huiting; Rong, Xianglu; Guo, Jiao] Guangdong Metab Dis Res Ctr Integrated Chinese &, Guangzhou, Guangdong, Peoples R China.
C3 Guangdong Pharmaceutical University
RP Guo, J (corresponding author), Guangdong Pharmaceut Univ, SATCM, Key Unit Modulating Liver Treat Hyperlipemia, Guangzhou, Guangdong, Peoples R China.; Guo, J (corresponding author), Guangdong Metab Dis Res Ctr Integrated Chinese &, Guangzhou, Guangdong, Peoples R China.
EM gyguoyz@163.com
FU National Natural Science Foundation of China [81503313]; Guangdong
   Province Natural Science Fund [2016A030313739, 2016B050501003]
FX This study was supported by a grant from the National Natural Science
   Foundation of China (Grant No. 81503313, 2015) and a research project
   with the Guangdong Province Natural Science Fund (Grant No.
   2016A030313739 and Grant No. 2016B050501003).
CR Bonafè M, 2012, BIOESSAYS, V34, P40, DOI 10.1002/bies.201100104
   Cao Y, 2012, PHYTOMEDICINE, V19, P686, DOI 10.1016/j.phymed.2012.03.011
   Chen YH, 2009, ANALYST, V134, P2003, DOI 10.1039/b907243h
   d'Alessandro ED, 2011, CLIN TER, V162, pE13
   De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Grizzi F, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-9
   Guo J, 2011, J ETHNOPHARMACOL, V135, P299, DOI 10.1016/j.jep.2011.03.012
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Hu XG, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-47
   Keppler D, 1985, LEUKOTRIENES LIVER I, DOI [10.1007/978-94-009-4904-1_14, DOI 10.1007/978-94-009-4904-1_14]
   Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383
   Meyer MC, 2005, CURR PHARM DESIGN, V11, P1301, DOI 10.2174/1381612053507521
   MOORE KP, 1990, J HEPATOL, V11, P263, DOI 10.1016/0168-8278(90)90123-9
   Narita M, 2008, NEUROSCIENCE, V152, P477, DOI 10.1016/j.neuroscience.2007.10.039
   Plumb RS, 2005, ANALYST, V130, P844, DOI 10.1039/b501767j
   Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449
   Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566
   Saravanan R, 2006, LIFE SCI, V78, P713, DOI 10.1016/j.lfs.2005.05.060
   Sergio G, 2008, INFLAMM RES, V57, P558, DOI 10.1007/s00011-008-7243-2
   Shiota A, 2013, J SEX MED, V10, P2423, DOI 10.1111/jsm.12260
   Song P, 2017, STUDY PREVALENCE CON
   Staley C, 2017, APPL MICROBIOL BIOT, V101, P47, DOI 10.1007/s00253-016-8006-6
   Tomás-Loba A, 2013, AGING CELL, V12, P93, DOI 10.1111/acel.12025
   Wang Q., 2016, Adv Aging Res, V5, P49, DOI [DOI 10.4236/AAR.2016.52005, 10.4236/aar.2016.52005]
   Wuttke D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002834
   Yang K, 2007, PLOS COMPUT BIOL, V3, P523, DOI 10.1371/journal.pcbi.0030055
   Zhong XL, 2012, CHROMATOGRAPHIA, V75, P111, DOI 10.1007/s10337-011-2164-6
NR 33
TC 8
Z9 9
U1 1
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD AUG 28
PY 2019
VL 10
AR 926
DI 10.3389/fphar.2019.00926
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA IT5NO
UT WOS:000482910700001
PM 31555127
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kalinina, OA
   Kalinin, SA
   Polack, EW
   Mikaelian, I
   Panda, S
   Costa, RH
   Adami, GR
AF Kalinina, OA
   Kalinin, SA
   Polack, EW
   Mikaelian, I
   Panda, S
   Costa, RH
   Adami, GR
TI Sustained hepatic expression of FoxM1B in transgenic mice has minimal
   effects on hepatocellular carcinoma development but increases cell
   proliferation rates in preneoplastic and early neoplastic lesions
SO ONCOGENE
LA English
DT Article
DE FoxM1B; hepatocytes; cell proliferation; diethylnitrosamine; adenoma;
   hepatocelluar carcinoma
ID TRANSFORMING-GROWTH-FACTOR; TRANSCRIPTION FACTOR TRIDENT;
   LIVER-REGENERATION; FACTOR-ALPHA; S-PHASE; C-MYC; CARBON-TETRACHLORIDE;
   TUMOR PROGRESSION; HEPATOCYTE ENTRY; GENE-EXPRESSION
AB Increased hepatic expression of the Forkhead transcription factor FoxM1B in adult mice accelerates hepatocyte proliferation after partial hepatectomy, while in hepatocytes in intact liver the transgenic (Tg) protein is inactive and has no effect on proliferation. To investigate the influence of FoxM1B on liver tumor formation, we examined the effect of sustained enrichment of FoxM1B in the hepatocytes of mice treated with a diethylnitrosamine (DEN)/phenobarbital tumor induction protocol. Tg enrichment of FoxM1B in hepatocytes did not increase the proliferation rate in normal liver tissue even when the protein was localized to the nucleus. However, it did cause an increase in the proliferation rate and size of preneoplastic and early neoplastic lesions, although having no effects on the total numbers of these lesions. As tumors progressed to hepatocellular carcinomas, the additional Tg FoxM1B protein had no effect on cell proliferation, and there was no increase in tumor burden compared to wild-type animals. This suggests that the artificial enrichment of FoxM1B in the liver, which has been suggested as a gene therapy protocol for liver dysfunction with aging, may not be tumorigenic in that organ.
C1 Univ Illinois, Coll Dent, Dept Oral Med & Diagnost Sci, Chicago, IL 60612 USA.
   Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA.
   Univ Illinois, Coll Vet Med, Vet Diagnost Lab, Urbana, IL 61802 USA.
   Univ Illinois, Coll Vet Med, Dept Vet Pathobiol, Urbana, IL 61802 USA.
   Jackson Lab, Dept Pathol, Bar Harbor, ME 04609 USA.
   Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60612 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   Jackson Laboratory; University of Illinois System; University of
   Illinois Chicago; University of Illinois Chicago Hospital
RP Adami, GR (corresponding author), Univ Illinois, Coll Dent, Dept Oral Med & Diagnost Sci, 801 S Paulina St,M-C 838, Chicago, IL 60612 USA.
RI Kalinin, Sergey/E-7741-2013
FU NCI NIH HHS [R01 CA 85529-05] Funding Source: Medline; NIDDK NIH HHS
   [R01 DK 54687-05] Funding Source: Medline
CR Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602
   Bell A, 1999, ONCOGENE, V18, P887, DOI 10.1038/sj.onc.1202379
   Birner P, 2001, AM J PATHOL, V158, P1991, DOI 10.1016/S0002-9440(10)64670-6
   Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   BUCHER NL, 1997, LIVER REGENERATION C
   Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780
   Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901
   Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823
   Cowen T, 2001, TRENDS GENET, V17, P109, DOI 10.1016/S0168-9525(00)02214-9
   Deane NG, 2001, CANCER RES, V61, P5389
   DRAGANI TA, 1986, CANCER LETT, V31, P171, DOI 10.1016/0304-3835(86)90008-X
   Factor VM, 1997, HEPATOLOGY, V26, P1434
   Fausto N, 1993, Prog Liver Dis, V11, P115
   Fausto N, 1991, Prog Growth Factor Res, V3, P219, DOI 10.1016/0955-2235(91)90008-R
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114
   FRITH CH, 1979, J ENVIRON PATHOL TOX, V3, P329
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   HUANG SN, 1995, HEPATOLOGY, V21, P620, DOI 10.1002/hep.1840210303
   Isenberg JS, 1997, CARCINOGENESIS, V18, P1511, DOI 10.1093/carcin/18.8.1511
   Ito T, 1998, HISTOCHEM CELL BIOL, V110, P589, DOI 10.1007/s004180050321
   JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q
   Kaestner KH, 2000, GENE DEV, V14, P142
   Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544
   KOIKE K, 1995, J GEN VIROL, V76, P3031, DOI 10.1099/0022-1317-76-12-3031
   Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065
   Korver W, 1997, IMMUNOBIOLOGY, V198, P157, DOI 10.1016/S0171-2985(97)80036-8
   Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5
   Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715
   LEE GH, 1992, CANCER RES, V52, P5162
   Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   MILLS JJ, 1997, LIVER REGENERATION C
   Okabe H, 2001, CANCER RES, V61, P2129
   PERAINO C, 1981, CARCINOGENESIS, V2, P463, DOI 10.1093/carcin/2.5.463
   Pierce RH, 2002, AM J PATHOL, V160, P1555, DOI 10.1016/S0002-9440(10)61101-7
   Pitot HC, 1996, J CANCER RES CLIN, V122, P257, DOI 10.1007/BF01261401
   Pitot HC, 2001, LANCET, V358, P859, DOI 10.1016/S0140-6736(01)06038-X
   PUGH TD, 1983, CANCER RES, V43, P1261
   Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862
   SANDGREN EP, 1989, ONCOGENE, V4, P715
   SANDGREN EP, 1997, LIVER REGENERATION C, P257
   Santoni-Rugiu E, 1998, CANCER RES, V58, P123
   SANTONIRUGIU E, 1998, LIVER GROWTH REPAIR, P100
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   SELL S, 1991, CANCER RES, V51, P1278
   TAMANO S, 1994, CARCINOGENESIS, V15, P1791, DOI 10.1093/carcin/15.9.1791
   TAUB R, 1997, LIVER REGENERATION C
   Teh MT, 2002, CANCER RES, V62, P4773
   Thorgeirsson SS, 2000, TOXICOL LETT, V112, P553, DOI 10.1016/S0378-4274(99)00224-6
   Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666
   WEBBER EM, 1994, AM J PATHOL, V145, P398
   Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827
   Ye HG, 1999, MOL CELL BIOL, V19, P8570
   Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626
NR 60
TC 43
Z9 52
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
J9 ONCOGENE
JI Oncogene
PD SEP 18
PY 2003
VL 22
IS 40
BP 6266
EP 6276
DI 10.1038/sj.onc.1206640
PG 11
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 724UZ
UT WOS:000185506200016
PM 13679865
DA 2024-02-19
ER

PT J
AU Oliva-Vilarnau, N
   Vorrink, SU
   Ingelman-Sundberg, M
   Lauschke, VM
AF Oliva-Vilarnau, Nuria
   Vorrink, Sabine U.
   Ingelman-Sundberg, Magnus
   Lauschke, Volker M.
TI A 3D Cell Culture Model Identifies Wnt/<i>β</i>-Catenin Mediated
   Inhibition of p53 as a Critical Step during Human Hepatocyte
   Regeneration
SO ADVANCED SCIENCE
LA English
DT Article; Early Access
DE alternative splicing analysis; dedifferentiation; liver regeneration;
   proteomics; transcription factor motif analysis; transcriptomics
ID LONG-TERM EXPANSION; LIVER-REGENERATION; BETA-CATENIN; MESSENGER-RNA;
   GROWTH; TARGET; SIGNATURES; ZONATION; REVEALS; PATHWAY
AB The liver is a highly regenerative organ. While mature hepatocytes under homeostatic conditions are largely quiescent, upon injury, they rapidly enter the cell cycle to recover the damaged tissue. In rodents, a variety of injury models have provided important insights into the molecular underpinnings that govern the proliferative activation of quiescent hepatocytes. However, little is known about the molecular mechanisms of human hepatocyte regeneration and experimental methods to expand primary human hepatocytes (PHH). Here, a 3D spheroid model of PHH is established to study hepatocyte regeneration and integrative time-lapse multi-omics analyses show that upon isolation from the native liver PHH acquire a regenerative phenotype, as seen in vivo upon partial hepatectomy. However, proliferation is limited. By analyzing global promoter motif activities, it is predicted that activation of Wnt/beta-catenin and inhibition of p53 signaling are critical factors required for human hepatocyte proliferation. Functional validations reveal that activation of Wnt signaling through external cues alone is sufficient to inhibit p53 and its proliferative senescence-inducing target PAI1 (SERPINE1) and drive proliferation of >50% of all PHH. A scalable 3D culture model is established to study the molecular and cellular biology of human hepatocyte regeneration. By using this model, an essential role of Wnt/beta-catenin signaling during human hepatocyte regeneration is identified.
C1 [Oliva-Vilarnau, Nuria; Vorrink, Sabine U.; Ingelman-Sundberg, Magnus; Lauschke, Volker M.] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.
C3 Karolinska Institutet
RP Lauschke, VM (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.
EM volker.lauschke@ki.se
RI Lauschke, Volker/O-3014-2017; Ingelman-Sundberg, Magnus/ABD-9302-2021
OI Lauschke, Volker/0000-0002-1140-6204; Oliva-Vilarnau,
   Nuria/0000-0002-3083-6701; Ingelman-Sundberg, Magnus/0000-0002-7255-9079
FU Swedish Research Council [2016-01153, 2016-01154]; Swedish Cancer
   Society [17-0599]; Strategic Research Programme in Diabetes (SFO
   Diabetes) at Karolinska Institutet; ERC HEPASPHER project [742020];
   National Genomics Infrastructure in Stockholm; Knut and Alice Wallenberg
   Foundation; Swedish Research Council; Science for Life Laboratory;
   Strategic Research Programme in Stem Cells and Regenerative Medicine
   (SFO StratRegen) at Karolinska Institutet
FX The work was supported by the Swedish Research Council [grant agreement
   numbers: 2016-01153 and 2016-01154], by the Swedish Cancer Society
   [17-0599], by the Strategic Research Programmes in Diabetes (SFO
   Diabetes) and Stem Cells and Regenerative Medicine (SFO StratRegen) at
   Karolinska Institutet, and by the ERC HEPASPHER project [grant agreement
   number 742020]. The authors acknowledge support from the National
   Genomics Infrastructure in Stockholm funded by Science for Life
   Laboratory, the Knut and Alice Wallenberg Foundation and the Swedish
   Research Council, and the Uppsala Multidisciplinary Center for Advanced
   Computational Science for assistance with massively parallel sequencing
   and access to the UPPMAX computational infrastructure. The authors thank
   Hui Gao for bioinformatic support, as well as Phil Newton, Gunnar
   Schulte, and Souren Mkrtchian for critical input on the manuscript.
CR Abu Rmilah A, 2019, WIRES DEV BIOL, V8, DOI 10.1002/wdev.340
   Apte U, 2006, HEPATOLOGY, V44, P992, DOI 10.1002/hep.21317
   Bachofner M, 2017, DEV CELL, V42, P616, DOI 10.1016/j.devcel.2017.07.025
   Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113
   Bangru S, 2018, NAT STRUCT MOL BIOL, V25, P928, DOI 10.1038/s41594-018-0129-2
   Barber K, 2007, GUT, V56, P279, DOI 10.1136/gut.2006.093195
   Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187
   Borude P, 2018, AM J PATHOL, V188, P1406, DOI 10.1016/j.ajpath.2018.03.006
   BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539
   Caldez MJ, 2018, DEV CELL, V47, P425, DOI 10.1016/j.devcel.2018.09.020
   Charni M, 2017, CELL DEATH DIFFER, V24, P8, DOI 10.1038/cdd.2016.117
   Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081
   Dabeva MD, 1998, CANCER RES, V58, P5825
   de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0
   Desai SS, 2016, HEPATOLOGY, V64, P261, DOI 10.1002/hep.28450
   Fernández MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773
   Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x
   Hu HL, 2018, CELL, V175, P1591, DOI 10.1016/j.cell.2018.11.013
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050
   Kwak B, 2018, INT J ONCOL, V53, P1800, DOI 10.3892/ijo.2018.4505
   Lauschke VM, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800347
   Lauschke VM, 2016, CHEM RES TOXICOL, V29, P1936, DOI 10.1021/acs.chemrestox.6b00150
   Lauschke VM, 2016, HEPATOLOGY, V64, P1743, DOI 10.1002/hep.28780
   Lee CA, 2018, J MOL MED, V96, P469, DOI 10.1007/s00109-018-1638-5
   Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401
   LOEB JN, 1975, J EXP MED, V142, P575, DOI 10.1084/jem.142.3.575
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Mancone C, 2010, J HEPATOL, V52, P234, DOI 10.1016/j.jhep.2009.11.013
   Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675
   Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016
   Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056
   Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786
   Ou-Yang Q, 2018, HEPATOLOGY, V67, P1071, DOI 10.1002/hep.29562
   Peng WC, 2018, CELL, V175, P1607, DOI 10.1016/j.cell.2018.11.012
   Percharde M, 2017, DEV CELL, V40, P9, DOI 10.1016/j.devcel.2016.11.010
   Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337
   Pocaterra A, 2019, J HEPATOL, V71, P130, DOI 10.1016/j.jhep.2019.02.022
   Rib L, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0222-0
   Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464
   Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001
   Sato Y, 2017, J BIOL CHEM, V292, P8019, DOI 10.1074/jbc.M116.774547
   Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111
   Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Vorrink SU, 2017, FASEB J, V31, P2696, DOI 10.1096/fj.201601375R
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Xia TT, 2018, BIOTECHNOL LETT, V40, P809, DOI 10.1007/s10529-018-2536-1
   Yang J, 2014, HEPATOLOGY, V60, P964, DOI 10.1002/hep.27082
   Yun MH, 2013, P NATL ACAD SCI USA, V110, P17392, DOI 10.1073/pnas.1310519110
   Zhang K, 2018, CELL STEM CELL, V23, P806, DOI 10.1016/j.stem.2018.10.018
NR 53
TC 32
Z9 33
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2198-3844
J9 ADV SCI
JI Adv. Sci.
PD 2020 AUG
PY 2020
VL 7
IS 15
AR 2000248
DI 10.1002/advs.202000248
EA JUN 2020
PG 12
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA NA4YD
UT WOS:000542118000001
PM 32775153
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, L
   Zhang, ZL
   Li, MM
   Wang, FX
   Jia, Y
   Zhang, F
   Shao, JJ
   Chen, AP
   Zheng, SZ
AF Wang, Ling
   Zhang, Zili
   Li, Mengmeng
   Wang, Feixia
   Jia, Yan
   Zhang, Feng
   Shao, Jiangjuan
   Chen, Anping
   Zheng, Shizhong
TI P53-dependent induction of ferroptosis is required for artemether to
   alleviate carbon tetrachloride-induced liver fibrosis and hepatic
   stellate cell activation
SO IUBMB LIFE
LA English
DT Article
DE ferroptosis; artemether; hepatic stellate cell; liver fibrosis; P53;
   molecular mechanism
ID INHIBITION; P53; APOPTOSIS; DEATH; ANGIOGENESIS; MECHANISMS; SENESCENCE;
   SORAFENIB; REGULATOR; PROTECTS
AB Ferroptosis is recently reported as a new mode of regulated cell death. Its essential characteristics are disturbed redox homeostasis, overloaded iron, and increased lipid peroxidation. However, the role of ferroptosis in liver fibrosis remains poorly understood. In this study, we attempted to investigate the effect of artemether (ART) on ferroptosis in hepatic fibrosis and to further clarify the possible mechanisms. Our data showed that ART treatment markedly attenuated liver injury and reduced fibrotic scar formation in the mouse model of liver fibrosis. Moreover, experiments in vitro also confirmed that ART treatment significantly decreased expression of hepatic stellate cell (HSC) activation markers. Interestingly, HSCs treated by ART presented morphological features of ferroptosis. Furthermore, ART remarkably triggered ferroptosis by promoting the accumulation of iron and lipid peroxides, whereas inhibition of ferroptosis by specific inhibitor ferrostatin-1 (Fer-1) completely abolished ART-induced antifibrosis effect. More importantly, our discovery determined that tumor suppressor P53 was an upstream molecule in the facilitation of ART-induced HSC ferroptosis. Conversely, knockdown of P53 by siRNA evidently blocked ART-induced HSC ferroptosis in turn exacerbated liver fibrosis. Overall, our findings revealed that P53-dependent induction of ferroptosis is necessary for ART to ameliorate CCl4-induced hepatic fibrosis and inhibit HSC activation. (c) 2018 IUBMB Life, 71(1):45-56, 2019
C1 [Wang, Ling; Zhang, Zili; Li, Mengmeng; Wang, Feixia; Jia, Yan; Zhang, Feng; Shao, Jiangjuan; Zheng, Shizhong] Nanjing Univ Chinese Med, Dept Pharmacol, Sch Pharm, Nanjing, Jiangsu, Peoples R China.
   [Zhang, Feng; Shao, Jiangjuan; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chine, Nanjing, Jiangsu, Peoples R China.
   [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.
C3 Nanjing University of Chinese Medicine; Nanjing University of Chinese
   Medicine; Saint Louis University
RP Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Nanjing, Jiangsu, Peoples R China.
EM nytws@163.com
RI Li, Mengmeng/Z-3722-2019; zhang, yimeng/JLL-7337-2023
OI Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China [81270514, 31571455,
   31401210, 31600653, 81600483]; Natural Science Foundation of Jiangsu
   Province [BK20140955]; Open Project Program of Jiangsu Key Laboratory
   for Pharmacology and Safety Evaluation of Chinese Materia Medica [JKLPSE
   201804, JKLPSE 201502]; Postgraduate Research & Practice Innovation
   Program of Jiangsu Province [KYCX17_1322, KYCX18_1579, KYLX16_1156];
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD),
FX This study was supported by the National Natural Science Foundation of
   China (81270514, 31571455, 31401210, 31600653 and 81600483), the Natural
   Science Foundation of Jiangsu Province (BK20140955), the Open Project
   Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation
   of Chinese Materia Medica (JKLPSE 201804 and JKLPSE 201502), the Project
   of the Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD), Postgraduate Research & Practice Innovation Program
   of Jiangsu Province (KYCX17_1322) (KYCX18_1579) and (KYLX16_1156).
   Finally, I sincerely thank my parents for their support and
   encouragement in a difficult period.
CR Altamirano-Barrera A, 2017, ANN HEPATOL, V16, P48, DOI 10.5604/16652681.1226814
   Alvarez SW, 2017, NATURE, V551, P639, DOI 10.1038/nature24637
   Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064
   Basu S, 2016, CELL CYCLE, V15, P2557, DOI 10.1080/15384101.2016.1215390
   Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1
   Chang LC, 2018, CANCER LETT, V416, P124, DOI 10.1016/j.canlet.2017.12.025
   Clemmer L, 2011, ANTIMICROB AGENTS CH, V55, P1383, DOI 10.1128/AAC.01277-10
   da Silva BD, 2017, CELL BIOL INT, V41, P946, DOI 10.1002/cbin.10790
   Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042
   Farsam V, 2011, INT IMMUNOPHARMACOL, V11, P1802, DOI 10.1016/j.intimp.2011.07.008
   Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137
   Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011
   Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner
   Jiang L, 2015, CELL CYCLE, V14, P2881, DOI 10.1080/15384101.2015.1068479
   Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Karin D, 2016, DIFFERENTIATION, V92, P84, DOI 10.1016/j.diff.2016.07.001
   Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948
   Lachaier E, 2014, M S-MED SCI, V30, P779, DOI 10.1051/medsci/20143008016
   Li TY, 2016, ONCOTARGET, V7, P11838, DOI 10.18632/oncotarget.7864
   Louandre C, 2015, CANCER LETT, V356, P971, DOI 10.1016/j.canlet.2014.11.014
   Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015
   Murphy ME, 2016, P NATL ACAD SCI USA, V113, P12350, DOI 10.1073/pnas.1615159113
   Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420
   Prives C, 2015, NATURE, V525, P199, DOI 10.1038/nature15212
   Shakeel K, 2019, J LIPOSOME RES, V29, P35, DOI 10.1080/08982104.2017.1410173
   Shimada K, 2016, CELL CHEM BIOL, V23, P225, DOI 10.1016/j.chembiol.2015.11.016
   Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021
   Sun X, 2015, ONCOGENE, V34, P5617, DOI 10.1038/onc.2015.32
   Sun XF, 2016, HEPATOLOGY, V64, P488, DOI 10.1002/hep.28574
   Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251
   Tacke F, 2015, J HEPATOL, V63, P1038, DOI 10.1016/j.jhep.2015.03.039
   Takemura T, 2013, BIOCHEM BIOPH RES CO, V437, P185, DOI 10.1016/j.bbrc.2013.05.097
   Tarangelo A, 2018, CELL REP, V22, P569, DOI 10.1016/j.celrep.2017.12.077
   Wang SJ, 2016, CELL REP, V17, P366, DOI 10.1016/j.celrep.2016.09.022
   Wang SJ, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1046581
   Wang XQ, 2016, EBIOMEDICINE, V7, P146, DOI 10.1016/j.ebiom.2016.03.042
   Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592
   Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158
   Xie YC, 2017, CELL REP, V20, P1692, DOI 10.1016/j.celrep.2017.07.055
   Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014
   Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010
   Zhang CX, 2018, J CELL BIOCHEM, V119, P2258, DOI 10.1002/jcb.26388
   Zhang ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.255
   Zhang ZL, 2016, FREE RADICAL BIO MED, V101, P272, DOI 10.1016/j.freeradbiomed.2016.10.498
   Zhang ZL, 2013, EUR J PHARMACOL, V721, P133, DOI 10.1016/j.ejphar.2013.09.042
   Zhao SF, 2017, IUBMB LIFE, V69, P115, DOI 10.1002/iub.1598
   Zhao XY, 2017, EXP THER MED, V14, P4083, DOI 10.3892/etm.2017.5063
NR 48
TC 101
Z9 115
U1 2
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD JAN
PY 2019
VL 71
IS 1
BP 45
EP 56
DI 10.1002/iub.1895
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA HE8FO
UT WOS:000453680500005
PM 30321484
OA Bronze
DA 2024-02-19
ER

PT J
AU JI, LL
AF JI, LL
TI ANTIOXIDANT ENZYME RESPONSE TO EXERCISE AND AGING
SO MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
LA English
DT Article
DE SUPEROXIDE; DISMUTASE; CATALASE; GLUTATHIONE PEROXIDASE; LIVER; HEART;
   SKELETAL MUSCLE
ID RAT SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; ADAPTIVE RESPONSE;
   METABOLISM; CATALASE; SYSTEMS; LIVER
AB Antioxidant enzymes play an important role in defending the cells against free radical-mediated oxidative damage. The present investigations, using rats as models, indicate that antioxidant enzyme systems undergo significant alteration during aging and in response to acute and chronic exercise. Hepatic and myocardial antioxidant enzymes show a general decline at older age, whereas activity of glutathione-related enzymes in the liver and mitochondrial enzymes in the heart increase significantly. Skeletal muscle antioxidant enzymes are uniformly elevated during aging. An acute bout of exercise can increase activity of certain antioxidant enzymes in various tissues. The mechanism for this activation is unclear. Exercise training has little effect on hepatic or myocardial enzyme systems but can cause adaptive responses in skeletal muscle antioxidant enzymes, particularly glutathione peroxidase. These findings suggest that both aging and exercise may impose an oxidative stress to the body.
C1 UNIV ILLINOIS,DEPT KINESIOL,URBANA,IL 61801.
   UNIV ILLINOIS,DIV NUTR SCI,URBANA,IL 61801.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
CR ALESSIO HM, 1988, J APPL PHYSIOL, V64, P1333, DOI 10.1152/jappl.1988.64.4.1333
   BARAKAT HA, 1989, J APPL PHYSIOL, V67, P1638, DOI 10.1152/jappl.1989.67.4.1638
   CALDARERA CM, 1973, B SOC ITAL BIOL SPER, V49, P72
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   Halliwell B., 1985, FREE RADICAL BIO MED, P1
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D., 1986, FREE RADICALS AGING, P3
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   JENKINS RR, 1988, SPORTS MED, V5, P156, DOI 10.2165/00007256-198805030-00003
   JENKINS RR, 1984, INT J SPORTS MED, V95, P11
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   JI LL, 1992, J AM COLL NUTR, V11, P79
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P137, DOI 10.1016/0003-9861(88)90622-4
   JI LL, 1992, J APPL PHYSIOL, V72, P549, DOI 10.1152/jappl.1992.72.2.549
   JI LL, 1991, GERONTOLOGY, V37, P317
   KANTER MM, 1985, J APPL PHYSIOL, V59, P1293
   LAUGHLIN MH, 1990, J APPL PHYSIOL, V68, P2337, DOI 10.1152/jappl.1990.68.6.2337
   MICHEL J, 1986, FREE RADICALS AGING, P51
   MITCHELL EW, 1991, THESIS U ILLINOIS UR
   NOHL H, 1979, MECH AGEING DEV, V11, P145, DOI 10.1016/0047-6374(79)90050-2
   Nohl H., 1986, FREE RADICALS AGING, P77
   PACKER L, 1986, BIOCH ASPECTS PHYSIC, P73
   QUINTANILHA AT, 1984, BIOCHEM SOC T, V12, P403, DOI 10.1042/bst0120403
   STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352
   VERTECHY M, 1989, EXP GERONTOL, V24, P211, DOI 10.1016/0531-5565(89)90012-0
NR 29
TC 280
Z9 311
U1 0
U2 14
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0195-9131
J9 MED SCI SPORT EXER
JI Med. Sci. Sports Exerc.
PD FEB
PY 1993
VL 25
IS 2
BP 225
EP 231
PG 7
WC Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Sport Sciences
GA KM063
UT WOS:A1993KM06300010
PM 8450725
DA 2024-02-19
ER

PT J
AU Youssef, JA
   Bouziane, M
   Badr, MZ
AF Youssef, JA
   Bouziane, M
   Badr, MZ
TI Age-dependent effects of nongenotoxic hepatocarcinogens on liver
   apoptosis in vivo
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE PPAR alpha; hepatocarcinogenicity; apoptosis; ageing
ID PEROXISOME PROLIFERATOR NAFENOPIN; ACTIVATED-RECEPTOR-ALPHA;
   DNA-SYNTHESIS; SPECIES-DIFFERENCES; ENZYME-ACTIVITIES; OXIDATIVE STRESS;
   PPAR-ALPHA; RAT-LIVER; TNF-ALPHA; SUPPRESSION
AB Aging sensitizes the liver to the hepatocarcinogenic effect of PPARalpha agonists via unknown mechanisms. This study was designed to investigate whether aging enhances the susceptibility of the liver to the anti-apoptotic effect of these chemicals. Since apoptosis serves to purge the liver of transformed cells, exaggerated inhibition of this process in aged livers may facilitate the progress of these cells to cancer. We quantified the effect of the PPARalpha agonists, clofibrate and Wy-14 643, on the mRNA levels of various elements of the apoptotic machinery in male Fisher-344 rats ranging in age from immaturity (4-week-old), young adulthood (10-week-old), middle age (50-week-old), to senescence (100-week-old). Clofibrate and Wy-14 643 either significantly diminished or exerted no effect on hepatic mRNA levels of several pro-apoptotic factors in immature, middle age and senescent animals. Unexpectedly, however, these PPARalpha agonists caused a remarkable 2- to 45-fold augmentation in the levels of the mRNA of Bax, caspase-2, and Fas mRNA in the young adult 10-week-old rats. A 47-75% decrease in the percent of apoptotic hepatocytes was observed only in 50- and 100-week-old rats treated with Wy-14 643. Data suggest that activation of PPARalpha alters the balance between pro- and antiapoptotic genes most significantly in livers of 50- and 100-week-old rats. Since suppression of apoptosis in the senescent liver is expected to diminish its ability to purge itself of already transformed cells, which may then progress to malignancy, exposure of senescent animals to PPARalpha agonists may be crucial to the ultimate outcome of liver cancer later in their life-span. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Missouri, Kansas City, MO 64108 USA.
   BD Pharmingen, San Diego, CA 92122 USA.
C3 University of Missouri System; University of Missouri Kansas City
RP Badr, MZ (corresponding author), Univ Missouri, 2411 Holmes St, Kansas City, MO 64108 USA.
EM badrm@umkc.edu
FU NCI NIH HHS [CA/OD 74384] Funding Source: Medline; NIA NIH HHS [AG
   18479] Funding Source: Medline
CR Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322
   CATTLEY RC, 1991, CARCINOGENESIS, V12, P469, DOI 10.1093/carcin/12.3.469
   Chao C, 2002, MECH AGEING DEV, V123, P1469, DOI 10.1016/S0047-6374(02)00086-6
   Goll V, 1999, TOXICOL APPL PHARM, V160, P21, DOI 10.1006/taap.1999.8737
   HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403
   Harvey N L, 1998, Adv Biochem Eng Biotechnol, V62, P107
   Hasmall SC, 2000, ARCH TOXICOL, V74, P85, DOI 10.1007/s002040050657
   Holden PR, 2000, CELL MOL BIOL, V46, P29
   HUBER W, 1991, CANCER RES, V51, P1789
   Isenberg JS, 1997, CARCINOGENESIS, V18, P1511, DOI 10.1093/carcin/18.8.1511
   KRAUPPGRASL B, 1991, CANCER RES, V51, P666
   LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043
   Perrone CE, 1998, TOXICOL APPL PHARM, V150, P277, DOI 10.1006/taap.1998.8413
   Plant NJ, 1998, CARCINOGENESIS, V19, P1521, DOI 10.1093/carcin/19.9.1521
   Roberts RA, 2000, TOXICOL LETT, V112, P49, DOI 10.1016/S0378-4274(99)00243-X
   ROBERTS RA, 1995, CARCINOGENESIS, V16, P1693, DOI 10.1093/carcin/16.8.1693
   Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43
   Rolfe M, 1997, CARCINOGENESIS, V18, P2277, DOI 10.1093/carcin/18.11.2277
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SUB Y, 2002, NAT MED, V8, P3
   Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312
   Wang C, 1999, MOL CELL BIOCHEM, V201, P25, DOI 10.1023/A:1007024905046
   Xu L, 1999, HORM METAB RES, V31, P278, DOI 10.1055/s-2007-978733
   Youssef J, 1998, CRIT REV TOXICOL, V28, P1, DOI 10.1080/10408449891344182
   Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575
NR 25
TC 15
Z9 15
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR
PY 2003
VL 124
IS 3
BP 333
EP 340
DI 10.1016/S0047-6374(02)00189-6
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 671CL
UT WOS:000182447600011
PM 12663131
DA 2024-02-19
ER

PT J
AU Yang, QQ
   Yan, C
   Yin, CY
   Gong, ZY
AF Yang, Qiqi
   Yan, Chuan
   Yin, Chunyue
   Gong, Zhiyuan
TI Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity
   in Hepatocellular Carcinoma
SO CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE Liver Cancer; TGFB1; Kras; Zebrafish
ID GROWTH-FACTOR-BETA; TRANSGENIC ZEBRAFISH; LIVER TUMORIGENESIS;
   EXPRESSION; MODEL; SENESCENCE; FIBROSIS; GENDER; FEMALE; CANCER
AB A higher serotonin synthesis and accumulation in male zebrafish resulted in increased activation of hepatic stellate cells and transforming growth factor B1 expression and this has contributed to the accelerated progression of hepatocellular carcinoma in male zebrafish with activated kras oncogene expression.
   BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) occurs more frequently and aggressively in men than in women. Although sex hormones are believed to play a critical role in this disparity, the possible contribution of other factors largely is unknown. We aimed to investigate the role of serotonin on its contribution of sex discrepancy during HCC.
   METHODS: By using an inducible zebrafish HCC model through hepatocyte-specific transgenic kras(V12) expression, differential rates of HCC in male and female fish were characterized by both pharmaceutical and genetic interventions. The findings were validated further in human liver disease samples.
   RESULTS: Accelerated HCC progression was observed in kras(V12)-expressing male zebrafish and male fish liver tumors were found to have higher hepatic stellate cell (HSC) density and activation. Serotonin, which is essential for HSC survival and activation, similarly were found to be synthesized and accumulated more robustly in males than in females. Serotonin-activated HSCs could promote HCC carcinogenesis and concurrently increase serotonin synthesis via transforming growth factor (Tgf)b1 expression, hence contributing to sex disparity in HCC. Analysis of liver disease patient samples showed similar male predominant serotonin accumulation and Tgfb1 expression.
   CONCLUSIONS: In both zebrafish HCC models and human liver disease samples, a predominant serotonin synthesis and accumulation in males resulted in higher HSC density and activation as well as Tgfb1 expression, thus accelerating HCC carcinogenesis in males.
C1 [Yang, Qiqi; Yan, Chuan; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.
   [Yan, Chuan; Gong, Zhiyuan] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore, Singapore.
   [Yin, Chunyue] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA.
C3 National University of Singapore; National University of Singapore;
   Cincinnati Children's Hospital Medical Center
RP Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.
EM dbsgzy@nus.edu.sg
RI Gong, Zhiyuan/H-8794-2012; yan, chuan/J-6876-2017
OI Gong, Zhiyuan/0000-0002-9660-5260; yan, chuan/0000-0002-7570-4059; yan,
   chuan/0000-0002-0449-7072; Yang, Qiqi/0000-0003-1109-5044
FU National Medical Research Council; Ministry of Education of Singapore
FX Supported by research grants from the National Medical Research Council
   and the Ministry of Education of Singapore. The sponsors had no role in
   the study design, or the collection, analysis, or interpretation of
   data.
CR Abdel-Razik A, 2016, EUR J GASTROEN HEPAT, V28, P599, DOI 10.1097/MEG.0000000000000569
   Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x
   Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367
   Bethea CL, 2013, BEHAV NEUROSCI, V127, P400, DOI 10.1037/a0032016
   Bocca C, 2015, CELL MOL GASTROENTER, V1, P477, DOI 10.1016/j.jcmgh.2015.06.011
   Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009
   Chew TW, 2014, ONCOGENE, V33, P2717, DOI 10.1038/onc.2013.240
   Dai Chen-Xin, 2009, BMC Cancer, V9, P418, DOI 10.1186/1471-2407-9-418
   Dohmen K, 2003, J GASTROEN HEPATOL, V18, P267, DOI 10.1046/j.1440-1746.2003.02936.x
   Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490
   Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120
   Farinati F, 2009, EUR J GASTROEN HEPAT, V21, P1212, DOI 10.1097/MEG.0b013e32831a86f8
   Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243
   Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42
   Hefaiedh Rania, 2013, Tunis Med, V91, P505
   Hirsova P, 2015, CELL MOL GASTROENTER, V1, P17, DOI 10.1016/j.jcmgh.2014.11.005
   Huang MB, 2014, HEPATOLOGY, V60, P1753, DOI 10.1002/hep.27285
   Huang ZP, 2008, J PINEAL RES, V45, P506, DOI 10.1111/j.1600-079X.2008.00627.x
   Imbe H, 2011, J SIGNAL TRANSDUCT, V2011
   Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731
   Ji JL, 2015, HEPATOLOGY, V62, P481, DOI 10.1002/hep.27822
   Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384
   Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee CM, 1999, CANCER, V86, P1143, DOI 10.1002/(SICI)1097-0142(19991001)86:7&lt;1143::AID-CNCR7&gt;3.0.CO;2-Z
   Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044
   Li Z, 2013, DIS MODEL MECH, V6, P414, DOI 10.1242/dmm.010462
   Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025
   Manoli M, 2012, COLD SPRING HARB PRO, V2012, ppdbprot069633, DOI DOI 10.1101/PDB.PR0T069633
   Morini Sergio, 2005, Italian Journal of Anatomy and Embryology, V110, P193
   Mucci LA, 2001, BRIT J OBSTET GYNAEC, V108, P291
   Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308
   Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002
   Roth KJ, 2015, CELL MOL GASTROENTER, V1, P589, DOI 10.1016/j.jcmgh.2015.09.005
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Sun LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117249
   Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003
   Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763
   Yin CY, 2012, HEPATOLOGY, V56, P1958, DOI 10.1002/hep.25757
   Yu MW, 2003, HEPATOLOGY, V38, P1393, DOI 10.1016/j.hep.2003.09.041
NR 43
TC 27
Z9 30
U1 0
U2 3
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-345X
J9 CELL MOL GASTROENTER
JI Cell. Mol. Gastroenterol. Hepatol.
PD MAY
PY 2017
VL 3
IS 3
BP 484
EP 499
DI 10.1016/j.jcmgh.2017.01.002
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FV4IP
UT WOS:000424537100030
PM 28462385
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ding, CY
   Yimiti, D
   Sanada, Y
   Matsubara, Y
   Nakasa, T
   Matsubara, K
   Adachi, N
   Miyaki, S
AF Ding, Chenyang
   Yimiti, Dilimulati
   Sanada, Yohei
   Matsubara, Yuki
   Nakasa, Tomoyuki
   Matsubara, Kiminori
   Adachi, Nobuo
   Miyaki, Shigeru
TI High-fat diet-induced obesity accelerates the progression of spontaneous
   osteoarthritis in senescence-accelerated mouse prone 8
SO MODERN RHEUMATOLOGY
LA English
DT Article; Early Access
DE Apoptosis; high-fat diet; obesity; osteoarthritis; SAMP8
ID APOPTOSIS; MODEL; BONE; MICE; INFLAMMATION; STRESS
AB Objectives: Ageing and obesity are major risk factors for osteoarthritis (OA), a widespread disease currently lacking efficient treatments. Senescence-accelerated mouse prone 8 (SAMP8) display early onset ageing phenotypes, including OA. This study investigates the impacts of high-fat diet (HFD)-induced obesity on OA development in SAMP8.
   Methods: SAMP8 at 5 weeks were fed either a normal chow diet or an HFD for 10 weeks to induce obesity. Parameters related to obesity, liver function, and lipid and glucose metabolism were analysed. At 14 weeks of age, knee joint pathology, bone mineral density, and muscle strength were assessed. Immunohistochemistry and TUNEL staining were performed to evaluate markers for cartilage degeneration and chondrocyte apoptosis.
   Results: At 14 weeks of age, HFD-induced obesity increased liver and adipose tissue inflammation in SAMP8 without further exacerbating diabetes. Histological scoring revealed aggravated cartilage, menisci deterioration, and synovitis, while no further loss of bone mineral density or muscle strength was observed. Increased chondrocyte apoptosis was detected in knee joints following HFD feeding.
   Conclusions: Ten weeks of HFD feeding promotes spontaneous OA progression in 14-week-old SAMP8, potentially via liver damage that subsequently leads to chondrocyte apoptosis. This ageing-obese mouse model may prove valuable for further exploration of spontaneous OA pathophysiology.
C1 [Ding, Chenyang; Yimiti, Dilimulati; Sanada, Yohei; Matsubara, Yuki; Adachi, Nobuo; Miyaki, Shigeru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Orthopaed Surg, Hiroshima, Japan.
   [Sanada, Yohei; Miyaki, Shigeru] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Hiroshima, Japan.
   [Nakasa, Tomoyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Artificial Joints & Biomat, Hiroshima, Japan.
   [Matsubara, Kiminori] Hiroshima Univ, Grad Sch Educ, Dept Human Life Sci Educ, Higashihiroshima, Japan.
   [Miyaki, Shigeru] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, 1-2-3 Kasumi Minami Ku, Hiroshima 7348551, Japan.
C3 Hiroshima University; Hiroshima University; Hiroshima University;
   Hiroshima University; Hiroshima University
RP Miyaki, S (corresponding author), Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, 1-2-3 Kasumi Minami Ku, Hiroshima 7348551, Japan.
EM miyaki@hiroshima-u.ac.jp
RI Miyaki, Shigeru/E-4293-2013; Ding, Chenyang/JNE-5505-2023
OI Miyaki, Shigeru/0000-0002-1602-5777; 
FU We thank T. Miyata, E. Ueda, DVM, M. A. Saito, and Y. Takagi for
   excellent technical support and M. Miyaki, DVM, Ph.D., for statistical
   analysis. A part of this work was carried out at the Analysis Center of
   Life Science, Natural Science Center for Basic R; Natural Science Center
   for Basic Research and Development, Hiroshima University
FX We thank T. Miyata, E. Ueda, DVM, M. A. Saito, and Y. Takagi for
   excellent technical support and M. Miyaki, DVM, Ph.D., for statistical
   analysis. A part of this work was carried out at the Analysis Center of
   Life Science, Natural Science Center for Basic Research and Development,
   Hiroshima University.
CR Asokan SM, 2020, AGING-US, V12, P7334, DOI 10.18632/aging.103081
   Berenbaum F, 2017, ARTHRITIS RHEUMATOL, V69, P9, DOI 10.1002/art.39842
   De Chiara F, 2020, HEPATOLOGY, V71, P874, DOI 10.1002/hep.30890
   Diekman BO, 2018, AGING CELL, V17, DOI 10.1111/acel.12771
   Evans AL, 2015, J BONE MINER RES, V30, P920, DOI 10.1002/jbmr.2407
   Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025
   Griffin TM, 2009, ARTHRITIS RHEUM-US, V60, P2935, DOI 10.1002/art.24854
   Guo AY, 2015, EXP ANIM TOKYO, V64, P425, DOI 10.1538/expanim.15-0025
   Guss JD, 2019, OSTEOARTHR CARTILAGE, V27, P129, DOI 10.1016/j.joca.2018.07.020
   Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014
   Han AL, 2021, INFLAMMOPHARMACOLOGY, V29, P1111, DOI 10.1007/s10787-021-00842-7
   Heydemann A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2902351
   Hu H, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03083
   Huang ZW, 2017, ARCH ORAL BIOL, V84, P125, DOI 10.1016/j.archoralbio.2017.09.021
   Hunter DJ, 2019, LANCET, V393, P1745, DOI 10.1016/S0140-6736(19)30417-9
   Hwang HS, 2015, INT J MOL SCI, V16, P26035, DOI 10.3390/ijms161125943
   Ionova-Martin SS, 2010, BONE, V46, P217, DOI 10.1016/j.bone.2009.10.015
   Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x
   Izquierdo V, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031453
   Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324
   Jiang LJ, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.703110
   Kawai T, 2021, AM J PHYSIOL-CELL PH, V320, pC375, DOI 10.1152/ajpcell.00379.2020
   Krenn V, 2002, PATHOL RES PRACT, V198, P317, DOI 10.1078/0344-0338-5710261
   Kwok J, 2016, OSTEOARTHR CARTILAGE, V24, P709, DOI 10.1016/j.joca.2015.11.006
   Li H, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1454-2
   Long HB, 2022, ARTHRITIS RHEUMATOL, V74, P1172, DOI 10.1002/art.42089
   Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898
   Marzetti E, 2017, AGING CLIN EXP RES, V29, P11, DOI 10.1007/s40520-016-0704-5
   Min YH, 2023, J NUTR BIOCHEM, V112, DOI 10.1016/j.jnutbio.2022.109223
   Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510
   Nagira K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66979-7
   Nazli SA, 2017, OSTEOARTHR CARTILAGE, V25, P1516, DOI 10.1016/j.joca.2017.05.011
   Pegreffi F, 2023, J CLIN MED, V12, DOI 10.3390/jcm12041532
   Quail DF, 2019, NAT REV ENDOCRINOL, V15, P139, DOI 10.1038/s41574-018-0126-x
   Rui YH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081084
   Sanada Y, 2022, ARTHRITIS RES THER, V24, DOI 10.1186/s13075-022-02916-5
   Sanchez-Lopez E, 2022, NAT REV RHEUMATOL, V18, P258, DOI 10.1038/s41584-022-00749-9
   Sansone V, 2019, BONE JOINT RES, V8, P582, DOI 10.1302/2046-3758.812.BJR-2019-0038.R1
   Svensson AM, 1996, J ENDOCRINOL, V151, P507, DOI 10.1677/joe.0.1510507
   Takada T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0792-1
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y
   Tan L, 2020, FASEB J, V34, P5818, DOI 10.1096/fj.201902746R
   Tan L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181473
   Thijssen E, 2015, RHEUMATOLOGY, V54, P588, DOI 10.1093/rheumatology/keu464
   Uehara Y, 2014, OSTEOARTHR CARTILAGE, V22, P1007, DOI 10.1016/j.joca.2014.04.025
   Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Zhou HW, 2004, RHEUMATOLOGY, V43, P555, DOI 10.1093/rheumatology/keh127
   Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135
NR 50
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1439-7595
EI 1439-7609
J9 MOD RHEUMATOL
JI Mod. Rheumatol.
PD 2023 JUL 31
PY 2023
DI 10.1093/mr/road069
EA JUL 2023
PG 10
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA S7GX8
UT WOS:001072828200001
PM 37522619
DA 2024-02-19
ER

PT J
AU Atamna, H
   Nguyen, A
   Schultz, C
   Boyle, K
   Newberry, J
   Kato, H
   Ames, BN
AF Atamna, Hani
   Nguyen, Andy
   Schultz, Carla
   Boyle, Kathleen
   Newberry, Justin
   Kato, Hiroyuki
   Ames, Bruce N.
TI Methylene blue delays cellular senescence and enhances key mitochondrial
   biochemical pathways
SO FASEB JOURNAL
LA English
DT Article
DE aging; complex TV; heme; cytochrome c
ID T-BUTYL HYDROXYLAMINE; IFOSFAMIDE-INDUCED ENCEPHALOPATHY; NO-SYNTHASE
   INHIBITOR; CYTOCHROME-C; IN-VITRO; MEMORY RETENTION; NITRIC-OXIDE;
   REDUCTION; RATS; SUPEROXIDE
AB Methylene blue (MB) has been used clinically for about a century to treat numerous ailments. We show that MB and other diaminophenothiazines extend the life span of human IMR90 fibroblasts in tissue culture by >20 population doubling (PDLs). MB delays senescence at nM levels in IMR90 by enhancing mitochondrial function. MB increases mitochondrial complex IV by 30%, enhances cellular oxygen consumption by 37-70%, increases heme synthesis, and reverses premature senescence caused by H2O2 or cadmium. MB also induces phase-2 antioxidant enzymes in hepG2 cells. Flavin-dependent enzymes are known to use NAD(P)H to reduce MB to leucomethylene blue (MBH2), whereas cytochrome c reoxidizes MBH2 to MB. Experiments on lysates from rat liver mitochondria suggest the ratio MB/cytochrome c is important for the protective actions of MB. We propose that the cellular senescence delay caused by MB is due to cycling between MB and MBH2 in mitochondria, which may partly explain the increase in specific mitochondrial activities. Cycling of MB between oxidized and reduced forms may block oxidant production by mitochondria. Mitochondrial dysfunction and oxidative stress are thought to be key aberrations that lead to cellular senescence and aging. MB may be useful to delay mitochondrial dysfunction with aging and the decrease in complex IV in Alzheimer disease.
C1 [Atamna, Hani] Childrens Hosp Oakland, Res Inst, Nutr Metab Ctr, Oakland, CA 94609 USA.
C3 Children's Hospital Oakland Research Institute; University of California
   System; University of California San Francisco; UCSF Medical Center;
   UCSF Benioff Children's Hospital Oakland
RP Atamna, H (corresponding author), Childrens Hosp Oakland, Res Inst, Nutr Metab Ctr, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.
EM hatamna@chori.org
CR Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103
   Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741
   Atamna H, 2001, FASEB J, V15, P2196, DOI 10.1096/fj.01-0134com
   Atamna H, 1996, BIOCHEM PHARMACOL, V51, P693, DOI 10.1016/S0006-2952(95)02258-9
   BONGARD RD, 1995, AM J PHYSIOL-LUNG C, V269, pL78, DOI 10.1152/ajplung.1995.269.1.L78
   Boon EM, 2003, BIOCONJUGATE CHEM, V14, P1140, DOI 10.1021/bc034139l
   BRISTOL DW, 2006, TOXICOLOGY CARCINOGE
   Callaway NL, 2004, PHARMACOL BIOCHEM BE, V77, P175, DOI 10.1016/j.pbb.2003.10.007
   Callaway NL, 2002, NEUROSCI LETT, V332, P83, DOI 10.1016/S0304-3940(02)00827-3
   Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807
   Chandler JE, 2000, THERIOGENOLOGY, V54, P261, DOI 10.1016/S0093-691X(00)00346-0
   Clifton Jack 2nd, 2003, Am J Ther, V10, P289
   de-Oliveira RW, 1999, BRAZ J MED BIOL RES, V32, P1529, DOI 10.1590/S0100-879X1999001200012
   DEGUCHI T, 1978, BIOCHIM BIOPHYS ACTA, V544, P8, DOI 10.1016/0304-4165(78)90204-0
   Demirbilek S, 2006, EUR SURG RES, V38, P35, DOI 10.1159/000091525
   Dierks EA, 1998, ARCH BIOCHEM BIOPHYS, V351, P1, DOI 10.1006/abbi.1997.0408
   Dorta DJ, 2003, J INORG BIOCHEM, V97, P251, DOI 10.1016/S0162-0134(03)00314-3
   Fujisawa H, 1999, J GERONTOL A-BIOL, V54, pB276, DOI 10.1093/gerona/54.7.B276
   Furian AF, 2007, NEUROCHEM INT, V50, P164, DOI 10.1016/j.neuint.2006.07.012
   Gabrielli D, 2004, PHOTOCHEM PHOTOBIOL, V79, P227, DOI 10.1562/BE-03-27.1
   Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013
   GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181
   Haluzik M, 1999, ENDOCR RES, V25, P163, DOI 10.1080/07435809909066138
   Haluzík M, 1998, PHYSIOL RES, V47, P337
   HAYFLICK L, 1992, EXP GERONTOL, V27, P363, DOI 10.1016/0531-5565(92)90066-9
   Hintze KJ, 2003, J NUTR, V133, P2721, DOI 10.1093/jn/133.9.2721
   Hipkiss AR, 2001, MECH AGEING DEV, V122, P169, DOI 10.1016/S0047-6374(00)00231-1
   HRUSHESKY WJM, 1985, LANCET, V1, P565
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   KAMAT PV, 1987, J PHYS CHEM-US, V91, P396, DOI 10.1021/j100286a029
   KELNER MJ, 1985, J BIOL CHEM, V260, P5168
   KELNER MJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P422, DOI 10.1016/0003-9861(88)90393-1
   Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200
   Kwok Edmund S H, 2006, J Intensive Care Med, V21, P359, DOI 10.1177/0885066606290671
   LAGERCRANTZ C, 1991, FREE RADICAL RES COM, V14, P395, DOI 10.3109/10715769109093428
   Lamond Scott, 2003, Reprod Biomed Online, V7, P407
   Lee JH, 2004, CARCINOGENESIS, V25, P1435, DOI 10.1093/carcin/bgh139
   MARTINEZ JL, 1978, PHYSIOL PSYCHOL, V6, P387
   MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5
   MCCORD JM, 1970, J BIOL CHEM, V245, P1374
   MCFARLAND GA, 1994, EXP CELL RES, V212, P167, DOI 10.1006/excr.1994.1132
   Mellish KJ, 2002, PHOTOCHEM PHOTOBIOL, V75, P392, DOI 10.1562/0031-8655(2002)075<0392:IVPAOA>2.0.CO;2
   Merker MP, 1997, AM J PHYSIOL-LUNG C, V272, pL673, DOI 10.1152/ajplung.1997.272.4.L673
   Patel PN, 2006, ANN PHARMACOTHER, V40, P299, DOI 10.1345/aph.1G114
   Pelgrims J, 2000, BRIT J CANCER, V82, P291, DOI 10.1054/bjoc.1999.0917
   Rezzani R, 2001, NEPHRON, V89, P329, DOI 10.1159/000046094
   Rice Lesley, 1998, Biochemical Society Transactions, V26, pS319
   Riedel W, 2003, MOL CELL BIOCHEM, V247, P83, DOI 10.1023/A:1024142400835
   SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R
   SILLS MR, 1994, ARCH PEDIAT ADOL MED, V148, P306, DOI 10.1001/archpedi.1994.02170030076017
   Sweet G, 2007, J AM COLL SURGEONS, V204, P454, DOI 10.1016/j.jamcollsurg.2006.12.030
   TEICHER BA, 1990, RADIAT RES, V121, P187, DOI 10.2307/3577503
   Visarius TM, 1999, J PHARMACOL EXP THER, V289, P820
   Wagner G, 2006, CURR DRUG TARGETS, V7, P1531
   Wagner SJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P343, DOI 10.1111/j.1751-1097.1998.tb05208.x
   WAGNER SJ, 1995, TRANSFUSION, V35, P407, DOI 10.1046/j.1537-2995.1995.35595259151.x
   Wariishi H, 2000, J BIOL CHEM, V275, P32919, DOI 10.1074/jbc.M004223200
   Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200
NR 58
TC 207
Z9 222
U1 0
U2 31
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAR
PY 2008
VL 22
IS 3
BP 703
EP 712
DI 10.1096/fj.07-9610com
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 276LQ
UT WOS:000254143700009
PM 17928358
DA 2024-02-19
ER

PT J
AU Vetuschi, A
   Cappariello, A
   Onori, P
   Gaudio, E
   Latella, G
   Pompili, S
   Sferra, R
AF Vetuschi, Antonella
   Cappariello, Alfredo
   Onori, Paolo
   Gaudio, Eugenio
   Latella, Giovanni
   Pompili, Simona
   Sferra, Roberta
TI Ferroptosis resistance cooperates with cellular senescence in the overt
   stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Article
DE NAFLD/NASH; senescence; ferroptosis; beta-galactosidase; gpx4
ID SCORING SYSTEM; MOUSE MODELS; DISEASE; CELLS; DIET; FIBROBLASTS; CANCER;
   APOPTOSIS; ABSENCE; FUTURE
AB Cellular senescence and ferroptosis are the two main, fine-tuned processes in tissue damage restraint; however, they can be overactivated in pathologies such as nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH), becoming dangerous stimuli. Senescence is characterized by a decline in cell division and an abnormal release of reactive oxygen species (ROS), and ferroptosis is represented by iron deposition associated with an excessive accumulation of ROS. ROS and cellular stress pathways are also drivers of NAFLD/NASH development. The etiology of NAFLD/NASH lies in poor diets enriched in fat and sugar. This food regimen leads to liver steatosis, resulting in progressive degeneration of the organ, with a late onset of irreversible fibrosis and cirrhosis. Few studies have investigated the possible connection between senescence and ferroptosis in NAFLD/NASH progression, despite the two events sharing some molecular players. We hypothesized a possible link between senescence and ferroptosis in a NAFLD background. To thoroughly investigate this in the context of "Western-style" diet (WSD) abuse, we used an amylin-modified liver NASH mouse model. The main NASH hallmarks have been confirmed in this model, as well as an increase in apoptosis, and Ki-67 and p53 expression in the liver. Senescent beta-galactosidase-positive cells were elevated, as well as the expression of the related secretory molecules Il-6 and MMP-1. Features of DNA damage and iron-overload were found in the livers of NASH mice. Gpx4 (glutathione peroxidase 4) expression, counteracting ferroptotic cell death, was increased. Notably, an increased number of senescent cells showing overexpression of gpx4 was also found. Our data seem to suggest that senescent cells acquire a gpx4-mediated mechanism of ferroptosis resistance and thus remain in the liver, fostering the deterioration of liver fitness.
C1 [Vetuschi, Antonella; Cappariello, Alfredo; Pompili, Simona; Sferra, Roberta] Univ LAquila, Dept Biotechnol & Appl Clin Sci, Edificio Angelo Camillo De Meis Coppito 2, I-67100 Laquila, Italy.
   [Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Latella, Giovanni] Univ LAquila, Dept Life Hlth & Environm Sci, Gastroenterol Hepatol & Nutr Div, Laquila, Italy.
C3 University of L'Aquila; Sapienza University Rome; University of L'Aquila
RP Cappariello, A (corresponding author), Univ LAquila, Dept Biotechnol & Appl Clin Sci, Edificio Angelo Camillo De Meis Coppito 2, I-67100 Laquila, Italy.
EM alftedo.cappariello@guest.univaq.it
OI Sferra, Roberta/0000-0003-3893-8320; Cappariello,
   Alfredo/0000-0002-1711-3373
CR Abid A, 2009, J HEPATOL, V51, P918, DOI 10.1016/j.jhep.2009.05.033
   Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Assy N, 2008, CAN J GASTROENTEROL, V22, P811, DOI 10.1155/2008/810961
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Cillero-Pastor B, 2008, ARTHRITIS RHEUM-US, V58, P2409, DOI 10.1002/art.23644
   Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013
   Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hampel B, 2005, AGING CELL, V4, P325, DOI 10.1111/j.1474-9726.2005.00180.x
   Hansen HH, 2017, DRUG DISCOV TODAY, V22, P1707, DOI 10.1016/j.drudis.2017.06.007
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kristiansen MNB, 2016, WORLD J HEPATOL, V8, P673, DOI 10.4254/wjh.v8.i16.673
   Lei PX, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00139
   Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2
   Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007
   Mells JE, 2015, J NUTR BIOCHEM, V26, P285, DOI 10.1016/j.jnutbio.2014.11.002
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Neuschwander-Tetri BA, 2013, CURR OPIN CLIN NUTR, V16, P446, DOI 10.1097/MCO.0b013e328361c4d1
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Pompili S, 2020, NUTRITION, V75-76, DOI [10.1016/j.nut.2020.110782, 10.1016/j.nut.2020-110782]
   Pompili S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164061
   Qi J, 2020, AM J PATHOL, V190, P68, DOI 10.1016/j.ajpath.2019.09.011
   Radhakrishnan S, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzaa078
   Schade M., 2018, WORLD J SURG SURG RE, V1, P1035
   Sferra R, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147280
   Sheka AC, 2020, JAMA-J AM MED ASSOC, V323, P1175, DOI 10.1001/jama.2020.2298
   Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021
   Tessitore A, 2017, ONCOTARGET, V8, P53482, DOI 10.18632/oncotarget.18585
   Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008
   Tsurusaki S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1678-y
   Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171
   Velazquez KT, 2019, WORLD J HEPATOL, V11, P619, DOI 10.4254/wjh.v11.i8.619
   Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007
   Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014
NR 42
TC 3
Z9 3
U1 2
U2 5
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1121-760X
EI 2038-8306
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PY 2022
VL 66
IS 3
AR 3391
DI 10.4081/ejh.2022.3391
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 5Q7BV
UT WOS:000873983100012
PM 35726536
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Cogger, VC
   Mohamad, M
   Solon-Biet, SM
   Senior, AM
   Warren, A
   O'Reilly, JN
   Tung, BT
   Svistounov, D
   McMahon, AC
   Fraser, R
   Raubenheimer, D
   Holmes, AJ
   Simpson, SJ
   Le Couteur, DG
AF Cogger, Victoria Carroll
   Mohamad, Mashani
   Solon-Biet, Samantha Marie
   Senior, Alistair M.
   Warren, Alessandra
   O'Reilly, Jennifer Nicole
   Bui Thanh Tung
   Svistounov, Dmitri
   McMahon, Aisling Clare
   Fraser, Robin
   Raubenheimer, David
   Holmes, Andrew J.
   Simpson, Stephen James
   Le Couteur, David George
TI Dietary macronutrients and the aging liver sinusoidal endothelial cell
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article
DE aging; fenestrations; microbiome
ID LIFE-SPAN; PSEUDOCAPILLARIZATION; AGE; BALANCE
AB Fenestrations are pores within the liver sinusoidal endothelial cells (LSECs) that line the sinusoids of the highly vascularized liver. Fenestrations facilitate the transfer of substrates between blood and hepatocytes. With pseudocapillarization of the hepatic sinusoid in old age, there is a loss of fenestrations. LSECs are uniquely exposed to gut-derived dietary and microbial substrates delivered by the portal circulation to the liver. Here we studied the effect of 25 diets varying in content of macronutrients and energy on LSEC fenestrations using the Geometric Framework method in a large cohort of mice aged 15 mo. Macronutrient distribution rather than total food or energy intake was associated with changes in fenestrations. Porosity and frequency were inversely associated with dietary fat intake, while fenestration diameter was inversely associated with protein or carbohydrate intake. Fenestrations were also linked to diet-induced changes in gut microbiome, with increased fenestrations associated with higher abundance of Firmicutes and reduced abundance of Bacteroidetes. Diet-induced changes in levels of several fatty acids (C16: 0, C19:0, and C20:4) were also significantly inversely associated with fenestrations, suggesting a link between dietary fat and modulation of lipid rafts in the LSECs. Diet influences fenestrations and these data reflect both the key role of the LSECs in clearing gut-derived molecules from the vascular circulation and the impact these molecules have on LSEC morphology.
C1 [Cogger, Victoria Carroll; Mohamad, Mashani; Solon-Biet, Samantha Marie; Warren, Alessandra; O'Reilly, Jennifer Nicole; Bui Thanh Tung; Svistounov, Dmitri; McMahon, Aisling Clare; Le Couteur, David George] Univ Sydney, Aging & Alzheimers Inst, Sydney, NSW 2006, Australia.
   [Cogger, Victoria Carroll; Mohamad, Mashani; Solon-Biet, Samantha Marie; Warren, Alessandra; O'Reilly, Jennifer Nicole; Bui Thanh Tung; Svistounov, Dmitri; McMahon, Aisling Clare; Le Couteur, David George] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2006, Australia.
   [Cogger, Victoria Carroll; Mohamad, Mashani; Solon-Biet, Samantha Marie; Warren, Alessandra; O'Reilly, Jennifer Nicole; Bui Thanh Tung; Svistounov, Dmitri; McMahon, Aisling Clare; Le Couteur, David George] Concord Hosp, Sydney, NSW, Australia.
   [Cogger, Victoria Carroll; Solon-Biet, Samantha Marie; Senior, Alistair M.; Raubenheimer, David; Holmes, Andrew J.; Simpson, Stephen James; Le Couteur, David George] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Mohamad, Mashani] Univ Teknol MARA, Fac Pharm, Bandar Puncak Alam, Selangor, Malaysia.
   [Senior, Alistair M.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia.
   [Bui Thanh Tung] Univ Pablo Olavide, CSIC, CIBERER Inst Salud San Carlos III, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville, Spain.
   [Svistounov, Dmitri] Univ Hosp North Norway, Ctr Clin Res & Educ, Tromso, Norway.
   [McMahon, Aisling Clare] Univ Leicester, British Heart Fdn Cardiovasc, Res Ctr, Dept Cardiovasc Sci, Leicester, Leics, England.
   [Fraser, Robin] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Fraser, Robin] Canterbury Dist Hlth Board, Dept Surg, Christchurch, New Zealand.
   [Fraser, Robin] Canterbury Dist Hlth Board, Dept Gastroenterol & Med, Christchurch, New Zealand.
   [Holmes, Andrew J.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
C3 University of Sydney; University of Sydney; ANZAC Research Institute;
   Concord Repatriation General Hospital; University of Sydney; Universiti
   Teknologi MARA; University of Sydney; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER; Consejo Superior de Investigaciones
   Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian
   Center for Developmental Biology (CABD); UiT The Arctic University of
   Tromso; University Hospital of North Norway; University of Leicester;
   University of Otago; University of Sydney
RP Le Couteur, DG (corresponding author), CERA Concord Hosp, Sydney, NSW 2139, Australia.
EM david.lecouteur@sydney.edu.au
RI Senior, Alistair/AAH-8409-2021; Research Institute, ANZAC/CAE-9030-2022;
   Holmes, Andrew/AAI-2845-2020; Solon-Biet, Samantha/R-6551-2017
OI Raubenheimer, David/0000-0001-9050-1447; Le Couteur,
   David/0000-0002-4227-5817; Simpson, Stephen J./0000-0003-0256-7687;
   Solon-Biet, Samantha/0000-0003-0608-958X
FU National Health and Medical Research Council (NHMRC) of Australia
   [571328, 571408]; Aging and Alzheimers Institute (AAAI); Aging and
   Alzheimers Research Foundation (AARF) of the Concord Hospital
FX This work was supported by the National Health and Medical Research
   Council (NHMRC) of Australia (Project Grant 571328, Program Grant
   571408) and the Aging and Alzheimers Institute (AAAI) and the Aging and
   Alzheimers Research Foundation (AARF) of the Concord Hospital.
CR Barton K., 2022, PACKAGE MUMIN MULTIM
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Burnham K. P., 2002, Model Selection and Multi-Model Inference, V2nd ed., DOI DOI 10.1007/B97636
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cheluvappa R, 2008, INT J EXP PATHOL, V89, P410, DOI 10.1111/j.1365-2613.2008.00602.x
   Cheluvappa R, 2007, J GASTROEN HEPATOL, V22, P1350, DOI 10.1111/j.1440-1746.2007.05016.x
   Cogger VC, 2015, JOVE-J VIS EXP, DOI 10.3791/52698
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001
   DOBBS BR, 1994, LIVER, V14, P230
   FERGUSON KA, 1975, BIOCHEMISTRY-US, V14, P146, DOI 10.1021/bi00672a025
   Fraser R, 2012, PATHOLOGY, V44, P181, DOI 10.1097/PAT.0b013e328351bcc8
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Ha CWY, 2014, WORLD J GASTROENTERO, V20, P16498, DOI 10.3748/wjg.v20.i44.16498
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787
   Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233
   Langelier B, 2010, J CELL BIOCHEM, V110, P1356, DOI 10.1002/jcb.22652
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2015, J GERONTOL A-BIOL, V70, P1499, DOI 10.1093/gerona/glu196
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Mook-Kanamori DO, 2014, J ENDOCRINOL INVEST, V37, P369, DOI 10.1007/s40618-013-0044-7
   O'Reilly JN, 2010, PATHOLOGY, V42, P255, DOI 10.3109/00313021003636469
   Paolella G, 2014, WORLD J GASTROENTERO, V20, P15518, DOI 10.3748/wjg.v20.i42.15518
   Sacerdoti D, 2015, PROSTAG OTH LIPID M, V120, P80, DOI 10.1016/j.prostaglandins.2015.05.008
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Simpson S.J., 2012, NATURE NUTR UNIFYING
   Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033
   Solon-Biet SM, 2015, P NATL ACAD SCI USA, V112, P3481, DOI 10.1073/pnas.1422041112
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58
   Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011
   Svistounov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046134
   Team RC, 2020, R: A Language and Environment for Statistical
   Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619
   Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1
   Wieland A, 2015, ALIMENT PHARM THER, V42, P1051, DOI 10.1111/apt.13376
   Yamamura K, 1999, RES POPUL ECOL, V41, P229
NR 42
TC 39
Z9 39
U1 2
U2 13
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0363-6135
EI 1522-1539
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD MAY 1
PY 2016
VL 310
IS 9
BP H1064
EP H1070
DI 10.1152/ajpheart.00949.2015
PG 7
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular
   Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Physiology
GA DK7OA
UT WOS:000375114200003
PM 26921440
OA Bronze
DA 2024-02-19
ER

PT J
AU Wang, MJ
   Chen, F
   Liu, QG
   Liu, CC
   Yao, H
   Yu, B
   Zhang, HB
   Yan, HX
   Ye, YB
   Chen, T
   Wangensteen, KJ
   Wang, X
   Hu, YP
   He, ZY
AF Wang, Min-Jun
   Chen, Fei
   Liu, Qing-Gui
   Liu, Chang-Cheng
   Yao, Hao
   Yu, Bing
   Zhang, Hai-Bin
   Yan, He-Xin
   Ye, Yibiao
   Chen, Tao
   Wangensteen, Kirk J.
   Wang, Xin
   Hu, Yi-Ping
   He, Zhi-Ying
TI Insulin-like growth factor 2 is a key mitogen driving liver repopulation
   in mice
SO CELL DEATH & DISEASE
LA English
DT Article
ID IN-VIVO; TRANSPLANTED HEPATOCYTES; PROLIFERATION; DISEASE; CELLS;
   REGENERATION; SENESCENCE; RECEPTORS; SELECTION; SURVIVAL
AB Hepatocyte transplantation holds great promise as an alternative to orthotopic organ transplantation in the treatment of liver diseases. However, obtaining clinically meaningful levels of liver repopulation has not been achieved because the mechanisms regulating hepatocyte proliferation in recipient livers have not yet been well characterized. In the mouse model of Hereditary Tyrosinemia Type I, the fumarylacetoacetate hydrolase-deficient (Fah(-/-)) mouse, we found gradually increasing expression level of insulin-like growth factor 2 (IGF2) in the hepatocytes of host livers. Similarly, high levels of IGF2 were found in the livers of patients with deficient FAH activity. Recombinant IGF2 directly promotes proliferation of primary hepatocytes in vitro. Inhibition on IGF2 expression through the interruption of PI3K/Akt and MAPK pathways significantly reduced the level of liver repopulation in Fah(-/-) mice. Interestingly, treatment with IGF2 before hepatocyte transplantation generally improved the amount of liver repopulation seen in various mice models of liver injury. Altogether, these findings underscore the underlying mechanisms of therapeutic liver repopulation in Fah(-/-) mice, and indicate that IGF2 is a potential hepatocyte mitogen for liver cell transplantation therapies.
C1 [Wang, Min-Jun; Chen, Fei; Liu, Qing-Gui; Liu, Chang-Cheng; Yao, Hao; Yu, Bing; Hu, Yi-Ping; He, Zhi-Ying] Second Mil Med Univ, Ctr Stem Cell & Med, Dept Cell Biol, Shanghai 200433, Peoples R China.
   [Wang, Min-Jun; Chen, Fei; Liu, Qing-Gui; Liu, Chang-Cheng; Yao, Hao; Yu, Bing; Hu, Yi-Ping; He, Zhi-Ying] Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai 200123, Peoples R China.
   [Liu, Chang-Cheng; He, Zhi-Ying] Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Inst Regenerat Med, Shanghai 200123, Peoples R China.
   [Zhang, Hai-Bin] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200433, Peoples R China.
   [Zhang, Hai-Bin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Anesthesia & Intens Med, Shanghai 200127, Peoples R China.
   [Ye, Yibiao; Chen, Tao] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.
   [Wangensteen, Kirk J.] Univ Penn, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA.
   [Wang, Xin] Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot 010070, Peoples R China.
   [Wang, Xin] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.
   [Wang, Xin] Hepatosci Inc, 725 San Aleso Ave, Sunnyvale, CA 94085 USA.
C3 Naval Medical University; Tongji University; Tongji University; Naval
   Medical University; Shanghai Jiao Tong University; Sun Yat Sen
   University; University of Pennsylvania; Inner Mongolia University;
   University of Minnesota System; University of Minnesota Twin Cities
RP Hu, YP; He, ZY (corresponding author), Second Mil Med Univ, Ctr Stem Cell & Med, Dept Cell Biol, Shanghai 200433, Peoples R China.; Hu, YP; He, ZY (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai 200123, Peoples R China.; He, ZY (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Inst Regenerat Med, Shanghai 200123, Peoples R China.
EM yphu@smmu.edu.cn; zyhe@tongji.edu.cn
RI yang, qing/JBR-8440-2023; Li, Wei/JLL-4365-2023; Yu, Bing/GSD-3362-2022
OI he, zhiying/0000-0002-0087-2277; Wangensteen, Kirk/0000-0001-6042-6490;
   yao, hao/0000-0002-2942-0004
FU National Natural Science Foundation of China [81471948, 81772954,
   31271474, 31601101, 31271469]; Shanghai Committee of Science and
   Technology of China [15JC1403900]; Science and Research Fund of Shanghai
   Municipal Commission of Health and Family Planning [20164Y0013];
   Shanghai Sailing Program [17YF1424400]; National Key Basic Research and
   Development Program of China [2011CB966200, 2010CB945600]; Shanghai
   Pujiang Program [17PJD045]; Science and Technology Development Fund Of
   Shanghai Pudong New Area [PKJ2017-Y16]
FX This work was funded by National Natural Science Foundation of China
   (81471948, 81772954, 31271474, 31601101, and 31271469), Shanghai
   Committee of Science and Technology of China (15JC1403900), Science and
   Research Fund of Shanghai Municipal Commission of Health and Family
   Planning (20164Y0013), Shanghai Sailing Program (17YF1424400), National
   Key Basic Research and Development Program of China (2011CB966200,
   2010CB945600), Shanghai Pujiang Program(17PJD045), and Science and
   Technology Development Fund Of Shanghai Pudong New Area (PKJ2017-Y16).
CR Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667
   Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712
   He ZY, 2012, INT J BIOCHEM CELL B, V44, P648, DOI 10.1016/j.biocel.2012.01.002
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Huebert RC, 2014, MAYO CLIN PROC, V89, P414, DOI 10.1016/j.mayocp.2013.10.023
   Kaldenbach M, 2012, GUT, V61, P1209, DOI 10.1136/gutjnl-2011-301345
   Kang Liang-I, 2012, Cells, V1, P1261, DOI 10.3390/cells1041261
   Karnezis AN, 2001, J CLIN INVEST, V108, P383, DOI 10.1172/JCI200111933
   Kimura M, 1998, EUR J PHARMACOL, V354, P271, DOI 10.1016/S0014-2999(98)00455-5
   Krause P, 2014, METHODS MOL BIOL, V1213, P29, DOI 10.1007/978-1-4939-1453-1_3
   LAMONERIE T, 1995, INT J CANCER, V61, P587, DOI 10.1002/ijc.2910610425
   Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008
   Lui JC, 2013, P NATL ACAD SCI USA, V110, P6181, DOI 10.1073/pnas.1219079110
   Menthena A, 2011, GASTROENTEROLOGY, V140, P1009, DOI 10.1053/j.gastro.2010.12.003
   Mogler C, 2015, EMBO MOL MED, V7, P332, DOI 10.15252/emmm.201404246
   Nagamoto Y, 2016, J HEPATOL, V64, P1068, DOI 10.1016/j.jhep.2016.01.004
   Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266
   Padrissa-Altés S, 2015, GUT, V64, P1444, DOI 10.1136/gutjnl-2014-307874
   Pascual-Lucas M, 2014, EMBO MOL MED, V6, P1246, DOI 10.15252/emmm.201404228
   Paulk NK, 2012, MOL THER, V20, P1981, DOI 10.1038/mt.2012.154
   Serra MP, 2012, HEPATOLOGY, V56, P760, DOI 10.1002/hep.25698
   Shafritz DA, 2011, INT J BIOCHEM CELL B, V43, P198, DOI 10.1016/j.biocel.2010.01.013
   Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010
   Stock P, 2017, AM J PATHOL, V187, P553, DOI 10.1016/j.ajpath.2016.11.016
   Turner RA, 2013, HEPATOLOGY, V57, P775, DOI 10.1002/hep.26065
   Vogel A, 2004, HEPATOLOGY, V39, P433, DOI 10.1002/hep.20077
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Wangensteen KJ, 2015, GENE DEV, V29, P904, DOI 10.1101/gad.258855.115
   Xiang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.230
   Yoshiya S, 2015, J GASTROENTEROL, V50, P573, DOI 10.1007/s00535-014-0992-5
NR 32
TC 16
Z9 16
U1 0
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JAN 18
PY 2018
VL 9
AR 26
DI 10.1038/s41419-017-0186-1
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA FZ1OW
UT WOS:000427347600002
PM 29348399
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU BORST, SE
   OLIVER, RJ
   SCARPACE, PJ
AF BORST, SE
   OLIVER, RJ
   SCARPACE, PJ
TI ALPHA1-ADRENERGIC AND ARGININE-VASOPRESSIN STIMULATION OF INOSITIDE
   HYDROLYSIS IN RAT HEPATOCYTES IS UNALTERED IN SENESCENCE
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
ID RECEPTOR SUBTYPES; ADENYLATE-CYCLASE; LIVER; CELLS
AB Alpha1-adrenergic receptors in the liver support glucose counterregulation by stimulating glycogenolysis and gluconeogenesis. We have recently reported that senescence is accompanied by reductions both in the density of alpha1 receptors in liver homogenates and in the affinity of these receptors for agonists (Borst and Scarpace, 1990a). The present studies were undertaken to determine what consequences these reductions may have for agonist-stimulated second messenger production. To this end we measured the density of alpha1-adrenergic receptors and agonist-stimulated phosphoinositide (PI) hydrolysis in short-term hepatocyte cultures derived from young and senescent rats. Receptor density in hepatocytes was unchanged with age. PI hydrolysis response to epinephrine was alpha1 in nature, as it was fully blocked by prazosin. The epinephrine response was unchanged with age, both in maximum response and in sensitivity. Similarly, the response to arginine vasopressin (AVP) was also unchanged with age.
C1 UNIV FLORIDA,DEPT PHARMACOL,GAINESVILLE,FL 32611.
C3 State University System of Florida; University of Florida
RP BORST, SE (corresponding author), GRECC 182,DUA MED CTR,ARCHER RD,GAINESVILLE,FL 32608, USA.
CR BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BORST SE, 1990, MECH AGEING DEV, V56, P275, DOI 10.1016/0047-6374(90)90088-W
   BORST SE, 1990, BRIT J PHARMACOL, V101, P650, DOI 10.1111/j.1476-5381.1990.tb14135.x
   BORST SE, 1990, J CARDIOVASC PHARM, V16, P444, DOI 10.1097/00005344-199009000-00014
   BORST SE, 1991, 2ND MESSENGERS PHOSP, V13, pP131
   DELEAN A, 1982, MOL PHARMACOL, V21, P5
   GONZALES RA, 1991, ALCOHOL, V8, P131, DOI 10.1016/0741-8329(91)91321-R
   HAN C, 1990, MOL PHARMACOL, V37, P903
   HUTCHINGS SE, 1978, P NATL ACAD SCI USA, V75, P901, DOI 10.1073/pnas.75.2.901
   ISHIKAWA Y, 1988, BIOCHIM BIOPHYS ACTA, V968, P203, DOI 10.1016/0167-4889(88)90009-2
   ISOM HC, 1984, P NATL ACAD SCI-BIOL, V81, P6378, DOI 10.1073/pnas.81.20.6378
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1985, AM J PHYSIOL, V248, pE712, DOI 10.1152/ajpendo.1985.248.6.E712
   MORGAN NG, 1983, J BIOL CHEM, V258, P5103
   OMALLEY K, 1988, J HYPERTENS, V6, pS59
   TAYLOR CW, 1986, TRENDS PHARMACOL SCI, V7, P238, DOI 10.1016/0165-6147(86)90331-7
   WILSON KM, 1990, J BIOL CHEM, V265, P17601
NR 17
TC 8
Z9 8
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD JAN
PY 1994
VL 49
IS 1
BP B18
EP B21
DI 10.1093/geronj/49.1.B18
PG 4
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA MQ845
UT WOS:A1994MQ84500009
PM 8282972
DA 2024-02-19
ER

PT J
AU Warren, A
   Chaberek, S
   Ostrowski, K
   Cogger, VC
   Hilmer, SN
   McCuskey, RS
   Fraser, R
   Le Couteur, DG
AF Warren, Alessandra
   Chaberek, Slawomir
   Ostrowski, Kazimierz
   Cogger, Victoria C.
   Hilmer, Sarah N.
   McCuskey, Robert S.
   Fraser, Robin
   Le Couteur, David G.
TI Effects of old age on vascular complexity and dispersion of the hepatic
   sinusoidal network
SO MICROCIRCULATION
LA English
DT Article
DE aging; liver; microcirculation; liver sinusoid; vascular casts; fractal
   dimensions; Fourier analysis; vascular dispersion; multiple indicator
   dilution
ID CARDIOVASCULAR-DISEASE ENTERPRISES; PERFUSED-RAT-LIVER; FRACTAL
   ANALYSIS; PARTIAL-HEPATECTOMY; MAJOR SHAREHOLDERS; SKELETAL-MUSCLE; DRUG
   CLEARANCE; CHAOS THEORY; AGING LIVER; BLOOD-FLOW
AB Objectives: In old age, there are marked changes in both the structure of the liver sinusoidal endothelial aging cell and liver perfusion. The objective of this study was to determine whether there are also changes in the microvascular architecture and vascular dispersion of the liver that might influence liver function.
   Methods: Vascular corrosion casts and light micrographs of young (4 months) and old (24 months) rat livers were compared. Fractal and Fourier analyses and micro-computed tomography were used.Vascular dispersion was determined from the dispersion number for sucrose and 100-nm microspheres in impulse response experiments.
   Results: Age did not affect sinusoidal dimensions, sinusoidal density were changes in the geometry and complexity of the sinusoidal network as determined by fractal dimension and degree of anisotropy.
   Conclusions: There are small, age-related changes in the architecture of the liver sinusoidal network, which may influence hepatic function and reflect broader aging changes in the microcirculation. However, simisoidal dimensions and hepatic vascular dispersion are not markedly influenced by old age.
C1 Concord RG Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
   Concord RG Hosp, ANSAC Res Inst, Sydney, NSW 2139, Australia.
   Univ Sydney, Sydney, NSW 2139, Australia.
   [Chaberek, Slawomir] Independent Clin Hosp, Warsaw, Poland.
   [Ostrowski, Kazimierz] Med Acad, Dept Histol, Warsaw, Poland.
   Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia.
   Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia.
   [McCuskey, Robert S.] Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ USA.
   [Fraser, Robin] Univ Otago, Christchurch Sch Med, Christchurch, New Zealand.
C3 Concord Repatriation General Hospital; Concord Repatriation General
   Hospital; University of Sydney; Royal North Shore Hospital; University
   of Sydney; Royal North Shore Hospital; University of Sydney; University
   of Arizona; University of Otago
RP Le Couteur, DG (corresponding author), Concord RG Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
EM dlecouteur@med.usyd..edu.au
RI Hilmer, Sarah/AAW-8554-2020
OI Hilmer, Sarah/0000-0002-5970-1501; Le Couteur, David/0000-0002-4227-5817
FU NIA NIH HHS [R21 AG-02582, R21 AG026582-02, R21 AG026582] Funding
   Source: Medline
CR Bassingthwaighte J.B., 1988, Advances in Experimental Medicine and Biology, V222, P15
   BASSINGTHWAIGHTE JB, 1989, CIRC RES, V65, P578, DOI 10.1161/01.RES.65.3.578
   Bearden SE, 2004, J PHYSIOL-LONDON, V561, P535, DOI 10.1113/jphysiol.2004.068262
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   Chelminiak P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051912
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   COOK JJ, 1992, J GERONTOL, V47, pB83, DOI 10.1093/geronj/47.3.B83
   CROSS SS, 1993, J PATHOL, V170, P479, DOI 10.1002/path.1711700412
   EVANS AM, 1991, J PHARM PHARMACOL, V43, P709, DOI 10.1111/j.2042-7158.1991.tb03463.x
   Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X
   FOLKOW B, 1993, PHYSIOL REV, V73, P725, DOI 10.1152/physrev.1993.73.4.725
   Froomes PR, 2003, NUCL MED BIOL, V30, P93, DOI 10.1016/S0969-8051(02)00386-4
   Fuite J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021904
   Gaudio E, 2005, J ANAT, V207, P107, DOI 10.1111/j.1469-7580.2005.00436.x
   GHIRARDI O, 1995, EXP GERONTOL, V30, P485, DOI 10.1016/0531-5565(95)00002-X
   Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4
   Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499
   GORESKY CA, 1992, HEPATOLOGY, V16, P173, DOI 10.1002/hep.1840160129
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Huet PM, 2005, HEPATOLOGY, V42, P1248, DOI 10.1002/hep.20991
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   JAVANAUD C, 1989, J ACOUST SOC AM, V86, P493, DOI 10.1121/1.398228
   Krucker T, 2006, MICROSC RES TECHNIQ, V69, P138, DOI 10.1002/jemt.20263
   Kyriazis M, 2003, BIOGERONTOLOGY, V4, P75, DOI 10.1023/A:1023306419861
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02
   LANDINI G, 1993, CURR EYE RES, V12, P23, DOI 10.3109/02713689308999492
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LECOUTEUR DG, 1993, AM J PHYSIOL, V264, pG767, DOI 10.1152/ajpgi.1993.264.4.G767
   LECOUTEUR DG, 2007, IN PRESS ANATOM REC
   LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806
   Macheras P, 1996, PHARMACEUT RES, V13, P663, DOI 10.1023/A:1016031129053
   MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V
   Marxen M, 2003, AM J PHYSIOL-HEART C, V284, pH1848, DOI 10.1152/ajpheart.00510.2002
   Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Payne GW, 2006, MICROCIRCULATION, V13, P275, DOI 10.1080/10739680600618710
   Poole DC, 2006, MICROCIRCULATION, V13, P279, DOI 10.1080/10739680600618793
   Riddle DR, 2003, AGEING RES REV, V2, P149, DOI 10.1016/S1568-1637(02)00064-8
   ROBERTS MS, 1988, J PHARMACOKINET BIOP, V16, P41, DOI 10.1007/BF01061862
   ROBERTS MS, 1986, J PHARMACOKINET BIOP, V14, P227, DOI 10.1007/BF01106706
   Sahin S, 2000, J PHARMACOL EXP THER, V295, P836
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Weiss M, 1998, J HEPATOL, V29, P476, DOI 10.1016/S0168-8278(98)80068-8
   Weiss M, 1997, J THEOR BIOL, V184, P1, DOI 10.1006/jtbi.1996.0265
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 56
TC 26
Z9 26
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1073-9688
EI 1549-8719
J9 MICROCIRCULATION
JI Microcirculation
PD APR
PY 2008
VL 15
IS 3
BP 191
EP 202
DI 10.1080/10739680701600856
PG 12
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA 292TG
UT WOS:000255288400002
PM 18386215
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Dongil, P
   Pérez-García, A
   Hurtado-Carneiro, V
   Herrero-de-Dios, C
   Alvarez, E
   Sanz, C
AF Dongil, Pilar
   Perez-Garcia, Ana
   Hurtado-Carneiro, Veronica
   Herrero-de-Dios, Carmen
   Alvarez, Elvira
   Sanz, Carmen
TI PAS kinase deficiency reduces aging effects in mice
SO AGING-US
LA English
DT Article
DE oxidative stress; mitochondrial function; antioxidant enzymes; liver
   regeneration; hepatic ROS
ID FOXO TRANSCRIPTION FACTORS; OXIDATIVE STRESS; LOADING CONTROL;
   LIFE-SPAN; MITOCHONDRIAL; ACTIVATION; DAMAGE; LIVER; NRF2; DNA
AB Several signaling pathways may be affected during aging. All are regulated by nutrient levels leading to a decline in mitochondrial function and autophagy and to an increase in oxidative stress. PAS Domain Kinase (PASK) is a nutrient and bioenergetic sensor. We have previously found that PASK plays a role in the control of hepatic metabolic balance and mitochondrial homeostasis. To investigate PASK's role in hepatic oxidative stress during aging, we analyzed the mitochondrial function, glucose tolerance, insulin resistance, and lipid-related parameters in aged PASK-deficient mice. Hepatic Pask mRNA decreased in step with aging, being undetectable in aged wild-type (WT) mice. Aged PASK-deficient mice recorded lower levels of ROS/RNS compared to aged WT. The regulators of mitochondrial biogenesis, PGC1a, SIRT1 and NRF2, decreased in aged WT, while aged PASK-deficient mice recorded a higher expression of NRF2, GCLm and HO1 proteins and CS activity under fasted conditions. Additionally, aged PASK-deficient mice recorded an overexpression of the longevity gene FoxO3a, and maintained elevated PCNA protein, suggesting that hepatic cell repair mechanisms might be functional. PASK-deficient mice have better insulin sensitivity and no glucose intolerance, as confirmed by a normal HOMA-IR index. PASK may be a good target for reducing damage during aging.
C1 [Dongil, Pilar; Perez-Garcia, Ana; Hurtado-Carneiro, Veronica; Alvarez, Elvira] Univ Complutense Madrid, Fac Med, Dept Biochem & Mol Biol, Inst Med Res,Hosp Clin San Carlos IdISSC, Ciudad Univ, Madrid, Spain.
   [Hurtado-Carneiro, Veronica; Alvarez, Elvira; Sanz, Carmen] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.
   [Dongil, Pilar; Perez-Garcia, Ana; Herrero-de-Dios, Carmen; Sanz, Carmen] Univ Complutense Madrid, Fac Med, Dept Cell Biol, Madrid, Spain.
C3 Hospital Clinico San Carlos; Complutense University of Madrid;
   Complutense University of Madrid
RP Hurtado-Carneiro, V (corresponding author), Univ Complutense Madrid, Fac Med, Dept Biochem & Mol Biol, Inst Med Res,Hosp Clin San Carlos IdISSC, Ciudad Univ, Madrid, Spain.; Hurtado-Carneiro, V (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.
EM verohur@med.ucm.es
RI ALVAREZ, ELVIRA/F-2994-2017; SANZ, CARMEN/L-7266-2014; Dongil,
   Pilar/AAD-7564-2020; García, Ana Pérez/AAH-5672-2019
OI ALVAREZ, ELVIRA/0000-0002-9074-3857; SANZ, CARMEN/0000-0001-7025-6667;
   Dongil, Pilar/0000-0002-6774-4480; HURTADO-CARNEIRO,
   VERONICA/0000-0003-2517-8895; Perez Garcia, Ana/0000-0002-5633-0418
FU Complutense University-Banco Santander Funding Programme for the
   Creation and Consolidation of Research Teams [GR3/14]; Mutua Madrilena
   Medical Research Foundation; CIBER for Diabetes and Associated Metabolic
   Disorders (CIBERDEM) of the Carlos III Health Institute (ISCIII);
   MINECO-ERDF [RTC-2016-4823-1]
FX This work was supported by grants from the Complutense University-Banco
   Santander Funding Programme for the Creation and Consolidation of
   Research Teams [GR3/14], Mutua Madrilena Medical Research Foundation,
   CIBER for Diabetes and Associated Metabolic Disorders (CIBERDEM) of the
   Carlos III Health Institute (ISCIII) and MINECO-ERDF (RTC-2016-4823-1).
CR Apostolova N, 2011, CURR PHARM DESIGN, V17, P4047, DOI 10.2174/138161211798764924
   Banasik K, 2011, J CLIN ENDOCR METAB, V96, pE119, DOI 10.1210/jc.2010-0881
   Biswas C, 2014, J BIOL CHEM, V289, P26882, DOI 10.1074/jbc.M114.567685
   Calabrese EJ, 2015, BIOGERONTOLOGY, V16, P693, DOI 10.1007/s10522-015-9601-0
   Cantó C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008
   Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336
   Castro MD, 2012, EXP GERONTOL, V47, P29, DOI 10.1016/j.exger.2011.10.002
   Chen XL, 2004, ARCH BIOCHEM BIOPHYS, V422, P197, DOI 10.1016/j.abb.2003.12.023
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   Colantoni A, 2001, J AM AGING ASSOC, V24, P51, DOI 10.1007/s11357-001-0007-3
   Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015
   Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028
   Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6
   Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104
   Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Dongil P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32192-w
   Edeas M, 2010, PATHOL BIOL, V58, P220, DOI 10.1016/j.patbio.2009.09.011
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027
   Goodarzi MT, 2010, J CLIN LAB ANAL, V24, P72, DOI 10.1002/jcla.20328
   Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086
   Hao HX, 2008, IUBMB LIFE, V60, P204, DOI 10.1002/iub.32
   Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104
   Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5
   Hurtado-Carneiro V, 2014, MOL NEUROBIOL, V50, P314, DOI 10.1007/s12035-013-8630-4
   Hurtado-Carneiro V, 2013, MOL NEUROBIOL, V48, P904, DOI 10.1007/s12035-013-8476-9
   Hurtado-Carneiro V, 2012, MOL NEUROBIOL, V45, P348, DOI 10.1007/s12035-012-8239-z
   Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327
   Katschinski DM, 2003, MOL CELL BIOL, V23, P6780, DOI 10.1128/MCB.23.19.6780-6789.2003
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   Kikani CK, 2019, P NATL ACAD SCI USA, V116, P10382, DOI 10.1073/pnas.1804013116
   Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594
   Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639
   Luo XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1670-6
   Marczuk-Krynicka Dorota, 2003, Med Sci Monit, V9, pBR131
   Morris BJ, 2015, GERONTOLOGY, V61, P515, DOI 10.1159/000375235
   Murtaza G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3494289
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Pérez-García A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29234-8
   Pérez-García A, 2018, J NUTR BIOCHEM, V57, P14, DOI 10.1016/j.jnutbio.2018.03.003
   de Almeida AJPO, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7941563
   Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12
   Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38
   Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Schläfli P, 2009, CELL MOL LIFE SCI, V66, P876, DOI 10.1007/s00018-009-8699-0
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Segalés J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1208, DOI 10.1152/ajpendo.00546.2012
   Sheng XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183076
   Solon-Biet SM, 2015, J ENDOCRINOL, V226, pR17, DOI 10.1530/JOE-15-0173
   Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x
   Thessen Anne E., 2012, Advances in Bioinformatics, V2012, P391574, DOI 10.1155/2012/391574
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675
   Wu XY, 2014, CELL REP, V8, P242, DOI 10.1016/j.celrep.2014.06.006
   Xie K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00178-3
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhang YKJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059122
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 65
TC 6
Z9 6
U1 0
U2 6
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD FEB 15
PY 2020
VL 12
IS 3
BP 2275
EP 2301
DI 10.18632/aging.102745
PG 27
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA KN4HC
UT WOS:000514798700018
PM 31974316
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Carrillo, MC
   Carnovale, CE
   Favre, C
   Monti, JA
   Scapini, C
AF Carrillo, MC
   Carnovale, CE
   Favre, C
   Monti, JA
   Scapini, C
TI Hepatic protein synthesis and serum aminoacid levels during liver
   regeneration in young and old malnourished rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; hepatectomy; malnutrition; protein synthesis; regenerating rat
   liver; serum amino acids
ID PARTIALLY HEPATECTOMIZED RATS; SMALL-INTESTINE; PLASMA; GROWTH; ACIDS;
   DIET
AB The aim of the present study was to measure protein synthesis in regenerating liver and to evaluate the impact of malnutrition in young and old rats. Two groups of male Wistar rats were used: young rats (4 months old) and old rats (18 months old). The rats were: allocated to malnutrition or ordinary food intake for 1 week. Half of each group was sham-operated and the other was partially hepatectomized 2 days before the end of diet manipulation.
   Hepatic protein synthesis was significantly increased in all hepatectomized groups compared with their respective sham group: young well-nourished hepatectomized rats, 44%, young malnourished hepatectomized rats, 55%; old well-nourished hepatectomized rats, 47%; and old malnurished hepatectomized rats only 21%. Hepatic DNA content was unchanged in all groups and liver RNA content was higher in young malnourished hepatectomized rats (21%, P < 0.05). Serum total amino acid concentration did not change in young well-nourished hepatectomized and young malnourished hepatectomized rats. This value did not show significant changes between old well-nourished hepatectomized and old well-nourished sham, but it increased 14% (P < 0.05) in old malnourished hepatectomized.
   It was concluded that (a) regeneration is not impaired by malnutrition in young rats and may even be better than in rats eating a normal diet, and (b) the deleterious effect of aging is revealed once old animals are exposed to malnutrition. It is manifested in the decreased rate of hepatic protein synthesis observed in old malnourished hepatectomized rats and in the augmentation of total serum amino acid concentration, where the hypercatabolism induced by hepatectomy is significantly greater.
RP Carrillo, MC (corresponding author), UNIV NACL ROSARIO,FAC CIENCIAS BIOQUIM,CONSEJO NACL INVEST CIENT & TECN,INST FIS EXPT,RA-2000 ROSARIO,ARGENTINA.
OI Carnovale, Cristina E/0000-0003-0605-001X
CR ABBASI AA, 1993, J AM GERIATR SOC, V41, P117, DOI 10.1111/j.1532-5415.1993.tb02043.x
   ALISON MR, 1986, PHYSIOL REV, V66, P499, DOI 10.1152/physrev.1986.66.3.499
   CAJONE F, 1980, INT J BIOCHEM, V12, P537, DOI 10.1016/0020-711X(80)90004-X
   CARRILLO MC, 1989, MECH AGEING DEV, V47, P1, DOI 10.1016/0047-6374(89)90002-X
   FERRIS GM, 1972, BIOCHIM BIOPHYS ACTA, V273, P73, DOI 10.1016/0304-4165(72)90192-4
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HOLECEK M, 1991, J HEPATOL, V13, P14, DOI 10.1016/0168-8278(91)90857-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASSORO EJ, 1988, LAB INVEST, V65, P500
   MCNURLAN MA, 1989, DIABETES METAB REV, V5, P165, DOI 10.1002/dmr.5610050206
   MCNURLAN MA, 1981, AM J PHYSIOL, V241, pE238, DOI 10.1152/ajpendo.1981.241.3.E238
   MCNURLAN MA, 1979, BIOCHEM J, V178, P373, DOI 10.1042/bj1780373
   MURAWAKI Y, 1992, RES COMMUN CHEM PATH, V77, P43
   MURAWAKI Y, 1991, GASTROENTEROL JPN, V26, P467
   NAGOSHI S, 1991, HEPATOLOGY, V14, P901, DOI 10.1002/hep.1840140524
   SKULLMAN S, 1991, SCAND J GASTROENTERO, V26, P1152, DOI 10.3109/00365529108998607
   SKULLMAN S, 1990, ACTA CHIR SCAND, V156, P717
   STIMPSON REJ, 1987, AM J SURG, V153, P189, DOI 10.1016/0002-9610(87)90812-9
   STRECKER W, 1980, HORM METAB RES, V12, P604, DOI 10.1055/s-2007-999210
   TEERLINK T, 1994, CLIN CHEM, V40, P245
   TSAI JL, 1992, BIOCHEM INT, V28, P205
   WANNEMACHER RW, 1965, ANAL BIOCHEM, V11, P320, DOI 10.1016/0003-2697(65)90020-5
   YU BP, 1994, P SOC EXP BIOL MED, V205, P97, DOI 10.3181/00379727-205-43684
NR 23
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD OCT 4
PY 1996
VL 91
IS 1
BP 55
EP 64
DI 10.1016/0047-6374(96)01779-4
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA VM012
UT WOS:A1996VM01200006
PM 8910260
DA 2024-02-19
ER

PT J
AU Anton, PE
   Rutt, LN
   Capper, C
   Orlicky, DJ
   McCullough, RL
AF Anton, Paige E.
   Rutt, Lauren N.
   Capper, Courtney
   Orlicky, David J.
   McCullough, Rebecca L.
TI Profiling the oxylipidome in aged mice after chronic ethanol feeding:
   Identifying lipid metabolites as drivers of hepatocyte stress
SO ALCOHOL
LA English
DT Article
DE aging; alcohol-associated liver disease; in flamm-aging; LC-MS; MS;
   oxylipins; Introduction
ID ALCOHOLIC LIVER-DISEASE; FATTY-ACID OXIDATION; COMPLEMENT ACTIVATION;
   AGING MICE; INFLAMMATION; CONSUMPTION; INJURY; PATHOGENESIS; DEFICIENCY;
   LEUKOTOXIN
AB The global population of people over the age of 65 is increasing and expected to reach 1.5 billion by 2050. While aging is associated with a number of chronic illnesses including dementia, the underlying contribution of alcohol misuse in the elderly is understudied. Long-term chronic alcohol misuse can lead to alcohol-associated liver disease, consisting of a spectrum of pathologies, including steatosis and cirrhosis; liver disease can be rapidly accelerated by non-resolving inflammation. Despite this knowl-edge, the mechanistic underpinnings of dysregulated host immunity and accelerated liver disease pro-gression in the aged by alcohol is unknown. Alcohol misuse in the elderly is on the rise and aging is associated with progressive increases in pro-inflammatory cytokine production. The goals of the current study are to characterize bioactive lipid mediators of inflammation by making use of a murine model of ethanol-induced liver disease in 3-month-old and 20-month-old mice by quantitatively profiling selected oxylipins in liver, brain and plasma. Following chronic ethanol exposure, liver injury, steatosis, and senescence markers were robustly increased in aged mice compared to young adult mice. Expression of proinflammatory cytokines and lipid metabolizing enzymes were increased in liver by both age and ethanol feeding. Lipoxygenase-derived lipid metabolites 9-and 13-hydroxy-octadecadienoic acid and 15-hydroxyeicosatetraenoic acid were increased in liver and plasma in ethanol-fed aged mice and positively correlated with liver injury. In plasma, 9,10-dihydroxy-octadecenoic acid/epoxy-octadecenoic acid plasma ratios correlated with liver injury in ethanol-fed aged mice. Finally, 15-hydroxyeicosatetraenoic acid and 9,10-dihydroxy-octadecenoic acid positively correlated between liver and plasma. Impor-tantly, leukotriene E4, 9,10-dihydroxy-octadecenoic acid and 15-hydroxyeicosatetraenoic acid increased lipid accumulation and ER stress in cultured AML12 hepatocytes. These data highlight the complexity of lipid metabolite networks but identify key mediators that may be used for diagnostic and prognostic markers in early stages of alcohol-related liver disease in patients of all ages.(c) 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Anton, Paige E.; Rutt, Lauren N.; Capper, Courtney; McCullough, Rebecca L.] Univ Colorado Anschutz Med Campus, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA.
   [Orlicky, David J.] Univ Colorado Anschutz Med Campus, Sch Med, Dept Pathol, Aurora, CO USA.
   [McCullough, Rebecca L.] Univ Colorado Anschutz Med Campus, Colorado Univ Alcohol Res Program, Aurora, CO USA.
   [McCullough, Rebecca L.] Univ Colorado Anschutz Med Campus, Sch Med, GI & Liver Innate Immune Program, Aurora, CO USA.
   [McCullough, Rebecca L.] Univ Colorado Anschutz Med Campus, 13850 E Montview Blvd,BoxC238-V20-3128, Aurora, CO 80045 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Anschutz
   Medical Campus; University of Colorado System; University of Colorado
   Anschutz Medical Campus; University of Colorado System; University of
   Colorado Anschutz Medical Campus; University of Colorado System;
   University of Colorado Anschutz Medical Campus
RP McCullough, RL (corresponding author), Univ Colorado Anschutz Med Campus, 13850 E Montview Blvd,BoxC238-V20-3128, Aurora, CO 80045 USA.
EM rebecca.mccullough@cuanschutz.edu
FU NIH [F31AA030213, T32ES029074, R00AA025386, R00AA025386-S1]; Associate
   Dean for Research; Skaggs School of Pharmacy; Department of
   Pharmaceutical Sciences in the School of Pharmacy at Colorado
   University; GI and Liver Innate Immune Program at Colorado University
FX This work was supported in part by NIH grants F31AA030213 (PEA),
   T32ES029074 (PEA/LNR), R00AA025386 (RLM), R00AA025386-S1 (RLM), pilot
   grant funds from the Associate Dean for Research, Skaggs School of
   Pharmacy (RLM), and startup funds from the Department of Pharmaceutical
   Sciences in the School of Pharmacy and the GI and Liver Innate Immune
   Program at Colorado University.
CR Ackert-Bicknell Cheryl L, 2015, Curr Protoc Mouse Biol, V5, P95, DOI 10.1002/9780470942390.mo140195
   Armstrong M, 2020, PROSTAG OTH LIPID M, V151, DOI 10.1016/j.prostaglandins.2020.106483
   Armstrong M, 2009, J CHROMATOGR B, V877, P3169, DOI 10.1016/j.jchromb.2009.08.011
   Azbukina NV, 2020, METABOLITES, V10, DOI 10.3390/metabo10060222
   Bergmann CB, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2120691119
   Bettaieb A, 2013, J BIOL CHEM, V288, P14189, DOI 10.1074/jbc.M113.458414
   BLOMSTRAND R, 1973, LIFE SCI, V13, P1131, DOI 10.1016/0024-3205(73)90380-9
   Brayton CF, 2012, VET PATHOL, V49, P85, DOI 10.1177/0300985811430696
   Bykov I, 2006, ANN MED, V38, P280, DOI 10.1080/07853890600664608
   CEDERBAUM AI, 1975, J BIOL CHEM, V250, P5122
   Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002
   Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0
   Chavez PRG, 2011, J NUTR, V141, P1049, DOI 10.3945/jn.110.136531
   Chiurchiù V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038
   Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041
   Das UN, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020241
   Fan XD, 2021, HEPATOLOGY, V73, P983, DOI 10.1002/hep.31419
   Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Gao B, 2019, DIGEST DIS SCI, V64, P1878, DOI 10.1007/s10620-019-05638-y
   Gao Bin, 2017, Gene Expression, V17, P173, DOI 10.3727/105221617X695519
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Geifman N, 2013, AGE, V35, P2357, DOI 10.1007/s11357-013-9510-6
   Gilroy DW, 2016, P NATL ACAD SCI USA, V113, pE3240, DOI 10.1073/pnas.1521453113
   Han JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32497-w
   HAYAKAWA M, 1986, BIOCHEM BIOPH RES CO, V137, P424, DOI 10.1016/0006-291X(86)91227-1
   Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708
   Jeon S, 2020, J LIPID RES, V61, P470, DOI 10.1194/jlr.R119000547
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Koch M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10319
   Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002
   Lanaspa MA, 2018, J CLIN INVEST, V128, P2226, DOI 10.1172/JCI94427
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376
   Lefèvre L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7801
   Loomba R, 2015, J LIPID RES, V56, P185, DOI 10.1194/jlr.P055640
   López-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112
   Maraldi C, 2006, ARCH INTERN MED, V166, P1490, DOI 10.1001/archinte.166.14.1490
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Martínez-Clemente M, 2010, HEPATOLOGY, V51, P817, DOI 10.1002/hep.23463
   Mashima R, 2015, REDOX BIOL, V6, P297, DOI 10.1016/j.redox.2015.08.006
   McCullough RL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02133
   McCullough RL, 2018, AM J PHYSIOL-GASTR L, V315, pG66, DOI 10.1152/ajpgi.00334.2017
   McCullough RL, 2016, MOL IMMUNOL, V75, P122, DOI 10.1016/j.molimm.2016.05.006
   McMahan RH, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-021-00247-8
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   Mijit M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030420
   Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3
   Moncan M, 2021, J CELL MOL MED, V25, P1359, DOI 10.1111/jcmm.16255
   Monks J, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0027-z
   Moos RH, 2009, ADDICTION, V104, P1293, DOI 10.1111/j.1360-0443.2009.02604.x
   Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC
   Nanji AA, 1997, GASTROENTEROLOGY, V112, P943, DOI 10.1053/gast.1997.v112.pm9041257
   Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541
   Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276
   Pansarasa O, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100935
   Pecorelli A, 2019, FREE RADICAL BIO MED, V134, P598, DOI 10.1016/j.freeradbiomed.2019.02.007
   PIKKARAINEN PH, 1967, PEDIATR RES, V1, P165, DOI 10.1203/00006450-196705000-00001
   Prescott JA, 2021, BIOCHEM J, V478, P2619, DOI 10.1042/BCJ20210139
   Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229
   Puzianowska-Kuznicka M, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0076-x
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Raszeja-Wyszomirska J, 2012, PROSTAG OTH LIPID M, V99, P51, DOI 10.1016/j.prostaglandins.2012.06.001
   Ren RX, 2022, HEPATOLOGY, V75, P646, DOI 10.1002/hep.32152
   Sasaki F, 2019, INT IMMUNOL, V31, P607, DOI 10.1093/intimm/dxz044
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   Shen H, 2014, EXP MOL PATHOL, V97, P338, DOI 10.1016/j.yexmp.2014.09.004
   Smathers RL, 2016, MOL IMMUNOL, V72, P9, DOI 10.1016/j.molimm.2016.02.008
   Song MJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107401
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Thurman JM, 2013, J CLIN INVEST, V123, P2218, DOI 10.1172/JCI65861
   Totani Y, 2000, EUR RESPIR J, V15, P75, DOI 10.1034/j.1399-3003.2000.15a14.x
   Vander Ploeg M, 2021, PROSTAG LEUKOTR ESS, V175, DOI 10.1016/j.plefa.2021.102360
   Ventura-Cots M, 2022, GUT, V71, P1856, DOI 10.1136/gutjnl-2021-324295
   Warner D, 2021, HEPATOL COMMUN, V5, P947, DOI 10.1002/hep4.1686
   Warner DR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204119
   Warner DR, 2017, AM J PATHOL, V187, P2232, DOI 10.1016/j.ajpath.2017.06.008
   Whitehead JC, 2014, J GERONTOL A-BIOL, V69, P621, DOI 10.1093/gerona/glt136
   WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674
   Xu GL, 2009, PSYCHIAT CLIN NEUROS, V63, P43, DOI 10.1111/j.1440-1819.2008.01904.x
   Zein CO, 2012, HEPATOLOGY, V56, P1291, DOI 10.1002/hep.25778
   Zhang WL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02759-0
   Zhu DL, 2012, J PHYSIOL SCI, V62, P163, DOI 10.1007/s12576-012-0196-9
NR 84
TC 3
Z9 3
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0741-8329
EI 1873-6823
J9 ALCOHOL
JI Alcohol
PD MAR
PY 2023
VL 107
BP 119
EP 135
DI 10.1016/j.alcohol.2022.08.012
EA MAR 2023
PG 17
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA A4DO4
UT WOS:000954652200001
PM 36150611
OA hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU WOODHOUSE, KW
AF WOODHOUSE, KW
TI DRUGS AND THE AGING GUT, LIVER AND PANCREAS
SO CLINICS IN GASTROENTEROLOGY
LA English
DT Article
C1 UNIV NEWCASTLE UPON TYNE, MED GERIATR, NEWCASTLE NE7 7DN, ENGLAND.
   ROYAL VICTORIA INFIRM, NEWCASTLE UPON TYNE NE1 4LP, TYNE & WEAR, ENGLAND.
C3 Newcastle University - UK; Newcastle University - UK
CR ABERNETHY DR, 1984, CLIN PHARMACOL THER, V35, P188, DOI 10.1038/clpt.1984.25
   ARBOIX M, 1984, BRIT J CLIN PHARMACO, V18, P475, DOI 10.1111/j.1365-2125.1984.tb02494.x
   AYD FJ, 1961, DIS NERV SYST, V22, P388
   AZADKHAN AK, 1980, GUT, V21, P232, DOI 10.1136/gut.21.3.232
   AZADKHAN AK, 1983, INFLAMM BOWEL DIS, P216
   BARON JH, 1983, ACTA GASTRO-ENT BELG, V46, P469
   BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003
   BARTLETT JG, 1984, TXB GASDTROENTEROLOG, P1091
   BASS JW, 1973, J PEDIATR-US, V83, P106, DOI 10.1016/S0022-3476(73)80328-2
   BETTLER S, 1983, SCHWEIZ MED WSCHR, V113, P630
   BOURKE JB, 1978, LANCET, V1, P706
   BULPITT CJ, 1973, BRIT MED J, V3, P485, DOI 10.1136/bmj.3.5878.485
   CAMPBELL WL, 1983, DIS COLON RECTUM, V26, P445, DOI 10.1007/BF02556523
   CARADOCDAVIES TH, 1984, AGE AGEING, V13, P295, DOI 10.1093/ageing/13.5.295
   CASTLEDEN C M, 1977, Age and Ageing, V6, P138, DOI 10.1093/ageing/6.3.138
   CASTLEDEN CM, 1977, BRIT MED J, V1, P10, DOI 10.1136/bmj.1.6052.10
   CASTLEDEN CM, 1979, BRIT J CLIN PHARMACO, V7, P49, DOI 10.1111/j.1365-2125.1979.tb00896.x
   CHAUDHRY AY, 1984, EUR J CLIN PHARMACOL, V27, P303, DOI 10.1007/BF00542164
   CHAUSSADE S, 1984, GASTROEN CLIN BIOL, V8, P152
   CLARKE IMC, 1971, BMJ-BRIT MED J, V2, P531, DOI 10.1136/bmj.2.5760.531-c
   CLINCH D, 1983, J ROY COLL PHYS LOND, V17, P228
   COLLINS FJ, 1979, BRIT MED J, V1, P1673, DOI 10.1136/bmj.1.6179.1673
   CONN HO, 1976, NEW ENGL J MED, V294, P473, DOI 10.1056/NEJM197602262940905
   CROOKS J, 1983, J CHRON DIS, V36, P85, DOI 10.1016/0021-9681(83)90047-4
   CUSACK B, 1979, CLIN PHARMACOL THER, V25, P772
   CUTLER NR, 1984, CLIN PHARMACOL THER, V36, P803, DOI 10.1038/clpt.1984.260
   DOUGLAS AP, 1981, TXB ADVERSE DRUG REA, P202
   DOUGLAS RA, 1961, MED J AUSTRALIA, V2, P893, DOI 10.5694/j.1326-5377.1961.tb70101.x
   DOWLING RH, 1977, CLIN GASTROENTEROL, V6, P141
   DUGGAN JM, 1970, MED J AUSTRALIA, V1, P797, DOI 10.5694/j.1326-5377.1970.tb116815.x
   EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
   FEELY J, 1981, NEW ENGL J MED, V304, P692, DOI 10.1056/NEJM198103193041202
   FEELY J, 1984, BRIT J CLIN PHARMACO, V17, P77, DOI 10.1111/j.1365-2125.1984.tb05002.x
   FEELY J, 1979, J CLIN EXPT GERONTOL, V1, P173
   FORSELL P, 1983, MED J AUSTRALIA, V2, P477, DOI 10.5694/j.1326-5377.1983.tb122596.x
   FRANKLIN JL, 1973, GASTROENTEROLOGY, V64, P517
   FULTON B, 1979, BRIT J CLIN PHARMACO, V7, pP418
   GERSHON H, 1973, P NATL ACAD SCI USA, V70, P909, DOI 10.1073/pnas.70.3.909
   GODSALL JW, 1984, AM J MED, V77, P747, DOI 10.1016/0002-9343(84)90378-4
   GOETZ CG, 1983, ARCH NEUROL-CHICAGO, V40, P325, DOI 10.1001/archneur.1983.04050050093019
   GOUDIE BM, 1982, LANCET, V1, P959
   GUGLER R, 1979, NEW ENGL J MED, V301, P435
   HALE WE, 1983, AGE AGEING, V12, P275, DOI 10.1093/ageing/12.4.275
   HALL RI, 1983, BRIT MED J, V287, P1182, DOI 10.1136/bmj.287.6400.1182
   HEINSIMER JA, 1985, J AM GERIATR SOC, V33, P184, DOI 10.1111/j.1532-5415.1985.tb04890.x
   HUGHES JD, 1983, MED J AUSTRALIA, V2, P12, DOI 10.5694/j.1326-5377.1983.tb142072.x
   HUMPHRIES TJ, 1984, AM J GASTROENTEROL, V79, P593
   INMAN WHW, 1978, BRIT MED J, V2, P1455, DOI 10.1136/bmj.2.6150.1455
   INMAN WHW, 1977, BRIT MED J, V1, P1500, DOI 10.1136/bmj.1.6075.1500
   JAMES OFW, 1983, CLIN GASTROENTEROL, V12, P671
   Jamshidi K, 1972, Minn Med, V55, P545
   JARNER D, 1983, SCAND J RHEUMATOL, V12, P254, DOI 10.3109/03009748309098544
   JARVIS EH, 1981, ADVERSE DRUG REACTIO, V86
   JENIKE MA, 1983, GERIATRICS, V38, P36
   JOLOBE OMP, 1984, DIGESTION, V29, P164, DOI 10.1159/000199027
   KAMPMANN JP, 1979, DRUGS ELDERLY, P77
   KLOTZ U, 1980, NEW ENGL J MED, V302, P1012, DOI 10.1056/NEJM198005013021807
   LAKEBAKAAR G, 1985, BRIT MED J, V290, P241, DOI 10.1136/bmj.290.6463.241-d
   LANGMAN MJS, 1980, MEYLERS SIDE EFFECTS, P618
   LANZA FL, 1981, AM J GASTROENTEROL, V75, P17
   LEEMING JT, 1978, TXB GERIATRIC MED GE, pH106
   LEESER J, 1985, BRIT MED J, V290, P241, DOI 10.1136/bmj.290.6463.241-c
   LEIKOLA E, 1957, J GERONTOL, V12, P48, DOI 10.1093/geronj/12.1.48
   LENDRUM R, 1981, ADVERSE DRUG REACTIO, V90
   LEVY M, 1974, NEW ENGL J MED, V290, P1158, DOI 10.1056/NEJM197405232902102
   LIPOWSKI ZJ, 1984, CLIN NEUROLOGY AGING, P277
   LUDERER JR, 1984, CLIN PHARMACOL THER, V35, P19, DOI 10.1038/clpt.1984.3
   MOGG GAG, 1979, BRIT J SURG, V66, P738, DOI 10.1002/bjs.1800661017
   NOVAK LP, 1972, J GERONTOL, V27, P438, DOI 10.1093/geronj/27.4.438
   OWEN JA, 1983, CLIN PHARMACOL THER, V34, P364, DOI 10.1038/clpt.1983.180
   PARKER WA, 1984, DRUG INTEL CLIN PHAR, V18, P980, DOI 10.1177/106002808401801206
   PARKES JD, 1984, CLIN NEUROPHARMACOL, V7, pS510
   PENFOLD D, 1977, BRIT MED J, V2, P1398
   PINES A, 1984, CURR MED RES OPIN, V8, P734, DOI 10.1185/03007998409110124
   Platt D., 1977, LIVER AGEING, P75
   REGARDH CG, 1983, EUR J CLIN PHARMACOL, V24, P221, DOI 10.1007/BF00613821
   RODYSILL KJ, 1983, ANN INTERN MED, V98, P561, DOI 10.7326/0003-4819-98-4-561_2
   ROGERS AI, 1966, J AMER MED ASSOC, V197, P185, DOI 10.1001/jama.1966.03110030079030
   ROUTLEDGE PA, 1979, BRIT J CLIN PHARMACO, V8, P243, DOI 10.1111/j.1365-2125.1979.tb01009.x
   RUBINOW A, 1984, ANN OPHTHALMOL, V16, P258
   RUBINOW A, 1984, TATROGENIC MORBIDITY
   SCHENTAG JJ, 1979, LANCET, V1, P177, DOI 10.1016/S0140-6736(79)90578-6
   SCHNEIDER RE, 1980, BRIT J CLIN PHARMACO, V10, P169, DOI 10.1111/j.1365-2125.1980.tb01736.x
   SCHULZEDELRIEU K, 1981, NEW ENGL J MED, V305, P29
   SERLIN MJ, 1979, LANCET, V2, P317
   SHEPHERD AMM, 1977, BRIT J CLIN PHARMACO, V4, P315, DOI 10.1111/j.1365-2125.1977.tb00719.x
   Sherlock S., 1981, DISEASES LIVER BILIA, P107
   SHOCK NW, 1963, J GERONTOL, V18, P1
   SJOQVIST F, 1983, J CHRON DIS, V36, P31, DOI 10.1016/0021-9681(83)90040-1
   SKAUNIC V, 1978, LIVER AGING 1978, P115
   Slee G L, 1983, Ned Tijdschr Geneeskd, V127, P1821
   SMITH JM, 1980, ARCH GEN PSYCHIAT, V37, P1368
   SMITHARD DJ, 1978, BRIT J CLIN PHARMACO, V5, P181, DOI 10.1111/j.1365-2125.1978.tb01621.x
   STEPHEN PJ, 1984, LANCET, V2, P1082
   STEWART RB, 1983, DIGEST DIS SCI, V28, P1062, DOI 10.1007/BF01295803
   SWIFT CG, 1978, EUR J CLIN PHARMACOL, V14, P149, DOI 10.1007/BF00607447
   SWIFT CG, 1981, BRIT J CLIN PHARMACO, V11, pP413
   TAGGART HM, 1982, BRIT MED J, V284, P1372, DOI 10.1136/bmj.284.6326.1372
   TEDESCO FJ, 1975, AM J DIG DIS, V20, P295, DOI 10.1007/BF01237785
   THOMAS TPL, 1984, GERONTOLOGY, V30, P60, DOI 10.1159/000212608
   THORSEN WB, 1968, ARCH INTERN MED, V121, P499, DOI 10.1001/archinte.121.6.499
   UTILI R, 1977, GASTROENTEROLOGY, V72, P610
   VANTRAPPEN GN, 1984, TXB GASTROENTEROLOGY, P26
   VERBEECK RK, 1984, EUR J CLIN PHARMACOL, V27, P91, DOI 10.1007/BF00553161
   VESTAL RE, 1975, CLIN PHARMACOL THER, V18, P425
   VESTAL RE, 1977, CLIN PHARMACOL THER, V21, P343
   VESTAL RE, 1979, CLIN PHARMACOL THER, V26, P181
   WIHOLM BE, 1984, BRIT MED J, V288, P545, DOI 10.1136/bmj.288.6416.545
   WILKINSON GR, 1983, J CHRON DIS, V36, P91, DOI 10.1016/0021-9681(83)90048-6
   WILKINSON GR, 1978, ACTA PSYCHIAT SCAND, P56
   WILLIAMSON J, 1980, AGE AGEING, V9, P73, DOI 10.1093/ageing/9.2.73
   WOODHOUSE KW, 1984, EUR J CLIN PHARMACOL, V26, P61, DOI 10.1007/BF00546710
   WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328
   WOODHOUSE KW, 1985, HUM TOXICOL, V4, P67, DOI 10.1177/096032718500400108
   1984, J ROYAL COLLEGE PHYS, V18, P7
   1985, 1985 NAT BOARD HLTH
NR 116
TC 6
Z9 6
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0300-5089
J9 CLIN GASTROENTEROL
PY 1985
VL 14
IS 4
BP 863
EP 881
PG 19
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AUT53
UT WOS:A1985AUT5300012
PM 2867842
DA 2024-02-19
ER

PT J
AU Abuja, PM
   Zatloukal, K
   Denk, H
AF Abuja, Peter M.
   Zatloukal, Kurt
   Denk, Helmut
TI Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for
   a Common Damage Mechanism of Steatohepatitis
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE steatohepatitis; pathomechanism; metabolism; stress defence;
   mitochondrial damage; hypoxic signalling; senescence; cirrhosis;
   hepatocellular carcinoma
ID NONALCOHOLIC FATTY LIVER; ACTIVATED-RECEPTOR-ALPHA; MITOCHONDRIAL
   RESPIRATORY-CHAIN; INDUCED OXIDATIVE STRESS; MALLORY BODY FORMATION;
   HEPATIC PPAR-ALPHA; C-MYC; SUCCINATE-DEHYDROGENASE; MOLECULAR-MECHANISM;
   INSULIN-RESISTANCE
AB Understanding the pathomechanism of steatohepatitis (SH) is hampered by the difficulty of distinguishing between causes and consequences, by the broad spectrum of aetiologies that can produce the phenotype, and by the long time-span during which SH develops, often without clinical symptoms. We propose that SH develops in four phases with transitions: (i) priming lowers stress defence; (ii) triggering leads to acute damage; (iii) adaptation, possibly associated with cellular senescence, mitigates tissue damage, leads to the phenotype, and preserves liver function at a lower level; (iv) finally, senescence prevents neoplastic transformation but favours fibrosis (cirrhosis) and inflammation and further reduction in liver function. Escape from senescence eventually leads to hepatocellular carcinoma. This hypothesis for a pathomechanism of SH is supported by clinical and experimental observations. It allows organizing the various findings to uncover remaining gaps in our knowledge and, finally, to provide possible diagnostic and intervention strategies for each stage of SH development.
C1 [Abuja, Peter M.; Zatloukal, Kurt; Denk, Helmut] Med Univ Graz, Diagnost & Res Inst Pathol, Diagnost & Res Ctr Mol Biomed, A-8010 Graz, Austria.
C3 Medical University of Graz
RP Abuja, PM (corresponding author), Med Univ Graz, Diagnost & Res Inst Pathol, Diagnost & Res Ctr Mol Biomed, A-8010 Graz, Austria.
EM peter.abuja@medunigraz.at; kurt.zatloukal@medunigraz.at;
   helmut.denk@medunigraz.at
OI Abuja, Peter Michael/0000-0003-1957-4066; Zatloukal,
   Kurt/0000-0001-5299-7218
CR Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210
   Agarwal E, 2019, J BIOL CHEM, V294, P10407, DOI 10.1074/jbc.AC119.008656
   Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Fafián-Labora JA, 2020, CELL METAB, V32, P71, DOI 10.1016/j.cmet.2020.06.004
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200
   Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004
   Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226
   Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009
   Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6
   Bicego R, 2020, ARCH BIOCHEM BIOPHYS, V692, DOI 10.1016/j.abb.2020.108535
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503
   Brunt EM, 2012, MacSween's pathology of the liver, P293
   Bruschi FV, 2020, LIVER INT, V40, P1098, DOI 10.1111/liv.14402
   Bruschi FV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228711
   Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Cazzagon N, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100286
   Chan IS, 2012, CANCER RES, V72, P6344, DOI 10.1158/0008-5472.CAN-12-1068
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Chen JD, 2019, AM J PHYSIOL-ENDOC M, V317, pE710, DOI 10.1152/ajpendo.00052.2019
   Chen JX, 2019, AGING-US, V11, P10839, DOI 10.18632/aging.102488
   Chinopoulos C, 2019, INT J BIOCHEM CELL B, V115, DOI 10.1016/j.biocel.2019.105580
   Cho EH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00455
   Cong WN, 2008, LIFE SCI, V82, P983, DOI 10.1016/j.lfs.2008.01.022
   Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659
   CUNNINGHAM CC, 1990, ALCOHOL ALCOHOLISM, V25, P127, DOI 10.1093/oxfordjournals.alcalc.a044987
   Daks A, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03871-w
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877
   DENK H, 1977, LAB INVEST, V36, P563
   Denk H, 2019, EXPERT OPIN THER TAR, V23, P393, DOI 10.1080/14728222.2019.1601703
   Denk H, 2019, BBA-MOL BASIS DIS, V1865, P929, DOI 10.1016/j.bbadis.2018.04.024
   Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935
   Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519
   Ding J, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010123
   Dou FF, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/2045259
   Duan S, 2009, CELL DEATH DIFFER, V16, P826, DOI 10.1038/cdd.2009.12
   Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038
   Effendi K, 2017, HEPATOL RES, V47, P3, DOI 10.1111/hepr.12847
   Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017
   Evangelou E, 2018, NAT GENET, V50, P1755, DOI 10.1038/s41588-018-0297-3
   Fafián-Labora JA, 2020, TRENDS CELL BIOL, V30, P628, DOI 10.1016/j.tcb.2020.05.003
   Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Fink BD, 2014, J PHARMACOL EXP THER, V351, P699, DOI 10.1124/jpet.114.219329
   Fink BD, 2012, J PHARMACOL EXP THER, V342, P709, DOI 10.1124/jpet.112.195586
   Fonseca MD, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0126-1
   Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019
   FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6
   Fuhrmann DC, 2013, BBA-PROTEINS PROTEOM, V1834, P2750, DOI 10.1016/j.bbapap.2013.09.023
   Galloway CA, 2014, AM J PHYSIOL-GASTR L, V307, pG632, DOI 10.1152/ajpgi.00182.2014
   Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796
   Geier A, 2021, GUT, V70, P1570, DOI 10.1136/gutjnl-2020-323202
   Gonzalez FJ, 2018, NAT REV ENDOCRINOL, V15, P21, DOI 10.1038/s41574-018-0096-z
   Gonzalez-Garcia M, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.642623
   Grivennikova VG, 2017, BBA-BIOENERGETICS, V1858, P109, DOI 10.1016/j.bbabio.2016.10.008
   Guldiken N, 2015, HEPATOLOGY, V62, P876, DOI 10.1002/hep.27891
   Hackenbeck T, 2009, CELL CYCLE, V8, P1386, DOI 10.4161/cc.8.9.8306
   Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360
   Halaby MJ, 2013, CELL CYCLE, V12, P2733, DOI 10.4161/cc.25785
   Ham PB, 2017, PROG NEUROBIOL, V157, P92, DOI 10.1016/j.pneurobio.2016.06.006
   Hanada S, 2012, J HISTOCHEM CYTOCHEM, V60, P475, DOI 10.1369/0022155412441478
   Harber KJ, 2020, METABOLITES, V10, DOI 10.3390/metabo10090372
   Harmon GS, 2011, CHEM REV, V111, P6321, DOI 10.1021/cr2001355
   He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12
   Hernández-Rodas MC, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700479
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Ho JJD, 2021, TRENDS BIOCHEM SCI, V46, P171, DOI 10.1016/j.tibs.2020.11.006
   Ho JJD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16504-1
   Ho JJD, 2018, CELL REP, V22, P17, DOI 10.1016/j.celrep.2017.12.031
   Huang H, 2013, PPAR RES, V2013, DOI 10.1155/2013/865604
   Hubbi ME, 2013, J BIOL CHEM, V288, P20768, DOI 10.1074/jbc.M113.476903
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003
   Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5
   Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075
   James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200
   James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200
   Jia P, 2019, EBIOMEDICINE, V49, P331, DOI 10.1016/j.ebiom.2019.10.023
   Jiang T, 2015, FREE RADICAL BIO MED, V88, P199, DOI 10.1016/j.freeradbiomed.2015.06.014
   Joshi-Barve S, 2015, CELL MOL GASTROENTER, V1, P356, DOI 10.1016/j.jcmgh.2015.05.006
   Kageyama S, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00642-17
   Keiran N, 2019, NAT IMMUNOL, V20, P581, DOI 10.1038/s41590-019-0372-7
   Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019
   Kim D, 2019, HEPATOLOGY, V70, P154, DOI 10.1002/hep.30530
   King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594
   Kleiner DE, 2018, MINERVA GASTROENTERO, V64, P28, DOI 10.23736/S1121-421X.17.02445-X
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020
   Kucukoglu O, 2014, HEPATOLOGY, V60, P169, DOI 10.1002/hep.27068
   Kuwano A, 2021, BIOCHEM BIOPHYS REP, V27, DOI 10.1016/j.bbrep.2021.101068
   Kuwano A, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.10028
   Kwan R, 2012, FASEB J, V26, P2318, DOI 10.1096/fj.11-198580
   Lahiri P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161083
   Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x
   Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10
   Lee KK, 2015, HEPATOLOGY, V61, P326, DOI 10.1002/hep.27385
   Leung YY, 2015, SEMIN ARTHRITIS RHEU, V45, P341, DOI 10.1016/j.semarthrit.2015.06.013
   Levy S, 2010, IUBMB LIFE, V62, P237, DOI 10.1002/iub.314
   Li DW, 2017, FREE RADICAL BIO MED, V110, P102, DOI 10.1016/j.freeradbiomed.2017.06.002
   Li J, 2017, BBA-MOL BASIS DIS, V1863, P2835, DOI 10.1016/j.bbadis.2017.07.017
   Li MH, 2019, J PHARMACOL EXP THER, V369, P67, DOI 10.1124/jpet.118.255216
   Li YH, 2015, BIOCHEM BIOPH RES CO, V463, P853, DOI 10.1016/j.bbrc.2015.06.023
   Lian AJ, 2017, MOL CELL ENDOCRINOL, V439, P395, DOI 10.1016/j.mce.2016.09.030
   Linares JF, 2015, CELL REP, V12, P1339, DOI 10.1016/j.celrep.2015.07.045
   Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020
   Liu SS, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03671-2
   Lu YT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0708-5
   Machado MV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060857
   Machado MV, 2016, GASTROENTEROLOGY, V150, P1769, DOI 10.1053/j.gastro.2016.02.066
   Macias-Ceja DC, 2019, MUCOSAL IMMUNOL, V12, P178, DOI 10.1038/s41385-018-0087-3
   Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441
   Mahajan V, 2011, GASTROENTEROLOGY, V141, P1080, DOI 10.1053/j.gastro.2011.05.039
   Maher JM, 2008, TOXICOL SCI, V106, P319, DOI 10.1093/toxsci/kfn177
   Malik A, 2021, CLIN J GASTROENTEROL, V14, P1579, DOI 10.1007/s12328-021-01491-7
   Manley S, 2013, EXP BIOL MED, V238, P525, DOI 10.1177/1535370213489446
   Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868
   Marchesi N, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4956080
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Matlac DM, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.589451
   MCCLUSKEY SA, 1986, MOL PHARMACOL, V30, P352
   MCCLUSKEY SA, 1988, MOL PHARMACOL, V34, P80
   McGill MR, 2019, BBA-MOL BASIS DIS, V1865, P1031, DOI 10.1016/j.bbadis.2018.08.037
   McGill MR, 2018, EXPERT REV MOL DIAGN, V18, P797, DOI 10.1080/14737159.2018.1508998
   McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008
   Mills EL, 2021, NAT METAB, V3, P604, DOI 10.1038/s42255-021-00389-5
   Moschen AR, 2013, TRENDS ENDOCRIN MET, V24, P537, DOI 10.1016/j.tem.2013.05.009
   Mossa AH, 2017, CELL SIGNAL, V37, P31, DOI 10.1016/j.cellsig.2017.05.014
   Moustakas II, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073446
   Mouzaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151829
   Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319
   Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399
   Nakamura A, 2013, INT J MOL SCI, V14, P21240, DOI 10.3390/ijms141121240
   Nalbantoglu I, 2014, WORLD J GASTROENTERO, V20, P9026, DOI 10.3748/wjg.v20.i27.9026
   Nan L, 2004, EXP MOL PATHOL, V77, P168, DOI 10.1016/j.yexmp.2004.06.003
   Navarro CDC, 2017, FREE RADICAL BIO MED, V113, P190, DOI 10.1016/j.freeradbiomed.2017.09.026
   Nesci S, 2020, TRENDS CELL BIOL, V30, P1, DOI 10.1016/j.tcb.2019.11.001
   Neuman MG, 2014, EXP MOL PATHOL, V97, P492, DOI 10.1016/j.yexmp.2014.09.005
   Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719
   Nikam A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31389-3
   Nikam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066094
   Ogrodnik M, 2017, CELL STRESS, V1, P70, DOI 10.15698/cst2017.10.108
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Pantazi E, 2013, WORLD J GASTROENTERO, V19, P7594, DOI 10.3748/wjg.v19.i43.7594
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Park JS, 2020, AUTOPHAGY, V16, P86, DOI 10.1080/15548627.2019.1598751
   Park SY, 2018, BIOCHEM BIOPH RES CO, V496, P673, DOI 10.1016/j.bbrc.2018.01.106
   Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004
   Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929
   Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x
   Polotsky VY, 2009, AM J RESP CRIT CARE, V179, P228, DOI 10.1164/rccm.200804-608OC
   Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400
   Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629
   Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089
   Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796
   Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09
   Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453
   Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038
   Régnier M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63579-3
   Riley NE, 2003, EXP MOL PATHOL, V74, P173, DOI 10.1016/S0014-4800(03)00005-4
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049
   Ryan DG, 2019, NAT METAB, V1, P16, DOI 10.1038/s42255-018-0014-7
   Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010
   Sanguino E, 2005, BRIT J PHARMACOL, V145, P853, DOI 10.1038/sj.bjp.0706260
   Sarin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.201
   Schafer MJ, 2017, MOL CELL ENDOCRINOL, V455, P93, DOI 10.1016/j.mce.2016.08.047
   Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022
   Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x
   Shaban Z, 2004, J VET MED SCI, V66, P1377, DOI 10.1292/jvms.66.1377
   Sheard MA, 2002, J CELL BIOCHEM, V85, P670, DOI 10.1002/jcb.10173
   Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82
   Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590
   Singla A, 2012, HEPATOLOGY, V56, P322, DOI 10.1002/hep.25664
   Smati S, 2022, GUT, V71, P807, DOI 10.1136/gutjnl-2020-323323
   Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x
   Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012
   Stienstra R, 2007, ENDOCRINOLOGY, V148, P2753, DOI 10.1210/en.2007-0014
   Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008
   Stumptner C, 2001, J HEPATOL, V34, P665, DOI 10.1016/S0168-8278(00)00099-4
   Stumptner C, 2007, HEPATOLOGY, V46, P851, DOI 10.1002/hep.21744
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Sulkowski PL, 2020, NATURE, V582, P586, DOI 10.1038/s41586-020-2363-0
   Sundaram SS, 2019, HEPATOL COMMUN, V3, P883, DOI 10.1002/hep4.1354
   Sundaram SS, 2016, J HEPATOL, V65, P560, DOI 10.1016/j.jhep.2016.04.010
   Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998
   Tarantino G, 2007, EUR J CLIN INVEST, V37, P48, DOI 10.1111/j.1365-2362.2007.01745.x
   Tian M, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03514-0
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Tirosh O, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2548154
   Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277
   Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563
   Wang H, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101148
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Williams JA, 2015, PHARMACOL RES, V102, P264, DOI 10.1016/j.phrs.2015.09.020
   Wong HS, 2021, FREE RADICAL BIO MED, V164, P223, DOI 10.1016/j.freeradbiomed.2020.12.447
   Woolbright Benjamin L, 2018, Curr Pharmacol Rep, V4, P346, DOI 10.1007/s40495-018-0147-0
   Wyss RK, 2021, AM J TRANSPLANT, V21, P1003, DOI 10.1111/ajt.16258
   Xu CY, 2020, NAT CELL BIOL, V22, P1170, DOI 10.1038/s41556-020-00579-5
   Xu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079841
   Yamada T, 2019, AUTOPHAGY, V15, P2012, DOI 10.1080/15548627.2019.1643185
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
   Yi WW, 2020, J CELL PHYSIOL, V235, P8402, DOI 10.1002/jcp.29684
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8
   Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001
   Zhu CY, 2021, NAT REV GASTRO HEPAT, V18, P131, DOI 10.1038/s41575-020-00365-6
   Zhu CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0344
   Zhu YM, 2013, CURR OPIN ONCOL, V25, P630, DOI 10.1097/01.cco.0000432527.49984.a3
   Zimmermann HW, 2012, LIVER INT, V32, P500, DOI 10.1111/j.1478-3231.2011.02665.x
NR 229
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2021
VL 22
IS 22
AR 12545
DI 10.3390/ijms222212545
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA XK7FF
UT WOS:000727626000001
PM 34830427
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Borkham-Kamphorst, E
   Schaffrath, C
   Van de Leur, E
   Haas, U
   Tihaa, L
   Meurer, SK
   Nevzorova, YA
   Liedtke, C
   Weiskirchen, R
AF Borkham-Kamphorst, Erawan
   Schaffrath, Christian
   Van de Leur, Eddy
   Haas, Ute
   Tihaa, Lidia
   Meurer, Steffen K.
   Nevzorova, Yulia A.
   Liedtke, Christian
   Weiskirchen, Ralf
TI The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts
   are mediated through induction of reactive oxygen species resulting in
   cellular senescence, apoptosis and attenuated TGF-β signaling
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Article
DE Portal myofibroblast; Hepatic stellate cell; Myofibroblast; Apoptosis;
   CCN protein; Senescence
ID PROTEIN CCN1 CYR61; HEPATIC STELLATE CELLS; LIVER FIBROSIS;
   GROWTH-FACTOR; MATRICELLULAR PROTEIN; RAT-LIVER; TNF-ALPHA; EXPRESSION;
   FIBROBLASTS; ACTIVATION
AB Cysteine-rich protein 61 (CCN1/CYR61) is a CCN (CYR61, CTGF (connective tissue growth factor), and NOV (Nephroblastoma overexpressed gene)) family matricellular protein comprising six secreted CCN proteins in mammals. CCN1/CYR61 expression is associated with inflammation and injury repair. Recent studies show that CCN1/CYR61 limits fibrosis in models of cutaneous wound healing by inducing cellular senescence in myofibroblasts of the granulation tissue which thereby transforms into an extracellular matrix-degrading phenotype. We here investigate CCN1/CYR61 expression in primary profibrogenic liver cells (i.e., hepatic stellate cells and periportal myofibroblasts) and found an increase of CCN1/CYR61 expression during early activation of hepatic stellate cells that declines in fully transdifferentiated myofibroblasts. By contrast, CCN1/CYR61 levels found in primary parenchymal liver cells (i.e., hepatocytes) were relatively low compared to the levels exhibited in hepatic stellate cells and portal myofibroblasts. In models of ongoing liver fibrogenesis, elevated levels of CCN1/CYR61 were particularly noticed during early periods of insult, while expression declined during prolonged phases of fibrogenesis. We generated an adenovirus type 5 encoding CCN1/CYR61 (i.e., Ad5-CMV-CCN1/CYR61) and overexpressed CCN1/CYR61 in primary portal myofibroblasts. Interestingly, overexpressed CCN1/CYR61 significantly inhibited production of collagen type I at both mRNA and protein levels as evidenced by quantitative real-time polymerase chain reaction, Western blot and immunocytochemistry. CCN1/CYR61 further induces production of reactive oxygen species (ROS) leading to dose-dependent cellular senescence and apoptosis. Additionally, we demonstrate that CCN1/CYR61 attenuates TGF-beta signaling by scavenging TGF-beta thereby mitigating in vivo liver fibrogenesis in a bile duct ligation model. Conclusion: In line with dermal fibrosis and scar formation, CCN1/CYR61 is involved in liver injury repair and tissue remodeling. CCN1/CYR61 gene transfer into extracellular matrix-producing liver cells is therefore potentially beneficial in liver fibrotic therapy. (c) 2014 Elsevier B.V. All rights reserved.
C1 [Borkham-Kamphorst, Erawan; Schaffrath, Christian; Van de Leur, Eddy; Haas, Ute; Tihaa, Lidia; Meurer, Steffen K.; Weiskirchen, Ralf] RWTH Aachen Univ Hosp, Inst Clin Chem & Pathobiochem, Aachen, Germany.
   [Nevzorova, Yulia A.; Liedtke, Christian] RWTH Aachen Univ Hosp, Dept Internal Med 3, Aachen, Germany.
C3 RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen
   University; RWTH Aachen University Hospital
RP Borkham-Kamphorst, E (corresponding author), RWTH Univ Hosp, Inst Clin Chem & Pathobiochem, D-52074 Aachen, Germany.
EM ekamphorst@ukaachen.de; rweiskirchen@ukaachen.de
RI Weiskirchen, Ralf/O-1734-2018; Liedtke, Christian/DTV-1874-2022
OI Weiskirchen, Ralf/0000-0003-3888-0931; Liedtke,
   Christian/0000-0003-4681-7887; Nevzorova, Yulia A/0000-0003-1390-8002
FU START project, Faculty of Medicine, RWTH-Aachen University; Deutsche
   Forschungsgemeinschaft [SFB/TRR57 P13]; Wilhelm-Sander Foundation for
   Cancer Research
FX This work was supported by grants from the START project, Faculty of
   Medicine, RWTH-Aachen University and the Deutsche Forschungsgemeinschaft
   (SFB/TRR57 P13). Y.A.N. is supported by the Wilhelm-Sander Foundation
   for Cancer Research. The authors extend their sincere thanks to Sabine
   Weiskirchen, Carmen Tag, and Sibille Sauer-Lehnen for technical
   assistance and primary cell isolation.
CR Arias M, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-29
   Athanasopoulos AN, 2007, J BIOL CHEM, V282, P26746, DOI 10.1074/jbc.M705200200
   Beaussier M, 2007, LAB INVEST, V87, P292, DOI 10.1038/labinvest.3700513
   BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N
   Borkham-Kamphorst E, 2004, LAB INVEST, V84, P766, DOI 10.1038/labinvest.3700094
   Borkham-Kamphorst E, 2008, LAB INVEST, V88, P1090, DOI 10.1038/labinvest.2008.71
   Borkham-Kamphorst E, 2012, LIVER INT, V32, P1342, DOI 10.1111/j.1478-3231.2012.02837.x
   BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503
   Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596
   Chen CC, 2010, J CELL COMMUN SIGNAL, V4, P63, DOI 10.1007/s12079-009-0080-4
   Cmielová J, 2012, J CELL BIOCHEM, V113, P1450, DOI 10.1002/jcb.24072
   Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x
   Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441
   Guyot C, 2007, J HEPATOL, V46, P142, DOI 10.1016/j.jhep.2006.08.013
   Hadjiargyrou M, 2000, J BONE MINER RES, V15, P1014, DOI 10.1359/jbmr.2000.15.6.1014
   Hilfiker-Kleiner D, 2004, CIRCULATION, V109, P2227, DOI 10.1161/01.CIR.0000127952.90508.9D
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Juric V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031303
   Juric V, 2009, MOL CELL BIOL, V29, P3266, DOI 10.1128/MCB.00064-09
   Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kinnman N, 2002, FRONT BIOSCI-LANDMRK, V7, pD496, DOI 10.2741/kinnman
   Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kruglov EA, 2002, J INVEST MED, V50, P179, DOI 10.2310/6650.2002.33431
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270
   Leu SJ, 2004, J BIOL CHEM, V279, P44177, DOI 10.1074/jbc.M407850200
   Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792
   Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002
   Sawai K, 2007, AM J PHYSIOL-RENAL, V293, pF1363, DOI 10.1152/ajprenal.00205.2007
   SAWTELL NM, 1989, J CELL BIOL, V109, P2929, DOI 10.1083/jcb.109.6.2929
   SCHAFER S, 1987, HEPATOLOGY, V7, P680, DOI 10.1002/hep.1840070411
   Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015
   Tuchweber B, 1996, LAB INVEST, V74, P265
   WEISKIRCHEN R, 1993, ONCOGENE, V8, P2317
   Weiskirchen R, 2011, FRONT BIOSCI-LANDMRK, V16, P1939, DOI 10.2741/3832
NR 40
TC 80
Z9 86
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 0006-3002
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD MAY
PY 2014
VL 1843
IS 5
BP 902
EP 914
DI 10.1016/j.bbamcr.2014.01.023
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA AF1LZ
UT WOS:000334476700009
PM 24487063
OA hybrid
DA 2024-02-19
ER

PT J
AU Moscato, S
   Cabiati, M
   Bianchi, F
   Panetta, D
   Burchielli, S
   Massimetti, G
   Del Ry, S
   Mattii, L
AF Moscato, Stefania
   Cabiati, Manuela
   Bianchi, Francesco
   Panetta, Daniele
   Burchielli, Silvia
   Massimetti, Gabriele
   Del Ry, Silvia
   Mattii, Letizia
TI Heart and liver connexin expression related to the first stage of aging:
   A study on naturally aged animals
SO ACTA HISTOCHEMICA
LA English
DT Article
DE Aging; Connexin; Rat; Heart; Liver; Immunohistochemistry
ID ATRIAL-FIBRILLATION
AB Connexins are membrane-spanning proteins that form membrane channels and hemichannels. They are involved in the cellular communication and in the maintenance of tissue homeostasis. Recent studies in humans and animals have demonstrated that the expression and distribution of Cx43, the most studied connexin, can change during aging. However, the research on the involvement of the other connexins in cardiac and hepatic aging is, at present, still very poor. Hence, the aim of this study is to evaluate the expression of Cx43 and Cx26 in the heart as well as Cx26 and Cx32 in the liver of a rat model that aged naturally, rather than prematurely because of genetic mutations or age-related diseases.
   The results obtained in the present study have demonstrated that these connexins decrease in rat cardiomyocytes and in rat hepatocytes as they age. This change was revealed only at protein level, as connexinmRNAs remained unchanged during aging. Moreover, the aged rats showed an increase in body fat, whose subcutaneous layer tended to be higher.
   Finally, how these changes could represent signs of physiological adaptation in successful aging was discussed.
C1 [Moscato, Stefania; Bianchi, Francesco; Mattii, Letizia] Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embriol, Pisa, Italy.
   [Moscato, Stefania; Mattii, Letizia] Univ Pisa, Interdept Res Ctr Nutraceut & Food Hlth, Pisa, Italy.
   [Moscato, Stefania] Smart Biointerfaces, Italian Inst Technol, Pisa, Italy.
   [Cabiati, Manuela; Panetta, Daniele; Del Ry, Silvia] CNR, Lab Biochem & Mol Biol, Inst Clin Physiol, Pisa, Italy.
   [Burchielli, Silvia] G Monasterio Fdn, Pisa, Italy.
   [Massimetti, Gabriele] Univ Pisa, Dept Clin & Expt Med, Psychiat Clin, Pisa, Italy.
   [Del Ry, Silvia] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.
C3 University of Pisa; University of Pisa; Istituto Italiano di Tecnologia
   - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia
   Clinica (IFC-CNR); University of Pisa; Scuola Superiore Sant'Anna
RP Mattii, L (corresponding author), Univ Pisa, Dept Clin & Expt Med, Via Roma 55, I-56126 Pisa, Italy.
EM letizia.mattii@med.unipi.it
RI Panetta, Daniele/A-8580-2013; MATTII, LETIZIA/B-6123-2018; Mattii,
   Letizia/AAZ-4735-2021; Del Ry, Silvia/C-1149-2015; MOSCATO,
   STEFANIA/B-6151-2018; Cabiati, Manuela/K-1306-2014
OI Panetta, Daniele/0000-0002-4184-0175; MATTII,
   LETIZIA/0000-0001-6835-7987; Del Ry, Silvia/0000-0001-7163-245X;
   MOSCATO, STEFANIA/0000-0001-9283-6902; Cabiati,
   Manuela/0000-0002-0811-6257
FU University of Pisa
FX This research was supported by a grant from University of Pisa.
CR Boengler K, 2006, EXP GERONTOL, V41, P485, DOI 10.1016/j.exger.2006.01.011
   Bonda TA, 2016, J CARDIOL, V68, P261, DOI 10.1016/j.jjcc.2015.10.001
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cabiati M, 2020, EXP GERONTOL, V133, DOI 10.1016/j.exger.2020.110879
   Cabiati M, 2020, PEPTIDES, V123, DOI 10.1016/j.peptides.2019.170173
   Cheng Z, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156423
   Cui L, 2018, MOL HUM REPROD, V24, P27, DOI 10.1093/molehr/gax058
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   De Maio A, 2002, J CELL PHYSIOL, V191, P269, DOI 10.1002/jcp.10108
   Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355
   Hausner EA, 2019, DRUG METAB DISPOS, V47, P673, DOI 10.1124/dmd.119.086611
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Jones SA, 2015, MECH AGEING DEV, V146, P72, DOI 10.1016/j.mad.2015.05.001
   Leybaert L, 2017, PHARMACOL REV, V69, P396, DOI 10.1124/pr.115.012062
   Moscato S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32405-2
   Mueller EE, 2011, CARDIOVASC RES, V89, P623, DOI 10.1093/cvr/cvq351
   Nagibin V, 2016, PHYSIOL RES, V65, pS91, DOI 10.33549/physiolres.933389
   Naiki-Ito A, 2012, TOXICOL PATHOL, V40, P715, DOI 10.1177/0192623312441402
   Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016
   Randhawa PK, 2018, KOREAN J PHYSIOL PHA, V22, P467
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   Sáez JC, 2014, FEBS LETT, V588, P1205, DOI 10.1016/j.febslet.2014.03.004
   Totland MZ, 2020, CELL MOL LIFE SCI, V77, P573, DOI 10.1007/s00018-019-03285-0
   Tribulová N, 2008, PHYSIOL RES, V57, pS1, DOI 10.33549/physiolres.931546
   Tribulova N, 2015, J ELECTROCARDIOL, V48, P434, DOI 10.1016/j.jelectrocard.2015.02.006
   Watanabe Masazumi, 2004, Exp Clin Cardiol, V9, P130
   Wu X, 2014, BIOCHEM BIOPH RES CO, V452, P340, DOI 10.1016/j.bbrc.2014.08.063
   Yan JJ, 2018, J MOL CELL CARDIOL, V114, P105, DOI 10.1016/j.yjmcc.2017.11.006
   Yanguas SC, 2016, EXCLI J, V15, P177, DOI 10.17179/excli2016-119
NR 29
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0065-1281
EI 1618-0372
J9 ACTA HISTOCHEM
JI Acta Histochem.
PD DEC
PY 2020
VL 122
IS 8
AR 151651
DI 10.1016/j.acthis.2020.151651
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA OY0PE
UT WOS:000593955400018
PM 33171391
DA 2024-02-19
ER

PT J
AU Capri, M
   Olivieri, F
   Lanzarini, C
   Remondini, D
   Borelli, V
   Lazzarini, R
   Graciotti, L
   Albertini, MC
   Bellavista, E
   Santoro, A
   Biondi, F
   Tagliafico, E
   Tenedini, E
   Morsiani, C
   Pizza, G
   Vasuri, F
   D'Errico, A
   Dazzi, A
   Pellegrini, S
   Magenta, A
   D'Agostino, M
   Capogrossi, MC
   Cescon, M
   Rippo, MR
   Procopio, AD
   Franceschi, C
   Grazi, GL
AF Capri, Miriam
   Olivieri, Fabiola
   Lanzarini, Catia
   Remondini, Daniel
   Borelli, Vincenzo
   Lazzarini, Raffaella
   Graciotti, Laura
   Albertini, Maria Cristina
   Bellavista, Elena
   Santoro, Aurelia
   Biondi, Fiammetta
   Tagliafico, Enrico
   Tenedini, Elena
   Morsiani, Cristina
   Pizza, Grazia
   Vasuri, Francesco
   D'Errico, Antonietta
   Dazzi, Alessandro
   Pellegrini, Sara
   Magenta, Alessandra
   D'Agostino, Marco
   Capogrossi, Maurizio C.
   Cescon, Matteo
   Rippo, Maria Rita
   Procopio, Antonio Domenico
   Franceschi, Claudio
   Grazi, Gian Luca
TI Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human
   liver aging markers sensitive to donor-recipient age-mismatch in
   transplants
SO AGING CELL
LA English
DT Article
DE age-mismatches; allograft; elderly donors; GLT1; microRNAs; N-glycans;
   telomere length
ID SERUM-PROTEIN GLYCOMICS; RAT-LIVER; SENESCENCE; EXPRESSION; OLDER
AB To understand why livers from aged donors are successfully used for transplants, we looked for markers of liver aging in 71 biopsies from donors aged 12-92years before transplants and in 11 biopsies after transplants with high donor-recipient age-mismatch. We also assessed liver function in 36 age-mismatched recipients. The major findings were the following: (i) miR-31-5p, miR-141-3p, and miR-200c-3p increased with age, as assessed by microRNAs (miRs) and mRNA transcript profiling in 12 biopsies and results were validated by RT-qPCR in a total of 58 biopsies; (ii) telomere length measured by qPCR in 45 samples showed a significant age-dependent shortage; (iii) a bioinformatic approach combining transcriptome and miRs data identified putative miRs targets, the most informative being GLT1, a glutamate transporter expressed in hepatocytes. GLT1 was demonstrated by luciferase assay to be a target of miR-31-5p and miR-200c-3p, and both its mRNA (RT-qPCR) and protein (immunohistochemistry) significantly decreased with age in liver biopsies and in hepatic centrilobular zone, respectively; (iv) miR-31-5p, miR-141-3p and miR-200c-3p expression was significantly affected by recipient age (older environment) as assessed in eleven cases of donor-recipient extreme age-mismatch; (v) the analysis of recipients plasma by N-glycans profiling, capable of assessing liver functions and biological age, showed that liver function recovered after transplants, independently of age-mismatch, and recipients apparently rejuvenated' according to their glycomic age. In conclusion, we identified new markers of aging in human liver, their relevance in donor-recipient age-mismatches in transplantation, and offered positive evidence for the use of organs from old donors.
C1 [Capri, Miriam; Lanzarini, Catia; Borelli, Vincenzo; Bellavista, Elena; Morsiani, Cristina; Pizza, Grazia] Alma Mater Studiorum, DIMES Dept Expt Diagnost & Specialty Med, Via S Giacomo 12, Bologna, Italy.
   [Capri, Miriam; Remondini, Daniel; Bellavista, Elena; Santoro, Aurelia; Biondi, Fiammetta] Alma Mater Studiorum, CIG, Interdept Ctr L Galvani, Pzza Porta S Donato 1, Bologna, Italy.
   [Olivieri, Fabiola; Lazzarini, Raffaella; Graciotti, Laura; Rippo, Maria Rita; Procopio, Antonio Domenico] Univ Politecn Marche, Dept Clin & Mol Sci, Via Tronto 10-A, Ancona, Italy.
   [Olivieri, Fabiola; Procopio, Antonio Domenico] INRCA IRCCS Natl Inst, Ctr Clin Pathol & Innovat Therapy, Via S Margherita 5, I-60124 Ancona, Italy.
   [Remondini, Daniel] Alma Mater Studiorum, Dept Phys & Astron DIFA, Via Berti Pichat 9-2, Bologna, Italy.
   [Remondini, Daniel] Alma Mater Studiorum, INFN Sez Bologna, Via Berti Pichat 9-2, Bologna, Italy.
   [Albertini, Maria Cristina] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.
   [Tagliafico, Enrico; Tenedini, Elena] Univ Modena & Reggio Emilia, Dept Life Sci, Ctr Genome Res, Via Campi 287, Modena, Italy.
   [Vasuri, Francesco; D'Errico, Antonietta] St Orsola Marcello Malpighi Hosp, F Addarii Inst Oncol & Transplant Pathol DIMES, I-40138 Bologna, Italy.
   [Dazzi, Alessandro; Pellegrini, Sara; Cescon, Matteo] St Orsola Marcello Malpighi Hosp, DIMEC Dept Gen Surg & Med Sci, I-40138 Bologna, Italy.
   [Magenta, Alessandra; Capogrossi, Maurizio C.] FLMM, Ist Dermopat Immacolata IRCCS, Vasc Pathol Lab, Via Monti Creta 104, I-00167 Rome, Italy.
   [D'Agostino, Marco] Sapienza Univ Rome, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy.
   [Franceschi, Claudio] Inst Neurol Sci Bologna, IRCCS, I-40139 Bologna, Italy.
   [Grazi, Gian Luca] Ist Nazl Tumori Regina Elena, Via Elio Chianesi 53, I-00144 Rome, Italy.
C3 Marche Polytechnic University; IRCCS INRCA; Istituto Nazionale di Fisica
   Nucleare (INFN); University of Urbino; Universita di Modena e Reggio
   Emilia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS
   Azienda Ospedaliero-Universitaria di Bologna; IRCCS Istituto Dermopatico
   dell'Immacolata (IDI); Sapienza University Rome; IRCCS Istituto delle
   Scienze Neurologiche di Bologna (ISNB); IRCCS Istituti Fisioterapici
   Ospitalieri (IFO); IRCCS Regina Elena
RP Capri, M (corresponding author), Alma Mater Studiorum, DIMES Dept Expt Diagnost & Specialty Med, Via S Giacomo 12, Bologna, Italy.
EM miriam.capri@unibo.it
RI Capri, Miriam/K-4700-2016; Remondini, Daniel/ABA-9971-2020; Olivieri,
   Fabiola/K-6465-2016; Grazi, Gian Luca/J-7215-2018; Franceschi,
   Claudio/L-4484-2017; D'ERRICO, ANTONIETTA/HGU-1912-2022; Vasuri,
   Francesco/K-5418-2016; magenta, alessandra/A-9473-2017; Tagliafico,
   Enrico/C-9079-2009; Procopio, Antonio Domenico/AAB-2451-2021; Albertini,
   Maria Cristina/AAG-6980-2019; tenedini, elena/ABB-3411-2020
OI Capri, Miriam/0000-0001-9077-0401; Olivieri,
   Fabiola/0000-0002-9606-1144; Grazi, Gian Luca/0000-0002-3279-0313;
   D'ERRICO, ANTONIETTA/0000-0003-2747-3732; Vasuri,
   Francesco/0000-0002-1145-6025; magenta, alessandra/0000-0002-9054-337X;
   Tagliafico, Enrico/0000-0003-0981-2542; Procopio, Antonio
   Domenico/0000-0001-6897-8724; Albertini, Maria
   Cristina/0000-0003-4549-1475; Remondini, Daniel/0000-0003-3185-7456;
   RIPPO, Maria Rita/0000-0003-3024-3495; Graciotti,
   Laura/0000-0002-1874-5217; Cescon, Matteo/0000-0003-1715-3794; Santoro,
   Aurelia/0000-0002-7187-1116; TENEDINI, Elena/0000-0003-0285-765X
FU PRIN; Universita Politecnica delle Marche; Grande Oriente d'Italia
   (GOI), Massoneria Italiana, Collegio delle Marche;  [FP7
   EU-259679-IDEAL];  [FP7 EU-602757-HUMAN]
FX This work was funded by PRIN2008 to GLG; FP7 EU-259679-IDEAL:
   'Integrated research on DEvelopmental determinants of Aging and
   Longevity' to CF; FP7 EU-602757-HUMAN: 'Health and the understanding of
   Metabolism, Aging and Nutrition' to CF. Further funds from the
   'Universita Politecnica delle Marche' to ADP and FO and in part by
   Grande Oriente d'Italia (GOI), Massoneria Italiana, Collegio delle
   Marche.
CR Agrawal P, 2014, P NATL ACAD SCI USA, V111, P4338, DOI 10.1073/pnas.1321524111
   Albertini MC, 2011, J BIOMED INFORM, V44, P615, DOI 10.1016/j.jbi.2011.02.006
   Banaudha K, 2011, HEPATOLOGY, V53, P53, DOI 10.1002/hep.24016
   Bates DJ, 2010, AGING CELL, V9, P1, DOI 10.1111/j.1474-9726.2009.00529.x
   Berger UV, 2006, ANAT EMBRYOL, V211, P595, DOI 10.1007/s00429-006-0109-x
   Bernardi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076540
   Bertuzzo VR, 2017, ANN SURG, V265, P388, DOI 10.1097/SLA.0000000000001681
   Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010
   Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006
   Cescon M, 2003, LIVER TRANSPLANT, V9, P1174, DOI 10.1053/jlts.2003.50234
   Cescon M, 2008, LIVER TRANSPLANT, V14, P672, DOI 10.1002/lt.21433
   Chen CY, 2009, J PROTEOME RES, V8, P463, DOI 10.1021/pr800656e
   Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Dall'Olio F, 2013, AGEING RES REV, V12, P685, DOI 10.1016/j.arr.2012.02.002
   Dimri M, 2013, CELL CYCLE, V12, P3537, DOI 10.4161/cc.26592
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Gastaca M, 2005, TRANSPLANT P, V37, P3851, DOI 10.1016/j.transproceed.2005.10.040
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Karpen SJ, 2010, HEPATOLOGY, V51, P364, DOI 10.1002/hep.23447
   KRITI J, 2014, J GERONTOL A-BIOL, V69, P779
   Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675
   Lakner AM, 2011, WORLD J GASTROENTERO, V17, P2536, DOI 10.3748/wjg.v17.i20.2536
   Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42
   Odze RD, 2009, SURG PATHOLOGY G I T
   Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001
   Ravaioli M, 2009, TRANSPL INT, V22, P423, DOI 10.1111/j.1432-2277.2008.00812.x
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606
   Sersté T, 2006, ACTA GASTRO-ENT BELG, V69, P296
   Shenvi SV, 2012, AGING CELL, V11, P297, DOI 10.1111/j.1474-9726.2011.00788.x
   Thorsen T, 2015, TRANSPLANTATION, V99, P2534, DOI 10.1097/TP.0000000000000728
   Vanderschaeghe D, 2009, MOL CELL PROTEOMICS, V8, P986, DOI 10.1074/mcp.M800470-MCP200
   Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z
   Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556
   Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
NR 40
TC 42
Z9 43
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR
PY 2017
VL 16
IS 2
BP 262
EP 272
DI 10.1111/acel.12549
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EM5UP
UT WOS:000395379500008
PM 27995756
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Gomez, CR
   Nomellini, V
   Baila, H
   Oshima, K
   Kovacs, EJ
AF Gomez, Christian R.
   Nomellini, Vanessa
   Baila, Horea
   Oshima, Kiyoko
   Kovacs, Elizabeth J.
TI COMPARISON OF THE EFFECTS OF AGING AND IL-6 ON THE HEPATIC INFLAMMATORY
   RESPONSE IN TWO MODELS OF SYSTEMIC INJURY: SCALD INJURY VERSUS IP LPS
   ADMINISTRATION
SO SHOCK
LA English
DT Article
DE Aging; ALT; burn; IL-6; liver; LPS
ID MULTIPLE ORGAN FAILURE; CELL-MEDIATED-IMMUNITY; ACUTE-PHASE RESPONSE;
   BURN INJURY; SEPTIC SHOCK; AGED MICE; EXPRESSION; INTERLEUKIN-6; MOUSE;
   REACTIVITY
AB Regard less of age, a marked elevation in circulating IL-6 levels correlates with increased mortality after injury or an inflammatory challenge. We previously reported that aged IL-6 knockout mice given LIPS have improved survival and reduced inflammatory response than LPS-treated aged wild type (WT) mice. Herein, we analyzed the effects of aging and IL-6 on the hepatic inflammatory response in two models of systemic injury: dorsal scald (burn) injury versus intraperitoneal LIPS administration. At 24 h after burn injury, circulating alanine aminotransferase and hepatic neutrophil accumulation were comparable regardless of age or IL-6 deficiency. However, at this same time point, these indicators of liver damage, in addition to hepatic levels of KC, a neutrophil chemoattractant, were increased in aged WT mice given LIPS relative to young WT mice given LIPS. The hepatic injury was drastically reduced in aged IL-6 knockout mice given LPS as compared with LPS-exposed aged WT mice. Our results suggest that the nature of the insult will determine the degree of remote injury in aged animals. In addition, the role of IL-6 as a contributing factor of tissue injury may be insult specific.
C1 [Gomez, Christian R.; Nomellini, Vanessa; Kovacs, Elizabeth J.] Loyola Univ, Med Ctr, Dept Surg, Burn & Shock Trauma Inst, Maywood, IL 60153 USA.
   [Gomez, Christian R.; Nomellini, Vanessa; Kovacs, Elizabeth J.] Loyola Univ, Med Ctr, Immunol & Aging Program, Maywood, IL 60153 USA.
   [Gomez, Christian R.] Univ Diego Portales, Fac Ciencias Salud, Santiago, Chile.
   [Nomellini, Vanessa; Kovacs, Elizabeth J.] Loyola Univ, Med Ctr, Stritch Sch Med, Maywood, IL 60153 USA.
   [Baila, Horea; Oshima, Kiyoko] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA.
C3 Loyola University Chicago; Loyola University Chicago; University Diego
   Portales; Loyola University Chicago; Loyola University Chicago
RP Kovacs, EJ (corresponding author), Loyola Univ, Med Ctr, Dept Surg, Burn & Shock Trauma Inst, Bldg 110,Room 4232,2160 S 1st Ave, Maywood, IL 60153 USA.
EM ekovacs@lumc.edu
RI Oshima, Kiyoko/CAF-1543-2022
FU National Institutes of Health [R01 AG018859, AG018859-S1, F30 AG029724]
FX This study was supported by the National Institutes of Health (grant no.
   R01 AG018859 to E.J.K., grant no. AG018859-S1 to E.J.K., and grant no.
   F30 AG029724 to V.N.).
CR AIKAWA N, 1987, BURNS, V13, P103, DOI 10.1016/0305-4179(87)90097-0
   *AM BURN ASS, 2002, NAT BURN REP 2002 RE
   Asfar P, 2004, CRIT CARE, V8, P170, DOI 10.1186/cc2418
   AYALA A, 1992, CYTOKINE, V4, P66, DOI 10.1016/1043-4666(92)90039-T
   Baue AE, 2006, SHOCK, V26, P438, DOI 10.1097/01.shk.0000228172.32587.7a
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Colantoni A, 2000, ALCOHOL CLIN EXP RES, V24, P1443, DOI 10.1111/j.1530-0277.2000.tb02115.x
   Csiszar A, 2003, FASEB J, V17, P1183, DOI 10.1096/fj.02-1049fje
   Faunce DE, 1997, J LEUKOCYTE BIOL, V62, P733, DOI 10.1002/jlb.62.6.733
   Gomez CR, 2006, SHOCK, V25, P581, DOI 10.1097/01.shk.000029553.39081.ec
   Gomez CR, 2007, CRIT CARE MED, V35, P246, DOI 10.1097/01.CCM.0000251639.05135.E0
   Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1
   Kopydlowski KM, 1999, J IMMUNOL, V163, P1537
   Kovacs EJ, 2004, J LEUKOCYTE BIOL, V76, P36, DOI 10.1189/jlb.1103538
   Kovacs EJ, 2002, J AM AGING ASSOC, V25, P3, DOI 10.1007/s11357-002-0001-4
   Li X, 2004, J LEUKOCYTE BIOL, V75, P443, DOI 10.1189/jlb.0603297
   LOEB WF, 1996, PATHOBIOLOGY AGING M, V1
   Murphy TJ, 2005, J LEUKOCYTE BIOL, V77, P16, DOI 10.1189/jlb.0704382
   NAPOLI J, 1994, GASTROENTEROLOGY, V107, P789, DOI 10.1016/0016-5085(94)90128-7
   Nomellini V, 2008, J LEUKOCYTE BIOL, V83, P1493, DOI 10.1189/jlb.1007672
   OHMORI Y, 1995, J IMMUNOL, V155, P3593
   PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008
   Paterson HM, 2003, J IMMUNOL, V171, P1473, DOI 10.4049/jimmunol.171.3.1473
   Pawelec G, 2004, TRENDS IMMUNOL, V25, P406, DOI 10.1016/j.it.2004.05.006
   Perl M, 2005, AM J PATHOL, V167, P1545, DOI 10.1016/S0002-9440(10)61240-0
   Plackett TP, 2007, J BURN CARE RES, V28, P167, DOI 10.1097/BCR.0b013E31802CB84F
   Prelog M, 2006, AUTOIMMUN REV, V5, P136, DOI 10.1016/j.autrev.2005.09.008
   Rose R, 2007, J APPL TOXICOL, V27, P602, DOI 10.1002/jat.1243
   Sauaia A, 1996, WORLD J SURG, V20, P392, DOI 10.1007/s002689900062
   Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268
   Swift ME, 2001, J INVEST DERMATOL, V117, P1027, DOI 10.1046/j.0022-202x.2001.01539.x
   Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996
   Walter R, 1998, J GERONTOL A-BIOL, V53, pB102, DOI 10.1093/gerona/53A.2.B102
   Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829
   Xie Guo-Qi, 2002, Hepatobiliary Pancreat Dis Int, V1, P558
NR 35
TC 30
Z9 33
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1073-2322
EI 1540-0514
J9 SHOCK
JI Shock
PD FEB
PY 2009
VL 31
IS 2
BP 178
EP 184
DI 10.1097/SHK.0b013e318180feb8
PG 7
WC Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Hematology; Surgery; Cardiovascular System
   & Cardiology
GA 396DV
UT WOS:000262573300012
PM 18636046
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Li, Y
   Xiong, L
   Gong, JP
AF Li, Yin
   Xiong, Lin
   Gong, Jianping
TI Lyn kinase enhanced hepatic fibrosis by modulating the activation of
   hepatic stellate cells
SO AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
LA English
DT Article
DE Lyn kinase; hepatic fibrosis; hepatic stellate cells; integrin alpha v
   beta 3
ID LIVER FIBROSIS; TYROSINE KINASE; COLLAGEN-I; PROLIFERATION; SENESCENCE;
   CIRRHOSIS; PROTEINS
AB The non-selectivity of tyrosine kinase inhibitors is the leading cause of drug withdrawals, and limits their application in anti-fibrosis. The role of Src tyrosine kinase Lyn in hepatic fibrosis remains elusive. In this study, we aimed to elucidate the role of Lyn kinase in the pathogenesis of hepatic fibrosis. Through examining Lyn-transgenic (Lyn TG) mice treated with CCl4 (carbon tetrachloride), we determined whether Lyn kinase is involved in the pathogenesis of hepatic fibrosis. On top of that, we also investigated the role of Lyn in the activation of hepatic stellate cells (HSCs) in vitro. Here, we showed that Lyn kinase was highly expressed in liver fibrosis upon CCl4 treatment. Meanwhile, Lyn TG mice showed that perivascular infiltration of mononuclear cells, and the markers of liver injury and hepatocytes apoptosis were significantly increased in liver tissue after CCl4 treatment. In comparison with wild-type (WT) mice after CCl4 treatment, we found that the fibrotic score in liver tissues of Lyn TG mice with the same treatment went up dramatically, so did the gene expression of fibrotic markers. In addition, over-expression of Lyn kinase drastically promoted the expression of HSCs activation markers in vivo or in vitro. Additionally, the Src-specific inhibitor PP2 significantly suppressed the increased expression of integrin alpha v beta 3 in TGF-beta 1-induced HSCs, and PP2 further induced HSC apoptosis in TGF-beta 1-treated cells. These results collectively indicated that Lyn kinase is implicated in the pathogenesis of hepatic fibrosis through the modulating of HSC activation.
C1 [Li, Yin] Chongqing Med Univ, Clin Coll 1, Chongqing 401331, Peoples R China.
   [Li, Yin] Chongqing Med Univ, Cent Lab, Affiliated Hosp 2, Chongqing 400010, Peoples R China.
   [Xiong, Lin] Chongqing Med Univ, Sch Lab Med, Chongqing 400016, Peoples R China.
   [Gong, Jianping] Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing 400010, Peoples R China.
C3 Chongqing Medical University; Chongqing Medical University; Chongqing
   Medical University; Chongqing Medical University
RP Gong, JP (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing 400010, Peoples R China.
EM gongjianping11@126.com
FU Chongqing medical university [201606]; National Natural Science
   Foundation of China [31370753]
FX This project was supported by Chongqing medical university students'
   scientific research and innovation Experimental Projects (201606). This
   study was supported by the National Natural Science Foundation of China
   (No. 31370753).
CR Abramovitch S, 2015, AM J PHYSIOL-GASTR L, V308, pG112, DOI 10.1152/ajpgi.00132.2013
   Balasubramanian A, 2006, J INFECT DIS, V194, P670, DOI 10.1086/505708
   Chen JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30957
   Chen JL, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.228
   Chen L, 2016, DIGEST DIS SCI, V61, P1961, DOI 10.1007/s10620-016-4075-8
   Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200
   Cinar R, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87336
   Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076
   Ding Q, 2015, WORLD J GASTROENTERO, V21, P9566, DOI 10.3748/wjg.v21.i32.9566
   Dropmann A, 2016, ONCOTARGET, V7, P19499, DOI 10.18632/oncotarget.6967
   Fukumoto Y, 2014, BIOCHEM BIOPH RES CO, V452, P542, DOI 10.1016/j.bbrc.2014.08.113
   Ge JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22141
   He LN, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0045-1
   Karin D, 2016, DIFFERENTIATION, V92, P84, DOI 10.1016/j.diff.2016.07.001
   Kim KH, 2016, MOL ENDOCRINOL, V30, P905, DOI 10.1210/me.2016-1029
   Kluwe J, 2009, J MOL MED, V87, P125, DOI 10.1007/s00109-008-0426-z
   Kong DS, 2013, BIOMED PHARMACOTHER, V67, P246, DOI 10.1016/j.biopha.2012.10.002
   Koyama Y, 2016, DIGEST DIS, V34, P589, DOI 10.1159/000445269
   Li D, 2015, EJNMMI RES, V5, P1, DOI 10.1186/s13550-015-0151-x
   Liu DB, 2015, MED SCI MONIT BASIC, V21, P253, DOI 10.12659/MSMBR.895463
   Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502
   Ni MM, 2016, J PHYSIOL BIOCHEM, V72, P9, DOI 10.1007/s13105-015-0452-6
   Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232
   Omar R, 2016, REV PHYSIOL BIOCH P, V172, P1, DOI 10.1007/112_2016_6
   Peng Y, 2016, ACTA PHARMACOL SIN, V37, P204, DOI 10.1038/aps.2015.129
   Qu K, 2016, ONCOTARGET, V7, P67650, DOI 10.18632/oncotarget.11767
   Qu K, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00300
   Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028
   Shao WH, 2014, EXPERT REV CLIN IMMU, V10, P573, DOI 10.1586/1744666X.2014.893827
   Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014
   Tsochatzis E, 2014, J HEPATOL, V60, P948, DOI 10.1016/j.jhep.2013.12.023
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   Tsochatzis EA, 2012, HEPATOLOGY, V56, P1983, DOI 10.1002/hep.25915
   Tsuda M, 2008, GLIA, V56, P50, DOI 10.1002/glia.20591
   Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701
   Wang P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00047
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Yin XG, 2016, ONCOTARGET, V7, P63767, DOI 10.18632/oncotarget.11654
   Zhang CY, 2016, INT J NANOMED, V11, P1097, DOI 10.2147/IJN.S101366
   Zhou XY, 2006, J BIOL CHEM, V281, P39757, DOI 10.1074/jbc.M605621200
NR 40
TC 7
Z9 7
U1 0
U2 6
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1943-8141
J9 AM J TRANSL RES
JI Am. J. Transl. Res.
PY 2017
VL 9
IS 6
BP 2865
EP 2877
PG 13
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA EZ2OJ
UT WOS:000404548300016
PM 28670375
DA 2024-02-19
ER

PT J
AU Misaka, T
   Suzuki, S
   Miyata, M
   Kobayashi, A
   Shishido, T
   Ishigami, A
   Saitoh, S
   Hirose, M
   Kubota, I
   Takeishi, Y
AF Misaka, Tomofumi
   Suzuki, Satoshi
   Miyata, Makiko
   Kobayashi, Atsushi
   Shishido, Tetsuro
   Ishigami, Akihito
   Saitoh, Shu-ichi
   Hirose, Masamichi
   Kubota, Isao
   Takeishi, Yasuchika
TI Deficiency of senescence marker protein 30 exacerbates angiotensin
   II-induced cardiac remodelling
SO CARDIOVASCULAR RESEARCH
LA English
DT Article
DE Senescence marker protein 30 (SMP30); Ageing; Remodelling; Oxidative
   stress; Apoptosis
ID CARDIOVASCULAR-DISEASE ENTERPRISES; OXIDATIVE STRESS; HEART-FAILURE;
   TRANSGENIC MICE; MAJOR SHAREHOLDERS; INDUCED APOPTOSIS; SMP30
   DEFICIENCY; NAD(P)H OXIDASE; KNOCKOUT MICE; RAT-LIVER
AB Ageing is an important risk factor of cardiovascular diseases including heart failure. Senescence marker protein 30 (SMP30), which was originally identified as an important ageing marker protein, is assumed to act as a novel anti-ageing factor in various organs. However, the role of SMP30 in the heart has not been previously explored. In this study, our aim was to elucidate the functional role of SMP30 on cardiac remodelling.
   SMP30 knockout (KO) mice and wild-type (WT) mice were subjected to continuous angiotensin II (Ang II) infusion. After 14 days, the extent of cardiac hypertrophy and myocardial fibrosis was significantly higher in SMP30-KO mice than in WT mice. Echocardiography revealed that SMP30-KO mice had more severely depressed systolic and diastolic function with left ventricular dilatation compared with WT mice. Generation of reactive oxygen species related with activation of nicotinamide adenine dinucleotide phosphate-oxidase was greater in SMP30-KO mice than in WT mice. The number of deoxynucleotidyl transferase-mediated dUTP nick end-labelling positive nuclei was markedly increased in SMP30-KO mice with activation of caspase-3, increases in the Bax to Bcl-2 ratio and phosphorylation of c-Jun N-terminal kinase compared with WT mice. Furthermore, the number of senescence-associated -galactosidase-positive cells was significantly increased via up-regulation of p21 gene expression in SMP30-KO mice compared with WT mice.
   This study demonstrated the first evidence that deficiency of SMP30 exacerbates Ang II-induced cardiac hypertrophy, dysfunction, and remodelling, suggesting that SMP30 has a cardio-protective role in cardiac remodelling with anti-oxidative and anti-apoptotic effects in response to Ang II.
C1 [Misaka, Tomofumi; Suzuki, Satoshi; Miyata, Makiko; Kobayashi, Atsushi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima 9601295, Japan.
   [Shishido, Tetsuro; Kubota, Isao] Yamagata Univ, Sch Med, Dept Internal Med 1, Yamagata 99023, Japan.
   [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
   [Hirose, Masamichi] Iwate Med Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Morioka, Iwate, Japan.
C3 Fukushima Medical University; Yamagata University; Tokyo Metropolitan
   Institute of Gerontology; Iwate Medical University
RP Takeishi, Y (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.
EM takeishi@fmu.ac.jp
FU Japan Society for the Promotion of Science [24591100]; Grants-in-Aid for
   Scientific Research [24591100, 25870584] Funding Source: KAKEN
FX This study was supported in part by a grant-in-aid for Scientific
   Research (No. 24591100, Y.T.) from the Japan Society for the Promotion
   of Science.
CR Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200
   Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771
   Arun P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016545
   Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020
   Carlson SH, 2000, HYPERTENSION, V35, pE1, DOI 10.1161/01.HYP.35.2.e1
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163
   Kobayashi A, 2007, HYPERTENSION, V50, P1040, DOI 10.1161/HYPERTENSIONAHA.107.097006
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7
   Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02
   LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5
   Machii H, 2010, MECH AGEING DEV, V131, P710, DOI 10.1016/j.mad.2010.09.009
   Matsushima S, 2009, AM J PHYSIOL-HEART C, V297, pH409, DOI 10.1152/ajpheart.01332.2008
   Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02
   Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27
   Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603
   Park M, 2009, AM J PHYSIOL-HEART C, V297, pH785, DOI 10.1152/ajpheart.00310.2009
   Ravassa S, 2000, HYPERTENSION, V36, P1065, DOI 10.1161/01.HYP.36.6.1065
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968
   TSAO CS, 1987, J NUTR, V117, P291, DOI 10.1093/jn/117.2.291
   Wang MY, 2010, J MOL CELL CARDIOL, V48, P765, DOI 10.1016/j.yjmcc.2010.01.006
   WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849
   Wilson RM, 2009, HYPERTENSION, V54, P583, DOI 10.1161/HYPERTENSIONAHA.109.134932
   Xue BJ, 2007, AM J PHYSIOL-HEART C, V292, pH1770, DOI 10.1152/ajpheart.01011.2005
   Yu R, 2013, J NUTR, V143, P1, DOI 10.3945/jn.112.168690
   Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614
   Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151
NR 42
TC 17
Z9 19
U1 1
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0008-6363
J9 CARDIOVASC RES
JI Cardiovasc. Res.
PD AUG 1
PY 2013
VL 99
IS 3
BP 461
EP 470
DI 10.1093/cvr/cvt122
PG 10
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 190LN
UT WOS:000322341600012
PM 23723062
DA 2024-02-19
ER

PT J
AU Gao, SH
   Long, F
   Jiang, Z
   Shi, J
   Ma, DX
   Yang, Y
   Bai, J
   Han, TL
AF Gao, ShanHu
   Long, Fei
   Jiang, Zheng
   Shi, Jun
   Ma, DongXue
   Yang, Yang
   Bai, Jin
   Han, Ting-Li
TI The complex metabolic interactions of liver tissue and hepatic exosome
   in PCOS mice at young and middle age
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE PCOS (polycystic ovarian syndrome); IR (insulin resistance); liver;
   exosome; metabolomics; aging
ID POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; BRANCHED-CHAIN;
   AMINO-ACIDS; DISEASE; COMMUNICATION; BIOMARKERS; WOMEN; OBESE
AB Polycystic ovary syndrome (PCOS) is a common age-related endocrinopathy that promotes the metabolic disorder of the liver. Growing evidence suggests that the pathophysiology of this disorder is closely associated with the interaction between the liver and its exosome. However, the underlying mechanism of the interactions remains unclear. In this study, we aimed to investigate the metabolite profiles of liver tissues and hepatic exosomes between normal (n = 11) and PCOS (n = 13) mice of young- and middle-age using gas chromatograph-mass spectrometry (GC-MS) based metabolomics analysis. Within the 145 identified metabolites, 7 and 48 metabolites were statistically different (p < 0.05, q < 0.05) in the liver tissue and exosomes, respectively, between PCOS and normal groups. The greater disparity in exosome indicated its potential to reflect the metabolic status of the liver. Based on hepatic exosome metabolome, the downregulations of glycolysis and TCA cycle were related to hepatic pathophysiology of PCOS independent of age. Fatty acids were the preferred substrates in young-age-PCOS liver while amino acids were the main substrates in middle-age-PCOS liver for the processes of gluconeogenesis. Overall, this study enables us to better understand the metabolic status of the PCOS liver at different ages, and exosome metabolomics shows its potential to gain the metabolic insights of parental cell or source organ.
C1 [Gao, ShanHu; Long, Fei; Shi, Jun; Ma, DongXue; Bai, Jin; Han, Ting-Li] Chongqing Med Univ, Coll Biomed Engn, State Key Lab Ultrasound Med & Engn, Chongqing, Peoples R China.
   [Jiang, Zheng] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.
   [Yang, Yang] Chongqing Med Univ, Affiliated Hosp 1, Dept Obstet, Chongqing, Peoples R China.
   [Han, Ting-Li] Chongqing Med Univ, Affiliated Hosp 2, Dept Obstet & Gynaecol, Chongqing, Peoples R China.
C3 Chongqing Medical University; Chinese University of Hong Kong; Chongqing
   Medical University; Chongqing Medical University
RP Bai, J; Han, TL (corresponding author), Chongqing Med Univ, Coll Biomed Engn, State Key Lab Ultrasound Med & Engn, Chongqing, Peoples R China.; Yang, Y (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Obstet, Chongqing, Peoples R China.; Han, TL (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Obstet & Gynaecol, Chongqing, Peoples R China.
EM 834023516@qq.com; sajinbai@cqmu.edu.cn; tinglihan@cqmu.edu.cn
RI Jiang, Zheng/HTR-9349-2023
OI Jiang, Zheng/0000-0001-7160-4512
FU National Natural Science Foundation of China; Chongqing Municipal
   Education Commission; Chongqing Science & Technology Commission; 
   [81871185];  [KJZD-K202100407];  [cstc2021jcyj-msxmX0213]; 
   [cstc2021jcyj-msxmX0165]
FX Funding This work was supported by the National Natural Science
   Foundation of China (No. 81871185), Chongqing Municipal Education
   Commission (KJZD-K202100407), and Chongqing Science & Technology
   Commission (cstc2021jcyj-msxmX0213, cstc2021jcyj-msxmX0165).
CR Abbott DH, 2021, CELL METAB, V33, P463, DOI 10.1016/j.cmet.2021.02.008
   Anagnostis P, 2018, METABOLISM, V86, P33, DOI 10.1016/j.metabol.2017.09.016
   Azziz R, 2018, OBSTET GYNECOL, V132, P321, DOI 10.1097/AOG.0000000000002698
   Azziz R, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.57
   Barzilai N, 2012, J GERONTOL A-BIOL, V67, P1329, DOI 10.1093/gerona/gls145
   Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196
   Daan NMP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165033
   Diane A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77621-x
   FELIG P, 1970, SCIENCE, V167, P1003, DOI 10.1126/science.167.3920.1003
   Hoshino A, 2020, CELL, V182, P1044, DOI 10.1016/j.cell.2020.07.009
   Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756
   Hu ZL, 2020, WORLD J STEM CELLS, V12, P803, DOI 10.4252/wjsc.v12.i8.803
   Hurwitz SN, 2019, JOVE-J VIS EXP, DOI 10.3791/59143
   Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25
   Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977
   Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004
   Kyselova A, 2019, METABOLISM, V90, P16, DOI 10.1016/j.metabol.2018.10.008
   Li YL, 2019, J CELL PHYSIOL, V234, P7435, DOI 10.1002/jcp.27501
   Liu J, 2020, J CELL MOL MED, V24, P11001, DOI 10.1111/jcmm.15747
   Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358
   Livadas S, 2014, EUR J ENDOCRINOL, V171, P301, DOI 10.1530/EJE-13-1007
   Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171
   MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7
   Macut D, 2016, HUM REPROD, V31, P1347, DOI 10.1093/humrep/dew076
   Mashouri L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0991-5
   Masyuk AI, 2013, J HEPATOL, V59, P621, DOI 10.1016/j.jhep.2013.03.028
   Mohamed AS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57252-7
   Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095
   Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018
   Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002
   Puhka M, 2017, THERANOSTICS, V7, P3824, DOI 10.7150/thno.19890
   Qi XY, 2019, NAT MED, V25, P1225, DOI 10.1038/s41591-019-0509-0
   Rajska A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144853
   Reclusa P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62920-0
   Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004
   Salva-Pastor N, 2019, J STEROID BIOCHEM, V194, DOI 10.1016/j.jsbmb.2019.105445
   Sarkar M, 2020, LIVER INT, V40, P355, DOI 10.1111/liv.14279
   Shao HL, 2018, CHEM REV, V118, P1917, DOI 10.1021/acs.chemrev.7b00534
   Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108
   Sun LY, 2012, J PROTEOME RES, V11, P2937, DOI 10.1021/pr3000317
   Sung S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123715
   Targher G, 2016, ENDOCRINE, V51, P211, DOI 10.1007/s12020-015-0640-8
   Teruel-Montoya R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40453-5
   van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125
   Vassilatou E, 2014, WORLD J GASTROENTERO, V20, P8351, DOI 10.3748/wjg.v20.i26.8351
   Wang HB, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0806-6
   Wang HW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/864894
   Wei LN, 2018, GENE, V661, P85, DOI 10.1016/j.gene.2018.03.079
   Wishart DS, 2019, PHYSIOL REV, V99, P1819, DOI 10.1152/physrev.00035.2018
   Wortzel I, 2019, DEV CELL, V49, P347, DOI 10.1016/j.devcel.2019.04.011
   Würtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895
   Xia YQ, 2020, ADV MATER, V32, DOI 10.1002/adma.202002054
   Zhang Y, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0282-2
   Zhao Y, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-153
   Zou Y, 2018, CHINESE MED J-PEKING, V131, P945, DOI 10.4103/0366-6999.229899
NR 55
TC 5
Z9 5
U1 4
U2 19
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD SEP 20
PY 2022
VL 13
AR 990987
DI 10.3389/fphys.2022.990987
PG 15
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 5Q7FG
UT WOS:000873992000001
PM 36203935
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Goo, MJ
   Ki, MR
   Lee, HR
   Yang, HJ
   Yuan, DW
   Hong, IH
   Park, JK
   Hong, KS
   Han, JY
   Hwang, OK
   Kim, DH
   Do, SH
   Cohn, RD
   Jeong, KS
AF Goo, Moon-Jung
   Ki, Mi-Ran
   Lee, Hye-Rim
   Yang, Hai-Jie
   Yuan, Dong-Wei
   Hong, Il-Hwa
   Park, Jin-Kyu
   Hong, Kyung-Sook
   Han, Jung-Youn
   Hwang, Ok-Kyung
   Kim, Dong-Hwan
   Do, Sun-Hee
   Cohn, Ronald D.
   Jeong, Kyu-Shik
TI <i>Helicobacter pylori</i> promotes hepatic fibrosis in the animal model
SO LABORATORY INVESTIGATION
LA English
DT Article
DE Helicobacter pylori; hepatic fibrosis; liver; senescence marker protein
   30; 16S rRNA
ID PRIMARY BILIARY-CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RAT-LIVER;
   STELLATE CELLS; MOUSE-LIVER; IN-VITRO; INFECTION; SEROPREVALENCE;
   EXPRESSION; GENE
AB Helicobacter pylori infection has been reported to be very common in patients with chronic liver diseases, including cirrhosis. To elucidate the pathological effect of H. pylori infection on the progression of hepatic fibrosis, C57BL/6 mice and Sprague-Dawley rats were orally inoculated with H. pylori, and hepatic fibrosis was induced with carbon tetrachloride (CCl4) administration. We observed the histopathological changes and the presence of H. pylori genes by PCR in the liver. Significant increase in the fibrotic score as well as in serum alanine aminotransferase and aspartate aminotransferase levels was shown in the CCl4 + H. pylori group compared with that in the CCl4-treated group. Compared with the CCl4-treated group, alpha-smooth muscle actin and transforming growth factor-beta 1 were enhanced; however, senescence marker protein-30, a multifunctional protein protecting hepatocytes against oxidative stress and apoptosis, was suppressed in the CCl4 + H. pylori group. The 16S rRNA (400 bp) was demonstrated by PCR for H. pylori genes from genomic DNA extracted from the liver, and H. pylori-infected mice showed 93.8% (15 of 16) seropositivity by contrast with seronegativity in all H. pylori-noninfected mice. In addition, immunohistochemical study against H. pylori showed positive antigen fragments in the liver of the infected groups. Consequently, our data suggest that H. pylori infection could be an important contributing infectious factor to the development of liver cirrhosis. Laboratory Investigation (2009) 89, 1291-1303; doi: 10.1038/labinvest.2009.90; published online 7 September 2009
C1 [Goo, Moon-Jung; Ki, Mi-Ran; Lee, Hye-Rim; Yang, Hai-Jie; Yuan, Dong-Wei; Hong, Il-Hwa; Park, Jin-Kyu; Hong, Kyung-Sook; Han, Jung-Youn; Hwang, Ok-Kyung; Kim, Dong-Hwan; Jeong, Kyu-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
   [Do, Sun-Hee] Konkuk Univ, Coll Vet Med, Dept Clin Pathol, Seoul, South Korea.
   [Cohn, Ronald D.] Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, Dept Pediat & Neurol, Baltimore, MD USA.
C3 Kyungpook National University; Konkuk University; Konkuk University
   Medical Center; Johns Hopkins University
RP Jeong, KS (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, 1370 Sangyeok Dong, Taegu 702701, South Korea.
EM jeongks@knu.ac.kr
RI Cohn, Ronald/AAC-5835-2021
OI Do, Sun Hee/0000-0003-2372-5269
FU 21st Century Frontier R&D Program, the Ministry of Science and
   Technology, Korea [CBM 31-B3003-01-01-00]
FX This research was supported by a grant (code: CBM 31-B3003-01-01-00)
   from the Center for Biological Modulators of the 21st Century Frontier
   R&D Program, the Ministry of Science and Technology, Korea.
CR Abdel-Hady H, 2007, HEPATOL RES, V37, P1026, DOI 10.1111/j.1872-034X.2007.00146.x
   Avenaud P, 2000, CANCER, V89, P1431, DOI 10.1002/1097-0142(20001001)89:7<1431::AID-CNCR4>3.0.CO;2-5
   Baroni GS, 1998, HEPATOLOGY, V27, P720
   BERRY LJ, 1959, J EXP MED, V110, P389, DOI 10.1084/jem.110.3.389
   Calvet X, 1997, J HEPATOL, V26, P1249, DOI 10.1016/S0168-8278(97)80459-X
   Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje
   CASINI A, 1991, HEPATOLOGY, V13, P758, DOI 10.1002/hep.1840130424
   Chen Ren, 2004, Ai Zheng, V23, P44
   Crowe SE, 2005, CURR OPIN GASTROEN, V21, P32
   Day AS, 2001, DIGEST DIS SCI, V46, P1943, DOI 10.1023/A:1010691216207
   Desmet VJ, 2004, J HEPATOL, V40, P860, DOI 10.1016/j.jhep.2004.03.007
   Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8
   Engin A, 2006, ANZ J SURG, V76, P512, DOI 10.1111/j.1445-2197.2006.03763.x
   Figura N, 1996, Helicobacter, V1, P187
   Fox JG, 1996, J CLIN MICROBIOL, V34, P2479, DOI 10.1128/JCM.34.10.2479-2482.1996
   Francavilla A, 1999, ITAL J GASTROENTEROL, V31, P669
   Fu YM, 2008, MOL PHARMACOL, V73, P399, DOI 10.1124/mol.107.039818
   George J, 2004, INT J BIOCHEM CELL B, V36, P307, DOI 10.1016/S1357-2725(03)00253-X
   Goo MJ, 2008, EUR J GASTROEN HEPAT, V20, P1045, DOI 10.1097/MEG.0b013e3282f5e9db
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Jeong DH, 2005, WORLD J GASTROENTERO, V11, P1141, DOI 10.3748/wjg.v11.i8.1141
   Jeong WI, 2007, J RADIAT RES, V48, P233, DOI 10.1269/jrr.0629
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0
   Mendler MH, 2002, HEPATOLOGY, V36, p407A
   Nilsson HO, 2000, J CLIN MICROBIOL, V38, P1072, DOI 10.1128/JCM.38.3.1072-1076.2000
   ORIYA K, 2008, INT J EXP PATHOL, V89, P401
   Pellicano R, 2000, J HEPATOL, V33, P648, DOI 10.1034/j.1600-0641.2000.033004648.x
   Ponzetto A, 2000, NETH J MED, V56, P206, DOI 10.1016/S0300-2977(00)00033-4
   Ponzetto A, 2003, MICROBIOLOGICA, V26, P321
   Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750
   Sar P, 2007, MOL CELL BIOCHEM, V303, P239, DOI 10.1007/s11010-007-9462-1
   SLATER TF, 1971, BIOCHEM J, V123, P805, DOI 10.1042/bj1230805
   Stalke P, 2001, Med Sci Monit, V7 Suppl 1, P271
   Tahashi Y, 2002, HEPATOLOGY, V35, P49, DOI 10.1053/jhep.2002.30083
   TAYLOR NS, 1995, J MED MICROBIOL, V42, P48, DOI 10.1099/00222615-42-1-48
   Tian Xue-fei, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P780
   Wadström T, 2001, GUT, V49, P454
   Wang X, 2003, APMIS, V111, P514, DOI 10.1034/j.1600-0463.2003.1110410.x
   Zubakhin A. A., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V114, P22
NR 40
TC 40
Z9 43
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD NOV
PY 2009
VL 89
IS 11
BP 1291
EP 1303
DI 10.1038/labinvest.2009.90
PG 13
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 512KR
UT WOS:000271248200009
PM 19736546
OA hybrid
DA 2024-02-19
ER

PT J
AU LOPEZTORRES, M
   PEREZCAMPO, R
   DEQUIROGA, GB
AF LOPEZTORRES, M
   PEREZCAMPO, R
   DEQUIROGA, GB
TI EFFECT OF NATURAL AGING AND ANTIOXIDANT INHIBITION ON LIVER ANTIOXIDANT
   ENZYMES, GLUTATHIONE SYSTEM, PEROXIDATION, AND OXYGEN-CONSUMPTION IN
   RANA-PEREZI
SO JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMIC AND
   ENVIRONMENTAL PHYSIOLOGY
LA English
DT Article
DE AGING; RADICALS; PEROXIDATION; SUPEROXIDE DISMUTASE; GLUTATHIONE
   PEROXIDASE
ID INDUCED LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; MUSCA-DOMESTICA;
   HYDROGEN-PEROXIDE; LIFE-SPAN; RAT-LIVER; INORGANIC PEROXIDES; AGING
   MOUSE; CATALASE; MICE
AB A study of the physiological role of oxygen free radicals in relation to the ageing process was performed using the liver of Rana perezi, an animal with a moderate rate of oxygen consumption and a life span substantially longer than that of laboratory rodents.
   Among the five different antioxidant enzymes only superoxide dismutase (SOD) showed an age-dependent decrease. Cytochrome oxidase (COX), glutathione status, in vivo and in vitro liver peroxidation, and metabolic rate did not vary as a function of age.
   Long-term (2.5 months) treatment with aminotriazole and diethyldithiocarbamate depleted catalase (CAT) activity and did not change both glutathione peroxidases (GPx), COX, reduced (GSH) and oxidized (GSSG) glutathione, or metabolic rate. This treatment resulted in great compensatory increases in SOD (to 250-460% of controls) and glutathione reductase (GR) (to 200%) which are possibly responsible for the lack of increase of in vivo and in vitro liver peroxidation and for the absence of changes in survival rate.
   The comparison of these results with previous data from other species suggests the possibility that decreases in antioxidant capacity in old age are restricted to animal species with high metabolic rates. Nevertheless, ageing can still be due to the continuous presence of small concentrations of O2 radicals in the tissues throughout life in animals with either high or low metabolic rates, because radical scavenging can not be 100% effective. Compensatory homeostasis among antioxidants seems to be a general phenomenon in different species.
C1 UNIV COMPLUTENSE MADRID, FAC BIOL, DEPT ANIM BIOL 2, E-28040 MADRID, SPAIN.
C3 Complutense University of Madrid
OI Barja, Gustavo/0000-0001-5736-4735
CR ALLEN RG, 1983, BIOCHEM J, V216, P503, DOI 10.1042/bj2160503
   BAIRD MB, 1971, GERONTOLOGY, V17, P105, DOI 10.1159/000211813
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CARRILLO MC, 1989, MECH AGEING DEV, V47, P1, DOI 10.1016/0047-6374(89)90002-X
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHATTERJEE SN, 1988, FREE RADICAL BIO MED, V4, P51, DOI 10.1016/0891-5849(88)90011-1
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   DEQUIROGA GB, 1988, J COMP PHYSIOL B, V158, P583, DOI 10.1007/BF00692567
   DEVASAGAYAM TPA, 1986, MECH AGEING DEV, V34, P13, DOI 10.1016/0047-6374(86)90101-6
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   FARMER KJ, 1989, FREE RADICAL BIO MED, V7, P23, DOI 10.1016/0891-5849(89)90096-8
   GEE DL, 1981, TOXICOL APPL PHARM, V60, P112, DOI 10.1016/0041-008X(81)90141-1
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   GUTTERIDGE JMC, 1982, INT J BIOCHEM, V14, P649, DOI 10.1016/0020-711X(82)90050-7
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   Kappus H, 1985, OXIDATIVE STRESS, P273, DOI [DOI 10.1016/B978-0-12-642760-8.50016-8, 10.1016/b978-0-12-642760-8.50016-8]
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAMMIKEEFE CJ, 1984, GERONTOLOGY, V30, P153, DOI 10.1159/000212623
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MULLER D, 1989, P IUBS, V17, P244
   PAOLETTI F, 1986, ANAL BIOCHEM, V154, P536, DOI 10.1016/0003-2697(86)90026-6
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   POMPELLA A, 1987, LIPIDS, V22, P206, DOI 10.1007/BF02537304
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RICHIE JP, 1988, P SOC EXP BIOL MED, V187, P235
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   ROSS MH, 1969, J NUTR, V97, P565, DOI 10.1093/jn/97.suppl_4.565
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13
   SOHAL RS, 1985, MECH AGEING DEV, V29, P317, DOI 10.1016/0047-6374(85)90071-5
   SOHAL RS, 1984, MECH AGEING DEV, V24, P185, DOI 10.1016/0047-6374(84)90070-8
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   SOHAL RS, 1988, EXP GERONTOL, V23, P211, DOI 10.1016/0531-5565(88)90008-3
   SOHAL RS, 1984, MECH AGEING DEV, V24, P175, DOI 10.1016/0047-6374(84)90069-1
   SOHAL RS, 1986, ADV FREE RADICAL BIO, V2, P117, DOI 10.1016/S8755-9668(86)80026-6
   STARKE PE, 1985, J BIOL CHEM, V260, P86
   STOHS SJ, 1986, LIVER AGING 1986 LIV, P59
   SUNDERMAN FW, 1984, TOXICOLOGY, V32, P11, DOI 10.1016/0300-483X(84)90030-1
   THAYER WS, 1986, FEBS LETT, V202, P137, DOI 10.1016/0014-5793(86)80664-0
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
NR 43
TC 24
Z9 26
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0174-1578
EI 1432-136X
J9 J COMP PHYSIOL B
JI J. Comp. Physiol. B-Biochem. Syst. Environ. Physiol.
PY 1991
VL 160
IS 6
BP 655
EP 661
DI 10.1007/BF00571264
PG 7
WC Physiology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Zoology
GA EZ530
UT WOS:A1991EZ53000009
PM 2045545
DA 2024-02-19
ER

PT J
AU FUJITA, S
   MORIMOTO, R
   CHIBA, M
   KITANI, K
   SUZUKI, T
AF FUJITA, S
   MORIMOTO, R
   CHIBA, M
   KITANI, K
   SUZUKI, T
TI EVALUATION OF THE INVOLVEMENT OF A MALE SPECIFIC CYTOCHROME-P-450
   ISOZYME IN SENESCENCE-ASSOCIATED DECLINE OF HEPATIC DRUG-METABOLISM IN
   MALE-RATS
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
C1 TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,CLIN PHYSIOL LAB 1,TOKYO 173,JAPAN.
C3 Tokyo Metropolitan Institute of Gerontology
RP FUJITA, S (corresponding author), CHIBA UNIV,FAC PHARMACEUT SCI,DEPT BIOPHARMACEUT,1-33 YAYOICHO,CHIBA 260,JAPAN.
CR ARMBRECHT HJ, 1982, EXP GERONTOL, V17, P41, DOI 10.1016/0531-5565(82)90007-9
   CHENG KC, 1982, J BIOL CHEM, V257, P2378
   CHIBA M, 1986, BIOCHEM PHARMACOL, V35, P2628, DOI 10.1016/0006-2952(86)90064-X
   CHIBA M, 1985, BIOCHEM PHARMACOL, V34, P898, DOI 10.1016/0006-2952(85)90773-7
   DANNAN GA, 1986, J BIOL CHEM, V261, P728
   FUJITA S, 1985, BIOCHEM BIOPH RES CO, V126, P117, DOI 10.1016/0006-291X(85)90579-0
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   FUJITA S, 1981, ISRAEL J CHEM, V21, P87, DOI 10.1002/ijch.198100021
   FUJITA S, 1986, LIVER AGING 1986, P103
   FUJITA S, 1982, LIVER AGING 1982, P55
   FUNAE Y, 1985, BIOCHIM BIOPHYS ACTA, V842, P119, DOI 10.1016/0304-4165(85)90193-X
   GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045
   GUSTAFSSON JA, 1974, J BIOL CHEM, V249, P711
   HARADA N, 1981, J BIOCHEM-TOKYO, V89, P237, DOI 10.1093/oxfordjournals.jbchem.a133187
   JANSSON I, 1985, J BIOL CHEM, V260, P7084
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KAMATAKI T, 1983, ARCH BIOCHEM BIOPHYS, V225, P758, DOI 10.1016/0003-9861(83)90087-5
   KAMATAKI T, 1976, MOL PHARMACOL, V12, P921
   KATO R, 1974, DRUG METAB REV, V3, P1
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KUWAHARA S, 1984, J BIOCHEM-TOKYO, V95, P703, DOI 10.1093/oxfordjournals.jbchem.a134660
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATSUMOTO T, 1986, J BIOCHEM-TOKYO, V100, P1359, DOI 10.1093/oxfordjournals.jbchem.a121842
   MORGAN ET, 1985, MOL PHARMACOL, V27, P471
   NOSHIRO M, 1978, J BIOCHEM, V83, P61, DOI 10.1093/oxfordjournals.jbchem.a131913
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   RAMPERSAUD A, 1987, ARCH BIOCHEM BIOPHYS, V252, P145, DOI 10.1016/0003-9861(87)90018-X
   RYAN DE, 1984, J BIOL CHEM, V259, P1239
   SCHMUCHER DL, 1982, LIVER AGING 1982, P75
   STIER A, 1982, LIVER AGING 1982, P3
   WAXMAN DJ, 1984, J BIOL CHEM, V259, P5481
   YAMAZOE Y, 1986, JPN J PHARMACOL, V42, P371, DOI 10.1254/jjp.42.371
NR 33
TC 27
Z9 27
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD NOV 15
PY 1989
VL 38
IS 22
BP 3925
EP 3931
DI 10.1016/0006-2952(89)90669-2
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CB113
UT WOS:A1989CB11300005
PM 2688651
DA 2024-02-19
ER

PT J
AU HOLLANDER, CF
   VANBEZOOIJEN, CFA
   SOLLEVELD, HA
AF HOLLANDER, CF
   VANBEZOOIJEN, CFA
   SOLLEVELD, HA
TI ANATOMY, FUNCTION AND AGING IN THE MOUSE-LIVER
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
C1 SK&F LABS,PHILADELPHIA,PA 19101.
   TNO,INST EXPTL GERONTOL,2280 HV RIJSWIJK,NETHERLANDS.
C3 GlaxoSmithKline; Netherlands Organization Applied Science Research
RP HOLLANDER, CF (corresponding author), LABS MSD CHIBRET,CTR RECH,DEPT EIM,BP 134,F-63200 RIOM,FRANCE.
CR Arias I. M., 1982, LIVER BIOL PATHOBIOL
   BERKVENS JM, 1974, BIOTECHNIEK, V13, P1
   CAMERON TP, 1985, FUND APPL TOXICOL, V5, P526, DOI 10.1016/0272-0590(85)90100-9
   DELEEUW AM, 1982, CELL TISSUE RES, V223, P201, DOI 10.1007/BF00221510
   DELEEUW AM, 1984, HEPATOLOGY, V4, P392
   DELEEUW AM, 1983, HEPATOLOGY, V3, P497
   DELEEUW AM, 1985, THESIS STATE U UTREC
   DUNN TB, 1954, JNCI-J NATL CANCER I, V14, P1281
   GRICE HC, 1984, SELECTION DOSES CHRO, P51
   HASEMAN JK, 1985, JNCI-J NATL CANCER I, V75, P975, DOI 10.1093/jnci/75.5.975
   HUMMEL KP, 1966, BIOL LABORATORY MOUS, P280
   KNOOK DL, 1978, RAT HEPATIC NEOPLASI, P8
   KNOOK DL, 1982, 2ND P INT KUPFF CELL
   MEDLOCK ES, 1983, ANAT REC, V207, P31, DOI 10.1002/ar.1092070105
   MEDLOCK ES, 1983, ANAT REC, V207, P43, DOI 10.1002/ar.1092070106
   MUTO M, 1975, ARCH HISTOL JAPON, V37, P369, DOI 10.1679/aohc1950.37.369
   ROGOFF TM, 1981, GASTROENTEROLOGY, V80, P854
   SHIMA A, 1976, EXP GERONTOL, V11, P193, DOI 10.1016/0531-5565(76)90033-4
   Solleveld H A, 1985, Toxicol Pathol, V13, P128
   THURMAN RG, 1985, HEPATOLOGY, V5, P144, DOI 10.1002/hep.1840050128
   Toth K., 1985, Monographs on pathology of laboratory animals. Digestive system, P92
   Van Bezooijen C. F. A., 1986, DRUGS AGING, P45
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VANZWIETEN MJ, 1985, MONOGRAPHS PATHOLOGY, P97
   WARD JM, 1984, CARCINOGENESIS MUTAG, P97
   Wisse E, 1979, Prog Liver Dis, V6, P153
   ZURCHER C, 1982, LIVER AGING 1982, P19
   1983, RELEVANCE MOUSE LIVE, P1
NR 28
TC 5
Z9 5
U1 0
U2 4
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0340-5761
J9 ARCH TOXICOL
JI Arch. Toxicol.
PY 1987
SU 10
BP 244
EP 250
PG 7
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA G8755
UT WOS:A1987G875500022
PM 3555415
DA 2024-02-19
ER

PT J
AU ONO, T
   UEHARA, Y
   KURISHITA, A
   TAWA, R
   SAKURAI, H
AF ONO, T
   UEHARA, Y
   KURISHITA, A
   TAWA, R
   SAKURAI, H
TI BIOLOGICAL SIGNIFICANCE OF DNA METHYLATION IN THE AGING PROCESS
SO AGE AND AGEING
LA English
DT Article
ID C-MYC GENE; NUCLEOTIDE-SEQUENCE; MESSENGER-RNA; SARCOMA-VIRUS; AGING
   PROCESS; MOUSE ALPHA; FOS GENE; MICE; CELLS; EXPRESSION
AB In order to understand the possible importance of DNA methylation in ageing, characteristics of its age-associated changes were examined in mouse and man. The total methylated deoxycytidine level in the genome decreased in the senescent period in mouse liver, but not in mouse brain and human liver. The examination of DNA methylation in each individual gene revealed that only a few genes showed alteration in the senescent phase while many genes change in the maturation period. The alterations were gene- and tissue-specific. Comparison of short-living mouse and long-living man for the age-associated changes of the c-myc gene methylation revealed that the rate of change in mouse was about 20 times faster than that in man. This suggests a deep involvement of DNA methylation in ageing. Further investigations into the causes and consequences of the changes would clarify a basic mechanism of ageing.
C1 KYOTO PHARMACEUT UNIV, DEPT ANALYT CHEM 1, YAMASHINA KU, KYOTO 607, JAPAN.
C3 Kyoto Pharmaceutical University
RP ONO, T (corresponding author), TOHOKU UNIV, SCH MED, DEPT RADIAT RES, SEIRYO MACHI 2-1, AOBA KU, SENDAI, MIYAGI 980, JAPAN.
CR ADAMS RLP, 1985, MOL BIOL DNA METHYLA, P115
   [Anonymous], MOL BIOL AGING GENE
   BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400
   BUETTI E, 1981, CELL, V23, P335, DOI 10.1016/0092-8674(81)90129-X
   CHANG ACY, 1978, NATURE, V275, P617, DOI 10.1038/275617a0
   CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914
   CUTLER RG, 1985, ASSESSMENT RISK LOW, P15
   DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X
   DEPINHO RA, 1986, P NATL ACAD SCI USA, V83, P1827, DOI 10.1073/pnas.83.6.1827
   FLORINE DL, 1980, CANCER RES, V40, P519
   GIRI CP, 1983, NUCLEIC ACIDS RES, V11, P305, DOI 10.1093/nar/11.2.305
   HOLLIDAY R, 1991, MUTAT RES, V250, P351, DOI 10.1016/0027-5107(91)90192-Q
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4
   KALINICH JF, 1989, RADIAT RES, V117, P185, DOI 10.2307/3577319
   KASHIMA N, 1985, NATURE, V313, P402, DOI 10.1038/313402a0
   KOMINAMI R, 1981, NUCLEIC ACIDS RES, V9, P3219, DOI 10.1093/nar/9.14.3219
   LEDER A, 1978, P NATL ACAD SCI USA, V75, P6187, DOI 10.1073/pnas.75.12.6187
   MARTIN GM, 1985, MOL BIOL AGING GENE, P7
   MAYSHOOPES LL, 1983, MOL CELL BIOL, V3, P1371, DOI 10.1128/MCB.3.8.1371
   MAYSHOOPES LL, 1989, INT REV CYTOL, V114, P181
   MINTY AJ, 1981, J BIOL CHEM, V256, P1008
   NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0
   ONO T, 1990, MUTAT RES, V237, P239, DOI 10.1016/0921-8734(90)90005-C
   ONO T, 1989, MECH AGEING DEV, V50, P27, DOI 10.1016/0047-6374(89)90056-0
   ONO T, 1985, MECH AGEING DEV, V32, P227, DOI 10.1016/0047-6374(85)90082-X
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   OSKARSSON M, 1980, SCIENCE, V207, P1222, DOI 10.1126/science.6243788
   RAMSDEN M, 1985, EMBO J, V4, P1449, DOI 10.1002/j.1460-2075.1985.tb03801.x
   RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464
   RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500
   SACHER GA, 1977, HDB BIOL AGING, P582
   SWISSHELM K, 1990, MUTAT RES, V237, P131, DOI 10.1016/0921-8734(90)90019-N
   TAWA R, 1992, MECH AGEING DEV, V62, P255, DOI 10.1016/0047-6374(92)90111-P
   TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x
   TIMIRAS PS, 1972, DEV PHYSL AGING, P411
   UEHARA Y, 1989, ONCOGENE, V4, P1023
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   YAMAGUCHI M, 1987, MOL CELL BIOL, V7, P2012, DOI 10.1128/MCB.7.5.2012
   ZAKUTHOURI R, 1983, NATURE, V306, P594, DOI 10.1038/306594a0
NR 41
TC 65
Z9 73
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-0729
EI 1468-2834
J9 AGE AGEING
JI Age Ageing
PD JAN
PY 1993
VL 22
IS 1
BP S34
EP S43
DI 10.1093/ageing/22.suppl_1.S34
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KJ976
UT WOS:A1993KJ97600020
PM 8438654
DA 2024-02-19
ER

PT J
AU Briones-Suarez, L
   Cifuentes, M
   Bravo-Sagua, R
AF Briones-Suarez, Lautaro
   Cifuentes, Mariana
   Bravo-Sagua, Roberto
TI Secretory Factors from Calcium-Sensing Receptor-Activated SW872
   Pre-Adipocytes Induce Cellular Senescence and A Mitochondrial
   Fragmentation-Mediated Inflammatory Response in HepG2 Cells
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE calcium-sensing receptor; cell senescence; pre-adipocyte; hepatocyte
ID EXPRESSION; MITOPHAGY; OBESITY; ALPHA; FAT
AB Adipose tissue inflammation in obesity has a deleterious impact on organs such as the liver, ultimately leading to their dysfunction. We have previously shown that activation of the calcium-sensing receptor (CaSR) in pre-adipocytes induces TNF-alpha and IL-1 beta expression and secretion; however, it is unknown whether these factors promote hepatocyte alterations, particularly promoting cell senescence and/or mitochondrial dysfunction. We generated conditioned medium (CM) from the pre-adipocyte cell line SW872 treated with either vehicle (CMveh) or the CaSR activator cinacalcet 2 mu M (CMcin), in the absence or presence of the CaSR inhibitor calhex 231 10 mu M (CMcin+cal). HepG2 cells were cultured with these CM for 120 h and then assessed for cell senescence and mitochondrial dysfunction. CMcin-treated cells showed increased SA-beta-GAL staining, which was absent in TNF-alpha- and IL-1 beta-depleted CM. Compared to CMveh, CMcin arrested cell cycle, increased IL-1 beta and CCL2 mRNA, and induced p16 and p53 senescence markers, which was prevented by CMcin+cal. Crucial proteins for mitochondrial function, PGC-1 alpha and OPA1, were decreased with CMcin treatment, concomitant with fragmentation of the mitochondrial network and decreased mitochondrial transmembrane potential. We conclude that pro-inflammatory cytokines TNF-alpha and IL-1 beta secreted by SW872 cells after CaSR activation promote cell senescence and mitochondrial dysfunction, which is mediated by mitochondrial fragmentation in HepG2 cells and whose effects were reversed with Mdivi-1. This investigation provides new evidence about the deleterious CaSR-induced communication between pre-adipocytes and liver cells, incorporating the mechanisms involved in cellular senescence.
C1 [Briones-Suarez, Lautaro; Cifuentes, Mariana; Bravo-Sagua, Roberto] Univ Chile, Inst Nutr & Food Technol INTA, Lab Obes & Metab OMEGA, Santiago 7830490, Chile.
   [Briones-Suarez, Lautaro] Univ Bio Bio, Fac Hlth & Food Sci, Dept Nutr & Publ Hlth, Chillan 3800708, Chile.
   [Cifuentes, Mariana] Univ Chile, Fac Med, Ctr Exercise Metab & Canc CEMC, Santiago 8380453, Chile.
   [Cifuentes, Mariana; Bravo-Sagua, Roberto] Adv Ctr Chron Dis ACCDiS, Santiago 8380492, Chile.
   [Bravo-Sagua, Roberto] Consortium Univ State Chile CUECH, Interuniv Ctr Hlth Aging CIES, Santiago 8320216, Chile.
C3 Universidad de Chile; Universidad del Bio-Bio; Universidad de Chile
RP Cifuentes, M; Bravo-Sagua, R (corresponding author), Univ Chile, Inst Nutr & Food Technol INTA, Lab Obes & Metab OMEGA, Santiago 7830490, Chile.; Cifuentes, M (corresponding author), Univ Chile, Fac Med, Ctr Exercise Metab & Canc CEMC, Santiago 8380453, Chile.; Cifuentes, M; Bravo-Sagua, R (corresponding author), Adv Ctr Chron Dis ACCDiS, Santiago 8380492, Chile.; Bravo-Sagua, R (corresponding author), Consortium Univ State Chile CUECH, Interuniv Ctr Hlth Aging CIES, Santiago 8320216, Chile.
EM mcifuentes@inta.uchile.cl; rbravosagua@inta.uchile.cl
RI ; Bravo-Sagua, Roberto/K-1103-2018; Cifuentes, Mariana/I-1054-2013
OI Briones, Lautaro/0000-0002-4830-7349; Bravo-Sagua,
   Roberto/0000-0001-8873-8699; Cifuentes, Mariana/0000-0001-9485-3490
CR Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Barroso WA, 2018, EUR J NUTR, V57, P1891, DOI 10.1007/s00394-017-1472-5
   Batista AF, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02099-x
   Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592
   Burton DGA, 2015, AGE, V37, DOI 10.1007/s11357-015-9764-2
   Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089
   Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005
   Chen ZQ, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.641098
   Chuang YC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143588
   Cifuentes M, 2012, MOL CELL ENDOCRINOL, V361, P24, DOI 10.1016/j.mce.2012.03.006
   D'Espessailles A, 2018, J CELL PHYSIOL, V233, P6232, DOI 10.1002/jcp.26490
   Desdín-Micó G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6
   Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   González-Gualda E, 2021, FEBS J, V288, P56, DOI 10.1111/febs.15570
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hansel C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093279
   Hashimoto S, 2016, LIVER SYSTEMIC DIS, P77
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Hou XY, 2022, J DERMATOL SCI, V105, P88, DOI 10.1016/j.jdermsci.2022.01.002
   Huang Y, 2021, NEUROCHEM RES, V46, P573, DOI 10.1007/s11064-020-03193-x
   Huang ZS, 2021, ACS OMEGA, V6, P9442, DOI 10.1021/acsomega.0c06066
   Ji SH, 2018, EXP CELL RES, V370, P292, DOI 10.1016/j.yexcr.2018.06.031
   Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020
   Kumar R, 2020, BIOGERONTOLOGY, V21, P325, DOI 10.1007/s10522-020-09861-3
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Lan F, 2020, AGING-US, V12, P18942, DOI 10.18632/aging.104052
   Li YJ, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.622950
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Mattar P, 2018, BBA-MOL BASIS DIS, V1864, P3585, DOI 10.1016/j.bbadis.2018.08.020
   Morio B, 2021, CELL CALCIUM, V94, DOI 10.1016/j.ceca.2020.102336
   Nagano T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31758
   Nair S, 2019, GLIA, V67, P1047, DOI 10.1002/glia.23587
   Niu ZD, 2016, ENVIRON TOXICOL PHAR, V45, P212, DOI 10.1016/j.etap.2016.06.006
   Ogrodnik M, 2019, TRENDS BIOCHEM SCI, V44, P996, DOI 10.1016/j.tibs.2019.06.011
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Parvizi M, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2020.165983
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Putti R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00109
   Renovato-Martins M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092828
   Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3
   Romero A, 2019, AGING CELL, V18, DOI 10.1111/acel.12913
   Shum M, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101134
   Spritzer PM, 2015, REPRODUCTION, V149, pR219, DOI 10.1530/REP-14-0435
   Sun XM, 2018, CHROMOSOMA, V127, P175, DOI 10.1007/s00412-018-0659-8
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Tyciakova S, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08237-1
   Wang QL, 2021, BIOENGINEERED, V12, P12812, DOI 10.1080/21655979.2021.2003661
   Wang YJ, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110660
   Xiong SQ, 2015, CELL REP, V12, P1391, DOI 10.1016/j.celrep.2015.07.047
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zamboni M, 2021, EXP GERONTOL, V143, DOI 10.1016/j.exger.2020.111162
   Zhang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175262
   Zhao J, 2021, BIOENGINEERED, V12, P3968, DOI 10.1080/21655979.2021.1948289
   Zhu Y, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.712489
NR 61
TC 0
Z9 0
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2023
VL 24
IS 6
AR 5217
DI 10.3390/ijms24065217
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA A5VE1
UT WOS:000955788100001
PM 36982291
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Iqbal, T
   Nawaz, A
   Karim, M
   Yaku, K
   Hikosaka, K
   Matsumoto, M
   Nakagawa, T
AF Iqbal, Tooba
   Nawaz, Allah
   Karim, Mariam
   Yaku, Keisuke
   Hikosaka, Keisuke
   Matsumoto, Michihiro
   Nakagawa, Takashi
TI Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article; Early Access
DE Nmnat1; NAFLD; NASH; Aging; NAD plus
ID CHOLINE-DEFICIENT DIET; NICOTINAMIDE MONONUCLEOTIDE; METHIONINE; SIRT1;
   RISK; ADENYLYLTRANSFERASE; PREVALENCE; METABOLISM; PROTECTS; OBESITY
AB Nicotinamide adenine dinucleotide (NAD+), a biological molecule integral to redox reactions involved in multiple cellular processes, has the potential to treat nonalcoholic fatty liver diseases (NAFLDs) and nonalcoholic steatohepatitis (NASH). Nicotinamide mononucleotide adenylyltransferase (Nmnat1), one of the NAD+ biosynthesizing enzymes, plays a central role in all NAD+ metabolic pathways and it is vital to embryonic development. However, the function of Nmnat1 in metabolic pathology and, specifically, in the development and progression of NAFLD and NASH remains unexplored. First, we generated hepatic Nmnat1 knockout (H-Nmnat1-/-) mice to investigate the physiological function of Nmnat1 and found that NAD+ levels were significantly lower in H-Nmnat1-/-mice than control mice. However, H- Nmnat1-/-mice appeared normal with comparable metabolic activity. Next, we used three different diet-induced NASH models to assess the pathophysiological role of Nmant1 in metabolic disorders and discovered that hepatic loos of Nmnat1 decreased 35%-40% of total NAD+ in an obese state. Never-theless, our analysis of phenotypic variations found comparable body composition, gene expression, and liver histology in all NASH models in H-Nmnat1-/-mice. We also found that aged H-Nmnat1-/- mice exhibited comparable liver phenotypes with control mice. These findings suggest that Nmnat1 has a redundancy to the pathophysiology of obesity-induced hepatic disorders.(c) 2022 Elsevier Inc. All rights reserved.
C1 [Iqbal, Tooba; Nawaz, Allah; Karim, Mariam; Yaku, Keisuke; Hikosaka, Keisuke; Nakagawa, Takashi] Univ Toyama, Fac Med, Dept Mol & Med Pharmacol, 2630 Sugitani, Toyama, Toyama 9300194, Japan.
   [Matsumoto, Michihiro] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Mol Metab Regulat, Shinjuku ku, Tokyo 1628655, Japan.
   [Nakagawa, Takashi] Univ Toyama, Res Ctr Predis Sci, 2630 Sugitani, Toyama, Toyama 9300194, Japan.
C3 University of Toyama; National Center for Global Health & Medicine -
   Japan; University of Toyama
RP Nakagawa, T (corresponding author), Univ Toyama, Fac Med, Dept Mol & Med Pharmacol, 2630 Sugitani, Toyama, Toyama 9300194, Japan.
EM nakagawa@med.u-toyama.ac.jp
RI Nakagawa, Takashi/F-3015-2010
OI Nakagawa, Takashi/0000-0001-5539-7605; Iqbal, Tooba/0009-0002-8207-3678
FU JSPS KAKENHI; AMED-PRIME; Kobayashi Foundation; Takeda Science
   Foundation; Tamura Science & Technology Foundation; Takeda Medical
   Research Foundation; Takahashi Industrial and Economic Research
   Foundation; Japan Foundation for Applied Enzymology; LOTTE Foundation;
   Rotary Yoneyama Memorial Scholarship; JST SPRING; Moonshot RD; 
   [20K20655];  [22gm6710007h0001];  [JPMJSP2145];  [JPMJMS2021]
FX This work was supported by the JSPS KAKENHI (20K20655) , AMED-PRIME
   (Grant Number 22gm6710007h0001) , and grants from the Kobayashi
   Foundation, Takeda Science Foundation, the Tamura Science & Technology
   Foundation, Takeda Medical Research Foundation, Takahashi Industrial and
   Economic Research Foundation, and Japan Foundation for Applied
   Enzymology to TN, and LOTTE Foundation to KY. We thank Rotary Yoneyama
   Memorial Scholarship for the financial support to TI. MK was supported
   by the JST SPRING (Grant Number JPMJSP2145) . This research was also
   supported by Moonshot R & D (Grant Number JPMJMS2021) .
CR Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014
   Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097
   Babetto E, 2010, J NEUROSCI, V30, P13291, DOI 10.1523/JNEUROSCI.1189-10.2010
   Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200
   Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104
   Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128
   Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001
   Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x
   Dall M, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101388
   Dall M, 2019, J BIOL CHEM, V294, P13304, DOI 10.1074/jbc.RA118.006756
   Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085
   Gao YJ, 2016, ONCOTARGET, V7, P33649, DOI 10.18632/oncotarget.9259
   Han X, 2019, PEERJ, V7, DOI 10.7717/peerj.7568
   Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594
   Jacobs Ans, 2016, Curr Protoc Mouse Biol, V6, P185, DOI 10.1002/cpmo.3
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kiss A, 2020, CANCERS, V12, DOI 10.3390/cancers12051180
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801
   Lee S, 2019, LAB ANIM RES, V35, DOI 10.1186/s42826-019-0016-y
   Li L, 2016, OBES REV, V17, P510, DOI 10.1111/obr.12407
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   Mantovani A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052350
   Marcolin Éder, 2011, Arq. Gastroenterol., V48, P72, DOI 10.1590/S0004-28032011000100015
   Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   Okabe K, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0527-8
   Oya J, 2014, INTERNAL MED, V53, P941, DOI 10.2169/internalmedicine.53.1580
   Paik JM, 2020, HEPATOLOGY, V72, P1605, DOI 10.1002/hep.31173
   Pelz S, 2012, EXP CELL RES, V318, P276, DOI 10.1016/j.yexcr.2011.11.005
   Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749
   Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009
   Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211
   Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9
   Shi XG, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf3895
   Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933
   Verghese PB, 2011, P NATL ACAD SCI USA, V108, P19054, DOI 10.1073/pnas.1107325108
   Yaku K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49547-6
   Yaku K, 2018, AGEING RES REV, V47, P1, DOI 10.1016/j.arr.2018.05.006
   Yamamoto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147037
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469
   Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200
NR 47
TC 2
Z9 2
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD 2022 DEC 25
PY 2022
VL 636
BP 89
EP 95
DI 10.1016/j.bbrc.2022.10.072
EA OCT 2022
PN 1
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 6Q4ZL
UT WOS:000891622200012
PM 36332487
OA hybrid
DA 2024-02-19
ER

PT J
AU Ohura, K
   Tasaka, K
   Hashimoto, M
   Imai, T
AF Ohura, Kayoko
   Tasaka, Katsumi
   Hashimoto, Mitsuru
   Imai, Teruko
TI Distinct Patterns of Aging Effects on the Expression and Activity of
   Carboxylesterases in Rat Liver and Intestine
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID AGE-RELATED-CHANGES; CATALYTIC-PROPERTIES; SERUM CARBOXYLESTERASE;
   HYDROLASE ACTIVITY; GENE-EXPRESSION; IDENTIFICATION; METABOLISM;
   ISOZYMES; PRODRUGS; PLASMA
AB The age-associated alteration in expression levels of carboxylesterases (CESs) can affect both intestinal and hepatic first-pass metabolism after oral administration of xenobiotic esters such as prodrugs. In this study, the age-related expression of CES isozymes and hydrolase activities were simultaneously investigated in liver, jejunum, and ileum from 8-, 46-, and 90-week-old rats. Rat liver expresses three major CES1 isozymes, Hydrolase A, Hydrolase B, and Hydrolase C, as well as one minor CES1 (Egasyn) and three minor CES2 isozymes (RL4, AY034877, and D50580). The mRNA and protein levels of major hepatic CES1 isozymes were decreased in an age-dependent manner, while those of minor CESs were maintained in all age groups. The hepatic hydrolase activity for temocapril was decreased in an age-dependent manner, accompanied by downregulation of Hydrolase B/C mRNA, while age-independent hydrolysis of propranolol derivatives was observed in rat liver, due to the contribution of Egasyn. Rat small intestine expresses one major CES2 (RL4) and four minor CESs (Hydrolase B, Hydrolase C, Egasyn, and AY034877). Interestingly, the expression of RL4 was age-dependently increased in both jejunum and ileum, while minor isozymes showed a constant expression across a wide age range. The up-regulation of RL4 expression with aging led to an increase of intestinal hydrolase activities for temocapril and propranolol derivatives. Consequently, age-dependent changes in the expression of CES isozymes affect the hydrolysis of xenobiotics in both rat liver and small intestine.
C1 [Ohura, Kayoko; Tasaka, Katsumi; Imai, Teruko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan.
C3 Kumamoto University
RP Imai, T (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.
EM iteruko@gpo.kumamoto-u.ac.jp
CR ALEXSON SEH, 1994, J BIOL CHEM, V269, P17118
   Anand SS, 2006, DRUG METAB DISPOS, V34, P389, DOI 10.1124/dmd.105.007807
   Bahar FG, 2012, J PHARM SCI-US, V101, P3979, DOI 10.1002/jps.23258
   Bolling BW, 2011, DRUG METAB DISPOS, V39, P1406, DOI 10.1124/dmd.111.038406
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Furihata T, 2005, BIOCHEM PHARMACOL, V69, P1287, DOI 10.1016/j.bcp.2005.01.017
   Holmes RS, 2010, MAMM GENOME, V21, P427, DOI 10.1007/s00335-010-9284-4
   Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412
   Imai T, 2005, DRUG METAB DISPOS, V33, P1185, DOI 10.1124/dmd.105.004226
   Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173
   Imai T, 2006, DRUG METAB DISPOS, V34, P1734, DOI 10.1124/dmd.106.009381
   Imai T, 2010, CURR DRUG METAB, V11, P793, DOI 10.2174/138920010794328904
   Imai T, 2010, J PESTIC SCI, V35, P229, DOI 10.1584/jpestics.R10-03
   Karanth S, 2000, TOXICOL SCI, V58, P282, DOI 10.1093/toxsci/58.2.282
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Masaki K, 2007, DRUG METAB DISPOS, V35, P1089, DOI 10.1124/dmd.106.013862
   Milad-Kodsi E, 2005, BBA-MOL CELL BIOL L, V1734, P62, DOI 10.1016/j.bbalip.2005.02.008
   MORGAN EW, 1994, ARCH BIOCHEM BIOPHYS, V315, P513, DOI 10.1006/abbi.1994.1532
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Palasz A, 2012, GENES NUTR, V7, P197, DOI 10.1007/s12263-011-0240-z
   Sanghani SP, 2002, EUR J BIOCHEM, V269, P4387, DOI 10.1046/j.1432-1033.2002.03121.x
   Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488
   Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257
   Satoh T, 2006, CHEM-BIOL INTERACT, V162, P195, DOI 10.1016/j.cbi.2006.07.001
   SHAMEEM M, 1993, J PHARM PHARMACOL, V45, P246, DOI 10.1111/j.2042-7158.1993.tb05547.x
   Shi DS, 2011, J INFECT DIS, V203, P937, DOI 10.1093/infdis/jiq145
   Shi D, 2008, TOXICOLOGY, V254, P97, DOI 10.1016/j.tox.2008.09.019
   Takai S, 1997, BIOL PHARM BULL, V20, P869
   Taketani M, 2007, LIFE SCI, V81, P924, DOI 10.1016/j.lfs.2007.07.026
   Vistoli G, 2009, CHEM BIODIVERS, V6, P2092, DOI 10.1002/cbdv.200900174
   Warrington JS, 2004, J PHARM PHARMACOL, V56, P819, DOI 10.1211/0022357023529
   Warrington JS, 2003, DRUG METAB DISPOS, V31, P1306, DOI 10.1124/dmd.31.11.1306
   Xiao D, 2012, BIOCHEM PHARMACOL, V84, P232, DOI 10.1016/j.bcp.2012.04.002
   YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879
   YAN BF, 1995, J BIOL CHEM, V270, P19128, DOI 10.1074/jbc.270.32.19128
   Yang DF, 2009, BIOCHEM PHARMACOL, V77, P238, DOI 10.1016/j.bcp.2008.10.005
   Yoshigae Y, 1999, CHIRALITY, V11, P10, DOI 10.1002/(SICI)1520-636X(1999)11:1<10::AID-CHIR2>3.0.CO;2-E
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
   Zhu HJ, 2009, DRUG METAB DISPOS, V37, P1819, DOI 10.1124/dmd.109.028209
NR 40
TC 15
Z9 17
U1 0
U2 10
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD FEB
PY 2014
VL 42
IS 2
BP 264
EP 273
DI 10.1124/dmd.113.054551
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 286XN
UT WOS:000329502700010
PM 24271336
DA 2024-02-19
ER

PT J
AU Zhang, T
   Liu, HP
   Zhu, CH
   Briggs, K
   Kang, YA
   Fleming, JA
   Curley, SA
AF Zhang, Ti
   Liu, Heping
   Zhu, Cihui
   Briggs, Katrina
   Kang, Ya'an
   Fleming, Jason A.
   Curley, Steven A.
TI Silencing thioredoxin induces liver cancer cell senescence under hypoxia
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE cellular senescence; DNA damage response; hepatocellular carcinoma;
   MHCC97H; thioredoxin
ID ENDOTHELIAL-CELLS; SYSTEM
AB Aim: Although thioredoxin 1 (TXN) has pleiotropic cellular functions as a redox-sensitive protein, very little is known about its role in tumor survival and growth under hypoxia. MHCC97H hepatocellular carcinoma cells have a high metastatic potential and high thioredoxin expression levels compared with their parent cell line, MHCC97. Thus, we used this cell line to explore the functional connections between TXN and hypoxia. Methods: MHCC97H cells were cultured under normoxia and hypoxia for specific periods after nucleofection with TXN siRNA or control siRNA. We assessed the beta-phenylethyl isothiocyanate (PEITC) sensitivity of the cells, cell proliferation, cell cycle and senescence, and DNA damage response by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, colony formation assays, flow cytometry, beta-galactosidase staining, western blotting, and immunohistochemistry. Results: beta-phenylethyl isothiocyanate treatment shifted reduced TXN to oxidized TXN in MHCC97H cells. Although silencing of TXN via siRNA had no effect on the PEITC sensitivity of the cells, it suppressed cell proliferation and colony formation under both normoxia and hypoxia. Under hypoxia, silencing TXN did not induce apoptosis but induced DNA damage response and cellular senescence. Conclusions: High TXN levels in MHCC97H cells protect them from DNA damage and cellular senescence under hypoxia. Targeting TXN might enhance the chemotherapeutic effects of some DNA-damaging agents against hepatocellular carcinoma.
C1 [Liu, Heping; Zhu, Cihui; Briggs, Katrina; Kang, Ya'an; Fleming, Jason A.; Curley, Steven A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.
   [Zhang, Ti] Tianjin Med Univ, Tianjin Canc Hosp, Dept Hepatobiliary Surg, Tianjin, Peoples R China.
C3 University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical
   University
RP Curley, SA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.
EM scurley@mdanderson.org
RI LIU, HE/IQR-5714-2023
OI zhu, cihui/0000-0003-3861-3075
FU National Institutes of Health through MD Anderson's Cancer Center
   [CA016672]
FX WE THANK ZHAO-YOU Tang at the Liver Cancer Institute, Zhongshan
   Hospital, Shanghai, China, for providing us with the HCC cell line
   MHCC97H; Zhen Fan and Samuel Mok at MD Anderson for the use of the
   hypoxia chamber; and Karen R. Muller and Kristine Ash for editing and
   submitting this manuscript. This research is supported in part by the
   National Institutes of Health through MD Anderson's Cancer Center
   Support Grant (CA016672).
CR Arnér ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009
   BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207
   Byun HS, 2005, FEBS LETT, V579, P4055, DOI 10.1016/j.febslet.2005.06.023
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ding SJ, 2004, PROTEOMICS, V4, P982, DOI 10.1002/pmic.200300653
   Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003
   Farina AR, 2001, EUR J BIOCHEM, V268, P405
   FERNANDO MR, 1992, EUR J BIOCHEM, V209, P917, DOI 10.1111/j.1432-1033.1992.tb17363.x
   HOLMGREN A, 1982, J BIOL CHEM, V257, P6926
   Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025
   Mukherjee A, 2008, BRIT J RADIOL, V81, pS57, DOI 10.1259/bjr/34180435
   Park JH, 2006, RESPIROLOGY, V11, P269, DOI 10.1111/j.1440-1843.2006.00849.x
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261
   Sally J, 2006, J NEURO-ONCOL, V77, P131, DOI 10.1007/s11060-005-9030-z
   Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009
   YOKOMIZO A, 1995, CANCER RES, V55, P4293
   Young JJ, 2010, BIOCHEM BIOPH RES CO, V392, P363, DOI 10.1016/j.bbrc.2010.01.026
NR 19
TC 8
Z9 8
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD JUL
PY 2012
VL 42
IS 7
BP 706
EP 713
DI 10.1111/j.1872-034X.2012.00973.x
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 956ZR
UT WOS:000305128600010
PM 22414001
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Unterluggauer, H
   Hütter, E
   Voglauer, R
   Grillari, J
   Vöth, M
   Bereiter-Hahn, J
   Jansen-Dürr, P
   Jendrach, M
AF Unterluggauer, Hermann
   Huetter, Eveline
   Voglauer, Regina
   Grillari, Johannes
   Voeth, Monika
   Bereiter-Hahn, Jurgen
   Jansen-Duerr, Pidder
   Jendrach, Marina
TI Identification of cultivation-independent markers of human endothelial
   cell senescence in vitro
SO BIOGERONTOLOGY
LA English
DT Article
DE in vitro aging; HUVEC; mitochondria; ROS; cell culture model
ID RAT-LIVER MITOCHONDRIA; EARLY-PASSAGE; TELOMERE REDUCTION;
   HYDROGEN-PEROXIDE; HUMAN FIBROBLASTS; OXIDATIVE DAMAGE; APOPTOSIS;
   CULTURE; VIVO; AGE
AB Human aging processes are regulated by many divergent pathways and on many levels. Thus, to understand such a complex system and define conserved mechanisms of aging, the use of cell culture-based models is a widespread practice. An often stated advantage of in vitro aging of primary cells is the high reproducibility compared to the much more intricate aging of organisms. However, the aging process of cultured cells is, like aging of organisms, not only defined by genetic but also by environmental factors, making it difficult to distinguish between cell culture condition-induced artefacts and true aspects of aging. Therefore we investigated aging of HUVEC (human umbilical vascular endothelial cells), a well-known and widely used model system for in vitro aging, with different, already well-established cell culture protocols. Culturing conditions had indeed a strong impact on cell proliferation, the replicative lifespan and apoptosis rates. However, despite these significant differences, we found also various robust markers that define senescent HUVEC: morphological changes, increased senescence-associated beta-galactosidase staining, cell cycle arrest in the GI phase, lowered mitochondrial membrane potential and increased oxidatively modified proteins were displayed independent of cell culture protocols and could therefore be considered also as markers for in vivo aging.
C1 Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Kinemat Cell Res Grp, D-60438 Frankfurt, Germany.
   Austrian Acad Sci, Inst Biomed Aging Res, Dept Mol Cell Biol, A-6020 Innsbruck, Austria.
   Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, A-1190 Vienna, Austria.
C3 Goethe University Frankfurt; Austrian Academy of Sciences; University of
   Natural Resources & Life Sciences, Vienna
RP Jendrach, M (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Kinemat Cell Res Grp, Max-Von-Laue-Str 9, D-60438 Frankfurt, Germany.
EM jendrach@bio.uni-frankfurt.de
RI Jansen-Dürr, Pidder/ABG-2466-2020; Grillari, Johannes/B-2967-2011
OI Jansen-Dürr, Pidder/0000-0001-7771-3429; Grillari,
   Johannes/0000-0001-5474-6332; Grillari, Regina/0000-0002-5487-2838
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323
   BEREITERHAHN J, 1976, BIOCHIM BIOPHYS ACTA, V423, P1, DOI 10.1016/0005-2728(76)90096-7
   Brack Christine, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P1929, DOI 10.1093/emboj/19.9.1929
   Chang MWF, 2005, EXP CELL RES, V309, P121, DOI 10.1016/j.yexcr.2005.05.002
   Chung SJ, 2004, J BIOCHEM MOL BIOL, V37, P239
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   GARFINKEL S, 1994, P NATL ACAD SCI USA, V91, P1559, DOI 10.1073/pnas.91.4.1559
   Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260
   Grillari J, 2000, EXP GERONTOL, V35, P187, DOI 10.1016/S0531-5565(00)00080-2
   Grzelak A, 2001, FREE RADICAL BIO MED, V30, P1418, DOI 10.1016/S0891-5849(01)00545-7
   Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001
   Harms C, 2004, MOL CELL NEUROSCI, V25, P69, DOI 10.1016/j.mcn.2003.09.012
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   Hayflick L, 2000, BRIT J CANCER, V83, P841, DOI 10.1054/bjoc.2000.1296
   Huang X, 2005, CELL CYCLE, V4, P801, DOI 10.4161/cc.4.6.1695
   Hütter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Leifeld L, 2006, AM J PATHOL, V168, P778, DOI 10.2353/ajpath.2006.050323
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   Mather MW, 2002, MECH AGEING DEV, V123, P707, DOI 10.1016/S0047-6374(01)00416-X
   Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444
   Minamino T, 2004, J MOL CELL CARDIOL, V36, P175, DOI 10.1016/j.yjmcc.2003.11.010
   Nakamichi N, 2005, J NEUROCHEM, V93, P84, DOI 10.1111/j.1471-4159.2005.02999.x
   Nyström T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599
   Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006
   Patil CK, 2005, MECH AGEING DEV, V126, P1040, DOI 10.1016/j.mad.2005.08.001
   Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613
   Ramakrishnan N, 1998, FREE RADICAL RES, V29, P283, DOI 10.1080/10715769800300321
   Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201
   Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200
   Savitha S, 2006, MECH AGEING DEV, V127, P349, DOI 10.1016/j.mad.2005.12.004
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Unterluggauer H, 2003, EXP GERONTOL, V38, P1149, DOI 10.1016/j.exger.2003.08.007
   Vasile E, 2001, FASEB J, V15, P458, DOI 10.1096/fj.00-0051com
   Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X
   Xiong H, 2004, NEUROBIOL AGING, V25, P349, DOI 10.1016/S0197-4580(03)00123-4
   Yang L, 2005, TALANTA, V68, P40, DOI 10.1016/j.talanta.2005.04.038
   Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4
   Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009
NR 50
TC 38
Z9 44
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD AUG
PY 2007
VL 8
IS 4
BP 383
EP 397
DI 10.1007/s10522-007-9082-x
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 193KB
UT WOS:000248271800001
PM 17377850
DA 2024-02-19
ER

PT J
AU Choi, JS
   Kim, JK
   Yang, YJ
   Kim, Y
   Kim, P
   Park, SG
   Cho, EY
   Lee, DH
   Choi, JW
AF Choi, Joon-Seok
   Kim, Jun Ki
   Yang, Yoon Jung
   Kim, Yeseul
   Kim, Pilhan
   Park, Sang Gyu
   Cho, Eun-Young
   Lee, Dae Ho
   Choi, Jin Woo
TI Identification of cromolyn sodium as an anti-fibrotic agent targeting
   both hepatocytes and hepatic stellate cells
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Pharmacogenomics; Liver fibrosis; Cirrhosis; Hepatic stellate cell;
   Hepatocyte; Cromolyn
ID TISSUE GROWTH-FACTOR; NORMAL HUMAN-LIVER; MAST-CELLS;
   CARBON-TETRACHLORIDE; FACTOR-BETA; FIBROSIS; EXPRESSION; PROLIFERATION;
   RATS; FIBROGENESIS
AB Liver fibrosis and cirrhosis, the late stage of fibrosis, are threatening diseases that lead to liver failure and patient death. Although aberrantly activated hepatic stellate cells (HSCs) are the main cause of disease initiation, the symptoms are primarily related to damaged hepatocytes. Thus, damaged hepatocytes, as well as HSCs, need to be simultaneously considered as therapeutic targets to develop more efficient treatments.
   Here, we suggest cromolyn sodium as an anti-fibrotic agent to commonly modulate hepatocytes and hepatic stellate cells. The differentially expressed genes from 6 normal and 40 cirrhotic liver tissues which were collected from GEO data were assessed by pharmacokinetic analysis using a connectivity map to identify agents that commonly revert abnormal hepatocytes and HSCs to normal conditions. Based on a series of analyses, a few candidates were selected. Candidates were tested in vitro to determine their anti-fibrotic efficacy on HSCs and hepatocytes. Cromolyn, which was originally developed as a mast cell stabilizer, showed the potential to ameliorate activated HSCs in vitro. The activation and collagen accumulation for HSC cell lines LX2 and HSC-T6 were reduced by 50% after cromolyn treatment at a low concentration without apoptosis. Furthermore, cromolyn treatment compromised the TGF-beta-induced epithelial mesenchyme transition and replicative senescence rate of hepatocytes, which are generally associated with fibrogenesis. Taken together, cromolyn may be the basis for an effective cure for fibrosis and cirrhosis because it targets both HSCs and hepatocytes. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Choi, Joon-Seok] Catholic Univ Daegu, Coll Pharm, Gyeongbuk 712702, South Korea.
   [Kim, Jun Ki] Asan Med Ctr, Ctr Biomed Engn, Asan Inst Life Sci, Seoul 138736, South Korea.
   [Kim, Jun Ki] Univ Ulsan, Coll Med, Seoul 138736, South Korea.
   [Yang, Yoon Jung; Choi, Jin Woo] Wonkwang Univ, Wonkwang Inst Integrat Biomed Sci, Iksan 570711, Chonbuk, South Korea.
   [Yang, Yoon Jung; Choi, Jin Woo] Wonkwang Univ, Dent Res Inst, Sch Dent, Iksan 570711, Chonbuk, South Korea.
   [Kim, Yeseul; Kim, Pilhan] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon 305338, South Korea.
   [Park, Sang Gyu] Ajou Univ, Dept Pharm, Suwon 443270, Gyenggi Do, South Korea.
   [Cho, Eun-Young; Lee, Dae Ho] Wonkwang Univ, Sch Med & Hosp, Dept Internal Med, Iksan 570711, Jeonbuk, South Korea.
   [Choi, Jin Woo] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, Gyeonggi Do, South Korea.
C3 Catholic University of Daegu; University of Ulsan; Asan Medical Center;
   University of Ulsan; Wonkwang University; Wonkwang University; Korea
   Advanced Institute of Science & Technology (KAIST); Ajou University;
   Wonkwang University; Seoul National University (SNU)
RP Choi, JW (corresponding author), Wonkwang Univ, Wonkwang Inst Integrat Biomed Sci, Iksan 570711, Chonbuk, South Korea.
EM jinwoo.ch@gmail.com
RI Kim, Pilhan/C-1836-2011
OI Kim, Pilhan/0000-0001-8388-1840; Cho, Eun Young/0000-0003-2604-918X
FU Basic Science Research Program [2008-0062484, 2014R1A1A1002431,
   NRF-2014R1A1A2057773, NRF-2015K2A7A1035896]; Global Frontier Program
   through the National Research Foundation of Korea (NRF) - Ministry of
   Science, ICT & Future Planning [2012M3A6A4054261, 2013M3A6A4072626];
   Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea
   [2015-7212]
FX This work was supported by the Basic Science Research Program
   [2008-0062484, 2014R1A1A1002431, NRF-2014R1A1A2057773 and
   NRF-2015K2A7A1035896] and the Global Frontier Program [2012M3A6A4054261
   and 2013M3A6A4072626] through the National Research Foundation of Korea
   (NRF) funded by the Ministry of Science, ICT & Future Planning. And it
   was also partially supported by a grant (2015-7212) from the Asan
   Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
CR Amayasu H, 2001, ANN ALLERG ASTHMA IM, V87, P146, DOI 10.1016/S1081-1206(10)62210-7
   Amiot L., 2015, J HEPATOL
   Amiot L, 2014, J HEPATOL, V60, P245, DOI 10.1016/j.jhep.2013.09.006
   BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055
   Blakey JD, 2011, BRIT J CLIN PHARMACO, V71, P824, DOI 10.1111/j.1365-2125.2011.03912.x
   Fend F, 2000, J CLIN PATHOL, V53, P666, DOI 10.1136/jcp.53.9.666
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   FRIEDMAN SL, 1992, HEPATOLOGY, V15, P234, DOI 10.1002/hep.1840150211
   GIAMPIERI MP, 1981, DIGESTION, V22, P165, DOI 10.1159/000198640
   Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x
   Henz BM, 2008, EXP DERMATOL, V17, P91, DOI 10.1111/j.1600-0625.2007.00658.x
   Hsu YC, 2005, J BIOMED SCI, V12, P185, DOI 10.1007/s11373-004-8167-7
   Huang GC, 2012, FRONT BIOSCI-LANDMRK, V17, P2495, DOI 10.2741/4067
   HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307
   Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542
   Ishii A, 2005, HEPATOL RES, V31, P127, DOI 10.1016/j.hepres.2005.01.007
   Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
   Jeong DH, 2005, WORLD J GASTROENTERO, V11, P1141, DOI 10.3748/wjg.v11.i8.1141
   Jin Yu-lan, 2012, Chinese Journal of Pathology, V41, P260, DOI 10.3760/cma.j.issn.0529-5807.2012.04.010
   Kanellakis P, 2012, CARDIOVASC RES, V95, P77, DOI 10.1093/cvr/cvs142
   Kim T, 2015, BMB REP, V48, P388, DOI 10.5483/BMBRep.2015.48.7.218
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Mauviel A, 2009, J INVEST DERMATOL, V129, P7, DOI 10.1038/jid.2008.385
   Mogler C, 2015, EMBO MOL MED, V7, P332, DOI 10.15252/emmm.201404246
   Neef M, 2006, J HEPATOL, V44, P167, DOI 10.1016/j.jhep.2005.06.015
   Patsenker E, 2011, AM J PHYSIOL-GASTR L, V301, pG425, DOI 10.1152/ajpgi.00050.2011
   Renko K, 2012, ENDOCRINOLOGY, V153, P2506, DOI 10.1210/en.2011-1863
   SCHMITT JK, 1995, AM J HYPERTENS, V8, P520, DOI 10.1016/0895-7061(95)00046-R
   Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028
   Tzeng JI, 2013, PHYTOTHER RES, V27, P1023, DOI 10.1002/ptr.4829
   Veerappan A, 2013, DNA CELL BIOL, V32, P206, DOI 10.1089/dna.2013.2005
   Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006
   Wen SL, 2014, J GASTROEN HEPATOL, V29, P1932, DOI 10.1111/jgh.12641
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yao QY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-156
   Zhang CQ, 2006, LIVER INT, V26, P1283, DOI 10.1111/j.1478-3231.2006.01378.x
NR 36
TC 14
Z9 18
U1 0
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
J9 PHARMACOL RES
JI Pharmacol. Res.
PD DEC
PY 2015
VL 102
BP 176
EP 183
DI 10.1016/j.phrs.2015.10.002
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CZ0KG
UT WOS:000366793100020
PM 26453959
DA 2024-02-19
ER

PT J
AU Liu, YY
   Wang, MJ
   Xu, W
   Zhang, HM
   Qian, WH
   Li, X
   Cheng, XB
AF Liu, Yuanyuan
   Wang, Mengjie
   Xu, Wei
   Zhang, Hongman
   Qian, Weihe
   Li, Xiang
   Cheng, Xingbo
TI Active vitamin D supplementation alleviates initiation and progression
   of nonalcoholic fatty liver disease by repressing the p53 pathway
SO LIFE SCIENCES
LA English
DT Article
DE Active vitamin D; Nonalcoholic fatty liver disease; p53 pathway;
   Senescence; Apoptosis; Oxidative stress
ID OXIDATIVE STRESS; CELLS; NAFLD; SENESCENCE; EXPRESSION; STEATOSIS;
   PROTECTS; ACTIVATION; APOPTOSIS; PROMOTER
AB Background/aims: Recent studies have found vitamin D deficiency promotes fat deposition into the hepatocytes, thus contributing to the development of nonalcoholic fatty liver disease (NAFLD), which is a hepatic manifestation of metabolic syndrome. This study aimed to investigate the potential effects of vitamin D on NAFLD with the involvement of the p53 pathway.
   Methods: Initially, an in vivo high-fat diet (HFD)-induced NAFLD mouse model was established. Then the HFD-induced NAFLD mice were treated with vitamin D. Next, the serum levels of TNF-alpha, GSH-px and malondialdehyde (MDA) were assessed using ELISA and ROS content was evaluated by flow cytometry, followed by the measurement of expression of Duox1, Duox2, SOD1, SOD2, PRDX1 I, ACC, SREBP1c, MTTP, PPAR alpha, p53, p21 and p16 using RT-qPCR and Western blot analysis. Positive expression of FAS and FASL proteins was measured using immunohistochemistry. TUNEL and Senescence-associated beta-galactosidase (SA-beta-Gal) staining were subsequently conducted to assess the senescence and apoptosis of hepatocytes.
   Results: HFD-induced mice treated with vitamin D presented with significantly increased GSH-px levels, as well as protein expression of SOD1, SOD2, PRDX1, MTTP and PPARa, but decreased MDA and ROS levels, expression of Duox1, Duox2, ACC, SREBP1c, p53, p21 and p16, positive expression of FAS and FASL proteins as well as impaired senescence and apoptosis of hepatocytes.
   Conclusion: Active vitamin D supplementation could potentially impede hepatocyte senescence and apoptosis via suppression of the p53 pathway, thus preventing the progression of NAFLD. Our study provides available evidence on the potential clinical utility of vitamin D supplementation in NAFLD.
C1 [Liu, Yuanyuan; Cheng, Xingbo] Soochow Univ, Affiliated Hosp 1, Dept Endocrinol, 188 Shizi St, Suzhou 215006, Peoples R China.
   [Liu, Yuanyuan; Zhang, Hongman] Nanjing Med Univ, Affiliated Huaian 1 Peoples Hosp, Dept Endocrinol, Huaian 223300, Peoples R China.
   [Wang, Mengjie] Lianshui Cty Peoples Hosp, Dept Clin Lab, Huaian 223400, Peoples R China.
   [Xu, Wei] Soochow Univ, Appl Technol Coll, Dept Comp & Software Engn, Suzhou 215325, Peoples R China.
   [Qian, Weihe; Li, Xiang] Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Clin Lab, 62 Huaihai South Rd, Xuzhou 223002, Jiangsu, Peoples R China.
C3 Soochow University - China; Nanjing Medical University; Soochow
   University - China; Xuzhou Medical University
RP Cheng, XB (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Endocrinol, 188 Shizi St, Suzhou 215006, Peoples R China.; Li, X (corresponding author), Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Clin Lab, 62 Huaihai South Rd, Xuzhou 223002, Jiangsu, Peoples R China.
EM lixiang_suda@163.com; Xingbo1107@sohu.com
RI Wang, xiaoxiao/GQQ-2846-2022; liu, 园园/HJI-4438-2023; liu,
   yuanyuan/IQS-2755-2023; liu, yuanyuan/GWZ-5838-2022; liu,
   yuanyuan/HSG-8372-2023
FU Huai'an Natural Science Foundation [HAB201722]; Nanjing Medical
   University Natural Science Foundation [2016NJMU137]
FX The present study was funded by the Huai'an Natural Science Foundation
   (Grant No. HAB201722) and Nanjing Medical University Natural Science
   Foundation (Grant No. 2016NJMU137).
CR Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/egh.11.6, 10.1586/EGH.11.6]
   Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Ashraf NU, 2015, FREE RADICAL RES, V49, P1405, DOI 10.3109/10715762.2015.1078461
   Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85
   Cimini Flavia Agata, 2019, World J Gastrointest Pathophysiol, V10, P11, DOI 10.4291/wjgp.v10.i2.11
   Cui ZH, 2017, ONCOTARGET, V8, P63281, DOI 10.18632/oncotarget.18793
   Derdak Z, 2013, J HEPATOL, V58, P785, DOI 10.1016/j.jhep.2012.11.042
   Eliades M, 2013, ALIMENT PHARM THER, V38, P246, DOI 10.1111/apt.12377
   Hodson L, 2019, NAT REV ENDOCRINOL, V15, P689, DOI 10.1038/s41574-019-0256-9
   Huang YY, 2013, WORLD J GASTROENTERO, V19, P8238, DOI 10.3748/wjg.v19.i45.8238
   Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14
   Kwok RM, 2013, HEPATOLOGY, V58, P1166, DOI 10.1002/hep.26390
   Li J, 2010, DIABETES OBES METAB, V12, P35, DOI 10.1111/j.1463-1326.2009.01093.x
   Ling QX, 2014, AM J CANCER RES, V4, P508
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   Nawata A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152549
   Qiao SJ, 2004, FEBS LETT, V577, P451, DOI 10.1016/j.febslet.2004.10.044
   Rhee EJ, 2019, ENDOCRINOL METAB, V34, P226
   Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737
   Saramäki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460
   Sawano T, 2015, ONCOL REP, V33, P2151, DOI 10.3892/or.2015.3814
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Sharifi N, 2014, ENDOCRINE, V47, P70, DOI 10.1007/s12020-014-0336-5
   Song HM, 2018, INT J MOL MED, V42, P193, DOI 10.3892/ijmm.2018.3593
   Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025
   Sumida Y, 2013, FREE RADICAL RES, V47, P869, DOI 10.3109/10715762.2013.837577
   Tao YF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01521
   Uberti F, 2014, J CLIN ENDOCR METAB, V99, P1367, DOI 10.1210/jc.2013-2103
   Valcheva P, 2014, ATHEROSCLEROSIS, V235, P247, DOI 10.1016/j.atherosclerosis.2014.05.911
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Vlajkovic SM, 2013, HEARING RES, V304, P145, DOI 10.1016/j.heares.2013.07.012
   Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449
   Yi G, 2013, INT J ONCOL, V43, P1503, DOI 10.3892/ijo.2013.2077
   Yin Y, 2012, EUR J CLIN INVEST, V42, P1189, DOI 10.1111/j.1365-2362.2012.02706.x
   Zelber-Sagi S, 2011, WORLD J GASTROENTERO, V17, P3377, DOI 10.3748/wjg.v17.i29.3377
   Zhao WL, 2007, RADIAT RES, V167, P581, DOI 10.1667/RR0814.1
NR 37
TC 17
Z9 22
U1 0
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD JAN 15
PY 2020
VL 241
AR 117086
DI 10.1016/j.lfs.2019.117086
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA KB0SV
UT WOS:000506211900004
PM 31756344
DA 2024-02-19
ER

PT J
AU Barzilai, N
   Banerjee, S
   Hawkins, M
   Chen, W
   Rossetti, L
AF Barzilai, N
   Banerjee, S
   Hawkins, M
   Chen, W
   Rossetti, L
TI Caloric restriction reverses hepatic insulin resistance in aging rats by
   decreasing visceral fat
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
DE visceral fat; hepatic insulin resistance; aging; hepatic glucose flux;
   caloric restriction
ID GLUCOSE-METABOLISM; ADIPOSE-TISSUE; DIABETES-MELLITUS; ABDOMINAL FAT;
   OBESITY; AGE; MUSCLE; WOMEN; HYPERGLYCEMIA; INTOLERANCE
AB Hyperinsulinemia and increased visceral/abdominal fat (VF) are common features of human aging. To examine the relationships among VF, peripheral, and hepatic insulin sensitivity, we studied 4- and 18-mo-old male Sprague-Dawley rats (n = 42) fed ad libitum (4 AL and 18 AL) or moderately calorie restricted (18 CR) up to 18 mo of age, Total fat mass (FM) and VF were decreased in 18 CR to approximately one-third of that of 18 AL (P < 0.001), while lean body mass (LBM) was unchanged, Most important, 18 CR had more FM (65 +/- 6 vs. 45 +/- 6 g) but less VF (7.8 +/- 0.6 vs. 12.3 +/- 3.3 g) compared with 4 AL (P < 0.01 for both). Thus, the effects of variable VF on HIS could be assessed, independent of FM and age.
   Marked hepatic insulin resistance ensued with aging (18 AL) and CR restored hepatic insulin sensitivity to the levels of young rats, while peripheral insulin sensitivity remained unchanged (by insulin clamp of 18 mU/kg/min), In fact, the rates of insulin infusion required to maintain basal hepatic glucose production in the presence of pancreatic clamp were 0.75 +/- 0.10, 1.41 +/- 0.13, and 0.51 +/- 0.12 mU/kg.min, in 4 AL, 18 AL, and 18 CR, respectively (P < 0.01 between all groups), and in 18 CR rats infused with insulin at similar rates as in the 18 AL (1.4 mU/kg/min) hepatic glucose production was decreased by 32% (P < 0.005). Furthermore, when 18 CR rats were fed AL for 14 d, VF rapidly and selectively increased and severe hepatic insulin resistance was induced, We propose that in this animal model the age-associated decrease in hepatic (rather than peripheral) insulin action is the major determinant of fasting hyperinsulinemia and that increased visceral adiposity plays the major role in inducing hepatic insulin resistance. Thus, interventions designed to prevent the accumulation of VF are likely to represent an effective mean to improve carbohydrate metabolism in aging.
C1 Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Geriatr, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Div Pediat Endocrinol, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine
RP Barzilai, N (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Geriatr, 1300 Morris Pk Ave,Belfer Bld 701, Bronx, NY 10461 USA.
EM barzilai@aecom.yu.edu
FU NIDDK NIH HHS [R0I-DK 48321, R01-DK 45024, DK 20541] Funding Source:
   Medline
CR BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   BARZILAI N, 1989, AGE, V12, P13, DOI 10.1007/BF02432513
   Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865
   BARZILAI N, 1993, J BIOL CHEM, V268, P25019
   BARZILAI N, 1996, AM J PHYSIOL, V20, pE930
   BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493
   BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252
   BOGARDUS C, 1985, AM J PHYSIOL, V248, pE286, DOI 10.1152/ajpendo.1985.248.3.E286
   BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673
   BUSETTO L, 1993, HORM METAB RES, V25, P365, DOI 10.1055/s-2007-1002121
   Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633
   COLBERG SR, 1995, J CLIN INVEST, V95, P1846, DOI 10.1172/JCI117864
   COON PJ, 1992, J CLIN ENDOCR METAB, V75, P1125, DOI 10.1210/jc.75.4.1125
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667
   ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739
   FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x
   GUMBINER B, 1992, METABOLISM, V41, P1115, DOI 10.1016/0026-0495(92)90296-M
   Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390
   IVY JL, 1991, MECH AGEING DEV, V61, P123, DOI 10.1016/0047-6374(91)90011-N
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997
   Kissebah A H, 1996, Diabetes Res Clin Pract, V30 Suppl, P25
   KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205
   MARIN P, 1992, METABOLISM, V41, P1242, DOI 10.1016/0026-0495(92)90016-4
   Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871
   NICKLAS BJ, 1995, AM J CLIN NUTR, V62, P918, DOI 10.1093/ajcn/62.5.918
   OSHAUGHNESSY IM, 1995, HYPERTENSION, V26, P186, DOI 10.1161/01.HYP.26.1.186
   PEIRIS AN, 1988, J CLIN ENDOCR METAB, V67, P760, DOI 10.1210/jcem-67-4-760
   PRAGER R, 1986, J CLIN INVEST, V78, P472, DOI 10.1172/JCI112599
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   REAVEN GM, 1985, J AM GERIATR SOC, V33, P286, DOI 10.1111/j.1532-5415.1985.tb07118.x
   Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846
   ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681
   ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981
   SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66
   WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247
   WOLFE RR, 1984, RADIOISOTOPES STABLE
NR 42
TC 224
Z9 243
U1 0
U2 6
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD APR 1
PY 1998
VL 101
IS 7
BP 1353
EP 1361
DI 10.1172/JCI485
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA ZF791
UT WOS:000072933600008
PM 9525977
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Kitani, K
AF Kitani, Kenichi
TI What really declines with age? The Hayflick Lecture for 2006 35th
   American Aging Association
SO AGE
LA English
DT Article
DE aging rodents; altered enzymes; antioxidant enzymes; (-)deprenyl;
   hepatic microsomal P-450 functions; maximal seizure response; protein
   lateral diffusion coefficients of cell surface membranes; sex- and
   strain-related differences; tetrahydrocurcumin
ID GLUTATHIONE-S-TRANSFERASE; PROTEIN-FREE DIET; ANTIOXIDANT
   ENZYME-ACTIVITIES; LATERAL DIFFUSION CONSTANT;
   DRUG-METABOLIZING-ENZYMES; LONG-TERM TREATMENT; LIFE-SPAN; DEPENDENT
   DECREASE; BILIARY-EXCRETION; PLASMA-MEMBRANE
AB In order to understand the basic mechanisms underlying the organismic aging process, considerable efforts have been devoted in the last half-century to biochemical (enzyme activity) alterations in specific tissues and organs of various organisms associated with aging. When a decline in enzyme activities with age has been found in a study, especially for key enzymes such as antioxidant enzymes, the results have often been interpreted as a cause for the aging of the entire body. Retrospectively, however, these changes turned out to be so variable-depending on species, strains and sexes of animals-that the interpretation of these results in general terms of aging became invalid. Further, unlike the prediction for the whole human body, many enzyme activities in a vital organ, such as the liver, remained unchanged, as long as the old subjects remained healthy. However, enzyme activities in old animals and humans are often more susceptible to morbidities and frailties, which themselves are often accompanied by infections and malnutrition. Despite the rather stable enzyme functions in the liver with age, a distinct and progressive decline in the lateral diffusion coefficient of proteins of hepatocyte plasma membranes has been demonstrated by fluorescence recovery after photobleaching (FRAP), which was implicated as the cause for the decline of hepatocyte functions such as ouabain (and taurocholate) hepatic uptake and their eventual biliary excretion. Since a similar decline in protein diffusion coefficients was observed in brain and muscle cells, it is likely that these changes are occurring in common with many cell types of the body, thus causing a delay in transmembrane transport of endogenous and exogenous substances whose transports are mediated by membrane proteins. In attempts to prolong the life spans of animals other than by calorie restriction, but instead using deprenyl or tetrahydrocurcumin, works by the author and coworkers are introduced and discussed. Despite limited success along these lines thus far, further attempts are encouraged, primarily to understand the mechanisms underlying organismic aging processes and to find a practical way to prolong the health span of the elderly.
C1 Natl Inst Longev Sci, Obushi, Aichi 4748522, Japan.
RP Kitani, K (corresponding author), Natl Inst Longev Sci, 36-3,Gengo,Morioka Cho, Obushi, Aichi 4748522, Japan.
EM kitani@nils.go.jp
CR ADELMAN RC, 1975, ENZYME INDUCTION, P303
   ANDERSON KE, 1982, NUTR REV, V40, P161, DOI 10.1111/j.1753-4887.1982.tb05298.x
   AU WYW, 1985, CLIN PHARMACOL THER, V37, P472, DOI 10.1038/clpt.1985.74
   Bickford PC, 1997, NEUROBIOL AGING, V18, P309, DOI 10.1016/S0197-4580(97)80313-2
   BONDE J, 1985, BRIT J CLIN PHARMACO, V20, P453, DOI 10.1111/j.1365-2125.1985.tb05096.x
   BRANDFONBRENER M, 1955, CIRCULATION, V12, P557, DOI 10.1161/01.CIR.12.4.557
   Carrillo MC, 2000, LIFE SCI, V67, P2539, DOI 10.1016/S0024-3205(00)00838-9
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   CARRILLO MC, 1991, INT CONGR SER, V940, P75
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P301, DOI 10.1016/0047-6374(92)90043-D
   CARRILLO MC, 1990, MECH AGEING DEV, V56, P237, DOI 10.1016/0047-6374(90)90085-T
   Carrillo MC, 2002, MECH AGEING DEV, V123, P1617, DOI 10.1016/S0047-6374(02)00097-0
   CARRILLO MC, 1989, MECH AGEING DEV, V47, P1, DOI 10.1016/0047-6374(89)90002-X
   Demetrius L, 2004, J GERONTOL A-BIOL, V59, P902, DOI 10.1093/gerona/59.9.B902
   Dirks AJ, 2006, MECH AGEING DEV, V127, P1, DOI 10.1016/j.mad.2005.09.001
   FUJITA S, 1986, LIVER AGING 1986 LIV, P115
   FUJITA S, 1982, LIVER AGING 1982, P55
   Gallagher IM, 1998, J NEURAL TRANSM-SUPP, P315
   Goto S, 2005, BIOGERONTOLOGY, V6, P211, DOI 10.1007/s10522-005-7949-2
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   IKENO Y, 2005, 34 ANN M AM AG ASS O, P32
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   IVY GO, 1991, INT CONGR SER, V940, P109
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   IVY GO, 1989, ADV EXP MED BIOL, V266, P31
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   KITANI K, 1985, LIFE SCI, V37, P1451, DOI 10.1016/0024-3205(85)90085-2
   KITANI K, 1991, INT CONGR SER, V940, P305
   KITANI K, 1984, J PHARMACOL EXP THER, V229, P231
   KITANI K, 1989, ARCH GERONTOL GERIAT, V9, P31, DOI 10.1016/0167-4943(89)90022-8
   KITANI K, 1987, LIFE SCI, V41, P1339, DOI 10.1016/0024-3205(87)90607-2
   KITANI K, 1978, EXP GERONTOL, V13, P9, DOI 10.1016/0531-5565(78)90024-4
   KITANI K, 1993, LIFE SCI, V52, P281, DOI 10.1016/0024-3205(93)90219-S
   Kitani K, 2002, ANN NY ACAD SCI, V959, P295, DOI 10.1111/j.1749-6632.2002.tb02101.x
   Kitani K, 2002, MECH AGEING DEV, V123, P1087, DOI 10.1016/S0047-6374(01)00392-X
   KITANI K, 1988, HEPATOLOGY, V8, P125, DOI 10.1002/hep.1840080124
   KITANI K, 1985, LIFE SCI, V36, P657, DOI 10.1016/0024-3205(85)90170-5
   KITANI K, 1991, ARCH GERONTOL GERIAT, V12, P133, DOI 10.1016/0167-4943(91)90024-K
   Kitani K, 1999, MECH AGEING DEV, V107, P299, DOI 10.1016/S0047-6374(98)00139-0
   KITANI K, 1978, LIVER AGING 1978
   KITANI K, 2005, 34 ANN M AM AG ASS O, P34
   KITANI K, 1986, LIVER AGING 1986 LIV
   KITANI K, 2005, BIOGERONTOLOGY, V6, P1
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   KITANI K, 2003, 32 ANN M AM AG ASS
   KITANI K, 1982, LIVER AGING 1982 LIV
   KITANI K, 1991, LIVER AGING 1990
   Kitani K, 2006, ANN NY ACAD SCI, V1067, P375, DOI 10.1196/annals.1354.053
   Kitani K, 2005, AGING INTERVENTIONS AND THERAPIES, P219, DOI 10.1142/9789812701329_0011
   KNOLL J, 1988, MECH AGEING DEV, V46, P237, DOI 10.1016/0047-6374(88)90128-5
   LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x
   Martin GM, 1997, MOL MED, V3, P356, DOI 10.1007/BF03401682
   MILGRAM NW, 1990, LIFE SCI, V47, P415, DOI 10.1016/0024-3205(90)90299-7
   Nagy IZ, 1999, EXP BRAIN RES, V124, P233, DOI 10.1007/s002210050618
   OHTA M, 1990, BIOCHEM PHARMACOL, V39, P1223, DOI 10.1016/0006-2952(90)90266-N
   OHTA M, 1988, BIOCHEM PHARMACOL, V37, P935
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REISS U, 1978, LIVER AGING 1978, P55
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203
   ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SONNE J, 1985, CLIN PHARMACOL THER, V37, P701, DOI 10.1038/clpt.1985.117
   WILLIAMS LR, 1995, ADV BEHAV BIOL, V44, P641
   WULF JH, 1975, EXP GERONTOL, V10, P101, DOI 10.1016/0531-5565(75)90040-6
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   Zs-Nagy I, 2001, MECH AGEING DEV, V122, P811, DOI 10.1016/S0047-6374(01)00237-8
   Zs-Nagy I, 1998, MECH AGEING DEV, V101, P257, DOI 10.1016/S0047-6374(97)00179-6
   Zs-Nagy I., 1994, MEMBRANE HYPOTHESIS
   ZSNAGY I, 1991, ARCH GERONTOL GERIAT, V12, P329, DOI 10.1016/0167-4943(91)90038-R
   ZSNAGY I, 1993, J GERONTOL, V48, pB86, DOI 10.1093/geronj/48.3.B86
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1984, MIKROSKOPIE, V41, P12
   ZSNAGY I, 1999, MECH AGEING DEV, V107, P299
NR 79
TC 11
Z9 12
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD MAR
PY 2007
VL 29
IS 1
BP 1
EP 14
DI 10.1007/s11357-006-9014-8
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 162QE
UT WOS:000246102400001
PM 19424826
OA Green Published
DA 2024-02-19
ER

PT J
AU Mulligan, JD
   Gonzalez, AA
   Kumar, R
   Davis, AJ
   Saupe, KW
AF Mulligan, JD
   Gonzalez, AA
   Kumar, R
   Davis, AJ
   Saupe, KW
TI Aging elevates basal adenosine monophosphate-activated protein kinase
   (AMPK) activity and eliminates hypoxic activation of AMPK in mouse liver
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID PANCREATIC BETA-CELLS; OXIDATIVE STRESS; TRANSCRIPTIONAL ACTIVITY;
   GENE-EXPRESSION; RAT-LIVER; OLD RATS; GLUCOSE; ENERGY; YOUNG;
   STIMULATION
AB Despite the central role of adenosine monophosphate-activated protein kinase (AMPK) in the cellular stress response, it is unknown whether age-related changes in AMPK activity play a role in the diminished stress tolerance that is characteristic of aging. To address this question, we determined in the mouse liver how normal aging affects 1) basal AMPK activity, and 2) the degree to which AMPK activity is increased by in vivo hypoxia. We found that the basal activity of AMPK alpha1, but not alpha2, was higher in livers from 24-month-old mice compared to those from 5-month-old mice. Furthermore, while hypoxia elevated AMPK alpha1 and alpha2 activities in livers from 5-month-old mice, hypoxia failed to increase the activity of either isoform of AMPK in 24-month-old mice. These findings suggest that age-associated changes in hepatic AMPK activity may play a role in the physiological changes that occur in the liver with normal aging.
C1 Univ Wisconsin, Dept Med, Madison, WI USA.
   Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison
RP Saupe, KW (corresponding author), Med Sci Ctr 1630, 1300 Univ Ave, Madison, WI 53706 USA.
EM kws@medicine.wisc.edu
RI gonzalez, asensio/S-7824-2019
OI gonzalez, asensio/0000-0001-5061-3735
FU NHLBI NIH HHS [HL-07936] Funding Source: Medline; NIA NIH HHS [AG-00908]
   Funding Source: Medline
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI14571
   Ashrafi K, 2000, GENE DEV, V14, P1872
   Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002
   CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1
   da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812
   DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x
   Frenkel-Denkberg G, 1999, FEBS LETT, V462, P341, DOI 10.1016/S0014-5793(99)01552-5
   Fryer LGD, 2002, BIOCHEM J, V363, P167, DOI 10.1042/0264-6021:3630167
   Gasbarrini A, 1998, SCAND J GASTROENTERO, V33, P1107
   Halseth AE, 2002, BIOCHEM BIOPH RES CO, V294, P798, DOI 10.1016/S0006-291X(02)00557-0
   Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X
   Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009
   Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990
   Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200
   Hopkins TA, 2003, BIOCHEM SOC T, V31, P207, DOI 10.1042/bst0310207
   Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x
   Jin QR, 2004, BIOCHEM BIOPH RES CO, V315, P555, DOI 10.1016/j.bbrc.2004.01.093
   Kaminskii Iu G, 1982, Biokhimiia, V47, P654
   Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3
   Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151
   KENNEY WL, 1987, SPORTS MED, V4, P446, DOI 10.2165/00007256-198704060-00004
   Kmiec Z, 2000, ACTA BIOCHIM POL, V47, P349
   KOSENKO EA, 1983, UKR BIOKHIM ZH+, V55, P425
   Kregel KC, 1996, J APPL PHYSIOL, V80, P540, DOI 10.1152/jappl.1996.80.2.540
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Leclerc I, 2002, BIOCHEM SOC T, V30, P307, DOI 10.1042/bst0300307
   Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200
   Light PE, 2003, CIRCULATION, V107, P1962, DOI 10.1161/01.CIR.0000069269.60167.02
   Lin SS, 2003, J BIOL CHEM, V278, P13390, DOI 10.1074/jbc.M212818200
   Lucy SD, 2003, CAN J APPL PHYSIOL, V28, P518, DOI 10.1139/h03-040
   Mariani J, 2000, J THORAC CARDIOV SUR, V120, P660, DOI 10.1067/mtc.2000.106528
   Martin C, 2003, LIFE SCI, V73, P327, DOI 10.1016/S0024-3205(03)00271-6
   Martin R, 2002, EXP GERONTOL, V37, P1481, DOI 10.1016/S0531-5565(02)00168-7
   Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1
   Peralta C, 2001, HEPATOLOGY, V34, P1164, DOI 10.1053/jhep.2001.29197
   Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048
   Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533
   TRIGUN SK, 1988, ARCH GERONTOL GERIAT, V7, P239, DOI 10.1016/0167-4943(88)90007-6
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002
   Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200
   Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299
   Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
NR 46
TC 38
Z9 48
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JAN
PY 2005
VL 60
IS 1
BP 21
EP 27
DI 10.1093/gerona/60.1.21
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 902MF
UT WOS:000227360500003
PM 15741278
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Bassett, ML
   Dahlstrom, JE
   Taylor, MC
   Koina, ME
   Maxwell, L
   Francis, D
   Jain, S
   McLean, AJ
AF Bassett, ML
   Dahlstrom, JE
   Taylor, MC
   Koina, ME
   Maxwell, L
   Francis, D
   Jain, S
   McLean, AJ
TI Ultrastructural changes in hepatic sinusoidal endothelial cells acutely
   exposed to colloidal iron
SO EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE hepatic; endothelial; sinusoidal; iron; colloid
ID PERFUSED-RAT-LIVER; KUPFFER CELLS; NITRIC-OXIDE; IN-VIVO; FENESTRAE;
   PSEUDOCAPILLARIZATION; CAPILLARIZATION; DEFENESTRATION; MATRIX; AGE
AB Hepatic sinusoidal endothelial cells form an important interface between the vascular system, represented by the sinusoids, and the space of Disse that surrounds the hepatocyte microvilli. This study aimed to assess the light microscopic and ultrastructural effects of acute exposure of hepatic sinusoidal endothelial cells to colloidal iron by injection of rats with iron polymaltose. Eight minutes after a single intravenous injection of iron polymaltose sinusoidal endothelial cells showed defenestration, and thickening and layering as assessed by transmission electron microscopy. Kupffer cells and stellate cells appeared activated. These changes were not observed in control animals, experiments using equivalent doses of maltose, or experiments using colloidal carbon except for Kupffer cell activation due to colloidal carbon. No significant light microscopic changes were seen in study or control animals. The findings indicate that acute exposure to colloidal iron causes changes in hepatic sinusoidal endothelial cells, stellate cells and Kupffer cells. This may be the result of a direct toxic effect of iron or increased production of reactive oxygen species. These observations suggest a possible mechanism for defenestration of sinusoidal endothelial cells in ageing and in disease states.
C1 Canberra Hosp, Gastroenterol Unit, Woden, ACT 2606, Australia.
   Canberra Hosp, Dept Geriatr Med, Woden, ACT 2606, Australia.
   Univ Sydney, Fac Med, Canberra Clin Sch, Sydney, NSW 2006, Australia.
   Dept Anat Pathol, Canberra, ACT, Australia.
   Australian Natl Univ, Canberra Hosp, John Curtin Sch Med Res, Woden, ACT, Australia.
   Univ Melbourne, Natl Ageing Res Inst, Parkville, Vic, Australia.
   Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.
   Aged Care Serv, Parkville, Vic, Australia.
C3 Australian National University; Canberra Hospital; Australian National
   University; Canberra Hospital; University of Sydney; Australian National
   University; Canberra Hospital; John Curtin School of Medical Research;
   National Ageing Research Institute; University of Melbourne; Royal
   Melbourne Hospital; University of Melbourne
RP Bassett, ML (corresponding author), Canberra Hosp, Gastroenterol Unit, POB 11, Woden, ACT 2606, Australia.
EM mark.bassett@act.gov.au
RI Taylor, Matthew/B-5903-2009; Dahlstrom, Jane/E-4683-2018
OI Taylor, Matthew/0000-0001-9576-1555; Dahlstrom, Jane/0000-0001-5608-693X
CR Az-ma T, 1999, BRIT J PHARMACOL, V126, P1462, DOI 10.1038/sj.bjp.0702438
   BHUNCHET E, 1993, HEPATOLOGY, V18, P1450
   CAPERNA TJ, 1987, J NUTR, V117, P312, DOI 10.1093/jn/117.2.312
   Cogger VC, 2001, PHARMACOL TOXICOL, V89, P306, DOI 10.1034/j.1600-0773.2001.d01-165.x
   COUVELARD A, 1993, AM J PATHOL, V143, P738
   DEACIUC IV, 1994, HEPATOLOGY, V19, P464
   Deaciuc IV, 1999, J HEPATOL, V30, P213, DOI 10.1016/S0168-8278(99)80064-6
   DELEEUW AM, 1990, J ELECTRON MICR TECH, V14, P218
   Gatmaitan Z, 1996, AM J PATHOL, V148, P2027
   HAUSMANN K, 1976, BLUT, V32, P289, DOI 10.1007/BF01005312
   HORN T, 1987, HEPATOLOGY, V7, P77, DOI 10.1002/hep.1840070117
   IANCU TC, 1985, J HEPATOL, V1, P261, DOI 10.1016/S0168-8278(85)80054-4
   KAWAMOTO S, 1995, AM J PHYSIOL-GASTR L, V268, pG47, DOI 10.1152/ajpgi.1995.268.1.G47
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Liochev SI, 1996, FREE RADICAL RES, V25, P369, DOI 10.3109/10715769609149059
   MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MORI T, 1993, HEPATOLOGY, V17, P891
   MORI T, 1994, ALCOHOL ALCOHOLISM, V29, P67
   Okayama N, 1999, MICROCIRCULATION, V6, P107, DOI 10.1038/sj.mn.7300039
   SCOAZEC JY, 1991, HEPATOLOGY, V14, P789, DOI 10.1002/hep.1840140508
   STEFFAN AM, 1995, HEPATOLOGY, V22, P395, DOI 10.1002/hep.1840220204
   Takashimizu S, 1999, ALCOHOL CLIN EXP RES, V23, p39S, DOI 10.1111/j.1530-0277.1999.tb04532.x
   URASHIMA S, 1993, ALCOHOL ALCOHOLISM, V28, P77, DOI 10.1093/alcalc/28.Supplement_1B.77
   Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114
   Yokomori H, 2000, LIVER, V20, P458, DOI 10.1034/j.1600-0676.2000.020006458.x
NR 26
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0940-2993
EI 1618-1433
J9 EXP TOXICOL PATHOL
JI Exp. Toxicol. Pathol.
PD JUL
PY 2003
VL 55
IS 1
BP 11
EP 16
DI 10.1078/0940-2993-00296
PG 6
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA 712PG
UT WOS:000184805600002
PM 12940623
DA 2024-02-19
ER

PT J
AU Maes, OC
   An, J
   Sarojini, H
   Wang, E
AF Maes, Olivier C.
   An, Jin
   Sarojini, Harshini
   Wang, Eugenia
TI Murine microRNAs implicated in liver functions and aging process
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; gene regulation; liver; MicroRNA; proteomics; oxidative stress
ID LIFE-SPAN; OXIDATIVE STRESS; GENE-EXPRESSION; CALORIC RESTRICTION; AGE;
   CELLS; MICE; METABOLISM; DISEASE; PROTEIN
AB Small non-coding microRNAs (miRNAs) are involved in gene regulation in various cellular and developmental processes, including mechanisms of aging. Here, the mouse liver was used as a paradigm for the study of miRNAs implicated in the aging process in mammals. Expression profiling of 367 murine miRNAs (Sanger Version 8.2) was assessed in livers from 4 to 33 months old mice, and their predicted targets were compared with proteomic profiling data generated from the same animals. Gradual increases in the levels of miR-669c and miR-709 were observed from mid-age of 18-33 months, while miR-93 and miR-214 were significantly up-regulated only in extremely old liver. In contrast, we did not identify any miRNAs showing significant down-regulation with age. Interestingly, the up-regulated miRNAs'targets are associated with cletoxification activity and regeneration capacity functions known to decline in old liver. In particular, three up-regulated miRNAs may contribute to the aging-related decline in oxidative defense by targeting various classes of glutathione S-transferases. Other proteins in decline in old liver and targeted by the up-regulated miRNAs are involved in mitochondrial functions or maintenance. Taken together, we identified the up-regulation of key miRNAs that may participate in the decline of regeneration and oxidative defense mechanisms in aging liver. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Wang, Eugenia] Univ Louisville, Dept Biochem & Mol Biol, Sch Med, Gheens Ctr Aging, Louisville, KY 40202 USA.
C3 University of Louisville
RP Wang, E (corresponding author), Univ Louisville, Dept Biochem & Mol Biol, Sch Med, Gheens Ctr Aging, 580 S Preston St, Louisville, KY 40202 USA.
EM eugenia.wang@louisville.edu
RI Sarojini, Harshini/AAD-4870-2019
OI Sarojini, Harshini/0000-0002-3103-9712
CR Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004
   Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003
   Boehm M, 2006, CELL CYCLE, V5, P837, DOI 10.4161/cc.5.8.2688
   Brown-Borg HM, 2005, EXP GERONTOL, V40, P115, DOI 10.1016/j.exger.2004.11.004
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Carrillo MC, 2001, EXP GERONTOL, V36, P255, DOI 10.1016/S0531-5565(00)00209-6
   Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969
   Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952
   Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562
   Cong YS, 2006, MECH AGEING DEV, V127, P332, DOI 10.1016/j.mad.2005.12.005
   Dozmorov I, 2001, J GERONTOL A-BIOL, V56, pB72, DOI 10.1093/gerona/56.2.B72
   Enoki N, 2007, J MOL HISTOL, V38, P321, DOI 10.1007/s10735-007-9105-6
   Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023
   Fernández-Cañón JM, 2002, MOL CELL BIOL, V22, P4943, DOI 10.1128/MCB.22.13.4943-4951.2002
   Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744
   Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396
   Holbrook NJ, 2002, BIOCHEM PHARMACOL, V64, P999, DOI 10.1016/S0006-2952(02)01169-3
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Ibáñez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x
   Ikeyama S, 2003, EXP GERONTOL, V38, P431, DOI 10.1016/S0531-5565(02)00239-5
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   Lacelle C, 2002, J GERONTOL A-BIOL, V57, pB285, DOI 10.1093/gerona/57.7.B285
   Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b
   Mazière P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002
   Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011
   Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5
   Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200
   Sarojini HII, 2007, BIOTECHNIQUES, V43, P213, DOI 10.2144/000112493
   Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sersté T, 2006, ACTA GASTRO-ENT BELG, V69, P296
   Spindler SR, 2007, ANNU REV NUTR, V27, P193, DOI 10.1146/annurev.nutr.27.061406.093743
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Toba G, 2000, GENE, V253, P179, DOI 10.1016/S0378-1119(00)00246-8
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Viña J, 2007, IUBMB LIFE, V59, P249, DOI 10.1080/15216540601178067
   Wang E, 2002, J GERONTOL A-BIOL, V57, pB400, DOI 10.1093/gerona/57.11.B400
   Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172
   Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434
NR 46
TC 157
Z9 174
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP
PY 2008
VL 129
IS 9
BP 534
EP 541
DI 10.1016/j.mad.2008.05.004
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 334QT
UT WOS:000258237000005
PM 18561983
DA 2024-02-19
ER

PT J
AU Moon, JS
   Goeminne, LJE
   Kim, JT
   Tian, JW
   Kim, SH
   Nga, H
   Kang, SG
   Kang, BKE
   Byun, JS
   Lee, YS
   Jeon, JH
   Shong, M
   Auwerx, J
   Ryu, D
   Yi, HS
AF Moon, Ji Sun
   Goeminne, Ludger J. E.
   Kim, Jung Tae
   Tian, Jing Wen
   Kim, Seok-Hwan
   Nga, Ha Thi
   Kang, Seul Gi
   Kang, Baeki E.
   Byun, Jin-Seok
   Lee, Young-Sun
   Jeon, Jae-Han
   Shong, Minho
   Auwerx, Johan
   Ryu, Dongryeol
   Yi, Hyon-Seung
TI Growth differentiation factor 15 protects against the aging-mediated
   systemic inflammatory response in humans and mice
SO AGING CELL
LA English
DT Article; Early Access
DE aging; inflammation; mitochondria; senescence; T cell
ID REGULATORY T-CELLS; MITOCHONDRIAL DYSFUNCTION; INSULIN-RESISTANCE;
   ADIPOSE-TISSUE; OBESITY; PERSPECTIVE; EXPRESSION; RECEPTOR; GDF15;
   INCREASES
AB Mitochondrial dysfunction is associated with aging-mediated inflammatory responses, leading to metabolic deterioration, development of insulin resistance, and type 2 diabetes. Growth differentiation factor 15 (GDF15) is an important mitokine generated in response to mitochondrial stress and dysfunction; however, the implications of GDF15 to the aging process are poorly understood in mammals. In this study, we identified a link between mitochondrial stress-induced GDF15 production and protection from tissue inflammation on aging in humans and mice. We observed an increase in serum levels and hepatic expression ofGDF15as well as pro-inflammatory cytokines in elderly subjects. Circulating levels of cell-free mitochondrial DNA were significantly higher in elderly subjects with elevated serum levels of GDF15. In the BXD mouse reference population, mice with metabolic impairments and shorter survival were found to exhibit higher hepaticGdf15expression. Mendelian randomization links reducedGDF15expression in human blood to increased body weight and inflammation. GDF15 deficiency promotes tissue inflammation by increasing the activation of resident immune cells in metabolic organs, such as in the liver and adipose tissues of 20-month-old mice. Aging also results in more severe liver injury and hepatic fat deposition inGdf15-deficient mice. Although GDF15 is not required for Th17 cell differentiation and IL-17 production in Th17 cells, GDF15 contributes to regulatory T-cell-mediated suppression of conventional T-cell activation and inflammatory cytokines. Taken together, these data reveal that GDF15 is indispensable for attenuating aging-mediated local and systemic inflammation, thereby maintaining glucose homeostasis and insulin sensitivity in humans and mice.
C1 [Moon, Ji Sun; Kim, Jung Tae; Tian, Jing Wen; Nga, Ha Thi; Kang, Seul Gi; Shong, Minho; Yi, Hyon-Seung] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Res Ctr Endocrine & Metab Dis, Daejeon 35015, South Korea.
   [Goeminne, Ludger J. E.; Auwerx, Johan] Ecole Polytech Fed Lausanne EPFL, Lab Integrat Syst Physiol, Lausanne, Switzerland.
   [Kim, Jung Tae; Tian, Jing Wen; Nga, Ha Thi; Kang, Seul Gi; Shong, Minho; Yi, Hyon-Seung] Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon, South Korea.
   [Kim, Seok-Hwan] Chungnam Natl Univ, Sch Med, Dept Surg, Daejeon, South Korea.
   [Kang, Baeki E.; Ryu, Dongryeol] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 16419, South Korea.
   [Byun, Jin-Seok] Kyungpook Natl Univ, Sch Dent, Dept Oral Med, Daegu, South Korea.
   [Lee, Young-Sun] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Jeon, Jae-Han] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea.
   [Ryu, Dongryeol] Sungkyunkwan Univ, SKKU BICS, Biomed Inst Convergence, Suwon, South Korea.
   [Ryu, Dongryeol] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea.
C3 Chungnam National University; Chungnam National University Hospital;
   Swiss Federal Institutes of Technology Domain; Ecole Polytechnique
   Federale de Lausanne; Chungnam National University; Chungnam National
   University; Sungkyunkwan University (SKKU); Kyungpook National
   University; Korea University; Korea University Medicine (KU Medicine);
   Kyungpook National University; Sungkyunkwan University (SKKU);
   Sungkyunkwan University (SKKU); Samsung Medical Center
RP Yi, HS (corresponding author), Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Res Ctr Endocrine & Metab Dis, Daejeon 35015, South Korea.; Ryu, D (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 16419, South Korea.
EM jmpbooks@cnu.ac.kr; jmpbooks@cnu.ac.kr
RI Ryu, Dongryeol/AAQ-3642-2020; Yi, Hyon-Seung/ABA-2729-2022; Kim,
   Seok-Hwan/G-9981-2015; Lee, Young-Sun/ABI-6420-2020; Auwerx,
   Johan/ABE-9307-2021; Kim, Seok-Hwan/AAV-3518-2021
OI Ryu, Dongryeol/0000-0001-5905-6760; Kim, Seok-Hwan/0000-0003-0209-0444;
   Lee, Young-Sun/0000-0001-6396-0859; Kim, Seok-Hwan/0000-0003-0209-0444;
   Goeminne, Ludger/0000-0002-8285-7766; Auwerx, Johan/0000-0002-5065-5393
FU Gilead Sciences Asia Ltd; Chungnam National University Hospital;
   National Research Foundation of Korea [2017K1A1A2013124,
   2017R1E1A1A01075126, 2018R1C1B6004439, 2019M3E5D1A02068575]
FX Gilead Sciences Asia Ltd; Chungnam National University Hospital;
   National Research Foundation of Korea, Grant/Award Number:
   2017K1A1A2013124, 2017R1E1A1A01075126, 2018R1C1B6004439 and
   2019M3E5D1A02068575
CR Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Byun JS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6862439
   Chehimi M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070068
   Choi MJ, 2020, DIABETOLOGIA, V63, P837, DOI 10.1007/s00125-019-05082-7
   Chung HK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17574-w
   Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110
   de Victoria EOM, 2009, DIABETES, V58, P385, DOI 10.2337/db08-0536
   Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393
   Fox JG, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Fukushima Y, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0082-9
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   Ho JE, 2012, CLIN CHEM, V58, P1582, DOI 10.1373/clinchem.2012.190322
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107
   Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078
   Jiang JY, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00097
   Jung SB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03998-z
   Kempf T, 2012, EUR J ENDOCRINOL, V167, P671, DOI 10.1530/EJE-12-0466
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kim KH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25098-0
   Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Lee SE, 2017, DIABETES, V66, P2774, DOI 10.2337/db17-0333
   Li L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23992
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lu JL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01173
   MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0
   Mirmiran P, 2014, ENDOCRINOL METAB, V29, P443, DOI 10.3803/EnM.2014.29.4.443
   Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003
   Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392
   Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098
   Nakayasu ES, 2020, CELL METAB, V31, P363, DOI 10.1016/j.cmet.2019.12.005
   Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818
   Picca A, 2018, REJUV RES, V21, P350, DOI 10.1089/rej.2017.1989
   Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412
   Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sanada F, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00012
   Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270
   Smyth GK., 2004, Stat Appl Genet Mol Biol, V3, P1, DOI DOI 10.2202/1544-6115.1027
   Tabula Muris Consortium, 2018, NATURE, V562, P367, DOI DOI 10.1038/S41586-018-0590-4
   Tran T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201584
   Tsai VWW, 2016, INT J OBESITY, V40, P193, DOI 10.1038/ijo.2015.242
   Van den Berge K, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1406-4
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Xiong YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8732
   Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021
   Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394
   Yi HS, 2019, ENDOCRINOL METAB, V34, P39, DOI 10.3803/EnM.2019.34.1.39
   Yi HS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1494-4
   Yi HS, 2018, J MOL ENDOCRINOL, V61, pR91, DOI 10.1530/JME-18-0005
   Youm YH, 2016, P NATL ACAD SCI USA, V113, P1026, DOI 10.1073/pnas.1514511113
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 56
TC 55
Z9 57
U1 3
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2020 AUG
PY 2020
VL 19
IS 8
AR e13195
DI 10.1111/acel.13195
EA JUL 2020
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NF6WG
UT WOS:000550456900001
PM 32691494
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU He, XQ
   Tian, Y
   Lei, L
   Zhi, Q
   Zhao, JC
   Ming, J
AF He, Xiaoqin
   Tian, Yong
   Lei, Lin
   Zhi, Qi
   Zhao, Jichun
   Ming, Jian
TI Protective effects of <i>Coreopsis tinctoria</i> buds extract against
   cognitive impairment and brain aging induced by D-galactose
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Coreopsis tinctoria buds; Polyphenol; Antioxidant stress; Cognitive
   impairment; Brain ageing
ID OXIDATIVE STRESS; PHENOLIC-ACID; ANTIOXIDANT; FLAVONOIDS; NUTT.;
   ACTIVATION; DAMAGE; LIVER; PARTS
AB The study investigated the polyphenol of Coreopsis tinctoria buds extract (CTBE) and its protective effects on cognitive dysfunction and brain damage induced by d-galactose in mice. Three polyphenols and nine flavonoids were characterized by UPLC/Q-TOF-MS, with major components as flavanomarein (13.644 mg/g dry weight) and marein (13.387 mg/g dry weight). Results showed CTBE significantly improved the learning, memory, and cognitive abilities and brain index of aging mice. Besides, CTBE reduced the content of malondialdehyde while increased the activity of glutathione peroxidase and superoxide dismutase and the the total antioxidants in brain. CTBE reversed the abnormality of Ach level, AChE activity, and hippocampus changes in aging mice. Therefore, CTBE, as a novel nutraceutical, could attenuate the cognitive damage and improve parameters related to brain senescence, partly by reducing the oxidative stress and hippocampal damage.
C1 [He, Xiaoqin; Tian, Yong; Lei, Lin; Zhi, Qi; Zhao, Jichun; Ming, Jian] Southwest Univ, Coll Food Sci, Tiansheng Rd 2, Chongqing 400715, Peoples R China.
   [Ming, Jian] Southwest Univ, Res Ctr Food Storage & Logist, Chongqing 400715, Peoples R China.
C3 Southwest University - China; Southwest University - China
RP Ming, J (corresponding author), Southwest Univ, Coll Food Sci, Tiansheng Rd 2, Chongqing 400715, Peoples R China.
EM food_mj@swu.edu.cn
RI Zhao, Jichun/ABG-6369-2021
OI Ming, Jian/0000-0001-6133-0335
FU National Natural Science Foundation of China [31771970]; Fundamental
   Research Funds for the Central Universities [XDJK2017B050]
FX The work was supported by National Natural Science Foundation of China
   (31771970) and Fundamental Research Funds for the Central Universities
   (XDJK2017B050)
CR Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Bai ZS, 2019, CHEM PHARM BULL, V67, P640, DOI 10.1248/cpb.c18-00926
   Chen LX, 2016, J CHROMATOGR A, V1428, P134, DOI 10.1016/j.chroma.2015.10.037
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chu YF, 2002, J AGR FOOD CHEM, V50, P6910, DOI 10.1021/jf020665f
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   Deng Y, 2017, ELECTROPHORESIS, V38, P2654, DOI 10.1002/elps.201700129
   Dias T, 2012, J ETHNOPHARMACOL, V139, P485, DOI 10.1016/j.jep.2011.11.038
   Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649
   Farag MA, 2013, PHYTOCHEMISTRY, V95, P177, DOI 10.1016/j.phytochem.2013.07.003
   Gillum RF, 2011, INT J ENV RES PUB HE, V8, P1244, DOI 10.3390/ijerph8041244
   Gong G.Q., 1991, J CHINA PHARM U, V22, P101
   Gong YS, 2016, EXP GERONTOL, V74, P21, DOI 10.1016/j.exger.2015.11.020
   Gouveia S, 2011, FOOD CHEM, V129, P333, DOI 10.1016/j.foodchem.2011.04.078
   Govindan S, 2016, EXP TOXICOL PATHOL, V68, P329, DOI 10.1016/j.etp.2016.04.001
   Guo LM, 2015, J FUNCT FOODS, V13, P11, DOI 10.1016/j.jff.2014.11.011
   Hou Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep45705
   Ji DB, 2009, PHYTOTHER RES, V23, P116, DOI 10.1002/ptr.2576
   Joseph JA, 2005, AM J CLIN NUTR, V81, p313S, DOI 10.1093/ajcn/81.1.313S
   Khan M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080928
   Le L, 2019, PHYTOMEDICINE, V53, P193, DOI 10.1016/j.phymed.2018.09.005
   Li LN, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0090-x
   Li N, 2015, J FUNCT FOODS, V17, P837, DOI 10.1016/j.jff.2015.06.027
   Li X, 2016, EXP GERONTOL, V83, P89, DOI 10.1016/j.exger.2016.07.012
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin X, 2014, CARBOHYD POLYM, V101, P533, DOI 10.1016/j.carbpol.2013.09.037
   Lu J, 2010, NEUROBIOL LEARN MEM, V93, P157, DOI 10.1016/j.nlm.2009.09.006
   Ma ZY, 2016, J FUNCT FOODS, V20, P575, DOI 10.1016/j.jff.2015.11.023
   Nam SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010176
   Peng A, 2019, FOOD RES INT, V123, P64, DOI 10.1016/j.foodres.2019.04.046
   Pourmemar E, 2017, EXP GERONTOL, V87, P16, DOI 10.1016/j.exger.2016.11.011
   Schliebs R, 2006, J NEURAL TRANSM, V113, P1625, DOI 10.1007/s00702-006-0579-2
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Song J, 2018, EXP NEUROL, V306, P45, DOI 10.1016/j.expneurol.2018.04.009
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Tian Y, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103464
   Tsai JC, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1604-8
   Ullah R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061195
   Wang W, 2015, J AGR FOOD CHEM, V63, P200, DOI 10.1021/jf504289g
   Wortmann M, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt143
   Wu WQ, 2014, FOOD FUNCT, V5, P158, DOI 10.1039/c3fo60400d
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yang Q, 2014, CHIN HERB MED, V6, P103, DOI 10.1016/S1674-6384(14)60015-0
   Yang YJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21101307
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhang WX, 2016, INDIAN J ANIM RES, V50, P769, DOI 10.18805/ijar.9630
   Zhi Q, 2018, J FUNCT FOODS, V44, P201, DOI 10.1016/j.jff.2018.03.019
   Zhou XX, 2013, PHYTOCHEM LETT, V6, P372, DOI 10.1016/j.phytol.2013.05.002
NR 49
TC 5
Z9 5
U1 2
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD OCT
PY 2020
VL 73
AR 104089
DI 10.1016/j.jff.2020.104089
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA OC9UN
UT WOS:000579501700038
OA gold
DA 2024-02-19
ER

PT J
AU Tunru-Dinh, VW
   Deshmukh-Rane, SA
   Wu, MLC
AF Tunru-Dinh, Vonny W.
   Deshmukh-Rane, Suvarna A.
   Wu, Mark Li-cheng
TI Incidental Hepatic Tissue Obtained via Routine Cholecystectomy
SO INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
LA English
DT Article
DE gallbladder; liver; cholecystectomy; grossing; artifact
ID PERCUTANEOUS LIVER-BIOPSY; COMPLICATIONS; DIAGNOSIS
AB Background. The hepatic tissue that may occupy specimens from routine cholecystectomies has yet to be studied. Our objectives were to determine the prevalence of hepatic tissue obtained at routine cholecystectomy, to determine whether such hepatic tissue can histologically withstand technical artifacts commonly associated with cholecystectomy, and to determine whether examining such hepatic tissue has diagnostic utility. Materials and Methods. We retrospectively reviewed 50 specimens from routine cholecystectomies that were performed by surgeons who lacked knowledge of our study. All 50 specimens were grossed according to standard protocol, with only limited, nontargeted sampling of the rough nonperitonealized margin, and were received without fixative. Results. Twelve specimens (24.0%) contained hepatic tissue. The hepatic tissue measured up to 44.5-mm long and 1.8-mm wide and contained up to 11 complete portal tracts. Hepatic tissue in 3 specimens satisfied criteria for adequacy established for core biopsies based on number of portal tracts or size. Despite cautery and delayed fixation, all hepatic tissue had surprisingly well-preserved histology. Pathologic findings included nonalcoholic fatty liver disease, von Meyenburg complex, chronic cholestasis, and senescence. Conclusions. The hepatic tissue that accompanies specimens from routine cholecystectomies may be relatively common, can be large, is well preserved, and can harbor diagnostically useful information.
C1 [Tunru-Dinh, Vonny W.] Western Reserve Care Syst, Youngstown, OH USA.
   [Deshmukh-Rane, Suvarna A.; Wu, Mark Li-cheng] Univ Calif Irvine, Irvine, CA USA.
C3 University System of Ohio; Case Western Reserve University; University
   of California System; University of California Irvine
RP Wu, MLC (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Sch Med, D440 Med Sci 1, Irvine, CA 92697 USA.
EM mlwu@uci.edu
OI Wu, Mark Li-cheng/0000-0002-0565-4076
CR Abraham S, 2003, SURG PATHOLOGY DISSE, P82
   [Anonymous], 2012, MACSWEENS PATHOLOGY
   [Anonymous], 2010, SCHEUERS LIVER BIOPS
   Chou PP, 2007, LABMEDICINE, V38, P85, DOI 10.1309/BNKBPH8FEPJOVCH2
   Cocariu EA, 2016, ROM J INTERN MED, V54, P105, DOI 10.1515/rjim-2016-0012
   Grant A., 1999, Gut, V45, pIV1
   Guido M, 2004, SEMIN LIVER DIS, V24, P89
   Kapoor VK, GALLBLADDER ANATOMY
   Kate V, PARTIAL GASTRECTOMY
   Maroju NK, TOTAL MESORECTAL EXC
   Natale G, 2017, J ANAT, V231, P417, DOI 10.1111/joa.12644
   Padget DL., 2007, PATHOLOGY SERVICE CO
   Patel S, 2011, AM J SURG PATHOL, V35, P1104, DOI 10.1097/PAS.0b013e31822179cc
   Poggio JL, ILEOCECAL RESECTION
   Potretzke TA, 2018, AM J ROENTGENOL, V211, P204, DOI 10.2214/AJR.17.18726
   Rad Masoud Pezeshki, 2016, Electron Physician, V8, P3456, DOI 10.19082/3456
   Shah ND, 2017, CLIN GASTROENTEROL H, V15, P784, DOI 10.1016/j.cgh.2017.01.011
   Shi C., COLL AM PATHOLOGISTS
   Short SS, 2013, J PEDIATR GASTR NUTR, V57, P644, DOI 10.1097/MPG.0b013e3182a0e0d8
   UCLA Health Pathology & Laboratory Medicine, GROSS MAN HEP
   University of Chicago, UCM PATH GALLBL
   Venugopal RL, PYLORUS PRESERVING P
NR 22
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1066-8969
EI 1940-2465
J9 INT J SURG PATHOL
JI Int. J. Surg. Pathol.
PD AUG
PY 2019
VL 27
IS 5
BP 499
EP 505
DI 10.1177/1066896918817374
PG 7
WC Pathology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Surgery
GA II0OK
UT WOS:000474904800005
PM 30520351
DA 2024-02-19
ER

PT J
AU Inoue, H
   Hanawa, N
   Katsumata-Tsuboi, R
   Katsumata, SI
   Takahashi, N
   Uehara, M
AF Inoue, Hirofumi
   Hanawa, Nobuaki
   Katsumata-Tsuboi, Rie
   Katsumata, Shi-Ichi
   Takahashi, Nobuyuki
   Uehara, Mariko
TI Down-regulation of senescence marker protein 30 by iron-specific
   chelator deferoxamine drives cell senescence
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Senescence marker protein 30; deferoxamine; cell senescence;
   beta-galactosidase activity
ID OXIDATIVE STRESS; INDUCED AUTOPHAGY; KNOCKOUT MICE; DEFICIENCY; SMP30;
   MECHANISMS; EXPRESSION; INDUCTION; BIOLOGY; LIVER
AB To our knowledge, this is the first study to report down-regulation of senescence marker protein 30 (SMP30) by iron-specific chelator deferoxamine (DFO) on FAO cell senescence, using a DNA microarray. Furthermore, DFO treatment increased senescence marker -galactosidase activity, whereas this activity was attenuated by overexpression of SMP30. Our data suggested that down-regulation of SMP30 drives cell senescence in iron-chelated condition.
C1 [Inoue, Hirofumi; Katsumata-Tsuboi, Rie; Takahashi, Nobuyuki; Uehara, Mariko] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Tokyo, Japan.
   [Hanawa, Nobuaki; Katsumata, Shi-Ichi] Tokyo Univ Agr, Fac Appl Biosci, Dept Food & Nutr Sci, Tokyo, Japan.
C3 Tokyo University of Agriculture; Tokyo University of Agriculture
RP Uehara, M (corresponding author), Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Tokyo, Japan.
EM mari@nodai.ac.jp
RI Takahashi, Nobuyuki/AAX-8671-2021
OI Takahashi, Nobuyuki/0000-0002-9705-662X
FU Grants-in-Aid for Scientific Research [16K16609] Funding Source: KAKEN
CR Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2
   Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Halis B, 2006, PEDIATR HEMAT ONCOL, V26, P108
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   Inoue H, 2017, BIOMED RES-TOKYO, V38, P343, DOI 10.2220/biomedres.38.343
   Inoue H, 2015, BIOSCI BIOTECH BIOCH, V79, P1366, DOI 10.1080/09168451.2015.1018125
   Jung KJ, 2015, J MOL MED, V93, P343, DOI 10.1007/s00109-014-1219-1
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2014, FEBS OPEN BIO, V4, P522, DOI 10.1016/j.fob.2014.05.003
   Marin JJG, 2016, FREE RADICAL BIO MED, V101, P71, DOI 10.1016/j.freeradbiomed.2016.09.025
   Min KS, 2015, BIOL PHARM BULL, V38, P1557, DOI 10.1248/bpb.b15-00341
   Misaka T, 2013, CARDIOVASC RES, V99, P461, DOI 10.1093/cvr/cvt122
   Sioutas A, 2017, J INFLAMM RES, V10, P29, DOI 10.2147/JIR.S128292
   Struewing IT, 2009, J BIOL CHEM, V284, P17595, DOI 10.1074/jbc.M109.001735
   Uehara M, 1997, J NUTR BIOCHEM, V8, P385, DOI 10.1016/S0955-2863(97)00045-4
   Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007
   Xue H, 2016, ANN NY ACAD SCI, V1375, P52, DOI 10.1111/nyas.13174
NR 21
TC 5
Z9 5
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PY 2018
VL 82
IS 5
BP 900
EP 903
DI 10.1080/09168451.2018.1440190
PG 4
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA GD8ZS
UT WOS:000430803400021
PM 29490582
OA Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Guaraldi, G
   Lonardo, A
   Maia, L
   Palella, FJ
AF Guaraldi, Giovanni
   Lonardo, Amedeo
   Maia, Liliana
   Palella, Frank J., Jr.
TI Metabolic concerns in aging HIV-infected persons: from serum lipid
   phenotype to fatty liver
SO AIDS
LA English
DT Article
DE aging; cardiometabolic risk; HIV; metabolic syndrome; nonalcoholic fatty
   liver disease; nonalcoholic steatohepatitis; virus-associated fatty
   liver disease
ID HUMAN-IMMUNODEFICIENCY-VIRUS; NONALCOHOLIC STEATOHEPATITIS;
   INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; FUNCTIONAL IMPAIRMENT;
   COGNITIVE IMPAIRMENT; CLINICAL-PRACTICE; GUT MICROBIOTA; IMMUNE-SYSTEM;
   OLDER-ADULTS
AB Among HIV-infected persons, the assessment of nonalcoholic fatty liver disease (NAFLD) provides a window through which overall metabolic health can be evaluated. In this review, we summarize clinical data that support the roles of aging and metabolic dysregulation as factors contributing to fatty liver/NAFLD among HIV-infected persons.
   Age-related metabolic alterations include hepatic anatomic and functional changes, altered homeostasis of gastrointestinal microbiota and anthropometric changes (such as a shift of body fat depots from the subcutaneous to the visceral compartment) that are often associated with the development of insulin resistance and increased cardiovascular risk.
   Fatty changes in the liver occur not only with metabolic disruption but also with virus-induced injury. Chronic hepatitis C virus infection is commonly associated with fatty liver, and can be related to both hepatitis C virus genotype and host metabolic features. Similarly, HIV infection is associated with fatty liver as a result of multiple viral and host factors. Clearly, lipodystrophy, dysregulation of the gut-liver axis and HIV infection itself may each contribute simultaneously to NAFLD pathogenesis. Although lifestyle changes are the mainstay of treatment, to date no drug has specifically been approved for use in persons with NAFLD. Moreover, current guidelines provide no specific therapeutic recommendations for persons with NAFLD older than 65 years.
   Well-designed studies characterizing the epidemiology, pathogenesis, clinical outcomes and potential therapeutic interventions for liver disease and associated metabolic comorbidities in older HIV-infected patients are urgently needed. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Via Pozzo, Modena, Italy.
   [Lonardo, Amedeo] Univ Modena & Reggio Emilia, Nuovo Osped Civile St Agostino Estense, Dept Biomed Metab & Neural Sci, Div Internal Med & Metab, Modena, Italy.
   [Lonardo, Amedeo] Azienda Osped Modena, Modena, Italy.
   [Maia, Liliana] Ctr Hosp Porto, Dept Infect Dis, Oporto, Portugal.
   [Palella, Frank J., Jr.] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio
   Emilia; Northwestern University; Feinberg School of Medicine
RP Guaraldi, G (corresponding author), Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Via Pozzo 71, I-41124 Modena, Italy.
EM giovanni.guaraldi@unimore.it
RI LONARDO, AMEDEO/I-5911-2019; Guaraldi, Giovanni/J-9467-2018
OI LONARDO, AMEDEO/0000-0001-9886-0698; 
CR Abbatecola AM, 2011, J NUTR HEALTH AGING, V15, P890, DOI 10.1007/s12603-011-0366-0
   Abbatecola AM, 2007, ARCH INTERN MED, V167, P2145, DOI 10.1001/archinte.167.19.2145-b
   Adinolfi LE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060803
   Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227
   Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264
   Bertolotti M, 2007, EUR J CLIN INVEST, V37, P501, DOI 10.1111/j.1365-2362.2007.01808.x
   BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827
   Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297
   Calza L, 2016, J ANTIMICROB CHEMOTH, V71, P1451, DOI 10.1093/jac/dkv494
   Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Chitturi S, 2007, J GASTROEN HEPATOL, V22, P967, DOI 10.1111/j.1440-1746.2007.04995.x
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   ClinicalTrials. gov, PHAS 2 TRIAL TES COG
   Coghlan ME, 2001, CLIN INFECT DIS, V33, P1914, DOI 10.1086/323783
   Cui J, 2016, J HEPATOL, V65, P369, DOI 10.1016/j.jhep.2016.04.021
   De Biasi S, 2016, AIDS, V30, P2599, DOI 10.1097/QAD.0000000000001247
   de Luis DA, 2010, NUTR HOSP, V25, P730, DOI 10.3305/nh.2010.25.5.4643
   Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540
   Erlandson KM, 2013, JAIDS-J ACQ IMM DEF, V63, P209, DOI 10.1097/QAI.0b013e318289bb7e
   Falutz J, 2011, BEST PRACT RES CL EN, V25, P517, DOI 10.1016/j.beem.2010.11.001
   Farrell G.C, 2011, CURR GERONTOL GERIAT, V2011, P1
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688
   Fraser A, 2007, ARTERIOSCL THROM VAS, V27, P2729, DOI 10.1161/ATVBAHA.107.152298
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Friedman S, 2016, CONTEMP CLIN TRIALS, V47, P356, DOI 10.1016/j.cct.2016.02.012
   Frisoli A, 2011, BONE, V48, P952, DOI 10.1016/j.bone.2010.12.025
   Guaraldi G, 2011, ARCH MED RES, V42, P690, DOI 10.1016/j.arcmed.2011.12.009
   Guaraldi G, 2010, JAIDS-J ACQ IMM DEF, V53, P278, DOI 10.1097/QAI.0b013e3181c990ed
   Hannah WN, 2016, HEPATOLOGY, V64, P2234, DOI 10.1002/hep.28699
   Hannah WN, 2016, CLIN LIVER DIS, V20, P339, DOI 10.1016/j.cld.2015.10.008
   Haufe S, 2011, HEPATOLOGY, V53, P1504, DOI 10.1002/hep.24242
   Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Hu B, 1997, AM J CLIN PATHOL, V108, P280
   Jankowski CM, 2008, OBESITY, V16, P1039, DOI 10.1038/oby.2007.84
   Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x
   Kitajima Y, 2010, J GASTROENTEROL, V45, P218, DOI 10.1007/s00535-009-0147-2
   Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007
   LEBOVICS E, 1985, HEPATOLOGY, V5, P293, DOI 10.1002/hep.1840050224
   Leng SX, 2004, AGING CLIN EXP RES, V16, P153
   Li M, 2012, J CLIN ENDOCR METAB, V97, P2033, DOI 10.1210/jc.2011-3010
   Lindsey C, 2005, ARCH PHYS MED REHAB, V86, P1102, DOI 10.1016/j.apmr.2004.09.028
   Lonardo A, 2006, WORLD J GASTROENTERO, V12, P5826, DOI 10.3748/wjg.v12.i36.5826
   Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005
   Lonardo A, 2016, WORLD J GASTROENTERO, V22, P9674, DOI 10.3748/wjg.v22.i44.9674
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   Lonardo A, 2013, CURR PHARM DESIGN, V19, P5177, DOI 10.2174/1381612811319290003
   Loria P, 2013, HEPATOL RES, V43, P51, DOI 10.1111/j.1872-034X.2012.01031.x
   Lui G, 2016, ALIMENT PHARM THER, V44, P411, DOI 10.1111/apt.13702
   MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442
   Maggio M, 2006, J AM GERIATR SOC, V54, P1832, DOI 10.1111/j.1532-5415.2006.00963.x
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110
   Mohammed SS, 2007, JAIDS-J ACQ IMM DEF, V45, P432, DOI 10.1097/QAI.0b013e318074efe3
   Morse CG, 2015, CLIN INFECT DIS, V60, P1569, DOI 10.1093/cid/civ101
   Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4
   Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623
   Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044
   Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4
   Newton JL, 2008, HEPATOLOGY, V48, P541, DOI 10.1002/hep.22371
   Noureddin M, 2013, HEPATOLOGY, V58, P1930, DOI 10.1002/hep.26455
   O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010
   Oh J, 2007, LANCET INFECT DIS, V7, P787, DOI 10.1016/S1473-3099(07)70287-6
   Paolisso G, 1999, EUR J CLIN INVEST, V29, P758
   Price JC, 2014, AM J GASTROENTEROL, V109, P695, DOI 10.1038/ajg.2014.32
   Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024
   Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038
   Rochira V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028512
   Rosenzweig JL, 2008, J CLIN ENDOCR METAB, V93, P3671, DOI 10.1210/jc.2008-0222
   Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Safadi R, 2014, CLIN GASTROENTEROL H, V12, P2085, DOI 10.1016/j.cgh.2014.04.038
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929
   Sattler FR, 2015, JAIDS-J ACQ IMM DEF, V68, P281, DOI 10.1097/QAI.0000000000000458
   SCHNEIDERMAN DJ, 1987, HEPATOLOGY, V7, P925, DOI 10.1002/hep.1840070522
   Sepe A, 2011, GERONTOLOGY, V57, P66, DOI 10.1159/000279755
   Stanley TL, 2014, JAMA-J AM MED ASSOC, V312, P380, DOI 10.1001/jama.2014.8334
   Stramaglia G, 2010, J NUTR HEALTH AGING, V14, P6, DOI 10.1007/s12603-010-0002-4
   Tafesh ZH, 2017, CURR OPIN INFECT DIS, V30, P12, DOI 10.1097/QCO.0000000000000344
   Tendler D, 2007, DIGEST DIS SCI, V52, P589, DOI 10.1007/s10620-006-9433-5
   Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   van der Poorten D, 2013, HEPATOLOGY, V57, P2180, DOI 10.1002/hep.26072
   Van Huyen JPD, 2003, AM J CLIN PATHOL, V119, P546, DOI 10.1309/8B8BJ6AP5KGV7C1H
   Vodkin I, 2015, ALIMENT PHARM THER, V41, P368, DOI 10.1111/apt.13052
   Wang CY, 2012, GERIATR GERONTOL INT, V12, P388, DOI 10.1111/j.1447-0594.2012.00851.x
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yilmaz Y, 2009, HEPATOLOGY, V49, P698, DOI 10.1002/hep.22752
NR 93
TC 34
Z9 35
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JUN 1
PY 2017
VL 31
SU 2
BP S147
EP S156
DI 10.1097/QAD.0000000000001483
PG 10
WC Immunology; Infectious Diseases; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Virology
GA EU7ZT
UT WOS:000401256500006
PM 28471945
DA 2024-02-19
ER

PT J
AU Vuica, A
   Hamzic, LF
   Vukojevic, K
   Jeric, M
   Puljak, L
   Grkovic, I
   Filipovic, N
AF Vuica, Ana
   Hamzic, Lejla Ferhatovic
   Vukojevic, Katarina
   Jeric, Milka
   Puljak, Livia
   Grkovic, Ivica
   Filipovic, Natalija
TI Aging and a long-term diabetes mellitus increase expression of 1
   α-hydroxylase and vitamin D receptors in the rat liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Liver; 1 alpha-Hydroxylase; VDR; Aging; Diabetes mellitus
ID HEPATIC STELLATE CELLS; FIBRILLARY ACIDIC PROTEIN; REGENERATION;
   ACTIVATION; PATHWAYS; DISEASE; MARKER; GROWTH; INJURY; D-3
AB Diabetes mellitus (DM) is a metabolic disorder associated with serious liver complications. As a metabolic chronic disease, DM is very common in the elderly. Recent studies suggest ameliorating effects of vitamin D on metabolic and oxidative stress in the liver tissue in an experimental model of DM. The aim of this study was to investigate the expression of vitamin D receptors (VDRs) and 1 alpha-hydroxylase, the key enzyme for the production of active vitamin D form (calcitriol) in the liver during long-term diabetes mellitus type 1 (DM1) in aging rats. We performed immunohistochemical analysis of liver expression of 1 alpha-hydroxylase and VDRs during aging in long-term streptozotocin-induced DM1. 1 alpha-Hydroxylase was identified in the monocyte/macrophage system of the liver. In addition to the nuclear expression, we also observed the expression of VDR in membranes of lipid droplets within hepatocytes. Aging and long-term DM1 resulted in significant increases in the number of 1 alpha-hydroxylase immunoreactive cells, as well as the percentage of strongly positive VDR hepatocytes. In conclusion, the liver has the capacity for active vitamin D synthesis in its monocyte/macrophage system that is substantially increased in aging and long-term diabetes mellitus. These conditions are also characterized by significant increases in vitamin D receptor expression in hepatocytes. The present study suggests that VDR signaling system could be a potential target in prevention of liver complications caused by diabetes and aging. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Vuica, Ana; Hamzic, Lejla Ferhatovic; Vukojevic, Katarina; Jeric, Milka; Puljak, Livia; Grkovic, Ivica; Filipovic, Natalija] Univ Spilt, Dept Anat Histol & Embryol, Sch Med, Split 21000, Croatia.
C3 University of Split
RP Filipovic, N (corresponding author), Univ Spilt, Dept Anat Histol & Embryol, Sch Med, Soltanska 2, Split 21000, Croatia.
EM natalija.filipovic@mefst.hr
RI Vukojevic, Katarina/D-5246-2017; Filipovic, Natalija/D-4964-2017;
   Vukojevic, Katarina/AAU-1906-2020; Puljak, Livia/D-5080-2017; Grković,
   Ivica/D-8728-2017
OI Vukojevic, Katarina/0000-0003-2182-2890; Filipovic,
   Natalija/0000-0002-8943-4109; Vukojevic, Katarina/0000-0003-2182-2890;
   Puljak, Livia/0000-0002-8467-6061; Grković, Ivica/0000-0001-9010-2091
FU Ministry of Science, Education and Sports, Republic of Croatia
   [216-2160528-0067]; Croatian Science Foundation [02.05./28]
FX The study was funded by the Ministry of Science, Education and Sports,
   Republic of Croatia grant no. 216-2160528-0067 and the Croatian Science
   Foundation (HRZZ) grant no. 02.05./28.
CR Agnic I., 2014, CARDIOVASC PATHOL
   Alkharfy KM, 2013, METAB SYNDR RELAT D, V11, P283, DOI 10.1089/met.2012.0068
   Barchetta I, 2012, HEPATOLOGY, V56, P2180, DOI 10.1002/hep.25930
   Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831
   Buniatian G, 1996, BIOL CELL, V87, P65, DOI 10.1016/S0248-4900(97)89838-3
   Chow ECY, 2014, GASTROENTEROLOGY, V146, P1048, DOI 10.1053/j.gastro.2013.12.027
   Davis CD, 2008, AM J CLIN NUTR, V88, p565S, DOI 10.1093/ajcn/88.2.565S
   Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285
   Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028
   Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004
   Gascon-Barré M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176
   George N, 2012, BRIT J NUTR, V108, P1410, DOI 10.1017/S0007114511006830
   Gocek E, 2007, FEBS LETT, V581, P1751, DOI 10.1016/j.febslet.2007.03.055
   Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069
   Guzey M, 2002, MOL CANCER THER, V1, P667
   Halicka HD, 2012, AGING-US, V4, P270, DOI 10.18632/aging.100450
   Halter JB, 2014, DIABETES, V63, P2578, DOI 10.2337/db14-0020
   Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215
   Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0
   Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010
   Hayes DP, 2010, BIOGERONTOLOGY, V11, P1, DOI 10.1007/s10522-009-9252-0
   Hernández-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044
   Hewison M, 2000, J MOL ENDOCRINOL, V25, P141, DOI 10.1677/jme.0.0250141
   KREUTZ M, 1993, BLOOD, V82, P1300, DOI 10.1182/blood.V82.4.1300.1300
   Liu HH, 2015, AGEING RES REV, V19, P43, DOI 10.1016/j.arr.2014.12.001
   Marshall TG, 2008, BIOESSAYS, V30, P173, DOI 10.1002/bies.20708
   Masek T, 2014, EXP GERONTOL, V60, P140, DOI 10.1016/j.exger.2014.10.015
   Michigami T, 1999, J BIOL CHEM, V274, P33531, DOI 10.1074/jbc.274.47.33531
   Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002
   Najmi Varzaneh Farnaz, 2013, Acta Med Iran, V51, P236
   Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946
   PINKUS GS, 1991, MODERN PATHOL, V4, P733
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   Sakuma T, 2003, BIOCHEM BIOPH RES CO, V312, P513, DOI 10.1016/j.bbrc.2003.10.131
   Segura C, 1999, HISTOCHEM CELL BIOL, V112, P163, DOI 10.1007/s004180050403
   Stöcklin E, 2013, INT J VITAM NUTR RES, V83, P92, DOI 10.1024/0300-9831/a000151
   Taniguchi E, 2001, J HISTOCHEM CYTOCHEM, V49, P121, DOI 10.1177/002215540104900112
   Tennakoon AH, 2013, EXP TOXICOL PATHOL, V65, P1159, DOI 10.1016/j.etp.2013.05.008
   Townsend K, 2005, J STEROID BIOCHEM, V97, P103, DOI 10.1016/j.jsbmb.2005.06.004
   UNDERWOOD JL, 1984, AM J PHYSIOL, V246, pE493, DOI 10.1152/ajpendo.1984.246.6.E493
   van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002
   Wijesundera KK, 2013, EXP TOXICOL PATHOL, V65, P799, DOI 10.1016/j.etp.2012.11.006
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x
   Xu J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00167
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Zoppini G, 2014, AM J GASTROENTEROL, V109, P1020, DOI 10.1038/ajg.2014.132
NR 47
TC 8
Z9 10
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2015
VL 72
BP 167
EP 176
DI 10.1016/j.exger.2015.10.005
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CW4UD
UT WOS:000364989100022
PM 26471398
DA 2024-02-19
ER

PT J
AU Mitchell, SJ
   Huizer-Pajkos, A
   Cogger, VC
   McLachlan, AJ
   Le Couteur, DG
   Jones, B
   de Cabo, R
   Hilmer, SN
AF Mitchell, Sarah J.
   Huizer-Pajkos, Aniko
   Cogger, Victoria C.
   McLachlan, Andrew J.
   Le Couteur, David G.
   Jones, Brett
   de Cabo, Rafael
   Hilmer, Sarah N.
TI Age-Related Pseudocapillarization of the Liver Sinusoidal Endothelium
   Impairs the Hepatic Clearance of Acetaminophen in Rats
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Acetaminophen; Pseudocapillarization; Aging; Isolated liver perfusion;
   Extraction
ID HYPOXIA-REOXYGENATION INJURY; GLUCOSE-TRANSPORT; IN-VITRO; DRUG;
   CIRRHOSIS; PHARMACOKINETICS; METABOLISM; EXTRACTION; BLOOD;
   HEPATOTOXICITY
AB We investigated the effect of age-related pseudocapillarization of the liver sinusoidal endothelium on the hepatic disposition of acetaminophen. The multiple indicator dilution technique assessed the hepatic disposition of tracer C-14-acetaminophen and reference markers in isolated perfused livers of young (n = 11) and old (n = 12) rats. Electron microscopy confirmed defenestration of the sinusoidal endothelium in old rats compared with young rats. Acetaminophen recovery following a single pass through the liver was significantly increased in old rats (0.64 +/- 0.04, old; 0.59 +/- 0.05, young; p < .05). In old age, there was significant reduction of the intercompartmental rate constant k(1) (0.34 +/- 0.10s(-1) old; 0.61 +/- 0.38s(-1) young; p < .05) and the permeability-surface area product for the transfer of acetaminophen across the sinusoidal endothelium (0.034 +/- 0.006 mL/s/g. old: 0.048 +/- 0.014 mL/s/g, young; p < .005). There was no difference in k(3). the measure of sequestration of acetaminophen that reflects enzyme activity. Age-related pseudocapillarization of the liver sinusoid resulted in increased acetaminophen recovery and decreased transfer of acetaminophen into the liver.
C1 [Mitchell, Sarah J.; Huizer-Pajkos, Aniko; Jones, Brett; Hilmer, Sarah N.] Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia.
   [Mitchell, Sarah J.; Huizer-Pajkos, Aniko; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia.
   [Mitchell, Sarah J.; Cogger, Victoria C.; Le Couteur, David G.; Hilmer, Sarah N.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.
   [Jones, Brett] Royal N Shore Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW, Australia.
   [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA.
C3 University of Sydney; Kolling Institute of Medical Research; Royal North
   Shore Hospital; Royal North Shore Hospital; University of Sydney;
   University of Sydney; University of Sydney; Royal North Shore Hospital;
   University of Sydney; National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA)
RP Mitchell, SJ (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, Lab Ageing & Pharmacol, Level 12 Kolling Bldg,Pacific Highway, St Leonards, NSW 2065, Australia.
EM sarah.mitchell@sydney.edu.au
RI de Cabo, Rafael Carlos/E-7996-2010; McLachlan, Andrew J/AFN-2474-2022;
   Hilmer, Sarah/AAW-8554-2020; de Cabo, Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; McLachlan, Andrew
   J/0000-0003-4674-0242; Hilmer, Sarah/0000-0002-5970-1501; de Cabo,
   Rafael/0000-0002-3354-2442; Le Couteur, David/0000-0002-4227-5817
FU Geoff and Elaine Penney Aging Research Unit, Royal North Shore Hospital;
   National Health and Medical Research Council of Australia [570968,
   570937]; Ageing and Alzheimers Research Foundation; National Institute
   on Aging of the National Institutes of Health, USA
FX This study was funded by the Geoff and Elaine Penney Aging Research
   Unit, Royal North Shore Hospital, by the National Health and Medical
   Research Council of Australia project grants #570968 and #570937, the
   Ageing and Alzheimers Research Foundation and was supported in part by
   the Intramural Research Program of the National Institute on Aging of
   the National Institutes of Health, USA.
CR BAINBRIDGE CA, 1977, J PHARM SCI, V66, P480, DOI 10.1002/jps.2600660405
   BELANGER PM, 1987, J PHARMACOKINET BIOP, V15, P133, DOI 10.1007/BF01062340
   Butler JM, 2008, CLIN PHARMACOKINET, V47, P297, DOI 10.2165/00003088-200847050-00002
   Cho CSL, 2001, AM J PHYSIOL-HEART C, V280, pH1802, DOI 10.1152/ajpheart.2001.280.4.H1802
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   CRONE C, 1963, ACTA PHYSIOL SCAND, V58, P292, DOI 10.1111/j.1748-1716.1963.tb02652.x
   Crone C., 1984, HDB PHYSL CARDIOVASC, V4, P411
   FENYVES D, 1993, HEPATOLOGY, V17, P301, DOI 10.1002/hep.1840170222
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   GORESKY CA, 1992, HEPATOLOGY, V16, P173, DOI 10.1002/hep.1840160129
   GORESKY CA, 1964, AM J PHYSIOL, V207, P883, DOI 10.1152/ajplegacy.1964.207.4.883
   GORESKY CA, 1983, AM J PHYSIOL, V245, pG1, DOI 10.1152/ajpgi.1983.245.1.G1
   GORESKY CA, 1974, J CLIN INVEST, V53, P634, DOI 10.1172/JCI107598
   GORESKY CA, 1963, AM J PHYSIOL, V204, P626
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hilmer SN, 2004, DRUG METAB DISPOS, V32, P794, DOI 10.1124/dmd.32.8.794
   Hilmer SN, 2004, EXP GERONTOL, V39, P53, DOI 10.1016/j.exger.2003.09.016
   HIRATE J, 1990, BIOPHARM DRUG DISPOS, V11, P245, DOI 10.1002/bdd.2510110309
   HUET PM, 1982, J CLIN INVEST, V70, P1234, DOI 10.1172/JCI110722
   Hung DY, 2002, J PHARMACOL EXP THER, V301, P1079, DOI 10.1124/jpet.301.3.1079
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   Ito Y, 2006, MICROCIRCULATION, V13, P19, DOI 10.1080/10739680500383423
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 2004, JPN J PHYSIOL, V54, P421, DOI 10.2170/jjphysiol.54.421
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LECOUTEUR D, 1995, INT HEPATOL COMMUN, V3, P244, DOI 10.1016/0928-4346(94)00186-9
   LECOUTEUR DG, 1994, J GASTROEN HEPATOL, V9, P385
   LECOUTEUR DG, 1994, TRANSPLANTATION, V58, P531, DOI 10.1097/00007890-199409150-00001
   LECOUTEUR DG, 1993, AM J PHYSIOL, V264, pG767, DOI 10.1152/ajpgi.1993.264.4.G767
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Mitchell SJ, 2011, J PHARM SCI-US, V100, P334, DOI 10.1002/jps.22235
   MITCHELL SJ, 2010, J CLIN PHAR IN PRESS
   PANG KS, 1988, J PHARMACOKINET BIOP, V16, P595, DOI 10.1007/BF01062014
   PANG KS, 1995, HEPATOLOGY, V22, P267, DOI 10.1016/0270-9139(95)90381-X
   RAWLINS MD, 1977, EUR J CLIN PHARMACOL, V11, P283, DOI 10.1007/BF00607678
   REICHEN J, 1988, J CLIN INVEST, V82, P2069, DOI 10.1172/JCI113828
   REICHEN J, 1986, J CLIN INVEST, V78, P448, DOI 10.1172/JCI112596
   RENKIN EM, 1959, AM J PHYSIOL, V197, P1205, DOI 10.1152/ajplegacy.1959.197.6.1205
   RIKANS LE, 1988, DRUG CHEM TOXICOL, V11, P237, DOI 10.3109/01480548809017880
   RIVORY LP, 1990, THESIS U QUEENSLAND
   VARIN F, 1985, J CLIN INVEST, V76, P1904, DOI 10.1172/JCI112186
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Wauthier V, 2006, LIFE SCI, V79, P1913, DOI 10.1016/j.lfs.2006.06.046
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
NR 46
TC 31
Z9 36
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2011
VL 66
IS 4
BP 400
EP 408
DI 10.1093/gerona/glq221
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 741AX
UT WOS:000288836600005
PM 21300741
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Hyeon, J
   Lee, J
   Kim, E
   Lee, HM
   Kim, KP
   Shin, J
   Park, HS
   Lee, YI
   Nam, CH
AF Hyeon, Jooseung
   Lee, Jihan
   Kim, Eunju
   Lee, Hyeong Min
   Kim, Kwang Pyo
   Shin, Jaejin
   Park, Hyung Soon
   Lee, Yun-Il
   Nam, Chang-Hoon
TI Vutiglabridin exerts anti-ageing effects in aged mice through
   alleviating age-related metabolic dysfunctions
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Ageing; Metabolism; Mitochondrial homeostasis; Inflammageing
ID MITOCHONDRIAL DYSFUNCTION; EXTRACELLULAR-MATRIX; ADIPOSE-TISSUE;
   STEM-CELL; LIFE-SPAN; TRANSCRIPTOME; INFLAMMATION; MACROPHAGES;
   AUTOPHAGY; MECHANISMS
AB Background: Ageing alters the ECM, leading to mitochondrial dysfunction and oxidative stress, which triggers an inflammatory response that exacerbates with age. Age-related changes impact satellite cells, affecting muscle regeneration, and the balance of proteins. Furthermore, ageing causes a decline in NAD+ levels, and alterations in fat metabolism that impact our health. These various metabolic issues become intricately intertwined with ageing, leading to a variety of individual-level diseases and profoundly affecting individuals' healthspan. Therefore, we hypothesize that vutiglabridin capable of alleviating these metabolic abnormalities will be able to ameliorate many of the problems associated with ageing.Method: The efficacy of vutiglabridin, which alleviates metabolic issues by enhancing mitochondrial function, was assessed in aged mice treated with vutiglabridin and compared to untreated elderly mice. On young mice, vutiglabridin-treated aged mice, and non-treated aged mice, the Senescence-associated beta-galactosidase staining and q-PCR for ageing marker genes were carried out. Bulk RNA-seq was carried out on GA muscle, eWAT, and liver from each group of mice to compare differences in gene expression in various gene pathways. Blood from each group of mice was used to compare and analyze the ageing lipid profile.Results: SA-beta-gal staining of eWAT, liver, kidney, and spleen of ageing mice showed that vutiglabridin had anti ageing effects compared to the control group, and q-PCR of ageing marker genes including Cdkn1a and Cdkn2a in each tissue showed that vutiglabridin reduced the ageing process. In aged mice treated with vutiglabridin, GA muscle showed improved homeostasis compared to controls, eWAT showed restored insulin sensitivity and prevented FALC-induced inflammation, and liver showed reduced inflammation levels due to prevented TLO formation, improved mitochondrial complex I assembly, resulting in reduced ROS formation. Furthermore, blood lipid analysis revealed that ageing-related lipid profile was relieved in ageing mice treated with vutiglabridin versus the control group. Conclusion: Vutiglabridin slows metabolic ageing mechanisms such as decreased insulin sensitivity, increased inflammation, and altered NAD+ metabolism in adipose tissue in mice experiments, while also retaining muscle homeostasis, which is deteriorated with age. It also improves the lipid profile in the blood and restores mitochondrial function in the liver to reduce ROS generation.
C1 [Hyeon, Jooseung; Lee, Jihan; Nam, Chang-Hoon] Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Aging & Immun Lab, Daegu 42988, South Korea.
   [Kim, Eunju; Lee, Hyeong Min; Kim, Kwang Pyo] Kyung Hee Univ, Inst Nat Sci, Global Ctr Pharmaceut Ingredient Mat, Dept Appl Chem, Yongin, South Korea.
   [Kim, Eunju; Lee, Hyeong Min; Kim, Kwang Pyo] Kyung Hee Univ, Kyung Hee Med Sci Res Inst, Dept Biomed Sci & Technol, Seoul, South Korea.
   [Lee, Hyeong Min; Shin, Jaejin; Park, Hyung Soon] Glaceum Inc, Res Dept, Suwon, South Korea.
   [Lee, Yun-Il] Daegu Gyeongbuk Inst Sci & Technol, Well Aging Res Ctr, Dept Interdisciplinary Studies, Div Biotechnol, Daegu, South Korea.
C3 Daegu Gyeongbuk Institute of Science & Technology (DGIST); Kyung Hee
   University; Kyung Hee University; Daegu Gyeongbuk Institute of Science &
   Technology (DGIST)
RP Nam, CH (corresponding author), Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Aging & Immun Lab, Daegu 42988, South Korea.
EM chang@dgist.ac.kr
FU DGIST R&D Program of the Ministry of Science and ICT [22-BRP-01]; GRRC
   program of Gyeonggi province [2023-B01]
FX This work was supported by the DGIST R & D Program of the Ministry of
   Science and ICT (22-BRP-01 for Jooseung Hyeon, Jihan Lee and Chang-Hoon
   Nam) and by the GRRC program of Gyeonggi province[ (GRRC Kyung Hee
   2023-B01) , Industrial Application Research of Medicinal, Pharmaceutical
   and Chemical Materials] for Eunju Kim and Kwang Pyo Kim.
CR Alcazar O, 2007, INVEST OPHTH VIS SCI, V48, P5662, DOI 10.1167/iovs.07-0392
   Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786
   Amen OM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00977
   Amorim JA, 2022, NAT REV ENDOCRINOL, V18, P243, DOI 10.1038/s41574-021-00626-7
   An JN, 2021, AGING-US, V13, P22649, DOI 10.18632/aging.203580
   Antony AK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02945
   Aunan JR, 2016, BRIT J SURG, V103, pE29, DOI 10.1002/bjs.10053
   Bejarano E, 2018, AGING CELL, V17, DOI 10.1111/acel.12777
   Benayoun BA, 2019, GENOME RES, V29, P697, DOI 10.1101/gr.240093.118
   Bénézech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215
   Bharath LP, 2020, CELL METAB, V32, P44, DOI 10.1016/j.cmet.2020.04.015
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Breil C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040708
   Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020
   Camell CD, 2019, CELL METAB, V30, P1024, DOI 10.1016/j.cmet.2019.10.006
   Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Castello A, 2015, TRENDS ENDOCRIN MET, V26, P746, DOI 10.1016/j.tem.2015.09.012
   Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071
   Chen Keng, 2021, Curr. Res. Cell Biol., V2, P2590
   Chen YN, 2020, EUR J PHARMACOL, V877, DOI 10.1016/j.ejphar.2020.173090
   Chini CCS, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00298-z
   Choi LS, 2021, INT J OBESITY, V45, P130, DOI 10.1038/s41366-020-00686-1
   Covarrubias A, 2013, CELL RES, V23, P984, DOI 10.1038/cr.2013.88
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Covarrubias AJ, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00305-3
   Crimmins EM, 2015, GERONTOLOGIST, V55, P901, DOI 10.1093/geront/gnv130
   Csapo R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00253
   Eum JY, 2020, J CHROMATOGR A, V1618, DOI 10.1016/j.chroma.2020.460849
   Feng ZY, 2016, ONCOTARGET, V7, P15410, DOI 10.18632/oncotarget.7645
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061
   Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845
   Garmany A, 2021, NPJ REGEN MED, V6, DOI 10.1038/s41536-021-00169-5
   Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010
   Ge HM, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.631991
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26
   Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7
   He M, 2020, CELL METAB, V31, P580, DOI 10.1016/j.cmet.2020.01.009
   Heino J, 2014, ADV EXP MED BIOL, V819, P143, DOI 10.1007/978-94-017-9153-3_10
   Heo J.W., 2023, bioRxiv, DOI [10.1101/2023.02.12, DOI 10.1101/2023.02.12]
   Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200
   Huang XH, 2014, BBA-MOL CELL BIOL L, V1841, P657, DOI 10.1016/j.bbalip.2013.08.006
   Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342
   Jannone G, 2020, J HISTOCHEM CYTOCHEM, V68, P269, DOI 10.1369/0022155420913534
   Johnson AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13048
   Kang S, 2022, bioRxiv, DOI [10.1101/2022.10.20.512990, 10.1101/ 2022.10.20.512990, DOI 10.1101/2022.10.20.512990]
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005
   Lee JW, 2016, RSC ADV, V6, P29512, DOI 10.1039/c6ra01965j
   Lee JW, 2013, J CHROMATOGR A, V1279, P98, DOI 10.1016/j.chroma.2013.01.020
   Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5
   Lisci M, 2021, SCIENCE, V374, DOI 10.1126/science.abe9977
   Liu LL, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-00355-y
   Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018
   Liu XF, 2022, NAT METAB, V4, P1202, DOI 10.1038/s42255-022-00634-5
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188
   Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516
   Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715
   Martins SG, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.673002
   McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010
   Melouane A, 2020, MITOCHONDRION, V50, P63, DOI 10.1016/j.mito.2019.10.007
   Melzer D, 2020, NAT REV GENET, V21, P88, DOI 10.1038/s41576-019-0183-6
   Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837
   Montoliu I, 2014, AGING-US, V6, P9, DOI 10.18632/aging.100630
   Moon SK, 2004, EXP GERONTOL, V39, P123, DOI 10.1016/j.exger.2003.09.019
   Muñoz-Cánoves P, 2020, FEBS J, V287, P406, DOI 10.1111/febs.15182
   Mutlu AS, 2021, DEV CELL, V56, P1394, DOI 10.1016/j.devcel.2021.03.034
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012
   Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003
   Papsdorf K, 2019, TRENDS CELL BIOL, V29, P97, DOI 10.1016/j.tcb.2018.09.004
   Paradis S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8060168
   Park S, 2021, MECH AGEING DEV, V197, DOI 10.1016/j.mad.2021.111498
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Pawlikowski B, 2017, DEV DYNAM, V246, P359, DOI 10.1002/dvdy.24495
   Pérez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Place DE, 2018, CURR OPIN IMMUNOL, V50, P32, DOI 10.1016/j.coi.2017.10.011
   Podhorecka M, 2017, POSTEP HIG MED DOSW, V71, P170
   Pontzer H, 2021, SCIENCE, V373, P808, DOI 10.1126/science.abe5017
   Rockenfeller P, 2015, CELL DEATH DIFFER, V22, P499, DOI 10.1038/cdd.2014.219
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Sahu A, 2021, NATURE AGING, V1, P1148, DOI 10.1038/s43587-021-00143-2
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Shin G.-C., 2021, bioRxiv, DOI [10.1101/2021.10.01.462722, DOI 10.1101/2021.10.01.462722]
   Stegeman R, 2017, J MOL BIOL, V429, P2427, DOI 10.1016/j.jmb.2017.06.019
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Stromsdorfer KL, 2016, CELL REP, V16, P1851, DOI 10.1016/j.celrep.2016.07.027
   Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759
   Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wu MH, 2020, CHIN MED-UK, V15, DOI 10.1186/s13020-020-00381-3
   Wu M, 2009, DIABETES-METAB RES, V25, P279, DOI 10.1002/dmrr.932
   Xie YL, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00222-7
   Xu B, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.149969
   Yamakawa H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051830
   Zaarur N, 2014, MOL CELL BIOL, V34, P1336, DOI 10.1128/MCB.00103-14
   Zeltz C, 2016, J CELL SCI, V129, P653, DOI 10.1242/jcs.180992
   Zhang Y, 2021, AGEING RES REV, V70, DOI 10.1016/j.arr.2021.101376
   Zhou QZ, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107694
NR 107
TC 0
Z9 0
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT 1
PY 2023
VL 181
AR 112269
DI 10.1016/j.exger.2023.112269
EA SEP 2023
PG 20
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA T3NU1
UT WOS:001077095000001
PM 37567452
OA hybrid
DA 2024-02-19
ER

PT J
AU Kwak, HC
   Kim, HC
   Oh, SJ
   Kim, SK
AF Kwak, Hui Chan
   Kim, Hyoung Chin
   Oh, Soo Jin
   Kim, Sang Kyum
TI Effects of age increase on hepatic expression and activity of cytochrome
   P450 in male C57BL/6 mice
SO ARCHIVES OF PHARMACAL RESEARCH
LA English
DT Article
DE Drug-metabolizing enzyme; Cytochrome P450; Aging; Male mice; Liver
ID LIVER-MICROSOMES; RAT-LIVER; MESSENGER-RNA; INDUCTION; INHIBITION;
   METABOLISM; ENZYMES; PROTEIN; FORMS
AB Effects of aging on hepatic expression and activity of cytochrome P450 (CYP) isoforms were investigated in male mice aged 2, 6, 18, and 30 months. Microsomal protein, total CYP, cytochrome b(5) and NADPH-dependent cytochrome P450 reductase contents in liver were fully expressed in young (2-month-old) mice. Neither Cyp1a1 nor Cyp2c was detected in any aged mice. And Cyp1a2 was maximally expressed at 2 months and decreased with age. Hepatic levels of Cyp2b10 and Cyp3a11 were decreased in 30-month-old mice. Hepatic Cyp2e1 levels were constantly maintained from 2-month to 30-month old mice. Hepatic activities of ethoxyresorufin-O-deethylase and methoxyresorufin-O-demethylase were gradually decreased after 6 months. The 30-month-old mice exhibited the lowest activity of midazolam 10-hydroxylase. Pentoxyresorufin-O-depenthylase activity was decreased in 30-month-old mice, but not statistically significant. There were no significant differences in hepatic activities of chlorzoxazone 6-hydroxylase and midazolam 4-hydroxylase. The present study shows that increasing age, especially 30-month-old mice, leads to decrease in expression and activity of hepatic CYP isoforms, suggesting that aging mice exhibit poor hepatic drug-metabolizing capacity.
C1 [Kwak, Hui Chan; Kim, Sang Kyum] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea.
   [Kim, Hyoung Chin; Oh, Soo Jin] KRIBB, Bioevaluat Ctr, Chungbuk, Ochang, South Korea.
C3 Chungnam National University; Korea Research Institute of Bioscience &
   Biotechnology (KRIBB)
RP Kim, SK (corresponding author), Chungnam Natl Univ, Coll Pharm, 99 Daehak Ro, Taejon 305764, South Korea.
EM diatree@kribb.re.kr; sangkim@cnu.ac.kr
OI Kim, Sang Kyum/0000-0001-5769-0792
FU Ministry for Health, Welfare, & Family Affairs, Republic of Korea
   [A101836]; National Research Foundation of Korea (NRF) - Ministry of
   Education [2013R1A1A2005981]
FX This study was supported by a Grant from the Korea Healthcare Technology
   R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of
   Korea (A101836) and by the Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education (2013R1A1A2005981).
CR BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8
   Chen JJ, 2003, ENVIRON TOXICOL, V18, P115, DOI 10.1002/tox.10107
   Chovan JP, 2007, XENOBIOTICA, V37, P459, DOI 10.1080/00498250701245250
   Cotreau MM, 2000, J PHARMACOL TOX MET, V43, P41, DOI 10.1016/S1056-8719(00)00086-1
   Estabrook R W, 1978, Methods Enzymol, V52, P212
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   Isabelle L., 1998, J CHROMATOGR A, V828, P291
   Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004
   KITADA M, 1991, JPN J CANCER RES, V82, P426, DOI 10.1111/j.1349-7006.1991.tb01866.x
   Kobayashi K, 2002, BIOCHEM PHARMACOL, V63, P889, DOI 10.1016/S0006-2952(01)00843-7
   Liptrott NJ, 2009, BRIT J PHARMACOL, V156, P497, DOI 10.1111/j.1476-5381.2008.00050.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAEDA K, 1984, BIOCHEM PHARMACOL, V33, P509, DOI 10.1016/0006-2952(84)90252-1
   Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875
   Minn A.L., 2006, DRUG METABOLISM TOXI, V6, P875
   OMIECINSKI CJ, 1990, CANCER RES, V50, P4315
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   SCHENKMAN JB, 1989, DRUG METAB REV, V20, P557, DOI 10.3109/03602538909103562
   Strobel H W, 1978, Methods Enzymol, V52, P89
   Tani Y, 1999, TOXICOL LETT, V106, P159, DOI 10.1016/S0378-4274(99)00055-7
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Yang MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059673
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
NR 23
TC 10
Z9 12
U1 0
U2 9
PU PHARMACEUTICAL SOC KOREA
PI SEOUL
PA 1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA
SN 0253-6269
EI 1976-3786
J9 ARCH PHARM RES
JI Arch. Pharm. Res.
PD MAY
PY 2015
VL 38
IS 5
BP 857
EP 864
DI 10.1007/s12272-014-0452-z
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CH8PZ
UT WOS:000354299800034
PM 25060948
DA 2024-02-19
ER

PT J
AU MURTHY, VK
   OREDIPE, OA
   STILES, MR
   SHIPP, JC
AF MURTHY, VK
   OREDIPE, OA
   STILES, MR
   SHIPP, JC
TI INCREASED FATTY-ACID UPTAKE, A FACTOR IN INCREASED HEPATIC
   TRIACYLGLYCEROL SYNTHESIS IN AGING RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 UNIV NEBRASKA,MED CTR,DEPT INTERNAL MED,OMAHA,NE 68105.
   UNIV NEBRASKA,MED CTR,DEPT BIOCHEM,OMAHA,NE 68105.
C3 University of Nebraska System; University of Nebraska Medical Center;
   University of Nebraska System; University of Nebraska Medical Center
CR BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331
   BOYNS DR, 1969, BRIT MED J, V1, P595, DOI 10.1136/bmj.1.5644.595
   CARLSON LA, 1972, LANCET, V1, P865
   CORNELL NW, 1973, BIOCHEM J, V134, P671, DOI 10.1042/bj1340671
   Eisenberg S, 1975, Adv Lipid Res, V13, P1
   EISENBERG S, 1985, ADV EXP MED BIOL, V183, P73
   GIANTURCO SH, 1985, ADV EXP MED BIOL, V183, P47
   HEIMBERG M, 1969, J BIOL CHEM, V244, P5131
   HOLLANDER D, 1983, EXP GERONTOL, V18, P287, DOI 10.1016/0531-5565(83)90039-6
   KRITCHEVSKY D, 1979, FED PROC, V38, P2001
   MALHOTRA S, 1978, MECH AGEING DEV, V8, P445, DOI 10.1016/0047-6374(78)90044-1
   MURTHY VK, 1977, DIABETES, V26, P222, DOI 10.2337/diabetes.26.3.222
   ONTKO JA, 1972, J BIOL CHEM, V247, P1788
   OREDIPE OA, DIABETES RES CLIN PR
   REAVEN GM, 1978, J GERONTOL, V33, P368, DOI 10.1093/geronj/33.3.368
   RONCARI DAK, 1975, J BIOL CHEM, V250, P4134
   SALEL AF, 1974, AM J MED, V57, P897, DOI 10.1016/0002-9343(74)90167-3
   STORY JA, 1976, LIPIDS, V11, P623, DOI 10.1007/BF02532876
   SUNDLER R, 1974, J BIOL CHEM, V249, P5102
   TOBEY TA, 1981, METABOLISM, V30, P583, DOI 10.1016/0026-0495(81)90135-9
   WOOD PDS, 1972, CIRCULATION, V45, P114, DOI 10.1161/01.CIR.45.1.114
   WOODSIDE WF, 1978, METABOLISM, V27, P1763, DOI 10.1016/0026-0495(78)90262-7
NR 22
TC 5
Z9 5
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD NOV 28
PY 1986
VL 37
IS 1
BP 49
EP 54
DI 10.1016/0047-6374(86)90117-X
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA F5596
UT WOS:A1986F559600005
PM 3821188
DA 2024-02-19
ER

PT J
AU Trocha, M
   Szelag, A
   Piesniewska, M
   Fereniec-Golkbiewska, L
   Grotthus, B
   Merwid-Lad, A
AF Trocha, Malgorzata
   Szelag, Adam
   Piesniewska, Malgorzata
   Fereniec-Golkbiewska, Lidia
   Grotthus, Bartosz
   Merwid-Lad, Anna
TI Effect of aging process on liver function in extracorporeal rat liver
   perfusion
SO HEPATO-GASTROENTEROLOGY
LA English
DT Article
DE aging; liver; function; extracorporeal liver perfusion
ID AGE; PROTEIN; TRANSPLANTATION; CHOLESTEROL; HYPOTHESIS
AB Background/Aims: Liver function appears to be well maintained in old age. However, the current state of knowledge about liver aging processes is incomplete. In this study, using extracorporeal liver perfusion model, we evaluated the differences between liver function in young and old rats.
   Methodology: Livers were harvested from groups of young (2 months) and old (12 months) rats and perfused for 2 hours with a perfusion fluid. After 10, 30, 60, 90 and 120 minutes of perfusion, glucose concentration as well as enzyme levels (alanine aminotransferase, aspartate aminotransferase and lactic dehydrogenase) were measured. On completion of perfusion all bile produced was collected.
   Results: All measured parameters changed significantly as a function of perfusion time in both groups. Changes in enzyme levels were most evident between 90 and 120 minutes of perfusion. In contrast to old rats, where glucose concentration decreased during all time periods of perfusion, in young rats the glucose concentration increased at the beginning of perfusion.
   Conclusions: The results suggest that livers obtained from older rats are damaged to a greater extent and are more susceptible to unfavorable conditions during perfusion than livers obtained from younger rats. Also, single measurement of liver enzymes is not enough for complete liver function assessment.
C1 Wroclaw Med Univ, Dept Pharmacol, PL-50345 Wroclaw, Poland.
C3 Wroclaw Medical University
RP Trocha, M (corresponding author), Wroclaw Med Univ, Dept Pharmacol, Mikulicza Radeckiego 2, PL-50345 Wroclaw, Poland.
EM gotro@fa.am.wroc.pl
RI Szelag, Adam/AAS-8198-2021; Merwid-Ląd, Anna/ABD-2151-2021
OI Merwid-Ląd, Anna/0000-0002-4597-0241; Grotthus,
   Bartosz/0000-0002-2569-2520; Szelag, Adam/0000-0001-8104-5267;
   Piesniewska, Malgorzata/0000-0003-3368-3496
CR ALEXANDER JW, 1991, TRANSPLANTATION, V51, P135, DOI 10.1097/00007890-199101000-00021
   AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Marino M, 2002, MECH AGEING DEV, V123, P1183, DOI 10.1016/S0047-6374(02)00009-X
   McCullough KD, 1997, CANCER RES, V57, P1807
   ROHER AE, 1993, J BIOL CHEM, V268, P3072
   SCHMUCKER DL, 1998, J GERONTOL A-BIOL, V53, pB513
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 16
TC 3
Z9 3
U1 0
U2 1
PU H G E UPDATE MEDICAL PUBLISHING S A
PI ATHENS
PA PO BOX 17257, ATHENS GR-10024, GREECE
SN 0172-6390
J9 HEPATO-GASTROENTEROL
JI Hepato-Gastroenterol.
PD JUN
PY 2007
VL 54
IS 76
BP 1207
EP 1211
PG 5
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA 183JC
UT WOS:000247568100051
PM 17629071
DA 2024-02-19
ER

PT J
AU STITH, RD
   MCCALLUM, RE
AF STITH, RD
   MCCALLUM, RE
TI EFFECTS OF AGING AND ENDOTOXIN ON HEPATIC GLUCOCORTICOID ACTION AND
   GLUCOSE-METABOLISM IN MICE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 UNIV OKLAHOMA, HLTH SCI CTR, COLL MED, DEPT MICROBIOL & IMMUNOL, OKLAHOMA CITY, OK 73190 USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP STITH, RD (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, COLL MED, DEPT PHYSIOL & BIOPHYS, OKLAHOMA CITY, OK 73190 USA.
FU NIAID NIH HHS [AI-20322] Funding Source: Medline
CR ADELMAN RC, 1975, ENZYME INDUCTION, P304
   [Anonymous], 1991, J DAIRY SCI
   BERRY LJ, 1980, MICROBIOLOGY 1980, P77
   CHANG HC, 1966, J BIOL CHEM, V241, P2413
   CHATTOPADHYAY B, 1983, J INFECTION, V7, P134, DOI 10.1016/S0163-4453(83)90548-0
   EXTON JH, 1972, METABOLISM, V21, P945, DOI 10.1016/0026-0495(72)90028-5
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   HINSHAW LB, 1976, CIRC SHOCK, V3, P1
   KALIMI M, 1983, ENDOCRINOLOGY, V113, P1161
   KALIMI M, 1983, ENDOCRINOLOGY, V112, P341, DOI 10.1210/endo-112-1-341
   Karanfilian R G, 1983, Adv Shock Res, V9, P125
   LES EP, 1969, J AM ASS LAB ANIMAL, V69
   McCallum R E, 1979, Adv Shock Res, V2, P113
   MCCALLUM RE, 1983, INFECT IMMUN, V39, P213, DOI 10.1128/IAI.39.1.213-219.1983
   OAKS WW, 1967, GERIATRICS, V22, P120
   ROTH GS, 1974, ENDOCRINOLOGY, V94, P82, DOI 10.1210/endo-94-1-82
   STITH RD, 1983, INFECT IMMUN, V40, P613, DOI 10.1128/IAI.40.2.613-621.1983
   WESTPHAL O, 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030
   Zahl PA, 1943, P SOC EXP BIOL MED, V54, P137
   Zar JH, 1974, Biostatistical Analysis, P101
NR 20
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PY 1985
VL 30
IS 1
BP 73
EP 78
DI 10.1016/0047-6374(85)90060-0
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AHH57
UT WOS:A1985AHH5700007
PM 3999815
DA 2024-02-19
ER

PT J
AU KANAI, S
   KITANI, K
   FUJITA, S
   KITAGAWA, H
AF KANAI, S
   KITANI, K
   FUJITA, S
   KITAGAWA, H
TI THE HEPATIC HANDLING OF SULFOBROMPHTHALEIN IN AGING FISCHER-344 RATS -
   INVIVO AND INVITRO STUDIES
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
C1 TOKYO METROPOLITAN INST GERONTOL,CLIN PHYSIOL LAB 1,35-2 SAKAECHO,ITABASHI KU,TOKYO 173,JAPAN.
   CHIBA UNIV,FAC PHARMACEUT SCI,DEPT BIOPHARMACEUT,CHIBA,JAPAN.
C3 Tokyo Metropolitan Institute of Gerontology; Chiba University
CR [Anonymous], 1978, PATHOLOGY AGING RATS
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   DAVIS RA, 1978, P NATL ACAD SCI USA, V75, P4130, DOI 10.1073/pnas.75.9.4130
   DELEEUWISRAEL FR, 1971, THESIS LEIDEN
   FORKER EL, 1969, J CLIN INVEST, V48, P654, DOI 10.1172/JCI106023
   FUJITA S, 1982, LIVER AGING 1982 LIV, P179
   GOLDSTEIN J, 1966, J LAB CLIN MED, V67, P863
   GREGUS Z, 1979, ARCH INT PHARMACOD T, V240, P180
   GROSZMANN RJ, 1969, P SOC EXP BIOL MED, V132, P712
   INOUE T, 1982, BIOMED GERONTOL, V6, P4
   KITANI K, 1984, GASTROENTEROLOGY, V86, P1136
   KITANI K, 1981, MECH AGEING DEV, V17, P381, DOI 10.1016/0047-6374(81)90055-5
   KITANI K, 1978, JPN J NUCL MED, V15, P999
   KITANI K, 1978, LIVER AGING, P145
   KITANI K, 1977, EXP GERONTOL, V13, P4
   KLAASSEN CD, 1969, TOXICOL APPL PHARM, V15, P143, DOI 10.1016/0041-008X(69)90142-2
   KLAASSEN CD, 1973, J PHARMACOL EXP THER, V184, P721
   KLAASSEN CD, 1967, AM J PHYSIOL, V213, P1322, DOI 10.1152/ajplegacy.1967.213.5.1322
   KLAASSEN CD, 1970, J PHARM EXP THER, V161, P361
   KROKER R, 1980, MECH AGEING DEV, V12, P367, DOI 10.1016/0047-6374(80)90069-X
   OHTA M, 1984, ARCH GERONTOL GERIAT, V3, P249, DOI 10.1016/0167-4943(84)90026-8
   OMAILLE ERL, 1966, J PHYSIOL-LONDON, V186, P424, DOI 10.1113/jphysiol.1966.sp008044
   PRIESTLY BG, 1970, P SOC EXP BIOL MED, V135, P373
   Skaunic V, 1970, Cesk Gastroenterol Vyz, V24, P206
   THOMPSON EN, 1965, GUT, V6, P266, DOI 10.1136/gut.6.3.266
   WARE AJ, 1973, AM J PHYSIOL, V225, P1260, DOI 10.1152/ajplegacy.1973.225.6.1260
   WHEELER HO, 1960, J CLIN INVEST, V39, P1131, DOI 10.1172/JCI104128
   WHELAN G, 1970, J LAB CLIN MED, V75, P542
   WHELAN G, 1967, P SOC EXP BIOL MED, V132, P704
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
NR 30
TC 15
Z9 15
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PY 1985
VL 4
IS 1
BP 73
EP 85
DI 10.1016/0167-4943(85)90020-2
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AGF09
UT WOS:A1985AGF0900009
PM 4004412
DA 2024-02-19
ER

PT J
AU CHATTERJEE, B
   MANCINI, MA
   ROY, AK
AF CHATTERJEE, B
   MANCINI, MA
   ROY, AK
TI THE SENESCENCE MARKER PROTEIN (SMP-2) OF THE RAT-LIVER - PURIFICATION,
   IMMUNOCHEMICAL CHARACTERIZATION AND AGE-DEPENDENT REGULATION
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
C1 OAKLAND UNIV,ROCHESTER,MI 48063.
   UNIV TEXAS,HLTH SCI CTR,DEPT OBSTET & GYNECOL,SAN ANTONIO,TX 78284.
C3 Oakland University; University of Texas System; University of Texas
   Health Science Center at San Antonio
RP CHATTERJEE, B (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.
FU NIA NIH HHS [AG-03527] Funding Source: Medline
CR ANTAKLY T, 1982, AM J ANAT, V165, P211, DOI 10.1002/aja.1001650209
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CHATTERJEE B, 1981, J BIOL CHEM, V256, P5939
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199
   OLSON NJ, 1989, CELL TO CELL COMMUNI, P71
   RAPPAPORT AM, 1980, LIVER BILIARY TRACT, V1, P1
   ROSENFELD GC, 1972, BIOCHEM BIOPH RES CO, V46, P1695, DOI 10.1016/0006-291X(72)90805-4
   ROY AK, 1985, MOL ASPECTS MED, V8, P1, DOI 10.1016/0098-2997(85)90004-4
   ROY AK, 1983, J BIOL CHEM, V258, P123
   ROY AK, 1986, CELLULAR ENDOCRINOLO, P401
   SARKAR FH, 1987, BIOCHEMISTRY-US, V26, P3965, DOI 10.1021/bi00387a033
   SARKAR FH, 1986, J ENDOCRINOL, V111, P205, DOI 10.1677/joe.0.1110205
   SONG CS, 1990, BIOCHEMISTRY-US, V29, P542, DOI 10.1021/bi00454a031
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 19
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD MAY 16
PY 1990
VL 1034
IS 2
BP 162
EP 169
DI 10.1016/0304-4165(90)90071-4
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA DH452
UT WOS:A1990DH45200007
PM 2354191
DA 2024-02-19
ER

PT J
AU Kong, B
   Zhu, Y
   Li, GD
   Williams, JA
   Buckley, K
   Tawfik, O
   Luyendyk, JP
   Guo, GL
AF Kong, Bo
   Zhu, Yan
   Li, Guodong
   Williams, Jessica A.
   Buckley, Kyle
   Tawfik, Ossama
   Luyendyk, James P.
   Guo, Grace L.
TI Mice with hepatocyte-specific FXR deficiency are resistant to
   spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE HCC; tissue specific FXR; bile acids
ID FARNESOID-X RECEPTOR; BILE-ACIDS; KNOCKOUT MICE; NUCLEAR RECEPTOR; LIVER
   CARCINOGENESIS; TUMOR-DEVELOPMENT; NULL MICE; ACTIVATION; STAT3;
   PROTECTS
AB Farnesoid X receptor (FXR) belongs to the nuclear receptor superfamily with its endogenous ligands bile acids. Mice with whole body FXR deficiency develop liver tumors spontaneously, but the underlying mechanism is unclear. Moreover, it is unknown whether FXR deficiency in liver alone serves as a tumor initiator or promoter during liver carcinogenesis. This study aims to evaluate the effects of hepatocyte-specific FXR deficiency (FXRhep-/-) in liver tumor formation. The results showed that FXRhep-/- mice did not show spontaneous liver tumorigenesis with aging (up to 24 mo of age). Therefore FXRhep-/- mice were fed a bile acid (cholic acid)-containing diet alone or along with a liver tumor initiator, diethylnitrosamine (DEN). Thirty weeks later, no tumors were found in wild-type or FXRhep-/- mice without any treatment or with DEN only. However, with cholic acid, while only some wildtype mice developed tumors, all FXRhep-/- mice presented with severe liver injury and tumors. Interestingly, FXRhep-/- mouse livers increased basal expression of tumor suppressor p53 protein, apoptosis, and decreased basal cyclin D1 expression, which may prevent tumor development in FXRhep-/- mice. However, cholic acid feeding reversed these effects in FXRhep-/- mice, which is associated with an increased cyclin D1 and decreased cell cycle inhibitors. More in-depth analysis indicates that the increased in cell growth might result from disturbance of the MAPK and JAK/Stat3 signaling pathways. In conclusion, this study shows that hepatic FXR deficiency may only serve as a tumor initiator, and increased bile acids is required for tumor formation likely by promoting cell proliferation.
C1 [Kong, Bo; Buckley, Kyle; Guo, Grace L.] Rutgers State Univ, Dept Pharmacol & Toxicol, Sch Pharm, Piscataway, NJ 08854 USA.
   [Zhu, Yan] Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China.
   [Li, Guodong] Harbin Med Univ, Hosp 4, Dept Gen Surg, Harbin, Peoples R China.
   [Li, Guodong] Harbin Med Univ, Hosp 4, Dept Gen Surg, Div Biobank Res, Harbin, Peoples R China.
   [Williams, Jessica A.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.
   [Tawfik, Ossama] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.
   [Luyendyk, James P.] Michigan State Univ, Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Capital
   Medical University; Harbin Medical University; Harbin Medical
   University; University of Kansas; University of Kansas Medical Center;
   University of Kansas; University of Kansas Medical Center; Michigan
   State University
RP Guo, GL (corresponding author), Rutgers State Univ, Dept Pharmacol & Toxicol, Sch Pharm, Piscataway, NJ 08854 USA.
EM guo@eohsi.rutgers.edu
RI Kong, Bo/G-7650-2014
OI Kong, Bo/0000-0002-8200-7817
FU National Institute of General Medical Sciences [R01GM104037]
FX This study was funded by National Institute of General Medical Sciences
   Grant R01GM104037 (principal investigator G. Guo).
CR Borude P, 2012, HEPATOLOGY, V56, P2344, DOI 10.1002/hep.25918
   CAMERON RG, 1982, CANCER RES, V42, P2426
   Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595
   Degirolamo C, 2015, HEPATOLOGY, V61, P161, DOI 10.1002/hep.27274
   Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Kitazawa Shunji, 1993, Hokkaido Journal of Medical Science, V68, P110
   Kong B, 2012, HEPATOLOGY, V56, P1034, DOI 10.1002/hep.25740
   Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e
   Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524
   Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384
   Li GD, 2013, AM J PHYSIOL-GASTR L, V305, pG829, DOI 10.1152/ajpgi.00155.2013
   Li GD, 2013, TOXICOL APPL PHARM, V272, P299, DOI 10.1016/j.taap.2013.06.016
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409
   Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Qiao D, 2001, CARCINOGENESIS, V22, P35, DOI 10.1093/carcin/22.1.35
   RAJEWSKY MF, 1966, SCIENCE, V152, P83, DOI 10.1126/science.152.3718.83
   Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003
   Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450
   TSUDA H, 1984, GANN, V75, P871
   Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2
   Wang Xichun, 2013, Curr Pathobiol Rep, V1, P29
   Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519
   Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390
   Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078
   Yang ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039789
   Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734
   Zhan L, 2016, AM J PHYSIOL-GASTR L, V310, pG93, DOI 10.1152/ajpgi.00252.2015
   Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157
   Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641
NR 33
TC 32
Z9 34
U1 0
U2 10
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD MAR 1
PY 2016
VL 310
IS 5
BP G295
EP G302
DI 10.1152/ajpgi.00134.2015
PG 8
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA DF4FN
UT WOS:000371303400001
PM 26744468
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU KOZURKOVA, M
   MISUROVA, E
   KROPACOVA, K
AF KOZURKOVA, M
   MISUROVA, E
   KROPACOVA, K
TI AGING AND RADIATION-INDUCED ALTERATIONS IN LIVER HISTONES
SO NEOPLASMA
LA English
DT Article
DE AGING; GAMMA RADIATION; HISTONES; RAT LIVER; DNA
ID CHROMATIN; H1-DEGREES; TISSUES; CELLS
AB Age-related changes in histones in the liver of normal mts and in rats irradiated with 5.7 Gy gamma rays were examined.
   Quantitative histone changes in growing and aging rats (from 1 to 28 months of age) were found to be mild only. As they paralleled the DNA changes, the histone/DNA ratio remained stable with age. In total extracted histones there was a decrease in the H1 proportion in older age groups with preceding increase in the H1(0) proportion. Thirty minutes after irradiation the amount of histones was reduced with age, probably due to an impaired extractability of histones. As the quantitative DNA changes were milder, the histone/DNA ratio decreased in aging liver after irradiation. Similar patterns of changes in proportion of the H1 fraction and H1(0) subfraction were observed in irradiated and nonirradiated animals, in the former with an earlier onset. Irradiation therefore, accelerated spontaneous age-related alterations.
RP KOZURKOVA, M (corresponding author), SAFARIK UNIV,DEPT CELLULAR & MOLEC BIOL,KOSICE 04167,SLOVAKIA.
RI Kozurkova, Maria/G-7433-2016
OI Kozurkova, Maria/0000-0002-2789-8397; Kozurkova,
   Maria/0000-0002-8344-0671
CR BUTLER JG, 1983, CURR MOL BIOL ORGAN, V3, P2599
   CSORDAS A, 1990, BIOCHEM J, V265, P23, DOI 10.1042/bj2650023
   FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0
   GRUNICKE HH, 1989, J CANCER RES CLIN, V115, P435, DOI 10.1007/BF00393332
   HARPER JF, 1984, COMPUT BIOL MED, V14, P437, DOI 10.1016/0010-4825(84)90044-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCGHEE JD, 1983, CELL, V33, P831, DOI 10.1016/0092-8674(83)90025-9
   MEDVEDEV ZA, 1989, T AGING RES, V13, P203
   MEDVEDEV ZA, 1990, EXP GERONTOL, V25, P189, DOI 10.1016/0531-5565(90)90050-C
   NORELL M, 1990, MECH AGEING DEV, V56, P63, DOI 10.1016/0047-6374(90)90115-V
   PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X
   PANYIM S, 1971, J BIOL CHEM, V246, P4206
   SREBREVA L, 1991, INT J BIOCHEM, V23, P189, DOI 10.1016/0020-711X(91)90188-S
   Suliova J, 1983, Bratisl Lek Listy, V80, P661
   Suliova J, 1982, Radiobiol Radiother (Berl), V23, P667
   SULIOVA J, 1983, RADIOBIOLOGIYA, V23, P513
   THOMAS JO, 1984, J CELL SCI S, V1, P1
   TSANEV R G, 1960, Biokhimiia, V25, P151
   WAGNER AP, 1982, EXP GERONTOL, V17, P173, DOI 10.1016/0531-5565(82)90022-5
   WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3
   ZLATANOVA JS, 1990, J CELL SCI, V96, P461
NR 21
TC 4
Z9 4
U1 1
U2 3
PU SLOVAK ACADEMIC PRESS LTD
PI BRATISLAVA
PA PO BOX 57, NAM SLOBODY 6, 810 05 BRATISLAVA, SLOVAKIA
SN 0028-2685
J9 NEOPLASMA
JI Neoplasma
PY 1994
VL 41
IS 2
BP 89
EP 94
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA NG999
UT WOS:A1994NG99900004
PM 8208319
DA 2024-02-19
ER

PT J
AU Yang, N
   Occean, JR
   Melters, DP
   Shi, CY
   Wang, L
   Stransky, S
   Doyle, ME
   Cui, CY
   Delannoy, M
   Fan, JS
   Slama, E
   Egan, JM
   De, SPY
   Cunningham, SC
   de Cabo, R
   Sidoli, S
   Dalal, Y
   Sen, P
AF Yang, Na
   Occean, James R.
   Melters, Daniel P.
   Shi, Changyou
   Wang, Lin
   Stransky, Stephanie
   Doyle, Maire E.
   Cui, Chang-Yi
   Delannoy, Michael
   Fan, Jinshui
   Slama, Eliza
   Egan, Josephine M.
   De, Supriyo
   Cunningham, Steven C.
   de Cabo, Rafael
   Sidoli, Simone
   Dalal, Yamini
   Sen, Payel
TI A hyper-quiescent chromatin state formed during aging is reversed by
   regeneration
SO MOLECULAR CELL
LA English
DT Article
ID DNA; AGE; REPLICATION; MECHANISMS; ALIGNMENT; CELLS; LIVER
AB Epigenetic alterations are a key hallmark of aging but have been limitedly explored in tissues. Here, using naturally aged murine liver as a model and extending to other quiescent tissues, we find that aging is driven by temporal chromatin alterations that promote a refractory cellular state and compromise cellular identity. Using an integrated multi-omics approach and the first direct visualization of aged chromatin, we find that globally, old cells show H3K27me3-driven broad heterochromatinization and transcriptional suppression. At the local level, site-specific loss of H3K27me3 over promoters of genes encoding developmental transcrip-tion factors leads to expression of otherwise non-hepatocyte markers. Interestingly, liver regeneration re-verses H3K27me3 patterns and rejuvenates multiple molecular and physiological aspects of the aged liver.
C1 [Yang, Na; Occean, James R.; Shi, Changyou; Wang, Lin; Cui, Chang-Yi; Sen, Payel] NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA.
   [Melters, Daniel P.; Dalal, Yamini] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 21224 USA.
   [Stransky, Stephanie] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.
   [Doyle, Maire E.; Egan, Josephine M.] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA.
   [Delannoy, Michael] Johns Hopkins Univ, JHU SOM Microscope Facil, Baltimore, MD 21205 USA.
   [Fan, Jinshui; De, Supriyo] NIA, Lab Genet & Genom, Computat Biol & Genom Core, NIH, Baltimore, MD 21224 USA.
   [Cunningham, Steven C.] Ascens St Agnes Hosp, Dept Surg, Baltimore, MD 21229 USA.
   [de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); National Institutes of Health (NIH) - USA; NIH National
   Cancer Institute (NCI); Yeshiva University; Albert Einstein College of
   Medicine; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); Johns Hopkins University; National Institutes
   of Health (NIH) - USA; NIH National Institute on Aging (NIA); National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)
RP Sen, P (corresponding author), NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA.
EM payel.sen@nih.gov
RI Cui, Chang-Yi/IXW-6646-2023; Stransky, Stephanie/JDD-2270-2023
OI Cui, Chang-Yi/0000-0002-9856-9427; Stransky,
   Stephanie/0000-0003-0844-2754; Occean, James/0000-0002-6823-6381
FU NIA IRP; Comparative Medicine Section at NIA; Taplin Biological Mass
   Spectrometry Facility and Spatial Tech-nologies Unit - NIH [ZIA
   BC011206]; NIH [S10 OD030286-01, P30 CA01333047, AG000679]; Leukemia
   Research Foundation; AFAR; Japan Agency for Medical Research and
   Development; Merck; Deerfield
FX We wish to acknowledge the NIA IRP for financial support. We thank
   Comparative Medicine Section at NIA for providing support with animal
   experiments. We thank Steven Henikoff and Kaifu Chen for discussions,
   Aubrey Mwinyogle and Artem Shmelev for human-liver biopsies, Elin
   Lehrmann GEO upload, and Myriam Gorospe and Shelley Berger for critical
   feedback. We thank the Taplin Biological Mass Spectrometry Facility and
   Spatial Technologies Unit for IP-MS and PhenoImager experiments,
   respectively. This work utilized the computational resources of the NIH
   HPC Biowulf cluster (http://hpc.nih.gov) . Some figures were made using
   BioRender and the model by Arne Fabritius and Radhika Patnala. The work
   was funded by NIH AG000679 to P.S., NIH ZIA BC011206 to Y.D., NIH S10
   OD030286-01, P30 CA01333047, Leukemia Research Foundation, AFAR, The
   Japan Agency for Medical Research and Development, Merck, and Deerfield
   to S. Stransky and S. Sidoli.
CR Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114
   Baumgart M, 2014, AGING CELL, V13, P965, DOI 10.1111/acel.12257
   Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   BUCHER NLR, 1964, CANCER RES, V24, P509
   BUCHER NLR, 1950, CANCER RES, V10, P324
   Cencioni C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101169
   Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112
   Chondronasiou D, 2022, AGING CELL, V21, DOI 10.1111/acel.13578
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Feng X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-139
   Fischer DS, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky675
   Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105
   Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313
   Henikoff S, 2020, ELIFE, V9, DOI 10.7554/eLife.63274
   Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108
   Horvath S, 2022, NATURE AGING, V2, P46, DOI 10.1038/s43587-021-00152-1
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jadhav U, 2020, MOL CELL, V78, P141, DOI 10.1016/j.molcel.2020.01.017
   Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4
   Kane AE, 2019, CRIT REV BIOCHEM MOL, V54, P61, DOI 10.1080/10409238.2019.1570075
   Kori Y, 2022, MOL OMICS, V18, P296, DOI 10.1039/d1mo00352f
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114
   Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lovén J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012
   Lund E, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku324
   Ma ZJ, 2018, ELIFE, V7, DOI [10.7554/elife.35368, 10.7554/eLife.35368]
   Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004
   Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002
   Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Mozhui K, 2022, ELIFE, V11, DOI 10.7554/eLife.75244
   Nabbi Arash, 2015, Cold Spring Harb Protoc, V2015, P773, DOI 10.1101/pdb.prot083741
   Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313
   Nativio R, 2020, NAT GENET, V52, P1024, DOI 10.1038/s41588-020-0696-0
   Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018
   Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584
   Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056
   Qin Q, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1934-6
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ramírez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365
   Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802
   Reverón-Gómez N, 2018, MOL CELL, V72, P239, DOI 10.1016/j.molcel.2018.08.010
   Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005
   Sarkar TJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15174-3
   Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168
   Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204
   Schwörer S, 2016, NATURE, V540, P428, DOI 10.1038/nature20603
   Sen P, 2019, MOL CELL, V73, P684, DOI 10.1016/j.molcel.2019.01.021
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598
   Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103
   Sidoli S, 2016, JOVE-J VIS EXP, DOI 10.3791/54112
   Sleiman MB, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108203
   Stark R, 2012, DIFFBIND DIFFERENTIA
   Stirling C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-122
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098
   Tvardovskiy A, 2017, NUCLEIC ACIDS RES, V45, P9272, DOI 10.1093/nar/gkx696
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022
   Walkiewicz MP, 2014, METHODS MOL BIOL, V1170, P589, DOI 10.1007/978-1-4939-0888-2_34
   Whitton H, 2018, AGING CELL, V17, DOI 10.1111/acel.12742
   Yang N, 2018, AGING-US, V10, P3590, DOI 10.18632/aging.101617
   Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145
   Yu JR, 2019, GENE DEV, V33, P903, DOI 10.1101/gad.325050.119
   Yuan M, 2006, BIOMETRICS, V62, P1089, DOI 10.1111/j.1541-0420.2006.00611.x
   Yuan ZF, 2018, J PROTEOME RES, V17, P2533, DOI 10.1021/acs.jproteome.8b00133
   Fiore APZP, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00059
   Zheng Y., 2020, CUT TAG DATA PROCESS, DOI [10.17504/protocols.io.bjk2kkye, DOI 10.17504/PROTOCOLS.IO.BJK2KKYE]
   Zhou WD, 2018, NAT GENET, V50, P591, DOI 10.1038/s41588-018-0073-4
NR 83
TC 1
Z9 1
U1 4
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD MAY 18
PY 2023
VL 83
IS 10
BP 1659
EP +
DI 10.1016/j.molcel.2023.04.005
EA MAY 2023
PG 30
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA I3FH4
UT WOS:001001666400001
PM 37116496
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Liu, LP
   Yannam, GR
   Nishikawa, T
   Yamamoto, T
   Basma, H
   Ito, R
   Nagaya, M
   Dutta-Moscato, J
   Stolz, DB
   Duan, FH
   Kaestner, KH
   Vodovotz, Y
   Soto-Gutierrez, A
   Fox, IJ
AF Liu, Liping
   Yannam, Govardhana Rao
   Nishikawa, Taichiro
   Yamamoto, Toshiyuki
   Basma, Hesham
   Ito, Ryotaro
   Nagaya, Masaki
   Dutta-Moscato, Joyeeta
   Stolz, Donna B.
   Duan, Fenghai
   Kaestner, Klaus H.
   Vodovotz, Yoram
   Soto-Gutierrez, Alejandro
   Fox, Ira J.
TI The microenvironment in hepatocyte regeneration and function in rats
   with advanced cirrhosis
SO HEPATOLOGY
LA English
DT Article
ID FACTOR-KAPPA-B; LIVER FIBROSIS; TRANSCRIPTIONAL NETWORKS;
   EXTRACELLULAR-MATRIX; CELLULAR SENESCENCE; TRANSPLANTATION; EXPRESSION;
   APOPTOSIS; NUCLEAR; PROLIFERATION
AB In advanced cirrhosis, impaired function is caused by intrinsic damage to the native liver cells and from the abnormal microenvironment in which the cells reside. The extent to which each plays a role in liver failure and regeneration is unknown. To examine this issue, hepatocytes from cirrhotic and age-matched control rats were isolated, characterized, and transplanted into the livers of noncirrhotic hosts whose livers permit extensive repopulation with donor cells. Primary hepatocytes derived from livers with advanced cirrhosis and compensated function maintained metabolic activity and the ability to secrete liver-specific proteins, whereas hepatocytes derived from cirrhotic livers with decompensated function failed to maintain metabolic or secretory activity. Telomere studies and transcriptomic analysis of hepatocytes recovered from progressively worsening cirrhotic livers suggest that hepatocytes from irreversibly failing livers show signs of replicative senescence and express genes that simultaneously drive both proliferation and apoptosis, with a later effect on metabolism, all under the control of a central cluster of regulatory genes, including nuclear factor ?B and hepatocyte nuclear factor 4a. Cells from cirrhotic and control livers engrafted equally well, but those from animals with cirrhosis and failing livers showed little initial evidence of proliferative capacity or function. Both, however, recovered more than 2 months after transplantation, indicating that either mature hepatocytes or a subpopulation of adult stem cells are capable of full recovery in severe cirrhosis. Conclusion: Transplantation studies indicate that the state of the host microenvironment is critical to the regenerative potential of hepatocytes, and that a change in the extracellular matrix can lead to regeneration and restoration of function by cells derived from livers with end-stage organ failure. (HEPATOLOGY 2011)
C1 [Nishikawa, Taichiro; Ito, Ryotaro; Nagaya, Masaki; Soto-Gutierrez, Alejandro; Fox, Ira J.] UPMC, Childrens Hosp Pittsburgh, Dept Surg, Pittsburgh, PA 15224 USA.
   [Liu, Liping; Yannam, Govardhana Rao; Yamamoto, Toshiyuki; Basma, Hesham] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA.
   [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA.
   [Dutta-Moscato, Joyeeta; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA.
   [Dutta-Moscato, Joyeeta; Vodovotz, Yoram] McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA USA.
   [Duan, Fenghai] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA.
   [Kaestner, Klaus H.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; University of Nebraska System; University of Nebraska
   Medical Center; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Brown University;
   University of Pennsylvania
RP Fox, IJ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Surg, 1 Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.
EM foxi@upmc.edu
RI Duan, Fenghai/J-3709-2014; liu, li/HGC-0900-2022
OI Duan, Fenghai/0000-0002-5084-0070; 
FU National Institutes of Health [DK48794, DK083556, DK072146-05]
FX Supported by National Institutes of Health Grants DK48794 (to I.J.F.),
   DK083556 (to A.S.-G.), and DK072146-05 (to Y.V.).
CR Batsi C, 2009, MECH AGEING DEV, V130, P409, DOI 10.1016/j.mad.2009.04.002
   Bu DX, ARTERIOSCLER THROMB, V30, P2604
   Bures J, 1976, TECHNIQUES BASIC EXP, P37
   DeLeve LD, 2007, SEMIN LIVER DIS, V27, P390, DOI 10.1055/s-2007-991515
   Dollé L, 2010, J HEPATOL, V52, P117, DOI 10.1016/j.jhep.2009.10.009
   Du XJ, 2009, ANN NY ACAD SCI, V1160, P278, DOI 10.1111/j.1749-6632.2008.03780.x
   Dudoit S, 2002, GENOME BIOL, V3
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Gkretsi V, 2008, HEPATOLOGY, V48, P1932, DOI 10.1002/hep.22537
   Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880
   Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.e04-05-0392
   Helenius M, 1999, EXP CELL RES, V248, P194, DOI 10.1006/excr.1999.4393
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Helenius M, 2001, ANTIOXID REDOX SIGN, V3, P147, DOI 10.1089/152308601750100669
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Issa R, 2002, FASEB J, V16, P47, DOI 10.1096/fj.02-0494fje
   JAGO MV, 1969, AM J PATHOL, V56, P405
   Kallis YN, 2011, GUT, V60, P525, DOI 10.1136/gut.2010.224436
   Kobayashi N, 2000, HEPATOLOGY, V31, P851, DOI 10.1053/he.2000.5636
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   LIN TY, 1979, ANN SURG, V190, P48, DOI 10.1097/00000658-197907000-00011
   Manduchi E, 2000, BIOINFORMATICS, V16, P685, DOI 10.1093/bioinformatics/16.8.685
   MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57
   MARTINEZHERNANDEZ A, 1991, HEPATOLOGY, V14, P864, DOI 10.1002/hep.1840140519
   MITO M, 1992, TRANSPLANT P, V24, P3052
   Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200
   PACK GT, 1962, SURGERY, V52, P617
   PESSAYRE D, 1978, GASTROENTEROLOGY, V74, P566
   PETERSON JE, 1965, J PATHOL BACTERIOL, V89, P153, DOI 10.1002/path.1700890117
   REICHEN J, 1987, HEPATOLOGY, V7, P67, DOI 10.1002/hep.1840070115
   Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9
   Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047
   Talamini MA, 1997, HEPATOLOGY, V25, P167, DOI 10.1053/jhep.1997.v25.pm0008985285
   Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421
   Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921
   VAUBOURDOLLE M, 1989, SCAND J GASTROENTERO, V24, P467, DOI 10.3109/00365528909093076
   Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053
   White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200
   Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x
NR 40
TC 53
Z9 57
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD MAY
PY 2012
VL 55
IS 5
BP 1529
EP 1539
DI 10.1002/hep.24815
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 929GN
UT WOS:000303049400023
PM 22109844
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Liao, JW
   Hong, LZ
   Wang, MF
   Tsai, SC
   Lin, YJ
   Chan, YC
AF Liao, J. -W.
   Hong, L. -Z.
   Wang, M. -F.
   Tsai, S. -C.
   Lin, Y. -J.
   Chan, Y. -C.
TI Mutagenic Safety and Fatty Liver Improvement of Nanonized Black Soybeans
   in Senescence-Accelerated Prone-8 Mice
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE fatty liver; nanonized black soybean; safety; senescence-accelerated
   mice
ID NANO-SE; SUBCHRONIC TOXICITY; ANTIOXIDANT; NANOPARTICLES; GENISTEIN;
   POWDER; GROWTH; GENOTOXICITY; ISOFLAVONES; REACTIVITY
AB Nanotechnology, as a new enabling technology, has the potential to revolutionize food systems. However, much attention has been focused on nanoparticle foods due to their potential physiological properties. This study was aimed to evaluate the mutagenic safety and fatty liver improvement of black soybean in senescence-accelerated mice (SAMP8). The mutagenic activity of black soybeans was investigated using the Ames test (Salmonella Typhimurium TA98, 100, 102, and 1535). Furthermore, senescence-accelerated prone-8 mice (SAMP8) have been reported to display spontaneous fatty liver. Male SAMP8 mice were divided into control and supplemented with 10% micronized or nanonized black soybeans diet and fed for 12 wk. The results revealed that the Ames test of micronized and nanonized black soybeans exhibited no mutagenicity. Administration of black soybeans to mice showed no effects on food intake and body and organ weights. The nanonized black soybean group had a lower degree of spontaneous fatty liver, alanine aminotransferase, and thiobarbituric acid-reactive substance concentrations, and had enhanced superoxide dismutase, catalase, and glutathione peroxidase activities of livers when compared with the SAMP8 control and micronized black soybean groups. The mice fed with black soybeans had significantly lower triglyceride concentrations than the SAMP8 control group. The results of this study suggest that nanonized black soybeans have no side effects and, moreover, may minimize liver lesions in SAMP8 mice.
C1 [Wang, M. -F.; Tsai, S. -C.; Lin, Y. -J.; Chan, Y. -C.] Providence Univ, Dept Food & Nutr, Shalu, Taiwan.
   [Hong, L. -Z.] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan.
   [Liao, J. -W.] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan.
C3 Providence University - Taiwan; Taichung Veterans General Hospital;
   National Chung Hsing University
RP Chan, YC (corresponding author), Providence Univ, Dept Food & Nutr, Shalu, Taiwan.
EM ycchan@pu.edu.tw
RI Liao, Jun/JUF-2784-2023
OI Liao, Jiunn-Wang/0000-0001-7374-1203; Chan, Yin
   Ching/0000-0001-9602-0775
FU Natl. Science Council, Taiwan [NSC-94-2622-B-126-001-CC3]; Taichung
   Veterans General Hospital; Providence Univ., Taichung, Taiwan, Republic
   of China [TCVGH-PU978104]
FX This study was supported by grants from the Natl. Science Council,
   Taiwan (NSC-94-2622-B-126-001-CC3), and the Taichung Veterans General
   Hospital and Providence Univ. (TCVGH-PU978104), Taichung, Taiwan,
   Republic of China. We sincerely thank Professor Yun-Ching Chung for
   technical assistance and Taimao Co., Ltd., Taichung, Taiwan, for
   supplying the black soybean samples.
CR Aebi H., 1983, METHODS ENZYM, P673
   Appelt LC, 1999, J NUTR, V129, P1820, DOI 10.1093/jn/129.10.1820
   Asli S, 2009, PLANT CELL ENVIRON, V32, P577, DOI 10.1111/j.1365-3040.2009.01952.x
   Bouwmeester H, 2009, REGUL TOXICOL PHARM, V53, P52, DOI 10.1016/j.yrtph.2008.10.008
   Chan YC, 2009, INT J NANOMED, V4, P27
   Chen Z, 2006, TOXICOL LETT, V163, P109, DOI 10.1016/j.toxlet.2005.10.003
   Delmonte P, 2006, J AOAC INT, V89, P1138
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Gilat T, 2003, HEPATOLOGY, V38, P436, DOI 10.1053/jhep.2003.50348
   Huang B, 2003, FREE RADICAL BIO MED, V35, P805, DOI 10.1016/S0891-5849(03)00428-3
   Jia X, 2005, LIFE SCI, V76, P1989, DOI 10.1016/j.lfs.2004.09.026
   Kabanov AV, 2006, ADV DRUG DELIVER REV, V58, P1597, DOI 10.1016/j.addr.2006.09.019
   Kádár E, 2010, ANAL BIOANAL CHEM, V396, P657, DOI 10.1007/s00216-009-3191-0
   Kawanishi S, 2005, ANTIOXID REDOX SIGN, V7, P1728, DOI 10.1089/ars.2005.7.1728
   Kim HC, 2002, BEHAV BRAIN RES, V131, P211, DOI 10.1016/S0166-4328(01)00382-5
   Kim JS, 2006, TOXICOL SCI, V89, P338, DOI 10.1093/toxsci/kfj027
   Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017
   Kirsch-Volders M, 2003, MUTAT RES-GEN TOX EN, V540, P153, DOI 10.1016/j.mrgentox.2003.07.005
   Krishna G, 2000, MUTAT RES-FUND MOL M, V453, P45, DOI 10.1016/S0027-5107(00)00074-9
   Lee CL, 2006, APPL MICROBIOL BIOT, V70, P533, DOI 10.1007/s00253-005-0137-0
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   Liu JR, 2006, BRIT J NUTR, V95, P939, DOI 10.1079/BJN20061752
   Marini H, 2008, J CLIN ENDOCR METAB, V93, P4787, DOI 10.1210/jc.2008-1087
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   McClain RM, 2006, FOOD CHEM TOXICOL, V44, P56, DOI 10.1016/j.fct.2005.05.021
   Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6
   Norppa H, 2006, MUTAT RES-FUND MOL M, V600, P37, DOI 10.1016/j.mrfmmm.2006.05.030
   Nzeako UC, 1996, AM J CLIN PATHOL, V105, P65
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Pereira IRO, 2006, MENOPAUSE, V13, P942, DOI 10.1097/01.gme.0000248703.22581.8a
   Pessayre D, 2004, EUR J GASTROEN HEPAT, V16, P1095, DOI 10.1097/00042737-200411000-00003
   Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005
   Siefker K, 2006, J MED FOOD, V9, P368, DOI 10.1089/jmf.2006.9.368
   Song LH, 2006, J RADIAT RES, V47, P157, DOI 10.1269/jrr.47.157
   Takahashi R, 2005, J AGR FOOD CHEM, V53, P4578, DOI 10.1021/jf048062m
   Takahata Y, 2001, J AGR FOOD CHEM, V49, P5843, DOI 10.1021/jf010307x
   Tonetti DA, 2007, NUTR CANCER, V58, P222, DOI 10.1080/01635580701328545
   Wang B, 2006, TOXICOL LETT, V161, P115, DOI 10.1016/j.toxlet.2005.08.007
   Wang B, 2008, J NANOPART RES, V10, P263, DOI 10.1007/s11051-007-9245-3
   Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001
   Wang YB, 2009, BIOL TRACE ELEM RES, V128, P184, DOI 10.1007/s12011-008-8264-y
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   WEI HC, 1995, P SOC EXP BIOL MED, V208, P124
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Yee S, 2008, FOOD CHEM TOXICOL, V46, P2713, DOI 10.1016/j.fct.2008.04.026
   Zhang ES, 2005, LIFE SCI, V76, P1099, DOI 10.1016/j.lfs.2004.08.015
   Zhang JS, 2001, BIOFACTORS, V15, P27, DOI 10.1002/biof.5520150103
NR 48
TC 4
Z9 4
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD JUN-JUL
PY 2010
VL 75
IS 5
BP T82
EP T90
DI 10.1111/j.1750-3841.2010.01638.x
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 623KX
UT WOS:000279739700040
PM 20629898
DA 2024-02-19
ER

PT J
AU Yokozawa, T
   Kim, HY
   Kim, HJ
   Okubo, T
   Chu, DC
   Juneja, LR
AF Yokozawa, Takako
   Kim, Hyun Young
   Kim, Hyun Ju
   Okubo, Tsutomu
   Chu, Djoing-Chi
   Juneja, Lekh Raj
TI Amla (<i>Emblica officinalis</i> Gaertn.) prevents dyslipidaemia and
   oxidative stress in the ageing process
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Amla; ageing; dyslipidaemia; oxidative stress
ID NF-KAPPA-B; PROLIFERATOR-ACTIVATED RECEPTORS; AGE-RELATED-CHANGES;
   FREE-RADICAL THEORY; RAT-KIDNEY; PPAR-ALPHA; TRANSCRIPTIONAL ACTIVITIES;
   ANTIOXIDANT ACTIVITY; PHYLLANTHUS-EMBLICA; MANGIFERA-INDICA
AB Amla (Emblica officinalis Gaertn.) is widely used in Indian medicine for the treatment of various diseases. We have investigated the effects of amla on the lipid metabolism and protein expression involved in oxidative stress during the ageing process. SunAmla or ethyl acetate extract of amla, a polyphenol-rich fraction, was administered at a dose of 40 or 10mg/kg body weight per d for 100d to young rats aged 2 months and aged rats aged 10 months. The lipid levels, such as cholesterol and TAG, in serum and liver were markedly elevated in aged control rats, while they were significantly decreased by the administration of amla. The PPAR alpha is known to regulate the transcription of genes involved in lipid and cholesterol metabolism. The PPAR alpha protein level in liver was reduced in aged control rats. However, the oral administration of amla significantly increased the hepatic PPAR alpha protein level. In addition, oral administration of amla significantly inhibited the serum and hepatic mitochondrial thiobarbituric acid-reactive substance levels in aged rats. Moreover, the elevated expression level of bax was significantly decreased after the oral administration of amla, while the level of bcl-2 led to a significant increase. Furthermore, the expressions of hepatic NF-kappa B, inducible NO synthase (iNOS), and cyclo-oxygenase-2 (COX-2) protein levels were also increased with ageing. However, amla extract reduced the iNOS and COX-2 expression levels by inhibiting NF-kappa B activation in aged rats. These results indicate that amla may prevent age-related hyperlipidaemia through attenuating oxidative stress in the ageing process.
C1 Toyama Univ, Inst Nat Med, Toyama 9300194, Japan.
   Taiyo Kagaku Co Ltd, Bionutr Div, Yokaichi 5100844, Japan.
C3 University of Toyama; TAIYO KAGAKU CO., LTD.
RP Yokozawa, T (corresponding author), Toyama Univ, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.
EM yokozawa@inm.u-toyama.ac.jp
RI Kim, Mi Jin/GXH-9639-2022
CR Anila L, 2003, FOOD CHEM, V83, P569, DOI 10.1016/S0308-8146(03)00155-9
   Anila L, 2002, J ETHNOPHARMACOL, V79, P81, DOI 10.1016/S0378-8741(01)00361-0
   ASMAWI MZ, 1993, J PHARM PHARMACOL, V45, P581, DOI 10.1111/j.2042-7158.1993.tb05605.x
   Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891
   Bandyopadhyay SK, 2000, J ETHNOPHARMACOL, V70, P171, DOI 10.1016/S0378-8741(99)00146-4
   Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003
   Bhattacharya Arunabh, 1999, Indian Journal of Experimental Biology, V37, P676
   Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0
   Buege J A, 1978, Methods Enzymol, V52, P302
   Chan SL, 2004, CLIN EXP PHARMACOL P, V31, P119, DOI 10.1111/j.1440-1681.2004.03975.x
   Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479
   de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405
   Deokar A.B., 1998, MED PLANTS GROWN RAJ, P48
   ELMEKKAWY S, 1995, CHEM PHARM BULL, V43, P641, DOI 10.1248/cpb.43.641
   Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Ghosal S, 1996, INDIAN J CHEM B, V35, P941
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   Inoue I, 1997, BIOCHEM BIOPH RES CO, V237, P606, DOI 10.1006/bbrc.1997.7196
   Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   Johnson D., 1967, Methods Enzymol, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9
   Jose JK, 2001, J ETHNOPHARMACOL, V75, P65, DOI 10.1016/S0378-8741(00)00378-0
   Jose JK, 1995, J CLIN BIOCHEM NUTR, V19, P63, DOI 10.3164/jcbn.19.63
   JUNG K, 1985, FEBS LETT, V183, P167, DOI 10.1016/0014-5793(85)80977-7
   Kim CH, 2004, EXP GERONTOL, V39, P1155, DOI 10.1016/j.exger.2004.04.003
   Kim HJ, 2005, J NUTR SCI VITAMINOL, V51, P413, DOI 10.3177/jnsv.51.413
   Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   LACKO AG, 1979, J AM GERIATR SOC, V5, P212
   Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Lin MT, 2003, CLIN NEUROSCI RES, V2, P305, DOI 10.1016/S1566-2772(03)00007-0
   NAITO C, 1978, JPN J GERIATR, V15, P187
   Pahan K, 2002, J BIOL CHEM, V277, P45984, DOI 10.1074/jbc.M200250200
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Perry LM, 1980, MED PLANTS E S E ASI
   PETERS JM, 1997, J BIOL CHEM, V272, P28307
   Poon HF, 2004, CLIN GERIATR MED, V20, P329, DOI 10.1016/j.cger.2004.02.005
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Ricote M, 2001, TRENDS PHARMACOL SCI, V22, P441, DOI 10.1016/S0165-6147(00)01802-2
   Sabu MC, 2002, J ETHNOPHARMACOL, V81, P155, DOI 10.1016/S0378-8741(02)00034-X
   Sakurai H, 1996, BBA-MOL BASIS DIS, V1316, P132, DOI 10.1016/0925-4439(96)00022-1
   Samhan-Arias AK, 2004, FREE RADICAL BIO MED, V37, P48, DOI 10.1016/j.freeradbiomed.2004.04.002
   Sanguino E, 2005, BRIT J PHARMACOL, V145, P853, DOI 10.1038/sj.bjp.0706260
   Sanguino E, 2004, BIOCHEM PHARMACOL, V68, P1411, DOI 10.1016/j.bcp.2004.06.008
   Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034
   Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581
   THAKUR CP, 1985, EXPERIENTIA, V41, P423, DOI 10.1007/BF02004540
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9
   Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001
   Yoon SO, 2002, MECH AGEING DEV, V123, P1597, DOI 10.1016/S0047-6374(02)00095-7
   Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023
   Yu BP, 2001, DIABETES RES CLIN PR, V54, pS73, DOI 10.1016/S0168-8227(01)00338-2
   Zhang YJ, 2001, CHEM PHARM BULL, V49, P537, DOI 10.1248/cpb.49.537
NR 60
TC 67
Z9 85
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JUN
PY 2007
VL 97
IS 6
BP 1187
EP 1195
DI 10.1017/S0007114507691971
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 182VA
UT WOS:000247530900022
PM 17506915
OA Bronze
DA 2024-02-19
ER

PT J
AU Schreiter, T
   Gieseler, RK
   Vílchez-Vargas, R
   Jauregui, R
   Sowa, JP
   Klein-Scory, S
   Broering, R
   Croner, RS
   Treckmann, JW
   Link, A
   Canbay, A
AF Schreiter, Thomas
   Gieseler, Robert K.
   Vilchez-Vargas, Ramiro
   Jauregui, Ruy
   Sowa, Jan-Peter
   Klein-Scory, Susanne
   Broering, Ruth
   Croner, Roland S.
   Treckmann, Juergen W.
   Link, Alexander
   Canbay, Ali
TI Transcriptome-Wide Analysis of Human Liver Reveals Age-Related
   Differences in the Expression of Select Functional Gene Clusters and
   Evidence for a PPP1R10-Governed 'Aging Cascade'
SO PHARMACEUTICS
LA English
DT Article
DE aging; EFS; hepatocellular carcinoma; inflammaging; liver regeneration;
   liver transcriptome; non-alcoholic fatty liver disease; non-alcoholic
   steatohepatitis; pharmacogenes; regulome
ID NUCLEAR TARGETING SUBUNIT; PROTEIN PHOSPHATASE 1; NONALCOHOLIC
   STEATOHEPATITIS; ABC TRANSPORTER; CELL-CYCLE; REGULATOR; DISEASE;
   INJURY; P53; DEFECTS
AB A transcriptome-wide analysis of human liver for demonstrating differences between young and old humans has not yet been performed. However, identifying major age-related alterations in hepatic gene expression may pinpoint ontogenetic shifts with important hepatic and systemic consequences, provide novel pharmacogenetic information, offer clues to efficiently counteract symptoms of old age, and improve the overarching understanding of individual decline. Next-generation sequencing (NGS) data analyzed by the Mann-Whitney nonparametric test and Ensemble Feature Selection (EFS) bioinformatics identified 44 transcripts among 60,617 total and 19,986 protein-encoding transcripts that significantly (p = 0.0003 to 0.0464) and strikingly (EFS score > 0.3:16 transcripts; EFS score > 0.2:28 transcripts) differ between young and old livers. Most of these age-related transcripts were assigned to the categories 'regulome', 'inflammaging', 'regeneration', and 'pharmacogenes'. NGS results were confirmed by quantitative real-time polymerase chain reaction. Our results have important implications for the areas of ontogeny/aging and the age-dependent increase in major liver diseases. Finally, we present a broadly substantiated and testable hypothesis on a genetically governed 'aging cascade', wherein PPP1R10 acts as a putative ontogenetic master regulator, prominently flanked by IGFALS and DUSP1. This transcriptome-wide analysis of human liver offers potential clues towards developing safer and improved therapeutic interventions against major liver diseases and increased insights into key mechanisms underlying aging.
C1 [Schreiter, Thomas; Gieseler, Robert K.; Sowa, Jan-Peter; Klein-Scory, Susanne; Canbay, Ali] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Dept Med, D-44892 Bochum, Germany.
   [Schreiter, Thomas; Gieseler, Robert K.; Sowa, Jan-Peter; Klein-Scory, Susanne] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Lab Immunol & Mol Biol, D-44892 Bochum, Germany.
   [Vilchez-Vargas, Ramiro; Link, Alexander] Otto Von Guericke Univ, Med Fac, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany.
   [Jauregui, Ruy] AgResearch, Grasslands Res Ctr, Data Sci Grasslands, Palmerston North 4410, New Zealand.
   [Broering, Ruth] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45147 Essen, Germany.
   [Croner, Roland S.] Otto Von Guericke Univ, Med Fac, Dept Gen Visceral Vasc & Transplantat Surg, D-39120 Magdeburg, Germany.
   [Treckmann, Juergen W.] Univ Duisburg Essen, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, D-45147 Essen, Germany.
   [Canbay, Ali] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Sect Hepatol & Gastroenterol, D-44892 Bochum, Germany.
C3 Ruhr University Bochum; Ruhr University Bochum; Otto von Guericke
   University; AgResearch - New Zealand; University of Duisburg Essen; Otto
   von Guericke University; University of Duisburg Essen; Ruhr University
   Bochum
RP Canbay, A (corresponding author), Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Dept Med, D-44892 Bochum, Germany.; Canbay, A (corresponding author), Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Sect Hepatol & Gastroenterol, D-44892 Bochum, Germany.
EM thomas.schreiter@ruhr-uni-bochum.de; rk.gieseler@gmx.de;
   ramiro.vilchez@med.ovgu.de; Ruy.Jauregui@agresearch.co.nz;
   jan.sowa@ruhr-uni-bochum.de; susanne.klein-scory@ruhr-uni-bochum.de;
   Ruth.Broering@uk-essen.de; roland.croner@med.ovgu.de;
   juergen-walter.treckmann@uk-essen.de; Alexander.Link@med.ovgu.de;
   ali.canbay@rub.de
RI Link, Alexander/AFK-7535-2022; Klein-Scory, Susanne/JMB-0127-2023;
   Broering, Ruth/W-9401-2019
OI Link, Alexander/0000-0002-9514-4562; Klein-Scory,
   Susanne/0000-0003-1930-3354; Broering, Ruth/0000-0002-7125-3246;
   Jauregui, Ruy/0000-0002-3484-8937; Canbay, Ali/0000-0001-6069-7899;
   Sowa, Jan-Peter/0000-0003-2943-0015; Vilchez-Vargas,
   Ramiro/0000-0001-6535-8212; Gieseler, Robert/0000-0002-3064-8516
FU German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)
   [250798584, CA267/13-3, CA267/14-1]; Dr. Heinz-Horst Deichmann
   Foundation; Wilhelm Laupitz Foundation; European Commission; European
   Funds for Regional Development (EFRE); Ministry of Economy, Science and
   Digitalization (Ministerium fur Wirtschaft, Wissenschaft und
   Digitalisierung) of the German State of Saxony-Anhalt, 'Autonomy in Old
   Age' (AiA) research group [ZS/2018/11/95324]; German Federal Ministry of
   Education and Research (Bundesministerium fur Bildung und Forschung,
   BMBF) within the 'Medical Informatics Funding Scheme' [FKZ 01ZZ1801H]
FX This research was funded by the German Research Foundation (Deutsche
   Forschungsgemeinschaft, DFG), project number 250798584 (CA267/13-3 and
   CA267/14-1) to A.C. and T.S.; the Dr. Heinz-Horst Deichmann Foundation
   to A.C.; the Wilhelm Laupitz Foundation to A.C.; the European
   Commission, European Funds for Regional Development (EFRE) to A.L. and
   R.V.V.; the Ministry of Economy, Science and Digitalization (Ministerium
   fur Wirtschaft, Wissenschaft und Digitalisierung) of the German State of
   Saxony-Anhalt as part of the `Autonomy in Old Age' (AiA) research group
   for the `LiLife' Project (ZS/2018/11/95324) to A.L. and R.V.V.; and by
   the German Federal Ministry of Education and Research (Bundesministerium
   fur Bildung und Forschung, BMBF) within the `Medical Informatics Funding
   Scheme' (FKZ 01ZZ1801H) to MIRACUM.
CR Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018
   Adnan N, 2020, BMC MED GENOMICS, V13, DOI 10.1186/s12920-020-0676-3
   Bahrami AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108505
   Bandyopadhyay Sabyasachi, 2020, Crit Care Explor, V2, pe0195, DOI 10.1097/CCE.0000000000000195
   Barth E, 2019, AGING-US, V11, P8556, DOI 10.18632/aging.102345
   Bloomer SA, 2020, HISTOCHEM CELL BIOL, V153, P37, DOI 10.1007/s00418-019-01827-y
   Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919
   Calment, 1998, JEANNE CALMENT GOGHS
   Canbay A, 2020, ALIMENT PHARM THER, V52, P1185, DOI 10.1111/apt.16016
   Caspari R, 2004, P NATL ACAD SCI USA, V101, P10895, DOI 10.1073/pnas.0402857101
   Choy MS, 2014, P NATL ACAD SCI USA, V111, P4097, DOI 10.1073/pnas.1317395111
   Cortazar MA, 2019, MOL CELL, V76, P896, DOI 10.1016/j.molcel.2019.09.031
   Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R
   Deng W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030256
   Denkinger CM, 2013, ARCH GERONTOL GERIAT, V56, P227, DOI 10.1016/j.archger.2012.05.006
   Tran DDH, 2016, CELL SIGNAL, V28, P438, DOI 10.1016/j.cellsig.2016.02.007
   Dobiezynska A, 2020, BIOCHEM BIOPH RES CO, V533, P391, DOI 10.1016/j.bbrc.2020.09.006
   Domené HM, 2009, HORM RES, V72, P129, DOI 10.1159/000232486
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739
   Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136
   Fisher LA, 2014, J BIOL CHEM, V289, P23745, DOI 10.1074/jbc.M114.572149
   Fortelny N, 2017, NATURE, V547, pE19, DOI 10.1038/nature22293
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Gehrke N, 2018, AM J PHYSIOL-GASTR L, V314, pG319, DOI 10.1152/ajpgi.00097.2017
   Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607
   Goronzy JJ, 2017, IMMUNITY, V46, P364, DOI 10.1016/j.immuni.2017.03.010
   Gottlieb A, 2019, DIGESTION, V100, P79, DOI 10.1159/000493259
   Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x
   Hanigan MH, 2015, HISTOCHEM CELL BIOL, V143, P505, DOI 10.1007/s00418-014-1295-x
   Hardeland R, 2012, AGING DIS, V3, P194
   Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x
   Hoppstädter J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01446
   Huang C, 2018, J PROTEOME RES, V17, P1485, DOI 10.1021/acs.jproteome.7b00828
   Huse SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2066-3
   Lucena MI, 2020, LANCET GASTROENTEROL, V5, P862, DOI 10.1016/S2468-1253(20)30006-6
   Jiang GX, 2010, MOL BIOL REP, V37, P3813, DOI 10.1007/s11033-010-0036-z
   Kim C, 2019, CELL REP, V29, P2202, DOI 10.1016/j.celrep.2019.10.044
   Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575
   Kim YM, 2003, J BIOL CHEM, V278, P13819, DOI 10.1074/jbc.M209621200
   Kondro W, 2004, SCIENCE, V304, P942
   Korhonen R, 2014, BASIC CLIN PHARMACOL, V114, P24, DOI 10.1111/bcpt.12141
   Landsverk HB, 2005, BIOCHEM J, V390, P709, DOI 10.1042/BJ20050678
   Landsverk HB, 2010, EMBO REP, V11, P868, DOI 10.1038/embor.2010.134
   Lee SJ, 2007, CELL DEATH DIFFER, V14, P1106, DOI 10.1038/sj.cdd.4402111
   Li Guilin, 2015, Yichuan, V37, P1185, DOI 10.16288/j.yczz.15-192
   Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200
   Liu XD, 2019, ADV EXP MED BIOL, V1141, P13, DOI 10.1007/978-981-13-7647-4_2
   Liu YX, 2008, MOL CANCER RES, V6, P624, DOI 10.1158/1541-7786.MCR-07-2019
   Marcos-Pérez D, 2020, GEROSCIENCE, V42, P1451, DOI 10.1007/s11357-020-00247-4
   Medawar P., 1952, UNSOLVED PROBLEM BIO
   Meier R, 2018, PHARMACOGENET GENOM, V28, P86, DOI 10.1097/FPC.0000000000000326
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3
   Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413
   Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618
   Moody L, 2020, BMC MED GENOMICS, V13, DOI 10.1186/s12920-020-00778-x
   Neumann U, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0142-8
   Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
   Nozaki I, 2004, AM J PATHOL, V165, P1907, DOI 10.1016/S0002-9440(10)63243-9
   Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100
   Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263
   Piao XH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003558
   Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048
   Piehler A, 2002, BIOCHEM BIOPH RES CO, V295, P408, DOI 10.1016/S0006-291X(02)00659-9
   Pingale KD, 2019, J GEN VIROL, V100, P471, DOI 10.1099/jgv.0.001229
   Poudel SB, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061384
   Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646
   Remeseiro B, 2019, COMPUT BIOL MED, V112, DOI 10.1016/j.compbiomed.2019.103375
   Rio DC., 2010, COLD SPRING HARBOR P, V6
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sandri M, 2008, J COMPUT GRAPH STAT, V17, P611, DOI 10.1198/106186008X344522
   Sandve GK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-353
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Sayed N, 2021, NATURE AGING, V1, P598, DOI 10.1038/s43587-021-00082-y
   Schattenberg JM, 2011, J HEPATOL, V55, P1272, DOI 10.1016/j.jhep.2011.03.008
   Seki N, 1998, J HUM GENET, V43, P202, DOI 10.1007/s100380050071
   Seselja K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184389
   Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721
   Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025
   Teumer A, 2016, AGING CELL, V15, P811, DOI 10.1111/acel.12490
   Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9
   Turan ZG, 2019, AGING CELL, V18, DOI 10.1111/acel.12965
   Turner KJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010073
   Walenkamp MJE, 2013, ENDOCR DEV, V24, P128, DOI 10.1159/000342841
   Wang FF, 2019, MOL CANCER RES, V17, P10, DOI 10.1158/1541-7786.MCR-17-0670
   Wang JY, 2021, HEPATOLOGY, V73, P104, DOI 10.1002/hep.31242
   Wang PX, 2017, NAT MED, V23, P439, DOI 10.1038/nm.4290
   Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96
   White CR, 2019, IMMUNOBIOLOGY, V224, P80, DOI 10.1016/j.imbio.2018.10.005
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Wilhelm M, 2017, NATURE, V547, pE23, DOI 10.1038/nature22294
   Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319
   Winkler M, 2021, J HEPATOL, V74, DOI 10.1016/j.jhep.2020.08.033
   Wit JM, 2016, GROWTH HORM IGF RES, V28, P57, DOI 10.1016/j.ghir.2015.11.005
   Wit JM, 2012, ENDOCR DEV, V23, P30, DOI 10.1159/000341739
   Yamaguchi Y, 2006, BBA-MOL CELL RES, V1763, P844, DOI 10.1016/j.bbamcr.2006.03.012
   Zaidman D, 2017, METHODS MOL BIOL, V1561, P279, DOI 10.1007/978-1-4939-6798-8_16
   Zhao SR, 2020, RNA, V26, P903, DOI 10.1261/rna.074922.120
   Zhu SL, 2017, NUCLEIC ACIDS RES, V45, P10583, DOI 10.1093/nar/gkx686
   Zuo LJ, 2014, AM J ADDICTION, V23, P526, DOI 10.1111/j.1521-0391.2014.12147.x
   Zuo LJ, 2012, NEUROPSYCHOPHARMACOL, V37, P557, DOI 10.1038/npp.2011.229
NR 104
TC 6
Z9 6
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4923
J9 PHARMACEUTICS
JI Pharmaceutics
PD DEC
PY 2021
VL 13
IS 12
AR 2009
DI 10.3390/pharmaceutics13122009
PG 22
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA XY1LU
UT WOS:000736743800001
PM 34959291
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Dou, FF
   Wu, BL
   Chen, JL
   Liu, T
   Yu, ZH
   Chen, C
AF Dou, Fangfang
   Wu, Beiling
   Chen, Jiulin
   Liu, Te
   Yu, Zhihua
   Chen, Chuan
TI PPARα Targeting GDF11 Inhibits Vascular Endothelial Cell Senescence in
   an Atherosclerosis Model
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID DIFFERENTIATION FACTOR 11; ACTIVATED RECEPTOR-ALPHA; INFLAMMATION;
   DYSFUNCTION; CHOLESTEROL; METABOLISM; MECHANISMS; PROTECTS; GROWTH;
   HEART
AB Atherosclerosis (AS) is a complex vascular disease that seriously harms the health of the elderly. It is closely related to endothelial cell aging, but the role of senescent cells in atherogenesis remains unclear. Studies have shown that peroxisome proliferator-activated receptor alpha (PPAR alpha) inhibits the development of AS by regulating lipid metabolism. Our previous research showed that PPAR alpha was involved in regulating the repair of damaged vascular endothelial cells. Using molecular biology and cell biology approaches to detect senescent cells in atherosclerosis-prone apolipoprotein E-deficient (Apoe(-/-)) mice, we found that PPARa delayed atherosclerotic plaque formation by inhibiting vascular endothelial cell senescence, which was achieved by regulating the expression of growth differentiation factor 11 (GDF11). GDF11 levels declined with age in several organs including the myocardium, bone, central nervous system, liver, and spleen in mice and participated in the regulation of aging. Our results showed that PPAR alpha inhibited vascular endothelial cell senescence and apoptosis and promoted vascular endothelial cell proliferation and angiogenesis by increasing GDF11 production. Taken together, these results demonstrated that PPARa inhibited vascular endothelial cell aging by promoting the expression of the aging-related protein GDF11, thereby delaying the occurrence of AS.
C1 [Dou, Fangfang; Wu, Beiling; Chen, Jiulin; Liu, Te; Yu, Zhihua; Chen, Chuan] Shanghai Univ Tradit Chinese Med, Shanghai Geriatr Inst Chinese Med, Shanghai 200031, Peoples R China.
C3 Shanghai University of Traditional Chinese Medicine
RP Yu, ZH; Chen, C (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Geriatr Inst Chinese Med, Shanghai 200031, Peoples R China.
EM ff_dou@163.com; beilingwu@126.com; chen_90@foxmail.com;
   liute1979@126.com; yzh1109@hotmail.com; chen9453@126.com
OI yu, zhi hua/0000-0001-5326-5545
FU Natural Science Foundation of China [81704129]; Shanghai Municipal
   Health Bureau Youth Fund [ZY (2018-2020)-CCCX-4004]
FX The present study was supported by grants from the Natural Science
   Foundation of China (program no. 81704129) and from the Shanghai
   Municipal Health Bureau Youth Fund (ZY (2018-2020)-CCCX-4004).
CR Bougarne N, 2018, ENDOCR REV, V39, P760, DOI 10.1210/er.2018-00064
   Choi BJ, 2013, EUR HEART J, V34, P2047, DOI 10.1093/eurheartj/eht132
   Dong YZ, 2017, DIABETES VASC DIS RE, V14, P14, DOI 10.1177/1479164116666762
   Dou FF, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190141
   Du GQ, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-016-0593-y
   Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b
   Erusalimsky JD, 2009, EXP PHYSIOL, V94, P299, DOI 10.1113/expphysiol.2008.043133
   Fan W, 2015, GENET TEST MOL BIOMA, V19, P379, DOI 10.1089/gtmb.2015.0002
   Gendron SP, 2016, INVEST OPHTH VIS SCI, V57, P5926, DOI 10.1167/iovs.16-20551
   Gervois P, 2012, EXPERT OPIN THER TAR, V16, P1113, DOI 10.1517/14728222.2012.715633
   Han L, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2016-0059
   Hayashi T, 2008, PHARMACOL THERAPEUT, V120, P333, DOI 10.1016/j.pharmthera.2008.09.002
   Hennuyer N, 2016, ATHEROSCLEROSIS, V249, P200, DOI 10.1016/j.atherosclerosis.2016.03.003
   Israelian-Konaraki Z, 2005, CARDIOLOGY, V103, P1, DOI 10.1159/000081845
   Jakob T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009753.pub2
   Jeon Y, 2014, BIOCHEM BIOPH RES CO, V450, P1553, DOI 10.1016/j.bbrc.2014.07.026
   Koopman JJE, 2017, LANCET, V389, P1676, DOI 10.1016/S0140-6736(17)30763-8
   Lalloyer F, 2011, ARTERIOSCL THROM VAS, V31, P1573, DOI 10.1161/ATVBAHA.110.220525
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Lubrano V, 2014, FREE RADICAL RES, V48, P841, DOI 10.3109/10715762.2014.929122
   Mei W, 2016, MOL THER, V24, P1926, DOI 10.1038/mt.2016.160
   Modrick ML, 2012, AM J PHYSIOL-REG I, V302, pR1184, DOI 10.1152/ajpregu.00557.2011
   Papaconstantinou J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111383
   Qi K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198403
   Rochette L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123998
   Rochette L, 2015, PHARMACOL THERAPEUT, V156, P26, DOI 10.1016/j.pharmthera.2015.10.006
   Sairyo M, 2018, J ATHEROSCLER THROMB, V25, P142, DOI 10.5551/jat.39693
   Schafer MJ, 2016, CELL METAB, V23, P1207, DOI 10.1016/j.cmet.2016.05.023
   Su HH, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0728-z
   Tesauro M, 2017, J INTERN MED, V281, P471, DOI 10.1111/joim.12605
   Thijssen DHJ, 2016, J PHYSIOL-LONDON, V594, P2275, DOI 10.1113/JP270597
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a
   Young EWK, 2010, LAB CHIP, V10, P143, DOI 10.1039/b913390a
   Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9
NR 35
TC 14
Z9 14
U1 0
U2 14
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD FEB 26
PY 2021
VL 2021
AR 2045259
DI 10.1155/2021/2045259
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA QU5SX
UT WOS:000627342500002
PM 33728018
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU KATZ, MS
   MCNAIR, CL
   HYMER, TK
   BOLAND, SR
AF KATZ, MS
   MCNAIR, CL
   HYMER, TK
   BOLAND, SR
TI EMERGENCE OF BETA ADRENERGIC-RESPONSIVE HEPATIC GLYCOGENOLYSIS IN
   MALE-RATS DURING POST-MATURATIONAL AGING
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
C1 AUDIE L MURPHY MEM VET HOSP,SAN ANTONIO,TX 78284.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital
RP KATZ, MS (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284, USA.
FU NIA NIH HHS [R01AGO3163] Funding Source: Medline
CR Bergmeyer H. U., 1974, METHOD ENZYMAT AN, P1205
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BLAIR JB, 1979, J BIOL CHEM, V254, P7579
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   FOSTER JL, 1978, ARCH BIOCHEM BIOPHYS, V189, P263, DOI 10.1016/0003-9861(78)90212-6
   HUTSON NJ, 1976, J BIOL CHEM, V251, P5200
   KALISH MI, 1977, BIOCHIM BIOPHYS ACTA, V483, P452, DOI 10.1016/0005-2744(77)90073-0
   KATZ J, 1976, P NATL ACAD SCI USA, V73, P3433, DOI 10.1073/pnas.73.10.3433
   KATZ MS, 1985, AM J PHYSIOL, V248, pE712, DOI 10.1152/ajpendo.1985.248.6.E712
   KATZ MS, 1983, 65TH ANN M END SOC S, P250
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORGAN NG, 1983, J BIOL CHEM, V258, P5103
   SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X
   SEAMON K, 1981, J BIOL CHEM, V256, P9799
   SHERLINE P, 1972, ENDOCRINOLOGY, V91, P680, DOI 10.1210/endo-91-3-680
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 17
TC 41
Z9 41
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 15
PY 1987
VL 147
IS 2
BP 724
EP 730
DI 10.1016/0006-291X(87)90990-9
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA J9468
UT WOS:A1987J946800029
PM 2820413
DA 2024-02-19
ER

PT J
AU Bacalini, MG
   Franceschi, C
   Gentilini, D
   Ravaioli, F
   Zhou, XY
   Remondini, D
   Pirazzini, C
   Giuliani, C
   Marasco, E
   Gensous, N
   Di Blasio, AM
   Ellis, E
   Gramignoli, R
   Castellani, G
   Capri, M
   Strom, S
   Nardini, C
   Cescon, M
   Grazi, GL
   Garagnani, P
AF Bacalini, Maria Giulia
   Franceschi, Claudio
   Gentilini, Davide
   Ravaioli, Francesco
   Zhou, Xiaoyuan
   Remondini, Daniel
   Pirazzini, Chiara
   Giuliani, Cristina
   Marasco, Elena
   Gensous, Noemie
   Di Blasio, Anna Maria
   Ellis, Ewa
   Gramignoli, Roberto
   Castellani, Gastone
   Capri, Miriam
   Strom, Stephen
   Nardini, Christine
   Cescon, Matteo
   Grazi, Gian Luca
   Garagnani, Paolo
TI Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE DNA methylation; Epigenetic clock; Epithelialmesenchymal transition
ID EPITHELIAL-MESENCHYMAL TRANSITION; DNA METHYLATION; GENE-EXPRESSION;
   HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; AGE;
   HYPERMETHYLATION; CANCER; FETAL
AB The feasibility of liver transplantation from old healthy donors suggests that this organ is able to preserve its functionality during aging. To explore the biological basis of this phenomenon, we characterized the epigenetic profile of liver biopsies collected from 45 healthy liver donors ranging from 13 to 90 years old using the Infinium HumanMethylation450 BeadChip. The analysis indicates that a large remodeling in DNA methylation patterns occurs, with 8,823 age-associated differentially methylated CpG probes. Notably, these age-associated changes tended to level off after the age of 60, as confirmed by Horvaths clock. Using stringent selection criteria, we further identified a DNA methylation signature of aging liver including 75 genomic regions. We demonstrated that this signature is specific for liver compared to other tissues and that it is able to detect biological age-acceleration effects associated with obesity. Finally, we combined DNA methylation measurements with available expression data. Although the intersection between the two omic characterizations was low, both approaches suggested a previously unappreciated role of epithelialmesenchymal transition and Wnt-signaling pathways in the aging of human liver.
C1 [Bacalini, Maria Giulia; Franceschi, Claudio; Pirazzini, Chiara] IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Franceschi, Claudio; Ravaioli, Francesco; Gensous, Noemie; Capri, Miriam; Garagnani, Paolo] Alma Mater Studiorum, DIMES Dept Expt Diagnost & Specialty Med, Via San Giacomo 12, I-40126 Bologna, Italy.
   [Franceschi, Claudio; Marasco, Elena; Castellani, Gastone; Capri, Miriam; Garagnani, Paolo] Alma Mater Studiorum, CIG, Interdept Ctr L Galvani, Bologna, Italy.
   [Gentilini, Davide] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy.
   [Zhou, Xiaoyuan] Shanghai Inst Biol Sci, Grp Clin Genom Networks, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.
   [Zhou, Xiaoyuan] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Zhou, Xiaoyuan] Univ San Francisco, Dept Neurol, San Francisco, CA 94117 USA.
   [Remondini, Daniel] Alma Mater Studiorum, Dept Phys & Astron DIFA, Bologna, Italy.
   [Remondini, Daniel] Alma Mater Studiorum, INFN Sez Bologna, Bologna, Italy.
   [Giuliani, Cristina; Castellani, Gastone] Univ Bologna, Dept Biol Geol & Environm Sci, Lab Mol Anthropol, Bologna, Italy.
   [Giuliani, Cristina; Castellani, Gastone] Univ Bologna, Ctr Genome Biol, Bologna, Italy.
   [Di Blasio, Anna Maria] Ist Auxol Italiano IRCCS, Milan, Italy.
   [Ellis, Ewa] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden.
   [Gramignoli, Roberto] Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden.
   [Strom, Stephen; Nardini, Christine; Garagnani, Paolo] Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
   [Strom, Stephen] Karolinska Univ Sjukhuset, Stockholm, Sweden.
   [Nardini, Christine; Garagnani, Paolo] CNR IAC Mauro Picone, Rome, Italy.
   [Nardini, Christine] Personal Genom Srl, Verona, Italy.
   [Cescon, Matteo] St Orsola Malpighi Hosp, Dept Med & Surg Sci, Gen Surg & Transplant Unit, Bologna, Italy.
   [Grazi, Gian Luca] Ist Nazl Tumori Regina Elena, Rome, Italy.
   [Garagnani, Paolo] S Orsola Malpighi Polyclin, Appl Biomed Res Ctr, Bologna, Italy.
   [Garagnani, Paolo] CNR, IGM, Unit Bologna, Bologna, Italy.
   [Garagnani, Paolo] Rizzoli Orthopaed Inst, Lab Musculoskeletal Cell Biol, Bologna, Italy.
C3 IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University
   of Pavia; Max Planck Society; Chinese Academy of Sciences; Chinese
   Academy of Sciences; University of Chinese Academy of Sciences, CAS;
   University of San Francisco; Istituto Nazionale di Fisica Nucleare
   (INFN); University of Bologna; University of Bologna; IRCCS Istituto
   Auxologico Italiano; Karolinska Institutet; Karolinska Institutet;
   Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR);
   Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); IRCCS
   Azienda Ospedaliero-Universitaria di Bologna; IRCCS Istituti
   Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; Consiglio Nazionale delle Ricerche
   (CNR); IRCCS Istituto Ortopedico Rizzoli
RP Franceschi, C (corresponding author), Alma Mater Studiorum, DIMES Dept Expt Diagnost & Specialty Med, Via San Giacomo 12, I-40126 Bologna, Italy.
EM claudio.franceschi@unibo.it
RI Bacalini, Maria Giulia/K-4931-2016; Ravaioli, Francesco/IQR-6887-2023;
   Remondini, Daniel/ABA-9971-2020; Gentilini, Davide/AAB-2567-2019;
   Gramignoli, Roberto/AAK-5387-2020; Grazi, Gian Luca/J-7215-2018;
   Pirazzini, Chiara/AAD-9318-2021; Capri, Miriam/K-4700-2016; Nardini,
   Christine/AGD-4177-2022; gramignoli, roberto/AAD-8669-2019; Nardini,
   Christine/G-6802-2017; Ravaioli, Francesco/CAA-6674-2022; Ellis, Ewa C
   S/D-5370-2014
OI Bacalini, Maria Giulia/0000-0003-1618-2673; Ravaioli,
   Francesco/0000-0001-6976-8489; Gramignoli, Roberto/0000-0003-3362-4170;
   Grazi, Gian Luca/0000-0002-3279-0313; Pirazzini,
   Chiara/0000-0001-8248-0295; Capri, Miriam/0000-0001-9077-0401; Nardini,
   Christine/0000-0001-7601-321X; Ravaioli, Francesco/0000-0001-6976-8489;
   Ellis, Ewa C S/0000-0002-3057-5337; Cescon, Matteo/0000-0003-1715-3794;
   Giuliani, Cristina/0000-0002-5318-6502; Gentilini,
   Davide/0000-0002-8391-0725; Remondini, Daniel/0000-0003-3185-7456;
   Garagnani, Paolo/0000-0002-4161-3626
FU Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR);
   Horizon 2020 Framework Programme [634821]; JPco-fuND; H2020 Marie
   Sklodowska-Curie Actions [675003];  [602757]; Marie Curie Actions (MSCA)
   [675003] Funding Source: Marie Curie Actions (MSCA)
FX This work was supported by Ministero dell'Istruzione, dell'Universita e
   della Ricerca (MIUR) (PRIN2008) to GLG; by the Seventh Framework
   Programme to CF (grant number 602757, HUMAN); by the Horizon 2020
   Framework Programme to CF and PG (grant number 634821, PROPAG-AGING); by
   JPco-fuND to CF (ADAGE). This project has received funding from the
   H2020 Marie Sklodowska-Curie Actions, grant agreement No 675003.
   http://www.birmingham.ac.uk/panini.
CR Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004
   Ashktorab H, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/2102674
   Bacalini MG, 2017, MECH AGEING DEV, V165, P156, DOI 10.1016/j.mad.2017.01.006
   Bacalini MG, 2017, J GERONTOL A-BIOL, V72, P1015, DOI 10.1093/gerona/glw185
   Bacalini MG, 2015, AGING-US, V7, P97, DOI 10.18632/aging.100718
   Bellavista E, 2014, MECH AGEING DEV, V141, P26, DOI 10.1016/j.mad.2014.09.003
   Bonder MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-860
   Bysani M, 2017, EPIGENOMICS-UK, V9, P105, DOI 10.2217/epi-2016-0087
   Calmon MF, 2015, EPIGENETICS-US, V10, P622, DOI 10.1080/15592294.2015.1050173
   Capri M, 2017, AGING CELL, V16, P262, DOI 10.1111/acel.12549
   Cescon M, 2008, LIVER TRANSPLANT, V14, P672, DOI 10.1002/lt.21433
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Chou YS, 2015, J CHIN MED ASSOC, V78, P438, DOI 10.1016/j.jcma.2015.05.002
   Day K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r102
   Dong D, 2017, ONCOTARGET, V8, P16109, DOI 10.18632/oncotarget.14884
   Fronza R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-86
   Gastaca M, 2016, TRANSPL P, V48, P2856, DOI 10.1016/j.transproceed.2016.06.063
   Giuliani C, 2016, AM J PHYS ANTHROPOL, V159, P585, DOI 10.1002/ajpa.22921
   Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939
   Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032
   He GY, 2015, EXP MOL PATHOL, V99, P374, DOI 10.1016/j.yexmp.2015.06.017
   Hofmann JW, 2014, AGE, V36, P1033, DOI 10.1007/s11357-014-9618-3
   Horvath S, 2015, AGING-US, V7, P1159, DOI 10.18632/aging.100861
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Huse SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2066-3
   Ikegami T, 2007, CELLS TISSUES ORGANS, V185, P213, DOI 10.1159/000101322
   Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x
   Khor Goot Heah, 2016, Asian Pac J Cancer Prev, V17, P219
   Kuo KK, 2015, HEPATOL RES, V45, P782, DOI 10.1111/hepr.12414
   Li CY, 2015, ONCOL REP, V33, P1207, DOI 10.3892/or.2014.3700
   Li J, 2017, NEOPLASIA, V19, P100, DOI 10.1016/j.neo.2016.12.009
   Li K, 2017, ONCOTARGET, V8, P5048, DOI 10.18632/oncotarget.13790
   Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226
   Lu J, 2016, HUM MOL GENET, V25, P1714, DOI 10.1093/hmg/ddw043
   Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm
   Qiu XP, 2016, DIGEST DIS SCI, V61, P149, DOI 10.1007/s10620-015-3878-3
   Rauch TA, 2012, TUMOR BIOL, V33, P287, DOI 10.1007/s13277-011-0282-2
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shen J, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0105-1
   Slieker RC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1053-6
   Steegenga Wilma T, 2014, Age (Dordr), V36, P9648, DOI 10.1007/s11357-014-9648-x
   Suchiman HED, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00287
   Tomizawa M, 2015, INT J ONCOL, V46, P1018, DOI 10.3892/ijo.2015.2830
   Wang W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10936
   Wang YY, 2014, TUMOR BIOL, V35, P7429, DOI 10.1007/s13277-014-1971-4
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034
NR 50
TC 28
Z9 30
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JAN
PY 2019
VL 74
IS 1
BP 1
EP 8
DI 10.1093/gerona/gly048
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA HQ1WM
UT WOS:000462190200001
PM 29554203
OA Green Published
DA 2024-02-19
ER

PT J
AU Tanasov, VS
   Neto, WK
   Gonçalves, L
   Maifrino, LBM
   de Sousa, RR
   Gama, EF
AF Tanasov, Valeria Simoes
   Neto, Walter Krause
   Goncalves, Leandro
   Mesiano Maifrino, Laura Beatriz
   de Sousa, Romeu Rodrigues
   Gama, Eliane Florencio
TI Use of Anabolic Steroid Altered the Liver Morphology of Rats
SO INTERNATIONAL JOURNAL OF MORPHOLOGY
LA English
DT Article
DE Aging; Testosterone proprionate; Hepatic tissue; Animals
AB The aim of this research was to investigate the effect of testosterone propionate administration in the liver of rats. The rats were divided in the following groups: Initial control (SC), Aged control (SE) and Anabolic group (SA). Testosterone propionate was administered three times per week during 16 weeks. Using morphoquantitative techniques, we quantified the volume densities of lobular and non-lobular parenchyma, area and number of nuclei of hepatocytes. The data were analyzed statistically using mean and standard deviation, ANOVA one-way and level of significance about p <= 0.05. Our results showed an increase in capillaries, perisinusoidal spaces and biliary ducts in SE group compared to SC. SA group showed a decrease in hepatic cells, non-lobular volume density and hepatocytes nuclei area, but also an increase in capillaries, perisinusoidal spaces, biliary ducts, number of hepatocytes and non-hepatocyte nuclei compared to SC. We conclude that a direct toxicity may have occurred, with consequent loss of the cells.
C1 [Tanasov, Valeria Simoes; Neto, Walter Krause; Goncalves, Leandro; Mesiano Maifrino, Laura Beatriz; de Sousa, Romeu Rodrigues; Gama, Eliane Florencio] Univ Sao Judas Tadeu, Lab Morphoquantitat Studies & Immunohistochem, Sao Paulo, Brazil.
   [Neto, Walter Krause; Mesiano Maifrino, Laura Beatriz] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil.
C3 Universidade Sao Judas Tadeu; Instituto Dante Pazzanese de Cardiologia
RP Neto, WK (corresponding author), Rua Taquari, Mooca, SP, Brazil.
EM wild_krause@hotmail.com
RI Neto, Walter Krause/R-2323-2017; MAIFRINO, LAURA/E-6769-2012; Gama,
   Eliane Florencio/G-1741-2014
OI Neto, Walter Krause/0000-0002-6881-0208; MAIFRINO,
   LAURA/0000-0002-9456-192X; Gama, Eliane Florencio/0000-0002-9770-8819
CR Bento-Silva MT, 2010, BRAZ J PHARM SCI, V46, P79, DOI 10.1590/S1984-82502010000100009
   De Souza R., 2008, GERIATRIA GERONTOLOG, P7
   Engelman M.F.B., 2001, ARQ BRAS ENDOCRINOL, V45, P173, DOI DOI 10.1590/S0004-27302001000200009
   Ferrioli E., 2011, TRATADO GERIATRIA GE
   Garcia Y, 2007, BIOMATERIALS, V28, P175, DOI 10.1016/j.biomaterials.2006.08.037
   Jeckel-Neto E. A., 2011, TRATADO GERIATRIA GE, P1741
   Liberman S., 2011, TRATADO GERIATRIA GE
   Lise M L, 1999, Rev Assoc Med Bras (1992), V45, P364
   Mandarim-de-Lacerda CA, 1995, METODOS QUANTITATIVO
   Martits Anna Maria, 2004, Rev. Assoc. Med. Bras., V50, P358, DOI 10.1590/S0104-42302004000400018
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Soares Cláudio N, 2002, Rev. Bras. Psiquiatr., V24, P48, DOI 10.1590/S1516-44462002000500010
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 13
TC 5
Z9 7
U1 0
U2 2
PU SOC CHILENA ANATOMIA
PI TEMUCO
PA CASILLA 54-D, TEMUCO, 00000, CHILE
SN 0717-9502
EI 0717-9367
J9 INT J MORPHOL
JI Int. J. Morphol.
PD SEP
PY 2014
VL 32
IS 3
BP 756
EP 760
PG 5
WC Anatomy & Morphology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology
GA AW7DG
UT WOS:000346424200002
OA gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Ferioli, ME
   Sessa, A
   Rabellotti, E
   Tunici, P
   Pinotti, O
   Perin, A
AF Ferioli, ME
   Sessa, A
   Rabellotti, E
   Tunici, P
   Pinotti, O
   Perin, A
TI Changes in hepatic polyamine catabolism in elderly rats
SO LIVER
LA English
DT Article
DE aging; diamine oxidase; liver (rat); polyamine oxidase;
   spermidine/spermine N-1-acetyltransferase
ID ORNITHINE DECARBOXYLASE; DIPLOID FIBROBLASTS; GLUTATHIONE LEVEL; DIAMINE
   OXIDASE; GROWTH-HORMONE; LIVER; SPERMIDINE; METABOLISM; MICE; AGE
AB Aims/Background: Given the important role of polyamines (putrescine, spermidine, spermine) in the modulation of macromolecular syntheses, gene expression and proteolysis, alterations in their metabolic pathways could be relevant during senescence. Since the few existing data address mainly polyamine biosynthesis, we studied the oxidative catabolism of polyamines in the liver of rats 3-36 months of age. Methods. Polyamine oxidase activity was fluorimetrically measured using N-1-acetyl-spermine as substrate. Spermidine/spermine N-1-acetyltransferase and diamine oxidase were measured by radiochemical methods using labeled acetyl-coenzyme A and putrescine, respectively, as substrate. Polyamines were separated by HPLC and fluorimetrically quantified after post-column derivatization with o-phthaldialdehyde. Results: Spermidine/spermine N-1-acetyltransferase activity increased in 36-month-old rats and polyamine oxidase activity in 24- and 36-month-old rats. A decline in spermine and increases in spermidine and putrescine in elderly rats suggested an activation of the interconversion pathway of higher into lower polyamines. The activity of diamine oxidase, which degrades putrescine, was enhanced starting from 12 months of age. Conclusion: In the liver of aged rats, an increase in the catabolic enzymes leads to a reconversion of the higher polyamines to putrescine. This increased catabolism may represent an important age-related change and may contribute to impairment of the expression of growth-related genes in senescence.
C1 CNR, Ctr Studio Patol Cellulare, I-20133 Milan, Italy.
   Univ Milan, Ctr Interdipartimentale Ric Biomed LITA Vialba, Milan, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); University of Milan
RP Ferioli, ME (corresponding author), CNR, Ctr Studio Patol Cellulare, Via Mangiagalli 31, I-20133 Milan, Italy.
CR Bachrach U, 1981, POLYAMINES BIOL MED, P151
   BEYER HS, 1992, J LAB CLIN MED, V119, P38
   CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690
   CELANO P, 1989, J BIOL CHEM, V264, P8922
   CHANG ZF, 1988, J BIOL CHEM, V263, P11431
   CHEN KY, 1986, J CELL PHYSIOL, V128, P27, DOI 10.1002/jcp.1041280106
   COFFINO P, 1991, J CELL BIOCHEM, V45, P54, DOI 10.1002/jcb.240450112
   Ferioli ME, 1996, BBA-MOL BASIS DIS, V1317, P15, DOI 10.1016/0925-4439(96)00029-4
   GEIGER PJ, 1972, ANAL BIOCHEM, V49, P467, DOI 10.1016/0003-2697(72)90450-2
   GritliLinde A, 1997, MOL CELL ENDOCRINOL, V126, P49, DOI 10.1016/S0303-7207(96)03969-X
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X
   HOLTTA E, 1977, BIOCHEMISTRY-US, V16, P91, DOI 10.1021/bi00620a015
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   LOSER C, 1988, J CHROMATOGR-BIOMED, V430, P249, DOI 10.1016/S0378-4347(00)83160-6
   MATSUI I, 1980, BIOCHIM BIOPHYS ACTA, V633, P87, DOI 10.1016/0304-4165(80)90040-9
   Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X
   OKUYAMA T, 1961, ARCH BIOCHEM BIOPHYS, V95, P242, DOI 10.1016/0003-9861(61)90141-2
   PERIN A, 1986, BIOCHEM J, V234, P119, DOI 10.1042/bj2340119
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3
   Seiler N, 1995, PROG BRAIN RES, V106, P333
   SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317
   SEILER N, 1981, ADV POLYAMINE RES, V3, P197
   SESSA A, 1994, AGENTS ACTIONS, V43, P69, DOI 10.1007/BF02005768
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SUZUKI O, 1984, EXPERIENTIA, V40, P838, DOI 10.1007/BF01951981
   WAJNBERG EF, 1989, FEBS LETT, V243, P141, DOI 10.1016/0014-5793(89)80116-4
NR 29
TC 6
Z9 6
U1 0
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0106-9543
J9 LIVER
JI Liver
PD OCT
PY 1998
VL 18
IS 5
BP 326
EP 330
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 133WH
UT WOS:000076710200005
PM 9831361
DA 2024-02-19
ER

PT J
AU Sharma, R
   Kumar, R
   Sharma, A
   Goel, A
   Padwad, Y
AF Sharma, Rohit
   Kumar, Ravi
   Sharma, Anamika
   Goel, Abhishek
   Padwad, Yogendra
TI Long-term consumption of green tea EGCG enhances murine health span by
   mitigating multiple aspects of cellular senescence in mitotic and
   post-mitotic tissues, gut dysbiosis, and immunosenescence
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article; Early Access
DE Senescence; EGCG; SASP; Autophagy; Nutrient signaling; Microbiota
ID SECRETORY PHENOTYPE; DNA-DAMAGE; LIFE-SPAN; ENDOTHELIAL-CELLS; OXIDATIVE
   STRESS; AUTOPHAGY; LIVER; AGE; INFLAMMATION; FIBROBLASTS
AB Cellular senescence is emerging as a major hallmark of aging, and its modulation presents an effective anti-aging strategy. This study attempted to understand the progression of cellular senescence in vivo, and whether it can be mitigated by chronic consumption of green tea catechin epigallocatechin gallate (EGCG). We profiled cellular senescence in various organs of mice at four different time-points of lifespan, and then explored the influence of EGCG consumption in impacting markers of cellular senescence, inflamm-aging, immunosenescence, and gut dysbiosis. We report that visceral adipose and intestinal tissues are highly vulnerable to cellular senescence due to an increase in DNA damage response, activation of cell cycle inhibitors, and senescence-associated secretory phenotype regulators. With advancing age, dysregulation in nutrient signaling mediators (AMPK/AKT/SIRT3/5), and a decrease in autophagy was also observed. Inflamm-aging markers (TNF-alpha/IL-1 beta) and splenic CD4/CD8 T cell ratio increased with age, while NK cell population decreased. Metagenomic analyses revealed an age-related decrease in the diversity of microbial species and an increase in the abundance of various pathogenic bacterial species. On the other hand, long-term EGCG consumption significantly attenuated markers of DNA damage, cell cycle inhibitors, senescence-associated secretory phenotype regulators, AMPK/AKT signaling, and enhanced SIRT3/5 expression and autophagy. Systemic inflamm-aging indicators decreased, while early T cell activation increased in EGCG fed animals. EGCG also suppressed the abundance of pathogenic bacteria and preserved microbial diversity. Our results suggest that adipose and intestine tissues are prone to cellular senescence and that chronic consumption of EGCG can attenuate several deleterious aspects of aging which could be implicated in developing anti-aging strategies. (C) 2022 Elsevier Inc. All rights reserved.
C1 [Sharma, Rohit; Kumar, Ravi; Sharma, Anamika; Goel, Abhishek; Padwad, Yogendra] CSIR Inst Himalayan Bioresource Technol, Acad Sci & Innovat Res, Nutr Technol Div, Palampur, Himachal Prades, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Institute of Himalayan Bioresource Technology (IHBT); Academy of
   Scientific & Innovative Research (AcSIR)
RP Sharma, R; Padwad, Y (corresponding author), Shoolini Univ Biotechnol & Management Sci, Fac Appl Sci & Biotechnol, Anim Tissue Culture Lab, Solan 173229, India.
EM rohit25sharma@gmail.com; yogendra@ihbt.res.in
RI Sharma, Anamika/E-9607-2019
OI Sharma, Anamika/0000-0002-0054-9904; Padwad,
   Yogendra/0000-0003-1793-9340; Sharma, Rohit/0000-0001-6209-3845; Kumar,
   Ravi/0000-0001-5787-7856
FU Department of Science and Technology, Government of India [IFA17-LSPA79]
FX This work was supported by a grant from the Department of Science and
   Technology, Government of India under the INSPIRE Faculty scheme
   (IFA17-LSPA79).
CR Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Boland BS, 2014, J CLIN EXP HEPATOL, V4, P1, DOI 10.1016/j.jceh.2014.01.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Braidy N, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00167
   Capparelli C, 2012, CELL CYCLE, V11, P3599, DOI 10.4161/cc.21884
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Dafre AL, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2715810
   Fernández AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Gonçalves S, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108860
   Han DW, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/850684
   Han XJ, 2016, AGING CELL, V15, P416, DOI 10.1111/acel.12446
   Holczer M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6721530
   Holderness J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017301
   Ilari S, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104851
   Ishaq A, 2018, J NUTR HEALTH AGING, V22, P555, DOI 10.1007/s12603-017-0968-2
   Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kabiljo J, 2019, GENE EXPR PATTERNS, V33, P11, DOI 10.1016/j.gep.2019.05.001
   Kim HS, 2013, J BIOL CHEM, V288, P22693, DOI 10.1074/jbc.M113.477505
   Kumar R, 2020, BIOGERONTOLOGY, V21, P325, DOI 10.1007/s10522-020-09861-3
   Kumar R, 2019, BIOGERONTOLOGY, V20, P171, DOI 10.1007/s10522-018-9785-1
   Kumar S, 2019, AGING-US, V11, P4145, DOI 10.18632/aging.102043
   Lilja S, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4793125
   Lin ZF, 2013, BIOCHEM BIOPH RES CO, V441, P191, DOI 10.1016/j.bbrc.2013.10.033
   Mahnke YD, 2007, CLIN LAB MED, V27, P469, DOI 10.1016/j.cII.2007.05.002
   Mair KH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00263
   Mariño G, 2014, AUTOPHAGY, V10, P1879, DOI 10.4161/auto.36413
   Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045
   Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600
   Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279
   Nations U., 2019, World Population Ageing 2019, DOI [10.18356/9789210051934, DOI 10.18356/9789210051934]
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Prattichizzo F, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1810327
   Ramstead AG, 2015, INT IMMUNOPHARMACOL, V26, P367, DOI 10.1016/j.intimp.2015.04.008
   Saccon TD, J GERONTOL A, V76, P1895
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Sharma A, 2018, INFLAMMOPHARMACOLOGY, V26, P1483, DOI 10.1007/s10787-018-0448-2
   Sharma R, 2021, PHARMANUTRITION, V18, DOI 10.1016/j.phanu.2021.100281
   Sharma R, 2021, BIOGERONTOLOGY, V22, P571, DOI 10.1007/s10522-021-09936-9
   Sharma R, 2020, AGEING RES REV, V63, DOI 10.1016/j.arr.2020.101141
   Sharma R, 2020, TRENDS FOOD SCI TECH, V98, P41, DOI 10.1016/j.tifs.2020.02.004
   Sharma R, 2020, NUTRITION, V77, DOI 10.1016/j.nut.2020.110785
   Sharma R, 2020, GUT MICROBES, V11, P335, DOI 10.1080/19490976.2019.1697148
   Sharma R, 2017, BIOGERONTOLOGY, V18, P367, DOI 10.1007/s10522-017-9696-6
   Shih Jennifer, 2013, Genes Cancer, V4, P91, DOI 10.1177/1947601912474931
   Singh BK, 2020, AGING-US, V12, P13958, DOI 10.18632/aging.103740
   Song P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030671
   Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08
   Tai HR, 2017, AUTOPHAGY, V13, P99, DOI 10.1080/15548627.2016.1247143
   Tumová L, 2017, PHARMACOGN MAG, V13, P260, DOI 10.4103/0973-1296.204558
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Verburgh K, 2015, AGING CELL, V14, P17, DOI 10.1111/acel.12284
   von Zglinicki T, 2021, ANTIOXID REDOX SIGN, V34, P308, DOI 10.1089/ars.2020.8048
   Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200
   Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010
   Wu M, 2021, CRIT REV FOOD SCI, V61, P2175, DOI 10.1080/10408398.2020.1773390
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Xiong LG, 2018, REDOX BIOL, V14, P305, DOI 10.1016/j.redox.2017.09.019
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhao L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.563
   Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643
   Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816
NR 69
TC 16
Z9 17
U1 5
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD 2022 SEP
PY 2022
VL 107
AR 109068
DI 10.1016/j.jnutbio.2022.109068
EA JUN 2022
PG 15
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 3J5TL
UT WOS:000833457400003
PM 35618244
DA 2024-02-19
ER

PT J
AU Matsugo, S
   Kitagawa, T
   Minami, S
   Esashi, Y
   Oomura, Y
   Tokumaru, S
   Kojo, S
   Matsushima, K
   Sasaki, K
AF Matsugo, S
   Kitagawa, T
   Minami, S
   Esashi, Y
   Oomura, Y
   Tokumaru, S
   Kojo, S
   Matsushima, K
   Sasaki, K
TI Age-dependent changes in lipid peroxide levels in peripheral organs, but
   not in brain, in senescence-accelerated mice
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE aging; chemical derivatization; lipid peroxides; high performance liquid
   chromatography; 1-naphthyldiphenylphosphine; 1-naphthyldiphenylphosphine
   oxide; senescence-accelerated mice
ID THIOBARBITURIC ACID REACTIVITY; OXIDATIVE STRESS; MOUSE SAM;
   HYDROPEROXIDES; INCREASE; MEMORY; TISSUES; LIVER; MODEL; RAT
AB The tissue concentration of lipid peroxides was determined in the brain, heart, liver, lung and kidney of accelerated senescence-prone (SAMP-8) and -resistant (SAMR-1) mice at 3, 6 and 9 months of age by a method involving chemical derivatization and high performance liquid chromatography. The level of lipid peroxides in the brain did not show an age-dependent change, but at each age the brain level of lipid peroxides was significantly higher in SAMP-8 than in SAMR-1. In contrast, the lipid peroxide levels in the peripheral organs showed increases with aging in both strains, and they were significantly higher in SAMP-8 than in SAM R-1 at both 3 and 6 months of age (except at 3 months of age in the kidney). These results suggest that increased oxidative stress in the brain and peripheral organs is a cause of the senescence-related degeneration and impairments seen in SAMP-8. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
C1 Toyama Univ, Fac Engn, Div Bioinformat Engn, Toyama 9308555, Japan.
   Toyama Univ, Fac Engn, Dept Chem & Biochem Engn, Toyama 9308555, Japan.
   Toyama Univ, Fac Engn, CREST, Toyama 9308555, Japan.
   Joetsu Univ Educ, Fac Educ, Dept Life & Hlth Sci, Niigata 9438512, Japan.
   Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan.
   Univ Tokyo, Grad Sch Med, CREST, Tokyo 1130033, Japan.
   Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan.
C3 University of Toyama; University of Toyama; Japan Science & Technology
   Agency (JST); University of Toyama; Joetsu University Education; Nara
   Womens University; Japan Science & Technology Agency (JST); University
   of Tokyo; University of Tokyo
RP Sasaki, K (corresponding author), Toyama Univ, Fac Engn, Div Bioinformat Engn, 3190 Gofuku, Toyama 9308555, Japan.
RI Kojo, Shosuke/GNP-0971-2022
CR AKASAKA K, 1987, ANAL LETT, V20, P731
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D
   KOSUGI H, 1987, ANAL BIOCHEM, V165, P456, DOI 10.1016/0003-2697(87)90296-X
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   OHTA A, 1989, BRAIN RES, V498, P195, DOI 10.1016/0006-8993(89)90421-6
   Sato E, 1996, MECH AGEING DEV, V86, P105, DOI 10.1016/0047-6374(95)01681-3
   SNEAR AE, 1960, J ORG CHEM, V25, P2001
   STANIMIROVIC DB, 1994, NEUROCHEM RES, V19, P1473, DOI 10.1007/BF00968993
   Sun F, 1999, CLIN SCI, V96, P185, DOI 10.1042/CS19980189
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TOKUMARU S, 1995, ANAL CHIM ACTA, V307, P97, DOI 10.1016/0003-2670(95)00045-2
   Tokumaru S, 1996, J AGR FOOD CHEM, V44, P2748, DOI 10.1021/jf960184u
   Tokumaru S, 1996, MECH AGEING DEV, V86, P67, DOI 10.1016/0047-6374(95)01674-0
   Tokumaru S, 1997, FREE RADICAL RES, V26, P169, DOI 10.3109/10715769709097795
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
NR 20
TC 53
Z9 55
U1 0
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JAN 7
PY 2000
VL 278
IS 1-2
BP 105
EP 108
DI 10.1016/S0304-3940(99)00907-6
PG 4
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 273QV
UT WOS:000084719100027
PM 10643812
DA 2024-02-19
ER

PT J
AU LU, MH
   HINSON, WG
   HE, DS
   TURTURRO, A
   HART, RW
AF LU, MH
   HINSON, WG
   HE, DS
   TURTURRO, A
   HART, RW
TI HEPATIC NUCLEAR PLOIDY DISTRIBUTION OF DIETARY-RESTRICTED MICE
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
ID FLOW CYTOMETRIC ANALYSIS; MOUSE HEPATOCYTE PLOIDY; CELL-CYCLE ANALYSIS;
   FOOD RESTRICTION; POLYPLOIDY; AGE; LIVER; HYPOTHESIS; KINETICS
AB Hepatic parenchymal cells in most adult mammals are polyploid, with most of the cells in the quiescent or low-proliferation state. Polyploidization has been related to carcinogenesis and aging, and both end points are significantly affected by dietary restriction (DR). Direct measures of hepatic nuclear polyploidization in DR B6C3F(1) mice have not been examined. We examined the effect of DR on distributions of nuclear ploidy in both sexes and on different age groups of B6C3F(1) mice. Differences between young and old male mice and between old male and female mice were also compared. Hepatic nuclear ploidy values were measured by flow cytometry. The DNA histograms were analyzed for the percentage of nuclei having different classes of DNA content by gating channels between the areas under the peaks of diploid, tetraploid, and octaploid. The results indicate that 1 or 26 months of DR started at 4 months of age did not alter hepatic nuclear ploidy distributions in young and old mice. Our data suggest that in the male mouse, polyploidization is established by 5 months of age for hepatic nuclei and that ploidy classes are affected by sex at 30 months of age. For females, effects in the octaploid nuclei are seen as a result of DR.
RP LU, MH (corresponding author), NATL CTR TOXICOL RES, NCTR DR, JEFFERSON, AR 72079 USA.
CR ALFERT M, 1958, EXP CELL RES, V15, P230, DOI 10.1016/0014-4827(58)90079-X
   BOEHM N, 1975, CURR TOP PATHOL, V60, P152
   BOHM N, 1981, HISTOCHEMISTRY, V72, P55, DOI 10.1007/BF00496779
   BRASCH K, 1980, CELL BIOL INT REP, V4, P217, DOI 10.1016/0309-1651(80)90077-6
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   CARLSON J, 1985, J TOXICOL ENV HEALTH, V15, P551, DOI 10.1080/15287398509530685
   Carriere R, 1969, Int Rev Cytol, V25, P201, DOI 10.1016/S0074-7696(08)60204-1
   CLAYSON DB, 1991, BIOL EFFECTS DIETARY, P55
   DIGERNES V, 1979, VIRCHOWS ARCH B, V32, P1
   DIGERNES V, 1981, ACTA PATH MICROB A S, V274, P300
   ENESCO HE, 1983, EXP GERONTOL, V18, P79, DOI 10.1016/0531-5565(83)90054-2
   ENESCO HE, 1991, MECH AGEING DEV, V59, P69, DOI 10.1016/0047-6374(91)90074-A
   EPSTEIN CJ, 1967, P NATL ACAD SCI USA, V57, P327, DOI 10.1073/pnas.57.2.327
   GAHAN PB, 1977, EXP GERONTOL, V12, P133, DOI 10.1016/0531-5565(77)90021-3
   GEISINGER KR, 1986, AM J CLIN PATHOL, V85, P536, DOI 10.1093/ajcp/85.5.536
   GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245
   GRAY JW, 1986, INT J RADIAT BIOL, V49, P237, DOI 10.1080/09553008514552531
   HELLER TD, 1990, GASTROENTEROLOGY, V98, P387, DOI 10.1016/0016-5085(90)90829-P
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   INAMDAR NARAYAN B., 1958, J MORPH, V103, P65, DOI 10.1002/jmor.1051030104
   LIPSCOMB HL, 1982, VIRCHOWS ARCH B, V41, P285, DOI 10.1007/BF02890287
   LU MH, 1991, MECH AGEING DEV, V59, P111, DOI 10.1016/0047-6374(91)90077-D
   MEDVEDEV ZA, 1986, EXP GERONTOL, V21, P277, DOI 10.1016/0531-5565(86)90037-9
   Melamed MR., 1979, Flow cytometry and sorting
   MORTREUIL-LANGLOIS M, 1960, C R Seances Soc Biol Fil, V153, P1544
   PARIZA MW, 1987, NUTR REV, V45, P1
   SCHWARZE PE, 1984, CARCINOGENESIS, V5, P1267, DOI 10.1093/carcin/5.10.1267
   SEVERIN E, 1984, CELL TISSUE RES, V238, P643, DOI 10.1007/BF00219883
   SEVERIN E, 1984, CELL TISSUE RES, V238, P649, DOI 10.1007/BF00219884
   SHIMA A, 1976, EXP GERONTOL, V11, P193, DOI 10.1016/0531-5565(76)90033-4
   STYLES JA, 1993, ENVIRON HEALTH PERSP, V101, P67, DOI 10.2307/3431844
   SWARTZ FJ, 1961, ANAT REC, V141, P219, DOI 10.1002/ar.1091410306
   TUCKER MJ, 1979, INT J CANCER, V23, P803, DOI 10.1002/ijc.2910230611
   TUL'TSEVA N. M., 1958, BIOFIZIKA [TRANSL], V3, P183
   TURTURRO A, 1991, ANN NY ACAD SCI, V621, P363
   URYVAEVA IV, 1981, J THEOR BIOL, V89, P557, DOI 10.1016/0022-5193(81)90028-X
   VANRAVENZWAAY B, 1987, CARCINOGENESIS, V8, P265, DOI 10.1093/carcin/8.2.265
   VINDELOV LL, 1980, CELL TISSUE KINET, V13, P299
   Weindruch R., 1988, RETARDATION AGING DI
   WITT WM, 1991, BIOL EFFECTS DIETARY, P65
NR 40
TC 5
Z9 5
U1 0
U2 0
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD DEC
PY 1993
VL 101
SU 5
BP 229
EP 233
DI 10.1289/ehp.93101s5229
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA NB891
UT WOS:A1993NB89100038
PM 8013412
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Supakar, PC
   Fujita, T
   Maruyama, N
AF Supakar, PC
   Fujita, T
   Maruyama, N
TI Identification of novel sequence-specific nuclear factors interacting
   with mouse senescence marker protein-30 gene promoter
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE senescence marker protein-30; SMP30; aging; DNA binding proteins;
   transcription factors; DNA-protein interactions; gene regulation
ID ANDROGEN RECEPTOR GENE; RAT-LIVER; HUMAN HOMOLOG; SMP30; AGE; CLONING
AB Senescence marker protein-30 (SMP30) gene expression declines during aging in mouse liver. SMP30 also plays a role as Ca2+-binding protein localized in cytosol of hepatocytes. To elucidate the molecular mechanism of regulation of SMP30 gene expression we have cloned its gene promoter and carried out DNA-protein interaction analyses by DNase I footprinting and electrophoretic mobility shift assay. We have identified a total of eight nuclear factor binding sites within 0.8 kb upstream of transcription start site. Three of these sites are novel DNA sequences with no homology to the existing transcription factor binding site database. Interaction of nuclear factors to these novel cognate sites are DNA sequence-specific. The other five sites correspond to binding sites of known transcription factors, Sp1, AP2, CCAAT box, Lyf-1, and GATA-1. Coordinated orchestration of these factors may contribute to regulation of SMP30 gene expression. (C) 2000 Academic Press.
C1 Inst Life Sci, Bhubaneswar 751023, Orissa, India.
   Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 173, Japan.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS); Tokyo Metropolitan Institute of Gerontology
RP Supakar, PC (corresponding author), Inst Life Sci, NALCO Sq, Bhubaneswar 751023, Orissa, India.
CR AMMENDOLA R, 1992, J BIOL CHEM, V267, P17944
   Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   Nietfeld W, 1996, IMMUNOL LETT, V49, P139, DOI 10.1016/0165-2478(95)02479-4
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   Supakar PC, 1996, BIOL SIGNAL, V5, P170
NR 14
TC 12
Z9 12
U1 0
U2 1
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 7
PY 2000
VL 272
IS 2
BP 436
EP 440
DI 10.1006/bbrc.2000.2799
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 327HC
UT WOS:000087787600023
PM 10833432
DA 2024-02-19
ER

PT J
AU TAUCHI, H
   SATO, T
   ITO, Y
AF TAUCHI, H
   SATO, T
   ITO, Y
TI MORPHOLOGICAL ASPECTS OF AGING LIVER - HALF A CENTURY OF PROGRESS IN
   JAPAN
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE INHIBITORY FACTOR; PARABIOSIS; NUTRITION AND AGING; HEPATOCYTES; AGE
   CHANGES; DARK CELL; MITOCHONDRIA
ID ENVIRONMENTAL-CONDITIONS; AGE
AB The most important morphological aspects of the physiological changes of the liver with age are decreases in the numbers of hepatocytes and their mitochondria, coupled with increases in their volumes. The latter is considered to partially compensate for the decrease in numbers of hepatocytes and mitochondria, but leads to a more limited reserve capacity and thus to a condition in which liver function can be more readily exhausted. The binuclearity and polyploidization of the hepatocytes increase with age and are considered to be due to inhibition of their cell division process. Our studies on the parabiosis between young and old rats and mice, on the implantation of isolated hepatocytes in the spleens of rats of different ages, and on the regenerative process after partial hepatectomy in rats of different ages, suggested the existence of humoral inhibitory factor(s) for the division of the cells and their mitochondria. Morphological studies on the native and Hawaiian Japanese, as well as on the USA Caucasians and the Costa Rican Latinos revealed that a difference in the process of the age-related decrease in hepatocyte number among different ethnicities is mainly due to differences in nutritional conditions rather than to genetic factors. Experimental studies are now being carried out on the effect(s) of various dietary conditions on age-related changes of the liver, and the results obtained support the findings of the geographical studies.
RP TAUCHI, H (corresponding author), AICHI MED UNIV,INST MED SCI AGING,NAGAKUTE,AICHI 48011,JAPAN.
CR ANDRE J, 1971, J ULTRASTRUCT RES, V37, P243
   ASANO K, 1992, MECH AGEING DEV, V64, P85, DOI 10.1016/0047-6374(92)90098-X
   Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404
   IKEDA H, 1985, MECH AGEING DEV, V31, P139, DOI 10.1016/S0047-6374(85)80024-5
   ITO Y, 1993, RECENT ADVANCES IN AGING SCIENCE, VOLS I AND II, P301
   ITO Y, 1990, BIOMED GERONTOL, V14, P137
   ITO Y, 1988, BIOMED GERONTOL, V12, P91
   KOBAYASHI H, 1965, Nagoya J Med Sci, V27, P167
   MERKER HJ, 1968, Z ZELLFORSCH MIK ANA, V86, P139, DOI 10.1007/BF00340364
   MIZUNO T, 1989, BIOMED GERONTOL, V13, P173
   MIZUNO T, 1991, BIOMED GERONTOL, V15, P158
   SATO T, 1970, GERONTOLOGY, V16, P368, DOI 10.1159/000211799
   SATO T, 1988, MECH AGEING DEV, V43, P229, DOI 10.1016/0047-6374(88)90033-4
   SATO T, 1979, MECH AGEING DEV, V11, P171, DOI 10.1016/0047-6374(79)90052-6
   SATO T, 1975, ACTA PATHOL JAPON, V25, P403
   SATO T, 1981, Japanese Journal of Geriatrics, V18, P325
   SHAMOTO M, 1968, J GERONTOL, V23, P1
   TAUCHI H, 1980, MECH AGEING DEV, V12, P183, DOI 10.1016/0047-6374(80)90094-9
   TAUCHI H, 1962, J GERONTOL, V17, P254, DOI 10.1093/geronj/17.3.254
   TAUCHI H, 1974, MECH AGEING DEV, V3, P279, DOI 10.1016/0047-6374(74)90024-4
   TAUCHI H, 1977, MECH AGEING DEV, V6, P333, DOI 10.1016/0047-6374(77)90034-3
   TAUCHI H, 1980, MECH AGEING DEV, V12, P7, DOI 10.1016/0047-6374(80)90023-8
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   TAUCHI H, 1961, Nagoya J Med Sci, V24, P97
   TAUCHI H, 1975, MECH AGEING DEV, V4, P71, DOI 10.1016/0047-6374(75)90008-1
   TAUCHI H, 1986, BIOMED GERONTOL, V10, P79
   TAUCHI H, 1988, MORPHOLOGY AGING
   TAUCHI H, 1952, J NAGOYA MED ASS, V66, P243
   TAUCHI H, 1985, THRESHOLDS AGING, P92
   TAUCHI H, 1992, B I MED SCI AGING AI, V3, P47
   TAUCHI H, 1984, ASIAN MED J, V27, P741
   Tauchi H., 1978, LIVER AGING 1978, P3
   TAUCHI HISASHI, 1953, NAGOYA MED JOUR, V1, P143
   TAUCHI HISASHI, 1954, NAGOYA MED JOUR, V2, P1
   WYLLIE AH, 1980, INT REV EXP PATHOL, V32, P223
NR 35
TC 7
Z9 7
U1 0
U2 3
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD SEP-OCT
PY 1994
VL 19
IS 2
BP 135
EP 144
DI 10.1016/0167-4943(94)90035-3
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA PY275
UT WOS:A1994PY27500005
PM 15374280
DA 2024-02-19
ER

PT J
AU Zhou, Y
   Xu, Q
   Dong, Y
   Zhu, S
   Song, S
   Sun, N
AF Zhou, Y.
   Xu, Q.
   Dong, Y.
   Zhu, S.
   Song, S.
   Sun, N.
TI Supplementation of mussel peptides reduces aging phenotype, lipid
   deposition and oxidative stress in D-galactose-induce aging mice
SO JOURNAL OF NUTRITION HEALTH & AGING
LA English
DT Article
DE Mussel peptides; d-galactose; oxidative stress; glucose and lipid
   homeostasis; PPARs
ID DAILY LIVING ADL; OLDER-ADULTS; ELDERLY-PEOPLE; INSTRUMENTAL ACTIVITIES;
   DISABILITY; INDEPENDENCE; TRENDS; LIFE; INTERVENTIONS; COMMUNITY
AB Aging is associated with glucose and lipid metabolism disorder. We aimed to examine the effects of mussel peptides on protecting against aging by regulating glucose and lipid metabolism.
   For the aging model, d-galactose (200 mg/kg) was administered subcutaneously to 8-month-old mice for 8 weeks. Mussel peptides (1,000 mg/kg) were simultaneously administered by intragastric gavage. The glucose and lipid metabolism profiles, aging phenotype and peroxisome proliferator-activated receptors (PPARs) expression in the liver and adipose tissue of ICR mice were measured.
   D-galactose-treated mice showed pronounced fat deposition and impaired glucose and lipid homeostasis, along with increased oxidative damage and aging. Mussel peptides improved metabolic status by reducing serum glucose and triglyceride levels, insulin resistance and hepatic free fatty acid, as well as enhancing serum high-density lipoprotein (HDL) level and hepatic glycogen content, accompanied with amelioration of aging phenotype and fat deposition. Moreover, mussel peptides ameliorated oxidative stress in aged liver tissues and promoted expression of peroxisome proliferator activated receptors alpha (PPAR alpha) and gamma (PPAR gamma) in liver and adipose tissues.
   These results indicate that mussel peptides protect against lipid metabolic disorders associated with aging via maintaining oxidative stress homeostasis and elevated expression levels of PPARs.
C1 [Zhou, Y.; Xu, Q.; Dong, Y.; Zhu, S.] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Peoples R China.
   [Zhou, Y.; Song, S.; Sun, N.] Dalian Polytech Univ, Sch Food Sci & Technol, Dalian 116034, Peoples R China.
   [Zhou, Y.; Song, S.; Sun, N.] Jiangsu Univ, Zhenjiang, Peoples R China.
C3 Jiangsu University; Dalian Polytechnic University; Jiangsu University
RP Dong, Y (corresponding author), Jiangsu Univ, Zhenjiang, Peoples R China.
EM jsdxydong@163.com
RI Song, Shuang/AAH-4818-2021
OI Song, Shuang/0000-0001-9718-8254; xu, qinggang/0000-0002-8659-7041
FU Jiangsu University Research Fund for Senior Professional Technical
   Talent [5501360006]; Project of natural science research area of Jiangsu
   Province [16KJB550001]; National Natural Science Foundation of China
   [31501431]
FX This work was supported by the Jiangsu University Research Fund for
   Senior Professional Technical Talent (No (5501360006), Project of
   natural science research area of Jiangsu Province (No. 16KJB550001) and
   the National Natural Science Foundation of China (No. 31501431).
CR Avila-Funes JA, 2014, J FRALITY AGING, V3, P206, DOI 10.14283/jfa.2014.25
   Beswick AD, 2010, REV CLIN GERONTOL, V20, P128, DOI 10.1017/S0959259810000079
   Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6
   Bleijenberg N, 2016, J AM GERIATR SOC, V64, P1779, DOI 10.1111/jgs.14325
   Bleijenberg N, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-16
   Covinsky KE, 1999, AM J MED, V106, P435, DOI 10.1016/S0002-9343(99)00052-2
   Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x
   Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556
   Deeg D.J.H., 2013, AGING EUROPEAN SOC, P117
   den Ouden ME, 2013, EXP GERONTOL
   Drubbel I., 2012, J GERONTOLOGY A
   Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728
   Finlayson M, 2005, J CLIN EPIDEMIOL, V58, P338, DOI 10.1016/j.jclinepi.2004.10.008
   Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x
   Gill TM, 2013, J AM MED DIR ASSOC, V14, P280, DOI 10.1016/j.jamda.2012.11.011
   Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x
   Gjonça E, 2009, J EPIDEMIOL COMMUN H, V63, P928, DOI 10.1136/jech.2008.082776
   GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746
   Han L, 2013, ANN EPIDEMIOL, V23, P87, DOI 10.1016/j.annepidem.2012.11.010
   Hoeymans N, 2012, AM J PUBLIC HEALTH, V102, P163, DOI 10.2105/AJPH.2011.300296
   Hoogendijk E, 2008, INT J PUBLIC HEALTH, V53, P281, DOI 10.1007/s00038-008-8079-9
   Hoogendijk EO, 2013, AGE AGEING, V42, P262, DOI 10.1093/ageing/afs163
   Judge JO, 1996, J AM GERIATR SOC, V44, P1332, DOI 10.1111/j.1532-5415.1996.tb01404.x
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016
   Kim K, J NUTR HLTH AGING, P1
   Klijs B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025325
   Laan W, 2013, MATURITAS
   Lin Jennifer S, 2012, J Am Geriatr Soc, V60, P2157, DOI 10.1111/j.1532-5415.2012.04214.x
   Lin SF, 2012, AM J PUBLIC HEALTH, V102, P2157, DOI 10.2105/AJPH.2011.300602
   Millán-Calenti JC, 2010, ARCH GERONTOL GERIAT, V50, P306, DOI 10.1016/j.archger.2009.04.017
   Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738
   Sjölund BM, 2014, ARCH GERONTOL GERIAT, V58, P370, DOI 10.1016/j.archger.2013.12.004
   Smith AK, 2013, JAMA INTERN MED, V173, P1506, DOI 10.1001/jamainternmed.2013.8738
   Stineman MG, 2011, J AM GERIATR SOC, V59, P454, DOI 10.1111/j.1532-5415.2010.03287.x
   VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1
   WEINBERGER M, 1992, J AM GERIATR SOC, V40, P585, DOI 10.1111/j.1532-5415.1992.tb02107.x
NR 36
TC 16
Z9 17
U1 4
U2 32
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 1279-7707
EI 1760-4788
J9 J NUTR HEALTH AGING
JI J. Nutr. Health Aging
PD DEC
PY 2017
VL 21
IS 10
BP 1314
EP 1320
DI 10.1007/s12603-016-0862-3
PG 7
WC Geriatrics & Gerontology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Nutrition & Dietetics
GA FP6MT
UT WOS:000417740900034
PM 29188895
DA 2024-02-19
ER

PT J
AU Marino, M
   Pallottini, V
   D'Eramo, C
   Cavallini, G
   Bergamini, E
   Trentalance, A
AF Marino, M
   Pallottini, V
   D'Eramo, C
   Cavallini, G
   Bergamini, E
   Trentalance, A
TI Age-related changes of cholesterol and dolichol biosynthesis in rat
   liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT 5th International NILS Workshop on Longevity Sciences
CY NOV 30-DEC 01, 2000
CL AICHI, JAPAN
SP Japan Fdn Aging & Hlth
DE dolichol; cholesterol; 3-hydroxy-3-methyl-glutaryl CoA reductase;
   ageing; caloric restriction; rat liver
ID HUMAN-TISSUES; METABOLISM; PHOSPHATE; ACCUMULATION; RESTRICTION
AB Ageing has been defined as a gradually decreased ability to maintain homeostatic potential and increased risk to die, associated with a tissue accumulation of altered proteins and lipids. Among other, increased concentration of an isoprenoid compound, dolichol (Dol), in mammalian tissues during ageing has been reported and it has been considered as a new biomarker of ageing. However, the mechanism and the role of this accumulation is still unknown. Aim of this work was to study the mechanism of age-dependent Dol accumulation in the liver analysing the activity of the hepatic rate-limiting enzyme of isoprenoid biosynthesis, the 3-hydroxy 3-methylglutaryl CoA reductase (HMGCoA reductase), the Dol synthesis by mevalonate (MVA), the Dol level in the plasma, and the cholesterol (Chol) synthesis and content of ageing rat fed ad libitum (AL) or subjected to the effect of food restriction. Since the caloric restrictions are the most reproducible way to slow ageing and to extend life span, animals on these nutritional regimens were used to study ageing related mechanisms. The data show that during ageing the hepatic Dol accumulation is associated with an increase of HMGCoA reductase activity, which is affected by diet restriction, and with an increase of MVA incorporation in Dol and Chol, which is not. In addition, the liver of aged rats maintains the capability to regulate its Chol content and to modify Chol delivery into the blood. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Roma Tre, Dept Biol, I-00146 Rome, Italy.
   Dept Expt Pathol, I-56126 Pisa, Italy.
C3 Roma Tre University
RP Marino, M (corresponding author), Univ Roma Tre, Dept Biol, Vle Marconi 446, I-00146 Rome, Italy.
RI Pallottini, Valentina/AAA-3218-2021
OI Pallottini, Valentina/0000-0003-2511-6168
CR ADAIR WL, 1982, J BIOL CHEM, V257, P8990
   BRUSCALUPI G, 1985, CELL MOL BIOL, V31, P365
   CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059
   CHOJNACKI T, 1988, BIOCHEM J, V251, P1
   CONCONI M, 1996, ARCH BIOCHEM BIOPHYS, V309, P24
   EGGENS I, 1983, BIOCHIM BIOPHYS ACTA, V751, P355, DOI 10.1016/0005-2760(83)90294-1
   ELMBERGER PG, 1989, LIPIDS, V24, P919, DOI 10.1007/BF02544535
   ERICSSON J, 1993, BIOCHIMIE, V75, P167, DOI 10.1016/0300-9084(93)90074-3
   Gruenler Jacob, 1994, Biochimica et Biophysica Acta, V1212, P259
   KIN NMKNY, 1983, J NEUROCHEM, V40, P1465, DOI 10.1111/j.1471-4159.1983.tb13592.x
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   MARINO M, 1990, BIOCHIM BIOPHYS ACTA, V1047, P192, DOI 10.1016/0005-2760(90)90047-2
   MARINO M, 1986, BIOSCIENCE REP, V257, P409
   MASORO EJ, 1995, HDB PHYSL AGEING
   Nanni G, 2000, LIFE SCI, V67, P2293, DOI 10.1016/S0024-3205(00)00819-5
   RIP JW, 1985, BIOCHEM J, V227, P705, DOI 10.1042/bj2270705
   Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
   VALTERSSON C, 1985, J BIOL CHEM, V260, P2742
   VIGO C, 1984, BIOCHIM BIOPHYS ACTA, V774, P221, DOI 10.1016/0005-2736(84)90295-5
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
NR 23
TC 38
Z9 42
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD APR 30
PY 2002
VL 123
IS 8
BP 1183
EP 1189
AR PII S0047-6374(02)00009-X
DI 10.1016/S0047-6374(02)00009-X
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 580MN
UT WOS:000177238500040
PM 12044967
DA 2024-02-19
ER

PT J
AU Palomero, J
   Galán, AI
   Muñoz, ME
   Tuñón, MJ
   González-Gallego, J
   Jiménez, R
AF Palomero, J
   Galán, AI
   Muñoz, ME
   Tuñón, MJ
   González-Gallego, J
   Jiménez, R
TI Effects of aging on the susceptibility to the toxic effects of
   cyclosporin A in rats.: Changes in liver glutathione and antioxidant
   enzymes
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE aging; antioxidant enzymes; cyclosporin A; free radicals; glutathione;
   hepatotoxicity; lipoperoxidation; liver; oxidative stress
ID INDUCED LIPID-PEROXIDATION; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE;
   BILIARY-SECRETION; FREE-RADICALS; DEFENSE; AGE; HEPATOTOXICITY;
   CATALASE; KIDNEY
AB Free radicals are involved in aging and cyclosporin A-induced toxicity. The age-related changes in the liver oxidative status of glutathione, lipid peroxidation, and the activity of the enzymatic antioxidant defense system, as well as the influence of aging on the susceptibility to the hepatotoxic effects of cyclosporin (CyA) were investigated in rats of different ages (1, 2, 4, and 24 months). The hepatic content of reduced glutathione (GSH) increased with aging, peaked at 4 months, and decreased in senescent rats. By contrast, glutathione disulfide (GSSG) and thiobarbituric acid-reactive substances (TBARS) concentrations and superoxide dismutase, catalase, and glutathione peroxidase activities were higher in the oldest than in the youngest rats. CyA treatment, besides inducing the well-known cholestatic syndrome, increased liver GSSG and TEARS contents and the GSSG/GSH molar ratio, and altered the nonenzymatic and enzymatic antioxidant defense systems. The CyA-induced cholestasis and hepatic depletion of GSH, and the increases in the GSSG/GSH ratio, and in GSSG and TEARS concentrations were higher in the older than the mature rats. Moreover, superoxide dismutase and catalase activities were found to be significantly decreased only in treated senescent rats. The higher CyA-induced oxidative stress, lipoperoxidation, and decreases in the antioxidant defense systems in the aged animals render them more susceptible to the hepatotoxic effects of cyclosporin. (C) 2001 Elsevier Science Inc.
C1 Univ Salamanca, Dept Fisiol & Farmacol, E-37007 Salamanca, Spain.
   Univ Leon, Dept Physiol, E-24071 Leon, Spain.
C3 University of Salamanca; Universidad de Leon
EM rajim@gugu.usal.es
RI Hernández, Ana Isabel Galán/AAC-5862-2021; JIMENEZ,
   RAFAEL/AAB-9656-2020; Tuñón, María Jesús/L-2456-2017; Palomero,
   Jesus/L-4783-2014; Gonzalez-Gallego, Javier/D-8219-2012
OI Hernández, Ana Isabel Galán/0000-0002-8879-4372; Palomero,
   Jesus/0000-0002-1013-9992; Gonzalez-Gallego, Javier/0000-0002-4386-9342
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Allen RG, 1998, AGE, V21, P47, DOI 10.1007/s11357-998-0007-7
   ATKINSON K, 1983, TRANSPLANT P, V15, P2761
   BACKMAN L, 1986, EXP MOL PATHOL, V45, P31, DOI 10.1016/0014-4800(86)90004-3
   Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465
   BEYER RE, 1990, FREE RADICAL BIO MED, V8, P545, DOI 10.1016/0891-5849(90)90154-B
   BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6
   Borel J F, 1996, Adv Pharmacol, V35, P115, DOI 10.1016/S1054-3589(08)60276-8
   CADRANEL JF, 1992, DIGEST DIS SCI, V37, P1473, DOI 10.1007/BF01296488
   CADRANEL JF, 1992, GASTROEN CLIN BIOL, V16, P314
   CADRANEL JF, 1990, J HEPATOL S, V14, P11
   CALNE RY, 1978, LANCET, V2, P1323
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Chan FKL, 1998, J HEPATOL, V28, P329, DOI 10.1016/0168-8278(88)80021-7
   CHRISTON R, 1995, J NUTR, V125, P3062
   deLema GP, 1997, TRANSPL P, V29, P1241
   Deters M, 1997, TOXICOLOGY, V123, P197, DOI 10.1016/S0300-483X(97)00123-6
   Durak I, 1998, NEPHRON, V78, P207, DOI 10.1159/000044912
   DURUIBE VA, 1989, PHARMACOLOGY, V39, P205, DOI 10.1159/000138599
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   FERNANDEZ E, 1995, J PHARMACOL EXP THER, V275, P442
   FERNANDEZ E, 1996, RECENT RES DEV ANTIM, V1, P181
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Galán AI, 1999, J PHARMACOL EXP THER, V290, P774
   GALAN AI, 1995, CLIN EXP PHARMACOL P, V22, P260, DOI 10.1111/j.1440-1681.1995.tb01991.x
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   INSELMANN G, 1991, EUR J CLIN INVEST, V21, P461, DOI 10.1111/j.1365-2362.1991.tb01395.x
   INSELMANN G, 1990, RES COMMUN CHEM PATH, V68, P189
   JENKINSON SG, 1991, AM J MED SCI, V302, P347, DOI 10.1097/00000441-199112000-00004
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   Jiménez R, 2000, CLIN EXP PHARMACOL P, V27, P991, DOI 10.1046/j.1440-1681.2000.03382.x
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   KRAHENBUHL S, 1994, HEPATOLOGY, V19, P471, DOI 10.1016/0270-9139(94)90027-2
   LOBER MI, 1987, TRANSPLANTATION, V43, P35
   Marchetti P, 2000, J ENDOCRINOL INVEST, V23, P482, DOI 10.1007/BF03343761
   MCCASHLAND TM, 1994, HEPATOLOGY, V19, P1381, DOI 10.1002/hep.1840190611
   McGrath LT, 1997, CLIN CHIM ACTA, V264, P1, DOI 10.1016/S0009-8981(97)00088-0
   MERTENS K, 1991, T AGING RES, V16, P165
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Morán D, 1998, J HEPATOL, V29, P68, DOI 10.1016/S0168-8278(98)80180-3
   NANJI AA, 1995, J LIPID RES, V36, P736
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PALOMERO J, 1998, GASTROENTEROL HEP S2, V21, P44
   PANOZZO MP, 1995, CLIN EXP PHARMACOL P, V22, P266, DOI 10.1111/j.1440-1681.1995.tb01992.x
   PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T
   Polavarapu R, 1998, HEPATOLOGY, V27, P1317, DOI 10.1002/hep.510270518
   REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   Rikans LE, 1997, ENVIRON TOXICOL PHAR, V4, P339, DOI 10.1016/S1382-6689(97)10032-1
   SADEG N, 1993, DRUG CHEM TOXICOL, V16, P165, DOI 10.3109/01480549309031994
   Sánchez-Campos S, 1999, PARASITOL RES, V85, P468, DOI 10.1007/s004360050579
   Santori G, 1997, RES COMMUN MOL PATH, V98, P165
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   SCHADE RR, 1983, TRANSPLANT P, V15, P2757
   SEKURA R, 1977, J BIOL CHEM, V252, P2599
   SOKOL RJ, 1993, HEPATOLOGY, V17, P869
   Tariq M, 1999, RENAL FAILURE, V21, P35, DOI 10.3109/08860229909066968
   TSAI LY, 1993, CLIN CHIM ACTA, V215, P41, DOI 10.1016/0009-8981(93)90247-2
   Vendemiale G, 1999, INT J CLIN LAB RES, V29, P49, DOI 10.1007/s005990050063
   Wolf A, 1997, J PHARMACOL EXP THER, V280, P1328
   YU BP, 1996, ANN NY ACAD SCI, V789, P1
NR 67
TC 71
Z9 75
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD APR 15
PY 2001
VL 30
IS 8
BP 836
EP 845
DI 10.1016/S0891-5849(01)00471-3
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 421KG
UT WOS:000168063100003
PM 11295526
DA 2024-02-19
ER

PT J
AU Kaji, K
   Factor, VM
   Andersen, JB
   Durkin, ME
   Tomokuni, A
   Marquardt, JU
   Matter, MS
   Hoang, T
   Conner, EA
   Thorgeirsson, SS
AF Kaji, Kosuke
   Factor, Valentina M.
   Andersen, Jesper B.
   Durkin, Marian E.
   Tomokuni, Akira
   Marquardt, Jens U.
   Matter, Matthias S.
   Hoang, Tanya
   Conner, Elizabeth A.
   Thorgeirsson, Snorri S.
TI DNMT1 Is a Required Genomic Regulator for Murine Liver Histogenesis and
   Regeneration
SO HEPATOLOGY
LA English
DT Article
ID DNA METHYLATION; DUCTULAR REACTIONS; PROGENITOR CELLS; GENE-EXPRESSION;
   STEM; HEPATOCYTES; MAINTENANCE; SENESCENCE; INSIGHTS; ORIGIN
AB DNA methyltransferase 1 (DNMT1) is an essential regulator maintaining both epigenetic reprogramming during DNA replication and genome stability. We investigated the role of DNMT1 in the regulation of postnatal liver histogenesis under homeostasis and stress conditions. We generated Dnmt1 conditional knockout mice (Dnmt1(Delta alb)) by crossing Dnmt1(fl/fl) with albumin-cyclization recombination transgenic mice. Serum, liver tissues, and primary hepatocytes were collected from 1-week-old to 20-week old mice. The Dnmt1(Delta alb) phenotype was assessed by histology, confocal and electron microscopy, biochemistry, as well as transcriptome and methylation profiling. Regenerative growth was induced by partial hepatectomy and exposure to carbon tetrachloride. The impact of Dnmt1 knockdown was also analyzed in hepatic progenitor cell lines; proliferation, apoptosis, DNA damage, and sphere formation were assessed. Dnmt1 loss in postnatal hepatocytes caused global hypomethylation, enhanced DNA damage response, and initiated a senescence state causing a progressive inability to maintain tissue homeostasis and proliferate in response to injury. The liver regenerated through activation and repopulation from progenitors due to lineage-dependent differences in albumin-cyclization recombination expression, providing a basis for selection of less mature and therefore less damaged hepatic progenitor cell progeny. Consistently, efficient knockdown of Dnmt1 in cultured hepatic progenitor cells caused severe DNA damage, cell cycle arrest, senescence, and cell death. Mx1-cyclization recombination-driven deletion of Dnmt1 in adult quiescent hepatocytes did not affect liver homeostasis. Conclusion: These results establish the indispensable role of DNMT1-mediated epigenetic regulation in postnatal liver growth and regeneration; Dnmt1(Delta alb) mice provide a unique experimental model to study the role of senescence and the contribution of progenitor cells to physiological and regenerative liver growth.
C1 [Kaji, Kosuke; Factor, Valentina M.; Andersen, Jesper B.; Durkin, Marian E.; Tomokuni, Akira; Marquardt, Jens U.; Matter, Matthias S.; Hoang, Tanya; Conner, Elizabeth A.; Thorgeirsson, Snorri S.] NCI, Lab Expt Carcinogenesis, Ctr Canc Res, NIH, 37 Convent Dr,MSC 4262,Bldg 37,Room 4146A, Bethesda, MD 20892 USA.
   [Andersen, Jesper B.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.
   [Marquardt, Jens U.] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); University of Copenhagen; Johannes Gutenberg University of Mainz
RP Thorgeirsson, SS (corresponding author), NCI, Lab Expt Carcinogenesis, Ctr Canc Res, NIH, 37 Convent Dr,MSC 4262,Bldg 37,Room 4146A, Bethesda, MD 20892 USA.
EM snorri_thorgeirsson@nih.gov
OI Andersen, Jesper B/0000-0003-1760-5244; Marquardt,
   Jens/0000-0002-8314-2682; Matter, Matthias/0000-0002-2005-5266
FU Intramural Research Program of the National Institutes of Health,
   National Cancer Institute, Center for Cancer Research; German Cancer Aid
   [DKH 110989]; Volkswagen Foundation (Lichtenberg program)
FX Supported by the Intramural Research Program of the National Institutes
   of Health, National Cancer Institute, Center for Cancer Research. J.U.M.
   is supported by grants from the German Cancer Aid (DKH 110989) and the
   Volkswagen Foundation (Lichtenberg program).
CR Acevedo LG, 2008, CANCER RES, V68, P2641, DOI 10.1158/0008-5472.CAN-07-5590
   Berasain C, 2014, HEPATOLOGY, V59, P2080, DOI 10.1002/hep.27000
   Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507
   Brown KD, 2007, NAT GENET, V39, P289, DOI 10.1038/ng0307-289
   Campbell S, 2013, CELL CYCLE, V12, P2675, DOI 10.4161/cc.25795
   Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982
   Chen WD, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25766
   Elliott EN, 2015, DEVELOPMENT, V142, P2163, DOI 10.1242/dev.117341
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   FACTOR VM, 1994, AM J PATHOL, V145, P409
   Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912
   Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653
   Gailhouste L, 2013, HEPATOLOGY, V58, P1153, DOI 10.1002/hep.26422
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   Georgia S, 2013, GENE DEV, V27, P372, DOI 10.1101/gad.207001.112
   Hailfinger S, 2006, HEPATOLOGY, V43, P407, DOI 10.1002/hep.21082
   Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131
   Iverson SV, 2011, HEPATOLOGY, V54, P655, DOI 10.1002/hep.24398
   Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730
   Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002
   Jörs S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585
   Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133
   Lu H, 2012, EPIGENETICS-US, V7, P914, DOI 10.4161/epi.21113
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nagahama Y, 2014, AM J PATHOL, V184, P3001, DOI 10.1016/j.ajpath.2014.07.005
   Nikolaou KC, 2015, EMBO J, V34, P430, DOI 10.15252/embj.201489279
   Novikoff PM, 1998, J HISTOCHEM CYTOCHEM, V46, P613, DOI 10.1177/002215549804600507
   O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155
   Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007
   Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683
   Singh K, 2012, AUTOPHAGY, V8, P236, DOI 10.4161/auto.8.2.18600
   Snykers S, 2009, J HEPATOL, V51, P187, DOI 10.1016/j.jhep.2009.03.009
   Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453
   Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07
   Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008
   Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016
   Viré E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431
   Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413
   Waterland RA, 2009, HUM MOL GENET, V18, P3026, DOI 10.1093/hmg/ddp241
   Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112
   Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034
   Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
NR 45
TC 40
Z9 43
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD AUG
PY 2016
VL 64
IS 2
BP 582
EP 598
DI 10.1002/hep.28563
PG 17
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DR6TP
UT WOS:000380034500027
PM 26999257
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Kato, K
   Logsdon, NJ
   Shin, YJ
   Palumbo, S
   Knox, A
   Irish, JD
   Rounseville, SP
   Rummel, SR
   Mohamed, M
   Ahmad, K
   Trinh, JM
   Kurundkar, D
   Knox, KS
   Thannickal, VJ
   Hecker, L
AF Kato, Kosuke
   Logsdon, Naomi J.
   Shin, Yoon-Joo
   Palumbo, Sunny
   Knox, Adam
   Irish, Joseph D.
   Rounseville, Skye P.
   Rummel, Sydney R.
   Mohamed, Mohamed
   Ahmad, Kareem
   Trinh, Johnny M.
   Kurundkar, Deepali
   Knox, Kenneth S.
   Thannickal, Victor J.
   Hecker, Louise
TI Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving
   Fibrosis in Aging
SO AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
LA English
DT Article
DE MyoD; senescence; apoptosis resistance; pulmonary fibrosis;
   myofibroblast plasticity
ID IDIOPATHIC PULMONARY-FIBROSIS; FIBROBLAST SENESCENCE; CELLULAR
   SENESCENCE; DIFFERENTIATION; REVERSAL; TISSUE; LIVER; RESISTANCE;
   PIRFENIDONE; MECHANISMS
AB Idiopathic pulmonary fibrosis (IPF) is a fatal age-associated disease with no cure. Although IPF is widely regarded as a disease of aging, the cellular mechanisms that contribute to this age-associated predilection remain elusive. In this study, we sought to evaluate the consequences of senescence on myofibroblast cell fate and fibrotic responses to lung injury in the context of aging. We demonstrated that nonsenescent lung myofibroblasts maintained the capacity for dedifferentiation, whereas senescent/IPF myofibroblasts exhibited an impaired capacity for dedifferentiation. We previously demonstrated that the transcription factor MyoD acts as a critical switch in the differentiation and dedifferentiation of myofibroblasts. Here, we demonstrate that decreased levels of MyoD preceded myofibroblast dedifferentiation and apoptosis susceptibility in nonsenescent cells, whereas MyoD expression remained elevated in senescent/IPFmyofibroblasts, which failed to undergo dedifferentiation and demonstrated resistance to apoptosis. Genetic strategies to silence MyoD restored the susceptibility of IPF myofibroblasts to undergo apoptosis and led to a partial reversal of age-associated persistent fibrosis in vivo. The capacity for myofibroblast dedifferentiation and subsequent apoptosis may be critical for normal physiologic responses to tissue injury, whereas restricted dedifferentiation and apoptosis resistance in senescent cells may underlie the progressive nature of age-associated human fibrotic disorders. These studies support the concept that senescence may promote profibrotic effects via impaired myofibroblast dedifferentiation and apoptosis resistance, which contributes to myofibroblast accumulation and ultimately persistent fibrosis in aging.
C1 [Kato, Kosuke; Shin, Yoon-Joo; Palumbo, Sunny; Knox, Adam; Irish, Joseph D.; Rounseville, Skye P.; Rummel, Sydney R.; Mohamed, Mohamed; Ahmad, Kareem; Trinh, Johnny M.; Kurundkar, Deepali; Hecker, Louise] Univ Arizona, Div Pulm Allergy & Crit Care & Sleep Med, Tucson, AZ 85724 USA.
   [Logsdon, Naomi J.; Thannickal, Victor J.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.
   [Knox, Kenneth S.] Univ Arizona, Dept Med, Coll Med Phoenix, Div Pulm & Crit Care Med, Phoenix, AZ USA.
   [Thannickal, Victor J.] Birmingham VA Med Ctr, Birmingham, AL USA.
   [Hecker, Louise] Southern Arizona VA Hlth Care Syst, Tucson, AZ USA.
C3 University of Arizona; University of Alabama System; University of
   Alabama Birmingham; University of Arizona; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical
   Center - Birmingham; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Southern Arizona Veterans Affairs Health Care
   System
RP Hecker, L (corresponding author), Univ Arizona, Dept Med, Div Pulm Allergy & Crit Care & Sleep Med, 1656 E Mabel St, Tucson, AZ 85724 USA.
EM lhecker@email.arizona.edu
RI kato, kosuke/I-5677-2015
OI kato, kosuke/0000-0001-9758-3262
FU Office of the Assistance Secretary of Defense for Health Affairs through
   the Peer Reviewed Medical Research Program [W81XWH-17-1-0443]; Veterans
   Administration Health System [1 I01 BX003919-01A1]; National Institutes
   of Health [1R21AG05476601, P01 HL114470, R01 AG046210]; VA Merit Award
   [I01BX003056]
FX Supported by the Office of the Assistance Secretary of Defense for
   Health Affairs through the Peer Reviewed Medical Research Program under
   award no. W81XWH-17-1-0443 (L.H.); Veterans Administration Health System
   grant 1 I01 BX003919-01A1 (L.H.); National Institutes of Health grants
   1R21AG05476601 (L.H.), P01 HL114470 (V.J.T.), and R01 AG046210 (V.J.T.);
   and VA Merit Award I01BX003056 (V.J.T.).
CR Al-Khalaf HH, 2013, AGE, V35, P549, DOI 10.1007/s11357-011-9378-2
   Alvarez D, 2017, AM J PHYSIOL-LUNG C, V313, pL1164, DOI 10.1152/ajplung.00220.2017
   Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240
   Bai L, 2019, AM J RESP CELL MOL, V60, P49, DOI 10.1165/rcmb.2018-0180OC
   BARJA F, 1986, LAB INVEST, V55, P226
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   BORDER WA, 1994, NEW ENGL J MED, V331, P1286
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Collard HR, 2010, AM J RESP CRIT CARE, V181, P771, DOI 10.1164/rccm.201001-0049ED
   Cui HC, 2017, AM J RESP CELL MOL, V56, P168, DOI 10.1165/rcmb.2016-0163OC
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   Driesen RB, 2014, CARDIOVASC RES, V101, P411, DOI 10.1093/cvr/cvt338
   Duan FF, 2019, AM J RESP CELL MOL, V60, P221, DOI 10.1165/rcmb.2018-0028OC
   El Agha E, 2017, CELL STEM CELL, V20, P261, DOI 10.1016/j.stem.2016.10.004
   Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0
   Fell CD, 2010, AM J RESP CRIT CARE, V181, P832, DOI 10.1164/rccm.200906-0959OC
   Flaherty KR, 2019, NEW ENGL J MED, V381, P1718, DOI 10.1056/NEJMoa1908681
   Garrison G, 2013, AM J RESP CELL MOL, V48, P550, DOI 10.1165/rcmb.2012-0262OC
   Hecker L, 2018, AM J PHYSIOL-LUNG C, V314, P1642, DOI 10.1152/ajplung.00275.2017
   Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182
   Hecker L, 2011, EXP CELL RES, V317, P1914, DOI 10.1016/j.yexcr.2011.03.016
   Hecker L, 2011, AM J MED SCI, V341, P431, DOI 10.1097/MAJ.0b013e31821a9d66
   Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78
   Hohmann MS, 2019, AM J RESP CELL MOL, V60, P28, DOI 10.1165/rcmb.2017-0289OC
   Jenkins RG, 2017, AM J RESP CELL MOL, V56, P667, DOI 10.1165/rcmb.2017-0096ST
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Karimi-Shah BA, 2015, NEW ENGL J MED, V372, P1189, DOI 10.1056/NEJMp1500526
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC
   Lehmann M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02367-2016
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490
   Mayorga M, 2004, J BIOL CHEM, V279, P34882, DOI 10.1074/jbc.M404616200
   Meyer K, 2016, J AM COLL CARDIOL, V67, P2018, DOI 10.1016/j.jacc.2016.02.047
   Misharin AV, 2018, AM J RESP CRIT CARE, V198, P834, DOI 10.1164/rccm.201806-1037ED
   Munguía-Reyes A, 2018, AM J RESP CELL MOL, V59, P65, DOI 10.1165/rcmb.2017-0115OC
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Pardo A, 2016, ANN AM THORAC SOC, V13, pS417, DOI 10.1513/AnnalsATS.201605-341AW
   Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC
   Raghu G, 2015, AM J RESP CRIT CARE, V191, P252, DOI 10.1164/rccm.201411-2044ED
   Rangarajan S, 2016, DRUGS, V76, P291, DOI 10.1007/s40265-015-0523-6
   Rangarajan S, 2016, AM J RESP CELL MOL, V54, P51, DOI 10.1165/rcmb.2014-0445OC
   Reddy AT, 2014, FASEB J, V28, P5299, DOI 10.1096/fj.14-256263
   Sanders YY, 2013, REDOX BIOL, V1, P8, DOI 10.1016/j.redox.2012.11.004
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Scruggs AM, 2018, AM J RESP CELL MOL, V59, P200, DOI 10.1165/rcmb.2017-0298OC
   Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810
   THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008
   Wallach-Dayan SB, 2015, J AUTOIMMUN, V59, P67, DOI 10.1016/j.jaut.2015.02.006
   Waters DW, 2018, AM J PHYSIOL-LUNG C, V315, pL162, DOI 10.1152/ajplung.00037.2018
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010
   Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412
   Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487
   Yang XH, 2014, EUR J PHARMACOL, V734, P83, DOI 10.1016/j.ejphar.2014.04.007
   Zhu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074535
NR 63
TC 48
Z9 52
U1 4
U2 16
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1044-1549
EI 1535-4989
J9 AM J RESP CELL MOL
JI Am. J. Respir. Cell Mol. Biol.
PD MAY
PY 2020
VL 62
IS 5
BP 633
EP 644
DI 10.1165/rcmb.2019-0092OC
PG 12
WC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
GA MY8BC
UT WOS:000558639600016
PM 31962055
OA Green Published
DA 2024-02-19
ER

PT J
AU Rikans, LE
   Lopez, TR
   Hornbrook, KR
AF Rikans, LE
   Lopez, TR
   Hornbrook, KR
TI Age and gender differences in hepatic ascorbic acid concentrations and
   NADPH-dehydroascorbic acid reductase activity
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE age and gender difference; ascorbic acid; dehydroascorbic acid
   reductase; rat liver
ID RAT-LIVER; PURIFICATION; GLUTATHIONE; TISSUES
AB Ascorbic acid content decreased with age in livers of male rats but not in those of female rats. The influence of aging on the regeneration of ascorbic acid from dehydroascorbic acid was investigated as a possible cause of declining ascorbate concentrations. The results demonstrate that hepatic NADPH-dehydroascorbic acid reductase activity is unaffected by aging.
RP Rikans, LE (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, POB 26901, OKLAHOMA CITY, OK 73190 USA.
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR DELBELLO B, 1994, BIOCHEM J, V304, P385, DOI 10.1042/bj3040385
   MACHLIN LJ, 1987, FASEB J, V1, P441, DOI 10.1096/fasebj.1.6.3315807
   MAELLARO E, 1994, BIOCHEM J, V301, P471, DOI 10.1042/bj3010471
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MEISTER A, 1992, BIOCHEM PHARMACOL, V44, P1905, DOI 10.1016/0006-2952(92)90091-V
   PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   RIKANS LE, 1992, J PHARMACOL EXP THER, V262, P271
   SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581
   STAHL RL, 1985, BIOCHIM BIOPHYS ACTA, V839, P119, DOI 10.1016/0304-4165(85)90189-8
   WELLS WW, 1994, J BIOENERG BIOMEMBR, V26, P369, DOI 10.1007/BF00762777
   ZANNONI V, 1974, BIOCHEM MED METAB B, V11, P41, DOI 10.1016/0006-2944(74)90093-3
NR 12
TC 13
Z9 13
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV 13
PY 1996
VL 91
IS 3
BP 165
EP 169
DI 10.1016/S0047-6374(96)01784-8
PG 5
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA WB689
UT WOS:A1996WB68900002
PM 9055240
DA 2024-02-19
ER

PT J
AU Gaia, S
   Olivero, A
   Smedile, A
   Ruella, M
   Abate, ML
   Fadda, M
   Rolle, E
   Omedè, P
   Bondesan, P
   Passera, R
   Risso, A
   Aragno, M
   Marzano, A
   Ciancio, A
   Rizzetto, M
   Tarella, C
AF Gaia, Silvia
   Olivero, Antonella
   Smedile, Antonina
   Ruella, Marco
   Abate, Maria Lorena
   Fadda, Maurizio
   Rolle, Emanuela
   Omede, Paola
   Bondesan, Paola
   Passera, Roberto
   Risso, Alessandra
   Aragno, Manuela
   Marzano, Alfredo
   Ciancio, Alessia
   Rizzetto, Mario
   Tarella, Corrado
TI Multiple courses of G-CSF in patients with decompensated cirrhosis:
   consistent mobilization of immature cells expressing hepatocyte markers
   and exploratory clinical evaluation
SO HEPATOLOGY INTERNATIONAL
LA English
DT Article
DE Bone marrow-derived stem cells; G-CSF; Liver advanced cirrhosis;
   Mobilization; CD34+ve cells; Hepatic markers
ID COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS;
   LIVER-INJURY; CHEMOTHERAPY
AB Introduction Bone marrow-derived cells (BMCs) include stem cells capable of self-renewal and differentiation into a variety of cell types. Administration of granulocyte colony-stimulating factor (G-CSF) induces the circulation of BMCs in the peripheral blood. A phase II prospective trial was carried out for evaluation of BMC mobilization induced by multiple courses of G-CSF in cirrhotic patients.
   Patients and methods Fifteen patients with advanced liver cirrhosis (Child-Pugh score a parts per thousand yen6 points) were enrolled and treated with a 3-day G-CSF course, administered at 3-month intervals for a total of four courses. BMC mobilization was assessed by evaluating CD34+ve cells using flow cytometry. Expressions of multiple hepatic and stem markers were assessed on mobilized CD34+ve cells. Feasibility and safety were explored; clinical and adverse events were compared to those of a control group. Telomere length was monitored to rule out early cell aging caused by G-CSF.
   Results A significant increase in G-CSF-induced circulating CD34+ve cells was consistently observed, although a progressive reduction of peak values was documented from cycle I to IV (p < 0.005). Mobilized CD34+ve cells expressed both stem and multiple hepatocyte markers, including mRNA of albumin and CYP2B6 (cytochrome P2 B6). Treatment was well tolerated, with no severe adverse events and no significant telomere length shortening following G-CSF. The procedure was safe. Overall, ten patients had either improved or had stable liver function tests (such as the Child-Pugh score), whereas five worsened and died from liver-related causes.
   Conclusion This study demonstrates that G-CSF can be safely administrated up to four times over a 1-year period in decompensated cirrhotic patients. The repeated BMC mobilization favors the circulation of stem cells coexpressing hepatic markers and mRNA of liver-related genes.
C1 [Gaia, Silvia; Olivero, Antonella; Smedile, Antonina; Abate, Maria Lorena; Rolle, Emanuela; Marzano, Alfredo; Ciancio, Alessia; Rizzetto, Mario] Univ Turin, S Giovanni Battista Hosp, Dept Gastrohepatol, AO Citta Salute & Sci, I-10126 Turin, Italy.
   [Ruella, Marco; Tarella, Corrado] Univ Turin, Div Hematol & Cell Therapy, Mauriziano Hosp, I-10126 Turin, Italy.
   [Fadda, Maurizio] Univ Turin, S Giovanni Battista Hosp, Dept Clin Nutr, AO Citta Salute & Sci, I-10126 Turin, Italy.
   [Omede, Paola; Bondesan, Paola] Univ Turin, S Giovanni Battista Hosp, Div Hematol 1, AO Citta Salute & Sci, I-10126 Turin, Italy.
   [Passera, Roberto] Univ Turin, S Giovanni Battista Hosp, Div Nucl Med 2, AO Citta Salute & Sci, I-10126 Turin, Italy.
   [Risso, Alessandra] Univ Turin, Ctr Mol Biotechnol, I-10126 Turin, Italy.
   [Aragno, Manuela] Univ Turin, Dept Med & Expt Oncol, I-10126 Turin, Italy.
C3 University of Turin; A.O.U. Citta della Salute e della Scienza di
   Torino; AOU San Giovanni Battista-Molinette; A.O.U. Citta della Salute e
   della Scienza di Torino; AOU San Giovanni Battista-Molinette; University
   of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San
   Giovanni Battista-Molinette; University of Turin; A.O.U. Citta della
   Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette;
   University of Turin; A.O.U. Citta della Salute e della Scienza di
   Torino; AOU San Giovanni Battista-Molinette; University of Turin;
   University of Turin; University of Turin
RP Gaia, S (corresponding author), Univ Turin, S Giovanni Battista Hosp, Dept Gastrohepatol, AO Citta Salute & Sci, C Bramante 88, I-10126 Turin, Italy.
EM silvia.gaia74@gmail.com
RI Passera, Roberto/ABI-7086-2020; Olivero, Antonella/K-8056-2019; marzano,
   alfredo/AAS-2988-2021; Ruella, Marco/GQP-8473-2022; Fadda,
   Maurizio/K-3091-2016
OI Olivero, Antonella/0000-0003-0327-3875; Ruella,
   Marco/0000-0003-4301-5811; Passera, Roberto/0000-0003-3372-2248; ARAGNO,
   Manuela/0000-0002-0453-5235; Fadda, Maurizio/0000-0001-9205-8450
FU Ministero Italiano Universita e Ricerca (MIUR) (PRIN) Rome, Italy;
   Ministero Italiano Universita e Ricerca (MIUR) (Ricerca locale), Rome,
   Italy; Regione Piemonte (Ricerca Sanitaria Finalizzata) Torino, Italy;
   Regione Piemonte (Ricerca Scientifica Applicata), Torino, Italy
FX This work was supported in part by grants from the Ministero Italiano
   Universita e Ricerca (MIUR) (PRIN 2006 and Ricerca locale), Rome, Italy;
   Regione Piemonte (Ricerca Sanitaria Finalizzata and Ricerca Scientifica
   Applicata), Torino, Italy. G-CSF Lenograstim (rHu G-CSF)
   (Myelostim<SUP>(R)</SUP>, Italfarmaco) was kindly provided by Azienda
   Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino
   (ex San Giovanni Battista of Torino). Study sponsors approved the design
   and protocol but had no involvement in the study design, data
   collection, analysis and interpretation, or in the writing of the report
   or the decision to submit the paper for publication.
CR Akard L P, 1996, J Hematother, V5, P271, DOI 10.1089/scd.1.1996.5.271
   Chow S, 2013, J CLIN APHERESIS, V28, P285, DOI 10.1002/jca.21252
   Corradini P, 2002, BLOOD, V99, P75, DOI 10.1182/blood.V99.1.75
   Couto BG, 2011, LIVER INT, V31, P391, DOI 10.1111/j.1478-3231.2010.02424.x
   Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251
   Gaia S, 2006, J GASTROEN HEPATOL, V21, P1801, DOI 10.1111/j.1440-1746.2006.04675.x
   Gaia S, 2006, J HEPATOL, V45, P13, DOI 10.1016/j.jhep.2006.02.018
   Garg V, 2012, GASTROENTEROLOGY, V142, P505, DOI 10.1053/j.gastro.2011.11.027
   Gehling UM, 2010, WORLD J GASTROENTERO, V16, P217, DOI 10.3748/wjg.v16.i2.217
   GIANNI AM, 1989, LANCET, V2, P580
   Haga J, 2007, STEM CELLS DEV, V16, P319, DOI 10.1089/scd.2006.0086
   Herencia C, 2011, J GASTROINTEST SURG, V15, P1459, DOI 10.1007/s11605-011-1541-7
   Hu B, 2008, AM J PHYSIOL-GASTR L, V295, pG45, DOI 10.1152/ajpgi.00024.2008
   Jin SZ, 2010, DIGEST DIS SCI, V55, P2805, DOI 10.1007/s10620-009-1117-5
   Lei Y, 2010, DIGEST DIS SCI, V55, P285, DOI 10.1007/s10620-009-0757-9
   Levesque JP, 2008, CURR OPIN ORGAN TRAN, V13, P53, DOI 10.1097/MOT.0b013e3282f42473
   Li N, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt22
   Lorenzini S, 2008, ALIMENT PHARM THERAP, V27, P932, DOI 10.1111/j.1365-2036.2008.03670.x
   Ng IOL, 2003, HEPATOLOGY, V38, P989, DOI 10.1053/jhep.2003.50395
   Panasiuk A, 2001, Rocz Akad Med Bialymst, V46, P100
   Pozotrigo M, 2013, BONE MARROW TRANSPL, V48, P1033, DOI 10.1038/bmt.2012.281
   Rocci A, 2007, EXP HEMATOL, V35, P673, DOI 10.1016/j.exphem.2006.12.006
   Ruella M, 2010, BONE MARROW TRANSPL, V45, P505, DOI 10.1038/bmt.2009.297
   Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182
   Spahr L, 2008, HEPATOLOGY, V48, P221, DOI 10.1002/hep.22317
   Swenson ES, 2008, LIVER INT, V28, P308, DOI 10.1111/j.1478-3231.2007.01659.x
   TARELLA C, 1995, BONE MARROW TRANSPL, V16, P223
   TARELLA C, 1991, EUR J CANCER, V27, P22, DOI 10.1016/0277-5379(91)90052-F
   Tarella C, 2010, CYTOTHERAPY, V12, P50, DOI 10.3109/14653240903300682
   Wan ZH, 2013, DIGEST DIS SCI, V58, P448, DOI 10.1007/s10620-012-2458-z
   Zocco MA, 2011, DIGEST LIVER DIS, V43, P147, DOI 10.1016/j.dld.2010.06.008
NR 31
TC 15
Z9 15
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1936-0533
EI 1936-0541
J9 HEPATOL INT
JI Hepatol. Int.
PD OCT
PY 2013
VL 7
IS 4
BP 1075
EP 1083
DI 10.1007/s12072-013-9473-9
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 264QS
UT WOS:000327895800016
PM 26202037
DA 2024-02-19
ER

PT J
AU Hofmann, JW
   McBryan, T
   Adams, PD
   Sedivy, JM
AF Hofmann, Jeffrey W.
   McBryan, Tony
   Adams, Peter D.
   Sedivy, John M.
TI The effects of aging on the expression of Wnt pathway genes in mouse
   tissues
SO AGE
LA English
DT Article
DE Aging; Wnt pathway; Cellular senescence
ID ADULT SMALL-INTESTINE; STEM-CELLS; CELLULAR SENESCENCE; SKELETAL-MUSCLE;
   DISEASE; CATENIN; RISK; FIBROSIS; ONSET; COLON
AB The Wnt signaling pathway is involved in the regulation of tissue patterning and organ development during embryogenesis and continues to contribute to the maintenance of tissue homeostasis in adulthood. Recently, Wnt signaling has also been implicated in the establishment and progression of replicative cellular senescence. Given the known roles of tissue homeostasis and cellular senescence in aging, we sought to determine whether Wnt signaling changes with age. We examined the expression of 84 Wnt pathway-related genes in the liver, lung, skeletal muscle, and brain tissue from young and old mice. Expression changes were compared with those seen in cellular senescence, and transcription factors that might mediate these changes were predicted bioinformatically. In aggregate, our data are indicative of a general decrease in Wnt signaling with age, especially in the lung and brain. Furthermore, the set of genes that are differentially expressed with age is distinct from the genes differentially expressed in cellular senescence. The transcription factors predicted to regulate these changes, Nf-kappa B, Myb, Nkx2-1, Nr5a2, and Ep300, are known to regulate inflammation, differentiation, lipid metabolism, and chromatin remodeling, all of which have previously been implicated in aging. Although our study does not address whether altered Wnt signaling is a cause or an effect of aging, the presence of a relationship between the two provides a starting point for further investigation.
C1 [Hofmann, Jeffrey W.; Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Labs Mol Med, Providence, RI 02903 USA.
   [McBryan, Tony; Adams, Peter D.] Univ Glasgow, Beatson Inst Canc Res, Glasgow, Lanark, Scotland.
   [McBryan, Tony; Adams, Peter D.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland.
C3 Brown University; University of Glasgow; Beatson Institute; University
   of Glasgow
RP Sedivy, JM (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Labs Mol Med, Providence, RI 02903 USA.
EM john_sedivy@brown.edu
OI Adams, Peter/0000-0002-0684-1770
FU NIH/NIA grants [R37 AG016694, R01 AG035328]; NRSA individual predoctoral
   MD/PhD fellowship from the NIH/NIA [F30 AG035592]; Glenn Award for
   Research on the Biological Mechanisms of Aging from the Glenn Foundation
   for Medical Research; BBSRC [BB/H021019/1] Funding Source: UKRI;
   Biotechnology and Biological Sciences Research Council [BB/H021019/1]
   Funding Source: researchfish
FX Research in the Sedivy laboratory was supported by NIH/NIA grants R37
   AG016694 and R01 AG035328 to J.M.S. J.W.H. was supported by a NRSA
   individual predoctoral MD/PhD fellowship from the NIH/NIA, F30 AG035592.
   J.M.S. was a senior scholar of the Ellison Medical Foundation and a
   recipient of the Glenn Award for Research on the Biological Mechanisms
   of Aging from the Glenn Foundation for Medical Research.
CR Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200
   Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903
   Arthur ST, 2012, INT J BIOL SCI, V8, P731, DOI 10.7150/ijbs.4262
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   Berwick DC, 2012, BIOCHEM SOC T, V40, P1123, DOI 10.1042/BST20120122
   Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4
   De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104
   Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2
   Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732
   Hoffman J, 2004, CELL CYCLE, V3, P554, DOI 10.4161/cc.3.5.858
   Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036
   Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100
   Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370
   Nelson DM, 2014, AGE IN PRESS
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82
   Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004
   Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034
NR 26
TC 42
Z9 46
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD JUN
PY 2014
VL 36
IS 3
BP 1033
EP 1040
DI 10.1007/s11357-014-9618-3
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AP5TT
UT WOS:000342142300003
PM 24488586
OA Green Published
DA 2024-02-19
ER

PT J
AU Chan, AW
   Patel, YA
   Choi, S
AF Chan, Austin W.
   Patel, Yuval A.
   Choi, Steve
TI Aging of the Liver: What This Means for Patients with HIV
SO CURRENT HIV/AIDS REPORTS
LA English
DT Article
DE Liver; HIV; Aging; Immunosenescence; Fibrogenesis; Co-infections
ID HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; SCAVENGER RECEPTOR
   CD163; STAGE RENAL-DISEASE; HUMAN KUPFFER CELLS; ALL-CAUSE MORTALITY;
   FIBROSIS PROGRESSION; IMMUNE ACTIVATION; BLOOD-FLOW; NATURAL-HISTORY
AB As the HIV population continues to live longer as a result of antiretroviral therapy, liver-related mortality has become one of the leading causes of non-AIDS related death in this patient population. The liver possesses a remarkable regenerative capacity but undergoes complex biological changes in response to aging and inflammation that result in decreased cellular regeneration and a tipping of the scales towards fibrogenesis. Patients with HIV infection have serological evidence of ongoing inflammation, with elevations in some biomarkers persisting despite adequate virologic control. In addition, HIV-co-infected patients have markers of advanced age on liver biopsy and increased prevalence of fibrosis as compared to an age-matched HCV mono-infected cohort. In this review, we will discuss the biology of aging, age-related changes in the liver, and the relevant mechanisms by which HIV causes inflammation in the context of accelerated aging, fibrosis of the liver, and other viral co-infection.
C1 [Chan, Austin W.] Duke Univ, Div Infect Dis, Dept Med, Sch Med, 315 Trent Dr,POB 102359, Durham, NC 27710 USA.
   [Patel, Yuval A.] Duke Univ, Sch Med, Dept Med, Div Gastroenterol, Durham, NC 27706 USA.
   [Choi, Steve] Duke Univ, Sch Med, Div Gastroenterol, Durham VA Med Ctr, Durham, NC USA.
C3 Duke University; Duke University; Duke University; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Durham VA
   Medical Center
RP Chan, AW (corresponding author), Duke Univ, Div Infect Dis, Dept Med, Sch Med, 315 Trent Dr,POB 102359, Durham, NC 27710 USA.
EM awc23@duke.edu
RI Choi, Steve/GZH-1598-2022
FU NEI NIH HHS [P30 EY001319, R01 EY013644, R01 EY019087] Funding Source:
   Medline; NIDDK NIH HHS [T32 DK007568] Funding Source: Medline; NIGMS NIH
   HHS [T32 GM086330] Funding Source: Medline
CR Aberg Judith A, 2012, Top Antivir Med, V20, P101
   Abraham AG, 2015, CLIN INFECT DIS, V60, P941, DOI 10.1093/cid/ciu919
   Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Ahsan MH, 2013, VIROLOGY, V446, P77, DOI 10.1016/j.virol.2013.07.026
   Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869
   Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604
   [Anonymous], 2015, HIV SURV REP
   Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6
   Assimakopoulos SF, 2014, INFECTION, V42, P951, DOI 10.1007/s15010-014-0666-5
   Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028
   Balagopal A, 2009, AIDS, V23, P2397, DOI 10.1097/QAD.0b013e3283324344
   Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137
   Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517
   Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336
   Bhatia-Dey N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00013
   Butt AA, 2015, JAMA INTERN MED, V175, P178, DOI 10.1001/jamainternmed.2014.6502
   Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Clayton F, 2001, AM J PATHOL, V159, P1933, DOI 10.1016/S0002-9440(10)63040-4
   Collins BH, 2013, LIVER INT, V33, P1175, DOI 10.1111/liv.12202
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Dandekar S, 2010, CURR OPIN HIV AIDS, V5, P173, DOI 10.1097/COH.0b013e328335eda3
   Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756
   Del Cornò M, 2016, J LEUKOCYTE BIOL, V100, P599, DOI 10.1189/jlb.4A1215-534R
   Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4
   Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026
   Dong MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014254
   Dubrow R, 2012, CURR OPIN ONCOL, V24, P506, DOI 10.1097/CCO.0b013e328355e131
   Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150
   Enomoto N, 2000, J GASTROEN HEPATOL, V15, pD20
   Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665
   Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064
   Fierbinteanu-Braticevici C, 2011, J GASTROINTEST LIVER, V20, P153
   Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055
   Gorenec L, 2016, MICROB PATHOGENESIS, V97, P125, DOI 10.1016/j.micpath.2016.06.008
   Green MR, 2008, CELL, V134, P562, DOI 10.1016/j.cell.2008.08.003
   Greuter T, 2016, J GASTROENTEROL, V51, P511, DOI 10.1007/s00535-016-1190-4
   Guaraldi G, 2011, ARCH MED RES, V42, P690, DOI 10.1016/j.arcmed.2011.12.009
   Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627
   Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21
   Hattab S, 2015, HIV MED, V16, P553, DOI 10.1111/hiv.12257
   Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711
   Hong IH, 2014, J BIOL CHEM, V289, P1106, DOI 10.1074/jbc.M113.526780
   Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007
   HOUSSET C, 1990, HUM PATHOL, V21, P404, DOI 10.1016/0046-8177(90)90202-G
   HUFERT FT, 1993, J ACQ IMMUN DEF SYND, V6, P772
   Hunt PW, 2014, CURR OPIN HIV AIDS, V9, P302, DOI 10.1097/COH.0000000000000072
   IBER FL, 1994, DRUG AGING, V5, P34, DOI 10.2165/00002512-199405010-00004
   Ipp H, 2014, CRIT REV CL LAB SCI, V51, P98, DOI 10.3109/10408363.2013.865702
   Kim CJ, 2012, MUCOSAL IMMUNOL, V5, P670, DOI 10.1038/mi.2012.72
   Kim CJ, 2013, J IMMUNOL, V191, P2164, DOI 10.4049/jimmunol.1300829
   Kim N, 2016, CNICS COH C RETR OPP
   Kirk GD, 2013, ANN INTERN MED, V158, P658, DOI 10.7326/0003-4819-158-9-201305070-00604
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Knudsen TB, 2016, J INFECT DIS, V214, P1198, DOI 10.1093/infdis/jiw263
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007
   Macías J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136
   Mahrouf-Yorgov M, 2011, REJUV RES, V14, P353, DOI 10.1089/rej.2010.1146
   MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   May MT, 2014, INT J EPIDEMIOL, V43, P691, DOI 10.1093/ije/dyt010
   Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196
   Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852
   Noureddin M, 2013, HEPATOLOGY, V58, P1644, DOI 10.1002/hep.26465
   Ottinger ME, 2014, SURG INFECT, V15, P800, DOI 10.1089/sur.2013.235
   Page EE, 2011, CURR OPIN HIV AIDS, V6, P472, DOI 10.1097/COH.0b013e32834bbc71
   Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16
   Patel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088934
   Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056
   POTTEN CS, 1990, DEVELOPMENT, V110, P1001
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x
   Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7
   Rueger S, 2015, GUT, V64, P1605, DOI 10.1136/gutjnl-2014-306997
   Sacchi P, 2015, DIGEST LIVER DIS, V47, P218, DOI 10.1016/j.dld.2014.11.012
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   SCHMITT MP, 1990, RES VIROLOGY, V141, P143, DOI 10.1016/0923-2516(90)90016-C
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8
   Sotaniemi EA, 1997, CLIN PHARMACOL THER, V61, P331, DOI 10.1016/S0009-9236(97)90166-1
   Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5
   Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042
   TOVO Cristiane Valle, 2013, Arq. Gastroenterol., V50, P19, DOI 10.1590/S0004-28032013000100005
   Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008
   Vance DE, 2011, J ASSOC NURSE AIDS C, V22, P17, DOI 10.1016/j.jana.2010.04.002
   Varadhan R, 2014, J GERONTOL A-BIOL, V69, P165, DOI 10.1093/gerona/glt023
   Verna E, 2016, NAFLD NASH HIV INFEC
   Videla LA, 2001, REDOX REP, V6, P155, DOI 10.1179/135100001101536265
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   Wada NI, 2015, AIDS, V29, P463, DOI 10.1097/QAD.0000000000000545
   Wakabayashi H, 2002, J SURG RES, V106, P246, DOI 10.1006/jsre.2002.6462
   Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147
   Wang KW, 2014, EXP TOXICOL PATHOL, V66, P351, DOI 10.1016/j.etp.2014.04.004
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 112
TC 7
Z9 7
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1548-3568
EI 1548-3576
J9 CURR HIV-AIDS REP
JI Curr. Hiv/Aids Rep.
PD DEC
PY 2016
VL 13
IS 6
BP 309
EP 317
DI 10.1007/s11904-016-0332-x
PG 9
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA EC4TO
UT WOS:000388127000001
PM 27557619
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Tollet-Egnell, P
   Flores-Morales, A
   Ståhlberg, N
   Malek, RL
   Lee, N
   Norstedt, G
AF Tollet-Egnell, P
   Flores-Morales, A
   Ståhlberg, N
   Malek, RL
   Lee, N
   Norstedt, G
TI Gene expression profile of the aging process in rat liver:: Normalizing
   effects of growth hormone replacement
SO MOLECULAR ENDOCRINOLOGY
LA English
DT Article
ID PROLIFERATOR-ACTIVATED RECEPTOR; AGE-RELATED-CHANGES; ALPHA PPAR-ALPHA;
   HEPATIC INSULIN-RESISTANCE; FATTY-ACID OXIDATION; UREA CYCLE ENZYMES;
   LIPID-METABOLISM; DEPENDENT CHANGES; MOUSE-LIVER; MITOCHONDRIA
AB The mechanisms that control life span and age-related phenotypes are not well understood. It has been suggested that aging or at least some of its symptoms are related to a physiological decline in GH levels with age. To test this hypothesis, and to improve our understanding of the cellular and molecular mechanisms behind the aging process, we have analyzed age-induced changes in gene expression patterns through the application of DNA chip technology. In the present study, the aging process was analyzed in rat liver in the presence or absence of GH replacement. Out of 3,000 genes printed on the microarrays, approximately 1,000 were detected in the rat liver. Among these, 47 unique transcripts were affected by the aging process in male rat livers. The largest groups of age-regulated transcripts encoded proteins involved in intermediary metabolism, mitochondrial respiration, and drug metabolism. Approximately 40% of the differentially expressed gene products were normalized after GH treatment. The majority of those transcripts have previously not been shown to be under GH control. The list of gene products that showed normalized expression levels in GH-treated old rats may shed further insight on the action and mechanism behind the positive effects of GH on, for example, fuel metabolism and body composition observed in different animal and human studies.
C1 Karolinska Hosp, Dept Mol Med, CMM, Karolinska Inst, S-17176 Stockholm, Sweden.
   Inst Genom Res, Rockville, MD 20850 USA.
C3 Karolinska Institutet; Karolinska University Hospital; J. Craig Venter
   Institute
RP Tollet-Egnell, P (corresponding author), Karolinska Hosp, Dept Mol Med, CMM, Karolinska Inst, L8-01, S-17176 Stockholm, Sweden.
EM petra.tollet.egnell@molmed.ki.se
FU NHLBI NIH HHS [HL-59781] Funding Source: Medline
CR ALEMANY J, 1988, EXP GERONTOL, V23, P25, DOI 10.1016/0531-5565(88)90017-4
   Angelin Bo, 1994, Current Opinion in Lipidology, V5, P160, DOI 10.1097/00041433-199405030-00002
   Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678
   BANDIERA S, 1986, ARCH BIOCHEM BIOPHYS, V248, P658, DOI 10.1016/0003-9861(86)90521-7
   Bartke A, 1998, ENDOCRINE, V8, P103, DOI 10.1385/ENDO:8:2:103
   Barzilai N, 1996, AM J PHYSIOL-ENDOC M, V270, pE930, DOI 10.1152/ajpendo.1996.270.6.E930
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   BLACKMAN MR, 1987, ENDOCRIN METAB CLIN, V16, P981, DOI 10.1016/S0889-8529(18)30454-7
   BOCOS C, 1995, J STEROID BIOCHEM, V53, P467, DOI 10.1016/0960-0760(95)00093-F
   BRADY PS, 1993, FASEB J, V7, P1039, DOI 10.1096/fasebj.7.11.8370473
   Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   CHATTERJEE B, 1986, J ENDOCRINOL, V108, P351, DOI 10.1677/joe.0.1080351
   CLEJAN S, 1980, ARCH BIOCHEM BIOPHYS, V203, P744, DOI 10.1016/0003-9861(80)90234-9
   CLEJAN S, 1986, ARCH BIOCHEM BIOPHYS, V246, P820, DOI 10.1016/0003-9861(86)90338-3
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115
   DEBEER LJ, 1983, DIABETES METAB, V9, P134
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Djouadi F, 1999, PROSTAG LEUKOTR ESS, V60, P339, DOI 10.1016/S0952-3278(99)80009-X
   DURNAM DM, 1983, ANAL BIOCHEM, V131, P385, DOI 10.1016/0003-2697(83)90188-4
   Eisen MB, 1999, METHOD ENZYMOL, V303, P179
   ENGEL F, 1964, METABOLIC ACTIONS PI, V5, P69
   Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717
   GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653
   Grofte T, 1997, HEPATOLOGY, V25, P964, DOI 10.1002/hep.510250429
   GUERRIERI F, 1994, BIOCHEM MOL BIOL INT, V33, P117
   GUSTAFSSON JA, 1983, ANNU REV PHYSIOL, V45, P51, DOI 10.1146/annurev.ph.45.030183.000411
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   HEUBI JE, 1983, J CLIN ENDOCR METAB, V57, P885, DOI 10.1210/jcem-57-5-885
   JEFFERY S, 1986, J ENDOCRINOL, V110, P123, DOI 10.1677/joe.0.1100123
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   JORGENSEN JOL, 1993, J CLIN ENDOCR METAB, V77, P1589, DOI 10.1210/jc.77.6.1589
   KAIKAUS RM, 1993, MOL CELL BIOCHEM, V123, P93, DOI 10.1007/BF01076479
   KATKOCIN DM, 1979, BIOCHEM MED METAB B, V22, P134, DOI 10.1016/0006-2944(79)90046-2
   KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160
   KIM JH, 1988, MECH AGEING DEV, V46, P263
   Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419
   MADDAIAH VT, 1981, ARCH BIOCHEM BIOPHYS, V210, P666, DOI 10.1016/0003-9861(81)90234-4
   MADDAIAH VT, 1976, ARCH BIOCHEM BIOPHYS, V173, P225, DOI 10.1016/0003-9861(76)90253-8
   MATSUBARA T, 1972, J BIOCHEM, V72, P1379, DOI 10.1093/oxfordjournals.jbchem.a130031
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   MODE A, 1989, MOL ENDOCRINOL, V3, P1142, DOI 10.1210/mend-3-7-1142
   MODE A, 1992, ADV ENZYME REGUL, V32, P255
   Mourrieras F, 1997, BIOCHEM J, V326, P345, DOI 10.1042/bj3260345
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   OHALLORAN DJ, 1995, GROWTH REGULAT, V5, P119
   PACITTI AJ, 1992, ANN SURG, V216, P353, DOI 10.1097/00000658-199209000-00015
   PALEKAR AG, 1981, BIOCHEM BIOPH RES CO, V100, P1604, DOI 10.1016/0006-291X(81)90702-6
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Rudling M, 1997, J CLIN INVEST, V99, P2239, DOI 10.1172/JCI119398
   RUDLING M, 1992, P NATL ACAD SCI USA, V89, P6983, DOI 10.1073/pnas.89.15.6983
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   SACCA L, 1994, ENDOCR REV, V15, P555, DOI 10.1210/er.15.5.555
   SATO T, 1995, BBA-LIPID LIPID MET, V1256, P327, DOI 10.1016/0005-2760(95)00040-J
   SCHMUCKER DL, 1990, EXP GERONTOL, V25, P403, DOI 10.1016/0531-5565(90)90029-2
   SCHUMER W, 1987, J GERONTOL, V42, P487, DOI 10.1093/geronj/42.5.487
   STEGER RW, 1993, J REPROD FERTIL, P61
   STROBL JS, 1994, PHARMACOL REV, V46, P1
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562
   TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129
   TIMIRAS PS, 1983, NEUROENDOCRINOLOGY A, P5
   Tollet-Egnell P, 2000, ENDOCRINOLOGY, V141, P910, DOI 10.1210/en.141.3.910
   Torra IP, 1999, CURR OPIN LIPIDOL, V10, P151, DOI 10.1097/00041433-199904000-00009
   Vance M L, 1998, Trans Am Clin Climatol Assoc, V109, P87
   VANLIEW JB, 1993, J GERONTOL, V48, pB184, DOI 10.1093/geronj/48.5.B184
   Verhelst J, 1997, CLIN ENDOCRINOL, V47, P485, DOI 10.1046/j.1365-2265.1997.3041112.x
   Verhoeven NM, 1998, J LIPID RES, V39, P66
   VIDAL H, 1993, METABOLISM, V42, P631, DOI 10.1016/0026-0495(93)90223-B
   VORBECK ML, 1982, ARCH BIOCHEM BIOPHYS, V214, P67, DOI 10.1016/0003-9861(82)90009-1
   WALKER RF, 1994, MECH AGEING DEV, V75, P215, DOI 10.1016/0047-6374(94)90011-6
   WOLF E, 1993, MECH AGEING DEV, V68, P71, DOI 10.1016/0047-6374(93)90141-D
   YAMADA J, 1995, RES COMMUN MOL PATH, V90, P173
   YAMADA J, 1994, ARCH BIOCHEM BIOPHYS, V315, P555, DOI 10.1006/abbi.1994.1536
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   ZAPHIROPOULOS PG, 1989, TRENDS PHARMACOL SCI, V10, P149, DOI 10.1016/0165-6147(89)90167-3
   Zhou YC, 1999, J BIOL CHEM, V274, P2672, DOI 10.1074/jbc.274.5.2672
NR 79
TC 83
Z9 88
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0888-8809
EI 1944-9917
J9 MOL ENDOCRINOL
JI Mol. Endocrinol.
PD FEB
PY 2001
VL 15
IS 2
BP 308
EP 318
DI 10.1210/me.15.2.308
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 398NH
UT WOS:000166762200009
PM 11158336
OA Bronze
DA 2024-02-19
ER

PT J
AU Zhang, YT
   Long, XD
   Ruan, X
   Wei, Q
   Zhang, L
   Wo, LL
   Huang, DD
   Lin, LS
   Wang, DF
   Xia, L
   Zhao, QH
   Liu, JL
   Zhao, Q
   He, M
AF Zhang, Yingting
   Long, Xidai
   Ruan, Xin
   Wei, Qian
   Zhang, Lin
   Wo, Lulu
   Huang, Dongdong
   Lin, Longshuai
   Wang, Difei
   Xia, Li
   Zhao, Qinghua
   Liu, Junling
   Zhao, Qian
   He, Ming
TI SIRT2-mediated deacetylation and deubiquitination of C/EBPβ prevents
   ethanol-induced liver injury
SO CELL DISCOVERY
LA English
DT Article
ID FATTY LIVER; FIBROBLAST ACTIVATION; OXIDATIVE STRESS; SIRT2;
   ACETYLATION; DISEASE; INFLAMMATION; LIPOCALIN-2; INHIBITION; FIBROSIS
AB Protein acetylation has emerged to play pivotal roles in alcoholic liver disease (ALD). Sirutin 2 (SIRT2) is a nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase involved in the regulation of aging, metabolism, and stress. However, the role of SIRT2 in ALD remains unclear. Here, we report that the SIRT2-mediated deacetylation-deubiquitination switch of CCAAT/enhancer-binding protein beta (C/EBP beta) prevents ALD. Our results showed that hepatic SIRT2 protein expression was negatively correlated with the severity of alcoholic liver injury in ALD patients. Liver-specific SIRT2 deficiency sensitized mice to ALD, whereas transgenic SIRT2 overexpression in hepatocytes significantly prevented ethanol-induced liver injury via normalization of hepatic steatosis, lipid peroxidation, and hepatocyte apoptosis. Mechanistically, we identified C/EBP beta as a critical substrate of SIRT2 implicated in ALD. SIRT2-mediated deacetylation at lysines 102 and 211 decreased C/EBP beta ubiquitination, resulting in enhanced protein stability and subsequently increased transcription of C/EBP beta-target gene LCN2. Importantly, hepatic deacetylated C/EBP beta and LCN2 compensation reversed SIRT2 deletion-induced ALD aggravation in mice. Furthermore, C/EBP beta protein expression was positively correlated with SIRT2 and LCN2 expression in the livers of ALD patients and was inversely correlated with ALD development. Therefore, activating SIRT2-C/EBP beta-LCN2 signaling pathway is a potential therapy for ALD.
C1 [Zhang, Yingting; Ruan, Xin; Wei, Qian; Wo, Lulu; Huang, Dongdong; Wang, Difei; Zhao, Qian; He, Ming] Shanghai Jiao Tong Univ, Minist Educ, Sch Med, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai, Peoples R China.
   [Long, Xidai] Youjiang Med Univ Nationalities, Affiliated Hosp, Dept Pathol, Baise, Guangxi, Peoples R China.
   [Zhang, Lin; Liu, Junling] Shanghai Jiao Tong Univ, Chinese Minist Educ, Dept Biochem & Mol Cell Biol, Sch Med,Key Lab Cell Differentiat & Apoptosis, Shanghai, Peoples R China.
   [Lin, Longshuai; Zhao, Qinghua] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Orthoped, Shanghai, Peoples R China.
   [Xia, Li] Shanghai Jiao Tong Univ, Sch Med, Dept Core Facil Basic Med Sci, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University; Youjiang Medical University for
   Nationalities; Shanghai Jiao Tong University; Shanghai Jiao Tong
   University; Shanghai Jiao Tong University
RP Zhao, Q; He, M (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Sch Med, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai, Peoples R China.
EM qzhao@shsmu.edu.cn; heming@shsmu.edu.cn
RI 核, 桃/AIC-1653-2022
OI He, Ming/0000-0002-2086-8312; wang, difei/0000-0001-7263-6401
FU National Natural Science Foundation of China [82070603, 92057118,
   81470841, 81772831, 81860489]; Shanghai Natural Science Foundation
   [19ZR1428400, 19ZR1440700]; Shanghai Pujiang Program by Science and
   Technology Commission of Shanghai Municipality [16PJ1405400]; Innovative
   research team of high-level local universities in Shanghai
   [SSMU-ZDCX20180800]; Youth Science and Technology Innovation Studio of
   Shanghai Jiao Tong University School of Medicine [JYKCGZS15]; Guangxi
   Natural Science Foundation [2017GXNSFGA198002, 2019AC19002]
FX This study was funded by the National Natural Science Foundation of
   China (82070603, 92057118, 81470841, and 81772831, 81860489); Shanghai
   Natural Science Foundation (19ZR1428400 and 19ZR1440700); Shanghai
   Pujiang Program by Science and Technology Commission of Shanghai
   Municipality (16PJ1405400); Innovative research team of high-level local
   universities in Shanghai (SSMU-ZDCX20180800); Youth Science and
   Technology Innovation Studio of Shanghai Jiao Tong University School of
   Medicine (JYKCGZS15); Guangxi Natural Science Foundation (Nos.
   2017GXNSFGA198002 and 2019AC19002). We thank Johan Auwerxd (Laboratory
   of Integrative Systems Physiology, NCEM, Ecole Polytechnique de
   Lausanne, Switzerland) for kindly providing the
   SIRT2<SUP>flox/flox</SUP> mice; Guoqiang Chen, Qing Zhong, Shaoming
   Shen, Xuyun Zhao (Shanghai Jiao Tong University School of Medicine), and
   Xiaoni Kong (Shanghai University of Traditional Chinese Medicine) for
   discussion; Core Facility of Basic Medical Sciences, Shanghai Jiao Tong
   University School of Medicine for the protein LC-MS analyses.
CR Altamirano J, 2014, GASTROENTEROLOGY, V146, P1231, DOI 10.1053/j.gastro.2014.01.018
   Arteaga M, 2016, AM J PHYSIOL-GASTR L, V310, pG1155, DOI 10.1152/ajpgi.00271.2015
   Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032
   Borkham-Kamphorst E, 2013, BBA-MOL BASIS DIS, V1832, P660, DOI 10.1016/j.bbadis.2013.01.014
   Cai Y, 2016, AM J PATHOL, V186, P2417, DOI 10.1016/j.ajpath.2016.05.006
   Chen JG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72172-7
   Chen YH, 2009, ACTA PHARMACOL SIN, V30, P1138, DOI 10.1038/aps.2009.109
   Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668
   Fuster D, 2018, NEW ENGL J MED, V379, P2579, DOI 10.1056/NEJMc1814129
   Gao B, 2016, GASTROENTEROLOGY, V150, P1704, DOI 10.1053/j.gastro.2016.01.025
   He FF, 2018, CELL PHYSIOL BIOCHEM, V46, P451, DOI 10.1159/000488613
   He M, 2020, CELL METAB, V31, P580, DOI 10.1016/j.cmet.2020.01.009
   Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857
   Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028
   Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563
   Katare PB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75301-4
   Kim D, 2019, GASTROENTEROLOGY, V157, P1055, DOI 10.1053/j.gastro.2019.06.026
   Kim HG, 2019, J HEPATOL, V71, P960, DOI 10.1016/j.jhep.2019.06.019
   Kim YY, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.105027
   Lee DH, 2019, BMB REP, V52, P190, DOI 10.5483/BMBRep.2019.52.3.083
   Lemos V, 2017, HUM MOL GENET, V26, P4105, DOI 10.1093/hmg/ddx298
   Li DJ, 2021, THERANOSTICS, V11, P4381, DOI 10.7150/thno.53652
   Li HJ, 2018, HEPATOLOGY, V68, P1604, DOI 10.1002/hep.29919
   Lin SZ, 2018, AGEING RES REV, V44, P22, DOI 10.1016/j.arr.2018.03.006
   Liu SS, 2019, IMMUNITY, V51, P522, DOI 10.1016/j.immuni.2019.06.014
   Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13
   Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103573
   Ponnusamy M, 2014, J PHARMACOL EXP THER, V350, P243, DOI 10.1124/jpet.113.212076
   Quan SH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34792-y
   Sarikhani M, 2018, CELL DEATH DIFFER, V25, P1638, DOI 10.1038/s41418-018-0069-8
   Sarikhani M, 2018, J BIOL CHEM, V293, P5281, DOI 10.1074/jbc.RA117.000915
   Satishchandran A, 2018, GASTROENTEROLOGY, V154, P238, DOI 10.1053/j.gastro.2017.09.022
   Singh CK, 2018, ANTIOXID REDOX SIGN, V28, P643, DOI 10.1089/ars.2017.7290
   Tang XQ, 2017, CIRCULATION, V136, P2051, DOI 10.1161/CIRCULATIONAHA.117.028728
   Teschke R, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6040106
   Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x
   Wang Y, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100961
   Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224
   Wieser V, 2016, J HEPATOL, V64, P872, DOI 10.1016/j.jhep.2015.11.037
   Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104
   Xu MJ, 2015, HEPATOLOGY, V61, P692, DOI 10.1002/hep.27447
   Yamada Y, 2016, FREE RADICAL RES, V50, P414, DOI 10.3109/10715762.2015.1134795
   Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534
   You Y, 2018, J HEPATOL, V69, P129, DOI 10.1016/j.jhep.2018.01.038
   Zhao D, 2020, BIOCHEM BIOPH RES CO, V533, P304, DOI 10.1016/j.bbrc.2020.09.035
   Zhao JJ, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0157-z
   Zheng RB, 2019, NUCLEIC ACIDS RES, V47, pD729, DOI 10.1093/nar/gky1094
NR 47
TC 17
Z9 18
U1 0
U2 23
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD OCT 12
PY 2021
VL 7
IS 1
AR 93
DI 10.1038/s41421-021-00326-6
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA WG1MK
UT WOS:000706762200001
PM 34642310
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Jeong, JW
   Lee, B
   Kim, DH
   Jeong, HO
   Moon, KM
   Kim, MJ
   Yokozawa, T
   Chung, HY
AF Jeong, Ji Won
   Lee, Bonggi
   Kim, Dae Hyun
   Jeong, Hyoung Oh
   Moon, Kyoung Mi
   Kim, Min Jo
   Yokozawa, Takako
   Chung, Hae Young
TI Mechanism of Action of Magnesium Lithospermate B against Aging and
   Obesity-Induced ER Stress, Insulin Resistance, and Inflammsome Formation
   in the Liver
SO MOLECULES
LA English
DT Article
DE magnesium lithospermate B; PPAR beta/delta; ER stress; insulin
   resistance; inflammasome; aging
ID ENDOPLASMIC-RETICULUM STRESS; FATTY-ACID OXIDATION; PPAR-DELTA; NLRP3
   INFLAMMASOME; HEPATIC STEATOSIS; GENE-EXPRESSION; BETA/DELTA;
   METABOLISM; PGC-1-ALPHA; ACTIVATION
AB Magnesium lithospermate B (MLB) is the biologically active compound of the water-soluble fraction of Salvia miltiorrhiza. Magnesium lithospermate B exhibits various biological functions, including antidiabetic, neuroprotective, and antioxidant effects. However, its beneficial effects on insulin sensitivity and related signaling pathways in the liver need to be elucidated. Our previous study reported that MLB is a PPAR beta/delta agonist in fibroblasts. Because insulin-sensitizing and anti-inflammatory effects of PPAR beta/delta has been reported in the liver, we investigated whether MLB has a beneficial effect on insulin-, ER stress- and inflammasome-related signaling in the livers of aging and obese animal models. Western blotting and protein-ligand docking simulation showed that MLB activated PPAR beta/delta and improved glucose tolerance in the livers of aging and obese animal models. MLB supplementation ameliorated aging or obesity-induced disruption of insulin signaling in the liver. Consistently, aging and obesity-induced increase in the protein levels of a gluconeogenic phosphoenolpyruvate carboxykinase was decreased by MLB. When molecular signaling pathways related to insulin signaling were examined in the liver, MLB supplementation suppressed ER stress- and inflammasome-related signaling molecules induced by aging and obesity. These results suggest that MLB may improve insulin resistance in the liver at least partially by suppressing ER stress and inflammasome formation in aging and obese animal models.
C1 [Jeong, Ji Won; Lee, Bonggi; Kim, Dae Hyun; Jeong, Hyoung Oh; Moon, Kyoung Mi; Kim, Min Jo; Chung, Hae Young] Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent MRCA, Coll Pharm, Busan 609735, South Korea.
   [Jeong, Ji Won] Coreana Cosmet Co Ltd, Cheonan Si 330833, Chungcheongnam, South Korea.
   [Lee, Bonggi] Korea Inst Oriental Med KIOM, Korean Med KM Applicat Ctr, Daegu 41062, South Korea.
   [Yokozawa, Takako] Univ Toyama, Grad Sch Sci & Engn Res, Toyama 9308555, Japan.
C3 Pusan National University; Korea Institute of Oriental Medicine (KIOM);
   University of Toyama
RP Chung, HY (corresponding author), Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent MRCA, Coll Pharm, Busan 609735, South Korea.
EM na881103@naver.com; bong3257@gmail.com; bioimmune@hanmail.net;
   gagagod84@gmail.com; omkksm@nate.com; kiki10304@gmail.com;
   yokozawa@inm.u-toyama.ac.jp; hyjung@pusan.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MSIP) [2009-0083538, NRF-2016R1C1B1008614]; Financial Supporting
   Project of Long-term Overseas Dispatch of PNU's Tenure-track Faculty
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No. 2009-0083538 and
   NRF-2016R1C1B1008614). This work was supported by the Financial
   Supporting Project of Long-term Overseas Dispatch of PNU's Tenure-track
   Faculty, 2015.
CR Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013
   Chen YJ, 2015, J FUNCT FOODS, V14, P163, DOI 10.1016/j.jff.2015.01.042
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Dibaise John K, 2013, Expert Rev Gastroenterol Hepatol, V7, P439, DOI 10.1586/17474124.2013.811061
   Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028
   Giordano C, 2009, PFLUG ARCH EUR J PHY, V458, P901, DOI 10.1007/s00424-009-0676-9
   Guo BC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00242
   Guo Shaodong, 2013, Drug Discov Today Dis Mech, V10, pe27
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025
   Jung YR, 2015, J NAT PROD, V78, P2110, DOI 10.1021/acs.jnatprod.5b00348
   Kim OK, 2015, ANN NUTR METAB, V67, P218, DOI 10.1159/000440905
   Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797
   Lebeaupin C., 2018, J HEPATOL
   Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103
   Lee MY, 2012, EXP MOL MED, V44, P578, DOI 10.3858/emm.2012.44.10.066
   Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4
   Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132
   Mollica MP, 2011, NUTR METAB CARDIOVAS, V21, P222, DOI 10.1016/j.numecd.2010.10.012
   Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041
   Muoio DM, 2004, SCIENCE, V306, P425, DOI 10.1126/science.1104680
   Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001
   Ozaki E, 2015, J INFLAMM RES, V8, P15, DOI 10.2147/JIR.S51250
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Palomer X, 2014, INT J CARDIOL, V174, P110, DOI 10.1016/j.ijcard.2014.03.176
   Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051
   Pan MH, 2010, FOOD FUNCT, V1, P15, DOI 10.1039/c0fo00103a
   Park CH, 2017, PHYTOTHER RES, V31, P721, DOI 10.1002/ptr.5789
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Reilly SM, 2008, FEBS LETT, V582, P26, DOI 10.1016/j.febslet.2007.11.040
   Roberts LD, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r75
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Salminen A, 2010, AGEING RES REV, V9, P211, DOI 10.1016/j.arr.2010.04.003
   Salvadó L, 2015, TRENDS ENDOCRIN MET, V26, P438, DOI 10.1016/j.tem.2015.05.007
   Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009
   Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09
   Shan WW, 2008, HEPATOLOGY, V47, P225, DOI 10.1002/hep.21925
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Song SH, 2014, CELL BIOCHEM BIOPHYS, V69, P347, DOI 10.1007/s12013-013-9806-2
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   YOKOZAWA T, 1992, NEPHRON, V60, P460, DOI 10.1159/000186809
   YOKOZAWA T, 1995, EXP TOXICOL PATHOL, V47, P341, DOI 10.1016/S0940-2993(11)80344-1
   Zhang Jinyu, 2016, J Clin Cell Immunol, V7
   Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112
   Zhao GR, 2008, FOOD CHEM TOXICOL, V46, P73, DOI 10.1016/j.fct.2007.06.034
   Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630
NR 49
TC 16
Z9 16
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2018
VL 23
IS 9
AR 2098
DI 10.3390/molecules23092098
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA GW9YP
UT WOS:000447365100011
PM 30134566
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU POST, DJ
   CARTER, KC
   PAPACONSTANTINOU, J
AF POST, DJ
   CARTER, KC
   PAPACONSTANTINOU, J
TI THE EFFECT OF AGING ON CONSTITUTIVE MESSENGER-RNA LEVELS AND
   LIPOPOLYSACCHARIDE INDUCIBILITY OF ACUTE PHASE GENES
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article
ID CELL-SPECIFIC EXPRESSION; POLY(A) BINDING-PROTEIN; ALPHA-1-ACID
   GLYCOPROTEIN; ALPHA-1-ANTITRYPSIN GENE; RIBONUCLEIC-ACID; RAT-LIVER;
   AGE; ALPHA-2U-GLOBULIN; SENESCENCE; INDUCTION
C1 UNIV TEXAS, MED BRANCH, DEPT HUMAN BIOL CHEM & GENET, F-43, GALVESTON, TX 77550 USA.
   SHRINERS BURN INST, GALVESTON UNIT, GALVESTON, TX 77550 USA.
C3 University of Texas System; University of Texas Medical Branch Galveston
CR ANDERSON KP, 1984, ARCH BIOCHEM BIOPHYS, V233, P624, DOI 10.1016/0003-9861(84)90488-0
   BAUMANN H, 1989, IN VITRO CELL DEV B, V25, P115
   BENNETT M, 1980, P NATL ACAD SCI-BIOL, V77, P6109, DOI 10.1073/pnas.77.10.6109
   BERNSTEIN P, 1989, TRENDS BIOCHEM SCI, V14, P373, DOI 10.1016/0968-0004(89)90011-X
   BIRCHENALLSPARKS MC, 1985, MECH AGEING DEV, V32, P99, DOI 10.1016/0047-6374(85)90039-9
   BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996
   BUTLER RN, 1987, AGING TODAYS ENV
   CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670
   CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0
   CARTER KC, 1989, J BIOL CHEM, V264, P515
   CARTER KC, 1991, IN PRESS BIOCH BIOPH
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CHIU KM, 1977, IMMUNOLOGY, V32, P997
   COOPER R, 1986, J BIOL CHEM, V261, P1849
   DARLINGTON GJ, 1986, J CELL BIOL, V103, P787, DOI 10.1083/jcb.103.3.787
   DESIMONE V, 1987, EMBO J, V6, P2759, DOI 10.1002/j.1460-2075.1987.tb02570.x
   ERIKSSON S, 1964, ACTA MED SCAND, V175, P197
   FLEMING JE, P NATL ACAD SCI USA, V85, P4099
   HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679
   IZBAN MG, 1989, J BIOL CHEM, V264, P9171
   KRAUTER KS, 1986, DNA-J MOLEC CELL BIO, V5, P29, DOI 10.1089/dna.1986.5.29
   KUCK U, 1985, CURR GENET, V9, P373, DOI 10.1007/BF00421608
   KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x
   LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324
   LIEHTSTEINER S, 1987, CELL, V51, P963
   MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487
   MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5
   MEDVEDEV ZA, 1984, MECH AGEING DEV, V28, P139, DOI 10.1016/0047-6374(84)90014-9
   MIFFLIN RC, 1988, SOMAT CELL MOLEC GEN, V14, P553, DOI 10.1007/BF01535310
   MONTGOMERY KT, 1990, MOL CELL BIOL, V10, P2625, DOI 10.1128/MCB.10.6.2625
   MORRONE G, 1988, J BIOL CHEM, V263, P12554
   MURTY CVR, 1988, BIOCHIM BIOPHYS ACTA, V949, P27, DOI 10.1016/0167-4781(88)90050-4
   NAGY IZ, 1988, ANN NY ACAD SCI, V521, P215
   ONO T, 1985, GERONTOLOGY, V31, P362, DOI 10.1159/000212725
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   PACIFICI GM, 1986, THER DRUG MONIT, V8, P259, DOI 10.1097/00007691-198609000-00003
   PAPACONSTANTINOU J, 1983, ARCH BIOCHEM BIOPHYS, V227, P542, DOI 10.1016/0003-9861(83)90483-6
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   RICHARDSON A, 1982, J GERONTOL, V37, P666, DOI 10.1093/geronj/37.6.666
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   RICHARDSON A, 1985, REV BIOL RES AGING, V2, P395
   ROY A, 1985, RES MONOGRAPHS CELL, V10
   ROY AK, 1985, MOL ASPECTS MED, V8, P1, DOI 10.1016/0098-2997(85)90004-4
   ROY AK, 1983, J BIOL CHEM, V258, P123
   ROY AK, 1984, 57TH P NOB S STER HO
   RUTHERFORD MS, 1986, MECH AGEING DEV, V35, P245, DOI 10.1016/0047-6374(86)90127-2
   RYAN RF, 1989, EXP CELL RES, V180, P36, DOI 10.1016/0014-4827(89)90210-3
   SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0
   SCHREIBER G, 1986, INFLAMMATION, V10, P59, DOI 10.1007/BF00916041
   SCHREIBER G, 1982, J BIOL CHEM, V257, P12071
   SENIOR RM, 1977, AM REV RESPIR DIS, V116, P469, DOI 10.1164/arrd.1977.116.3.469
   SHAIN SA, 1983, ENDOCRINOLOGY, V113, P1292, DOI 10.1210/endo-113-4-1292
   SHARP H L, 1971, Hospital Practice, V6, P83
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   WAGGONER S, 1990, GENETIC EFFECTS AGIN, V2, P255
   WAREHAM KA, 1987, NATURE, V327, P725, DOI 10.1038/327725a0
   WEBSTER GC, 1984, MECH AGEING DEV, V24, P335, DOI 10.1016/0047-6374(84)90118-0
   WELLINGER R, 1986, MECH AGEING DEV, V34, P203, DOI 10.1016/0047-6374(86)90035-7
NR 60
TC 15
Z9 15
U1 0
U2 1
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 E 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PD JUL 1
PY 1991
VL 621
BP 66
EP 77
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FZ453
UT WOS:A1991FZ45300005
DA 2024-02-19
ER

PT J
AU Ryu, SW
   Woo, JH
   Kim, YH
   Lee, YS
   Park, JW
   Bae, YS
AF Ryu, SW
   Woo, JH
   Kim, YH
   Lee, YS
   Park, JW
   Bae, YS
TI Downregulation of protein kinase CKII is associated with cellular
   senescence
SO FEBS LETTERS
LA English
DT Article
DE senescence; protein kinase CKII; gene silencing; human lung fibroblast;
   rat tissue
ID HUMAN FIBROBLASTS; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; CASEIN KINASE-2;
   NUCLEAR-MATRIX; IN-VIVO; CK2; CYCLE; EXPRESSION; TUMORS
AB Protein kinase CKII (CKII) plays a critical role in cell growth and proliferation. In this study, we examine how CKII activity is regulated during cellular senescence. Our results demonstrate that CKII activity apparently decreases during both replicative and H2O2-induced senescence in human diploid fibroblast IMR-90 cells. The mRNA and protein levels of CKII alpha decreases significantly during replicative and H2O2-induced senescence, while only slight reduction in those of CKII beta is observed during replicative senescence. Treatment of IMR-90 cells with CKII inhibitors 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole and apigenin led cells to acquire a senescent phenotype as judged by the senescence-associated P-galactosidase marker and overexpression of p53 and p21(Waf-1). Knockdown of CKII alpha in IMR-90 cells by RNA interference also dramatically induced the senescent phenotype. In parallel, CKII activity was transcriptional downregulated in rat liver and testis with advancing age. Taken together, these results suggest that downregulation of CKII activity is tightly associated not only with cellular senescence but also with organism aging. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea.
   Kyungpook Natl Univ, Coll Nat Sci, Dept Microbiol, Taegu 702701, South Korea.
C3 Kyungpook National University; Kyungpook National University
RP Bae, YS (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea.
EM ysbae@mail.knu.ac.kr
RI Park, Ji Won/JCD-9105-2023
OI Park, Ji Won/0000-0003-0046-8175; Bae, Young-Seuk/0000-0002-5520-4444
FU NIA NIH HHS [AG 01188] Funding Source: Medline
CR ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000
   BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112
   BOLDYREFF B, 1995, GENOMICS, V29, P253, DOI 10.1006/geno.1995.1239
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043
   DAYAMAKIN M, 1994, CANCER RES, V54, P2262
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9
   GIETZ RD, 1995, J BIOL CHEM, V270, P13017, DOI 10.1074/jbc.270.22.13017
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   Guo CH, 1999, CANCER RES, V59, P1146
   HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905
   HATHAWAY GM, 1979, J BIOL CHEM, V254, P762
   HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038
   ISSINGER OG, 1993, PHARMACOL THERAPEUT, V59, P1, DOI 10.1016/0163-7258(93)90039-G
   JAKOBI R, 1992, J BIOL CHEM, V267, P23894
   Kramer DL, 2001, CANCER RES, V61, P7754
   LIN WJ, 1991, J BIOL CHEM, V266, P5664
   Lorenz P, 1999, FEBS LETT, V448, P283, DOI 10.1016/S0014-5793(99)00388-9
   LORENZ P, 1993, J BIOL CHEM, V268, P2733
   MUNSTERMANN U, 1990, EUR J BIOCHEM, V189, P251, DOI 10.1111/j.1432-1033.1990.tb15484.x
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Niefind K, 1998, EMBO J, V17, P2451, DOI 10.1093/emboj/17.9.2451
   Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210
   Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291
   PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986
   PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X
   Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862
   SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shore LJ, 1997, J BIOL CHEM, V272, P12536, DOI 10.1074/jbc.272.19.12536
   STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Tawfic S, 1996, J CELL BIOCHEM, V62, P165, DOI 10.1002/(SICI)1097-4644(199608)62:2<165::AID-JCB4>3.0.CO;2-Q
   Villeponteau B, 1997, EXP GERONTOL, V32, P383, DOI 10.1016/S0531-5565(96)00155-6
   Wirkner U, 1998, GENOMICS, V48, P71, DOI 10.1006/geno.1997.5136
   Yamane K, 2005, CLIN CANCER RES, V11, P2355, DOI 10.1158/1078-0432.CCR-04-1734
   ZANDOMENI RO, 1989, BIOCHEM J, V262, P469, DOI 10.1042/bj2620469
   Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997
NR 39
TC 48
Z9 53
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD FEB 6
PY 2006
VL 580
IS 3
BP 988
EP 994
DI 10.1016/j.febslet.2006.01.028
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 010UD
UT WOS:000235222500041
PM 16442104
DA 2024-02-19
ER

PT J
AU SONG, CS
   RAO, TR
   DEMYAN, WF
   MANCINI, MA
   CHATTERJEE, B
   ROY, AK
AF SONG, CS
   RAO, TR
   DEMYAN, WF
   MANCINI, MA
   CHATTERJEE, B
   ROY, AK
TI ANDROGEN RECEPTOR MESSENGER-RIBONUCLEIC-ACID (MESSENGER-RNA) IN THE
   RAT-LIVER - CHANGES IN MESSENGER-RNA LEVELS DURING MATURATION, AGING,
   AND CALORIE RESTRICTION
SO ENDOCRINOLOGY
LA English
DT Article
ID ALPHA-2U-GLOBULIN GENE-EXPRESSION; GROWTH-HORMONE; DEPENDENT SYNTHESIS;
   SEXUAL DIMORPHISM; BINDING-PROTEIN; CYTOCHROME-P-450; INDUCTION;
   GLOBULIN; INCREASE; CLONING
AB By means of RNAase protection assay with an antisense cRNA probe, we have shown that the liver of the young adult male rat contains androgen receptor (AR) mRNA to a level of 4% compared to the prostate.  Steady state levels of AR mRNA in the liver show both sex and age specificity.  Compared to that of the male, the female liver contains a markedly reduced amount of AR mRNA.  AR mRNA is almost undetectable in livers of prepubertal male (< 35 days old) and senescent male (> 750 days old) rats.  Both prepubertal and senescent animals are relatively insensitive to the androgenic induction of alpha-2u-globulin, a hepatic secretory protein.  The agedependent decline in hepatic androgen sensitivity and AR mRNA level can be delayed considerably by a 40% reduction in the dietary calorie intake.  Analysis of poly (A)-containing RNA from two liver cell populations, hepatocytes and nonhepatocytes, revealed that only the hepatocytes that express alpha-2u-globulin gene contain AR mRNA.  From these results and our earlier observation of in vitro induction of alpha-2u-globulin in isolated rat liver, we conclude 1) that androgen can act directly on hepatocytes to promote alpha-2u-globulin synthesis; 2) that changes in the hepatic androgen sensitivity during maturation and aging are reflections of the age-dependent expression of the receptor gene; and 3) that retardation of the age-dependent loss of androgen sensitivity by calorie restriction is due to a concomitant delay in the decline of the hepatic AR mRNA level.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT OBSTET & GYNECOL,DIV MOLEC GENET,SAN ANTONIO,TX 78284.
   UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio
FU NIA NIH HHS [AG-03527] Funding Source: Medline; NIDDK NIH HHS [DK-14744]
   Funding Source: Medline
CR AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539
   BUZEK SW, 1988, BIOL REPROD, V39, P39, DOI 10.1095/biolreprod39.1.39
   CARTER ND, 1981, FEBS LETT, V128, P114, DOI 10.1016/0014-5793(81)81094-0
   CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211
   CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559
   DOLAN KP, 1983, BIOCHEM ACTION HORM, V10, P1
   EAGON PK, 1989, ARCH BIOCHEM BIOPHYS, V268, P161, DOI 10.1016/0003-9861(89)90577-8
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   GARG LC, 1974, J PHARMACOL EXP THER, V197, P297
   GILMAN M, 1987, CURRENT PROTOCOLS MO
   GUSTAFSSON JA, 1983, ANNU REV PHYSIOL, V45, P51, DOI 10.1146/annurev.ph.45.030183.000411
   GUZELIAN PS, 1988, P NATL ACAD SCI USA, V85, P9783, DOI 10.1073/pnas.85.24.9783
   HUSMAN B, 1985, MOL CELL ENDOCRINOL, V40, P205, DOI 10.1016/0303-7207(85)90176-5
   HWUNG YP, 1990, MOL CELL BIOL, V10, P1784, DOI 10.1128/MCB.10.4.1784
   JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128
   JEFFERY S, 1986, J ENDOCRINOL, V110, P123, DOI 10.1677/joe.0.1100123
   Kawasaki E. S., 1990, PCR PROTOCOLS GUIDE, P21
   LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   MILIN B, 1973, NATURE-NEW BIOL, V242, P248, DOI 10.1038/newbio242248a0
   MURTY CVR, 1987, ENDOCRINOLOGY, V121, P1814
   NORSTEDT G, 1984, CELL, V36, P805, DOI 10.1016/0092-8674(84)90030-8
   Pertoft H, 1987, CELL SEPARATION METH, P1
   QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P22, DOI 10.1210/mend-4-1-22
   ROSENFELD GC, 1972, BIOCHEM BIOPH RES CO, V46, P1695, DOI 10.1016/0006-291X(72)90805-4
   ROY AK, 1982, J BIOL CHEM, V257, P7834
   ROY AK, 1974, BIOCHIM BIOPHYS ACTA, V354, P213, DOI 10.1016/0304-4165(74)90008-7
   ROY AK, 1973, ENDOCRINOLOGY, V92, P957, DOI 10.1210/endo-92-3-957
   ROY AK, 1983, RECENT PROG HORM RES, V39, P425
   ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345
   ROY AK, 1975, ENDOCRINOLOGY, V94, P1501
   Sambrook J., 1989, MOL CLONING LABORATO, V2nd
   SARKAR FH, 1987, BIOCHEMISTRY-US, V26, P3965, DOI 10.1021/bi00387a033
   SARKAR FH, 1986, J ENDOCRINOL, V111, P205, DOI 10.1677/joe.0.1110205
   VANDIJCK P, 1989, MOL CELL ENDOCRINOL, V64, P195, DOI 10.1016/0303-7207(89)90146-9
   VERHOEVEN G, 1988, ENDOCRINOLOGY, V122, P1541, DOI 10.1210/endo-122-4-1541
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
   WEINDRUCH R, 1988, RETARDATION AGING DI
   ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5
NR 45
TC 79
Z9 86
U1 0
U2 0
PU ENDOCRINE SOC
PI BETHESDA
PA 4350 EAST WEST HIGHWAY SUITE 500, BETHESDA, MD 20814-4110
SN 0013-7227
J9 ENDOCRINOLOGY
JI Endocrinology
PD JAN
PY 1991
VL 128
IS 1
BP 349
EP 356
DI 10.1210/endo-128-1-349
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EQ492
UT WOS:A1991EQ49200045
PM 1986927
DA 2024-02-19
ER

PT J
AU Gunasekar, SK
   Heebink, J
   Carpenter, DH
   Kumar, A
   Xie, LT
   Zhang, HX
   Schilling, JD
   Sah, R
AF Gunasekar, Susheel K. .
   Heebink, John
   Carpenter, Danielle H. .
   Kumar, Ashutosh
   Xie, Litao
   Zhang, Haixia
   Schilling, Joel D. .
   Sah, Rajan
TI Adipose-targeted SWELL1 deletion exacerbates obesity- and age-related
   nonalcoholic fatty liver disease
SO JCI INSIGHT
LA English
DT Article
ID KINASE C-EPSILON; HEPATIC STEATOSIS; HEPATOCELLULAR-CARCINOMA; VASCULAR
   DEVELOPMENT; ESSENTIAL COMPONENT; INSULIN-RESISTANCE; LIPIDOMIC
   ANALYSIS; BLOOD-PRESSURE; BETA-CELL; PIEZO1
AB Healthy expansion of adipose tissue is critical for the maintenance of metabolic health, providing an optimized reservoir for energy storage in the form of triacylglycerol-rich lipoproteins. Dysfunctional adipocytes that are unable to efficiently store lipid can result in lipodystrophy and contribute to nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome. Leucine-rich repeat containing protein 8a/SWELL1 functionally encodes the volume-regulated anion channel complex in adipocytes, is induced in early obesity, and is required for normal adipocyte expansion during high-fat feeding. Adipose-specific SWELL1 ablation (Adipo KO) leads to insulin resistance and hyperglycemia during caloric excess, both of which are associated with NAFLD. Here, we show that Adipo-KO mice exhibited impaired adipose depot expansion and excess lipolysis when raised on a variety of high-fat diets, resulting in increased diacylglycerides and hepatic steatosis, thereby driving liver injury. Liver lipidomic analysis revealed increases in oleic acid-containing hepatic triacylglycerides and injurious hepatic diacylglyceride species, with reductions in hepatocyte-protective phospholipids and antiinflammatory free fatty acids. Aged Adipo-KO mice developed hepatic steatosis on a regular chow diet, and Adipo-KO male mice developed spontaneous, aggressive hepatocellular carcinomas (HCCs). These data highlight the importance of adipocyte SWELL1 for healthy adipocyte expansion to protect against NAFLD and HCC in the setting of overnutrition and with aging.
C1 [Gunasekar, Susheel K. .; Heebink, John; Kumar, Ashutosh; Xie, Litao; Zhang, Haixia; Schilling, Joel D. .; Sah, Rajan] Washington Univ, Dept Internal Med, Cardiovasc Div, Sch Med, St Louis, MO USA.
   [Carpenter, Danielle H. .] St Louis Univ, Dept Pathol, Sch Med, St Louis, MO USA.
   [Sah, Rajan] John Cochran VA Med Ctr, St Louis, MO USA.
   [Sah, Rajan] Washington Univ, Sch Med, 425 S Euclid Ave, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Saint Louis University; Washington
   University (WUSTL)
RP Sah, R (corresponding author), Washington Univ, Sch Med, 425 S Euclid Ave, St Louis, MO 63110 USA.
EM rajan.sah@wustl.edu
OI Schilling, Joel/0000-0002-3884-1994; Kumar,
   Ashutosh/0000-0002-2623-0416; Carpenter, Danielle/0000-0001-7203-7046;
   Sah, Rajan/0000-0003-1092-1244
FU Washington University Institute of Clinical and Translational Sciences -
   NIH/National Center for Advancing Translational Sciences, Clinical and
   Translational Science Awards grant [R01DK131188]; Diabetes Research Core
   grant (National Institute of Diabetes and Digestive and Kidney Diseases
   [NIDDK]) [R01DK106009]; NIH NIDDK [R01DK126068, R01DK127080,
   I01BX005072]; NIH VA Merit grant [UL1 TR002345]; Roy J. Carver Trust; 
   [P30 DK 020579]
FX This work was supported by the grants from the Washington University
   Institute of Clinical and Translational Sciences, which is, in part,
   supported by the NIH/National Center for Advancing Translational
   Sciences, Clinical and Translational Science Awards grant UL1 TR002345,
   Diabetes Research Core grant (National Institute of Diabetes and
   Digestive and Kidney Diseases [NIDDK] P30 DK 020579), NIH NIDDK
   R01DK131188 (to JDS), NIH NIDDK R01DK106009 (to RS), R01DK126068 (to
   RS), R01DK127080 (to RS), NIH VA Merit grant I01BX005072 (to RS), and
   the Roy J. Carver Trust grant (to RS). The graphical abstract was
   created with BioRender.com.
CR Alghanem AF, 2021, ELIFE, V10, DOI 10.7554/eLife.61313
   Allison SJ, 2017, NAT REV NEPHROL, V13, P3, DOI [10.1038/nrneph.2015.195, 10.1038/nrneph.2016.165]
   Aragno M, 2009, FREE RADICAL BIO MED, V47, P1067, DOI 10.1016/j.freeradbiomed.2009.07.016
   Arendt BM, 2015, HEPATOLOGY, V61, P1565, DOI 10.1002/hep.27695
   Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010
   Bastías-Pérez M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113234
   Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000659, 10.1161/CIR.0000000000000746]
   Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   Bosy-Westphal A, 2019, EUR J CLIN NUTR, V73, P209, DOI 10.1038/s41430-018-0323-7
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Cheng YW, 2019, INT J OBESITY, V43, P2469, DOI 10.1038/s41366-019-0431-z
   Chiappini F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46658
   Chiba T, 2016, J PHARM PHARMACOL, V68, P1567, DOI 10.1111/jphp.12646
   Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030
   Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270
   Dal Bello B, 2010, CLIN CANCER RES, V16, P2157, DOI 10.1158/1078-0432.CCR-09-1978
   Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727
   Demeulemeester D, 2005, BIOCHEM BIOPH RES CO, V329, P105, DOI 10.1016/j.bbrc.2005.01.103
   Depner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083756
   Eisinger K, 2014, EXP MOL PATHOL, V97, P37, DOI 10.1016/j.yexmp.2014.05.002
   Frank MBO, 2015, BIOMECH MODEL MECHAN, V14, P15, DOI 10.1007/s10237-014-0582-8
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Garcia-Jaramillo M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214387
   Golabi P, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011518
   Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775
   Gunasekar SK, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28435-0
   Gunasekar SK, 2019, ADIPOCYTE, V8, P223, DOI 10.1080/21623945.2019.1612223
   Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017
   Hansen HH, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01356-2
   Hyman AJ, 2017, CURR TOP MEMBR, V79, P37, DOI 10.1016/bs.ctm.2016.11.001
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Ishii H, 2009, J HEPATOL, V50, P562, DOI 10.1016/j.jhep.2008.10.031
   Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683
   Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005
   Juárez-Hernández E, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0191-8
   Kang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02664-0
   Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08
   Kumar A, 2020, ELIFE, V9, DOI 10.7554/eLife.58941
   Lee Yoon Kwang, 2018, Liver Res, V2, P209, DOI 10.1016/j.livres.2018.12.001
   Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701
   Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007
   Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922
   Liu WL, 2016, P NATL ACAD SCI USA, V113, P2288, DOI 10.1073/pnas.1525093113
   Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002
   Lu WX, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/1459790
   Maric I, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.828522
   Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675
   Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024
   Nobili V, 2013, NUTR METAB CARDIOVAS, V23, P1066, DOI 10.1016/j.numecd.2012.10.010
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
   Parker R., 2018, LIVER RES, V2, P35, DOI [DOI 10.1016/J.LIVRES.2018.02.002, 10.1016/J.LIVRES.2018.02.002]
   Pellegrinelli V, 2014, J PATHOL, V233, P183, DOI 10.1002/path.4347
   Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763
   Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024
   Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111
   Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754
   Rossmeisl M, 2014, BBA-MOL CELL BIOL L, V1841, P267, DOI 10.1016/j.bbalip.2013.11.010
   Sanyal Arun J, 2015, Trans Am Clin Climatol Assoc, V126, P271
   Shoham N, 2014, BIOPHYS J, V106, P1421, DOI 10.1016/j.bpj.2014.01.045
   Shoham N, 2012, BIOMECH MODEL MECHAN, V11, P1029, DOI 10.1007/s10237-011-0371-6
   Shoham N, 2012, AM J PHYSIOL-CELL PH, V302, pC429, DOI 10.1152/ajpcell.00167.2011
   Softic S, 2016, DIABETES, V65, P2187, DOI 10.2337/db16-0213
   Sohn JH, 2018, J BIOL CHEM, V293, P13974, DOI 10.1074/jbc.RA118.003541
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   Tanaka N, 2010, BIOCHEM PHARMACOL, V80, P1601, DOI 10.1016/j.bcp.2010.07.031
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   ter Horst KW, 2017, CELL REP, V19, P1997, DOI 10.1016/j.celrep.2017.05.035
   TOMITA M, 1994, HEPATOLOGY, V20, P317, DOI 10.1002/hep.1840200208
   Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x
   Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826
   Vroegrijk IOCM, 2013, OBESITY, V21, P2037, DOI 10.1002/oby.20354
   Wang SP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16026-w
   Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343
   White JPM, 2016, PHYSIOL REV, V96, P911, DOI 10.1152/physrev.00016.2015
   Xie LT, 2017, CHANNELS, V11, P673, DOI 10.1080/19336950.2017.1373225
   Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021
   Younossi ZM, 2018, CLIN LIVER DIS, V22, P1, DOI 10.1016/j.cld.2017.08.001
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123
   Yuan Y, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000564
   Zhang YH, 2017, NAT CELL BIOL, V19, P504, DOI 10.1038/ncb3514
   Zhao C, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00373
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
NR 86
TC 0
Z9 0
U1 3
U2 8
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD MAR 8
PY 2023
VL 8
IS 5
AR e154940
DI 10.1172/jci.insight.154940
PG 18
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 9W6AT
UT WOS:000949160000001
PM 36749637
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Marshall, A
   Lutfeali, R
   Raval, A
   Chakravarti, DN
   Chakravarti, B
AF Marshall, Adrienne
   Lutfeali, Reshma
   Raval, Alpan
   Chakravarti, Deb N.
   Chakravarti, Bulbul
TI Differential hepatic protein tyrosine nitration of mouse due to aging -
   Effect on mitochondrial energy metabolism, quality control machinery of
   the endoplasmic reticulum and metabolism of drugs
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Aging; Tyrosine nitration; Mouse liver
ID AGE-RELATED-CHANGES; ALDEHYDE DEHYDROGENASE-ACTIVITY; ATP SYNTHASE;
   BINDING-PROTEIN; LIVER; HEART; EXPRESSION; PEROXYNITRITE; CA2+-ATPASE;
   TARGETS
AB Aging is the inevitable fate of life which leads to the gradual loss of functions of different organs and organelles of all living organisms. The liver is no exception. Oxidative damage to proteins and other macromolecules is widely believed to be the primary cause of aging. One form of oxidative damage is tyrosine nitration of proteins, resulting in the potential loss of their functions. In this study, the effect of age on the nitration of tyrosine in mouse liver proteins was examined. Liver proteins from young (19-22 weeks) and old (24 months) C57/BL6 male mice were separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted onto nitrocellulose membranes. Proteins undergoing tyrosine nitration were identified using anti-nitrotyrosine antibody. Three different protein bands were found to contain significantly increased levels of nitrotyrosine in old mice (Wilconxon rank-sum test, p < 0.05). Electrospray ionization liquid chromatography tandem mass spectrometry (ESI-LC-MS/MS) was used to identify the proteins in these bands, which included aldehyde dehydrogenase 2, Aldehyde dehydrogenase family 1, subfamily A1, ATP synthase, H+ transporting, mitochondrial F1 complex, beta subunit, selenium-binding protein 2, and protein disulfide-isomerase precursor. The possible impairment of their functions can lead to altered hepatic activity and have been discussed. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Marshall, Adrienne; Lutfeali, Reshma; Raval, Alpan; Chakravarti, Deb N.; Chakravarti, Bulbul] Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA.
   [Marshall, Adrienne] Scripps Coll, Claremont, CA 91711 USA.
   [Raval, Alpan] Claremont Grad Univ, Sch Math Sci, Claremont, CA 91711 USA.
   [Chakravarti, Deb N.; Chakravarti, Bulbul] CUNY York Coll, Dept Chem, Jamaica, NY 11451 USA.
   [Chakravarti, Bulbul] CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA.
C3 Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of
   Applied Life Sciences; Claremont Colleges; Scripps College; Claremont
   Colleges; Claremont Graduate School; City University of New York (CUNY)
   System; York College NY (CUNY); City University of New York (CUNY)
   System; York College NY (CUNY)
RP Chakravarti, B (corresponding author), CUNY York Coll, Dept Biol, 94-20 Guy R Brewer Blvd, Jamaica, NY 11451 USA.
EM bchakravarti@york.cuny.edu
RI Marshall, Adrienne/AAW-1932-2021
OI Raval, Alpan/0000-0002-2689-3594
FU National Science Foundation [FIBR 0527023, EMT 0523643]; NSF [0527023];
   Department of Biology, York College, City University of New York;
   Department of Chemistry, York College, City University of New York;
   Direct For Biological Sciences; Emerging Frontiers [0527023] Funding
   Source: National Science Foundation
FX This work was supported in part by National Science Foundation Grants
   FIBR 0527023 and EMT 0523643. RL worked on the project as part of the
   outreach program of the above NSF Grant 0527023. The authors would also
   like to thank Department of Biology and Department of Chemistry, York
   College, City University of New York for support.
CR Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3
   Chakravarti B, 1998, MECH AGEING DEV, V104, P41, DOI 10.1016/S0047-6374(98)00049-9
   Chakravarti B, 2008, ARCH BIOCHEM BIOPHYS, V474, P22, DOI 10.1016/j.abb.2008.02.001
   Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865
   Chakravarti B, 2009, PROTEOMICS, V9, P580, DOI 10.1002/pmic.200700208
   DANH HC, 1983, J NEUROCHEM, V41, P618, DOI 10.1111/j.1471-4159.1983.tb04786.x
   Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311
   GUERRIERI F, 1992, ANN NY ACAD SCI, V671, P395, DOI 10.1111/j.1749-6632.1992.tb43813.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Haynes V, 2010, AM J PHYSIOL-ENDOC M, V298, pE978, DOI 10.1152/ajpendo.00739.2009
   Hoivik DJ, 1996, FUND APPL TOXICOL, V32, P79, DOI 10.1006/faat.1996.0109
   Hurst JK, 2002, J CLIN INVEST, V109, P1287, DOI 10.1172/JCI200215816
   Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3
   Lokuta AJ, 2005, CIRCULATION, V111, P988, DOI 10.1161/01.CIR.0000156461.81529.D7
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001
   Nuss JE, 2008, BIOCHEM BIOPH RES CO, V365, P355, DOI 10.1016/j.bbrc.2007.10.194
   Pfeiffer S, 2001, FASEB J, V15, P2355, DOI 10.1096/fj.01-0295com
   PUMFORD NR, 1990, TOXICOL APPL PHARM, V104, P521, DOI 10.1016/0041-008X(90)90174-S
   PUMFORD NR, 1992, BIOCHEM BIOPH RES CO, V182, P1348, DOI 10.1016/0006-291X(92)91881-P
   Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X
   SMOLEN A, 1982, COMP BIOCHEM PHYS B, V73, P815, DOI 10.1016/0305-0491(82)90322-4
   Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940
   van der Vlies D, 2002, BIOCHEM J, V366, P825, DOI 10.1042/BJ20020618
   VANDERVLIET A, 1994, BIOCHEM J, V303, P295, DOI 10.1042/bj3030295
   VANDERVLIET A, 1995, ARCH BIOCHEM BIOPHYS, V319, P341, DOI 10.1006/abbi.1995.1303
   Viner RI, 1999, BIOCHEM J, V340, P657, DOI 10.1042/0264-6021:3400657
   Yarian CS, 2005, BIOCHEM BIOPH RES CO, V330, P151, DOI 10.1016/j.bbrc.2005.02.135
   Yoon M, 2006, TOXICOL SCI, V89, P386, DOI 10.1093/toxsci/kfj045
NR 29
TC 8
Z9 8
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 4
PY 2013
VL 430
IS 1
BP 231
EP 235
DI 10.1016/j.bbrc.2012.10.142
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 081KI
UT WOS:000314320700040
PM 23159622
DA 2024-02-19
ER

PT J
AU Rosenberg, N
   Van Haele, M
   Lanton, T
   Brashi, N
   Bromberg, Z
   Adler, H
   Giladi, H
   Peled, A
   Goldenberg, DS
   Axelrod, JH
   Simerzin, A
   Chai, C
   Paldor, M
   Markezana, A
   Yaish, D
   Shemulian, Z
   Gross, D
   Barnoy, S
   Gefen, M
   Amran, O
   Claerhout, S
   Fernández-Vaquero, M
   García-Beccaria, M
   Heide, D
   Shoshkes-Carmel, M
   Arras, DS
   Elgavish, S
   Nevo, Y
   Benyamini, H
   Tirnitz-Parker, JEE
   Sanchez, A
   Herrera, B
   Safadi, R
   Kaestner, KH
   Rose-John, S
   Roskams, T
   Heikenwalder, M
   Galun, E
AF Rosenberg, Nofar
   Van Haele, Matthias
   Lanton, Tali
   Brashi, Neta
   Bromberg, Zohar
   Adler, Hanan
   Giladi, Hilla
   Peled, Amnon
   Goldenberg, Daniel S.
   Axelrod, Jonathan H.
   Simerzin, Alina
   Chai, Chofit
   Paldor, Mor
   Markezana, Auerlia
   Yaish, Dayana
   Shemulian, Zohar
   Gross, Dvora
   Barnoy, Shanny
   Gefen, Maytal
   Amran, Osher
   Claerhout, Sofie
   Fernandez-Vaquero, Mirian
   Garcia-Beccaria, Maria
   Heide, Danijela
   Shoshkes-Carmel, Michal
   Arras, Dirk Schmidt
   Elgavish, Sharona
   Nevo, Yuval
   Benyamini, Hadar
   Tirnitz-Parker, Janina E. E.
   Sanchez, Aranzazu
   Herrera, Blanca
   Safadi, Rifaat
   Kaestner, Klaus H.
   Rose-John, Stefan
   Roskams, Tania
   Heikenwalder, Mathias
   Galun, Eithan
TI Combined hepatocellular-cholangiocarcinoma derives from liver progenitor
   cells and depends on senescence and IL-6 trans-signaling
SO JOURNAL OF HEPATOLOGY
LA English
DT Article; Early Access
DE Cancer stem cells; Hepatocarcinogenesis; Oval cells;
   Inflammation-induced cancer
ID P-GLYCOPROTEIN GENE; SCLEROSING CHOLANGITIS; HOMOZYGOUS DISRUPTION;
   FIBROSIS PROGRESSION; DUCTULAR REACTION; STEM-CELLS; CANCER; CARCINOMA;
   INFLAMMATION; MECHANISMS
AB Background & Aims: Primary liver cancers include hepatocel-lular carcinoma (HCC), intrahepatic cholangiocarcinoma (CCA) and combined HCC-CCA tumors (cHCC-CCA). It has been sug-gested, but not unequivocally proven, that hepatic progenitor cells (HPCs) can contribute to hepatocarcinogenesis. We aimed to determine whether HPCs contribute to HCC, cHCC-CCA or both types of tumors. Methods: To trace progenitor cells during hepatocarcinogenesis, we generated Mdr2-KO mice that harbor a yellow fluorescent protein (YFP) reporter gene driven by the Foxl1 promoter which is expressed specifically in progenitor cells. These mice (Mdr2- KOFoxl1-CRE;RosaYFP) develop chronic inflammation and HCCs by the age of 14-16 months, followed by cHCC-CCA tumors at the age of 18 months. Results: In this Mdr2-KOFoxl1-CRE;RosaYFP mouse model, liver progenitor cells are the source of cHCC-CCA tumors, but not the source of HCC. Ablating the progenitors, caused reduction of cHCC-CCA tumors but did not affect HCCs. RNA-sequencing revealed enrichment of the IL-6 signaling pathway in cHCC-CCA tumors compared to HCC tumors. Single-cell RNA -sequencing (scRNA-seq) analysis revealed that IL-6 is expressed by immune and parenchymal cells during senescence, and that IL-6 is part of the senescence-associated secretory phenotype. Administration of an anti-IL-6 antibody to Mdr2-KOFoxl1-CRE;RosaYFP mice inhibited the development of cHCC-CCA tu-mors. Blocking IL-6 trans-signaling led to a decrease in the number and size of cHCC-CCA tumors, indicating their depen-dence on this pathway. Furthermore, the administration of a senolytic agent inhibited IL-6 and the development of cHCC-CCA tumors. Conclusion: Our results demonstrate that cHCC-CCA, but not HCC tumors, originate from HPCs, and that IL-6, which de-rives in part from cells in senescence, plays an important role in this process via IL-6 trans-signaling. These findings could be applied to develop new therapeutic approaches for cHCC-CCA tumors. Lay summary: Combined hepatocellular carcinoma- cholangiocarcinoma is the third most prevalent type of primary liver cancer (i.e. a cancer that originates in the liver). Herein, we show that this type of cancer originates in stem cells in the liver and that it depends on inflammatory signaling. Specifically, we identify a cytokine called IL-6 that appears to be important in the development of these tumors. Our results could be used for the development of novel treatments for these aggressive tumors. (c) 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Rosenberg, Nofar; Lanton, Tali; Brashi, Neta; Bromberg, Zohar; Adler, Hanan; Giladi, Hilla; Peled, Amnon; Goldenberg, Daniel S.; Axelrod, Jonathan H.; Simerzin, Alina; Chai, Chofit; Paldor, Mor; Markezana, Auerlia; Yaish, Dayana; Shemulian, Zohar; Gross, Dvora; Barnoy, Shanny; Gefen, Maytal; Amran, Osher; Galun, Eithan] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene & Cell Therapy, Jerusalem, Israel.
   [Van Haele, Matthias; Claerhout, Sofie; Roskams, Tania] Katholieke Univ Leuven, Dept Imaging & Pathol Translat Cell & Tissue Res, Leuven, Belgium.
   [Van Haele, Matthias; Claerhout, Sofie; Roskams, Tania] Univ Hosp Leuven, Leuven, Belgium.
   [Fernandez-Vaquero, Mirian; Garcia-Beccaria, Maria; Heide, Danijela; Heikenwalder, Mathias] German Canc Res Ctr, Div Chron flammat & Canc, Heidelberg, Germany.
   [Shoshkes-Carmel, Michal; Kaestner, Klaus H.] Univ Penn, Ctr Translat Res, Perelman Sch Med, Dept Genet, Philadelphia, PA USA.
   [Shoshkes-Carmel, Michal; Kaestner, Klaus H.] Univ Penn, Inst Diabet Obes & Metab, Ctr Translat Res, Perelman Sch Med, Philadelphia, PA USA.
   [Arras, Dirk Schmidt; Rose-John, Stefan] Christian Albrechts Univ Kiel, Inst Biochem, Kiel, Germany.
   [Elgavish, Sharona; Nevo, Yuval; Benyamini, Hadar] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Bioinformat Unit, Jerusalem, Israel.
   [Tirnitz-Parker, Janina E. E.] Univ Western Australia, Ctr Med Res, Crawley, WA, Australia.
   [Tirnitz-Parker, Janina E. E.] Harry Perkins Inst Med Res, Crawley, WA, Australia.
   [Sanchez, Aranzazu; Herrera, Blanca] Univ Complutense Madrid, Fac Pharm, Dept Biochem & Mol Biol, Madrid, Spain.
   [Safadi, Rifaat] Hadassah Hebrew Univ Hosp, Liver Inst, Jerusalem, Israel.
   [Van Haele, Matthias] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, Maastricht, Netherlands.
   [Arras, Dirk Schmidt] Univ Salzburg, Dept Biosci, Salzburg, Austria.
   [Heikenwalder, Mathias] Med Fac Tuebingen MFT, M3 Res Inst, Rosenauer Weg 30, D-72076 Tubingen, Germany.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center; KU
   Leuven; KU Leuven; University Hospital Leuven; Helmholtz Association;
   German Cancer Research Center (DKFZ); University of Pennsylvania;
   University of Pennsylvania; University of Kiel; Hebrew University of
   Jerusalem; University of Western Australia; Harry Perkins Institute of
   Medical Research; Complutense University of Madrid; Hebrew University of
   Jerusalem; Hadassah University Medical Center; Maastricht University;
   Salzburg University
RP Galun, E (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene & Cell Therapy, Jerusalem, Israel.; Heikenwalder, M (corresponding author), German Canc Res Ctr, Div Chron flammat & Canc, Heidelberg, Germany.
EM m.heikenwaelder@dkfz-heidelberg.de; eithang@hadassah.org.il
RI Sánchez, Aránzazu/H-7810-2015; Herrera, Blanca/K-1803-2014; Rose-John,
   Stefan/A-7998-2010; Schmidt-Arras, Dirk/ABB-6644-2020
OI Sánchez, Aránzazu/0000-0001-9145-6633; Herrera,
   Blanca/0000-0002-2415-2055; Rose-John, Stefan/0000-0002-7519-3279;
   Schmidt-Arras, Dirk/0000-0002-1072-7495; Axelrod,
   Jonathan/0000-0002-8996-3916; Roskams, Tania/0000-0002-2816-1530;
   Markezana, Aurelia/0000-0002-5909-1985; Claerhout,
   Sofie/0000-0003-0857-0211; Tirnitz-Parker, Janina/0000-0002-3558-5892
FU NIH [CA197081-02]; MOST; ISF collaboration with Canada [2473/2017]; ISF
   [486/2017, ISF 41/2011]; ICORE [ISF 41/2011]; Deutsche
   Forschungsgemeinschaft, Bonn, Germany [SFB841, SFB877]; ERC advance
   [786575]; Kron foundation; Raskin foundation; Robert Benson foundation;
   (ER) Consolidator grant (HepatoMetaboPath); Wilhelm Sander-Stiftung;
   Rainer Honig Stiftung; Deutsche Krebshilfe projects [70113166,
   70113167]; German-Israeli Cooperation in Cancer Research (DKFZ-MOST);
   Helmholtz-Gemeinschaft; Zukunftsthema Immunology and Inflammation
   [ZT-0027];  [SFB/TR 209];  [314905040];  [SFBTR1335];  [360372040];
   European Research Council (ERC) [786575] Funding Source: European
   Research Council (ERC)
FX The work of Eithan Galun (EG) was supported by grants from the NIH
   CA197081-02, the MOST, the ISF collaboration with Canada (2473/2017) ,
   the personal ISF (486/2017 and the ISF and ICORE - (ISF 41/2011) , the
   Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB841) and the ERC
   advance-GA No. 786575 - RxmiRcanceR (EG) . The work of EG was also
   supported by the Kron, Raskin and the Robert Benson foundations. Mathias
   Heikenwalder is supported by an (ER) Consolidator grant
   (HepatoMetaboPath) , the SFB/TR 209 project ID 314905040, SFBTR1335
   project ID 360372040, the Wilhelm Sander-Stiftung, the the Rainer Honig
   Stiftung, Deutsche Krebshilfe projects 70113166 and 70113167,
   German-Israeli Cooperation in Cancer Research (DKFZ-MOST) , the
   Helmholtz-Gemeinschaft, and Zukunftsthema Immunology and Inflammation
   (ZT-0027) (M.H.) . The work of Stefan Rose-John was supported by the
   Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB877, Project A1;
   SFB841, Project C1) and by the Cluster of Excellence "Inflammation at
   Interfaces".
CR Almalé L, 2019, STEM CELLS, V37, P1108, DOI 10.1002/stem.3038
   Barashi N, 2013, HEPATOLOGY, V58, P1021, DOI 10.1002/hep.26403
   Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   Brunt E, 2018, HEPATOLOGY, V68, P113, DOI 10.1002/hep.29789
   Calderaro J, 2019, J HEPATOL, V71, P616, DOI 10.1016/j.jhep.2019.06.001
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Clerbaux LA, 2019, AM J PATHOL, V189, P1569, DOI 10.1016/j.ajpath.2019.04.011
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2
   Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009
   Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142
   Galun E, 2016, HEPATOLOGY, V63, P354, DOI 10.1002/hep.28344
   Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45
   Govaere O, 2014, GUT, V63, P674, DOI 10.1136/gutjnl-2012-304351
   He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Ikenaga N, 2015, AM J PATHOL, V185, P325, DOI 10.1016/j.ajpath.2014.10.013
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172
   Ko S, 2020, ANNU REV PATHOL-MECH, V15, P23, DOI 10.1146/annurev-pathmechdis-012419-032824
   Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006
   Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005
   Lee TKW, 2021, NAT REV GASTRO HEPAT, DOI 10.1038/s41575-021-00508-3
   Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025
   Martínez-Zamudio RI, 2020, NAT CELL BIOL, V22, P842, DOI 10.1038/s41556-020-0529-5
   MAUAD TH, 1994, AM J PATHOL, V145, P1237
   Moeini A, 2017, J HEPATOL, V66, P952, DOI 10.1016/j.jhep.2017.01.010
   NG IOL, 1995, AM J CLIN PATHOL, V104, P313
   POPPER HANS, 1957, JOUR MT SINAI HOSP, V24, P551
   Potikha T, 2013, HEPATOLOGY, V58, P192, DOI 10.1002/hep.26335
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Roskams T, 1998, SEMIN DIAGN PATHOL, V15, P259
   Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705
   Salmonowicz H, 2017, AGING CELL, V16, P432, DOI 10.1111/acel.12580
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Schaub JR, 2018, NATURE, V557, P247, DOI 10.1038/s41586-018-0075-5
   Schumertl T, 2022, BBA-MOL CELL RES, V1869, DOI 10.1016/j.bbamcr.2021.119143
   Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811
   Shriki A, 2021, CANCER RES, V81, P4766, DOI 10.1158/0008-5472.CAN-21-0321
   Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048
   SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9
   Spolverato G, 2019, J SURG ONCOL, V119, P278, DOI 10.1002/jso.25331
   Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008
   Tirnitz-Parker JEE, 2019, HEPATOLOGY, V69, P2286, DOI 10.1002/hep.30340
   Wan SS, 2014, GASTROENTEROLOGY, V147, P1393, DOI 10.1053/j.gastro.2014.08.039
   Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024
   Yousefzadeh MJ, 2021, NATURE, V594, P100, DOI 10.1038/s41586-021-03547-7
   Yuan DT, 2017, CANCER CELL, V31, P771, DOI 10.1016/j.ccell.2017.05.006
   Zhao L, 2018, MODERN PATHOL, V31, P150, DOI 10.1038/modpathol.2017.115
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
   Zhu Y, 2020, HEPATOLOGY, V72, P305, DOI 10.1002/hep.31200
NR 54
TC 18
Z9 18
U1 10
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD 2022 DEC
PY 2022
VL 77
IS 6
BP 1631
EP 1641
DI 10.1016/j.jhep.2022.07.029
EA NOV 2022
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 7B9WA
UT WOS:000899473900003
PM 35988690
OA hybrid
DA 2024-02-19
ER

PT J
AU Li, BS
   Zhu, RZ
   Lim, SH
   Seo, JH
   Choi, BM
AF Li, Bing Si
   Zhu, Ri Zhe
   Lim, Seok-Hee
   Seo, Jae Ho
   Choi, Byung-Min
TI Apigenin Alleviates Oxidative Stress-Induced Cellular Senescence via
   Modulation of the SIRT1-NAD<SUP>+</SUP>-CD38 Axis
SO AMERICAN JOURNAL OF CHINESE MEDICINE
LA English
DT Article
DE Apigenin; Oxidative Stress; Anti-Aging; SIRT1; CD38
ID NAD(+) METABOLISM; IN-VITRO; CD38; ACTIVATION; PHENOTYPE; TARGET; CELLS
AB Oxidative stress-induced cellular senescence is now regarded as an important driving mechanism in chronic lung diseases-particularly chronic obstructive pulmonary disease (COPD). 4',5,7-trihydroxyflavone (Apigenin) is a natural flavonoid product abundantly present in fruits, vegetables, and Chinese medicinal herbs. It has been known that apigenin has anti-oxidant, anti-inflammatory and liver-protecting effects. The efficacy of apigenin for lung aging, however, has not been reported. In this study, we selected the hydrogen peroxide (H2O2)- or doxorubicin (DOXO)-induced senescence model in WI-38 human embryonic lung fibroblast cells to determine the potential anti-aging effects of apigenin in vitro and associated molecular mechanisms. We found that apigenin reduced senescence-associated beta-galactosidase (SA-beta-gal) activity and promoted cell growth, concomitant with a decrease in levels of Acetyl (ac)-p53, p21(Waf1/Cip1), and p16(Ink4a) and an increase in phospho (p)-Rb. Apigenin also increased the activation ratio of silent information regulator 1 (SIRT1), nicotinamide adenine dinucleotide (NAD(+)), and NAD(+)/NADH and inhibited cluster of differentiation 38 (CD38) activity in a concentration-dependent manner. SIRT1 inhibition by SIRT1 siRNA abolished the anti-aging effect of apigenin. In addition, CD38 inhibition by CD38 siRNA or apigenin increased the SIRT1 level and reduced H2O2-induced senescence. Our findings suggest that apigenin is a promising phytochemical for reducing the impact of senescent cells in age-related lung diseases such as COPD.
C1 [Li, Bing Si; Zhu, Ri Zhe; Lim, Seok-Hee; Seo, Jae Ho; Choi, Byung-Min] Wonkwang Univ, Sch Med, Dept Biochem, 460 Iksandae Ro, Iksan 54538, Jeonbuk, South Korea.
C3 Wonkwang University
RP Choi, BM (corresponding author), Wonkwang Univ, Sch Med, Dept Biochem, 460 Iksandae Ro, Iksan 54538, Jeonbuk, South Korea.
EM bmchoi@wku.ac.kr
FU Wonkwang University
FX This study was supported by Wonkwang University in 2021.
CR Ahmadian M, 2018, FREE RADICAL RES, V52, P775, DOI 10.1080/10715762.2018.1470328
   Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com
   Barnes PJ, 2019, AM J RESP CRIT CARE, V200, P556, DOI 10.1164/rccm.201810-1975TR
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Chatterjee S, 2018, CELL METAB, V27, P85, DOI 10.1016/j.cmet.2017.10.006
   Cheng XS, 2011, ANAT HISTOL EMBRYOL, V40, P21, DOI 10.1111/j.1439-0264.2010.01033.x
   Choi S, 2016, INT J MOL MED, V38, P627, DOI 10.3892/ijmm.2016.2626
   Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890
   Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139
   Even B, 2018, AGING CELL, V17, DOI 10.1111/acel.12837
   HAYFLICK L, 1962, AM J HYG, V75, P240, DOI 10.1093/oxfordjournals.aje.a120247
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   He JS, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190112
   Hecker L, 2018, AM J PHYSIOL-LUNG C, V314, P1642, DOI 10.1152/ajplung.00275.2017
   Kim HJ, 2019, AGING CELL, V18, DOI 10.1111/acel.13016
   Li TX, 2013, MOL MED REP, V7, P1889, DOI 10.3892/mmr.2013.1444
   Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525
   Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479
   Müller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32
   Nobukuni S, 2002, RESPIROLOGY, V7, P217, DOI 10.1046/j.1440-1843.2002.00400.x
   Perrott KM, 2017, GEROSCIENCE, V39, P161, DOI 10.1007/s11357-017-9970-1
   Piegari E, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0334-4
   Song ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112699
   Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP
   Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC
   Wang LF, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01125
   Wang Y, 2004, EXP CELL RES, V298, P188, DOI 10.1016/j.yexcr.2004.04.012
   Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006
   Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132
   Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7
   Zamora-Ros R, 2010, J AM DIET ASSOC, V110, P390, DOI 10.1016/j.jada.2009.11.024
   Zeng ZL, 2017, BIOCHEM BIOPH RES CO, V486, P1021, DOI 10.1016/j.bbrc.2017.03.155
   Zhao LC, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00514
   Zhou N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22628
NR 37
TC 23
Z9 25
U1 0
U2 32
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0192-415X
EI 1793-6853
J9 AM J CHINESE MED
JI Am. J. Chin. Med.
PY 2021
VL 49
IS 05
BP 1235
EP 1250
DI 10.1142/S0192415X21500592
PG 16
WC Integrative & Complementary Medicine; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; General & Internal Medicine
GA TE3FX
UT WOS:000669900700011
PM 34049472
DA 2024-02-19
ER

PT J
AU PRABHAKARAM, M
   SINGH, SN
AF PRABHAKARAM, M
   SINGH, SN
TI PROPERTIES OF PURIFIED LIVER GLUTAMATE-DEHYDROGENASE OF AGING RATS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
C1 BANARAS HINDU UNIV, DEPT ZOOL, BIOCHEM LAB, VARANASI 221005, UTTAR PRADESH, INDIA.
C3 Banaras Hindu University (BHU)
CR ABUERREISH GM, 1978, MECH AGEING DEV, V7, P425, DOI 10.1016/0047-6374(78)90083-0
   ANDERSON PJ, 1976, CAN J BIOCHEM CELL B, V54, P194, DOI 10.1139/o76-029
   BURROWS RB, 1980, MECH AGEING DEV, V13, P307, DOI 10.1016/0047-6374(80)90075-5
   CHEE PY, 1979, J NEUROCHEM, V33, P53, DOI 10.1111/j.1471-4159.1979.tb11705.x
   CHEE PY, 1978, FED PROC, V37, P392
   CHEN JC, 1972, J CELL PHYSIOL, V80, P141, DOI 10.1002/jcp.1040800115
   CHIU YJD, 1980, EXP GERONTOL, V15, P511, DOI 10.1016/0531-5565(80)90003-0
   CRAIG NC, 1970, J CELL BIOL, V45, P554, DOI 10.1083/jcb.45.3.554
   DALZIEL K, 1972, BIOCHEM J, V126, P975, DOI 10.1042/bj1260975
   DREYFUS JC, 1983, ALTERED PROTEINS AGI, P35
   Eisenberg H, 1976, Adv Protein Chem, V30, P101, DOI 10.1016/S0065-3233(08)60479-9
   FAHIEN LA, 1969, ARCH BIOCHEM BIOPHYS, V130, P449, DOI 10.1016/0003-9861(69)90057-5
   FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HUANG CY, 1972, J BIOL CHEM, V247, P3638
   JACOBUS S, 1980, MECH AGEING DEV, V12, P311, DOI 10.1016/0047-6374(80)90064-0
   Kanungo M.S., 1980, BIOCH AGEING
   KING KS, 1970, J BIOL CHEM, V245, P4391
   KOBERSTEIN R, 1973, EUR J BIOCHEM, V36, P545, DOI 10.1111/j.1432-1033.1973.tb02942.x
   KURTZ DI, 1978, EXP GERONTOL, V13, P397, DOI 10.1016/0531-5565(78)90050-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATTEO G, 1980, ARCH BIOCHEM BIOPHYS, V200, P55
   MCCARTHY AD, 1980, BIOCHEM J, V191, P605, DOI 10.1042/bj1910605
   PETELL JK, 1979, J BIOL CHEM, V254, P8179
   PRABHAKARAM M, 1984, BIOCHEM INT, V9, P399
   PRABHAKARAM M, 1986, ARCH GERONTOL GERIAT, V5, P57, DOI 10.1016/0167-4943(86)90008-7
   PRABHAKARAM M, 1984, THESIS BANARAS HINDU
   PRABHAKARAM M, 1985, LIFE SCI ADV, V4, P1
   PRASANNA HR, 1979, BIOCHEM BIOPH RES CO, V86, P552, DOI 10.1016/0006-291X(79)91749-2
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   RICHARDSON A, 1981, HDB BIOCH AGING, P29
   ROTHSTEIN M, 1977, MECH AGEING DEV, V6, P241, DOI 10.1016/0047-6374(77)90025-2
   ROTHSTEIN M, 1980, BIOCHIM BIOPHYS ACTA, V614, P591, DOI 10.1016/0005-2744(80)90248-X
   ROTHSTEIN M, 1979, MECH AGEING DEV, V9, P197, DOI 10.1016/0047-6374(79)90099-X
   ROTHSTEIN M, 1985, MOL BIOL AGING, P193
   SHARMA HK, 1980, J BIOL CHEM, V255, P5043
   SHARMA HK, 1978, BIOCHEMISTRY-US, V17, P2869, DOI 10.1021/bi00607a027
   SUND H, 1976, INT J POLYM MATER, V4, P251, DOI 10.1080/00914037608072382
   SUND H, 1975, SUBUNITS BIOL SYST C, P225
   SZAJNERT MF, 1983, GERONTOLOGY, V29, P311, DOI 10.1159/000213132
   WEBER A, 1976, BIOCHIM BIOPHYS ACTA, V444, P810, DOI 10.1016/0304-4165(76)90328-7
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WILSON PD, 1982, GERONTOLOGY, V28, P32, DOI 10.1159/000212509
   YIELDING KL, 1960, BIOCHEM BIOPH RES CO, V2, P303, DOI 10.1016/0006-291X(60)90189-3
   YOUNG VR, 1979, FED PROC, V38, P1994
NR 46
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD DEC
PY 1988
VL 7
IS 4
BP 297
EP 309
DI 10.1016/0167-4943(88)90013-1
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA R4257
UT WOS:A1988R425700007
PM 3228334
DA 2024-02-19
ER

PT J
AU Cogger, VC
   Mross, PE
   Hosie, MJ
   Ansselin, AD
   McLean, AJ
   Le Couteur, DG
AF Cogger, VC
   Mross, PE
   Hosie, MJ
   Ansselin, AD
   McLean, AJ
   Le Couteur, DG
TI The effect of acute oxidative stress on the ultrastructure of the
   perfused rat liver
SO PHARMACOLOGY & TOXICOLOGY
LA English
DT Article
ID SINUSOIDAL ENDOTHELIAL-CELLS; HYPOXIA-REOXYGENATION INJURY;
   HYDROGEN-PEROXIDE; MEGAMITOCHONDRIA; HEPATOCYTES; APOPTOSIS; DISEASE;
   DAMAGE
AB Ageing and liver disease are associated with ultrastructural changes in the hepatic sinusoid. Because of the possibility that reactive oxygen species could mediate these processes, we examined the effect of acute oxidative stress on the ultrastructure of the intact liver. Rat livers were perfused ex vivo, in situ with hydrogen peroxide via the portal vein. The livers were then fixed and the ultrastructure of the liver tissue examined with transmission and scanning electron microscopy. The effects of hydrogen peroxide were largely confined to the perisinusoidal areas. The sinusoidal endothelial cells became swollen and more porous, with large gaps replacing sieve plates. The space of Disse showed an increase in volume and the density of hepatocyte projections decreased. Kupffer cell activation was noted. Little or no ultrastructural change was observed within the hepatocytes. Oxidative stress delivered via the portal vein dramatically alters the ultrastructure of the perisinusoidal regions of the liver. This process may contribute to the pathogenesis of disease and age-related changes in the liver.
C1 Concord RG Hosp, Ctr Res & Educ Ageing, Concord, NSW 2139, Australia.
   Univ Sydney, Canberra Clin Sch, Garran, ACT 2605, Australia.
   Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia.
   Univ Sydney, Electron Microscope Unit, Sydney, NSW 2006, Australia.
   Canberra Hosp, Dept Geriatr Med, Garran, ACT 2605, Australia.
   Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.
C3 Concord Repatriation General Hospital; University of Sydney; University
   of Sydney; University of Sydney; Australian National University;
   Canberra Hospital; Australian National University; John Curtin School of
   Medical Research
RP Le Couteur, DG (corresponding author), Concord RG Hosp, Ctr Res & Educ Ageing, Bldg 61A, Concord, NSW 2139, Australia.
OI Le Couteur, David/0000-0002-4227-5817
CR ANIYA Y, 1993, BIOCHEM PHARMACOL, V45, P37
   [Anonymous], FREE RADICALS BIOL M
   [Anonymous], 1979, STEREOLOGICAL METHOD
   Arii S, 2000, J Hepatobiliary Pancreat Surg, V7, P40, DOI 10.1007/s005340050152
   BRONK SF, 1991, HEPATOLOGY, V14, P150, DOI 10.1002/hep.1840140125
   Cavazzoni M, 1999, FEBS LETT, V449, P53, DOI 10.1016/S0014-5793(99)00400-7
   Deaciuc IV, 1999, J HEPATOL, V30, P213, DOI 10.1016/S0168-8278(99)80064-6
   DOBBS BR, 1994, LIVER, V14, P230
   FRASER R, 1980, BRIT J EXP PATHOL, V61, P222
   FRASER R, 1980, PATHOLOGY, V12, P371, DOI 10.3109/00313028009077098
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   Karbowski M, 1999, FREE RADICAL BIO MED, V26, P396, DOI 10.1016/S0891-5849(98)00209-3
   Karbowski M, 1997, BBA-LIPID LIPID MET, V1349, P242, DOI 10.1016/S0005-2760(97)00140-9
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LEBAIL B, 1990, J ELECTRON MICR TECH, V14, P257, DOI 10.1002/jemt.1060140307
   LECOUTEUR DG, 1994, TRANSPLANTATION, V58, P531, DOI 10.1097/00007890-199409150-00001
   LECOUTEUR DG, 1999, PHARMACOL TOXICOL, V84, P1
   Mueller S, 1997, ANAL BIOCHEM, V245, P55, DOI 10.1006/abio.1996.9939
   OTTO G, 1984, TRANSPLANT P, V16, P1247
   PAROLA M, 1993, ROLE FREE RADICALS B, P115
   REYNOLDS ES, 1965, J CELL BIOL, V25, P53, DOI 10.1083/jcb.25.3.53
   RIKANS LE, 1994, MECH AGEING DEV, V76, P89, DOI 10.1016/0047-6374(94)91584-9
   Samarasinghe DA, 2000, HEPATOLOGY, V31, P160, DOI 10.1002/hep.510310124
   Sarphie TG, 1996, HEPATOLOGY, V23, P788, DOI 10.1053/jhep.1996.v23.pm0008666333
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   Teranishi M, 1999, J ELECTRON MICROSC, V48, P637, DOI 10.1093/oxfordjournals.jmicro.a023730
   Wack KE, 2001, HEPATOLOGY, V33, P363, DOI 10.1053/jhep.2001.21998
   Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270
   Zavodnik L, 1999, EXP TOXICOL PATHOL, V51, P446, DOI 10.1016/S0940-2993(99)80038-4
NR 31
TC 36
Z9 39
U1 0
U2 1
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0901-9928
J9 PHARMACOL TOXICOL
JI Pharmacol. Toxicol.
PD DEC
PY 2001
VL 89
IS 6
BP 306
EP 311
DI 10.1034/j.1600-0773.2001.d01-165.x
PG 6
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 506CL
UT WOS:000172952300005
PM 11903956
DA 2024-02-19
ER

PT J
AU Fielder, E
   Wan, TF
   Alimohammadiha, G
   Ishaq, A
   Low, E
   Weigand, BM
   Kelly, G
   Parker, C
   Griffin, B
   Jurk, D
   Korolchuk, V
   von Zglinicki, T
   Miwa, S
   Isales, C
AF Fielder, Edward
   Wan, Tengfei
   Alimohammadiha, Ghazaleh
   Ishaq, Abbas
   Low, Evon
   Weigand, B. Melanie
   Kelly, George
   Parker, Craig
   Griffin, Brigid
   Jurk, Diana
   Korolchuk, Viktor, I
   von Zglinicki, Thomas
   Miwa, Satomi
   Isales, Carlos
TI Short senolytic or senostatic interventions rescue progression of
   radiation-induced frailty and premature ageing in mice
SO ELIFE
LA English
DT Article
DE ageing; senescence; senolytic; metformin; frailty; Mouse
ID NADPH OXIDASE NOX4; SENESCENT CELLS; SECRETORY PHENOTYPE; DNA-DAMAGE;
   METFORMIN; EXPRESSION; CANCER; NAVITOCLAX; SURVIVORS; MORTALITY
AB Cancer survivors suffer from progressive frailty, multimorbidity, and premature morbidity. We hypothesise that therapy-induced senescence and senescence progression via bystander effects are significant causes of this premature ageing phenotype. Accordingly, the study addresses the question whether a short anti-senescence intervention is able to block progression of radiation-induced frailty and disability in a pre-clinical setting. Male mice were sublethally irradiated at 5 months of age and treated (or not) with either a senolytic drug (Navitoclax or dasatinib + quercetin) for 10 days or with the senostatic metformin for 10 weeks. Follow -up was for 1 year. Treatments commencing within a month after irradiation effectively reduced frailty progression (p < 0.05) and improved muscle (p < 0.01) and liver (p < 0.05) function as well as short -term memory (p < 0.05) until advanced age with no need for repeated interventions. Senolytic interventions that started late, after radiation-induced premature frailty was manifest, still had beneficial effects on frailty (p < 0.05) and short -term memory (p < 0.05). Metformin was similarly effective as senolytics. At therapeutically achievable concentrations, metformin acted as a senostatic neither via inhibition of mitochondrial complex I, nor via improvement of mitophagy or mitochondrial function, but by reducing nonmitochondrial reactive oxygen species production via NADPH oxidase 4 inhibition in senescent cells. Our study suggests that the progression of adverse long -term health and quality -of -life effects of radiation exposure, as experienced by cancer survivors, might be rescued by short -term adjuvant anti-senescence interventions.
C1 [Fielder, Edward; Wan, Tengfei; Alimohammadiha, Ghazaleh; Ishaq, Abbas; Low, Evon; Weigand, B. Melanie; Kelly, George; Parker, Craig; Griffin, Brigid; Jurk, Diana; Korolchuk, Viktor, I; von Zglinicki, Thomas; Miwa, Satomi; Isales, Carlos] Newcastle Univ, Newcastle Univ Biosci Inst, Newcastle Upon Tyne, England.
   [Ishaq, Abbas] Alcyomics Ltd, The Biosphere, Newcastle Helix, Draymans Way, Newcastle, England.
   [Weigand, B. Melanie; Jurk, Diana] Mayo Clin Rochester, Robert & Arlene Kogod Ctr Aging, Dept Physiol & Biomed Engn, Rochester, MN USA.
C3 Newcastle University - UK; Mayo Clinic
RP von Zglinicki, T (corresponding author), Newcastle Univ, Newcastle Univ Biosci Inst, Newcastle Upon Tyne, England.
EM t.vonzglinicki@ncl.ac.uk
OI Fielder, Edward/0000-0003-2834-8706; Ishaq, Abbas/0000-0001-6344-466X;
   Jurk, Diana/0000-0003-4486-0857; Wan, Tengfei/0000-0002-0273-3721
FU Cancer Research UK [C12161/A24009]; Biotechnology and Biological
   Sciences Research Council [BB/S006710/1, BH174490]; UK SPINE Bridge
   [B06]
FX Cancer Research UK C12161/A24009 Thomas von Zglinicki; Biotechnology and
   Biological Sciences Research Council BB/S006710/1 Thomas von Zglinicki;
   UK SPINE Bridge B06 Thomas von Zglinicki Satomi Miwa; Biotechnology and
   Biological Sciences Research Council BH174490 Viktor I Korolchuk;
   Biotechnology and Biological Sciences Research Council Diana Jurk
CR Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272
   Blagosklonny MV, 2017, ONCOTARGET, V8, P35492, DOI 10.18632/oncotarget.18033
   Bluethmann SM, 2016, CANCER EPIDEM BIOMAR, V25, P1029, DOI 10.1158/1055-9965.EPI-16-0133
   Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897
   Bronikowski AM, 2022, AGING CELL, V21, DOI 10.1111/acel.13542
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Cameron Kerry M, 2012, Longev Healthspan, V1, P3, DOI 10.1186/2046-2395-1-3
   Campbell JM, 2017, AGEING RES REV, V40, P31, DOI 10.1016/j.arr.2017.08.003
   Chandra A, 2020, J BONE MINER RES, V35, P1119, DOI 10.1002/jbmr.3978
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cupit-Link MC, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2017-000250
   Cytlak U, 2020, IMMUNITY, V53, P353, DOI 10.1016/j.immuni.2020.07.003
   da Silva PFL, 2019, AGING CELL, V18, DOI 10.1111/acel.12848
   Damlaj M, 2019, BLOOD REV, V33, P63, DOI 10.1016/j.blre.2018.07.003
   Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006
   Demaria M, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1299666
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Fielder E, 2020, AGING CELL, V19, DOI 10.1111/acel.13188
   Fielder E, 2019, MECH AGEING DEV, V180, P63, DOI 10.1016/j.mad.2019.03.006
   Fontana L, 2018, MECH AGEING DEV, V176, P19, DOI 10.1016/j.mad.2018.10.005
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Goy C, 2014, EXP GERONTOL, V56, P45, DOI 10.1016/j.exger.2014.03.005
   Hägg S, 2021, ELIFE, V10, DOI 10.7554/eLife.63425
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Hudgins AD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00059
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Jena BC, 2020, BBA-REV CANCER, V1874, DOI 10.1016/j.bbcan.2020.188416
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kobashigawa LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104888
   Kojima G, 2018, AGE AGEING, V47, P193, DOI 10.1093/ageing/afx162
   Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Le ONL, 2010, AGING CELL, V9, P398, DOI 10.1111/j.1474-9726.2010.00567.x
   Le Pelletier L, 2021, ELIFE, V10, DOI [10.7554/eLife.62635, 10.7554/eLife.62635.sa1, 10.7554/eLife.62635.sa2]
   Lener B, 2009, BIOCHEM J, V423, P363, DOI 10.1042/BJ20090666
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Miwa S, 2016, FREE RADICAL BIO MED, V90, P173, DOI 10.1016/j.freeradbiomed.2015.11.011
   Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837
   Moiseeva O, 2013, AGING CELL, V12, P489, DOI 10.1111/acel.12075
   Mookerjee SA, 2015, JOVE-J VIS EXP, DOI 10.3791/53464
   Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840
   Mylonas KJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abb0203
   Nadon NL, 2017, EBIOMEDICINE, V21, P3, DOI 10.1016/j.ebiom.2016.11.038
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Nelsons G, 2018, MECH AGEING DEV, V170, P30, DOI 10.1016/j.mad.2017.08.005
   Ness KK, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.7467
   Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268
   Ogrodnik M, 2021, AGING CELL, V20, DOI 10.1111/acel.13296
   Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI [10.1016/j.cmet.2018.12.008, 10.1016/j.cmet.2019.01.013]
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Orszaghova Z, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.770413
   Palacio L, 2017, ONCOGENE, V36, P1309, DOI 10.1038/onc.2016.298
   Palacio L, 2019, AGING CELL, V18, DOI 10.1111/acel.12971
   Palliyaguru DL, 2020, J GERONTOL A-BIOL, V75, P2037, DOI 10.1093/gerona/glaa148
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003728
   Rezende F, 2017, REDOX BIOL, V11, P312, DOI 10.1016/j.redox.2016.12.012
   Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634
   Rockwood K, 2015, INTERD T GERONT GERI, V41, P1, DOI 10.1159/000381127
   Saleh T, 2019, CANCER RES, V79, P1044, DOI 10.1158/0008-5472.CAN-18-3437
   Sato N, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0420-x
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Selvarani R, 2021, GEROSCIENCE, V43, P1135, DOI 10.1007/s11357-020-00274-1
   Seol MA, 2012, J VET SCI, V13, P331, DOI 10.4142/jvs.2012.13.4.331
   Shi Y, 2021, MOL MED REP, V24, DOI 10.3892/mmr.2021.12351
   Shi YJ, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2020.118877
   Short S, 2019, EBIOMEDICINE, V41, P683, DOI 10.1016/j.ebiom.2019.01.056
   Tarantini S, 2021, GEROSCIENCE, V43, P2427, DOI 10.1007/s11357-021-00440-z
   te Poele RH, 2002, CANCER RES, V62, P1876
   von Zglinicki T., 2021, HDB BIOL AGING, P53, DOI 10.1016/C2012-0-07319-X
   Wang CP, 2017, J DIABETES COMPLICAT, V31, P679, DOI [10.1016/jjdiacomp.2017.01.013, 10.1016/j.jdiacomp.2017.01.013]
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327
   Whitehead JC, 2014, J GERONTOL A-BIOL, V69, P621, DOI 10.1093/gerona/glt136
   WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220
   Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yabluchanskiy A, 2020, GEROSCIENCE, V42, P409, DOI 10.1007/s11357-020-00154-8
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
   Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207
NR 90
TC 17
Z9 16
U1 2
U2 7
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD MAY 4
PY 2022
VL 11
AR e75492
DI 10.7554/eLife.75492
PG 29
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 1W0SG
UT WOS:000806491100001
PM 35507395
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Jansen, PLM
AF Jansen, PLM
TI Liver disease in the elderly
SO BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
LA English
DT Article
DE liver function; elderly; old age; non-alcoholic steatohepatitis; viral
   hepatitis; hepatocellular carcinoma; alcoholic liver disease;
   cholestatic liver disease; liver transplantation; gallstones
ID AGE-RELATED-CHANGES; EARLY HEPATOCELLULAR-CARCINOMA; HEPATITIS-C VIRUS;
   NON-B-HEPATITIS; NONALCOHOLIC STEATOHEPATITIS; GALLSTONE DISEASE;
   SURGICAL RESECTION; ALCOHOL-PROBLEMS; VIRAL-HEPATITIS; UNITED-STATES
AB Ageing of the liver mainly affects the sinusoids and the Kupffer cells. Pseudocapillarization, manifested by reduced sinusoidal fenestration and subendothelial collagen deposition, causes a reduction in oxygen-dependent hepatocyte functions such as oxidative drug metabolism. The liver mass in old people is somewhat reduced and the liver blood flow is diminished. This causes a reduction in the clearance of rapidly cleared drugs, but the clearance of slowly cleared drugs is not affected. The overall capacity of the liver to regenerate is maintained in old people. Therefore, hepatic resections for hepatocellular carcinoma can be carried out in non-cirrhotic elderly people. For liver transplantations, biological age is more important than calendar age. Transplantations in frail old people and in elderly people with very poor liver function are associated with increased morbidity and limited survival. In relatively healthy old people, the results are as good as those in younger age groups. An increased prevalence of hepatitis C associated cirrhosis and hepatocellular carcinoma in the elderly population is to be expected, at least in the next 20 years. There is a high prevalence of gallstones among old people, in particular among females. For symptomatic choledocholithiasis in elderly patients, endoscopic bile duct clearance does not necessarily need to be followed by cholecystectomy.
C1 Univ Groningen Hosp, Dept Gastroenterol & Hepatol, NL-9713 GZ Groningen, Netherlands.
C3 University of Groningen
RP Jansen, PLM (corresponding author), Univ Groningen Hosp, Dept Gastroenterol & Hepatol, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands.
RI Jansen, Peter LM/I-4509-2013
CR Attili AF, 1997, HEPATOLOGY, V26, P809, DOI 10.1002/hep.510260401
   BARBARA L, 1987, HEPATOLOGY, V7, P913, DOI 10.1002/hep.1840070520
   Bayon LG, 1996, HEPATOLOGY, V23, P1224, DOI 10.1002/hep.510230542
   Beutels M, 1998, Acta Gastroenterol Belg, V61, P4
   BROUWER A, 1986, ARCH GERONTOL GERIAT, V5, P317, DOI 10.1016/0167-4943(86)90034-8
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   Chien NT, 1999, J AM GERIATR SOC, V47, P1110, DOI 10.1111/j.1532-5415.1999.tb05236.x
   Collins BH, 2000, TRANSPLANTATION, V70, P780, DOI 10.1097/00007890-200009150-00012
   Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010
   Day CP, 2000, J ROY COLL PHYS LOND, V34, P557
   Deuffic S, 1999, HEPATOLOGY, V29, P1596, DOI 10.1002/hep.510290528
   El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227
   El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001
   FAGAN EA, 1990, BRIT MED BULL, V46, P462, DOI 10.1093/oxfordjournals.bmb.a072410
   Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X
   Harnois DM, 1999, LIVER TRANSPLANT SUR, V5, P192, DOI 10.1002/lt.500050307
   Harris DR, 2001, ANN INTERN MED, V134, P120, DOI 10.7326/0003-4819-134-2-200101160-00012
   HOOFNAGLE JH, 1995, HEPATOLOGY, V21, P240, DOI 10.1002/hep.1840210137
   Houwerzijl E J, 2000, Ned Tijdschr Geneeskd, V144, P1923
   Jain A, 1998, TRANSPL P, V30, P1403, DOI 10.1016/S0041-1345(98)00290-5
   Johnson I, 2000, INT J GERIATR PSYCH, V15, P575, DOI 10.1002/1099-1166(200007)15:7<575::AID-GPS151>3.0.CO;2-0
   KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409
   Larrey D, 2000, J HEPATOL, V32, P77, DOI 10.1016/S0168-8278(00)80417-1
   Laurin J, 1996, HEPATOLOGY, V23, P1464
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814
   Levy MF, 2001, ANN SURG, V233, P107, DOI 10.1097/00000658-200101000-00016
   Lirussi F, 1999, EUR J GASTROEN HEPAT, V11, P485, DOI 10.1097/00042737-199905000-00004
   Llovet JM, 2000, LIVER TRANSPLANT, V6, pS11, DOI 10.1053/jlts.2000.18684
   Llovet JM, 2000, HEPATOLOGY, V31, P1019, DOI 10.1053/he.2000.6959
   Llovet JM, 2000, BEST PRACT RES CL GA, V14, P991, DOI 10.1053/bega.2000.0143
   Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629
   Lui WY, 1999, HEPATO-GASTROENTEROL, V46, P640
   Luyckx FH, 2000, DIABETES METAB, V26, P98
   Maher J, 2001, HEPATOLOGY, V33, P311, DOI 10.1053/jhep.2001.0330311
   Majno PE, 2000, HEPATOLOGY, V31, P899, DOI 10.1053/he.2000.5763
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Newton JL, 2000, AGE AGEING, V29, P305, DOI 10.1093/ageing/29.4.305
   Ono Y, 2000, AM J CLIN ONCOL-CANC, V23, P564, DOI 10.1097/00000421-200012000-00006
   Ponsioen CY, 1999, AM J GASTROENTEROL, V94, P2403
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   POYNARD T, 1995, NEW ENGL J MED, V332, P1457, DOI 10.1056/NEJM199506013322201
   Rajan M, 2000, Indian J Gastroenterol, V19, P158
   Rushfeldt C, 1999, J SURG RES, V82, P209, DOI 10.1006/jsre.1998.5532
   Saito M, 2000, GASTROINTEST ENDOSC, V51, P540, DOI 10.1016/S0016-5107(00)70286-0
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Schalm SW, 1999, GASTROENTEROLOGY, V117, P408, DOI 10.1053/gast.1999.0029900408
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Seeff LB, 2001, HEPATOLOGY, V33, P455, DOI 10.1053/jhep.2001.21905
   Suarez Y, 2000, Clin Liver Dis, V4, P591, DOI 10.1016/S1089-3261(05)70128-8
   Sugauchi F, 2000, J MED VIROL, V62, P456, DOI 10.1002/1096-9071(200012)62:4&lt;456::AID-JMV10&gt;3.0.CO;2-3
   Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121
   Weyerer S, 1999, AUST NZ J PSYCHIAT, V33, P825, DOI 10.1046/j.1440-1614.1999.00653.x
   Williams D, 1996, AGE AGEING, V25, P377, DOI 10.1093/ageing/25.5.377
   WYNNE H, 1987, AGE AGEING, V16, P153, DOI 10.1093/ageing/16.3.153
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   WYNNE HA, 1993, AGE AGEING, V22, P354, DOI 10.1093/ageing/22.5.354
   WYNNE HA, 1992, AGE AGEING, V21, P417, DOI 10.1093/ageing/21.6.417
   Zetterman RK, 1998, TRANSPLANTATION, V66, P500, DOI 10.1097/00007890-199808270-00015
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 63
TC 54
Z9 57
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1521-6918
EI 1532-1916
J9 BEST PRACT RES CL GA
JI Best Pract. Res. Clin. Gastroenterol.
PD FEB
PY 2002
VL 16
IS 1
BP 149
EP 158
DI 10.1053/bega.2002.0271
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 519VM
UT WOS:000173746200011
PM 11977934
DA 2024-02-19
ER

PT J
AU DICE, JF
AF DICE, JF
TI CELLULAR THEORIES OF AGING AS RELATED TO THE LIVER
SO HEPATOLOGY
LA English
DT Article
RP DICE, JF (corresponding author), HARVARD UNIV, SCH MED, DEPT PHYSIOL & BIOPHYS, BOSTON, MA 02115 USA.
FU NIA NIH HHS [AG 00187, AG 02783] Funding Source: Medline
CR BELL E, 1978, SCIENCE, V202, P1158, DOI 10.1126/science.725592
   BUCALA R, 1984, P NATL ACAD SCI-BIOL, V81, P105, DOI 10.1073/pnas.81.1.105
   BURROWS RB, 1982, MECH AGEING DEV, V19, P85, DOI 10.1016/0047-6374(82)90053-7
   CARLIN CR, 1983, NATURE, V306, P617, DOI 10.1038/306617a0
   COHEN MP, 1983, EXP GERONTOL, V18, P461, DOI 10.1016/0531-5565(83)90025-6
   CRISTOFALO VJ, 1982, TESTING THEORIES AGI, P201
   CROY RG, 1983, P NATL ACAD SCI-BIOL, V80, P4699, DOI 10.1073/pnas.80.15.4699
   DICE JF, 1982, J BIOL CHEM, V257, P4624
   ENAT R, 1984, P NATL ACAD SCI-BIOL, V81, P1411, DOI 10.1073/pnas.81.5.1411
   FURANO K, 1984, EXP CELL RES, V156, P15
   GERSHON D, 1979, MECH AGEING DEV, V9, P189, DOI 10.1016/0047-6374(79)90098-8
   GOLDSTEIN S, 1979, FED PROC, V38, P1862
   HADLEY EC, 1982, TESTING THEORIES AGI, P115
   HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435
   HARLEY CB, 1981, J CLIN INVEST, V68, P988, DOI 10.1172/JCI110353
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAYFLICK L, 1980, MECH AGEING DEV, V14, P59, DOI 10.1016/0047-6374(80)90106-2
   HOLLIDAY R, 1975, FED PROC, V34, P51
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   KIRKWOOD TBL, 1984, NATURE, V308, P226, DOI 10.1038/308226a0
   KITANI K, 1978, LIVER AGING 1978
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MCKERROW JH, 1979, MECH AGEING DEV, V10, P371, DOI 10.1016/0047-6374(79)90019-8
   MEDVEDEV ZA, 1983, EXP GERONTOL, V18, P73, DOI 10.1016/0531-5565(83)90053-0
   MEDVEDEV ZA, 1980, MECH AGEING DEV, V14, P1, DOI 10.1016/0047-6374(80)90102-5
   NOSE K, 1980, J CELL PHYSIOL, V102, P51, DOI 10.1002/jcp.1041020108
   OKADA AA, 1984, MECH AGEING DEV, V26, P341, DOI 10.1016/0047-6374(84)90105-2
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   ORGEL LE, 1973, NATURE, V244, P441, DOI 10.1038/243441a0
   PLISKO A, 1983, J GERONTOL, V38, P513, DOI 10.1093/geronj/38.5.513
   PONGOR S, 1984, P NATL ACAD SCI-BIOL, V81, P2684, DOI 10.1073/pnas.81.9.2684
   POPPER H, 1985, PROGR LIVER DISEASES, V14
   REIS RJS, 1980, CELL, V21, P739, DOI 10.1016/0092-8674(80)90437-7
   RHOME D, 1981, P NATL ACAD SCI USA, V78, P5009
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   RIVETT AJ, 1985, J BIOL CHEM, V260, P300
   ROTHSTEIN M, 1983, ALTERED PROTEINS AGI, P1
   SHARMA HK, 1979, ARCH BIOCHEM BIOPHYS, V194, P275, DOI 10.1016/0003-9861(79)90619-2
   SMITH JR, 1984, INT REV CYTOL, V89, P151, DOI 10.1016/S0074-7696(08)61303-0
   STEIN GH, 1982, P NATL ACAD SCI-BIOL, V79, P5287, DOI 10.1073/pnas.79.17.5287
   STREHLER B, 1971, J THEOR BIOL, V33, P429, DOI 10.1016/0022-5193(71)90091-9
   WANG E, 1985, J CELL BIOL, V100, P545, DOI 10.1083/jcb.100.2.545
   YUAN PM, 1981, MECH AGEING DEV, V17, P151, DOI 10.1016/0047-6374(81)90081-6
NR 45
TC 25
Z9 26
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PY 1985
VL 5
IS 3
BP 508
EP 513
DI 10.1002/hep.1840050328
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AJF95
UT WOS:A1985AJF9500027
PM 3997080
OA Bronze
DA 2024-02-19
ER

PT J
AU Mikula-Pietrasik, J
   Uruski, P
   Pakula, M
   Maksin, K
   Szubert, S
   Wozniak, A
   Naumowicz, E
   Szpurek, D
   Tykarski, A
   Ksiazek, K
AF Mikula-Pietrasik, Justyna
   Uruski, Pawel
   Pakula, Martyna
   Maksin, Konstantin
   Szubert, Sebastian
   Wozniak, Aldona
   Naumowicz, Eryk
   Szpurek, Dariusz
   Tykarski, Andrzej
   Ksiazek, Krzysztof
TI Oxidative stress contributes to hepatocyte growth factor-dependent
   prosenescence activity of ovarian cancer cells
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Cellular senescence; Hepatocyte growth factor; Mesothelial cells;
   Ovarian cancer; Peritoneum
ID PERITONEAL MESOTHELIAL CELLS; MODEL IN-VIVO; REPLICATIVE SENESCENCE;
   CELLULAR SENESCENCE; ENDOTHELIAL-CELLS; FIBROBLASTS; ACTIVATION;
   METASTASIS; GENERATION; PHENOTYPE
AB The cancer-promoting activity of senescent peritoneal mesothelial cells (HPMCs) has already been well evidenced both in vitro and in vivo. Here we sought to determine if ovarian cancer cells may activate senescence in HPMCs. The study showed that conditioned medium (CM) from ovarian cancer cells (OVCAR-3, SKOV-3, A2780) inhibited growth and promoted the development of senescence phenotype (increased SA-beta-Gal,gamma-H2A. X, 53BP1, and decreased Cx43) in HPMCs. An analysis of tumors isolated from the peritoneum of patients with ovarian cancer revealed an abundance of senescent HPMCs in proximity to cancerous tissue. The presence of senescent HPMCs was incidental when fragments of peritoneum free from cancer were evaluated. An analysis of the cells' secretome followed by intervention studies with exogenous proteins and neutralizing antibodies revealed hepatocyte growth factor (HGF) as the mediator of the pro-senescence impact of the cancer cells. The activity of cancerous CM and HGF was associated with an induction of mitochondrial oxidative stress. Signaling pathways involved in the senescence of HPMCs elicited by the cancer-derived CM and HGF included p38 MAPK, AKT and NF-kappa B. HPMCs that senesced prematurely in response to the cancer-derived CM promoted adhesion of ovarian cancer cells, however this effect was effectively prevented by the cell protection against oxidative stress. Collectively, our findings indicate that ovarian cancer cells can elicit HGF-dependent senescence in HPMCs, which may contribute to the formation of a metastatic niche for these cells within the peritoneal cavity.
C1 [Mikula-Pietrasik, Justyna; Uruski, Pawel; Pakula, Martyna; Tykarski, Andrzej; Ksiazek, Krzysztof] Poznan Univ Med Sci, Dept Hypertensiol Angiol & Internal Med, Dluga 1-2 Str, PL-61848 Poznan, Poland.
   [Maksin, Konstantin; Wozniak, Aldona] Poznan Univ Med Sci, Dept Clin Pathol, Przybyszewskiego 49 Str, PL-60355 Poznan, Poland.
   [Szubert, Sebastian; Szpurek, Dariusz] Poznan Univ Med Sci, Div Gynecol Surg, Polna 33 Str, PL-60535 Poznan, Poland.
   [Naumowicz, Eryk] Med Ctr HCP, Gen Surg Ward, 28 Czerwca 1956 R 223-229 Str, PL-61485 Poznan, Poland.
C3 Poznan University of Medical Sciences; Poznan University of Medical
   Sciences; Poznan University of Medical Sciences
RP Ksiazek, K (corresponding author), Poznan Univ Med Sci, Dept Hypertensiol Angiol & Internal Med, Dluga 1-2 Str, PL-61848 Poznan, Poland.
EM jmikula@ump.edu.pl; puruski@ump.edu.pl; mpakula@ump.edu.pl;
   kmaksin@gmail.com; szuberts@o2.pl; aldona.wozniak@wp.pl;
   eryknaumowicz@plusnet.pl; dszpurek@gmail.com; tykarski@o2.pl;
   kksiazek@ump.edu.pl
RI Książek, Krzysztof/ADY-3895-2022; Pietrasik, Justyna/JCE-2548-2023;
   Uruski, Paweł/AAJ-6583-2021
OI Książek, Krzysztof/0000-0002-6066-5747; Pietrasik,
   Justyna/0000-0002-8267-5428; Uruski, Paweł/0000-0002-6798-3043; Pakula,
   Martyna/0000-0001-5720-8791
FU National Science Centre, Poland [2014/15/B/NZ3/00421]
FX This work was supported by a grant from the National Science Centre,
   Poland (2014/15/B/NZ3/00421).
CR Ahn J, 2013, APOPTOSIS, V18, P870, DOI 10.1007/s10495-013-0835-5
   Allen RG, 1999, J CELL PHYSIOL, V180, P114, DOI 10.1002/(SICI)1097-4652(199907)180:1<114::AID-JCP13>3.0.CO;2-0
   Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394
   Beyne-Rauzy O, 2004, ONCOGENE, V23, P7507, DOI 10.1038/sj.onc.1208024
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109
   Fokas E, 2007, CANCER METAST REV, V26, P705, DOI 10.1007/s10555-007-9088-5
   Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003
   Jagadeeswaran R, 2007, AM J PHYSIOL-LUNG C, V292, pL1488, DOI 10.1152/ajplung.00147.2006
   Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778
   Ksiazek K, 2008, FREE RADICAL BIO MED, V45, P460, DOI 10.1016/j.freeradbiomed.2008.04.032
   Ksiazek K, 2009, AM J PATHOL, V174, P1230, DOI 10.2353/ajpath.2009.080613
   Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105
   LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039
   Matte I, 2015, INT J CANCER, V137, P289, DOI 10.1002/ijc.29385
   Mikula-Pietrasik J., 2014, J GERONTOL A
   Mikula-Pietrasik J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.417
   Mikula-Pietrasik J, 2016, OXID MED CELL LONGEV, V2016, P1, DOI 10.1155/2016/2069290
   Mikula-Pietrasik J, 2016, CELL ONCOL, V39, P473, DOI 10.1007/s13402-016-0289-1
   Mikula-Pietrasik J, 2016, CLIN EXP METASTAS, V33, P15, DOI 10.1007/s10585-015-9753-y
   Mikula-Pietrasik J, 2015, ONCOTARGET, V6, P29178, DOI 10.18632/oncotarget.4932
   Mikula-Pietrasik J, 2014, CANCER LETT, V355, P310, DOI 10.1016/j.canlet.2014.09.041
   Mikula-Pietrasik J, 2014, GYNECOL ONCOL, V134, P624, DOI 10.1016/j.ygyno.2014.06.022
   Mikula-Pietrasik J, 2013, INT J BIOCHEM CELL B, V45, P2087, DOI 10.1016/j.biocel.2013.07.004
   Mikula-Pietrasik J, 2012, FREE RADICAL BIO MED, V52, P2234, DOI 10.1016/j.freeradbiomed.2012.03.014
   Miyazaki M, 1998, BIOCHEM BIOPH RES CO, V246, P255, DOI 10.1006/bbrc.1998.8593
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103
   Sapochnik M., 2016, ONCOTARGET
   Sosinska P, 2014, BIOGERONTOLOGY, V15, P407, DOI 10.1007/s10522-014-9505-4
   Spallarossa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015583
   Statuto M, 2002, EXP GERONTOL, V37, P1113, DOI 10.1016/S0531-5565(02)00089-X
   Terada T, 2011, INT J CLIN EXP PATHO, V4, P631
   Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061
   Uekawa N, 2004, FEBS LETT, V575, P30, DOI 10.1016/j.febslet.2004.08.033
   Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009
   Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556
   Wang YM, 2007, FREE RADICAL RES, V41, P963, DOI 10.1080/10715760701445045
   Xie C, 2014, ONCOL LETT, V7, P159, DOI 10.3892/ol.2013.1693
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004
   Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103
NR 42
TC 23
Z9 25
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD SEP
PY 2017
VL 110
BP 270
EP 279
DI 10.1016/j.freeradbiomed.2017.06.015
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA FB3NK
UT WOS:000406049200026
PM 28652056
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   CAI, Y
   KOSANKE, SD
   VENKATARAMAN, PS
AF RIKANS, LE
   CAI, Y
   KOSANKE, SD
   VENKATARAMAN, PS
TI REDOX CYCLING AND HEPATOTOXICITY OF DIQUAT IN AGING MALE FISCHER 344
   RATS
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; X-RAY ABSORPTIOMETRY; LEAN BODY-MASS;
   LIPID-PEROXIDATION; HEPATIC-NECROSIS; OXIDANT STRESS; ASCORBIC-ACID;
   LIVER; PARAQUAT; IRON
AB The aim of this study was to determine the influence of aging on diquat-induced redox cycling in liver microsomes and diquat hepatotoxicity in rats. Diquat-stimulated production of superoxide anion radical and NADPH-cytochrome c (P-450) reductase activity were measured in liver microsomes prepared from male Fischer 344 rats at ages representing young adulthood (5-6 months), middle age (15-16 months), and old age (24-27 months). Both activities were decreased substantially (40%) in old rats. Diquat-induced liver damage was assessed 6 hr after the administration of diquat (0.1 mmol/kg, ip) on the basis of serum ALT and sorbitol dehydrogenase activities, hepatic microsomal cytochrome P-450 loss, and histological evaluation. The classical manifestations of hepatotoxicity in diquat-treated rats were as severe in old rats as in young-adult ones, despite the age-associated drop in redox cycling capacity. Diquat treatment also resulted in decreased concentrations of hepatic glutathione and ascorbic acid, increased concentrations of hepatic nonheme iron, and decreased liver weights. The changes in glutathione, nonheme iron, and liver weight were more pronounced in livers of middle-aged and old rats than in those of young-adult rats. These age-dependent differences could not be explained on the basis of plasma diquat concentrations, which were similar in the three age groups of rats. The absence of an effect of aging on the hepatotoxic effects of diquat indicates that redox cycling capacity is not limiting for the development of liver damage. Other effects of diquat were influenced by aging, but their relevancy to the hepatotoxicity is uncertain.
C1 UNIV OKLAHOMA HLTH SCI CTR,COLL MED,DEPT PATHOL,OKLAHOMA CITY,OK 73190.
   UNIV OKLAHOMA HLTH SCI CTR,COLL MED,DEPT PEDIAT,OKLAHOMA CITY,OK 73190.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA HLTH SCI CTR,COLL MED,DEPT PHARMACOL,OKLAHOMA CITY,OK 73190, USA.
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR BERGMEYER HU, 1974, METHOD ENZYMAT AN, P752
   BRAILLON PM, 1992, PEDIATR RES, V32, P77, DOI 10.1203/00006450-199207000-00015
   BURK RF, 1980, J CLIN INVEST, V65, P1024, DOI 10.1172/JCI109754
   CHAN GM, 1992, J BONE MINER RES, V7, P369
   DANIEL JW, 1966, BRIT J IND MED, V23, P133
   Eklow-Lastbom L, 1986, Free Radic Res Commun, V2, P57, DOI 10.3109/10715768609088055
   GERLACH U, 1974, METHOD ENZYMAT AN, P569
   GILL R, 1983, J CHROMATOGR, V255, P483, DOI 10.1016/S0021-9673(01)88303-5
   KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7
   KUTHAN H, 1982, BIOCHEM J, V203, P551, DOI 10.1042/bj2030551
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   NAKAGAWA Y, 1991, BIOCHEM PHARMACOL, V42, P883, DOI 10.1016/0006-2952(91)90049-B
   NEUSCHWANDERTETRI BA, 1989, ANAL BIOCHEM, V179, P236, DOI 10.1016/0003-2697(89)90121-8
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   OVE P, 1972, BIOCHIM BIOPHYS ACTA, V277, P211, DOI 10.1016/0005-2787(72)90367-X
   PETRY TW, 1992, TOXICOLOGY, V74, P33, DOI 10.1016/0300-483X(92)90041-C
   REIF DW, 1992, FREE RADICAL BIO MED, V12, P417, DOI 10.1016/0891-5849(92)90091-T
   REIF DW, 1988, TOXICOL APPL PHARM, V93, P506, DOI 10.1016/0041-008X(88)90054-3
   RIKANS LE, 1981, EXP GERONTOL, V16, P253, DOI 10.1016/0531-5565(81)90021-8
   RIKANS LE, 1993, TOXICOL APPL PHARM, V118, P263, DOI 10.1006/taap.1993.1032
   RIKANS LE, 1992, J PHARMACOL EXP THER, V262, P271
   RIKANS LE, 1984, TOXICOL APPL PHARM, V73, P243, DOI 10.1016/0041-008X(84)90329-6
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   ROSE MS, 1976, BIOCHEM PHARMACOL, V25, P419, DOI 10.1016/0006-2952(76)90344-0
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SMITH CV, 1987, BIOCHEM BIOPH RES CO, V144, P415, DOI 10.1016/S0006-291X(87)80526-0
   SMITH CV, 1985, J PHARMACOL EXP THER, V235, P172
   SMITH CV, 1987, MOL PHARMACOL, V32, P417
   SMITH CV, 1992, TOXICOLOGIST, V12, P76
   SMITH MT, 1984, METHOD ENZYMOL, V105, P505
   SPALDING DJM, 1989, TOXICOL APPL PHARM, V101, P319, DOI 10.1016/0041-008X(89)90280-9
   VERMILION JL, 1978, J BIOL CHEM, V253, P2694
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   ZANNONI V, 1974, BIOCHEM MED METAB B, V11, P41, DOI 10.1016/0006-2944(74)90093-3
   1978, BRIT J HAEMATOL, V38, P291
   1981, MAMMALIAN MODELS RES, P75
   1990, BRIT J HAEMATOL, V75, P615
NR 37
TC 9
Z9 9
U1 0
U2 0
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0090-9556
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD JUL-AUG
PY 1993
VL 21
IS 4
BP 605
EP 610
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA LP256
UT WOS:A1993LP25600008
PM 8104118
DA 2024-02-19
ER

PT J
AU MARCHESINI, G
   BUA, V
   BRUNORI, A
   BIANCHI, G
   PISI, P
   FABBRI, A
   ZOLI, M
   PISI, E
AF MARCHESINI, G
   BUA, V
   BRUNORI, A
   BIANCHI, G
   PISI, P
   FABBRI, A
   ZOLI, M
   PISI, E
TI GALACTOSE ELIMINATION CAPACITY AND LIVER VOLUME IN AGING MAN
SO HEPATOLOGY
LA English
DT Article
C1 UNIV BOLOGNA, POLICLIN S ORSOLA, IST CLIN MED GEN & TERAPIA, I-40138 BOLOGNA, ITALY.
   UNIV BOLOGNA, POLICLIN S ORSOLA, IST RADIOL, I-40138 BOLOGNA, ITALY.
C3 IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of
   Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University
   of Bologna
RI bianchi, giampaolo/AAD-6147-2021; Fabbri, Andrea/K-9994-2016
OI Fabbri, Andrea/0000-0002-9837-4638; Marchesini,
   Giulio/0000-0003-2407-9860
CR BARROWS GH, 1980, GASTROENTEROLOGY, V79, P1099
   Bean RB, 1926, AM J PHYS ANTHROPOL, V9, P293, DOI 10.1002/ajpa.1330090317
   Boscaini M, 1987, Surg Endosc, V1, P103, DOI 10.1007/BF00312695
   Boyd E, 1933, ARCH PATHOL, V16, P350
   CARR D, 1976, BRIT J RADIOL, V49, P776, DOI 10.1259/0007-1285-49-585-776
   DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286
   Descovich G C, 1981, G Ital Cardiol, V11, P1591
   FRESTON JW, 1967, CLIN SCI, V33, P301
   GOSINK BB, 1981, J CLIN ULTRASOUND, V9, P37, DOI 10.1002/jcu.1870090110
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   HAZELL K, 1970, Gerontologia Clinica, V12, P10
   ISHII T, 1978, J AM GERIATR SOC, V26, P391, DOI 10.1111/j.1532-5415.1978.tb05384.x
   KAMPMANN JP, 1975, GERIATRICS, V30, P91
   KOFF RS, 1973, GASTROENTEROLOGY, V65, P300
   LEASK R G S, 1973, Age and Ageing, V2, P14, DOI 10.1093/ageing/2.1.14
   MACLENNAN WJ, 1977, GERONTOLOGY, V23, P360, DOI 10.1159/000212209
   NIE NH, 1975, STATISTICAL PACKAGE
   NIE NH, 1981, SPSS UPDATE, P7
   RASMUSSEN SN, 1978, DAN MED BULL, V25, P1
   REED AH, 1972, CLIN CHEM, V18, P57
   SCHNEGG M, 1986, J HEPATOL, V3, P164, DOI 10.1016/S0168-8278(86)80022-8
   SHARLAND D E, 1972, Age and Ageing, V1, P168, DOI 10.1093/ageing/1.3.168
   THOMPSON EN, 1965, GUT, V6, P266, DOI 10.1136/gut.6.3.266
   TYGSTRUP N, 1966, SCAND J CLIN LAB INV, VS 18, P118
   TYGSTRUP N, 1983, DIAGNOSTIC PROCEDURE, P17
   VANTHIEL DH, 1985, GASTROENTEROLOGY, V88, P1812, DOI 10.1016/0016-5085(85)90005-8
   VESTAL RE, 1978, LIVER AGING 1978, P343
   WANLESS IR, 1980, GASTROENTEROLOGY, V79, P1063
   WEEKE B, 1972, ACTA MED SCAND, V192, P149
   ZOLI M, 1986, LIVER, V6, P286
   ZOLI M, 1986, J ULTRAS MED, V5, P563, DOI 10.7863/jum.1986.5.10.563
   1982, EUR HEART J, V3, P184
NR 32
TC 123
Z9 124
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD SEP-OCT
PY 1988
VL 8
IS 5
BP 1079
EP 1083
DI 10.1002/hep.1840080516
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA Q2655
UT WOS:A1988Q265500015
PM 3417228
DA 2024-02-19
ER

PT J
AU Pacheco-Rivera, R
   Fattel-Fazenda, S
   Arellanes-Robledo, J
   Silva-Olivares, A
   Alemán-Lazarini, L
   Rodríguez-Segura, M
   Pérez-Carreon, J
   Villa-Treviño, S
   Shibayama, M
   Serrano-Luna, J
AF Pacheco-Rivera, Ruth
   Fattel-Fazenda, Samia
   Arellanes-Robledo, Jaime
   Silva-Olivares, Angelica
   Aleman-Lazarini, Leticia
   Rodriguez-Segura, Miguel
   Perez-Carreon, Julio
   Villa-Trevino, Saul
   Shibayama, Mineko
   Serrano-Luna, Jesus
TI Double staining of β-galactosidase with fibrosis and cancer markers
   reveals the chronological appearance of senescence in liver
   carcinogenesis induced by diethylnitrosamine
SO TOXICOLOGY LETTERS
LA English
DT Article
DE Senescence; N-Diethylnitrosamine; Fibrosis; Hepatocarcinogenesis
ID CELLULAR SENESCENCE; HEPATOCELLULAR-CARCINOMA; REPLICATIVE SENESCENCE;
   STELLATE CELLS; DNA-DAMAGE; CYCLIN D1; HETEROCHROMATIN; P53;
   ACCUMULATION; HEPATOCYTES
AB Cellular senescence is characterized by irreversible cell arrest and is associated with the development of chronic diseases, including cancer. Here, we investigated the induction of cellular senescence during liver carcinogenesis. Liver cancer was induced in Fischer 344 rats with a weekly intraperitoneal injection of diethylnitrosamine (50 mg/kg body weight) for 16 weeks. Double-detection of beta-galactosidase with Ki67 for cell proliferation; a-SMA and Pdgfrb for cell specificity; p53, p21, p16, and cyclin D1, CDK2, and CDK4 for senescence-associated molecular pathways and gamma-glutamyltranspeptidase (GGT) for hepatocarcinogenesis was assessed to determine the association of these markers with cellular senescence. DNA damage was measured through senescence-associated heterochromatin foci (SAHF) detection. Progressive cellular senescence was observed in both fibrotic septa and hepatocytes from week 10 to 18. The maximum peak of positive senescent and fibrotic cells was observed at week 16 and decreased at week 18, but cell proliferation remained high. Whereas the increased p16 expression and SAHF were concomitant with that of beta-galactosidase, those of p53 and p21 were barely detected. Furthermore, beta-galactosidase positive myofibroblast-like cells were mainly surrounding GGT-positive tumors. Our findings showed that in hepatocarcinogenesis by diethylnitrosamine, cellular senescence is associated with p16 pathway activation and is mainly localized in myofibroblast-like cells. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Pacheco-Rivera, Ruth; Fattel-Fazenda, Samia; Villa-Trevino, Saul; Serrano-Luna, Jesus] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07360, DF, Mexico.
   [Silva-Olivares, Angelica; Shibayama, Mineko] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Infect, Mexico City 07360, DF, Mexico.
   [Silva-Olivares, Angelica; Shibayama, Mineko] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Mol Pathogenesis, Mexico City 07360, DF, Mexico.
   [Aleman-Lazarini, Leticia] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Mol Biomed, Mexico City 07360, DF, Mexico.
   [Rodriguez-Segura, Miguel] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Phys, Mexico City 07360, DF, Mexico.
   [Arellanes-Robledo, Jaime; Perez-Carreon, Julio] Natl Inst Genom Med, Mexico City 14610, DF, Mexico.
   [Pacheco-Rivera, Ruth] Natl Polytech Inst, Natl Sch Biol Sci, Dept Biochem, Mexico City 01134, DF, Mexico.
C3 Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional
   - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico
   Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto
   Nacional de Medicina Genomica; Instituto Politecnico Nacional - Mexico
RP Serrano-Luna, J (corresponding author), Natl Polytech Inst, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07360, DF, Mexico.
EM jjserrano07@yahoo.com.mx
RI Arellanes-Robledo, Jaime/P-3926-2017; VILLA, SAUL/AAU-3346-2020
OI Arellanes-Robledo, Jaime/0000-0001-7363-4870; VILLA,
   SAUL/0000-0002-8292-8157; Perez-Carreon, Julio Isael/0000-0001-9284-7775
FU CONACYT [83710, 91672]
FX The authors wish to thank J. Torres-Mena M.Sc., S. Hernandez-Garcia, S.
   Galindo-Gomez, and E. Arce-Popoca, for their valuable technical
   assistance. The authors also want to express their gratitude to the
   UPEAL-CINVESTAV staff, Dr. J. Fernandez, R. Leyva-Munoz, R.
   Gaxiola-Centeno, B.E. Chavez-Alvarez and M.A. Lopez-Lopez for their
   assistance with animal breeding, care and handling. This project was
   supported by grant No. 83710 and fellowship No. 91672 from CONACYT.
CR Arellanes-Robledo J, 2006, ANTICANCER RES, V26, P1271
   Badiola I, 2015, AGEING RES REV, V23, P125, DOI 10.1016/j.arr.2015.03.004
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carnero Amancio, 2013, Methods Mol Biol, V965, P63, DOI 10.1007/978-1-62703-239-1_4
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Donnellan R, 1998, J CLIN PATHOL-MOL PA, V51, P1
   DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   ENOMOTO K, 1982, CANCER RES, V42, P2330
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232
   Holliday R, 1996, BIOESSAYS, V18, P3, DOI 10.1002/bies.950180103
   Hydbring P, 2010, AGING-US, V2, P244, DOI 10.18632/aging.100140
   Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Lin H, 2013, HEPATOLOGY, V57, P171, DOI 10.1002/hep.25991
   Lu WJ, 2014, CARCINOGENESIS, V35, P915, DOI 10.1093/carcin/bgt401
   Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003
   Marongiu F, 2014, AGING-US, V6, P26, DOI 10.18632/aging.100631
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Mitra J, 1999, MOL CELL BIOL, V19, P3916
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7
   Pascale RM, 2002, HEPATOLOGY, V35, P1341, DOI 10.1053/jhep.2002.33682
   Peurala E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3376
   Qu K, 2014, FRONT MED-PRC, V8, P227, DOI 10.1007/s11684-014-0327-1
   Ramakrishna G, 2013, LIVER CANCER, V2, P367, DOI 10.1159/000343852
   RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517
   Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wang ZY, 2013, AUTOPHAGY, V9, P925, DOI 10.4161/auto.24229
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776
   Yildiz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064016
   Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06
NR 51
TC 16
Z9 16
U1 2
U2 17
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD JAN 22
PY 2016
VL 241
BP 19
EP 31
DI 10.1016/j.toxlet.2015.11.011
PG 13
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA DA2VA
UT WOS:000367653700003
PM 26589970
DA 2024-02-19
ER

PT J
AU Nguyen, PT
   Kanno, K
   Pham, QT
   Kikuchi, Y
   Kakimoto, M
   Kobayashi, T
   Otani, Y
   Kishikawa, N
   Miyauchi, M
   Arihiro, K
   Ito, M
   Tazuma, S
AF Phuong Thao Nguyen
   Kanno, Keishi
   Quoc Thang Pham
   Kikuchi, Yuka
   Kakimoto, Masaki
   Kobayashi, Tomoki
   Otani, Yuichiro
   Kishikawa, Nobusuke
   Miyauchi, Mutsumi
   Arihiro, Koji
   Ito, Masanori
   Tazuma, Susumu
TI Senescent hepatic stellate cells caused by deoxycholic acid modulates
   malignant behavior of hepatocellular carcinoma
SO JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
LA English
DT Article; Early Access
DE Deoxycholic acid; Cellular senescence; Hepatic stellate cells;
   Hepatocellular carcinoma; Epithelial mesenchymal transition;
   Senescence-associated secretory phenotype
ID EPITHELIAL-MESENCHYMAL TRANSITION; CELLULAR SENESCENCE; N-CADHERIN;
   LIVER; APOPTOSIS
AB Purpose Deoxycholic acid (DCA), a secondary bile acid, is reportedly increased in the serum of patients with nonalcoholic steatohepatitis and animals with experimentally induced hepatocellular carcinoma (HCC), but its contribution to malignant behaviors of HCC has not been precisely clarified. This study aimed to examine the effect of DCA on hepatic stellate cells (HSCs), a major component of nonparenchymal cells in the liver, and its subsequent indirect effect on HCC cells. Methods LX2 cells, a human HSC line, were treated with DCA in vitro. Then, HuH7 cells, a human hepatoma cell line, were incubated in conditioned media of DCA-treated LX2 to investigate the subsequent effect focusing on malignant behaviors. Results DCA resulted in cellular senescence in LX2 with the decreased cell proliferation via cell cycle arrest at G0/1 phase, together with the induction of senescence-associated secretory phenotype (SASP) factors. To investigate the influence of SASP factors secreted by HSCs in response to DCA, HCC cells were treated with conditioned media that promoted cell migration and invasion via induction of epithelial mesenchymal transition. These changes were attenuated in the presence of neutralizing antibody against IL8 or TGF beta. Pathological analysis of surgical specimens from HCC patients revealed that senescent HSCs were detected in the stroma surrounding HCC. Conclusion Our data suggest an important role of HSC senescence caused by DCA for the malignant biological behaviors of HCC via induction of SASP factors, particularly IL8 and TGF beta.
C1 [Phuong Thao Nguyen; Kanno, Keishi; Quoc Thang Pham; Kikuchi, Yuka; Kakimoto, Masaki; Kobayashi, Tomoki; Otani, Yuichiro; Kishikawa, Nobusuke; Ito, Masanori; Tazuma, Susumu] Hiroshima Univ Hosp, Dept Gen Internal Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.
   [Quoc Thang Pham] Hiroshima Univ, Dept Mol Pathol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.
   [Quoc Thang Pham] Univ Med & Pharm Ho Chi Minh City, Dept Pathol, Ho Chi Minh City, Vietnam.
   [Miyauchi, Mutsumi] Hiroshima Univ, Dept Oral Maxillopathobiol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.
   [Arihiro, Koji] Hiroshima Univ Hosp, Dept Pathol, Hiroshima, Japan.
C3 Hiroshima University; Hiroshima University; Hochiminh City University of
   Medicine & Pharmacy; Hiroshima University; Hiroshima University
RP Kanno, K (corresponding author), Hiroshima Univ Hosp, Dept Gen Internal Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.
EM kkanno@hiroshima-u.ac.jp
RI Pham, Quoc Thang/AAP-5919-2021; KANNO, KEISHI/AAA-6853-2021; KAKIMOTO,
   MASAKI/ABF-4084-2020
OI Pham, Quoc Thang/0000-0001-8787-367X; Nguyen, Phuong
   Thao/0000-0003-4651-5168
FU Japan Society for the Promotion of Science
FX This work was supported in part by grants-in-aid from the Japan Society
   for the Promotion of Science to P.T. Nguyen and K. Kanno.
CR Aranha MM, 2008, EUR J GASTROEN HEPAT, V20, P519, DOI 10.1097/MEG.0b013e3282f4710a
   Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527
   Bilusic M, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0706-x
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Cook JW, 1940, NATURE, V145, P627, DOI 10.1038/145627a0
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Evangelou K, 2017, METHODS MOL BIOL, V1534, P111, DOI 10.1007/978-1-4939-6670-7_10
   Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x
   Frey N, 2018, NAT REV GASTRO HEPAT, V15, P81, DOI 10.1038/nrgastro.2017.146
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Fu XT, 2015, INT J ONCOL, V46, P587, DOI 10.3892/ijo.2014.2761
   Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037
   Honma N, 2006, LAB INVEST, V86, P687, DOI 10.1038/labinvest.3700427
   Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435
   Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452
   Jemal A, 2017, JNCI-J NATL CANCER I, V109, DOI [DOI 10.1093/JNCI/DJX030, 10.1093/jnci/djx030]
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008
   Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Kim JH, 2020, ADV EXP MED BIOL, V1240, P25, DOI 10.1007/978-3-030-38315-2_2
   Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Liu H, 2015, WORLD J GASTROENTERO, V21, P10367, DOI 10.3748/wjg.v21.i36.10367
   Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506
   Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098
   Mannaerts I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084071
   Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451
   Mikula M, 2006, J CELL PHYSIOL, V209, P560, DOI 10.1002/jcp.20772
   Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550
   Nguyen PT, 2011, J ORAL PATHOL MED, V40, P77, DOI 10.1111/j.1600-0714.2010.00966.x
   Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0
   Oda K, 2015, CLIN J GASTROENTEROL, V8, P1, DOI 10.1007/s12328-014-0548-5
   Saga K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103043
   Shinji S, 2018, ONCOTARGET, V9, P2553, DOI 10.18632/oncotarget.23510
   Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245
   Sun LN, 2016, AM J PHYSIOL-GASTR L, V311, pG91, DOI 10.1152/ajpgi.00027.2015
   Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065
   van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253
   Xing SP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061556
   Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
NR 44
TC 24
Z9 24
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0171-5216
EI 1432-1335
J9 J CANCER RES CLIN
JI J. Cancer Res. Clin. Oncol.
PD 2020 DEC
PY 2020
VL 146
IS 12
BP 3255
EP 3268
DI 10.1007/s00432-020-03374-9
EA SEP 2020
PG 14
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA PD0TW
UT WOS:000565155200001
PM 32870388
DA 2024-02-19
ER

PT J
AU Park, JH
   Ha, H
AF Park, Jong Hee
   Ha, Hunjoo
TI Short-term Treatment of Daumone Improves Hepatic Inflammation in Aged
   Mice
SO KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
LA English
DT Article
DE Aging; Hep G2 cells; Inflammation; Liver; Pheromones
ID LIFE-SPAN; DIETARY RESTRICTION; CALORIE RESTRICTION; SENESCENCE;
   INCREASES; LONGEVITY
AB Chronic inflammation has been proposed as one of the main molecular mechanisms of aging and age-related diseases. Although evidence in humans is limited, short-term calorie restriction (CR) has been shown to have anti-inflammatory effects in aged experimental animals. We reported on the long-term treatment of daumone, a synthetic pheromone secreted by Caenorhabditis elegans in an energy deficient environment, extends the life-span and attenuates liver injury in aged mice. The present study examined whether late onset short-term treatment of daumone exerts anti-inflammatory effects in the livers of aged mice. Daumone was administered orally at doses of 2 or 20 mg/kg/day for 5 weeks to 24-month-old male C57BL/6J mice. Increased liver macrophage infiltration and gene expression of proinflammatory cytokines in aged mice were significantly attenuated by daumone treatment, suggesting that short-term oral administration of daumone may have hepatoprotective effects. Daumone also dose-dependently suppressed tumor necrosis factor-alpha (TNF-alpha)-induced nuclear factor-kappa B (NF-kappa B) phosphorylation in HepG2 cells. The present data demonstrated that short-term treatment of daumone has anti-inflammatory effects in aged mouse livers possibly through suppression of NF-kappa B signaling and suggest that daumone may become a lead compound targeting aging and age-associated diseases.
C1 [Park, Jong Hee; Ha, Hunjoo] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea.
C3 Ewha Womans University
RP Ha, H (corresponding author), Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, 52 Ewhayoedae Gil, Seoul 120750, South Korea.
EM hha@ewha.ac.kr
OI Ha, Hunjoo/0000-0002-5601-1265
FU NRF grant - Korean Government (MEST) [NRF-2012R1A2A1A03006092]
FX This study was supported by NRF-2012R1A2A1A03006092 from an NRF grant
   funded by the Korean Government (MEST).
CR Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   Cantó C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Franceschi C, 2003, BIOCHEM SOC T, V31, P457, DOI 10.1042/BST0310457
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Goto S, 2002, ANN NY ACAD SCI, V959, P50, DOI 10.1111/j.1749-6632.2002.tb02082.x
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hu Patrick J, 2007, WormBook, P1
   Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201
   Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2
   Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001
   Park JH, 2014, AGING CELL, V13, P709, DOI 10.1111/acel.12224
   Seo AY, 2006, ANTIOXID REDOX SIGN, V8, P529, DOI 10.1089/ars.2006.8.529
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   Zhang WF, 2014, ANN HEPATOL, V13, P489, DOI 10.1016/S1665-2681(19)31247-5
NR 25
TC 10
Z9 10
U1 0
U2 4
PU KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
PI SEOUL
PA C/O EDITORIAL OFFICE, 448-13 SEOKYO-DONG, SEOUL, SOUTH KOREA
SN 1226-4512
EI 2093-3827
J9 KOREAN J PHYSIOL PHA
JI KOREAN J. PHYSIOL. PHARMACOL.
PD MAY
PY 2015
VL 19
IS 3
BP 269
EP 274
DI 10.4196/kjpp.2015.19.3.269
PG 6
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA CH6MY
UT WOS:000354151900012
PM 25954133
OA hybrid, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Handler, JA
   Brian, WR
AF Handler, JA
   Brian, WR
TI Effect of aging on mixed-function oxidation and conjugation by isolated
   perfused rat livers
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE liver; cytochrome P450; mixed-function oxidation; glucuronidation;
   senescence; p-nitrophenol
ID DRUG-METABOLIZING-ENZYMES; PARA-NITROPHENOL; BODY-WATER; AGE;
   CYTOCHROME-P-450; GLUCURONIDATION; MITOCHONDRIA; DISPOSITION;
   INHIBITION; MICROSOMES
AB Aging is known to decrease hepatic cytochrome P450 content in rats. However, limited information is available on the effects of aging on mixed-function oxidation and conjugation in intact liver. The purpose of these studies was to determine the effects of aging on oxidation and conjugation of p-nitrophenol (pNP) in perfused livers from male Sprague-Dawley rats. Livers from senescent (22-24 months) or young adult (3-6 months) rats were perfused in a nonrecirculating hemoglobin-free system and supplemented with pNP (60 mu M). Glucuronide and sulfate conjugates of the oxidation product, 4-nitrocatechol, in effluent perfusate were cleaved enzymatically and 4-nitrocatechol was determined colorimetrically. Rates of 4-nitrocatechol production were decreased in senescent compared with young adult rats (0.61 +/- 0.14 vs 0.92 +/- 0.15 mu mol/g/hr). However, the rates of oxidation of pNP in microsomes from senescent rats were similar to those in young adult rats. Hepatic malate content was decreased approximately 50% in livers from senescent compared with young adult rats in the presence and absence of pNP, suggesting that movement of reducing equivalents from the mitochondria to the cytosol, and thus cytosolic NADPH supply, may have been diminished by senescence. The rates of conjugation of 60 mu M pNP in perfused livers from senescent rats were similar to those in young adult rats, but K-m and V-max values of microsomal 4-nitrocatechol glucuronyltransferase were about 2.5- and 1.6-fold higher, respectively, in livers from senescent compared with young adult rats. Hepatic glycogen content was about 50% lower in livers from senescent compared with young adult rats, but the contents of UDP-glucose and UDP glucuronic acid were similar between the two groups. Taken together, the data are consistent with the hypothesis that rates of mixed-function oxidation are decreased in intact livers from senescent compared with young adult rats, due possibly to age-related changes in cofactor supplies. Glucuronidation of low, but not high, concentrations of substrates may be affected by age-related changes in K-m and V-max values of microsomal glucuronyltransferase. (C) 1991 Elsevier Science Inc.
C1 SMITHKLINE BEECHAM PHARMACEUT, DEPT DRUG METAB, KING OF PRUSSIA, PA 19406 USA.
   SMITHKLINE BEECHAM PHARMACEUT, DEPT PHARMACOKINET, KING OF PRUSSIA, PA 19406 USA.
C3 GlaxoSmithKline; GlaxoSmithKline
RP Handler, JA (corresponding author), SMITHKLINE BEECHAM PHARMACEUT, DEPT TOXICOL, MC UE0364, 709 SWEDELAND RD, KING OF PRUSSIA, PA 19406 USA.
CR BACH B, 1981, CLIN PHARMACOKINET, V6, P389, DOI 10.2165/00003088-198106050-00005
   BELINSKY SA, 1987, NUTRITIONAL TOXICOLO, V2, P41
   BOWMAN BA, 1991, NUTR ELDERLY, P43
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BROZEK J, 1952, FED PROC, V11, P784
   BRUCE A, 1980, SCAND J CLIN LAB INV, V40, P461, DOI 10.3109/00365518009101869
   CONWAY JG, 1988, MOL PHARMACOL, V33, P111
   FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4
   FROHLING KW, 1973, BIOCHIM BIOPHYS ACTA, V327, P46, DOI 10.1016/0005-2744(73)90102-2
   GOLDBERG ND, 1974, METHOD ENZYMAT AN, P1600
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   HANDLER JA, 1988, ARCH BIOCHEM BIOPHYS, V264, P114, DOI 10.1016/0003-9861(88)90576-0
   HOLTZCLAW WD, 1984, ARCH BIOCHEM BIOPHYS, V233, P345, DOI 10.1016/0003-9861(84)90455-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LOWRY OH, 1966, J BIOL CHEM, V241, P2268
   MEYDANI M, 1994, NUTR TOXICOLOGY, P49
   REINKE LA, 1985, DRUG METAB DISPOS, V13, P548
   REINKE LA, 1981, J PHARMACOL EXP THER, V217, P863
   REINKE LA, 1983, ARCH BIOCHEM BIOPHYS, V225, P313, DOI 10.1016/0003-9861(83)90035-8
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SCHOELLER DA, 1989, AM J CLIN NUTR, V50, P1176, DOI 10.1093/ajcn/50.5.1176
   SCHOLZ R, 1973, EUR J BIOCHEM, V38, P64, DOI 10.1111/j.1432-1033.1973.tb03034.x
   Steel R.G.D., 1980, PRINCIPLES PROCEDURE
   SWEENY DJ, 1986, AGE, V9, P95, DOI 10.1007/BF02432280
   TARLOFF JB, 1991, P SOC EXP BIOL MED, V197, P297
   THURMAN RG, 1979, PHARMACOL REV, V31, P229
   TSANG P, 1990, CLIN LAB MED, V10, P479
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   ZHONG Z, 1991, CANCER RES, V51, P4511
NR 31
TC 11
Z9 11
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD JUL 1
PY 1997
VL 54
IS 1
BP 159
EP 164
DI 10.1016/S0006-2952(97)00159-7
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA XR394
UT WOS:A1997XR39400019
PM 9296362
DA 2024-02-19
ER

PT J
AU Milligan, DA
   Tyler, EJ
   Bishop, CL
AF Milligan, Deborah A.
   Tyler, Eleanor J.
   Bishop, Cleo L.
TI Tissue engineering to better understand senescence: Organotypics come of
   age
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Tissue engineering; 3D organotypic culture; Senescence; Living skin
   equivalent; Remodelling the microenvironment; Drug discovery and
   development
ID COLLAGEN FRAGMENTATION; CELL SENESCENCE; IN-VITRO; SKIN; FIBROBLASTS;
   MICROENVIRONMENT; ASSAYS
AB The recent advent of 'organs in a dish' has revolutionised the research landscape. These 3D culture systems have paved the way for translational, post genomics research by enabling scientists to model diseases in the laboratory, grow patient-derived organoids, and unite this technology with other cuffing-edge methodologies such as drug discovery. Fields such as dermatology and neuroscience have revolutionised the development of robust 3D models, which faithfully recapitulate native physiology in vivo to provide important functional and mechanistic insights. These models have underpinned a rapid growth in the number of organs and myriad of human diseases that can be modelled in 3D, which currently includes breast, cerebral cortex, heart, intestine, kidney, liver, lung, neural tube, pancreas, prostate, skin and stomach, as well as patient derived tumours. However, so far, they have not yet been employed extensively in the study of fundamental cellular programmes such as senescence. Thus, tissue engineering and 3D culture offer an exciting opportunity to further understand the bright and dark sides of senescence in a more complex and physiologically relevant environment. Below, we will discuss previous approaches to investigating senescence and ageing using organotypic models, and some potential opportunities for future research.
C1 [Milligan, Deborah A.; Tyler, Eleanor J.; Bishop, Cleo L.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.
C3 University of London; Queen Mary University London
RP Bishop, CL (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.
EM c.l.bishop@qmul.ac.uk
OI Bishop, Cleo/0000-0002-6189-8163; Tyler, Eleanor/0000-0001-8945-4823
FU BBSRC [BB/P002579/1, BB/N503629/1]; Unilever [MA-2015-00299N-1,
   MA-2015-00055]; BBSRC [BB/P002579/1, 1632663] Funding Source: UKRI
FX Deborah Milligan is funded by the BBSRC (BB/N503629/1) and Unilever
   (MA-2015-00055). Eleanor Tyler is funded by the BBSRC (BB/P002579/1) and
   Unilever (MA-2015-00299N-1).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Adamus J, 2014, J INVEST DERMATOL, V134, P1131, DOI 10.1038/jid.2013.468
   Anh TNH, 2012, AM J PHYSIOL-LUNG C, V302, pL226, DOI 10.1152/ajplung.00059.2011
   Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005
   Chamcheu JC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091089
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Diekmann J, 2016, EXP DERMATOL, V25, P56, DOI 10.1111/exd.12866
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Fisher GJ, 2016, AGING CELL, V15, P67, DOI 10.1111/acel.12410
   Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599
   Funk WD, 2000, EXP CELL RES, V258, P270, DOI 10.1006/excr.2000.4945
   Gschwandtner M, 2013, ALLERGY, V68, P37, DOI 10.1111/all.12051
   Huang Y, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600734
   Jorfi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20436-8
   Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004
   Lämmermann I, 2018, NPJ AGING MECH DIS, V4, DOI 10.1038/s41514-018-0023-5
   Liu GH, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1131-x
   Mosteiro L, 2018, AGING CELL, V17, DOI 10.1111/acel.12711
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4
   Pfannkuche JJ, 2020, CONNECT TISSUE RES, V61, P304, DOI 10.1080/03008207.2019.1665652
   Quan TH, 2013, J INVEST DERMATOL, V133, P1362, DOI 10.1038/jid.2012.509
   Quan TH, 2013, J INVEST DERMATOL, V133, P658, DOI 10.1038/jid.2012.364
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shichi Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47416-w
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Sung KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076373
   Terlecki-Zaniewicz L, 2019, J INVEST DERMATOL, V139, P2425, DOI 10.1016/j.jid.2019.05.015
   Tran C, 2014, J EUR ACAD DERMATOL, V28, P415, DOI 10.1111/jdv.12113
   Victorelli S, 2019, EMBO J, V38, DOI 10.15252/embj.2019101982
   WEST MD, 1994, ARCH DERMATOL, V130, P87, DOI 10.1001/archderm.130.1.87
   Wu DY, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1686-1
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Yun MH, 2015, ELIFE, V4, DOI 10.7554/eLife.05505
NR 36
TC 5
Z9 5
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP
PY 2020
VL 190
AR 111261
DI 10.1016/j.mad.2020.111261
PG 5
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NO3NF
UT WOS:000569391600007
PM 32461142
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Serviddio, G
   Bellanti, F
   Romano, AD
   Tamborra, R
   Rollo, T
   Altomare, E
   Vendemiale, G
AF Serviddio, G.
   Bellanti, F.
   Romano, A. D.
   Tamborra, R.
   Rollo, T.
   Altomare, E.
   Vendemiale, G.
TI Bioenergetics in aging: mitochondrial proton leak in aging rat liver,
   kidney and heart
SO REDOX REPORT
LA English
DT Article; Proceedings Paper
CT Meeting of the HNE-Club
CY JUN 16-18, 2006
CL Genoa, ITALY
SP HNE Club
DE aging; mitochondria; respiratory chain; membrane potential; proton
   conductance
ID SKELETAL-MUSCLE; MECHANISMS
AB Aging is associated with a decline in performance in many organs and loss of physiological performance can be due to free radicals. Mitochondria are incompletely coupled: during oxidative phosphorylation some of the redox energy is dissipated as natural proton leak across the inner membrane. To verify whether proton leak occurs in mitochondria during aging, we measured the mitochondrial respiratory chain activity, membrane potential and proton leak in liver, kidneys and heart of young and old rats. Mitochondria from old rats showed normal rates of Complex I and Complex II respiration. However, they had a lower membrane potential compared to mitochondria from younger rats. In addition, they exhibited an increased rate of proton conductance which partially dissipated the mitochondrial membrane potential when the rate of electron transport was suppressed. This could compromise energy homeostasis in aging cells in conditions that require additional energy supply and could minimize oxidative damage to DNA.
C1 Univ Foggia, Inst Geriatr, Dept Med & Occupat Sci, I-71100 Foggia, Italy.
   IRCCS, Foggia, Italy.
   Univ Foggia, Inst Internal Med, Dept Med & Occupat Sci, I-71100 Foggia, Italy.
C3 University of Foggia; IRCCS Casa Sollievo Della Sofferenza; University
   of Foggia
RP Vendemiale, G (corresponding author), Univ Foggia, Dipartimento Sci Med & Lavoro, I-71100 Foggia, Italy.
EM g.vendemiale@unifg.it
RI serviddio, gaetano/C-7629-2011; Romano, Antonino Davide/ABB-3039-2021;
   Romano, Antonino D/Q-8810-2017
OI serviddio, gaetano/0000-0002-6424-7841; Romano, Antonino
   Davide/0000-0003-0559-2917; Romano, Antonino D/0000-0003-0559-2917;
   BELLANTI, Francesco/0000-0002-8196-7373
CR Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413
   Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203
   BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S
   BROWN GC, 1988, BIOCHEM J, V252, P473, DOI 10.1042/bj2520473
   Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412
   Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   Kun E, 1979, Methods Enzymol, V55, P115
   Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957
   Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450
   NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1
   POEHLMAN ET, 1990, AM J PHYSIOL, V259, pE66, DOI 10.1152/ajpendo.1990.259.1.E66
   PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0
   Scarpace PJ, 2000, DIABETES, V49, P431, DOI 10.2337/diabetes.49.3.431
   SCOTTO AW, 1983, ARCH BIOCHEM BIOPHYS, V222, P150, DOI 10.1016/0003-9861(83)90512-X
   Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Welle S, 1996, AM J CLIN NUTR, V63, P151, DOI 10.1093/ajcn/63.2.151
NR 20
TC 55
Z9 56
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1351-0002
EI 1743-2928
J9 REDOX REP
JI Redox Rep.
PD FEB
PY 2007
VL 12
IS 1-2
BP 91
EP 95
DI 10.1179/135100007X162112
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology
GA 153XB
UT WOS:000245470000020
PM 17263918
DA 2024-02-19
ER

PT J
AU Xu, JH
   Jiao, K
   Liu, X
   Sun, Q
   Wang, K
   Xu, HB
   Zhang, SY
   Wu, Y
   Wu, LG
   Liu, D
   Wang, W
   Liu, HR
AF Xu, Jiahui
   Jiao, Kun
   Liu, Xin
   Sun, Qi
   Wang, Ke
   Xu, Haibo
   Zhang, Shangyue
   Wu, Ye
   Wu, Linguo
   Liu, Dan
   Wang, Wen
   Liu, Huirong
TI Omi/HtrA2 Participates in Age-Related Autophagic Deficiency in Rat Liver
SO AGING AND DISEASE
LA English
DT Article
DE Omi/HtrA2; age; autophagy; liver
ID SERINE-PROTEASE; MEDIATED AUTOPHAGY; BECLIN 1; HTRA; IDENTIFICATION;
   INHIBITOR; MUTATIONS; APOPTOSIS; GENE; XIAP
AB Liver is a vital organ with many important functions, and the maintenance of normal hepatic function is necessary for health. As an essential mechanism for maintaining cellular homeostasis, autophagy plays an important role in ensuring normal organ function. Studies have indicated that the degeneration of hepatic function is associated with autophagic deficiency in aging liver. However, the underlying mechanisms still remain unclear. The serine protease Omi/HtrA2 belongs to the HtrA family and promotes apoptosis through either the caspase-dependent or caspase-independent pathway. Mice lacking Omi/HtrA2 exhibited progeria symptoms (premature aging), which were similar to the characteristics of autophagic insufficiency. In this study, we demonstrated that both the protein level of Omi/HtrA2 in liver and hepatic function were reduced as rats aged, and there was a positive correlation between them. Furthermore, several autophagy-related proteins (LC3II/I, Beclin-1 and LAMP2) in rat liver were decreased significantly with the increasing of age. Finally, inhibition of Omi/HtrA2 resulted in reduced autophagy and hepatic dysfunction. In conclusion, these results suggest that Omi/HtrA2 participates in age-related autophagic deficiency in rat liver. This study may offer a novel insight into the mechanism involved in liver aging.
C1 Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.
   Capital Med Univ, Beijing Key Lab Metab Disorders Related Cardiovas, Beijing, Peoples R China.
C3 Capital Medical University; Capital Medical University
RP Wang, W; Liu, HR (corresponding author), Capital Med Univ, Beijing, Peoples R China.
EM wangwen@ccmu.edu.cn; liuhr2000@126.com
RI Xu, Jiawen/JEF-5028-2023; xu, jia/GSD-6347-2022; liu, hui/HTO-8112-2023;
   wang, yixuan/JGM-3893-2023
FU Natural Sciences Foundation of China (NSFC) [81270283]
FX This study was supported by the Natural Sciences Foundation of China
   (NSFC) (81270283, to Huirong Liu).
CR Alkan A, 2015, ANN ONCOL, V26, P443, DOI 10.1093/annonc/mdu554
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200
   Cilenti L, 2014, BBA-MOL CELL RES, V1843, P1295, DOI 10.1016/j.bbamcr.2014.03.027
   Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   Dagda RK, 2009, J BIOENERG BIOMEMBR, V41, P473, DOI 10.1007/s10863-009-9255-1
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005
   Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581
   Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168
   Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006
   Gelino Sara, 2012, J Clin Exp Pathol, VSuppl 4
   Gewirtz DA, 2013, AUTOPHAGY, V9, P808, DOI 10.4161/auto.23922
   Goo HG, 2014, EXP CELL RES, V328, P456, DOI 10.1016/j.yexcr.2014.07.032
   Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Hua F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8951
   Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191
   Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117
   Kang S, 2013, AUTOPHAGY, V9, P420, DOI 10.4161/auto.22920
   Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55
   LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989
   Liu D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010119
   Liu HR, 2005, CIRCULATION, V111, P90, DOI 10.1161/01.CIR.0000151613.90994.17
   Maejima Y, 2016, J MOL CELL CARDIOL, V95, P19, DOI 10.1016/j.yjmcc.2015.10.032
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006
   Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211
   Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215
   Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   Wagner KH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060338
   Watanabe T, 2004, MECH DEVELOP, V121, P791, DOI 10.1016/j.mod.2004.04.004
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhou HY, 2012, J PINEAL RES, V52, P120, DOI 10.1111/j.1600-079X.2011.00926.x
NR 41
TC 12
Z9 12
U1 0
U2 4
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD DEC
PY 2018
VL 9
IS 6
BP 1031
EP 1042
DI 10.14336/AD.2018.0221
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HJ9CV
UT WOS:000457497300008
PM 30574416
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Rowland, ME
   Jiang, Y
   Beier, F
   Bérubé, NG
AF Rowland, Megan E.
   Jiang, Yan
   Beier, Frank
   Berube, Nathalie G.
TI Inactivation of hepatic ATRX in <i>Atrx</i> Foxglcre mice prevents
   reversal of aging-like phenotypes by thyroxine
SO AGING-US
LA English
DT Article
DE ATRX; premature aging; thyroid hormone; IGF-1; transcription
ID GILFORD-PROGERIA-SYNDROME; MOUSE MODEL; X SYNDROME; LIFE-SPAN; RECEPTOR
   FUNCTION; SOMATOTROPH AXIS; IMPRINTED GENES; THYROID-HORMONE;
   EXPRESSION; MUTATIONS
AB ATRX is an ATP-dependent chromatin remodeler required for the maintenance of genomic integrity. We previously reported that conditional Atrx ablation in the mouse embryonic forebrain and anterior pituitary using the Foxglcre driver causes reduced health and lifespan. In these mice, premature aging-like phenotypes were accompanied by low circulating levels of insulin-like growth factor 1 (IGF-1) and thyroxine (T4), hormones that maintain stem cell pools and normal metabolic profiles, respectively. Based on emerging evidence that T4 stimulates expression of IGF-1 in pre-pubertal mice, we tested whether T4 supplementation in Atrx Foxglcre mice could restore IGF-1 levels and ameliorate premature aging-like phenotypes. Despite restoration of normal serum T4 levels, we did not observe improvements in circulating IGF-1. In the liver, thyroid hormone target genes were differentially affected upon T4 treatment, with Igf1 and several other thyroid hormone responsive genes failing to recover normal expression levels. These findings hinted at Cre-mediated Atrx inactivation in the liver of Atrx Foxglcre mice, which we confirmed. We conclude that the phenotypes observed in the Atrx Foxglcre mice can be explained in part by a role of ATRX in the liver to promote T4-mediated Igf1 expression, thus explaining the inefficacy of T4 therapy observed in this study.
C1 [Rowland, Megan E.; Jiang, Yan; Berube, Nathalie G.] Western Univ, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada.
   [Rowland, Megan E.; Jiang, Yan; Berube, Nathalie G.] Western Univ, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada.
   [Rowland, Megan E.; Jiang, Yan; Beier, Frank; Berube, Nathalie G.] Childrens Hlth Res Inst, London, ON, Canada.
   [Beier, Frank] Western Univ, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada.
   [Beier, Frank] Western Univ, Western Bone & Joint Inst, London, ON, Canada.
C3 Western University (University of Western Ontario); Western University
   (University of Western Ontario); Western University (University of
   Western Ontario); Western University (University of Western Ontario)
RP Bérubé, NG (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada.; Bérubé, NG (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada.; Bérubé, NG (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.
EM nberube@uwo.ca
RI Berube, Nathalie G/E-3885-2015; Beier, Frank/T-4734-2019; Beier,
   Frank/G-4595-2013
OI Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537;
   Rowland, Megan/0009-0000-2967-2992
FU Ontario Graduate Scholarship; Canadian Institutes for Health Research
   MOP [142369]
FX This work was supported by an Ontario Graduate Scholarship to Megan E.
   Rowland. Operating funds were from the Canadian Institutes for Health
   Research MOP#142369.
CR Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168
   Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109
   Baumann C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-29
   Bérubé NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329
   Bérubé NG, 2002, HUM MOL GENET, V11, P253, DOI 10.1093/hmg/11.3.253
   Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944
   Chatzinikolaou G, 2017, NAT CELL BIOL, V19, P421, DOI 10.1038/ncb3499
   Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866
   Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058
   Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007
   Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003
   Gonzalo S, 2017, AGEING RES REV, V33, P18, DOI 10.1016/j.arr.2016.06.007
   Grontved L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8048
   Guntur Anyonya R, 2013, Bonekey Rep, V2, P437, DOI 10.1038/bonekey.2013.171
   Hébert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732
   Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Karikkineth AC, 2017, AGEING RES REV, V33, P3, DOI 10.1016/j.arr.2016.08.002
   Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023
   Levy MA, 2015, HUM MOL GENET, V24, P1824, DOI 10.1093/hmg/ddu596
   Levy MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-468
   Li Y, 2016, CHEMBIOCHEM, V17, P928, DOI 10.1002/cbic.201500655
   Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879
   Mariño G, 2010, P NATL ACAD SCI USA, V107, P16268, DOI 10.1073/pnas.1002696107
   McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Oshima J, 2017, AGEING RES REV, V33, P105, DOI 10.1016/j.arr.2016.03.002
   Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899
   Ratnakumar K, 2012, GENE DEV, V26, P433, DOI 10.1101/gad.179416.111
   Sadic D, 2015, EMBO REP, V16, P836, DOI 10.15252/embr.201439937
   Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103
   van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002
   Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103
   Visser WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149941
   Voon HPJ, 2015, CELL REP, V11, P405, DOI 10.1016/j.celrep.2015.03.036
   Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634
   Williams GR, 2018, J ENDOCRINOL INVEST, V41, P99, DOI 10.1007/s40618-017-0753-4
   Xing WR, 2012, J BONE MINER RES, V27, P1067, DOI 10.1002/jbmr.1551
   Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5
   Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100
NR 40
TC 1
Z9 2
U1 0
U2 3
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN
PY 2018
VL 10
IS 6
BP 1223
EP 1238
DI 10.18632/aging.101462
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GL8EE
UT WOS:000437446300008
PM 29883366
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Ozcagli, E
   Kara, M
   Kotil, T
   Fragkiadaki, P
   Tzatzarakis, MN
   Tsitsimpikou, C
   Stivaktakis, PD
   Tsoukalas, D
   Spandidos, DA
   Tsatsakis, AM
   Alpertunga, B
AF Ozcagli, Eren
   Kara, Mehtap
   Kotil, Tugba
   Fragkiadaki, Persefoni
   Tzatzarakis, Manolis N.
   Tsitsimpikou, Christina
   Stivaktakis, Polychronis D.
   Tsoukalas, Dimitrios
   Spandidos, Demetrios A.
   Tsatsakis, Aristides M.
   Alpertunga, Buket
TI Stanozolol administration combined with exercise leads to decreased
   telomerase activity possibly associated with liver aging
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE stanozolol; phosphatase and tensin homolog; telomerase reverse
   transcriptase; telomerase activity; 16--hydroxystanozolol;
   3-hydroxystanozolol
ID ANDROGENIC STEROID ABUSE; LONG-TERM EXPOSURE; NANDROLONE DECANOATE;
   HEPATOCELLULAR-CARCINOMA; NUTRITIONAL SUPPLEMENTS; GENE-EXPRESSION;
   GENOTOXICITY; RABBITS; ZONATION; GLYCOL
AB Anabolic agents are doping substances which are commonly used in sports. Stanozolol, a 17-alkylated derivative of testosterone, has a widespread use among athletes and bodybuilders. Several medical and behavioral adverse effects are associated with anabolic androgenic steroids (AAS) abuse, while the liver remains the most well recognized target organ. In the present study, the hepatic effects of stanozolol administration in rats at high doses resembling those used for doping purposes were investigated, in the presence or absence of exercise. Stanozolol and its metabolites, 16--hydroxystanozolol and 3-hydroxystanozolol, were detected in rat livers using liquid chromatography-mass spectrometry (LC-MS). Telomerase activity, which is involved in cellular aging and tumorigenesis, was detected by examining telomerase reverse transcriptase (TERT) and phosphatase and tensin homolog (PTEN) expression levels in the livers of stanozolol-treated rats. Stanozolol induced telomerase activity at the molecular level in the liver tissue of rats and exercise reversed this induction, reflecting possible premature liver tissue aging. PTEN gene expression in the rat livers was practically unaffected either by exercise or by stanozolol administration.
C1 [Ozcagli, Eren; Kara, Mehtap; Alpertunga, Buket] Istanbul Univ, Fac Pharm, Dept Pharmaceut Toxicol, TR-34116 Istanbul, Turkey.
   [Kotil, Tugba] Istanbul Univ, Dept Histol & Embryol, Fac Med, TR-34116 Istanbul, Turkey.
   [Fragkiadaki, Persefoni; Tzatzarakis, Manolis N.; Stivaktakis, Polychronis D.; Tsoukalas, Dimitrios; Tsatsakis, Aristides M.] Univ Crete, Lab Forens Sci & Toxicol, Sch Med, POB 1393, Iraklion 71003, Greece.
   [Tsitsimpikou, Christina] Gen Chem State Lab Greece, Athens 11521, Greece.
   [Spandidos, Demetrios A.] Univ Crete, Sch Med, Lab Clin Virol, Iraklion 71003, Greece.
C3 Istanbul University; Istanbul University; University of Crete;
   University of Crete
RP Alpertunga, B (corresponding author), Istanbul Univ, Fac Pharm, Dept Pharmaceut Toxicol, TR-34116 Istanbul, Turkey.; Tsatsakis, AM (corresponding author), Univ Crete, Lab Forens Sci & Toxicol, Sch Med, POB 1393, Iraklion 71003, Greece.
EM toxlab.uoc@gmail.com; tunga@istanbul.edu.tr
RI Kotil, Tuğba/AAH-7572-2019; TSOUKALAS, DIMITRIS/JNS-3199-2023;
   Tsatsakis, Aristidis/H-2890-2013; kara, mehtap/IQW-7948-2023; Ozcagli,
   Eren/AAD-6058-2020; KOTİL, TUĞBA/IWE-5331-2023; Alpertunga,
   Buket/AAD-6135-2020; Kotil, Tuğba/L-3783-2016; Kara,
   Mehtap/AAD-3363-2019; kara, mehtap/B-3243-2019
OI Kotil, Tuğba/0000-0003-1261-0597; TSOUKALAS,
   DIMITRIS/0000-0001-6885-6209; Tsatsakis, Aristidis/0000-0003-3824-2462;
   Kotil, Tuğba/0000-0003-1261-0597; Kara, Mehtap/0000-0001-7764-5593;
   Spandidos, Demetrios/0000-0002-1146-931X; Stivaktakis,
   Polychronis/0000-0001-6004-2948; Ozcagli, Eren/0000-0003-3472-1693
FU Istanbul University Scientific Research Projects [54169-24416]
FX This study was supported by Istanbul University Scientific Research
   Projects (grant no. 54169-24416).
CR Akincilar SC, 2016, CELL MOL LIFE SCI, V73, P1659, DOI 10.1007/s00018-016-2146-9
   Ampuero J, 2014, GASTROENT HEPAT-BARC, V37, P71, DOI 10.1016/j.gastrohep.2013.09.009
   Aye M, 2010, FOOD CHEM TOXICOL, V48, P1905, DOI 10.1016/j.fct.2010.04.032
   Balcells G, 2017, DRUG TEST ANAL, V9, P1001, DOI 10.1002/dta.2107
   Bausserman LL, 1997, METABOLISM, V46, P992, DOI 10.1016/S0026-0495(97)90267-5
   Berthelot-Ricou A, 2011, FERTIL STERIL, V96, P1002, DOI 10.1016/j.fertnstert.2011.07.1106
   Boada LD, 1999, ARCH TOXICOL, V73, P465, DOI 10.1007/s002040050636
   Brustia R, 2017, CLIN RES HEPATOL GAS
   Buttner Andreas, 2010, Handb Exp Pharmacol, P459, DOI 10.1007/978-3-540-79088-4_19
   Camargo ICC, 2009, ACTA BIOL HUNG, V60, P253, DOI 10.1556/ABiol.60.2009.3.2
   Chilton WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092088
   Cunningham RL, 2006, HORM BEHAV, V50, P410, DOI 10.1016/j.yhbeh.2006.05.002
   Chuffa LGD, 2011, ANAT REC, V294, P335, DOI 10.1002/ar.21314
   Deshmukh NIK, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-162
   Djojosubroto MW, 2005, HEPATOLOGY, V42, P1127, DOI 10.1002/hep.20822
   El-Serag HB, 2014, AM J GASTROENTEROL, V109, P1427, DOI 10.1038/ajg.2014.214
   Gopinathan S, 2013, J PHARMACOL TOX MET, V68, P284, DOI 10.1016/j.vascn.2013.02.009
   Hansma P, 2016, AM J FOREN MED PATH, V37, P21, DOI 10.1097/PAF.0000000000000218
   Harkin KR, 2000, J AM VET MED ASSOC, V217, P681, DOI 10.2460/javma.2000.217.681
   Healing G, 2016, J APPL TOXICOL, V36, P140, DOI 10.1002/jat.3155
   Huang CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/275431
   Jung S, 2013, INT J ONCOL, V43, P1587, DOI 10.3892/ijo.2013.2064
   JUNGERMANN K, 1988, SEMIN LIVER DIS, V8, P329, DOI 10.1055/s-2008-1040554
   Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143
   Kanayama G, 2008, DRUG ALCOHOL DEPEN, V98, P1, DOI 10.1016/j.drugalcdep.2008.05.004
   Kara M, 2017, EXP THER MED, V13, P614, DOI 10.3892/etm.2016.3974
   Kesler T, 2014, J GASTROEN HEPATOL, V29, P1852, DOI 10.1111/jgh.12809
   Kicman AT, 2008, BRIT J PHARMACOL, V154, P502, DOI 10.1038/bjp.2008.165
   Kioukia-Fougia N, 2016, RECENT PATENTS INFLA, V10, P72, DOI 10.2174/1872213X10666160923163700
   Kumar M, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080043
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ludlow AT, 2017, EXP PHYSIOL, V102, P397, DOI 10.1113/EP086189
   Mateus-Avois L, 2005, J CHROMATOGR B, V816, P193, DOI 10.1016/j.jchromb.2004.11.033
   Matrisciano F, 2010, NEUROPHARMACOLOGY, V58, P1078, DOI 10.1016/j.neuropharm.2010.01.015
   Mishra Swetasmita, 2016, World J Methodol, V6, P163, DOI 10.5662/wjm.v6.i2.163
   OECD, 2000, Guidance Document on the Recognition, Assessment, and Useof Clinical Signs as Humane Endpoints for Experimental Animals Usedin Safety Evaluation
   Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8
   Pettersson J, 2008, BRIT J CLIN PHARMACO, V65, P253, DOI 10.1111/j.1365-2125.2007.03001.x
   Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005
   Rentoukas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035739
   Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009
   Salvador JP, 2008, ANAL BIOCHEM, V376, P221, DOI 10.1016/j.ab.2008.02.009
   Socas L, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.013599
   Solbach P, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0288-0
   Stimac D, 2002, J CLIN GASTROENTEROL, V35, P350, DOI 10.1097/00004836-200210000-00013
   Tapis F, TELOMERES ARE PROTEC
   Tsitsimpikou C, 2016, TOXICOL LETT, V259, P21, DOI 10.1016/j.toxlet.2016.06.1122
   Tsitsimpikou C, 2013, TOXICOLOGY, V307, P109, DOI 10.1016/j.tox.2012.11.002
   Tsitsimpikou C, 2011, INT J SPORT NUTR EXE, V21, P377, DOI 10.1123/ijsnem.21.5.377
   Tucci P, 2012, STEROIDS, V77, P269, DOI 10.1016/j.steroids.2011.12.014
   Vardavas AI, 2016, FOOD CHEM TOXICOL, V94, P250, DOI 10.1016/j.fct.2016.06.016
   Vasilaki F, 2016, TOXICOL LETT, V241, P143, DOI 10.1016/j.toxlet.2015.10.026
   Wojtyla A, 2011, MOL BIOL REP, V38, P3339, DOI 10.1007/s11033-010-0439-x
   World Anti doping Agency, 2017 LIST PROH SUBST
   Xu YC, 2016, GENES-BASEL, V7, DOI 10.3390/genes7060022
   Yang CH, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-21
   Yi XJ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/946432
   Zar T, 2007, SEMIN DIALYSIS, V20, P217, DOI 10.1111/j.1525-139X.2007.00280.x
   Zhou X, 2015, PATHOL RES PRACT, V211, P316, DOI 10.1016/j.prp.2014.11.016
NR 59
TC 8
Z9 8
U1 0
U2 14
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD JUL
PY 2018
VL 42
IS 1
BP 405
EP 413
DI 10.3892/ijmm.2018.3644
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA GP1MT
UT WOS:000440580900039
PM 29717770
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Nabeshi, H
   Oikawa, S
   Inoue, S
   Nishino, K
   Kawanishi, S
AF Nabeshi, Hiromi
   Oikawa, Shinji
   Inoue, Sumiko
   Nishino, Kohsuke
   Kawanishi, Shosuke
TI Proteomic analysis for protein carbonyl as an indicator of oxidative
   damage in senescence-accelerated mice
SO FREE RADICAL RESEARCH
LA English
DT Article
DE senescence-accelerated mouse; proteomics; aging; carbonyl protein;
   reactive oxygen species
ID CU,ZN-SUPEROXIDE DISMUTASE; ENDOPLASMIC-RETICULUM; SUPEROXIDE-DISMUTASE;
   ALZHEIMERS-DISEASE; STRESS; BRAIN; IDENTIFICATION; EXPRESSION; SAM;
   ADENOSYLTRANSFERASE
AB The senescence-accelerated prone mouse strain 8 (SAMP8) exhibits a remarkable age-accelerated deterioration in learning and memory. In this study, we identified carbonyl modification, a marker of protein oxidation, in liver and brain of SAMP8 from peptide mass fingerprints using MALDI-TOF mass spectrometry in combination with LC-MS/MS analysis. Carbonyl modification of Cu, Zn-superoxide dismutase (Cu, Zn-SOD) in liver at 3 month and hippocampal cholinergic neurostimulating peptide precursor protein (HCNP-pp) in brain at 9 month were higher in SAMP8 compared with control SAMR1. We demonstrated carbonyl modification of purified Cu, Zn-SOD increased by the reaction with H2O2. Therefore, progressive accumulation of oxidative damage to Cu, Zn-SOD, may cause dysfunction of defense systems against oxidative stress in SAMP8 with a higher oxidative states, leading to acceleration of aging. Furthermore, carbonyl modification of HCNP-pp may be involved in pathophysiological alterations associated with deterioration in the learning and memory in the brain seen in SAMP8.
C1 Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie, Japan.
   Kyoto Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Kyoto, Japan.
   Doshisha Womens Coll, Fac Human Life & Sci, Dept Food Sci & Nutr, Kyoto, Japan.
C3 Mie University; Kyoto University
RP Kawanishi, S (corresponding author), Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie, Japan.
EM kawanisi@doc.medic.mie-u.ac.jp
CR Avila MA, 1998, BIOFACTORS, V8, P27, DOI 10.1002/biof.5520080106
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Beynon RJ, 2002, J CHEM ECOL, V28, P1429, DOI 10.1023/A:1016252703836
   Butterfield DA, 1998, ANN NY ACAD SCI, V854, P448, DOI 10.1111/j.1749-6632.1998.tb09924.x
   Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674
   Castegna A, 2002, FREE RADICAL BIO MED, V33, P562, DOI 10.1016/S0891-5849(02)00914-0
   Chang PWG, 1997, J CELL BIOCHEM, V64, P217, DOI 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#
   Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562
   Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265
   FRIEDMAN V, 1990, MECH AGEING DEV, V52, P27, DOI 10.1016/0047-6374(90)90142-3
   Getchell TV, 2003, AGEING RES REV, V2, P211, DOI 10.1016/S1568-1637(02)00066-1
   Hosokawa M, 2002, MECH AGEING DEV, V123, P1553, DOI 10.1016/S0047-6374(02)00091-X
   Hosokawa M, 1999, NEUROBIOL AGING, V20, P117, DOI 10.1016/S0197-4580(99)00029-9
   Kang JH, 1997, MOL CELLS, V7, P777
   Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211
   Kawanishi S, 2001, MUTAT RES-REV MUTAT, V488, P65, DOI 10.1016/S1383-5742(00)00059-4
   Kurokawa T, 2001, NEUROSCI LETT, V298, P135, DOI 10.1016/S0304-3940(00)01755-9
   Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051
   Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   OJIKA K, 1984, P NATL ACAD SCI-BIOL, V81, P2567, DOI 10.1073/pnas.81.8.2567
   Ojika K, 2000, PROG NEUROBIOL, V60, P37, DOI 10.1016/S0301-0082(99)00021-0
   OJIKA K, 1994, DEV BRAIN RES, V79, P1, DOI 10.1016/0165-3806(94)90043-4
   OOKAWARA T, 1992, J BIOL CHEM, V267, P18505
   Park JW, 1996, J GERONTOL A-BIOL, V51, pB337, DOI 10.1093/gerona/51A.5.B337
   Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X
   Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200
   Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437
   SATO K, 1992, J BIOL CHEM, V267, P25371
   Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TROLIN CG, 1994, EUR NEUROPSYCHOPHARM, V4, P469, DOI 10.1016/0924-977X(94)90295-X
   WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341
   Yasui F, 2003, NEUROSCI LETT, V350, P66, DOI 10.1016/S0304-3940(03)00827-9
   Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741
NR 36
TC 34
Z9 45
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD NOV
PY 2006
VL 40
IS 11
BP 1173
EP 1181
DI 10.1080/10715760600847580
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 090FS
UT WOS:000240936700007
PM 17050171
DA 2024-02-19
ER

PT J
AU Kadono, K
   Kageyama, S
   Nakamura, K
   Hirao, H
   Ito, T
   Kojima, H
   Dery, KJ
   Li, XL
   Kupiec-Weglinski, JW
AF Kadono, Kentaro
   Kageyama, Shoichi
   Nakamura, Kojiro
   Hirao, Hirofumi
   Ito, Takahiro
   Kojima, Hidenobu
   Dery, Kenneth J.
   Li, Xiaoling
   Kupiec-Weglinski, Jerzy W.
TI Myeloid Ikaros-SIRT1 signaling axis regulates hepatic inflammation and
   pyroptosis in ischemia-stressed mouse and human liver
SO JOURNAL OF HEPATOLOGY
LA English
DT Article; Early Access
ID T-CELL IMMUNOGLOBULIN; NLRP3 INFLAMMASOME; ISCHEMIA/REPERFUSION INJURY;
   REPERFUSION INJURY; CUTTING EDGE; GASDERMIN D; ACTIVATION; SIRT1;
   TRANSPLANTATION; MACROPHAGE
AB Background & Aims: Although Ikaros (IKZF1) is a well-established transcriptional regulator in leukocyte lymphopoiesis and differentiation, its role in myeloid innate immune responses remains unclear. Sirtuin 1 (SIRT1) is a histone/protein deacetylase involved in cellular senescence, inflammation, and stress resistance. Whether SIRT1 signaling is essential in myeloid cell activation remains uncertain, while the molecular communication between Ikaros and SIRT1, two major transcriptional regulators, has not been studied.
   Methods: We undertook molecular and functional studies to interrogate the significance of the myeloid Ikaros-SIRT1 axis in innate immune activation and whether it may serve as a homeostatic sentinel in human liver transplant recipients (hepatic biopsies) and murine models of sterile hepatic inflammation (liver warm ischemia-reperfusion injury in wild-type, myeloid-specific Sirt1-knockout, and CD11b-DTR mice) as well as primary bone marrow-derived macrophage (BMM) cultures (Ikaros silencing vs. overexpression).
   Results: In our clinical study, we identified increased postreperfusion hepatic Ikaros levels, accompanied by augmented inflammasome signaling yet depressed SIRT1, as a mechanism of hepatocellular damage in liver transplant recipients. In our experimental studies, we identified infiltrating macrophages as the major source of Ikaros in IR-stressed mouse livers. Then, we demonstrated that Ikaros-regulated pyroptosis - induced by canonical inflammasome signaling in BMM cultures - was SIRT1 dependent. Consistent with the latter, myeloid-specific Ikaros signaling augmented hepatic pyroptosis to aggravate proinflammatory responses in vivo by negatively regulating SIRT1 in an AMPK-dependent manner. Finally, myeloid-specific SIRT1 was required to suppress pyroptosis, pro-inflammatory phenotype, and ultimately mitigate hepatocellular injury in ischemia-stressed murine livers.
   Conclusion: These findings identify the Ikaros-SIRT1 axis as a novel mechanistic biomarker of pyroptosis and a putative checkpoint regulator of homeostasis in response to acute hepatic stress/injury in mouse and human livers.
   Lay summary: This report describes how crosstalk between Ikaros and SIRT1, two major transcriptional regulators, influence acute hepatic inflammation in murine models of liver ischemia-reperfusion injury and liver transplant recipients. We show that the myeloid Ikaros-SIRT1 axis regulates inflammasome-pyroptotic cell death and hepatocellular damage in stressed livers. Thus, the Ikaros-SIRT1 axis may serve as a novel checkpoint regulator that is required for homeostasis in response to acute liver injury in mice and humans. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
C1 [Kadono, Kentaro; Kageyama, Shoichi; Nakamura, Kojiro; Hirao, Hirofumi; Ito, Takahiro; Kojima, Hidenobu; Dery, Kenneth J.; Kupiec-Weglinski, Jerzy W.] UCLA, David Geffen Sch Med, Dumont UCLA Transplantat Ctr, Dept Surg,Div Liver & Pancreas Transplantat, Los Angeles, CA 90095 USA.
   [Kageyama, Shoichi; Nakamura, Kojiro] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan.
   [Li, Xiaoling] NIEHS, Signal Transduct Lab, POB 12233, Res Triangle Pk, NC 27709 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Kyoto University; National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS)
RP Kupiec-Weglinski, JW (corresponding author), Dumont UCLA Transplantat Ctr, 77-120 CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.
EM jkupiec@mednet.ucla.edu
RI Nakamura, Kojiro/AFN-3737-2022
OI Nakamura, Kojiro/0000-0002-9619-9039; Hirao,
   Hirofumi/0000-0001-6975-2436
FU NIH [P01 AI120944, R01 DK062357, R01 DK107533, R01 AI155856]; Intramural
   Research Program of the NIH/NIEHS [Z01 ES102205]
FX This work was supported by NIH Grants P01 AI120944, R01 DK062357, R01
   DK107533, and R01 AI155856 (JWKW). This work was also supported in part
   by the Intramural Research Program of the NIH/NIEHS Z01 ES102205 (XL).
CR Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Chan LN, 2017, NATURE, V542, P479, DOI 10.1038/nature21076
   de Ana CL, 2019, J IMMUNOL, V202, P1112, DOI 10.4049/jimmunol.1801270
   de Kreutzenberg SV, 2015, NUTR METAB CARDIOVAS, V25, P686, DOI 10.1016/j.numecd.2015.03.007
   Dutkowski P, 2015, GASTROENTEROLOGY, V148, P307, DOI 10.1053/j.gastro.2014.08.045
   Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747
   Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018
   Hakeem AR, 2013, LIVER TRANSPLANT, V19, P551, DOI 10.1002/lt.23618
   He M, 2020, CELL METAB, V31, P580, DOI 10.1016/j.cmet.2020.01.009
   He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139
   Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479
   Hua SY, 2019, INT IMMUNOPHARMACOL, V68, P145, DOI 10.1016/j.intimp.2019.01.002
   Hundertmark J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02418
   Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535
   Ji HF, 2014, HEPATOLOGY, V60, P2052, DOI 10.1002/hep.27334
   Jin YT, 2020, CELL MOL IMMUNOL, V17, P1245, DOI 10.1038/s41423-019-0318-x
   Kamo N, 2013, HEPATOLOGY, V58, P351, DOI 10.1002/hep.26320
   Kazankov K, 2019, NAT REV GASTRO HEPAT, V16, P145, DOI 10.1038/s41575-018-0082-x
   Kolachala VL, 2021, APOPTOSIS, V26, P361, DOI 10.1007/s10495-021-01673-1
   Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Li JC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2437-9
   Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6
   Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977
   Marke R, 2018, HAEMATOLOGICA, V103, P565, DOI 10.3324/haematol.2017.185603
   Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474
   Monteiro S, 2021, GUT, V70, P379, DOI 10.1136/gutjnl-2019-320170
   Nakamura K, 2018, AM J TRANSPLANT, V18, P1110, DOI 10.1111/ajt.14586
   Nakamura K, 2017, J HEPATOL, V67, P1232, DOI 10.1016/j.jhep.2017.08.010
   Nakamura K, 2017, LIVER TRANSPLANT, V23, P1282, DOI 10.1002/lt.24821
   Oh KS, 2018, J IMMUNOL, V201, P757, DOI 10.4049/jimmunol.1800158
   Ouzounidis N, 2016, LIVER TRANSPLANT, V22, P237, DOI 10.1002/lt.24359
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Pu ZC, 2020, AM J CHINESE MED, V48, P1693, DOI 10.1142/S0192415X20500846
   Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009
   Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707
   Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10
   Schwickert TA, 2019, NAT IMMUNOL, V20, P1517, DOI 10.1038/s41590-019-0490-2
   Seok JK, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.618231
   Shen XD, 2003, HEPATOLOGY, V37, P296, DOI 10.1053/jhep.2003.50066
   Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514
   Shi Y, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0954-8
   Stengel S, 2021, GUT, V70, P622, DOI 10.1136/gutjnl-2020-321597
   Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933
   Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2
   Uchida Y, 2010, GASTROENTEROLOGY, V139, P2195, DOI 10.1053/j.gastro.2010.07.003
   Wang Y, 2011, FEBS LETT, V585, P986, DOI 10.1016/j.febslet.2010.11.047
   Wiggins KA, 2019, AGING CELL, V18, DOI 10.1111/acel.12946
   Xia SY, 2021, NATURE, V593, P607, DOI 10.1038/s41586-021-03478-3
   Yang QL, 2019, IMMUNOLOGY, V157, P95, DOI 10.1111/imm.13056
   Yue S, 2017, J IMMUNOL, V198, P3588, DOI 10.4049/jimmunol.1601428
   Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115
   Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225
   Zhang M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120596
   Zhang ZQ, 2018, J GENET GENOMICS, V45, P25, DOI 10.1016/j.jgg.2018.01.002
NR 57
TC 32
Z9 34
U1 14
U2 36
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD 2022 APR
PY 2022
VL 76
IS 4
BP 896
EP 909
DI 10.1016/j.jhep.2021.11.026
EA MAR 2022
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 4W8SD
UT WOS:000860425300016
PM 34871625
OA Green Accepted, Green Published, hybrid
HC Y
HP N
DA 2024-02-19
ER

PT J
AU ZSNAGY, I
   CUTLER, RG
   KITANI, K
   OHTA, M
AF ZSNAGY, I
   CUTLER, RG
   KITANI, K
   OHTA, M
TI COMPARISON OF THE LATERAL DIFFUSION CONSTANT OF HEPATOCYTE
   MEMBRANE-PROTEINS IN 2 WILD MOUSE STRAINS OF CONSIDERABLY DIFFERENT
   LONGEVITY - FRAP STUDIES ON LIVER SMEARS
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
ID FLUORESCENCE PHOTOBLEACHING RECOVERY; CONCANAVALIN-A RECEPTORS;
   AGE-DEPENDENT DECREASE; PLASMA-MEMBRANE; BIOLOGICAL-MEMBRANES;
   CELL-MEMBRANES; MOBILITY; RAT; AUTOFLUORESCENCE; GLYCOPROTEIN
AB The liver cells of male and female wild mice (Peromyscus leucopus and Mus musculus) have been studied in young, adult, and old age groups. Because P. leucopus displays a life expectancy of 7-8 years, the age groups of this strain were from 5.5 to 68 months. M. musculus survives only to about 2.5 years; therefore, the age groups of this strain ranged from 6 to 27 months. Protein lateral diffusion in hepatocyte membranes was measured by means of fluorescence recovery after photobleaching (FRAP) in liver smears. The peroxide-induced autofluorescence was utilized as a fluorescent label, which in H2O2 treated liver smears is caused by the oxidation of riboflavin bound uniformly to all proteins of the cell membrane. This way the average lateral diffusion constant (D) and the fractional recovery of those proteins can be measured. In both males and females of both strains D displayed a negative linear age correlation. Intraspecies sex differences were small and statistically insignificant. However, interspecies comparisons of males or females resulted in a strongly significant difference: although the intercept points of the regression lines describing D were identical in both strains (3.1 x 10(-10) cm2/sec), the decay of D with aging was about 2.5 times faster in the short-living M. musculus than in the long-living P. leucopus. By the end of life expectancy, both strains reached practically identical values (about 1.9 x 10(-10) cm3/sec). The results lend further support to the membrane hypothesis of aging.
C1 TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL, DEPT CLIN PHYSIOL, TOKYO 173, JAPAN.
   NIA, GERONTOL RES CTR, BALTIMORE, MD 21224 USA.
C3 Tokyo Metropolitan Institute of Gerontology; National Institutes of
   Health (NIH) - USA; NIH National Institute on Aging (NIA)
RP ZSNAGY, I (corresponding author), UNIV MED SCH DEBRECEN, VERZAR INT LAB EXPTL GERONTOL, HUNGARIAN SECT, H-4012 DEBRECEN, HUNGARY.
CR AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4
   CHERRY RJ, 1979, BIOCHIM BIOPHYS ACTA, V559, P289, DOI 10.1016/0304-4157(79)90009-1
   DAWSON RMC, 1969, DATA BIOCH RES, P507
   DELAAT SW, 1979, BIOCHIM BIOPHYS ACTA, V558, P247, DOI 10.1016/0005-2736(79)90064-6
   DELAAT SW, 1980, P NATL ACAD SCI-BIOL, V77, P1526
   DRAGSTEN P, 1979, P NATL ACAD SCI USA, V76, P5163, DOI 10.1073/pnas.76.10.5163
   GOLAN DE, 1980, P NATL ACAD SCI-BIOL, V77, P2537, DOI 10.1073/pnas.77.5.2537
   JACOBSON K, 1984, J CELL BIOL, V99, P1624, DOI 10.1083/jcb.99.5.1624
   KITANI K, 1991, INT CONGR SER, V940, P305
   KITANI K, 1992, ARCH GERONTOL GERIAT, V14, P27, DOI 10.1016/0167-4943(92)90004-N
   KITANI K, 1988, HEPATOLOGY, V8, P125, DOI 10.1002/hep.1840080124
   KLEINFELD AM, 1981, BIOCHIM BIOPHYS ACTA, V649, P471, DOI 10.1016/0005-2736(81)90438-7
   LUSTYIK G, 1987, BIOCHIM BIOPHYS ACTA, V896, P57, DOI 10.1016/0005-2736(87)90356-7
   NAGY VZ, 1988, TISSUE CELL, V20, P229, DOI 10.1016/0040-8166(88)90044-4
   NOKUBO M, 1988, BIOCHIM BIOPHYS ACTA, V939, P441, DOI 10.1016/0005-2736(88)90090-9
   NOKUBO M, 1989, BIOCHIM BIOPHYS ACTA, V981, P303, DOI 10.1016/0005-2736(89)90041-2
   OHTA M, 1990, BIOCHEM PHARMACOL, V39, P1223, DOI 10.1016/0006-2952(90)90266-N
   PETTY HR, 1980, P NATL ACAD SCI-BIOL, V77, P6587, DOI 10.1073/pnas.77.11.6587
   SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111
   SCHLESSINGER J, 1976, P NATL ACAD SCI USA, V73, P2409, DOI 10.1073/pnas.73.7.2409
   SCHLESSINGER J, 1977, P NATL ACAD SCI USA, V74, P2909, DOI 10.1073/pnas.74.7.2909
   Smith GS, 1990, GENETIC EFFECTS AGIN, P457
   Snedecor GW, 1980, STAT METHODOL, V7th, P39
   SU YX, 1984, BIOCHIM BIOPHYS ACTA, V776, P92, DOI 10.1016/0005-2736(84)90254-2
   VAZ WLC, 1982, MEMBRANE RECONSTITUT, P83
   WODA BA, 1979, J IMMUNOL, V123, P2161
   WOLF DE, 1980, P NATL ACAD SCI-BIOL, V77, P2043, DOI 10.1073/pnas.77.4.2043
   WU ES, 1982, P NATL ACAD SCI-BIOL, V79, P4962, DOI 10.1073/pnas.79.16.4962
   YECHIEL E, 1985, J BIOL CHEM, V260, P9132
   YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7
   ZSNAGY I, 1990, ARCH GERONTOL GERIAT, V11, P243, DOI 10.1016/0167-4943(90)90068-H
   ZSNAGY I, 1988, BIOCHIM BIOPHYS ACTA, V939, P551, DOI 10.1016/0005-2736(88)90102-2
   ZSNAGY I, 1988, ANN NY ACAD SCI, V521, P215, DOI 10.1111/j.1749-6632.1988.tb35280.x
   ZSNAGY I, 1991, ARCH GERONTOL GERIAT, V12, P329, DOI 10.1016/0167-4943(91)90038-R
   ZSNAGY I, 1989, EXP GERONTOL, V24, P317, DOI 10.1016/0531-5565(89)90004-1
   ZSNAGY I, 1979, MECH AGEING DEV, V9, P237, DOI 10.1016/0047-6374(79)90102-7
   ZSNAGY I, 1986, EXP GERONTOL, V21, P555, DOI 10.1016/0531-5565(86)90007-0
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1984, MIKROSKOPIE, V41, P12
   ZSNAGY I, 1991, INT CONGR SER, V940, P321
   ZSNAGY I, 1978, J THEOR BIOL, V75, P189, DOI 10.1016/0022-5193(78)90230-8
   ZSNAGY I, 1987, BIOL AGE AGING RISK, P147
   ZSNAGY I, 1989, J GERONTOL BIOL SCI, V44, pB85
   ZSNAGY I, 1989, CRC HDB FREE RADICAL, V1, P199
NR 44
TC 12
Z9 12
U1 0
U2 2
PU GERONTOLOGICAL SOC AMER
PI WASHINGTON
PA 1030 15TH ST NW, STE 250, WASHINGTON, DC 20005202-842 USA
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD MAY
PY 1993
VL 48
IS 3
BP B86
EP B92
DI 10.1093/geronj/48.3.B86
PG 7
WC Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA LA889
UT WOS:A1993LA88900008
DA 2024-02-19
ER

PT J
AU Bavik, C
   Coleman, I
   Dean, JP
   Knudsen, B
   Plymate, S
   Nelson, PS
AF Bavik, C
   Coleman, I
   Dean, JP
   Knudsen, B
   Plymate, S
   Nelson, PS
TI The gene expression program of prostate fibroblast senescence modulates
   neoplastic epithelial cell proliferation through paracrine mechanisms
SO CANCER RESEARCH
LA English
DT Article
ID HEPATOCYTE GROWTH-FACTOR; INTRAEPITHELIAL NEOPLASIA; CANCER;
   AMPHIREGULIN; CARCINOMA; STROMA; PROGRESSION; PATHWAYS; PROMOTES;
   CULTURE
AB The greatest risk factor for developing carcinoma of the prostate is advanced age. Potential molecular and physiologic contributors to the frequency of cancer occurrence in older individuals include the accumulation of somatic mutations through defects in genome maintenance, epigenetic gene silencing, oxidative stress, loss of immune surveillance, telomere dysfunction, chronic inflammation, and alterations in tissue microenvironment. In this context, the process of prostate carcinogenesis can be influenced through interactions between intrinsic cellular alterations and the extrinsic microenvironment and macroenvironment, both of which change substantially as a consequence of aging. In this study, we sought to characterize the molecular alterations that occur during the process of prostate fibroblast senescence to identify factors in the aged tissue microenvironment capable of promoting the proliferation and potentially the neoplastic progression of prostate epithelium. We evaluated three mechanisms leading to cell senescence: oxidative stress, DNA damage, and replicative exhaustion. We identified a consistent program of gene expression that includes a subset of paracrine factors capable of influencing adjacent prostate epithelial growth. Both direct coculture and conditioned medium from senescent prostate fibroblasts stimulated epithelial cell proliferation, 3-fold and 2-fold, respectively. The paracrine-acting proteins fibroblast growth factor 7, hepatocyte growth factor, and amphiregulin (AREG) were elevated in the extracellular environment of senescent prostate fibroblasts. Exogenous AREG alone stimulated prostate epithelial cell growth, and neutralizing antibodies and small interfering RNA targeting AREG attenuated, but did not completely abrogate the growth-promoting effects of senescent fibroblast conditioned medium. These results support the concept that aging-related changes in the prostate microenvironment may contribute to the progression of prostate neoplasia.
C1 Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.
   Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA.
   Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.
   Univ Washington, Dept Med, Seattle, WA 98195 USA.
C3 Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred
   Hutchinson Cancer Center; University of Washington; University of
   Washington Seattle
RP Nelson, PS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Mailstop D4-100,1100 Fairview Ave N, Seattle, WA 98109 USA.
EM pnelson@fhcrc.org
FU NCI NIH HHS [CA 85859, CA 97186, CA 015704] Funding Source: Medline;
   NIDDK NIH HHS [DK 65204] Funding Source: Medline
CR Adam RM, 1999, ENDOCRINOLOGY, V140, P5866, DOI 10.1210/en.140.12.5866
   Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G
   Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922
   Bièche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Bonham M, 2002, CANCER RES, V62, P3920
   Bostwick DG, 2004, PROSTATE, V58, P164, DOI 10.1002/pros.10322
   Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204
   Chang BD, 1999, CANCER RES, V59, P3761
   Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007
   Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043
   CURTIS HJ, 1965, CANCER RES, V25, P1305
   DEROBERTIS EM, 1991, DEVELOPMENT, V112, P669
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
   EBERT M, 1994, CANCER RES, V54, P3959
   Forsyth IA, 1997, MOL CELL ENDOCRINOL, V126, P41, DOI 10.1016/S0303-7207(96)03967-6
   Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9
   Gmyrek GA, 2001, AM J PATHOL, V159, P579, DOI 10.1016/S0002-9440(10)61729-4
   Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231
   Hawkins V, 1999, NUCLEIC ACIDS RES, V27, P204, DOI 10.1093/nar/27.1.204
   HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14
   Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B
   HURBIN A, 2005, J BIOL CHEM, V14, P14
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Kenny PA, 2003, INT J CANCER, V107, P688, DOI 10.1002/ijc.11491
   KHOURY H, 2004, MOL BIOL CELL, V17, P17
   Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101
   LINSKENS MHK, 1995, SCIENCE, V267, P17, DOI 10.1126/science.7848496
   Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000
   MAHTOUK K, 2005, ONCOGENE, V28, P28
   MartinezLacaci I, 1996, J CELL PHYSIOL, V169, P497, DOI 10.1002/(SICI)1097-4652(199612)169:3<497::AID-JCP10>3.0.CO;2-3
   Miyazaki M, 1998, BIOCHEM BIOPH RES CO, V246, P255, DOI 10.1006/bbrc.1998.8593
   MIYAZAWA K, 1994, J BIOL CHEM, V269, P8966
   Nakashiro K, 2000, AM J PATHOL, V157, P795, DOI 10.1016/S0002-9440(10)64593-2
   Nakashiro K, 2003, ONCOL REP, V10, P1149
   Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299
   Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562
   Olumi AF, 1999, CANCER RES, V59, P5002
   OPITZ JM, 1985, AM J MED GENET, V21, P1, DOI 10.1002/ajmg.1320210102
   RUBIN H, 1985, CANCER RES, V45, P2935
   RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802
   SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3
   Sirotnak FM, 2004, MOL CARCINOGEN, V41, P150, DOI 10.1002/mc.20051
   Skrtic S, 1997, ENDOCRINOLOGY, V138, P4683, DOI 10.1210/en.138.11.4683
   Soto AM, 2004, BIOESSAYS, V26, P1097, DOI 10.1002/bies.20087
   Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0
   STEWART TA, 1981, P NATL ACAD SCI-BIOL, V78, P6314, DOI 10.1073/pnas.78.10.6314
   Torring N, 2005, PROSTATE, V64, P1, DOI 10.1002/pros.20214
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
NR 54
TC 334
Z9 388
U1 0
U2 16
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JAN 15
PY 2006
VL 66
IS 2
BP 794
EP 802
DI 10.1158/0008-5472.CAN-05-1716
PG 9
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 006RQ
UT WOS:000234915100029
PM 16424011
DA 2024-02-19
ER

PT J
AU Xue, W
   Zender, L
   Miething, C
   Dickins, RA
   Hernando, E
   Krizhanovsky, V
   Cordon-Cardo, C
   Lowe, SW
AF Xue, Wen
   Zender, Lars
   Miething, Cornelius
   Dickins, Ross A.
   Hernando, Eva
   Krizhanovsky, Valery
   Cordon-Cardo, Carlos
   Lowe, Scott W.
TI Senescence and tumour clearance is triggered by p53 restoration in
   murine liver carcinomas
SO NATURE
LA English
DT Article
ID CELL SENESCENCE; ONCOGENIC RAS; KILLER-CELLS; SUPPRESSION; CANCER;
   TUMORIGENESIS; PATHWAY; NEVI
AB Although cancer arises from a combination of mutations in oncogenes and tumour suppressor genes, the extent to which tumour suppressor gene loss is required for maintaining established tumours is poorly understood. p53 is an important tumour suppressor that acts to restrict proliferation in response to DNA damage or deregulation of mitogenic oncogenes, by leading to the induction of various cell cycle checkpoints, apoptosis or cellular senescence(1,2). Consequently, p53 mutations increase cell proliferation and survival, and in some settings promote genomic instability and resistance to certain chemotherapies(3). To determine the consequences of reactivating the p53 pathway in tumours, we used RNA interference (RNAi) to conditionally regulate endogenous p53 expression in a mosaic mouse model of liver carcinoma(4,5). We show that even brief reactivation of endogenous p53 in p53-deficient tumours can produce complete tumour regressions. The primary response to p53 was not apoptosis, but instead involved the induction of a cellular senescence program that was associated with differentiation and the upregulation of inflammatory cytokines. This program, although producing only cell cycle arrest in vitro, also triggered an innate immune response that targeted the tumour cells in vivo, thereby contributing to tumour clearance. Our study indicates that p53 loss can be required for the maintenance of aggressive carcinomas, and illustrates how the cellular senescence program can act together with the innate immune system to potently limit tumour growth.
C1 Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.
   Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.
   Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA.
C3 Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard
   Hughes Medical Institute; Memorial Sloan Kettering Cancer Center
RP Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.
EM lowe@cshl.edu
RI Dickins, Ross A/K-2852-2012; Miething, Cornelius/F-9498-2014;
   Krizhanovsky, Valery/D-1336-2010
OI Dickins, Ross A/0000-0003-4112-5304; Miething,
   Cornelius/0000-0003-4699-3805; Hernando, Eva/0000-0003-1023-0312;
   Krizhanovsky, Valery/0000-0002-3977-5482; Xue, Wen/0000-0002-9797-8042
FU NCI NIH HHS [P30 CA008748, P01 CA087497] Funding Source: Medline
CR Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788
   Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651
   Ghiringhelli F, 2006, IMMUNOL REV, V214, P229, DOI 10.1111/j.1600-065X.2006.00445.x
   Gorgoulis VG, 2005, LAB INVEST, V85, P502, DOI 10.1038/labinvest.3700241
   Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283
   Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615
   Hong F, 2003, CANCER RES, V63, P9023
   Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22
   Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje
   Roninson IB, 2003, CANCER RES, V63, P2705
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4
   SHULTZ LD, 1995, J IMMUNOL, V154, P180
   Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650
   Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   VENTURA A, 2007, NATURE          0124, DOI DOI 10.1038/NATURE05541
   Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059
   Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030
NR 30
TC 1886
Z9 2176
U1 4
U2 222
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD FEB 8
PY 2007
VL 445
IS 7128
BP 656
EP 660
DI 10.1038/nature05529
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 133UM
UT WOS:000244039400046
PM 17251933
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Sekoguchi, S
   Nakajima, T
   Moriguchi, M
   Jo, M
   Nishikawa, T
   Katagishi, T
   Kimura, H
   Minami, M
   Itoh, Y
   Kagawa, K
   Tani, Y
   Okanoue, T
AF Sekoguchi, Satoru
   Nakajima, Tomoki
   Moriguchi, Michihisa
   Jo, Masayasu
   Nishikawa, Taichiro
   Katagishi, Tatsuo
   Kimura, Hiroyuki
   Minami, Masahito
   Itoh, Yoshito
   Kagawa, Keizo
   Tani, Yoichi
   Okanoue, Takeshi
TI Role of cell-cycle turnover and oxidative stress in telomere shortening
   and cellular senescence in patients with chronic hepatitis C
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE chronic hepatitis C; fibrosis; oxidative stress; quantitative
   fluorescence in situ hybridization; replicative senescence; telomere
ID CHRONIC LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; DNA-DAMAGE; SERUM
   AMINOTRANSFERASE; NORMAL INDIVIDUALS; NATURAL-HISTORY; VIRUS-INFECTION;
   LENGTH; FIBROSIS; IRON
AB Background: In addition to the telomere shortening that occurs with cell division, oxidative stress can damage or shorten telomeres and induce a condition termed premature senescence, possibly before telomeres become critically short. We investigated the effects of cell-cycle turnover and oxidative stress on cellular senescence in hepatitis C virus (HCV)-related chronic liver injury.
   Methods: Using quantitative fluorescence in situ hybridization, the telomere lengths of hepatocytes in biopsy specimens from HCV-positive patients were estimated. We assessed clinicopathological parameters that reflect cell-cycle turnover, including Ki-67 positive index, serum alanine aminotransferase (ALT) level and degree of fibrosis, and also oxidative stress-related parameters, such as 8-hydroxy-2'-deoxyguanosine (8-OHdG) expression. Nuclear size and DNA content of hepatocytes were measured as morphological features of senescence.
   Results: Telomere shortening correlated with the degree of cell turnover, hepatic fibrosis and morphological features of aging cells. Furthermore, the rate of telomere shortening per year was positively correlated with fibrosis progression. In cases of no or mild fibrosis, telomere lengths of positive patients were generally shorter than those of 8-OHdG-negative patients, and this trend achieved statistical significance in advanced-stage fibrosis. HCV carriers with persistently normal serum ALT level (PNAL) showed significantly longer telomeres than patients with active hepatitis and mild fibrosis. There was no significant difference in telomere lengths between HCV carriers with PNAL and normal controls.
   Conclusions: Cell-cycle turnover is the primary mechanism of telomere shortening, and can induce fibrosis progression and cellular senescence. However, oxidative stress can be an accelerator of senescence, especially in advanced-stage fibrosis.
C1 Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan.
   Fukuchiyama City Hosp, Dept Med, Fukuchiyama, Japan.
   DakoCytomat, Dept Med Sci, Kyoto, Japan.
C3 Kyoto Prefectural University of Medicine
RP Sekoguchi, S (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto 6028566, Japan.
EM ssekoguchi@ybb.ne.jp
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-1
   Farinati F, 1999, FREE RADICAL BIO MED, V27, P1284, DOI 10.1016/S0891-5849(99)00161-6
   Ichiba M, 2003, LIVER INT, V23, P338, DOI 10.1034/j.1478-3231.2003.00868.x
   Igarashi M, 2003, CLIN CANCER RES, V9, P5264
   Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711
   Kato J, 2001, CANCER RES, V61, P8697
   Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kitada T, 2001, J HEPATOL, V35, P613, DOI 10.1016/S0168-8278(01)00171-4
   KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511
   Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303
   LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3
   Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200
   Mahmood S, 2004, ANTIOXID REDOX SIGN, V6, P19, DOI 10.1089/152308604771978318
   Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9
   Nakajima T, 2004, BIOCHEM BIOPH RES CO, V325, P1131, DOI 10.1016/j.bbrc.2004.10.152
   Okanoue T, 2005, J HEPATOL, V43, P599, DOI 10.1016/j.jhep.2005.04.008
   Okanoue T, 1996, LIVER, V16, P241
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Shedlofsky SI, 1998, HEPATO-GASTROENTEROL, V45, P349
   Shen ZZ, 2000, BIOCHEMISTRY-US, V39, P5474, DOI 10.1021/bi992809y
   Sumida Y, 2001, LIVER, V21, P295, DOI 10.1034/j.1600-0676.2001.210501.x
   Sumida Y, 2000, J HEPATOL, V33, P616, DOI 10.1034/j.1600-0641.2000.033004616.x
   Tchirkov A, 2003, HUM MOL GENET, V12, P227, DOI 10.1093/hmg/ddg023
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Toussaint Olivier, 2002, TheScientificWorldJOURNAL, V2, P230
   Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   WATANABE T, 1978, VIRCHOWS ARCH B, V27, P307
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x
   Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1053/jhep.1996.v23.pm0008675148
NR 36
TC 55
Z9 58
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD FEB
PY 2007
VL 22
IS 2
BP 182
EP 190
DI 10.1111/j.1440-1746.2006.04454.x
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 130HX
UT WOS:000243791800007
PM 17295869
DA 2024-02-19
ER

PT J
AU Salgado, CL
   Corea, AFM
   Covre, LP
   Guedes, HLD
   Falqueto, A
   Gomes, DCO
AF Salgado, Caio Loureiro
   Mendez Corea, Andres Felipe
   Covre, Luciana Polaco
   De Matos Guedes, Herbet Leonel
   Falqueto, Aloisio
   Oliviera Gomes, Daniel Claudio
TI Ageing impairs protective immunity and promotes susceptibility to murine
   visceral leishmaniasis
SO PARASITOLOGY
LA English
DT Article; Early Access
DE Inflammation; Leishmania infantum; senescence; visceral leishmaniasis
ID AMERICAN TEGUMENTARY LEISHMANIASIS; HEMATOPOIETIC STEM-CELLS; AGED MICE;
   T-CELLS; MUCOSAL LEISHMANIASIS; STREPTOCOCCUS-PNEUMONIAE; CELLULAR
   SENESCENCE; BALB/C MICE; IFN-GAMMA; TNF-ALPHA
AB It is well accepted that the impact of diseases is generally more detrimental in elderly individuals than in younger ones. Changes in the immune system due to ageing can directly affect the ability to respond effectively to infections and may contribute to the higher morbidities and mortalities in the elderly population. Leishmaniasis is a complex of clinically unique diseases caused by obligate intracellular protozoa belonging to genus Leishmania, wherein visceral leishmaniasis (VL) is the most severe form and is fatal if left untreated. In this study, aged mice (72 weeks old) presented increased susceptibility to L. infantum infection compared to younger mice (4-6-week-old), with notable parasitism in both the spleen and liver, as well as exhibiting hepatosplenomegaly. A pronounced inflammatory profile was observed in the aged-infected mice, with excessive production of TNF-alpha and nitrite, along with diminished IFN-gamma production and reduced proliferative capacity of T cells (assessed by expression of the Ki67 marker). Additionally, both CD4(+) and CD8(+) T cells from the aged-infected mice presented increased expression of the inhibitory receptors PD-1 and KLRG1 that strongly correlated with the parasitism found in the liver and spleen of this group. Overall, the data reported in this study suggests for the first time that ageing may negatively impact the VL outcome and provides a perspective for new therapeutic strategies involving manipulation of immunosenescence features against Leishmania infection.
C1 [Salgado, Caio Loureiro; Oliviera Gomes, Daniel Claudio] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Mendez Corea, Andres Felipe; Oliviera Gomes, Daniel Claudio] Univ Fed Espirito Santo, Nucleo Biotecnol, Vitoria, ES, Brazil.
   [Covre, Luciana Polaco] UCL, Div Med, London, England.
   [De Matos Guedes, Herbet Leonel] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [De Matos Guedes, Herbet Leonel] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, Rio De Janeiro, Brazil.
   [Falqueto, Aloisio] Univ Fed Espirito Santo, Dept Med Social, Vitoria, ES, Brazil.
C3 Universidade Federal do Espirito Santo; Universidade Federal do Espirito
   Santo; University of London; University College London; Fundacao Oswaldo
   Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do
   Espirito Santo
RP Gomes, DCO (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.; Gomes, DCO (corresponding author), Univ Fed Espirito Santo, Nucleo Biotecnol, Vitoria, ES, Brazil.
EM dgomes@ndi.ufes.br
RI Salgado, Caio Loureiro/AAS-3401-2020; de Matos Guedes, Herbert
   Leonel/K-6191-2014
OI Salgado, Caio Loureiro/0000-0002-4423-6723; de Matos Guedes, Herbert
   Leonel/0000-0002-3819-3069
FU Fundacao de Amparo a Pesquisa do Espirito Santo-FAPES/Newton Fund;
   Medical Research and Coordination for the Improvement of Higher
   Education Personnel - CAPES-Brazil
FX This work was supported by Fundacao de Amparo a Pesquisa do Espirito
   Santo-FAPES/Newton Fund and Medical Research and Coordination for the
   Improvement of Higher Education Personnel - CAPES-Brazil.
CR Aiello A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02247
   Akbar AN, 2016, TRENDS IMMUNOL, V37, P866, DOI 10.1016/j.it.2016.09.002
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Araujo-Melo MH, 2010, J LARYNGOL OTOL, V124, P1056, DOI 10.1017/S0022215110001325
   Barbé-Tuana F, 2020, SEMIN IMMUNOPATHOL, V42, P545, DOI 10.1007/s00281-020-00806-z
   BENDER BS, 1991, IMMUNOLOGY, V72, P514
   Bogdan Christian, 2020, Cytokine X, V2, P100041, DOI 10.1016/j.cytox.2020.100041
   Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2
   Carvalho LP, 2007, PARASITE IMMUNOL, V29, P251, DOI 10.1111/j.1365-3024.2007.00940.x
   Cerqueira E, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01550
   Chen J, 2020, J IMMUNOL, V205, P313, DOI 10.4049/jimmunol.2000380
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Cincurá C, 2017, AM J TROP MED HYG, V97, P761, DOI 10.4269/ajtmh.16-0349
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Covre LP, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03001
   da Fonseca-Martins AM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56336-8
   de Lima VMF, 2007, VET IMMUNOL IMMUNOP, V115, P189, DOI 10.1016/j.vetimm.2006.10.003
   de Moura RG, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.632667
   Diniz DS, 2012, REV SOC BRAS MED TRO, V45, P597, DOI 10.1590/S0037-86822012000500011
   Ehrchen J, 2004, INFECT IMMUN, V72, P5106, DOI 10.1128/IAI.72.9.5106-5114.2004
   Fang M, 2010, J EXP MED, V207, P2369, DOI 10.1084/jem.20100282
   Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   GARDNER ID, 1980, REV INFECT DIS, V2, P801
   Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321
   Horta Maria Fatima, 2012, J Parasitol Res, V2012, P203818, DOI 10.1155/2012/203818
   Jirmanus L, 2012, AM J TROP MED HYG, V86, P426, DOI 10.4269/ajtmh.2012.11-0378
   Krone CL, 2013, INFECT IMMUN, V81, P4615, DOI 10.1128/IAI.00618-13
   Lanna A, 2017, NAT IMMUNOL, V18, P354, DOI 10.1038/ni.3665
   Larbi A, 2011, AGEING RES REV, V10, P370, DOI 10.1016/j.arr.2010.09.008
   Leal JM, 2015, PARASITOLOGY, V142, P1640, DOI 10.1017/S0031182015001250
   Leng J, 2011, VACCINE, V29, P8147, DOI 10.1016/j.vaccine.2011.08.027
   Liang SC, 2006, EUR J IMMUNOL, V36, P58, DOI 10.1002/eji.200535458
   LIEW FY, 1990, IMMUNOLOGY, V71, P556
   Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709
   MAUCH P, 1982, BLOOD, V60, P245
   Müller-Durovic B, 2016, J IMMUNOL, V197, P2891, DOI 10.4049/jimmunol.1600590
   Murasko DM, 2005, IMMUNOL REV, V205, P285, DOI 10.1111/j.0105-2896.2005.00273.x
   Norman DC, 2016, CLIN GERIATR MED, V32, P433, DOI 10.1016/j.cger.2016.02.005
   Oliveira AGL, 2013, ACTA TROP, V128, P36, DOI 10.1016/j.actatropica.2013.06.005
   Oliveira F, 2011, AM J TROP MED HYG, V85, P70, DOI 10.4269/ajtmh.2011.10-0680
   Silva KLO, 2019, COMP IMMUNOL MICROB, V62, P76, DOI 10.1016/j.cimid.2018.12.002
   Pavlicek D, 2017, IMMUN AGEING, V14, DOI 10.1186/s12979-017-0103-6
   Plunkett FJ, 2007, J IMMUNOL, V178, P7710, DOI 10.4049/jimmunol.178.12.7710
   Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228
   Prata Larissa G P Langhi, 2018, Semin Immunol, V40, P101275, DOI 10.1016/j.smim.2019.04.003
   Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500
   REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.immunol.13.1.151
   Rodrigues V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1412-x
   Rodrigues V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004096
   Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157
   SCOTT P, 1989, IMMUNOL REV, V112, P161, DOI 10.1111/j.1600-065X.1989.tb00557.x
   SCOTT P, 1991, J IMMUNOL, V147, P3149
   Silva RDE, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.620144
   Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008
   Sorci G, 2021, INFECT GENET EVOL, V88, DOI 10.1016/j.meegid.2020.104698
   Speziali E, 2010, SCAND J IMMUNOL, V71, P240, DOI 10.1111/j.1365-3083.2010.02370.x
   SQUIRES KE, 1989, J IMMUNOL, V143, P4244
   Toapanta FR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-112
   Torres-Guerrero Edoardo, 2017, F1000Res, V6, P750, DOI 10.12688/f1000research.11120.1
   Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x
   Tsuji S, 2022, NATURE AGING, V2, P115, DOI 10.1038/s43587-022-00170-7
   Wang JM, 2013, J VIROL, V87, P11626, DOI 10.1128/JVI.01515-13
   Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197
   Williams AE, 2015, AM J PHYSIOL-LUNG C, V308, pL539, DOI 10.1152/ajplung.00141.2014
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
NR 68
TC 1
Z9 1
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD 2022 AUG
PY 2022
VL 149
IS 9
BP 1249
EP 1256
AR S0031182022000828
DI 10.1017/S0031182022000828
EA JUN 2022
PG 8
WC Parasitology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Parasitology
GA 2U4IZ
UT WOS:000817774600001
PM 35670372
OA Green Submitted
DA 2024-02-19
ER

PT J
AU UMEZAWA, M
   HOSOKAWA, M
   KOHNO, A
   ISHIKAWA, S
   KITAGAWA, K
   TAKEDA, T
AF UMEZAWA, M
   HOSOKAWA, M
   KOHNO, A
   ISHIKAWA, S
   KITAGAWA, K
   TAKEDA, T
TI DIETARY SOYBEAN PROTEIN COMPARED WITH CASEIN RETARDS SENESCENCE IN THE
   SENESCENCE-ACCELERATED MOUSE
SO JOURNAL OF NUTRITION
LA English
DT Article
DE SENESCENCE ACCELERATED MOUSE; LIFE SPAN; DIETARY PROTEIN; SENILE
   AMYLOID; SECONDARY AMYLOID
ID UNLABELED IMMUNOPEROXIDASE METHOD; AGE-RELATED-CHANGES; MURINE MODEL;
   SAM; MICE; RESTRICTION; DISEASE; RATS
AB The effects of replacing dietary casein with soybean protein on mean life span, mean life span of the last one-tenth of a group, grading scores of senescence and deposition of senile amyloid were investigated in senescence accelerated mice (SAM-P/1) compared with a control strain (SAM-R/1). SAM-R/1 mice fed the soybean protein-containing diet had mean life spans of 618 +/- 42 d (males) and 578 +/- 62 d (females), 58% (males) and 44% (females) longer than those of corresponding casein fed mice (P < 0.01). Similarly, in SAM-P/1 mean life-spans were 265 +/- 16 d (males) and 307 +/- 23 d (females) in the soybean diet group, 27% (males) and 30% (females) longer than in the casein diet groups (P < 0.01). The mean life span of the last one-tenth of each group fed soybean protein was significantly longer than the corresponding group fed casein. In SAM-R/1 mice, pathological studies revealed that severe secondary amyloid deposition (amyloid A protein) in the kidneys, spleen, stomach and liver was significantly suppressed, in males only, by replacing casein with soybean protein (P < 0.01). The occurrence of contracted kidneys caused by the infiltration of amyloid A protein was suppressed in SAM-R/1 mice fed the soybean protein-containing diet (P < 0.05). The deposition of senile amyloid in SAM-P/1 mice with aging was retarded by replacing casein with soybean protein (P < 0.01). These results indicate that dietary protein source is important in modulating the advance of senescence in SAM.
C1 KYOTO UNIV,CHEST DIS RES INST,DEPT SENESCENCE BIOL,KYOTO 606,JAPAN.
   SEINAN JOGAKUIN COLL,DEPT FOOD & NUTR,FUKUOKA 803,JAPAN.
C3 Kyoto University
RP UMEZAWA, M (corresponding author), KOSHIEN UNIV,DEPT NUTR,10-1 MOMIJIGAOKA,TAKARAZUKA,HYOGO 665,JAPAN.
CR CHEN WH, 1989, AM J PATHOL, V135, P379
   ELDRIDGE AC, 1982, J AGR FOOD CHEM, V30, P353, DOI 10.1021/jf00110a035
   ERIKSEN N, 1976, P NATL ACAD SCI USA, V73, P964, DOI 10.1073/pnas.73.3.964
   ERSKINE RJ, 1989, AM J VET RES, V50, P2093
   FUJIHARA S, 1980, LAB INVEST, V43, P358
   GLENNER GG, 1976, INT REV EXPT PATHOLO, V15, P25
   Grayzel HG, 1934, ARCH PATHOL, V17, P50
   HESTON WE, 1945, J NATL CANCER I, V6, P41, DOI 10.1093/jnci/6.1.41
   HIGUCHI K, 1983, LAB INVEST, V48, P231
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   IRWIN GR, 1969, P SOC EXP BIOL MED, V130, P819, DOI 10.3181/00379727-130-33663
   IWASAKI K, 1988, J GERONTOL, V43, pB5, DOI 10.1093/geronj/43.1.B5
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KEDAR I, 1973, BRIT J EXP PATHOL, V54, P553
   KOHNO A, 1985, J NUTR, V115, P1259, DOI 10.1093/jn/115.10.1259
   KRITCHEVSKY D, 1982, ATHEROSCLEROSIS, V41, P429, DOI 10.1016/0021-9150(82)90208-8
   MACHLIN LJ, 1987, FASEB J, V1, P441, DOI 10.1096/fasebj.1.6.3315807
   MASORO EJ, 1989, LAB INVEST, V60, P165
   MATSUMURA A, 1982, LAB INVEST, V47, P270
   MATSUSHITA M, 1986, AM J PATHOL, V125, P276
   MESSINA M, 1991, JNCI-J NATL CANCER I, V83, P541, DOI 10.1093/jnci/83.8.541
   OAKENFULL DG, 1979, BRIT J NUTR, V42, P209, DOI 10.1079/BJN19790108
   PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355
   ROBERT GDS, 1980, PRINCIPLES PROCEDURE, P112
   SHIMADA A, 1992, J NEUROPATH EXP NEUR, V51, P440, DOI 10.1097/00005072-199207000-00006
   SKINNER M, 1977, LAB INVEST, V36, P420
   Steel R. G. D., 1980, PRINCIPLES PROCEDURE, P504
   STERNBERGER LA, 1979, IMMUNOCYTOCHEMISTRY, P104
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKEDA T, 1988, AMYLOID AMYLOIDOSIS, P685
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
   TANAKA K, 1984, J NUTR, V114, P26, DOI 10.1093/jn/114.1.26
   UMEZAWA M, 1990, J NUTR, V120, P1393, DOI 10.1093/jn/120.11.1393
   WESTERMARK P, 1979, SCAND J IMMUNOL, V9, P193, DOI 10.1111/j.1365-3083.1979.tb02722.x
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   Yasumoto K., 1983, Nutritional Science of Soy Protein (Japan), V4, P35
NR 37
TC 18
Z9 18
U1 0
U2 4
PU AMER INST NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-3166
J9 J NUTR
JI J. Nutr.
PD NOV
PY 1993
VL 123
IS 11
BP 1905
EP 1912
DI 10.1093/jn/123.11.1905
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA MF526
UT WOS:A1993MF52600018
PM 8229307
OA Bronze
DA 2024-02-19
ER

PT J
AU Wu, N
   Zhou, TH
   Carpino, G
   Baiocchi, L
   Kyritsi, K
   Kennedy, L
   Ceci, L
   Chen, LX
   Wu, CD
   Kundu, D
   Barupala, N
   Franchitto, A
   Onori, P
   Ekser, B
   Gaudio, E
   Francis, H
   Glaser, S
   Alpini, G
AF Wu, Nan
   Zhou, Tianhao
   Carpino, Guido
   Baiocchi, Leonardo
   Kyritsi, Konstantina
   Kennedy, Lindsey
   Ceci, Ludovica
   Chen, Lixian
   Wu, Chaodong
   Kundu, Debjyoti
   Barupala, Nipuni
   Franchitto, Antonio
   Onori, Paolo
   Ekser, Burcin
   Gaudio, Eugenio
   Francis, Heather
   Glaser, Shannon
   Alpini, Gianfranco
TI Prolonged administration of a secretin receptor antagonist inhibits
   biliary senescence and liver fibrosis in Mdr2<SUP>-/-</SUP> mice
SO HEPATOLOGY
LA English
DT Article
ID PRIMARY SCLEROSING CHOLANGITIS; FUNCTIONAL-HETEROGENEITY; CHOLESTATIC
   LIVER; GROWTH; CHOLANGIOCYTES; PROLIFERATION; ACTIVATION; EXPRESSION;
   CIRRHOSIS
AB Background and Aims: Secretin (SCT) and secretin receptor (SR, only expressed on cholangiocytes within the liver) play key roles in modulating liver phenotypes. Forkhead box A2 (FoxA2) is required for normal bile duct homeostasis by preventing the excess of cholangiocyte proliferation. Shortterm administration of the SR antagonist (SCT 5- 27) decreased ductular reaction and liver fibrosis in bile duct ligated and Mdr2-/- [primary sclerosing cholangitis (PSC), model] mice. We aimed to evaluate the effectiveness and risks of long-term SCT 5-27 treatment in Mdr2-/- mice. Approach and Results: In vivo studies were performed in male wild-type and Mdr2-/- mice treated with saline or SCT 5-27 for 3 months and human samples from late-stage PSC patients and healthy controls. Compared with controls, biliary SCT/SR expression and SCT serum levels increased in Mdr2-/- mice and late-stage PSC patients. There was a significant increase in ductular reaction, biliary senescence, liver inflammation, angiogenesis, fibrosis, biliary expression of TGF-ss 1/VEGF-A axis, and biliary phosphorylation of protein kinase A and ERK1/2 in Mdr2-/- mice. The biliary expression of miR-125b and FoxA2 decreased in Mdr2-/compared with wild-type mice, which was reversed by long-term SCT 5-27 treatment. In vitro, SCT 5-27 treatment of a human biliary PSC cell line decreased proliferation and senescence and SR/TGF-ss 1/VEGF-A axis but increased the expression of miR-125b and FoxA2. Downregulation of FoxA2 prevented SCT 5-27-induced reduction in biliary damage, whereas overexpression of FoxA2 reduced proliferation and senescence in the human PSC cell line. Conclusions: Modulating the SCT/SR axis may be critical for managing PSC.
C1 [Wu, Nan; Zhou, Tianhao; Kyritsi, Konstantina; Kennedy, Lindsey; Ceci, Ludovica; Chen, Lixian; Kundu, Debjyoti; Barupala, Nipuni; Francis, Heather; Alpini, Gianfranco] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA.
   [Carpino, Guido; Ceci, Ludovica; Onori, Paolo; Gaudio, Eugenio] Univ Sapienza Rome, Dept Anat Hist Forens Med & Orthopaed Sci, Rome, Italy.
   [Baiocchi, Leonardo] Tor Vergata Univ, Unit Hepatol, Rome, Italy.
   [Kennedy, Lindsey; Francis, Heather; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Res, Indianapolis, IN USA.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr, College Stn, TX USA.
   [Franchitto, Antonio] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.
   [Ekser, Burcin] Indiana Univ, Dept Surg, Div Transplant Surg, Indianapolis, IN USA.
   [Glaser, Shannon] Texas A&M Univ, Dept Med Physiol, Sch Med, Bryan, TX USA.
   [Francis, Heather] Indiana Ctr Liver Res, Richard L Roudebush VA Med Ctr, 702 Rotary Circle,Rm 013B, Indianapolis, IN 46202 USA.
   [Francis, Heather] Indiana Univ, Gastroenterol, Med, 702 Rotary Circle,Rm 013B, Indianapolis, IN 46202 USA.
   [Glaser, Shannon] Texas A&M Univ, Sch Med, MREBII Off 2342,8447 Riverside Pkwy, Bryan, TX 77807 USA.
   [Alpini, Gianfranco] Indiana Ctr Liver Res, Richard L Roudebush VA Med Ctr, 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.
   [Alpini, Gianfranco] Indiana Univ, Gastroenterol, Med, 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.
C3 Indiana University System; Indiana University Bloomington; Sapienza
   University Rome; University of Rome Tor Vergata; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center; Texas A&M University System; Texas A&M
   University College Station; Foro Italico University of Rome; Indiana
   University System; Indiana University-Purdue University Indianapolis;
   Texas A&M University System; Texas A&M University College Station; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Richard L. Roudebush VA Medical Center; Indiana University System;
   Indiana University-Purdue University Indianapolis; Texas A&M University
   System; Texas A&M University College Station; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA
   Medical Center; Indiana University System; Indiana University-Purdue
   University Indianapolis
RP Francis, H (corresponding author), Indiana Ctr Liver Res, Richard L Roudebush VA Med Ctr, 702 Rotary Circle,Rm 013B, Indianapolis, IN 46202 USA.; Francis, H (corresponding author), Indiana Univ, Gastroenterol, Med, 702 Rotary Circle,Rm 013B, Indianapolis, IN 46202 USA.; Glaser, S (corresponding author), Texas A&M Univ, Sch Med, MREBII Off 2342,8447 Riverside Pkwy, Bryan, TX 77807 USA.; Alpini, G (corresponding author), Indiana Ctr Liver Res, Richard L Roudebush VA Med Ctr, 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.; Alpini, G (corresponding author), Indiana Univ, Gastroenterol, Med, 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.
EM nawu@iu.edu; zhouv@iu.edu; guido.carpino@uniroma1.it;
   baiocchi@uniroma2.it; kkyritsi@iu.edu; linkenn@iu.edu; lceci@iu.edu;
   chenlix@iu.edu; cdwu@tamu.edu; debkundu@iu.edu; nipubaru@iu.edu;
   antonio.franchitto@uniroma1.it; paolo.onori@uniroma1.it;
   bekser@iupui.edu; eugenio.gaudio@uniroma1.it; heafranc@iu.edu;
   sglaser@tamu.edu; Galpini@iu.edu
RI Carpino, Guido/AAB-9692-2019
OI ceci, Ludovica/0000-0002-2131-8494; kundu, Debjyoti/0000-0002-7209-0100;
   Ekser, Burcin/0000-0003-0741-8007; CARPINO, Guido/0000-0001-8570-2519;
   Kennedy, Lindsey/0000-0001-9224-8940; Wu, Chaodong/0000-0001-8569-8070
FU Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University;
   Indiana University Health - Indiana University School of Medicine
   Strategic Research Initiative; VA Merit award [DK108959, IK6BX005226];
   US Department of Veteran's Affairs, Biomedical Laboratory Research and
   Development Service and Development Service; NIH [DK054811, DK115184,
   DK076898, DK107310, DK132891, DK110035, DK062975, AA028711,
   5I01BX000574, 1IK2BX005306]; Senior Career Scientist Award [IK6
   BX004601]; Career Scientist Award; Richard L. Roudebush VA Medical
   Center, Indianapolis, IN; Texas A&M University, Department of Medical
   Physiology, Medical Research Building, Bryan, TX;  [1I01BX003031]; 
   [DK119421]
FX This work was supported by the Hickam Endowed Chair, Gastroenterology,
   Medicine, Indiana University, the Indiana University Health - Indiana
   University School of Medicine Strategic Research Initiative, the Senior
   Career Scientist Award (IK6 BX004601), and the VA Merit award
   (5I01BX000574) to Gianfranco Alpini and the Career Scientist Award
   (IK6BX005226) and the VA Merit award (1I01BX003031) to Heather Francis,
   and Career Development Award-2 to Lindsey Kennedy (1IK2BX005306) from
   the US Department of Veteran's Affairs, Biomedical Laboratory Research
   and Development Service and Development Service and the NIH grants
   DK108959 and DK119421 (Heather Francis), DK054811, DK115184, DK076898,
   DK107310, DK132891, DK110035, DK062975, and AA028711 to Drs. Gianfranco
   Alpini and Shannon Glaser. This material results from work supported by
   resources at the Richard L. Roudebush VA Medical Center, Indianapolis,
   IN, and Texas A&M University, Department of Medical Physiology, Medical
   Research Building, Bryan, TX. The views expressed in this article are
   those of the authors and do not necessarily represent the Department of
   Veterans Affairs views.
CR Afroze Syeda, 2013, Ann Transl Med, V1, P29, DOI 10.3978/j.issn.2305-5839.2012.12.01
   Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767
   Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073
   Alpini Gianfranco, 1997, American Journal of Physiology, V272, pG1064
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   Bica C, 2020, EXP THER MED, V20, P2387, DOI 10.3892/etm.2020.8882
   Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853
   Cai QX, 2020, METABOLISM, V104, DOI 10.1016/j.metabol.2020.154140
   Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3
   Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294
   Chen LX, 2021, HEPATOLOGY, V74, P1845, DOI 10.1002/hep.31871
   Csillag V, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00371
   Delis S, 2009, DIGEST LIVER DIS, V41, P72, DOI 10.1016/j.dld.2007.11.016
   Francis H, 2007, LAB INVEST, V87, P473, DOI 10.1038/labinvest.3700533
   Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034
   Gaudio E, 1996, GASTROENTEROLOGY, V111, P1118, DOI 10.1016/S0016-5085(96)70081-1
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657
   Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6
   Goode EC, 2016, THER ADV CHRONIC DIS, V7, P68, DOI 10.1177/2040622315605821
   Govaere O, 2019, J PATHOL, V248, P66, DOI 10.1002/path.5228
   Hafezi-Nejad N, 2019, EUR J RADIOL, V112, P7, DOI 10.1016/j.ejrad.2018.12.024
   Huang YZ, 2002, J BIOL CHEM, V277, P19889, DOI 10.1074/jbc.M111412200
   Hyun J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14135
   Ikenaga N, 2015, AM J PATHOL, V185, P325, DOI 10.1016/j.ajpath.2014.10.013
   Iravani Shahrokh, 2020, Gastroenterol Hepatol Bed Bench, V13, P115
   Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022
   Kegel V, 2016, JOVE-J VIS EXP, DOI 10.3791/53069
   Kennedy L, 2023, J HEPATOL, V78, P99, DOI 10.1016/j.jhep.2022.07.034
   Kennedy L, 2019, FASEB J, V33, P10269, DOI 10.1096/fj.201802606R
   McDaniel K, 2017, HEPATOLOGY, V65, P544, DOI 10.1002/hep.28831
   Nakanuma Y, 2010, PATHOL INT, V60, P167, DOI 10.1111/j.1440-1827.2009.02500.x
   Pagano E, 2022, GUT, V71, P509, DOI 10.1136/gutjnl-2020-323363
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Spirli C, 2010, GASTROENTEROLOGY, V138, P360, DOI 10.1053/j.gastro.2009.09.005
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126
   Tanino T, 2018, BIOCHEM PHARMACOL, V158, P318, DOI 10.1016/j.bcp.2018.11.001
   Wu N, 2022, HEPATOLOGY, V75, P797, DOI 10.1002/hep.32233
   Wu N, 2018, AM J PATHOL, V188, P2264, DOI 10.1016/j.ajpath.2018.06.015
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Xiao YT, 2015, J HEPATOL, V62, P889, DOI 10.1016/j.jhep.2014.10.033
   You K, 2018, MOL THER-NUCL ACIDS, V12, P57, DOI 10.1016/j.omtn.2018.04.016
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 44
TC 1
Z9 1
U1 3
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUN
PY 2023
VL 77
IS 6
BP 1849
EP 1865
DI 10.1097/HEP.0000000000000310
PG 17
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA H5SK2
UT WOS:000996557500017
PM 36799446
DA 2024-02-19
ER

PT J
AU Uddin, MN
   Nishio, N
   Ito, S
   Suzuki, H
   Isobe, K
AF Uddin, Mohammad Nizam
   Nishio, Naomi
   Ito, Sachiko
   Suzuki, Haruhiko
   Isobe, Ken-ichi
TI Autophagic activity in thymus and liver during aging
SO AGE
LA English
DT Article
DE TEC; Hepatocytes; Autophagy; Aging; Liver
ID CELLS; EPITHELIUM; MECHANISMS; PATHWAYS
AB Impaired or deficient autophagy is believed to cause or contribute to aging, as well as several age-related pathologies. Thymic epithelial cells had a high constitutive level of autophagy. The autophagic process may play a supporting role or even a crucial role in the presentation of self-Ags in the thymus to shape the T-cell repertoires. Autophagic activity in the liver is important for the balance of energy and nutrients for basic cell functions. The abundance of autophagic structure in both cortical and medullary thymic epithelial cells and liver with mouse age has not been examined in detail. Here, we demonstrated that the architecture of mouse thymus and liver markedly changed with age. We found that the expression of LC3 detected by immunofluorescence and Western blot analysis was greatly decreased in thymus and liver of 12-month-old mice. The same level of reduction was observed in thymus and liver of 24-month-old mice. Ultrastructure analysis by an electron microscope revealed that the number of autophagic structure/vacuole in total thymic epithelial cells and hepatocytes decrease with age. The age-related decrease of autophagic structure in thymic epithelial cells may cause the reduction of immunocompetent T-cell pool in aged mice. The age-related decrease of autophagy in liver may induce accumulation of cellular materials in liver of aged mice.
C1 [Uddin, Mohammad Nizam; Nishio, Naomi; Ito, Sachiko; Suzuki, Haruhiko; Isobe, Ken-ichi] Nagoya Univ, Dept Immunol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668520, Japan.
C3 Nagoya University
RP Isobe, K (corresponding author), Nagoya Univ, Dept Immunol, Grad Sch Med, Showa Ku, 65 Turumai Cho, Nagoya, Aichi 4668520, Japan.
EM kisobe@med.nagoya-u.ac.jp
RI ito, Sachiko/M-4877-2014
FU Ministry of Education, Science, Technology, Sports and Culture, Japan;
   Hori Information Science Promotion Foundation, Japan
FX We thank Yoshikazu Fujita for technical assistance with electron
   microscopy and Ikuyo Mizuguchi for confocal microscopic study. This work
   was supported by the Ministry of Education, Science, Technology, Sports
   and Culture, Japan and The Hori Information Science Promotion
   Foundation, Japan.
CR Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358
   Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460
   Kasai M, 2009, J IMMUNOL, V183, P7278, DOI 10.4049/jimmunol.0804087
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436
   Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161
   Milicevic NM, 2008, J ANAT, V212, P114, DOI 10.1111/j.1469-7580.2007.00851.x
   Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749
   Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108
   MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543
   Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208
   Rajawat YS, 2008, HORM-INT J ENDOCRINO, V7, P46, DOI 10.14310/horm.2002.1111037
   Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107
   Uddin MN, 2010, J IMMUNOTOXICOL, V7, P165, DOI 10.3109/15476910903510806
   Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146
NR 21
TC 49
Z9 55
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 AGE
JI Age
PD FEB
PY 2012
VL 34
IS 1
BP 75
EP 85
DI 10.1007/s11357-011-9221-9
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 878YP
UT WOS:000299294100007
PM 21387084
OA Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Bejma, J
   Ramires, P
   Ji, LL
AF Bejma, J
   Ramires, P
   Ji, LL
TI Free radical generation and oxidative stress with ageing and exercise:
   Differential effects in the myocardium and liver
SO ACTA PHYSIOLOGICA SCANDINAVICA
LA English
DT Article
DE ageing; exercise; heart; river; oxidative damage; reactive oxygen
   species
ID ANTIOXIDANT ENZYME-SYSTEMS; SKELETAL-MUSCLE; LIPID-PEROXIDATION;
   HEART-MITOCHONDRIA; REACTIVE OXYGEN; GLUTATHIONE; DAMAGE; RAT;
   RESPONSES; HYDROPEROXIDE
AB Reactive oxygen species and other oxidants are implicated in the mechanisms of biological ageing and exercise-induced tissue damage. The present study examined the effects of ageing and an acute bout of exercise on intracellular oxidant generation, lipid peroxidation, protein oxidation and glutathione (GSH) status in the heart and liver of young adult (8 month, N = 24) and old (24 month, N = 24) male Fischer 344 rats. Young rats ran on treadmill at 25 m min(-1), 5% grade until exhaustion (55.4 +/- 2.7 min), whereas old rats ran at 15 m min(-1). 5% until exhaustion (58.0 +/- 2.7 min). Rate of dichlorofluorescin (DCFH) oxidation, an indication of intracellular oxidant production, was significantly higher in the homogenates of aged heart and liver compared with their young counterparts. In the isolated heart and liver mitochondria, ageing increased oxidant production by 29 and 32% (P < 0.05), respectively. Acute exercise increased oxidant production in the aged heart but not in the liver. When nicodinamide dinucleotide phosphate (reduced), adenosine diphosphate and Fe(3+) were included in the assay, DCFH oxidation rate was 47 and 34% higher (P < 0.05) in the aged heart and liver homogenates, respectively, than the young ones. The age differences in the induced slate reached 83 and 140% (P < 0.01) in isolated heart and liver mitochondria, respectively. Lipid peroxidation was increased in the aged liver and exercised aged heart, whereas protein carbonyl content was elevated only in the aged heart (P < 0.05). Although our data using DCFH method probably underestimated cellular oxidant production because of rime delay and antioxidant competition, it is clear that oxidative stress was enhanced in both heart and liver with old age. Furthermore, aged myocardium showed greater susceptibility to oxidative stress after heavy exercise.
C1 Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison
RP Ji, LL (corresponding author), Univ Wisconsin, Dept Kinesiol, 2000 Observ Dr, Madison, WI 53706 USA.
RI Ramires, Paulo/E-4431-2013
CR AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8
   [Anonymous], METHOD ENZYMOL
   ASUNCION JG, 1996, FASEB J, V10, P333
   Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465
   BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   Fiebig R, 1996, AGE, V19, P83, DOI 10.1007/BF02434087
   Glinn MA, 1997, BBA-BIOENERGETICS, V1318, P246, DOI 10.1016/S0005-2728(96)00142-9
   GOTO S, 1995, MCBU, P151
   HALLIWELL B, 1989, FREE RADICAL BIO MED, P379
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   Ji L.L., 2000, HDB OXIDANTS ANTIOXI, P689
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   JI LL, 1992, J APPL PHYSIOL, V72, P549, DOI 10.1152/jappl.1992.72.2.549
   Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566
   KUMAR CT, 1992, MOL CELL BIOCHEM, V111, P109
   LAWLER JM, 1993, MED SCI SPORT EXER, V25, P1259
   LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Matsuo M., 1993, FREE RADICALS AGING, P143
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   ONeill CA, 1996, J APPL PHYSIOL, V81, P1197, DOI 10.1152/jappl.1996.81.3.1197
   Pamplona R, 1999, MECH AGEING DEV, V106, P283, DOI 10.1016/S0047-6374(98)00121-3
   Reid MB, 1998, ACTA PHYSIOL SCAND, V162, P401, DOI 10.1046/j.1365-201X.1998.0303f.x
   REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797
   SAWADA M, 1992, J CELL BIOCHEM, V48, P296, DOI 10.1002/jcb.240480310
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   STADTMAN ER, 1992, FREE RADICALS AGING, P64
   URCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 37
TC 157
Z9 177
U1 0
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0001-6772
J9 ACTA PHYSIOL SCAND
JI Acta Physiol. Scand.
PD AUG
PY 2000
VL 169
IS 4
BP 343
EP 351
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 359RD
UT WOS:000089625100011
PM 10951126
DA 2024-02-19
ER

PT J
AU Colantoni, A
   Idilman, R
   de Maria, N
   Duffner, LA
   Van Thiel, DH
   Witte, PL
   Kovacs, EJ
AF Colantoni, A
   Idilman, R
   de Maria, N
   Duffner, LA
   Van Thiel, DH
   Witte, PL
   Kovacs, EJ
TI Evidence of oxidative injury during aging of the liver in a mouse model.
SO JOURNAL OF THE AMERICAN AGING ASSOCIATION
LA English
DT Article
ID SINUSOIDAL ENDOTHELIAL-CELLS; REOXYGENATION INJURY; MITOCHONDRIAL DECAY;
   ANTIOXIDANT ENZYMES; APOPTOSIS; DAMAGE; MECHANISM; ORGANS; RATS
AB The aim of the present study was to determine whether oxidative stress contributes to aging of the liver in a mouse model. Liver was obtained from young (3-5 months old) and aged (18-24 months old) mice. No age-induced gross changes in liver morphology were detected by light microscopy. Apoptosis was measured using the fragment end labeling of DNA for the immunohistochemical identification of the apoptotic nuclei. The total apoptotic cells represented 1% of the total cells in livers of young mice and 8% in those of aged mice. Among the total apoptotic cells in livers of aged animals, 15% were hepatocytes, 40% sinusoidal endothelial cells, and 45% bile duct cells. Hepatic lipid peroxidation, expressed as malonaldehyde levels, protein oxidation, measured by protein carbonyl content, and DNA oxidation, measured as 8-hydroxy-2 ' -deoxyguanosine (oxo(8)dG), were significantly increased in the livers of aged animals as compared to younger mice. The apoptotic cells presented elevated levels of oxidized DNA, detected by immunohistochemistry using an antibody directed against oxo(8)dG in serial sections. These results suggest that livers of aged animals presents evidence of increased oxidative injury and apoptosis. Because the apoptotic cells in the aged livers are mostly bile duct cells and sinusoidal endothelial cells, the cells most sensitive to oxidative stress injury, it can be hypothesized that reactive oxygen species-induced apoptosis in these cells contributes to the aging of the liver.
C1 Loyola Univ, Med Ctr, Div Gastroenterol & Hepatol, Dept Med, Maywood, IL 60153 USA.
   Loyola Univ, Stritch Sch Med, Dept Cell Biol Neurobiol & Anat, Immunol & Aging Program, Maywood, IL 60153 USA.
   Loyola Univ, Dept Surg, Burn & Shock Trauma Inst, Maywood, IL 60153 USA.
C3 Loyola University Chicago; Loyola University Chicago; Loyola University
   Chicago
RP Colantoni, A (corresponding author), Loyola Univ, Med Ctr, Div Gastroenterol & Hepatol, Dept Med, 2160 S 1st Ave,Bldg 114 Room 48, Maywood, IL 60153 USA.
EM acolan@lumc.edu
CR AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   Bohr V, 1998, TOXICOL LETT, V103, P47
   BUFA LM, 1993, ARCH PATHOL LAB MED, V117, P1208
   BURT AD, 1993, SEMIN LIVER DIS, V13, P21, DOI 10.1055/s-2007-1007335
   Caraceni Paolo, 1995, P191
   Clément MV, 1999, FREE RADICAL RES, V30, P247, DOI 10.1080/10715769900300271
   Colantoni A, 1999, TRANSPLANT P, V31, P1052, DOI 10.1016/S0041-1345(98)01900-9
   Colantoni A, 1998, FREE RADICAL BIO MED, V25, P87, DOI 10.1016/S0891-5849(98)00033-1
   Colantoni A, 2000, ALCOHOL CLIN EXP RES, V24, P1467, DOI 10.1111/j.1530-0277.2000.tb02118.x
   Cui JK, 2000, FASEB J, V14, P955
   DELEEUW AM, 1990, J ELECTRON MICR TECH, V14, P218
   DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1
   FUJII Y, 1994, HEPATOLOGY, V20, P177
   Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   JANSSEN YMW, 1993, LAB INVEST, V69, P261
   Kohli V, 1999, TRANSPLANTATION, V67, P1099, DOI 10.1097/00007890-199904270-00003
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   MAHER JJ, 1993, SEMIN LIVER DIS, V13, P13, DOI 10.1055/s-2007-1007334
   Matés JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   MONETTE J, 1995, DRUG AGING, V7, P203, DOI 10.2165/00002512-199507030-00005
   Motoyama S, 2000, CRIT CARE MED, V28, P1509, DOI 10.1097/00003246-200005000-00042
   NOACK K, 1993, TRANSPLANTATION, V56, P495, DOI 10.1097/00007890-199309000-00001
   O'Mahony M S, 1994, Semin Gastrointest Dis, V5, P197
   Pamplona R, 2000, J GERONTOL A-BIOL, V55, pB286, DOI 10.1093/gerona/55.6.B286
   Roberts SK, 1997, GASTROENTEROLOGY, V112, P269, DOI 10.1016/S0016-5085(97)70244-0
   Samarasinghe DA, 1996, HEPATOLOGY, V24, P1230
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Strazzabosco M, 2000, J GASTROEN HEPATOL, V15, P244, DOI 10.1046/j.1440-1746.2000.02091.x
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   VAUBOURDOLLE M, 1993, HEPATOLOGY, V17, P423
   Warner HR, 1999, ANN NY ACAD SCI, V887, P1
NR 36
TC 12
Z9 15
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 J AM AGING ASSOC
JI J. Am. Aging Assoc.
PD APR
PY 2001
VL 24
IS 2
BP 51
EP 57
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 454BQ
UT WOS:000169952900002
PM 23604875
OA Green Published
DA 2024-02-19
ER

PT J
AU PATNAIK, SK
   SHARMA, R
   PATNAIK, R
AF PATNAIK, SK
   SHARMA, R
   PATNAIK, R
TI DIFFERENTIAL-EFFECTS OF HYDROCORTISONE ON ASPARTATE-AMINOTRANSFERASE
   ISOENZYMES OF THE LIVER OF RATS DURING GROWTH, DEVELOPMENT, AND
   SENESCENCE
SO BIOCHEMISTRY INTERNATIONAL
LA English
DT Article
RP PATNAIK, SK (corresponding author), BANARAS HINDU UNIV, INST TECHNOL, DEPT PHARMACEUT, ENZYME ENGN LAB, VARANASI 221005, UTTAR PRADESH, INDIA.
RI Patnaik, Ranjana/AAZ-4440-2020; Patnaik, Ranjana/D-1469-2017
OI Patnaik, Ranjana/0000-0002-8131-177X; Patnaik,
   Ranjana/0000-0002-8131-177X
CR ADELMAN RC, 1975, ENZYME INDUCTION, P303
   BOYD JW, 1961, BIOCHEM J, V81, P434, DOI 10.1042/bj0810434
   BRAUNSTEIN AE, 1973, ENZYMES, P339
   FLEISHER GA, 1960, P SOC EXP BIOL MED, V103, P229, DOI 10.3181/00379727-103-25469
   GARRETT HE, 1966, STATISTICS PSYCHOL E
   HERZFELD A, 1971, BIOCHIM BIOPHYS ACTA, V237, P88, DOI 10.1016/0304-4165(71)90033-X
   JOHANNESSEN E., 1940, Nordisk Medicin, V8, P2231
   Kanungo M. S., 1980, BIOCH AGING
   KANUNGO MS, 1975, NATURE, V253, P366, DOI 10.1038/253366a0
   KANUNGO MS, 1972, P NATL ACAD SCI USA, V69, P2035, DOI 10.1073/pnas.69.8.2035
   KANUNGO MS, 1978, LIVER AGING, P253
   KARMEN A, 1955, J CLIN INVEST, V34, P126, DOI 10.1172/JCI103055
   KATUNUMA N, 1962, J VITAMINOL, V8, P309, DOI 10.5925/jnsv1954.8.309
   LARDY HA, 1965, P NATL ACAD SCI USA, V53, P1410, DOI 10.1073/pnas.53.6.1410
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NAKATA Y, 1964, J BIOCHEM, V55, P199
   PATNAIK R, 1987, IN PRESS BIOCH INT
   PATNAIK SK, 1979, CELL BIOL INT REP, V3, P607, DOI 10.1016/0309-1651(79)90059-6
   PATNAIK SK, 1980, J BIOCHEM-TOKYO, V87, P1249
   PATNAIK SK, 1978, J BIOCHEM-TOKYO, V84, P1315, DOI 10.1093/oxfordjournals.jbchem.a132251
   ROTH GS, 1975, EXP GERONTOL, V10, P1, DOI 10.1016/0531-5565(75)90009-1
   ROTH GS, 1974, EXP GERONTOL, V9, P27, DOI 10.1016/0531-5565(74)90004-7
   SHARMA R, 1985, MOL PHYSIOL, V7, P195
   SHARMA R, 1984, EXPERIENTIA, V40, P97, DOI 10.1007/BF01959123
   SHARMA R, 1982, DEV GROWTH DIFFER, V24, P501, DOI 10.1111/j.1440-169X.1982.00501.x
   SHARMA R, 1982, BIOCHEM INT, V5, P561
   SHARMA R, 1984, ARCH GERONTOL GERIAT, V3, P167, DOI 10.1016/0167-4943(84)90008-6
   SHARMA R, 1983, BIOCHEM INT, V7, P535
   SINGER S, 1973, INT J BIOCHEM, V4, P569, DOI 10.1016/0020-711X(73)90035-9
   WILSON PD, 1973, GERONTOLOGY, V19, P79, DOI 10.1159/000211964
   YADAV RNS, 1983, MOL PHYSIOL, V3, P193
NR 31
TC 5
Z9 5
U1 0
U2 0
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE, NSW 2204, AUSTRALIA
SN 0158-5231
J9 BIOCHEM INT
PD SEP
PY 1987
VL 15
IS 3
BP 611
EP 617
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA K4562
UT WOS:A1987K456200014
PM 3426629
DA 2024-02-19
ER

PT J
AU Jia, FP
   Diao, P
   Wang, XJ
   Hu, X
   Kimura, T
   Nakamuta, M
   Nakamura, I
   Shirotori, S
   Sato, Y
   Moriya, K
   Koike, K
   Gonzalez, FJ
   Nakayama, J
   Aoyama, T
   Tanaka, N
AF Jia, Fangping
   Diao, Pan
   Wang, Xiaojing
   Hu, Xiao
   Kimura, Takefumi
   Nakamuta, Makoto
   Nakamura, Ibuki
   Shirotori, Saki
   Sato, Yoshiko
   Moriya, Kyoji
   Koike, Kazuhiko
   Gonzalez, Frank J.
   Nakayama, Jun
   Aoyama, Toshifumi
   Tanaka, Naoki
TI Dietary Restriction Suppresses Steatosis-Associated Hepatic
   Tumorigenesis in Hepatitis C Virus Core Gene Transgenic Mice
SO LIVER CANCER
LA English
DT Article
DE NF-kappa B; STAT3; Cyclin D1; p62/SQSTM1; Senescence
ID ACTIVATED-RECEPTOR-ALPHA; FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA;
   GROWTH-FACTOR; CALORIE RESTRICTION; KAPPA-B; PROTEIN; PROGRESSION;
   EXPRESSION; OVEREXPRESSION
AB Background and Aims: Dietary restriction (DR) is a preventive strategy for obesity, metabolic syndrome, cardiovascular disease, and diabetes. Although an interconnection between obesity, metabolic syndrome, fatty liver, and hepatocellular carcinoma has been documented, the mechanism and impact of DR on steatosis-derived hepatocarcinogenesis are not fully understood. This study aimed to evaluate whether DR can prevent hepatic tumorigenesis. Methods: Male hepatitis C virus core gene transgenic (HCVcpTg) mice that develop spontaneous age-dependent insulin resistance, hepatic steatosis, and ensuing liver tumor development without apparent hepatic fibrosis, were fed with either a control diet ad libitum (control group) or 70% of the same control diet (DR group) for 15 months, and liver phenotypes were investigated. Results: DR significantly reduced the number and volume of liver tumors. DR attenuated hepatic oxidative and endoplasmic reticulum stress and markedly suppressed nuclear factor-kappa B, signal transducer and activator of transcription 3 (STAT3) and STAT5, and phosphorylation of extracellular signal-regulated kinase, leading to downregulation of several pro-oncogenic mediators, such as cyclin D1. Serum insulin and insulin-like growth factor 1 levels, as well as hepatic expression of insulin receptor substrate 1/2, phosphatidylinositol-3 kinase, and serine/threonine-protein kinase AKT, were downregulated by DR. A transcriptome analysis revealed that STAT3 signaling and lipogenesis were the most suppressed hepatocarcinogenic pathways affected by DR. Additionally, DR stimulated autophagy and p62/sequestosome 1 degradation, enhanced phosphorylation of AMP-activated protein kinase alpha, increased fibroblast growth factor 21 expression, and attenuated expression of senescence-associated secretory phenotypes. Conclusion: DR suppressed steatosis-associated hepatic tumorigenesis in HCVcpTg mice, mainly due to attenuation of pathways involved in inflammation, cellular stress, cell proliferation, insulin signaling, and senescence. These findings support the notion that persistent 30% reduction of daily food intake is beneficial for preventing steatosis-associated hepatocarcinogenesis caused by HCV core protein. (c) 2020 The Author(s) Published by S. Karger AG, Basel
C1 [Jia, Fangping; Diao, Pan; Wang, Xiaojing; Hu, Xiao; Nakamura, Ibuki; Shirotori, Saki; Aoyama, Toshifumi; Tanaka, Naoki] Shinshu Univ, Dept Metab Regulat, Sch Med, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.
   [Wang, Xiaojing] Zhejiang Univ, Lishui Hosp, Dept Gastroenterol, Sch Med, Lishui, Peoples R China.
   [Hu, Xiao] Hebei Med Univ, Dept Pathophysiol, Shjiazhuang, Peoples R China.
   [Kimura, Takefumi] Shinshu Univ, Dept Gastroenterol, Sch Med, Matsumoto, Nagano, Japan.
   [Nakamuta, Makoto] Kyushu Med Ctr, Dept Gastroenterol, Fukuoka, Japan.
   [Sato, Yoshiko; Nakayama, Jun] Shinshu Univ, Dept Mol Pathol, Sch Med, Matsumoto, Nagano, Japan.
   [Moriya, Kyoji] Univ Tokyo, Dept Infect Control & Prevent, Tokyo, Japan.
   [Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan.
   [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.
   [Tanaka, Naoki] Shinshu Univ, Res Ctr Social Syst, Matsumoto, Nagano, Japan.
C3 Shinshu University; Zhejiang University; Hebei Medical University;
   Shinshu University; Shinshu University; University of Tokyo; University
   of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer
   Institute (NCI); Shinshu University
RP Tanaka, N (corresponding author), Shinshu Univ, Dept Metab Regulat, Sch Med, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.
EM naopi@shinshu-u.ac.jp
RI Kimura, Takefumi T/D-3412-2011; Wang, Xiaojing/HNI-4384-2023
OI Kimura, Takefumi T/0000-0002-1481-1029; Wang,
   Xiaojing/0000-0001-6921-3619; Gonzalez, Frank/0000-0002-7990-2140;
   Tanaka, Naoki/0000-0002-3212-3836
CR Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772
   Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021
   Cantarini MC, 2006, HEPATOLOGY, V44, P446, DOI 10.1002/hep.21272
   Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099
   Deane NG, 2001, CANCER RES, V61, P5389
   Dragani TA, 2010, J HEPATOL, V52, P252, DOI 10.1016/j.jhep.2009.11.015
   Fontana L, 2018, MECH AGEING DEV, V176, P19, DOI 10.1016/j.mad.2018.10.005
   He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048
   Hu X, 2019, CARCINOGENESIS
   Hu X, 2017, J NUTR BIOCHEM, V39, P77, DOI 10.1016/j.jnutbio.2016.09.015
   Inagaki-Ohara K, 2014, ONCOGENE, V33, P74, DOI 10.1038/onc.2012.540
   Jeong SH, 2018, J CLIN INVEST, V128, P1010, DOI 10.1172/JCI95802
   Jiang X, 2019, CANCERS, V11, DOI 10.3390/cancers11050647
   Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050
   Kaltenecker D, 2019, CYTOKINE, V124, DOI 10.1016/j.cyto.2018.10.014
   Kay J, 2019, DNA REPAIR, V83, DOI 10.1016/j.dnarep.2019.102673
   Kimura T, 2018, WORLD J GASTROENTERO, V24, P1440, DOI 10.3748/wjg.v24.i13.1440
   Kimura T, 2017, HEPATOL RES, V47, P405, DOI 10.1111/hepr.12762
   Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131
   Kopeina GS, 2017, BBA-REV CANCER, V1867, P29, DOI 10.1016/j.bbcan.2016.11.002
   Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514
   Makwana K, 2017, AGING-US, V9, P1825, DOI 10.18632/aging.101270
   Maurel M, 2014, CANCER CELL, V26, P301, DOI 10.1016/j.ccr.2014.08.007
   Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527
   Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053
   Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030
   Nagaya T, 2010, J HEPATOL, V53, P724, DOI 10.1016/j.jhep.2010.04.033
   Nogueira LM, 2012, CANCER MED-US, V1, P275, DOI 10.1002/cam4.23
   O'Flanagan CH, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0873-x
   Okada H, 2005, INT J ONCOL, V26, P369
   Park S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/984643
   Sakurai Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03299-3
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]
   Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022
   Singhal G, 2018, MOL METAB, V13, P56, DOI 10.1016/j.molmet.2018.03.002
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594
   Tanaka N, 2008, INT J CANCER, V122, P124, DOI 10.1002/ijc.23056
   Tanaka N, 2019, WORLD J GASTROENTERO, V25, P163, DOI 10.3748/wjg.v25.i2.163
   Tanaka N, 2017, PHARMACOL THERAPEUT, V179, P142, DOI 10.1016/j.pharmthera.2017.05.011
   Tanaka N, 2017, BBA-MOL BASIS DIS, V1863, P3170, DOI 10.1016/j.bbadis.2017.08.017
   Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012
   Tanaka N, 2015, J BIOL CHEM, V290, P3092, DOI 10.1074/jbc.M114.605980
   Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630
   Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   Wang XJ, 2019, ARCH TOXICOL, V93, P1713, DOI 10.1007/s00204-019-02440-7
   Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926
   Zeng Sulin, 2018, Cancer Transl Med, V4, P70, DOI 10.4103/ctm.ctm_22_18
NR 53
TC 15
Z9 14
U1 1
U2 7
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 2235-1795
EI 1664-5553
J9 LIVER CANCER
JI Liver Cancer
PD SEP
PY 2020
VL 9
IS 5
BP 529
EP 548
DI 10.1159/000508308
PG 20
WC Oncology; Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Gastroenterology & Hepatology
GA NS9AS
UT WOS:000572548100005
PM 33083279
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Jia, YY
   Wu, CY
   Rivera-Piza, A
   Kim, YJ
   Lee, JH
   Lee, SJ
AF Jia, Yaoyao
   Wu, Chunyan
   Rivera-Piza, Adriana
   Kim, Yeon-Ji
   Lee, Ji Hae
   Lee, Sung-Joon
TI Mechanism of Action of Cyanidin 3-O-Glucoside in Gluconeogenesis and
   Oxidative Stress-Induced Cancer Cell Senescence
SO ANTIOXIDANTS
LA English
DT Article
DE Cyanidin 3-O-glucoside; natural products; phytochemicals; antioxidants;
   adiponectin signaling; hepatic autophagy; oxidative stress;
   anti-carcinogenic activity; HepG2 cells
ID ACTIVATED PROTEIN-KINASE; ADIPONECTIN RECEPTORS; INSULIN-RESISTANCE;
   AUTOPHAGY; AMPK; PHOSPHORYLATION; HEPATOCYTES; METABOLISM; HEALTH; MOUSE
AB Cyanidin-3-O-glucoside (C3G) is a natural anthocyanin abundant in fruits and vegetables that interacts and possibly modulates energy metabolism and oxidative stress. This study investigated the effect of C3G on gluconeogenesis and cancer cell senescence. C3G activates adenosine monophosphate-activated protein kinase (AMPK), a cellular energy sensor involved in metabolism and the aging process. C3G suppressed hepatic gluconeogenesis by reducing the expression of gluconeogenic genes through the phosphorylation inactivation of CRTC2 and HDAC5 coactivators via AMPK. C3G did not directly interact with AMPK but, instead, activated AMPK through the adiponectin receptor signaling pathway, as demonstrated through adiponectin receptor gene knockdown experiments. In addition, C3G increased cellular AMP levels in cultured hepatocytes, and the oral administration of C3G in mice elevated their plasma adiponectin concentrations. These effects collectively contribute to the activation of AMPK. In addition, C3G showed potent antioxidant activity and induced cellular senescence, and apoptosis in oxidative-stress induced senescence in hepatocarcinoma cells. C3G increased senescence-associated beta-galactosidase expression, while increasing the expression levels of P16, P21 and P53, key markers of cellular senescence. These findings demonstrate that anthocyanin C3G achieves hypoglycemic effects via AMPK activation and the subsequent suppression of gluconeogenesis and exhibits anti-cancer activity through the induction of apoptosis and cellular senescence.
C1 [Jia, Yaoyao; Wu, Chunyan; Rivera-Piza, Adriana; Kim, Yeon-Ji; Lee, Ji Hae; Lee, Sung-Joon] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 02841, South Korea.
   [Lee, Sung-Joon] Korea Univ, Coll Life Sci & Biotechnol, Dept Food Biosci & Technol, Seoul 02841, South Korea.
C3 Korea University; Korea University
RP Lee, SJ (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 02841, South Korea.; Lee, SJ (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Dept Food Biosci & Technol, Seoul 02841, South Korea.
EM janciey0227@gmail.com; chunyanwu87@gmail.com; adri.ripiz@gmail.com;
   mindfulless@hanmail.net; jihae@korea.kr; junelee@korea.ac.kr
RI Kim, Yeon Ji/AAE-1906-2022
FU National Research Foundation of Korea (NRF) - Korean government (MSIT)
   [NRF-2019R1A2C3005227]; Korea University
FX We thank to Kiran Bhilare for his assistance in the reference search.
   This work was supported by National Research Foundation of Korea (NRF)
   grants funded by the Korean government (MSIT) (Grant Nos.
   NRF-2019R1A2C3005227) and a Korea University Grant.
CR Acquaviva R, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11101485
   Ahmed EK, 2010, AGING CELL, V9, P252, DOI 10.1111/j.1474-9726.2010.00555.x
   Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11
   Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702
   Badiola I, 2015, AGEING RES REV, V23, P125, DOI 10.1016/j.arr.2015.03.004
   Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025
   Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326
   Chen JL, 2022, CRIT REV FOOD SCI, V62, P7242, DOI 10.1080/10408398.2021.1913092
   Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128
   Fitzgerald AL, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.44
   Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200
   Gibellini Lara, 2010, Cancers (Basel), V2, P1288, DOI 10.3390/cancers2021288
   Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019
   Gowd V, 2017, TRENDS FOOD SCI TECH, V68, P1, DOI 10.1016/j.tifs.2017.07.015
   He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754
   Hemminki A, 1999, CELL MOL LIFE SCI, V55, P735, DOI 10.1007/s000180050329
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200
   Jia YY, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01231-6
   Joshi T, 2019, J CELL PHYSIOL, V234, P17212, DOI 10.1002/jcp.28528
   Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Lawless C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032117
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Malavolta M, 2014, NUTR RES, V34, P1017, DOI 10.1016/j.nutres.2014.02.006
   Mannino G, 2021, AGRICULTURE-BASEL, V11, DOI 10.3390/agriculture11030212
   Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068
   Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942
   Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661
   Palsamy P, 2010, J CELL PHYSIOL, V224, P423, DOI 10.1002/jcp.22138
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962
   Reczek CR, 2017, ANNU REV CANC BIOL, V1, P79, DOI 10.1146/annurev-cancerbio-041916-065808
   Salomone F, 2016, LIVER INT, V36, P5, DOI 10.1111/liv.12975
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895
   Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2
   Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185
   Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189
   Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035
   Wu C, 2017, J CLIN INVEST, V127, P4118, DOI [10.1172/jci89344, 10.1172/JCI89344]
   Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705
   Yan LJ, 2014, REDOX BIOL, V2, P165, DOI 10.1016/j.redox.2014.01.002
   Yang ZX, 2021, FOODS, V10, DOI 10.3390/foods10061386
   Yilmaz Goler A., 2021, CURR NUTRACEUTICALS, V2, P47, DOI [10.2174/2665978601999200807160528, DOI 10.2174/2665978601999200807160528]
   Zha DQ, 2017, ENDOCRINOLOGY, V158, P2022, DOI 10.1210/en.2016-1765
   Zhu W, 2012, FREE RADICAL BIO MED, V52, P314, DOI 10.1016/j.freeradbiomed.2011.10.483
NR 52
TC 5
Z9 6
U1 2
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD APR
PY 2022
VL 11
IS 4
AR 749
DI 10.3390/antiox11040749
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 0S3QF
UT WOS:000786191300001
PM 35453434
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Brady, CW
AF Brady, Carla W.
TI Liver disease in menopause
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Liver disease; Menopause; Aging
ID ESTROGEN-RECEPTOR-ALPHA; HEPATITIS-C; HEPATOCELLULAR-CARCINOMA;
   LIPID-PEROXIDATION; FIBROSIS; WOMEN; AGE; GENDER; RISK; SEX
AB There are numerous physiologic and biochemical changes in menopause that can affect the function of the liver and mediate the development of liver disease. Menopause represents a state of growing estrogen deficiency, and this loss of estrogen in the setting of physiologic aging increases the likelihood of mitochondrial dysfunction, cellular senescence, declining immune responses to injury, and disarray in the balance between antioxidant formation and oxidative stress. The sum effect of these changes can contribute to increased susceptibility to development of significant liver pathology, particularly nonalcoholic fatty liver disease and hepatocellular carcinoma, as well as accelerated progression of fibrosis in liver diseases, as has been particularly demonstrated in hepatitis C virus liver disease. Recognition of the unique nature of these mediating factors should raise suspicion for liver disease in perimenopausal and menopausal women and offer an opportunity for implementation of aggressive treatment measures so as to avoid progression of liver disease to cirrhosis, liver cancer and liver failure.
C1 Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC 27710 USA.
C3 Duke University
RP Brady, CW (corresponding author), Duke Univ, Med Ctr, Div Gastroenterol, Box 3913, Durham, NC 27710 USA.
EM carla.brady@dm.duke.edu
RI Brady, Carla/AAH-7144-2020; Brady, Carla/AAV-3249-2020
OI Brady, Carla/0000-0003-3088-3118
CR [Anonymous], 2012, GASTROENTEROLOGY, V142, P1592, DOI [DOI 10.1053/J.GASTR0.2012.04.001], DOI 10.1053/J.GASTRO.2012.04.001, DOI 10.1002/HEP.25762]
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005
   Belli LS, 2007, LIVER TRANSPLANT, V13, P733, DOI 10.1002/lt.21093
   Chen JQ, 2005, BBA-MOL CELL RES, V1746, P1, DOI 10.1016/j.bbamcr.2005.08.001
   Chen JQ, 2004, J CELL BIOCHEM, V93, P358, DOI 10.1002/jcb.20178
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931
   Degli Esposti Davide, 2012, Biochem Res Int, V2012, P387626, DOI 10.1155/2012/387626
   Di Martino V, 2004, HEPATOLOGY, V40, P1426, DOI 10.1002/hep.20463
   Djahanbakhch O, 2007, J PATHOL, V211, P219, DOI 10.1002/path.2108
   Doshi Sejal B, 2013, J Midlife Health, V4, P140, DOI 10.4103/0976-7800.118990
   Flynn JM, 2008, AM J PHYSIOL-ENDOC M, V295, pE637, DOI 10.1152/ajpendo.90407.2008
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Gameiro Catia, 2010, Front Biosci (Elite Ed), V2, P1299
   Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759
   Grattagliano I, 2009, WORLD J GASTROENTERO, V15, P4865, DOI 10.3748/wjg.15.4865
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P237, DOI 10.3748/wjg.v18.i3.237
   IBER FL, 1994, DRUG AGING, V5, P34, DOI 10.2165/00002512-199405010-00004
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9
   Kovats S, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P53, DOI 10.1007/978-3-642-02155-8_3
   Kumar Pardeep, 2011, J Aging Res, V2011, P580245, DOI 10.4061/2011/580245
   Lai JC, 2011, HEPATOLOGY, V54, P418, DOI 10.1002/hep.24390
   Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448
   Li CL, 2015, INT J CANCER, V136, P761, DOI 10.1002/ijc.29052
   Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Manson JE, 2010, OVERVIEW MENOPAUSE M
   Moorthy K, 2005, EXP GERONTOL, V40, P295, DOI 10.1016/j.exger.2005.01.004
   Murphy SL, 2013, NATL VITAL STAT REPO
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90
   Polotsky HN, 2010, SEMIN REPROD MED, V28, P426, DOI 10.1055/s-0030-1262902
   RAMADORI G, 1990, VIRCHOWS ARCH B, V59, P349, DOI 10.1007/BF02899424
   Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321
   Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127
   Shimizu I, 2001, LIVER, V21, P342, DOI 10.1034/j.1600-0676.2001.210507.x
   Singh SP, 2002, J BIOL CHEM, V277, P4232, DOI 10.1074/jbc.M109678200
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   The American Congress of Obstetricians and Gynecologists, 2011, WOM HLTH STATS FACTS
   van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049
   Velarde MC, 2013, PHYSIOL GENOMICS, V45, P106, DOI 10.1152/physiolgenomics.00155.2012
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027
   Villacres MC, 2004, HUM IMMUNOL, V65, P476, DOI 10.1016/j.humimm.2004.02.021
   Vrachnis N, 2014, MATURITAS, V78, P174, DOI 10.1016/j.maturitas.2014.04.014
   Welt CK, 1999, J CLIN ENDOCR METAB, V84, P105, DOI 10.1210/jc.84.1.105
   Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Xia HJ, 2009, CELL MOL IMMUNOL, V6, P433, DOI 10.1038/cmi.2009.55
   Yang DY, 2014, CANCER-AM CANCER SOC, V120, P3707, DOI 10.1002/cncr.28912
   Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761
   Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307
   Yoneda M, 2014, HEPATOLOGY, V60, P1792, DOI 10.1002/hep.27097
NR 57
TC 80
Z9 85
U1 0
U2 12
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD JUL 7
PY 2015
VL 21
IS 25
BP 7613
EP 7620
DI 10.3748/wjg.v21.i25.7613
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CM3LW
UT WOS:000357584700001
PM 26167064
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Xie, D
   Chen, F
   Zhang, YY
   Shi, B
   Song, JH
   Chaudhari, K
   Yang, SH
   Zhang, GJ
   Sun, XL
   Taylor, HS
   Li, D
   Huang, YQ
AF Xie, Di
   Chen, Fan
   Zhang, Yuanyuan
   Shi, Bei
   Song, Jiahui
   Chaudhari, Kiran
   Yang, Shao-Hua
   Zhang, Gary J.
   Sun, Xiaoli
   Taylor, Hugh S.
   Li, Da
   Huang, Yingqun
TI Let-7 underlies metformin-induced inhibition of hepatic glucose
   production
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE metformin; Let-7; TET3; liver; diabetes
ID REDOX REGULATION; GENE-THERAPY; LIVER; ACCUMULATION; EXPRESSION;
   MECHANISM; EFFICACY
AB Metformin, the frontline antidiabetic drug, has gained increasing attention for the prevention and treatment of aging, cancer, and cardiovascular disease. Yet a clear mechanistic understanding of its action is still lacking, largely due to the suprapharmacological concentrations of metformin used in most studies. Here, we report an inhibition of glucose production by primary hepatocytes from dietary and genetic mouse models of type 2 diabetes (T2D) using metformin at clinically relevant concentrations. Mechanistically, metformin up-regulates microRNA let-7 that in turn down-regulates TET3, evoking a change in the ratio of hepatocyte nuclear factor 4 alpha (HNF4 alpha) isoforms and subsequent inhibition of key gluconeogenic genes. Importantly, this let-7-mediated mechanism is faithfully recapitulated in mice with T2D chronically treated with therapeutic doses of metformin. Furthermore, hepatic delivery of let-7 ameliorates hyperglycemia and improves glucose homeostasis in diabetic mice, whereas liver-specific inhibition of let-7 abrogates these beneficial effects of metformin. Moreover, let-7 overexpression decreases glucose production from primary hepatocytes from obese humans. Thus, we propose the reactivation of a let-7-dependent pathway that is pathologically repressed in the liver of diabetes as a major mechanism of metformin action and that liver-specific delivery of let-7 represents a potential therapeutic for T2D. Our findings are also pertinent to the development of therapeutic strategies for other chronic diseases.
C1 [Chen, Fan] Hubei Acad Agr Sci, Hubei Key Lab Anim Embryo Engn & Mol Breeding, Wuhan 430070, Hubei, Peoples R China.
   [Zhang, Yuanyuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing 210029, Jiangsu, Peoples R China.
   [Sun, Xiaoli] Nantong Univ, Ctr Reprod Med, Dept Obstet & Gynecol, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.
   [Xie, Di; Chen, Fan; Zhang, Yuanyuan; Zhang, Gary J.; Sun, Xiaoli; Taylor, Hugh S.; Huang, Yingqun] Yale Univ, Dept Obstet Gynecol & Reprod Sci, Sch Med, New Haven, CT 06510 USA.
   [Xie, Di; Huang, Yingqun] Yale Univ, Yale Ctr Mol & Syst Metab, Sch Med, New Haven, CT 06520 USA.
   [Shi, Bei] China Med Univ, Med Basic Expt Teaching Ctr, Shenyang 110004, Peoples R China.
   [Song, Jiahui; Li, Da] China Med Univ, Ctr Reprod Med, Shengjing Hosp, Shenyang 110004, Peoples R China.
   [Chaudhari, Kiran; Yang, Shao-Hua] Univ North Texas, Inst Hlth Aging, Dept Pharmacol & Neurosci, Hlth Sci Ctr, Ft Worth, TX 76107 USA.
C3 Hubei Academy of Agricultural Sciences; Nanjing Medical University;
   Nantong University; Yale University; Yale University; China Medical
   University; China Medical University; University of North Texas System;
   University of North Texas Denton
RP Huang, YQ (corresponding author), Yale Univ, Dept Obstet Gynecol & Reprod Sci, Sch Med, New Haven, CT 06510 USA.; Huang, YQ (corresponding author), Yale Univ, Yale Ctr Mol & Syst Metab, Sch Med, New Haven, CT 06520 USA.; Li, D (corresponding author), China Med Univ, Ctr Reprod Med, Shengjing Hosp, Shenyang 110004, Peoples R China.
EM leeda@ymail.com; yingqun.huang@yale.edu
RI zhang, yuanyuan/GYA-4428-2022; Yuan yuan, Zhang/CAH-6633-2022
OI chen, fan/0000-0002-0787-8049; Shi, Bei/0000-0001-8063-9100; Xie,
   Di/0000-0002-8852-281X
FU National Institute of Diabetes and Digestive and Kidney Diseases of the
   NIH [DK119386, DK124321]; National Natural Science Foundation of China
   [82071607]; LiaoNing Revitalization Talents Program [XLYC1907071]; Fok
   Ying Tung Education Foundation [151039]; National Institute of
   Neurological Disorders and Stroke [R01NS109583]
FX We thank Kathy Harry at the Yale Liver Center for isolating mouse
   primary hepatocytes. Research reported in this publication was supported
   by grants from the National Institute of Diabetes and Digestive and
   Kidney Diseases of the NIH (DK119386 and DK124321 to Y.H.); grants from
   the National Natural Science Foundation of China (No. 82071607), the
   LiaoNing Revitalization Talents Program (No. XLYC1907071), and the Fok
   Ying Tung Education Foundation (No. 151039) to D.L.; and a grant from
   the National Institute of Neurological Disorders and Stroke
   (R01NS109583) to S.-H.Y. Y.H. is the guarantor of this work and, as
   such, has full access to all the data in the study and takes
   responsibility for the integrity of the data and the accuracy of the
   data analysis.
CR Agius L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093240
   Alshawi A, 2019, J BIOL CHEM, V294, P2839, DOI 10.1074/jbc.RA118.006670
   Aquilano K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00196
   Bao B, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.05
   Briançon N, 2004, J BIOL CHEM, V279, P33398, DOI 10.1074/jbc.M405312200
   Busch B, 2016, NUCLEIC ACIDS RES, V44, P3845, DOI 10.1093/nar/gkw099
   Cao TF, 2020, FASEB J, V34, P8625, DOI 10.1096/fj.202000073RRRRR
   Cao TF, 2019, ONCOGENE, V38, P5356, DOI 10.1038/s41388-019-0808-4
   Carbonell T, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101607
   Chandel NS, 2016, CELL METAB, V23, P569, DOI 10.1016/j.cmet.2016.03.010
   Chaudhari K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234571
   Chipman LB, 2019, TRENDS GENET, V35, P215, DOI 10.1016/j.tig.2018.12.005
   Chirshev E, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0240-y
   Cusi K, 1996, J CLIN ENDOCR METAB, V81, P4059, DOI 10.1210/jc.81.11.4059
   de Vasconcellos JF, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1273-x
   Fachim HA, 2020, ADIPOCYTE, V9, P443, DOI 10.1080/21623945.2020.1798632
   Foretz M, 2019, NAT REV ENDOCRINOL, V15, P569, DOI 10.1038/s41574-019-0242-2
   Frid A, 2010, DIABETES CARE, V33, P1291, DOI 10.2337/dc09-1284
   Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109
   George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538
   Gormsen LC, 2019, DIABETOLOGIA, V62, P1251, DOI 10.1007/s00125-019-4872-7
   Gormsen LC, 2016, J NUCL MED, V57, P1920, DOI 10.2967/jnumed.116.177774
   Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000
   Greissel A, 2015, THROMB HAEMOSTASIS, V114, P390, DOI 10.1160/TH14-10-0852
   Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040
   Hooykaas MJG, 2018, RNA BIOL, V15, P1410, DOI 10.1080/15476286.2018.1537746
   Hopkins BL, 2018, ANTIOXID REDOX SIGN, V28, P62, DOI 10.1089/ars.2016.6871
   Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063
   Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303
   Jensen JB, 2016, DIABETES, V65, P1724, DOI 10.2337/db16-0032
   Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755
   Lalau JD, 2003, DIABETES OBES METAB, V5, P93, DOI 10.1046/j.1463-1326.2003.00241.x
   LALAU JD, 1995, DIABETES CARE, V18, P779, DOI 10.2337/diacare.18.6.779
   LaMoia TE, 2021, ENDOCR REV, V42, P77, DOI 10.1210/endrev/bnaa023
   Lan J, 2018, CANCER LETT, V418, P250, DOI 10.1016/j.canlet.2018.01.010
   Li D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14185-z
   Lio CWJ, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-019-9973-4
   Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875
   Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   McCreight LJ, 2020, DIABETOLOGIA, V63, P444, DOI 10.1007/s00125-019-05042-1
   Miesbach W, 2018, BLOOD, V131, P1022, DOI 10.1182/blood-2017-09-804419
   Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309
   Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]
   Rena G, 2018, CIRCULATION, V137, P422, DOI 10.1161/CIRCULATIONAHA.117.031735
   Sharabi K, 2017, CELL, V169, P148, DOI 10.1016/j.cell.2017.03.001
   Sutkowska E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91174-7
   Tomin T, 2020, METABOLITES, V10, DOI 10.3390/metabo10020071
   Torres-Padilla ME, 2001, MECH DEVELOP, V109, P183, DOI 10.1016/S0925-4773(01)00521-4
   WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345
   Wu LW, 2015, ELIFE, V4, DOI 10.7554/eLife.09431
   Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33
   Xu YT, 2020, CELL REP, V30, P1310, DOI 10.1016/j.celrep.2019.12.092
   Zake DM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249594
   Zhang N, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120304
   Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033
   Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931
NR 58
TC 8
Z9 8
U1 5
U2 27
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 5
PY 2022
VL 119
IS 14
AR e2122217119
DI 10.1073/pnas.2122217119
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 2P3OW
UT WOS:000819656000013
PM 35344434
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Li, JX
   Wang, S
   Yao, L
   Ma, P
   Chen, ZW
   Han, TL
   Yuan, CL
   Zhang, J
   Jiang, LR
   Liu, L
   Ke, DZ
   Li, CL
   Yamahara, J
   Li, YH
   Wang, JW
AF Li, Jinxiu
   Wang, Shang
   Yao, Ling
   Ma, Peng
   Chen, Zhiwei
   Han, Ting-Li
   Yuan, Chunlin
   Zhang, Jun
   Jiang, Lirong
   Liu, Li
   Ke, Dazhi
   Li, Chunli
   Yamahara, Johji
   Li, Yuhao
   Wang, Jianwei
TI 6-gingerol ameliorates age-related hepatic steatosis: Association with
   regulating lipogenesis, fatty acid oxidation, oxidative stress and
   mitochondrial dysfunction
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE 6-Gingerol; Ageing; Fatty Liver; PPAR alpha; Mitochondria
ID ZINGIBER-OFFICINALE ROSCOE; LIVER-DISEASE; INSULIN-RESISTANCE;
   LIPID-METABOLISM; GINGER; INFLAMMATION; PREVALENCE; RATS; POPULATION;
   INHIBITION
AB The prevalence of NAFLD increases with age. As the main active ingredient of ginger, 6-gingerol significantly improves lipid metabolism abnormalities in adult rodents. However, few studies have reported its effect on age-related NAFLD. This study was to investigate the effects of 6-gingerol on age-related hepatic steatosis and its potential targets. As expected, 6-gingerol dramatically normalized the hepatic triglyceride content, plasma insulin and HOMA-IR index of ageing rats. Mechanistically, 6-gingerol affected lipid metabolism by increasing beta-oxidation and decreasing lipogenesis through activation of PPAR alpha and CPT1 alpha and inhibition of DGAT-2. Furthermore, 6-gingerol reversed the decreases in citrate, Cs and ATP, lessened the damage caused by ROS, and upregulated mitochondrial marker enzymes NOX, SDH, and SIRT3 in the ageing liver, indicating its ability to strengthen mitochondria' function. Our results showed 6-gingerol exerted a positive effect on insulin sensitivity by regulating Akt. In conclusion, the hepatic anti-steatotic effect of 6-gingerol is associated with inhibition of de novo lipogenesis, upregulation of fatty acid oxidation, reduction in oxidative stress and synergistic enhancement of mitochondrial function.
C1 [Li, Jinxiu; Yao, Ling; Chen, Zhiwei; Yuan, Chunlin; Wang, Jianwei] Chongqing Med Univ, Chongqing Key Lab Tradit Chinese Med Prevent & Cu, Chongqing, Peoples R China.
   [Wang, Shang; Ma, Peng; Zhang, Jun; Jiang, Lirong; Liu, Li] Chongqing Med Univ, Fac Basic Med Sci, Chongqing, Peoples R China.
   [Han, Ting-Li] Chongqing Med Univ, Dept Obstet, Affiliated Hosp 1, Chongqing, Peoples R China.
   [Ke, Dazhi] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China.
   [Li, Chunli] Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China.
   [Yamahara, Johji] Pharmafood Inst, Kyoto, Japan.
   [Li, Yuhao] Sydney Inst Tradit Chinese Med, Endocrinol & Metab Grp, Sydney Inst Hlth Sci, Sydney, NSW, Australia.
C3 Chongqing Medical University; Chongqing Medical University; Chongqing
   Medical University; Chongqing Medical University; Chongqing Medical
   University
RP Wang, JW (corresponding author), Chongqing Med Univ, Chongqing Key Lab Tradit Chinese Med Prevent & Cu, Chongqing, Peoples R China.
EM wjwcq68@163.com
RI Zhang, Yihao/JGM-3514-2023; chen, zhiwei/AAP-5465-2020; Liu,
   Yixuan/JFJ-2820-2023; li, Li/JPA-0218-2023; Wang, Guanhua/JXM-6373-2024;
   wen, Wen/KBB-1727-2024; Li, Chun/HKW-1738-2023; LI, JIAN/JAX-3092-2023;
   yuan, lin/JDW-7387-2023
OI Jinxiu, Li/0000-0003-1445-7434
FU National Natural Science Foundation of China [81374033, 81673659];
   Natural Science Foundation of Chongqing [cstc2017jcyjAX0374,
   cstc2018jcyjAX0176]; Foundation of Chongqing Education Committee
   [KJ1600233]; Foundation of Chongqing Health and Family Planning
   Commission [ZY201702133]
FX This work was financially supported by the National Natural Science
   Foundation of China (Grant No: 81374033 and 81673659), the Natural
   Science Foundation of Chongqing (Grant No: cstc2017jcyjAX0374 and
   cstc2018jcyjAX0176), the Foundation of Chongqing Education Committee
   (Grant No: KJ1600233), China, and the Foundation of Chongqing Health and
   Family Planning Commission (Grant No: ZY201702133).
CR Abolaji AO, 2017, CHEM-BIOL INTERACT, V270, P15, DOI 10.1016/j.cbi.2017.03.017
   Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085
   Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097
   Bedogni G, 2007, HEPATOLOGY, V46, P1387, DOI 10.1002/hep.21827
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P996, DOI 10.1111/ggi.12192
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729
   Heras ND, 2017, APPL PHYSIOL NUTR ME, V42, P209, DOI 10.1139/apnm-2016-0374
   Ding JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13729
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Galbo T, 2013, AGING-US, V5, P770, DOI 10.18632/aging.100611
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Guan LL, 2013, EXP GERONTOL, V48, P1387, DOI 10.1016/j.exger.2013.09.001
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Kantartzis K, 2009, CLIN SCI, V116, P531, DOI 10.1042/CS20080306
   Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448
   Lonardo A, 2017, WORLD J GASTROENTERO, V23, P6571, DOI 10.3748/wjg.v23.i36.6571
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046
   Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x
   Nicoll R, 2009, INT J CARDIOL, V131, P408, DOI 10.1016/j.ijcard.2007.07.107
   Pan JJ, 2014, WORLD J HEPATOL, V6, P274, DOI 10.4254/wjh.v6.i5.274
   Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039
   Poulose N, 2015, BBA-MOL BASIS DIS, V1852, P2442, DOI 10.1016/j.bbadis.2015.08.017
   Reher DS, 2015, POP STUD-J DEMOG, V69, pS57, DOI 10.1080/00324728.2014.963421
   Samokhvalov V, 2004, BIOCHIMIE, V86, P39, DOI 10.1016/j.biochi.2003.10.019
   Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211
   Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108
   Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4
   Tzeng TF, 2015, PHYTOMEDICINE, V22, P452, DOI 10.1016/j.phymed.2015.01.015
   Tzeng TF, 2015, NUTRIENTS, V7, P999, DOI 10.3390/nu7020999
   Wang ZL, 2014, EUR J GASTROEN HEPAT, V26, P1015, DOI 10.1097/MEG.0000000000000151
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   Xing XM, 2014, TOXICOL APPL PHARM, V280, P207, DOI 10.1016/j.taap.2014.08.001
   Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006
   Zhang M, 2014, OXID MED CELL LONGEV, V2014
   Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297
   Zhou L, 2016, J PHARMACOL EXP THER, V356, P74, DOI 10.1124/jpet.115.229005
   Zhu CP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05029
NR 45
TC 33
Z9 36
U1 5
U2 39
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD JAN 1
PY 2019
VL 362
BP 125
EP 135
DI 10.1016/j.taap.2018.11.001
PG 11
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA HH8HE
UT WOS:000455971700015
PM 30408433
DA 2024-02-19
ER

PT J
AU Vizioli, MG
   Liu, TH
   Miller, KN
   Robertson, NA
   Gilroy, K
   Lagnado, AB
   Perez-Garcia, A
   Kiourtis, C
   Dasgupta, N
   Lei, X
   Kruger, PJ
   Nixon, C
   Clark, W
   Jurk, D
   Bird, TG
   Passos, JF
   Berger, SL
   Dou, ZX
   Adams, PD
AF Vizioli, Maria Grazia
   Liu, Tianhui
   Miller, Karl N.
   Robertson, Neil A.
   Gilroy, Kathryn
   Lagnado, Anthony B.
   Perez-Garcia, Arantxa
   Kiourtis, Christos
   Dasgupta, Nirmalya
   Lei, Xue
   Kruger, Patrick J.
   Nixon, Colin
   Clark, William
   Jurk, Diana
   Bird, Thomas G.
   Passos, Joao F.
   Berger, Shelley L.
   Dou, Zhixun
   Adams, Peter D.
TI Mitochondria-to-nucleus retrograde signaling drives formation of
   cytoplasmic chromatin and inflammation in senescence
SO GENES & DEVELOPMENT
LA English
DT Article
DE cytoplasmic chromatin; inflammation; mitochondria; senescence
ID DNA-DAMAGE RESPONSE; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE
   DEACETYLASE INHIBITOR; SECRETORY PHENOTYPE; LIVER-CANCER; LYSINE 16;
   MECHANISMS; REVEALS; CELLS; REDOX
AB Cellular senescence is a potent tumor suppressor mechanism but also contributes to aging and aging-related diseases. Senescence is characterized by a stable cell cycle arrest and a complex proinflammatory secretome, termed the senescence-associated secretory phenotype (SASP). We recently discovered that cytoplasmic chromatin fragments (CCFs), extruded from the nucleus of senescent cells, trigger the SASP through activation of the innate immunity cytosolic DNA sensing cGAS-STING pathway. However, the upstream signaling events that instigate CCF formation remain unknown. Here, we show that dysfunctional mitochondria, linked to down-regulation of nuclear-encoded mitochondrial oxidative phosphorylation genes, trigger a ROS-JNK retrograde signaling pathway that drives CCF formation and hence the SASP. JNK links to 53BP1, a nuclear protein that negatively regulates DNA double-strand break (DSB) end resection and CCF formation. Importantly, we show that low-dose HDAC inhibitors restore expression of most nuclear-encoded mitochondrial oxidative phosphorylation genes, improve mitochondrial function, and suppress CCFs and the SASP in senescent cells. In mouse models, HDAC inhibitors also suppress oxidative stress, CCF, inflammation, and tissue damage caused by senescence-inducing irradiation and/or acetaminophen-induced mitochondria dysfunction. Overall, our findings outline an extended mitochondria-to-nucleus retrograde signaling pathway that initiates formation of CCF during senescence and is a potential target for drug-based interventions to inhibit the proaging SASP.
C1 [Vizioli, Maria Grazia; Robertson, Neil A.; Gilroy, Kathryn; Perez-Garcia, Arantxa; Kiourtis, Christos; Nixon, Colin; Clark, William; Bird, Thomas G.; Adams, Peter D.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.
   [Vizioli, Maria Grazia; Robertson, Neil A.; Gilroy, Kathryn; Perez-Garcia, Arantxa; Kiourtis, Christos; Adams, Peter D.] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland.
   [Vizioli, Maria Grazia; Dou, Zhixun] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.
   [Vizioli, Maria Grazia; Dou, Zhixun] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.
   [Vizioli, Maria Grazia; Dou, Zhixun] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.
   [Liu, Tianhui; Miller, Karl N.; Dasgupta, Nirmalya; Lei, Xue; Adams, Peter D.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.
   [Lagnado, Anthony B.; Kruger, Patrick J.; Jurk, Diana; Passos, Joao F.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.
   [Lagnado, Anthony B.; Jurk, Diana; Passos, Joao F.] Newcastle Univ, Newcastle Univ Inst Ageing, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Bird, Thomas G.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh EH1 64TJ, Midlothian, Scotland.
   [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Epigenet Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
C3 Beatson Institute; University of Glasgow; Harvard University;
   Massachusetts General Hospital; Harvard University; Harvard University;
   Harvard Medical School; Massachusetts General Hospital; Sanford Burnham
   Prebys Medical Discovery Institute; Mayo Clinic; Newcastle University -
   UK; University of Edinburgh; University of Pennsylvania
RP Adams, PD (corresponding author), Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.; Adams, PD (corresponding author), Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland.; Dou, ZX (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.; Dou, ZX (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Dou, ZX (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Adams, PD (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.
EM zdou@mgh.harvard.edu; padams@sbpdiscovery.org
RI Dasgupta, Nirmalya/GSD-9997-2022; Bird, Tom/H-3840-2019
OI Dasgupta, Nirmalya/0000-0002-0289-5712; Bird, Tom/0000-0002-6120-1581;
   Adams, Peter/0000-0002-0684-1770; Robertson, Neil/0000-0002-9509-1157;
   Kiourtis, Christos/0000-0002-6682-5668; Gilroy,
   Kathryn/0000-0003-4607-194X; Passos, Joao/0000-0001-8765-1890; Lei,
   Xue/0000-0001-9647-3782; Jurk, Diana/0000-0003-4486-0857
FU Core Services and Advanced Technologies at the Cancer Research UK
   Beatson Institute [C596/A17196]; Glenn Foundation for Medical Research
   Postdoctoral Fellowships [PD18082, PD19131]; Ted Nash Foundation; Cancer
   Research UK Beatson Institute Core funding [A171196]; Wellcome Trust
   [WT107492Z]; National Institutes of Health [K99AG053406];  [AG031862]; 
   [F32 AG066459]; BBSRC [BB/H022384/1, BB/K017314/1] Funding Source: UKRI;
   MRC [2106041] Funding Source: UKRI
FX We thank all members of the Adams laboratory for critical discussion. We
   thank Dr. Stephan Tait for generous sharing of reagents, and Dr. Karthic
   Swaminathan for his help with confocal microscopy. We acknowledge the
   Core Services and Advanced Technologies at the Cancer Research UK
   Beatson Institute (C596/A17196), with particular thanks to the Animal
   Core Facility and Biological Services Unit and Histology. Special thanks
   to Karen Blyth for advice on animal experiments. The work in the
   laboratory of P.D.A. and S.L.B. was supported by AG031862. K.N.M. and
   N.D. were supported by Glenn Foundation for Medical Research
   Postdoctoral Fellowships (PD18082 and PD19131, respectively). K.N.M. was
   also supported by F32 AG066459. A.B.L. and J.F.P. were supported by the
   Ted Nash Foundation. C.K. was supported by Cancer Research UK Beatson
   Institute Core funding (A171196). T.G.B. was funded by the Wellcome
   Trust (WT107492Z). Z.D. was supported by National Institutes of Health
   K99AG053406. S.L.B. and P.D.A. were supported by AG031862.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Bond DM, 2014, TRENDS CELL BIOL, V24, P100, DOI 10.1016/j.tcb.2013.08.001
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170
   Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050
   Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548
   Dupré A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63
   Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360
   Forootan SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16491-2
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637
   Glück S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586
   Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925
   Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100
   Hull EE, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8797206
   Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Kleiner RE, 2015, NAT CHEM BIOL, V11, P807, DOI [10.1038/NCHEMBIO.1908, 10.1038/nchembio.1908]
   Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036
   Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020
   Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Mann BS, 2007, CLIN CANCER RES, V13, P2318, DOI 10.1158/1078-0432.CCR-06-2672
   McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Nelson G, 2018, MECH AGEING DEV, V170, P30, DOI [10.1016/j.mad.2017.08.005, DOI 10.1016/J.MAD.2017.08.005.PII:S0047-6374(17)30075-1]
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Niedernhofer LJ, 2018, NAT REV DRUG DISCOV, V17
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003728
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Ramachandran Anup, 2017, J Clin Transl Res, V3, P157, DOI 10.18053/jctres.03.2017S1.002
   Robb EL, 2015, FREE RADICAL BIO MED, V89, P883, DOI 10.1016/j.freeradbiomed.2015.08.021
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09
   Shi XY, 2017, MED SCI MONITOR, V23, P5793, DOI 10.12659/MSM.904597
   Shi Y, 2014, CELL DEATH DIFFER, V21, P612, DOI 10.1038/cdd.2013.186
   Short S, 2019, EBIOMEDICINE, V41, P683, DOI 10.1016/j.ebiom.2019.01.056
   Tao D, 2004, ACTA BIOCH BIOPH SIN, V36, P618, DOI 10.1093/abbs/36.9.618
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836
   Walsh J, 2014, J PROTEOMICS, V108, P171, DOI 10.1016/j.jprot.2014.05.007
   Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620
   Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
NR 67
TC 154
Z9 162
U1 5
U2 54
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD MAR 1
PY 2020
VL 34
IS 5-6
BP 428
EP 445
DI 10.1101/gad.331272.119
PG 18
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA KS6RB
UT WOS:000518433600012
PM 32001510
OA Green Accepted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Yzydorczyk, C
   Li, N
   Rigal, E
   Chehade, H
   Mosig, D
   Armengaud, JB
   Rolle, T
   Krishnasamy, A
   Orozco, E
   Siddeek, B
   Juvet, C
   Vergely, C
   Simeoni, U
AF Yzydorczyk, Catherine
   Li, Na
   Rigal, Eve
   Chehade, Hassib
   Mosig, Dolores
   Armengaud, Jean Baptiste
   Rolle, Thibaud
   Krishnasamy, Anithan
   Orozco, Eulalia
   Siddeek, Benazir
   Juvet, Christian
   Vergely, Catherine
   Simeoni, Umberto
TI Calorie Restriction in Adulthood Reduces Hepatic Disorders Induced by
   Transient Postnatal Overfeeding in Mice
SO NUTRIENTS
LA English
DT Article
DE liver; developmental programming; stress-induced premature senescence;
   oxidative stress; reversibility; DOHaD
ID FATTY LIVER-DISEASE; OXIDATIVE STRESS; DIETARY RESTRICTION; RATS LEADS;
   LIFE-SPAN; SIRT1; EXPRESSION; MITOCHONDRIAL; EPIDEMIOLOGY; SENESCENCE
AB Impaired early nutrition influences the risk of developing metabolic disorders in later life. We observed that transient postnatal overfeeding (OF) in mice induces long-term hepatic alterations, characterized by microsteatosis, fibrosis associated with oxidative stress (OS), and stress-induced premature senescence (SIPS). In this study, we investigated whether such changes can be reversed by moderate calorie restriction (CR). C57BL/6 male mice pups were maintained during lactation in litters adjusted to nine pups in the normal feeding (NF) group and three pups in the transient postnatal OF group. At six months of age, adult mice from the NF and OF groups were randomly assigned to an ad libitum diet or CR (daily energy supply reduced by 20%) for one month. In each group, at the age of seven months, analysis of liver structure, liver markers of OS (superoxide anion, antioxidant defenses), and SIPS (lipofuscin, p53, p21, p16, pRb/Rb, Acp53, sirtuin-1) were performed. CR in the OF group reduced microsteatosis, decreased levels of superoxide anion, and increased protein expression of catalase and superoxide dismutase. Moreover, CR decreased lipofuscin staining, p21, p53, Acp53, and p16 but increased pRb/Rb and sirtuin-1 protein expression. CR did not affect the NF group. These results suggest that CR reduces hepatic disorders induced by OF.
C1 [Yzydorczyk, Catherine; Chehade, Hassib; Mosig, Dolores; Armengaud, Jean Baptiste; Rolle, Thibaud; Krishnasamy, Anithan; Orozco, Eulalia; Siddeek, Benazir; Juvet, Christian; Simeoni, Umberto] CHU Vaudois, Div Pediat, Woman Mother Child Dept, DOHaD Lab, CH-1011 Lausanne, Switzerland.
   [Yzydorczyk, Catherine; Chehade, Hassib; Mosig, Dolores; Armengaud, Jean Baptiste; Rolle, Thibaud; Krishnasamy, Anithan; Orozco, Eulalia; Siddeek, Benazir; Juvet, Christian; Simeoni, Umberto] Univ Lausanne, CH-1011 Lausanne, Switzerland.
   [Li, Na; Rigal, Eve; Vergely, Catherine] Univ Bourgogne Franche Comte, UFR Sci Sante, EA7460, Equipe Physiopathol & Epidemiol Cerebrocardiovasc, F-21000 Dijon, France.
C3 University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV);
   University of Lausanne; Universite de Bourgogne
RP Yzydorczyk, C (corresponding author), CHU Vaudois, Div Pediat, Woman Mother Child Dept, DOHaD Lab, CH-1011 Lausanne, Switzerland.; Yzydorczyk, C (corresponding author), Univ Lausanne, CH-1011 Lausanne, Switzerland.
EM catherine.yzydorczyk@chuv.ch; na.li@unil.ch; eve.rigal@u-bourgogne.fr;
   hassib.chehade@chuv.ch; dolores.mosig@me.com;
   jean-baptiste.armengaud@chuv.ch; Rotib7@gmail.com;
   anithan.krishnasamy@gmail.com; eulalia_of@hotmail.com;
   benazir.siddeek@chuv.ch; christian.juvet@chuv.ch;
   cvergely@u-bourgogne.fr; umberto.simeoni@chuv.ch
RI Vergely, Catherine/L-9534-2015; Simeoni, Umberto/GRO-6971-2022; SIMEONI,
   Umberto/AAQ-1870-2021
OI Vergely, Catherine/0000-0003-4009-776X; Simeoni,
   Umberto/0000-0003-0730-9337; SIMEONI, Umberto/0000-0003-0730-9337;
   Chehade, Hassib/0000-0001-5019-2547; YZYDORCZYK,
   Catherine/0000-0002-0617-7558; SIDDEEK, Benazir/0000-0003-2764-6656
FU French Ministry of Research; Institut National de la Sante et de la
   Recherche Medicale (INSERM, France); CHUV-University of Lausanne
   (Switzerland) [30034]
FX This work was supported by grants from the French Ministry of Research
   and the Institut National de la Sante et de la Recherche Medicale
   (INSERM, France) for the generation of the animal model and by CHUV (No:
   30034)-University of Lausanne (Switzerland) and theW. and E. Grand
   d'Hauteville Foundation For Academic Biomedical and Nursing Research
   (Lausanne, Switzerland) for laboratory analyses on the hepatic tissue.
CR Alam Shahinul, 2016, World J Gastrointest Pathophysiol, V7, P211, DOI 10.4291/wjgp.v7.i2.211
   Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243
   Bales CW, 2013, J CARDIOPULM REHABIL, V33, P201, DOI 10.1097/HCR.0b013e318295019e
   Barja G, 2000, AGING CLIN EXP RES, V12, P342, DOI 10.1007/BF03339859
   Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   Chen LH, 1996, AGE, V19, P101, DOI 10.1007/BF02434089
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Colak Y, 2014, J GASTROINTEST LIVER, V23, P311, DOI [10.15403/jgld.2014.1121.233.yck, 10.1543/jgld.20l4.1121.233.yck]
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Cunha ACDR, 2009, J NUTR BIOCHEM, V20, P435, DOI 10.1016/j.jnutbio.2008.05.002
   Duque-Guimaraes DE, 2013, TRENDS ENDOCRIN MET, V24, P525, DOI 10.1016/j.tem.2013.05.006
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113
   Habbout A, 2013, J NUTR, V143, P553, DOI 10.3945/jn.112.172825
   Habbout A, 2012, BIOCHIMIE, V94, P117, DOI 10.1016/j.biochi.2011.09.023
   Huschtscha LI, 1999, CARCINOGENESIS, V20, P921, DOI 10.1093/carcin/20.6.921
   Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202
   Juif J.G., 2004, MED NEONATALE FOETAL, P515
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kim KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30111
   Kirk E, 2009, GASTROENTEROLOGY, V136, P1552, DOI 10.1053/j.gastro.2009.01.048
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kurylowicz A, 2016, INT J OBESITY, V40, P1635, DOI 10.1038/ijo.2016.131
   Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34
   Li N, 2016, SCI REP-UK, V6, DOI 10.1038/srep30817
   Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942
   Li YJ, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.120.1373
   Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002
   Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P154, DOI 10.1055/s-0029-1211159
   Rodrigues AL, 2007, J ENDOCRINOL, V195, P485, DOI 10.1677/JOE-07-0046
   Rusli F, 2015, MOL NUTR FOOD RES, V59, P533, DOI 10.1002/mnfr.201400621
   Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stankovic M, 2013, GEN PHYSIOL BIOPHYS, V32, P277, DOI 10.4149/gpb_2013027
   Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje
   SU Y, 1990, EXP CLIN ENDOCRINOL, V96, P301, DOI 10.1055/s-0029-1211023
   Tobita T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149344
   Vassallo PF, 2014, BLOOD, V123, P2116, DOI 10.1182/blood-2013-02-484956
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6
   Yu HY, 2014, J CLIN MED, V3, P1050, DOI 10.3390/jcm3031050
   Yzydorczyk C, 2015, ARCH PEDIATRIE, V22, P1047, DOI 10.1016/j.arcped.2015.05.019
   Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251
   Yzydorczyk C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11756-2
   Zhu Y, 2018, BIOMED PHARMACOTHER, V105, P246, DOI 10.1016/j.biopha.2018.05.022
NR 52
TC 15
Z9 16
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2019
VL 11
IS 11
AR 2796
DI 10.3390/nu11112796
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JV3OC
UT WOS:000502274600247
PM 31744052
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Prattichizzo, F
   Giuliani, A
   Mensà, E
   Sabbatinelli, J
   De Nigris, V
   Rippo, MR
   La Sala, L
   Procopio, AD
   Olivieri, F
   Ceriello, A
AF Prattichizzo, Francesco
   Giuliani, Angelica
   Mensa, Emanuela
   Sabbatinelli, Jacopo
   De Nigris, Valeria
   Rippo, Maria Rita
   La Sala, Lucia
   Procopio, Antonio Domenico
   Olivieri, Fabiola
   Ceriello, Antonio
TI Pleiotropic effects of metformin: Shaping the microbiome to manage type
   2 diabetes and postpone ageing
SO AGEING RESEARCH REVIEWS
LA English
DT Article
DE Microbiota; Gut flora; Short-chain fatty acids; Gluconeogenesis; Insulin
   sensitivity; Complex I; AMPK; mTOR; Inflammaging; Senescence
ID GLUCAGON-LIKE PEPTIDE-1; DIET-INDUCED OBESITY; CATION TRANSPORTER 1;
   HEPATIC GLUCOSE-PRODUCTION; LOW-GRADE INFLAMMATION; INCREASES LIFE-SPAN;
   GUT MICROBIOTA; INSULIN SENSITIVITY; AKKERMANSIA-MUCINIPHILA; SECRETORY
   PHENOTYPE
AB Metformin is the first-choice therapy to lower glycaemia and manage type 2 diabetes. Continuously emerging epidemiological data and experimental models are showing additional protective effects of metformin against a number of age-related diseases (ARDs), e.g., cardiovascular diseases and cancer. This evidence has prompted the design of a specific trial, i.e., the Targeting Aging with Metformin (TAME) trial, to test metformin as an anti ageing molecule. However, a unifying or prevailing mechanism of action of metformin is still debated. Here, we summarize the epidemiological data linking metformin to ARD prevention. Then, we dissect the deeply studied mechanisms of action explaining its antihyperglycemic effect and the putative mechanisms supporting its anti ageing properties, focusing on studies using clinically pertinent doses. We hypothesize that the molecular observations obtained in different models with metformin could be indirectly mediated by its effect on gut flora. Novel evidence suggests that metformin reshapes the human microbiota, promoting the growth of beneficial bacterial species and counteracting the expansion of detrimental bacterial species. In turn, this action would influence the balance between pro- and anti-inflammatory circulating factors, thereby promoting glycaemic control and healthy ageing. This framework may reconcile diverse observations, providing information for designing further studies to elucidate the complex interplay between metformin and the metabiome harboured in mammalian body compartments, thereby paving the way for innovative, bacterial-based therapeutics to manage type 2 diabetes and foster a longer healthspan.
C1 [Prattichizzo, Francesco; La Sala, Lucia; Ceriello, Antonio] IRCCS MultiMed, Via Fantoli 16-15, Milan, Italy.
   [Giuliani, Angelica; Mensa, Emanuela; Sabbatinelli, Jacopo; Rippo, Maria Rita; Procopio, Antonio Domenico; Olivieri, Fabiola] Univ Politecn Marche, Dept Clin & Mol Sci, DISCLIMO, Ancona, Italy.
   [De Nigris, Valeria; Ceriello, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.
   [Procopio, Antonio Domenico; Olivieri, Fabiola] IRCCS INRCA, Ctr Clin Pathol & Innovat Therapy, Italian Natl Res Ctr Aging, Ancona, Italy.
   [Ceriello, Antonio] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.
C3 IRCCS Multimedica; Marche Polytechnic University; University of
   Barcelona; Hospital Clinic de Barcelona; IDIBAPS; IRCCS INRCA; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERDEM
RP Prattichizzo, F (corresponding author), IRCCS MultiMed, Via Fantoli 16-15, Milan, Italy.
EM francesco.prattichizzo@multimedica.it
RI Olivieri, Fabiola/K-6465-2016; Luu, Nguyen/JPL-9089-2023; Giuliani,
   Angelica/AAB-9024-2019; La Sala, Lucia/A-4467-2019; Prattichizzo,
   Francesco/J-3046-2018; Sabbatinelli, Jacopo/U-1851-2018; Procopio,
   Antonio Domenico/AAB-2451-2021; La Sala, Lucia/AAC-3458-2022
OI Olivieri, Fabiola/0000-0002-9606-1144; La Sala,
   Lucia/0000-0002-7580-1377; Prattichizzo, Francesco/0000-0002-2959-2658;
   Sabbatinelli, Jacopo/0000-0001-9947-6778; Procopio, Antonio
   Domenico/0000-0001-6897-8724; La Sala, Lucia/0000-0002-7580-1377; RIPPO,
   Maria Rita/0000-0003-3024-3495; Giuliani, Angelica/0000-0002-8477-8519
FU La Marato de TV3; IDIBAPS
FX This work was supported in part by grants from La Marato de TV3 and
   IDIBAPS to A.C.
CR Almaça J, 2014, P NATL ACAD SCI USA, V111, P17612, DOI 10.1073/pnas.1414053111
   Andersson C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000433
   Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12
   Andújar-Plata P, 2012, DIABETES RES CLIN PR, V95, P1, DOI 10.1016/j.diabres.2011.09.022
   Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625
   Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273
   Anisimov VN, 2010, AGING-US, V2, P760, DOI 10.18632/aging.100230
   Asemi Z, 2013, ANN NUTR METAB, V63, P1, DOI 10.1159/000349922
   Bäckhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104
   Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5
   BAILEY CJ, 1994, BRIT J PHARMACOL, V112, P671, DOI 10.1111/j.1476-5381.1994.tb13128.x
   Balakumar M, 2018, EUR J NUTR, V57, P279, DOI 10.1007/s00394-016-1317-7
   Banerjee J, 2016, METABOLISM, V65, P1679, DOI 10.1016/j.metabol.2016.06.011
   Bannister CA, 2014, DIABETES OBES METAB, V16, P1165, DOI 10.1111/dom.12354
   Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011
   Bauer PV, 2018, CELL METAB, V27, P101, DOI 10.1016/j.cmet.2017.09.019
   Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013
   Beaumont M., 2018, FASEB J
   Bérard E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095671
   Biagi E, 2017, MECH AGEING DEV, V165, P180, DOI 10.1016/j.mad.2016.12.013
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Biagi PL, 1999, MECH AGEING DEV, V107, P181, DOI 10.1016/S0047-6374(98)00148-1
   Blagosklonny MV, 2013, CANCER BIOL THER, V14, P1092, DOI 10.4161/cbt.27350
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Bo S, 2012, DIABETES OBES METAB, V14, P23, DOI 10.1111/j.1463-1326.2011.01480.x
   Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791
   Boulangé CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Boussageon R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001204
   Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620
   Buse JB, 2016, DIABETES CARE, V39, P198, DOI 10.2337/dc15-0488
   But A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113162
   Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035
   Calder PC, 2017, AGEING RES REV, V40, P95, DOI 10.1016/j.arr.2017.09.001
   Cameron AR, 2016, CIRC RES, V119, P652, DOI 10.1161/CIRCRESAHA.116.308445
   Campbell JM, 2017, AGEING RES REV, V40, P31, DOI 10.1016/j.arr.2017.08.003
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625
   Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012
   Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360
   Chelakkot C, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.282
   Chen J., 2017, ELIFE, V6
   Chen JJ, 2012, BRIT J NUTR, V107, P1429, DOI 10.1017/S0007114511004491
   Chiang John Y L, 2017, Liver Res, V1, P3, DOI 10.1016/j.livres.2017.05.001
   Chien HC, 2016, DRUG METAB DISPOS, V44, P356, DOI 10.1124/dmd.115.066647
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Chimerel C, 2014, CELL REP, V9, P1202, DOI 10.1016/j.celrep.2014.10.032
   Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778
   De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111
   de la Cuesta-Zuluaga J, 2017, DIABETES CARE, V40, P54, DOI 10.2337/dc16-1324
   de Mello VD, 2017, SCI REP-UK, V7, DOI 10.1038/srep46337
   De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013
   den Besten G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136364
   den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213
   Dinakaran V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105221
   Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018
   Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5
   Drucker DJ, 2016, CELL METAB, V24, P15, DOI 10.1016/j.cmet.2016.06.009
   Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787
   Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388
   Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223
   Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110
   Fang JQ, 2018, AGING CELL, V17, DOI 10.1111/acel.12765
   Fiorentino TV, 2017, J CLIN ENDOCR METAB, V102, P3979, DOI 10.1210/jc.2017-00348
   Fontana L, 2018, AGING CELL, V17, DOI 10.1111/acel.12746
   Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671
   Forouzandeh F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001202
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2003, BIOCHEM SOC T, V31, P457, DOI 10.1042/BST0310457
   Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005
   Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231
   Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6
   Fujisaka S, 2018, CELL REP, V22, P3072, DOI 10.1016/j.celrep.2018.02.060
   Fujisaka S, 2016, J CLIN INVEST, V126, P4430, DOI 10.1172/JCI86674
   Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372
   Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960
   Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883
   Ghosh S, 2015, J GERONTOL A-BIOL, V70, P232, DOI 10.1093/gerona/glu067
   Gladyshev VN, 2016, AGING CELL, V15, P594, DOI 10.1111/acel.12480
   Gorboulev V, 2018, MOL PHARMACOL, V93, P402, DOI 10.1124/mol.117.110767
   GORDON HA, 1966, J GERONTOL, V21, P380, DOI 10.1093/geronj/21.3.380
   Gormsen LC, 2016, J NUCL MED, V57, P1920, DOI 10.2967/jnumed.116.177774
   Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000
   Guigoz Y, 2008, CURR OPIN CLIN NUTR, V11, P13, DOI 10.1097/MCO.0b013e3282f2bfdf
   Halicka HD, 2011, AGING-US, V3, P1028, DOI 10.18632/aging.100397
   Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001
   He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003
   Hong Y, 2008, J CLIN PHARMACOL, V48, P696, DOI 10.1177/0091270008316884
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Howell JJ, 2017, CELL METAB, V25, P463, DOI 10.1016/j.cmet.2016.12.009
   Hull RL, 2005, DIABETES, V54, P2235, DOI 10.2337/diabetes.54.7.2235
   Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166
   Johanns M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10856
   Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kilkkinen A, 2008, INT J CANCER, V123, P2152, DOI 10.1002/ijc.23622
   Kim KA, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0625-7
   Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852
   Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   Li AY, 2016, MOL CELL ENDOCRINOL, V434, P36, DOI 10.1016/j.mce.2016.06.008
   Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175
   Lin HC, 2015, JAMA OPHTHALMOL, V133, P915, DOI 10.1001/jamaophthalmol.2015.1440
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951
   Lustgarten MS, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00212
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z
   Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979
   Mardinoglu A, 2016, CELL METAB, V23, P10, DOI 10.1016/j.cmet.2015.12.012
   Mardinoglu A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156487
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Maruthur NM, 2016, ANN INTERN MED, V164, P740, DOI 10.7326/M15-2650
   Mikkelsen KH, 2016, DIABETES OBES METAB, V18, P444, DOI 10.1111/dom.12637
   Mikkelsen K. H., 2016, AGEING RES REV, V48, P87
   Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808
   Moiseeva O, 2013, AGING CELL, V12, P489, DOI 10.1111/acel.12075
   Monami M, 2017, INT J CARDIOL, V240, P414, DOI 10.1016/j.ijcard.2017.03.163
   Mor A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011523
   Mulherin AJ, 2011, ENDOCRINOLOGY, V152, P4610, DOI 10.1210/en.2011-1485
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7
   Newman JC, 2016, J GERONTOL A-BIOL, V71, P1424, DOI 10.1093/gerona/glw149
   Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901
   Noren Hooten N, 2016, AGING CELL, V15, P572, DOI 10.1111/acel.12469
   Olivieri F, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9076485
   Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236
   Prattichizzo F, 2018, REDOX BIOL, V15, P170, DOI 10.1016/j.redox.2017.12.001
   Prattichizzo F, 2018, AGEING RES REV, V41, P1, DOI 10.1016/j.arr.2017.10.003
   Pryor R, 2015, BIOCHEM J, V471, P307, DOI 10.1042/BJ20150497
   Pujadas G, 2017, ENDOCRINE, V56, P509, DOI 10.1007/s12020-016-1052-0
   Pussinen PJ, 2011, DIABETES CARE, V34, P392, DOI 10.2337/dc10-1676
   Qian F, 2012, AGING CELL, V11, P104, DOI 10.1111/j.1474-9726.2011.00759.x
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Rampelli S, 2013, AGING-US, V5, P902, DOI 10.18632/aging.100623
   Ravcheev DA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00674
   Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]
   Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105
   Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468
   Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
   Scudellari M, 2015, NATURE, V517, P426, DOI 10.1038/517426a
   Selman C, 2011, PHILOS T R SOC B, V366, P99, DOI 10.1098/rstb.2010.0243
   Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862
   Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016
   Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839
   Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558
   Stang M, 1999, DIABETES CARE, V22, P925, DOI 10.2337/diacare.22.6.925
   Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170
   SUM CF, 1992, DIABETIC MED, V9, P61, DOI 10.1111/j.1464-5491.1992.tb01716.x
   Sundelin EIO, 2017, CLIN PHARMACOL THER, V102, P841, DOI 10.1002/cpt.701
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Triggle CR, 2017, ACTA PHYSIOL, V219, P138, DOI 10.1111/apha.12644
   Tropini C, 2017, CELL HOST MICROBE, V21, P433, DOI 10.1016/j.chom.2017.03.010
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   van Stee MF, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0738-4
   Vardarli I, 2014, DIABETES, V63, P663, DOI 10.2337/db13-0805
   Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858
   Wang XK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12676
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220
   Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010
   Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI14178
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345
   Wu LF, 2016, CELL, V167, P1705, DOI 10.1016/j.cell.2016.11.055
   Xu GS, 2015, FREE RADICAL BIO MED, V87, P15, DOI 10.1016/j.freeradbiomed.2015.05.045
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Yaku K, 2012, MOL CELL BIOCHEM, V370, P7, DOI 10.1007/s11010-012-1392-x
   Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018
   Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zhang CS, 2016, CELL METAB, V24, P521, DOI 10.1016/j.cmet.2016.09.003
   Zhang QQ, 2016, MEDICINA-LITHUANIA, V52, P28, DOI 10.1016/j.medici.2015.11.008
   Zhou KX, 2009, DIABETES, V58, P1434, DOI 10.2337/db08-0896
NR 188
TC 68
Z9 74
U1 2
U2 42
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD DEC
PY 2018
VL 48
BP 87
EP 98
DI 10.1016/j.arr.2018.10.003
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Geriatrics & Gerontology
GA HC4RI
UT WOS:000451791500008
PM 30336272
DA 2024-02-19
ER

PT J
AU Meng, DY
   Zhang, BH
   Wang, YY
   Zheng, TT
   Hu, R
   Wang, B
   Otsu, KY
   Wang, Y
   Huang, GH
AF Meng, Deyun
   Zhang, Baohua
   Wang, Yanyan
   Zheng, Tingting
   Hu, Ran
   Wang, Bin
   Otsu, Kinya
   Wang, Ying
   Huang, Gonghua
TI p38α Deficiency in T Cells Ameliorates Diet-Induced Obesity, Insulin
   Resistance, and Adipose Tissue Senescence
SO DIABETES
LA English
DT Article
ID PROTEIN-KINASE PLAYS; DIFFERENTIATION; METABOLISM; MTOR; ADIPOGENESIS;
   INFLAMMATION; DYSFUNCTION; GROWTH; FAT
AB Adipose tissue-resident T cells play vital roles in regulating inflammation and metabolism in obesity, but the underlying mechanisms remain unclear. Here, we show that high-fat diet (HFD) feeding enhances p38 activity in adipose-resident T cells. T cell-specific deletion of p38 alpha, an essential subunit of p38 expressed in most immune cells, protected mice from HFD-induced obesity, hepatic steatosis, adipose tissue inflammation, and insulin resistance. Mice with p38 alpha deletion in T cells exhibited higher energy expenditure. Mechanistically, p38 alpha promoted T-cell glycolysis through mechanistic target of rapamycin signaling, leading to enhanced Th1 differentiation. Accordingly, genetic deletion of p38 alpha alleviated ongoing diet-induced obesity. Unexpectedly, p38 alpha signaling in T cells promoted adipose tissue senescence during obesity and aging. Taken together, our results identify p38 alpha in T cells as an essential regulator of obesity, insulin resistance, and adipose tissue senescence, and p38 alpha may be a therapeutic target for obese- or aging-associated diseases.
C1 [Meng, Deyun; Zheng, Tingting; Wang, Ying; Huang, Gonghua] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai, Peoples R China.
   [Zhang, Baohua] Tongji Univ, Dept Clin Lab Med, Shanghai Peoples Hosp 10, Shanghai, Peoples R China.
   [Wang, Yanyan; Zheng, Tingting; Wang, Bin; Huang, Gonghua] Guangdong Med Univ, Guangdong Prov Key Lab Med Mol Diagnost, Dongguan, Peoples R China.
   [Hu, Ran] Tongji Univ, Basic Dept, Shanghai Peoples Hosp 10, Canc Ctr, Shanghai, Peoples R China.
   [Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan.
   [Otsu, Kinya] Kings Coll London, Sch Cardiovasc Med & Sci, London, England.
C3 Shanghai Jiao Tong University; Chinese Academy of Sciences; Tongji
   University; Guangdong Medical University; Tongji University; Osaka
   University; University of London; King's College London
RP Huang, GH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai, Peoples R China.; Huang, GH (corresponding author), Guangdong Med Univ, Guangdong Prov Key Lab Med Mol Diagnost, Dongguan, Peoples R China.
EM gonghua.huang@gdmu.edu.cn
RI liu, xiao/HKE-9880-2023
OI Zhang, Baohua/0000-0002-1394-9640
FU National Natural Science Foundation of China [31670897, 91642104,
   81471528, 82001702]; National Key R&D Program of China [2018YFC0115900];
   British Heart Foundation [CH/11/3/29051]
FX <BOLD>T</BOLD>his work was supported by grants 31670897, 91642104, and
   81471528 (G.H.) and 82001702 (T.Z.) from the National Natural Science
   Foundation of China, 2018YFC0115900 (G.H.) from the National Key R&D
   Program of China, and CH/11/3/29051 (K.O.) from the British Heart
   Foundation.
CR Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996
   Anerillas C, 2020, GEROSCIENCE, V42, P397, DOI 10.1007/s11357-020-00183-3
   Antony AK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02945
   Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963
   Bühler S, 2014, EXPERT OPIN THER PAT, V24, P535, DOI 10.1517/13543776.2014.894977
   Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200
   Chornoguz O, 2017, J IMMUNOL, V198, P3939, DOI 10.4049/jimmunol.1601078
   Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323
   Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005
   Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x
   Engin A, 2017, ADV EXP MED BIOL, V960, P1, DOI 10.1007/978-3-319-48382-5_1
   Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002
   Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710
   Frydrych L, 2018, J LEUKOCYTE BIOL, V104, P525, DOI 10.1002/JLB.5VMR0118-021RR
   Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019
   Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017
   Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207
   Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002
   Hwang S, 2020, HEPATOLOGY, V72, P873, DOI 10.1002/hep.31390
   Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3
   Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343
   Khan S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00267
   Kumashiro N, 2013, DIABETES, V62, P2183, DOI 10.2337/db12-1311
   Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449
   Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002
   Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8
   Li YY, 2021, NAT IMMUNOL, V22, P1175, DOI 10.1038/s41590-021-01010-3
   MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956
   Matesanz N, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004455
   Mau T, 2018, EXP GERONTOL, V105, P27, DOI 10.1016/j.exger.2017.10.014
   Mauro C, 2017, CELL METAB, V25, P593, DOI 10.1016/j.cmet.2017.01.008
   Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005
   Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912
   Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]
   Salvestrini V, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00266
   Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606
   Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887
   Tanti Jean-Francois, 2012, Front Endocrinol (Lausanne), V3, P181, DOI 10.3389/fendo.2012.00181
   Trim W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00169
   Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287
   Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001
   Zhang SJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004225
   Zheng TT, 2018, P NATL ACAD SCI USA, V115, pE12313, DOI 10.1073/pnas.1814705115
NR 48
TC 3
Z9 3
U1 2
U2 4
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD JUN
PY 2022
VL 71
IS 6
BP 1205
EP 1217
DI 10.2337/db21-0653
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 7K3JY
UT WOS:000905183300005
PM 35349644
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Furrer, K
   Rickenbacher, A
   Tian, YH
   Jochum, W
   Bittermann, AG
   Käch, A
   Humar, B
   Graf, R
   Moritz, W
   Clavien, PA
AF Furrer, Katarzyna
   Rickenbacher, Andreas
   Tian, Yinghua
   Jochum, Wolfram
   Bittermann, Anne Greet
   Kaech, Andres
   Humar, Bostjan
   Graf, Rolf
   Moritz, Wolfgang
   Clavien, Pierre-Alain
TI Serotonin reverts age-related capillarization and failure of
   regeneration in the liver through a VEGF-dependent pathway
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE aging liver; fenestrations; sinusoidal microperfusion
ID HEPATIC SINUSOIDAL ENDOTHELIUM; RAT-LIVER; TRANSPLANTATION; DISEASE;
   GROWTH; MODEL; MICE; SIZE; CELL; PSEUDOCAPILLARIZATION
AB The function of the liver is well-preserved during the aging process, although some evidence suggests that liver regeneration might be impaired with advanced age. We observed a decreased ability of the liver to restore normal volume after partial hepatectomy in elderly mice, and we identified a pathway that rescued regeneration and was triggered by serotonin. 2,5-dimethoxy-4-iodoamphetamine (DOI), a serotonin receptor agonist, reversed the age-related pseudocapillarization of old liver and improved hepatosinusoidal blood flow. After hepatectomy, the open fenestrae were associated with a restored attachment of platelets to endothelium and the initiation of a normal regenerative response, including the up-regulation of essential growth mediators and serotonin receptors. In turn, hepatocyte proliferation recovered along with regain of liver volume and animal survival. DOI operates through the release of VEGF, and its effects could be blocked with anti-VEGF antibodies both in vitro and in vivo. These results suggest that pseudocapillarization in the aged acts as a barrier to liver regeneration. DOI breaks this restraint through an endothelium-dependent mechanism driven by VEGF. This pathway highlights a target for reversing the age-associated decline in the capacity of the liver to regenerate.
C1 [Furrer, Katarzyna; Rickenbacher, Andreas; Tian, Yinghua; Humar, Bostjan; Graf, Rolf; Moritz, Wolfgang; Clavien, Pierre-Alain] Univ Zurich Hosp, Dept Surg, Lab Swiss Hepato Pancreato Biliary HPB, CH-8091 Zurich, Switzerland.
   [Furrer, Katarzyna; Rickenbacher, Andreas; Tian, Yinghua; Humar, Bostjan; Graf, Rolf; Moritz, Wolfgang; Clavien, Pierre-Alain] Univ Zurich Hosp, Transplantat Ctr, CH-8091 Zurich, Switzerland.
   [Bittermann, Anne Greet; Kaech, Andres] Univ Zurich Hosp, Ctr Microscopy & Image Anal, CH-8091 Zurich, Switzerland.
   [Jochum, Wolfram] Kantonsspital, Inst Pathol, CH-9007 St Gallen, Switzerland.
C3 University of Zurich; University Zurich Hospital; University of Zurich;
   University Zurich Hospital; University of Zurich; University Zurich
   Hospital; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen
RP Clavien, PA (corresponding author), Univ Zurich Hosp, Dept Surg, Lab Swiss Hepato Pancreato Biliary HPB, CH-8091 Zurich, Switzerland.
EM clavien@access.uzh.ch
OI Furrer, Katarzyna/0000-0002-3403-9806; Ziegler, Urs/0000-0001-7860-1867;
   Humar, Bostjan/0000-0002-7956-3062; Graf, Rolf/0000-0001-7449-7302
FU Swiss National Science Foundation [3200B0-109906]
FX We thank Udo Ungethum and Martha Bain for excellent technical support.
   We are grateful to Ashraf El-Badry for help with intravital microscopy.
   This work was supported by Swiss National Science Foundation Grant
   3200B0-109906 (to P.-A.C.).
CR Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d
   Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156
   Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Corsonello A, 2010, CURR MED CHEM, V17, P571, DOI 10.2174/092986710790416326
   DOBBS BR, 1994, LIVER, V14, P230
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Funyu J, 2001, BIOCHEM BIOPH RES CO, V280, P481, DOI 10.1006/bbrc.2000.4148
   Furrer K, 2008, HEPATOLOGY, V47, P1615, DOI 10.1002/hep.22164
   García JJ, 2001, EUR J PHARMACOL, V428, P169, DOI 10.1016/S0014-2999(01)01342-5
   GUERRIERI F, 1992, ANN NY ACAD SCI, V671, P395, DOI 10.1111/j.1749-6632.1992.tb43813.x
   HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Ho-Tin-Noé B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Ikegami T, 2000, TRANSPLANTATION, V70, P1703, DOI 10.1097/00007890-200012270-00007
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Jackson LN, 2009, CLIN CANCER RES, V15, P2747, DOI 10.1158/1078-0432.CCR-08-2346
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Kaita KDE, 1997, LIVER, V17, P13
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Le Couteur DG, 2007, ANN NY ACAD SCI, V1114, P79, DOI 10.1196/annals.1396.003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842
   Mackey S, 2003, HEPATOLOGY, V38, P1349, DOI 10.1016/j.hep.2003.10.007
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   MORI T, 1993, HEPATOLOGY, V17, P891
   Nocito A, 2008, CANCER RES, V68, P5152, DOI 10.1158/0008-5472.CAN-08-0202
   Nocito A, 2007, GASTROENTEROLOGY, V133, P608, DOI 10.1053/j.gastro.2007.05.019
   Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d
   SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Selzner N, 2003, GASTROENTEROLOGY, V124, P692, DOI 10.1053/gast.2003.50098
   Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441
   Taub R, 1996, CLIN LAB MED, V16, P341, DOI 10.1016/S0272-2712(18)30273-7
   Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103
   Tian YH, 2011, HEPATOLOGY, V53, P253, DOI 10.1002/hep.23960
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   WOODHOUSE K, 1992, BIOPHARM DRUG DISPOS, V13, P311, DOI 10.1002/bdd.2510130502
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   Xu J, 2007, AM J PHYSIOL-RENAL, V293, pF1468, DOI 10.1152/ajprenal.00246.2007
   Yamaji M, 2010, MICROVASC RES, V80, P372, DOI 10.1016/j.mvr.2010.07.006
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
NR 53
TC 66
Z9 76
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 15
PY 2011
VL 108
IS 7
BP 2945
EP 2950
DI 10.1073/pnas.1012531108
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 721TB
UT WOS:000287377000060
PM 21282654
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Ding, CB
   Yu, ZB
   Sefik, E
   Zhou, J
   Kaffe, E
   Wang, GY
   Li, B
   Flavell, RA
   Hu, WG
   Ye, YQ
   Li, HB
AF Ding, Chenbo
   Yu, Zhibin
   Sefik, Esen
   Zhou, Jing
   Kaffe, Eleanna
   Wang, Gaoyang
   Li, Bin
   Flavell, Richard A.
   Hu, Weiguo
   Ye, Youqiong
   Li, Hua-Bing
TI A T<sub>reg</sub>-specific long noncoding RNA maintains immune-metabolic
   homeostasis in aging liver
SO NATURE AGING
LA English
DT Article; Early Access
ID CELLS; ACCUMULATION; PHENOTYPE; FREQUENCY; INNATE; MUSCLE
AB Regulatory T (T-reg) cells have an important role in age-related diseases and inflammation; however, the underlying mechanisms are not fully understood. Li et al. identify a T-reg-specific long noncoding RNA, Altre, that binds Yin Yang 1 to regulate liver T-reg mitochondrial function in old mice. Altre deletion accelerates aging-associated liver pathogenesis.
   Regulatory T (T-reg) cells modulate several aging-related liver diseases. However, the molecular mechanisms regulating T-reg function in this context are unknown. Here we identified a long noncoding RNA, Altre (aging liver T-reg-expressed non-protein-coding RNA), which was specifically expressed in the nucleus of T-reg cells and increased with aging. T-reg-specific deletion of Altre did not affect T-reg homeostasis and function in young mice but caused T-reg metabolic dysfunction, inflammatory liver microenvironment, liver fibrosis and liver cancer in aged mice. Depletion of Altre reduced T-reg mitochondrial integrity and respiratory capacity, and induced reactive oxygen species accumulation, thus increasing intrahepatic T-reg apoptosis in aged mice. Moreover, lipidomic analysis identified a specific lipid species driving T-reg aging and apoptosis in the aging liver microenvironment. Mechanistically, Altre interacts with Yin Yang 1 to orchestrate its occupation on chromatin, thereby regulating the expression of a group of mitochondrial genes, and maintaining optimal mitochondrial function and T-reg fitness in the liver of aged mice. In conclusion, the T-reg-specific nuclear long noncoding RNA Altre maintains the immune-metabolic homeostasis of the aged liver through Yin Yang 1-regulated optimal mitochondrial function and the T-reg-sustained liver immune microenvironment. Thus, Altre is a potential therapeutic target for the treatment of liver diseases affecting older adults.
C1 [Ding, Chenbo; Yu, Zhibin; Zhou, Jing; Wang, Gaoyang; Li, Bin; Ye, Youqiong; Li, Hua-Bing] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Med Ctr Aging,Ctr Immune Related Dis,Shanghai Inst, Shanghai, Peoples R China.
   [Ding, Chenbo; Yu, Zhibin; Zhou, Jing; Li, Hua-Bing] Shanghai Jiao Tong Univ, Yale Inst Immune Metab, Sch Med, Shanghai, Peoples R China.
   [Sefik, Esen; Kaffe, Eleanna; Flavell, Richard A.] Yale Univ, Dept Immunobiol, Dept Immunobiol, New Haven, CT USA.
   [Sefik, Esen; Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, Howard Hughes Med Inst, New Haven, CT USA.
   [Hu, Weiguo; Li, Hua-Bing] Shanghai Jiao Tong Univ, Med Ctr Aging, Dept Geriatr, Dept Geriatr, Shanghai, Peoples R China.
   [Li, Hua-Bing] Chongqing Int Inst Immunol, Chongqing, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Yale
   University; Howard Hughes Medical Institute; Yale University; Shanghai
   Jiao Tong University
RP Li, HB (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Med Ctr Aging,Ctr Immune Related Dis,Shanghai Inst, Shanghai, Peoples R China.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Yale Inst Immune Metab, Sch Med, Shanghai, Peoples R China.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Med Ctr Aging, Dept Geriatr, Dept Geriatr, Shanghai, Peoples R China.; Li, HB (corresponding author), Chongqing Int Inst Immunol, Chongqing, Peoples R China.
EM huabing.li@shsmu.edu.cn
RI lI, Bin/AAR-4966-2021; Hu, weiguo/A-4988-2011; Li, Huabing/M-5390-2013
OI lI, Bin/0000-0002-7640-8884; Sefik, Esen/0000-0002-6807-3498; Ye,
   Youqiong/0000-0001-8332-4710; Flavell, Richard/0000-0003-4461-0778;
   Ding, Chenbo/0000-0002-3236-842X; Li, Huabing/0000-0003-3573-6803
FU National Natural Science Foundation of China [82341017, 82030042,
   32070917, 82111540277, 82202017, 82271756]; Chongqing International
   Institute for Immunology [2021YJC01]; Ministry of Science and Technology
   of China [2021YFA1100800]; Shanghai Science and Technology Commission
   [20JC1417400, 201409005500, 20JC1410100, 20ZR1472900, 22QA1408100];
   Shanghai Municipal Health Commission [2022XD047, 2022JC001]; Innovative
   Research Team of High-Level Local Universities in Shanghai
   [SHSMU-ZDCX20212501, SHSMU-ZDCX20212500]; China Postdoctoral Science
   Foundation [2021M702160]
FX We thank W. Li for helping with the mass spectrometry analysis; J. Zhao
   and J. Hu for their help with genotyping and sample collection; P.
   Ranney and C. Hughes for their initial help and suggestions in the
   generation of the Altre loxP mice; X. Wang and H. Li for their
   contribution to the key discussion; all members of the Li laboratories
   for discussions and suggestions; and the sequencing and flow cytometry
   core facilities at Shanghai Institute of Immunology for their support.
   This work was supported by the National Natural Science Foundation of
   China (nos. 82341017, 82030042, 32070917 and 82111540277 to H.-B.L.; no.
   82202017 to C.D.; no. 82271756 to J.Z.), the Chongqing International
   Institute for Immunology (no. 2021YJC01 to H.-B.L.), the Ministry of
   Science and Technology of China (no. 2021YFA1100800 to H.-B.L.), the
   Shanghai Science and Technology Commission (nos. 20JC1417400,
   201409005500 and 20JC1410100 to H.-B.L.; no. 20ZR1472900 to Y.Y.; no.
   22QA1408100 to J.Z.), the Shanghai Municipal Health Commission (nos.
   2022XD047 and 2022JC001 to H.-B.L.), the Innovative Research Team of
   High-Level Local Universities in Shanghai (no. SHSMU-ZDCX20212501 to
   H.-B.L.; no. SHSMU-ZDCX20212500 to J.Z.), and the China Postdoctoral
   Science Foundation (no. 2021M702160 to C.D.). The funders had no role in
   study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Albillos A, 2022, NAT REV GASTRO HEPAT, V19, P112, DOI 10.1038/s41575-021-00520-7
   Rios DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13777-3
   Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151
   Bedke T, 2010, J IMMUNOL, V184, P5562, DOI 10.4049/jimmunol.0902458
   Brajic A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01989
   Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054
   CHANG LS, 1989, J VIROL, V63, P3479, DOI 10.1128/JVI.63.8.3479-3488.1989
   Cheung EC, 2022, NAT REV CANCER, V22, P280, DOI 10.1038/s41568-021-00435-0
   Choi YS, 2015, GUT, V64, P1303, DOI 10.1136/gutjnl-2013-306213
   Chougnet CA, 2011, J IMMUNOL, V186, P156, DOI 10.4049/jimmunol.1001505
   Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132
   Darrigues J, 2018, GERONTOLOGY, V64, P28, DOI 10.1159/000478044
   De Cecco M, 2019, NATURE, V572, pE5, DOI [10.1038/s41586-019-1350-9, 10.1038/s41586-018-0784-9]
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Fan MR, 2020, NATURE, V582, P129, DOI 10.1038/s41586-020-2309-6
   Field CS, 2020, CELL METAB, V31, P422, DOI 10.1016/j.cmet.2019.11.021
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080
   Guo ZL, 2020, J CLIN INVEST, V130, P5893, DOI 10.1172/JCI136466
   Hann A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.719954
   Harman CCD, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.1918062118
   Huang YL, 2021, AGING CELL, V20, DOI 10.1111/acel.13523
   Ikeno Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.584048
   Jeffery HC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00334
   Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928
   Jiang RQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15129
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646
   Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011
   Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346
   Kumar P, 2018, J AUTOIMMUN, V95, P77, DOI 10.1016/j.jaut.2018.08.007
   Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009
   Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004
   Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450
   Li J, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1353
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Luo XJ, 2018, GASTROENTEROLOGY, V155, P1971, DOI 10.1053/j.gastro.2018.09.010
   Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823
   Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622
   Matias MI, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109911
   Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613
   Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1016/j.ctim.2007.01.003, 10.1002/0471142735.im1501s88, 10.1002/0471142735.im1501s77]
   Nallagangula KS, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2017-0083
   Noureddin M, 2013, HEPATOLOGY, V58, P1644, DOI 10.1002/hep.26465
   Papsdorf K, 2019, TRENDS CELL BIOL, V29, P97, DOI 10.1016/j.tcb.2018.09.004
   Paquissi FC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01195
   Pellegrini M, 2007, CELL DEATH DIFFER, V14, P338, DOI 10.1038/sj.cdd.4401997
   Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114
   Ravichandran G, 2019, J HEPATOL, V71, P773, DOI 10.1016/j.jhep.2019.05.023
   Roh YS, 2018, AM J PATHOL, V188, P2574, DOI 10.1016/j.ajpath.2018.07.011
   Ron-Harel N, 2018, P NATL ACAD SCI USA, V115, P13347, DOI 10.1073/pnas.1804149115
   Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007
   Ronaldson A, 2016, PSYCHOPHARMACOLOGY, V233, P1661, DOI 10.1007/s00213-015-3876-3
   Rosenkranz D, 2007, J NEUROIMMUNOL, V188, P117, DOI 10.1016/j.jneuroim.2007.05.011
   Sakamuru S, 2016, METHODS MOL BIOL, V1473, P17, DOI 10.1007/978-1-4939-6346-1_2
   Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3
   Sousa-Franco A, 2019, AGING CELL, V18, DOI 10.1111/acel.12870
   Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004
   Torrao RC, 2014, FREE RADICAL BIO MED, V71, P26, DOI 10.1016/j.freeradbiomed.2014.03.002
   Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002
   Van Herck MA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00082
   Vendramin R, 2017, EMBO J, V36, P1123, DOI 10.15252/embj.201695546
   Wawman RE, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01889
   Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z
   Wohlwend M, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc7367
   Wu NB, 2021, NATURE, V592, P606, DOI 10.1038/s41586-021-03283-y
   Yao RW, 2019, NAT CELL BIOL, V21, P542, DOI 10.1038/s41556-019-0311-8
   Ying Z, 2017, J CLIN INVEST, V127, P1725, DOI 10.1172/JCI90439
   Zemmour D, 2017, P NATL ACAD SCI USA, V114, pE3472, DOI 10.1073/pnas.1700946114
   Zhang HG, 2022, CELL DEATH DIFFER, V29, P351, DOI 10.1038/s41418-021-00858-0
NR 77
TC 4
Z9 4
U1 7
U2 13
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD 2023 JUL
PY 2023
VL 3
IS 7
BP 813
EP +
DI 10.1038/s43587-023-00428-8
EA JUN 2023
PG 26
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA M0ET0
UT WOS:001000905600003
PM 37277640
DA 2024-02-19
ER

PT J
AU Tong, L
   Wang, L
   Yao, SS
   Jin, LN
   Yang, J
   Zhang, YF
   Ning, G
   Zhang, ZG
AF Tong, Lei
   Wang, Long
   Yao, Shuangshuang
   Jin, Lina
   Yang, Jian
   Zhang, Yifei
   Ning, Guang
   Zhang, Zhiguo
TI PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid
   oxidation
SO CELL DEATH & DISEASE
LA English
DT Article
ID ACTIVATED RECEPTOR-DELTA; LIVER-DISEASE; LIPID-METABOLISM; PROGRESSION;
   LIPOGENESIS; DEFICIENT; INDUCTION; PROTECTS; AGONIST; GLUCOSE
AB Peroxisome proliferator-activated receptor delta (PPAR delta) belongs to the nuclear receptor family and is involved in metabolic diseases. Although PPARd is known to attenuate hepatic lipid deposition, its mechanism remains unclear. Here, we show that PPAR delta is a potent stimulator of hepatic autophagic flux. The expression levels of PPAR delta and autophagy-related proteins were decreased in liver tissues from obese and ageing mice. Pharmacological and adenovirus-mediated increases in PPAR delta expression and activity were achieved in obese transgenic db/db and high fat diet-fed mice. Using genetic, pharmacological and metabolic approaches, we demonstrate that PPAR delta reduces intrahepatic lipid content and stimulates beta-oxidation in liver and hepatic cells by an autophagy-lysosomal pathway involving AMPK/mTOR signalling. These results provide novel insight into the lipolytic actions of PPAR delta through autophagy in the liver and highlight its potential beneficial effects in NAFLD.
C1 [Tong, Lei; Wang, Long; Yao, Shuangshuang; Jin, Lina; Yang, Jian; Zhang, Yifei; Ning, Guang; Zhang, Zhiguo] Shanghai Jiao Tong Univ, Shanghai Inst Endocrine & Metab Dis, Ruijin Hosp,China Natl Res Ctr Metab Dis,Sch Med, Dept Endocrinol & Metab,Shanghai Clin Ctr Endocri, Shanghai 200025, Peoples R China.
C3 Shanghai Jiao Tong University
RP Zhang, ZG (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Endocrine & Metab Dis, Ruijin Hosp,China Natl Res Ctr Metab Dis,Sch Med, Dept Endocrinol & Metab,Shanghai Clin Ctr Endocri, Shanghai 200025, Peoples R China.
EM zhangzhiguo@outlook.com
RI Zhang, Yifei/GRO-3001-2022
OI Yang, Jian/0000-0002-3390-5127
FU National Natural Science Foundation of China [81570719, 81670797
   81471074, 81770863, 81500660]; Key Laboratory for Endocrine and
   Metabolic Diseases, Chinese Ministry of Public Health [1994DP131044];
   Ministry of Science & Technology Innovation [2011YQ030114]; Basic
   Important Program [10JC141100]; Ministry of Health [201002002]; National
   Key New Drug Creation and Manufacturing Program by the Ministry of
   Science and Technology [2012ZX09303006-001]; Shanghai Municipal Natural
   Science Foundation; Shanghai Municipal Education Commission; Shanghai
   Education Development Foundation [14SG17]
FX This study was supported by the National Natural Science Foundation of
   China (Nos. 81570719, 81670797 81471074, 81770863, and 81500660) with
   partial support from the Key Laboratory for Endocrine and Metabolic
   Diseases, Chinese Ministry of Public Health (No. 1994DP131044), the
   Ministry of Science & Technology Innovation Fund and Projects (No.
   2011YQ030114), the Basic Important Program (No. 10JC141100), the Sector
   Funds of the Ministry of Health (No. 201002002), and the National Key
   New Drug Creation and Manufacturing Program by the Ministry of Science
   and Technology (No. 2012ZX09303006-001). This study was supported by the
   Shanghai Municipal Natural Science Foundation (18ZR1433000) the Fund of
   Shanghai Municipal Education Commission and Shanghai Education
   Development Foundation (No. 14SG17).
CR Bajaj M, 2007, DIABETOLOGIA, V50, P1723, DOI 10.1007/s00125-007-0698-9
   Bays HE, 2011, J CLIN ENDOCR METAB, V96, P2889, DOI 10.1210/jc.2011-1061
   Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025
   Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037
   Bojic LA, 2013, CURR OPIN LIPIDOL, V24, P171, DOI 10.1097/MOL.0b013e32835cc949
   Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x
   Demir M, 2015, J DIGEST DIS, V16, P541, DOI 10.1111/1751-2980.12291
   Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042
   Farah BL, 2016, J HEPATOL, V64, P370, DOI 10.1016/j.jhep.2015.10.008
   Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019
   Gross B, 2017, NAT REV ENDOCRINOL, V13, P36, DOI 10.1038/nrendo.2016.135
   Iwaisako K, 2012, P NATL ACAD SCI USA, V109, pE1369, DOI 10.1073/pnas.1202464109
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210
   Lee JY, 2011, DIABETES METAB J, V35, P489, DOI 10.4093/dmj.2011.35.5.489
   Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011
   Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042
   Martinez-Lopez N, 2015, ANNU REV NUTR, V35, P215, DOI 10.1146/annurev-nutr-071813-105336
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4
   Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028
   Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690
   Palomer X, 2014, INT J CARDIOL, V174, P110, DOI 10.1016/j.ijcard.2014.03.176
   Risérus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318
   Shan WW, 2008, HEPATOLOGY, V47, P225, DOI 10.1002/hep.21925
   Singh R, 2010, RESULTS PROBL CELL D, V52, P35, DOI 10.1007/978-3-642-14426-4_4
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271
   Song YM, 2012, AUTOPHAGY, V8, P1085, DOI 10.4161/auto.20260
   Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012
   Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016
   Tamura S, 2005, J CLIN INVEST, V115, P1139, DOI 10.1172/JCI200524930
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132
   Toshima T, 2014, J GASTROENTEROL, V49, P907, DOI 10.1007/s00535-013-0835-9
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   Wu HT, 2011, HORM METAB RES, V43, P631, DOI 10.1055/s-0031-1280781
   Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765
NR 44
TC 46
Z9 50
U1 4
U2 24
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD FEB 27
PY 2019
VL 10
AR 197
DI 10.1038/s41419-019-1458-8
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HN8PS
UT WOS:000460458300003
PM 30814493
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Quimby, JM
   Maranon, DG
   Battaglia, CLR
   McLeland, SM
   Brock, WT
   Bailey, SM
AF Quimby, Jessica M.
   Maranon, David G.
   Battaglia, Christine L. R.
   McLeland, Shannon M.
   Brock, William T.
   Bailey, Susan M.
TI Feline chronic kidney disease is associated with shortened telomeres and
   increased cellular senescence
SO AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
LA English
DT Article
DE kidney; telomere; senescence; feline; aging
ID OXIDATIVE STRESS; RENAL-DISEASE; LENGTH ASSESSMENT; CATS; EXPRESSION;
   QUANTIFICATION; P16(INK4A); BIOMARKER; TISSUES; INJURY
AB Telomeres are protective structures at the ends of chromosomes that have important implications for aging. To address the question of whether telomeres contribute to feline chronic kidney disease (CKD), we evaluated kidney, liver, and skin samples from 12 cats with naturally occurring CKD, 12 young normal cats, and 6 old normal cats. Telomere length was assessed using standard telomere fluorescent in situ hybridization (TEL-FISH) combined with immunohistochemistry (TELI-FISH) to identify proximal (PTEC) and distal tubular epithelial cells (DTEC), whereas senescence-associated beta-galactosidase (SABG) staining was used to evaluate senescence. Results revealed statistically significant decreases in the average telomere fluorescence intensity (TFI) of PTEC in CKD cats compared with young and geriatric normal cats, and in the DTEC of CKD cats compared with young normal cats. When histograms of individual TFI were compared, statistically significant decreases in the PTEC and DTEC of CKD cats were observed compared with young and geriatric normal cats. Concomitantly, a statistically significant increase in SABG staining was seen in CKD kidney samples compared with young normal cats. CKD cats tended to have increased SABG staining in the kidney compared with normal geriatric cats, but this did not reach statistical significance. No significant telomere shortening in liver or skin from any group was observed. Real-time quantitative telomeric repeat amplification protocol assessment of renal telomerase activity revealed comparable low levels of telomerase activity in all groups. Our results suggest that shortened telomeres and increased senescence in the kidneys of CKD cats may represent novel targets for interventional therapy.
C1 [Quimby, Jessica M.; Brock, William T.] Colorado State Univ, Dept Clin Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA.
   [Maranon, David G.; Battaglia, Christine L. R.; Bailey, Susan M.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.
   [McLeland, Shannon M.] Colorado State Univ, Dept Mol Biol Immunol & Pathol, Ft Collins, CO 80523 USA.
C3 Colorado State University; Colorado State University; Colorado State
   University
RP Quimby, JM (corresponding author), Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA.
EM jquimby@colostate.edu
RI Maranon, David G/AAL-2505-2020; Quimby, Jessica/P-1720-2019
FU Morris Animal Foundation
FX This study was funded by a grant from the Morris Animal Foundation.
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Boyd LM, 2008, J VET INTERN MED, V22, P1111, DOI 10.1111/j.1939-1676.2008.0163.x
   Brandt LE, 2012, VET PATHOL, V49, P693, DOI 10.1177/0300985811410720
   Cadile CD, 2001, AM J VET RES, V62, P1578, DOI 10.2460/ajvr.2001.62.1578
   Cottliar A, 2000, AM J GASTROENTEROL, V95, P2301
   DIBARTOLA SP, 1987, J AM VET MED ASSOC, V190, P1196
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   López-Diazguerrero NE, 2012, CELL BIOL INT, V36, P409, DOI 10.1042/CBI20110308
   Feng X, 2011, MOL MED REP, V4, P255, DOI 10.3892/mmr.2011.436
   Fusaro L, 2009, J VET DIAGN INVEST, V21, P369, DOI 10.1177/104063870902100312
   Goldberg-Bittman L, 2008, CANCER GENET CYTOGEN, V184, P105, DOI 10.1016/j.cancergencyto.2008.04.006
   Hamet P, 2001, HYPERTENSION, V37, P760, DOI 10.1161/01.HYP.37.2.760
   Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342
   Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239
   Hirota J, 1996, J VET MED SCI, V58, P1025, DOI 10.1292/jvms.58.10_1025
   Hou M, 2001, CLIN CHEM, V47, P519
   Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0
   Joosten SA, 2003, AM J PATHOL, V162, P1305, DOI 10.1016/S0002-9440(10)63926-0
   Kao MPC, 2010, J HUM HYPERTENS, V24, P1, DOI 10.1038/jhh.2009.70
   Keegan RF, 2010, J VET INTERN MED, V24, P514, DOI 10.1111/j.1939-1676.2010.0498.x
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074
   Mai S, 2006, J CELL BIOCHEM, V97, P904, DOI 10.1002/jcb.20760
   Masi S, 2011, FREE RADICAL BIO MED, V50, P730, DOI 10.1016/j.freeradbiomed.2010.12.031
   McKevitt TR, 2003, AM J VET RES, V64, P1496, DOI 10.2460/ajvr.2003.64.1496
   Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9
   Melk A, 2005, AM J TRANSPLANT, V5, P1375, DOI 10.1111/j.1600-6143.2005.00846.x
   Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x
   Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444
   Naesens M, 2011, DISCOV MED, V11, P65
   Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757
   Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1
   Perico N, 2011, CURR OPIN NEPHROL HY, V20, P312, DOI 10.1097/MNH.0b013e328344c327
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Popolo A, 2013, FREE RADICAL RES, V47, P346, DOI 10.3109/10715762.2013.779373
   Reyes JL, 2002, KIDNEY INT, V62, P476, DOI 10.1046/j.1523-1755.2002.00479.x
   Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008
   Rodríguez-Iturbe B, 2010, NEPHRON CLIN PRACT, V116, pC81, DOI 10.1159/000314656
   Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005
   Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013
   Takubo K, 2010, GERIATR GERONTOL INT, V10, pS197, DOI 10.1111/j.1447-0594.2010.00605.x
   Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005
   Tchakmakjian L, 2004, NEPHRON EXP NEPHROL, V98, pE82, DOI 10.1159/000080683
   Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008
   von Figura G, 2009, J MOL MED, V87, P1165, DOI 10.1007/s00109-009-0509-5
   Yu S, 2006, VET RES COMMUN, V30, P403, DOI 10.1007/s11259-006-3269-5
NR 50
TC 25
Z9 27
U1 0
U2 22
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1931-857X
EI 1522-1466
J9 AM J PHYSIOL-RENAL
JI Am. J. Physiol.-Renal Physiol.
PD AUG
PY 2013
VL 305
IS 3
BP F295
EP F303
DI 10.1152/ajprenal.00527.2012
PG 9
WC Physiology; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Urology & Nephrology
GA 195JU
UT WOS:000322699000009
PM 23720342
DA 2024-02-19
ER

PT J
AU Lenk, L
   Pein, M
   Will, O
   Gomez, B
   Viol, F
   Hauser, C
   Egberts, JH
   Gundlach, JP
   Helm, O
   Tiwari, S
   Weiskirchen, R
   Rose-John, S
   Röcken, C
   Mikulits, W
   Wenzel, P
   Schneiderk, G
   Saur, D
   Schäfer, H
   Sebens, S
AF Lenk, Lennart
   Pein, Maren
   Will, Olga
   Gomez, Beatriz
   Viol, Fabrice
   Hauser, Charlotte
   Egberts, Jan-Hendrik
   Gundlach, Jan-Paul
   Helm, Ole
   Tiwari, Sanjay
   Weiskirchen, Ralf
   Rose-John, Stefan
   Roecken, Christoph
   Mikulits, Wolfgang
   Wenzel, Patrick
   Schneiderk, Guenter
   Saur, Dieter
   Schaefer, Heiner
   Sebens, Susanne
TI The hepatic microenvironment essentially determines tumor cell dormancy
   and metastatic outgrowth of pancreatic ductal adenocarcinoma
SO ONCOIMMUNOLOGY
LA English
DT Article
DE dormancy; pancreatic cancer; tumor stroma; metastases; inflammation
ID COLORECTAL-CANCER; STELLATE CELLS; PHASE-III; PROGRESSION; SENESCENCE;
   BEVACIZUMAB; GEMCITABINE; INHIBITION; MECHANISMS; RESECTION
AB Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed when liver metastases already emerged. This study elucidated the impact of hepatic stromal cells on growth behavior of premalignant and malignant pancreatic ductal epithelial cells (PDECs). Liver sections of tumor-bearing KPC mice comprised micrometastases displaying low proliferation located in an unobtrusive hepatic microenvironment whereas macrometastases containing more proliferating cells were surrounded by hepatic myofibroblasts (HMFs). In an age-related syngeneic PDAC mouse model livers with signs of age-related inflammation exhibited significantly more proliferating disseminated tumor cells (DTCs) and micrometastases despite comparable primary tumor growth and DTC numbers. Hepatic stellate cells (HSC), representing a physiologic liver stroma, promoted an IL-8 mediated quiescence-associated phenotype (QAP) of PDECs in coculture. QAP included flattened cell morphology, Ki67-negativity and reduced proliferation, elevated senescence-associated beta galactosidase activity and diminished p-Erk/p-p38-ratio. In contrast, proliferation of PDECs was enhanced by VEGF in the presence of HMF. Switching the micromilieu from HSC to HMF or blocking VEGF reversed QAP in PDECs. This study demonstrates how HSCs induce and maintain a reversible QAP in disseminated PDAC cells, while inflammatory HMFs foster QAP reversal and metastatic outgrowth. Overall, the importance of the hepatic microenvironment in induction and reversal of dormancy during PDAC metastasis is emphasized.
C1 [Lenk, Lennart; Gomez, Beatriz; Helm, Ole; Schaefer, Heiner; Sebens, Susanne] Christian Albrechts Univ Kiel CAU, Inst Expt Canc Res, Campus Kiel, Kiel, Germany.
   [Lenk, Lennart; Gomez, Beatriz; Helm, Ole; Schaefer, Heiner; Sebens, Susanne] Univ Med Ctr Schleswig Holstein UKSH, Campus Kiel, Kiel, Germany.
   [Pein, Maren] German Canc Res Ctr, Cell Biol & Tumor Biol Program, Heidelberg, Germany.
   [Pein, Maren] HI STEM gGmbH, Heidelberg Inst Stem Cell Technol & Expt Med, Heidelberg, Germany.
   [Will, Olga; Tiwari, Sanjay] CAU, Clin Radiol & Neuroradiol, Mol Imaging North Competence Ctr, Campus Kiel, Kiel, Germany.
   [Will, Olga; Tiwari, Sanjay] UKSH, Campus Kiel,Arnold Heller Str 3,Haus 17, Kiel, Germany.
   [Viol, Fabrice] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany.
   [Hauser, Charlotte; Egberts, Jan-Hendrik; Gundlach, Jan-Paul] UKSH, Dept Gen Visceral Thorac Transplantat & Pediat Su, Campus Kiel, Kiel, Germany.
   [Weiskirchen, Ralf] Rhein Westfal TH Aachen, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, Aachen, Germany.
   [Rose-John, Stefan] CAU, Dept Biochem, Kiel, Germany.
   [Roecken, Christoph] UKSH, Inst Pathol, Campus Kiel, Kiel, Germany.
   [Mikulits, Wolfgang] Med Univ Vienna, Comprehens Canc Ctr, Div Inst Canc Res, Dept Med 1, Vienna, Austria.
   [Wenzel, Patrick; Schneiderk, Guenter; Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany.
C3 University of Kiel; Schleswig Holstein University Hospital; Helmholtz
   Association; German Cancer Research Center (DKFZ); University of Kiel;
   Schleswig Holstein University Hospital; University of Hamburg;
   University Medical Center Hamburg-Eppendorf; University of Kiel;
   Schleswig Holstein University Hospital; RWTH Aachen University;
   University of Kiel; University of Kiel; Schleswig Holstein University
   Hospital; Medical University of Vienna; University of Hamburg;
   University Medical Center Hamburg-Eppendorf; Technical University of
   Munich
RP Sebens, S (corresponding author), Univ Med Ctr Schleswig Holstein UKSH, Campus Kiel, Kiel, Germany.; Sebens, S (corresponding author), UKSH, Campus Kiel,Arnold Heller Str 3,Haus 17, Kiel, Germany.; Sebens, S (corresponding author), Christian Albrechts Univ Kiel, Inst Expt Canc Res, Grp Inflammatory Carcinogenesis, Campus Kiel,Arnold Heller Str 3,Haus 17, D-24105 Kiel, Germany.
EM susanne.sebens@email.uni-kiel.de
RI Rose-John, Stefan/A-7998-2010; Sebens, Susanne/C-1222-2010; Tiwari,
   Sanjay/Q-1853-2016; Lenk, Lennart/AAH-3112-2020; Röcken,
   Christoph/A-9239-2010; Mikulits, Wolfgang/AAH-4043-2021; Egberts,
   Jan-Hendrik/E-3211-2015; Weiskirchen, Ralf/O-1734-2018; Schäfer,
   Heiner/C-1055-2011; Saur, Dieter/O-8355-2015
OI Rose-John, Stefan/0000-0002-7519-3279; Tiwari,
   Sanjay/0000-0002-3804-3300; Röcken, Christoph/0000-0002-6989-8002;
   Weiskirchen, Ralf/0000-0003-3888-0931; Saur, Dieter/0000-0001-5874-0210;
   Mikulits, Wolfgang/0000-0003-4612-7106; Schafer,
   Heiner/0000-0001-6936-9090
FU Medical Faculty of Christian-Albrechts-University Kiel; Deutsche
   Forschungsgemeinschaft [SE1831/2-3]; Cluster of Excellence Infammation
   at interfaces
FX This work was supported by the Medical Faculty of
   Christian-Albrechts-University Kiel and the Deutsche
   Forschungsgemeinschaft (SE1831/2-3) and the Cluster of Excellence
   Infammation at interfaces.
CR Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684
   Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256
   Aiello NM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12819
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Tung BT, 2015, AGING CLIN EXP RES, V27, P775, DOI 10.1007/s40520-015-0366-8
   Chatterjee M, 2011, INT J CANCER, V129, P61, DOI 10.1002/ijc.25655
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169
   De Cock JM, 2016, CANCER RES, V76, P6778, DOI 10.1158/0008-5472.CAN-16-0608
   Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gallmeier E, 2015, GUT, V64, P1676, DOI 10.1136/gutjnl-2014-309066
   Grünwald B, 2016, GASTROENTEROLOGY, V151, P1011, DOI 10.1053/j.gastro.2016.07.043
   Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060
   Hasan MR, 2011, INT J CANCER, V129, P2115, DOI 10.1002/ijc.26179
   Helm O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094357
   Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023
   Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Li AH, 2011, AM J PATHOL, V178, P1340, DOI 10.1016/j.ajpath.2010.11.058
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753
   Müerköster SS, 2008, ONCOGENE, V27, P1122, DOI 10.1038/sj.onc.1210728
   Mürköster SS, 2007, ONCOGENE, V26, P2759, DOI 10.1038/sj.onc.1210076
   Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295
   Neuzillet C, 2015, PHARMACOL THERAPEUT, V155, P80, DOI 10.1016/j.pharmthera.2015.08.006
   Nielsen SR, 2016, NAT CELL BIOL, V18, P549, DOI 10.1038/ncb3340
   Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377
   Proell V, 2005, BBA-MOL CELL RES, V1744, P76, DOI 10.1016/j.bbamcr.2004.12.009
   Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208
   Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025
   Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007
   Rougier P, 2013, EUR J CANCER, V49, P2633, DOI 10.1016/j.ejca.2013.04.002
   Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198
   Schumacher JD, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8323747
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI [10.3322/caac.20006, 10.3322/caac.21387, 10.3322/caac.21601, 10.3322/caac.20073, 10.3322/caac.21654, 10.3322/caac.21332, 10.3322/caac.21551, 10.3322/caac.21254]
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793
   Sperti C, 1997, WORLD J SURG, V21, P195, DOI 10.1007/s002689900215
   Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P7620, DOI 10.3748/wjg.v19.i43.7620
   Tuveson DA, 2012, CELL, V148, P21, DOI 10.1016/j.cell.2011.12.021
   Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233
   von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Yu J, 2015, GUT, V64, P1783, DOI 10.1136/gutjnl-2014-308653
NR 50
TC 31
Z9 35
U1 0
U2 14
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2162-402X
J9 ONCOIMMUNOLOGY
JI OncoImmunology
PY 2018
VL 7
IS 1
AR e1368603
DI 10.1080/2162402X.2017.1368603
PG 14
WC Oncology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Immunology
GA FU8CP
UT WOS:000424080200004
PM 29296518
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lee, EJ
   Hwang, I
   Lee, JY
   Park, JN
   Kim, KC
   Kim, GH
   Kang, CM
   Kim, I
   Lee, SY
   Kim, HS
AF Lee, Eun Ju
   Hwang, Injoo
   Lee, Ji Yeon
   Park, Jong Nam
   Kim, Keun Cheon
   Kim, Gi-Hwan
   Kang, Chang-Mo
   Kim, Irene
   Lee, Seo-Yeon
   Kim, Hyo-Soo
TI Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone
   Marrow Mesenchymal Stem Cells via RAD51
SO MOLECULAR THERAPY
LA English
DT Article
ID STROMAL CELLS; LIFE-SPAN; HOMOLOGOUS RECOMBINATION; TELOMERASE
   EXPRESSION; DNA; INSTABILITY; DIFFERENTIATION; IMMORTALIZATION;
   REGENERATION; MAINTENANCE
AB Human embryonic stem cell-derived mesenchymal stem cells (hE-MSCs) have greater proliferative capacity than other human mesenchymal stem cells (hMSCs), suggesting that they may have wider applications in regenerative cellular therapy. In this study, to uncover the anti-senescence mechanism in hE-MSCs, we compared hE-MSCs with adult bone marrow (hBM-MSCs) and found that hepatocyte growth factor (HGF) was more abundantly expressed in hE-MSCs than in hBM-MSCs and that it induced the transcription of RAD51 and facilitated its SUMOylation at K70. RAD51 induction/modification by HGF not only increased telomere length but also increased mtDNA replication, leading to increased ATP generation. Moreover, HGF-treated hBM-MSCs showed significantly better therapeutic efficacy than naive hBM-MSCs. Together, the data suggest that the RAD51-mediated effects of HGF prevent hMSC senescence by promoting telomere lengthening and inducing mtDNA replication and function, which opens the prospect of developing novel therapies for liver disease.
C1 [Lee, Eun Ju; Lee, Seo-Yeon] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.
   [Hwang, Injoo; Lee, Ji Yeon; Park, Jong Nam; Kim, Keun Cheon; Kim, Gi-Hwan; Kim, Irene] Seoul Natl Univ, Mol Med & Biopharmaceut Sci, Seoul, South Korea.
   [Kang, Chang-Mo] Korea Inst Radiol & Med Sci, Seoul, South Korea.
   [Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Mol Med & Biopharmaceut Sci, Seoul, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Korea Institute of Radiological &
   Medical Sciences; Seoul National University (SNU)
RP Kim, HS (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Mol Med & Biopharmaceut Sci, 101 DeaHak Ro, Seoul 03080, South Korea.
EM hyosoo@snu.ac.kr
RI lee, wj/JNR-4926-2023; Lee, Eun-ju/JAN-8749-2023
FU Korea Health Technology R&D Project "Strategic Center of Cell and Bio
   Therapy for Heart, Diabetes Center" through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfqre (MHW),
   Republic of Korea [HI17C2085]; Korea Health Technology R&D Project
   "Korea Research-Driven Hospital" through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfqre (MHW),
   Republic of Korea [HI14C1277]
FX This study was supported by grants from the Korea Health Technology R&D
   Project "Strategic Center of Cell and Bio Therapy for Heart, Diabetes
   Center" (HI17C2085) and "Korea Research-Driven Hospital" (HI14C1277)
   through the Korea Health Industry Development Institute (KHIDI), funded
   by the Ministry of Health & Welfqre (MHW), Republic of Korea. The
   funders had no role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268
   [Anonymous], [No title captured]
   Berg K, 2015, TOXICOLOGY, V327, P47, DOI 10.1016/j.tox.2014.10.001
   Bertolo A, 2016, J TISSUE ENG REGEN M, V10, P149, DOI 10.1002/term.1734
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7
   Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030
   Detry O, 2017, J HEPATOL, V67, P47, DOI 10.1016/j.jhep.2017.03.001
   Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255
   Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009
   Hara S, 2008, BIOCHEM BIOPH RES CO, V370, P123, DOI 10.1016/j.bbrc.2008.03.042
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hayashi S, 1996, BIOCHEM BIOPH RES CO, V220, P539, DOI 10.1006/bbrc.1996.0440
   Inui T, 2002, EXP CELL RES, V273, P147, DOI 10.1006/excr.2001.5446
   Kang SK, 2004, STEM CELLS, V22, P1356, DOI 10.1634/stemcells.2004-0023
   Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111
   Kwon YW, 2015, BIOMATERIALS, V59, P102, DOI 10.1016/j.biomaterials.2015.03.031
   Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321
   Lafferty-Whyte K, 2009, ONCOGENE, V28, P3765, DOI 10.1038/onc.2009.238
   Le S, 1999, GENETICS, V152, P143
   Lee EJ, 2012, BIOMATERIALS, V33, P7039, DOI 10.1016/j.biomaterials.2012.06.047
   Lee EJ, 2012, MOL THER, V20, P155, DOI 10.1038/mt.2011.202
   Lee EJ, 2010, TISSUE ENG PT A, V16, P705, DOI 10.1089/ten.tea.2008.0596
   Lu R, 2014, ONCOGENE, V33, P1495, DOI 10.1038/onc.2013.103
   Marampon F, 2016, ONCOTARGET, V7, P64526, DOI 10.18632/oncotarget.12267
   Marión RM, 2010, ADV EXP MED BIOL, V695, P118, DOI 10.1007/978-1-4419-7037-4_9
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026
   Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309
   Pickett HA, 2015, NAT STRUCT MOL BIOL, V22, P875, DOI 10.1038/nsmb.3106
   Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011
   Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601
   Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Sage JM, 2013, MITOCHONDRION, V13, P350, DOI 10.1016/j.mito.2013.04.004
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Samsonraj RM, 2013, GENE, V519, P348, DOI 10.1016/j.gene.2013.01.039
   Shams S, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/747245
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Shima H, 2013, J CELL SCI, V126, P5284, DOI 10.1242/jcs.133744
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   Suk KT, 2016, HEPATOLOGY, V64, P2185, DOI 10.1002/hep.28693
   Takeuchi M, 2007, IN VITRO CELL DEV-AN, V43, P129, DOI 10.1007/s11626-007-9021-9
   Tyrka AR, 2015, EXP GERONTOL, V66, P17, DOI 10.1016/j.exger.2015.04.002
   Wang J, 2000, NATURE, V405, P755, DOI 10.1038/35015674
   West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127
   Yoshida T, 2013, BLOOD, V122, P3149, DOI 10.1182/blood-2013-01-474916
   Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202
   Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882
NR 50
TC 25
Z9 25
U1 1
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAR 7
PY 2018
VL 26
IS 3
BP 845
EP 859
DI 10.1016/j.ymthe.2017.12.015
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA FZ9EG
UT WOS:000427911800021
PM 29398486
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Delladetsima, J
   Alexandrou, P
   Giaslakiotis, K
   Psichogiou, M
   Hatzis, G
   Sypsa, V
   Tiniakos, D
AF Delladetsima, Johanna
   Alexandrou, Paraskevi
   Giaslakiotis, Konstantinos
   Psichogiou, Mina
   Hatzis, Gregory
   Sypsa, Vana
   Tiniakos, Dina
TI Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older
   age and advanced liver disease
SO VIRCHOWS ARCHIV
LA English
DT Article
DE Hepatitis C; HCV; Progenitor cells; Age; Senescence; Cell proliferation
ID DUCTULAR REACTION; STEM-CELLS; REGENERATION; EXPRESSION; HEPATOCYTES;
   CIRRHOSIS; NECROSIS; SENESCENCE; EXPANSION; FIBROSIS
AB Hepatic progenitor cells (HPC) appear in a variety of liver diseases. Their occurrence in chronic hepatitis C (CHC) remains unclear, and triggering factors have to be elucidated. The presence of HPC in CHC was examined in relation to histological and virological parameters and patient age. Fifty liver biopsies of HCV-infected patients were examined. The presence of HPC was evaluated by immunohistochemical expression of keratin 7 (K7). Double immunostaining with K7 and cell proliferation marker Ki-67 was undertaken. Ductular reaction at the limiting plate, mean number of isolated progenitor cells (IPC) and isolated ductular structures (IDS) were quantified. The predominant distribution pattern of IPC and IDS and the presence of K7(+) hepatocytes were registered. Relationship between ductular reaction, IPC, IDS, presence of K7(+) hepatocytes, and patient age, hepatitis grade and stage, HCV RNA, and HCV genotype was examined. Prominent ductular reaction and increased numbers of IPC and IDS correlated significantly with older age and severe fibrosis/cirrhosis. The above HPC subtypes were not proliferating. Periportal/periseptal distribution pattern of IPC and IDS and presence of K7(+) hepatocytes were significantly more frequent in advanced hepatitis stages and in patients older than 40 years. Intraparenchymal distribution pattern correlated with younger age, lobular activity, and early fibrosis stage. K7(+) hepatocytes were encountered almost exclusively in the periportal pattern and in the presence of interface hepatitis and were more frequent among HCV genotype-1 patients. HPC activation in CHC is a common but diverse phenomenon closely related to patient age and hepatitis stage.
C1 [Delladetsima, Johanna; Alexandrou, Paraskevi; Giaslakiotis, Konstantinos] Univ Athens, Sch Med, Dept Pathol 1, Athens 11527, Greece.
   [Psichogiou, Mina] Univ Athens, Sch Med, Dept Propaedeut Med 1, Athens 11527, Greece.
   [Hatzis, Gregory] Univ Athens, Sch Med, Dept Pathophysiol, Athens 11527, Greece.
   [Sypsa, Vana] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens 11527, Greece.
   [Tiniakos, Dina] Univ Athens, Sch Med, Lab Histol & Embryol, Athens 11527, Greece.
C3 National & Kapodistrian University of Athens; Athens Medical School;
   National & Kapodistrian University of Athens; Athens Medical School;
   Athens Medical School; National & Kapodistrian University of Athens;
   Athens Medical School; National & Kapodistrian University of Athens;
   National & Kapodistrian University of Athens; Athens Medical School
RP Delladetsima, J (corresponding author), Univ Athens, Sch Med, Dept Pathol 1, 75 Mikras Asias Str, Athens 11527, Greece.
EM jokadelladetsima@hotmail.com
RI Tiniakos, Dina G/AAA-5708-2020; SYPSA, VANA/A-5082-2008
OI SYPSA, VANA/0000-0002-9430-7614
FU "Kapodistrias" research grants [70/4/9680, 70/4/6549]; Special Accounts
   Research Fund (ELKE); National and Kapodistrian University of Athens,
   Greece
FX The authors acknowledge the support of "Kapodistrias" research grants
   70/4/9680 (J.D.) and 70/4/6549 (D. T.), Special Accounts Research Fund
   (ELKE), National and Kapodistrian University of Athens, Greece. The
   technical expertise of Dr. Despoina Karandrea is recognized.
CR Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453
   Bisgaard HC, 1999, AM J PATHOL, V155, P1075, DOI 10.1016/S0002-9440(10)65210-8
   Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   Crosby HA, 1998, AM J PATHOL, V152, P771
   DELLADETSIMA JK, 1995, J PATHOL, V175, P69, DOI 10.1002/path.1711750111
   Demetris AJ, 1996, AM J PATHOL, V149, P439
   DESMET V, 1995, PATHOL RES PRACT, V191, P513, DOI 10.1016/S0344-0338(11)80870-8
   Eleazar JA, 2004, J HEPATOL, V41, P983, DOI 10.1016/j.jhep.2004.08.017
   Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   Fotiadu A, 2004, LIVER INT, V24, P268, DOI 10.1111/j.1478-3231.2004.00908.x
   Fujita M, 2000, MODERN PATHOL, V13, P152, DOI 10.1038/modpathol.3880029
   GERBER MA, 1983, AM J PATHOL, V110, P70
   Hytiroglou P, 2004, AM J CLIN PATHOL, V121, P324, DOI 10.1309/5HR90TNC4Q4JRXWX
   Ikeda K, 1999, HEPATOLOGY, V29, P1760, DOI 10.1002/hep.510290640
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132
   Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218
   Libbrecht L, 2000, J PATHOL, V192, P373, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH700&gt;3.0.CO;2-5
   Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6
   Lowes KN, 2003, GUT, V52, P1327, DOI 10.1136/gut.52.9.1327
   Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   RAY MB, 1993, LIVER, V13, P36
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Roskams T, 2003, J HEPATOL, V39, P431, DOI 10.1016/S0168-8278(03)00333-7
   Roskams T, 1998, J HEPATOL, V29, P455, DOI 10.1016/S0168-8278(98)80065-2
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   SARRAF C, 1994, AM J PATHOL, V145, P1114
   Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900
   Tan JY, 2002, LIVER, V22, P365, DOI 10.1034/j.1600-0676.2002.01622.x
   Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124
   Tsamandas AC, 2006, LIVER INT, V26, P817, DOI 10.1111/j.1478-3231.2006.01306.x
   Wagayama H, 2001, DIGEST DIS SCI, V46, P2074, DOI 10.1023/A:1011977923941
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
NR 39
TC 22
Z9 24
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
EI 1432-2307
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD OCT
PY 2010
VL 457
IS 4
BP 457
EP 466
DI 10.1007/s00428-010-0957-x
PG 10
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 657TG
UT WOS:000282434700007
PM 20721577
DA 2024-02-19
ER

PT J
AU Ogawa, T
   Ohira, A
   Amemiya, T
AF Ogawa, T
   Ohira, A
   Amemiya, T
TI Ageing transition of superoxide dismutase in rat retina
SO HISTOCHEMICAL JOURNAL
LA English
DT Article
ID MUSCLE MITOCHONDRIAL-DNA; ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION;
   PIGMENT EPITHELIUM; BRAIN; LIVER; SENESCENCE; PROTEINS; LEVEL; MICE
AB To examine the relationship between retinal ageing and superoxide dismutase, the distribution and expression of the dismutase was studied in the retina of 2-year-old Sprague-Dawley albino rats with immunohistochemistry and immunochemical quantitative analysis. Eight-week-old Sprague-Dawley albino rats were used as controls. In 2-year-old rats, manganese superoxide dismutase (Mn-SOD) immunoreactivities in the photoreceptor inner segments, the outer nuclear layer and the inner plexiform layer were stronger than those in 8-week-old rats. Copper-zinc superoxide dismutase (CuZn-SOD) immunoreactivities in the outer nuclear layer and inner plexiform layer of 2-year-old rats were stronger than those in 8-week-old rats. Faint CuZn-SOD immunoreactivity became visible in the photoreceptor inner segments of 2-year-old rats, whereas no CuZn-SOD immunoreactivity was observed in 8-week-old rats. Our immunochemical quantitative analysis also showed an increase in the immunoreactivities of superoxide dismutases in the sensory retina with age. The transition of the dismutases may have some relationship with retinal ageing. (C) 1998 Chapman & Hall.
C1 Nagasaki Univ, Sch Med, Dept Ophthalmol, Nagasaki 852, Japan.
C3 Nagasaki University
RP Ohira, A (corresponding author), Nagasaki Univ, Sch Med, Dept Ophthalmol, 1-7-1 Sakamoto, Nagasaki 852, Japan.
RI ohira, akihiro/G-8352-2017
OI ohira, akihiro/0000-0002-1307-5592
CR Barber A A, 1967, Adv Gerontol Res, V2, P355
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   DeLaPaz MA, 1996, CURR EYE RES, V15, P273, DOI 10.3109/02713689609007621
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   GEREMIA E, 1990, NEUROCHEM RES, V15, P719, DOI 10.1007/BF00973653
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HIRAMATSU M, 1992, J NEUROCHEM, V58, P1160, DOI 10.1111/j.1471-4159.1992.tb09375.x
   HOGAN MJ, 1971, HISTOLOGY HUMAN EYE, P421
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JI LL, 1991, GERONTOLOGY, V37, P317
   KAGAN VE, 1973, BIOCHIM BIOPHYS ACTA, V330, P76, DOI 10.1016/0005-2736(73)90285-X
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LESTIENNE P, 1988, LANCET, V1, P885
   LILES MR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1285, DOI 10.1001/archopht.1991.01080090111033
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   NAKANE PK, 1974, J HISTOCHEM CYTOCHEM, V22, P1084, DOI 10.1177/22.12.1084
   Noell W K, 1966, Invest Ophthalmol, V5, P450
   OLIVER PD, 1992, INVEST OPHTH VIS SCI, V33, P1909
   ROY D, 1983, EXP GERONTOL, V18, P185, DOI 10.1016/0531-5565(83)90031-1
   SCARPA M, 1987, P SOC EXP BIOL MED, V185, P129
   SLOT JW, 1986, LAB INVEST, V55, P363
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   TANIGUCHI N, 1992, ADV CLIN CHEM, V29, P1, DOI 10.1016/S0065-2423(08)60221-8
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WEISIGER RA, 1973, J BIOL CHEM, V248, P3582
   YAMASHITA H, 1992, RETINA-J RET VIT DIS, V12, P59, DOI 10.1097/00006982-199212010-00012
NR 33
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0018-2214
J9 HISTOCHEM J
JI Histochem.J.
PD MAY
PY 1998
VL 30
IS 5
BP 325
EP 330
DI 10.1023/A:1003228326884
PG 6
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA ZK468
UT WOS:000073323900005
DA 2024-02-19
ER

PT J
AU Cahill, A
   Hershman, S
   Davies, A
   Sykora, P
AF Cahill, A
   Hershman, S
   Davies, A
   Sykora, P
TI Ethanol feeding enhances age-related deterioration of the rat hepatic
   mitochondrion
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE mitochondrial DNA; respiration; polymerase-blocking lesions; citrate
   synthase
ID LIVER-MITOCHONDRIA; ENERGY-METABOLISM; IN-VITRO; LIPID-PEROXIDATION;
   PROTEIN-SYNTHESIS; OXIDATIVE DAMAGE; DNA-SYNTHESIS; CONSUMPTION;
   RESPIRATION; GLUTATHIONE
AB Chronic ethanol feeding damages the hepatic mitochondrion by increasing mitochondrial DNA ( mtDNA) oxidation, lowering mtDNA yields and impairing mitochondrial respiration. These effects are also seen during aging. By employing a 21-day chronic feeding regimen, we investigated the effects of ethanol consumption on mtDNA content and mitochondrial respiration in 2-, 12-, and 24-mo-old male rats. Aging resulted in decreased mtDNA content, increased mtDNA damage ( as indicated by inhibition of Taq polymerase progression), and a decline in state 3 respiration; effects that were further exacerbated by ethanol feeding. Additionally, ethanol consumption caused an increase in the levels of citrate synthase while not impacting mitochondrial protein content. In conclusion, ethanol and aging combine to cause deterioration in the structural and functional integrity of the hepatic mitochondrion. The additive effects of aging and ethanol feeding may have serious consequences for hepatic energy metabolism in aged animals, and their detrimental combination may serve as one of the molecular mechanisms underlying the progression of alcoholic liver disease.
C1 Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
C3 Jefferson University
RP Cahill, A (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA.
EM alan.cahill@jefferson.edu
FU NIAAA NIH HHS [R01 AA012225, R21 AA014151, AA-012225] Funding Source:
   Medline
CR ALEMANY J, 1988, EXP GERONTOL, V23, P25, DOI 10.1016/0531-5565(88)90017-4
   ALVARO D, 1995, DIGEST DIS SCI, V40, P1592, DOI 10.1007/BF02285216
   Bailey SM, 1998, HEPATOLOGY, V28, P1318, DOI 10.1002/hep.510280521
   Bailey SM, 2001, ALCOHOL CLIN EXP RES, V25, P726, DOI 10.1111/j.1530-0277.2001.tb02273.x
   BARAONA E, 1975, SCIENCE, V190, P794, DOI 10.1126/science.1198096
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   BRITTON RS, 1984, ALCOHOL CLIN EXP RES, V8, P528, DOI 10.1111/j.1530-0277.1984.tb05723.x
   BURKE JP, 1979, LAB INVEST, V41, P393
   Cahill A, 1999, HEPATOLOGY, V30, P881, DOI 10.1002/hep.510300434
   Cahill A, 1997, BIOCHEM BIOPH RES CO, V235, P286, DOI 10.1006/bbrc.1997.6774
   Caparroz-Assef SM, 2001, CELL BIOCHEM FUNCT, V19, P117, DOI 10.1002/cbf.904
   Carini R, 2000, BBA-MOL BASIS DIS, V1502, P508, DOI 10.1016/S0925-4439(00)00075-2
   COHEN NS, 1985, BIOCHEM J, V229, P205, DOI 10.1042/bj2290205
   COLEMAN WB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P142, DOI 10.1016/0005-2728(90)90136-R
   COLEMAN WB, 1991, BIOCHIM BIOPHYS ACTA, V1058, P178, DOI 10.1016/S0005-2728(05)80235-X
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   DEVI BG, 1994, ALCOHOL CLIN EXP RES, V18, P1436, DOI 10.1111/j.1530-0277.1994.tb01447.x
   DONOHUE TM, 1994, ALCOHOL CLIN EXP RES, V18, P536, DOI 10.1111/j.1530-0277.1994.tb00906.x
   FERNANDEZCHECA JC, 1991, J CLIN INVEST, V87, P397, DOI 10.1172/JCI115010
   FRENCH SW, 1983, HEPATOLOGY, V3, P34
   GARCIARUIZ C, 1994, J CLIN INVEST, V94, P193, DOI 10.1172/JCI117306
   Goodell S, 1998, MECH AGEING DEV, V101, P245, DOI 10.1016/S0047-6374(97)00182-6
   Hagen TM, 1998, ANN NY ACAD SCI, V854, P214, DOI 10.1111/j.1749-6632.1998.tb09904.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HIRANO T, 1992, J SURG RES, V53, P238, DOI 10.1016/0022-4804(92)90041-W
   HIRANO T, 1992, HEPATOLOGY, V16, P1423
   Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249
   ISRAEL Y, 1983, PHARMACOL BIOCHEM BE, V18, P433, DOI 10.1016/0091-3057(83)90213-7
   Jenkins GJS, 2000, MOL CARCINOGEN, V27, P289, DOI 10.1002/(SICI)1098-2744(200004)27:4<289::AID-MC7>3.0.CO;2-9
   KATYARE SS, 1989, BRIT J PHARMACOL, V96, P51, DOI 10.1111/j.1476-5381.1989.tb11783.x
   Kerai MDJ, 1999, ALCOHOL ALCOHOLISM, V34, P529, DOI 10.1093/alcalc/34.4.529
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   KUZNETSOV AV, 2003, MITOCHONDRIAL PHYSL, V8, P1
   Leij-Halfwerk S, 2000, J HEPATOL, V32, P887, DOI 10.1016/S0168-8278(00)80092-6
   LIEBER CS, 1994, METHOD ENZYMOL, V233, P585
   LINDENBA.J, 1969, NATURE, V224, P806, DOI 10.1038/224806a0
   Lossa S, 2001, Horm Metab Res, V33, P343
   Mansouri A, 1999, GASTROENTEROLOGY, V117, P181, DOI 10.1016/S0016-5085(99)70566-4
   Mansouri A, 2001, J PHARMACOL EXP THER, V298, P737
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   MOORE P, 1979, NATURE, V278, P664, DOI 10.1038/278664a0
   MUKHERJEE A, 1976, J BIOL CHEM, V251, P2155
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navder KP, 1997, J NUTR, V127, P1800, DOI 10.1093/jn/127.9.1800
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467
   Pastorino JG, 1999, BIOCHEM BIOPH RES CO, V265, P405, DOI 10.1006/bbrc.1999.1696
   PONNAPPA BC, 1990, BIOCHIM BIOPHYS ACTA, V1036, P107, DOI 10.1016/0304-4165(90)90021-N
   Rashid A, 1999, HEPATOLOGY, V29, P1131, DOI 10.1002/hep.510290428
   Rolo AP, 2000, TOXICOL SCI, V57, P177, DOI 10.1093/toxsci/57.1.177
   Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   Schild L, 2003, FASEB J, V17, P2194, DOI 10.1096/fj.02-1170com
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   SPACH PI, 1987, BIOCHIM BIOPHYS ACTA, V894, P460, DOI 10.1016/0005-2728(87)90125-3
   SPACH PI, 1979, BIOCHEM J, V178, P23, DOI 10.1042/bj1780023
   Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100
   UYSAL M, 1989, MECH AGEING DEV, V48, P85, DOI 10.1016/0047-6374(89)90028-6
   Venkatraman A, 2003, HEPATOLOGY, V38, P141, DOI 10.1053/jhep.2003.50293
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   VILLANI G, 1978, P NATL ACAD SCI USA, V75, P3037, DOI 10.1073/pnas.75.7.3037
   Yoshida K, 2001, NUCLEIC ACIDS RES, V29, P4206, DOI 10.1093/nar/29.20.4206
NR 63
TC 18
Z9 19
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD DEC
PY 2005
VL 289
IS 6
BP G1115
EP G1123
DI 10.1152/ajpgi.00193.2005
PG 9
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 983ZI
UT WOS:000233270500019
PM 16020655
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Maroni, L
   Pinto, C
   Giordano, DM
   Saccomanno, S
   Banales, JM
   Spallacci, D
   Albertini, MC
   Orlando, F
   Provinciali, M
   Milkiewicz, M
   Melum, E
   Labiano, I
   Milkiewicz, P
   Rychlicki, C
   Trozzi, L
   Scarpelli, M
   Benedetti, A
   Baroni, GS
   Marzioni, M
AF Maroni, Luca
   Pinto, Claudio
   Giordano, Debora Maria
   Saccomanno, Stefania
   Banales, Jesus M.
   Spallacci, Daniele
   Albertini, Maria Cristina
   Orlando, Fiorenza
   Provinciali, Mauro
   Milkiewicz, Malgorzata
   Melum, Espen
   Labiano, Ibone
   Milkiewicz, Piotr
   Rychlicki, Chiara
   Trozzi, Luciano
   Scarpelli, Marina
   Benedetti, Antonio
   Baroni, Gianluca Svegliati
   Marzioni, Marco
TI Aging-Related Expression of Twinfilin-1 Regulates Cholangiocyte
   Biological Response to Injury
SO HEPATOLOGY
LA English
DT Article
ID ACCELERATED MOUSE SAM; CELLULAR SENESCENCE; SCLEROSING CHOLANGITIS;
   LIVER-DISEASE; MODEL; MIR-29; AGE; SURVEILLANCE; ACTIVATION; PROTEIN
AB Disorders of the biliary tree develop and progress differently according to patient age. It is currently not known whether the aging process affects the response to injury of cholangiocytes. The aim of this study was to identify molecular pathways associated with cholangiocyte aging and to determine their effects in the biological response to injury of biliary cells. A panel of microRNAs (miRs) involved in aging processes was evaluated in cholangiocytes of young and old mice (2 months and 22 months of age, respectively) and subjected to a model of sclerosing cholangitis. Intracellular pathways that are common to elevated miRs were identified by in silico analysis. Cell proliferation and senescence were evaluated in Twinfilin-1 (Twf1) knocked-down cells. In vivo, senescence-accelerated prone mice (Samp8, a model for accelerated aging), Twf1(-/-), or their respective controls were subjected to DDC (3,5-diethoxycarbonyl-1,4-dihydrocollidine). Cholangiocytes from DDC-treated mice showed up-regulation of a panel of aging-related miRs. Twf1 was identified by in silico analysis as a common target of the up-regulated miRs. Twf1 expression was increased both in aged and diseased cholangiocytes, and in human cholangiopathies. Knock-down of Twf1 in cholangiocytes reduced cell proliferation. Senescence and senescence-associated secretory phenotype marker expression increased in Twf1 knocked-down cholangiocytes following pro-proliferative and pro-senescent (10-day lipopolysaccharide) stimulation. In vivo, Samp8 mice showed increased biliary proliferation, fibrosis, and Twf1 protein expression level, whereas Twf1(-/-) had a tendency toward lower biliary proliferation and fibrosis following DDC administration compared with control animals. Conclusion: We identified Twf1 as an important mediator of both cholangiocyte adaptation to aging processes and response to injury. Our data suggest that disease and aging might share common intracellular pathways.
C1 [Maroni, Luca; Pinto, Claudio; Giordano, Debora Maria; Saccomanno, Stefania; Spallacci, Daniele; Rychlicki, Chiara; Trozzi, Luciano; Benedetti, Antonio; Baroni, Gianluca Svegliati; Marzioni, Marco] Univ Politecn Marche, Dept Gastroenterol & Hepatol, Ancona, Italy.
   [Saccomanno, Stefania; Scarpelli, Marina] Univ Politecn Marche, Inst Pathol Anat & Histopathol, Ancona, Italy.
   [Banales, Jesus M.; Labiano, Ibone] Univ Basque Country UPV EHU, Dept Liver & Gastrointestinal Dis, Biodonostia Hlth Res Inst, Donostia Univ Hosp,Ikerbasque,CIBERehd, San Sebastian, Spain.
   [Albertini, Maria Cristina] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.
   [Orlando, Fiorenza; Provinciali, Mauro] IRCCS INRCA, Adv Technol Ctr Aging Res, Expt Anim Models Aging Unit, Sci Technol Area, Ancona, Italy.
   [Milkiewicz, Malgorzata] Pomeranian Med Univ, Dept Med Biol, Szczecin, Poland.
   [Melum, Espen] Natl Hosp Norway, Norwegian PSC Res Ctr, Div Surg Inflammatory Dis & Transplantat, Dept Transplantat Med,Oslo Univ Hosp, Oslo, Norway.
   [Melum, Espen] Natl Hosp Norway, Internal Med Res Inst, Div Surg Inflammatory Dis & Transplantat, Oslo Univ Hosp, Oslo, Norway.
   [Milkiewicz, Piotr] Med Univ Warsaw, Liver & Internal Med Unit, Dept Gen Transplant & L Surg, Warsaw, Poland.
C3 Marche Polytechnic University; Marche Polytechnic University; University
   of Basque Country; Instituto de Investigacion Sanitaria Biodonostia;
   University Hospital Donostia; CIBER - Centro de Investigacion Biomedica
   en Red; CIBEREHD; Basque Foundation for Science; University of Urbino;
   IRCCS INRCA; Pomeranian Medical University; University of Oslo; National
   Hospital Norway; University of Oslo; National Hospital Norway; Medical
   University of Warsaw
RP Maroni, L (corresponding author), Univ Politecn Marche, Dept Gastroenterol, Nuovo Polo Didattico, 3 Piano,Via Tronto 10, I-60020 Ancona, Italy.
EM luca.maroni@live.it
RI Albertini, Maria Cristina/AAG-6980-2019; Banales, Jesus M/R-9739-2019;
   Marzioni, Marco/A-8153-2011; Orlando, Fiorenza/AAB-3441-2021;
   Milkiewicz, Malgorzata/A-9428-2015; Miele, Luca/C-2255-2015; Benedetti,
   Antonio/A-8189-2011
OI Albertini, Maria Cristina/0000-0003-4549-1475; Marzioni,
   Marco/0000-0001-6014-6165; Orlando, Fiorenza/0000-0001-7351-4430; Miele,
   Luca/0000-0003-3464-0068; Melum, Espen/0000-0001-6903-6878;
   svegliati-baroni, gianluca/0000-0003-4399-3359; Banales, Jesus
   M./0000-0002-5224-2373; Pinto, Claudio/0000-0001-8585-9495; Milkiewicz,
   Malgorzata/0000-0002-2064-0545; Benedetti, Antonio/0000-0003-0280-4574;
   MARONI, LUCA/0000-0003-4707-7374
FU Basque Government [PRE_2016_1_0152] Funding Source: Medline; Fondo
   Europeo de Desarrollo Regional Funding Source: Medline; Spanish Ministry
   of Economy and Competitiveness [FIS PI15/01132, FIS PI12/00380] Funding
   Source: Medline; Università Politecnica delle Marche
   [040020_R.SCIENT.A_2018] Funding Source: Medline; Norwegian PSC Research
   Center, Southeastern Norwegian Health Authorities and Research Council
   of Norway Funding Source: Medline; Basque Foundation for Innovation and
   Health Research [BIO15/CA/016/BD] Funding Source: Medline; Miguel Servet
   Programme [CON14/00129] Funding Source: Medline; Fundación Científica de
   la Asociación Española Contra el Cáncer Funding Source: Medline
CR Albertini MC, 2011, J BIOMED INFORM, V44, P615, DOI 10.1016/j.jbi.2011.02.006
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Aunan JR, 2016, BRIT J SURG, V103, pE29, DOI 10.1002/bjs.10053
   Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691
   Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133
   Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455
   Folch J, 2018, CURR NEUROPHARMACOL, V16, P1466, DOI 10.2174/1570159X15666170707155345
   Franchitto A, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.10.03
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   Johnston AB, 2015, NAT CELL BIOL, V17, P1504, DOI 10.1038/ncb3252
   Kaeberlein M, 2015, SCIENCE, V350, P1191, DOI 10.1126/science.aad3267
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kirkland JL, 2013, EXP GERONTOL, V48, P1, DOI 10.1016/j.exger.2012.11.014
   Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Mariño G, 2010, P NATL ACAD SCI USA, V107, P16268, DOI 10.1073/pnas.1002696107
   Maroni L, 2017, AM J PATHOL, V187, P366, DOI 10.1016/j.ajpath.2016.10.010
   Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108
   Marzioni M, 2013, J HEPATOL, V58, P750, DOI 10.1016/j.jhep.2012.11.033
   Marzioni M, 2010, J HEPATOL, V53, P663, DOI 10.1016/j.jhep.2010.04.022
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Mocchegiani F, 2015, ANN TRANSPL, V20, P218, DOI 10.12659/AOT.892393
   Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860
   Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436
   National Institute on Aging & World Health Organization, 2011, GLOBAL HLTH AGING
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   O'Hara SP, 2013, J HEPATOL, V58, P575, DOI 10.1016/j.jhep.2012.10.011
   Palmgren S, 2002, J CELL SCI, V115, P881
   Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Rizvi S, 2015, CLIN GASTROENTEROL H, V13, P2152, DOI 10.1016/j.cgh.2015.05.035
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124
   Ugalde AP, 2010, AGING-US, V2, P1017, DOI 10.18632/aging.100262
   Weismüller TJ, 2017, GASTROENTEROLOGY, V152, P1975, DOI 10.1053/j.gastro.2017.02.038
   Welling TH, 2008, LIVER TRANSPLANT, V14, P73, DOI 10.1002/lt.21354
   Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
NR 50
TC 9
Z9 9
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD SEP
PY 2019
VL 70
IS 3
BP 883
EP 898
DI 10.1002/hep.30466
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA IU6JO
UT WOS:000483692800010
PM 30561764
DA 2024-02-19
ER

PT J
AU Idrissi, ME
   Hachem, H
   Koering, C
   Merle, P
   Thénoz, M
   Mortreux, F
   Wattel, E
AF Idrissi, M. E.
   Hachem, H.
   Koering, C.
   Merle, P.
   Thenoz, M.
   Mortreux, F.
   Wattel, E.
TI HBx triggers either cellular senescence or cell proliferation depending
   on cellular phenotype
SO JOURNAL OF VIRAL HEPATITIS
LA English
DT Article
DE cell cycle; cellular senescence; HBx; hepatitis B virus-encoded
   oncoproteins; malignant liver cells; preS2
ID HEPATITIS-B-VIRUS; HUMAN HEPATOCELLULAR-CARCINOMA; X-PROTEIN;
   BETA-CATENIN; DNA; INTEGRATION; LIVER; EXPRESSION; CANCER; GROWTH
AB Replicative senescence is a hallmark of chronic liver diseases including chronic hepatitis B virus (HBV) infection, whereas HBV-encoded oncoproteins HBx and preS2 have been found to overcome senescence. HBx possesses a C-terminal truncation mainly in hepatocellular carcinomas but also in noncancerous liver tissues. Here, by cell counting, BrdU incorporation, MTT proliferation assay, cell cycle analysis, SA-gal staining and Western blotting in primary and malignant cells, we investigated the effect of HBx C-terminal mutants on cellular senescence. HBx C-terminal mutants were found to trigger cellular senescence in primary MRC5 cells, and malignant liver cells Huh7, and SK-Hep1. In contrast, these mutants promoted the proliferation of HepG2 malignant liver cells. The pro-senescent effect of HBx relied on an increased p16(INK4a) and p21(Waf1/Cip1) expression, and a decreased phosphorylation of Rb. Together, these results suggest that the two main variants of HBx present in HBV-infected liver possess opposite effects on cellular senescence that depend on the phenotype of infected cells.
C1 [Idrissi, M. E.; Hachem, H.; Koering, C.; Thenoz, M.; Mortreux, F.; Wattel, E.] Univ Lyon 1, CNRS, UMR5239, Oncovirol & Biotherapies, F-69365 Lyon, France.
   [Merle, P.] Ctr Rech Cancerol Lyon, CNRS, INSERM, U1052,UMR5286, Lyon, France.
   [Merle, P.] Univ Lyon 1, F-69622 Villeurbanne, France.
   [Merle, P.] Grp Hosp Lyon Nord, Hosp Civils Lyon, Serv Hepatol & Gastroenterol, Lyon, France.
   [Wattel, E.] Univ Lyon 1, Serv Hematol, Ctr Hosp Lyon Sud, Pavillon Marcel Berard, Pierre Benite, France.
C3 CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole
   Normale Superieure de Lyon (ENS de LYON); Universite Claude Bernard Lyon
   1; Universite Jean Monnet; CNRS - National Institute for Biology (INSB);
   UNICANCER; Centre Leon Berard; Universite Claude Bernard Lyon 1;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Universite Claude Bernard Lyon 1; CHU
   Lyon; Universite Claude Bernard Lyon 1; CHU Lyon
RP Wattel, E (corresponding author), Hematol Clin, Pavillon Marcel Berard 1G,Ctr Hosp Lyon Sud 165,C, F-69495 Pierre Benite, France.
EM eric.wattel@ens-lyon.fr
RI mortreux, franck/M-5944-2014; mortreux, franck/T-4564-2019
OI mortreux, franck/0000-0002-4840-021X; mortreux,
   franck/0000-0002-4840-021X
FU Ligue Nationale contre le Cancer (comite de la Savoie); Ligue Nationale
   contre le Cancer (comite de la Loire et du Rhone); Agence Nationale pour
   la Recherche (ANR); Hospices Civils de Lyon; University Lyon-1; Centre
   National pour la Recherche Scientifique (CNRS); Institut National de la
   Sante et de la Recherche Medicale (Inserm); Amgen; Celgene; Novartis;
   INCA; Region Rhone-Alpes (cluster 10); Association pour la Recherche sur
   le Cancer (ARC); Lyon I University; Inserm; Hospices Civils de Lyon
   (AVIESAN CHRT); Nice University; Hopitaux de Nice
FX We thank KJ Wu and R Dalla-Favera for TERTLuc800 and pMT2TMyc, X Liu for
   3'-HBx deletion mutants and pcS2, M Strubin for pcDNA3-HBx and pWPT-HBx,
   and R Weinberg for pBABE-hTERT. This work was supported by the Ligue
   Nationale contre le Cancer (comites de la Savoie, de la Loire et du
   Rhone), Agence Nationale pour la Recherche (ANR), Hospices Civils de
   Lyon, University Lyon-1, Centre National pour la Recherche Scientifique
   (CNRS), Institut National de la Sante et de la Recherche Medicale
   (Inserm), Amgen, Celgene, Novartis and INCA (PAIR-HCC project). M.E.I.
   was supported by bursaries from the Region Rhone-Alpes (cluster 10) and
   from the Association pour la Recherche sur le Cancer (ARC). P.M. is
   supported by Hospices Civils de Lyon and Lyon I University. F.M. is
   supported by Inserm and by Hospices Civils de Lyon (AVIESAN CHRT 2010).
   E.G. is supported by Nice University and Hopitaux de Nice. E.W. is
   supported by Hospices Civils de Lyon and Lyon I University.
CR Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Bontron S, 2002, J BIOL CHEM, V277, P38847, DOI 10.1074/jbc.M205722200
   Cagatay T, 2002, ONCOGENE, V21, P7971, DOI 10.1038/sj.onc.1205919
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carruba G, 1999, ANN NY ACAD SCI, V886, P212, DOI 10.1111/j.1749-6632.1999.tb09419.x
   CASELMANN WH, 1990, P NATL ACAD SCI USA, V87, P2970, DOI 10.1073/pnas.87.8.2970
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Diala I, 2013, EMBO REP, V14, P356, DOI 10.1038/embor.2013.16
   El Idrissi M, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-64
   Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291
   HSU HC, 1991, HEPATOLOGY, V13, P923, DOI 10.1016/0270-9139(91)90264-V
   Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2
   KEKULE AS, 1990, NATURE, V343, P457, DOI 10.1038/343457a0
   Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x
   Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072
   Kim YJ, 2010, CANCER LETT, V288, P226, DOI 10.1016/j.canlet.2009.07.007
   Kimbi GC, 2005, WORLD J GASTROENTERO, V11, P6416, DOI 10.3748/wjg.v11.i41.6416
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee JO, 2005, ONCOGENE, V24, P6617, DOI 10.1038/sj.onc.1208827
   Liu H, 2007, BIOCHEM BIOPH RES CO, V355, P379, DOI 10.1016/j.bbrc.2007.01.160
   Liu XH, 2008, CARCINOGENESIS, V29, P1207, DOI 10.1093/carcin/bgn111
   Liu XH, 2008, BIOCHEM BIOPH RES CO, V373, P643, DOI 10.1016/j.bbrc.2008.06.087
   Luan F, 2009, GUT, V58, P1528, DOI 10.1136/gut.2008.174029
   Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082
   Mason WS, 2010, J VIROL, V84, P8308, DOI 10.1128/JVI.00833-10
   Merle P, 2009, VIRUSES-BASEL, V1, P852, DOI 10.3390/v1030852
   NAGAYA T, 1987, GENE DEV, V1, P773, DOI 10.1101/gad.1.8.773
   Oishi N, 2007, CANCER SCI, V98, P1540, DOI 10.1111/j.1349-7006.2007.00579.x
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Park SH, 2011, J GEN VIROL, V92, P1309, DOI 10.1099/vir.0.029512-0
   Sirma H, 1999, ONCOGENE, V18, P4848, DOI 10.1038/sj.onc.1202867
   Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295
   Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979
   Toh ST, 2013, CARCINOGENESIS, V34, P787, DOI 10.1093/carcin/bgs406
   Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298
   WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230
   Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064
   Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613
   Zhang H, 2008, ACTA PHARMACOL SIN, V29, P473, DOI 10.1111/j.1745-7254.2008.00764.x
   Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008
   Zhao J, 2010, HEPATOLOGY, V51, P142, DOI 10.1002/hep.23247
NR 43
TC 13
Z9 15
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1352-0504
EI 1365-2893
J9 J VIRAL HEPATITIS
JI J. Viral Hepatitis
PD FEB
PY 2016
VL 23
IS 2
BP 130
EP 138
DI 10.1111/jvh.12450
PG 9
WC Gastroenterology & Hepatology; Infectious Diseases; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Infectious Diseases; Virology
GA DC0ZD
UT WOS:000368945700008
PM 26316075
DA 2024-02-19
ER

PT J
AU Mosteiro, L
   Pantoja, C
   de Martino, A
   Serrano, M
AF Mosteiro, Lluc
   Pantoja, Cristina
   de Martino, Alba
   Serrano, Manuel
TI Senescence promotes invivo reprogramming through p16<SUP>INK4a</SUP> and
   IL-6
SO AGING CELL
LA English
DT Article
DE interleukin-6; p16Ink4a; plasticity; pluripotency; reprogramming; SASP;
   senescence
ID CELLULAR SENESCENCE; CELLS; LIVER; LOCUS; INTERLEUKIN-6-DEFICIENT;
   RESTORATION; PATHWAY; CANCER; LEADS; P21
AB Cellular senescence is a damage response aimed to orchestrate tissue repair. We have recently reported that cellular senescence, through the paracrine release of interleukin-6 (IL6) and other soluble factors, strongly favors cellular reprogramming by Oct4, Sox2, Klf4, and c-Myc (OSKM) in nonsenescent cells. Indeed, activation of OSKM in mouse tissues triggers senescence in some cells and reprogramming in other cells, both processes occurring concomitantly and in close proximity. In this system, Ink4a/Arf-null tissues cannot undergo senescence, fail to produce IL6, and cannot reprogram efficiently; whereas p53-null tissues undergo extensive damage and senescence, produce high levels of IL6, and reprogram efficiently. Here, we have further explored the genetic determinants of invivo reprogramming. We report that Ink4a, but not Arf, is necessary for OSKM-induced senescence and, thereby, for the paracrine stimulation of reprogramming. However, in the absence of p53, IL6 production and reprogramming become independent of Ink4a, as revealed by the analysis of Ink4a/Arf/p53 deficient mice. In the case of the cell cycle inhibitor p21, its protein levels are highly elevated upon OSKM activation in a p53-independent manner, and we show that p21-null tissues present increased levels of senescence, IL6, and reprogramming. We also report that Il6-mutant tissues are impaired in undergoing reprogramming, thus reinforcing the critical role of IL6 in reprogramming. Finally, young female mice present lower efficiency of invivo reprogramming compared to male mice, and this gender difference disappears with aging, both observations being consistent with the known anti-inflammatory effect of estrogens. The current findings regarding the interplay between senescence and reprogramming may conceivably apply to other contexts of tissue damage.
C1 [Mosteiro, Lluc; Pantoja, Cristina; de Martino, Alba; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid, Spain.
   [Pantoja, Cristina; Serrano, Manuel] BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain.
   [Serrano, Manuel] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain.
C3 Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona
   Institute of Science & Technology; Institute for Research in Biomedicine
   - IRB Barcelona; ICREA
RP Serrano, M (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona, Spain.
EM manuel.serrano@irbbarcelona.org
RI Rodriguez, Jose A/G-7324-2015; Serrano, Manuel/H-2634-2015
OI Rodriguez, Jose A/0000-0002-2094-264X; Serrano,
   Manuel/0000-0001-7177-9312; Mosteiro, Lluc/0000-0003-4041-9706; De
   Martino Rodriguez, Alba/0000-0002-2436-9852
FU FPU contract from the Spanish Ministry of Education (MECD); CNIO;
   Spanish Ministry of Economy - European Regional Development Fund (RETOS
   project); European Research Council (ERC Advanced Grant); European Union
   (RISK-IR project); Botin Foundation; Banco Santander (Santander
   Universities Global Division)
FX M. was recipient of an FPU contract from the Spanish Ministry of
   Education (MECD). Work in the laboratory of M.S. was funded by the CNIO
   and by grants from the Spanish Ministry of Economy co-funded by the
   European Regional Development Fund (RETOS project), the European
   Research Council (ERC Advanced Grant), the European Union (RISK-IR
   project), and the Botin Foundation and Banco Santander (Santander
   Universities Global Division). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586
   Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609
   Brady JJ, 2013, NAT CELL BIOL, V15, P1244, DOI 10.1038/ncb2835
   BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0
   Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13
   Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020
   Chuprin A, 2013, GENE DEV, V27, P2356, DOI 10.1101/gad.227512.113
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Davaapil H, 2017, DEVELOPMENT, V144, P106, DOI 10.1242/dev.138222
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Dubois-Pot-Schneider H, 2014, HEPATOLOGY, V60, P2077, DOI 10.1002/hep.27353
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592
   JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6
   Kalaitzidis D., 2017, TRENDS ENDOCRIN MET, V16, P46
   Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3
   Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311
   KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0
   Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290
   Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397
   Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575
   Marión RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   NELSON JF, 1981, BIOL REPROD, V24, P784, DOI 10.1095/biolreprod24.4.784
   Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004
   Scoumanne A, 2011, NUCLEIC ACIDS RES, V39, P213, DOI 10.1093/nar/gkq778
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Zhang Jin, 2008, Curr Mol Med, V8, P845, DOI 10.2174/156652408786733748
   Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002
NR 45
TC 109
Z9 113
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR
PY 2018
VL 17
IS 2
AR e12711
DI 10.1111/acel.12711
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FZ0CJ
UT WOS:000427234300004
PM 29280266
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU MANCINI, MA
   CHATTERJEE, B
   ROY, AK
AF MANCINI, MA
   CHATTERJEE, B
   ROY, AK
TI AGE-DEPENDENT REVERSAL OF THE LOBULAR DISTRIBUTION OF ANDROGEN-INDUCIBLE
   ALPHA-2U-GLOBULIN AND ANDROGEN-REPRESSIBLE SMP-2 IN RAT-LIVER
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE ANDROGEN INDUCTION; ALPHA-2U GLOBULIN; SENESCENCE MARKER PROTEIN-2;
   AGING; PARACRINE EFFECT; CELL HETEROGENEITY; CELL CELL INTERACTIONS;
   HEPATIC PROTEINS; IMMUNOCYTOCHEMISTRY; RAT
ID BINDING-PROTEIN; MESSENGER-RNA; INDUCTION; HETEROGENEITY; HEPATOCYTES;
   EXPRESSION
AB Hepatocytes situated at pericentral and periportal zones of the liver lobule show differences in the expression of several liver-specific genes, such as androgen-inducible alpha-2u globulin and androgen-repressible senescence marker protein-2 (SMP-2).  A marked temporal difference in the expression of these two androgen-regulated genes has also been observed.  The liver of the pre-pubertal male rat is insensitive to androgen, and during this period hepatocytes synthesize only SMP-2.  During young adult life (> 40 days), the liver becomes androgen sensitive and concomitant synthesis of alpha-2u globulin and repression of SMP-2 occur.  In the senescent male rat (> 750 days), the liver again becomes androgen insensitive when the decline in alpha-2u globulin is accompanied by an increase in SMP-2 synthesis.  In this article we present results to show a correlation between the temporal and spatial (intralobular) changes in the expression of the androgen-inducible alpha-2u globulin and the androgen-repressible SMP-2 in rat hepatocytes.  Results indicate that the temporal changes in hepatic androgen sensitivity are dictated by the intralobular location of the hepatocytes.  Hepatocytes located around the central vein (pericentral/perivenous) may benefit from a paracrine advantage for the expression of a subset of genes, including the gene for the androgen receptor.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT OBSTET & GYNECOL,DIV MOLEC GENET,SAN ANTONIO,TX 78284.
   UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio
FU NIA NIH HHS [AG-03527, T32 AG-00165] Funding Source: Medline; NIDDK NIH
   HHS [DK-14744] Funding Source: Medline
CR ANTAKLY T, 1982, AM J ANAT, V165, P211, DOI 10.1002/aja.1001650209
   BASS NM, 1989, HEPATOLOGY, V9, P12, DOI 10.1002/hep.1840090104
   BENNETT AL, 1987, J CELL BIOL, V105, P1073, DOI 10.1083/jcb.105.3.1073
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CHATTERJEE B, 1981, J BIOL CHEM, V256, P5939
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   JUNGERMANN K, 1978, TRENDS BIOCHEM SCI, V3, P198, DOI 10.1016/S0968-0004(78)91764-4
   MOTWANI NM, 1984, J BIOL CHEM, V259, P3653
   OGURA K, 1990, BIOCHEM BIOPH RES CO, V166, P1494, DOI 10.1016/0006-291X(90)91036-R
   OLSON MJ, 1989, CELL INTERCOMMUNICAT, P71
   PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999
   RICH KJ, 1989, BIOCHEM PHARMACOL, V38, P3305, DOI 10.1016/0006-2952(89)90629-1
   ROY AK, 1983, RECENT PROG HORM RES, V39, P425
   ROY AK, 1979, BIOCHEM ACTION HORM, V6, P482
   ROY AK, 1986, CELLULAR ENDOCRINOLO, P401
   SARKAR FH, 1986, J ENDOCRINOL, V111, P205, DOI 10.1677/joe.0.1110205
   SONG CS, IN PRESS ENDOCRINOLO
   TRABER PG, 1989, J BIOL CHEM, V264, P10292
NR 18
TC 15
Z9 15
U1 0
U2 0
PU HISTOCHEMICAL SOC INC
PI NEW YORK
PA MT SINAI MEDICAL CENTER 19 EAST 98TH ST SUTIE 9G, NEW YORK, NY 10029
SN 0022-1554
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD APR
PY 1991
VL 39
IS 4
BP 401
EP 405
DI 10.1177/39.4.1706374
PG 5
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA FC518
UT WOS:A1991FC51800002
PM 1706374
DA 2024-02-19
ER

PT J
AU Chernova, T
   Nicotera, P
   Smith, AG
AF Chernova, T
   Nicotera, P
   Smith, AG
TI Heme deficiency is associated with senescence and causes suppression of
   <i>N</i>-methyl-D-aspartate receptor subunits expression in primary
   cortical neurons
SO MOLECULAR PHARMACOLOGY
LA English
DT Article
ID ERYTHROPOIETIC PROTOPORPHYRIA; ALZHEIMERS-DISEASE; GENE-EXPRESSION;
   CARBON-MONOXIDE; LIVER-DISEASE; CELLS; RAT; PROTEIN; MICE; BETA
AB Heme is a crucial component of many pharmacological and toxicological processes, and studies have suggested that heme deficiency may play a role in cellular ageing. A model of ageing neurons was established using prolonged cultures of BALB/c mouse primary cortical neurons. Aged neurons displayed a senescent phenotype and a marked up-regulation of cathepsin-L expression. Down-regulation of the candidate neuron-specific genes for N-methyl-D-aspartate (NMDA) receptor subunits (NMDA zeta 1 and -epsilon 2) and neurofilament light peptide (NF-L) were found to be characteristic of the aging process as reported in vivo (Brain Res 907: 71-83, 2001; Brain Res Mol Brain Res 99: 40-45, 2002). In contrast, the genes for the controlling enzymes of heme synthesis and degradation (5-aminolevulinate synthase 1 and heme oxygenase 1, respectively) were up-regulated, implying depletion of a regulatory heme pool. Inhibition of heme synthesis (by 70-80%) at different enzymic steps by succinyl acetone and N-methylprotoporphyrin IX resulted in the earlier lowered expression of NMDA zeta 1 and -epsilon 2 and NF-L. Exogenous hemin added to heme- depleted cells rescued the expression of these neuron-specific genes. Culture of cortical neurons from BALB/c Fech(m1Pas) mutant mice demonstrating depressed heme synthesis showed premature senescence and reduced expression of NMDA zeta 1 and -epsilon 2 receptor subunits and NF-L compared with wild-type cells. Our findings suggest that reduced availability of heme in neurons associated with senescence may have significant effects on synaptic function.
C1 Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
C3 University of Leicester
RP Chernova, T (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.
EM tc28@le.ac.uk
CR Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101
   Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799
   BITAR MS, 1987, MECH AGEING DEV, V38, P189, DOI 10.1016/0047-6374(87)90078-9
   Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047
   Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024
   Davies R, 2005, AM J PATHOL, V166, P1041, DOI 10.1016/S0002-9440(10)62325-5
   DEMATTEIS F, 1982, J NEUROCHEM, V39, P551
   DeMatteis F, 1996, CAN J PHYSIOL PHARM, V74, P1, DOI 10.1139/cjpp-74-1-1
   DEMATTEIS F, 1981, BIOCHEM J, V196, P811, DOI 10.1042/bj1960811
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eckles-Smith K, 2000, MOL BRAIN RES, V78, P154, DOI 10.1016/S0169-328X(00)00088-7
   Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633
   Ingi T, 1996, J NEUROSCI, V16, P5621
   ISHII DN, 1978, NATURE, V274, P372, DOI 10.1038/274372a0
   Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724
   Kumar S, 2005, PSYCHOPHARMACOLOGY, V183, P241, DOI 10.1007/s00213-005-0161-x
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986
   Magnusson KR, 2002, MOL BRAIN RES, V99, P40, DOI 10.1016/S0169-328X(01)00344-8
   Meyer RP, 2002, MOL PHARMACOL, V62, P1061, DOI 10.1124/mol.62.5.1061
   Navarro S, 2005, EXP DERMATOL, V14, P26, DOI 10.1111/j.0906-6705.2005.00248.x
   Nicotera P, 2003, TOXICOL SCI, V74, P4, DOI 10.1093/toxsci/kfg109
   Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835
   Ossowska K, 2001, BRAIN RES, V907, P71, DOI 10.1016/S0006-8993(01)02601-4
   PATERNITI JR, 1978, ARCH BIOCHEM BIOPHYS, V191, P792, DOI 10.1016/0003-9861(78)90421-6
   RANK JM, 1993, HEPATOLOGY, V18, P1404, DOI 10.1016/0270-9139(93)90231-B
   ROSSI E, 1988, CLIN CHEM, V34, P2481
   Sangerman J, 2001, BRAIN RES BULL, V54, P405, DOI 10.1016/S0361-9230(01)00426-9
   Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/1523086041798006
   Sassa S, 1996, INT J HEMATOL, V63, P167
   Sengupta A, 2005, MOL BRAIN RES, V137, P23, DOI 10.1016/j.molbrainres.2005.02.007
   SHEDLOFSKY SI, 1987, BIOCHEM J, V248, P229, DOI 10.1042/bj2480229
   Taketani S, 1998, HEPATOLOGY, V27, P808, DOI 10.1002/hep.510270324
   Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d
   TSCHUDY DP, 1981, J BIOL CHEM, V256, P9915
   TUTOIS S, 1991, J CLIN INVEST, V88, P1730, DOI 10.1172/JCI115491
   Uylings HBM, 2002, BRAIN COGNITION, V49, P268, DOI 10.1006/brcg.2001.1500
   Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019
   Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5
   Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431
NR 40
TC 55
Z9 70
U1 0
U2 2
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0026-895X
EI 1521-0111
J9 MOL PHARMACOL
JI Mol. Pharmacol.
PD MAR
PY 2006
VL 69
IS 3
BP 697
EP 705
DI 10.1124/mol.105.016675
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 012SN
UT WOS:000235359900005
PM 16306232
DA 2024-02-19
ER

PT J
AU Watanabe, Y
   Abe, H
   Kimura, N
   Arao, Y
   Ishikawa, N
   Yuichiro, M
   Setsu, T
   Sakamaki, A
   Kamimura, H
   Yokoo, T
   Kamimura, K
   Tsuchiya, A
   Terai, S
AF Watanabe, Yusuke
   Abe, Hiroyuki
   Kimura, Naruhiro
   Arao, Yoshihisa
   Ishikawa, Natsuki
   Yuichiro, Maeda
   Setsu, Toru
   Sakamaki, Akira
   Kamimura, Hiroteru
   Yokoo, Takeshi
   Kamimura, Kenya
   Tsuchiya, Atsunori
   Terai, Shuji
TI Navitoclax improves acute-on-chronic liver failure by eliminating
   senescent cells in mice
SO HEPATOLOGY RESEARCH
LA English
DT Article; Early Access
DE acute-on-chronic liver failure; mitochondrial function; navitoclax;
   senescence-associated secretory phenotype
ID MITOCHONDRIAL DYSFUNCTION; CELLULAR SENESCENCE; OXIDATIVE STRESS;
   STEM-CELLS; CLEARANCE; FIBROSIS
AB AimAcute-on-chronic liver failure (ACLF), a disease with poor prognosis, is reportedly caused by cellular senescence due to mitochondrial dysfunction. In this study, we described and analyzed the underlying mechanism of a novel approach for ACLF using ABT263/navitoclax (Navi) that selectively eliminates senescent cells. MethodsIrradiation-induced senescent hepatocytes were used for in vitro evaluation of the effects of Navi on ACLF (n = 6 for each group). Lipopolysaccharide- and carbon tetrachloride-induced ACLF mouse model was used for in vivo evaluation of the effects of Navi administration compared with the control using one-way or two-way analysis of variance, followed by Student's t-test or Kruskal-Wallis test. The effects on the senescence-associated secretory phenotype (n = 8 for each group) and mitochondrial functions, including adenosine triphosphate concentration and membrane potential (n = 8 for each group), were investigated using real-time polymerase chain reaction, immunohistochemistry, and enzyme analysis. ResultsNavi eliminated irradiation-induced senescent hepatocytes in vitro, leading to non-senescent hepatocyte proliferation. Navi eliminated senescent cells in the liver in vivo, resulting in downregulation of mRNA expression of senescence-associated secretory phenotype factors, a decrease of liver enzymes, and upregulated proliferation of non-senescent cells in the liver. Regarding mitochondrial functional assessment in the liver, adenosine triphosphate concentration and membrane potential were upregulated after Navi administration in vitro and in vivo. ConclusionsNavi may ameliorate ACLF damage by eliminating senescent cells in the liver, downregulating senescence-associated secretory phenotype factors, and upregulating mitochondrial functions. We believe that this novel approach using Navi will pave the way for ACLF treatment.
C1 [Watanabe, Yusuke; Yokoo, Takeshi] Niigata Univ, Sch Med, Div Preempt Med Digest Dis & Hlth Act Life, Niigata, Japan.
   [Watanabe, Yusuke; Abe, Hiroyuki; Kimura, Naruhiro; Arao, Yoshihisa; Ishikawa, Natsuki; Yuichiro, Maeda; Setsu, Toru; Sakamaki, Akira; Kamimura, Hiroteru; Yokoo, Takeshi; Kamimura, Kenya; Tsuchiya, Atsunori; Terai, Shuji] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan.
   [Watanabe, Yusuke] Niigata Univ, Sch Med, Div Preempt Med Digest Dis & Hlth Act Life, 1-757 Asahimachi Dori,Chuo Ku, Niigata 9518510, Japan.
C3 Niigata University; Niigata University; Niigata University
RP Watanabe, Y (corresponding author), Niigata Univ, Sch Med, Div Preempt Med Digest Dis & Hlth Act Life, 1-757 Asahimachi Dori,Chuo Ku, Niigata 9518510, Japan.
EM ywatanabe19840421@med.niigata-u.ac.jp
RI Kamimura, Kenya/U-6797-2019
OI Kamimura, Kenya/0000-0001-7182-4400; Terai, Shuji/0000-0002-5439-635X;
   Arao, Yoshihisa/0000-0002-3972-8539; Kamimura,
   Hiroteru/0000-0002-9135-3092
FU Japanese Society for the Promotion of Sciences [21K15993]
FX ACKNOWLEDGMENT This research was funded by a Grant-in-Aid for Scientific
   Research from the Japanese Society for the Promotion of Sciences
   (21K15993) awarded to Yusuke Watanabe.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722
   da Silva PFL, 2019, AGING CELL, V18, DOI 10.1111/acel.12848
   Enomoto M, 2022, HEPATOL RES, V52, P390, DOI 10.1111/hepr.13743
   Finkenstedt A, 2013, LIVER TRANSPLANT, V19, P879, DOI 10.1002/lt.23678
   Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017
   Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026
   Jing J, 2021, HEPATOL RES, V51, P490, DOI 10.1111/hepr.13594
   Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Le Couteur DG, 2012, J GERONTOL A-BIOL, V67, P168, DOI 10.1093/gerona/glr095
   Li FF, 2017, ACTA PHARM SIN B, V7, P326, DOI 10.1016/j.apsb.2016.09.003
   Liao PC, 2020, METHOD CELL BIOL, V155, P3, DOI 10.1016/bs.mcb.2019.10.002
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453
   Mochida S, 2022, HEPATOL RES, V52, P417, DOI 10.1111/hepr.13763
   Moreau R, 2020, J HEPATOL, V72, P688, DOI 10.1016/j.jhep.2019.11.009
   Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042
   Nojiri S, 2019, HEPATOL RES, V49, P118, DOI 10.1111/hepr.13238
   Olson JC, 2011, HEPATOLOGY, V54, P1864, DOI 10.1002/hep.24622
   Putignano A, 2017, LIVER TRANSPLANT, V23, P234, DOI 10.1002/lt.24654
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Underwood PW, 2015, CLIN TRANSPLANT, V29, P1076, DOI 10.1111/ctr.12629
   Watanabe T, 2020, REGEN THER, V14, P252, DOI 10.1016/j.reth.2020.03.012
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Yang H, 2020, AGING-US, V12, P12750, DOI 10.18632/aging.103177
   Yoshiji H, 2021, J GASTROENTEROL, V56, P593, DOI 10.1007/s00535-021-01788-x
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
NR 40
TC 0
Z9 0
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD 2023 MAY
PY 2023
VL 53
IS 5
BP 460
EP 472
DI 10.1111/hepr.13879
EA JAN 2023
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA E3FV5
UT WOS:000917144200001
PM 36628578
DA 2024-02-19
ER

PT J
AU Videla, LA
   Tapia, G
   Fernández, V
AF Videla, LA
   Tapia, G
   Fernández, V
TI Influence of aging on Kupffer cell respiratory activity in relation to
   particle phagocytosis and oxidative stress parameters in mouse liver
SO REDOX REPORT
LA English
DT Article
ID MANNOSE-SPECIFIC RECEPTORS; AGE-RELATED-CHANGES; PERFUSED-RAT-LIVER;
   SUPEROXIDE-DISMUTASE; MACROPHAGES; HEPATOTOXICITY; HEPATOCYTES; BINDING;
   INJURY; HEART
AB The influence of aging on the respiratory activity of stimulated Kupffer cells was investigated in the isolated perfused mouse liver in relation to colloidal carbon phagocytosis, and the content of glutathione (GSH) and protein carbonyls as parameters related to oxidative stress. Livers from aged (22 months) mice exhibited significant 35% and 65% decreases in the carbon uptake and in the carbon-induced O-2 consumption compared to young (3 months) animals.. respectively, with a concomitant 46% diminution in the carbon-induced O-2 consumption/carbon uptake ratio. Hepatic GSH depletion was observed in aged mice compared to young animals. whereas protein oxidation was enhanced. It is concluded that aging leads to an impairment in the functional capacity of Kupffer cells reflected by a substantial reduction in their respiratory burst activity, lessened endocytic capacity and enhanced oxidative stress, that may contribute to increased susceptibility of the liver to noxious challenges.
C1 Univ Chile, Fac Med, ICBM, Programa Farmacol Mol & Clin, Santiago, Chile.
C3 Universidad de Chile
RP Videla, LA (corresponding author), Univ Chile, Fac Med, ICBM, Programa Farmacol Mol & Clin, Santiago, Chile.
EM lvidela@machi.med.uchile.cl
CR BERGMEYER H.U., 1974, METHODS ENZYMATIC AN, P574, DOI DOI 10.1016/B978-0-12-091302-2.50010-4
   BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   COWPER KB, 1990, BIOCHEM J, V266, P141, DOI 10.1042/bj2660141
   DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x
   Dini L, 1996, MECH AGEING DEV, V90, P21, DOI 10.1016/0047-6374(96)01748-4
   DINI L, 1990, MECH AGEING DEV, V56, P117, DOI 10.1016/0047-6374(90)90003-X
   DURHAM SK, 1990, J PATHOL, V162, P341, DOI 10.1002/path.1711620412
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAYTLICK L, 1977, HDB BIOL AGING, P159
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   JANDL RC, 1978, J CLIN INVEST, V61, P1176, DOI 10.1172/JCI109033
   JUNGERMANN K, 1986, ENZYME, V35, P161, DOI 10.1159/000469338
   KNOOK DL, 1989, IMMUNOL INVEST, V18, P339
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   LENTINI A, 1992, BIOSCIENCE REP, V12, P453, DOI 10.1007/BF01122033
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maria CS, 1996, FREE RADICAL RES, V25, P401, DOI 10.3109/10715769609149062
   MARTIN G, 1994, MECH AGEING DEV, V73, P157, DOI 10.1016/0047-6374(94)90048-5
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Sans J, 1999, FREE RADICAL RES, V30, P489, DOI 10.1080/10715769900300531
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   STOTS SJ, 1982, BIOCHEM PHARMACOL, V31, P2113
   STOTS SJ, 1980, AGE, V3, P11
   Tapia G, 1997, FREE RADICAL RES, V26, P267, DOI 10.3109/10715769709097805
   Tapia G, 1998, HEPATOLOGY, V27, P1311, DOI 10.1002/hep.510270517
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   Tsukamoto H, 1997, CELLS HEPATIC SINUSO, V6, P244
   VARGA F, 1978, LIVER AGING, P327
   VIDELA LA, 1987, CELL BIOCHEM FUNCT, V5, P273, DOI 10.1002/cbf.290050406
   WANG JF, 1993, ARCH BIOCHEM BIOPHYS, V304, P189, DOI 10.1006/abbi.1993.1338
   Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114
   WYNNE HA, 1990, AGE AGEING, V19, P1, DOI 10.1093/ageing/19.1.1
   Yamano T, 2000, TOXICOL APPL PHARM, V162, P68, DOI 10.1006/taap.1999.8833
NR 37
TC 26
Z9 28
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1351-0002
EI 1743-2928
J9 REDOX REP
JI Redox Rep.
PY 2001
VL 6
IS 3
BP 155
EP 159
DI 10.1179/135100001101536265
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 463DH
UT WOS:000170461200006
PM 11523590
DA 2024-02-19
ER

PT J
AU Selvarani, R
   Nguyen, HV
   Thadathil, N
   Wolf, RF
   Freeman, WM
   Wiley, CD
   Deepa, SS
   Richardson, A
AF Selvarani, Ramasamy
   Nguyen, Hoang Van Michelle
   Thadathil, Nidheesh
   Wolf, Roman F.
   Freeman, Willard M.
   Wiley, Christopher D.
   Deepa, Sathyaseelan S.
   Richardson, Arlan
TI Characterization of novel mouse models to study the role of necroptosis
   in aging and age-related diseases
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Necroptosis; Receptor-interacting protein kinase; Ripk3; Mixed lineage
   kinase domain like protein; Mlkl; Inflammation; Knockin mice; Chronic
   liver diseases; Fibrosis; Steatosis; Cell senescence
ID CELL-DEATH; CHRONIC INFLAMMATION; RIP3; ACTIVATION; NECROSIS
AB To study the impact of necroptosis-induced chronic inflammation on age-related diseases and aging, two knockin mouse models (Ripk3-KI and Mlkl-KI) were generated that overexpress two genes involved in necroptosis (Ripk3 or Mlkl) when crossed to Cre transgenic mice. Crossing Ripk3-KI or Mlkl-KI mice to albumin-Cre transgenic mice produced hepatocyte specific hRipk3-KI or hMlkl-KI mice, which express the two transgenes only in the liver. Ripk3 and Mlkl proteins were overexpressed 10- and fourfold, respectively, in the livers of the hRipk3-KI or hMlkl-KI mice. Treating young (2-month) hRipk3-KI or hMlkl-KI mice with carbon tetrachloride (CCl4), a chemical inducer of oxidative stress, resulted in increased necroptosis (Mlkl-oligomers) and inflammation in the liver compared to control mice receiving CCl4. Mlkl-oligomerization also was significantly increased in old (18-month) hRipk3-KI and hMlkl-KI mice compared to old control (Cre negative, Ripk3-KI and Mlkl-KI) mice. The increase in necroptosis was associated with an increase in inflammation, e.g., inflammatory cytokines (TNF alpha, IL-6) and macrophage markers (F4/80, CD68). Importantly, steatosis (triglycerides) and fibrosis (e.g., picrosirius red staining, hydroxyproline levels, and transcripts for TGF beta, Col1 alpha 1, and Col3 alpha 1) that increase with age were significantly higher in the livers of the old hRipk3-KI or hMlkl-KI mice compared to old control mice. In addition, markers of cellular senescence were significantly increased in the livers of the old hRipk3-KI and hMlkl-KI mice. Thus, the first mouse models have been developed that allow researchers to study the impact of inducing necroptosis in specific cells/tissues on chronic inflammation in aging and age-related diseases.
C1 [Selvarani, Ramasamy; Thadathil, Nidheesh; Deepa, Sathyaseelan S.; Richardson, Arlan] Univ Oklahoma, Hlth Sci Ctr, Biochem & Mol Biol, Oklahoma City, OK 73019 USA.
   [Nguyen, Hoang Van Michelle] Univ Oklahoma, Hlth Sci Ctr, Nutr Sci, Oklahoma City, OK USA.
   [Wolf, Roman F.; Freeman, Willard M.; Richardson, Arlan] Okalahoma Vet Affairs Med Ctr, Oklahoma City, OK USA.
   [Freeman, Willard M.] Okalahoma Med Res Fdn, Oklahoma City, OK USA.
   [Wiley, Christopher D.] Jean Mayer USDA Human Nutr Ctr Aging, Boston, MA USA.
   [Deepa, Sathyaseelan S.] Stephenson Canc Ctr, Oklahoma City, OK USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; United States Department of Agriculture (USDA);
   University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP Richardson, A (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Biochem & Mol Biol, Oklahoma City, OK 73019 USA.; Richardson, A (corresponding author), Okalahoma Vet Affairs Med Ctr, Oklahoma City, OK USA.
EM arlan-richardson@ouhsc.edu
RI Freeman, Willard Morgan/GYQ-5841-2022
OI Freeman, Willard Morgan/0000-0001-7027-999X
FU The authors would like to thank the Imaging Core facility at Oklahoma
   Medical Research Foundation (OMRF) for performing Picrosirius Red
   staining and Ricke Peelor, Sandra Rigsby, and Dr. Benjamin Miller (Aging
   and Metabolism Research Program, OMRF) for assi
FX The authors would like to thank the Imaging Core facility at Oklahoma
   Medical Research Foundation (OMRF) for performing Picrosirius Red
   staining and Ricke Peelor, Sandra Rigsby, and Dr. Benjamin Miller (Aging
   and Metabolism Research Program, OMRF) for assistance with the
   hydroxyproline assay.
CR Afonso MB, 2021, GUT, V70, P2359, DOI 10.1136/gutjnl-2020-321767
   Afonso MB, 2015, CLIN SCI, V129, P721, DOI 10.1042/CS20140732
   Bian PY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00303
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Caccamo A, 2017, NAT NEUROSCI, V20, P1236, DOI 10.1038/nn.4608
   Chen JX, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1606-4
   Deepa SS, 2018, AGING CELL, V17, DOI 10.1111/acel.12770
   Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711
   Deng XX, 2019, AGING DIS, V10, P807, DOI 10.14336/AD.2018.0728
   Dhar D, 2020, EXP BIOL MED, V245, P96, DOI 10.1177/1535370219898141
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Fang TY, 2022, INT J BIOL SCI, V18, P5681, DOI 10.7150/ijbs.65044
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0
   Huang HL, 2012, WORLD J GASTROENTERO, V18, P6605, DOI 10.3748/wjg.v18.i45.6605
   Liu B, 2015, FOOD FUNCT, V6, P3454, DOI [10.1039/c5fo00563a, 10.1039/C5FO00563A]
   Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146
   Meng LJ, 2015, P NATL ACAD SCI USA, V112, P11007, DOI 10.1073/pnas.1514730112
   Mohammed S, 2023, MOL CANCER RES, V21, P933, DOI 10.1158/1541-7786.MCR-22-0820
   Mohammed S, 2021, AGING CELL, V20, DOI 10.1111/acel.13512
   Mohammed S, 2021, FREE RADICAL BIO MED, V164, P315, DOI 10.1016/j.freeradbiomed.2020.12.449
   Morgan JE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06057-9
   Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113
   Moujalled DM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.18
   Negroni A, 2017, DIGEST LIVER DIS, V49, P1201, DOI 10.1016/j.dld.2017.08.017
   Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051
   Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191
   Roh JS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e27
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Selvarani R, 2021, GEROSCIENCE, V43, P1135, DOI 10.1007/s11357-020-00274-1
   Song JY, 2007, EXP TOXICOL PATHOL, V59, P29, DOI 10.1016/j.etp.2007.02.005
   Thadathil N, 2022, AGING CELL, V21, DOI 10.1111/acel.13676
   Thadathil N, 2021, GEROSCIENCE, V43, P2345, DOI 10.1007/s11357-021-00448-5
   Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568
   Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273
   Wu XQ, 2020, J HEPATOL, V73, P617, DOI 10.1016/j.jhep.2020.03.023
   Zhang XH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1490-8
NR 37
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 DEC
PY 2023
VL 45
IS 6
BP 3241
EP 3256
DI 10.1007/s11357-023-00955-7
EA OCT 2023
PG 16
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA Y3WH0
UT WOS:001079791200002
PM 37792157
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Saga, K
   Iwashita, Y
   Hidano, S
   Aso, Y
   Isaka, K
   Kido, Y
   Tada, K
   Takayama, H
   Masuda, T
   Hirashita, T
   Endo, Y
   Ohta, M
   Kobayashi, T
   Inomata, M
AF Saga, Kunihiro
   Iwashita, Yukio
   Hidano, Shinya
   Aso, Yuiko
   Isaka, Kenji
   Kido, Yasutoshi
   Tada, Kazuhiro
   Takayama, Hiroomi
   Masuda, Takashi
   Hirashita, Teijiro
   Endo, Yuichi
   Ohta, Masayuki
   Kobayashi, Takashi
   Inomata, Masafumi
TI Secondary Unconjugated Bile Acids Induce Hepatic Stellate Cell
   Activation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE hepatic stellate cell; secondary unconjugated bile acid; DNA microarray;
   tumor necrosis factor signaling pathway
ID NF-KAPPA-B; LIVER-CANCER; QUANTITATIVE ESTIMATION; RECEPTOR FXR;
   TNF-ALPHA; INFLAMMATION; FIBROSIS; OBESITY; DIFFERENTIATION; BIOLOGY
AB Hepatic stellate cells (HSCs) are key players in liver fibrosis, cellular senescence, and hepatic carcinogenesis. Bile acids (BAs) are involved in the activation of HSCs, but the detailed mechanism of this process remains unclear. We conducted a comprehensive DNA microarray study of the human HSC line LX-2 treated with deoxycholic acid (DCA), a secondary unconjugated BA. Additionally, LX-2 cells were exposed to nine BAs and studied using immunofluorescence staining, enzyme-linked immunosorbent assay, and flow cytometry to examine the mechanisms of HSC activation. We focused on the tumor necrosis factor (TNF) pathway and revealed upregulation of genes related to nuclear factor kappa B (NF-B) signaling and senescence-associated secretory phenotype factors. -Smooth muscle actin (-SMA) was highly expressed in cells treated with secondary unconjugated BAs, including DCA, and a morphological change associated with radial extension of subendothelial protrusion was observed. Interleukin-6 level in culture supernatant was significantly higher in cells treated with secondary unconjugated BAs. Flow cytometry showed that the proportion of cells highly expressing -SMA was significantly increased in HSCs cultured with secondary unconjugated BAs. We demonstrated that secondary unconjugated BAs induced the activation of human HSCs.
C1 [Saga, Kunihiro; Iwashita, Yukio; Aso, Yuiko; Isaka, Kenji; Tada, Kazuhiro; Takayama, Hiroomi; Masuda, Takashi; Hirashita, Teijiro; Endo, Yuichi; Ohta, Masayuki; Inomata, Masafumi] Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, 1-1 Idaigaoka, Hasama, Oita 8795593, Japan.
   [Hidano, Shinya; Kobayashi, Takashi] Oita Univ, Fac Med, Dept Infect Dis Control, 1-1 Idaigaoka, Hasama, Oita 8795593, Japan.
   [Kido, Yasutoshi] Oita Univ, Fac Med, Dept Environm & Prevent Med, 1-1 Idaigaoka, Hasama, Oita 8795593, Japan.
C3 Oita University; Oita University; Oita University
RP Saga, K (corresponding author), Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, 1-1 Idaigaoka, Hasama, Oita 8795593, Japan.
EM saga9216@oita-u.ac.jp; iwashita@oita-u.ac.jp; hshinya@oita-u.ac.jp;
   asoyui.experi@gmail.com; m1341101@oita-u.ac.jp; kidoyasu@oita-u.ac.jp;
   kaztada@oita-u.ac.jp; t-1603@oita-u.ac.jp; tmasuda@oita-u.ac.jp;
   teij03@oita-u.ac.jp; endo@oita-u.ac.jp; ohta@oita-u.ac.jp;
   takashik@oita-u.ac.jp; inomata@oita-u.ac.jp
RI Kido, Yasutoshi/AAW-3688-2021; Endo, Yuichi/AAM-8998-2021
OI Kido, Yasutoshi/0000-0003-3615-2631; Saga, Kunihiro/0000-0001-7432-6327
FU Japan Society for the Promotion of Science (JSPS) KAKENHI [JP17K10671]
FX This work was supported by the Japan Society for the Promotion of
   Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (C)
   JP17K10671.
CR Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Boufker HI, 2011, BONE, V49, P1219, DOI 10.1016/j.bone.2011.08.013
   Chang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120713
   Chanwat R, 2018, ASIAN J ENDOSC SURG, V11, P93, DOI 10.1111/ases.12494
   DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001
   Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001
   Friedman SL, 1997, J GASTROENTEROL, V32, P424, DOI 10.1007/BF02934504
   Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gressner OA, 2007, J CELL MOL MED, V11, P1031, DOI 10.1111/j.1582-4934.2007.00092.x
   Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029
   Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002
   Hanaoka J, 2013, SURG TODAY, V43, P300, DOI 10.1007/s00595-012-0248-z
   HEUMAN DM, 1989, J LIPID RES, V30, P719
   Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008
   Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139
   Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Kitada H, 2003, J BIOL CHEM, V278, P17838, DOI 10.1074/jbc.M210634200
   Kordes C, 2015, DIGEST DIS, V33, P332, DOI 10.1159/000371673
   Lade A, 2014, CURR OPIN ONCOL, V26, P100, DOI 10.1097/CCO.0000000000000042
   Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123
   Li Tiangang, 2012, J Lipids, V2012, P754067, DOI 10.1155/2012/754067
   Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932
   Margheritis E, 2016, ACS CHEM BIOL, V11, P2908, DOI 10.1021/acschembio.6b00624
   Murphy K.M., 2016, JANEWAYS IMMUNOBIOLO, P87
   Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007
   Ogaly HA, 2015, MOLECULES, V20, P13518, DOI 10.3390/molecules200813518
   Pahwa R, 2016, J DIABETES COMPLICAT, V30, P563, DOI 10.1016/j.jdiacomp.2016.01.014
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056
   Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023
   Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Sawitza I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13320
   Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Senoo H, 2017, ANAT SCI INT, V92, P387, DOI 10.1007/s12565-017-0395-9
   Shinji S, 2018, ONCOTARGET, V9, P2553, DOI 10.18632/oncotarget.23510
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Sommerfeld A, 2009, J BIOL CHEM, V284, P22173, DOI 10.1074/jbc.M109.005355
   STREET JM, 1983, J LIPID RES, V24, P491
   Su HY, 2012, AM J PHYSIOL-GASTR L, V303, pG1245, DOI 10.1152/ajpgi.00439.2011
   Suga T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169719
   Tanaka K, 2012, JPN J CLIN ONCOL, V42, P212, DOI 10.1093/jjco/hyr198
   Treyer M, 2002, LANGMUIR, V18, P1043, DOI 10.1021/la011111u
   Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203
   Valanejad L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170960
   Wang X, 2013, MATH MECH COMPLEX SY, V1, P1
   Watanabe K, 2018, OBES SURG, V28, P1532, DOI 10.1007/s11695-017-3052-4
   Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514
   Wu YW, 2015, ACTA PHARMACOL SIN, V36, P1395, DOI 10.1038/aps.2015.91
   Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016
NR 59
TC 18
Z9 18
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT
PY 2018
VL 19
IS 10
AR 3043
DI 10.3390/ijms19103043
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA GY9HB
UT WOS:000448951000198
PM 30301191
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Ishigami, A
   Kondo, Y
   Nanba, R
   Ohsawa, T
   Handa, S
   Kubo, S
   Akita, M
   Maruyama, N
AF Ishigami, A
   Kondo, Y
   Nanba, R
   Ohsawa, T
   Handa, S
   Kubo, S
   Akita, M
   Maruyama, N
TI SMP30 deficiency in mice causes an accumulation of neutral lipids and
   phospholipids in the liver and shortens the life span
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE aging; SMP30; phospholipid; neutrallipid; knockout mice; cardiolipin;
   sphingomyelin
ID SENESCENCE MARKER PROTEIN-30; THIN-LAYER CHROMATOGRAMS; FAT-BODY
   PROTEIN; RAT-LIVER; EXPRESSION; PURIFICATION; REGUCALCIN; APOPTOSIS;
   LUCIFERIN; TISSUES
AB Senescence marker protein-30 (SMP30) is an androgen-independent factor that decreases with aging. SMP30-deficient (SMP30Y/-) mice are viable and fertile but lower in body weight and shorter in life span than the wild-type. In the electron microscope, hepatocytes from SMP30Y/- but not the wild-type mice at 12 months of age clearly contained many lipid droplets, abnormally enlarged mitochondria with indistinct cristae, and enlarged lysosomes filled with electron-dense bodies. In liver specimens from SMP30Y/- mice, the marked number of lipid droplets visible around the central vein increased notably in size and amount as the animals aged. Biochemical analysis of neutral lipids, total hepatic triglyceride, and cholesterol from SMP30Y/- mice showed approximately 3.6- and 3.3-fold higher levels, respectively. than those from age-matched wild-type mice. Moreover, values for total hepatic phospholipids from SMP30Y/- mice were approximately 3.7-fold higher than those for their wild-type counterparts. By thin-layer chromatography analysis, phosphatidylethanolamine, cardiolipin, phosphatidylcholine, phosphatidylserine, and sphingomyelin accumulations were detected separately in lipid extracts from SMP30Y/- mouse livers and provided results that strongly indicate the profound effect of an SMP30 deficiency on the metabolism of these neutral lipids and phospholipids. Conceivably, this abnormality of lipid metabolism is sufficient to curtail the life span of SMP30-deficient mice. (C) 2004 Elsevier Inc. All rights reserved.
C1 Tokyo Metropolitan Inst Gerontol, Organ Disorder & Aging Res Grp, Itabashi Ku, Tokyo 1730015, Japan.
   Saitama Med Sch, Biomed Res Ctr, Div Morphol Sci, Moroyama, Saitama 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Saitama Medical University
RP Maruyama, N (corresponding author), Tokyo Metropolitan Inst Gerontol, Organ Disorder & Aging Res Grp, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM maruyama@tmig.or.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami,
   Akihito/0000-0001-7875-7482
CR Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Gomi K, 2002, GENE, V294, P157, DOI 10.1016/S0378-1119(02)00764-3
   Gomi K, 2001, J BIOL CHEM, V276, P36508, DOI 10.1074/jbc.M105528200
   Goto SG, 2000, J INSECT PHYSIOL, V46, P1111, DOI 10.1016/S0022-1910(99)00221-8
   Hansen IA, 2002, EUR J BIOCHEM, V269, P954, DOI 10.1046/j.0014-2956.2001.02736.x
   HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   ISHII K, 2002, J OTOLARYNGOL JPN, V105, P915
   KUROKI Y, 1991, J BIOL CHEM, V266, P3068
   McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3
   Müthing J, 1998, ANAL BIOCHEM, V257, P67, DOI 10.1006/abio.1997.2504
   Nakajima Y, 2000, J BIOCHEM-TOKYO, V127, P901, DOI 10.1093/oxfordjournals.jbchem.a022685
   RYU EK, 1979, J LIPID RES, V20, P561
   Sato A, 2000, MECH DEVELOP, V92, P273, DOI 10.1016/S0925-4773(99)00331-7
   Takahashi H, 2000, J CELL BIOCHEM, V78, P121
   Xue JH, 2000, J CELL BIOCHEM, V80, P285
NR 26
TC 90
Z9 105
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 12
PY 2004
VL 315
IS 3
BP 575
EP 580
DI 10.1016/j.bbrc.2004.01.091
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 779JQ
UT WOS:000189291900008
PM 14975739
DA 2024-02-19
ER

PT J
AU Yu, XJ
   Wang, YT
   Song, YF
   Gao, XD
   Deng, HK
AF Yu, Xiaojie
   Wang, Yuting
   Song, Yifan
   Gao, Xianda
   Deng, Hongkui
TI AP-1 is a regulatory transcription factor of inflammaging in the murine
   kidney and liver
SO AGING CELL
LA English
DT Article; Early Access
DE aging; AP-1; inflammation; kidney; liver; transcription factor
ID ENERGY-METABOLISM; EXPRESSION; SENESCENCE; LONGEVITY; SIGNATURE;
   BIOMARKER; CULTURE; PROFILE; CELLS
AB Aging is characterized by chronic low-grade inflammation in multiple tissues, also termed "inflammaging", which represents a significant risk factor for many aging-related chronic diseases. However, the mechanisms and regulatory networks underlying inflammaging across different tissues have not yet been fully elucidated. Here, we profiled the transcriptomes and epigenomes of the kidney and liver from young and aged mice and found that activation of the inflammatory response is a conserved signature in both tissues. Moreover, we revealed links between transcriptome changes and chromatin dynamics through integrative analysis and identified AP-1 and ETS family transcription factors (TFs) as potential regulators of inflammaging. Further in situ validation showed that c-JUN (a member of the AP-1 family) was mainly activated in aged renal and hepatic cells, while increased SPI1 (a member of the ETS family) was mostly induced by elevated infiltration of macrophages, indicating that these TFs have different mechanisms in inflammaging. Functional data demonstrated that genetic knockdown of Fos, a major member of the AP-1 family, significantly attenuated the inflammatory response in aged kidneys and livers. Taken together, our results revealed conserved signatures and regulatory TFs of inflammaging in the kidney and liver, providing novel targets for the development of anti-aging interventions.
C1 [Yu, Xiaojie; Wang, Yuting; Song, Yifan; Deng, Hongkui] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China.
   [Gao, Xianda; Deng, Hongkui] Peking Univ, Sch Basic Med Sci, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China.
   [Deng, Hongkui] Peking Univ, Hlth Sci Ctr, Peking Tsinghua Ctr Life Sci, Sch Life Sci,MOE Key Lab Cell Proliferat & Differe, Beijing, Peoples R China.
   [Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, MOE Engn Res Ctr Regenerat Med, Hlth Sci Ctr,Sch Basic Med Sci,State Key Lab Nat &, Beijing, Peoples R China.
C3 Peking University; Peking University; Peking University; Peking
   University
RP Deng, HK (corresponding author), Peking Univ, Hlth Sci Ctr, Peking Tsinghua Ctr Life Sci, Sch Life Sci,MOE Key Lab Cell Proliferat & Differe, Beijing, Peoples R China.; Deng, HK (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, MOE Engn Res Ctr Regenerat Med, Hlth Sci Ctr,Sch Basic Med Sci,State Key Lab Nat &, Beijing, Peoples R China.
EM hongkui_deng@pku.edu.cn
RI Li, Xinyue/JVN-4601-2024; LEI, LEI/JTS-4675-2023; wang,
   xi/JNT-5162-2023; wang, jiaqi/JSL-7112-2023; li, jiaxin/JNT-5073-2023;
   zhao, wei/JZD-4475-2024; lei, lei/JSL-3106-2023; wu,
   jialin/JPY-4408-2023; Zhang, Yusi/JNS-2335-2023; LI, SHA/JNR-9956-2023;
   li, mengyang/JWO-9551-2024; Zhang, Zixuan/JSL-3603-2023; Liu,
   Zhihao/JUF-7651-2023; li, rui/JVM-8999-2024; yu, xiaojie/GSI-9676-2022;
   Wang, Yanan/JVZ-7957-2024; Yuan, Fang/JQV-7426-2023; qi,
   qi/JWP-1757-2024; Chen, Feng/JQW-8742-2023
OI yu, xiaojie/0000-0003-4373-0321; Deng, Hongkui/0000-0003-3045-4428
FU National Natural Science Foundation of China [32288102]
FX National Natural Science Foundation of China, Grant/Award Number:
   32288102
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Alic N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004619
   Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592
   Browder KC, 2022, NATURE AGING, V2, P243, DOI 10.1038/s43587-022-00183-2
   Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109
   Catic A, 2018, PROG MOL BIOL TRANSL, V155, P85, DOI 10.1016/bs.pmbts.2017.12.003
   Challis B., 2006, NAT METHODS, V3, P658, DOI [10.1038/nmeth907, DOI 10.1038/NMETH907]
   Charni-Natan M, 2020, STAR PROTOC, V1, DOI 10.1016/j.xpro.2020.100086
   Ciapponi L, 2002, MECH DEVELOP, V115, P35, DOI 10.1016/S0925-4773(02)00093-X
   Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]
   De Maeyer RPH, 2021, IMMUNOL LETT, V230, P1, DOI 10.1016/j.imlet.2020.12.003
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dobson AJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008212
   Dong AQ, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2022.109454
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Field AE, 2018, MOL CELL, V71, P882, DOI 10.1016/j.molcel.2018.08.008
   Fischer F, 2022, PHYSIOL REV, V102, P1449, DOI 10.1152/physrev.00017.2021
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fulop T, 2018, SEMIN IMMUNOL, V40, P17, DOI 10.1016/j.smim.2018.09.003
   Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54
   Guerrero A, 2021, TRENDS NEUROSCI, V44, P714, DOI 10.1016/j.tins.2021.06.007
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Jin CJ, 2020, AM J PHYSIOL-GASTR L, V318, pG736, DOI 10.1152/ajpgi.00345.2018
   Kanasaki K, 2012, HYPERTENS RES, V35, P1121, DOI 10.1038/hr.2012.159
   Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3
   Landsberger T., 2022, BIORXIV, DOI [10.1101/2022.09.26.509471, DOI 10.1101/2022.09.26.509471]
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Li DW, 2017, CELL STEM CELL, V21, P819, DOI 10.1016/j.stem.2017.10.012
   Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2
   Liu C, 2021, ADV SCI, V8, DOI 10.1002/advs.202004433
   Liu F, 2022, GENES DIS, V9, P1248, DOI 10.1016/j.gendis.2021.06.010
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mancuso P, 2019, FRONT ENDOCRINOL, V10, DOI [10.3389/fendo.2019.00137, 10.3389/fendo.019.00137]
   Martínez-Zamudio RI, 2020, NAT CELL BIOL, V22, P842, DOI 10.1038/s41556-020-0529-5
   Mayran A, 2018, J BIOL CHEM, V293, P13795, DOI 10.1074/jbc.R117.001232
   Moestrup SK, 2005, CURR OPIN LIPIDOL, V16, P301, DOI 10.1097/01.mol.0000169350.45944.d4
   Mogilenko DA, 2022, NAT REV IMMUNOL, V22, P484, DOI 10.1038/s41577-021-00646-4
   O'Brown ZK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005734
   Piedrafita A, 2021, FASEB J, V35, DOI 10.1096/fj.202100782RR
   Pimenova AA, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105217
   Qiao YC, 2016, J BIOL CHEM, V291, P18309, DOI 10.1074/jbc.A115.702571
   Rechsteiner C., 2022, BIORXIV, DOI [10.1101/2022.08.11.502778, DOI 10.1101/2022.08.11.502778]
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076
   Shavlakadze T, 2019, CELL REP, V28, P3263, DOI 10.1016/j.celrep.2019.08.043
   Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798
   Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017
   Srivastava A, 2020, GENOM PROTEOM BIOINF, V18, P430, DOI 10.1016/j.gpb.2020.12.001
   Stadhouders R, 2019, NATURE, V569, P345, DOI 10.1038/s41586-019-1182-7
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Tsurumi A, 2012, EPIGENETICS-US, V7, P680, DOI 10.4161/epi.20540
   Ucar D, 2017, J EXP MED, V214, P3123, DOI 10.1084/jem.20170416
   Wang K, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01211-8
   Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13
   Wang YT, 2022, PROTEIN CELL, V13, P742, DOI 10.1007/s13238-021-00894-z
   Willis SN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01605-1
   Wolfe H, 2018, MECH AGEING DEV, V173, P84, DOI 10.1016/j.mad.2018.05.003
   Xia SJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8426874
   Xiao FH, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abf2017
   Xu LY, 2020, AGING CELL, V19, DOI 10.1111/acel.13267
   Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733
   Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873
   Zhang C, 2021, AGING CELL, V20, DOI 10.1111/acel.13315
   ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373
   Zhang FR, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020235
   Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5
   Zhou X, 2018, CURR GENOMICS, V19, P464, DOI 10.2174/1389202919666180503125850
NR 71
TC 2
Z9 2
U1 6
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 JUL
PY 2023
VL 22
IS 7
DI 10.1111/acel.13858
EA MAY 2023
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA M6VN8
UT WOS:000983054000001
PM 37154113
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Denchi, EL
   Celli, G
   de Lange, T
AF Denchi, Eros Lazzerini
   Celli, Giulia
   de Lange, Titia
TI Hepatocytes with extensive telomere deprotection and fusion remain
   viable and regenerate liver mass through endoreduplication
SO GENES & DEVELOPMENT
LA English
DT Article
DE DNA damage; TRF2; endoreduplication; hepatocyte; telomere
ID HEPATOCELLULAR-CARCINOMA; DYSFUNCTIONAL TELOMERES; APOPTOSIS; CELLS;
   TRF2; ATM; PROGRESSION; SENESCENCE; MICE; P53
AB We report that mouse liver cells are highly resistant to extensive telomere dysfunction. In proliferating cells, telomere dysfunction results in chromosome end fusions, a DNA damage signal, and apoptosis or senescence. To determine the consequences of telomere dysfunction in noncycling cells, we used conditional deletion of the telomeric protein TRF2 in hepatocytes. TRF2 loss resulted in telomeric accumulation of gamma-H2AX and frequent telomere fusions, indicating telomere deprotection. However, there was no induction of p53 or apoptosis, and liver function appeared unaffected. Furthermore, the loss of TRF2 did not compromise liver regeneration after partial hepatectomy. Remarkably, liver regeneration occurred without cell division involving endoreduplication and cell growth, thereby circumventing the chromosome segregation problems associated with telomere fusions. We conclude that nondividing hepatocytes can maintain and regenerate liver function despite substantial loss of telomere integrity.
C1 Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA.
C3 Rockefeller University
RP de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.
EM delange@mail.rockefeller.edu
RI lazzerini denchi, eros/F-7913-2010; Denchi, Eros
   Lazzerini/AAD-8208-2020; de Lange, Titia/B-8263-2011
OI lazzerini denchi, eros/0000-0001-5378-4644; de Lange,
   Titia/0000-0002-9267-367X
FU NIA NIH HHS [R56 AG016642, AG16642, R01 AG016642] Funding Source:
   Medline; NIGMS NIH HHS [GM49046, R01 GM049046, R37 GM049046] Funding
   Source: Medline
CR Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275
   Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444
   d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   Farazi PA, 2003, CANCER RES, V63, P5021
   Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321
   KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125
   Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004
   Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411
   Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565
   Plentz RR, 2005, HEPATOLOGY, V42, P522, DOI 10.1002/hep.20847
   Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0
   Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119
NR 22
TC 92
Z9 111
U1 0
U2 1
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0890-9369
J9 GENE DEV
JI Genes Dev.
PD OCT 1
PY 2006
VL 20
IS 19
BP 2648
EP 2653
DI 10.1101/gad.1453606
PG 6
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 091OM
UT WOS:000241038200004
PM 17015429
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU FROLKIS, VV
   KOBZAR, AL
   PARAMONOVA, GI
AF FROLKIS, VV
   KOBZAR, AL
   PARAMONOVA, GI
TI CHANGES IN THE PLASMATIC MEMBRANE-CHARACTERISTICS DURING MICROSOMAL
   MONOOXYGENASE INDUCTION IN THE LIVER OF ADULT AND OLD RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE PLASMATIC MEMBRANE; MICROSOMAL OXIDATION; INVERTERS; AGING
AB The experiments on adult (6-8 months) and old (24-26 months) male Wistar rats have shown that treatment of animals with phenobarbital results in a significant increase in hepatic microsomal enzyme content, plasmatic membrane Na+,K+ ATPase activities and the elevation of hepatocyte membrane potential value. It is presumed that the changes in plasmatic membrane characteristics during microsomal monooxygenase induction are related to the synthesis of specific intracellular factors (invertors). This assumption was verified by the experiments with 'cellular hybrid' system (cytosol - plasmatic membranes). Using this cross-systems, it was shown that the hepatocyte cytosol of rats treated with phenobarbital produced Na+,K+-ATPase activity. The extent of Na+,K+-ATPase activation was essentially lower when cytosol derived from old rat hepatocytes was used. The presence of specific factors that activated Na+,K+-ATPase in hepatocyte plasmatic membrane was also discovered in blood serum of induced adult and old rats.
RP FROLKIS, VV (corresponding author), AMS UKRAINE,INST GERONTOL,VYSHGORODSKAYA ST 67,KIEV 254114,UKRAINE.
RI Paramonova, Galina/T-3791-2019
OI Paramonova, Galina/0000-0001-6568-2434
CR Archakov A. I., 1975, Microsomal Oxidation
   FROLKIS V V, 1989, Zeitschrift fuer Alternsforschung, V44, P3
   FROLKIS VV, 1992, MECH AGEING DEV, V66, P187, DOI 10.1016/0047-6374(92)90135-Z
   FROLKIS VV, 1992, DOKL AKAD NAUK+, V324, P229
   FROLKIS VV, 1973, EXPERIENTIA, V14, P108
   FROLKIS VV, 1990, MECH AGEING DEV, V60, P55
   FROLKIS VV, 1980, DOKLADI ACAD NAUK UK, V3, P249
   KAPLYA AA, 1980, BIOCH J UKRAINI, V2, P40
   Karuzina II, 1977, Modern methods in biochemistry, P49
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   KOSTUJK PG, 1960, MICROELECTRODE TECHN
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYAHOVICH VV, 1981, INDUCTION KSENOBIOTI
   MICHELL RH, 1965, BIOCHEM BIOPH RES CO, V21, P333, DOI 10.1016/0006-291X(65)90198-1
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   PARAMONOVA GI, 1992, PROBLEMI STARENIYA D, V1, P192
   RATHBUN WB, 1969, ANAL BIOCHEM, V28, P436, DOI 10.1016/0003-2697(69)90198-5
   ROBINSON JD, 1979, BIOCHIM BIOPHYS ACTA, V549, P142
   Szego C., 1981, BIOCHEM ACTION HORM, V8, P307
NR 19
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY 12
PY 1995
VL 80
IS 2
BP 139
EP 145
DI 10.1016/0047-6374(94)01566-5
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA RB321
UT WOS:A1995RB32100006
PM 7564564
DA 2024-02-19
ER

PT J
AU Zhou, GX
   Hou, F
   He, H
   Xue, Y
   Wang, YB
   Chen, XY
   Zhu, FQ
AF Zhou, Guangxi
   Hou, Fei
   He, Heng
   Xue, Yuan
   Wang, Yibo
   Chen, Xueying
   Zhu, Fengqin
TI Myocyte Enhancer Factor 2A Contributes to the TGF-β1-Mediated
   Cholangiocyte Epithelial to Mesenchymal Transition and Senescence in
   Cholestatic Liver Fibrosis
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE MEF2A; EMT; senescence; fibrosis; cholangiocytes
ID DNA METHYLTRANSFERASE INHIBITORS; PROMOTER METHYLATION;
   PLATINUM-RESISTANT; GENE-EXPRESSION; CPG METHYLATION; LUNG-CANCER;
   HYPOMETHYLATION; EPIGENETICS; CELLS; DIFFERENTIATION
AB Background: Cholangiocytes are primary targets in chronic cholestatic liver diseases. Myocyte enhancer factor 2A (MEF2A) is a transcription factor with a crucial role in some fibrogenic diseases. However, whether it contributes to cholestatic liver fibrosis is still ob-scure. Methods: A bile duct-ligated (BDL) mouse model was established to detect MEF2A expression during cholestatic liver fibrosis. In addition, human intrahepatic biliary epithelial cells (HIBECs) were transfected with lentivirus-expressing shMEF2A (LV-shMEF2A) to regulate the expression of MEF2A in vitro. Biomarkers of epithelial to mesenchymal transition (EMT), senescence, and fibrogen-esis were evaluated using various assays: Quantitative real-time polymerase chain reaction (qRT-PCR), western blotting, senescence -associated 0-galactosidase (SA -0-gal), and immunofluorescence. Furthermore, MEF2A expression and cytoplasm translocation induced by transforming growth factor 01 (TGF-01) in HIBECs were determined by qRT-PCR, western blotting, and immunofluorescence. The expression of TGF-01-induced MEF2A, EMT, senescence, and fibrosis markers inhibited by p38 MAPK signaling were evaluated by western blotting. Finally, the peripheral blood from primary biliary cholangitis (PBC) patients and healthy controls (HCs) was collected to analyze expression of MEF2A using Enzyme-linked immunosorbent assay (ELISA). Results: We found that MEF2A expression increased in liver tissues of BDL mice, and positively related to the extent of fibrosis. Silencing MEF2A in HIBECs restrained TGF-01-induced EMT, senescence, and fibrotic reaction. Moreover, TGF-01 enhanced the expression of MEF2A and induced its cytoplasm translocation in a concentration-and time-dependent manner, partially through interacting with p38 MAPK. The expression of MEF2A was also higher in the serum of PBC patients than in HCs, and positively correlated with fibrosis degree. Conclusions: Our study demon-strates that MEF2A is a central mediator linking TGF-01-induced EMT and senescence in HIBECs. We propose it as a novel biomarker of fibrogenesis in cholestatic liver fibrosis. We also suggest inhibiting MEF2A as a potential strategy in treating cholestatic liver fibrosis.
C1 [Zhou, Guangxi; He, Heng; Xue, Yuan; Wang, Yibo; Zhu, Fengqin] Jining Med Univ, Affiliated Hosp, Dept Gastroenterol, Jining 272000, Shandong, Peoples R China.
   [Zhou, Guangxi; Zhu, Fengqin] Shandong Univ Tradit Chinese Med, Jinan 250355, Shandong, Peoples R China.
   [Hou, Fei] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Dept Crit Liver Dis, Beijing, Peoples R China.
   [Chen, Xueying] Jining Med Univ, Dept Cardiol, Affiliated Hosp, Jining 272000, Shandong, Peoples R China.
C3 Jining Medical University; Shandong University of Traditional Chinese
   Medicine; Capital Medical University; Jining Medical University
RP Zhu, FQ (corresponding author), Jining Med Univ, Affiliated Hosp, Dept Gastroenterol, Jining 272000, Shandong, Peoples R China.; Zhu, FQ (corresponding author), Shandong Univ Tradit Chinese Med, Jinan 250355, Shandong, Peoples R China.
EM zhufqin@126.com
RI Li, Huizhen/JPX-2563-2023; chen, yan/JRY-4645-2023
FU Tai Shan Young Scholar Foundation of Shandong Province [tsqn202103190];
   TCM Science and Technology Project of Shandong Province [Q-2022134]; Key
   research and development plan of Jining City [2021YXNS045, 2021YXNS144];
   Postdoctoral Fund of the Affiliated Hospital of Jining Medical
   University [JYFY303574]
FX Funding This work was supported by grants from Tai Shan Young Scholar
   Foundation of Shandong Province (tsqn202103190) , TCM Science and
   Technology Project of Shandong Province (Q-2022134) , Key research and
   development plan of Jining City (2021YXNS045, 2021YXNS144) , and
   Postdoctoral Fund of the Affiliated Hospital of Jining Medical
   University (JYFY303574) .
CR Al Emran A, 2019, TRENDS IMMUNOL, V40, P328, DOI 10.1016/j.it.2019.02.004
   Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477
   An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071
   Barbano R, 2013, EPIGENETICS-US, V8, P105, DOI 10.4161/epi.23319
   Barchitta M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081843
   Barchitta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109478
   Barve A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111322
   BAYLIN SB, 1986, CANCER RES, V46, P2917
   Baylin SB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019505
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Benson EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141279
   Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042
   Bian YJ, 2020, NATURE, V585, P277, DOI 10.1038/s41586-020-2682-1
   Biswas S, 2017, PHARMACOL THERAPEUT, V173, P118, DOI 10.1016/j.pharmthera.2017.02.011
   Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694
   Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034
   Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887
   Burris HH, 2014, J APPL TOXICOL, V34, P113, DOI 10.1002/jat.2904
   Cecotka A, 2018, INTERDISCIP SCI, V10, P33, DOI 10.1007/s12539-018-0285-4
   Chao C, 2013, CANCER CAUSE CONTROL, V24, P1615, DOI 10.1007/s10552-013-0249-2
   Chen C, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.935536
   Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012
   Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564
   Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779
   Chen X, 2020, ACTA PHARMACOL SIN B, V10, P723, DOI 10.1016/j.apsb.2019.09.006
   Chiappinelli KB, 2016, CANCER RES, V76, P1683, DOI 10.1158/0008-5472.CAN-15-2125
   Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011
   Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699
   Chua GNL, 2019, ACS MED CHEM LETT, V10, P180, DOI 10.1021/acsmedchemlett.8b00474
   Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148
   Crispo F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080798
   Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013
   Dear AE, 2016, NEW ENGL J MED, V374, P684, DOI 10.1056/NEJMcibr1514673
   Derissen EJB, 2013, ONCOLOGIST, V18, P619, DOI 10.1634/theoncologist.2012-0465
   Desai S, 2014, ONCOTARGET, V5, P8202, DOI 10.18632/oncotarget.1159
   Duhen T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05072-0
   Ehrlich M, 2019, EPIGENETICS-US, V14, P1141, DOI 10.1080/15592294.2019.1638701
   Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33
   Elia I, 2021, NAT METAB, V3, P21, DOI 10.1038/s42255-020-00317-z
   Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360
   Fang F, 2014, ONCOTARGET, V5, P3579, DOI 10.18632/oncotarget.1961
   Fang F, 2010, CANCER-AM CANCER SOC, V116, P4043, DOI 10.1002/cncr.25204
   Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279
   Franco F, 2020, NAT METAB, V2, P1001, DOI 10.1038/s42255-020-00280-9
   Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105
   Gao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11960
   Gevensleben H, 2016, ONCOTARGET, V7, P79943, DOI 10.18632/oncotarget.13161
   Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007
   Giri AK, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00385
   Gnyszka A, 2013, ANTICANCER RES, V33, P2989
   Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006
   Goltz D, 2017, LEUKEMIA, V31, P738, DOI 10.1038/leu.2016.328
   Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737
   Goyos A, 2011, J IMMUNOL, V186, P372, DOI 10.4049/jimmunol.1001467
   HANADA M, 1993, BLOOD, V82, P1820
   Hatzimichael E, 2009, CLIN LYMPHOMA MYELOM, V9, P239, DOI 10.3816/CLM.2009.n.047
   He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944
   Heiland DH, 2017, ONCOTARGET, V8, P42214, DOI 10.18632/oncotarget.15031
   Héninger E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00029
   Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146
   Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870
   Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110
   Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636
   Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005
   Ilyas S, 2015, J IMMUNOL, V195, P5117, DOI 10.4049/jimmunol.1501657
   Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549
   Janson PCJ, 2008, J IMMUNOL, V181, P2878, DOI 10.4049/jimmunol.181.4.2878
   Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816
   Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797
   Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23
   Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792
   Karpf AR, 2006, EPIGENETICS-US, V1, P116, DOI 10.4161/epi.1.3.2988
   Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68
   Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82
   Kioussis D, 2007, SCIENCE, V317, P620, DOI 10.1126/science.1143777
   Kishton RJ, 2017, CELL METAB, V26, P94, DOI 10.1016/j.cmet.2017.06.016
   Klughammer J, 2018, NAT MED, V24, P1611, DOI 10.1038/s41591-018-0156-x
   Koch A, 2018, NAT REV CLIN ONCOL, V15, P459, DOI 10.1038/s41571-018-0004-4
   Kosmider O, 2009, HAEMATOL-HEMATOL J, V94, P1676, DOI 10.3324/haematol.2009.011205
   Kottakis F, 2016, NATURE, V539, P390, DOI 10.1038/nature20132
   Ladle BH, 2016, P NATL ACAD SCI USA, V113, P10631, DOI 10.1073/pnas.1524490113
   Lay FD, 2015, GENOME RES, V25, P467, DOI 10.1101/gr.183368.114
   Li CY, 2020, HAEMATOLOGICA, V105, P148, DOI 10.3324/haematol.2018.208835
   Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782
   Lim Unhee, 2012, Methods Mol Biol, V863, P359, DOI 10.1007/978-1-61779-612-8_23
   Liu X, 2016, NAT REV GASTRO HEPAT, V13, P126, DOI 10.1038/nrgastro.2016.16
   Luo CY, 2018, SCIENCE, V361, P1336, DOI 10.1126/science.aat6806
   Mahmood N, 2019, ADV EXP MED BIOL, V1164, P179, DOI 10.1007/978-3-030-22254-3_14
   Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909
   Matei DE, 2010, GYNECOL ONCOL, V116, P195, DOI 10.1016/j.ygyno.2009.09.043
   Maugeri A, 2021, DIS MARKERS, V2021, DOI 10.1155/2021/9910878
   McGuire MH, 2019, EBIOMEDICINE, V43, P127, DOI 10.1016/j.ebiom.2019.04.045
   McKinney EF, 2016, CURR OPIN IMMUNOL, V43, P74, DOI 10.1016/j.coi.2016.09.005
   Mehta A, 2015, CANCER METAST REV, V34, P229, DOI 10.1007/s10555-015-9563-3
   Morales-Nebreda L, 2019, TRANSL RES, V204, P1, DOI 10.1016/j.trsl.2018.08.001
   Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373
   Nervi C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0157-2
   Nishiyama A, 2021, TRENDS GENET, V37, P1012, DOI 10.1016/j.tig.2021.05.002
   Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017
   Nowicki S, 2015, FEBS J, V282, P2796, DOI 10.1111/febs.13295
   Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359
   Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007
   Patil V, 2014, EPIGENETICS-US, V9, P823, DOI 10.4161/epi.28741
   Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807
   Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520
   Rashkovan M, 2019, GENE DEV, V33, P1460, DOI 10.1101/gad.326470.119
   Rau RE, 2016, BLOOD, V128, P971, DOI 10.1182/blood-2015-11-684225
   Raval RR, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-14
   Raynal NJM, 2012, CANCER RES, V72, P1170, DOI 10.1158/0008-5472.CAN-11-3248
   RIGGS AD, 1983, ADV CANCER RES, V40, P1, DOI 10.1016/S0065-230X(08)60678-8
   Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056
   Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395
   Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707
   Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465
   Shanmugam M, 2009, CURR OPIN ONCOL, V21, P531, DOI 10.1097/CCO.0b013e32832f57ec
   Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030
   Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027
   Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343
   Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117
   Smith CC, 2018, J CLIN INVEST, V128, P4804, DOI 10.1172/JCI121476
   Stone ML, 2017, P NATL ACAD SCI USA, V114, pE10981, DOI 10.1073/pnas.1712514114
   Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607
   Subramaniam D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00080
   Sukari A, 2016, ANTICANCER RES, V36, P5593, DOI 10.21873/anticanres.11144
   Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604
   Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085
   Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116
   Thomas RM, 2012, J BIOL CHEM, V287, P22900, DOI 10.1074/jbc.M111.312785
   Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849
   Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001
   Turcan S, 2013, ONCOTARGET, V4, P1729, DOI 10.18632/oncotarget.1412
   Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014
   Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983
   Winders BR, 2004, J IMMUNOL, V173, P7377, DOI 10.4049/jimmunol.173.12.7377
   Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007
   Wong DJ, 1997, CANCER RES, V57, P2619
   Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542
   Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014
   Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006
   Yamazaki J, 2013, EPIGENETICS-US, V8, P92, DOI 10.4161/epi.23243
   Yang R, 2019, GENOME BIOL, V21, DOI 10.1186/s13059-019-1921-y
   Yau HL, 2019, TRENDS CELL BIOL, V29, P31, DOI 10.1016/j.tcb.2018.07.006
   Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5
   YOUNG HA, 1994, J IMMUNOL, V153, P3603
   Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144
   Zeng JD, 2019, PHARMACOL RES, V149, DOI 10.1016/j.phrs.2019.104352
   Zhang MW, 2017, J ZHEJIANG UNIV-SC B, V18, P365, DOI 10.1631/jzus.B1600579
   Zhao SG, 2020, NAT GENET, V52, P778, DOI 10.1038/s41588-020-0648-8
   Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2
NR 153
TC 0
Z9 0
U1 2
U2 5
PU IMR PRESS
PI ROBINSON
PA 112 ROBINSON RD, ROBINSON, SINGAPORE
SN 2768-6701
EI 2768-6698
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD DEC
PY 2022
VL 27
IS 12
AR 324
DI 10.31083/j.fbl2712324
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA CR6N0
UT WOS:001127009800004
PM 36624941
OA gold
DA 2024-02-19
ER

PT J
AU Stoka, V
   Turk, V
   Bredesen, DE
AF Stoka, Veronika
   Turk, Vito
   Bredesen, Dale E.
TI Differential regulation of the intrinsic pathway of apoptosis in brain
   and liver during ageing
SO FEBS LETTERS
LA English
DT Article
DE age-dependent caspase activation; apoptosis-resistant tissues;
   cytochrome c/2 '-deoxyadenosine 5 '-triphosphate activation; intrinsic
   pathway; mitochondrial pathway; strain-dependent caspase activation
ID ACTIVATING FACTOR-I; PROGRAMMED CELL-DEATH; CYTOCHROME-C; CASPASE
   ACTIVATION; GRANZYME-B; RAT-BRAIN; PROTEASE; APAF-1; RESISTANCE;
   PROTEINS
AB The intrinsic (mitochondria-dependent) pathway of apoptosis is one of the major pathways leading to cell death. We evaluated cytochrome c/apoptotic protease activation factor-1 (Apaf-1)-dependent activation of caspase-3 in brain and liver of different strains of rodents at different stages of development. In cell-free extracts from brain and liver of Sprague-Dawley rats, caspase was activated by cytochrome c/2'-deoxyadenosine 5'-triphosphate at both neonatal and adult stages. In adult brain extracts from Wistar rats, no activation of caspase was observed while extracts from neonatal brain and liver and from adult liver were activated. In CD-I mouse, only neonatal extracts were activated. Alteration in levels of endogenous inhibitors of apoptosis were not responsible for the lack of activation observed. Instead, decrease in the content of Apaf-1 and caspase-3 and some degradation of caspase-9 during brain ageing were observed. These results suggest that a decrease in apoptosis activation during ageing is not tissue-specific, but rather displays a complex dependence on species and strains of animals. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana 1000, Slovenia.
   Buck Inst Age Res, Novato, CA 94945 USA.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
C3 Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute;
   Buck Institute for Research on Aging; University of California System;
   University of California San Francisco
RP Turk, V (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol Biol, Jamova 39, Ljubljana 1000, Slovenia.
EM vito.turk@ijs.si; dbredesen@buckinstitute.org
RI Stoka, Veronika/AAM-2283-2021
FU NIA NIH HHS [AG12282, R01 AG012282] Funding Source: Medline; NINDS NIH
   HHS [R01 NS033376, NS33376] Funding Source: Medline
CR Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8
   Bratton SB, 2001, CELL DEATH DIFFER, V8, P425, DOI 10.1038/sj.cdd.4400834
   Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269
   Burgess DH, 1999, CELL DEATH DIFFER, V6, P256, DOI 10.1038/sj.cdd.4400489
   Canning J, 2003, ENDOCRINOLOGY, V144, P9, DOI 10.1210/en.2002-220988
   Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0
   Dias N, 2005, BIOCHEM PHARMACOL, V70, P1, DOI 10.1016/j.bcp.2005.03.021
   Dong Z, 2003, AM J PATHOL, V163, P663, DOI 10.1016/S0002-9440(10)63693-0
   Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720
   Fujita E, 1999, BIOCHEM BIOPH RES CO, V264, P550, DOI 10.1006/bbrc.1999.1387
   Goffredo D, 2005, PHARMACOL RES, V52, P140, DOI 10.1016/j.phrs.2005.01.006
   Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016
   Hiona A, 2004, ANN NY ACAD SCI, V1019, P96, DOI 10.1196/annals.1297.018
   Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585
   Honarpour N, 2001, P NATL ACAD SCI USA, V98, P9683, DOI 10.1073/pnas.171283198
   Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003
   Jia L, 2001, BLOOD, V98, P414, DOI 10.1182/blood.V98.2.414
   Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508
   Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200
   Lindsten T, 2005, NEUROSCIENTIST, V11, P10, DOI 10.1177/1073858404269267
   Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101
   Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7
   Mayorga M, 2004, J BIOL CHEM, V279, P34882, DOI 10.1074/jbc.M404616200
   Momoi T, 2003, NEUROREPORT, V14, P111, DOI 10.1097/00001756-200301200-00021
   NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0
   Olson AL, 2001, AMBUL PEDIATR, V1, P91, DOI 10.1367/1539-4409(2001)001<0091:PCPRAP>2.0.CO;2
   Ota K, 2002, J BIOCHEM, V131, P131, DOI 10.1093/oxfordjournals.jbchem.a003067
   Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914
   Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0
   Shimohama S, 2001, BIOCHEM BIOPH RES CO, V289, P1063, DOI 10.1006/bbrc.2001.6108
   SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085
   Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606
   Stoka V, 2005, FEBS LETT, V579, P6147, DOI 10.1016/j.febslet.2005.09.087
   Wetzel M, 2004, APOPTOSIS, V9, P649, DOI 10.1023/B:APPT.0000038038.42809.e2
   Wolf BB, 2001, J BIOL CHEM, V276, P34244, DOI 10.1074/jbc.M011778200
   Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001
   Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X
   Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549
NR 40
TC 20
Z9 22
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD JUN 26
PY 2006
VL 580
IS 15
BP 3739
EP 3745
DI 10.1016/j.febslet.2006.05.066
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 058VB
UT WOS:000238691600026
PM 16777102
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Reijne, AC
   Ciapaite, J
   van Dijk, TH
   Havinga, R
   van der Zee, EA
   Groen, AK
   Reijngoud, DJ
   Bakker, BM
   van Dijk, G
AF Reijne, Aaffien C.
   Ciapaite, Jolita
   van Dijk, Theo H.
   Havinga, Rick
   van der Zee, Eddy A.
   Groen, Albert K.
   Reijngoud, Dirk-Jan
   Bakker, Barbara M.
   van Dijk, Gertjan
TI Whole-Body Vibration Partially Reverses Aging-Induced Increases in
   Visceral Adiposity and Hepatic Lipid Storage in Mice
SO PLOS ONE
LA English
DT Article
ID RAT SKELETAL-MUSCLE; BONE-MINERAL DENSITY; UNCOUPLING PROTEIN-2;
   POSTMENOPAUSAL WOMEN; METABOLIC-RATE; OBESE WOMEN; EXERCISE; STRENGTH;
   MITOCHONDRIA; STIMULATION
AB At old age, humans generally have declining muscle mass and increased fat deposition, which can increase the risk of developing cardiometabolic diseases. While regular physical activity postpones these age-related derangements, this is not always possible in the elderly because of disabilities or risk of injury. Whole-body vibration (WBV) training may be considered as an alternative to physical activity particularly in the frail population. To explore this possibility, we characterized whole-body and organ-specific metabolic processes in 6-month and 25-month old mice, over a period of 14 weeks of WBV versus sham training. WBV training tended to increase blood glucose turnover rates and stimulated hepatic glycogen utilization during fasting irrespective of age. WBV was effective in reducing white fat mass and hepatic triglyceride content only in old but not in young mice and these reductions were related to upregulation of hepatic mitochondrial uncoupling of metabolism (assessed by high-resolution respirometry) and increased expression of uncoupling protein 2. Because these changes occurred independent of changes in food intake and whole-body metabolic rate (assessed by indirect calorimetry), the liver-specific effects of WBV may be a primary mechanism to improve metabolic health during aging, rather than that it is a consequence of alterations in energy balance.
C1 [Reijne, Aaffien C.; van Dijk, Gertjan] Univ Groningen, Unit Behav Neurosci, Neurobiol, Groningen Inst Evolutionary Life Sci, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.
   [Reijne, Aaffien C.; Ciapaite, Jolita; Havinga, Rick; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
   [Reijne, Aaffien C.; Ciapaite, Jolita; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Syst Biol Ctr Energy Metab & Ageing, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
   [van Dijk, Theo H.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands.
   [van der Zee, Eddy A.] Univ Groningen, Mol Neurobiol Unit, Groningen Inst Evolutionary Life Sci, Neurobiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.
   [van Dijk, Gertjan] Univ Groningen, ESRIG Ctr Isotope Res, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
C3 University of Groningen; University of Groningen; University of
   Groningen; University of Groningen; University of Groningen; University
   of Groningen
RP van Dijk, G (corresponding author), Univ Groningen, Unit Behav Neurosci, Neurobiol, Groningen Inst Evolutionary Life Sci, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.; van Dijk, G (corresponding author), Univ Groningen, ESRIG Ctr Isotope Res, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM Gertjan.van.dijk@rug.nl
RI van der Zee, Eddy/AAZ-2120-2020; Dijk, Theo van/H-6436-2013
OI Dijk, Theo van/0000-0003-2713-049X; Bakker, Barbara/0000-0001-6274-3633;
   Ciapaite, Jolita/0000-0001-8761-9233; van Dijk,
   Gertjan/0000-0002-6565-4019; Reijngoud, Dirk-Jan/0000-0003-1157-4491
FU Netherlands Organization for Scientific Research (NWO) [853.00.110];
   Rosalind Franklin Fellowship for the University of Groningen
FX This work was supported by a grant from the Netherlands Organization for
   Scientific Research (NWO, grant no. 853.00.110);
   http://www.nwo.nl/onderzoek-en-resultaten/onderzoeksprojecten/94/2300159
   494.html. Barbara M. Bakker was supported by a Rosalind Franklin
   Fellowship for the University of Groningen. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ando H, 2003, SCAND J WORK ENV HEA, V29, P216, DOI 10.5271/sjweh.724
   Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008
   Badin PM, 2013, TRENDS ENDOCRIN MET, V24, P607, DOI 10.1016/j.tem.2013.08.001
   Bann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116058
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413
   Baum Klaus, 2007, Int J Med Sci, V4, P159
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067
   Bosco C, 1999, CLIN PHYSIOL, V19, P183
   BURKE D, 1976, J NEUROL NEUROSUR PS, V39, P729, DOI 10.1136/jnnp.39.8.729
   Cochrane DJ, 2012, SCAND J MED SCI SPOR, V22, P705, DOI 10.1111/j.1600-0838.2011.01411.x
   Conn VS, 2014, J PRIM CARE COMMUNIT, V5, P211, DOI 10.1177/2150131913520328
   Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2
   Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003
   Hazell TJ, 2012, EUR J APPL PHYSIOL, V112, P413, DOI 10.1007/s00421-011-1984-2
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang CC, 2014, INT J MED SCI, V11, P1218, DOI 10.7150/ijms.9975
   Issurin VB, 1999, J SPORT SCI, V17, P177, DOI 10.1080/026404199366073
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Kim TN, 2015, J CELL BIOCHEM, V116, P1171, DOI 10.1002/jcb.25077
   Kvorning T, 2006, EUR J APPL PHYSIOL, V96, P615, DOI 10.1007/s00421-006-0139-3
   Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803
   Lau RWK, 2011, CLIN REHABIL, V25, P975, DOI 10.1177/0269215511405078
   LAVOINNE A, 1987, BIOCHEM J, V248, P429, DOI 10.1042/bj2480429
   Lin CI, 2015, METABOLISM, V64, P1146, DOI 10.1016/j.metabol.2015.05.007
   Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2
   LUSK G, 1976, ELEMENTS SCI NUTR
   Maddalozzo GF, 2008, INT J OBESITY, V32, P1348, DOI 10.1038/ijo.2008.111
   Mildaziene V, 2002, TOXICOL SCI, V65, P220, DOI 10.1093/toxsci/65.2.220
   Nagase I, 2001, FEBS LETT, V494, P175, DOI 10.1016/S0014-5793(01)02341-9
   Naghii MR, 2011, ACTA PHYSIOL HUNG, V98, P442, DOI 10.1556/APhysiol.98.2011.4.7
   Oklejewicz M, 1997, J BIOL RHYTHM, V12, P413, DOI 10.1177/074873049701200503
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   Prisby RD, 2008, AGEING RES REV, V7, P319, DOI 10.1016/j.arr.2008.07.004
   Rees SS, 2008, PHYS THER, V88, P462, DOI 10.2522/ptj.20070027
   Regterschot GRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100506
   Riedel G, 2010, FEMS FOR, P5
   Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739
   Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390
   Roelants M, 2004, INT J SPORTS MED, V25, P1, DOI 10.1055/s-2003-45238
   Samec S, 1999, POSTSTARVATION GENE, V17, P1339
   Srere PA, 1963, ACTA CHEM SCAND
   Stuermer EK, 2010, CALCIFIED TISSUE INT, V87, P168, DOI 10.1007/s00223-010-9381-0
   Tapp LR, 2014, CLIN INTERV AGING, V9, P63, DOI 10.2147/CIA.S30048
   Timmer M., 2006, FEBS LETT, V3, p089.31
   van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842
   van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008
   van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200
   Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245
   VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740
   Vissers D, 2009, PHYSICIAN SPORTSMED, V37, P88, DOI 10.3810/psm.2009.10.1733
   Vissers D, 2010, OBESITY FACTS, V3, P93, DOI 10.1159/000301785
   von Stengel S, 2011, OSTEOPOROSIS INT, V22, P317, DOI 10.1007/s00198-010-1215-4
   Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111
   Wilms B, 2012, INT J SPORTS MED, V33, P740, DOI 10.1055/s-0032-1306284
   WINKLER E, 1994, J BIOL CHEM, V269, P2508
   Zhao L, 2014, EXP GERONTOL, V56, P3, DOI 10.1016/j.exger.2014.02.001
NR 60
TC 12
Z9 12
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 17
PY 2016
VL 11
IS 2
AR e0149419
DI 10.1371/journal.pone.0149419
PG 18
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DF3BJ
UT WOS:000371218400080
PM 26886917
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Zhang, JB
   Lu, TY
   Xiao, JQ
   Du, C
   Chen, HT
   Li, R
   Sui, X
   Pan, ZH
   Xiao, CC
   Zhao, XG
   Yao, J
   Liu, YS
   Lei, YG
   Ruan, Y
   Zhang, J
   Li, H
   Zhang, Q
   Zhang, YC
   Cai, JY
   Yang, Y
   Zheng, J
AF Zhang, Jiebin
   Lu, Tongyu
   Xiao, Jiaqi
   Du, Cong
   Chen, Haitian
   Li, Rong
   Sui, Xin
   Pan, Zihao
   Xiao, Cuicui
   Zhao, Xuegang
   Yao, Jia
   Liu, Yasong
   Lei, Yunguo
   Ruan, Ying
   Zhang, Jian
   Li, Hua
   Zhang, Qi
   Zhang, Yingcai
   Cai, Jianye
   Yang, Yang
   Zheng, Jun
TI MSC-derived extracellular vesicles as nanotherapeutics for promoting
   aged liver regeneration
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Early Access
DE Mesenchymal stem cells; Extracellular vesicles; Aged liver; Liver
   regeneration; Mitophagy
ID MICE; ATG4; PROLIFERATION; AUTOPHAGY; INJURY; ROLES; CELLS
AB Aging is one of the critical factors to impair liver regeneration leading to a high incidence of severe complications after hepatic surgery in the elderly population without any effective treatment for clinical administration. As cell -free nanotherapeutics, mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have been demonstrated the therapeutic potentials on liver diseases. However, the effects of MSC-EVs on the proliferation of aged he-patocytes are largely unclear. In this study, we found MSCs could reduce the expression of senescence-associated markers in the liver and stimulate its regeneration in aged mice after receiving a two-thirds partial hepatectomy (PHx) through their secreted MSC-EVs. Using RNA-Seq and AAV9 vector, we mechanistically found that these effects of UC-MSC-EVs partially attributed to inducing Atg4B-related mitophagy. This effect repairs the mito-chondrial status and functions of aged hepatocytes to promote their proliferation. And protein mass spectrum analysis uncovered that DEAD-Box Helicase 5 (DDX5) enriches in UC-MSC-EVs, which interacts with E2F1 to facilitate its nuclear translocation for activating the expression of Atg4B. Collectively, our data show that MSC-EVs act nanotherapeutic potentials in anti-senescence and promoting regeneration of aged liver by transferring DDX5 to regulate E2F1-Atg4B signaling pathway that induce mitophagy, which highlights the clinical applica-tion valuation of MSC-EVs for preventing severe complications in aged population receiving liver surgery.
C1 [Zhang, Jiebin; Lu, Tongyu; Xiao, Jiaqi; Chen, Haitian; Yao, Jia; Liu, Yasong; Lei, Yunguo; Zhang, Jian; Li, Hua; Zhang, Yingcai; Cai, Jianye; Yang, Yang; Zheng, Jun] Sun Yat sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Organ Transplantat Res Ctr Guangdong Prov,Guangdon, Guangzhou 510630, Peoples R China.
   [Zhang, Jiebin; Lu, Tongyu; Xiao, Jiaqi; Chen, Haitian; Liu, Yasong; Lei, Yunguo; Zhang, Jian; Li, Hua; Yang, Yang; Zheng, Jun] Sun Yat sen Univ, Liver Transplantat Ctr, Organ Transplantat Res Ctr Guangdong Prov, Guangdong Prov Engn Lab Transplantat Med,Affiliate, Guangzhou 510630, Peoples R China.
   [Zhang, Jiebin; Lu, Tongyu; Xiao, Jiaqi; Chen, Haitian; Li, Rong; Xiao, Cuicui; Yao, Jia; Liu, Yasong; Lei, Yunguo; Zhang, Jian; Li, Hua; Zhang, Yingcai; Cai, Jianye; Yang, Yang; Zheng, Jun] Sun Yat sen Univ, Guangdong Higher Educ Inst, Guangdong Key Lab Liver Dis Res, Key Lab Liver Dis Biotherapy & Translat Med,Affili, Guangzhou 510630, Peoples R China.
   [Du, Cong; Zhang, Qi] Sun Yat sen Univ, Affiliated Hosp 3, Biol Treatment Ctr, Guangzhou 510630, Peoples R China.
   [Sui, Xin; Zhao, Xuegang] Sun Yat sen Univ, Affiliated Hosp 3, Surg ICU, Guangzhou 510630, Peoples R China.
   [Pan, Zihao] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Gastrointestinal Surg, Guangzhou 510080, Peoples R China.
   [Xiao, Cuicui] Sun Yat sen Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou 510630, Peoples R China.
   [Ruan, Ying] Sun Yat sen Univ, Affiliated Hosp 3, Dept thyroid & breast Surg, Guangzhou 510630, Peoples R China.
   [Zhang, Yingcai; Cai, Jianye; Yang, Yang; Zheng, Jun] Sun Yat sen Univ, Affiliated Hosp, Organ Transplantat Res Ctr Guangdong Prov, Dept Hepat Surg, Guangzhou 510630, Guangdong, Peoples R China.
   [Zhang, Yingcai; Cai, Jianye; Yang, Yang; Zheng, Jun] Sun Yat sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Organ Transplantat Res Ctr Guangdong Prov, Guangzhou 510630, Guangdong, Peoples R China.
C3 Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University;
   Sun Yat Sen University; Sun Yat Sen University; Southern Medical
   University - China; Guangdong Academy of Medical Sciences & Guangdong
   General Hospital; Sun Yat Sen University; Sun Yat Sen University; Sun
   Yat Sen University; Sun Yat Sen University
RP Zhang, YC; Cai, JY; Yang, Y; Zheng, J (corresponding author), Sun Yat sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Organ Transplantat Res Ctr Guangdong Prov,Guangdon, Guangzhou 510630, Peoples R China.; Zhang, YC; Cai, JY; Yang, Y; Zheng, J (corresponding author), Sun Yat sen Univ, Guangdong Higher Educ Inst, Guangdong Key Lab Liver Dis Res, Key Lab Liver Dis Biotherapy & Translat Med,Affili, Guangzhou 510630, Peoples R China.; Zhang, YC; Cai, JY; Yang, Y; Zheng, J (corresponding author), Sun Yat sen Univ, Affiliated Hosp, Organ Transplantat Res Ctr Guangdong Prov, Dept Hepat Surg, Guangzhou 510630, Guangdong, Peoples R China.; Zhang, YC; Cai, JY; Yang, Y; Zheng, J (corresponding author), Sun Yat sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Organ Transplantat Res Ctr Guangdong Prov, Guangzhou 510630, Guangdong, Peoples R China.
EM zhangyc3@mail.sysu.edu.cn; caijianyeah@163.com; yysysu@163.com;
   zhengj67@mail2.sysu.edu.cn
RI Cai, Jianye/GOK-2676-2022; Xiao, Cuicui/HHS-1788-2022; Lu,
   Jia/JVO-6891-2024; LI, YUN/JTV-7108-2023; Liu, Liu/JXM-8208-2024; xu,
   wei/JZD-2112-2024; wang, zhe/JNE-3510-2023
OI Xiao, Cuicui/0009-0004-0208-249X; 
FU National Bioengineering Research Center Cultivation Platform [WW201905];
   National key research and development program [2017YFA0104304]; National
   Natural Science Foundation of China [81900597, 81802897, 81901943,
   81770648, 81970567, 82100693, 82170631, 81870449, 81972286, 82002508];
   Science and Technology Program of Guangdong Province [2019B020236003];
   Science and Technology Program of Guangzhou City [201803040005,
   202201011013]; Natural Science Foundation of Guangdong Province
   [2019A1515011698, 2021A1515012136, 2021A1515011156, 2021A1515010571,
   2022A1515012453, 2022A1515012331]; Medical Scientific Research
   Foundation of Guangdong Province [A2020120]; Guangdong Basic and Applied
   Basic Research Foundation [2020A1515110687, 2021A1515111058]; Guangzhou
   Basic and Applied Basic Research Foundation [202102020237]; Major talent
   project cultivation plan project [P02093, P02095]; Academician Shusen
   Lanjuan Talent foundation; Excellent Young Talent Program of Guangdong
   Provincial People's Hospital [KY012021186]; China Postdoctoral Science
   Foundation [2022M713621, 2022M713617]
FX This work was supported by the grants from the National Bioengineering
   Research Center Cultivation Platform (WW201905) , National key research
   and development program (2017YFA0104304) , National Natural Science
   Foundation of China (81900597, 81802897, 81901943, 81770648, 81970567,
   82100693, 82170631, 81870449, 81972286, 82002508) , Science and
   Technology Program of Guangdong Province (2019B020236003) , Science and
   Technology Program of Guangzhou City (201803040005, 202201011013) ,
   Natural Science Foundation of Guangdong Province (2019A1515011698,
   2021A1515012136, 2021A1515011156, 2021A1515010571, 2022A1515012453,
   2022A1515012331) , Medical Scientific Research Foundation of Guangdong
   Province (A2020120) , Guangdong Basic and Applied Basic Research
   Foundation (2020A1515110687, 2021A1515111058) , Guangzhou Basic and
   Applied Basic Research Foundation (202102020237) , Major talent project
   cultivation plan project (P02093, P02095) , Excellent Young Talent
   Program of Guangdong Provincial People's Hospital (KY012021186) , China
   Postdoctoral Science Foundation (2022M713621, 2022M713617) and
   Academician Shusen Lanjuan Talent foundation.
CR An  P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16092-0
   Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]
   Cao HM, 2019, ACS NANO, V13, P3522, DOI 10.1021/acsnano.8b09776
   Chistiakov DA, 2012, CELLS TISSUES ORGANS, V196, P291, DOI 10.1159/000335697
   Chun SK, 2018, AGING CELL, V17, DOI 10.1111/acel.12761
   Haga S, 2010, LAB INVEST, V90, P1718, DOI 10.1038/labinvest.2010.119
   Israde-Alcántara I, 2012, P NATL ACAD SCI USA, V109, pE738, DOI 10.1073/pnas.1110614109
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403
   Lee CW, 2018, GASTROENTEROLOGY, V154, P46, DOI 10.1053/j.gastro.2017.09.049
   Legrand JMD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09972-7
   Li PS, 2019, PHARMACOL THERAPEUT, V200, P42, DOI 10.1016/j.pharmthera.2019.04.005
   Li Y, 2018, AGING-US, V10, P1902, DOI 10.18632/aging.101511
   Liu YN, 2018, EBIOMEDICINE, V36, P140, DOI 10.1016/j.ebiom.2018.08.054
   Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089
   Lu TY, 2022, BIOMATERIALS, V284, DOI 10.1016/j.biomaterials.2022.121486
   Maremanda KP, 2019, TOXICOL APPL PHARM, V385, DOI 10.1016/j.taap.2019.114788
   Mazurek A, 2012, CANCER DISCOV, V2, P812, DOI 10.1158/2159-8290.CD-12-0116
   Nyamao RM, 2019, BBA-REV CANCER, V1871, P85, DOI 10.1016/j.bbcan.2018.11.003
   Phinney DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9472
   Qin T, 2021, CELL DEATH DIFFER, V28, P1110, DOI 10.1038/s41418-020-00640-8
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Taniguchi T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.114
   Nguyen TN, 2021, MOL CELL, V81, P2013, DOI 10.1016/j.molcel.2021.03.001
   van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236
   Varderidou-Minasian S, 2020, THERANOSTICS, V10, P5979, DOI 10.7150/thno.40122
   Wang JH, 2012, AUTOPHAGY, V8, P140, DOI 10.4161/auto.8.1.18391
   Wang ZD, 2015, CANCER SCI, V106, P1303, DOI 10.1111/cas.12755
   Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861
   Wu GH, 2019, P NATL ACAD SCI USA, V116, P20453, DOI 10.1073/pnas.1909047116
   Xu Y, 2020, AUTOPHAGY, V16, P3, DOI 10.1080/15548627.2019.1603547
   Yang JY, 2011, CELL CYCLE, V10, P144, DOI 10.4161/cc.10.1.14455
   Yao J, 2019, FASEB J, V33, P1695, DOI 10.1096/fj.201800131RR
   Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652
   Yuan JP, 2020, ONCOGENE, V39, P6664, DOI 10.1038/s41388-020-01460-3
   Zhang H, 2019, HEPATOLOGY, V69, P1046, DOI 10.1002/hep.30300
   Zhang L, 2016, CANCER LETT, V373, P19, DOI 10.1016/j.canlet.2016.01.022
   Zhang YC, 2017, CYTOTHERAPY, V19, P194, DOI 10.1016/j.jcyt.2016.11.005
   Zhang YC, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02246-4
   Zheng J, 2020, ADV SCI, V7, DOI 10.1002/advs.201903746
   Zheng J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2424-1
   Zheng J, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12546
NR 42
TC 7
Z9 7
U1 5
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD 2023 APR
PY 2023
VL 356
BP 402
EP 415
DI 10.1016/j.jconrel.2023.02.032
EA MAR 2023
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Pharmacology & Pharmacy
GA A5BK9
UT WOS:000955273200001
PM 36858264
DA 2024-02-19
ER

PT J
AU Noh, SG
   Jung, HJ
   Kim, S
   Arulkumar, R
   Kim, DH
   Park, D
   Chung, HY
AF Noh, Sang Gyun
   Jung, Hee Jin
   Kim, Seungwoo
   Arulkumar, Radha
   Kim, Dae Hyun
   Park, Daeui
   Chung, Hae Young
TI Regulation of Circadian Genes Nr1d1 and Nr1d2 in Sex-Different Manners
   during Liver Aging
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE aging; circadian rhythm; liver; Nr1d1; Nr1d2; sex difference
ID REV-ERB-ALPHA; CLOCK GENE; EXPRESSION PATTERNS; DOWN-REGULATION;
   RHYTHMS; INFLAMMATION; MICE; ARCHITECTURE; METABOLISM; REPRESSION
AB Background: Circadian rhythm is associated with the aging process and sex differences; however, how age and sex can change circadian regulation systems remains unclear. Thus, we aimed to evaluate age- and sex-related changes in gene expression and identify sex-specific target molecules that can regulate aging. Methods: Rat livers were categorized into four groups, namely, young male, old male, young female, and old female, and the expression of several genes involved in the regulation of the circadian rhythm was confirmed by in silico and in vitro studies. Results: Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses showed that the expression of genes related to circadian rhythms changed more in males than in females during liver aging. In addition, differentially expressed gene analysis and quantitative real-time polymerase chain reaction/western blotting analysis revealed that Nr1d1 and Nr1d2 expression was upregulated in males during liver aging. Furthermore, the expression of other circadian genes, such as Arntl, Clock, Cry1/2, Per1/2, and Rora/c, decreased in males during liver aging; however, these genes showed various gene expression patterns in females during liver aging. Conclusions: Age-related elevation of Nr1d1/2 downregulates the expression of other circadian genes in males, but not females, during liver aging. Consequently, age-related upregulation of Nr1d1/2 may play a more crucial role in the change in circadian rhythms in males than in females during liver aging.
C1 [Noh, Sang Gyun; Kim, Seungwoo; Arulkumar, Radha; Chung, Hae Young] Pusan Natl Univ, Interdisciplinary Res Program Bioinformat & Longe, 2,Busandaehak Ro 63Beon Gil, Busan 46241, South Korea.
   [Noh, Sang Gyun; Jung, Hee Jin; Kim, Seungwoo; Arulkumar, Radha; Kim, Dae Hyun; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Dept Pharm, 2,Busandaehak Ro 63Beon Gil, Busan 46241, South Korea.
   [Park, Daeui] Korea Inst Toxicol, Dept Predict Toxicol, 141 Gajeong Ro, Daejeon 34114, South Korea.
C3 Pusan National University; Pusan National University; Korea Institute of
   Toxicology
RP Chung, HY (corresponding author), Pusan Natl Univ, Interdisciplinary Res Program Bioinformat & Longe, 2,Busandaehak Ro 63Beon Gil, Busan 46241, South Korea.; Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Pharm, 2,Busandaehak Ro 63Beon Gil, Busan 46241, South Korea.
EM hyjung@pusan.ac.kr
RI Park, Daeui/HOH-1179-2023
OI Park, Daeui/0000-0002-9452-5849; Chung, Hae Young/0000-0002-3215-8828;
   Jung, Hee Jin/0000-0001-7212-5572
FU National Research Foundation (NRF) - Korean Government
   [NRF-2018R1A2A3075425]
FX ? This study was supported by a National Research Foundation (NRF) grant
   funded by the Korean Government (NRF-2018R1A2A3075425).
CR Acosta-Rodríguez VA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22922-6
   Adafer R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123770
   Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011
   Astafev AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09289-9
   Auclair M, 2021, AM J PHYSIOL-ENDOC M, V320, pE219, DOI 10.1152/ajpendo.00131.2020
   Baburski AZ, 2016, EXP GERONTOL, V73, P5, DOI 10.1016/j.exger.2015.11.002
   Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003
   Banks G, 2016, MAMM GENOME, V27, P332, DOI 10.1007/s00335-016-9639-6
   Barth E, 2021, AGING-US, V13, P25694, DOI 10.18632/aging.203788
   Bekki H, 2020, OSTEOARTHR CARTILAGE, V28, P966, DOI 10.1016/j.joca.2020.04.004
   Billon C, 2019, J BIOL CHEM, V294, P10, DOI 10.1074/jbc.AC118.002127
   Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102
   Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200
   Cao XM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021174118
   Chai C, 2020, GASTROENTEROLOGY, V159, P999, DOI 10.1053/j.gastro.2020.05.056
   Chen L, 2022, EUR J MED CHEM, V229, DOI 10.1016/j.ejmech.2021.114065
   Chen XQ, 2015, HORM BEHAV, V75, P55, DOI 10.1016/j.yhbeh.2015.07.020
   Chen Y, 2021, AM J TRANSL RES, V13, P4182
   Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048
   Cox KH, 2019, J MOL ENDOCRINOL, V63, pR93, DOI 10.1530/JME-19-0153
   Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002
   Dai LJ, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11113117
   Davis K, 2019, ANAT REC, V302, P1447, DOI 10.1002/ar.24004
   De Nobrega AK, 2020, EUR J NEUROSCI, V51, P454, DOI 10.1111/ejn.14176
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   El-Karaksy SM, 2016, J RECEPT SIG TRANSD, V36, P207, DOI 10.3109/10799893.2015.1075042
   Emens JS, 2015, SLEEP MED CLIN, V10, P435, DOI 10.1016/j.jsmc.2015.08.001
   Fauber BP, 2015, BIOORG MED CHEM LETT, V25, P2907, DOI 10.1016/j.bmcl.2015.05.055
   Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327
   Gardner RS, 2020, NEUROBIOL LEARN MEM, V172, DOI 10.1016/j.nlm.2020.107232
   Goedhart J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76603-3
   Gombert M, 2019, TRANSL RES, V206, P107, DOI 10.1016/j.trsl.2018.12.001
   Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y
   Griffin P, 2019, P NATL ACAD SCI USA, V116, P5102, DOI 10.1073/pnas.1812405116
   Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232
   Han SC, 2019, ARCH BIOCHEM BIOPHYS, V668, P1, DOI 10.1016/j.abb.2019.05.003
   Hergenhan S, 2020, J MOL BIOL, V432, P3700, DOI 10.1016/j.jmb.2019.12.044
   Hirao J, 2011, J TOXICOL SCI, V36, P9, DOI 10.2131/jts.36.9
   Hood S, 2017, J CLIN INVEST, V127, P437, DOI 10.1172/JCI90328
   Hu VW, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-7
   Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043
   Hunter AL, 2021, ELIFE, V10, DOI 10.7554/eLife.63324
   Isayama K, 2014, J REPROD DEVELOP, V60, P362, DOI 10.1262/jrd.2014-040
   Iwahana E, 2008, HORM BEHAV, V53, P422, DOI 10.1016/j.yhbeh.2007.11.014
   Jia M, 2021, ONCOL REP, V45, P1033, DOI 10.3892/or.2020.7914
   Kawamura M, 2014, ANDROLOGY-US, V2, P225, DOI 10.1111/j.2047-2927.2013.00161.x
   Kim JH, 2021, INVESTIG CLIN UROL, V62, P690, DOI 10.4111/icu.20210284
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Kuljis DA, 2013, ENDOCRINOLOGY, V154, P1501, DOI 10.1210/en.2012-1921
   Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y
   Lee H, 2017, MOL MED REP, V16, P422, DOI 10.3892/mmr.2017.6578
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Liu H, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2314-6
   Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253
   Martin M., 2011, EMBnet. J., V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]
   Morioka N, 2016, MOL CELL NEUROSCI, V72, P72, DOI 10.1016/j.mcn.2016.01.007
   Nadeem A, 2015, PHARMACOL RES, V99, P248, DOI 10.1016/j.phrs.2015.06.001
   Nicolaides NC, 2020, EUR J NEUROSCI, V52, P2575, DOI 10.1111/ejn.14692
   Okyar A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46977-0
   Page AJ, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030844
   Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967
   Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002
   Pourcet B, 2018, GASTROENTEROLOGY, V154, P1449, DOI 10.1053/j.gastro.2017.12.019
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043
   Rohr KE, 2021, HORM BEHAV, V127, DOI 10.1016/j.yhbeh.2020.104888
   Sato S, 2014, J IMMUNOL, V192, P407, DOI 10.4049/jimmunol.1301982
   Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386
   Serin Y, 2019, ANN NUTR METAB, V74, P322, DOI 10.1159/000500071
   Sharma A, 2021, CURR NEUROPHARMACOL, V19, P248, DOI 10.2174/1570159X18666200429013041
   Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030
   Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/fmc.11.9, 10.4155/FMC.11.9]
   Spitschan M, 2022, ELIFE, V11, DOI 10.7554/eLife.65419
   Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219
   Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150
   Textoris J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012190
   Tong X, 2013, COMPR PHYSIOL, V3, P917, DOI 10.1002/cphy.c120017
   Trott AJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007156
   Vaghefi SSE, 2021, IRAN J KIDNEY DIS, V15, P351, DOI 10.52547/ijkd.6242
   Wang LG, 2022, THERIOGENOLOGY, V180, P17, DOI 10.1016/j.theriogenology.2021.12.009
   Wang XL, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.696554
   Wang ZJ, 2021, J INFLAMM RES, V14, P5901, DOI 10.2147/JIR.S326091
   Welz PS, 2020, J MOL BIOL, V432, P3661, DOI 10.1016/j.jmb.2019.12.036
   Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213
   Wyse CA, 2010, BRAIN RES, V1337, P21, DOI 10.1016/j.brainres.2010.03.113
   Xiao L, 2016, MOL IMMUNOL, V80, P17, DOI 10.1016/j.molimm.2016.10.006
   Xu H, 2021, CLIN CHIM ACTA, V512, P12, DOI 10.1016/j.cca.2020.11.011
   Yamamuro D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234439
   Yanar K, 2019, REJUV RES, V22, P409, DOI 10.1089/rej.2018.2159
   Yang YX, 2020, AM J PHYSIOL-GASTR L, V319, pG549, DOI 10.1152/ajpgi.00152.2020
   Yin JW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251478
   Zhang TP, 2018, DRUG METAB DISPOS, V46, P248, DOI 10.1124/dmd.117.078105
   Zhao LJ, 2021, SCI TOTAL ENVIRON, V785, DOI 10.1016/j.scitotenv.2021.147323
NR 93
TC 5
Z9 5
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2022
VL 23
IS 17
AR 10032
DI 10.3390/ijms231710032
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 4J2ID
UT WOS:000851091500001
PM 36077427
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Yu, AQ
   Wang, J
   Zhou, XJ
   Chen, KY
   Cao, YD
   Wang, ZX
   Mao, ZB
AF Yu, Ai Qing
   Wang, Jie
   Zhou, Xiao Jia
   Chen, Ke Yu
   Cao, You De
   Wang, Zhi Xiao
   Mao, Ze Bin
TI Senescent Cell-Secreted Netrin-1 Modulates Aging-Related Disorders by
   Recruiting Sympathetic Fibers
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Article
DE sympathetic fibers; senescent cells; netrin-1; aged tissues;
   aging-related disorders
ID NEURAL INVASION; NERVOUS-SYSTEM; CANCER; OSTEOARTHRITIS; CLEARANCE;
   TARGET
AB Cellular senescence is implicated in several lines of aging-related disorders. However, the potential molecular mechanisms by which cellular senescence modulates age-related pathologies remain largely unexplored. Herein, we report that the density of sympathetic fibers (SFs) is significantly elevated in naturally aged mouse tissues and human colon adenoma tissues compared to the SFs densities in the corresponding young mouse tissues and human non-lesion colon tissues. A dorsal root ganglion (DRG)-human diploid fibroblast coculture assay revealed that senescent cells promote the outgrowth of SFs, indicating that the senescent cells induce recruitment of SFs in vitro. Additionally, subcutaneous transplantation of 2BS fibroblasts in nude mice shows that transplanted senescent 2BS fibroblasts promote SFs infiltration. Intra-articular senolytic molecular injection can reduce SFs density and inhibit SFs infiltration caused by senescent cells in osteoarthritis (OA), suggesting senescent cells promote the infiltration of SFs in vivo in aged tissues. Notably, the elevated level of SFs contributes to impaired cognitive function in naturally aged mice, which can be reversed by treatment with propranolol hydrochloride, a non-selective beta receptor blocker that inhibits sympathetic nerve activity (SNA) by blocking non-selective beta receptors. Additionally, 6-hydroxydopamine (6-OHDA)-induced sympathectomy improved hepatic sympathetic overactivity mediated hepatic steatosis in high fat diet (HFD)-fed APOE knockout mice (APOE(-/-) mice) by reducing hepatic SNA. Taken together, this study concludes that senescent cell-secreted netrin-1 mediated SFs outgrowth and infiltration, which contributes to aging-related disorders, suggesting that clearing senescent cells or inhibiting SNA is a promising therapeutic strategy for improving sympathetic nervous system (SNS) hyperactivity-induced aging-related pathologies.
C1 [Yu, Ai Qing; Cao, You De] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Clin Lab, Changsha, Peoples R China.
   [Yu, Ai Qing; Wang, Zhi Xiao] Hubei Univ Med, Hubei Key Lab Embryon Stem Cell Res, Shiyan, Peoples R China.
   [Yu, Ai Qing; Mao, Ze Bin] Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Res Ctr Aging, Dept Biochem & Biophys,Sch Basic Med Sci,Hlth Sci, Beijing, Peoples R China.
   [Wang, Jie; Zhou, Xiao Jia; Chen, Ke Yu; Wang, Zhi Xiao] Hubei Univ Med, Taihe Hosp, Dept Cardiol, Shiyan, Peoples R China.
C3 Hunan Normal University; Hubei University of Medicine; Peking
   University; Hubei University of Medicine
RP Cao, YD (corresponding author), Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Clin Lab, Changsha, Peoples R China.; Wang, ZX (corresponding author), Hubei Univ Med, Hubei Key Lab Embryon Stem Cell Res, Shiyan, Peoples R China.; Mao, ZB (corresponding author), Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Res Ctr Aging, Dept Biochem & Biophys,Sch Basic Med Sci,Hlth Sci, Beijing, Peoples R China.; Wang, ZX (corresponding author), Hubei Univ Med, Taihe Hosp, Dept Cardiol, Shiyan, Peoples R China.
EM youde120@aliyun.com; 634661423@qq.com; mzbbjmu@sina.com
FU National Natural Science Foundation of China [81771505, 81773079]; Open
   research projects of Hubei Key Laboratory of Embryonic Stem Cell
   Research [2020ESOF005]
FX We appreciate the technical support provided by Mailgene biosciences
   Company Limited for plasmid construction. Our work was supported by the
   National Natural Science Foundation of China (grant numbers 81771505 and
   81773079), and Open research projects of Hubei Key Laboratory of
   Embryonic Stem Cell Research (grant number 2020ESOF005).
CR Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069
   Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Ceyhan GO, 2008, BIOCHEM BIOPH RES CO, V374, P442, DOI 10.1016/j.bbrc.2008.07.035
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142
   de Lucia C, 2019, INT J BIOCHEM CELL B, V108, P29, DOI 10.1016/j.biocel.2019.01.004
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Huan HB, 2017, BRAIN BEHAV IMMUN, V59, P118, DOI 10.1016/j.bbi.2016.08.016
   Hurr C, 2019, J PHYSIOL-LONDON, V597, P4565, DOI 10.1113/JP277994
   Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324
   Jin B, 2014, AGING CELL, V13, P879, DOI 10.1111/acel.12249
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Li L, 2018, CANCER CELL, V33, P368, DOI 10.1016/j.ccell.2018.01.010
   Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361
   Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005
   Patil P, 2019, AGING CELL, V18, DOI 10.1111/acel.12927
   Raihan O, 2019, CELL REP, V28, P78, DOI 10.1016/j.celrep.2019.06.002
   Renz BW, 2018, CANCER CELL, V34, P863, DOI 10.1016/j.ccell.2018.10.010
   Renz BW, 2018, CANCER CELL, V33, P75, DOI 10.1016/j.ccell.2017.11.007
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Sermer D, 2019, NAT REV CLIN ONCOL, V16, P494, DOI 10.1038/s41571-019-0190-8
   Sorota S, 2014, J CARDIOVASC PHARM, V63, P466, DOI 10.1097/FJC.0000000000000064
   Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wang LJ, 2015, ONCOTARGET, V6, P33805, DOI 10.18632/oncotarget.5668
   Zahalka AH, 2017, SCIENCE, V358, P321, DOI 10.1126/science.aah5072
   Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569
   Zheng J, 2017, J NEUROSCI, V37, P4145, DOI 10.1523/JNEUROSCI.3333-16.2017
   Zheng WW, 2019, FASEB J, V33, P4077, DOI 10.1096/fj.201801851R
   Zhuo DX, 2010, J BIOL CHEM, V285, P31491, DOI 10.1074/jbc.M109.068387
NR 38
TC 3
Z9 3
U1 2
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD DEC 16
PY 2020
VL 12
AR 507140
DI 10.3389/fnagi.2020.507140
PG 14
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA PL8WU
UT WOS:000603395600001
PM 33390926
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU MERRY, BJ
   HOLEHAN, AM
   LEWIS, SEM
   GOLDSPINK, DF
AF MERRY, BJ
   HOLEHAN, AM
   LEWIS, SEM
   GOLDSPINK, DF
TI THE EFFECTS OF AGING AND CHRONIC DIETARY RESTRICTION ON INVIVO HEPATIC
   PROTEIN-SYNTHESIS IN THE RAT
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 QUEENS UNIV BELFAST,CTR MED BIOL,DEPT PHYSIOL,BELFAST BT9 5BL,NORTH IRELAND.
C3 Queens University Belfast
RP MERRY, BJ (corresponding author), UNIV HULL,WOLFSON INST,HULL HU6 7RX,N HUMBERSIDE,ENGLAND.
RI Lewis, Sheena E M/ABI-8338-2020
CR ALT JM, 1980, LAB ANIM, V14, P95, DOI 10.1258/002367780780942809
   BEAUCHENE RE, 1970, J GERONTOL, V25, P359, DOI 10.1093/geronj/25.4.359
   BIRCHENALLSPARK.MC, 1985, J NUTR, V115, P110
   CONDE RD, 1976, BIOCHEM J, V158, P385, DOI 10.1042/bj1580385
   CONIGLIO JJ, 1979, MECH AGEING DEV, V11, P77, DOI 10.1016/0047-6374(79)90026-5
   DU JT, 1977, EXP GERONTOL, V12, P181, DOI 10.1016/0531-5565(77)90004-3
   ELHAJ AJ, 1986, COMP BIOCHEM PHYS A, V85, P281, DOI 10.1016/0300-9629(86)90251-3
   ENESCO HE, 1983, EXP GERONTOL, V18, P79, DOI 10.1016/0531-5565(83)90054-2
   FERN EB, 1974, BIOCHEM J, V142, P413, DOI 10.1042/bj1420413
   GAETANI S, 1969, J NUTR, V99, P307, DOI 10.1093/jn/99.3.307
   GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719
   GOLDBERG AL, 1975, AM J PHYSIOL, V228, P310, DOI 10.1152/ajplegacy.1975.228.1.310
   GOLDSPINK DF, 1985, COMP BIOCHEM PHYS B, V82, P849, DOI 10.1016/0305-0491(85)90534-6
   GOLDSPINK DF, 1986, CARDIOVASC RES, V20, P672, DOI 10.1093/cvr/20.9.672
   GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507
   HENSHAW EC, 1971, J BIOL CHEM, V246, P436
   KANUNGO MS, 1970, EXP GERONTOL, V5, P261, DOI 10.1016/0531-5565(70)90047-1
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   LIEPA GU, 1980, AM J PHYSIOL, V238, pE253, DOI 10.1152/ajpendo.1980.238.3.E253
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MERRY BJ, 1985, EXP GERONTOL, V20, P15, DOI 10.1016/0531-5565(85)90005-1
   MERRY BJ, 1981, EXP GERONTOL, V16, P431, DOI 10.1016/0531-5565(81)90025-5
   MERRY BJ, 1981, CLIN ENDOCRINOL META, P3
   MERRY BJ, 1986, SOC STUDY HUMAN BIOL, V25, P223
   MORGAN EH, 1971, J BIOL CHEM, V246, P3500
   OVE P, 1972, BIOCHIM BIOPHYS ACTA, V277, P211, DOI 10.1016/0005-2787(72)90367-X
   PENZES L, 1975, AKTUEL GERONTOL, V8, P583
   PERRY SW, 1965, J PATHOL BACTERIOL, V80, P729
   RICCA GA, 1978, J CELL PHYSIOL, V97, P137, DOI 10.1002/jcp.1040970202
   VANBEZOOIJEN CFA, 1977, MECH AGEING DEV, V6, P293, DOI 10.1016/0047-6374(77)90031-8
   VISKUP RW, 1979, EXP AGING RES, V5, P487, DOI 10.1080/03610737908257223
   Waterlow J.C., 1978, PROTEIN TURNOVER MAM
   WATERLOW JC, 1968, CLIN SCI, V35, P287
   HDB NUTR AGED
NR 35
TC 38
Z9 38
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUL
PY 1987
VL 39
IS 2
BP 189
EP 199
DI 10.1016/0047-6374(87)90008-X
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA J1233
UT WOS:A1987J123300008
PM 2442570
DA 2024-02-19
ER

PT J
AU JENA, BS
   PATNAIK, BK
AF JENA, BS
   PATNAIK, BK
TI EFFECT OF MALONATE AND PARA-CHLOROPHENOXY ACETIC-ACID ON HEPATIC
   SUCCINIC-DEHYDROGENASE ACTIVITY OF AGING LIZARDS
SO GERONTOLOGY
LA English
DT Article
C1 BERHAMPUR UNIV,DEPT ZOOL,BERHAMPUR 760007,ORISSA,INDIA.
C3 Berhampur University
CR DAWSON RMC, 1969, DATA BIOCH RES, P384
   GERSHON D, 1979, MECH AGEING DEV, V9, P189, DOI 10.1016/0047-6374(79)90098-8
   HOLLANDERCZYTKO H, 1983, PLANT SCI LETT, V29, P89, DOI 10.1016/0304-4211(83)90027-5
   KARA TC, 1981, GERONTOLOGY, V27, P187, DOI 10.1159/000212472
   KUN E, 1949, SCIENCE, V109, P144, DOI 10.1126/science.109.2824.144
   LEHNINGER AL, 1983, BIOCHEMISTRY-US, P460
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARCUS DL, 1982, EXP GERONTOL, V17, P429, DOI 10.1016/S0531-5565(82)80004-1
   NANDY K, 1968, J GERONTOL, V23, P82, DOI 10.1093/geronj/23.1.82
   NANDY K, 1978, MECH AGEING DEV, V8, P131, DOI 10.1016/0047-6374(78)90013-1
   OHTANI R, 1983, EXP GERONTOL, V18, P105, DOI 10.1016/0531-5565(83)90003-7
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   ORGEL LE, 1973, NATURE, V243, P441
   PANINI SR, 1974, BIOCHIM BIOPHYS ACTA, V368, P29, DOI 10.1016/0005-2728(74)90094-2
   PATNAIK BK, 1981, EXP GERONTOL, V16, P295, DOI 10.1016/0531-5565(81)90048-6
   RAO KL, 1973, EXP GERONTOL, V8, P173, DOI 10.1016/0531-5565(73)90009-0
   REISS U, 1975, J BIOL CHEM, V250, P826
   ROTHSTEIN M, 1977, MECH AGEING DEV, V6, P241, DOI 10.1016/0047-6374(77)90025-2
   ROTHSTEIN M, 1979, MECH AGEING DEV, V9, P197, DOI 10.1016/0047-6374(79)90099-X
   ROY D, 1983, EXP GERONTOL, V18, P185, DOI 10.1016/0531-5565(83)90031-1
   SAHU N, 1988, GERONTOLOGY, V34, P179, DOI 10.1159/000212949
   SCHOFIELD JD, 1978, EXP GERONTOL, V13, P147, DOI 10.1016/0531-5565(78)90007-4
   SHARMA HK, 1979, ARCH BIOCHEM BIOPHYS, V194, P275, DOI 10.1016/0003-9861(79)90619-2
   SHARMA HK, 1978, BIOCHEMISTRY-US, V17, P2869, DOI 10.1021/bi00607a027
   SINGER TP, 1957, ADV ENZYMOL REL S BI, V18, P65
   VENKAIAH B, 1978, INDIAN J BIOCHEM BIO, V15, P219
NR 27
TC 3
Z9 3
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD JAN-FEB
PY 1990
VL 36
IS 1
BP 12
EP 18
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DH792
UT WOS:A1990DH79200003
PM 2384219
DA 2024-02-19
ER

PT J
AU Xu, DX
   Yang, J
   Yu, WC
   Wei, J
AF Xu, Dexin
   Yang, Jing
   Yu, Wenchen
   Wei, Jie
TI Anthocyanins from Black Chokeberry Delayed Ageing-related Degenerative
   Changes in the Heart
SO INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH
LA English
DT Article
DE Anthocyanins; Aornia mealnocarpa; Aged; DNA damage; Molecular docking
ID KLOTHO-RELATED PROTEIN; DNA-DAMAGE; LIVER; MICE
AB Aim: Aging is the greatest risk factor for most neurodegenerative diseases. Cardiovascular circulatory system is an important part of maintaining normal human life activities. The core of the aging process is DNA damage, a food additive called Anthocyanin which has shown high efficacy in preventing aging, We examine whether anthocyanins could keep young mice from accelerated ageing of the heart. Materials and Methods: In order to accelerate ageing, Mice of Kunming were injected with D-galactose and they were given anthocyanins of 20 and 40 mg/kg as an intervention. Results: The whole function and structure of heart were evaluated after eight weeks and the expression levels of genes involved in the DNA damage signalling pathway were evaluated through Western blot analysis. Reduction of the heart index and the heart tissue damage was delayed by Anthocyanins. it maintained the stability of the redox system in serum such as GSH-PX, T-SOD and MDA and heart tissue. In the DNA damage signalling pathway, the expression levels of sensors such as ATM and ATR and effectors such as Chk1 and Chk2 were reduced. Conclusion: Anthocyanins can be diffusely used to slow ageing-related deterioration of heart structure and function by inhibiting DNA damage in the field of health products.
C1 [Xu, Dexin; Yang, Jing; Yu, Wenchen; Wei, Jie] Dept Liaoning Univ, Chongshan Middle Rd 66, Shenyang, Liaoning, Peoples R China.
RP Wei, J (corresponding author), Liaoning Univ, Dept Life Sci, Chongshan Middle Rd 66, Shenyang, Liaoning, Peoples R China.
EM J.Wei2015@hotmail.com
FU Science and Technology Government Department Fund in Liaoning province
   [LYB201611]; National Natural Science Foundation of China [31701656]
FX This work was supported by the Science and Technology Government
   Department Fund in Liaoning province (Grant No. LYB201611) and the
   National Natural Science Foundation of China (Grant No. 31701656).
CR Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Hayashi Y, 2016, VITAM HORM, V101, P1, DOI 10.1016/bs.vh.2016.02.011
   Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hügel HM, 2016, PHYTOMEDICINE, V23, P220, DOI 10.1016/j.phymed.2015.12.012
   Jiang Z, 2015, NAT PROD RES, V30, P1
   Jie W, 2017, PLANT FOOD HUM NUTR, V72, P1
   Kulling SE, 2008, PLANTA MED, V74, P1625, DOI 10.1055/s-0028-1088306
   Lin BW, 2017, BRIT J PHARMACOL, V174, P1226, DOI 10.1111/bph.13627
   Maynard S, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025130
   Min JY, 2011, NEUROSCI LETT, V500, P157, DOI 10.1016/j.neulet.2011.05.048
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Popovic D, 2016, LIFE SCI, V157, P168, DOI 10.1016/j.lfs.2016.06.007
   Rhind N, 2000, J CELL SCI, V113, P3889
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Soares JP, 2014, AGING-US, V6, P432, DOI 10.18632/aging.100667
   Subash S, 2014, NEURAL REGEN RES, V9, P1557, DOI 10.4103/1673-5374.139483
   Wei J, 2017, J AGR FOOD CHEM, V65, P5973, DOI 10.1021/acs.jafc.7b02136
   Wei J, 2016, INDIAN J PHARM EDUC, V50, P368, DOI 10.5530/Ijper.50.3.8
NR 20
TC 6
Z9 6
U1 2
U2 20
PU ASSOC PHARMACEUTICAL TEACHERS INDIA
PI BANGALORE
PA AL-AMEEN COLL PHARMACY, OPP LALBACH MAIN GATE, HOSUR MAIN RD, BANGALORE,
   560 027, INDIA
SN 0019-5464
J9 INDIAN J PHARM EDUC
JI Indian J. Pharm. Educ. Res.
PD JAN-MAR
PY 2019
VL 53
IS 1
BP 112
EP 116
DI 10.5530/ijper.53.1.15
PG 5
WC Education, Scientific Disciplines; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Education & Educational Research; Pharmacology & Pharmacy
GA HG4NX
UT WOS:000454953300015
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Zhou, Y
   Zhang, L
   Ma, Y
   Xie, L
   Yang, YY
   Jin, C
   Chen, H
   Zhou, Y
   Song, GQ
   Jia, D
   Wu, J
AF Zhou, Yuan
   Zhang, Li
   Ma, Yue
   Xie, Li
   Yang, Yong-Yu
   Jin, Cheng
   Chen, Hui
   Zhou, Ying
   Song, Guang-Qi
   Ding, Jia
   Wu, Jian
TI Secretome of senescent hepatic stellate cells favors malignant
   transformation from nonalcoholic steatohepatitis-fibrotic progression to
   hepatocellular carcinoma
SO THERANOSTICS
LA English
DT Article
DE Nonalcoholic steatohepatitis; Hepatocellular carcinoma; Hepatic stellate
   cell; Senescence; Senescence-associated secretary phenotype
ID CELLULAR SENESCENCE; LIVER; FIBROSIS; ACTIVATION; APOPTOSIS; CANCER;
   ANGIOGENESIS; TRANSITION; PATHWAY; INJURY
AB Background: Hepatic fibrosis is a premalignant lesion, and how injured hepatocytes transform into malignancy in a fibrotic microenvironment is poorly understood. Senescence is one of major fates of activated hepatic stellate cells (HSCs). Paucity of literature is available regarding the influence of senescent HSCs on behavior of steatotic hepatocytes.
   Methods: Senescent HSCs were identified in a murine model of nonalcoholic steatohepatitis (NASH)-fibrosis-hepatocellular carcinoma (HCC) and human NASH-HCC specimens. Secretome of senescent HSCs was analyzed by label-free mass-spectrum (NanoRPLC-MS/MS) and verified quantitatively.
   Results: Senescent HSCs were increased along with the progression from nonalcoholic fatty liver (NAFL), NASH to NASH-fibrosis, and reached a peak at the stage of advanced fibrosis and then decreased when hepatocellular dysplasia or HCC was developed. Critical components affecting proliferation, epithelial-mesenchymal transition (EMT) or migration were identified from secretome of senescent HSCs, and may activate morphogenic hedgehog or oncogenic Wnt signaling pathways to accelerate malignant transformation of steatotic or dysplastic hepatocytes. Primary hepatocytes stimulated with conditioned medium from senescent HSCs, in co-culture or co-cultured in 3D spheroids with senescent HSCs exhibited an enhanced proliferating or EMT profile.
   Conclusion: Senescent HSCs secreted a characterized protein profile favoring malignant transformation of steatotic or dysplastic hepatocytes through activating morphogenic hedgehog or oncogenic Wnt signaling pathways in the progression from NASH to malignancy.
C1 [Zhou, Yuan; Zhang, Li; Ma, Yue; Xie, Li; Yang, Yong-Yu; Jin, Cheng; Chen, Hui; Wu, Jian] Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol & Parasitol, MOE NHC CAMS Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
   [Ding, Jia] Fudan Univ, Shanghai Jingan Dist Cent Hosp, Dept Gastroenterol, Shanghai 200040, Peoples R China.
   [Zhou, Ying; Song, Guang-Qi] Puheng Technol Co Ltd, Joint Lab Biomat & Translat Med, Suzhou 215163, Peoples R China.
   [Wu, Jian] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai 200032, Peoples R China.
   [Wu, Jian] Fudan Univ, Shanghai Inst Liver Dis, Shanghai Med Coll, Shanghai 200032, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Fudan University
RP Jia, D (corresponding author), Fudan Univ, Shanghai Jingan Dist Cent Hosp, Dept Gastroenterol, Shanghai 200040, Peoples R China.; Song, GQ (corresponding author), Puheng Technol Co Ltd, Joint Lab Biomat & Translat Med, Suzhou 215163, Peoples R China.; Wu, J (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Shanghai Med Coll, 138 Yixue Yuan Rd,POB 228, Shanghai 200032, Peoples R China.
EM guangqi.song@puhengtec.com; jiading12@fudan.edu.cn; jian.wu@fudan.edu.cn
RI Wu, Jian/AAU-5221-2020
OI Wu, Jian/0000-0001-9933-7364
FU National Natural Science Foundation of China [81572356, 81871997,
   82170624, 81702982]; National Key R/D Program of China [2016YFE0107400];
   Natural Science Foundation of Shanghai [17ZR1424800]; development fund
   for Shanghai talents [2019117]
FX This study is supported partially by the National Natural Science
   Foundation of China (NSFC#81572356, 81871997, 82170624 to J.W.; and
   #81702982 to J.D.); the National Key R/D Program of China
   (#2016YFE0107400) to J.W.; Natural Science Foundation of Shanghai
   (#17ZR1424800 to J.D.) and the development fund for Shanghai talents
   (#2019117 to J.D.).
CR Affo S, 2017, ANNU REV PATHOL-MECH, V12, P153, DOI 10.1146/annurev-pathol-052016-100322
   Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965
   Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chao HM, 2017, ONCOTARGET, V8, P2604, DOI 10.18632/oncotarget.13733
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Ding J, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010123
   Faggioli F, 2018, HEPATOLOGY, V67, P1970, DOI 10.1002/hep.29636
   Fang D, 2021, EXP CELL RES, V406, DOI 10.1016/j.yexcr.2021.112727
   Fernández M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559
   Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Ioannou GN, 2021, J HEPATOL, V75, P1476, DOI 10.1016/j.jhep.2021.08.012
   Jing CY, 2021, ONCOGENE, V40, P2910, DOI 10.1038/s41388-021-01705-9
   Kang Q, 2021, J VIRAL HEPATITIS, V28, P1284, DOI 10.1111/jvh.13558
   Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li FM, 2020, NAT CELL BIOL, V22, P728, DOI 10.1038/s41556-020-0511-2
   Li HY, 2021, BIOSENS BIOELECTRON, V174, DOI 10.1016/j.bios.2020.112738
   Liu XJ, 2020, LIVER INT, V40, P830, DOI 10.1111/liv.14370
   Lou GH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0289-z
   Pacheco-Rivera R, 2016, TOXICOL LETT, V241, P19, DOI 10.1016/j.toxlet.2015.11.011
   Pan L, 2018, BIOMED PHARMACOTHER, V106, P68, DOI 10.1016/j.biopha.2018.06.040
   Perugorria MJ, 2019, NAT REV GASTRO HEPAT, V16, P121, DOI 10.1038/s41575-018-0075-9
   Rahman S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-8
   Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426
   Shao YY, 2021, ANAL CHEM, V93, P9408, DOI 10.1021/acs.analchem.1c00965
   Song Y, 2023, HEPATOLOGY, V78, P1433, DOI 10.1097/HEP.0000000000000319
   Sung CK, 2004, AM J PHYSIOL-GASTR L, V286, pG722, DOI 10.1152/ajpgi.00411.2003
   Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065
   van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253
   Wang W, 2019, CELL ONCOL, V42, P769, DOI 10.1007/s13402-019-00460-0
   Wu J, 2004, HEPATOLOGY, V40, P195, DOI 10.1002/hep.20288
   Wu J, 2016, ONCOTARGET, V7, P42762, DOI 10.18632/oncotarget.8641
   Xu G, 2017, LAB INVEST, V97, P1201, DOI 10.1038/labinvest.2017.84
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu HX, 2019, MOL IMMUNOL, V107, P29, DOI 10.1016/j.molimm.2019.01.004
   Yu MC, 2004, HEPATOLOGY, V40, P1312, DOI 10.1002/hep.20488
   Zhan SS, 2006, HEPATOLOGY, V43, P435, DOI 10.1002/hep.21093
   Zhang SZ, 2020, ADV EXP MED BIOL, V1217, P261, DOI 10.1007/978-981-15-1025-0_16
   Zhao JW, 2023, BRIT J PHARMACOL, V180, P1072, DOI 10.1111/bph.15997
NR 47
TC 1
Z9 1
U1 2
U2 2
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2023
VL 13
IS 13
BP 4430
EP 4448
DI 10.7150/thno.85369
PG 19
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA U6MO0
UT WOS:001085926200009
PM 37649614
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Petropoulos, I
   Friguet, B
AF Petropoulos, Isabelle
   Friguet, Bertrand
TI Maintenance of proteins and aging: The role of oxidized protein repair
SO FREE RADICAL RESEARCH
LA English
DT Article
DE protein oxidation; protein maintenance; aging; replicative senescence;
   proteasome; peptide methionine sulfoxide reductases
ID METHIONINE-SULFOXIDE-REDUCTASE; CROSS-LINKED PROTEIN; OXIDATIVE STRESS;
   PROTEASOME ACTIVITY; LON PROTEASE; RAT-LIVER; REPLICATIVE SENESCENCE;
   SELECTIVE DEGRADATION; ANTIOXIDANT DEFENSE; HUMAN FIBROBLASTS
AB According to the free radical theory of aging proposed by Denham Harman (Journal of Gerontology 1956, 11, pp. 298-300), the continuous oxidative damage to cellular components over an organism's life span is a causal factor of the aging process. The age-related build-up of oxidized protein is therefore resulting from increased protein oxidative damage and/or decreased elimination of oxidized proteins. In this mini-review, we will address the fate, during aging, of the protein maintenance systems that are involved in the degradation of irreversibly oxidized proteins and in the repair of reversible protein oxidative damage with a special focus on the methionine sulfoxide reductases system. Since these protein degradation and repair systems have been found to be impaired with age, it is proposed that not only failure of redox homeostasis but, as importantly, failure of protein maintenance are critical factors in the aging process.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, EA 3106, IFR 117, F-75251 Paris 05, France.
C3 Universite Paris Cite
RP Friguet, B (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, EA 3106, IFR 117, CC 7128,2 Pl Jussieu, F-75251 Paris 05, France.
EM bfriguet@paris7.jussieu.fr
OI Petropoulos, Isabelle/0000-0001-9205-7458; Friguet,
   Bertrand/0000-0001-8085-1961
CR Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Bartlett RK, 2003, BIOCHEMISTRY-US, V42, P3231, DOI 10.1021/bi026956z
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075
   Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Brot N, 2000, BIOPOLYMERS, V55, P288, DOI 10.1002/1097-0282(2000)55:4<288::AID-BIP1002>3.0.CO;2-M
   Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569
   Bulteau AL, 2006, ANTIOXID REDOX SIGN, V8, P136, DOI 10.1089/ars.2006.8.136
   Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663
   Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200
   Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4
   Carrard G, 2003, INT J BIOCHEM CELL B, V35, P728, DOI 10.1016/S1357-2725(02)00356-4
   Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200
   Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200
   Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   Davis DA, 2000, BIOCHEM J, V346, P305, DOI 10.1042/0264-6021:3460305
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   Díaz-Hernández M, 2003, J NEUROSCI, V23, P11653
   Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172
   FAROUT L, 2006, ARCH BIOCH BIOPHYS
   Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   Friguet B, 2000, ANN NY ACAD SCI, V908, P143
   Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028
   GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0
   Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080
   Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0
   Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020
   Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X
   Hanbauer I, 2006, FREE RADICAL BIO MED, V40, P1391, DOI 10.1016/j.freeradbiomed.2005.12.017
   Hansel A, 2005, BBA-PROTEINS PROTEOM, V1703, P239, DOI 10.1016/j.bbapap.2004.09.010
   Hansel A, 2002, FASEB J, V16, P911, DOI 10.1096/fj.01-0737fje
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375
   Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811
   JOHNSON D, 1978, J BIOL CHEM, V253, P7142
   Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101
   Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Kim HY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-11
   Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131
   Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620
   Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101
   Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Mary J, 2004, EXP GERONTOL, V39, P1117, DOI 10.1016/j.exger.2004.06.008
   Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   Petropoulos I, 2005, BBA-PROTEINS PROTEOM, V1703, P261, DOI 10.1016/j.bbapap.2004.08.018
   Petropoulos I, 2001, BIOCHEM J, V355, P819, DOI 10.1042/bj3550819
   Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220
   Picot CR, 2005, FREE RADICAL BIO MED, V39, P1332, DOI 10.1016/j.freeradbiomed.2005.06.017
   Picot CR, 2004, FEBS LETT, V558, P74, DOI 10.1016/S0014-5793(03)01530-8
   PICOT CR, 2006, IN PRESS EXP GERONTO
   Rivett AJ, 2004, CURR PROTEIN PEPT SC, V5, P153, DOI 10.2174/1389203043379774
   Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199
   Saghert D, 2006, P NATL ACAD SCI USA, V103, P8656, DOI 10.1073/pnas.0602826103
   Schallreuter KU, 2006, BIOCHEM BIOPH RES CO, V342, P145, DOI 10.1016/j.bbrc.2006.01.124
   Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200
   Sigalov AB, 2002, ANTIOXID REDOX SIGN, V4, P553, DOI 10.1089/15230860260196353
   Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490
   Sreekumar PG, 2005, BIOCHEM BIOPH RES CO, V334, P245, DOI 10.1016/j.bbrc.2005.06.081
   Tête-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8
   Viteri G, 2004, ARCH BIOCHEM BIOPHYS, V427, P197, DOI 10.1016/j.abb.2004.05.006
   Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015
   Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200
   Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443
   WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247
   Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100
NR 82
TC 60
Z9 70
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD DEC
PY 2006
VL 40
IS 12
BP 1269
EP 1276
DI 10.1080/10715760600917144
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 102XY
UT WOS:000241848100007
PM 17090416
DA 2024-02-19
ER

PT J
AU Kundu, D
   Kennedy, L
   Zhou, TH
   Ekser, B
   Meadows, V
   Sybenga, A
   Kyritsi, K
   Chen, LX
   Ceci, L
   Wu, N
   Wu, CD
   Glaser, S
   Carpino, G
   Onori, P
   Gaudio, E
   Alpini, G
   Francis, H
AF Kundu, Debjyoti
   Kennedy, Lindsey
   Zhou, Tianhao
   Ekser, Burcin
   Meadows, Vik
   Sybenga, Amelia
   Kyritsi, Konstantina
   Chen, Lixian
   Ceci, Ludovica
   Wu, Nan
   Wu, Chaodong
   Glaser, Shannon
   Carpino, Guido
   Onori, Paolo
   Gaudio, Eugenio
   Alpini, Gianfranco
   Francis, Heather
TI p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat
   diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling
SO HEPATOLOGY
LA English
DT Article
ID CELLULAR SENESCENCE; DAMAGE; INHIBITION; TRYPTOPHAN; FIBROSIS; E2F1
AB Background and Aims: NAFLD is characterized by steatosis, hepatic inflammation, and fibrosis, which can develop into NASH. Patients with NAFLD/NASH have increased ductular reaction (DR) and biliary senescence. High fat/high cholesterol diet feeding increases biliary senescence, DR, and biliary insulin-like growth factor-1 (IGF-1) expression in mice. p16/IGF-1 converges with fork-head box transcription factor O1 (FOXO1) through E2F1. We evaluated p16 inhibition on NAFLD phenotypes and biliary E2F1/FOXO1/IGF-1 signaling.
   Approach and Results: 4-week wild-type (C57BL/6J) male mice were fed a control diet (CD) or high fat/high cholesterol diet and received either p16 or control Vivo Morpholino (VM) by tail vein injection 2x during the 16th week of feeding. We confirmed p16 knockdown and examined: (i) NAFLD phenotypes; (ii) DR and biliary senescence; (iii) serum metabolites; and (iv) biliary E2F1/FOXO1/IGF-1 signaling. Human normal, NAFLD, and NASH liver samples and isolated cholangiocytes treated with control or p16 VM were evaluated for p16/E2F1/FOXO1/IGF-1 signaling. p16 VM treatment reduced cholangiocyte and hepatocyte p16. In wild-type high fat/high cholesterol diet mice with control VM, there were increased (i) NAFLD phenotypes; (ii) DR and biliary senescence; (iii) serum metabolites; and (iv) biliary E2F1/FOXO1/IGF-1 signaling; however, p16 VM treatment reduced these parameters. Biliary E2F1/FOX-O1/IGF-1 signaling increased in human NAFLD/NASH but was blocked by p16 VM. In vitro, p16 VM reduced biliary E2f1 and Foxo1 transcription by inhibiting RNA pol II binding and E2F1 binding at the Foxo1 locus, respectively. Inhibition of E2F1 reduced biliary FOXO1 in vitro.
   Conclusion: Attenuating hepatic p16 expression may be a therapeutic approach for improving NAFLD/NASH phenotypes.
C1 [Kundu, Debjyoti; Kennedy, Lindsey; Zhou, Tianhao; Meadows, Vik; Kyritsi, Konstantina; Chen, Lixian; Ceci, Ludovica; Wu, Nan; Alpini, Gianfranco; Francis, Heather] Indiana Univ Sch Med Res, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA.
   [Kennedy, Lindsey; Alpini, Gianfranco; Francis, Heather] Richard L Roudebush VA Med Ctr, Dept Res, Indianapolis, IN USA.
   [Ekser, Burcin] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN USA.
   [Sybenga, Amelia] UVM Hlth Network, Burlington, VT USA.
   [Ceci, Ludovica; Carpino, Guido; Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr, College Stn, TX USA.
   [Glaser, Shannon] Texas A&M Univ, Sch Med, College Stn, TX USA.
   [Francis, Heather] Richard L Roudebush VA Med Ctr, Med 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.
   [Francis, Heather] Indiana Univ, Gastroenterol, Med 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Richard L. Roudebush VA Medical Center; Indiana University System;
   Indiana University Bloomington; Sapienza University Rome; Texas A&M
   University System; Texas A&M University College Station; Texas A&M
   University System; Texas A&M University College Station; US Department
   of Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center; Indiana University System; Indiana
   University-Purdue University Indianapolis
RP Francis, H (corresponding author), Richard L Roudebush VA Med Ctr, Med 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.; Francis, H (corresponding author), Indiana Univ, Gastroenterol, Med 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.
EM debkundu@iu.edu; linkenn@iu.edu; zhouv@iu.edu; bekser@iupui.edu;
   vikmead@iu.edu; Amelia.Sybenga@uvmhealth.org; kkyritsi@iu.edu;
   chenlix@iu.edu; lceci@iu.edu; nawu@iu.edu; cdwu@tamu.edu;
   sglaser@tamu.edu; guido.carpino@uniroma1.it; paolo.onori@uniroma1.it;
   eugenio.gaudio@uniroma1.it; Galpini@iu.edu; heafranc@iu.edu
OI Ekser, Burcin/0000-0003-0741-8007; Meadows, Vik/0000-0002-8983-4305;
   kundu, Debjyoti/0000-0002-7209-0100; CARPINO, Guido/0000-0001-8570-2519;
   Kennedy, Lindsey/0000-0001-9224-8940; ceci, Ludovica/0000-0002-2131-8494
FU Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University;
   Indiana University Health-Indiana University School of Medicine
   Strategic Research Initiative; Senior Career Scientist Award [IK6
   BX004601]; VA Merit award [5I01BX000574, 1I01BX003031]; Career Scientist
   Award [IK6BX005226]; US Department of Veteran's Affairs [1IK2BX005306];
   Biomedical Laboratory Research and Development Service; NIH [DK108959,
   DK119421, DK054811, DK115184, DK076898, DK107310, DK110035, DK062975,
   AA028711]; PSC Partners Seeking a Cure; Sapienza University of Rome;
   Richard L. Roudebush VA Medical Center, Indianapolis, IN; Medical
   Physiology, Medical Research Building, Temple, Texas
FX This work was supported by the Hickam Endowed Chair, Gastroenterology,
   Medicine, Indiana University, the Indiana University Health-Indiana
   University School of Medicine Strategic Research Initiative, the Senior
   Career Scientist Award (IK6 BX004601), and the VA Merit award
   (5I01BX000574) to Gianfranco Alpini. The Career Scientist Award
   (IK6BX005226) and the VA Merit award (1I01BX003031) to Heather Francis.
   Career Development Award-2 to Lindsey Kennedy (1IK2BX005306) from the US
   Department of Veteran's Affairs, Biomedical Laboratory Research and
   Development Service and NIH grants DK108959 and DK119421 (Heather
   Francis), DK054811, DK115184, DK076898, DK107310, DK110035, DK062975 and
   AA028711 (Gianfranco Alpini and Shannon Glaser) and the PSC Partners
   Seeking a Cure (Gianfranco Alpini). Eugenio Gaudio and Paolo Onori were
   supported by research funds from Sapienza University of Rome. Portions
   of these studies were supported by resources at the Richard L. Roudebush
   VA Medical Center, Indianapolis, IN, and Medical Physiology, Medical
   Research Building, Temple, Texas. The views expressed in this article
   are those of the authors and do not necessarily represent the views of
   the Department of Veterans Affairs.
CR Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111
   Alsuraih M, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100250
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Carpino G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15943-z
   Carpino G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157246
   Cazzagon N, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100286
   Chen LX, 2021, HEPATOLOGY, V74, P1845, DOI 10.1002/hep.31871
   Chiba M, 2011, J CLIN PATHOL, V64, P564, DOI 10.1136/jcp.2011.090175
   Denechaud PD, 2016, J CLIN INVEST, V126, P137, DOI 10.1172/JCI81542
   Dong X Charlie, 2017, Liver Res, V1, P168, DOI 10.1016/j.livres.2017.11.004
   Enooku K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47216-2
   Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220
   Georgin-Lavialle S, 2016, ALLERGY, V71, P416, DOI 10.1111/all.12802
   Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x
   Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JC132914, 10.1172/JCI32914]
   Kennedy L, 2021, HEPATOLOGY, V74, P164, DOI 10.1002/hep.31713
   Kennedy L, 2018, AM J PATHOL, V188, P600, DOI 10.1016/j.ajpath.2017.11.016
   Kennedy LL, 2014, LAB INVEST, V94, P1406, DOI 10.1038/labinvest.2014.129
   Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280
   Kousteni S, 2011, J BONE MINER RES, V26, P912, DOI 10.1002/jbmr.306
   Kyritsi K, 2020, GENE EXPRESSION, V20, P89, DOI 10.3727/105221620X15889714507961
   Loomba R, 2020, ALIMENT PHARM THER, V51, P1149, DOI 10.1111/apt.15679
   Lv FQ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00176
   Lv FQ, 2017, BIOCHEM BIOPH RES CO, V486, P264, DOI 10.1016/j.bbrc.2017.03.023
   Mason SL, 2002, ONCOGENE, V21, P4220, DOI 10.1038/sj.onc.1205524
   Masoodi M, 2021, NAT REV GASTRO HEPAT, V18, P835, DOI 10.1038/s41575-021-00502-9
   Mau T, 2018, EXP GERONTOL, V105, P27, DOI 10.1016/j.exger.2017.10.014
   Meadows V, 2021, HEPATOLOGY, V74, P2684, DOI 10.1002/hep.32028
   Nobili V, 2018, J PEDIATR-US, V194, P100, DOI 10.1016/j.jpeds.2017.10.036
   Nobili V, 2012, HEPATOLOGY, V56, P2142, DOI 10.1002/hep.25742
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Petrescu AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72681-5
   Pi HF, 2019, FASEB J, V33, P11870, DOI 10.1096/fj.201900812R
   Pierantonelli I, 2019, TRANSPLANTATION, V103, pe1, DOI 10.1097/TP.0000000000002480
   Piras C, 2021, METABOLITES, V11, DOI 10.3390/metabo11100694
   Pirola CJ, 2018, WORLD J GASTROENTERO, V24, P1601, DOI 10.3748/wjg.v24.i15.1601
   Rockey DC, 2019, AM J PATHOL, V189, P2209, DOI 10.1016/j.ajpath.2019.07.019
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tang M, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04730-y
   Valenti L, 2008, DIABETES, V57, P1355, DOI 10.2337/db07-0714
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Zhang AN, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061864
   Zhang LQ, 2021, CELL MOL GASTROENTER, V11, P697, DOI 10.1016/j.jcmgh.2020.10.006
   Zhang XY, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0595-5
NR 48
TC 0
Z9 0
U1 11
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUL
PY 2023
VL 78
IS 1
BP 243
EP 257
DI 10.1097/HEP.0000000000000307
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA R1JJ4
UT WOS:001061970900025
PM 36799449
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Takahashi, S
   Tanaka, N
   Fukami, T
   Xie, C
   Yagai, T
   Kim, D
   Velenosi, TJ
   Yan, TT
   Krausz, KW
   Levi, M
   Gonzalez, FJ
AF Takahashi, Shogo
   Tanaka, Naoki
   Fukami, Tatsuki
   Xie, Cen
   Yagai, Tomoki
   Kim, Donghwan
   Velenosi, Thomas J.
   Yan, Tingting
   Krausz, Kristopher W.
   Levi, Moshe
   Gonzalez, Frank J.
TI Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article
ID EPITHELIAL-CELL PROLIFERATION; SALT EXPORT PUMP;
   HEPATOCELLULAR-CARCINOMA; SPONTANEOUS HEPATOCARCINOGENESIS; MICE;
   DEFICIENCY; MYC; ACTIVATION; EXPRESSION; INHIBITION
AB Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths worldwide, and an association between altered bile acid (BA) metabolism, down-regulation of farnesoid X receptor (FXR), which is a master regulator of BA metabolism, and hepatocarcinogenesis has been documented. While global FXR deficiency in mice results in spontaneous HCC with aging, the contribution of tissue-specific FXR deficiency to hepatocarcinogenesis remains unclear. In this study, the prevalence of hepatic tumors, expression of genes related to tumorigenesis, and serum/liver BA levels were compared among male whole-body Fxr-null, hepatocyte-specific Fxr-null (Fxr(Delta Hep)), and enterocyte-specific Fxr-null (Fxr(Delta Hep) ) mice at the age of 3, 14, and 20 months. More than 90% of 20-month-old whole-body Fxr-null mice had hepatic tumors with enhanced hepatic expression of myelocytomatosis oncogene (Myc) and cyclin-dependent kinase 4 (Cdk4) messenger RNAs (mRNAs) and elevated serum taurocholate (TCA) and tauromuricholate (TMCA) and their respective unconjugated derivatives. The incidence of hepatic tumors was significantly lower in Fxr(Delta Hep) and Fxr(Delta IE) mice (20% and 5%, respectively), and the increases in Myc and Cdk4 mRNA or serum BA concentrations were not detected in these mice compared to FXr(floxed)([fl]/fl) mice; a similar tendency was observed in 14-month-old mice. However, increased hepatic c-Myc protein expression was found only in Fxr-null mice at the age of 3, 14, and 20 months. Treatment with TCA induced Myc expression in Fxr-null cultured primary mouse hepatocytes but not in wild-type (WT) mouse hepatocytes, demonstrating that the combination of hepatocyte FXR disruption with elevated TCA is required for Myc induction and ensuing age-dependent hepatocarcinogenesis in Fxr-null mice. Conclusion: There is a relatively low risk of hepatic tumors by inhibition of FXR in enterocytes, likely due to the lack of increased TCA and Myc induction.
C1 [Fukami, Tatsuki] Kanazawa Univ, Fac Pharmaceut Sci, Dept Drug Metab & Toxicol, Kanazawa, Ishikawa, Japan.
   [Takahashi, Shogo; Fukami, Tatsuki; Xie, Cen; Yagai, Tomoki; Kim, Donghwan; Velenosi, Thomas J.; Yan, Tingting; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bldg 37,Room 3106,37 Convent Dr, Bethesda, MD 20892 USA.
   [Takahashi, Shogo; Levi, Moshe] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA.
   [Tanaka, Naoki] Shinshu Univ, Dept Metab Regulat, Sch Med, Matsumoto, Nagano, Japan.
   [Tanaka, Naoki] Shinshu Univ, Int Res Ctr Agr Food Ind, Matsumoto, Nagano, Japan.
C3 Kanazawa University; National Institutes of Health (NIH) - USA; NIH
   National Cancer Institute (NCI); Georgetown University; Shinshu
   University; Shinshu University
RP Gonzalez, FJ (corresponding author), NCI, Lab Metab, NIH, Bldg 37,Room 3106,37 Convent Dr, Bethesda, MD 20892 USA.
EM gonzalef@mail.nih.gov
RI Fukami, Tatsuki/C-8907-2015; Xie, Cen/HKM-6955-2023; Takahashi,
   Shogo/GVS-9010-2022
OI Xie, Cen/0000-0002-4574-8456; Takahashi, Shogo/0000-0002-3831-5353;
   Tanaka, Naoki/0000-0002-3212-3836; Kim, Donghwan/0000-0002-0139-2494;
   Gonzalez, Frank/0000-0002-7990-2140
FU National Cancer Institute Intramural Research Program, Center for Cancer
   Research, National Institutes of Health (NIH) [U54 ES16015]; NIH
   [R01DK098336, 1R01AG049493]; Japanese Society for the Promotion of
   Science; Japanese Society for the Promotion of Sciences, Advancing
   Strategic International Networks to Accelerate the Circulation of
   Talented Researchers [S2601]
FX Supported by the National Cancer Institute Intramural Research Program,
   Center for Cancer Research, National Institutes of Health (NIH) and
   award U54 ES16015 (to F.J.G.), NIH 1R01AG049493, and NIH R01DK098336 (to
   M.L.), a Japanese Society for the Promotion of Science Research
   Fellowship for a Japanese Biomedical and Behavioral Researcher at NIH
   (KAITOKU-NIH to S.T. and T.Y.), and the Japanese Society for the
   Promotion of Sciences, Advancing Strategic International Networks to
   Accelerate the Circulation of Talented Researchers (No. S2601 to F.T.).
CR Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030
   Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009
   Calvisi D, 2017, GUT, V66, P1179, DOI 10.1136/gutjnl-2016-313547
   Chen Y, 2013, HEPATOLOGY, V57, P1530, DOI 10.1002/hep.26187
   Degirolamo C, 2015, HEPATOLOGY, V61, P161, DOI 10.1002/hep.27274
   Fang ZZ, 2016, TOXICOL APPL PHARM, V291, P21, DOI 10.1016/j.taap.2015.12.003
   Fujimoto A, 2016, NAT GENET, V48, P700, DOI 10.1038/ng0616-700a
   FURIHATA C, 1994, CANCER LETT, V83, P215, DOI 10.1016/0304-3835(94)90322-0
   Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057
   Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166
   Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Kimura T, 2018, WORLD J GASTROENTERO, V24, P1440, DOI 10.3748/wjg.v24.i13.1440
   Kimura T, 2017, HEPATOL RES, V47, P405, DOI 10.1111/hepr.12762
   Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287
   Komatsu M, 2008, J HEPATOL, V49, P810, DOI 10.1016/j.jhep.2008.05.016
   Komatsu M, 2015, BBA-MOL BASIS DIS, V1852, P473, DOI 10.1016/j.bbadis.2014.12.011
   Kong B, 2016, AM J PHYSIOL-GASTR L, V310, pG295, DOI 10.1152/ajpgi.00134.2015
   Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384
   Liu NA, 2012, MOL ENDOCRINOL, V26, P775, DOI 10.1210/me.2011-1383
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409
   Meng ZP, 2012, J HEPATOL, V57, P1004, DOI 10.1016/j.jhep.2012.06.016
   Niu YD, 2017, HEPATOLOGY, V65, P893, DOI 10.1002/hep.28924
   Perrone EE, 2012, J SURG RES, V178, P155, DOI 10.1016/j.jss.2012.02.029
   Qu AJ, 2014, J HEPATOL, V60, P331, DOI 10.1016/j.jhep.2013.09.024
   Rao CV, 2017, CARCINOGENESIS, V38, P2, DOI 10.1093/carcin/bgw118
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038
   Takahashi S, 2017, TOXICOL SCI, V158, P334, DOI 10.1093/toxsci/kfx094
   Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594
   Tanaka N, 2008, INT J CANCER, V122, P124, DOI 10.1002/ijc.23056
   Tanaka N, 2017, PHARMACOL THERAPEUT, V179, P142, DOI 10.1016/j.pharmthera.2017.05.011
   Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630
   Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390
   Yamaguchi J, 2004, SURGERY, V135, P215, DOI 10.1016/j.surg.2003.08.025
   Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078
   Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342
NR 38
TC 34
Z9 34
U1 1
U2 16
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD DEC
PY 2018
VL 2
IS 12
BP 1567
EP 1582
DI 10.1002/hep4.1263
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HD7JX
UT WOS:000452729400013
PM 30556042
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Yildiz, G
   Arslan-Ergul, A
   Bagislar, S
   Konu, O
   Yuzugullu, H
   Gursoy-Yuzugullu, O
   Ozturk, N
   Ozen, C
   Ozdag, H
   Erdal, E
   Karademir, S
   Sagol, O
   Mizrak, D
   Bozkaya, H
   Ilk, HG
   Ilk, O
   Bilen, B
   Cetin-Atalay, R
   Akar, N
   Ozturk, M
AF Yildiz, Gokhan
   Arslan-Ergul, Ayca
   Bagislar, Sevgi
   Konu, Ozlen
   Yuzugullu, Haluk
   Gursoy-Yuzugullu, Ozge
   Ozturk, Nuri
   Ozen, Cigdem
   Ozdag, Hilal
   Erdal, Esra
   Karademir, Sedat
   Sagol, Ozgul
   Mizrak, Dilsa
   Bozkaya, Hakan
   Ilk, Hakki Gokhan
   Ilk, Ozlem
   Bilen, Biter
   Cetin-Atalay, Rengul
   Akar, Nejat
   Ozturk, Mehmet
TI Genome-Wide Transcriptional Reorganization Associated with
   Senescence-to-Immortality Switch during Human Hepatocellular
   Carcinogenesis
SO PLOS ONE
LA English
DT Article
ID CELLULAR SENESCENCE; REPLICATIVE SENESCENCE; MOLECULAR SIGNATURE;
   MICROARRAY ANALYSIS; TELOMERE LENGTH; HEPATITIS-C; CARCINOMA; LIVER;
   GENE; EXPRESSION
AB Senescence is a permanent proliferation arrest in response to cell stress such as DNA damage. It contributes strongly to tissue aging and serves as a major barrier against tumor development. Most tumor cells are believed to bypass the senescence barrier (become "immortal") by inactivating growth control genes such as TP53 and CDKN2A. They also reactivate telomerase reverse transcriptase. Senescence-to-immortality transition is accompanied by major phenotypic and biochemical changes mediated by genome-wide transcriptional modifications. This appears to happen during hepatocellular carcinoma (HCC) development in patients with liver cirrhosis, however, the accompanying transcriptional changes are virtually unknown. We investigated genome-wide transcriptional changes related to the senescence-to-immortality switch during hepatocellular carcinogenesis. Initially, we performed transcriptome analysis of senescent and immortal clones of Huh7 HCC cell line, and identified genes with significant differential expression to establish a senescence-related gene list. Through the analysis of senescence-related gene expression in different liver tissues we showed that cirrhosis and HCC display expression patterns compatible with senescent and immortal phenotypes, respectively; dysplasia being a transitional state. Gene set enrichment analysis revealed that cirrhosis/senescence-associated genes were preferentially expressed in non-tumor tissues, less malignant tumors, and differentiated or senescent cells. In contrast, HCC/immortality genes were up-regulated in tumor tissues, or more malignant tumors and progenitor cells. In HCC tumors and immortal cells genes involved in DNA repair, cell cycle, telomere extension and branched chain amino acid metabolism were up-regulated, whereas genes involved in cell signaling, as well as in drug, lipid, retinoid and glycolytic metabolism were down-regulated. Based on these distinctive gene expression features we developed a 15-gene hepatocellular immortality signature test that discriminated HCC from cirrhosis with high accuracy. Our findings demonstrate that senescence bypass plays a central role in hepatocellular carcinogenesis engendering systematic changes in the transcription of genes regulating DNA repair, proliferation, differentiation and metabolism.
C1 [Yildiz, Gokhan; Arslan-Ergul, Ayca; Bagislar, Sevgi; Konu, Ozlen; Yuzugullu, Haluk; Gursoy-Yuzugullu, Ozge; Ozturk, Nuri; Ozen, Cigdem; Bilen, Biter; Cetin-Atalay, Rengul; Ozturk, Mehmet] Bilkent Univ, Dept Mol Biol & Genet, BilGen Genet & Biotechnol Ctr, Ankara, Turkey.
   [Yildiz, Gokhan; Bagislar, Sevgi; Yuzugullu, Haluk; Gursoy-Yuzugullu, Ozge; Ozturk, Mehmet] Univ Grenoble 1, INSERM, CRI U823, Grenoble, France.
   [Ozdag, Hilal; Akar, Nejat] Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey.
   [Erdal, Esra] Dokuz Eylul Univ, Sch Med, Dept Med Biol, Izmir, Turkey.
   [Karademir, Sedat] Dokuz Eylul Univ, Sch Med, Dept Surg, Izmir, Turkey.
   [Sagol, Ozgul] Dokuz Eylul Univ, Sch Med, Dept Pathol, Izmir, Turkey.
   [Mizrak, Dilsa; Bozkaya, Hakan] Ankara Univ, Dept Gastroenterol, TR-06100 Ankara, Turkey.
   [Ilk, Hakki Gokhan] Ankara Univ, Dept Elect Engn, TR-06100 Ankara, Turkey.
   [Ilk, Ozlem] Middle E Tech Univ, Dept Stat, TR-06531 Ankara, Turkey.
C3 Ihsan Dogramaci Bilkent University; Communaute Universite Grenoble
   Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et
   de la Recherche Medicale (Inserm); Ankara University; Dokuz Eylul
   University; Dokuz Eylul University; Dokuz Eylul University; Ankara
   University; Ankara University; Middle East Technical University
RP Ozturk, M (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, BilGen Genet & Biotechnol Ctr, Ankara, Turkey.
EM ozturk@fen.bilkent.edu.tr
RI YILDIZ, Gokhan/AAE-7001-2019; Ozturk, Nuri/F-4140-2011; ERGUL, AYCA
   ARSLAN/AAH-1655-2020; ERGUL, AYCA ARSLAN/F-6655-2012; Erdal,
   Esra/AAE-1339-2019; Bagislar, sevgi/ITT-0696-2023; Ilk,
   Ozlem/L-9093-2013; Cetin-Atalay, Rengul/O-9826-2014; Sevgili, Hilal
   Özdağ/C-9929-2009; ILK, HAKKI GOKHAN/AAA-1055-2021; Erdal,
   Esra/T-9057-2018; Akar, Nejat/H-2949-2019; ozturk, mehmet/G-3330-2014;
   OZTURK, MEHMET/AAS-7241-2021; Cetin-Atalay, Rengul/F-5780-2013; Öztürk,
   Mehmet/JFJ-3399-2023
OI YILDIZ, Gokhan/0000-0002-6714-3343; Ozturk, Nuri/0000-0001-5206-4127;
   ERGUL, AYCA ARSLAN/0000-0001-7024-907X; ERGUL, AYCA
   ARSLAN/0000-0001-7024-907X; Erdal, Esra/0000-0001-7264-0574; Ilk,
   Ozlem/0000-0002-4179-0534; Cetin-Atalay, Rengul/0000-0003-2408-6606;
   Sevgili, Hilal Özdağ/0000-0001-7940-2499; ILK, HAKKI
   GOKHAN/0000-0003-4365-8286; Erdal, Esra/0000-0001-7264-0574; OZTURK,
   MEHMET/0000-0002-6092-9706; Cetin-Atalay, Rengul/0000-0003-2408-6606;
   Yuzugullu, Haluk/0000-0002-1039-2998; Bagislar Bremang,
   Sevgi/0000-0003-3203-9607; Bilen, Biter/0000-0001-9452-3512; Ozen,
   Cigdem/0000-0001-8098-3454
FU TUBITAK [104S045, 106S151, 109S191, 111T558, BIDEB-2211, BIDEB-2214];
   State Planning Office (DPT-Kaniltek Project); EMBO fellowships; Turkish
   Academy of Sciences; Institut National de Cancer; La Ligue Nationale
   Contre le Cancer in France (Equipe labelisee)
FX This study was supported by grants from TUBITAK (104S045, 106S151,
   109S191, 111T558) with additional support from State Planning Office
   (DPT-Kaniltek Project), Turkish Academy of Sciences, Institut National
   de Cancer and La Ligue Nationale Contre le Cancer in France (Equipe
   labelisee). G.Y. was supported by TUBITAK (BIDEB-2211 and BIDEB-2214)
   and EMBO fellowships. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ADACHI S, 1991, HEPATOLOGY, V14, P776, DOI 10.1002/hep.1840140506
   Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021
   Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822
   Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016
   Brunt EM, 2007, LIVER INT, V27, P662, DOI 10.1111/j.1478-3231.2007.01470.x
   Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003
   Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173
   Caron C, 2010, ONCOGENE, V29, P5171, DOI 10.1038/onc.2010.259
   Chang YJE, 2000, J VIROL, V74, P4174, DOI 10.1128/JVI.74.9.4174-4182.2000
   Ciró M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131
   Clemente C, 2002, CANCER LETT, V178, P123, DOI 10.1016/S0304-3835(01)00843-6
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213
   FUJIWARA Y, 1993, CANCER RES, V53, P857
   Grimes A, 2009, CANCER RES TREAT, V41, P187, DOI 10.4143/crt.2009.41.4.187
   Gursoy-Yuzugullu O, 2011, LIVER INT, V31, P561, DOI 10.1111/j.1478-3231.2011.02474.x
   Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543
   Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259
   Kang SK, 2004, STEM CELLS, V22, P1356, DOI 10.1634/stemcells.2004-0023
   Kim JW, 2004, HEPATOLOGY, V39, P518, DOI 10.1002/hep.20053
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34
   Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014
   Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315
   Nam SW, 2005, HEPATOLOGY, V42, P809, DOI 10.1002/hep.20878
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103
   Paradis V, 2003, AM J PATHOL, V163, P733, DOI 10.1016/S0002-9440(10)63700-5
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271
   Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552
   Rudolph KL, 2009, GASTROENTEROLOGY, V137, P754, DOI 10.1053/j.gastro.2009.07.037
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023
   Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542
   Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299
   Urabe Y, 1996, LIVER, V16, P293
   Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622
   Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90
   Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100
   Zou JX, 2007, P NATL ACAD SCI USA, V104, P18067, DOI 10.1073/pnas.0705814104
NR 68
TC 49
Z9 55
U1 2
U2 33
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 15
PY 2013
VL 8
IS 5
AR e64016
DI 10.1371/journal.pone.0064016
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 145XK
UT WOS:000319052700071
PM 23691139
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Piccinin, E
   Arconzo, M
   Graziano, G
   Vacca, M
   Peres, C
   Bellafante, E
   Villani, G
   Moschetta, A
AF Piccinin, Elena
   Arconzo, Maria
   Graziano, Giusi
   Vacca, Michele
   Peres, Claudia
   Bellafante, Elena
   Villani, Gaetano
   Moschetta, Antonio
TI Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the Mouse
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE liver metabolism; liver diseases; coactivators; PGC-1; microRNA
ID ACTIVATED RECEPTOR-GAMMA; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC
   STEATOHEPATITIS; MITOCHONDRIAL BIOGENESIS; COACTIVATOR PGC-1-ALPHA;
   CIRCULATING MICRORNAS; INDUCIBLE COACTIVATOR; URSODEOXYCHOLIC ACID;
   TRANSCRIPTION FACTOR; CELLULAR SENESCENCE
AB The fine-tuning of liver metabolism is essential to maintain the whole-body homeostasis and to prevent the onset of diseases. The peroxisome proliferator-activated receptor-gamma coactivators (PGC-1s) are transcriptional key players of liver metabolism, able to regulate mitochondrial function, gluconeogenesis and lipid metabolism. Their activity is accurately modulated by post-translational modifications. Here, we showed that specific PGC-1s expression can lead to the upregulation of different microRNAs widely implicated in liver physiology and diseases development and progression, thus offering a new layer of complexity in the control of hepatic metabolism.
C1 [Piccinin, Elena; Moschetta, Antonio] Univ Bari Aldo Moro, Dept Interdisciplinary Med, Piazza Giulio Cesare 11, I-70124 Bari, Italy.
   [Arconzo, Maria; Graziano, Giusi; Peres, Claudia; Moschetta, Antonio] Natl Inst Biostuct & Biosyst, INBB, I-00136 Rome, Italy.
   [Vacca, Michele] Addenbrookes Hosp, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Box 289, Cambridge CB2 0QQ, England.
   [Bellafante, Elena] Fdn Mario Negri Sud, I-66030 Chieti, Italy.
   [Villani, Gaetano] Aldo Moro Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, I-70124 Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; University of Cambridge;
   Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's
   Hospital; Universita degli Studi di Bari Aldo Moro
RP Moschetta, A (corresponding author), Univ Bari Aldo Moro, Dept Interdisciplinary Med, Piazza Giulio Cesare 11, I-70124 Bari, Italy.; Moschetta, A (corresponding author), Natl Inst Biostuct & Biosyst, INBB, I-00136 Rome, Italy.
EM elena.piccinin@uniba.it; arconzomaria92@gmail.com;
   giusi.graziano78@gmail.com; mv400@medschl.cam.ac.uk;
   claudiaperes18@gmail.com; elenabellafante@gmail.com;
   gaetano.villani@uniba.it; antonio.moschetta@uniba.it
RI Piccinin, Elena/K-3795-2018; Moschetta, Antonio/AAC-5295-2022; Vacca,
   Michele/B-4736-2013; Moschetta, Antonio/K-6211-2016
OI Piccinin, Elena/0000-0002-6514-2689; Vacca, Michele/0000-0002-1973-224X;
   Moschetta, Antonio/0000-0003-2123-6074
FU Italian Association for Cancer Research (AIRC) [IG 18987]; MIUR
   [PRIN2017J3E2W2_002]; JPI-EU FATMAL, Interreg V-A Greece-Italy 2014-2020
   [MIS 5003627]
FX A. Moschetta is funded by the Italian Association for Cancer Research
   (AIRC, IG 18987), MIUR PRIN2017J3E2W2_002, JPI-EU FATMAL, Interreg V-A
   Greece-Italy 2014-2020 MIS 5003627.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x
   Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001
   Aoi W, 2010, AM J PHYSIOL-ENDOC M, V298, pE799, DOI 10.1152/ajpendo.00448.2009
   Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bellafante E, 2013, HEPATOLOGY, V57, P1343, DOI 10.1002/hep.26222
   Borgius LJ, 2002, J BIOL CHEM, V277, P49761, DOI 10.1074/jbc.M205641200
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109
   Castro RE, 2013, J HEPATOL, V58, P119, DOI 10.1016/j.jhep.2012.08.008
   Celikbilek M, 2014, WORLD J HEPATOL, V6, P613, DOI 10.4254/wjh.v6.i8.613
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen SY, 2017, FASEB J, V31, P1085, DOI 10.1096/fj.201601022R
   Chen W, 2017, GENE, V636, P87, DOI 10.1016/j.gene.2017.09.027
   Chen WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132734
   Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569
   Delic D, 2011, PARASITOL RES, V108, P1111, DOI 10.1007/s00436-010-2152-z
   Ding JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13729
   Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002
   Erener S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89656
   Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005
   Fang ZJ, 2016, INT J MOL MED, V38, P845, DOI 10.3892/ijmm.2016.2659
   Feng YY, 2014, CELL PHYSIOL BIOCHEM, V34, P1983, DOI 10.1159/000366394
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Fu T, 2014, MOL CELL BIOL, V34, P4130, DOI 10.1128/MCB.00596-14
   Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109
   Fujita H, 2015, EMBO J, V34, P1042, DOI 10.15252/embj.201489897
   Han HS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01878-6
   He SY, 2018, ARTIF CELL NANOMED B, V46, P217, DOI 10.1080/21691401.2018.1453830
   Heindryckx F, 2016, EMBO MOL MED, V8, P729, DOI 10.15252/emmm.201505925
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539
   Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614
   Iwagami Y, 2018, J CELL MOL MED, V22, P3987, DOI 10.1111/jcmm.13681
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jiang WW, 2015, J GASTROEN HEPATOL, V30, P933, DOI 10.1111/jgh.12878
   Jiang WW, 2015, LIVER INT, V35, P914, DOI 10.1111/liv.12674
   Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164
   Kirchmeyer M, 2018, J LEUKOCYTE BIOL, V104, P987, DOI 10.1002/JLB.MA1217-499RR
   Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200
   Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843
   Krützfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Latorre J, 2017, INT J OBESITY, V41, P620, DOI 10.1038/ijo.2017.21
   Lavery CA, 2016, OBESITY, V24, P1741, DOI 10.1002/oby.21561
   Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006
   Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013
   Li C, 2017, ONCOTARGET, V8, P28683, DOI 10.18632/oncotarget.15640
   Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013
   Li T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115577
   Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861
   Liang JC, 2013, J HEPATOL, V58, P535, DOI 10.1016/j.jhep.2012.10.024
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   Ma LA, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0262-0
   Ma W, 2017, EXP THER MED, V14, P2853, DOI 10.3892/etm.2017.4847
   Maniyadath B, 2019, CELL REP, V26, P2212, DOI 10.1016/j.celrep.2019.01.087
   Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200
   Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004
   Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9
   Mou TG, 2019, BIOMED PHARMACOTHER, V111, P891, DOI 10.1016/j.biopha.2018.12.121
   Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904
   Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80
   Piccinin E, 2019, NAT REV GASTRO HEPAT, V16, P160, DOI 10.1038/s41575-018-0089-3
   Piccinin E, 2018, HEPATOLOGY, V67, P884, DOI 10.1002/hep.29484
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100
   Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5
   Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101
   Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200
   Stanga Z, 2008, EUR J CLIN NUTR, V62, P687, DOI 10.1038/sj.ejcn.1602854
   Sun LY, 2014, J MOL CELL CARDIOL, V75, P1, DOI 10.1016/j.yjmcc.2014.06.012
   Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87
   Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005
   Tian XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158657
   Tinay I, 2018, PROSTATE, V78, P927, DOI 10.1002/pros.23650
   Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455
   Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06
   Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200
   Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632
   Wang XX, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4042509
   Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007
   Wei W, 2018, ONCOL LETT, V16, P6960, DOI 10.3892/ol.2018.9555
   Wen FY, 2018, INT J BIOCHEM CELL B, V94, P133, DOI 10.1016/j.biocel.2017.11.008
   Woollett LA, 2003, J LIPID RES, V44, P935, DOI 10.1194/jlr.M200478-JLR200
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xia SF, 2017, J ENDOCRINOL, V234, P201, DOI [10.1530/JOE-17-0044, 10.1530/joe-17-0044]
   Xu XS, 2015, ONCOTARGET, V6, P3988, DOI 10.18632/oncotarget.2905
   Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031
   Yan XL, 2017, CANCER RES, V77, P6704, DOI 10.1158/0008-5472.CAN-17-1915
   Ying XY, 2019, J CELL BIOCHEM, V120, P1620, DOI 10.1002/jcb.27461
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Yu J, 2019, BIOCHEM BIOPH RES CO, V512, P150, DOI 10.1016/j.bbrc.2019.03.054
   Zheng JJ, 2013, INT J MOL MED, V32, P17, DOI 10.3892/ijmm.2013.1356
   Zhuge BZ, 2017, BIOCHEM BIOPH RES CO, V494, P687, DOI 10.1016/j.bbrc.2017.10.149
NR 114
TC 2
Z9 2
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2019
VL 20
IS 22
AR 5735
DI 10.3390/ijms20225735
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA JW0YW
UT WOS:000502786800217
PM 31731670
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Thampy, KG
   Haas, MJ
   Mooradian, AD
AF Thampy, KG
   Haas, MJ
   Mooradian, AD
TI Age-related changes in rat hepatic acetyl-coenzyme A carboxylase
SO PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
ID LIPOGENIC ENZYMES; COA CARBOXYLASE; GENE-EXPRESSION; A CARBOXYLASE;
   LIVER; PURIFICATION; NUTRIENTS; FAT
AB Acetyl-CoA carboxylase (ACC) catalyzes the rate-limiting step in the synthesis of long-chain fatty acids. Since aging influences adiposity, we studied the activity of ACC and its mRNA content in livers of 4-, 12-, and 24-month-old male Fischer 344 rats. The mean (+/- SEM) activity of ACC (mU/mg protein) in liver homogenates from 4-month-old rats was 1.01 +/- 0.14. There was an 80% increase in activity (1.83 +/- 0.27) in 12-month-old rats (P < 0.01). However, there was significantly less activity (0.46 +/- 0.06) in livers of 24-month-old rats (P < 0.001). The total activity of ACC (per g liver) followed the same trend. The enzyme from all age groups was purified by avidin-affinity chromatography, The purified preparation migrated as a major protein band (M-r 262,000) on sodium dodecyl sulfate (SDS)-polyacrylamide gels. The specific activity of the purified preparation was 1.5, 1,8, and 1.8 U/mg for 4-, 12-, and 24-month-old rats, respectively. The alkali-labile phosphate content was 5.66 +/- 0.17, 5.64 +/- 0.21,and 6.21 +/- 0.35 mols P-l/mole subunit for 4-, 12-, and 24-month-old rats, respectively. These age-related differences were not significant. The hepatic ACC mRNA measured by ribonuclease protection assay when corrected for G3PDH mRNA was significantly reduced in 24-month-old rats (0.24 +/- 0.03) compared with 12-month-old (0.58 +/- 0.04) or 4-month-old rats (0.43 +/- 0.007) P< 0.01, In summary: (i) Aging in rats is associated with significant changes in ACC activity; (ii) the purified ACC preparations from the three age groups had similar specific activity and similar phosphate content; and (iii) the changes in ACC mRNA content of the liver paralleled the changes in total enzyme activity when 12-month-old rats were compared with 24-month-old rats whereas the increase in ACC activity in 12-month-old rats compared with 4-month-old rats could not be ascribed to changes in hepatic mRNA levels. These results indicate that the age-related changes in hepatic ACC occur at a post-translational level during early years of aging and at a pretranslational level at late states of senescence. These changes may contribute to the age-related alterations in body adiposity.
C1 St Louis Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA.
C3 Saint Louis University
RP Mooradian, AD (corresponding author), St Louis Univ, Div Endocrinol, 3691 Rutger,Suite 101, St Louis, MO 63110 USA.
RI Mooradian, Arshag/IAP-5640-2023
CR BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0
   BROWNSEY RW, 1987, ENZYMES B, V18, P123, DOI DOI 10.1016/S1874-6047(08)60256-5
   CHACONAS G, 1980, METHOD ENZYMOL, V65, P7588
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V132, P613
   GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448
   HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7
   KAISER FE, 1983, METABOLISM, V32, P838, DOI 10.1016/0026-0495(83)90116-6
   KATSURADA A, 1986, BIOCHIM BIOPHYS ACTA, V878, P200
   KIM KH, 1983, CURR TOP CELL REGUL, V22, P143
   Mooradian AD, 1999, MECH AGEING DEV, V108, P139, DOI 10.1016/S0047-6374(99)00007-X
   MOORADIAN AD, 1991, J ENDOCRINOL, V128, P79, DOI 10.1677/joe.0.1280079
   Mooradian AD., 1994, REHABILITATION AGING, P3
   Mott JW, 1999, AM J CLIN NUTR, V69, P1007
   PAPE ME, 1988, ARCH BIOCHEM BIOPHYS, V267, P104, DOI 10.1016/0003-9861(88)90013-6
   Schoeffner DJ, 1999, J TOXICOL ENV HEAL A, V56, P449, DOI 10.1080/009841099157917
   THAMPY KG, 1985, J BIOL CHEM, V260, P6318
   THAMPY KG, 1988, J BIOL CHEM, V263, P6447
   THAMPY KG, 1988, J BIOL CHEM, V263, P6454
   THAMPY KG, 1986, ADV PROTEIN PHOSPHAT, V3, P257
   WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 21
TC 1
Z9 1
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0037-9727
J9 P SOC EXP BIOL MED
JI Proc. Soc. Exp. Biol. Med.
PD NOV
PY 2000
VL 225
IS 2
BP 123
EP 127
DI 10.1046/j.1525-1373.2000.22515.x
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 368RW
UT WOS:000090132200003
PM 11044254
DA 2024-02-19
ER

PT J
AU Lee, HS
   Crane, GG
   Merok, JR
   Tunstead, JR
   Hatch, NL
   Panchalingam, K
   Powers, MJ
   Griffith, LG
   Sherley, JL
AF Lee, HS
   Crane, GG
   Merok, JR
   Tunstead, JR
   Hatch, NL
   Panchalingam, K
   Powers, MJ
   Griffith, LG
   Sherley, JL
TI Clonal expansion of adult rat hepatic stem cell lines by suppression of
   asymmetric cell kinetics (SACK)
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE adult stem cell; asymmetric cell kinetics; xanthosine; IMPDH; p53;
   hepatocyte; cholangiocyte; bile duct
ID PROGENITOR CELLS; LIVER; CULTURE; IDENTIFICATION; DEHYDROGENASE;
   HEPATOCYTES; EXPRESSION
AB Adult stem cells have potential use for several biomedical applications, including cell replacement therapy, gene therapy, and tissue engineering. However, such applications have been limited due to difficulties encountered in expanding functional adult stem cells. We have developed a new approach to the problem of adult stem cell expansion based on the suppression of asymmetric cell kinetics (SACK). We postulated that asymmetric cell kinetics, required for adult stem cell function, were a major barrier to their expansion in culture. As such, conversion of adult stem cells from asymmetric cell kinetics to symmetric cell kinetics would promote their exponential expansion and longterm propagation in culture. The purine nucleoside xanthosine (Xs), which promotes guanine ribonucleotide biosynthesis, can be used to reversibly convert cells from asymmetric cell kinetics to symmetric cell kinetics. We used Xs supplementation to derive clonal epithelial cell lines from adult rat liver that have properties of adult hepatic stem cells. The properties of two Xs-derived cell lines, Lig-8 and Lig-13, are described in detail and compared to properties of adult rat hepatic cell lines derived without Xs supplementation. The Xs-derived cell lines exhibit Xs-dependent asymmetric cell kinetics and Xs-dependent expression of mature hepatic differentiation markers. Interestingly, Lig-8 cells produce progeny with properties consistent with hepatocyte differentiation, while Lig-13 progeny cells have properties consistent with bile duct epithelium differentiation. A stable adult cholangiocyte stem cell line has not been previously described. Consistent with the principles of their derivation, the SACK-derived hepatic cell lines exhibit neither senescence nor tumorigenic properties, and their differentiation properties are stable after longterm culture. These characteristics of SACK-derived stem cell lines underscore asymmetric cell kinetics as an essential adult stem cell property with potential to be the basis for a general approach to expansion and propagation of diverse adult stem cells. (C) 2003 Wiley Periodicals, Inc.
C1 MIT, Biol Engn Div, Ctr Biotechnol Proc Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA.
C3 Massachusetts Institute of Technology (MIT); Massachusetts Institute of
   Technology (MIT)
RP Sherley, JL (corresponding author), MIT, Biol Engn Div, Ctr Biotechnol Proc Engn, 77 Massachusetts Ave,Bldg 16,Room 743B, Cambridge, MA 02139 USA.
RI griffith, linda/GWC-8754-2022
OI griffith, linda/0000-0002-1801-5548; LEE, HSUAN-SHU/0000-0002-8017-0434
CR ALPINI G, 1994, HEPATOLOGY, V20, P494, DOI 10.1002/hep.1840200231
   CLARKE J, 2002, BASIC CELL CULTURE, P290
   Coumoul X, 2001, CANCER RES, V61, P3942
   FARBER E, 1956, CANCER RES, V16, P142
   FAUSTO N, 1993, P SOC EXP BIOL MED, V204, P237
   Glimm H, 1999, BLOOD, V94, P2161, DOI 10.1182/blood.V94.7.2161.419k32_2161_2168
   Grisham J. W., 1997, P233, DOI 10.1016/B978-012563455-7/50009-X
   Grisham J W, 1995, Verh Dtsch Ges Pathol, V79, P47
   GRISHAM JW, 1993, P SOC EXP BIOL MED, V204, P270
   Grompe M, 2001, COLD SPRING HARBOR M, P455
   Haruna Y, 1996, HEPATOLOGY, V23, P476
   HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   JOPLIN R, 1994, GUT, V35, P875, DOI 10.1136/gut.35.7.875
   Liu Y, 1998, J CELL PHYSIOL, V177, P364, DOI 10.1002/(SICI)1097-4652(199811)177:2<364::AID-JCP18>3.0.CO;2-9
   Liu YA, 1998, MOL BIOL CELL, V9, P15, DOI 10.1091/mbc.9.1.15
   Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7
   McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186
   MEROK JR, 2001, J BIOMED BIOTECHNOL, V1, P24
   Michalopoulos GK, 1999, HEPATOLOGY, V29, P90, DOI 10.1002/hep.510290149
   Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103
   Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Plescia CP, 2001, DIFFERENTIATION, V68, P254, DOI 10.1046/j.1432-0436.2001.680413.x
   POTTEN CS, 1988, J CELL SCI, P45
   Powers MJ, 1997, BIOTECHNOL BIOENG, V53, P415, DOI 10.1002/(SICI)1097-0290(19970220)53:4<415::AID-BIT10>3.0.CO;2-F
   Rambhatla L, 2001, J BIOMED BIOTECHNOL, V1, P28, DOI DOI 10.1155/S1110724301000079
   Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900
   SHERLEY JL, 1991, J BIOL CHEM, V266, P24815
   Sherley JL, 2003, ACS SYM SER, V839, P59
   Sherley JL, 2002, STEM CELLS, V20, P561, DOI 10.1634/stemcells.20-6-561
   SHERLEY JL, 1995, CELL PROLIFERAT, V28, P137, DOI 10.1111/j.1365-2184.1995.tb00062.x
   SHERMAN G, 1995, EDUC LEADERSHIP, V53, P92
   SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139
   SIGLER SH, 1995, DIFFERENTIATION, V59, P35
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778
   Vogel G, 2001, SCIENCE, V292, P1820, DOI 10.1126/science.292.5523.1820
   YOUNG PR, 1986, MULTIDOMAIN PROTEINS, P55
   Zaret KS, 1996, ANNU REV PHYSIOL, V58, P231, DOI 10.1146/annurev.ph.58.030196.001311
NR 41
TC 51
Z9 68
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD SEP 30
PY 2003
VL 83
IS 7
BP 760
EP 771
DI 10.1002/bit.10727
PG 12
WC Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology
GA 712XC
UT WOS:000184823800002
PM 12889016
DA 2024-02-19
ER

PT J
AU Seo, AY
   Hofer, T
   Sung, B
   Judge, S
   Chung, HY
   Leeuwenburgh, C
AF Seo, Arnold Y.
   Hofer, Tim
   Sung, Bokyung
   Judge, Sharon
   Chung, Hae Y.
   Leeuwenburgh, Christiaan
TI Hepatic oxidative stress during aging: Effects of 8% long-term calorie
   restriction and lifelong exercise
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article
ID KAPPA-B ACTIVATION; C-REACTIVE PROTEIN; TRANSCRIPTION FACTOR; RAT-LIVER;
   LONGEVITY; RNA; AGE; DNA; 8-HYDROXY-2-DEOXYGUANOSINE; ANTIOXIDANTS
AB Hepatic aging may involve alterations in redox status, resulting in enhanced oxidant production and changes in specific signaling pathways that lead to a pro-inflammatory response. The authors investigated whether mild calorie restriction and long-term voluntary exercise could attenuate these changes. Four groups of male Fischer 344 rats were compared: young (6 mo), old (24 mo), old calorie restricted (8% CR, 24 mo) and old CR with daily voluntary wheel running (Exercise; 8% CR, 24 mo). Levels of endogenous reactive oxygen species (ROS), nitric oxide (NO-) and peroxynitrite (ONOO-) were significantly higher in the old ad libitum fed group compared to the young group. Sulfhydryl (-SH) content was significantly reduced and glutathione (GSH) content tended to be lower in the old animals. Old rats had significantly increased nuclear presence of NF-kappa B and in connection, increased levels of regulatory cytosolic phosphorylated I-kappa B alpha and decreased dephosphorylated I-kappa B alpha, suggesting an increased inflammatory response. Interestingly, a significant increase in liver RNA oxidation (8-oxo-7,8-dihydroguanosine) in the old ad libitum fed rats was detected and DNA oxidation (8-oxo-7,8-dihydro-2'-deoxyguanosine) tended to be increased. The age-associated increase in oxidative stress and upregulation of pro-inflammatory proteins was attenuated in the livers from both the CR and the exercise + CR groups.
C1 Univ Florida, Coll Med, Inst Aging, Dept Aging & Geriatr ResInst Aging,Biochem Aging, Gainesville, FL 32610 USA.
   Pusan Natl Univ, Coll Pharm, Aging Tissue Bank, Pusan 609735, South Korea.
C3 State University System of Florida; University of Florida; Pusan
   National University
RP Leeuwenburgh, C (corresponding author), Univ Florida, Coll Med, Inst Aging, Dept Aging & Geriatr ResInst Aging,Biochem Aging, 1329 SW 16th St,Room 5277, Gainesville, FL 32610 USA.
EM cleeuwen@aging.ufl.edu
RI Sung, Bokyung/AAX-5697-2021
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257
FU NIA NIH HHS [AG21042, R01-AG17994] Funding Source: Medline
CR Agrawal A, 2003, IMMUNOLOGY, V108, P539, DOI 10.1046/j.1365-2567.2003.01608.x
   ALI SF, 1992, NEUROTOXICOLOGY, V13, P637
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Caillaud C, 1999, FREE RADICAL BIO MED, V26, P1292, DOI 10.1016/S0891-5849(98)00342-6
   Carrillo R, 2002, NEUROCIRUGIA, V13, P37
   CATHCART R, 1984, METHOD ENZYMOL, V105, P352
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003
   Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   Finch CE, 1997, EXP NEUROL, V143, P82, DOI 10.1006/exnr.1996.6339
   Goto S, 2004, ANN NY ACAD SCI, V1019, P471, DOI 10.1196/annals.1297.085
   HABIB A, 1993, J BIOL CHEM, V268, P23448
   Han SS, 2001, CANCER LETT, V164, P119, DOI 10.1016/S0304-3835(01)00378-0
   Hayakawa H, 2002, BIOCHEMISTRY-US, V41, P12739, DOI 10.1021/bi0201872
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   HIGASHI T, 1998, TANPAKUSHITSU KAKUSA, V33, P1365
   Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014
   Hofer T, 2005, BIOL CHEM, V386, P333, DOI 10.1515/bc.2005.040
   Hofer T, 1998, CHEM RES TOXICOL, V11, P882, DOI 10.1021/tx980041x
   Holloszy JO, 1997, J APPL PHYSIOL, V82, P399, DOI 10.1152/jappl.1997.82.2.399
   HOLLOSZY JO, 1991, J APPL PHYSIOL, V70, P1529, DOI 10.1152/jappl.1991.70.4.1529
   HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826
   HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641
   HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868
   Judge S, 2005, AM J PHYSIOL-REG I, V289, pR1564, DOI 10.1152/ajpregu.00396.2005
   Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149
   Kalain R, 2006, J GERONTOL A-BIOL, V61, P211, DOI 10.1093/gerona/61.3.211
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9
   KOOY NW, 1994, FREE RADICAL BIO MED, V16, P149, DOI 10.1016/0891-5849(94)90138-4
   Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0
   LADEMARCO MF, 1992, J BIOL CHEM, V267, P16323
   Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433
   LEEUWENBURGH C, 1995, ARCH BIOCHEM BIOPHYS, V316, P941, DOI 10.1006/abbi.1995.1125
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   Merényi G, 1998, CHEM RES TOXICOL, V11, P243, DOI 10.1021/tx980026s
   Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4
   Nagata N, 1999, J BIOCHEM-TOKYO, V125, P658, DOI 10.1093/oxfordjournals.jbchem.a022333
   Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365
   Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje
   Phillips T, 2004, REJUV RES, V7, P243, DOI 10.1089/rej.2004.7.243
   Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167
   Radák Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   SHIGENAGA MK, 1991, FREE RADICAL BIO MED, V10, P211, DOI 10.1016/0891-5849(91)90078-H
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003
   Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009
   Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148
   WACKER WEC, 1959, J BIOL CHEM, V234, P3257
   Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   Zeeh J, 2001, ARCH GERONTOL GERIAT, V32, P255, DOI 10.1016/S0167-4943(01)00090-5
NR 60
TC 60
Z9 67
U1 0
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD MAR-APR
PY 2006
VL 8
IS 3-4
BP 529
EP 538
DI 10.1089/ars.2006.8.529
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 042OZ
UT WOS:000237539200027
PM 16677097
DA 2024-02-19
ER

PT J
AU Capel, F
   Rolland-Valognes, G
   Dacquet, C
   Brun, M
   Lonchampt, M
   Ktorza, A
   Lockhart, B
   Galizzi, JP
AF Capel, Frederic
   Rolland-Valognes, Gaelle
   Dacquet, Catherine
   Brun, Manuel
   Lonchampt, Michel
   Ktorza, Alain
   Lockhart, Brian
   Galizzi, Jean-Pierre
TI Analysis of Sterol-Regulatory Element-Binding Protein 1c Target Genes in
   Mouse Liver during Aging and High-Fat Diet
SO JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS
LA English
DT Article
DE Aging; Obesity; Liver; Gene expression
ID TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; ENZYME GENES; EXPRESSION;
   OBESITY; LIPIN; LIPOGENESIS; PREVALENCE; METABOLISM; INDUCTION
AB Background: The sterol regulatory element-binding protein (SREBP) 1c contributes to the transcriptional coordination of cholesterol, fatty acid, and carbohydrate metabolisms. Alterations in these processes accelerate the progression of hepatic steatosis and insulin resistance during aging and obesity. Methods: Using an ex vivo chromatin immunoprecipitation coupled to microarray (ChIP-on-chip) technique combined with genome-wide gene expression analysis, we analyzed the transcriptomic adaptations mediated by Srebp-1c binding to gene promoters in the liver of mice fed with a low-fat diet or a high-fat diet (HFD) for either 1 or 12 months. Results: Aging had a higher transcriptional impact than HFD and modified the expression of genes involved in fatty acid oxidation and oxidative stress. HFD was associated with a marked induction of genes involved in lipid and cholesterol metabolism. The prolonged high-fat feeding together with the aging effects stimulates inflammatory pathways. ChIP-on-chip applied to aging and HFD analyses revealed that the binding of SREBP-1c to a series of promoters accompanied a paralleled modification of gene expression. Therefore, SREBP-1c could play a role in aging and high-fat feeding through the regulation of genes involved in lipid metabolism and inflammatory response. Conclusions: This study represents an original ex vivo experiment to elucidate the molecular events involved in metabolic disorders. Copyright (C) 2013 S. Karger AG, Basel
C1 [Capel, Frederic; Rolland-Valognes, Gaelle; Lockhart, Brian; Galizzi, Jean-Pierre] Inst Rech Servier, Croissy Sur Seine, France.
   [Dacquet, Catherine; Brun, Manuel; Lonchampt, Michel; Ktorza, Alain] Inst Rech Servier, Suresnes, France.
C3 Servier; Institut de Recherches Internationales Servier; Servier;
   Institut de Recherches Internationales Servier
RP Capel, F (corresponding author), Human Nutr Res Ctr INRA Clermont Ferrand, Human Nutr Unit, BP 321,58 Rue Montalembert, FR-63009 Clermont Ferrand 1, France.
EM frederic.capel@clermont.inra.fr
RI Capel, Frederic/AAW-8838-2020
OI Capel, Frederic/0000-0002-0133-0277
FU European Union [LSHM-CT-2005-018734]
FX This work was supported in part by grants from the European Union
   [Integrated Project CRESCENDO (http://www.crescendoip.org), contract No.
   LSHM-CT-2005-018734]
CR Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162
   Canbay A, 2007, Z GASTROENTEROL, V45, P35, DOI 10.1055/s-2006-927368
   Capel F, 2011, J NUTRIGENET NUTRIGE, V4, P154, DOI 10.1159/000328190
   Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597
   Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737
   Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430
   Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951
   Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238
   Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008
   Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x
   Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377
   Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Nobili V, 2005, CLIN CHIM ACTA, V355, P105, DOI 10.1016/j.cccn.2004.12.022
   Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200
   Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002
   Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133
   Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014
   Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412
   Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004
   Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106
   Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832
   Smyth GK., 2004, Stat Appl Genet Mol Biol, V3, P1, DOI DOI 10.2202/1544-6115.1027
   Sommerfeld A, 2011, MOL CELL ENDOCRINOL, V332, P21, DOI 10.1016/j.mce.2010.11.020
   Team RDC, 2009, R LANG ENV STAT COMP
   Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221
   Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899
NR 36
TC 17
Z9 20
U1 1
U2 11
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-6499
EI 1661-6758
J9 J NUTRIGENET NUTRIGE
JI J. Nutrigenet. Nutrigenomics
PY 2013
VL 6
IS 2
BP 107
EP 122
DI 10.1159/000350751
PG 16
WC Genetics & Heredity; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Nutrition & Dietetics
GA 178RQ
UT WOS:000321465500006
PM 23774190
OA gold
DA 2024-02-19
ER

PT J
AU Kim, DH
   Ha, S
   Choi, YJ
   Dong, HH
   Yu, BP
   Chung, HY
AF Kim, Dae Hyun
   Ha, Sugyeong
   Choi, Yeon Ja
   Dong, H. Henry
   Yu, Byung Pal
   Chung, Hae Young
TI Altered FoxO1 and PPARγ interaction in age-related ER stress-induced
   hepatic steatosis
SO AGING-US
LA English
DT Article
DE aging process; FoxO1; PPAR gamma; ER stress; lipid accumulation
ID ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR FOXO1; ACTIVATED
   RECEPTOR-GAMMA; LEPTIN-DEFICIENT MICE; INSULIN-RESISTANCE; FATTY LIVER;
   MOLECULAR-MECHANISMS; INCREASED EXPRESSION; GENE-EXPRESSION; VLDL
   PRODUCTION
AB Decreased forkhead box O1 (FoxO1) activity induces hyperlipidemia and increased PPAR gamma, leading to hyperlipidemia in association with endoplasmic reticulum (ER) stress. In the liver, aging and comorbidities such as hyperlipidemia and diabetes significantly influence a wide variety of steatosis, but the underlying mechanisms are complex and remain elusive.
   To establish the modulatory role of FoxO1 and the functional consequences of its altered interaction with PPAR gamma, in the present study, we utilized a cell culture system, aged rats and diabetic db/db mice.
   We found that, under ER stress, FoxO1 induces PPAR gamma-mediated lipid accumulation in aged rat livers. Our data also showed that the FoxO1-induced hepatic lipid accumulation was negatively regulated by Akt signaling. PPAR gamma, a key lipogenesis transcription factor, was increased in aged liver, resulting in lipid accumulation via hepatic ER stress under hyperglycemic conditions. We further demonstrated that loss of FoxO1 causes a decline in PPAR gamma expression and reduces lipid accumulation. In addition, the interaction between FoxO1 and PPAR gamma was shown to induce hepatic steatosis in aging and db/db mice.
   We provide evidence that, in aged rats, FoxO1 interaction with PPAR gamma promotes hepatic steatosis, due to hyperglycemia-induced ER stress which causes an impairment in Akt signaling, such as aging-related diabetes.
C1 [Kim, Dae Hyun; Ha, Sugyeong; Chung, Hae Young] Pusan Natl Univ, Dept Pharm, Coll Pharm, Busan 46241, South Korea.
   [Choi, Yeon Ja] Dongguk Univ, Dept Biopharmaceut Engn, Div Chem & Biotechnol, Gyeongju 38066, South Korea.
   [Dong, H. Henry] Univ Pittsburgh, Dept Pediat, Childrens Hosp Pittsburgh, Sch Med,UPMC, Pittsburgh, PA 15224 USA.
   [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
C3 Pusan National University; Dongguk University; Pennsylvania Commonwealth
   System of Higher Education (PCSHE); University of Pittsburgh; University
   of Texas System; University of Texas Health Science Center at San
   Antonio
RP Chung, HY (corresponding author), Pusan Natl Univ, Dept Pharm, Coll Pharm, Busan 46241, South Korea.
EM hyjung@pusan.ac.kr
OI Dong, H. Henry/0000-0003-0279-5241
FU National Research Foundation of Korea (NRF) - Korea government (MSIT)
   [2018R1A2A3075425]; Basic Science Research Program through the NRF -
   Ministry of Education [NRF-2018R1A6A3A11046180]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIT) (2018R1A2A3075425).
   This research was also supported by the Basic Science Research Program
   through the NRF, funded by the Ministry of Education
   (NRF-2018R1A6A3A11046180).
CR Ables GP, 2012, PPAR RES, V2012, DOI 10.1155/2012/912351
   Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421
   Bose SK, 2014, J VIROL, V88, P4195, DOI 10.1128/JVI.03327-13
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646
   Cook JR, 2015, DIABETES, V64, P1951, DOI 10.2337/db14-1506
   Coudriet GM, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040085
   Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200
   Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408
   Guo Shaodong, 2013, Drug Discov Today Dis Mech, V10, pe27
   Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025
   Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JC132914, 10.1172/JCI32914]
   Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200
   Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6
   Kim DH, 2016, J AGR FOOD CHEM, V64, P6819, DOI 10.1021/acs.jafc.6b02644
   Kim DH, 2014, ENDOCRINOLOGY, V155, P1255, DOI 10.1210/en.2013-1856
   Kim OK, 2015, ANN NUTR METAB, V67, P218, DOI 10.1159/000440905
   Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797
   Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036
   Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004
   Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103
   Lee MY, 2012, EXP MOL MED, V44, P578, DOI 10.3858/emm.2012.44.10.066
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026
   Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003
   Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980
   Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595
   Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003
   Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132
   Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099
   Muoio DM, 2004, SCIENCE, V306, P425, DOI 10.1126/science.1104680
   Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001
   Navab M, 2008, CURR OPIN CLIN NUTR, V11, P459, DOI 10.1097/MCO.0b013e32830460c2
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Palomer X, 2014, INT J CARDIOL, V174, P110, DOI 10.1016/j.ijcard.2014.03.176
   Panici JA, 2010, FASEB J, V24, P5073, DOI 10.1096/fj.10-163253
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Polvani S, 2012, PPAR RES, V2012, DOI 10.1155/2012/641087
   Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Salminen A, 2010, AGEING RES REV, V9, P211, DOI 10.1016/j.arr.2010.04.003
   Salvadó L, 2015, TRENDS ENDOCRIN MET, V26, P438, DOI 10.1016/j.tem.2015.05.007
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Tereshina E V, 2009, Adv Gerontol, V22, P129
   Valenti L, 2008, DIABETES, V57, P1355, DOI 10.2337/db07-0714
   van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Wierzbicki M, 2009, J PHYSIOL PHARMACOL, V60, P99
   Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200
   Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112
NR 57
TC 9
Z9 10
U1 4
U2 22
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN 30
PY 2019
VL 11
IS 12
BP 4125
EP 4144
DI 10.18632/aging.102042
PG 20
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA IH0YT
UT WOS:000474219200019
PM 31246177
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT S
AU Xie, H
   Zhao, SL
   Liu, SF
AF Xie, Han
   Zhao, Shouliang
   Liu, Shangfeng
BE Wang, Z
TI Aging of Human Adult Stem Cells
SO AGING AND AGING-RELATED DISEASES: MECHANISMS AND INTERVENTIONS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Adult stem cells; Senescence; Organ aging; Regeneration
ID BONE-MARROW; EXTRACELLULAR-MATRIX; DIFFERENTIATION; SENESCENCE; DISEASE;
   STRESS; MARKER
AB With the continuous development of stem cell research in recent years, it is realized that stem cell aging may be the core issue of organ aging. As an important approach and main content of regenerative medicine, the stem cell research brings great hope to overcome difficult diseases and improve the quality of life for human beings and become the key to solve this issue. Based on this research, the varying characteristics of stem cells in aging could be recognized; the role of stem cells in the organ aging and regeneration will be revealed; the function of stem cells will be controllable and regulatable in tissues and organs; the stem cells from tissues and organs with rapid or slow cell renewal (e.g., liver and neuron) could be continuously observed from the levels of cellular molecules and dynamic complex. With the assistance of systematical research approaches, the function and mechanism studies can be conducted via multi-perspectives and levels during the different stages of organ aging and regeneration. All of the abovementioned requires great efforts to thoroughly understand the basic rule and the way of stem cell regulation in organ aging and regeneration. Final to the end, the dream of antiaging, efficient repair, and organ remodeling could be realized and also can meet the major needs of population health and disease treatment in our country, meaningfully to contribute benefits for the health of human beings.
C1 [Xie, Han; Zhao, Shouliang; Liu, Shangfeng] Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai, Peoples R China.
C3 Fudan University
RP Liu, SF (corresponding author), Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai, Peoples R China.
EM shangfengliufudan@163.com
CR De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010
   He S, 2008, J IMMUNOL, V181, P7581, DOI 10.4049/jimmunol.181.11.7581
   Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753
   Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651
   Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021
   Kim Mi Jung, 2008, Int J Stem Cells, V1, P55
   Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043
   Lebel M., 2011, CURR GERONTOL GERIAT, V2011, P1, DOI [DOI 10.1155/2011/859415, 10.1155/2011/859415]
   Li CY, 2009, J HEPATOL, V50, P1174, DOI 10.1016/j.jhep.2009.01.028
   Lin Y, 2013, NEURO-ONCOLOGY, V15, P1008, DOI 10.1093/neuonc/not042
   Massagué J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023
   Mavila N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050401
   Mayack SR, 2010, NATURE, V463, P495, DOI 10.1038/nature08749
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420
   Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Rubin J Peter, 2003, Aesthet Surg J, V23, P504, DOI 10.1016/j.asj.2003.09.001
   Singh SK, 2003, CANCER RES, V63, P5821
   Skowronska-Krawczyk D, 2015, MOL CELL, V59, P931, DOI 10.1016/j.molcel.2015.07.027
   Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459
   Swindell WR, 2009, MECH AGEING DEV, V130, P393, DOI 10.1016/j.mad.2009.03.004
   Wang FD, 2001, CELL RES, V11, P135, DOI 10.1038/sj.cr.7290078
   Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22
   Zhu LQ, 2006, J IMMUNOL, V177, P8226, DOI 10.4049/jimmunol.177.11.8226
NR 30
TC 1
Z9 1
U1 1
U2 5
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-13-1117-8; 978-981-13-1116-1
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1086
BP 105
EP 115
DI 10.1007/978-981-13-1117-8_7
D2 10.1007/978-981-13-1117-8
PG 11
WC Geriatrics & Gerontology; Medicine, Research & Experimental
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Research & Experimental Medicine
GA BL6LE
UT WOS:000454387000008
PM 30232755
DA 2024-02-19
ER

PT J
AU Boichuck, M
   Zorea, J
   Elkabets, M
   Wolfson, M
   Fraifeld, VE
AF Boichuck, Maria
   Zorea, Jonathan
   Elkabets, Moshe
   Wolfson, Marina
   Fraifeld, Vadim E.
TI c-Met as a new marker of cellular senescence
SO AGING-US
LA English
DT Article
DE cellular senescence; c-Met; Akt; Stat3; human dermal and pulmonary
   fibroblasts
ID HEPATOCYTE GROWTH-FACTOR; FIBROBLAST SENESCENCE; CANCER; EXPRESSION;
   REGULATOR; CELLS; CONTRIBUTES; FIBROSIS; PATHWAY; STRESS
AB Here, we reported for the first time an increased expression of c-Met protein in primary cultures of human dermal and pulmonary fibroblasts of late passages. This suggests that c-Met could serve as an early marker of cellular senescence (CS). The levels of c-Met-related signaling proteins phospho-Akt and Stat3 were also increased in (pre)senescent fibroblasts. Considering the anti-apoptotic activity of Akt and the involvement of Stat3 in mediating the effects of proinflammatory cytokines, the findings of this study indicate that c-Met could contribute through its downstream targets or partners to at least two major phenotypical features of CS - resistance to apoptosis and senescence-associated secretory phenotype.
C1 [Boichuck, Maria; Zorea, Jonathan; Elkabets, Moshe; Wolfson, Marina; Fraifeld, Vadim E.] Ben Gurion Univ Negev, Ctr Multidisciplinary Res Aging, Shraga Segal Dept Microbiol Immunol & Genet, IL-8410501 Beer Sheva, Israel.
C3 Ben Gurion University
RP Fraifeld, VE (corresponding author), Ben Gurion Univ Negev, Ctr Multidisciplinary Res Aging, Shraga Segal Dept Microbiol Immunol & Genet, IL-8410501 Beer Sheva, Israel.
EM vadim.fraifeld@gmail.com
OI Zorea, Jonathan/0000-0002-8602-8869; Boichuck, Maria/0000-0002-5444-0760
FU Fund in Memory of Dr. Amir Abramovich; Israel-America Foundation; Israel
   Science Foundation [ISF 700/16]; Concern Foundation [7895]
FX This study was supported by the Fund in Memory of Dr. Amir Abramovich
   (to VEF), the Israel-America Foundation (to VEF), the Israel Science
   Foundation (ISF 700/16; to ME) and the Concern Foundation (#7895; to
   ME).
CR Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592
   Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261
   Boissinot M, 2014, CANCERS, V6, P1631, DOI 10.3390/cancers6031631
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102
   Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950
   Davaapil H, 2017, DEVELOPMENT, V144, P106, DOI 10.1242/dev.138222
   de Magalhaes JP, 2018, MECH AGEING DEV, V170, P2, DOI 10.1016/j.mad.2017.07.001
   De Silva DM, 2017, BIOCHEM SOC T, V45, P855, DOI 10.1042/BST20160132
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Ersahin T, 2015, MOL BIOSYST, V11, P1946, DOI 10.1039/c5mb00101c
   Evangelou K, 2017, AGING CELL, V16, P192, DOI 10.1111/acel.12545
   Fathi N, 2018, INT J BIOL MACROMOL, V117, P993, DOI 10.1016/j.ijbiomac.2018.05.121
   Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205
   Giglio S, 2015, BIOMEDICINES, V3, P32, DOI 10.3390/biomedicines3010032
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182
   Hong S, 2018, ENVIRON TOXICOL PHAR, V59, P138, DOI 10.1016/j.etap.2018.03.014
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kandhaya-Pillai R, 2017, AGING-US, V9, P2411, DOI 10.18632/aging.101328
   Kawaguchi Y, 2002, J RHEUMATOL, V29, P1877
   Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639
   Kojima Hirotada, 2013, JAKSTAT, V2, pe25763, DOI 10.4161/jkst.25763
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lorda-Diez CI, 2015, AGING-US, V7, P974, DOI 10.18632/aging.100844
   Maroun CR, 2014, PHARMACOL THERAPEUT, V142, P316, DOI 10.1016/j.pharmthera.2013.12.014
   Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836
   Mikula-Pietrasik J, 2017, FREE RADICAL BIO MED, V110, P270, DOI 10.1016/j.freeradbiomed.2017.06.015
   Mikula-Pietrasik J, 2016, CELL ONCOL, V39, P473, DOI 10.1007/s13402-016-0289-1
   Miyazaki M, 1998, BIOCHEM BIOPH RES CO, V246, P255, DOI 10.1006/bbrc.1998.8593
   Mosteiro L, 2018, AGING CELL, V17, DOI 10.1111/acel.12711
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Qin ZP, 2017, J DERMATOL SCI, V88, P289, DOI 10.1016/j.jdermsci.2017.08.003
   Sagi Z, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00517
   Sagiv A, 2016, AGING-US, V8, P328, DOI 10.18632/aging.100897
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Tacutu R, 2011, AGING-US, V3, P1178, DOI 10.18632/aging.100413
   Tan P, 2016, MOL CELL BIOCHEM, V422, P1, DOI 10.1007/s11010-016-2796-9
   Tokunou M, 2001, AM J PATHOL, V158, P1451, DOI 10.1016/S0002-9440(10)64096-5
   Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Waters DW, 2018, AM J PHYSIOL-LUNG C, V315, pL162, DOI 10.1152/ajplung.00037.2018
   Weichhart T, 2018, GERONTOLOGY, V64, P127, DOI 10.1159/000484629
   Yanai H, 2018, AGEING RES REV, V41, P18, DOI 10.1016/j.arr.2017.10.004
   Yanai H, 2015, AGING-US, V7, P664, DOI 10.18632/aging.100807
   Yehuda S, 2017, BIOGERONTOLOGY, V18, P525, DOI 10.1007/s10522-017-9688-6
   Zhao XX, 2018, J EXP ZOOL PART B, V330, P406, DOI 10.1002/jez.b.22836
NR 52
TC 11
Z9 12
U1 2
U2 15
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD MAY 15
PY 2019
VL 11
IS 9
BP 2889
EP 2897
DI 10.18632/aging.101961
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HY7RE
UT WOS:000468332900025
PM 31085799
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Hua, YA
   Robinson, TJ
   Cao, YT
   Shi, GP
   Ren, J
   Nair, S
AF Hua, Yinan
   Robinson, Timothy J.
   Cao, Yongtao
   Shi, Guo-Ping
   Ren, Jun
   Nair, Sreejayan
TI Cathepsin K knockout alleviates aging-induced cardiac dysfunction
SO AGING CELL
LA English
DT Article
DE aging; apoptosis; cardiac remodeling; cathepsin K; cardiac function;
   cardiac hypertrophy
ID MEDIATED HEPATOCYTE APOPTOSIS; CONTRACTILE DYSFUNCTION; DIASTOLIC
   DYSFUNCTION; OXIDATIVE STRESS; POTENTIAL ROLE; CYTOCHROME-C; ACTIVATION;
   HEART; SENESCENCE; MITOCHONDRIA
AB Aging is a major risk factor for cardiovascular disease. It has previously been shown that protein levels of cathepsin K, a lysosomal cysteine protease, are elevated in the failing heart and that genetic ablation of cathepsin K protects against pressure overload-induced cardiac hypertrophy and contractile dysfunction. Here we test the hypothesis that cathepsin K knockout alleviates age-dependent decline in cardiac function. Cardiac geometry, contractile function, intracellular Ca2+ properties, and cardiomyocyte apoptosis were evaluated using echocardiography, fura-2 technique, immunohistochemistry, Western blot and TUNEL staining, respectively. Aged (24-month-old) mice exhibited significant cardiac remodeling (enlarged chamber size, wall thickness, myocyte cross-sectional area, and fibrosis), decreased cardiac contractility, prolonged relengthening along with compromised intracellular Ca2+ release compared to young (6-month-old) mice, which were attenuated in the cathepsin K knockout mice. Cellular markers of senescence, including cardiac lipofuscin, p21 and p16, were lower in the aged-cathepsin K knockout mice compared to their wild-type counterpart. Mechanistically, cathepsin K knockout mice attenuated an age-induced increase in cardiomyocyte apoptosis and nuclear translocation of mitochondrial apoptosis-inducing factor (AIF). In cultured H9c2 cells, doxorubicin stimulated premature senescence and apoptosis. Silencing of cathepsin K blocked the doxorubicin-induced translocation of AIF from the mitochondria to the nuclei. Collectively, these results suggest that cathepsin K knockout attenuates age-related decline in cardiac function via suppressing caspase-dependent and caspase-independent apoptosis.
C1 [Hua, Yinan; Ren, Jun; Nair, Sreejayan] Univ Wyoming, Coll Hlth Sci, Sch Pharm, Div Pharmaceut Sci, Laramie, WY 82071 USA.
   [Hua, Yinan; Ren, Jun; Nair, Sreejayan] Univ Wyoming, Coll Hlth Sci, Sch Pharm, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
   [Robinson, Timothy J.] Univ Wyoming, Coll Hlth Sci, WWAMI Med Educ, Laramie, WY 82071 USA.
   [Cao, Yongtao] Indiana Univ Penn, Dept Math, Indiana, PA 15705 USA.
   [Shi, Guo-Ping] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA.
C3 University of Wyoming; University of Wyoming; University of Wyoming;
   Pennsylvania State System of Higher Education (PASSHE); Indiana
   University of Pennsylvania; Harvard University; Harvard Medical School;
   Brigham & Women's Hospital
RP Nair, S (corresponding author), Univ Wyoming, Coll Hlth Sci, Sch Pharm, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
EM sreejay@uwyo.edu
RI Ren, Jun/ACG-5366-2022
OI Ren, Jun/0000-0002-0275-0783
FU National Center for Research Resources [P20RR016474]; National Institute
   of General Medical Sciences [P20GM103432]
FX This project was supported in part by grants from the National Center
   for Research Resources (P20RR016474) and the National Institute of
   General Medical Sciences (P20GM103432).
CR Al-Shamahi A, 2009, IDRUGS, V12, P799
   Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033
   Chen M, 2004, CARDIOVASC RES, V63, P682, DOI 10.1016/j.cardiores.2004.04.018
   Cheng XW, 2006, HYPERTENSION, V48, P979, DOI 10.1161/01.HYP.0000242331.99369.2f
   Cheng XW, 2012, CIRCULATION, V125, P1551, DOI 10.1161/CIRCULATIONAHA.111.066712
   Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130
   Funicello M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000683
   Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914
   Guicciardi ME, 2001, AM J PATHOL, V159, P2045, DOI 10.1016/S0002-9440(10)63056-8
   Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018
   Hua YA, 2013, HYPERTENSION, V61, P1184, DOI 10.1161/HYPERTENSIONAHA.111.00947
   Hua YN, 2013, DIABETES, V62, P498, DOI 10.2337/db12-0350
   Hua YN, 2011, BASIC RES CARDIOL, V106, P1173, DOI 10.1007/s00395-011-0222-8
   Ishisaka R, 1999, CELL STRUCT FUNCT, V24, P465, DOI 10.1247/csf.24.465
   Ishisaka R, 2001, J BIOCHEM-TOKYO, V129, P35, DOI 10.1093/oxfordjournals.jbchem.a002833
   Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lakatta EG, 1999, J AM GERIATR SOC, V47, P613, DOI 10.1111/j.1532-5415.1999.tb02579.x
   Liu MB, 2012, AGE, V34, P621, DOI 10.1007/s11357-011-9259-8
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   Naito AT, 2010, CIRC RES, V107, P1295, DOI 10.1161/CIRCRESAHA.110.223776
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001
   Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425
   Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018
   Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009
   Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8
   Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947
   Yang M, 2008, ARTERIOSCL THROM VAS, V28, P2202, DOI 10.1161/ATVBAHA.108.172320
   Yang XP, 2006, FASEB J, V20, P1024, DOI 10.1096/fj.05-5288fje
   Yang XP, 2005, ENDOCRINE, V26, P127, DOI 10.1385/ENDO:26:2:127
   Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013
   Xiao Y, 2006, J CLIN ENDOCR METAB, V91, P4520, DOI 10.1210/jc.2005-2486
   Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599
NR 33
TC 35
Z9 41
U1 3
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD JUN
PY 2015
VL 14
IS 3
BP 345
EP 351
DI 10.1111/acel.12276
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA CH0DN
UT WOS:000353689400005
PM 25692548
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU da Cunha, MDB
   Arruda, SF
AF Barreto da Cunha, Marcela de Sa
   Arruda, Sandra Fernandes
TI Tucum-do-Cerrado (<i>Bactris setosa</i> Mart.) May Promote Anti-Aging
   Effect by Upregulating SIRT1-Nrf2 Pathway and Attenuating Oxidative
   Stress and Inflammation
SO NUTRIENTS
LA English
DT Article
DE tucum-do-cerrado; phytochemicals; aging; sirtuins; Nrf2; oxidative
   stress; inflammation
ID LIFE-SPAN; IRON OVERLOAD; DIETARY RESVERATROL; ALL-CAUSE; KAPPA-B; MICE;
   AGE; MARKERS; LIVER; PHYTOCHEMICALS
AB Aging may be related to oxidative damage accumulation and a low-grade inflammation, both responses are modulated by iron and phytochemicals. This study investigated the effect of tucum-do-cerrado (Bactris setosa Mart.) consumption on the expression of sirtuins (SIRT 1 and 3) and senescence marker protein-30 (SMP30), and on the redox and inflammatory responses, in adult rats supplemented or not with dietary iron. Male Wistar rats were treated for 12 weeks with: control diet (CT); iron enriched-diet (+Fe); control diet + 15% tucum-do-cerrado (Tuc); or iron enriched-diet + 15% tucum-do-cerrado (Tuc + Fe). Iron supplementation (+Fe) increased liver, spleen and intestine iron levels, transferrin saturation, serum iron, serum TNF- and IL-6 levels, hepatic carbonyl content and and superoxide dismutase (SOD) activity, hepatic Nrf2 protein and Nqo1 mRNA levels and decreased the renal Sirt1 mRNA levels in relation to CT group. Tucum-do-cerrado consumption (Tuc) increased hepatic SOD activity, Nrf2 and SIRT1 mRNA and protein contents, and Nqo1 mRNA levels, while it decreased the renal SOD activity compared with the CT diet. The consumption of tucum-do-cerrado associated with the iron-enriched diet (Tuc + Fe) increased the iron levels in tissues and serum transferrin saturation, compared to the CT diet, while promoting a decrease in hepatic carbonyl and renal malondialdehyde levels, marginally reducing serum IL-6 levels, and increasing hepatic SIRT1 protein content, renal Sirt1 and hepatic Nrf2 mRNA levels, compared to the +Fe group. None of the treatments altered Smp30 mRNA levels. The results suggest that tucum-do-cerrado consumption might promote an anti-aging effect by increasing SIRT1 expression, which may enhance Nrf2 mRNA and protein levels and its downstream pathway, which in turn decrease oxidative damage to proteins and the levels of inflammatory cytokines (IL-6 and TNF-), induced by iron excess.
C1 [Barreto da Cunha, Marcela de Sa; Arruda, Sandra Fernandes] Univ Brasilia, Fac Hlth Sci, Postgrad Program Human Nutr, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.
   [Arruda, Sandra Fernandes] Univ Brasilia, Fac Hlth Sci, Dept Nutr, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.
C3 Universidade de Brasilia; Universidade de Brasilia
RP da Cunha, MDB (corresponding author), Univ Brasilia, Fac Hlth Sci, Postgrad Program Human Nutr, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.
EM desa.marcela@gmail.com; sandrafarruda@gmail.com
RI da Cunha, Marcela S B/F-6523-2014; Arruda, Sandra
   Fernandes/AAC-6778-2019; de Sá Barreto da Cunha, Marcela/JRX-8665-2023
OI da Cunha, Marcela S B/0000-0002-1388-033X; de Sá Barreto da Cunha,
   Marcela/0000-0002-1388-033X; Fernandes Arruda,
   Sandra/0000-0003-0774-8276
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Decanato de Pesquisa e Inovacao (DPI) of the University of Brasilia
FX We thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES) for the scholarship and the Decanato de Pesquisa e Inovacao
   (DPI) of the University of Brasilia for financial aid.
CR Ansari A, 2017, AGING CELL, V16, P4, DOI 10.1111/acel.12538
   Arruda LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061058
   Asseburg H, 2016, NEUROMOL MED, V18, P378, DOI 10.1007/s12017-016-8428-4
   Azevedo M. O., 2010, TECNICAS BASICAS EM
   BARANOWSKA I, 1995, SCI TOTAL ENVIRON, V159, P155, DOI 10.1016/0048-9697(95)04218-P
   Becerril-Ortega J, 2014, NEUROBIOL AGING, V35, P2288, DOI 10.1016/j.neurobiolaging.2014.04.019
   Boeing JS, 2017, FOOD CHEM, V220, P427, DOI 10.1016/j.foodchem.2016.09.188
   Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8
   Candan N, 2008, NEUROTOXICOLOGY, V29, P708, DOI 10.1016/j.neuro.2008.04.012
   Chaudhuri D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144280
   Das SK, 2016, LIVER INT, V36, P246, DOI 10.1111/liv.12893
   Del Bo C, 2015, FOOD FUNCT, V6, P2890, DOI 10.1039/c5fo00657k
   Doulias PT, 2008, FREE RADICAL RES, V42, P253, DOI 10.1080/10715760801911649
   Edrey YH, 2014, FREE RADICAL BIO MED, V71, P368, DOI 10.1016/j.freeradbiomed.2014.03.038
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Fustinoni-Reis AM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020038
   Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   Huang KP, 2015, MOL CELL ENDOCRINOL, V399, P178, DOI 10.1016/j.mce.2014.08.014
   Joseph SV, 2016, CRIT REV FOOD SCI, V56, P419, DOI 10.1080/10408398.2013.767221
   Jung KJ, 2015, J MOL MED, V93, P343, DOI 10.1007/s00109-014-1219-1
   Kawabata K, 2015, FOOD FUNCT, V6, P1399, DOI [10.1039/C4FO01178C, 10.1039/c4fo01178c]
   Kim YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132151
   Kondo Y, 2014, FEBS OPEN BIO, V4, P522, DOI 10.1016/j.fob.2014.05.003
   Li SQ, 2016, MOL MED REP, V13, P1833, DOI 10.3892/mmr.2015.4710
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Fernández-Real JM, 2014, LANCET DIABETES ENDO, V2, P513, DOI 10.1016/S2213-8587(13)70174-8
   McCord J. M., 2001, ANAL SUPEROXIDE DISM
   Monti D, 2017, MECH AGEING DEV, V165, P129, DOI 10.1016/j.mad.2016.12.008
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Oyebode O, 2014, J EPIDEMIOL COMMUN H, V68, P856, DOI 10.1136/jech-2013-203500
   Park SK, 2016, NUTR RES PRACT, V10, P3, DOI 10.4162/nrp.2016.10.1.3
   Piloni NE, 2016, BIOMETALS, V29, P119, DOI 10.1007/s10534-015-9902-4
   Porquet D, 2013, AGE, V35, P1851, DOI 10.1007/s11357-012-9489-4
   Qin S, 2016, MOL NUTR FOOD RES, V60, P1731, DOI 10.1002/mnfr.201501017
   Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Richert S, 2002, ARCH BIOCHEM BIOPHYS, V397, P430, DOI 10.1006/abbi.2001.2683
   Rosa FR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030110
   Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2
   Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0
   Schöttker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111
   Serra A, 2011, FOOD FUNCT, V2, P562, DOI 10.1039/c1fo10083a
   Si HW, 2014, J NUTR BIOCHEM, V25, P581, DOI 10.1016/j.jnutbio.2014.02.001
   Silva-Gomes S, 2014, J HEPATOL, V60, P354, DOI 10.1016/j.jhep.2013.09.004
   Stefanson AL, 2014, NUTRIENTS, V6, P3777, DOI 10.3390/nu6093777
   Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   WHO Global Health, 2017, GLOB HLTH AG WHAT AR
   Xu JZ, 2012, EXP GERONTOL, V47, P100, DOI 10.1016/j.exger.2011.10.011
   Yuan YJ, 2016, MECH AGEING DEV, V155, P10, DOI 10.1016/j.mad.2016.02.003
   Zhang Y, 2015, FOOD FUNCT, V6, P927, DOI [10.1039/c4fo01051e, 10.1039/C4FO01051E]
   Zhao L, 2015, J NUTR BIOCHEM, V26, P1174, DOI 10.1016/j.jnutbio.2015.05.009
NR 53
TC 35
Z9 35
U1 1
U2 8
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2017
VL 9
IS 11
AR 1243
DI 10.3390/nu9111243
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FO1TH
UT WOS:000416547200081
PM 29135935
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Liu, JL
   Reid, J
   Trochsler, M
   Leopardi, L
   Edwards, S
   Maddern, G
AF Liu, Jianliang
   Reid, Jessica
   Trochsler, Markus
   Leopardi, Lisa
   Edwards, Suzanne
   Maddern, Guy
TI Impact of Ageing on Hepatic Malignancy Resection: Is Age Really a Risk
   Factor for Mortality?
SO WORLD JOURNAL OF SURGERY
LA English
DT Article; Early Access
ID ATRIAL-FIBRILLATION; MAJOR HEPATECTOMY; LIVER RESECTION; SURGERY;
   DEFINITION; DELIRIUM; OUTCOMES
AB Background With an ageing population, it is paramount for surgeons to comprehend the implications of age on surgical outcomes. This study aims to identify the effects of age on perioperative outcomes post-hepatectomy. Methods Between 2001 and 2017, 357 hepatectomies were performed in our centre for malignancy. Data recorded include demographic, histopathology and perioperative outcomes. Patients were divided into three age groups (Group 1 < 65 years, Group 2 65-74 years, Group 3 >= 75 years). Results With increasing age, there was a trend towards patient having: ASA >= 3 (from 32.1% to 60.9%, p < 0.0001), clear margins (from 80.4% to 88.3%, p = 0.2256), days of hospitalisation (from 9.5 +/- 6.9 to 12 +/- 8.0, p = 0.0003), days of ICU admission (from 2.3 +/- 2.8 to 2.8 +/- 12.9, p = 0.0790) and morbidity (from 39% to 58.5%, p = 0.0073). Cardiovascular complications and postoperative delirium increase with age. There was no significant difference in mortality across the three groups. Univariate and bivariate binary logistic regressions found no association between mortality and age. When adjusted for age, 30- and 90-day mortality was significantly associated with Clavien-Dindo >= 3, length of hospital and cardiac complications. Additionally, 90-day mortality was significantly associated with ASA score >= 3, mass of liver resected, length of ICU stay and hepatobiliary, pulmonary and genitourinary complications. Conclusion Increased age is associated with increased post-hepatectomy complications, prolonged hospital stay and ICU admission. However, age itself is not a contraindication for hepatectomy and is not associated with increased mortality. Good histopathology outcomes and low mortality rates are achievable with careful patient selection and appropriate perioperative management.
C1 [Liu, Jianliang] Univ Adelaide, Fac Hlth & Med Sci, Med Sch, Adelaide, SA, Australia.
   [Reid, Jessica; Trochsler, Markus; Leopardi, Lisa] Univ Adelaide, Queen Elizabeth Hosp, Discipline Surg, Adelaide, SA, Australia.
   [Edwards, Suzanne] Univ Adelaide, Sch Publ Hlth, Adelaide Hlth Technol Assessment, Adelaide, SA, Australia.
   [Maddern, Guy] Univ Adelaide, Queen Elizabeth Hosp, Dept Surg, 28 Woodville Rd, Woodville, SA 5011, Australia.
C3 University of Adelaide; University of Adelaide; University of Adelaide;
   University of Adelaide
RP Maddern, G (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Surg, 28 Woodville Rd, Woodville, SA 5011, Australia.
EM guy.maddern@adelaide.edu.au
OI Liu, Jianliang/0000-0001-5520-2011
CR Alawami M, 2018, J SAUDI HEART ASSOC, V30, P40, DOI 10.1016/j.jsha.2017.03.008
   Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2
   De Blasi V, 2018, DIGEST SURG, V35, P333, DOI 10.1159/000486522
   Gupta AK, 2018, ANZ J SURG, V88, pE756, DOI 10.1111/ans.14475
   Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901
   Liu JL, 2019, ANZ J SURG, V89, P1144, DOI 10.1111/ans.15304
   Melloul E, 2012, WORLD J SURG, V36, P2161, DOI 10.1007/s00268-012-1621-1
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Mizuguchi T, 2015, SURG TODAY, V45, P259, DOI 10.1007/s00595-014-0863-y
   Neufeld KJ, 2013, J CLIN NEUROPHYSIOL, V30, P438, DOI 10.1097/WNP.0b013e3182a73e31
   Petrowsky H, 2005, WORLD J SURG, V29, P1093, DOI 10.1007/s00268-005-1130-6
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   Reddy SK, 2011, HPB, V13, P494, DOI 10.1111/j.1477-2574.2011.00330.x
   Royster RL, 2017, ANESTH ANALG, V125, P10, DOI 10.1213/ANE.0000000000002070
   Schiergens TS, 2014, J GASTROINTEST SURG, V18, P1161, DOI 10.1007/s11605-014-2516-2
   Schwartz SM, 2018, J THORAC CARDIOV SUR, V156, P762, DOI 10.1016/j.jtcvs.2018.04.111
   Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3
   United Nations DoEaSA Population Division, 2019, STESASERA423 UN DOEA, V423
   Vaporciyan AA, 2004, J THORAC CARDIOV SUR, V127, P779, DOI 10.1016/j.jtcvs.2003.07.011
   Verma A, 2018, J AM COLL CARDIOL, V71, P749, DOI 10.1016/j.jacc.2017.12.034
   Wei F, 2018, ANZ J SURG, V82, P1, DOI [10.1097/SLA.0000000000003116, DOI 10.1097/SLA.0000000000003116]
   Zenilman M E, 1998, Curr Probl Surg, V35, P99, DOI 10.1016/S0011-3840(98)80003-8
NR 22
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0364-2313
EI 1432-2323
J9 WORLD J SURG
JI World J.Surg.
PD 2021 MAR
PY 2021
VL 45
IS 3
BP 841
EP 848
DI 10.1007/s00268-020-05850-2
EA NOV 2020
PG 8
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA QA9BI
UT WOS:000585788500001
PM 33146783
DA 2024-02-19
ER

PT J
AU El Maï, M
   Bird, M
   Allouche, A
   Targen, S
   Serifoglu, N
   Lopes-Bastos, B
   Guigonis, JM
   Kang, D
   Pourcher, T
   Yue, JX
   Ferreira, MG
AF El Mai, Mounir
   Bird, Malia
   Allouche, Asma
   Targen, Seniye
   Serifoglu, Naz
   Lopes-Bastos, Bruno
   Guigonis, Jean-Marie
   Kang, Da
   Pourcher, Thierry
   Yue, Jia-Xing
   Ferreira, Miguel Godinho
TI Gut-specific telomerase expression counteracts systemic aging in
   telomerase-deficient zebrafish
SO NATURE AGING
LA English
DT Article; Early Access
ID MICROBIOTA COMPOSITION; CELLULAR SENESCENCE; STEM-CELLS; CANCER;
   DISEASE; MICE; STRESS; HEALTH; LIVER; LONG
AB Telomere shortening is a hallmark of aging and genetic telomerase deficiency causes premature aging phenotypes and reduces lifespan. Here the authors show that gut-specific telomerase expression is sufficient to rescue aging phenotypes and extend the lifespan of telomerase-deficient zebrafish, as well as ameliorate signs of aging in wild-type animals.
   Telomere shortening is a hallmark of aging and is counteracted by telomerase. As in humans, the zebrafish gut is one of the organs with the fastest rate of telomere decline, triggering early tissue dysfunction during normal zebrafish aging and in prematurely aged telomerase mutants. However, whether telomere-dependent aging of an individual organ, the gut, causes systemic aging is unknown. Here we show that tissue-specific telomerase expression in the gut can prevent telomere shortening and rescues premature aging of tert(-/-). Induction of telomerase rescues gut senescence and low cell proliferation, while restoring tissue integrity, inflammation and age-dependent microbiota dysbiosis. Averting gut aging causes systemic beneficial impacts, rescuing aging of distant organs such as reproductive and hematopoietic systems. Conclusively, we show that gut-specific telomerase expression extends the lifespan of tert(-/-) by 40%, while ameliorating natural aging. Our work demonstrates that gut-specific rescue of telomerase expression leading to telomere elongation is sufficient to systemically counteract aging in zebrafish.
C1 [El Mai, Mounir; Bird, Malia; Allouche, Asma; Targen, Seniye; Serifoglu, Naz; Lopes-Bastos, Bruno; Ferreira, Miguel Godinho] Univ Cote Dazur, Inst Res Canc & Aging Nice IRCAN, CNRS, INSERM U1081,UMR7284, Nice, France.
   [El Mai, Mounir; Ferreira, Miguel Godinho] Inst Gulbenkian Ciencias, Oeiras, Portugal.
   [Guigonis, Jean-Marie; Pourcher, Thierry] Univ Cote Dazur, Inst Sci Vivant Freder Joliot, Lab Transporter Imaging & Radiotherapy Oncol, Commissariat Energie Atom & Energies Alternat, Nice, France.
   [Kang, Da; Yue, Jia-Xing] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China.
C3 Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Cote d'Azur; Instituto
   Gulbenkian de Ciencia; Universite Cote d'Azur; CEA; State Key Lab
   Oncology South China; Sun Yat Sen University
RP Ferreira, MG (corresponding author), Univ Cote Dazur, Inst Res Canc & Aging Nice IRCAN, CNRS, INSERM U1081,UMR7284, Nice, France.; Ferreira, MG (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.
EM Miguel-Godinho.FERREIRA@unice.fr
RI Godinho Ferreira, Miguel/F-9290-2012; Lopes Bastos, Bruno
   Miguel/AAV-9371-2021; Yue, Jia-Xing/H-5592-2019
OI Godinho Ferreira, Miguel/0000-0002-8363-7183; Lopes Bastos, Bruno
   Miguel/0000-0002-0517-9455; Yue, Jia-Xing/0000-0002-2122-9221; Bird,
   Malia/0000-0001-8871-155X
FU Fondation ARC pour la Recherche sur le Cancer [PJA20161205137];
   Fondation pour la Recherche Medicale [EQU201903007804]; Ville de Nice;
   Howard Hughes Medical Institute International Early Career Scientist
   grant [LISBOA-010145-FEDER-022170]; Fonds Europeen de Developpement
   Regional, Region Provence Alpes-Cote d'Azur; Conseil Departemental 06,
   Instituts Thematiques Multiorganismes Cancer Aviesan (plan cancer);
   Canceropole Provence Alpes-Cote d'Azur, Gis Ibisa, Centre National de la
   Recherche Scientifique
FX We thank members from the telomeres and genome stability and the
   telomere shortening and cancer laboratories for fruitful discussions. We
   thank F. Graslin for processing the metabolomics samples. We thank E.
   Lazzerini Denchi (National Institutes of Health/National Cancer
   Institute), L. Saude (Instituto de Medicina Molecula), D. Vallenzano
   (Friedrich-Loeffler-Institute) and A. R. Araujo (Institut de
   Pharmacologie Moleculaire et Cellulaire) for critically reading our
   manuscript. This work was supported by the Fondation ARC pour la
   Recherche sur le Cancer (PJA20161205137) and the Fondation pour la
   Recherche Medicale (EQU201903007804). M.E.M. was supported by a
   postdoctoral fellowship from the Ville de Nice. This work was also
   supported by the Universite Cpte d'Azur-Academie 4 (installation grant:
   Action 2-2019) and the Howard Hughes Medical Institute International
   Early Career Scientist grant awarded to M.G.F. We thank the Instituto
   Gulbenkian de Ciencia (IGC) histology unit, IGC imaging unit and the IGC
   Fish Facility for assistance with experimental planning, sample
   processing, data collection and excellent animal care. The IGC Fish
   Facility is financed by Congento LISBOA-01-0145-FEDER-022170 and
   cofinanced by Fundacao para a Ciencia e a Tecnologia and Lisboa2020,
   under the PORTUGAL2020 agreement (European Regional Development Fund).
   The work was also performed using the PEMAV fish facility, imaging core
   facility (PICMI) and the Genomics facilities at the Institute for
   Research on Cancer and Aging supported by the Fonds Europeen de
   Developpement Regional, Region Provence Alpes-Cpte d'Azur, Conseil
   Departemental 06, Instituts Thematiques Multiorganismes Cancer Aviesan
   (plan cancer), Canceropole Provence Alpes-Cpte d'Azur, Gis Ibisa, Centre
   National de la Recherche Scientifique and Institut National de la Sante
   et de la Recherche Medicale. The funders had no role in study design,
   data collection and analysis, decision to publish or preparation of the
   manuscript.
CR Anchelin M, 2013, DIS MODEL MECH, V6, P1101, DOI 10.1242/dmm.011635
   Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bárcena C, 2018, CELL REP, V24, P2392, DOI 10.1016/j.celrep.2018.07.089
   Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Blackburn E. H., 2002, ENCY LIFE SCI, P323
   Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8
   Carneiro MC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005798
   Chakravarti D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18420-w
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004
   Demanelis K, 2020, SCIENCE, V369, P1333, DOI 10.1126/science.aaz6876
   El Mai M, 2020, ELIFE, V9, DOI 10.7554/eLife.54935
   Ellis PS, 2022, IMMUN AGEING, V19, DOI 10.1186/s12979-022-00287-8
   Esteves A, 2016, J LIPID RES, V57, P219, DOI 10.1194/jlr.M062232
   Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9
   Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213
   Funk MC, 2020, EMBO REP, V21, DOI 10.15252/embr.202050047
   Glousker G, 2015, BRIT J HAEMATOL, V170, P457, DOI 10.1111/bjh.13442
   González-Suárez E, 2005, ONCOGENE, V24, P2256, DOI 10.1038/sj.onc.1208413
   González-Suárez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619
   Gregorieff A, 2015, NATURE, V526, P715, DOI 10.1038/nature15382
   Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214
   Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Hiippala K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01706
   Huang YT, 2019, ZOONOSES PUBLIC HLTH, V66, P679, DOI 10.1111/zph.12580
   Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520
   Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364
   Jonassaint NL, 2013, AGING CELL, V12, P319, DOI 10.1111/acel.12041
   Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042
   Kenny HA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7220
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kinouchi Y, 1998, J GASTROENTEROL, V33, P343, DOI 10.1007/s005350050094
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Kitada M, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9020130
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma YC, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008766
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345
   Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027076
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Okumura S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25965-x
   Opresko PL, 2017, AGEING RES REV, V33, P52, DOI 10.1016/j.arr.2016.05.009
   Ostrakhovitch EA, 2019, AGEING RES REV, V49, P144, DOI 10.1016/j.arr.2018.10.010
   Paramos-de-Carvalho D, 2021, ELIFE, V10, DOI 10.7554/eLife.72449
   Raju P, 2020, J CLIN INVEST, V130, P5197, DOI 10.1172/JCI138697
   Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Saitoh S, 2002, CLIN DIAGN LAB IMMUN, V9, P54, DOI 10.1128/CDLI.9.1.54-59.2002
   Ségal-Bendirdjian E, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00332
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Smith P, 2017, ELIFE, V6, DOI 10.7554/eLife.27014
   Srivastava S, 2019, METABOLITES, V9, DOI 10.3390/metabo9120301
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Teo YV, 2019, CELL REP, V27, P997, DOI 10.1016/j.celrep.2019.03.104
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Thongon N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27206-7
   Townsley DM, 2014, BLOOD, V124, P2775, DOI 10.1182/blood-2014-05-526285
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yui J, 1998, BLOOD, V91, P3255, DOI 10.1182/blood.V91.9.3255.3255_3255_3262
NR 71
TC 5
Z9 5
U1 13
U2 19
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD 2023 MAY
PY 2023
VL 3
IS 5
BP 567
EP +
DI 10.1038/s43587-023-00401-5
EA MAY 2023
PG 30
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA G3RB9
UT WOS:000981376000003
PM 37142828
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Haga, S
   Morita, N
   Irani, K
   Fujiyoshi, M
   Ogino, T
   Ozawa, T
   Ozaki, M
AF Haga, Sanae
   Morita, Naoki
   Irani, Kaikobad
   Fujiyoshi, Masato
   Ogino, Tetsuya
   Ozawa, Takeaki
   Ozaki, Michitaka
TI p66<SUP>Shc</SUP> has a pivotal function in impaired liver regeneration
   in aged mice by a redox-dependent mechanism
SO LABORATORY INVESTIGATION
LA English
DT Article
DE Akt; apoptosis; caspase-3; in vivo imaging; oxidative stress; p66(Shc)
ID FLUORESCENT PROTEIN INDICATORS; OXIDATIVE STRESS; HEPATIC RESECTION;
   FAILURE; P66SHC; GENETICS; MAMMALS; KINASE; INJURY; SHC
AB Liver regeneration involves complicated processes and is affected by various patho-physiological conditions. This study was designed to examine the molecular mechanisms underlying the aging-associated impairment of liver regeneration. Male C57BL/6J mice were used as young and aged mice (<10 weeks and >20 months old, respectively). These mice were subjected to 70% partial hepatectomy (PH). Liver regeneration and liver injury/stresses were evaluated chronologically after PH. Post-hepatectomy liver regeneration was markedly impaired in aged mice. Though the extent of hepatocyte proliferation in the regenerating liver was similar in aged and young mice, cell growth was absent in aged mice. Oxidative stress (OS) was observed immediately after hepatectomy, followed by marked apoptosis in aged mice. Signaling molecules regarding cell proliferation (mitogen-activated protein kinase, STAT3, p46/52(Shc)) and anti-oxidation (catalase, superoxide dismutase, Ref-1, glutathione peroxidase) were expressed/activated after hepatectomy in livers of both aged and young mice. Akt was not activated in aged-mouse liver, but its expression was similar to that in young mice. p66(Shc), known as an age-/oxidant-associated protein, was strongly phosphorylated. By knocking down p66(Shc), the impairment of liver regeneration was normalized. OS immediately after hepatectomy induced subsequent liver injury (apoptosis), and deletion of p66(Shc) suppressed both OS and hepatocyte apoptosis in the regenerating liver of aged mice. Though we need additional data in other animal models to fully understand the mechanism, p66(Shc) may have a pivotal function in the impairment of liver regeneration in aged mice by triggering OS and subsequent apoptosis. This data may provide a clue to understanding the mechanism underlying the association between aging and the impairment of liver regeneration. Laboratory Investigation (2010) 90, 1718-1726; doi:10.1038/labinvest.2010.119; published online 21 June 2010
C1 [Ozaki, Michitaka] Hokkaido Univ, Sch Med, Dept Mol Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Haga, Sanae] JSPS, Tokyo, Japan.
   [Morita, Naoki] Natl Inst Adv Ind Sci & Technol, Res Inst Genome Based Biofactory, Sapporo, Hokkaido, Japan.
   [Irani, Kaikobad] Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Pittsburgh, PA 15260 USA.
   [Ogino, Tetsuya] Okayama Univ, Dept Pathol & Expt Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.
   [Ozawa, Takeaki] Univ Tokyo, Dept Chem, Sch Sci, Tokyo 113, Japan.
C3 Hokkaido University; Japan Society for the Promotion of Science;
   National Institute of Advanced Industrial Science & Technology (AIST);
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Okayama University; University of Tokyo
RP Ozaki, M (corresponding author), Hokkaido Univ, Sch Med, Dept Mol Surg, Kita Ku, N-15,W-7, Sapporo, Hokkaido 0608638, Japan.
EM mozaki@m07.itscom.net
RI Ozaki, Michitaka/A-4549-2012; OGINO, Tetsuya/B-1999-2011; Morita,
   Naoki/M-6399-2018
OI Morita, Naoki/0000-0002-5758-4014; Irani, Kaikobad/0000-0001-9194-7387
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   [17659396, 19659317, 20249060]; JSPS; Grants-in-Aid for Scientific
   Research [17659396, 19659317, 20249060] Funding Source: KAKEN
FX We thank Ms R Igarashi for the excellent technical support. This work
   was supported by a Grant-in-Aid for Scientific Research from the
   Ministry of Education, Culture, Sports, Science, and Technology of Japan
   (#17659396, 19659317, and 20249060 to MO) and JSPS grant for Young
   Scientists (SH).
CR Aldrighetti L, 2006, J SURG ONCOL, V93, P186, DOI 10.1002/jso.20342
   Aldrighetti L, 2003, WORLD J SURG, V27, P1149, DOI 10.1007/s00268-003-7072-y
   Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200
   Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5
   Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117
   Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200
   Fausto N, 2001, LIVER TRANSPLANT, V7, P835, DOI 10.1053/jlts.2001.27865
   Haga S, 2005, J HEPATOL, V43, P799, DOI 10.1016/j.jhep.2005.03.027
   Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018
   Haga S, 2009, ANTIOXID REDOX SIGN, V11, P2563, DOI [10.1089/ars.2009.2681, 10.1089/ARS.2009.2681]
   Haga S, 2009, HEPATOLOGY, V49, P204, DOI 10.1002/hep.22583
   Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200
   Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538
   Kellersmann R, 2002, LIVER, V22, P56, DOI 10.1034/j.1600-0676.2002.00011.x
   Kountouras J, 2001, HEPATO-GASTROENTEROL, V48, P556
   Lu YB, 2001, J EXP MED, V193, P545, DOI 10.1084/jem.193.4.545
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004
   Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172
   Pellegrini M, 2005, APOPTOSIS, V10, P13, DOI 10.1007/s10495-005-6057-8
   Petrowsky H, 2005, WORLD J SURG, V29, P1093, DOI 10.1007/s00268-005-1130-6
   Purdom S, 2003, BIOGERONTOLOGY, V4, P181, DOI 10.1023/A:1025123413403
   Purdom S, 2003, TRENDS MOL MED, V9, P206, DOI 10.1016/S1471-4914(03)00048-0
   Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Shirabe K, 1999, J AM COLL SURGEONS, V188, P304, DOI 10.1016/S1072-7515(98)00301-9
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Topal B, 2003, EUR J SURG ONCOL, V29, P248, DOI 10.1053/ejso.2002.1421
   Wu YL, 2004, WORLD J GASTROENTERO, V10, P1995
   Yamamori T, 2005, J MOL CELL CARDIOL, V39, P992, DOI 10.1016/j.yjmcc.2005.09.003
   Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F
NR 33
TC 31
Z9 33
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD DEC
PY 2010
VL 90
IS 12
BP 1718
EP 1726
DI 10.1038/labinvest.2010.119
PG 9
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 687CK
UT WOS:000284751600003
PM 20567235
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Kovacovicova, K
   Skolnaja, M
   Heinmaa, M
   Mistrik, M
   Pata, P
   Pata, I
   Bartek, J
   Vinciguerra, M
AF Kovacovicova, Kristina
   Skolnaja, Marianna
   Heinmaa, Mihkel
   Mistrik, Martin
   Pata, Pille
   Pata, Illar
   Bartek, Jiri
   Vinciguerra, Manlio
TI Senolytic Cocktail Dasatinib+Quercetin (D+Q) Does Not Enhance the
   Efficacy of Senescence-Inducing Chemotherapy in Liver Cancer
SO FRONTIERS IN ONCOLOGY
LA English
DT Article
DE NAFLD (non-alcoholic fatty liver disease); HCC (hepatocellular
   carcinoma); senolytic agents; quercertin; dasatinib
ID HEPATOCELLULAR-CARCINOMA; CELLULAR SENESCENCE; DOWN-REGULATION; PTEN;
   DOXORUBICIN; SORAFENIB; STEATOSIS; HCC
AB Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, which develops in the context of fibrosis and cirrhosis caused by chronic inflammation, in turn due to non-alcoholic fatty liver disease (NAFLD), alcohol consumption and/or hepatitis viral infection. An increased number of senescent cells are associated with age-related tissue degeneration during NAFLD-induced HCC, or during chemotherapeutic treatment. Senolytic agents target selectively senescent cells. A combination of the senolytic drugs dasatinib and quercetin (D + Q) reduced hepatic lipid accumulation and alleviated age-associated physical dysfunction in mice. However, whether D + Q can impact the treatment of HCC, at the end-stage of the NAFLD inflammatory spectrum, is unknown. Here, using two well-established HCC cell lines (HepG2, Huh-7), we demonstrate that the maximal cytostatic doses for D and/or Q (1 + 1 mu M) lacked efficacy in removing doxorubicin-induced beta-gal-positive senescent cells. Moreover, D + Q did not affect doxorubicin-dependent induction of flattened morphology, activation of p16, expression of SASP-associated genes or formation of gamma H2AX foci. We then investigated the antitumor efficacy of doxorubicin, D + Q, or the combination, in xenograft studies conducted with HCC cells inoculated in athymic nude mice. Doxorubicin reduced tumor growth by 30% compared to control mice, while D + Q was ineffective in synergizing with doxorubicin and in clearing doxorubicin-induced HCC senescent cells. Unexpectedly, D + Q alone appeared to have acute pro-tumorigenic effects in control mice. While our data need to be confirmed in animal models that fully recapitulate NAFLD, we demonstrate that these compounds are ineffective, alone or in synergy with senescence-inducing chemotherapy, against experimental HCC.
C1 [Kovacovicova, Kristina; Vinciguerra, Manlio] Int Clin Res Ctr FNUSA ICRC, Brno, Czech Republic.
   [Skolnaja, Marianna; Heinmaa, Mihkel; Pata, Pille] Tallinn Univ Technol, Dept Chem & Biotechnol, Tallinn, Estonia.
   [Skolnaja, Marianna; Pata, Pille; Pata, Illar] IVEX Lab, Tallinn, Estonia.
   [Mistrik, Martin; Bartek, Jiri] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic.
   [Bartek, Jiri] Danish Canc Soc Res Ctr, Genome Integr Unit, Copenhagen, Denmark.
   [Bartek, Jiri] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, Solna, Sweden.
   [Vinciguerra, Manlio] UCL, Inst Liver & Digest Hlth, Div Med, London, England.
C3 St Anne's University Hospital Brno (FNUSA-ICRC); Tallinn University of
   Technology; Palacky University Olomouc; Danish Cancer Society;
   Karolinska Institutet; University of London; University College London
RP Vinciguerra, M (corresponding author), Int Clin Res Ctr FNUSA ICRC, Brno, Czech Republic.; Vinciguerra, M (corresponding author), UCL, Inst Liver & Digest Hlth, Div Med, London, England.
EM manlio.vinciguerra@fnusa.cz
RI Pata, Illar/HLH-7992-2023; Vinciguerra, Manlio/N-1309-2015; Bartek,
   Jiri/G-5870-2014; Kovacovicova, Kristina/C-4964-2019
OI Vinciguerra, Manlio/0000-0002-1768-3894; Pata,
   Pille/0000-0002-4761-139X; Mistrik, Martin/0000-0002-2321-0348
FU European Social Fund; European Regional Development Fund-Project MAGNET
   [CZ.02.1.01/0.0/0.0/15_003/0000492]
FX Our work is supported by the European Social Fund and European Regional
   Development Fund-Project MAGNET (No. CZ.02.1.01/0.0/0.0/15_003/0000492).
CR Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Borghesan M, 2016, CANCER RES, V76, P594, DOI 10.1158/0008-5472.CAN-15-1336
   Choi J, 2008, J SURG RES, V150, P219, DOI 10.1016/j.jss.2008.01.029
   Enos RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167979
   Eren MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124837
   Gores GJ, 2014, NAT REV GASTRO HEPAT, V11, P645, DOI 10.1038/nrgastro.2014.157
   Jueliger S, 2016, EPIGENETICS-US, V11, P709, DOI 10.1080/15592294.2016.1214781
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Llovet JM, 2018, NAT REV CLIN ONCOL, V15, P599, DOI 10.1038/s41571-018-0073-4
   Lo Re O, 2018, HEPATOLOGY, V67, P636, DOI 10.1002/hep.29519
   Loaiza N, 2016, BBA-REV CANCER, V1865, P155, DOI 10.1016/j.bbcan.2016.01.007
   Luker KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep10332
   Noppe G, 2009, CYTOM PART A, V75A, P910, DOI 10.1002/cyto.a.20796
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Podrini C, 2015, FASEB J, V29, P1676, DOI 10.1096/fj.14-262717
   Rappa F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054458
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010
   Vinciguerra M, 2009, J HEPATOL, V50, P1132, DOI 10.1016/j.jhep.2009.01.027
   Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737
   Weiland T, 2014, INT J CANCER, V134, P235, DOI 10.1002/ijc.28350
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yang JD, 2017, CANCER-AM CANCER SOC, V123, P81, DOI 10.1002/cncr.30246
   Zhang XF, 2012, INT J MOL SCI, V13, P5866, DOI 10.3390/ijms13055866
NR 25
TC 59
Z9 60
U1 2
U2 20
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2234-943X
J9 FRONT ONCOL
JI Front. Oncol.
PD OCT 30
PY 2018
VL 8
AR 459
DI 10.3389/fonc.2018.00459
PG 7
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA GY6CZ
UT WOS:000448674200001
PM 30425964
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhu, RY
   Ouyang, YZ
   Chen, YH
   Zhang, LZ
   Nie, JP
   Farag, MA
   Capanoglu, E
   Zhao, C
AF Zhu, Ruiyu
   Ouyang, Yuezhen
   Chen, Yihan
   Zhang, Lizhu
   Nie, Jianping
   Farag, Mohamed A.
   Capanoglu, Esra
   Zhao, Chao
TI The therapeutic potential for senescence-associated diabetes of green
   alga Enteromorpha prolifera polysaccharide
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Green alga; Enteromorpha prolifera polysaccharides; Type 2 diabetes
   mellitus; Ageing; Gut microbiota
ID STRUCTURAL-CHARACTERIZATION; GRIFOLA-FRONDOSA; GUT MICROBIOTA;
   HETEROPOLYSACCHARIDE; ANTIOXIDANT
AB DEAE-52 and Sephadex G-100 columns were used to isolate Enteromorpha prolifera polysaccharide (EPP), which contains alpha-L-Rhap-(1 -> 4)-alpha-L-Arap-(1 -> 2)-alpha-L-Rhap-(1 -> 3)-beta-D-Galp-(1 -> structural fragment, along with alpha-L-Rhap-(1 -> and -> 2)-alpha-L-Rhap-(1 -> 3)-beta-D-GlcpA-(1 -> side bonds that connect to -> 3,6)-beta-D-Galp-(1 ->. The anti -ageing and hypoglycemic activities of EPP were assessed using an ageing diabetic mice model, and the revealed that EPP could improve glucose metabolism-associated parameters and inhibit the expression of ageing associ-ated genes, including p16INK4a, p38 MAPK, NOX-1, VEGF, and AGER, thus preventing liver damage. Moreover, gut microbiota profiling revealed that EPP significantly increased the abundances of o_Lactobacillaceae, c_Bacilli, f_Lactobacillaceae, g_Lactobacillus, and p_Firmicutes, showing that EPP has a probiotic effect on enhancing the beneficial microbiota in ageing diabetic mice. In summary, EPP might serve as a potential bioactive compound to alleviate hyperglycaemia and ageing in diabetic in mice and further clinical studies are required to verify these effects.
C1 [Zhu, Ruiyu] Zhejiang Univ Sci & Technol, Sch Biol & Chem Engn, Hangzhou 310023, Peoples R China.
   [Zhao, Chao] Fujian Agr & Forestry Univ, Coll Marine Sci, Fuzhou, Peoples R China.
   [Ouyang, Yuezhen; Chen, Yihan; Zhang, Lizhu; Nie, Jianping] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Peoples R China.
   [Farag, Mohamed A.] Cairo Univ, Coll Pharm, Pharmacognosy Dept, Cairo, Egypt.
   [Capanoglu, Esra] Istanbul Tech Univ, Fac Chem & Met Engn, Dept Food Engn, TR-34469 Istanbul, Turkiye.
   [Zhao, Chao] Fujian Agr & Forestry Univ, Inst Oceanol, Key Lab Marine Biotechnol Fujian Prov, Fuzhou 350002, Peoples R China.
   [Chen, Yihan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China.
   [Zhao, Chao] 15 Shangxiadian Rd, Fuzhou 350002, Peoples R China.
C3 Zhejiang University of Science & Technology; Fujian Agriculture &
   Forestry University; Fujian Agriculture & Forestry University; Egyptian
   Knowledge Bank (EKB); Cairo University; Istanbul Technical University;
   Fujian Agriculture & Forestry University; Jiangnan University
RP Zhao, C (corresponding author), 15 Shangxiadian Rd, Fuzhou 350002, Peoples R China.
EM zhchao@live.cn
RI Capanoglu, Esra/A-4455-2018; Zhu, Ruiyu/U-5565-2019
OI Capanoglu, Esra/0000-0003-0335-9433; 
FU Key Project of the Natural Science Foundation of Fujian Province
   [2020J02032]; Zhejiang Provincial Basic Public Welfare Research Project
   [LGN20C200012]; Double First-Class Construction Plan of Fujian
   Agriculture and Forestry University [KSYLX013]; Fujian 'Young Eagle
   Program' Youth Top Talent Program
FX This work was supported by the Key Project of the Natural Science
   Foundation of Fujian Province (2020J02032) and Zhejiang Provincial Basic
   Public Welfare Research Project (No. LGN20C200012) . The project was
   also funded by Double First-Class Construction Plan of Fujian
   Agriculture and Forestry University (KSYLX013) and Fujian 'Young Eagle
   Program' Youth Top Talent Program.
CR Ambasta RK, 2020, BIOCHEM BIOPH RES CO, V529, P1094, DOI 10.1016/j.bbrc.2020.07.014
   Archer AC, 2021, PROBIOTICS ANTIMICRO, V13, P1068, DOI 10.1007/s12602-021-09744-0
   Batista TM, 2020, P NATL ACAD SCI USA, V117, P6733, DOI 10.1073/pnas.1922370117
   Bian X., MICROB BIOTECHNOL
   Cai LL, 2018, CARBOHYD POLYM, V184, P354, DOI 10.1016/j.carbpol.2017.12.083
   Chattopadhyay K, 2007, FOOD CHEM, V104, P928, DOI 10.1016/j.foodchem.2006.12.048
   Chen YH, 2022, INT J BIOL MACROMOL, V212, P97, DOI 10.1016/j.ijbiomac.2022.05.109
   Chen YH, 2020, INT J BIOL MACROMOL, V163, P2295, DOI 10.1016/j.ijbiomac.2020.09.041
   Chen YQ, 2018, CARBOHYD POLYM, V198, P452, DOI 10.1016/j.carbpol.2018.06.077
   Cianflone E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061558
   Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017
   DeJong EN, 2020, CELL HOST MICROBE, V28, P180, DOI 10.1016/j.chom.2020.07.013
   Deng YJ, 2020, INT J BIOL MACROMOL, V153, P755, DOI 10.1016/j.ijbiomac.2020.03.057
   Fazi R, 2015, J CHEM INF MODEL, V55, P2443, DOI 10.1021/acs.jcim.5b00419
   Gao HS, 2017, FASEB J, V31, P3527, DOI 10.1096/fj.201700002R
   He ZY, 2019, J CONTROL RELEASE, V301, P119, DOI 10.1016/j.jconrel.2019.03.014
   Huang LP, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02039
   Kadowaki T., 2012, CELL, V148, P621
   Li Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0615-9
   Lin GP, 2020, INT J BIOL MACROMOL, V150, P1084, DOI 10.1016/j.ijbiomac.2019.10.114
   Lin GP, 2021, PHARMACOL RES, V165, DOI 10.1016/j.phrs.2021.105436
   Liu J, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101476
   Liu XY, 2019, INT J BIOL MACROMOL, V139, P342, DOI 10.1016/j.ijbiomac.2019.07.195
   Liu XY, 2020, CARBOHYD POLYM, V236, DOI 10.1016/j.carbpol.2020.116056
   Ouyang YZ, 2022, MOL NUTR FOOD RES, V66, DOI 10.1002/mnfr.202100564
   Papaconstantinou J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111383
   Rajeswari M, 2014, BIOINFORMATION, V10, P157, DOI 10.6026/97320630010157
   Schoeler M, 2019, REV ENDOCR METAB DIS, V20, P461, DOI 10.1007/s11154-019-09512-0
   Sun KY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7108604
   Ticinesi A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071633
   Vaiserman A, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100957
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Wan XZ, 2020, J AGR FOOD CHEM, V68, P1186, DOI 10.1021/acs.jafc.9b06282
   Wang HY, 2019, CARBOHYD POLYM, V211, P39, DOI 10.1016/j.carbpol.2019.01.101
   Wang SH, 2020, GEROSCIENCE, V42, P333, DOI 10.1007/s11357-019-00137-4
   Wang Y, 2020, J AGR FOOD CHEM, V68, P15154, DOI 10.1021/acs.jafc.0c05060
   Warner SO, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00567
   Wen YX, 2021, TRENDS FOOD SCI TECH, V111, P628, DOI 10.1016/j.tifs.2021.03.028
   Wu DS, 2020, ALGAL RES, V51, DOI 10.1016/j.algal.2020.102083
   Yu Y, 2017, CARBOHYD POLYM, V165, P221, DOI 10.1016/j.carbpol.2017.02.011
   Zhao C, 2019, CRIT REV FOOD SCI, V59, P830, DOI 10.1080/10408398.2018.1501658
   Zhao C, 2016, CARBOHYD POLYM, V144, P382, DOI 10.1016/j.carbpol.2015.12.005
NR 42
TC 1
Z9 1
U1 10
U2 26
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR 31
PY 2023
VL 232
AR 123465
DI 10.1016/j.ijbiomac.2023.123465
EA JAN 2023
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 8X9WA
UT WOS:000932355500001
PM 36720326
DA 2024-02-19
ER

PT J
AU Chen, Y
   An, XL
   Wang, ZM
   Guan, SH
   An, HY
   Huang, QY
   Zhang, HB
   Liang, L
   Huang, B
   Wang, HY
   Lu, M
   Nie, H
   Wang, J
   Dai, XP
   Lu, X
AF Chen, Yue
   An, Xinglan
   Wang, Zengmiao
   Guan, Shuanghong
   An, Hongyu
   Huang, Qingyuan
   Zhang, Haobo
   Liang, Lin
   Huang, Bo
   Wang, Huiyu
   Lu, Min
   Nie, Huan
   Wang, Jun
   Dai, Xiangpeng
   Lu, Xin
TI Transcriptome and lipidome profile of human mesenchymal stem cells with
   reduced senescence and increased trilineage differentiation ability upon
   drug treatment
SO AGING-US
LA English
DT Article
DE lipidomics; transcriptomics; hMSCs; aging; drugs
ID TRANSPLANTATION; HOMEOSTASIS; PATHWAY; LIVER; NRF2
AB Human Mesenchymal stem cells (hMSCs) are multi-potential cells which are widely used in cell therapy. However, the frequently emerged senescence and decrease of differentiation capabilities limited the broad applications of MSC. Several strategies such as small molecules treatment have been widely studied and used to improve the stem characteristics bypassing the senescence but the exact mechanisms for them to reduce senescence have not been fully studied. In this study, hMSCs were treated by rapamycin, oltipraz, metformin, and vitamin C for the indicated time and these cells were subjected to senescence evaluation and trilineage differentiation. Furthermore, transcriptomics and lipidomics datasets of hMSCs after drug treatment were analyzed to interpret biological pathways responsible for their anti-senescence effects. Although four drugs exhibited significant activities in promoting MSC osteogenic differentiation, metformin is the optimal drug to promote trilineage differentiation. GO terms illustrated that the anti-aging effects of drugs were mainly associated with cellular senescence, mitotic and meiosis process. Biosynthesis of phosphatidylcholines (PC) and phosphatidylethanolamine (PE) were inhibited whereas production of phosphatidylinositols (PIs) and saturated fatty acids (SFA)/ mono-unsaturated fatty acids (MUFA) conversion was activated. Medium free fatty acids (FFA) was increased in hMSCs with different anti-aging phenotypes. Therefore, we established a comprehensive method in assessing drug intervention based on the results of transcriptomics and lipidomics. The method can be used to study different biological phenotypes upon drug intervention in MSC which will extend the clinical application of hMSCs.
C1 [Chen, Yue; Guan, Shuanghong; An, Hongyu; Huang, Qingyuan; Zhang, Haobo; Liang, Lin; Huang, Bo; Lu, Min; Nie, Huan; Lu, Xin] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Heilongjiang, Peoples R China.
   [An, Xinglan; Dai, Xiangpeng] Jilin Univ, Hosp 1, Natl & Local Joint Engn Lab Anim Models Human Dis, Changchun 130021, Peoples R China.
   [Wang, Zengmiao] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.
   [Wang, Zengmiao] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.
   [Wang, Huiyu] Qiqihar Med Univ, Sch Pharm, Qiqihar 161000, Heilongjiang, Peoples R China.
   [Wang, Jun] BeiGene Beijing Co Ltd, Beijing 102206, Peoples R China.
C3 Harbin Institute of Technology; Jilin University; University of
   California System; University of California San Diego; Beijing Normal
   University; Qiqihar Medical University
RP Chen, Y; Lu, X (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Heilongjiang, Peoples R China.; An, XL; Dai, XP (corresponding author), Jilin Univ, Hosp 1, Natl & Local Joint Engn Lab Anim Models Human Dis, Changchun 130021, Peoples R China.; Wang, J (corresponding author), BeiGene Beijing Co Ltd, Beijing 102206, Peoples R China.
EM ychenbio@hit.edu.cn; anxinglan@jlu.edu.cn; junwangcqb@pku.edu.cn;
   daixiangpeng@jlu.edu.cn; hsinland@hit.edu.cn
RI wang, hui/HSG-6135-2023; Lu, min/JPL-4028-2023
FU National Natural Science Foundation of China [81972558, 31701076];
   Natural Science Foundation of Heilongjiang Province [QC2017016];
   Fundamental Research Funds for the Central Universities [HIT. NSRIF.
   201855]; Postdoctoral Special Funds of Heilongjiang Province
   [LBH-Q20095]; China Postdoctoral Science Foundation [2019M661136]
FX This work was supported by the National Natural Science Foundation of
   China, Grant number: 81972558 (to X.D.) and 31701076 (to Y.C.); the
   Natural Science Foundation of Heilongjiang Province, Grant number:
   QC2017016, Fundamental Research Funds for the Central Universities,
   Grant number: HIT. NSRIF. 201855, Postdoctoral Special Funds of
   Heilongjiang Province, Grant number: LBH-Q20095 to Y.C.; China
   Postdoctoral Science Foundation Funded Project, Grant number:
   2019M661136 to X.L.
CR Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011
   Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809
   Deng LP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10831-8
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Fang JQ, 2018, AGING CELL, V17, DOI 10.1111/acel.12765
   Fu LN, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000201
   Geng LL, 2019, PROTEIN CELL, V10, P417, DOI 10.1007/s13238-018-0567-y
   Haller S, 2017, CELL STEM CELL, V21, P806, DOI 10.1016/j.stem.2017.11.008
   Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023
   Heidari Banafsheh, 2013, Avicenna Journal of Medical Biotechnology, V5, P104
   Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906
   Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156
   Kawanishi N, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0785-6
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228
   Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001
   Li Y, 2016, PROTEIN CELL, V7, P478, DOI 10.1007/s13238-016-0278-1
   Lin H, 2018, CONN'S HANDBOOK OF MODELS FOR HUMAN AGING, 2ND EDITION, P975, DOI 10.1016/B978-0-12-811353-0.00071-3
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu X, 2019, J PROTEOME RES, V18, P2065, DOI 10.1021/acs.jproteome.8b00936
   Lu X, 2019, MOL CARCINOGEN, V58, P749, DOI 10.1002/mc.22967
   Maruthur NM, 2016, ANN INTERN MED, V164, P740, DOI 10.7326/M15-2650
   Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011
   Mukherjee S, 2009, J TRANSPLANT, V2009, DOI 10.1155/2009/701464
   Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4
   Ren RT, 2017, CELL METAB, V26, P460, DOI 10.1016/j.cmet.2017.07.019
   Ren XQ, 2019, CELL REP, V26, P3643, DOI 10.1016/j.celrep.2019.02.088
   Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105
   Rudan MV, 2020, P NATL ACAD SCI USA, V117, P22173, DOI 10.1073/pnas.2011310117
   Shora HA, 2020, BMC INFECT DIS, V1, P018, DOI DOI 10.1093/cid/ciaa344
   Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446
   VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721
   Wang JF, 2004, HAEMATOLOGICA, V89, P837
   Wang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-017-0003-0
   Wiwie Christian, 2019, Syst Med (New Rochelle), V2, P1, DOI 10.1089/sysm.2018.0013
   Wu ZM, 2018, PROTEIN CELL, V9, P333, DOI 10.1007/s13238-018-0517-8
   Yan PZ, 2019, CELL STEM CELL, V24, P447, DOI 10.1016/j.stem.2018.12.002
   Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128
   Yuan H, 2021, MOL CELL BIOCHEM, V476, P247, DOI 10.1007/s11010-020-03901-9
   Zhang YS, 2004, MOL CANCER THER, V3, P885
   Zhu XP, 2019, FREE RADICAL BIO MED, V141, P192, DOI 10.1016/j.freeradbiomed.2019.06.019
NR 41
TC 7
Z9 7
U1 1
U2 15
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD APR 15
PY 2021
VL 13
IS 7
BP 9991
EP 10014
PG 24
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA RO1CA
UT WOS:000640785300022
PM 33795523
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Tanno, S
   Fukuda, I
   Saito, Y
   Ogawa, K
AF Tanno, S
   Fukuda, I
   Saito, Y
   Ogawa, K
TI Prohibitin expression is decreased in the regenerating liver but not in
   chemically induced hepatic tumors in rats
SO JAPANESE JOURNAL OF CANCER RESEARCH
LA English
DT Article
DE prohibitin; liver regeneration; hepatocarcinogenesis
ID HUMAN-DIPLOID FIBROBLASTS; CELL-LINES; GENE-MUTATIONS; MESSENGER-RNA;
   PROTEIN; CARCINOGENESIS; SENESCENCE; GROWTH
AB Expression of prohibitin, a growth-regulatory protein, was immunohistochemically investigated in normal rat tissues, regenerating livers, and chemically induced preneoplastic and neoplastic hepatic lesions. Specific cell types including hepatocytes, striated and smooth muscle cells, cardiac cells, squamous epithelial cells, sebaceous gland cells, hair root outer sheath cells, salivary gland duct epithelial cells, chondrocytes, immature spermatocytes and oocytes were found to be positive. In regenerating livers, prohibitin protein disappeared as early as 3 h after two-thirds hepatectomy and returned to near the original level by 24 h, while its mRNA level did not markedly vary. The timing of the disappearance was coincident with the expression of c-myc, suggesting a relation to quiescent hepatocytes entering the cell cycle. However, no pronounced decrease was evident in the most hyperplastic hepatic nodules and hepatocellular carcinomas investigated. Examination of 9 rat hepatocellular carcinoma cell lines, 6 hyperplastic hepatic nodules and 5 hepatocellular carcinomas revealed a single case of a base substitution in prohibitin cDNA, identified as a synonymous sense change. The observed abundant expression of prohibitin in quiescent hepatocytes and its rapid loss under conditions of regeneration indicate a growth-regulatory function, but our results do not suggest any critical role in rat hepatocarcinogenesis.
C1 Asahikawa Med Coll, Dept Pathol, Asahikawa, Hokkaido 078, Japan.
C3 Asahikawa Medical College
RP Ogawa, K (corresponding author), Asahikawa Med Coll, Dept Pathol, 4-5-3-11 Nishikagura, Asahikawa, Hokkaido 078, Japan.
CR ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4
   CHOONGKITTAWORN NM, 1993, BIOL REPROD, V49, P300, DOI 10.1095/biolreprod49.2.300
   CLIBY W, 1993, GYNECOL ONCOL, V50, P34, DOI 10.1006/gyno.1993.1160
   DellOrco RT, 1996, EXP GERONTOL, V31, P245, DOI 10.1016/0531-5565(95)02009-8
   EVELETH DD, 1986, NUCLEIC ACIDS RES, V14, P6169, DOI 10.1093/nar/14.15.6169
   FAUSTO N, 1989, LAB INVEST, V60, P4
   FUKUDA I, 1993, MOL CARCINOGEN, V7, P257, DOI 10.1002/mc.2940070408
   GRISHAM JW, 1962, CANCER RES, V22, P842
   IKONEN E, 1995, FEBS LETT, V358, P273, DOI 10.1016/0014-5793(94)01444-6
   ISOMURA H, 1993, J CELL PHYSIOL, V154, P329, DOI 10.1002/jcp.1041540216
   JUPE ER, 1995, EXP CELL RES, V218, P577, DOI 10.1006/excr.1995.1194
   Jupe ER, 1996, EXP CELL RES, V224, P128, DOI 10.1006/excr.1996.0120
   LIU XT, 1994, BIOCHEM BIOPH RES CO, V201, P409, DOI 10.1006/bbrc.1994.1716
   LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407
   LUMPKIN CK, 1995, ALCOHOL, V12, P357, DOI 10.1016/0741-8329(95)00018-M
   LUMPKIN CK, 1985, EXP CELL RES, V160, P544, DOI 10.1016/0014-4827(85)90201-0
   MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7
   MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5
   MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372
   NUELL MJ, 1989, EXP GERONTOL, V24, P469, DOI 10.1016/0531-5565(89)90053-3
   OGAWA K, 1980, CANCER RES, V40, P725
   PEREIRASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042, DOI 10.1073/pnas.85.16.6042
   RABES HM, 1977, EXCERPTA MED, P31
   ROSKAMS AJI, 1993, J CELL PHYSIOL, V157, P289, DOI 10.1002/jcp.1041570211
   SATO T, 1993, GENOMICS, V17, P762, DOI 10.1006/geno.1993.1402
   SATO T, 1992, CANCER RES, V52, P1643
   SATOH K, 1989, CARCINOGENESIS, V10, P2107, DOI 10.1093/carcin/10.11.2107
   SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232
   SOLT D, 1976, NATURE, V263, P701, DOI 10.1038/263701a0
   TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x
NR 32
TC 15
Z9 15
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0910-5050
J9 JPN J CANCER RES
JI Jpn. J. Cancer Res.
PD DEC
PY 1997
VL 88
IS 12
BP 1155
EP 1164
DI 10.1111/j.1349-7006.1997.tb00344.x
PG 10
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA YQ507
UT WOS:000071394700009
PM 9473733
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Cogger, VC
   Svistounov, D
   Warren, A
   Zykova, S
   Melvin, RG
   Solon-Biet, SM
   O'Reilly, JN
   McMahon, AC
   Ballard, JWO
   De Cabo, R
   Le Couteur, DG
   Lebel, M
AF Cogger, Victoria C.
   Svistounov, Dmitri
   Warren, Alessandra
   Zykova, Svetlana
   Melvin, Richard G.
   Solon-Biet, Samantha M.
   O'Reilly, Jennifer N.
   McMahon, Aisling C.
   Ballard, J. William O.
   De Cabo, Rafa
   Le Couteur, David G.
   Lebel, Michel
TI Liver Aging and Pseudocapillarization in a Werner Syndrome Mouse Model
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Sinusoid; Endothelium; Mitochondria; Electron microscopy; Seahorse
   analyzer
ID AGE-RELATED-CHANGES; SYNDROME PROTEIN; SYNDROME HELICASE; EXPRESSION;
   INSULIN; MICE; DNA; MUTATION; GENE; INFLAMMATION
AB Werner syndrome is a progeric syndrome characterized by premature atherosclerosis, diabetes, cancer, and death in humans. The knockout mouse model created by deletion of the RecQ helicase domain of the mouse Wrn homologue gene (Wrn(Delta hel/Delta hel)) is of great interest because it develops atherosclerosis and hypertriglyceridemia, conditions associated with aging liver and sinusoidal changes. Here, we show that Wrn(Delta hel/Delta hel) mice exhibit increased extracellular matrix, defenestration, decreased fenestration diameter, and changes in markers of liver sinusoidal endothelial cell inflammation, consistent with age-related pseudocapilliarization. In addition, hepatocytes are larger, have increased lipofuscin deposition, more frequent nuclear morphological anomalies, decreased mitochondria number, and increased mitochondrial diameter compared to wild-type mice. The Wrn(Delta hel/Delta hel) mice also have altered mitochondrial function and altered nuclei. Microarray data revealed that the Wrn(Delta hel/Delta hel) genotype does not affect the expression of many genes within the isolated hepatocytes or liver sinusoidal endothelial cells. This study reveals that Wrn(Delta hel/Delta hel) mice have accelerated typical age-related liver changes including pseudocapillarization. This confirms that pseudocapillarization of the liver sinusoid is a consistent feature of various aging models. Moreover, it implies that DNA repair may be implicated in normal aging changes in the liver.
C1 [Cogger, Victoria C.; Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana; Solon-Biet, Samantha M.; O'Reilly, Jennifer N.; McMahon, Aisling C.; Le Couteur, David G.] Univ Sydney, Ctr Educ & Res Aging, Sydney, NSW 2139, Australia.
   [Cogger, Victoria C.; Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana; Solon-Biet, Samantha M.; O'Reilly, Jennifer N.; McMahon, Aisling C.; Le Couteur, David G.] Univ Sydney, ANZAC Med Res Inst, Sydney, NSW 2139, Australia.
   [Cogger, Victoria C.; Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana; Solon-Biet, Samantha M.; O'Reilly, Jennifer N.; McMahon, Aisling C.; Le Couteur, David G.] Concord Hosp, Sydney, NSW 2139, Australia.
   [Melvin, Richard G.; Ballard, J. William O.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
   [Solon-Biet, Samantha M.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2139, Australia.
   [De Cabo, Rafa] NIA, Expt Gerontol Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Lebel, Michel] Univ Laval, Hop Hotel Dieu Quebec, Ctr Rech Cancerol, Quebec City, PQ G1K 7P4, Canada.
C3 University of Sydney; University of Sydney; ANZAC Research Institute;
   Concord Repatriation General Hospital; University of New South Wales
   Sydney; University of Sydney; National Institutes of Health (NIH) - USA;
   NIH National Institute on Aging (NIA); Laval University
RP Cogger, VC (corresponding author), Univ Sydney, Ctr Educ & Res Aging, Gate 3,Hosp Rd, Sydney, NSW 2139, Australia.
EM victoria.cogger@sydney.edu.au
RI Ballard, John William O./ABB-2743-2020; de Cabo, Rafael
   Carlos/E-7996-2010; Melvin, Richard George/AGH-4179-2022; Research
   Institute, ANZAC/CAE-9030-2022; de Cabo, Rafael/J-5230-2016; Solon-Biet,
   Samantha/R-6551-2017
OI Ballard, John William O./0000-0002-2358-6003; de Cabo, Rafael
   Carlos/0000-0003-2830-5693; Melvin, Richard George/0000-0001-6428-6763;
   de Cabo, Rafael/0000-0002-3354-2442; Le Couteur,
   David/0000-0002-4227-5817; Solon-Biet, Samantha/0000-0003-0608-958X
FU National Health and Medical Research Council [570937]; Ramaciotti
   Foundation [RN 23/08]
FX We acknowledge the financial support of the National Health and Medical
   Research Council (570937) and Ramaciotti Foundation (RN 23/08).
CR Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67
   ANDREW W, 1962, AM J ANAT, V110, P1, DOI 10.1002/aja.1001100102
   Andrews GR, 2002, EXP GERONTOL, V37, P1303, DOI 10.1016/S0531-5565(02)00097-9
   Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017
   Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378
   Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x
   Cogger VC, 2009, LIVER BIOL PATHOBIOL, P387
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004
   Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651
   Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108
   GAHAN PB, 1984, EXP GERONTOL, V19, P355, DOI 10.1016/0531-5565(84)90044-5
   González M, 2004, PFLUG ARCH EUR J PHY, V448, P383
   Goto M, 2013, BIOSCI TRENDS, V7, P13, DOI 10.5582/bst.2013.v7.1.13
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Huang Y, 2013, LIVER INT, V33, P1249, DOI 10.1111/liv.12184
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145
   Kitamoto T, 2012, DIABETES CARE, V35, pE83, DOI 10.2337/dc12-1179
   Labbé A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P191, DOI 10.1007/978-90-481-8556-6_11
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Le Couteur DG, 2006, AGING AND THE ELDERL, P153
   Lebel M, 2003, AM J PATHOL, V162, P1559, DOI 10.1016/S0002-9440(10)64290-3
   Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097
   Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000
   Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011
   Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitchell SJ, 2011, J GERONTOL A-BIOL, V66, P400, DOI 10.1093/gerona/glq221
   Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221
   Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023
   Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Raines SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE517, DOI 10.1152/ajpendo.00241.2011
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139
   Simon-Santamaria J, 2010, J GERONTOL A-BIOL, V65, P951, DOI 10.1093/gerona/glq108
   Stacchiotti A, 2008, EXP GERONTOL, V43, P330, DOI 10.1016/j.exger.2008.01.009
   Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913
   Tanaka T, 2010, J NUTR SCI VITAMINOL, V56, P335, DOI 10.3177/jnsv.56.335
   Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925
   Wang L, 2000, GENETICS, V154, P357
   Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Yamamoto K, 2003, J Orthop Surg (Hong Kong), V11, P224
NR 50
TC 34
Z9 35
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD SEP
PY 2014
VL 69
IS 9
BP 1076
EP 1086
DI 10.1093/gerona/glt169
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AR2JB
UT WOS:000343409000004
PM 24149428
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Kondo, Y
   Hasegawa, G
   Okada, H
   Senmaru, T
   Fukui, M
   Nakamura, N
   Sawada, M
   Kitawaki, J
   Okanoue, T
   Kishimoto, Y
   Amano, A
   Maruyama, N
   Obayashi, H
   Ishigami, A
AF Kondo, Yoshitaka
   Hasegawa, Goji
   Okada, Hiroshi
   Senmaru, Takafumi
   Fukui, Michiaki
   Nakamura, Naoto
   Sawada, Morio
   Kitawaki, Jo
   Okanoue, Takeshi
   Kishimoto, Yuki
   Amano, Akiko
   Maruyama, Naoki
   Obayashi, Hiroshi
   Ishigami, Akihito
TI <i>Leprdb</i>/<i>db</i> Mice with Senescence Marker Protein-30 Knockout
   (<i>Leprdb</i>/<i>db</i> <i>Smp30Y</i>/-) Exhibit Increases in Small
   Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard Diet
SO PLOS ONE
LA English
DT Article
ID HEPATIC STEATOSIS; GENE-EXPRESSION; ACID; PLASMA; STEATOHEPATITIS;
   LIPOPROTEINS; ACCUMULATION; CHOLESTEROL; VALIDATION; DISEASE
AB Background/Aims: The senescence marker protein-30 (SMP30) is a 34 kDa protein originally identified in rat liver that shows decreased levels with age. Several functional studies using SMP30 knockout (Smp30(Y/-)) mice established that SMP30 functions as an antioxidant and protects against apoptosis. To address the potential role of SMP30 in nonalcoholic fatty liver disease (NAFLD) pathogenesis, we established Smp30(Y/-) mice on a Lepr(db/db) background (Lepr(db/db) Smp30(Y/-) mice).
   Research Design/Principal Findings: Male Lepr(db/db) Smp30(Y/-) mice were fed a standard diet (340 kcal/100 g, fat 5.6%) for 16 weeks whereupon the lipid/lipoprotein profiles, hepatic expression of genes related to lipid metabolism and endoplasmic reticulum stress markers were analyzed by HPLC, quantitative RT-PCR and western blotting, respectively. Changes in the liver at a histological level were also investigated. The amount of SMP30 mRNA and protein in livers was decreased in Lepr(db/db) Smp30(Y/+) mice compared with Lepr(db/+) Smp30(Y/+) mice. Compared with Lepr(db/db) Smp30(Y/+) mice, 24 week old Lepr(db/db) Smp30(Y/-) mice showed: i) increased small dense LDL-cho and decreased HDL-cho levels; ii) fatty liver accompanied by numerous inflammatory cells and increased oxidative stress; iii) decreased mRNA expression of genes involved in fatty acid oxidation (PPAR alpha) and lipoprotein uptake (LDLR and VLDLR) but increased CD36 levels; and iv) increased endoplasmic reticulum stress.
   Conclusion: Our data strongly suggest that SMP30 is closely associated with NAFLD pathogenesis, and might be a possible therapeutic target for NAFLD.
C1 [Kondo, Yoshitaka; Kishimoto, Yuki; Amano, Akiko; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan.
   [Hasegawa, Goji; Okada, Hiroshi; Senmaru, Takafumi; Fukui, Michiaki; Nakamura, Naoto; Obayashi, Hiroshi] Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Kyoto, Japan.
   [Sawada, Morio; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan.
   [Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan.
   [Obayashi, Hiroshi] Inst Bioresponse Informat, Kyoto, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Kyoto Prefectural
   University of Medicine; Kyoto Prefectural University of Medicine
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan.
EM ishigami@tmig.or.jp
RI Okada, Hiroshi/AAG-1588-2020; Yoshitaka, Kondo/AFK-7721-2022
OI Okada, Hiroshi/0000-0002-1707-970X; Yoshitaka,
   Kondo/0000-0002-0046-9429; Fukui, Michiaki/0000-0003-0903-1797; Amano,
   Akiko/0000-0003-4324-2758; Ishigami, Akihito/0000-0001-7875-7482
FU Japan Society for the Promotion of Science [24380073, 23590441,
   23790122, 23591317]; Grants-in-Aid for Scientific Research [23591317,
   23790122, 23590441] Funding Source: KAKEN
FX This study is supported by the Japan Society for the Promotion of
   Science (http://www.jsps.go.jp/english/e-grants/index.html) KAKENHI
   Grant Number 24380073 (A. Ishigami), 23590441 (N. Maruyama), 23790122
   (Y. Kondo) and 23591317 (G. Hasegawa). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25
   Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x
   Cali AMG, 2007, DIABETES CARE, V30, P3093, DOI 10.2337/dc07-1088
   Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Fukui M, 2011, BIOCHEM BIOPH RES CO, V415, P252, DOI 10.1016/j.bbrc.2011.10.025
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Kim JC, 1997, LAB ANIM, V11, P113
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lv S, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-17
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009
   Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3
   Qiu SQ, 1998, J LIPID RES, V39, P1661
   Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364
   Senmaru T, 2013, METABOLISM
   Sugino I, 2011, J ATHEROSCLER THROMB, V18, P1, DOI 10.5551/jat.5447
   Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300
   Toledo FGS, 2006, DIABETES CARE, V29, P1845, DOI 10.2337/dc06-0455
   Usui S, 2002, J LIPID RES, V43, P805
NR 34
TC 22
Z9 23
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 3
PY 2013
VL 8
IS 6
AR e65698
DI 10.1371/journal.pone.0065698
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 157CD
UT WOS:000319872300090
PM 23755269
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Sharma, S
   Maras, JS
   Das, S
   Hussain, S
   Mishra, AK
   Shasthry, SM
   Sharma, CB
   Weiss, E
   Elkrief, L
   Rautou, PE
   Gilgenkrantz, H
   Lotersztajn, S
   Paradis, V
   de la Grange, P
   Junot, C
   Moreau, R
   Sarin, SK
AF Sharma, Shvetank
   Maras, Jaswinder S.
   Das, Sukanta
   Hussain, Shabir
   Mishra, Ashwani K.
   Shasthry, Saggere M.
   Sharma, Chhagan B.
   Weiss, Emmanuel
   Elkrief, Laure
   Rautou, Pierre-Emmanuel
   Gilgenkrantz, Helene
   Lotersztajn, Sophie
   Paradis, Valerie
   de la Grange, Pierre
   Junot, Christophe
   Moreau, Richard
   Sarin, Shiv K.
TI Pre-therapy liver transcriptome landscape in Indian and French patients
   with severe alcoholic hepatitis and steroid responsiveness
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LARGE GENE LISTS; GLUCOCORTICOID-RECEPTOR; REGENERATION; SPECTROMETRY;
   METABOLOME; ANNOTATION; MECHANISMS; STRATEGY; SURVIVAL; DATABASE
AB Patients with severe alcoholic hepatitis (SAH) not responding to glucocorticoid therapy have higher mortality, though they do not differ in their baseline clinical characteristics and prognostic scores from those who respond to therapy. We hypothesized that the baseline hepatic gene expression differs between responders (R) and non-responders (NR). Baseline liver transcriptome was compared between R and NR in Indian (16 each) and French (5 NR, 3 R) patients with SAH. There were differentially expressed genes (DEGs) between NR and R, in Indian (1106 over-expressed, 96 under-expressed genes) and French patients (65 over-expressed, 142 under-expressed genes). Indian NR had features of hepatocyte senescence and French NR exhibited under-expression of genes involved in cell division, indicating a central defect in the capacity of hepatocytes for self-renewal in both populations. Markers of hepatic progenitor cell proliferation were either very few (Indian patients) or absent (French patients). No DEGs were enriched in inflammatory pathways and there were no differences in nuclear receptor subfamily 3 group C member 1 (NR3C1) transcript expression and splicing between NR and R. Our results reveal that baseline hepatic transcriptome is reflective of subsequent glucocorticoid non-response and indicate impaired regenerative potential of the liver as an underlying phenomenon in NR.
C1 [Sharma, Shvetank; Maras, Jaswinder S.; Das, Sukanta; Hussain, Shabir] Inst Liver & Biliary Sci, Dept Mol & Cellular Med, New Delhi, India.
   [Mishra, Ashwani K.] NexGenBio Life Sci, New Delhi, India.
   [Shasthry, Saggere M.; Sarin, Shiv K.] Inst Liver & Biliary Sci, Dept Hepatol, New Delhi, India.
   [Sharma, Chhagan B.] Inst Liver & Biliary Sci, Dept Pathol, New Delhi, India.
   [Weiss, Emmanuel; Lotersztajn, Sophie; Paradis, Valerie; Moreau, Richard] Univ Paris Diderot, CNRS, CRI, INSERM, Paris, France.
   [Elkrief, Laure; Rautou, Pierre-Emmanuel; Paradis, Valerie; Moreau, Richard] Hop Beaujon, AP HP, Serv Hepatol, Dept Hosp Univ DHU UNITY, Clichy, France.
   [Gilgenkrantz, Helene] Univ Paris 05, CNRS, Inst Cochin, INSERM, Paris, France.
   [Paradis, Valerie] Hop Beaujon, AP HP, Dept Anatomopathol, Clichy, France.
   [de la Grange, Pierre] Inst Cerveau & Moelle Epiniere ICM, Genosplice, Paris, France.
   [Junot, Christophe] CEA Saclay, MetaboHUB Paris, Lab Etud Metab Medicaments, DSV iBiTec S SPI, Paris, France.
   [Moreau, Richard] COMUE Sorbonne Paris Cite, Lab Excellence Inflamex, Paris, France.
C3 Institute of Liver & Biliary Sciences (ILBS); Institute of Liver &
   Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS);
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Centre National de la Recherche Scientifique (CNRS); Universite Paris
   Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire
   Paul-Brousse - APHP; Hopital Universitaire Beaujon - APHP; Universite
   Paris Cite; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Centre National de la Recherche Scientifique (CNRS);
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Beaujon - APHP; Hopital Universitaire Hotel-Dieu -
   APHP; Hopital Universitaire Paul-Brousse - APHP; Sorbonne Universite;
   CEA
RP Sarin, SK (corresponding author), Inst Liver & Biliary Sci, Dept Hepatol, New Delhi, India.
EM sksarin@ilbs.in
RI Moreau, Richard/S-1300-2019; Paradis, Valerie/X-9097-2019; Elkrief,
   Laure/AAC-9142-2022; Junot, Christophe/AAG-2251-2020; Mishra, Ashwani
   Kumar/AAA-3998-2020; Weiss, Emmanuel/AAD-7231-2020; Gilgenkrantz,
   Helene/G-5534-2017; Rautou, Pierre-Emmanuel/ISA-6844-2023; Lotersztajn,
   Sophie/K-9160-2017
OI Moreau, Richard/0000-0003-0862-403X; Elkrief, Laure/0000-0003-2843-1710;
   Mishra, Ashwani Kumar/0000-0002-8872-1886; Maras, Jaswinder
   Singh/0000-0003-3938-362X; Sharma, Shvetank/0000-0001-7139-2011; Rautou,
   Pierre-Emmanuel/0000-0001-9567-1859; Paradis,
   Valerie/0000-0003-3142-3762; Das, Sukanta/0000-0002-2376-1174;
   gilgenkrantz, helene/0000-0001-6770-4561; Weiss,
   Emmanuel/0000-0002-2854-9607; lotersztajn, Sophie/0000-0002-0053-7807
FU Indo-French Centre for the Promotion of Advanced Research (CEFIPRA)
   [4903]
FX Authors are also thankful to Dr. Jessica Zucman-Rossi for her valuable
   inputs on the manuscript. The current study was supported by the grant
   no. 4903 of the Indo-French Centre for the Promotion of Advanced
   Research (CEFIPRA).
CR Boudah S, 2014, J CHROMATOGR B, V966, P34, DOI 10.1016/j.jchromb.2014.04.025
   Dubuquoy L, 2015, GUT, V64, P1949, DOI 10.1136/gutjnl-2014-308410
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g
   Kumar M, 2013, HEPATOL INT, V7, P134, DOI 10.1007/s12072-012-9380-5
   Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   Louvet A, 2009, GASTROENTEROLOGY, V137, P541, DOI 10.1053/j.gastro.2009.04.062
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Maras JS, 2015, HEPATOLOGY, V61, P1306, DOI 10.1002/hep.27636
   Mathurin P, 2013, JAMA-J AM MED ASSOC, V310, P1033, DOI 10.1001/jama.2013.276300
   Mathurin P, 2011, NEW ENGL J MED, V365, P1790, DOI 10.1056/NEJMoa1105703
   Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097
   Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007
   Paugh SW, 2015, NAT GENET, V47, P607, DOI 10.1038/ng.3283
   Rivers C, 1999, J CLIN ENDOCR METAB, V84, P4283, DOI 10.1210/jc.84.11.4283
   Schmidt U, 2008, P NATL ACAD SCI USA, V105, pE101, DOI 10.1073/pnas.0809354105
   Sinclair D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03539
   Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39
   SMITH M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002886
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
NR 26
TC 14
Z9 15
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 28
PY 2017
VL 7
AR 6816
DI 10.1038/s41598-017-07161-4
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FC1PP
UT WOS:000406610000067
PM 28754919
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Reichard, M
   Blazek, R
   Zak, J
   Cellerino, A
   Polacik, M
AF Reichard, Martin
   Blazek, Radim
   Zak, Jakub
   Cellerino, Alessandro
   Polacik, Matej
TI The sources of sex differences in aging in annual fishes
SO JOURNAL OF ANIMAL ECOLOGY
LA English
DT Article; Early Access
DE adult sex ratio; demographic ageing; gender; Nothobranchius furzeri;
   predation; senescence; social environment
ID AFRICAN ANNUAL FISHES; LIFE-SPAN; NATURAL-POPULATIONS; MORTALITY COSTS;
   EVOLUTION; SELECTION; PATTERNS; LONGEVITY; RATES
AB Intersexual differences in life span (age at death) and aging (increase in mortality risk associated with functional deterioration) are widespread among animals, from nematodes to humans. Males often live shorter than females, but there is substantial unexplained variation among species and populations. Despite extensive research, it is poorly understood how life span differences between the sexes are modulated by an interplay among genetic, environmental and social factors. The goal of our study was to test how sex differences in life span and ageing are modulated by social and environmental factors, and by intrinsic differences between males and females. To disentangle the complex basis of sex differences in life span and aging, we combined comparative data from sex ratios in 367 natural populations of four species of African annual killifish with experimental results on sex differences in life span and aging from eight laboratory populations tested in treatments that varied social and environmental conditions. In the wild, females consistently outlived males. In captivity, sex-specific mortality depended on social conditions. In social-housed experimental groups, male-biased mortality persisted in two aggressive species, but ceased in two placid species. When social and physical contacts were prevented by housing all fish individually, male-biased mortality ceased in all four species. This outcome held across benign and challenging environmental conditions. Fitting demographic survival models revealed that increased baseline mortality was primarily responsible for a shorter male life span in social-housing conditions. The timing and rate of aging were not different between the sexes. No marker of functional aging we recorded in our study (lipofuscin accumulation, proliferative changes in kidney and liver) differed between males and females, despite their previously confirmed association with functional aging in Nothobranchius killifish. We show that sex differences in life span and aging in killifish are driven by a combination of social and environmental conditions, rather than differential functional aging. They are primarily linked to sexual selection but precipitated through multiple processes (predation, social interference). This demonstrates how sex-specific mortality varies among species even within an ecologically and evolutionary discrete lineage and explains how external factors mediate this difference.
C1 [Reichard, Martin; Blazek, Radim; Zak, Jakub; Polacik, Matej] Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic.
   [Reichard, Martin] Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, Lodz, Poland.
   [Reichard, Martin] Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.
   [Zak, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.
   [Cellerino, Alessandro] Scuola Normale Super Pisa, Dept Neurosci, Bio SNS, Pisa, Italy.
   [Cellerino, Alessandro] Leibniz Inst, Fritz Lipmann Inst Age Res, Jena, Germany.
C3 Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech
   Academy of Sciences; University of Lodz; Masaryk University Brno;
   Charles University Prague; Scuola Normale Superiore di Pisa
RP Reichard, M (corresponding author), Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic.; Reichard, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, Lodz, Poland.; Reichard, M (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.
EM reichard@ivb.cz
RI Cellerino, Alessandro/AAJ-7453-2020; Polačik, Matej/A-8260-2010; Žák,
   Jakub/HMO-7100-2023; Reichard, Martin/C-6563-2009; Blazek,
   Radim/L-9163-2013
OI Cellerino, Alessandro/0000-0003-3834-0097; Polačik,
   Matej/0000-0003-1309-2146; Žák, Jakub/0000-0003-2845-8323; Reichard,
   Martin/0000-0002-9306-0074; Blazek, Radim/0000-0003-1150-0273
FU Grantova Agentura Ceske Republiky [19-01781S]
FX Grantova Agentura Ceske Republiky, Grant/Award Number: 19-01781S
CR Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1
   Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019
   Bartáková V, 2015, J BIOGEOGR, V42, P1832, DOI 10.1111/jbi.12567
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Baumgart M, 2015, BIOGERONTOLOGY, V16, P63, DOI 10.1007/s10522-014-9535-y
   Beirne C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1086
   Blazek R, 2017, EVOLUTION, V71, P386, DOI 10.1111/evo.13127
   Boonekamp JJ, 2020, J ANIM ECOL, V89, P1395, DOI 10.1111/1365-2656.13186
   Bronikowski AM, 2011, SCIENCE, V331, P1325, DOI 10.1126/science.1201571
   Cellerino A, 2016, BIOL REV, V91, P511, DOI 10.1111/brv.12183
   Chen HY, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0217
   Clutton-Brock T, 2021, SCIENCE, V373, DOI 10.1126/science.abc9699
   Colchero F, 2012, METHODS ECOL EVOL, V3, P466, DOI 10.1111/j.2041-210X.2012.00186.x
   Cui RF, 2019, CELL, V178, P385, DOI 10.1016/j.cell.2019.06.004
   Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011
   Fisher RA, 1930, GENETICAL THEORY NAT, DOI [10.5962/bhl.title.27468, DOI 10.5962/BHL.TITLE.27468]
   Foo YZ, 2017, BIOL REV, V92, P551, DOI 10.1111/brv.12243
   Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0
   Fromhage L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12517
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Genade T., 2005, LAB MANUAL CULTURING
   Gordon EH, 2017, EXP GERONTOL, V89, P30, DOI 10.1016/j.exger.2016.12.021
   Gotthard K, 2000, OECOLOGIA, V122, P36, DOI 10.1007/PL00008833
   Gupta S, 2020, P NATL ACAD SCI USA, V117, P16481, DOI 10.1073/pnas.2003603117
   HAAS R, 1976, EVOLUTION, V30, P614, DOI 10.1111/j.1558-5646.1976.tb00938.x
   Harvey P.H., 1991, P203
   Hu CK, 2018, AGING CELL, V17, DOI 10.1111/acel.12757
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Keller S., 1992, SCIENCE, V213, P1397, DOI [10.1126/science.6973822, DOI 10.1126/SCIENCE.6973822]
   Keppeler FW, 2016, HYDROBIOLOGIA, V773, P225, DOI 10.1007/s10750-016-2705-y
   Krysanov E, 2018, COMP CYTOGENET, V12, P387, DOI 10.3897/CompCytogen.v12i3.25092
   Lemaitre JF, 2020, P NATL ACAD SCI USA, V117, P8546, DOI 10.1073/pnas.1911999117
   Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560
   Maklakov AA, 2013, BIOESSAYS, V35, P717, DOI 10.1002/bies.201300021
   Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196
   Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381, DOI 10.1093/gerona/55.8.B381
   Polacik M, 2016, NAT PROTOC, V11, P1396, DOI 10.1038/nprot.2016.080
   Polacik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022684
   Promislow D, 2003, BEHAV GENET, V33, P191, DOI 10.1023/A:1022562103669
   PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142
   Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956
   Regan JC, 2013, BEST PRACT RES CL EN, V27, P467, DOI 10.1016/j.beem.2013.05.016
   Reichard, 2020, SEX DIFFERENCES LIFE, DOI 10.6084/m9.figshare.12752648.v2
   REICHARD M, 2022, MOL ECOL
   Reichard M, 2019, ELIFE, V8, DOI 10.7554/eLife.41548
   Reichard M, 2017, ECOL EVOL, V7, P2294, DOI 10.1002/ece3.2851
   Reichard M, 2016, ANNUAL FISHES: LIFE HISTORY STRATEGY, DIVERSITY, AND EVOLUTION, P133
   Reichard M, 2014, EVOL ECOL, V28, P1105, DOI 10.1007/s10682-014-9732-9
   Reichwald K, 2015, CELL, V163, P1527, DOI 10.1016/j.cell.2015.10.071
   Sandford M, 2020, REV AQUACULT, V12, P542, DOI 10.1111/raq.12339
   Sedlácek O, 2014, ZOOL ANZ, V253, P207, DOI 10.1016/j.jcz.2013.12.004
   Sielezniew M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66922-w
   Sowersby W, 2020, EVOL ECOL, V34, P411, DOI 10.1007/s10682-020-10041-5
   Székely T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0342
   Therneau T., 2015, CRAN REPOSIT
   THOMAS RE, 1986, T AM FISH SOC, V115, P52, DOI 10.1577/1548-8659(1986)115<52:EOFTOM>2.0.CO;2
   Tompkins EM, 2019, J ANIM ECOL, V88, P986, DOI 10.1111/1365-2656.12944
   Tozzini ET, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-77
   Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226
   TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677
   Vrtílek M, 2018, CURR BIOL, V28, pR822, DOI 10.1016/j.cub.2018.06.031
   Vrtílek M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22878-6
   Wildekamp R. H., 2004, WORLD KILLIES ATLAS
   Xirocostas ZA, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2019.0867
   Zák J, 2020, EXP GERONTOL, V140, DOI 10.1016/j.exger.2020.111073
   Zák J, 2018, J THERM BIOL, V78, P257, DOI 10.1016/j.jtherbio.2018.10.015
NR 66
TC 3
Z9 3
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8790
EI 1365-2656
J9 J ANIM ECOL
JI J. Anim. Ecol.
PD 2022 MAR
PY 2022
VL 91
IS 3
BP 540
EP 550
DI 10.1111/1365-2656.13656
EA JAN 2022
PG 11
WC Ecology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Zoology
GA ZK6MH
UT WOS:000740860400001
PM 34954818
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Shigano, M
   Takasawa, H
   Hamada, S
AF Shigano, Miyuki
   Takasawa, Hironao
   Hamada, Shuichi
TI The effect of aging on the repeated-dose liver micronucleus assay
SO GENES AND ENVIRONMENT
LA English
DT Article
DE Liver micronucleus assay; Collagenase; Hepatocyte; Repeated-dose liver
   micronucleus assay; Clofibrate
ID COLLABORATIVE STUDY-GROUP; MUTAGEN SOCIETY JEMS; YOUNG-RATS; ADULT RATS
AB Background: The liver micronucleus (MN) assay is an effective and important in vivo test for detecting genotoxic compounds. In particular, the repeated-dose liver MN (RDLMN) assay which greatly facilitates incorporation of the liver MN assay into the general toxicity study has been developed. Usefulness of the RDLMN assay was appraised highly in the 7th International Workshops on Genotoxicity Testing (2017 in Tokyo) in that sufficient numbers and types of chemicals were studied and easy integration into the general toxicity study is preferred from the 3R's point of view. However, it was pointed out that it is necessary to evaluate the effect of age at the start of 4-week repeated administration, since there are limited data, where only those of rats of 6 week of age at the start of administration are available.
   In this study, we conducted the 4-week RDLMN assay using rats of 6 and 8 weeks of age (at the start of administration) to investigate the effect of age on the liver MN inducibility. Clofibrate, a weak inducer of liver MN, was used in this study to detect the slight difference in the liver MN induction.
   Results: The liver MN induced by clofibrate was detected in both rats of 6 and 8 weeks of age at the start of administration. However, the liver MN induction was lower in rats of 8 weeks of age compared to rats of 6 weeks of age at the start of administration.
   Conclusion: These results suggest that the liver MN inducibility decreases with age. Therefore, we recommend the use of rats of 6 weeks of age at start of administration to reliably detect the liver MN induction in the RDLMN assay.
C1 [Shigano, Miyuki; Takasawa, Hironao] LSIM Safety Inst Corp, Kashima Labs, Safety Assessment Dept, 14-1 Sunayama, Kamisu, Ibaraki 3140255, Japan.
   [Hamada, Shuichi] Bozo Res Ctr Inc, Setagaya Ku, 1-3-11 Hanegi, Tokyo 1560042, Japan.
C3 Bozo Research Center Inc.
RP Shigano, M (corresponding author), LSIM Safety Inst Corp, Kashima Labs, Safety Assessment Dept, 14-1 Sunayama, Kamisu, Ibaraki 3140255, Japan.
EM shigano.miyuki@ma.medience.co.jp
CR Asaoka Y, 2010, J VET MED SCI, V72, P471, DOI 10.1292/jvms.09-0397
   Hamada S, 2003, MUTAGENESIS, V18, P273, DOI 10.1093/mutage/18.3.273
   Hamada S, 2015, MUTAT RES-GEN TOX EN, V780, P2, DOI 10.1016/j.mrgentox.2015.01.001
   KASTENBAUM MA, 1970, MUTAT RES, V9, P527, DOI 10.1016/0027-5107(70)90038-2
   Kirkland D, 2019, MUTAT RES-GEN TOX EN, V847, DOI 10.1016/j.mrgentox.2019.03.008
   Narumi K, 2012, MUTAT RES-GEN TOX EN, V747, P234, DOI 10.1016/j.mrgentox.2012.05.012
   Suzuki H, 2005, MUTAT RES-GEN TOX EN, V583, P133, DOI 10.1016/j.mrgentox.2005.03.012
   Suzuki H, 2009, MUTAGENESIS, V24, P9, DOI 10.1093/mutage/gen047
   Takasawa H, 2010, MUTAT RES-GEN TOX EN, V698, P30, DOI 10.1016/j.mrgentox.2010.02.009
   Takasawa H, 2010, MUTAT RES-GEN TOX EN, V698, P24, DOI 10.1016/j.mrgentox.2010.02.010
   Takayanagi T, 2015, MUTAT RES-GEN TOX EN, V780, P117, DOI 10.1016/j.mrgentox.2015.01.002
   UNO Y, 1992, TOXICOL LETT, V63, P191
   Uno Y, 2015, MUTAT RES-GEN TOX EN, V783, P19, DOI 10.1016/j.mrgentox.2015.03.001
NR 13
TC 3
Z9 3
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1880-7046
EI 1880-7062
J9 GENES ENVIRON
JI Gene Environ.
PD SEP 9
PY 2021
VL 43
IS 1
AR 37
DI 10.1186/s41021-021-00212-3
PG 5
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA UO6WM
UT WOS:000694833800001
PM 34503583
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU ASANO, K
   AMAGASE, S
   MATSUURA, ET
   YAMAGISHI, H
AF ASANO, K
   AMAGASE, S
   MATSUURA, ET
   YAMAGISHI, H
TI CHANGES IN THE RAT-LIVER MITOCHONDRIAL-DNA UPON AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE PROTEIN BOUND DNA; BUOYANT DENSITY; DNA ADSORPTION TO MICA
ID CELLS
AB During experiments on the molecular basis of morphological and functional changes observed in rat liver mitochondria upon aging, we found that the buoyant density profile of mitochondrial DNA (mtDNA) shows a wide distribution pattern especially in the lighter region than that of young rat liver mtDNA. The heterogeneous pattern may be partly recovered to become similar to that of young rat liver mtDNA by treatment with proteinase K. Therefore, it is quite likely that mtDNA of old rat liver contains firmly bound protein(s) or peptides. During the morphological observation of mtDNA by electron microscopy, we found that mtDNA of old rat had a novel property, that is, the ability to attach to negatively charged mica in the absence of magnesium ions, although their morphological features showing circular 5-mu-m contour length form did not change. Further, mtDNA gained resistance against EcoRI digestion during aging. This property was not shared by the DNA from young animal. and might be due to the binding protein(s).
C1 OSAKA UNIV,INST MOLEC & CELLULAR BIOL,SUITA,OSAKA 565,JAPAN.
   KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 606,JAPAN.
   OCHANOMIZU UNIV,DEPT BIOL,TOKYO 112,JAPAN.
C3 Osaka University; Kyoto University; Ochanomizu University
RP ASANO, K (corresponding author), KYOTO UNIV,COLL MED TECHNOL,DIV GEN EDUC,53 KAWAHARA MACHI,SAKYO KU,KYOTO 606,JAPAN.
CR ALBRING M, 1973, FEBS LETT, V35, P4, DOI 10.1016/0014-5793(73)80564-2
   ANDRE J, 1971, J ULTRA MOL STRUCT R, V37, P244
   ARBER W, 1969, ANNU REV BIOCHEM, V38, P467, DOI 10.1146/annurev.bi.38.070169.002343
   ASANO K, 1976, ENDOCRINOLOGY, V99, P977, DOI 10.1210/endo-99-4-977
   ASANO K, 1977, LIFE SCI, V21, P49, DOI 10.1016/0024-3205(77)90423-4
   ASANO K, 1965, J MOL BIOL, V14, P71, DOI 10.1016/S0022-2836(65)80231-5
   CANO J, 1986, ARCH GERONTOL GERIAT, V5, P41, DOI 10.1016/0167-4943(86)90006-3
   Economos A.C., 1980, EXP GERONTOL, V15, P575
   FLANNERY GR, 1989, ANN HUM BIOL, V16, P259, DOI 10.1080/03014468900000372
   KISSANE JM, 1958, J BIOL CHEM, V233, P184
   KOLLER T, 1974, BIOPOLYMERS, V13, P995, DOI 10.1002/bip.1974.360130514
   KUNISADA T, 1983, PLASMID, V9, P8, DOI 10.1016/0147-619X(83)90027-6
   LITOSHENKO AY, 1981, EXP GERONTOL, V16, P213, DOI 10.1016/0531-5565(81)90015-2
   LOEB LA, 1982, ANNU REV BIOCHEM, V52, P429
   MASSIE H R, 1981, Age (Media), V9, P42
   MASSIE HR, 1975, GERONTOLOGY, V21, P231, DOI 10.1159/000212049
   MIGUEL J, 1983, EXP GERONTOL, V18, P167
   MURRAY MA, 1982, MECH AGEING DEV, V20, P233, DOI 10.1016/0047-6374(82)90090-2
   PICO L, 1988, MECHANISMS AGING DEV, V43, P279
   RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144
   SHARP PA, 1972, J MOL BIOL, V71, P471, DOI 10.1016/0022-2836(72)90363-4
   TAUCHI H, 1962, J GERONTOL, V17, P254, DOI 10.1093/geronj/17.3.254
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   TAUCHI H, 1961, J MED SCI, V24, P97
   Tauchi H., 1978, LIVER AGING 1978, P3
   WHITE FA, 1985, MECH AGEING DEV, V30, P153, DOI 10.1016/0047-6374(85)90004-1
   YAMAGISHI H, 1976, J VIROL, V18, P1016, DOI 10.1128/JVI.18.3.1016-1023.1976
   YAMAGISHI H, 1982, PLASMID, V8, P299, DOI 10.1016/0147-619X(82)90067-1
NR 28
TC 17
Z9 17
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD NOV 1
PY 1991
VL 60
IS 3
BP 275
EP 284
DI 10.1016/0047-6374(91)90040-7
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GL168
UT WOS:A1991GL16800005
PM 1753810
DA 2024-02-19
ER

PT J
AU Borkham-Kamphorst, E
   Steffen, BT
   Van de Leur, E
   Haas, U
   Tihaa, L
   Friedman, SL
   Weiskirchen, R
AF Borkham-Kamphorst, Erawan
   Steffen, Bettina T.
   Van de Leur, Eddy
   Haas, Ute
   Tihaa, Lidia
   Friedman, Scott L.
   Weiskirchen, Ralf
TI CCN1/CYR61 overexpression in hepatic stellate cells induces ER
   stress-related apoptosis
SO CELLULAR SIGNALLING
LA English
DT Article
DE Unfolded protein response; ER stress; Hepatic stellate cells;
   Myofibroblasts; Matricellular protein; CCN1/CYR61
ID UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; LIVER FIBROSIS;
   TAUROURSODEOXYCHOLIC ACID; CELLULAR SENESCENCE; MYOFIBROBLASTS;
   INDUCTION; MITOCHONDRIA; NUCLEUS; SIGNALS
AB CCN1/CYR61 is a matricellular protein of the CCN family, comprising six secreted proteins specifically associated with the extracellular matrix (ECM). CCN1 acts as an enhancer of the cutaneous wound healing process by preventing hypertrophic scar formation through induction of myofibroblast senescence. In liver fibrosis, the senescent cells are primarily derived from activated hepatic stellate cells (HSC) that initially proliferate in response to liver damage and are the major source of ECM. We investigate here the possible use of CCN1 as a senescence inducer to attenuate liver fibrogenesis by means of adenoviral gene transfer in primary HSC, myofibroblasts (MFB) and immortalized HSC lines (i.e. LX-2, CFSC-2G). Infection with Ad5-CMV-CCN1 induced large amounts of CCN1 protein in all these cells, resulting in an overload of the endoplasmic reticulum (ER) and in a compensatory unfolded protein response (UPR). The UPR resulted in upregulation of ER chaperones including BIP/Grp78, Grp94 and led to an activation of IRE1 alpha as evidenced by spliced XBP1 mRNA with IRE1 alpha-induced JNK phosphorylation. The UPR arm PERK and eIF2a was phosphorylated, combined with significant CHOP upregulation. Ad5-CMV-CCN1 induced HSC apoptosis that was evident by proteolytic cleavage of caspase-12, caspase-9 and the executor caspase-3 and positive TUNEL stain. Remarkably, Ad5-CMV-CCN1 effectively reduced collagen type I mRNA expression and protein. We conclude that the matricellular protein CCN1 gene transfer induces HSC apoptosis through ER stress and UPR. (C) 2015 The Authors. Published by Elsevier Inc.
C1 [Borkham-Kamphorst, Erawan; Steffen, Bettina T.; Van de Leur, Eddy; Haas, Ute; Tihaa, Lidia; Weiskirchen, Ralf] RWTH Aachen Univ Hosp, Inst Mol Pathobiochem Expt Gene Therapy & Clinica, Aachen, Germany.
   [Friedman, Scott L.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA.
C3 RWTH Aachen University; RWTH Aachen University Hospital; Icahn School of
   Medicine at Mount Sinai
RP Borkham-Kamphorst, E (corresponding author), RWTH Univ Hosp, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, D-52074 Aachen, Germany.
EM ekamphorst@ukaachen.de; rweiskirchen@ukaachen.de
RI Weiskirchen, Ralf/O-1734-2018
OI Weiskirchen, Ralf/0000-0003-3888-0931
FU Faculty of Medicine at the RWTH-Aachen University; German Research
   Foundation [SFB/TRR57 P13]; NIH [DK RO1-056621, AA RO1-020709]
FX This work was supported by a START grant from the Faculty of Medicine at
   the RWTH-Aachen University to EBK and a grant from the German Research
   Foundation (SFB/TRR57 P13) to RW. SLF is supported by grants NIH DK
   RO1-056621 and NIH AA RO1-020709.
CR Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014
   BEUERS U, 1993, GASTROENTEROLOGY, V104, P604, DOI 10.1016/0016-5085(93)90433-D
   BEUERS U, 1993, J CLIN INVEST, V92, P2984, DOI 10.1172/JCI116921
   BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762
   Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197
   Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79
   Chami M, 2008, MOL CELL, V32, P641, DOI 10.1016/j.molcel.2008.11.014
   Csordás G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016
   Evangelisti C, 2014, ONCOTARGET, V5, P7886, DOI 10.18632/oncotarget.2318
   Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   GREENWEL P, 1991, LAB INVEST, V65, P644
   Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327
   Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513
   Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Quan TH, 2012, J CELL BIOCHEM, V113, P3011, DOI 10.1002/jcb.24179
   Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   SCHAFER S, 1987, HEPATOLOGY, V7, P680, DOI 10.1002/hep.1840070411
   Schröder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134
   Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x
   Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]
   Weiskirchen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075692
   Weiskirchen R, 2011, FRONT BIOSCI-LANDMRK, V16, P1939, DOI 10.2741/3832
   Welihinda AA, 1999, GENE EXPRESSION, V7, P293
   Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
NR 38
TC 41
Z9 51
U1 2
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0898-6568
EI 1873-3913
J9 CELL SIGNAL
JI Cell. Signal.
PD JAN
PY 2016
VL 28
IS 1
BP 34
EP 42
DI 10.1016/j.cellsig.2015.10.013
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA CZ1RJ
UT WOS:000366882700005
PM 26515130
OA hybrid
DA 2024-02-19
ER

PT J
AU Iwagami, Y
   Zou, J
   Zhang, HY
   Cao, K
   Ji, CC
   Kim, MR
   Huang, CK
AF Iwagami, Yoshifumi
   Zou, Jing
   Zhang, Hongyu
   Cao, Kevin
   Ji, Chengcheng
   Kim, Miran
   Huang, Chiung-Kuei
TI Alcohol-mediated miR-34a modulates hepatocyte growth and apoptosis
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE Bcl2; CDK6; cyclin D1; Sirt1
ID FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA CELLS; C-MET EXPRESSION;
   ANDROGEN RECEPTOR; DOWN-REGULATION; LUNG-CANCER; STEM-CELLS;
   MICRORNA-34A; MICE; P53
AB MicroRNAs (miRs) have been recently shown to be heavily involved in the development of alcoholic liver disease (ALD) and suggested as a potential therapeutic target in ALD. The miR-34a was consistently reported to be significantly elevated in several ALD rodent models, but it remains unclear how miR-34a modulates the cellular behaviours of hepatocytes in ALD development and progression. This study aims to characterize alcohol-induced miR-34a impact on hepatocytes growth and apoptosis. The miRNA array was performed to assess changes in miRNA after chronic alcohol feeding. Liver and blood samples were used to examine ALD progression. The miR-34a was overexpressed in human hepatocytes to evaluate its impact on cell growth and apoptosis. Real-time quantitative PCR and Western blot were used to determine the growth and apoptosis molecular signalling pathways associated with miR-34a. Alcohol feeding significantly promoted fatty liver progression, serum ALT levels, apoptosis and miR-34a expression in rat liver. Overexpression of miR-34a in human hepatocytes suppressed cell growth signallings, including c-Met, cyclin D1 and cyclin-dependent kinase 6 (CDK6). The miR-34a might also inhibit the expression of sirtuin 1 (Sirt1) and its target, B-cell lymphoma 2. Interestingly, the expression of miR-34a reverses the suppressive effects of ethanol on cell growth. But, miR-34a promotes hepatocyte senescence and apoptosis. Although the miR-34a-mediated down-regulation of cell growth-associated genes may contribute to cell growth retardation, other miR-34a targets, such as Sirt1, may reverse this phenotype. Future studies will be needed to clarify the role of miR-34a in ALD progression.
C1 [Huang, Chiung-Kuei] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA.
   Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
C3 Lifespan Health Rhode Island; Rhode Island Hospital; Brown University
RP Huang, CK (corresponding author), Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA.
EM Chiung-Kuei_Huang@Brown.edu
RI Iwagami, Yoshifumi/AAJ-3184-2021
OI Huang, Chiung-Kuei/0000-0001-6331-7898
FU NIGMS [P20GM103430-12]; Rhode Island Foundation [134279]
FX Funding for this work was provided by NIGMS P20GM103430-12 and Rhode
   Island Foundation #134279.
CR Bataller R, 2015, SEMIN LIVER DIS, V35, P146, DOI 10.1055/s-0035-1550054
   Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419
   Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919
   Castro RE, 2013, J HEPATOL, V58, P119, DOI 10.1016/j.jhep.2012.08.008
   Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937
   Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010
   Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797
   Craig VJ, 2012, LEUKEMIA, V26, P2421, DOI 10.1038/leu.2012.110
   Cramer T, 2004, LIVER INT, V24, P335, DOI 10.1111/j.1478-3231.2004.0926.x
   Dang YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061054
   Derdak Z, 2013, J HEPATOL, V58, P785, DOI 10.1016/j.jhep.2012.11.042
   Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109
   Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219
   He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939
   Huang CK, 2015, J HEPATOL, V63, P191, DOI 10.1016/j.jhep.2015.02.030
   Huang CK, 2013, STEM CELL RES, V11, P938, DOI 10.1016/j.scr.2013.06.001
   Huang CK, 2013, HEPATOLOGY, V57, P1550, DOI 10.1002/hep.26135
   Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796
   Lai KP, 2012, EMBO MOL MED, V4, P791, DOI 10.1002/emmm.201101140
   Laterza OF, 2013, BIOMARK MED, V7, P205, DOI [10.2217/BMM.12.107, 10.2217/bmm.12.107]
   Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035
   Li XF, 2015, MOL MED REP, V11, P1017, DOI 10.3892/mmr.2014.2846
   Lin Q, 2015, MOL MED REP, V12, P5709, DOI 10.3892/mmr.2015.4185
   Maricic I, 2015, HEPATOLOGY, V61, P1357, DOI 10.1002/hep.27632
   Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010
   Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1
   Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062
   Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113
   Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com
   Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996
   Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013
   Roychowdhury S, 2012, ALCOHOL CLIN EXP RES, V36, P1139, DOI 10.1111/j.1530-0277.2011.01720.x
   Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057
   Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87
   van Keimpema M, 2014, BLOOD, V124, P3431, DOI 10.1182/blood-2014-01-553412
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wang HJ, 2012, ANNU REV NUTR, V32, P343, DOI 10.1146/annurev-nutr-072610-145138
   Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655
   Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105
   Yang F, 2014, TECHNOL CANCER RES T, V13, P77, DOI 10.7785/tcrt.2012.500364
NR 42
TC 12
Z9 14
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD AUG
PY 2018
VL 22
IS 8
BP 3987
EP 3995
DI 10.1111/jcmm.13681
PG 9
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA GN9IJ
UT WOS:000439508300027
PM 29873178
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Jiang, W
   Ou, ZL
   Zhu, Q
   Zai, HY
AF Jiang, Wei
   Ou, Zhenglin
   Zhu, Qin
   Zai, Hongyan
TI RagC GTPase regulates mTOR to promote chemoresistance in senescence-like
   HepG2 cells
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE senescence; mTOR; GTPase; liver cancer; chemoresistance
ID ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; CANCER; TARGET; RNA
AB Radiotherapy and chemotherapy can arrest cancer cells in a senescence-like state, which can lead to therapy resistance and cancer relapse. mTOR is hyperactivated in senescent cells but the mechanisms remain unclear. In this study, we examine the roles of several mTOR-regulated GTPases in senescence-like liver cancer cells and the mechanisms in drug resistance. We show that although RagC, Rheb, Rab1A, Rab5 and Arf1 GTPases were required for optimal mTOR activation in proliferating HepG2 cells, only RagC and Rheb are required in the senescence-like counterparts. Consistently, the drug resistance of the senescence-like HepG2 can be reduced by knocking down RagC and Rheb but not the other GTPases. Autophagic and lysosomal activity were increased in senescence-like cells; pharmacological inhibition of autophagy-lysosome decreased mTOR activity and preferentially sensitized senescence-like HepG2 cells to chemotherapy drugs including trametinib, cisplatin, and doxorubicin. In liver cancer patients, expression of RagC and Rheb but not other GTPases examined was associated with unfavorable prognosis. Our study therefore has defined a key role of Rag-Rheb GTPase in mediating mTOR activation and drug resistance in senescence-like HepG2 cells, which could have important implications in developing second-line treatments for liver cancer patients.
C1 [Jiang, Wei; Ou, Zhenglin; Zhu, Qin; Zai, Hongyan] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China.
   [Jiang, Wei; Ou, Zhenglin; Zhu, Qin; Zai, Hongyan] Cent South Univ, Natl Clin Res Ctr Geriat Disorders, Changsha, Hunan, Peoples R China.
C3 Central South University; Central South University
RP Zai, HY (corresponding author), Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China.; Zai, HY (corresponding author), Cent South Univ, Natl Clin Res Ctr Geriat Disorders, Changsha, Hunan, Peoples R China.
EM 1029165173@qq.com
CR Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carroll B, 2020, SEMIN CELL DEV BIOL, V107, P103, DOI 10.1016/j.semcdb.2020.02.007
   Carroll B, 2017, J CELL BIOL, V216, P1949, DOI 10.1083/jcb.201610113
   Chambers CR, 2021, MOL ONCOL, V15, P3242, DOI 10.1002/1878-0261.13042
   Chen XS, 2020, CELL SIGNAL, V73, DOI 10.1016/j.cellsig.2020.109706
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Efeyan A, 2014, DEV CELL, V29, P321, DOI 10.1016/j.devcel.2014.03.017
   Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756
   Gordon RR, 2012, DRUG RESIST UPDATE, V15, P123, DOI 10.1016/j.drup.2012.01.002
   Groenewoud MJ, 2013, BIOCHEM SOC T, V41, P951, DOI 10.1042/BST20130037
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200
   Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472
   Joy J, 2021, DEV CELL, V56, P2043, DOI 10.1016/j.devcel.2021.06.009
   Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107
   Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483
   Makhoul Christian, 2021, Fac Rev, V10, P50, DOI 10.12703/r/10-50
   Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314
   Moreno DF, 2019, ELIFE, V8, DOI 10.7554/eLife.48240
   Mossmann D, 2018, NAT REV CANCER, V18, P744, DOI 10.1038/s41568-018-0074-8
   Murugan AK, 2019, SEMIN CANCER BIOL, V59, P92, DOI 10.1016/j.semcancer.2019.07.003
   Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386
   Recasens A, 2019, TRENDS PHARMACOL SCI, V40, P128, DOI 10.1016/j.tips.2018.12.004
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Stracka D, 2014, J BIOL CHEM, V289, P25010, DOI 10.1074/jbc.M114.574335
   Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247
   Thomas JD, 2016, CANCER CELL, V30, P181, DOI 10.1016/j.ccell.2016.06.014
   Thompson EL, 2021, CANCERS, V13, DOI 10.3390/cancers13092241
   Wang BK, 2021, ONCOGENE, V40, P5590, DOI 10.1038/s41388-021-01911-5
   Wang LQ, 2022, NAT REV CANCER, V22, P340, DOI 10.1038/s41568-022-00450-9
   Wei YH, 2015, BIOL REV, V90, P167, DOI 10.1111/brv.12103
   Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179
   Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263
   Zhang H, 2000, EXP CELL RES, V259, P284, DOI 10.1006/excr.2000.4965
NR 38
TC 1
Z9 1
U1 2
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD OCT 4
PY 2022
VL 13
AR 949737
DI 10.3389/fphys.2022.949737
PG 10
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 5M1SH
UT WOS:000870883700001
PM 36267578
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ishigami, A
   Fujita, T
   Handa, S
   Shirasawa, T
   Koseki, H
   Kitamura, T
   Enomoto, N
   Sato, N
   Shimosawa, T
   Maruyama, N
AF Ishigami, A
   Fujita, T
   Handa, S
   Shirasawa, T
   Koseki, H
   Kitamura, T
   Enomoto, N
   Sato, N
   Shimosawa, T
   Maruyama, N
TI Senescence marker protein-30 knockout mouse liver is highly susceptible
   to tumor necrosis factor-α- and Fas-mediated apoptosis
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID RAT-LIVER; X-CHROMOSOME; CELL-DEATH; SMP30; EXPRESSION; REGUCALCIN;
   CA2+; GENE; INTRANUCLEAR; HEPATOCYTES
AB Senescence marker protein-30 (SMP30) is a calcium-binding protein that decreases in an androgen-independent manner with aging. To elucidate the physiological role of this protein, we introduced a null mutation of the SMP30 gene into the germ line of mice. Despite the complete lack of SMP30 (SMP30-/-), these mutant mice were indistinguishable from their wild-type (SMP30+/+) littermates in terms of development and fertilization capability. We then investigated the tissue susceptibility for apoptosis induced by cytokine using primary cultured hepatocytes, because SMP30 could rescue cells from cell death caused by calcium influx, using a calcium ionophore as previously described. SMP30-/- hepatocytes were found to be more susceptible to apoptosis induced by tumor necrosis factor-alpha (TNF-alpha) plus actinomycin D (ActD) than SMP30+/+ hepatocytes. In addition, the TNF-alpha/ActD-induced caspase-8 activity in SMP30-/- hepatocytes was twofold greater than that in SMP30+/+ hepatocytes. In contrast, no significant difference was observed in the TNF-a/ActD-induced nuclear factor-kappaB activation of SMP30+/+ versus SMP30-/- hepatocytes, indicating that SMP30 is not related to TNF-alpha/ActD-induced nuclear factor-kappaB activation itself. Moreover, deletion of the SMP30 gene enhanced liver injury after treatment in vivo with anti-Fas antibody and the SMP30+/- mice showed intermediate susceptibility to Fas-induced apoptosis. Collectively, these results demonstrate that SMP30 acts to protect cells from apoptosis.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
   Tokyo Metropolitan Inst Gerontol, Dept Mol Genet, Itabashi Ku, Tokyo 1730015, Japan.
   Chiba Univ, Grad Sch Med, Dept Mol Embryol, Chiba, Japan.
   Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan
   Institute of Gerontology; Chiba University; Juntendo University
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
RI Koseki, Haruhiko/I-3825-2014; Shimosawa, Tatsuo/A-2920-2015
OI Koseki, Haruhiko/0000-0001-8424-5854; Shimosawa,
   Tatsuo/0000-0002-8742-5129; Ishigami, Akihito/0000-0001-7875-7482
CR Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305
   Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568
   BELLOMO G, 1992, CANCER RES, V52, P1342
   Chevalier S, 2000, EUR J BIOCHEM, V267, P4624, DOI 10.1046/j.1432-1327.2000.01487.x
   Clarkson RWE, 2000, J BIOL CHEM, V275, P12737, DOI 10.1074/jbc.275.17.12737
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Goto SG, 2000, J INSECT PHYSIOL, V46, P1111, DOI 10.1016/S0022-1910(99)00221-8
   Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914
   Guidotti JE, 2001, HEPATOLOGY, V33, P10, DOI 10.1053/jhep.2001.20678
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   ISHIGAMI A, 1994, J CELL PHYSIOL, V158, P231, DOI 10.1002/jcp.1041580204
   Koller H, 1996, BRAIN, V119, P2021, DOI 10.1093/brain/119.6.2021
   Kong SK, 1997, ONCOLOGY-BASEL, V54, P55
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Nakajima Y, 2000, J BIOCHEM-TOKYO, V127, P901, DOI 10.1093/oxfordjournals.jbchem.a022685
   OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0
   PRENTKI M, 1980, BIOCHIM BIOPHYS ACTA, V627, P262, DOI 10.1016/0304-4165(80)90456-0
   PROCHNIEWICZNAKAYAMA E, 1983, J CELL BIOL, V97, P1663, DOI 10.1083/jcb.97.6.1663
   RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T
   Sato A, 2000, MECH DEVELOP, V92, P273, DOI 10.1016/S0925-4773(99)00331-7
   SHIMOKAWA N, 1993, FEBS LETT, V316, P79, DOI 10.1016/0014-5793(93)81740-Q
   Takahashi H, 2000, J CELL BIOCHEM, V78, P121
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058
   Xue JH, 2000, J CELL BIOCHEM, V80, P285
   Yuan JY, 1997, CURR OPIN CELL BIOL, V9, P247, DOI 10.1016/S0955-0674(97)80069-5
NR 32
TC 148
Z9 176
U1 2
U2 6
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD OCT
PY 2002
VL 161
IS 4
BP 1273
EP 1281
DI 10.1016/S0002-9440(10)64404-5
PG 9
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 601NQ
UT WOS:000178453000020
PM 12368201
OA Green Published
DA 2024-02-19
ER

PT J
AU Régnier, M
   Polizzi, A
   Smati, S
   Lukowicz, C
   Fougerat, A
   Lippi, Y
   Fouché, E
   Lasserre, F
   Naylies, C
   Bétoulières, C
   Barquissau, V
   Mouisel, E
   Bertrand-Michel, J
   Batut, A
   Al Saati, T
   Canlet, C
   Tremblay-Franco, M
   Ellero-Simatos, S
   Langin, D
   Postic, C
   Wahli, W
   Loiseau, N
   Guillou, H
   Montagner, A
AF Regnier, Marion
   Polizzi, Arnaud
   Smati, Sarra
   Lukowicz, Celine
   Fougerat, Anne
   Lippi, Yannick
   Fouche, Edwin
   Lasserre, Frederic
   Naylies, Claire
   Betoulieres, Colette
   Barquissau, Valentin
   Mouisel, Etienne
   Bertrand-Michel, Justine
   Batut, Aurelie
   Al Saati, Talal
   Canlet, Cecile
   Tremblay-Franco, Marie
   Ellero-Simatos, Sandrine
   Langin, Dominique
   Postic, Catherine
   Wahli, Walter
   Loiseau, Nicolas
   Guillou, Herve
   Montagner, Alexandra
TI Hepatocyte-specific deletion of <i>Pparα</i> promotes NAFLD in the
   context of obesity
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACTIVATED-RECEPTOR-ALPHA; HIGH-FAT DIET; ADIPOSE-TISSUE; ADAPTIVE
   RESPONSE; LIPID-METABOLISM; GENE-EXPRESSION; LIVER; STEATOHEPATITIS;
   INFLAMMATION; FIBROSIS
AB Peroxisome proliferator activated receptor alpha (PPAR alpha) acts as a fatty acid sensor to orchestrate the transcription of genes coding for rate-limiting enzymes required for lipid oxidation in hepatocytes. Mice only lacking Ppar alpha in hepatocytes spontaneously develop steatosis without obesity in aging. Steatosis can develop into non alcoholic steatohepatitis (NASH), which may progress to irreversible damage, such as fibrosis and hepatocarcinoma. While NASH appears as a major public health concern worldwide, it remains an unmet medical need. In the current study, we investigated the role of hepatocyte PPAR alpha in a preclinical model of steatosis. For this, we used High Fat Diet (HFD) feeding as a model of obesity in C57BL/6J male Wild-Type mice (WT), in whole-body Ppar alpha (-) deficient mice (Ppar alpha (-/-)) and in mice lacking Ppar alpha only in hepatocytes (Ppar alpha (hep-/-)). We provide evidence that Ppar alpha deletion in hepatocytes promotes NAFLD and liver inflammation in mice fed a HFD. This enhanced NAFLD susceptibility occurs without development of glucose intolerance. Moreover, our data reveal that non-hepatocytic PPAR alpha activity predominantly contributes to the metabolic response to HFD. Taken together, our data support hepatocyte PPAR alpha as being essential to the prevention of NAFLD and that extra-hepatocyte PPAR alpha activity contributes to whole-body lipid homeostasis.
C1 [Regnier, Marion; Polizzi, Arnaud; Smati, Sarra; Lukowicz, Celine; Fougerat, Anne; Lippi, Yannick; Fouche, Edwin; Lasserre, Frederic; Naylies, Claire; Betoulieres, Colette; Canlet, Cecile; Tremblay-Franco, Marie; Ellero-Simatos, Sandrine; Wahli, Walter; Loiseau, Nicolas; Guillou, Herve; Montagner, Alexandra] Paul Sabatier Univ, Univ Toulouse, INP Purpan, Toxalim,INRAE UMR 1331,ENVT, F-31027 Toulouse, France.
   [Smati, Sarra; Barquissau, Valentin; Mouisel, Etienne; Langin, Dominique; Montagner, Alexandra] Paul Sabatier Univ, Inst Natl Sante & Rech Med INSERM, Inst Metab & Cardiovasc Dis, UMR1048,Univ Toulouse, Toulouse, France.
   [Bertrand-Michel, Justine; Batut, Aurelie] Inst Natl Sante & Rech Med INSERM, Metatoul Lipid Facil, MetaboHUB, UMR1048,Inst Metab & Cardiovasc Dis, Toulouse, France.
   [Al Saati, Talal] CHU Purpan, Serv Histopathol Expt Unite INSERM, UPS, ENVT US006,CREFRE Inserm, F-31024 Toulouse 3, France.
   [Langin, Dominique] Toulouse Univ Hosp, Lab Clin Biochem, Toulouse, France.
   [Postic, Catherine] Inst Cochin, Inst Natl Sante & Rech Med INSERM, U1016, Paris, France.
   [Wahli, Walter] Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Clin Sci Bldg,11 Mandalay Rd, Singapore, Singapore.
   [Wahli, Walter] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.
C3 Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse;
   Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National
   Polytechnique de Toulouse; INRAE; Universite Toulouse III - Paul
   Sabatier; Universite de Toulouse; Universite Toulouse III - Paul
   Sabatier; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite de Toulouse; Universite Toulouse III - Paul
   Sabatier; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite de Toulouse; Universite Toulouse III - Paul
   Sabatier; Universite de Toulouse; Universite Toulouse III - Paul
   Sabatier; CHU de Toulouse; Universite Paris Cite; Institut National de
   la Sante et de la Recherche Medicale (Inserm); Nanyang Technological
   University; University of Lausanne
RP Guillou, H; Montagner, A (corresponding author), Paul Sabatier Univ, Univ Toulouse, INP Purpan, Toxalim,INRAE UMR 1331,ENVT, F-31027 Toulouse, France.; Montagner, A (corresponding author), Paul Sabatier Univ, Inst Natl Sante & Rech Med INSERM, Inst Metab & Cardiovasc Dis, UMR1048,Univ Toulouse, Toulouse, France.
EM herve.guillou@inrae.fr; alexandra.montagner@inserm.fr
RI Guillou, Hervé/AGL-0750-2022; LOISEAU, Nicolas/ADN-2394-2022; Smati,
   Sarra/ABH-3217-2020; Guillou, Herve/AAG-2826-2020
OI Guillou, Hervé/0000-0002-5363-9081; LOISEAU,
   Nicolas/0000-0003-3783-0879; Smati, Sarra/0000-0002-5749-983X; Guillou,
   Herve/0000-0002-5363-9081; REGNIER, Marion/0000-0002-5005-0597; Lippi,
   Yannick/0000-0003-4717-078X; Mouisel, Etienne/0000-0002-4676-5709;
   Montagner, Alexandra/0000-0002-4800-5105
FU Universite Paul Sabatier (Toulouse); Lee Kong Chian School of Medicine,
   Nanyang Technological University Singapore; ANR "Fumolip"; ANR
   "Hepadialogue"; JPI HDHL - FATMAL; Region Occitanie
FX We thank all members of the EZOP staff for their careful help from the
   early start of this project. We thank Lea Morra-Charrot and Laurent
   Monbrun from Anexplo for their excellent work on plasma biochemistry. We
   thank the staff from the Genotoul: Anexplo, GeT-TRiX and
   Metatoul-Lipidomic facilities. The authors wish to thank Pr Daniel
   Metzger, Pr Pierre Chambon (IGBMC, Illkirch, France) and the staff of
   the Mouse Clinical Institute (Illkirch, France) for their critical
   support in this project. We thank Pr Didier Trono (EPFL, Lausanne,
   Switzerland) for providing the Albumin-Cre mice. We thank Dr Joel Haas,
   Pr Bart Staels and Dr Thierry Pineau for constructive discussions. We
   thank Dr Thierry Pineau for providing us with Ppar alpha-null mice. M.R.
   is supported by a PhD grant from Universite Paul Sabatier (Toulouse).
   W.W. is supported by the Lee Kong Chian School of Medicine, Nanyang
   Technological University Singapore start-up Grant. This work was funded
   by ANR "Fumolip" and "Hepadialogue" (to C.P,. D.L., N.L. and H.G.).
   S.E.-S., N.L., A.M. and H.G. are supported by the JPI HDHL - FATMAL.
   A.M., W.W., D.L., N.L. and H.G. were supported by Region Occitanie.
CR Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Barquissau V, 2016, MOL METAB, V5, P352, DOI 10.1016/j.molmet.2016.03.002
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   Brocker CN, 2018, J LIPID RES, V59, P2140, DOI [10.1194/jlr.M088419, 10.1194/jlr.m088419]
   Bünger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006
   Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253
   Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036
   Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577
   Cotter DG, 2014, AM J PHYSIOL-ENDOC M, V307, pE176, DOI 10.1152/ajpendo.00087.2014
   Defour M, 2018, MOL METAB, V10, P39, DOI 10.1016/j.molmet.2018.01.023
   Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Dubois V, 2017, J CLIN INVEST, V127, P1202, DOI 10.1172/JCI88894
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Farrell G, 2019, HEPATOLOGY, V69, P2241, DOI 10.1002/hep.30333
   Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044
   Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019
   Goldstein I, 2015, TRENDS ENDOCRIN MET, V26, P699, DOI 10.1016/j.tem.2015.09.005
   Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320
   Gross B, 2017, NAT REV ENDOCRINOL, V13, P36, DOI 10.1038/nrendo.2016.135
   Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191
   Hernández EA, 2017, J CLIN INVEST, V127, P695, DOI 10.1172/JCI89444
   Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001
   Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170
   Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307
   Iroz A, 2017, CELL REP, V21, P403, DOI 10.1016/j.celrep.2017.09.065
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002
   Kharitonenkov A, 2015, TRENDS ENDOCRIN MET, V26, P608, DOI 10.1016/j.tem.2015.09.007
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779
   Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581
   Le Cao KA, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.01601694981383, DOI 10.1371/JOURNAL.PONE.01601694981383]
   LEE SST, 1995, MOL CELL BIOL, V15, P3012
   Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473
   Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710
   Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969
   Mansouri RM, 2008, ENDOCRINOLOGY, V149, P3215, DOI 10.1210/en.2007-1339
   Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003
   Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798
   Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132
   Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468
   Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039
   Polizzi A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101624
   Rando G, 2016, ELIFE, V5, DOI 10.7554/eLife.11853
   Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038
   Régnier M, 2018, MOL CELL ENDOCRINOL, V471, P75, DOI 10.1016/j.mce.2017.07.035
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431
   Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045
   Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002
   Singhal G, 2018, MOL METAB, V13, P56, DOI 10.1016/j.molmet.2018.03.002
   Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461
   Stienstra R, 2007, ENDOCRINOLOGY, V148, P2753, DOI 10.1210/en.2007-0014
   Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tamura S, 2005, J CLIN INVEST, V115, P1139, DOI 10.1172/JCI200524930
   Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358
   van Diepen JA, 2014, J HEPATOL, V61, P366, DOI 10.1016/j.jhep.2014.04.013
   Wettstein G, 2017, HEPATOL COMMUN, V1, P524, DOI 10.1002/hep4.1057
   Wong VWS, 2018, NAT REV GASTRO HEPAT, V15, P461, DOI 10.1038/s41575-018-0014-9
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 70
TC 67
Z9 69
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 16
PY 2020
VL 10
IS 1
AR 6489
DI 10.1038/s41598-020-63579-3
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA ND8GV
UT WOS:000562142100008
PM 32300166
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Selzner, M
   Selzner, N
   Jochum, W
   Graf, R
   Clavien, PA
AF Selzner, Markus
   Selzner, Nazia
   Jochum, Wolfram
   Graf, Rolf
   Clavien, Pierre-Alain
TI Increased ischemic injury in old mouse liver: An ATP-dependent mechanism
SO LIVER TRANSPLANTATION
LA English
DT Article
ID REPERFUSION INJURY; HEPATITIS-C; RAT-LIVER; AGE; TRANSPLANTATION;
   RESPONSES; DONORS; DAMAGE
AB Although livers exhibit only minimal morphologic changes with age, how older livers tolerate pathologic conditions such as normothermic ischemia is unknown. Young 6-week-old mice and old 60-week-old mice underwent 60 minutes of hepatic ischemia and various periods of reperfusion. Markers of hepatocyte injury, hepatic energy content, and mitochondrial function were determined. Ischemic preconditioning and glucose injection were evaluated as protective strategies against reperfusion injury in old mice. Reperfusion injury was far worse in old mice compared with mice in the young control group. Ischemic preconditioning was highly protective against reperfusion injury in young but not in old mice. Older livers had dramatically reduced adenosine triphosphate (ATP) levels and glycogen contents. The low intrahepatic energy level in old mice was associated with a reduced mitochondrial ATP production. Preoperative injection of glucose restored the intrahepatic ATP content and protected against reperfusion injury. Furthermore, glucose injection restored the protective effect of ischemic preconditioning, resulting in additive protection when both strategies were combined. Aging of the liver is associated with mitochondrial dysfunction and decreased intrahepatic energy content, resulting in poorer tolerance against ischemic injury. Improving intrahepatic ATP levels in old livers by glucose injection protects the old liver against ischemic injury and restores the protective effects of ischemic preconditioning.
C1 Univ Zurich Hosp, Swiss HPB Ctr, Hepatopancreatobiliary Ctr, Dept Visceral Surg, CH-8091 Zurich, Switzerland.
   Univ Zurich Hosp, Swiss HPB Ctr, Hepatopancreatobiliary Ctr, Dept Transplantat, CH-8091 Zurich, Switzerland.
   Univ Zurich Hosp, Swiss HPB Ctr, Hepatopancreatobiliary Ctr, Dept Pathol, CH-8091 Zurich, Switzerland.
C3 University of Zurich; University Zurich Hospital; University of Zurich;
   University Zurich Hospital; University of Zurich; University Zurich
   Hospital
RP Clavien, PA (corresponding author), Univ Zurich, Dept Visceral Surg & Transplantat, Ramistr 100, CH-8091 Zurich, Switzerland.
EM Clavien@chir.unizh.ch
RI Selzner, Markus/AAE-9071-2020; Selzner, Nazia/AAI-1469-2020
OI Selzner, Markus/0000-0002-4326-0887; Selzner, Nazia/0000-0002-9435-2597;
   Graf, Rolf/0000-0001-7449-7302
FU NIDDK NIH HHS [DK54048-01A1] Funding Source: Medline
CR ABOUNA GM, 1987, SURGERY, V101, P91
   Berenguer M, 2005, J HEPATOL, V42, P448, DOI 10.1016/j.jhep.2005.01.011
   Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d
   Clavien PA, 2003, LANCET, V361, P1742, DOI 10.1016/S0140-6736(03)13341-7
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   Gasbarrini A, 1998, FREE RADICAL BIO MED, V24, P211, DOI 10.1016/S0891-5849(97)00056-7
   Gonzalez-Chamorro A, 1998, HEPATO-GASTROENTEROL, V45, P510
   Harris NR, 1998, AM J PHYSIOL-HEART C, V274, pH1509, DOI 10.1152/ajpheart.1998.274.5.H1509
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LECOUTEUR DG, 1994, TRANSPLANTATION, V58, P531, DOI 10.1097/00007890-199409150-00001
   Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066
   MADARIAGA JR, 1995, ANN SURG ONCOL, V2, P483, DOI 10.1007/BF02307080
   Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Peralta C, 2003, TRANSPLANT P, V35, P1800, DOI 10.1016/S0041-1345(03)00571-2
   Petrowsky H, 2005, WORLD J SURG, V29, P1093, DOI 10.1007/s00268-005-1130-6
   PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024
   Rifai K, 2004, J HEPATOL, V41, P446, DOI 10.1016/j.jhep.2004.05.013
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Selzner N, 2006, BRIT J SURG, V93, P587, DOI 10.1002/bjs.5281
   Shah PC, 1999, MECH AGEING DEV, V107, P37, DOI 10.1016/S0047-6374(98)00127-4
   Vajdová K, 2002, HEPATOLOGY, V36, P1543, DOI 10.1053/jhep.2002.37189
   VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P549
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   Yadav SS, 1998, AM J PHYSIOL-GASTR L, V275, pG1341, DOI 10.1152/ajpgi.1998.275.6.G1341
NR 27
TC 100
Z9 109
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
EI 1527-6473
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD MAR
PY 2007
VL 13
IS 3
BP 382
EP 390
DI 10.1002/lt.21100
PG 9
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA 141WH
UT WOS:000244609200012
PM 17318856
OA Bronze
DA 2024-02-19
ER

PT J
AU Sun, KY
   Zhang, YZ
   Li, YL
   Yang, PY
   Sun, YT
AF Sun, Kaiyue
   Zhang, Yingzi
   Li, Yingliang
   Yang, Pengyu
   Sun, Yingting
TI Biochemical Targets and Molecular Mechanism of Matrine against Aging
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE matrine; aging; network pharmacology; PARP1; NAD(+)
ID LIFE-SPAN; WEB SERVER; MITOCHONDRIAL; PATHWAY; UPDATE; IDENTIFICATION;
   INHIBITION; MITOPHAGY; GROMACS
AB The aim of this study is to explore the potential targets and molecular mechanism of matrine (MAT) against aging. Bioinformatic-based network pharmacology was used to investigate the aging-related targets and MAT-treated targets. A total of 193 potential genes of MAT against aging were obtained and then the top 10 key genes (cyclin D1, cyclin-dependent kinase 1, Cyclin A2, androgen receptor, Poly [ADP-ribose] polymerase-1 (PARP1), histone-lysine N-methyltransferase, albumin, mammalian target of rapamycin, histone deacetylase 2, and matrix metalloproteinase 9) were filtered by the molecular complex detection, maximal clique centrality (MMC) algorithm, and degree. The Metascape tool was used for analyzing biological processes and pathways of the top 10 key genes. The main biological processes were response to an inorganic substance and cellular response to chemical stress (including cellular response to oxidative stress). The major pathways were involved in cellular senescence and the cell cycle. After an analysis of major biological processes and pathways, it appears that PARP1/nicotinamide adenine dinucleotide (NAD(+))-mediated cellular senescence may play an important role in MAT against aging. Molecular docking, molecular dynamics simulation, and in vivo study were used for further investigation. MAT could interact with the cavity of the PARP1 protein with the binding energy at -8.5 kcal/mol. Results from molecular dynamics simulations showed that the PARP1-MAT complex was more stable than PARP1 alone and that the binding-free energy of the PARP1-MAT complex was -15.962 kcal/mol. The in vivo study showed that MAT could significantly increase the NAD(+) level of the liver of d-gal-induced aging mice. Therefore, MAT could interfere with aging through the PARP1/NAD(+)-mediated cellular senescence signaling pathway.
C1 [Sun, Kaiyue; Zhang, Yingzi; Li, Yingliang; Yang, Pengyu; Sun, Yingting] Shanxi Agr Univ, Coll Vet Med, Jinzhong 030801, Peoples R China.
C3 Shanxi Agricultural University
RP Sun, KY (corresponding author), Shanxi Agr Univ, Coll Vet Med, Jinzhong 030801, Peoples R China.
EM sunkaiyue21@163.com; sxxncc@163.com
RI lu, Li/KBA-2603-2024; zhao, lin/JJF-0406-2023; Zhang,
   Yuan/JUF-7293-2023; wang, yi/JYO-8193-2024; Yang, Fan/JMA-9594-2023;
   wang, xiaoxuan/JMP-6531-2023; wang, zhe/JNE-3510-2023; Yun,
   Ji/KAL-9759-2024; Li, Wei/JLL-4365-2023; li, Li/JPA-0218-2023; Wang,
   Xuechun/JRX-6509-2023; zhang, ly/JMB-7214-2023; zheng,
   yan/JKJ-3632-2023; Li, Yao/JJC-2927-2023; Liu, Zhihao/JUF-7651-2023;
   Zhang, Yunyi/JHS-3626-2023; xiang, wei/JXL-3308-2024; Wang,
   Xin/JVE-0200-2024; zhang, xiao/JCN-8822-2023; Liu, Jie/JCP-1070-2023;
   yang, liu/JXX-5043-2024; wang, xi/JNT-5162-2023; liu,
   jingwen/JQW-9270-2023; Zhang, Wei/JKI-3565-2023; Yang,
   Fan/JVO-8611-2024; chen, gang/JRX-1197-2023; Wang, Jing/JRW-1512-2023;
   li, li/JVP-2971-2024; zhang, ying/JQX-1479-2023; zhao,
   yan/JNT-6961-2023; Li, Yan/JRW-0176-2023; sun, chen/JCP-0396-2023; Li, J
   N/JXL-5833-2024; liu, yuhao/JWP-0475-2024; liu, xingyu/JXW-9444-2024;
   YI, J/JJE-7713-2023; li, yifan/JHU-9272-2023; Liu, Yang/JVD-6777-2023;
   wang, xin/JWA-3772-2024; Wang, Jin/KAM-5595-2024; yang,
   xiao/JLL-7721-2023; Li, Yan/JUU-5189-2023; li, tao/JVO-9006-2024; zhao,
   lin/JPK-8436-2023; Liu, Shaobo/JUU-5767-2023; LI, WEI/JUE-9796-2023;
   Ling, Li/JYO-7043-2024; zhang, xinyu/JKI-8403-2023; Li,
   YU/JQV-2716-2023; Zhou, Yue/JHS-8791-2023; liu, yang/JMB-9083-2023; Li,
   Wen/JQI-4757-2023; Liu, Xiong/JWO-1231-2024; wang, wei/JYP-7819-2024;
   peng, jy/JMB-2297-2023; LIU, LIYING/KAM-4121-2024; yang,
   rui/JHI-3328-2023; Wang, yl/JNR-4963-2023; Zhang, Yun/JCN-7026-2023;
   yuanyuan, Li/JEZ-6497-2023; Jing, Jing/JSK-6237-2023; WANG,
   YUHAO/KBB-0213-2024; liu, xiao/JLL-2119-2023; Chen, Yu/JLL-0171-2023;
   wang, xiaoqiang/JMT-2783-2023; wang, jun/JPY-3635-2023; li,
   jincheng/GQP-6856-2022; Li, Kexin/KAO-2519-2024; Zhang,
   Bo/JVD-9890-2024; Li, Lei/JPE-6543-2023; WANG, YING/JLM-9219-2023; Wang,
   Yue/JRY-8962-2023
OI Liu, Xiong/0000-0001-9021-3031; peng, jy/0000-0001-9665-1059; Wang,
   Yue/0000-0001-8673-6358
FU Science and Technology Innovation Project of Universities in Shanxi
   Province [2021L177]; Innovation Projects of College of Veterinary
   Medicine, Shanxi Agricultural University [DY-Q001]
FX This work was supported by the Science and Technology Innovation Project
   of Universities in Shanxi Province (2021L177) and Innovation Projects of
   College of Veterinary Medicine, Shanxi Agricultural University
   (DY-Q001).
CR Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Chaib S, 2022, NAT MED, V28, P1556, DOI 10.1038/s41591-022-01923-y
   Cui Q, 2020, J ETHNOPHARMACOL, V257, DOI 10.1016/j.jep.2020.112891
   De Vivo M, 2016, J MED CHEM, V59, P4035, DOI 10.1021/acs.jmedchem.5b01684
   Di S, 2021, J ETHNOPHARMACOL, V276, DOI 10.1016/j.jep.2021.114180
   Elmasry GF, 2019, BIOORG CHEM, V87, P655, DOI 10.1016/j.bioorg.2019.03.068
   Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   Gao XY, 2022, STEM CELL REV REP, V18, P2315, DOI 10.1007/s12015-022-10370-8
   Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024
   Guo SS, 2023, P NATL ACAD SCI USA, V120, DOI 10.1073/pnas.2213857120
   Han XJ, 2016, AGING CELL, V15, P416, DOI 10.1111/acel.12446
   Harel A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-348
   He XR, 2015, J ETHNOPHARMACOL, V172, P10, DOI 10.1016/j.jep.2015.06.010
   Hou HJ, 2019, J CELL BIOCHEM, V120, P13573, DOI 10.1002/jcb.28632
   Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015
   Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m
   Li PY, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00028
   Liu H, 2013, J ETHNOPHARMACOL, V146, P773, DOI 10.1016/j.jep.2013.02.004
   Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300
   Liu ZW, 2017, EUR J PHARMACOL, V804, P21, DOI 10.1016/j.ejphar.2017.03.061
   Mehdizadeh M, 2022, NAT REV CARDIOL, V19, P250, DOI 10.1038/s41569-021-00624-2
   Mitchell E, 2020, BRIT J HOSP MED, V81, DOI 10.12968/hmed.2019.0377
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Nickel J, 2014, NUCLEIC ACIDS RES, V42, pW26, DOI 10.1093/nar/gku477
   Pan JL, 2019, J FORESTRY RES, V30, P1105, DOI 10.1007/s11676-019-00883-3
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Pinzi L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184331
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13
   Salmaso V, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00923
   Sas K, 2018, MOLECULES, V23, DOI 10.3390/molecules23010191
   Shi JF, 2020, LIFE SCI, V261, DOI 10.1016/j.lfs.2020.118354
   Song JZ, 1999, J CHROMATOGR A, V857, P303, DOI 10.1016/S0021-9673(99)00758-X
   Sun KY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7108604
   Sun KY, 2019, METAB BRAIN DIS, V34, P173, DOI 10.1007/s11011-018-0335-y
   Sun N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24401
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Wang J, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020254
   Wang X, 2017, NUCLEIC ACIDS RES, V45, pW356, DOI 10.1093/nar/gkx374
   Wei RJ, 2018, CELL STRESS CHAPERON, V23, P1295, DOI 10.1007/s12192-018-0937-7
   Weichhart T, 2018, GERONTOLOGY, V64, P127, DOI 10.1159/000484629
   Wu ZH, 2018, INT J NEUROPSYCHOPH, V21, P764, DOI 10.1093/ijnp/pyy028
   Xia QH, 2018, AGING DIS, V9, P17, DOI 10.14336/AD.2017.0230
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu S, 2019, AGING CELL, V18, DOI 10.1111/acel.12918
   Yang J, 2015, INT J MOL SCI, V16, P25744, DOI 10.3390/ijms161025744
   Yuan HD, 2017, MOLECULES, V22, DOI 10.3390/molecules22071135
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang L, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158450
   Zhang Y, 2020, MOLECULES, V25, DOI 10.3390/molecules25184094
   Zhang ZF, 2014, BIOCHEM PHARMACOL, V91, P74, DOI 10.1016/j.bcp.2014.07.002
   Zhou X, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.915784
   Zhou YJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24234258
NR 57
TC 0
Z9 0
U1 4
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2023
VL 24
IS 12
AR 10098
DI 10.3390/ijms241210098
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA K3CL3
UT WOS:001015249600001
PM 37373246
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Sanz, N
   Díez-Fernández, C
   Cascales, M
AF Sanz, N
   Díez-Fernández, C
   Cascales, M
TI Aging delays the post-necrotic restoration of liver function
SO BIOFACTORS
LA English
DT Article
AB Age-associated changes in liver injury and post-necrotic regeneration were studied in rats aged 6 and 30 months in a period of 96 h following a dose of thioacetamide (6.6 mmol/kg body weight). Hepatocellular necrosis was detected in both groups by serum aspartate aminotransferase, but the severity of injury was significantly lower (one fourth, p < 0.001) in the oldest. Differences were observed in hepatocyte FAD monooxygenase activity between 6 and 30 months old rats at 24 h (278 versus 170%, p < 0.001, respectively) and also in GSH/GSSG ratio, in protein thiol groups and in malondialdehyde. Glutathione. peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase activities rose markedly in both groups, this increase being slightly lower in the oldest. Superoxide dismutase and catalase did not show significant changes between both groups. At the end of the 96 h experimental period the restoration towards normal of GSG/GSSG, protein thiols malondialdehyde and the activities of Cu-Zn superoxide dismutase and catalase were significantly lower in hepatocytes from 30 months old rats. We summarize that the main age-related changes in the sequenced process of liver injury and regeneration occurred to a lesser extent in severity of injury and delayed response in the post-necrotic restoration of liver function, probably due to a lower increase in antioxidant enzyme system.Age-associated changes in liver injury and post-necrotic regeneration were studied in rats aged 6 and 30 months in a period of 96 h following a dose of thioacetamide (6.6 mmol/kg body weight). Hepatocellular necrosis was detected in both groups by serum aspartate aminotransferase, but the severity of injury was significantly lower (one fourth, p < 0.001) in the oldest. Differences were observed in hepatocyte FAD monooxygenase activity between 6 and 30 months old rats at 24 h (278 versus 170%, p < 0.001, respectively) and also in GSH/GSSG ratio, in protein thiol groups and in malondialdehyde. Glutathione. peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase activities rose markedly in both groups, this increase being slightly lower in the oldest. Superoxide dismutase and catalase did not show significant changes between both groups. At the end of the 96 h experimental period the restoration towards normal of GSG/GSSG, protein thiols malondialdehyde and the activities of Cu-Zn superoxide dismutase and catalase were significantly lower in hepatocytes from 30 months old rats. We summarize that the main age-related changes in the sequenced process of liver injury and regeneration occurred to a lesser extent in severity of injury and delayed response in the post-necrotic restoration of liver function, probably due to a lower increase in antioxidant enzyme system.
C1 Univ Complutense Madrid, Fac Farm, CSIC, Inst Bioquim, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; Consejo Superior de Investigaciones
   Cientificas (CSIC)
RP Cascales, M (corresponding author), Univ Complutense Madrid, Fac Farm, CSIC, Inst Bioquim, Plaza Ramon & Cajal SN, E-28040 Madrid, Spain.
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHIELI E, 1984, TOXICOLOGY, V31, P41, DOI 10.1016/0300-483X(84)90154-9
   Del Maestro R.F., 1983, OXYGEN RADICALS THEI, V2, P28
   DiezFernandez C, 1996, J HEPATOL, V24, P460, DOI 10.1016/S0168-8278(96)80167-X
   DIEZFERNANDEZ C, 1993, HEPATOLOGY, V18, P912, DOI 10.1002/hep.1840180424
   FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667
   Katz Norbert, 1993, P55
   KITANI K, 1994, ARCH GERONTOL GERIAT, V19, P145, DOI 10.1016/0167-4943(94)90036-1
   MANGIPUDY RS, 1995, PHARMACOL TOXICOL, V77, P182, DOI 10.1111/j.1600-0773.1995.tb01010.x
   MEHENDALE HM, 1994, FASEB J, V8, P1285, DOI 10.1096/fasebj.8.15.8001741
   Norwood TH, 1996, EXP GERONTOL, V31, P61, DOI 10.1016/0531-5565(95)02020-9
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   Sanz N, 1996, BBA-MOL BASIS DIS, V1315, P123, DOI 10.1016/0925-4439(95)00113-1
   SEGLEN PO, 1993, METHODS TOXICOLOGY I, V1, P234
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   STEER CJ, 1995, FASEB J, V9, P1396, DOI 10.1096/fasebj.9.14.7589980
   SUM CY, 1982, BIOCHEM PHARMACOL, V31, P69, DOI 10.1016/0006-2952(82)90238-6
NR 17
TC 6
Z9 7
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0951-6433
J9 BIOFACTORS
JI Biofactors
PY 1998
VL 8
IS 1-2
SI SI
BP 103
EP 109
DI 10.1002/biof.5520080118
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA V3148
UT WOS:000171767300019
PM 9699017
DA 2024-02-19
ER

PT J
AU Kaverina, N
   Schweickart, RA
   Chan, GC
   Maggiore, JC
   Eng, DG
   Zeng, YT
   McKinzie, SR
   Perry, HS
   Ali, A
   O'Connor, C
   Pereira, BMV
   Theberge, AB
   Vaughan, JC
   Loretz, CJ
   Chang, ATY
   Hukriede, NA
   Bitzer, M
   Pippin, JW
   Wessely, O
   Shankland, SJ
AF Kaverina, Natalya
   Schweickart, R. Allen
   Chan, Gek Cher
   Maggiore, Joseph C.
   Eng, Diana G.
   Zeng, Yuting
   McKinzie, Sierra R.
   Perry, Hannah S.
   Ali, Adilijiang
   O'Connor, Christopher
   Pereira, Beatriz Maria Veloso
   Theberge, Ashleigh B.
   Vaughan, Joshua C.
   Loretz, Carol J.
   Chang, Anthony
   Hukriede, Neil A.
   Bitzer, Markus
   Pippin, Jeffrey W.
   Wessely, Oliver
   Shankland, Stuart J.
TI Inhibiting NLRP3 signaling in aging podocytes improves their life-and
   health-span
SO AGING-US
LA English
DT Article
DE kidney; podocyte; NLRP3 inflammasome; aging; reporter
ID PARIETAL EPITHELIAL-CELLS; CHRONIC KIDNEY-DISEASE; INFLAMMASOME;
   ACTIVATION; EXPRESSION; VOLUME; INJURY; DEATH; SIZE; AGE
AB The decrease in the podocyte's lifespan and health-span that typify healthy kidney aging cause a decrease in their normal structure, physiology and function. The ability to halt and even reverse these changes becomes clinically relevant when disease is superimposed on an aged kidney. RNA-sequencing of podocytes from middle-aged mice showed an inflammatory phenotype with increases in the NLRP3 inflammasome, signaling for IL2/Stat5, IL6 and TNF, interferon gamma response, allograft rejection and complement, consistent with inflammaging. Furthermore, injury-induced NLRP3 signaling in podocytes was further augmented in aged mice compared to young ones. The NLRP3 inflammasome (NLRP3, Caspase-1, IL1 & beta; IL-18) was also increased in podocytes of middle-aged humans. Higher transcript expression for NLRP3 in human glomeruli was accompanied by reduced podocyte density and increased global glomerulosclerosis and glomerular volume. Pharmacological inhibition of NLRP3 with MCC950, or gene deletion, reduced podocyte senescence and the genes typifying aging in middle-aged mice, which was accompanied by an improved podocyte lifespan and health-span. Moreover, modeling the injury-dependent increase in NLRP3 signaling in human kidney organoids confirmed the anti-senescence effect of MC9950. Finally, NLRP3 also impacted liver aging. Together, these results suggest a critical role for the NLRP3 inflammasome in podocyte and liver aging.
C1 [Kaverina, Natalya; Eng, Diana G.; McKinzie, Sierra R.; Pereira, Beatriz Maria Veloso; Loretz, Carol J.; Pippin, Jeffrey W.; Shankland, Stuart J.] Univ Washington, Div Nephrol, Seattle, WA 98109 USA.
   [Schweickart, R. Allen; Wessely, Oliver] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44106 USA.
   [Chan, Gek Cher] Natl Univ Singapore Hosp, Dept Med, Div Nephrol, Singapore, Singapore.
   [Maggiore, Joseph C.; Hukriede, Neil A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15261 USA.
   [Zeng, Yuting; Perry, Hannah S.; Ali, Adilijiang; Theberge, Ashleigh B.; Vaughan, Joshua C.] Univ Washington, Dept Chem, Seattle, WA 98109 USA.
   [O'Connor, Christopher; Bitzer, Markus] Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA.
   [Vaughan, Joshua C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98109 USA.
   [Chang, Anthony] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.
   [Shankland, Stuart J.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.
C3 University of Washington; University of Washington Seattle; Cleveland
   Clinic Foundation; National University of Singapore; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; University of Washington; University of Washington Seattle;
   University of Michigan System; University of Michigan; University of
   Washington; University of Washington Seattle; University of Chicago;
   University of Washington; University of Washington Seattle
RP Shankland, SJ (corresponding author), Univ Washington, Div Nephrol, Seattle, WA 98109 USA.; Wessely, O (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44106 USA.; Shankland, SJ (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.
EM wesselo@ccf.org; stuartjs@uw.edu
OI Bitzer, Markus/0000-0002-3711-2984; Eng, Diana/0000-0003-1157-917X;
   Pippin, Jeffrey/0009-0000-1629-1728; Veloso Pereira, Beatriz
   Maria/0000-0002-4511-3346
FU Singapore Ministry of Health's National Medical Research Council (NMRC)
   [NMRC/FLWSHP/053/2017];  [5 R01 DK 056799-10];  [5 R01 DK056799-12];  [1
   R01 DK097598-01A1];  [UC2 DK126006];  [R01 DK123031-01];  [NIH/NIA
   5R01AG046231];  [DK12600601];  [W81XWH-19-1-0025];  [DK128851]; 
   [T32GM008268];  [2UC2 DK126122];  [T32EB001026]
FX Grants Supporting Work: 5 R01 DK 056799-10, 5 R01 DK056799-12, 1 R01
   DK097598-01A1, UC2 DK126006, R01 DK123031-01, NIH/NIA 5R01AG046231,
   DK12600601, W81XWH-19-1-0025, DK128851, T32GM008268, 2UC2 DK126122. G.
   C. Chan was supported by the Singapore Ministry of Health's National
   Medical Research Council (NMRC) under its NMRC Research Training
   Fellowship (NMRC/FLWSHP/053/2017). J. C. Maggiore was funded in part by
   training grant # T32EB001026.
CR Anderson S, 2009, J AM SOC NEPHROL, V20, P1199, DOI 10.1681/ASN.2008080860
   Bai M, 2017, AM J PHYSIOL-RENAL, V312, pF556, DOI 10.1152/ajprenal.00332.2016
   Baylis C, 2009, SEMIN NEPHROL, V29, P569, DOI 10.1016/j.semnephrol.2009.07.003
   Berg UB, 2006, NEPHROL DIAL TRANSPL, V21, P2577, DOI 10.1093/ndt/gfl227
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Bhargava R, 2019, CURR OPIN RHEUMATOL, V31, P167, DOI 10.1097/BOR.0000000000000578
   Blevins HM, 2022, FRONT AGING NEUROSCI, V14, DOI 10.3389/fnagi.2022.879021
   Camici Marcello, 2011, Front Biosci (Schol Ed), V3, P995
   Cheng YC, 2017, NEPHROLOGY, V22, P43, DOI 10.1111/nep.13145
   Cheng YC, 2015, EXP BIOL MED, V240, P467, DOI 10.1177/1535370214553772
   Conley SM, 2017, CURR DRUG TARGETS, V18, P1019, DOI 10.2174/1389450117666160817103435
   Corcoran SE, 2021, PHARMACOL REV, V73, P968, DOI 10.1124/pharmrev.120.000171
   Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038
   Cui AY, 2017, JOVE-J VIS EXP, DOI 10.3791/55178
   Cui Z, 2011, AM J KIDNEY DIS, V57, P575, DOI 10.1053/j.ajkd.2010.09.022
   Dai X, 2021, REDOX BIOL, V45, DOI 10.1016/j.redox.2021.102033
   Dasgupta N, 2023, CELL, V186, P233, DOI 10.1016/j.cell.2022.12.040
   DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286
   Denic A, 2017, J AM SOC NEPHROL, V28, P313, DOI 10.1681/ASN.2016020154
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eremina V, 2004, CURR OPIN NEPHROL HY, V13, P9, DOI 10.1097/00041552-200401000-00002
   Fang YD, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI141848
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Fu R, 2017, ARTHRITIS RHEUMATOL, V69, P1636, DOI 10.1002/art.40155
   Gallego P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102148
   Ge SW, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0351-2
   Goldberg S, 2010, J AM SOC NEPHROL, V21, P579, DOI 10.1681/ASN.2009091004
   Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009
   Grams ME, 2013, NAT REV NEPHROL, V9, P18, DOI 10.1038/nrneph.2012.248
   Guo CH, 2019, J AUTOIMMUN, V103, DOI 10.1016/j.jaut.2019.05.014
   Hamarsheh S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15497-1
   Heeringa SF, 2008, NEPHROL DIAL TRANSPL, V23, P3527, DOI 10.1093/ndt/gfn271
   Hong CJ, 2023, KIDNEY INT, V103, P218, DOI 10.1016/j.kint.2022.11.001
   Hou Y, 2020, BIOCHEM BIOPH RES CO, V521, P791, DOI 10.1016/j.bbrc.2019.10.194
   Hoy WE, 2003, KIDNEY INT, V63, P31, DOI 10.1046/j.1523-1755.63.s83.8.x
   Hu HQ, 2022, FASEB J, V36, DOI 10.1096/fj.202101988R
   Huber MD, 2007, J CELL BIOL, V179, P583, DOI 10.1083/jcb.200710156
   Hughson MD, 2020, ANAT REC, V303, P2526, DOI 10.1002/ar.24249
   Ichimura K, 2008, J AM SOC NEPHROL, V19, P1463, DOI 10.1681/ASN.2007101138
   Ikezumi Y, 2013, AM J NEPHROL, V38, P149, DOI 10.1159/000353898
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973
   Kaverina NV, 2020, AGING-US, V12, P17601, DOI 10.18632/aging.103788
   Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328
   Kim DH, 2015, J CELL SCI, V128, P3375, DOI 10.1242/jcs.166330
   Komada T, 2019, NAT REV NEPHROL, V15, P501, DOI 10.1038/s41581-019-0158-z
   Kooman JP, 2017, EXP GERONTOL, V87, P156, DOI 10.1016/j.exger.2016.02.003
   Lang JS, 2018, NEPHROL DIAL TRANSPL, V33, P986, DOI 10.1093/ndt/gfx229
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lee MY, 2022, NAT PROTOC, V17, P819, DOI 10.1038/s41596-021-00667-2
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Liu XQ, 2023, CELL, V186, P287, DOI 10.1016/j.cell.2022.12.017
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lucafò M, 2021, CTS-CLIN TRANSL SCI, V14, P964, DOI 10.1111/cts.12961
   Marín-Aguilar F, 2020, AGING CELL, V19, DOI 10.1111/acel.13050
   Marini F, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2879-1
   Marshall CB, 2016, AM J PHYSIOL-RENAL, V311, pF831, DOI 10.1152/ajprenal.00313.2016
   Marshall CB, 2010, AM J PHYSIOL-RENAL, V298, pF1140, DOI 10.1152/ajprenal.00216.2009
   Melsom T, 2022, J AM SOC NEPHROL, V33, P1891, DOI 10.1681/ASN.2022030323
   Miettinen M, 2011, AM J SURG PATHOL, V35, P432, DOI 10.1097/PAS.0b013e318206b67b
   Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022
   Navarro-Pando JM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abc7409
   Naylor RW, 2021, NAT REV NEPHROL, V17, P112, DOI 10.1038/s41581-020-0329-y
   Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054
   Ohse T, 2010, AM J PHYSIOL-RENAL, V298, pF702, DOI 10.1152/ajprenal.00428.2009
   Pippin JW, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI156250
   Pottel H, 2016, NEPHROL DIAL TRANSPL, V31, P798, DOI 10.1093/ndt/gfv454
   Prakash S, 2009, SEMIN NEPHROL, V29, P497, DOI 10.1016/j.semnephrol.2009.06.006
   Przepiorski A, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02752-z
   Przepiorski A, 2021, JOVE-J VIS EXP, DOI 10.3791/62452
   Puelles VG, 2016, AM J PHYSIOL-RENAL, V310, pF656, DOI 10.1152/ajprenal.00497.2015
   Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427
   Romero A, 2022, AGING DIS, V13, P284, DOI 10.14336/AD.2021.0617
   Sander V, 2020, STAR PROTOC, V1, DOI 10.1016/j.xpro.2020.100150
   Schaub JA, 2022, J CLIN PATHOL, V75, P121, DOI 10.1136/jclinpath-2020-207149
   Schneider RRS, 2017, AGING-US, V9, P524, DOI 10.18632/aging.101176
   Shahzad K, 2022, KIDNEY INT, V102, P766, DOI 10.1016/j.kint.2022.06.010
   Shankland SJ, 2021, J AM SOC NEPHROL, V32, P2697, DOI [10.1681/ASN.2021-05-0614, 10.1681/ASN.2021050614]
   Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262
   Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038
   Spadaro O, 2022, SCIENCE, V375, P671, DOI 10.1126/science.abg7292
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Taniguchi H, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110814
   WALKER F, 1972, J PATHOL, V107, P123, DOI 10.1002/path.1711070207
   Wang YL, 2020, KIDNEY INT, V98, P1160, DOI 10.1016/j.kint.2020.05.052
   Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488
   Wiggins J, 2009, SEMIN NEPHROL, V29, P587, DOI 10.1016/j.semnephrol.2009.07.012
   Wu JN, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136329
   Wu M, 2021, METABOLISM, V118, DOI 10.1016/j.metabol.2021.154748
   Wu Wei, 2019, Zhongguo Zhong Yao Za Zhi, V44, P5457, DOI 10.19540/j.cnki.cjcmm.20191114.401
   Xu XH, 2021, EXP CELL RES, V408, DOI 10.1016/j.yexcr.2021.112863
   Yan J, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12645
   Yang XJ, 2018, MED SCI MONITOR, V24, P6832, DOI 10.12659/MSM.909810
   Yin LJ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.771931
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
   Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688
   Zhang CJ, 2021, AM J PHYSIOL-CELL PH, V320, pC355, DOI 10.1152/ajpcell.00403.2020
   Zhang J, 2013, AM J PHYSIOL-RENAL, V304, pF1375, DOI 10.1152/ajprenal.00020.2013
   Zhang J, 2012, NEPHRON EXP NEPHROL, V121, pE23, DOI 10.1159/000342808
   Zhao JJ, 2015, ARTHRITIS RHEUMATOL, V67, P1036, DOI 10.1002/art.38993
   Zhao M, 2018, KIDNEY DIS-BASEL, V4, P83, DOI 10.1159/000488242
   Zhu L M, 1987, Hua Xi Yi Ke Da Xue Xue Bao, V18, P339
NR 102
TC 5
Z9 5
U1 1
U2 2
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL 31
PY 2023
VL 15
IS 14
BP 6658
EP 6689
PG 32
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA O5XD1
UT WOS:001044526700008
PM 37487005
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Escudero, B
   Lucas, D
   Albo, C
   Dhup, S
   Bacher, JW
   Sánchez-Muñoz, A
   Fernández, M
   Rivera-Torres, J
   Carmona, RM
   Fuster, E
   Carreiro, C
   Bernad, R
   Gonzáles, MA
   Andrés, V
   Blanco, L
   Roche, E
   Fabregat, I
   Samper, E
   Bernad, A
AF Escudero, Beatriz
   Lucas, Daniel
   Albo, Carmen
   Dhup, Suveera
   Bacher, Jeff W.
   Sanchez-Munoz, Aranzazu
   Fernandez, Margarita
   Rivera-Torres, Jose
   Carmona, Rosa M.
   Fuster, Encarnacio
   Carreiro, Candelas
   Bernad, Raquel
   Gonzales, Manuel A.
   Andres, Vicente
   Blanco, Luis
   Roche, Enrique
   Fabregat, Isabel
   Samper, Enrique
   Bernad, Antonio
TI Polμ Deficiency Increases Resistance to Oxidative Damage and Delays
   Liver Aging
SO PLOS ONE
LA English
DT Article
ID DNA-POLYMERASE-MU; STRAND BREAK REPAIR; PATHWAY; CANCER; CELLS;
   MECHANISMS; LONGEVITY; DEFINES; HEALTH; ROLES
AB pol mu an error- prone PoIX polymerase that contributes to classical NHEJ DNA repair. Mice lacking Pol mu (Pol mu (-/-)) show altered hematopoiesis homeostasis Pol mu 2/ 2 mice have increased learning capacity at old ages, suggesting delayed brain aging. Here we investigated the effect of Pol mu 2/ 2 deficiency on liver aging. We found that old Pol mu (-/-) mice (> 20 month) have greater liver regenerative capacity compared with wt animals. Old Pol mu (-/-) liver showed reduced genomic instability and increased apoptosis resistance. However, Pol mu (-/-) mice did not show an extended life span and other organs ( e. g., heart) aged normally. Our results suggest that Pol mu deficiency activates transcriptional networks that reduce constitutive apoptosis, leading to enhanced liver repair at old age.
C1 [Escudero, Beatriz; Albo, Carmen; Dhup, Suveera; Carmona, Rosa M.; Carreiro, Candelas; Gonzales, Manuel A.; Samper, Enrique; Bernad, Antonio] CNIC, Dept Cardiol Regenerat, Madrid, Spain.
   [Escudero, Beatriz; Lucas, Daniel; Carmona, Rosa M.; Bernad, Raquel; Gonzales, Manuel A.; Samper, Enrique; Bernad, Antonio] Campus Univ Auto noma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid, Spain.
   [Bacher, Jeff W.] Promega Corp, Genet Anal Grp, Madison, WI USA.
   [Sanchez-Munoz, Aranzazu; Fernandez, Margarita] Univ Complutense, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain.
   [Rivera-Torres, Jose; Andres, Vicente] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Aterotrombosis & Imagen, Madrid, Spain.
   [Fuster, Encarnacio; Roche, Enrique] Miguel Hernandez Univ, Inst Bioengn, Elche, Alicante, Spain.
   [Blanco, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Canto Blanco, Madrid, Spain.
   [Roche, Enrique] CIBERobn CB12 03 30038 Inst Salud Carlos, Madrid, Spain.
   [Fabregat, Isabel] Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain.
C3 Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo
   Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional
   de Biotecnologia (CNB); Promega Corporation; Complutense University of
   Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC);
   Universidad Miguel Hernandez de Elche; Consejo Superior de
   Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular
   Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red;
   CIBEROBN; University of Barcelona; Institut d'Investigacio Biomedica de
   Bellvitge (IDIBELL)
RP Bernad, A (corresponding author), CNIC, Dept Cardiol Regenerat, Madrid, Spain.
EM abernad@cnic.es
RI Blanco, Luis/I-1848-2015; Rivera-Torres, José/P-2793-2015; Lucas,
   Daniel/ABB-6893-2021; Dhup, Suveera/AAU-7630-2021; Sánchez,
   Aránzazu/H-7810-2015; Roche, Enrique J/V-5738-2017; Andres,
   Vicente/I-6440-2014; Bernad, Antonio/P-8573-2017; Fernández,
   Margarita/H-9077-2015; Fabregat, Isabel/H-7038-2015
OI Rivera-Torres, José/0000-0003-0365-9604; Lucas,
   Daniel/0000-0002-0147-5425; Sánchez, Aránzazu/0000-0001-9145-6633;
   Roche, Enrique J/0000-0001-5128-1672; Andres,
   Vicente/0000-0002-0125-7209; Fernández, Margarita/0000-0001-7207-2028;
   Dhup, Suveera/0000-0002-6689-6597; Fabregat, Isabel/0000-0003-0136-8440;
   Bernad, Antonio/0000-0003-0620-9668
FU Ministry of Science and Innovation [SAF 2008-02099, PLE2009-0147,
   PSE-010000-2009-3]; Comunidad Autonoma de Madrid [S2010/BMD-2420];
   European Commission [FP7-HEALTH-2009/CARE-MI]; Spanish Ministry of
   Economy and Competiveness; Pro-CNIC Foundation
FX This work was supported by grants to AB from the Ministry of Science and
   Innovation (SAF 2008-02099; PLE2009-0147 and PSE-010000-2009-3),
   Comunidad Autonoma de Madrid (S2010/BMD-2420), and the European
   Commission (FP7-HEALTH-2009/CARE-MI. CC is supported by The Spanish
   Ministry of Economy and Competiveness and the Pro-CNIC Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andrade P, 2009, P NATL ACAD SCI USA, V106, P16203, DOI 10.1073/pnas.0908492106
   Bacher JW, 2005, MOL CARCINOGEN, V44, P285, DOI 10.1002/mc.20146
   Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6
   Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891
   Brown-Borg HM, 2006, AGE, V28, P145, DOI 10.1007/s11357-006-9003-y
   Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944
   Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123
   Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029
   Chayot R, 2010, DNA REPAIR, V9, P1187, DOI 10.1016/j.dnarep.2010.09.001
   Domínguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731
   Factor VM, 2010, PLOS ONE, V16, P5, DOI DOI 10.1371/J0URNAL.P0NE.0012739
   Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Holzenberger M, 2004, EXP GERONTOL, V39, P1761, DOI 10.1016/j.exger.2004.08.017
   Huffman DM, 2010, INTERD T GERONT GERI, V37, P1, DOI 10.1159/000319991
   Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8
   Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07
   Lucas D, 2005, EUR J IMMUNOL, V35, P1601, DOI 10.1002/eji.200526015
   Lucas D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053243
   Lucas D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000389
   Martínez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025
   Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949
   McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012
   Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10
   Peterson MJ, 2010, METAB SYNDR RELAT D, V8, P317, DOI 10.1089/met.2009.0090
   Ruiz JF, 2004, NUCLEIC ACIDS RES, V32, P5861, DOI 10.1093/nar/gkh929
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Yu QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021770
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
   Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516
NR 32
TC 5
Z9 6
U1 2
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 1
PY 2014
VL 9
IS 4
AR e93074
DI 10.1371/journal.pone.0093074
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AE6KM
UT WOS:000334101100041
PM 24691161
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Speziali, E
   Aranha, CHM
   Teixeira-Carvalho, A
   Santiago, AF
   Oliveira, RP
   Rezende, MC
   Carneiro, CM
   Negrao-Corrêa, D
   Coelho, PMZ
   Faria, AMC
AF Speziali, E.
   Aranha, C. H. M.
   Teixeira-Carvalho, A.
   Santiago, A. F.
   Oliveira, R. P.
   Rezende, M. C.
   Carneiro, C. M.
   Negrao-Correa, D.
   Coelho, P. M. Z.
   Faria, A. M. C.
TI Ageing Down-Modulates Liver Inflammatory Immune Responses to Schistosome
   Infection in Mice
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID NAIVE IMMIGRANT POPULATION; CELL RESPONSES; MANSONI; IL-10; AGE;
   FIBROSIS; DISEASE; GAMMA
AB Ageing is associated with several alterations in the immune system. Our aim in this study was to compare the development of immunity to Schistosoma mansoni infection in young versus aged C57Bl/6 mice using the liver as the main organ to evaluate pathological alterations and immune responses. In the acute phase, young mice had large liver granulomas with fibrosis and inflammatory cells. Chronic phase in young animals was associated with immunomodulation of granulomas that became reduced in size and cellular infiltrate. On the other hand, aged animals presented granulomas of smaller sizes already in the acute phase. Chronic infection in these mice was followed by no alteration in any of the inflammatory parameters in the liver. In concert with this finding, there was an increase in activated CD4+ T, CD19+ B and NK liver cells in young mice after infection whereas old mice had already higher frequencies of activated B, NK and CD4+ T liver cells and infection does not change these frequencies. After infection, liver production of inflammatory and regulatory cytokines such as IFN-gamma, IL-4 and IL-10 increased in young but not in old mice that had high levels of IL-4 and IL-10 regardless of their infection status. Our data suggest that the unspecific activation status of the immune system in aged mice impairs inflammatory as well as regulatory immune responses to S. mansoni infection in the liver, where major pathological alterations and immunity are at stage. This poor immune reactivity may have a beneficial impact on disease development.
C1 [Speziali, E.; Santiago, A. F.; Oliveira, R. P.; Faria, A. M. C.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Speziali, E.; Aranha, C. H. M.] Univ Vale Rio Doce, Governador Valadares, Brazil.
   [Aranha, C. H. M.; Carneiro, C. M.] Univ Fed Ouro Preto, Lab Imunopatol Nucleo Pesquisa Ciencias Biol, Ouro Preto, Brazil.
   [Teixeira-Carvalho, A.; Coelho, P. M. Z.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Rezende, M. C.; Negrao-Correa, D.] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
C3 Universidade Federal de Minas Gerais; University Vale Rio Doce;
   Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Universidade
   Federal de Minas Gerais
RP Faria, AMC (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM afaria@icb.ufmg.br
RI Faria, Ana Maria/AAK-8688-2021; de Oliveira, Rafael Pires/B-9161-2015;
   carneiro, claudia m/B-6205-2013; Santiago, Andrezza F/L-9685-2014;
   carneiro, Claudia Martins/AAP-4455-2020; Coelho, Priscila/JCE-1771-2023;
   Coelho, Paulo Marcos Zech/ABE-6169-2021
OI de Oliveira, Rafael Pires/0000-0002-5941-7009; carneiro, Claudia
   Martins/0000-0002-6002-857X; Coelho, Paulo Marcos
   Zech/0000-0002-2443-8897; Faria, Ana Maria/0000-0002-0604-8510
FU FAPEMIG, Brazil [CBB-948/06]; CNPq
FX This work was supported by a grant from FAPEMIG, Brazil (CBB-948/06).
   Some of the authors are recipients of research fellowships (A. M. C. F.,
   D.N-C. P.M.Z.C.) and scholarships (A. F. S.) from CNPq and one was a
   recipient of a Post-doctoral fellowship from FAPEMIG (E. S.) during the
   development of this study.
CR Adewusi OI, 1996, EXP PARASITOL, V84, P115, DOI 10.1006/expr.1996.0097
   ANDRADE ZA, 1993, INT J EXP PATHOL, V74, P195
   Bosshardt SC, 1997, PARASITE IMMUNOL, V19, P347, DOI 10.1046/j.1365-3024.1997.d01-224.x
   Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x
   Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027
   Cheever AW, 2002, MEM I OSWALDO CRUZ, V97, P917, DOI 10.1590/S0074-02762002000700002
   CHENSUE SW, 1993, J IMMUNOL, V151, P1391
   Coelho PMZ, 2004, MEM I OSWALDO CRUZ, V99, P109, DOI 10.1590/S0074-02762004000900020
   COLLEY DG, 1977, AM J TROP MED HYG, V26, P88, DOI 10.4269/ajtmh.1977.26.88
   Comin F, 2008, ACTA TROP, V108, P124, DOI 10.1016/j.actatropica.2008.05.004
   Comin F, 2007, CLIN EXP IMMUNOL, V149, P274, DOI 10.1111/j.1365-2249.2007.03403.x
   Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x
   Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Malaquias LCC, 1997, SCAND J IMMUNOL, V46, P393, DOI 10.1046/j.1365-3083.1997.d01-136.x
   Mocchegiani E, 2004, AGING CELL, V3, P177, DOI 10.1111/j.1474-9728.2004.00107.x
   Mwatha JK, 1998, J IMMUNOL, V160, P1992
   Naus CWA, 1999, INFECT IMMUN, V67, P3444, DOI 10.1128/IAI.67.7.3444-3451.1999
   Ouma JH, 1998, PARASITOLOGY, V117, P123, DOI 10.1017/S0031182098002935
   PELLEGRINO J., 1956, REV BRASIL MALARIOL E DOENCAS TROP, V8, P589
   Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006
   Sadler CH, 2003, EUR J IMMUNOL, V33, P880, DOI 10.1002/eji.200323501
   Silva LM, 2000, MEM I OSWALDO CRUZ, V95, P353, DOI 10.1590/S0074-02762000000300010
   Speziali E, 2004, MEDIAT INFLAMM, V13, P327, DOI 10.1080/09629350400008802
   Speziali E, 2009, CELL IMMUNOL, V256, P1, DOI 10.1016/j.cellimm.2009.01.010
   Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x
   Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015
NR 27
TC 7
Z9 9
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-9475
EI 1365-3083
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD APR
PY 2010
VL 71
IS 4
BP 240
EP 248
DI 10.1111/j.1365-3083.2010.02370.x
PG 9
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 573MQ
UT WOS:000275918400003
PM 20384867
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU da Costa, VMC
   Moreira, DG
   Rosenthal, D
AF da Costa, VMC
   Moreira, DG
   Rosenthal, D
TI Thyroid function and aging: gender-related differences
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID FISCHER 344/N RATS; BROWN-NORWAY RAT; IODOTHYRONINE DEIODINASE;
   PITUITARY; THYROTROPIN; AGE; GLAND; LIVER; TRIIODOTHYRONINE; CONVERSION
AB The effects of aging on human or animal thyroid function are still not well defined. We evaluated some aspects of thyroid function during aging using an animal model (young and old Dutch-Miranda rats). In old rats of both genders, serum thyroxine (T4) decreased but serum thyrotrophin (TSH) remained unaltered, suggesting a disturbance in the pituitary-thyroid feedback mechanism during aging. Serum tri-iodothyronine (T3) only decreased in old males, possibly because female rats are almost twice as efficient in hepatic T4 to T3 deiodination. Thyroidal T4-5'-deiodinase activity did not change much during aging, although it decreased slightly in males. Thyroidal iodothyronine-deiodinase type I mRNA expression but not total thyroidal enzymatic activity were higher in female than in male rats. Thus, ovarian/testicular hormones may modulate the expression and/or the activity of hepatic and thyroidal type I iodothyronine-deiodinase. Thyroperoxidase (TPO) and thyroglobulin (Tg) expression were higher in young male rats than in females. In males, TPO and Tg gene expression decreased with aging, suggesting that androgens might increase their expression. Our results showed that aging induces real changes in rat thyroid gland function and regulation, affecting at least pituitary, thyroid and liver functions. Furthermore, some of these changes were gender related, indicating that gonadal hormones may modulate thyroid gland function and regulation.
C1 Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Fisiol Endocrina, BR-21949900 Rio De Janeiro, Brazil.
C3 Universidade Federal do Rio de Janeiro
RP da Costa, VMC (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Fisiol Endocrina, BR-21949900 Rio De Janeiro, Brazil.
RI Moreira, Débora/GPX-3225-2022
OI Rosenthal, Doris/0000-0001-7136-5961
CR Bates JM, 1999, ENDOCRINOLOGY, V140, P844, DOI 10.1210/en.140.2.844
   BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0
   Borges PP, 1998, LIFE SCI, V62, P2035, DOI 10.1016/S0024-3205(98)00175-1
   BOYE N, 1984, MOL CELL ENDOCRINOL, V37, P295, DOI 10.1016/0303-7207(84)90099-6
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cizza G, 1996, NEUROENDOCRINOLOGY, V64, P440, DOI 10.1159/000127150
   CIZZA G, 1992, ENDOCRINOLOGY, V131, P2672, DOI 10.1210/en.131.6.2672
   CONSOLE GM, 1995, ACTA ANAT, V152, P28
   daCosta VMC, 1996, LIFE SCI, V59, P1515, DOI 10.1016/0024-3205(96)00482-1
   DONDA A, 1989, ENDOCRINOLOGY, V124, P1305, DOI 10.1210/endo-124-3-1305
   ERICKSON VJ, 1982, ENDOCRINOLOGY, V111, P434, DOI 10.1210/endo-111-2-434
   GERBER H, 1987, ENDOCRINOLOGY, V120, P1758, DOI 10.1210/endo-120-5-1758
   Gruenewald DA, 2000, J ANDROL, V21, P72
   ISHII H, 1981, J CLIN ENDOCR METAB, V52, P1211, DOI 10.1210/jcem-52-6-1211
   KAPLAN MM, 1980, J CLIN INVEST, V66, P551, DOI 10.1172/JCI109887
   KLUG TL, 1979, ENDOCRINOLOGY, V104, P1136, DOI 10.1210/endo-104-4-1136
   Lisboa PC, 1997, BRAZ J MED BIOL RES, V30, P1479, DOI 10.1590/S0100-879X1997001200016
   Lu CC, 2000, METABOLISM, V49, P253, DOI 10.1016/S0026-0495(00)91533-6
   MORLEY JE, 1995, ENDOCRINOL METAB, P1813
   PEKARY AE, 1989, ENDOCRINOLOGY, V125, P679, DOI 10.1210/endo-125-2-679
   PEKARY AE, 1983, J GERONTOL, V38, P653, DOI 10.1093/geronj/38.6.653
   Salvatore D, 1996, J CLIN INVEST, V98, P962, DOI 10.1172/JCI118880
   Samuels MH, 1998, THYROID, V8, P803, DOI 10.1089/thy.1998.8.803
   SOLOMON DH, 1991, THYROID HORMONE META, P267
   STUDER H, 1978, ENDOCRINOLOGY, V102, P1576, DOI 10.1210/endo-102-5-1576
   Wang C, 1999, J ANDROL, V20, P509
   WOODMAN DD, 1997, LAB ANIMAL ENDOCRINO, P129
   Zar J.H., 1996, BIOSTAT ANAL, P179
   [No title captured]
NR 29
TC 74
Z9 78
U1 0
U2 3
PU SOC ENDOCRINOLOGY
PI BRISTOL
PA 17/18 THE COURTYARD, WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4NQ, ENGLAND
SN 0022-0795
J9 J ENDOCRINOL
JI J. Endocrinol.
PD OCT
PY 2001
VL 171
IS 1
BP 193
EP 198
DI 10.1677/joe.0.1710193
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 481MJ
UT WOS:000171522800019
PM 11572803
OA Bronze
DA 2024-02-19
ER

PT J
AU Zhang, J
   Zang, SF
   Yang, WJ
   Chen, YJ
   Zhuang, ZJ
   Luo, Y
   Zhou, G
   Zhao, BY
   Wang, BY
   Shi, JP
AF Zhang, Jing
   Zang, Shufei
   Yang, Wenjun
   Chen, Yingji
   Zhuang, Zhenjie
   Luo, Yan
   Zhou, Gang
   Zhao, Baiyun
   Wang, Bingyuan
   Shi, Junping
TI Shortened leucocyte telomere length is associated independently with
   fibrosis stage in non-alcoholic fatty liver disease
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Ageing; fibrosis; leucocyte telomere shortening; non-alcoholic fatty
   liver disease
ID STRONG HEART FAMILY; HEPATOCYTE SENESCENCE; AMERICAN-INDIANS; DAMAGE;
   INDIVIDUALS; PROGRESSION; HEPATITIS; P21
AB This study aimed to assess the difference in leucocyte telomere length (LTL) between non-alcoholic fatty liver disease (NAFLD) patients and healthy controls. We measured LTL using a real-time PCR based method in 100 NAFLD patients and 100 healthy controls, and the relationship between short LTL and the risk and severity of the disease was examined using multivariate logistic regression analyses. We found mean LTL was significantly shorter in NAFLD patients than in controls (P < 0.001). Subjects with short LTL had a significantly elevated risk of NAFLD (OR: 3.095, 95% CI: 1.594-6.010; P = 0.001). Moreover, LTL was observed markedly shorter in NAFLD patients with fibrosis compared to patients with non-fibrosis (P = 0.010), multivariate logistic regression analysis indicated that short LTL was independently associated with a higher risk of severe fibrosis stage in NAFLD (OR: 10.799, 95% CI: 1.168-99.832, P = 0.036). Further analysis showed a linear correlation between LTL and the expression of hepatocyte senescent marker p21 (r = -0.413, P = 0.011). In conclusion, these results suggest that short LTL is closely associated with NAFLD and the severity of NAFLD fibrosis, and LTL has potential as a possible non-invasive prognosis biomarker for monitoring the severity of NAFLD fibrosis.
C1 [Zhang, Jing; Wang, Bingyuan] China Med Univ, Affiliated Hosp 1, Dept Elderly Gastroenterol, Nanjing St 115, Shenyang 110001, Liaoning, Peoples R China.
   [Zang, Shufei] Hangzhou Normal Univ, Affiliated Hosp, Dept Endocrine Dis, Hangzhou, Zhejiang, Peoples R China.
   [Yang, Wenjun] Hangzhou Normal Univ, Affiliated Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China.
   [Chen, Yingji] Hangzhou Normal Univ, Affiliated Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China.
   [Zhou, Gang] Hangzhou Normal Univ, Affiliated Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.
   [Shi, Junping] Hangzhou Normal Univ, Affiliated Hosp, Dept Liver Dis, 126 Wenzhou Rd, Hangzhou 310015, Zhejiang, Peoples R China.
   [Zhuang, Zhenjie; Luo, Yan; Shi, Junping] Hangzhou Normal Univ, Affiliated Hosp, Ctr Translat Medi, Hangzhou, Zhejiang, Peoples R China.
   [Zhao, Baiyun] Hangzhou Normal Univ, Affiliated Hosp, Drug Clin Trial Inst, Hangzhou, Zhejiang, Peoples R China.
C3 China Medical University; Hangzhou Normal University; Hangzhou Normal
   University; Hangzhou Normal University; Hangzhou Normal University;
   Hangzhou Normal University; Hangzhou Normal University; Hangzhou Normal
   University
RP Wang, BY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Elderly Gastroenterol, Nanjing St 115, Shenyang 110001, Liaoning, Peoples R China.; Shi, JP (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Dept Liver Dis, 126 Wenzhou Rd, Hangzhou 310015, Zhejiang, Peoples R China.
EM wangby0908@163.com; davidshi0571@126.com
RI Shi, Junping/AAX-7337-2021
OI Yang, Wenjun/0000-0003-1474-5364; Shi, Jun-ping/0000-0001-9434-897X
FU National Natural Science Foundation of China [81570524]; Natural Science
   Foundation of Zhejiang Province [LQ16H290003]; Science and Techology
   Project of Hangzhou City [2060-402]; Health Project of Hangzhou City
   [2015A09]
FX The authors thank all of the participants in the study. This work was
   supported by grants from the National Natural Science Foundation of
   China (81570524), Natural Science Foundation of Zhejiang Province
   (LQ16H290003), Science and Techology Project of Hangzhou City (2060-402)
   and the Health Project of Hangzhou City (2015A09).
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979
   Aviv A, 2012, MUTAT RES-FUND MOL M, V730, P68, DOI 10.1016/j.mrfmmm.2011.05.001
   Brunt EM, 2007, LIVER INT, V27, P662, DOI 10.1111/j.1478-3231.2007.01470.x
   Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chen SF, 2014, AGING-US, V6, P380, DOI 10.18632/aging.100664
   Fan JG, 2011, J DIGEST DIS, V12, P38, DOI 10.1111/j.1751-2980.2010.00476.x
   Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003
   Liu J, CLIN EXP PHARM
   Marcon F, 2012, MUTAGENESIS, V27, P49, DOI 10.1093/mutage/ger056
   Masi S, 2014, EUR HEART J, V35, P3296, DOI 10.1093/eurheartj/ehu226
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   O'Donovan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019687
   O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848
   Pathai S, 2013, AIDS, V27, P2375, DOI 10.1097/QAD.0b013e328363bf7f
   Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087
   Seki S, 2005, HEPATOL RES, V33, P132, DOI 10.1016/j.hepres.2005.09.020
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Urabe Y, 1996, LIVER, V16, P293
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837
   Zhao JY, 2014, DIABETES, V63, P354, DOI 10.2337/db13-0744
NR 30
TC 2
Z9 2
U1 0
U2 3
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2017
VL 10
IS 7
BP 11204
EP 11212
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FB3QS
UT WOS:000406058200172
DA 2024-02-19
ER

PT J
AU CORNET, M
   MERTENS, K
   CALLAERTS, A
   SONCK, W
   VERCRUYSSE, A
   ROGIERS, V
AF CORNET, M
   MERTENS, K
   CALLAERTS, A
   SONCK, W
   VERCRUYSSE, A
   ROGIERS, V
TI AGE-RELATED AND GENDER-RELATED CHANGES IN THE HEPATIC-METABOLISM OF
   2-METHYLPROPENE AND RELATIONSHIP TO EPOXIDE METABOLIZING ENZYMES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE 2-METHYLPROPENE (ISOBUTENE); EPOXIDE; AGING; GENDER; EPOXIDE
   METABOLIZING ENZYMES (RAT LIVER)
ID GLUTATHIONE S-TRANSFERASES; RAT-LIVER; DRUG-METABOLISM;
   CYTOCHROME-P-450; ISOBUTENE; MICE; BIOTRANSFORMATION; HEPATOCYTES;
   HYDROLASES; MICROSOMES
AB The effect of age and gender on the in vitro biotransformation of 2-methylpropene, an alkene metabolized to 2-methyl-1,2-epoxypropane, was studied. The epoxide concentration and the epoxide metabolizing enzymatic activities were investigated in male and female Brown Norway rats of different ages. Liver tissue of senescent rats was exposed to smaller 2-methyl-1,2-epoxypropane concentrations than that of young animals, although changes during ageing were rather modest. With advancing age a feminization of male glutathione S-transferase and cytosolic epoxide hydrolase activities was found, as well as a significant decline of the female microsomal epoxide hydrolase activity and an increase of the cytochrome P-450 content in the oldest female rats.
RP CORNET, M (corresponding author), FREE UNIV BRUSSELS,DEPT TOXICOL,LAARBEEKLAAN 103,B-1090 BRUSSELS,BELGIUM.
OI Rogiers, Vera/0000-0003-0635-7740
CR BIRNBAUM LS, 1979, CHEM-BIOL INTERACT, V26, P245, DOI 10.1016/0009-2797(79)90028-0
   BIRNBAUM LS, 1991, ANNU REV PHARMACOL, V31, P101
   BIRNBAUM LS, 1987, J AM GERIATR SOC, V35, P51, DOI 10.1111/j.1532-5415.1987.tb01319.x
   BONATE PL, 1991, J CLIN PHARMACOL, V31, P684, DOI 10.1002/j.1552-4604.1991.tb03760.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARRILLO MC, 1991, BIOCHIM BIOPHYS ACTA, V1077, P325, DOI 10.1016/0167-4838(91)90547-D
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1225, DOI 10.3109/00498258809042246
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   COECKE S, 1990, MECH AGEING DEV, V55, P189, DOI 10.1016/0047-6374(90)90026-C
   CORNET M, 1991, ARCH TOXICOL, V65, P263, DOI 10.1007/BF01968959
   CORNET M, 1992, MUTAT RES, V271, P213, DOI 10.1016/0165-1161(92)90016-F
   CSANADY GA, 1991, ARCH TOXICOL, V65, P100, DOI 10.1007/BF02034934
   EDWARDS AM, 1984, BIOCHEM PHARMACOL, V33, P1537, DOI 10.1016/0006-2952(84)90425-8
   FUJITA S, 1989, BIOCHEM PHARMACOL, V38, P3925, DOI 10.1016/0006-2952(89)90669-2
   GALINSKY RE, 1990, J PHARMACOL EXP THER, V255, P577
   GILL SS, 1983, ANAL BIOCHEM, V131, P273, DOI 10.1016/0003-2697(83)90166-5
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HOLLANDER CF, 1976, LAB ANIM SCI, V26, P320
   HORBACH GJMJ, 1992, XENOBIOTICA, V22, P515, DOI 10.3109/00498259209053114
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KAUR S, 1985, DRUG METAB DISPOS, V13, P711
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KITAHARA A, 1982, LIVER AGING 1982, P135
   MERTENS K, 1991, J CHROMATOGR-BIOMED, V565, P149, DOI 10.1016/0378-4347(91)80379-Q
   MOODY DE, 1986, BIOCHEM PHARMACOL, V35, P2073, DOI 10.1016/0006-2952(86)90573-3
   NORUSIS MJ, 1984, SPSS PC PLUS IBM PC, pB131
   OESCH F, 1987, ARCH TOXICOL, V60, P174, DOI 10.1007/BF00296975
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PATERSON P, 1984, XENOBIOTICA, V14, P849, DOI 10.3109/00498258409151483
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   RIKANS LE, 1984, TOXICOL APPL PHARM, V73, P243, DOI 10.1016/0041-008X(84)90329-6
   SAITO K, 1991, XENOBIOTICA, V21, P575, DOI 10.3109/00498259109039497
   SASTRE J, 1992, MECH AGEING DEV, V62, P181, DOI 10.1016/0047-6374(92)90054-H
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   VANBEZOOIJEN C, 1986, LIVER DRUGS AGEING, P25
   VANBEZOOIJEN CFA, 1989, J PHARMACOL EXP THER, V251, P683
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
NR 37
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY
PY 1994
VL 74
IS 1-2
BP 103
EP 115
DI 10.1016/0047-6374(94)90102-3
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NN661
UT WOS:A1994NN66100009
PM 7934201
DA 2024-02-19
ER

PT J
AU Coppel, S
   Mathur, K
   Ekser, B
   Patidar, KR
   Orman, E
   Desai, AP
   Vilar-Gomez, E
   Kubal, C
   Chalasani, N
   Nephew, L
   Ghabril, M
AF Coppel, Scott
   Mathur, Karan
   Ekser, Burcin
   Patidar, Kavish R.
   Orman, Eric
   Desai, Archita P.
   Vilar-Gomez, Eduardo
   Kubal, Chandrashekhar
   Chalasani, Naga
   Nephew, Lauren
   Ghabril, Marwan
TI Extra-hepatic comorbidity burden significantly increases 90-day
   mortality in patients with cirrhosis and high model for endstage liver
   disease
SO BMC GASTROENTEROLOGY
LA English
DT Article
DE Cirrhosis; Comorbidity; Charlson comorbidity index; Liver
   transplantation; Mortality
ID HEART-FAILURE; TRANSPLANTATION; VALIDATION; INDEX
AB BackgroundWe examined how extra-hepatic comorbidity burden impacts mortality in patients with cirrhosis referred for liver transplantation (LT).MethodsAdults with cirrhosis evaluated for their first LT in 2012 were followed through their clinical course with last follow up in 2019. Extra-hepatic comorbidity burden was measured using the Charlson Comorbidity Index (CCI). The endpoints were 90-day transplant free survival (Cox-Proportional Hazard regression), and overall mortality (competing risk analysis).ResultsThe study included 340 patients, mean age 5611, 63% male and MELD-Na 17.2 +/- 6.6. The CCI was 0 (no comorbidities) in 44%, 1-2 in 44% and>2 (highest decile) in 12%, with no differences based on gender but higher CCI in patients with fatty and cryptogenic liver disease. Thirty-three (10%) of 332 patients not receiving LT within 90days died. Beyond MELD-Na, the CCI was independently associated with 90-day mortality (hazard ratio (HR), 1.32 (95% confidence interval (CI) 1.02-1.72). Ninety-day mortality was specifically increased with higher CCI category and MELD >= 18 (12% (CCI=0), 22% (CCI=1-2) and 33% (CCI>2), (p =0.002)) but not MELD-Na <= 17. At last follow-up, 69 patients were alive, 100 underwent LT and 171 died without LT. CCI was associated with increased overall mortality in the competing risk analysis (Sub-HR 1.24, 95%CI 1.1-1.4).Conclusions Extra-hepatic comorbidity burden significantly impacts short-term mortality in patients with cirrhosis and high MELD-Na. This has implications in determining urgency of LT and mortality models in cirrhosis and LT waitlisting, especially with an ageing population with increasing prevalence of fatty liver disease.
C1 [Coppel, Scott] Indiana Univ, Med, Indianapolis, IN 46204 USA.
   [Mathur, Karan; Patidar, Kavish R.; Orman, Eric; Desai, Archita P.; Vilar-Gomez, Eduardo; Chalasani, Naga; Nephew, Lauren; Ghabril, Marwan] Indiana Univ, Gastroenterol & Hepatol, 702 Rotary Circle,Suite 225, Indianapolis, IN 46202 USA.
   [Ekser, Burcin; Kubal, Chandrashekhar] Indiana Univ, Transplant Surg, Indianapolis, IN 46204 USA.
C3 Indiana University System; Indiana University-Purdue University
   Indianapolis; Indiana University System; Indiana University-Purdue
   University Indianapolis; Indiana University System; Indiana
   University-Purdue University Indianapolis
RP Ghabril, M (corresponding author), Indiana Univ, Gastroenterol & Hepatol, 702 Rotary Circle,Suite 225, Indianapolis, IN 46202 USA.
EM mghabril@iu.edu
RI Kubal, Chandrashekhar/AAX-4744-2021; Desai, Archita/AAE-1923-2019;
   Nephew, Lauren/AAY-9123-2021; Ghabril, Marwan/AAF-8661-2020; Patidar,
   Kavish Rohit/AHD-7910-2022; Ekser, Burcin/I-3288-2019
OI Desai, Archita/0000-0001-8731-2370; Nephew, Lauren/0000-0003-0837-0746;
   Ghabril, Marwan/0000-0002-4784-3246; Ekser, Burcin/0000-0003-0741-8007
CR Arya A, 2013, CAN J SURG, V56, pE39, DOI 10.1503/cjs.004512
   BIANCHI G, 1994, HEPATOLOGY, V20, P119, DOI 10.1002/hep.1840200119
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Cullaro G, 2018, AM J TRANSPLANT, V18, P1214, DOI 10.1111/ajt.14608
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170
   Formiga F, 2018, AGING CLIN EXP RES, V30, P927, DOI 10.1007/s40520-017-0853-1
   Fraccaro P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004973
   Ghabril M, 2019, GASTROENTEROLOGY, V157, P1245, DOI 10.1053/j.gastro.2019.07.006
   JEPSEN P, 2014, GASTROENTEROLOGY, V146, P147, DOI DOI 10.1053/j.gastro.2013.09.019
   Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209
   Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581
   Motwani K, 2020, CLIN J GASTROENTEROL, V13, P732, DOI 10.1007/s12328-020-01141-4
   Moylan CA, 2008, JAMA-J AM MED ASSOC, V300, P2371, DOI 10.1001/jama.2008.720
   Nagai S, 2018, GASTROENTEROLOGY, V155, P1451, DOI 10.1053/j.gastro.2018.07.025
   O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388
   Sanchis J, 2019, EUR J INTERN MED, V62, P48, DOI 10.1016/j.ejim.2019.01.018
   Sanchis J, 2011, MAYO CLIN PROC, V86, P291, DOI 10.4065/mcp.2010.0702
   Pham T, 2016, CLIN LIVER DIS, V20, P403, DOI 10.1016/j.cld.2015.10.014
   Volk ML, 2007, LIVER TRANSPLANT, V13, P1515, DOI 10.1002/lt.21172
   Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039
   Xu Y, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-016-0559-4
NR 21
TC 5
Z9 5
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-230X
J9 BMC GASTROENTEROL
JI BMC Gastroenterol.
PD SEP 16
PY 2020
VL 20
IS 1
AR 302
DI 10.1186/s12876-020-01448-z
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA NT6XQ
UT WOS:000573081500002
PM 32938387
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Mattarozzi, K
   Cretella, L
   Guarino, M
   Stracciari, A
AF Mattarozzi, Katia
   Cretella, Lucia
   Guarino, Maria
   Stracciari, Andrea
TI Minimal Hepatic Encephalopathy: Follow-Up 10 Years After Successful
   Liver Transplantation
SO TRANSPLANTATION
LA English
DT Article
DE Minimal hepatic encephalopathy; Liver transplantation; Cognitive
   processes
ID COGNITIVE FUNCTION; COMPLICATIONS
AB Background. The long-term effect of liver transplantation (LT) on cognitive functions and the complete reversibility of minimal hepatic encephalopathy are poorly documented. Much evidence indicates that spatial attention improves starting from the immediate period after LT. However, at least in the first 2 years, some cognitive defects seem to persist to some degree, especially for supramodal nonverbal cognitive functions. The aim of this study is to investigate (i) whether the improvements observed in the perioperative period fluctuate or remain stable 10 years after LT and (ii) whether the functions that have been found defective also improve.
   Methods. We called patients previously included in a prospective study (Mattarozzi et al., Arch Neurol 2004; 61: 242) for a further neuropsychological evaluation. We compared the cognitive evaluation after 7 to 10 years with previous data gathered 6 and 18 months after LT.
   Results. The improvements obtained in the first 2 years after transplantation remain stable during the 7 to 10 years thereafter, especially for visuospatial attention, F(12,96) 1.70; P = 0.04 and selective attention, F(6,66) 3.51; P = 0.005. Furthermore, these findings also seem to suggest an improvement in supramodal cognitive functions, such as spatial planning intelligence, measured by the Elithorn Maze Test, F(3,33) 7.42; P = 0.002. Verbal short-term memory, F(3,33) 3.69; P = 0.038, and visuospatial short-term memory, F(6,64) 2.97; P = 0.013, show a more fluctuating trend over time.
   Conclusions. Despite the risk of surgery, the neurotoxicity of immunosuppression therapy, and the effects of aging and related comorbidities, our data indicate that LT is able to significantly improve patients' cognitive functions in the long term.
C1 [Mattarozzi, Katia] Univ Bologna, Dept Psychol, I-40127 Bologna, Italy.
   [Cretella, Lucia; Guarino, Maria; Stracciari, Andrea] Univ Bologna, S Orsola Malpighi Hosp, Neurol Unit, I-40127 Bologna, Italy.
C3 University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di
   Bologna; University of Bologna
RP Mattarozzi, K (corresponding author), Univ Bologna, Dept Psychol, Vle Berti Pichat 5, I-40127 Bologna, Italy.
EM katia.mattarozzi@unibo.it
RI guarino, maria/AAC-5654-2021
OI guarino, maria/0000-0002-8894-2187; MATTAROZZI,
   KATIA/0000-0003-1784-750X; stracciari, andrea/0000-0002-7058-4772
CR Campagna F, 2010, METAB BRAIN DIS, V25, P115, DOI 10.1007/s11011-010-9183-0
   Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297
   GARCIA MR, 2010, TRANSPLANTATION, V89, P589
   Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792
   MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12
   Mattarozzi K, 2004, ARCH NEUROL-CHICAGO, V61, P242, DOI 10.1001/archneur.61.2.242
   Mechtcheriakov S, 2004, LIVER TRANSPLANT, V10, P77, DOI 10.1002/lt.20009
   Novelli G., 1986, Neurol. Psichiatria", V47, P278
   Osterrieth P.A., 1944, ARCH PSYCHOLOGIE, V30, P206
   Rovira A, 2007, HEPATOLOGY, V46, P1485, DOI 10.1002/hep.21911
   Senzolo M, 2009, TRANSPL P, V41, P1295, DOI 10.1016/j.transproceed.2009.03.087
   Spinnler H., 1987, Italalian Journal of Neurological Scencesi, V6, P21
   Stewart CA, 2005, METAB BRAIN DIS, V20, P193, DOI 10.1007/s11011-005-7207-x
   Stracciari A, 2001, METAB BRAIN DIS, V16, P3, DOI 10.1023/A:1011698526025
   Wechsler D., 1987, WECHSLER MEMORY SCAL
   Wechsler D., 2012, Wechsler adult intelligence scale-revised, V4th ed.
NR 16
TC 23
Z9 25
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD MAR 27
PY 2012
VL 93
IS 6
BP 639
EP 643
DI 10.1097/TP.0b013e318244f734
PG 5
WC Immunology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Surgery; Transplantation
GA 906MT
UT WOS:000301350100015
PM 22245876
OA Bronze
DA 2024-02-19
ER

PT J
AU Gao, JQ
   Yu, ZP
   Jing, S
   Jiang, WH
   Liu, C
   Yu, CY
   Sun, JH
   Wang, CM
   Chen, JG
   Li, H
AF Gao, Jiaqi
   Yu, Zepeng
   Jing, Shu
   Jiang, Weihai
   Liu, Cong
   Yu, Chunyan
   Sun, Jinghui
   Wang, Chunmei
   Chen, Jianguang
   Li, He
TI Protective effect of Anwulignan against D-galactose-induced hepatic
   injury through activating p38 MAPK-Nrf2-HO-I pathway in mice
SO CLINICAL INTERVENTIONS IN AGING
LA English
DT Article
DE Schisandra; antioxidant capacity; caspase-3
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SCHISANDRA-SPHENANTHERA;
   MASS-SPECTROMETRY; OXIDATIVE STRESS; HEME OXYGENASE; INDUCED LIVER;
   AGING MICE; NRF2; AMINOTRANSFERASE; EXPRESSION
AB Background: Liver aging is a significant risk factor for chronic liver diseases. Oxidative stress has been considered as a conjoint pathological mechanism for the initiation and progression of liver aging. It has been reported that D-galactose (D-gal)-induced hepatic injury is an experimental model well established closely similar to morphological and functional features of liver aging. Schisandra sphenanthera Rehd. et Wils (S. sphenanthera, Schisandraceae), as a famous traditional Chinese medicine, has been used for thousands of years in China to treat various disorders, including liver dysfunctions. This study was aimed to understand whether Anwulignan, one of the monomeric compounds in the lignans from S. sphenanthera, could improve the hepatic injury induced by D-gal in mice and to examine the possible mechanisms.
   Methods: ICR mice were used to produce hepatic injury by 220 mg kg-1 D-gal subcutaneously once daily for 42 days. The effects of oral Anwulignan on liver index; serial AST and ALT levels; histological changes; SOD, GSH-Px, MDA, and 8-OHdG in the liver and peripheral blood; expression of p38 mitogen-activated protein kinase (MAPK), Nrf2, and HO-1 in the liver; and HepG2 cell viability, and decrease caspase-3 contents in liver were examined.
   Results: Anwulignan could significantly increase the liver index, lower aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in the peripheral blood, elevate superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities, and decrease malonaldehyde (MDA) and 8-hydroxy-2-deoxyguanosine (8-OHdG) contents in the peripheral blood and liver. Furthermore, Anwulignan could upregulate the expression of p38 mitogen-activated protein kinase (MAPK), Nrf2, and HO-1 in the liver, increase the HepG2 cell viability, and decrease caspase-3 contents in liver.
   Conclusion: Anwulignan has protective effects against the hepatic injury induced by D-gal, which may be related to its antioxidant capacity through activating p38 MAPK-Nrf2-HO-1 pathway, increases the injured cell viability, and decreases the caspase-3 contents in liver.
C1 [Gao, Jiaqi; Yu, Zepeng; Liu, Cong; Yu, Chunyan; Sun, Jinghui; Wang, Chunmei; Chen, Jianguang; Li, He] Beihua Univ, Dept Pharmacol, Coll Pharm, 3999 Binjiang East Rd, Jilin 132013, Jilin, Peoples R China.
   [Jing, Shu; Jiang, Weihai] Beihua Univ, Affiliated Hosp, Jilin, Jilin, Peoples R China.
C3 Beihua University; Beihua University
RP Chen, JG; Li, H (corresponding author), Beihua Univ, Dept Pharmacol, Coll Pharm, 3999 Binjiang East Rd, Jilin 132013, Jilin, Peoples R China.
EM chenjg@beihua.edu.cn; yitonglh@126.com
RI Sun, Jinghui/AAB-3845-2020
FU Jilin Provincial Science and Technology Department [201603103YY,
   20162004, 20170309006YY, 20150311047YY]; Jilin City Bureau of Science
   and Technology [20162004, 20166018, 20163024, 20163054]
FX We thank all our colleagues working at the Jilin Schisandra Development
   and Industrialization Engineering Research Center. This study is
   financially supported by Grants from Jilin Provincial Science and
   Technology Department (201603103YY, 20162004, 20170309006YY, and
   20150311047YY) and Jilin City Bureau of Science and Technology
   (20166018, 20163024, 20163054, and 20162004).
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323
   Deng YF, 2014, ENVIRON SCI TECHNOL, V48, P8212, DOI 10.1021/es502010v
   Dong FX, 2017, BIOCHEM BIOPH RES CO, V491, P636, DOI 10.1016/j.bbrc.2017.07.151
   Dong Liang, 2013, Journal of Agricultural Science and Technology (Beijing), V15, P53
   Fan SH, 2009, INT IMMUNOPHARMACOL, V9, P91, DOI 10.1016/j.intimp.2008.10.008
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Fx F., 2014, HENAN TRADITIONAL CH, V34, P1711
   Gao JianPing, 2003, Chinese Journal of Natural Medicines, V1, P89
   Go YM, 2017, CLIN SCI, V131, P1669, DOI 10.1042/CS20160897
   Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287
   Harrington HA, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-26
   He M, 2009, BIOL PHARM BULL, V32, P55, DOI 10.1248/bpb.32.55
   Hosseini M., 2017, DRUG CHEM TOXICOL, P1
   Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074
   Jetawattana S., 2005, FREE RADICAL BIO MED, V22, P9
   Jiang Shi-li, 2005, Fudan Xuebao (Yixuekexueban), V32, P467
   Jiang Si-Jia, 2005, Chinese Journal of Natural Medicines, V3, P78
   Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020
   Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63
   Kozakowska Magdalena, 2015, Postepy Biochem, V61, P147
   Liu JS, 1988, CHINESE J ORG CHEM, V03, P227
   Lu Y, 2009, J CHROMATOGR A, V1216, P1980, DOI 10.1016/j.chroma.2008.09.070
   Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6
   Perry DK, 1997, J BIOL CHEM, V272, P18530, DOI 10.1074/jbc.272.30.18530
   RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420
   Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005
   Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800
   Truyen N, 2010, J BIOL CHEM, V284, P13291
   Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684
   Wang GP, 2013, CHINESE MED CLIN, V31, P467
   Wang Yan-han, 2003, Zhongguo Zhong Yao Za Zhi, V28, P1155
   Wei H, 2010, ANAL CHIM ACTA, V662, P97, DOI 10.1016/j.aca.2009.12.039
   WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2
   Wong SY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0723-3
   Xiao WL, 2008, PHYTOCHEMISTRY, V69, P2862, DOI 10.1016/j.phytochem.2008.09.010
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Xu MJ, 2005, J CHROMATOGR B, V828, P55, DOI 10.1016/j.jchromb.2005.09.029
   Yang YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/980276
   [于春艳 Yu Chunyan], 2014, [中国病理生理杂志, Chinese Journal of Pathophysiology], V30, P1967
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257
   Zhang HZ, 2017, J SEP SCI, V40, P574, DOI 10.1002/jssc.201600954
   Zhao H, 2018, FOOD NUTR RES, V62, P20
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
NR 47
TC 32
Z9 41
U1 0
U2 19
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-1998
J9 CLIN INTERV AGING
JI Clin. Interv. Aging
PY 2018
VL 13
BP 1859
EP 1869
DI 10.2147/CIA.S173838
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GW2FH
UT WOS:000446697800001
PM 30323572
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Shan, SF
   Zheng, TL
   Zhang, CX
   Song, XJ
   Chen, JY
   Shi, Y
   You, J
   Cheng, G
   Xiong, JY
AF Shan, Shufang
   Zheng, Tianli
   Zhang, Chaoxiong
   Song, Xuejiao
   Chen, Jiayi
   Shi, Ying
   You, Jia
   Cheng, Guo
   Xiong, Jingyuan
TI Yogurt and <i>Streptococcus thermophilus</i> metabolites ameliorated
   telomere attrition in D-galactose-induced ageing mice and
   <i>t</i>-BHP-challenged HepG2 cells
SO INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article; Early Access
DE Fermented dairy product; lactic acid bacteria; oxidative stress;
   relative telomere length; senescence
ID LIFE-STYLE FACTORS; FATTY-ACIDS; DIETARY PATTERNS; LENGTH; ASSOCIATION;
   ADHERENCE; SURVIVAL; MARKERS; STRESS; RISK
AB Antioxidant-rich diets affect telomere length, an integrative marker associated with age-related diseases. Yogurt exerts antioxidative capacity and is speculated to support healthy ageing. However, direct experimental evidence is missing. Here, the effects of yogurt and dairy-fermenting bacteria on D-galactose-induced ageing mice and chemically challenged HepG2 cells were evaluated. Relative telomere length (RTL) in leucocyte and liver were significantly longer in yogurt (1.21 +/- 0.07; 1.23 +/- 0.11) and Streptococcus thermophilus group (1.18 +/- 0.15; 1.13 +/- 0.12). When t-BHP-challenged HepG2 cells were treated with digested yogurt and S. thermophilus, the senescence index (13.67 +/- 3.30; 19.67 +/- 2.87) were lower and RTL (1.25 +/- 0.11; 1.18 +/- 0.10) were longer than the model. Antioxidative effects were observed for yogurt and S. thermophilus metabolites, whereas milk and Lactobacillus rhamnosus metabolites showed minimal influence on RTL and oxidative stress. In conclusion, this study showed that yogurt and S. thermophilus metabolites ameliorated telomere attrition in ageing mice and t-BHP-challenged HepG2 cells, possibly by reducing oxidative stress.
C1 [Cheng, Guo; Xiong, Jingyuan] Sichuan Univ, Hlth Food Evaluat Res Ctr, West China Sch Publ Hlth, 16 Renminnan Rd 3rd Sect, Chengdu 610041, Peoples R China.
   Sichuan Univ, West China Hosp 4, 16 Renminnan Rd 3rd Sect, Chengdu 610041, Peoples R China.
C3 Sichuan University; Sichuan University
RP Cheng, G; Xiong, JY (corresponding author), Sichuan Univ, Hlth Food Evaluat Res Ctr, West China Sch Publ Hlth, 16 Renminnan Rd 3rd Sect, Chengdu 610041, Peoples R China.
EM gcheng@scu.edu.cn; jzx0004@tigermail.auburn.edu
RI Xiong, Jingyuan/AAC-8743-2021; chen, jia/JLM-4733-2023; Chen,
   Jia/HQZ-3908-2023; chen, jia/JDW-7660-2023; Chen, Jiayi/GZM-5106-2022;
   chen, jiayi/IAP-9353-2023
OI Xiong, Jingyuan/0000-0001-9354-862X; Cheng, Guo/0000-0002-0945-5728
FU National Nature Science Foundation of China [81402642]; Department of
   Science and Technology of Sichuan Province; Chengdu Science and
   Technology Bureau; Public Health and Preventive Medicine Provincial
   Experiment Teaching Center at Sichuan University; Food Safety Monitoring
   and Risk Assessment Key Laboratory of Sichuan Province
FX This study was funded by National Nature Science Foundation of China
   (Grant 81402642), Department of Science and Technology of Sichuan
   Province, and Chengdu Science and Technology Bureau (Jingyuan Xiong).
   This study was also supported by Public Health and Preventive Medicine
   Provincial Experiment Teaching Center at Sichuan University, and Food
   Safety Monitoring and Risk Assessment Key Laboratory of Sichuan
   Province.
CR Barnes RP, 2019, MECH AGEING DEV, V177, P37, DOI 10.1016/j.mad.2018.03.013
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389
   Boesten D.M., 2013, OXIDATIVE MED CELLUL, V2013, P1
   Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chan R, 2010, BRIT J NUTR, V103, P107, DOI 10.1017/S0007114509991383
   Chen JN, 2017, ONCOTARGET, V8, P7301, DOI 10.18632/oncotarget.14236
   Cohen S, 2013, JAMA-J AM MED ASSOC, V309, P699, DOI 10.1001/jama.2013.613
   Crous-Bou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6674
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   El-Abbadi NH, 2014, AM J CLIN NUTR, V99, p1263S, DOI 10.3945/ajcn.113.073957
   Fardet A, 2018, NUTR RES REV, V31, P52, DOI [10.1017/S0954422417000191, 10.1017/s0954422417000191]
   Farvin KHS, 2010, FOOD CHEM, V123, P1090, DOI 10.1016/j.foodchem.2010.05.029
   Freitas-Simoes TM, 2016, METABOLISM, V65, P406, DOI 10.1016/j.metabol.2015.11.004
   García-Calzón S, 2015, CLIN NUTR, V34, P694, DOI 10.1016/j.clnu.2014.07.015
   Goldbohm RA, 2011, AM J CLIN NUTR, V93, P615, DOI 10.3945/ajcn.110.000430
   Goldstein EJC, 2015, CLIN INFECT DIS, V60, pS98, DOI 10.1093/cid/civ072
   Gong YH, 2018, CLIN NUTR, V37, P1232, DOI 10.1016/j.clnu.2017.05.005
   Guan JZ, 2012, GERONTOLOGY, V58, P62, DOI 10.1159/000327821
   Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227
   Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hor YY, 2019, J MED FOOD, V22, P1, DOI 10.1089/jmf.2018.4229
   Lee JY, 2015, EUR J CLIN NUTR, V69, P1048, DOI 10.1038/ejcn.2015.58
   Liang FQ, 2018, J AGR FOOD CHEM, V66, P6317, DOI 10.1021/acs.jafc.8b01875
   Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Margolis KL, 2011, J NUTR, V141, P1969, DOI 10.3945/jn.111.143339
   Oliveira RPS, 2009, INT J FOOD MICROBIOL, V128, P467, DOI 10.1016/j.ijfoodmicro.2008.10.012
   Pala V, 2011, INT J CANCER, V129, P2712, DOI 10.1002/ijc.26193
   Sheng R, 2013, INT J CARDIOL, V162, P199, DOI 10.1016/j.ijcard.2011.07.083
   Sonestedt E, 2011, EUR J EPIDEMIOL, V26, P609, DOI 10.1007/s10654-011-9589-y
   Song Y, 2013, J NUTR, V143, P907, DOI 10.3945/jn.113.175422
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   Watfa G, 2011, J NUTR HEALTH AGING, V15, P277, DOI 10.1007/s12603-010-0275-7
   Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986
   Zhou MC, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0157-x
NR 38
TC 3
Z9 3
U1 3
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-5423
EI 1365-2621
J9 INT J FOOD SCI TECH
JI Int. J. Food Sci. Technol.
PD 2020 JUN
PY 2020
VL 55
IS 6
SI SI
BP 2509
EP 2516
DI 10.1111/ijfs.14502
EA JAN 2020
PG 8
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA LQ2AW
UT WOS:000507853000001
DA 2024-02-19
ER

PT J
AU MALONEY, AG
   SCHMUCKER, DL
   VESSEY, DS
   WANG, RK
AF MALONEY, AG
   SCHMUCKER, DL
   VESSEY, DS
   WANG, RK
TI THE EFFECTS OF AGING ON THE HEPATIC-MICROSOMAL MIXED-FUNCTION OXIDASE
   SYSTEM OF MALE AND FEMALE MONKEYS
SO HEPATOLOGY
LA English
DT Article
C1 VET ADM MED CTR,CELL BIOL & AGING SECT 151E,SAN FRANCISCO,CA 94121.
   VET ADM MED CTR,LIVER STUDIES UNIT,SAN FRANCISCO,CA 94121.
   UNIV CALIF SAN FRANCISCO,DEPT ANAT,SAN FRANCISCO,CA 94143.
   UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143.
   UNIV CALIF SAN FRANCISCO,CTR LIVER,SAN FRANCISCO,CA 94143.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco
FU NIADDK NIH HHS [AM 25878] Funding Source: Medline
CR Adelman RC, 1972, ADV GERONTOLOGICAL R, V4, P1
   ANTHONY LE, 1973, J NUTR, V103, P811, DOI 10.1093/jn/103.6.811
   ARMBRECHT HJ, 1982, EXP GERONTOL, V17, P41, DOI 10.1016/0531-5565(82)90007-9
   BAIRD MB, 1983, EXP GERONTOL, V18, P47, DOI 10.1016/0531-5565(83)90050-5
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BIRNBAUM LS, 1980, EXP GERONTOL, V15, P259, DOI 10.1016/0531-5565(80)90030-3
   BITAR M, 1983, MECH AGEING DEV, V23, P285, DOI 10.1016/0047-6374(83)90029-5
   BUTLER RN, 1984, AGING PROCESS THERAP
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   GAFFNEY BJ, 1975, P NATL ACAD SCI USA, V72, P664, DOI 10.1073/pnas.72.2.664
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   GRINNA LS, 1977, MECH AGEING DEV, V6, P197, DOI 10.1016/0047-6374(77)90021-5
   GUSTAFSSON JA, 1983, ANNU REV PHYSIOL, V45, P51, DOI 10.1146/annurev.ph.45.030183.000411
   Hawcroft D M, 1982, Arch Gerontol Geriatr, V1, P55, DOI 10.1016/0167-4943(82)90006-1
   HUBBELL WL, 1971, J AM CHEM SOC, V93, P314
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1968, JPN J PHARMACOL, V18, P381, DOI 10.1254/jjp.18.381
   KITANI K, 1984, PHARM MORPHOLOGICAL, P105
   KITANI K, 1982, LIVER AGING 1982
   Masters B. S. S., 1967, METHOD ENZYMOL, V10, P565
   McElhaney R.N., 1982, CURRENT TOPICS MEMBR, V17
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   RADIN NS, 1969, METHOD ENZYMOL, V14, P245
   RIKANS LE, 1984, MECH AGEING DEV, V25, P335, DOI 10.1016/0047-6374(84)90006-X
   RUDEL LL, 1973, J LIPID RES, V14, P364
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   SCHMUCKER DL, 1980, P SOC EXP BIOL MED, V165, P178
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   SCHMUCKER DL, 1985, REV BIOL RES AGING, V2, P465
   Skipski V. P., 1969, METHOD ENZYMOL, V14, P530
   SONDERMAN H, 1978, BIOCH BIOPHYS ACTA, V515, P209
   SUTTER MA, 1985, BIOCHEM PHARMACOL, V34, P2983, DOI 10.1016/0006-2952(85)90025-5
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VESSEY DA, 1982, HORIZONS BIOCH BIOPH, V1, P139
   VESTAL RF, 1982, J AM GERIATR SOC, V30, P191, DOI 10.1111/j.1532-5415.1982.tb01303.x
   ZAKIM D, 1980, PRINCIPLES METABOLIC, P337
NR 40
TC 42
Z9 44
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD MAR-APR
PY 1986
VL 6
IS 2
BP 282
EP 287
DI 10.1002/hep.1840060221
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA A7629
UT WOS:A1986A762900020
PM 3082734
DA 2024-02-19
ER

PT J
AU Zhou, GX
   Hou, F
   He, H
   Xue, Y
   Wang, YB
   Chen, XY
   Zhu, FQ
AF Zhou, Guangxi
   Hou, Fei
   He, Heng
   Xue, Yuan
   Wang, Yibo
   Chen, Xueying
   Zhu, Fengqin
TI Myocyte Enhancer Factor 2A Contributes to the TGF-<i>β</i>1-Mediated
   Cholangiocyte Epithelial to Mesenchymal Transition and Senescence in
   Cholestatic Liver Fibrosis
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE MEF2A; EMT; senescence; fibrosis; cholangiocytes
ID PROTEIN EXPRESSION; ACTIVATION; MEF2; AUTOPHAGY; PATHWAYS; DISEASE;
   MUSCLE; GROWTH; CELLS; DNA
AB Background: Cholangiocytes are primary targets in chronic cholestatic liver diseases. Myocyte enhancer factor 2A (MEF2A) is a transcription factor with a crucial role in some fibrogenic diseases. However, whether it contributes to cholestatic liver fibrosis is still obscure. Methods: A bile duct-ligated (BDL) mouse model was established to detect MEF2A expression during cholestatic liver fibrosis. In addition, human intrahepatic biliary epithelial cells (HIBECs) were transfected with lentivirus-expressing shMEF2A (LV-shMEF2A) to regulate the expression of MEF2A in vitro. Biomarkers of epithelial to mesenchymal transition (EMT), senescence, and fibrogenesis were evaluated using various assays: Quantitative real-time polymerase chain reaction (qRT-PCR), western blotting, senescenceassociated beta-galactosidase (SA-beta-gal), and immunofluorescence. Furthermore, MEF2A expression and cytoplasm translocation induced by transforming growth factor beta 1 (TGF-beta 1) in HIBECs were determined by qRT-PCR, western blotting, and immunofluorescence. The expression of TGF-beta 1-induced MEF2A, EMT, senescence, and fibrosis markers inhibited by p38 MAPK signaling were evaluated by western blotting. Finally, the peripheral blood from primary biliary cholangitis (PBC) patients and healthy controls (HCs) was collected to analyze expression of MEF2A using Enzyme-linked immunosorbent assay (ELISA). Results: We found that MEF2A expression increased in liver tissues of BDL mice, and positively related to the extent of fibrosis. Silencing MEF2A in HIBECs restrained TGF-beta 1-induced EMT, senescence, and fibrotic reaction. Moreover, TGF-beta 1 enhanced the expression of MEF2A and induced its cytoplasm translocation in a concentration- and time-dependent manner, partially through interacting with p38 MAPK. The expression of MEF2A was also higher in the serum of PBC patients than in HCs, and positively correlated with fibrosis degree. Conclusions: Our study demonstrates that MEF2A is a central mediator linking TGF-beta 1-induced EMT and senescence in HIBECs. We propose it as a novel biomarker of fibrogenesis in cholestatic liver fibrosis. We also suggest inhibiting MEF2A as a potential strategy in treating cholestatic liver fibrosis.
C1 [Zhou, Guangxi; He, Heng; Xue, Yuan; Wang, Yibo; Zhu, Fengqin] Jining Med Univ, Affiliated Hosp, Dept Gastroenterol, Jining 272000, Shandong, Peoples R China.
   [Zhou, Guangxi; Zhu, Fengqin] Shandong Univ Tradit Chinese Med, Jinan 250355, Shandong, Peoples R China.
   [Hou, Fei] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Dept Crit Liver Dis, Beijing 100015, Peoples R China.
   [Chen, Xueying] Jining Med Univ, Affiliated Hosp, Dept Cardiol, Jining 272000, Shandong, Peoples R China.
C3 Jining Medical University; Shandong University of Traditional Chinese
   Medicine; Capital Medical University; Jining Medical University
RP Zhu, FQ (corresponding author), Jining Med Univ, Affiliated Hosp, Dept Gastroenterol, Jining 272000, Shandong, Peoples R China.; Zhu, FQ (corresponding author), Shandong Univ Tradit Chinese Med, Jinan 250355, Shandong, Peoples R China.
EM zhufqin@126.com
RI Li, Huizhen/JPX-2563-2023; chen, yan/JRY-4645-2023
FU Tai Shan Young Scholar Foundation of Shandong Province [tsqn202103190];
   TCM Science and Technology Project of Shandong Province [Q-2022134]; Key
   research and development plan of Jining City [2021YXNS045, 2021YXNS144];
   Postdoctoral Fund of the Affiliated Hospital of Jining Medical
   University [JYFY303574]
FX This work was supported by grants from Tai Shan Young Scholar Foundation
   of Shandong Province (tsqn202103190), TCM Science and Technology Project
   of Shandong Province (Q-2022134), Key research and development plan of
   Jining City (2021YXNS045, 2021YXNS144), and Postdoctoral Fund of the
   Affiliated Hospital of Jining Medical University (JYFY303574).
CR Bogert PS, 2022, CURR OPIN GASTROEN, V38, P121, DOI 10.1097/MOG.0000000000000805
   Chen XY, 2015, INT J BIOCHEM CELL B, V69, P52, DOI 10.1016/j.biocel.2015.10.012
   Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196
   Cilenti F, 2021, IMMUNITY, V54, P1665, DOI 10.1016/j.immuni.2021.05.016
   Fabris L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2953727
   Feng J, 2018, DRUG DES DEV THER, V12, P1837, DOI 10.2147/DDDT.S162950
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Frangogiannis NG, 2020, J EXP MED, V217, DOI 10.1084/jem.20190103
   Garcia-Irigoyen O, 2014, LIVER INT, V34, pE257, DOI 10.1111/liv.12337
   Gjyshi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26670-4
   Hirschfield GM, 2017, J HEPATOL, V67, P145, DOI 10.1016/j.jhep.2017.03.022
   Hirschfield GM, 2010, GASTROENTEROLOGY, V139, P1481, DOI 10.1053/j.gastro.2010.09.004
   Ishikawa F, 2010, ONCOGENE, V29, P909, DOI 10.1038/onc.2009.387
   Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011
   Kim JM, 2017, INTEGR CANCER THER, V16, P360, DOI 10.1177/1534735416670987
   Li H, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.682247
   Liu BR, 2022, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.775392
   Liu JJ, 2015, CELL PHYSIOL BIOCHEM, V36, P155, DOI 10.1159/000374060
   Lleo A, 2014, SEMIN LIVER DIS, V34, P273, DOI 10.1055/s-0034-1383727
   Mehta PB, 2001, ONCOGENE, V20, P5359, DOI 10.1038/sj.onc.1204688
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Meyer M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062200
   Nakanuma Y, 2015, J HEPATOL, V62, P934, DOI 10.1016/j.jhep.2014.11.027
   O'Hara SP, 2013, J HEPATOL, V58, P575, DOI 10.1016/j.jhep.2012.10.011
   Ornatsky OI, 1996, J BIOL CHEM, V271, P24927, DOI 10.1074/jbc.271.40.24927
   Pan Y, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/6890423
   Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088
   Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367
   Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624
   Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704
   Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Sato Y, 2007, AM J PATHOL, V171, P1859, DOI 10.2353/ajpath.2007.070337
   Sung R, 2014, J GASTROEN HEPATOL, V29, P395, DOI 10.1111/jgh.12349
   Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wang XM, 2004, GASTROENTEROLOGY, V127, P1174, DOI 10.1053/j.gastro.2004.07.007
   Xiao Q, 2021, ONCOGENE, V40, P3364, DOI 10.1038/s41388-021-01774-w
   Yang SH, 1999, MOL CELL BIOL, V19, P4028
   Zhang WW, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00322
   Zhang XR, 2020, CLIN MOL HEPATOL, V26, P128, DOI 10.3350/cmh.2019.0001n
   Zhang ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.255
   Zhao YL, 2016, BIOMED REP, V4, P269, DOI 10.3892/br.2016.578
   Zhou TH, 2019, EBIOMEDICINE, V48, P130, DOI 10.1016/j.ebiom.2019.09.013
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 45
TC 0
Z9 0
U1 2
U2 5
PU IMR PRESS
PI ROBINSON
PA 112 ROBINSON RD, ROBINSON, SINGAPORE
SN 2768-6701
EI 2768-6698
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD DEC
PY 2022
VL 27
IS 12
DI 10.31083/j.fbl2712324
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 8C8DG
UT WOS:000917832600006
PM 36624941
OA gold
DA 2024-02-19
ER

PT J
AU Schloesser, A
   Campbell, G
   Glüer, CC
   Rimbach, G
   Huebbe, P
AF Schloesser, Anke
   Campbell, Graeme
   Glueer, Claus-Christian
   Rimbach, Gerald
   Huebbe, Patricia
TI Restriction on an Energy-Dense Diet Improves Markers of Metabolic Health
   and Cellular Aging in Mice Through Decreasing Hepatic mTOR Activity
SO REJUVENATION RESEARCH
LA English
DT Article
ID CALORIC RESTRICTION; MAMMALIAN TARGET; OXIDATIVE STRESS;
   SKELETAL-MUSCLE; GENE-EXPRESSION; RHESUS-MONKEYS; LIFE-SPAN; IN-VIVO;
   AGE; OBESITY
AB Dietary restriction (DR) on a normal low-fat diet improves metabolic health and may prolong life span. However, it is still uncertain whether restriction of an energy-dense, high-fat diet would also be beneficial and mitigate age-related processes. In the present study, we determined biomarkers of metabolic health, energy metabolism, and cellular aging in obesity-prone mice subjected to 30% DR on a high-fat diet for 6 months. Dietary-restricted mice had significantly lower body weights, less adipose tissue, lower energy expenditure, and altered substrate oxidation compared to their ad libitum-fed counterparts. Hepatic major urinary proteins (Mup) expression, which is linked to glucose and energy metabolism, and biomarkers of metabolic health, including insulin, glucose, cholesterol, and leptin/adiponectin ratio, were likewise reduced in high-fat, dietary-restricted mice. Hallmarks of cellular senescence such as Lamp2a and Hsc70 that mediate chaperone-mediated autophagy were induced and mechanistic target of rapamycin (mTOR) signaling mitigated upon high-fat DR. In contrast to DR applied in low-fat diets, anti-oxidant gene expression, proteasome activity, as well as 5 '-adenosine monophosphate-activated protein kinase (AMPK) activation were not changed, suggesting that high-fat DR may attenuate some processes associated with cellular aging without the induction of cellular stress response or energy deprivation.
C1 [Schloesser, Anke; Rimbach, Gerald; Huebbe, Patricia] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany.
   [Campbell, Graeme; Glueer, Claus-Christian] Univ Kiel, Sect Biomed Imaging, Dept Diagnost Radiol, Kiel, Germany.
C3 University of Kiel; University of Kiel
RP Huebbe, P (corresponding author), Inst Human Nutr & Food Sci, H Rodewald Str 6, D-24118 Kiel, Germany.
EM huebbe@foodsci.uni-kiel.de
RI Rimbach, Gerald/A-7178-2011; Glüer, Claus-Christian/C-9752-2010
OI Glüer, Claus-Christian/0000-0003-3539-8955; Rimbach,
   Gerald/0000-0001-7888-4684
FU German Ministry of Education and Science (BMBF) [0315681]
FX This study was supported financially by a grant of the German Ministry
   of Education and Science (BMBF 0315681) entitled "Aetiology,
   pathophysiology and prevention of catching up body fat mass after body
   weight reduction: Avoiding yo-yo effects in the treatment of obesity."
CR Austad SN, 2012, NATURE, V489, P210, DOI 10.1038/nature11484
   Bales CW, 2013, J CARDIOPULM REHABIL, V33, P201, DOI 10.1097/HCR.0b013e318295019e
   Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965
   Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766
   Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212
   Boesch-Saadatmandi C, 2012, PHARMACOL RES, V65, P523, DOI 10.1016/j.phrs.2012.02.007
   Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Couzin-Frankel J, 2014, SCIENCE, V343, P1068, DOI 10.1126/science.343.6175.1068
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   Cui MX, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/852754
   Dhahbi JM, 1997, J NUTR, V127, P1758, DOI 10.1093/jn/127.9.1758
   Dhahbi JM, 2001, BIOCHEM BIOPH RES CO, V284, P335, DOI 10.1006/bbrc.2001.4972
   Donato AJ, 2013, AGING CELL, V12, P772, DOI 10.1111/acel.12103
   Duivenvoorde LPM, 2011, J MOL ENDOCRINOL, V47, P81, DOI 10.1530/JME-11-0001
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Giller K, 2013, FREE RADICAL BIO MED, V61, P170, DOI 10.1016/j.freeradbiomed.2013.03.023
   Giller K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0101
   Gürtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010
   Gutman R, 2007, PHYSIOL BEHAV, V90, P95, DOI 10.1016/j.physbeh.2006.08.033
   Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015
   HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   HEYDARI AR, 1995, J NUTR, V125, P410
   HOCMAN G, 1988, COMP BIOCHEM PHYS A, V91, P209, DOI 10.1016/0300-9629(88)90407-0
   Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107
   Kalupahana NS, 2011, OBESITY, V19, P245, DOI 10.1038/oby.2010.196
   Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921
   Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006
   Lopez-Dominguez JA, 2014, J GERONTOL A-BIOL
   Lublinsky S, 2009, J DIGIT IMAGING, V22, P222, DOI 10.1007/s10278-008-9152-x
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   Mendelsohn AR, 2012, REJUV RES, V15, P334, DOI 10.1089/rej.2012.1347
   Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103
   MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830
   OKAUCHI N, 1995, DIABETES RES CLIN PR, V27, P97, DOI 10.1016/0168-8227(95)01029-D
   Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]
   Park S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/984643
   Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018
   Pfaffenbach KT, 2012, J CELL PHYSIOL, V227, P3803, DOI 10.1002/jcp.24090
   Pfaffenbach KT, 2010, J NUTR, V140, P879, DOI 10.3945/jn.109.119883
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412
   Stein PK, 2012, AGING CELL, V11, P644, DOI 10.1111/j.1474-9726.2012.00825.x
   Thondamal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5879
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Verdery RB, 1998, ARCH INTERN MED, V158, P900, DOI 10.1001/archinte.158.8.900
   Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211
   Walsh ME, 2014, FREE RADICAL BIO MED, V66, P88, DOI 10.1016/j.freeradbiomed.2013.05.037
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243
   Wang Y, 2014, DIABETES METAB J, V38, P321, DOI 10.4093/dmj.2014.38.5.321
   WU B, 1993, J GERONTOL, V48, pB50, DOI 10.1093/geronj/48.2.B50
   Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 58
TC 26
Z9 30
U1 0
U2 15
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD FEB 1
PY 2015
VL 18
IS 1
BP 30
EP 39
DI 10.1089/rej.2014.1630
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CB5QO
UT WOS:000349682800005
PM 25405871
OA Green Published
DA 2024-02-19
ER

PT J
AU Rinehart, CA
   Watson, JM
   Torti, VR
   Palmieri, D
AF Rinehart, CA
   Watson, JM
   Torti, VR
   Palmieri, D
TI The role of interleukin-1 in interactive senescence and age-related
   human endometrial cancer
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE aging; endometrium; interleukin-1; stromal epithelial interactions;
   senescence
ID LIVER EPITHELIAL-CELLS; REPLICATIVE SENESCENCE; HUMAN-FIBROBLASTS;
   GENE-EXPRESSION; DNA-SYNTHESIS; IDENTIFICATION; INDUCTION; TISSUE;
   DIFFERENTIATION; BIOLOGY
AB The causes of the age-related increase in cancer rates are poorly understood. One cause could be age-related changes in the stromal/epithelial cell interactions that facilitate tumorigenesis, We tested the hypothesis that aging of human endometrial stromal fibroblasts (ESF) alters their influence over endometrial epithelial cells, ESF from adults were found to inhibit anchorage-independent proliferation, to restrain colony outgrowth, and to induce formation of normal tissue architecture by human endometrial cancer cells. As ESF age, these inhibitory influences on malignant-like behaviors by epithelial cells are altered, becoming stimulatory, Age-related change in interleubin-1 alpha (IL-1 alpha) expression is a molecular determinant of ESF/epithelial cell interactions. Levels of IL-1 alpha and IL-1-induced mRNAs increase in ESF with age, Treatment with IL-1 accelerates age-related changes in mRNA abundance and loss of ESF restraint over malignancy-associated behaviors by epithelial cells, Transfection of ESF with the intracellular IL-1 receptor antagonist preserved the young phenotype with respect to interactions with epithelial cells and prevented age-associated increases in gro alpha and IL-8 mRNA levels, Our results indicate that aging of ESF is accompanied by an interactive senescence that alters ESF signaling to cancer cells and could contribute to increased cancer rates by providing a microenvironment that is more conducive to tumorigenesis, (C) 1999 Academic Press.
C1 Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina School of Medicine
RP Torti, VR (corresponding author), Chem Ind Inst Toxicol, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.
EM torti@ciit.org
RI Palmieri, Diane/B-4258-2015
FU NCI NIH HHS [CA31733] Funding Source: Medline; NIEHS NIH HHS [ES07145,
   ES07017] Funding Source: Medline
CR ANISIMOV VN, 1989, SEMIN ONCOL, V16, P10
   BECK JC, 1989, IN VITRO CELL DEV B, V25, P409, DOI 10.1007/BF02624625
   BOYD JA, 1990, IN VITRO CELL DEV B, V26, P701
   Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5
   Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   CHRISTENSEN C, 1987, GYNECOL ONCOL, V28, P25, DOI 10.1016/S0090-8258(87)80005-7
   Cunha G R, 1992, Epithelial Cell Biol, V1, P18
   CUNHA GR, 1985, CELL DIFFER DEV, V17, P137, DOI 10.1016/0045-6039(85)90481-6
   DAWE CJ, 1964, JNCI-J NATL CANCER I, V33, P441
   DILMAN VM, 1984, DEV BIOL CANC, P103
   DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI 10.1016/S0065-2776(08)60642-2
   DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884
   FUJII H, 1982, J UROLOGY, V128, P858, DOI 10.1016/S0022-5347(17)53221-8
   GERSCHENSON M, 1986, P NATL ACAD SCI USA, V83, P7307, DOI 10.1073/pnas.83.19.7307
   GRAY R, 1991, CANCER RES, V51, P6470
   HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732
   HASKILL S, 1991, P NATL ACAD SCI USA, V88, P3681, DOI 10.1073/pnas.88.9.3681
   HAYASHI N, 1991, CANCER RES, V51, P4924
   KUMAR S, 1992, P NATL ACAD SCI USA, V89, P4683, DOI 10.1073/pnas.89.10.4683
   LEE LW, 1991, CANCER RES, V51, P5238
   LUMPKIN CK, 1985, EXP CELL RES, V160, P544, DOI 10.1016/0014-4827(85)90201-0
   MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499
   MARTIN M, 1988, TRENDS PHARMACOL SCI, V9, P171, DOI 10.1016/0165-6147(88)90033-8
   MATSUMURA T, 1979, J GERONTOL, V34, P328, DOI 10.1093/geronj/34.3.328
   MCCULLOUGH KD, 1994, CANCER RES, V54, P3668
   McCullough KD, 1997, CANCER RES, V57, P1807
   MILLER AD, 1989, BIOTECHNIQUES, V7, P980
   MILLER RA, 1991, CANCER, V68, P2496, DOI 10.1002/1097-0142(19911201)68:11+<2496::AID-CNCR2820681503>3.0.CO;2-B
   NEWELL GR, 1989, SEMIN ONCOL, V16, P3
   NORWOOD TH, 1974, P NATL ACAD SCI USA, V71, P2231, DOI 10.1073/pnas.71.6.2231
   PALMIERI D, 1999, IN PRESS EXP CELL RE
   Peto R, 1985, IARC Sci Publ, P43
   PETO R, 1975, BRIT J CANCER, V32, P411, DOI 10.1038/bjc.1975.242
   PIERCE GB, 1983, AM J PATHOL, V113, P115
   PODESTA AH, 1984, P NATL ACAD SCI-BIOL, V81, P7608, DOI 10.1073/pnas.81.23.7608
   RINEHART CA, 1993, CARCINOGENESIS, V14, P993, DOI 10.1093/carcin/14.5.993
   Rinehart CA, 1997, MOL CARCINOGEN, V18, P187, DOI 10.1002/(SICI)1098-2744(199704)18:4<187::AID-MC1>3.0.CO;2-B
   RUBIN H, 1985, CANCER RES, V45, P2935
   SAWYER RH, 1993, EPITHELIAL MESENCHYM
   SIEGFRIED JM, 1984, IN VITRO CELL DEV B, V20, P25
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526
   SUGIMURA Y, 1986, PROSTATE, V9, P217, DOI 10.1002/pros.2990090302
   TOMBRANTINK J, 1989, INVEST OPHTH VIS SCI, V30, P1700
   WATSON JM, 1995, J IMMUNOL, V155, P4467
   WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768
   1993, STRATEGIES MANAGING
NR 48
TC 16
Z9 16
U1 0
U2 0
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAY 1
PY 1999
VL 248
IS 2
BP 599
EP 607
DI 10.1006/excr.1999.4430
PG 9
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA 194CV
UT WOS:000080175300027
PM 10222152
DA 2024-02-19
ER

PT J
AU Chronowski, C
   Akhanov, V
   Chan, D
   Catic, A
   Finegold, M
   Sahin, E
AF Chronowski, Christopher
   Akhanov, Viktor
   Chan, Doug
   Catic, Andre
   Finegold, Milton
   Sahin, Ergun
TI Fructose Causes Liver Damage, Polyploidy, and Dysplasia in the Setting
   of Short Telomeres and p53 Loss
SO METABOLITES
LA English
DT Article
DE telomeres; liver fibrosis; p53; fructose; triglyceride
ID CHROMOSOMAL INSTABILITY; TERMINAL TRANSFERASE; ULCERATIVE-COLITIS; CELL
   SENESCENCE; STEM-CELLS; LIFE-SPAN; DISEASE; FIBROSIS; DYSFUNCTION;
   TETRAHYMENA
AB Studies in humans and model systems have established an important role of short telomeres in predisposing to liver fibrosis through pathways that are incompletely understood. Recent studies have shown that telomere dysfunction impairs cellular metabolism, but whether and how these metabolic alterations contribute to liver fibrosis is not well understood. Here, we investigated whether short telomeres change the hepatic response to metabolic stress induced by fructose, a sugar that is highly implicated in non-alcoholic fatty liver disease. We find that telomere shortening in telomerase knockout mice (TKO) imparts a pronounced susceptibility to fructose as reflected in the activation of p53, increased apoptosis, and senescence, despite lower hepatic fat accumulation in TKO mice compared to wild type mice with long telomeres. The decreased fat accumulation in TKO is mediated by p53 and deletion of p53 normalizes hepatic fat content but also causes polyploidy, polynuclearization, dysplasia, cell death, and liver damage. Together, these studies suggest that liver tissue with short telomers are highly susceptible to fructose and respond with p53 activation and liver damage that is further exacerbated when p53 is lost resulting in dysplastic changes.
C1 [Chronowski, Christopher; Akhanov, Viktor; Catic, Andre; Sahin, Ergun] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   [Chan, Doug; Catic, Andre] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
   [Finegold, Milton] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   [Sahin, Ergun] Baylor Coll Med, Dept Physiol & Biophys, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine
RP Sahin, E (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.; Sahin, E (corresponding author), Baylor Coll Med, Dept Physiol & Biophys, Houston, TX 77030 USA.
EM christopher.chronowski@bcm.edu; Viktor.Akhanov@bcm.edu; dchan@bcm.edu;
   Andre.Catic@bcm.edu; finegold@bcm.edu; esahin@bcm.edu
OI Catic, Andre/0000-0002-3572-7598
FU Ted Nash Long Life Foundation; Edward Mallinckrodt Jr. Foundation; NIA
   RO1 grant [R01AG047924]; National Institute of Diabetes and Digestive
   and Kidney Diseases (NIDDK) [R01DK115454]
FX This research was funded by the Ted Nash Long Life Foundation, the
   Edward Mallinckrodt Jr. Foundation, and an NIA RO1 grant (R01AG047924),
   all to E.S. A.C. is a CPRIT Scholar in Cancer Research (RR140038), and
   is supported by the Ted Nash Long Life Foundation and the National
   Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
   R01DK115454.
CR Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535
   Alves-Paiva RM, 2018, LIVER INT, V38, P144, DOI 10.1111/liv.13529
   Amano H, 2019, CELL METAB, V29, P1274, DOI 10.1016/j.cmet.2019.03.001
   Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246
   Armanios M, 2012, MUTAT RES-FUND MOL M, V730, P52, DOI 10.1016/j.mrfmmm.2011.10.013
   Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046
   Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166
   BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234
   Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031
   Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291
   Dong K, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.10
   Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608
   Federico A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041314
   Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217
   Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644
   GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0
   GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044
   Iredale J, 2008, PHARMACOL RES, V58, P129, DOI 10.1016/j.phrs.2008.06.011
   JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6
   Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172
   Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09
   Kurinna S, 2013, HEPATOLOGY, V57, P2004, DOI 10.1002/hep.26233
   Labuschagne CF, 2018, BBA-REV CANCER, V1870, P32, DOI 10.1016/j.bbcan.2018.06.001
   Lechel A, 2004, J HEPATOL, V41, P491, DOI 10.1016/j.jhep.2004.06.010
   Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41
   Loyer X, 2016, GUT, V65, P1882, DOI 10.1136/gutjnl-2014-308883
   MacKenzie B, 2015, AM J PHYSIOL-LUNG C, V308, pL1014, DOI 10.1152/ajplung.00291.2014
   Marino S, 2000, GENE DEV, V14, P994
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Missios P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5924
   O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989
   Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266
   Porteiro B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15111
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008
   Risques RA, 2006, CURR OPIN GASTROEN, V22, P382, DOI 10.1097/01.mog.0000231812.95525.a7
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Saitoh Y, 2010, HISTOCHEM CELL BIOL, V133, P229, DOI 10.1007/s00418-009-0663-4
   Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003
   Sansregret L, 2018, NAT REV CLIN ONCOL, V15, P139, DOI 10.1038/nrclinonc.2017.198
   Savage SA, 2014, PROG MOL BIOL TRANSL, V125, P41, DOI 10.1016/B978-0-12-397898-1.00002-5
   Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5
   Savage Sharon A, 2009, Pediatr Blood Cancer, V53, P520, DOI 10.1002/pbc.22061
   Sellmann C, 2015, J NUTR BIOCHEM, V26, P1183, DOI 10.1016/j.jnutbio.2015.05.011
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sheahan S, 2004, ONCOGENE, V23, P1489, DOI 10.1038/sj.onc.1207280
   Sheka AC, 2020, JAMA-J AM MED ASSOC, V323, P1175, DOI 10.1001/jama.2020.2298
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75
   Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385
   SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002
   Wang XW, 2013, J MOL CELL BIOL, V5, P147, DOI 10.1093/jmcb/mjs064
   Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
NR 70
TC 3
Z9 3
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-1989
J9 METABOLITES
JI Metabolites
PD JUN
PY 2021
VL 11
IS 6
AR 394
DI 10.3390/metabo11060394
PG 16
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA SY6PQ
UT WOS:000666007900001
PM 34204343
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU ALTERMAN, M
   CARVAN, M
   SRIVASTAVA, V
   LEAKEY, J
   HART, R
   BUSBEE, D
AF ALTERMAN, M
   CARVAN, M
   SRIVASTAVA, V
   LEAKEY, J
   HART, R
   BUSBEE, D
TI EFFECTS OF AGING AND LONG-TERM CALORIC RESTRICTION ON HEPATIC-MICROSOMAL
   MONOOXYGENASES IN FEMALE FISCHER 344 RATS - ALTERATIONS IN BASAL
   CYTOCHROME-P-450 CATALYTIC ACTIVITIES
SO AGE
LA English
DT Article
ID DRUG-METABOLIZING-ENZYMES; AGE-RELATED-CHANGES; LIVER-MICROSOMES; UPDATE
AB The effects of aging and caloric restriction on uninduced levels of hepatic microsomal cytochrome P-450s and specific P-450-related catalytic activities were evaluated in female Fischer 344 rats. Microsomes were isolated from livers of ad libitum (AL) fed rats 1, 3, 6, 16 and 26 months of age, and from calorie-restricted (CR) rats 6, 16 and 26 months of age. The recovery of microsomal protein was higher in CR than AL rats at 6, 16 and 26 months of age. Between ages 3 and 26 months there was a gradual decline in recovered microsomal P-450, but the differences between successive age categories were not significant. A different trend was observed for total cytochrome P-450 per liver. AL rats showed a 2-fold decline in P-450/liver between 6 and 26 months of age, while P-450/liver of corresponding CR rats increased 1.7-fold. Neither cytochrome b5 nor NADPH cytochrome C reductase varied consistently as a function of increased age, with all age groups showing greater reductase activity for CR rats than for AL rats. Phenobarbital (PB) and methylcholanthrene (MC) inducible cytochrome P-450 catalytic activities (pentoxy [PROD] and ethoxy [EROD] resorufin O-deethylases) exhibited similar age-related alterations that were distinctly different from the two other enzymes examined. Both PROD and EROD showed dramatic declines in activity between 1 and 3 months of age, with a slight increase in activity at 6 months and maintenance of the activity levels through 26 months. Benzphetamine N-demethylase (BND) and aniline p-hydroxylase (APH) activities were also altered as a function of increased age, with CR rats exhibiting increased isozyme activity above that seen for aging AL rats. Calorie restriction appears to have a modulating effect, compensating for an age-related decline of hepatic microsomal monooxygenase activity in female Fischer 344 rats.
C1 TEXAS A&M UNIV SYST,COLL VET MED,DEPT ANAT & PUBL HLTH,COLL STN,TX 77843.
   TEXAS A&M UNIV SYST,COLL MED,DEPT PHYSIOL,COLL STN,TX 77843.
   NATL CTR TOXICOL RES,JEFFERSON,AR 72079.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M University System; Texas A&M University College Station; US Food &
   Drug Administration (FDA)
CR AL'TERMAN M A, 1981, Biokhimiya, V46, P222
   [Anonymous], 1986, CYTOCHROME P 450 STR
   BIRNBAUM LS, ANN REV PHARM TOXICO, V31, P101
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   GONZALEZ FJ, 1989, PHARMACOL REV, V40, P244
   JONETANI T, 1965, J BIOL CHEM, V240, P4509
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KITANI K, 1988, GERONTOLOGY, V34, P55, DOI 10.1159/000212931
   LEAKEY JA, BIOL EFFECTS DIETARY, P207
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MASORO EJ, 1985, J NUTR, V115, P842, DOI 10.1093/jn/115.7.842
   NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1
   OBRAIEN PJ, 1978, METHOD ENZYMOL, V52, P409
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   POHL RJ, 1980, ANAL BIOCHEM, V107, P150, DOI 10.1016/0003-2697(80)90505-9
   RIKANS LE, 1989, MECH AGEING DEV, V48, P267, DOI 10.1016/0047-6374(89)90088-2
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   RUCKPAUL K, 1984, CYTOCHROME P JKO
   Schenkman J B, 1986, Adv Exp Med Biol, V197, P107
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SCHMUCKER DL, 1980, EXP GERONTOL, V15, P321, DOI 10.1016/0531-5565(80)90037-6
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   SCHUMUCKER DL, 1991, J GERONTOL, V46, pB23
   SKETT P, 1988, PHARMACOL THERAPEUT, V38, P269, DOI 10.1016/0163-7258(88)90007-1
   SYN J, 1986, EXP GERONTOL, V21, P523
   WALFORD RL, 1987, J NUTR, V117, P1650, DOI 10.1093/jn/117.10.1650
   Werringloer J, 1978, Methods Enzymol, V52, P297
   YELLAND C, 1991, AGE AGEING, V20, P16, DOI 10.1093/ageing/20.1.16
   ZAPHIROPOULOS PG, 1989, TRENDS PHARMACOL SCI, V10, P149, DOI 10.1016/0165-6147(89)90167-3
NR 32
TC 12
Z9 13
U1 0
U2 4
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD JAN
PY 1993
VL 16
IS 1
BP 1
EP 8
DI 10.1007/BF02436124
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KD002
UT WOS:A1993KD00200001
DA 2024-02-19
ER

PT J
AU Xue, WJ
   He, CF
   Zhou, RY
   Xu, XD
   Xiang, LX
   Wang, JT
   Wang, XR
   Zhou, HG
   Guo, JC
AF Xue, Wen-Jiao
   He, Cheng-Feng
   Zhou, Ren-Yuan
   Xu, Xiao-Die
   Xiang, Lv-Xuan
   Wang, Jian-Tao
   Wang, Xin-Ru
   Zhou, Hou-Guang
   Guo, Jing-Chun
TI High glucose and palmitic acid induces neuronal senescence by NRSF/REST
   elevation and the subsequent mTOR-related autophagy suppression
SO MOLECULAR BRAIN
LA English
DT Article
ID CELLULAR SENESCENCE; LIFE-SPAN; CANCER; REST; NRSF
AB Cell senescence is a basic aging mechanism. Previous studies have found that the cellular senescence in adipose tissue and other tissues, such as the pancreas, muscle and liver, is associated with the pathogenesis and progression of type 2 diabetes; however, strong evidence of whether diabetes directly causes neuronal senescence in the brain is still lacking. In this study, we constructed a high glucose and palmitic acid (HGP) environment on PC12 neuronal cells and primary mouse cortical neurons to simulate diabetes. Our results showed that after HGP exposure, neurons exhibited obvious senescence-like phenotypes, including increased NRSF/REST level, mTOR activation and cell autophagy suppression. Downregulation of NRSF/REST could remarkably alleviate p16, p21 and gamma H2A.X upregulations induced by HGP treatment, and enhance mTOR-autophagy of neurons. Our results suggested that the diabetic condition could directly induce neuronal senescence, which is mediated by the upregulation of NRSF/REST and subsequent reduction of mTOR-autophagy.
C1 [Xue, Wen-Jiao; He, Cheng-Feng; Xu, Xiao-Die; Xiang, Lv-Xuan; Guo, Jing-Chun] Fudan Univ, State Key Lab Med Neurobiol, Jingan Dist Ctr Hosp Shanghai, Dept Translat Neurosci, Shanghai, Peoples R China.
   [Xue, Wen-Jiao; He, Cheng-Feng; Xu, Xiao-Die; Xiang, Lv-Xuan; Guo, Jing-Chun] Fudan Univ, Inst Brain Sci, MOE Frontiers Ctr Brain Sci, Shanghai, Peoples R China.
   [Wang, Jian-Tao; Wang, Xin-Ru; Zhou, Hou-Guang] Fudan Univ, Natl Clin Res Ctr Aging & Med, Huashan Hosp, Dept Geriatr Neurol, Shanghai, Peoples R China.
   [Zhou, Ren-Yuan] Fudan Univ, Jingan Dist Cent Hosp, Dept Urol, Shanghai, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Fudan University
RP Guo, JC (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Jingan Dist Ctr Hosp Shanghai, Dept Translat Neurosci, Shanghai, Peoples R China.; Guo, JC (corresponding author), Fudan Univ, Inst Brain Sci, MOE Frontiers Ctr Brain Sci, Shanghai, Peoples R China.; Zhou, HG (corresponding author), Fudan Univ, Natl Clin Res Ctr Aging & Med, Huashan Hosp, Dept Geriatr Neurol, Shanghai, Peoples R China.
EM zhg7376@163.com; jingchunguo@shmu.edu.cn
FU National Science Foundation of China [81671392, 81871098, 81571361];
   Shanghai Municipal Science and Technology Major Project [2018SHZDZX01];
   Shanghai Center for Brain Science and Brain-Inspired Technology;
   Projects of Shanghai Health and Health Committee on Integration of
   traditional Chinese and Western Medicine [ZY(2018-2020)-FWTX-3007,
   ZHYY-ZXYJHZX-201915]; Shanghai Municipal Key Clinical Specialty
   [shslczdzk02802]; Construction of Key Disciplines of Health System in
   Jing'an District [2021ZD01]; ZJ Lab
FX This work was supported by grants from the National Science Foundation
   of China (81671392 to J.-C.G. and 81871098, 81571361 to H.-G.Z.);
   Shanghai Municipal Science and Technology Major Project
   (No.2018SHZDZX01), ZJ Lab, and Shanghai Center for Brain Science and
   Brain-Inspired Technology to J.-C.G.; the Projects of Shanghai Health
   and Health Committee on Integration of traditional Chinese and Western
   Medicine (ZY(2018-2020)-FWTX-3007, ZHYY-ZXYJHZX-201915) and Shanghai
   Municipal Key Clinical Specialty (Geriatrics, No. shslczdzk02802) to
   H.-G.Z.; Construction of Key Disciplines of Health System in Jing'an
   District (2021ZD01) to R.-Y.Z.
CR Aguayo-Mazzucato C, 2019, CELL METAB, V30, P129, DOI 10.1016/j.cmet.2019.05.006
   Bloomgarden Z, 2013, J DIABETES, V5, P369, DOI 10.1111/1753-0407.12086
   Bucala R, 2014, J CLIN INVEST, V124, P1887, DOI 10.1172/JCI75224
   Bury JJ, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-020-01109-y
   Cho E, 2015, ONCOL REP, V33, P1459, DOI 10.3892/or.2014.3675
   Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418
   Coulson JM, 2005, CURR BIOL, V15, pR665, DOI 10.1016/j.cub.2005.08.032
   Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020
   Fernandes V, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104948
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hwang JY, 2018, CURR OPIN NEUROBIOL, V48, P193, DOI 10.1016/j.conb.2017.12.008
   Ishikawa S, 2020, AGING CELL, V19, DOI 10.1111/acel.13071
   Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x
   Kawamura M, 2019, NEUROSCI LETT, V699, P59, DOI 10.1016/j.neulet.2019.01.042
   Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939
   Korf ESC, 2006, DIABETES CARE, V29, P2268, DOI 10.2337/dc06-0243
   Kuo LJ, 2008, IN VIVO, V22, P305
   Lepagnol-Bestel AM, 2007, NEUROREPORT, V18, P441, DOI 10.1097/WNR.0b013e328011dc81
   Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y
   Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163
   Maeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123169
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI [10.1016/j.cmet.2018.12.008, 10.1016/j.cmet.2019.01.013]
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Palmer AK, 2019, DIABETOLOGIA, V62, P1835, DOI 10.1007/s00125-019-4934-x
   Palmer AK, 2015, DIABETES, V64, P2289, DOI 10.2337/db14-1820
   Pogoda A, 2021, CURR MED CHEM, V28, P2783, DOI 10.2174/0929867327666200705225821
   Rocchi A, 2021, AGING CELL, V20, DOI 10.1111/acel.13471
   Roriz JS, 2009, BBA-MOL BASIS DIS, V1792, P432, DOI 10.1016/j.bbadis.2008.12.003
   Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863
   Song ZQ, 2015, J MOL NEUROSCI, V56, P131, DOI 10.1007/s12031-014-0474-5
   Tan FCC, 2014, BIOGERONTOLOGY, V15, P643, DOI 10.1007/s10522-014-9532-1
   Thellung S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040901
   Thibault O, 2013, EUR J PHARMACOL, V719, P34, DOI 10.1016/j.ejphar.2013.07.024
   Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008
   Weichhart T, 2018, GERONTOLOGY, V64, P127, DOI 10.1159/000484629
   Xiao-Die X, 2020, BIOCHEM BIOPH RES CO, V527, P785, DOI 10.1016/j.bbrc.2020.04.106
   Zhao YG, 2017, MOL NEUROBIOL, V54, P541, DOI 10.1007/s12035-015-9658-4
   Zullo JM, 2019, NATURE, V574, P359, DOI 10.1038/s41586-019-1647-8
NR 40
TC 8
Z9 8
U1 2
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1756-6606
J9 MOL BRAIN
JI Mol. Brain
PD JUL 18
PY 2022
VL 15
IS 1
AR 61
DI 10.1186/s13041-022-00947-2
PG 12
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 3A0RQ
UT WOS:000826974100001
PM 35850767
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Abu-Tair, L
   Axelrod, JH
   Doron, S
   Ovadya, Y
   Krizhanovsky, V
   Galun, E
   Amer, J
   Safadi, R
AF Abu-Tair, Lina
   Axelrod, Jonathan H.
   Doron, Sarit
   Ovadya, Yossi
   Krizhanovsky, Valery
   Galun, Eithan
   Amer, Johnny
   Safadi, Rifaat
TI Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via
   Toll-Like Receptor-9
SO PLOS ONE
LA English
DT Article
ID HEPATIC STELLATE CELLS; NK CELLS; ACTIVATION; TLR9;
   TOLL-LIKE-RECEPTOR-9; ACCUMULATION; MODULATION; SENESCENCE; RESPONSES;
   DISEASE
AB The toll-like receptor-9 (TLR9) agonist cytosine phosphate guanine (CpG), activates hepatic stellate cells (HSCs) and mediates fibrosis. We investigated the TLR9 effects on lymphocyte/HSCs interactions. Liver fibrosis was induced in wild-type (WT) mice by intra-peritoneal carbon-tetrachloride (CCl4) induction for 6 weeks. Fibrotic groups were intravenously treated by a vehicle versus CpG along last 2 weeks. Compared to vehicle-treated fibrotic WT, the in-vivo CpG-treatment significantly attenuated hepatic fibrosis and inflammation, associated with decreased CD8 and increased NK liver cells. In-vitro, co-cultures with vehicle-treated fibrotic NK cells increased HSCs proliferation (P<0.001) while their CpG-treated counterparts achieved a significant decrease. To investigate the role of lymphocytes, TLR9(-/-) mice induced-hepatic fibrosis were used. Although TLR9(-/-) mice manifested lower fibrotic profile as compared to their wild-type (WT) counterparts, senescence (SA-beta-Gal activity) in the liver and ALT serum levels were significantly greater. In an adoptive transfer model; irradiated WT and TLR9(-/-) recipients were reconstituted with naive WT or TLR9(-/-) lymphocytes. The adoptive transfer of TLR9(-/-) versus WT lymphocytes led to increased fibrosis of WT recipients. TLR9(-/-) fibrotic recipients reconstituted with TLR9(-/-) or WT lymphocytes showed no changes in hepatic fibrosis severity or ALT serum levels. TLR9 activation had inconsistent effects on lymphocytes and HSCs. The net balance of TLR9 activation in WT, displayed significant anti-fibrotic activity, accompanied by CD8 suppression and increased NK-cells, activity and adherence to HSCs. The pro-fibrotic and pro-inflammatory properties of TLR9(-/-) lymphocytes fail to activate HSCs with an early senescence in TLR9(-/-) mice.
C1 [Abu-Tair, Lina; Doron, Sarit; Amer, Johnny; Safadi, Rifaat] Hadassah Med Ctr, Div Med, Liver Unit, IL-91120 Jerusalem, Israel.
   [Abu-Tair, Lina; Doron, Sarit; Amer, Johnny; Safadi, Rifaat] Hadassah Med Ctr, Div Med, Gastroenterol Unit, IL-91120 Jerusalem, Israel.
   [Axelrod, Jonathan H.; Galun, Eithan] Hadassah Med Ctr, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel.
   [Ovadya, Yossi; Krizhanovsky, Valery] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Weizmann Institute of Science
RP Amer, J (corresponding author), Hadassah Med Ctr, Div Med, Liver Unit, Kiryat Haddasah, IL-91120 Jerusalem, Israel.
EM johnnyamer@hotmail.com
RI Galun, Eithan/AAD-9117-2022
OI Galun, Eithan/0000-0002-6243-6702
FU Israel Science Foundation [1169/09]; Chief Scientist Office - Ministry
   of Health, Israel [3-5937]
FX This research was supported by the Israel Science Foundation no.
   1169/09. This study was also supported (in part) by grant no. 3-5937
   from the Chief Scientist Office - Ministry of Health, Israel. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aoyama T, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/192543
   Arad U, 2005, HUM GENE THER, V16, P361, DOI 10.1089/hum.2005.16.361
   Avraham Y, 2012, AM J PHYSIOL-GASTR L, V302, pG1364, DOI 10.1152/ajpgi.00191.2011
   Ballas ZK, 2007, IMMUNOL RES, V39, P15, DOI 10.1007/s12026-007-0066-3
   Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365
   Gäbele E, 2008, BIOCHEM BIOPH RES CO, V376, P271, DOI 10.1016/j.bbrc.2008.08.096
   Gao B, 2010, GASTROENTEROLOGY, V139, P27, DOI 10.1053/j.gastro.2010.05.018
   Girart MV, 2007, J IMMUNOL, V179, P3472, DOI 10.4049/jimmunol.179.6.3472
   Graubardt N, 2012, HEPATOLOGY, V2, P1
   Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540
   Guillerey C, 2012, BLOOD, V120, P90, DOI 10.1182/blood-2012-02-410936
   Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400
   Horani A, 2007, AM J PHYSIOL-GASTR L, V292, pG628, DOI 10.1152/ajpgi.00137.2006
   Jiang W, 2009, J IMMUNOL, V182, P3768, DOI 10.4049/jimmunol.0800973
   Kamar N, 2005, J MED VIROL, V76, P482, DOI 10.1002/jmv.20387
   Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028
   Lichtenegger FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044266
   Marcenaro E, 2011, ADV EXP MED BIOL, V780, P45, DOI 10.1007/978-1-4419-5632-3_5
   Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025
   Merlo A, 2007, J LEUKOCYTE BIOL, V82, P509, DOI 10.1189/jlb.0207100
   Miranda SRP, 1997, BLOOD, V90, P444
   Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052
   Muhanna N, 2008, HEPATOLOGY, V48, P963, DOI 10.1002/hep.22413
   Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136
   Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182
   Rosenstiel P, 2013, CURR OPIN GASTROEN, V29, P125, DOI 10.1097/MOG.0b013e32835da2c7
   Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206
   Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sugauchi F, 2006, J INFECT DIS, V193, P563, DOI 10.1086/499823
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867
   Yan Z, 2012, NANOTECHNOLOGY, V23, P1
NR 37
TC 17
Z9 19
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 10
PY 2013
VL 8
IS 12
AR e82571
DI 10.1371/journal.pone.0082571
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 275VW
UT WOS:000328707400084
PM 24340043
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Jun, JI
   Lau, LF
AF Jun, Joon-Il
   Lau, Lester F.
TI Cellular senescence controls fibrosis in wound healing
SO AGING-US
LA English
DT Article
DE CCN1; senescence; wound healing; integrin; inflammation
ID ONCOGENE-INDUCED SENESCENCE; PLASMINOGEN-ACTIVATOR INHIBITOR-1;
   REPLICATIVE SENESCENCE; MOLECULAR-MECHANISMS; TUMOR SUPPRESSION; LIVER
   FIBROSIS; IN-VIVO; REPAIR; INDUCTION; IGFBP7
AB Mammalian wound healing involves the rapid synthesis and deposition of extracellular matrix (ECM) to maintain tissue integrity during repair. This process must be tightly controlled, as its deregulation may result in fibrosis, scarring, and loss of tissue function. Recent studies have uncovered an efficient and parsimonious mechanism for rendering fibrogenesis self-limiting in wound healing: in such diverse organs as the liver and skin, the myofibroblasts that initially proliferate and produce ECM are themselves eventually driven into senescence, blocking their further proliferation and converting them into matrix-degrading cells. Myofibroblast senescence in skin wounds is triggered by a dynamically expressed matricellular protein, CCN1/CYR61, which acts through integrin-mediated induction of oxidative stress. We propose that the onset of myofibroblast senescence is a programmed wound healing response that functions as a self-limiting mechanism for fibrogenesis, and this process may be regulated by the ECM microenvironment through the expression of CCN1/CYR61.
C1 [Jun, Joon-Il; Lau, Lester F.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.
EM LFLau@uic.edu
OI Lau, Lester/0000-0002-4364-2914
FU National Institutes of Health [GM78492, HL081390, CA46565]
FX We thank Chih-Chiun Chen for helpful comments on the manuscript. This
   work was supported by grants from the National Institutes of Health
   (GM78492, HL081390, and CA46565) to L.F.L.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204
   Chan JCY, 2001, AM J PATHOL, V159, P1681, DOI 10.1016/S0002-9440(10)63015-5
   Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200
   Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010
   Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   IOCONO JA, 2010, NAT CELL BIOL, V12, P676
   Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a
   Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104
   Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603
   Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x
   Scurr LL, 2010, CELL, V141, P717, DOI 10.1016/j.cell.2010.04.021
   Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811
   Telgenhoff D, 2005, CELL DEATH DIFFER, V12, P695, DOI 10.1038/sj.cdd.4401632
   Vande Berg JS, 2005, WOUND REPAIR REGEN, V13, P76, DOI 10.1111/j.1067-1927.2005.130110.x
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wajapeyee N, 2010, CELL, V141, P746, DOI 10.1016/j.cell.2010.05.014
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22
NR 44
TC 183
Z9 207
U1 4
U2 28
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP
PY 2010
VL 2
IS 9
BP 627
EP 631
DI 10.18632/aging.100201
PG 5
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 657VR
UT WOS:000282447100013
PM 20930261
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Lee, JS
   Ward, WO
   Ren, HZ
   Vallanat, B
   Darlington, GJ
   Han, ES
   Laguna, JC
   DeFord, JH
   Papaconstantinou, J
   Selman, C
   Corton, JC
AF Lee, Janice S.
   Ward, William O.
   Ren, Hongzu
   Vallanat, Beena
   Darlington, Gretchen J.
   Han, Eun-Soo
   Laguna, Juan C.
   DeFord, James H.
   Papaconstantinou, John
   Selman, Colin
   Corton, J. Christopher
TI Meta-analysis of gene expression in the mouse liver reveals biomarkers
   associated with inflammation increased early during aging
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Aging; Longevity; Liver; Meta-analysis; Microarrays; Xenobiotic
   metabolism; Inflammation
ID LONGEVITY-ASSOCIATED GENES; AGE-RELATED-CHANGES; FACTOR-KAPPA-B; CALORIC
   RESTRICTION; TRANSCRIPTIONAL PROFILE; MITOCHONDRIAL-FUNCTION; XENOBIOTIC
   METABOLISM; LYMPHOID NEOGENESIS; AIR-POLLUTION; UP-REGULATION
AB Aging is associated with a loss of cellular homeostasis, a decline in physiological function and an increase in various pathologies. Employing a meta-analysis, hepatic gene expression profiles from four independent mouse aging studies were interrogated. There was little overlap in the number of genes or canonical pathways perturbed, suggesting that independent study-specific factors may play a significant role in determining age-dependent gene expression. However, 43 genes were consistently altered during aging in three or four of these studies, including those that (1) exhibited progressively increased expression starting from 12 months of age, (2) exhibited similar expression changes in models of progeria at young ages and dampened or no changes in old longevity mouse models, (3) were associated with inflammatory tertiary lymphoid neogenesis (TLN) associated with formation of ectopic lymphoid structures observed in chronically inflamed tissues, and (4) overlapped with genes perturbed by aging in brain, muscle, and lung. Surprisingly, around half of the genes altered by aging in wild-type mice exhibited similar expression changes in adult long-lived mice compared to wild-type controls, including those associated with intermediary metabolism and feminization of the male-dependent gene expression pattern. Genes unique to aging in wild-type mice included those linked to TLN. Published by Elsevier Ireland Ltd.
C1 [Lee, Janice S.; Ward, William O.; Ren, Hongzu; Vallanat, Beena; Corton, J. Christopher] US EPA, NCEA, NHEERL ORD, Res Triangle Pk, NC 27711 USA.
   [Ren, Hongzu; Vallanat, Beena] US EPA, NHEERL Toxicogen Core, Res Triangle Pk, NC 27711 USA.
   [Darlington, Gretchen J.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   [Darlington, Gretchen J.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   [Han, Eun-Soo] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.
   [Laguna, Juan C.] Univ Barcelona, Pharmacol Unit, Dept Pharmacol & Therapeut Chem, Sch Pharm, Barcelona, Spain.
   [DeFord, James H.; Papaconstantinou, John] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Selman, Colin] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland.
C3 United States Environmental Protection Agency; United States
   Environmental Protection Agency; Baylor College of Medicine; Baylor
   College of Medicine; University of Tulsa; University of Barcelona;
   University of Texas System; University of Texas Medical Branch
   Galveston; University of Aberdeen
RP Lee, JS (corresponding author), US EPA, NCEA, NHEERL ORD, Res Triangle Pk, NC 27711 USA.
EM lee.janices@epa.gov; ward.william@epa.gov; ren.hongzu@epa.gov;
   vallanat.beena@epa.gov; gretchen@bcm.tmc.edu; eun-han@utulsa.edu;
   jclagunae@ub.edu; jhdeford@utmb.edu; jpapacon@utmb.edu;
   c.selman@abdn.ac.uk; corton.chris@epa.gov
RI Laguna, JCLaguna - Juan C./C-5481-2017
OI Laguna, JCLaguna - Juan C./0000-0002-7082-0704; Lee,
   Janice/0000-0002-4331-8452; Selman, Colin/0000-0002-8727-0593
FU U.S. Environmental Protection Agency
FX The information in this document has been funded by the U.S.
   Environmental Protection Agency. It has been subjected to review by the
   National Health and Environmental Effects Research Laboratory and
   approved for publication. Approval does not signify that the contents
   reflect the views of the Agency, nor does mention of trade names or
   commercial products constitute endorsement or recommendation for use.
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063
   Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264
   Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   Boylston WH, 2006, AGE, V28, P125, DOI 10.1007/s11357-006-9008-6
   Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x
   Butler RN, 2004, J GERONTOL A-BIOL, V59, P560
   Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016
   Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927
   Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249
   Crimmins E, 2008, ADV CLIN CHEM, V46, P161, DOI 10.1016/S0065-2423(08)00405-8
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Dollé MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008
   Dozmorov I, 2002, J GERONTOL A-BIOL, V57, pB99, DOI 10.1093/gerona/57.3.B99
   EDAMATSU R, 1995, BIOCHEM BIOPH RES CO, V211, P847, DOI 10.1006/bbrc.1995.1889
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802
   Engler MM, 1998, BIOCHEM MOL BIOL INT, V46, P1117
   Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242
   Fischer P, 2003, EUR RESPIR J, V21, p34S, DOI 10.1183/09031936.03.00402503
   Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006
   Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001
   Gouveia N, 2000, J EPIDEMIOL COMMUN H, V54, P750, DOI 10.1136/jech.54.10.750
   Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104
   Guo Mingruo, 2009, P1
   Hayflick L, 2007, PLOS GENET, V3, P2351, DOI 10.1371/journal.pgen.0030220
   Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001
   He W., 2005, 65 US 2005
   HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528
   Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507
   Hjelmström P, 2001, J LEUKOCYTE BIOL, V69, P331
   Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620
   Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107
   KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381
   McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291
   McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132
   Misra V, 2007, PHYSIOL GENOMICS, V31, P429, DOI 10.1152/physiolgenomics.00060.2007
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Németh J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099
   Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025
   Pagano MB, 2007, P NATL ACAD SCI USA, V104, P2855, DOI 10.1073/pnas.0606091104
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   Park SK, 2008, J NUTR, V138, P1010, DOI 10.1093/jn/138.6.1010
   Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Sandström T, 2003, EUR RESPIR J, V21, p92S, DOI 10.1183/09031936.03.00403503
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Selman C, 2008, SCIENCE, V320, DOI 10.1126/science.1152366
   Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002
   Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003
   Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984
   Vilà L, 2008, J GERONTOL A-BIOL, V63, P1043, DOI 10.1093/gerona/63.10.1043
   Waghray A, 2002, J BIOL CHEM, V277, P11533, DOI 10.1074/jbc.M109557200
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   Wendt W, 2008, BRAIN RES, V1232, P7, DOI 10.1016/j.brainres.2008.07.067
   Wennmalm K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r109
   Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605
   Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829
   Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3
   Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
NR 79
TC 32
Z9 35
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUL
PY 2012
VL 133
IS 7
BP 467
EP 478
DI 10.1016/j.mad.2012.05.006
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 991IL
UT WOS:000307694600001
PM 22704917
DA 2024-02-19
ER

PT J
AU Moon, CM
   Shin, SS
   Heo, SH
   Jeong, YY
AF Moon, Chung-Man
   Shin, Sang Soo
   Heo, Suk Hee
   Jeong, Yong Yeon
TI Metabolic Alterations Associated with Early-Stage Hepatocellular
   Carcinoma and Their Correlation with Aging and Enzymatic Activity in
   Patients with Viral Hepatitis-Induced Liver Cirrhosis: A Preliminary
   Study
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE liver cirrhosis; hepatocellular carcinoma; spectroscopy; aging;
   enzymatic activity
ID MAGNETIC-RESONANCE-SPECTROSCOPY; HEPATOCARCINOGENESIS; MRS
AB Liver cirrhosis (LC) can develop hepatocellular carcinoma (HCC). However, noninvasive early diagnosis of HCCs in the cirrhotic liver is still challenging. We aimed to quantify the hepatic metabolites in normal control (NC), cirrhotic liver without HCC, cirrhotic liver with HCC (CLH), and early-stage HCC groups using proton magnetic resonance spectroscopy (H-1-MRS) with a long echo-time (TE) and to assess the potential association between the levels of hepatic metabolites in these four groups and aging and enzymatic activity. Thirty NCs, 30 viral hepatitis-induced LC patients without HCC, and 30 viral hepatitis-induced LC patients with HCC were included in this study. H-1-MRS measurements were performed on a localized voxel of the normal liver parenchyma (n = 30) from NCs, cirrhotic liver parenchyma (n = 30) from LC patients without HCC, and each of the cirrhotic liver parenchyma (n = 30) and HCC (n = 30) from the same patients in the CLH group. Generalized estimating equations were used to evaluate potential risk factors for changes in metabolite levels. Potential associations between metabolite levels and age and serum enzymatic activities were assessed by correlation analysis. The levels of lactate+triglyceride (Lac+TG) and choline (Cho) in HCC were significantly higher compared to those in LC and CLH. A potential risk factor for changes in the Lac+TG and Cho levels was age, specifically 60-80 years of age. In particular, the Lac+TG level was associated with a high odds ratio of HCC in males aged 60-80 years. The Lac+TG and Cho concentrations were positively correlated with lactate dehydrogenase and alkaline phosphatase activities, respectively. Our findings suggested that H-1-MRS measurement with a long TE was useful in quantifying hepatic Lac+TG and Cho levels, where higher Lac+TG and Cho levels were most likely associated with HCC-related metabolism in the viral hepatitis-induced cirrhotic liver. Further, the level of Lac+TG in HCC was highly correlated with older age and lactate dehydrogenase activity.
C1 [Moon, Chung-Man] Natl Inst Biomed Imaging & Bioengn, Quantitat Med Imaging Sect, NIH, Bethesda, MD 20892 USA.
   [Moon, Chung-Man] Chonnam Natl Univ, Res Inst Med Sci, Gwangju 61469, South Korea.
   [Shin, Sang Soo; Heo, Suk Hee; Jeong, Yong Yeon] Chonnam Natl Univ, Dept Radiol, Med Sch, Gwangju 61469, South Korea.
   [Shin, Sang Soo] Chonnam Natl Univ Hosp, Dept Radiol, Gwangju 61469, South Korea.
   [Heo, Suk Hee; Jeong, Yong Yeon] Chonnam Natl Univ, Hwasun Hosp, Dept Radiol, Hwasun 58128, South Korea.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Biomedical Imaging & Bioengineering (NIBIB); Chonnam National
   University; Chonnam National University; Chonnam National University;
   Chonnam National University Hospital; Chonnam National University
RP Shin, SS (corresponding author), Chonnam Natl Univ, Dept Radiol, Med Sch, Gwangju 61469, South Korea.; Shin, SS (corresponding author), Chonnam Natl Univ Hosp, Dept Radiol, Gwangju 61469, South Korea.
EM chmanmoon2@gmail.com; kjradsss@gmail.com; sheo@jnu.ac.kr;
   yjeong@jnu.ac.kr
RI Moon, Chung-Man/ABC-5501-2020
OI Shin, Sang Soo/0000-0002-5752-7431
FU National Research Foundation of Korea [2017R1A6A3A11030092,
   2018R1D1A3B07043473]; Central Medical Service Co., Ltd. [CRE17181-7]
FX This work was supported by the funds from the National Research
   Foundation of Korea (2017R1A6A3A11030092; 2018R1D1A3B07043473) and the
   Central Medical Service Co., Ltd. (CRE17181-7).
CR Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011
   Dagnelie PC, 2010, WORLD J GASTROENTERO, V16, P1577, DOI 10.3748/wjg.v16.i13.1577
   Darpolor MM, 2011, NMR BIOMED, V24, P506, DOI 10.1002/nbm.1616
   Efremidis SC, 2002, EUR RADIOL, V12, P753, DOI 10.1007/s00330-001-1142-z
   Erstad DJ, 2017, J HEPATOCELL CARCINO, V4, P81, DOI 10.2147/JHC.S107370
   Flemming JA, 2014, CANCER-AM CANCER SOC, V120, P3485, DOI 10.1002/cncr.28832
   Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622
   Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086
   Kim SY, 2017, JAMA ONCOL, V3, P456, DOI 10.1001/jamaoncol.2016.3147
   Kim TH, 2017, J MAGN RESON IMAGING, V46, P1298, DOI 10.1002/jmri.25673
   Mitchell DG, 2015, HEPATOLOGY, V61, P1056, DOI 10.1002/hep.27304
   Moon CM, 2019, MOL IMAGING BIOL, V21, P842, DOI 10.1007/s11307-019-01322-9
   Moon CM, 2018, LIVER INT, V38, P1117, DOI 10.1111/liv.13695
   Moon CM, 2017, BIOCHEM BIOPH RES CO, V482, P112, DOI 10.1016/j.bbrc.2016.08.118
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Perman William H, 2009, Top Magn Reson Imaging, V20, P89, DOI 10.1097/RMR.0b013e3181c422f1
   Prasad SR, 2005, RADIOGRAPHICS, V25, P321, DOI 10.1148/rg.252045083
   Soper R, 2002, PATHOLOGY, V34, P417, DOI 10.1080/0031302021000009324
   ter Voert EGW, 2011, WORLD J GASTROENTERO, V17, P5133, DOI 10.3748/wjg.v17.i47.5133
   Wang JA, 2011, TUMOR BIOL, V32, P223, DOI 10.1007/s13277-010-0116-7
   Xu H, 2006, ACAD RADIOL, V13, P1532, DOI 10.1016/j.acra.2006.09.001
   Xu L, 2013, WORLD J GASTROENTERO, V19, P1472, DOI 10.3748/wjg.v19.i9.1472
   Zhang L, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0082-4
NR 23
TC 8
Z9 8
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD MAR
PY 2020
VL 9
IS 3
AR 765
DI 10.3390/jcm9030765
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LF2UT
UT WOS:000527278800154
PM 32178316
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Shen, D
   Li, H
   Zhou, R
   Liu, MJ
   Yu, H
   Wu, DF
AF Shen, Dan
   Li, Hao
   Zhou, Rui
   Liu, Meng-jie
   Yu, Hong
   Wu, Dong-Fang
TI Pioglitazone attenuates aging-related disorders in aged apolipoprotein E
   deficient mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Pioglitazone; PPAR gamma signaling; Age-related disorders;
   Apolipoprotein E deficient mice; Anti-aging
ID PROLIFERATOR-ACTIVATED RECEPTOR; OXIDATIVE STRESS; PPAR-GAMMA;
   ATHEROSCLEROSIS; INFLAMMATION; DISEASE; RISK; METABOLISM; LONGEVITY;
   RELEVANCE
AB Pioglitazone (Piog) activates peroxisome proliferator activated receptor-gamma (PPAR gamma) and is widely used in clinic for the treatment of diabetes mellitus. PPAR gamma in various tissues has the essential regulatory role of multiple metabolic function, suggest that PPAR gamma signaling may contribute to aging processes. However, little is known about the consequences of Piog on aging in aged animal models. We used apolipoprotein E deficient (apoE(-/-)) mice model to evaluate the effects of Piog on aging-related disorders. Our results showed that long-term and low-dose Piog treatment significantly reduced aortic atherosclerosis, aging-related renal glomerulosclerosis and interstitial fibrosis, and hepatic steatosis, while improved the dermis in skin atrophy, compared to the control group. These morphological alterations were linked to the role of Piog, including regulation of plasma cholesterol and triglycerides (TG) levels, increased antioxidant superoxide dismutase (SOD) activity and decreased myeloperoxidase (MPO) activity. Moreover, accompanied with up-regulation of PPAR gamma expression, Piog had obviously increased the mRNA levels of anti-aging genes Sirtuin1 and Klotho, decreased the p53 protein level, and altered the expression of several genes involving cholesterol excretion, TG biosynthesis and inflammation in the liver. In conclusion, Piog treatment is effective to modulate the oxidative and inflammatory status, cell senescence, and lipid metabolism, contributing to attenuate several aging-related disorders in the aged apoE(-/-) mice, thereby maybe a promising protective therapy of aging and age-related diseases.
C1 [Shen, Dan] Wuhan Univ, Dept Internal Med & Geriatr, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China.
   [Shen, Dan; Li, Hao; Zhou, Rui; Liu, Meng-jie; Yu, Hong; Wu, Dong-Fang] Wuhan Univ, Hubei Prov Key Lab Dev Originated Dis, Wuhan 430071, Hubei, Peoples R China.
   [Li, Hao; Wu, Dong-Fang] Wuhan Univ, Zhongnan Hosp, Dept Pharm, Wuhan 430071, Hubei, Peoples R China.
   [Zhou, Rui; Liu, Meng-jie; Yu, Hong] Wuhan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Wuhan 430071, Hubei, Peoples R China.
C3 Wuhan University; Wuhan University; Wuhan University; Wuhan University
RP Wu, DF (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Pharm, Wuhan 430071, Hubei, Peoples R China.
EM dfwu2010@whu.edu.cn
FU National Natural Science Foundation of China [81570417, 81270364];
   Natural Science Foundation of Hubei Province, China [2012FFB04424]
FX This work was supported by the National Natural Science Foundation of
   China (81570417 to DFW, 81270364 to HY); the Natural Science Foundation
   of Hubei Province, China (2012FFB04424 to DS). We thank Daping Fan at
   the University of South Carolina, USA, for proofreading the manuscript
   and his invaluable advice.
CR Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005
   Ang LS, 2008, EXP GERONTOL, V43, P615, DOI 10.1016/j.exger.2008.03.010
   Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752
   Bao Q, 2014, MOL CELL ENDOCRINOL, V394, P115, DOI 10.1016/j.mce.2014.07.005
   Barbieri M, 2004, EXP GERONTOL, V39, P1095, DOI 10.1016/j.exger.2004.03.034
   Blalock EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010405
   Bonomini F, 2013, BIOGERONTOLOGY, V14, P209, DOI 10.1007/s10522-013-9424-9
   Crenshaw DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117973
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Derosa Giuseppe, 2012, Curr Mol Pharmacol, V5, P272
   Du F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111932
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011
   Hamblin M, 2009, ANTIOXID REDOX SIGN, V11, P1415, DOI [10.1089/ars.2008.2280, 10.1089/ARS.2008.2280]
   Haramizu S, 2011, J GERONTOL A-BIOL, V66, P646, DOI 10.1093/gerona/glr037
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878
   Ji AL, 2012, J LIPID RES, V53, P446, DOI 10.1194/jlr.M017079
   Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x
   Kim T, 2013, WORLD J CARDIOL, V5, P164, DOI 10.4330/wjc.v5.i6.164
   Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005
   Lan LF, 2015, CNS NEUROSCI THER, V21, P410, DOI 10.1111/cns.12374
   Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Marsillach J, 2008, FREE RADICAL BIO MED, V45, P146, DOI 10.1016/j.freeradbiomed.2008.03.023
   Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61
   Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com
   Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P200, DOI 10.1038/jcbfm.2010.78
   Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761
   Quintanilla RA, 2014, PPAR RES, V2014, DOI 10.1155/2014/768594
   Ruan XZ, 2008, AM J PHYSIOL-RENAL, V294, pF1032, DOI 10.1152/ajprenal.00152.2007
   Sung B, 2004, J GERONTOL A-BIOL, V59, P997
   Sung BY, 2006, EXP GERONTOL, V41, P590, DOI 10.1016/j.exger.2006.04.005
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   Ulrich-Lai YM, 2013, EXP GERONTOL, V48, P671, DOI 10.1016/j.exger.2012.08.011
   van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]
   Xu YY, 2015, J LIPID RES, V56, P1891, DOI 10.1194/jlr.M058776
   Xu YC, 2015, ENDOCR REV, V36, P174, DOI 10.1210/er.2013-1079
   Yamamoto S, 2015, ATHEROSCLEROSIS, V242, P56, DOI 10.1016/j.atherosclerosis.2015.06.055
   Yang HC, 2009, J AM SOC NEPHROL, V20, P2380, DOI 10.1681/ASN.2008111138
   Zardi EM, 2013, CURR MED CHEM, V20, P3370, DOI 10.2174/09298673113209990136
   Zhou CY, 2013, DIS MARKERS, V2013, P97, DOI 10.1155/2013/816189
NR 44
TC 25
Z9 30
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD FEB
PY 2018
VL 102
BP 101
EP 108
DI 10.1016/j.exger.2017.12.002
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FV9QI
UT WOS:000424922800015
PM 29221940
OA hybrid
DA 2024-02-19
ER

PT J
AU Arai, Y
   Martin-Ruiz, CM
   Takayama, M
   Abe, Y
   Takebayashi, T
   Koyasu, S
   Suematsu, M
   Hirose, N
   von Zglinicki, T
AF Arai, Yasumichi
   Martin-Ruiz, Carmen M.
   Takayama, Michiyo
   Abe, Yukiko
   Takebayashi, Toru
   Koyasu, Shigeo
   Suematsu, Makoto
   Hirose, Nobuyoshi
   von Zglinicki, Thomas
TI Inflammation, But Not Telomere Length, Predicts Successful Ageing at
   Extreme Old Age: A Longitudinal Study of Semi-supercentenarians
SO EBIOMEDICINE
LA English
DT Article
DE Centenarian; Ageing; Inflammation; Telomere
ID LIFE-SPAN; ANTIINFLAMMATORY DRUGS; CARDIOVASCULAR EVENTS; MORTALITY;
   CENTENARIANS; MORBIDITY; HEALTH; ASSOCIATION; SENESCENCE; BIOMARKERS
AB To determine the most important drivers of successful ageing at extreme old age, we combined community-based prospective cohorts: Tokyo Oldest Old Survey on Total Health (TOOTH), Tokyo Centenarians Study (TCS) and Japanese Semi-Supercentenarians Study (JSS) comprising 1554 individuals including 684 centenarians and (semi-)supercentenarians, 167 pairs of centenarian offspring and spouses, and 536 community-living very old (85 to 99 years). We combined z scores from multiple biomarkers to describe haematopoiesis, inflammation, lipid and glucose metabolism, liver function, renal function, and cellular senescence domains. In Cox proportional hazard models, inflammation predicted all-cause mortality with hazard ratios (95% CI) 1.89 (1.21 to 2.95) and 1.36 (1.05 to 1.78) in the very old and (semi-)supercentenarians, respectively. In linear forward stepwise models, inflammation predicted capability (10.8% variance explained) and cognition (8.6% variance explained) in (semi-) supercentenarians better than chronologic age or gender. The inflammation score was also lower in centenarian offspring compared to age-matched controls with. (95% CI) = -0.795 (-1.436 to -0.154). Centenarians and their offspring were able to maintain long telomeres, but telomere length was not a predictor of successful ageing in centenarians and semi-supercentenarians. We conclude that inflammation is an important malleable driver of ageing up to extreme old age in humans. Crown Copyright (C) 2015 Published by Elsevier B.V.
C1 [Arai, Yasumichi; Abe, Yukiko; Suematsu, Makoto; Hirose, Nobuyoshi] Keio Univ, Sch Med, Ctr Supercentenarian Res, Tokyo 1608582, Japan.
   [Martin-Ruiz, Carmen M.; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Takayama, Michiyo] Keio Univ, Sch Med, Ctr Prevent Med, Tokyo 1608582, Japan.
   [Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo 1608582, Japan.
   [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo 1608582, Japan.
   [Suematsu, Makoto] JST, ERATO, Suematsu Gas Biol Project, Tokyo, Japan.
   [Koyasu, Shigeo] RIKEN Ctr Integrat Med Sci IMS, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan.
   [Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan.
C3 Keio University; Newcastle University - UK; Keio University; Keio
   University; Keio University; Japan Science & Technology Agency (JST);
   RIKEN; Keio University
RP Hirose, N (corresponding author), Keio Univ, Sch Med, Ctr Supercentenarian Res, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
EM hirosen@keio.jp; t.vonzglinicki@ncl.ac.uk
RI Martin-Ruiz, C/JGC-6974-2023; Takebayashi, Toru/AAB-9356-2019; Suematsu,
   Makoto/O-5762-2018; Takebayashi, Toru/K-7526-2013; Suematsu,
   Makoto/I-8135-2013
OI Takebayashi, Toru/0000-0002-8268-8026; Suematsu,
   Makoto/0000-0002-7165-6336; Takebayashi, Toru/0000-0002-8268-8026;
   Suematsu, Makoto/0000-0002-7165-6336; Martin-Ruiz,
   Carmen/0000-0002-3361-6974; von Zglinicki, Thomas/0000-0002-5939-0248
FU Biotechnology and Biological Sciences Research Council [BB/I020748/1]
   Funding Source: Medline; Medical Research Council [G0601333] Funding
   Source: Medline; BBSRC [BB/I020748/1] Funding Source: UKRI; MRC
   [G0601333] Funding Source: UKRI; Biotechnology and Biological Sciences
   Research Council [BB/I020748/1] Funding Source: researchfish; Medical
   Research Council [G0601333] Funding Source: researchfish
CR Akbaraly TN, 2013, CAN MED ASSOC J, V185, pE763, DOI 10.1503/cmaj.122072
   Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223
   Arai Y, 2014, J GERONTOL A-BIOL, V69, P486, DOI 10.1093/gerona/glt146
   Arai Y, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-35
   Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106
   Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303
   Caballero B, 2009, MECH AGEING DEV, V130, P722, DOI 10.1016/j.mad.2009.09.001
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Derhovanessian E, 2010, J IMMUNOL, V185, P4618, DOI 10.4049/jimmunol.1001629
   Eisenberg DTA, 2014, EUR J HUM GENET, V22, P8, DOI 10.1038/ejhg.2013.202
   Fouweather T., 2015, EUR J PUB HLTH
   Gangemi S, 2005, MEDIAT INFLAMM, P245, DOI 10.1155/MI.2005.245
   Gondo Y, 2006, J GERONTOL A-BIOL, V61, P305, DOI 10.1093/gerona/61.3.305
   Hardeland R, 2013, J PINEAL RES, V55, P325, DOI 10.1111/jpi.12090
   Hayhoe RPG, 2010, HUM IMMUNOL, V71, P676, DOI 10.1016/j.humimm.2010.03.014
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363
   Iinuma T, 2015, J DENT RES, V94, p28S, DOI 10.1177/0022034514552493
   Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2
   Jenny NS, 2012, J GERONTOL A-BIOL, V67, P970, DOI 10.1093/gerona/glr261
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052
   Kimura M, 2007, AM J PHYSIOL-REG I, V293, pR2210, DOI 10.1152/ajpregu.00615.2007
   Kojima T, 2004, EXP GERONTOL, V39, P1595, DOI 10.1016/j.exger.2004.05.007
   Martin-Ruiz C. M., 2014, INT J EPIDEMIOL
   Martin-Ruiz C, 2014, P NUTR SOC, V73, P422, DOI 10.1017/S0029665114000147
   Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001
   Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x
   Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112
   Pavlidis N, 2012, CRIT REV ONCOL HEMAT, V83, P145, DOI 10.1016/j.critrevonc.2011.09.007
   Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598
   Pellicano R, 2014, Minerva Gastroenterol Dietol, V60, P255
   Rainsford K. D., 2007, V42, P3
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Sansoni P, 2014, EXP GERONTOL, V55, P54, DOI 10.1016/j.exger.2014.03.020
   Schnabel RB, 2013, ARTERIOSCL THROM VAS, V33, P1728, DOI 10.1161/ATVBAHA.112.301174
   Stepanova M, 2015, ONCOTARGET, V6, P1414, DOI 10.18632/oncotarget.2725
   Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415
   Strand V, 2007, LANCET, V370, P2138, DOI 10.1016/S0140-6736(07)61909-6
   Strindhall J, 2007, EXP GERONTOL, V42, P753, DOI 10.1016/j.exger.2007.05.001
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Takayama M, 2007, J GERONTOL A-BIOL, V62, P774, DOI 10.1093/gerona/62.7.774
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tedone E, 2014, EXP GERONTOL, V58, P90, DOI 10.1016/j.exger.2014.06.018
   Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   Varadhan R, 2014, J GERONTOL A-BIOL, V69, P165, DOI 10.1093/gerona/glt023
NR 47
TC 189
Z9 210
U1 0
U2 18
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD OCT
PY 2015
VL 2
IS 10
BP 1549
EP 1558
DI 10.1016/j.ebiom.2015.07.029
PG 10
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA CX8ND
UT WOS:000365959700055
PM 26629551
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kim, JY
   Atanassov, I
   Dethloff, F
   Kroczek, L
   Langer, T
AF Kim, Jun Yong
   Atanassov, Ilian
   Dethloff, Frederik
   Kroczek, Lara
   Langer, Thomas
TI Time-resolved proteomic analyses of senescence highlight metabolic
   rewiring of mitochondria
SO LIFE SCIENCE ALLIANCE
LA English
DT Article
ID CELLULAR SENESCENCE; MASS-SPECTROMETRY; DYSFUNCTION; CELLS; CONTRIBUTES;
   MAINTENANCE; LIVER; TOOL
AB Mitochondrial dysfunction and cellular senescence are hallmarks of aging. However, the relationship between these two phenomena remains incompletely understood. In this study, we investigated the rewiring of mitochondria upon development of the senescent state in human IMR90 fibroblasts. Determining the bioenergetic activities and abundance of mitochondria, we demonstrate that senescent cells accumulate mitochondria with reduced OXPHOS activity, resulting in an overall increase of mitochondrial activities in senescent cells. Time-resolved proteomic analyses revealed extensive reprogramming of the mitochondrial proteome upon senescence development and allowed the identification of metabolic pathways that are rewired with different kinetics upon establishment of the senescent state. Among the early responding pathways, the degradation of branched-chain amino acid was increased, whereas the one carbon folate metabolism was decreased. Late-responding pathways include lipid metabolism and mitochondrial translation. These signatures were confirmed by metabolic flux analyses, highlighting metabolic rewiring as a central feature of mitochondria in cellular senescence. Together, our data provide a comprehensive view on the changes in mitochondrial proteome in senescent cells and reveal how the mitochondrial metabolism is rewired in senescent cells.
C1 [Kim, Jun Yong; Atanassov, Ilian; Dethloff, Frederik; Kroczek, Lara; Langer, Thomas] Max Planck Inst Biol Ageing, Cologne, Germany.
   [Langer, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany.
   [Kim, Jun Yong] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA USA.
C3 Max Planck Society; University of Cologne; Harvard University; Harvard
   Medical School
RP Langer, T (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.; Langer, T (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany.
EM tlanger@age.mpg.de
RI Kim, Jun Yong/JPL-6952-2023; Atanassov, Ilian/L-2464-2016
OI Kim, Jun Yong/0000-0003-1810-6615; Kroczek, Lara/0000-0001-7462-6768;
   Atanassov, Ilian/0000-0001-8259-2545
CR Ahmad T, 2015, FASEB J, V29, P2912, DOI 10.1096/fj.14-268276
   Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Dörr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437
   Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Fafián-Labora J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1550-0
   Flor AC, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.75
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/NCHEMBIO.1961, 10.1038/nchembio.1961]
   Hubackova S, 2019, CELL DEATH DIFFER, V26, P276, DOI 10.1038/s41418-018-0118-3
   Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96
   Hung V, 2017, ELIFE, V6, DOI 10.7554/eLife.24463
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Iqbal A., 2021, Flaski
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lanz MC, 2022, MOL CELL, V82, P3255, DOI 10.1016/j.molcel.2022.07.017
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401
   Liu S, 2022, BIORXIV, DOI [10.1101/2022.08.29.505761, DOI 10.1101/2022.08.29.505761]
   McCann MR, 2021, METABOLITES, V11, DOI 10.3390/metabo11010051
   Millner A, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.202000013
   Minton DR, 2018, MOL CELL, V69, P610, DOI 10.1016/j.molcel.2018.01.024
   Miwa S, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158447
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4
   Neurohr GE, 2019, CELL, V176, P1083, DOI 10.1016/j.cell.2019.01.018
   Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003728
   Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800
   Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schwaiger M, 2017, ANAL CHEM, V89, P7667, DOI 10.1021/acs.analchem.7b01624
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074
   Tai HR, 2017, AUTOPHAGY, V13, P99, DOI 10.1080/15548627.2016.1247143
   Team RC, 2020, R: A Language and Environment for Statistical
   Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321
   Viana MP, 2015, METHOD CELL BIOL, V125, P77, DOI 10.1016/bs.mcb.2014.10.003
   Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119
   Wallace M, 2018, NAT CHEM BIOL, V14, P1021, DOI 10.1038/s41589-018-0132-2
   Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792
   Wiley CD, 2021, CELL METAB, V33, P1124, DOI 10.1016/j.cmet.2021.03.008
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006
   Zhang L, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158450
NR 63
TC 0
Z9 0
U1 4
U2 5
PU LIFE SCIENCE ALLIANCE LLC
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
EI 2575-1077
J9 LIFE SCI ALLIANCE
JI Life Sci. Alliance
PD SEP
PY 2023
VL 6
IS 9
DI 10.26508/lsa.202302127
PG 17
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA J8RR8
UT WOS:001012247200001
PM 37321846
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU WARD, WF
AF WARD, WF
TI FOOD RESTRICTION ENHANCES THE PROTEOLYTIC CAPACITY OF THE AGING
   RAT-LIVER
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
RP WARD, WF (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT PHYSIOL,SAN ANTONIO,TX 78284, USA.
FU NIA NIH HHS [AGO1188] Funding Source: Medline
CR BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827
   BIRCHENALLSPARKS MC, 1985, J NUTR, V115, P944, DOI 10.1093/jn/115.7.944
   CRIE JS, 1981, J MOL CELL CARDIOL, V13, P589, DOI 10.1016/0022-2828(81)90329-1
   DRAPER NR, 1966, APPLIED REGRESSION A
   ELHAJ AJ, 1986, COMP BIOCHEM PHYS A, V85, P281, DOI 10.1016/0300-9629(86)90251-3
   GOLDSPINK DF, 1985, COMP BIOCHEM PHYS B, V82, P849, DOI 10.1016/0305-0491(85)90534-6
   GOLDSPINK DF, 1987, EXP GERONTOL, V22, P67, DOI 10.1016/0531-5565(87)90016-7
   GOLDSPINK DF, 1986, CARDIOVASC RES, V20, P672, DOI 10.1093/cvr/20.9.672
   GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507
   HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   IWASAKI K, 1988, J GERONTOL, V43, pB5, DOI 10.1093/geronj/43.1.B5
   KHAIRALLAH EA, 1976, J BIOL CHEM, V251, P1375
   KHAIRALLAH EA, 1984, INTRACELLULAR PROTEI, P373
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MASORO EJ, 1985, MOL BIOL AGING, P105
   MEERSON FZ, 1978, J MOL CELL CARDIOL, V10, P145, DOI 10.1016/0022-2828(78)90039-1
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   MILLWARD D J, 1978, Biochemical Society Transactions, V6, P494
   MILLWARD DJ, 1973, INTRACELLULAR PROTEI, P158
   MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543
   MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0
   OVE P, 1972, BIOCHIM BIOPHYS ACTA, V277, P211, DOI 10.1016/0005-2787(72)90367-X
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   RICHARDSON A, 1985, HDB NUTRITION AGED
   RICKETTS WG, 1985, J CELL PHYSIOL, V125, P492, DOI 10.1002/jcp.1041250319
   SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169
   SCHWORER CM, 1981, J BIOL CHEM, V256, P7652
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   Waterlow J.C., 1978, PROTEIN TURNOVER MAM
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 34
TC 40
Z9 44
U1 0
U2 1
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD SEP
PY 1988
VL 43
IS 5
BP B121
EP B124
DI 10.1093/geronj/43.5.B121
PG 4
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA Q0488
UT WOS:A1988Q048800006
PM 3418027
DA 2024-02-19
ER

PT J
AU Sosic-Jurjevic, B
   Lütjohann, D
   Trifunovic, S
   Pavlovic, S
   Mitic, SB
   Jovanovic, L
   Ristic, N
   Marina, L
   Ajdzanovic, V
   Filipovic, B
AF Sosic-Jurjevic, Branka
   Lutjohann, Dieter
   Trifunovic, Svetlana
   Pavlovic, Sladan
   Mitic, Slavica Borkovic
   Jovanovic, Ljubisa
   Ristic, Natasa
   Marina, Ljiljana
   Ajdzanovic, Vladimir
   Filipovic, Branko
TI Differences in Cholesterol Metabolism, Hepato-Intestinal Aging, and
   Hepatic Endocrine Milieu in Rats as Affected by the Sex and Age
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE sex differences; age; cholesterol metabolism; oxidative stress; liver;
   small intestine
ID OXIDATIVE STRESS; TRANSPORTERS ABCG5; GENDER-DIFFERENCE;
   HYDROGEN-PEROXIDE; LIVER; 27-HYDROXYCHOLESTEROL; ABSORPTION; CATALASE;
   DISEASE; ENZYMES
AB Age and sex influence serum cholesterol levels, but the underlying mechanisms remain unclear. To investigate further, we measured cholesterol, precursors (surrogate synthesis markers), degradation products (oxysterols and bile acid precursors) in serum, the liver, jejunum, and ileum, as well as serum plant sterols (intestinal absorption markers) in male and female Wistar rats (4 and 24 months old). The analysis of histomorphometric and oxidative stress parameters (superoxide dismutase, catalase, glutathione-related enzyme activities, lipid peroxide, and protein carbonyl concentrations) in the liver and jejunum offered further insights into the age- and sex-related differences. The hepatic gene expression analysis included AR, ERa, and sex-specific growth hormone-regulated (Cyp2c11 and Cyp2c12) and thyroid-responsive (Dio1, Tbg, and Spot 14) genes by qPCR. We observed age-related changes in both sexes, with greater prominence in females. Aged females had significantly higher serum cholesterol (p < 0.05), jejunum cholesterol (p < 0.05), and serum plant sterols (p < 0.05). They exhibited poorer hepato-intestinal health compared with males, which was characterized by mild liver dysfunction (hydropic degeneration, increased serum ALT, p < 0.05, and decreased activity of some antioxidant defense enzymes, p < 0.05), mononuclear inflammation in the jejunal lamina propria, and age-related decreases in jejunal catalase and glutathione peroxidase activity (p < 0.05). Aged females showed increased levels of 27-hydroxycholesterol (p < 0.05) and upregulated ERa gene expression (p < 0.05) in the liver. Our study suggests that the more significant age-related increase in serum cholesterol in females is associated with poorer hepato-intestinal health and increased jejunal cholesterol absorption. The local increase in 27-hydroxycholesterol during aging might reduce the hepatoprotective effects of endogenous estrogen in the female liver.
C1 [Sosic-Jurjevic, Branka; Trifunovic, Svetlana; Ristic, Natasa; Ajdzanovic, Vladimir; Filipovic, Branko] Univ Belgrade, Natl Inst Republ Serbia, Inst Biol Res Sinisa Stankovic, Dept Cytol, Bulevar Despota Stefana 142, Belgrade 11060, Serbia.
   [Lutjohann, Dieter] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Venusberg Campus 1, D-53127 Bonn, Germany.
   [Pavlovic, Sladan; Mitic, Slavica Borkovic] Univ Belgrade, Natl Inst Republ Serbia, Inst Biol Res Sinisa Stankovic, Dept Physiol, Bulevar Despota Stefana 142, Belgrade 11060, Serbia.
   [Jovanovic, Ljubisa] Univ Belgrade, Univ Clin Ctr Serbia, Fac Med, Dept Pathol & Med Cytol, Dr Koste Todorovica 26, Belgrade 11000, Serbia.
   [Marina, Ljiljana] Univ Belgrade, Fac Med, Natl Ctr Infertil & Endocrinol Gender, Clin Endocrinol Diabet & Metab Dis, Koste Todorovica 6, Belgrade 11000, Serbia.
C3 University of Belgrade; University of Bonn; University of Belgrade;
   Clinical Centre of Serbia; University of Belgrade; University of
   Belgrade
RP Sosic-Jurjevic, B (corresponding author), Univ Belgrade, Natl Inst Republ Serbia, Inst Biol Res Sinisa Stankovic, Dept Cytol, Bulevar Despota Stefana 142, Belgrade 11060, Serbia.
EM brankasj@ibiss.bg.ac.rs; dieter.luetjohann@ukbonn.de;
   lanat@ibiss.bg.ac.rs; sladjan@ibiss.bg.ac.rs; borkos@ibiss.bg.ac.rs;
   jovanovicljubisa18@gmail.com; negicn@ibiss.bg.ac.rs; ljikka@yahoo.com;
   avlada@ibiss.bg.ac.rs; brankof@ibiss.bg.ac.rs
RI Pavlović, Sladjan/AAH-9740-2021; Šošić-Jurjević, Branka/AHD-4810-2022;
   Marina, Ljiljana/AAH-1185-2019
OI Pavlović, Sladjan/0000-0002-5651-7178; Šošić-Jurjević,
   Branka/0000-0002-5496-0619; Marina, Ljiljana/0000-0003-2664-3664;
   Jovanovic, Ljubisa/0000-0003-1931-4475; Lutjohann,
   Dieter/0000-0002-7941-8308; Borkovic-Mitic, Slavica/0000-0003-4895-9985
FU Ministry of Science, Technological Development and Innovations of the
   Republic of Serbia [451-03-47/2023-01/200007]
FX This work was supported by the Ministry of Science, Technological
   Development and Innovations of the Republic of Serbia via direct
   financing of our institute (contract number: 451-03-47/2023-01/200007).
   The Ministry is engaged only in the research and preparation of the
   article funding.
CR ABBOTT RD, 1983, ARTERIOSCLEROSIS, V3, P260, DOI 10.1161/01.ATV.3.3.260
   Alfonso F, 2018, EUR HEART J, V39, P2559, DOI 10.1093/eurheartj/ehy348
   Aydin S, 2010, BIOGERONTOLOGY, V11, P335, DOI 10.1007/s10522-009-9257-8
   Barrett KE, 2016, CLIN EXP PHARMACOL P, V43, P1097, DOI 10.1111/1440-1681.12646
   Barros PR, 2021, FRONT AGING-LAUSANNE, V2, DOI 10.3389/fragi.2021.727604
   Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366
   Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071
   Chen Y, 2011, CHINESE J PHYSIOL, V54, P385, DOI 10.4077/CJP.2011.AMM080
   Claiborne A.J.F.C.P., 1985, HDB METHODS OXYGEN R, DOI DOI 10.1016/0531-5565(85)90021-X
   CLIFTON PM, 1992, ARTERIOSCLER THROMB, V12, P955, DOI 10.1161/01.ATV.12.8.955
   Della Torre S, 2017, ADV EXP MED BIOL, V1043, P141, DOI 10.1007/978-3-319-70178-3_8
   DiStefano JK, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa134
   Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P7578, DOI 10.3748/wjg.v12.i47.7578
   Duan LP, 2006, AM J PHYSIOL-GASTR L, V290, pG269, DOI 10.1152/ajpgi.00172.2005
   Duan LP, 2004, J LIPID RES, V45, P1312, DOI 10.1194/jlr.M400030-JLR200
   Duan YJ, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01125-5
   DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Engels K, 2015, EUR THYROID J, V4, P81, DOI 10.1159/000381020
   GLATZLE D, 1974, EXPERIENTIA, V30, P665
   Haghikia A, 2022, EUR HEART J, V43, P518, DOI 10.1093/eurheartj/ehab644
   Halliwell B, 2022, ARCH BIOCHEM BIOPHYS, V726, DOI 10.1016/j.abb.2022.109246
   Houghton LA, 2016, GASTROENTEROLOGY, V150, P1332, DOI 10.1053/j.gastro.2016.02.017
   Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515
   Félix-Redondo FJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-542
   Kander MC, 2017, J CELL MOL MED, V21, P1024, DOI 10.1111/jcmm.13038
   Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429
   Kucera O, 2014, WORLD J GASTROENTERO, V20, P8364, DOI 10.3748/wjg.v20.i26.8364
   Lam M, 2018, MOL PHARMACOL, V93, P101, DOI 10.1124/mol.117.110742
   Lee WR, 2014, CLIN LIPIDOL, V9, P617, DOI 10.2217/CLP.14.53
   Libby P, 2021, NATURE, V592, P524, DOI 10.1038/s41586-021-03392-8
   Lütjohann D, 2023, NUTRIENTS, V15, DOI 10.3390/nu15092202
   Mackay DS, 2014, J CHROMATOGR B, V957, P116, DOI 10.1016/j.jchromb.2014.02.052
   Malhotra P, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00467
   Man JHJ, 2020, CIRC RES, V126, P1297, DOI 10.1161/CIRCRESAHA.120.315930
   Mauvais-Jarvis F, 2021, PHARMACOL REV, V73, P730, DOI 10.1124/pharmrev.120.000206
   Mesquita CS, 2014, ANAL BIOCHEM, V458, P69, DOI 10.1016/j.ab.2014.04.034
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Neeland IJ, 2019, LANCET DIABETES ENDO, V7, P715, DOI 10.1016/S2213-8587(19)30084-1
   Olkkonen VM, 2012, BIOMOLECULES, V2, P76, DOI 10.3390/biom2010076
   Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502
   Pandak WM, 2002, J BIOL CHEM, V277, P48158, DOI 10.1074/jbc.M205244200
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Pascot A, 2002, ATHEROSCLEROSIS, V160, P399, DOI 10.1016/S0021-9150(01)00579-2
   Patel SB, 2008, J CLIN LIPIDOL, V2, pS11, DOI 10.1016/j.jacl.2008.01.007
   Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264
   REHNCRONA S, 1980, J NEUROCHEM, V34, P1630, DOI 10.1111/j.1471-4159.1980.tb11254.x
   Ren JX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08452-6
   Rizzetto L, 2018, J AUTOIMMUN, V92, P12, DOI 10.1016/j.jaut.2018.05.008
   Rodríguez-Correa E, 2020, NUTR DIABETES, V10, DOI 10.1038/s41387-020-0127-4
   Saint-Denis M, 1998, ARCH ENVIRON CON TOX, V35, P602, DOI 10.1007/s002449900422
   Sato Y, 2022, CURR ATHEROSCLER REP, V24, P23, DOI 10.1007/s11883-022-00980-5
   Sayaf K, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231810654
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shen MQ, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/294278
   Sosic-Jurjevic B, 2019, J STEROID BIOCHEM, V190, P1, DOI 10.1016/j.jsbmb.2019.03.009
   Sosic-Jurjevic B, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020791
   TAMURA M, 1982, J BIOCHEM-TOKYO, V92, P1019, DOI 10.1093/oxfordjournals.jbchem.a134017
   Umetani M, 2014, CELL METAB, V20, P172, DOI 10.1016/j.cmet.2014.05.013
   VANLENTEN BJ, 1980, ATHEROSCLEROSIS, V37, P569, DOI 10.1016/0021-9150(80)90064-7
   Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801
   VRANCKX R, 1994, J ENDOCRINOL, V142, P77, DOI 10.1677/joe.0.1420077
   Wang YJ, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104248
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Younossi ZM, 2020, GUT, V69, P564, DOI 10.1136/gutjnl-2019-318813
   Zakari M, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12980
   Zhu DS, 2020, HUM REPROD, V35, P1933, DOI 10.1093/humrep/deaa124
NR 70
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2023
VL 24
IS 16
AR 12624
DI 10.3390/ijms241612624
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA Q5CB6
UT WOS:001057686300001
PM 37628805
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Arruda, LF
   Arruda, SF
   Campos, NA
   de Valencia, FF
   Siqueira, EMD
AF Arruda, Lorena Fernandes
   Arruda, Sandra Fernandes
   Campos, Natalia Aboudib
   de Valencia, Fernando Fortes
   de Almeida Siqueira, Egle Machado
TI Dietary Iron Concentration May Influence Aging Process by Altering
   Oxidative Stress in Tissues of Adult Rats
SO PLOS ONE
LA English
DT Article
ID REGULATORY HORMONE HEPCIDIN; ANTIOXIDANT ENZYMES; DOWN-REGULATION;
   UP-REGULATION; CREB-H; EXPRESSION; METABOLISM; SENESCENCE; DAMAGE; LIVER
AB Iron is an essential element. However, in its free form, iron participates in redox-reactions, leading to the production of free radicals that increase oxidative stress and the risk of damaging processes. Living organisms have an efficient mechanism that regulates iron absorption according to their iron content to protect against oxidative damage. The effects of restricted and enriched-iron diets on oxidative stress and aging biomarkers were investigated. Adult Wistar rats were fed diets containing 10, 35 or 350 mg/kg iron (adult restricted-iron, adult control-iron and adult enriched-iron groups, respectively) for 78 days. Rats aged two months were included as a young control group. Young control group showed higher hemoglobin and hematocrit values, lower levels of iron and lower levels of MDA or carbonyl in the major studied tissues than the adult control group. Restricted-iron diet reduced iron concentrations in skeletal muscle and oxidative damage in the majority of tissues and also increased weight loss. Enriched-iron diet increased hematocrit values, serum iron, gamma-glutamyl transferase, iron concentrations and oxidative stress in the majority of tissues. As expected, young rats showed higher mRNA levels of heart and hepatic L-Ferritin (Ftl) and kidneys SMP30 as well as lower mRNA levels of hepatic Hamp and interleukin-1 beta (Il1b) and also lower levels of liver protein ferritin. Restricted-iron adult rats showed an increase in heart Ftl mRNA and the enriched-iron adult rats showed an increase in liver nuclear factor erythroid derived 2 like 2 (Nfe2l2) and Il1b mRNAs and in gut divalent metal transporter-1 mRNA (Slc11a2) relative to the control adult group. These results suggest that iron supplementation in adult rats may accelerate aging process by increasing oxidative stress while iron restriction may retards it. However, iron restriction may also impair other physiological processes that are not associated with aging.
C1 [Arruda, Lorena Fernandes] Univ Brasilia, Fac Hlth Sci, Brasilia, DF, Brazil.
   [Arruda, Sandra Fernandes; Campos, Natalia Aboudib] Univ Brasilia, Dept Nutr, Fac Hlth Sci, Brasilia, DF, Brazil.
   [de Valencia, Fernando Fortes; de Almeida Siqueira, Egle Machado] Univ Brasilia, Inst Biol Sci, Dept Cell Biol, Brasilia, DF, Brazil.
C3 Universidade de Brasilia; Universidade de Brasilia; Universidade de
   Brasilia
RP Arruda, LF (corresponding author), Univ Brasilia, Fac Hlth Sci, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil.
EM fernandeslfarruda@gmail.com
RI Arruda, Sandra/A-9528-2014; Arruda, Sandra Fernandes/AAC-6778-2019
OI Fernandes Arruda, Sandra/0000-0003-0774-8276
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Decanato de Pesquisa e Pos-Graduacao (DPP), University of Brasilia,
   Brazil
FX This study was financially supported by Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Decanato de Pesquisa
   e Pos-Graduacao (DPP), University of Brasilia, Brazil. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Ago T, 2010, AGING-US, V2, P1012, DOI 10.18632/aging.100261
   Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7
   Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004
   Arvapalli RK, 2010, CARDIOVASC TOXICOL, V10, P108, DOI 10.1007/s12012-010-9068-9
   BARANOWSKA I, 1995, SCI TOTAL ENVIRON, V159, P155, DOI 10.1016/0048-9697(95)04218-P
   Beard JL, 1996, NUTR REV, V54, P295, DOI 10.1111/j.1753-4887.1996.tb03794.x
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021
   Bulvik B, 2009, MECH AGEING DEV, V130, P139, DOI 10.1016/j.mad.2008.10.002
   Bulvik BE, 2012, AGE, V34, P693, DOI 10.1007/s11357-011-9268-7
   Candan N, 2008, NEUROTOXICOLOGY, V29, P708, DOI 10.1016/j.neuro.2008.04.012
   CHAM BE, 1985, ANAL BIOCHEM, V151, P561, DOI 10.1016/0003-2697(85)90220-9
   Chen HJ, 2009, BIOMETALS, V22, P827, DOI 10.1007/s10534-009-9229-0
   Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332
   Christiansen H, 2007, RADIOLOGY, V242, P189, DOI 10.1148/radiol.2421060083
   Collins JE, 2008, J NUTR, V138, P2284, DOI 10.3945/jn.108.096347
   Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5
   De Domenico I, 2009, CELL METAB, V10, P245, DOI 10.1016/j.cmet.2009.09.005
   Dröge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x
   Du F, 2012, J NUTR BIOCHEM, V23, P1694, DOI 10.1016/j.jnutbio.2011.12.002
   Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003
   Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771
   Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312
   Fan Y, 2009, TOXICOL PATHOL, V37, P209, DOI 10.1177/0192623308328544
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5
   Galaris D, 2008, HORM-INT J ENDOCRINO, V7, P114, DOI 10.1007/BF03401502
   Garrick MD, 2012, BIOMETALS, V25, P787, DOI 10.1007/s10534-012-9522-1
   Gentile CL, 2010, MOL CELL BIOCHEM, V344, P99, DOI 10.1007/s11010-010-0533-3
   Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697
   Habig W H, 1981, Methods Enzymol, V77, P218
   Hahn P, 2009, EXP GERONTOL, V44, P594, DOI 10.1016/j.exger.2009.06.006
   Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   HermesLima M, 1996, AM J PHYSIOL-REG I, V271, pR918, DOI 10.1152/ajpregu.1996.271.4.R918
   Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007
   Huang Q, 2001, TOXICOL SCI, V63, P196, DOI 10.1093/toxsci/63.2.196
   Inamura J, 2005, HEPATOL RES, V33, P198, DOI 10.1016/j.hepres.2005.08.005
   Joanisse DR, 1996, AM J PHYSIOL-REG I, V271, pR545, DOI 10.1152/ajpregu.1996.271.3.R545
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158
   Kurz T, 2011, INT J BIOCHEM CELL B, V43, P1686, DOI 10.1016/j.biocel.2011.08.016
   Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Maranhao AQ, 2003, TECNICAS BASICAS BIO
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009
   Moon MS, 2012, TOXICOL SCI, V129, P74, DOI 10.1093/toxsci/kfs193
   Muñoz M, 2011, J CLIN PATHOL, V64, P281, DOI 10.1136/jcp.2010.079046
   Oliveira BF, 2010, THESCIENTIFICWORLDJO, V10, P1121, DOI 10.1100/tsw.2010.94
   Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154
   Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008
   Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3
   Pietrangelo A, 2011, J HEPATOL, V54, P173, DOI 10.1016/j.jhep.2010.08.004
   Polla AS, 2003, AGEING RES REV, V2, P25, DOI 10.1016/S1568-1637(02)00048-X
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Richert S, 2002, ARCH BIOCHEM BIOPHYS, V397, P430, DOI 10.1006/abbi.2001.2683
   Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0
   Siqueira EMAASG, 2006, COMUN CIENC SAUDE, V17, P229
   Sobocanec S, 2008, BIOGERONTOLOGY, V9, P335, DOI 10.1007/s10522-008-9145-7
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Souza HP, 2002, AM J PHYSIOL-HEART C, V282, pH466, DOI 10.1152/ajpheart.00482.2001
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Umur EE, 2011, GERIATR GERONTOL INT, V11, P504, DOI 10.1111/j.1447-0594.2011.00694.x
   Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639
   Villar-Cheda B, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.006
   Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825
   Wang Q, 2008, ENDOCRINOLOGY, V149, P3920, DOI 10.1210/en.2007-1626
   Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8
   Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865
   Xu JZ, 2012, EXP GERONTOL, V47, P100, DOI 10.1016/j.exger.2011.10.011
   Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007
   Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040
NR 76
TC 36
Z9 41
U1 0
U2 23
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 12
PY 2013
VL 8
IS 4
AR e61058
DI 10.1371/journal.pone.0061058
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 123JP
UT WOS:000317385300046
PM 23593390
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Kyritsi, K
   Francis, H
   Zhou, TH
   Ceci, L
   Wu, N
   Yang, ZH
   Meng, FY
   Chen, LX
   Baiocchi, L
   Kundu, D
   Kennedy, L
   Liangpunsakul, S
   Wu, CD
   Glaser, S
   Alpini, G
AF Kyritsi, Konstantina
   Francis, Heather
   Zhou, Tianhao
   Ceci, Ludovica
   Wu, Nan
   Yang, Zhihong
   Meng, Fanyin
   Chen, Lixian
   Baiocchi, Leonardo
   Kundu, Debjyoti
   Kennedy, Lindsey
   Liangpunsakul, Suthat
   Wu, Chaodong
   Glaser, Shannon
   Alpini, Gianfranco
TI Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the
   Mdr2<SUP>-/-</SUP> Mouse Model of Primary Sclerosing Cholangitis
SO GENE EXPRESSION-THE JOURNAL OF LIVER RESEARCH
LA English
DT Article
DE Biliary epithelium; Cholangiocytes; Cholangiopathies; Liver; miRNA
AB Biliary senescence and hepatic fibrosis are hallmarks of cholangiopathies including primary sclerosing cholangitis (PSC). Senescent cholangiocytes display senescence-associated secretory phenotypes [SASPs, e.g., transforming growth factor-beta 1 (TGF-beta 1)] that further increase biliary senescence (by an autocrine loop) and trigger liver fibrosis by paracrine mechanisms. The aim of this study was to determine the effect of p16 inhibition and role of the TGF-beta 1/microRNA (miR)-34a/sirtuin 1 (SIRT1) axis in biliary damage and liver fibrosis in the Mdr2(-/-) mouse model of PSC. We treated (i) in vivo male wild-type (WT) and Mdr2(-/-) mice with p16 Vivo-Morpholino or controls before measuring biliary mass [intrahepatic bile duct mass (IBDM)] and senescence, biliary SASP levels, and liver fibrosis, and (ii) in vitro intrahepatic murine cholangiocyte lines (IMCLs) with small interfering RNA against p16 before measuring the mRNA expression of proliferation, senescence, and fibrosis markers. p16 and miR-34a increased but SIRT1 decreased in Mdr2(-/-) mice and PSC human liver samples compared to controls. p16 immunoreactivity and biliary senescence and SASP levels increased in Mdr2(-/-) mice but decreased in Mdr2(-/-) mice treated with p16 Vivo-Morpholino. The increase in IBDM and hepatic fibrosis (observed in Mdr2(-/-) mice) returned to normal values in Mdr2(-/-) mice treated with p16 Vivo-Morpholino. TGF-beta 1 immunoreactivity and biliary SASPs levels were higher in Mdr2(-/-) compared to those of WT mice but returned to normal values in Mdr2(-/-) mice treated with p16 Vivo-Morpholino. The expression of fibrosis/senescence markers decreased in cholangiocytes from Mdr2(-/-) mice treated with p16 Vivo-Morpholino (compared to Mdr2(-/-) mice) and in IMCLs (after p16 silencing) compared to controls. Modulation of the TGF-beta 1/miR-34a/SIRT1 axis may be important in the management of PSC phenotypes.
C1 [Kyritsi, Konstantina; Francis, Heather; Ceci, Ludovica; Wu, Nan; Meng, Fanyin; Chen, Lixian; Liangpunsakul, Suthat; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA.
   [Francis, Heather; Yang, Zhihong; Meng, Fanyin; Kundu, Debjyoti; Kennedy, Lindsey; Liangpunsakul, Suthat; Alpini, Gianfranco] Indiana Univ, Med, Hepatol & Gastroenterol, Indianapolis, IN USA.
   [Zhou, Tianhao; Glaser, Shannon] Texas A&M Univ, Dept Med Physiol, Coll Med, Bryan, TX USA.
   [Baiocchi, Leonardo] Univ Roma Tor Vergata, Dept Med, Liver Unit, Rome, Italy.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr, College Stn, TX USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Richard L. Roudebush VA Medical Center; Indiana University System;
   Indiana University-Purdue University Indianapolis; Texas A&M University
   System; Texas A&M University College Station; University of Rome Tor
   Vergata; Texas A&M University System; Texas A&M University College
   Station
RP Alpini, G (corresponding author), Richard L Roudebush VA Med Ctr, Indiana Ctr Liver Res, Med, 1481 W 10th St,Dedicat Wing Room D-2004, Indianapolis, IN 46202 USA.; Alpini, G (corresponding author), Indiana Univ, Gastroenterol Med Cellular & Integrat Physiol Bio, 1481 W 10th St,Dedicat Wing Room D-2004, Indianapolis, IN 46202 USA.
EM galpini@iu.edu
RI Yang, Zhihong/L-5024-2019
FU Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University;
   Indiana University Health -Indiana University School of Medicine
   Strategic Research Initiative; VA Merit awards [5I01BX000574]; United
   States Department of Veteran's Affairs, Biomedical Laboratory Research
   and Development Service [1I01BX003031, 1I01BX001724]; NIH [DK108959,
   DK119421, DK054811, DK076898, DK107310, DK110035, DK062975, AA025997,
   AA025157, AA026385]; BaylorScott & White Research Institute
FX This work was supported by the Hickam Endowed Chair, Gastroenterology,
   Medicine, Indiana University and the Indiana University Health -Indiana
   University School of Medicine Strategic Research Initiative, the VA
   Merit awards to Dr. Alpini (5I01BX000574), Dr. Francis (1I01BX003031),
   and Dr. Meng (1I01BX001724) from the United States Department of
   Veteran's Affairs, Biomedical Laboratory Research and Development
   Service, and NIH grants DK108959 and DK119421 (H.F.), DK054811,
   DK076898, DK107310, DK110035, DK062975, AA025997, and AA025157 to Drs.
   Alpini, Meng, and Glaser, AA026385 (Z.Y.), and partly from the
   BaylorScott & White Research Institute. This material is the result of
   work supported by resources at the Central Texas Veterans Health Care
   System, Temple, TX, Richard L. Roudebush VA Medical Center,
   Indianapolis, IN, and Medical Physiology, Medical Research Building,
   Temple, TX. The views expressed in this article are those of the authors
   and do not necessarily represent the views of the Department of Veterans
   Affairs.
CR Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767
   ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bertolani C, 2006, AM J PATHOL, V169, P2042, DOI 10.2353/ajpath.2006.060081
   Blagosklonny MV, 2014, CELL CYCLE, V13, P3628, DOI 10.4161/15384101.2014.985507
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Feliciano Andrea, 2011, J Aging Res, V2011, P205378, DOI 10.4061/2011/205378
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657
   Glaser SS, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000994
   Guo M, 2017, BIOMED PHARMACOTHER, V96, P1527, DOI 10.1016/j.biopha.2017.11.075
   ISHII M, 1989, GASTROENTEROLOGY, V97, P1236, DOI 10.1016/0016-5085(89)91695-8
   Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012
   Kanno N, 2001, AM J PHYSIOL-GASTR L, V281, pG612, DOI 10.1152/ajpgi.2001.281.3.G612
   Kennedy L, 2019, FASEB J, V33, P10269, DOI 10.1096/fj.201802606R
   Kennedy L, 2018, AM J PATHOL, V188, P600, DOI 10.1016/j.ajpath.2017.11.016
   Kyritsi K, 2017, AM J PATHOL, V187, P1551, DOI 10.1016/j.ajpath.2017.03.013
   LeSage GD, 1999, AM J PHYSIOL-GASTR L, V276, pG1289, DOI 10.1152/ajpgi.1999.276.5.G1289
   Li R, 2018, J CELL BIOCHEM, V119, P2135, DOI 10.1002/jcb.26375
   Li Y, 2020, INT IMMUNOPHARMACOL, V83, DOI 10.1016/j.intimp.2020.106386
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Mancinelli R, 2010, AM J PATHOL, V176, P1790, DOI 10.2353/ajpath.2010.090677
   Meadows V, 2019, BBA-MOL BASIS DIS, V1865, DOI 10.1016/j.bbadis.2019.165557
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Nakanuma Y, 2015, J HEPATOL, V62, P934, DOI 10.1016/j.jhep.2014.11.027
   Natarajan SK, 2014, HEPATOLOGY, V60, P1942, DOI 10.1002/hep.27175
   Niu BL, 2018, MOL MED REP, V18, P1609, DOI 10.3892/mmr.2018.9088
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Que KT, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0930-0
   Sasaki M, 2014, DIGEST DIS SCI, V59, P358, DOI 10.1007/s10620-013-2920-6
   Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Sato-Matsubara M, 2017, J BIOL CHEM, V292, P18961, DOI 10.1074/jbc.M117.793794
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tan YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111424
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Vollmar B, 2002, SHOCK, V18, P348, DOI 10.1097/00024382-200210000-00010
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wasik U, 2017, SCI REP-UK, V7, DOI 10.1038/srep44769
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Wu T, 2014, ANN CLIN LAB SCI, V44, P410
   Xu HF, 2020, HISTOCHEM CELL BIOL, V154, P107, DOI 10.1007/s00418-020-01867-9
   Zhang YX, 2014, HEPATOLOGY, V60, P919, DOI 10.1002/hep.27121
   Zhao R, 2016, EBIOMEDICINE, V8, P30, DOI 10.1016/j.ebiom.2016.04.017
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 48
TC 19
Z9 22
U1 0
U2 0
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 1052-2166
EI 1555-3884
J9 GENE EXPRESSION
JI Gene Expr.
PY 2020
VL 20
IS 2
BP 89
EP 103
DI 10.3727/105221620X15889714507961
PG 15
WC Biotechnology & Applied Microbiology; Gastroenterology & Hepatology;
   Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Gastroenterology & Hepatology;
   Genetics & Heredity
GA VL6GK
UT WOS:000895438000002
PM 32393417
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Pesta, DH
   Perry, RJ
   Guebre-Egziabher, F
   Zhang, DY
   Jurczak, M
   Fischer-Rosinsky, A
   Daniels, MA
   Willmes, DM
   Bhanot, S
   Bornstein, SR
   Knauf, F
   Samuel, VT
   Shulman, GI
   Birkenfeld, AL
AF Pesta, Dominik H.
   Perry, Rachel J.
   Guebre-Egziabher, Fitsum
   Zhang, Dongyan
   Jurczak, Michael
   Fischer-Rosinsky, Antje
   Daniels, Martin A.
   Willmes, Diana M.
   Bhanot, Sanjay
   Bornstein, Stefan R.
   Knauf, Felix
   Samuel, Varman T.
   Shulman, Gerald I.
   Birkenfeld, Andreas L.
TI Prevention of diet-induced hepatic steatosis and hepatic insulin
   resistance by second generation antisense oligonucleotides targeted to
   the longevity gene <i>mIndy (Slc13a5)</i>
SO AGING-US
LA English
DT Article
DE Indy; aging; hepatic insulin resistance; type 2 diabetes; Slc13a5
ID COUPLED CITRATE TRANSPORTER; AMINO-ACID PROFILES; LONG-LIVED INDY;
   LIFE-SPAN; CAENORHABDITIS-ELEGANS; FATTY LIVER; MICE; RESTRICTION;
   RECEPTOR; DISEASE
AB Reducing the expression of the Indy (I'm Not Dead Yet) gene in lower organisms extends life span by mechanisms resembling caloric restriction. Similarly, deletion of the mammalian homolog, mIndy (Slc13a5), encoding for a plasma membrane tricarboxylate transporter, protects from aging- and diet-induced adiposity and insulin resistance in mice. The organ specific contribution to this phenotype is unknown. We examined the impact of selective inducible hepatic knockdown of mIndy on whole body lipid and glucose metabolism using 2'-O-methoxyethyl chimeric anti-sense oligonucleotides (ASOs) in high-fat fed rats. 4-week treatment with 2'-O-methoxyethyl chimeric ASO reduced mIndy mRNA expression by 91% (P<0.001) compared to control ASO. Besides similar body weights between both groups, mIndy-ASO treatment lead to a 74% reduction in fasting plasma insulin concentrations as well as a 35% reduction in plasma triglycerides. Moreover, hepatic triglyceride content was significantly reduced by the knockdown of mIndy, likely mediating a trend to decreased basal rates of endogenous glucose production as well as an increased suppression of hepatic glucose production by 25% during a hyperinsulinemic-euglycemic clamp. Together, these data suggest that inducible liver-selective reduction of mIndy in rats is able to ameliorate hepatic steatosis and insulin resistance, conditions occurring with high calorie diets and during aging.
C1 [Pesta, Dominik H.; Perry, Rachel J.; Guebre-Egziabher, Fitsum; Jurczak, Michael; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06519 USA.
   [Pesta, Dominik H.; Perry, Rachel J.; Zhang, Dongyan; Shulman, Gerald I.] Yale Univ, Sch Med, Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06519 USA.
   [Perry, Rachel J.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA.
   [Pesta, Dominik H.] Univ Innsbruck, Med Sect, Dept Sport Sci, A-6020 Innsbruck, Austria.
   [Pesta, Dominik H.] Med Univ Innsbruck, D Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria.
   [Pesta, Dominik H.] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Ctr Diabet Res,Partner Dusseldorf, Inst Clin Diabetol,German Diabet Ctr, Dusseldorf, Germany.
   [Fischer-Rosinsky, Antje; Daniels, Martin A.] Charite, Sch Med, Dept Endocrinol Diabet & Nutr, Berlin, Germany.
   [Daniels, Martin A.; Willmes, Diana M.; Bornstein, Stefan R.; Birkenfeld, Andreas L.] Tech Univ Dresden, Med Clin 3, Sect Metab Vasc Med, Dresden, Germany.
   [Daniels, Martin A.; Willmes, Diana M.; Bornstein, Stefan R.; Birkenfeld, Andreas L.] Tech Univ Dresden, PLID, Dresden, Germany.
   [Willmes, Diana M.; Bornstein, Stefan R.; Birkenfeld, Andreas L.] German Ctr Diabet Res DZD, Dresden, Germany.
   [Bhanot, Sanjay] ISIS Pharmaceut, 2280 Faraday Ave, Carlsbad, CA 92008 USA.
   [Bornstein, Stefan R.; Birkenfeld, Andreas L.] Kings Coll London, Rayne Inst, Sect Diabet & Nutr Sci, London WC2R 2LS, England.
   [Knauf, Felix] Univ Clin Erlangen, Erlangen, Germany.
   [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT 06516 USA.
C3 Yale University; Yale University; Yale University; Howard Hughes Medical
   Institute; University of Innsbruck; Medical University of Innsbruck;
   Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf;
   Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Technische Universitat Dresden; Technische
   Universitat Dresden; Isis Pharmaceuticals Inc; University of London;
   King's College London; University of Erlangen Nuremberg; US Department
   of Veterans Affairs; Veterans Health Administration (VHA); VA
   Connecticut Healthcare System
RP Pesta, DH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06519 USA.
EM dominik.pesta@ddz.uni-duesseldorf.de;
   andreas.birkenfeld@uniklinikum-dresden.de
RI Pesta, Dominik/AAV-7108-2020; Carmen, Team3/Y-7384-2019; Shulman, Gerald
   I./P-7176-2019; Knauf, Felix/ABC-2513-2021; Birkenfeld, Andreas
   L./U-3954-2019
OI Pesta, Dominik/0000-0002-5089-3586; Carmen, Team3/0000-0002-3614-0924;
   Shulman, Gerald I./0000-0003-1529-5668; Birkenfeld, Andreas
   L./0000-0003-1407-9023; Lab, Carmen/0000-0002-5935-3236; Knauf,
   Felix/0000-0001-5762-1404; Perry, Rachel/0000-0003-0748-8064; Daniels,
   Martin Andre/0000-0002-1782-3973
FU Austrian Science Fund (FWF) [J 3267]; German Research Foundation
   [BI1292/4-2]; German Center for Diabetes Research (DZD); National
   Institutes of Health [R01 DK-40936, P30 DK-45735]; Austrian Science Fund
   (FWF) [J 3267] Funding Source: researchfish
FX This project was supported by grants from the Austrian Science Fund
   (FWF), project number J 3267, the German Research Foundation
   (BI1292/4-2), the German Center for Diabetes Research (DZD) and the
   National Institutes of Health (R01 DK-40936, P30 DK-45735).
CR Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021
   BANCEL E, 1994, ANN BIOL CLIN-PARIS, V52, P667
   Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672
   Birkenfeld AL, 2011, J BIOL CHEM, V286, P36163, DOI 10.1074/jbc.M111.228817
   Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Cheng S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7791
   Chu X, 2013, DIABETES, V62, P561, DOI 10.2337/db12-0139
   de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031
   Edwards C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0167-2
   Emran S, 2014, AGING-US, V6, P390, DOI 10.18632/aging.100665
   Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007
   Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807
   Gopal E, 2007, PHARM RES-DORDR, V24, P575, DOI 10.1007/s11095-006-9176-1
   Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006
   Hardies K, 2015, BRAIN, V138, DOI 10.1093/brain/awv263
   Huard K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17391
   Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827
   Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108
   Knauf F, 2006, BIOCHEM J, V397, P25, DOI 10.1042/BJ20060409
   Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571
   Li LH, 2015, MOL PHARMACOL, V87, P674, DOI 10.1124/mol.114.097287
   Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542
   Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106
   Neuschäfer-Rube F, 2015, TOXICOLOGY, V337, P1, DOI 10.1016/j.tox.2015.08.007
   Neuschäfer-Rube F, 2014, DIABETES, V63, P1048, DOI 10.2337/db13-0749
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   Palmer ND, 2015, J CLIN ENDOCR METAB, V100, pE463, DOI 10.1210/jc.2014-2357
   Rogers RP, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00204
   Rogers RP, 2014, AGING-US, V6, P335, DOI 10.18632/aging.100658
   Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137
   Rozing MP, 2009, AGING-US, V1, P714, DOI 10.18632/aging.100071
   Ruckenstuhl C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004347
   Schwarz F, 2015, AGING-US, V7, P553, DOI 10.18632/aging.100791
   Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Tillin T, 2015, DIABETOLOGIA, V58, P968, DOI 10.1007/s00125-015-3517-8
   Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106
   Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774
   Willmes DM, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303020
NR 40
TC 29
Z9 33
U1 0
U2 1
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD DEC
PY 2015
VL 7
IS 12
BP 1086
EP 1093
DI 10.18632/aging.100854
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DB5BU
UT WOS:000368528900009
PM 26647160
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Nakajima, T
   Nakashima, T
   Yamaoka, J
   Shibuya, A
   Konishi, E
   Okada, Y
   Jo, M
   Nishikawa, T
   Itoh, Y
   Yoshikawa, T
AF Nakajima, Tomoki
   Nakashima, Toshiaki
   Yamaoka, Junko
   Shibuya, Akiko
   Konishi, Eiichi
   Okada, Yoshihisa
   Jo, Masayasu
   Nishikawa, Taichirou
   Itoh, Yoshihito
   Yoshikawa, Toshikazu
TI Greater age and hepatocellular aging are independent risk factors for
   hepatocellular carcinoma arising from non-B non-C non-alcoholic chronic
   liver disease
SO PATHOLOGY INTERNATIONAL
LA English
DT Article
DE hepatocellular aging; hepatocellular carcinoma; non-B non-C
   non-alcoholic liver disease; relative nuclear size
ID CHRONIC HEPATITIS-C; OXIDATIVE STRESS; HEPATOCARCINOGENESIS; SENESCENCE;
   INFECTION; FEATURES; FISH
AB We previously reported that hepatocellular aging can be assessed by measuring the nuclear size of hepatocytes. We attempted to elucidate whether this method is useful to identify the high risk group of hepatocellular carcinoma (HCC) in the patients with non-B non-C non-alcoholic liver injury. Fourteen patients with HCC and 78 without HCC, both of whom presented with non-B non-C non-alcoholic chronic liver injury and underwent liver biopsy, were selected. Twelve histologically normal liver tissues were selected as controls. The relative nuclear size (RNS) was calculated as the average nuclear size of the hepatocytes divided by that of lymphocytes. Multiple clinicopathological parameters were studied. The RNS values of normal livers ranged from 1.32 to 2.10, showing a gradual increase in an age-dependent manner. The RNS values of the injured livers without HCC increased after middle age. Univariate analysis identified greater age, existence of diabetes and RNS, as significantly positive contributors and ALT value and the degree of steatosis as negative contributors for the occurrence of HCC. Only age and RNS retained significance in multivariate analysis. All of the HCC patients were older than 50 and showed RNS values higher than 2.00. Therefore, such patients are classified as a high risk group of HCC.
C1 [Nakajima, Tomoki; Nakashima, Toshiaki; Yamaoka, Junko; Shibuya, Akiko] Saiseikai Kyoto Hosp, Dept Med, Nagaoka Kyo 6170814, Japan.
   [Konishi, Eiichi] Saiseikai Kyoto Hosp, Dept Clin Pathol, Nagaoka Kyo, Japan.
   [Okada, Yoshihisa; Jo, Masayasu; Nishikawa, Taichirou; Itoh, Yoshihito; Yoshikawa, Toshikazu] Kyoto Prefectural Univ, Med Grad Sch Med Sci, Kyoto 606, Japan.
C3 Kyoto Prefectural University
RP Nakajima, T (corresponding author), Saiseikai Kyoto Hosp, Dept Med, 8 Minamihirao, Nagaoka Kyo City, Kyoto 6170814, Japan.
EM tomnaka@silver.ocn.ne.jp
OI Konishi, Eiichi/0000-0002-7122-2271
CR Abe H, 2008, J GASTROENTEROL, V43, P967, DOI 10.1007/s00535-008-2264-8
   Alexia C, 2004, BIOCHEM PHARMACOL, V68, P1003, DOI 10.1016/j.bcp.2004.05.029
   Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167
   Hatanaka K, 2007, INTERVIROLOGY, V50, P24, DOI 10.1159/000096309
   HAYASHI T, 2010, KANZO, V51, P697
   Hepperger C, 2007, CHROMOSOMA, V116, P117, DOI 10.1007/s00412-006-0084-2
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   *LIV CANC STUD GRO, 2005, ACTA HEPATOL JPN, V46, P234
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110
   Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271
   Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552
   Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Tanaka S, 2011, J ATHEROSCLER THROMB, V18, P115, DOI 10.5551/jat.5926
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yokoi Y, 2005, J GASTROENTEROL, V40, P274, DOI 10.1007/s00535-004-1536-1
NR 21
TC 9
Z9 9
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1320-5463
J9 PATHOL INT
JI Pathol. Int.
PD OCT
PY 2011
VL 61
IS 10
BP 572
EP 576
DI 10.1111/j.1440-1827.2011.02743.x
PG 5
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 826EF
UT WOS:000295333600003
PM 21951665
DA 2024-02-19
ER

PT J
AU Huang, YL
   Shen, ZQ
   Huang, CH
   Lin, CH
   Tsai, TF
AF Huang, Yi-Long
   Shen, Zhao-Qing
   Huang, Chen-Hua
   Lin, Chao-Hsiung
   Tsai, Ting-Fen
TI Cisd2 slows down liver aging and attenuates age-related metabolic
   dysfunction in male mice
SO AGING CELL
LA English
DT Article; Early Access
DE Cisd2; fibrosis; liver aging; non-alcoholic fatty liver disease;
   oxidative stress; RNA sequencing; transcriptomics
ID LIFE-SPAN; HEME OXYGENASE-1; GENE-EXPRESSION; INFLAMMATION; HOMEOSTASIS;
   DISEASE; DNA
AB The liver plays a pivotal role in mammalian aging. However, the mechanisms underlying liver aging remain unclear. Cisd2 is a pro-longevity gene in mice. Cisd2 mediates lifespan and healthspan via regulation of calcium homeostasis and mitochondrial functioning. Intriguingly, the protein level of Cisd2 is significantly decreased by about 50% in the livers of old male mice. This down-regulation of Cisd2 may result in the aging liver exhibiting non-alcoholic fatty liver disease (NAFLD) phenotype. Here, we use Cisd2 transgenic mice to investigate whether maintaining Cisd2 protein at a persistently high level is able to slow down liver aging. Our study identifies four major discoveries. Firstly, that Cisd2 expression attenuates age-related dysregulation of lipid metabolism and other pathological abnormalities. Secondly, revealed by RNA sequencing analysis, the livers of old male mice undergo extensive transcriptomic alterations, and these are associated with steatosis, hepatitis, fibrosis, and xenobiotic detoxification. Intriguingly, a youthful transcriptomic profile, like that of young 3-month-old mice, was found in old Cisd2 transgenic male mice at 26 months old. Thirdly, Cisd2 suppresses the age-associated dysregulation of various transcription regulators (Nrf2, IL-6, and Hnf4a), which keeps the transcriptional network in a normal pattern. Finally, a high level of Cisd2 protein protects the liver from oxidative stress, and this is associated with a reduction in mitochondrial DNA deletions. These findings demonstrate that Cisd2 is a promising target for the development of therapeutic agents that, by bringing about an effective enhancement of Cisd2 expression, will slow down liver aging.
C1 [Huang, Yi-Long; Shen, Zhao-Qing; Huang, Chen-Hua; Lin, Chao-Hsiung; Tsai, Ting-Fen] Natl Yang Ming Chiao Tung Univ, Dept Life Sci, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.
   [Huang, Yi-Long; Shen, Zhao-Qing; Huang, Chen-Hua; Lin, Chao-Hsiung; Tsai, Ting-Fen] Natl Yang Ming Chiao Tung Univ, Inst Genome Sci, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.
   [Huang, Yi-Long; Lin, Chao-Hsiung; Tsai, Ting-Fen] Natl Yang Ming Chiao Tung Univ, Aging & Hlth Res Ctr, Taipei, Taiwan.
   [Tsai, Ting-Fen] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Taiwan.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University; National Yang Ming Chiao Tung University; National Health
   Research Institutes - Taiwan
RP Tsai, TF (corresponding author), Natl Yang Ming Chiao Tung Univ, Dept Life Sci, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.; Tsai, TF (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Genome Sci, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.
EM tftsai@ym.edu.tw
OI LIN, CHAO-HSIUNG/0000-0001-6344-271X; Huang,
   Chen-Hua/0000-0003-4681-4256; Shen, Zhao-Qing/0000-0001-9126-0219;
   Huang, Yi-Long/0000-0002-0980-4828; TSAI, TING-FEN/0000-0003-3239-4430
FU National Health Research Institutes [MG-109-PP-19, MG-110-PP-15];
   Ministry of Science and Technology [MOST 109-2311-B-010-003, MOST
   109-2320-B-010-043, MOST 109-2327-B-010-002, MOST 110-2634-F-010-004]
FX National Health Research Institutes, Grant/Award Number: MG-109-PP-19
   and MG-110-PP-15; Ministry of Science and Technology, Grant/Award
   Number: MOST 109-2311-B-010-003, MOST 109-2320-B-010-043, MOST
   109-2327-B-010-002 and MOST 110-2634-F-010-004
CR Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Chakravarthy MV, 2020, ENDOCRIN DIAB METAB, V3, DOI 10.1002/edm2.112
   Chen YF, 2010, ANN NY ACAD SCI, V1201, P58, DOI 10.1111/j.1749-6632.2010.05619.x
   Chen YF, 2009, AUTOPHAGY, V5, P1043, DOI 10.4161/auto.5.7.9351
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025
   Cheng CF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113447
   Chocron ES, 2019, BBA-MOL BASIS DIS, V1865, P285, DOI 10.1016/j.bbadis.2018.09.035
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Huang YL, 2018, AGING CELL, V17, DOI 10.1111/acel.12705
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006
   Lonardo A, 2019, HEPATOLOGY, V70, P1457, DOI 10.1002/hep.30626
   Lu H, 2016, ACTA PHARM SIN B, V6, P393, DOI 10.1016/j.apsb.2016.07.003
   Marjot T, 2020, ENDOCR REV, V41, P66, DOI 10.1210/endrev/bnz009
   Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Protzer U, 2007, GASTROENTEROLOGY, V133, P1156, DOI 10.1053/j.gastro.2007.07.021
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Shen ZQ, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.118954
   Shen ZQ, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1441627
   Shen ZQ, 2017, CELL REP, V21, P2198, DOI 10.1016/j.celrep.2017.10.099
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Tsui TY, 2005, HEPATOLOGY, V42, P335, DOI 10.1002/hep.20803
   Wang CH, 2014, FREE RADICAL RES, V48, P1109, DOI 10.3109/10715762.2014.936431
   Wang LX, 2020, REDOX BIOL, V31, DOI 10.1016/j.redox.2019.101410
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210
   WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674
   Yeh CH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239238
   Yeh CH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000508
NR 35
TC 17
Z9 17
U1 3
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2021 DEC
PY 2021
VL 20
IS 12
AR e13523
DI 10.1111/acel.13523
EA NOV 2021
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA XO6QH
UT WOS:000721451000001
PM 34811857
OA Green Published
DA 2024-02-19
ER

PT J
AU Rutkute, K
   Karakashian, AA
   Giltiay, NV
   Dobierzewska, A
   Nikolova-Karakashian, MN
AF Rutkute, Kristina
   Karakashian, Alexander A.
   Giltiay, Natalia V.
   Dobierzewska, Aneta
   Nikolova-Karakashian, Mariana N.
TI Aging in rat causes hepatic hyperresposiveness to interleukin-1β which
   is mediated by neutral sphingomyelinase-2
SO HEPATOLOGY
LA English
DT Article
ID RECEPTOR-ASSOCIATED KINASE; AGE-ASSOCIATED INCREASE; C-REACTIVE PROTEIN;
   KAPPA-B; CERAMIDE; EXPRESSION; INHIBITOR; LIVER; TAK1; SCYPHOSTATIN
AB The process of aging has recently been shown to substantially affect the ability of cells to respond to inflammatory challenges. We demonstrate that aging leads to hepatic hyperresponsiveness to interleukin 1 ss (IL-1 ss), and we examine the factors that could be responsible for this phenomenon. IL-1 ss-induced phosphorylation of c-jun N-terminal kinase (JNK) in hepatocytes isolated from aged rats was 3 times more potent than that in hepatocytes from young rats. Moreover, JNK was activated by substantially lower doses of IL-1 ss. These age-related changes in JNK phosphorylation correlated with diminished IL-1 ss-induced degradation of interleukin-1 receptor-associated kinase-1 (IRAK-1). Expression levels of IL1 ss receptor I, total JNK, IRAK-1, and transforming growth factor-ss-activated kinase-1 (TAK-1) were not affected by aging. However, increased neutral sphingomyelinase activity was observed in hepatocytes from old animals, which we show is caused by induction of the plasma membrane localized neutral sphingomyelinase-2 (NSMase-2). We provide evidence that NSMase-2 is both required and sufficient for the onset of IL-1 ss hyperresponsiveness during aging. Overexpression of NSMase-2 in hepatocytes from young rats leads both to a reduction in IRAK-1 degradation and potentiation of JNK phosphorylation, mimicking that seen in hepatocytes from old animals. More importantly, inhibition of NSMase activity in hepatocytes from aged rats using either scyphostatin or short interfering ribonucleic acid (siRNA) leads to reversion to the "young" phenotype of IL-1 ss response. Conclusion: These results show that the process of aging causes increased basal NSMase-2 activity in hepatocytes, which in turn leads to IRAK-1 stabilization, JNK potentiation, and ultimately IL-1 ss hyperresponsiveness.
C1 Univ Kentucky, Coll Med, AB Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA.
C3 University of Kentucky
RP Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Coll Med, AB Chandler Med Ctr, Dept Physiol, 800 Rose St, Lexington, KY 40536 USA.
EM rnnikolo@uky.edrt
RI Giltiay, Natalia V./H-8655-2019; Giltiay, Natalia/AAH-2130-2019
OI Giltiay, Natalia/0000-0001-7284-514X
FU NIA NIH HHS [R01 AG026711, R01 AG019223, R01 AG026711-01A2] Funding
   Source: Medline
CR ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X
   Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549
   Adib-Conquy M, 2002, J BIOL CHEM, V277, P27927, DOI 10.1074/jbc.M200705200
   Ballou SP, 1996, AGE AGEING, V25, P224, DOI 10.1093/ageing/25.3.224
   BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G
   Bernardo K, 2000, J BIOL CHEM, V275, P7641, DOI 10.1074/jbc.275.11.7641
   Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0
   CHEN JQ, 1995, J BIOL CHEM, V270, P25233, DOI 10.1074/jbc.270.42.25233
   Claycombe KJ, 2002, J BIOL CHEM, V277, P30784, DOI 10.1074/jbc.M204463200
   Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Davis RJ, 1999, BIOCHEM SOC SYMP, P1
   Di lorio A, 2003, CYTOKINE, V22, P198
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Han D, 1995, MECH AGEING DEV, V84, P39, DOI 10.1016/0047-6374(95)01634-C
   Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200
   Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479
   Hsieh CC, 2003, MECH AGEING DEV, V124, P733, DOI 10.1016/S0047-6374(03)00083-6
   HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217
   Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4
   KAHOVCOVA J, 1969, J CHROMATOGR, V40, P90, DOI 10.1016/S0021-9673(01)96622-1
   Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje
   Krabbe KS, 2001, CLIN DIAGN LAB IMMUN, V8, P333, DOI 10.1128/CDLI.8.2.333-338.2001
   Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281
   Lozanski G, 1997, BIOCHEM J, V328, P271, DOI 10.1042/bj3280271
   Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200
   MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3
   Nara F, 1999, J ANTIBIOT, V52, P531, DOI 10.7164/antibiotics.52.531
   Nara F, 1999, J ANTIBIOT, V52, P525, DOI 10.7164/antibiotics.52.525
   NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718
   Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465
   OBEID LM, 2003, SCI AGING KNOWLEDGE, pPE27
   PETKOVA DH, 1988, EXP GERONTOL, V23, P19, DOI 10.1016/0531-5565(88)90016-2
   ROSENTHAL CJ, 1975, J CLIN INVEST, V55, P746, DOI 10.1172/JCI107985
   Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255
   Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417
   Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141
   Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102
   Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0
   Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1
   WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689
   Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319
   Wu DY, 2003, J BIOL CHEM, V278, P10983, DOI 10.1074/jbc.M207470200
   Yamamoto K, 2002, AM J PATHOL, V161, P1805, DOI 10.1016/S0002-9440(10)64457-4
   Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540
   Zerofsky M, 2005, AGING CELL, V4, P103, DOI 10.1111/j.1474-9728.2005.00147.x
NR 48
TC 27
Z9 36
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2007
VL 46
IS 4
BP 1166
EP 1176
DI 10.1002/HEP.21777
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 216WU
UT WOS:000249910500027
PM 17668873
OA Bronze
DA 2024-02-19
ER

PT J
AU Zhen, YZ
   Lin, YJ
   Li, KJ
   Zhang, GL
   Zhao, YF
   Wang, MM
   Wei, JB
   Wei, J
   Hu, G
AF Zhen, Yong-Zhan
   Lin, Ya-Jun
   Li, Kai-Ji
   Zhang, Guang-Ling
   Zhao, Yu-Fang
   Wang, Mei-Mei
   Wei, Jing-Bo
   Wei, Jie
   Hu, Gang
TI Effects of rhein lysinate on D-galactose-induced aging mice
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article; Proceedings Paper
CT Paediatric Virology Workshop
CY OCT 10-10, 2015
CL Athens, GREECE
DE rhein lysinate; anti-aging; D-galactose; oxidative stress; antioxidant
ID OXIDATIVE STRESS; REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; MOUSE
   MODEL; EXPRESSION; SIRT1; P16(INK4A); DISEASE; BRAIN
AB The aim of the present study was to investigate the anti-aging effects of rhein lysinate (RHL), and to explore its mechanism of action in a D-galactose-induced aging mouse model. Aging was induced by D-galactose (100 mg/kg/day) that was subcutaneously injected to animals for 8 weeks. RHL was simultaneously administered once a day by intragastric gavage. The appetite, mental condition, body weight and organ index of the mice were monitored. Superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities were determined, and the levels of malondialdehyde (MDA) in the liver, kidney and serum were measured by appropriate assay kits. Western blot analysis was used to detect proteins associated with age. The results indicated that RHL may improve the appetite, mental state and organ conditions of the model mice, improve the activities of SOD and GSH-Px, reduce MDA levels and modulate the expression of age-associated proteins (Sirtuin 1, p21 and p16) in D-galactose-induced mice. Therefore, RHL may be effective at suppressing the aging process through a combination of enhancing antioxidant activity, scavenging free radicals and modulating aging-associated gene expression. Introduction
C1 [Zhen, Yong-Zhan; Zhang, Guang-Ling; Zhao, Yu-Fang; Wang, Mei-Mei; Wei, Jing-Bo] North China Univ Sci & Technol, Sch Basic Med Sci, Tangshan Key Lab Preclin & Basic Res Chron Dis, Hebei Key Lab Chron Dis, Tangshan 063000, Hebei, Peoples R China.
   [Lin, Ya-Jun; Wei, Jie; Hu, Gang] Minist Hlth, Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China.
   [Lin, Ya-Jun; Wei, Jie; Hu, Gang] Minist Hlth, Beijing Inst Geriatr, Beijing 100730, Peoples R China.
   [Li, Kai-Ji] Hebei United Univ, Basic Med Coll, Dept Histol & Embryol, Tangshan 063000, Hebei, Peoples R China.
C3 North China University of Science & Technology; Beijing Hospital; North
   China University of Science & Technology
RP Hu, G (corresponding author), Minist Hlth, Beijing Hosp, Key Lab Geriatr, 1 Dahua Rd, Beijing 100730, Peoples R China.
EM huganglys2010@126.com
RI Liu, Jiahe/JPL-6372-2023
FU National Natural Science Foundation of China [81001439]; General Program
   of Natural Science Foundation of Hebei Province of China [H2012401030]
FX The present study was supported by grants from the National Natural
   Science Foundation of China (no. 81001439) and the General Program of
   Natural Science Foundation of Hebei Province of China (no. H2012401030).
CR Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Butterfield DA, 2014, BBA-MOL BASIS DIS, V1842, P1693, DOI 10.1016/j.bbadis.2014.06.010
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Datta HS, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep015
   Du H, 2012, J ENDOCRINOL INVEST, V35, P607, DOI 10.1007/BF03345796
   Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Herranz D, 2010, AGING-US, V2, P315, DOI 10.18632/aging.100156
   Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028
   Hu G, 2013, ACTA PHARMACOL SIN, V34, P515, DOI 10.1038/aps.2012.177
   Jo-Watanabe A, 2014, AGING CELL, V13, P519, DOI 10.1111/acel.12204
   Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001
   Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x
   Koyama H, 2013, MOLECULES, V18, P1383, DOI 10.3390/molecules18021383
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Li L, 2005, LIFE SCI, V77, P230, DOI 10.1016/j.lfs.2004.12.024
   Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513
   Li YJ, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.120.1373
   Li Zhan, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2435
   Lin YJ, 2011, ACTA PHARMACOL SIN, V32, P1246, DOI 10.1038/aps.2011.101
   Malaguti C, 2008, INT IMMUNOPHARMACOL, V8, P782, DOI 10.1016/j.intimp.2008.01.020
   Mao J, 2015, AGING CELL, DOI [10.1111/acel.12356, DOI 10.1111/ACEL.12356.[]
   Martin G, 2004, BIORHEOLOGY, V41, P549
   Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x
   Mukherjee A, 2015, EXP GERONTOL, V69, P211, DOI 10.1016/j.exger.2015.06.022
   Nasto LA, 2013, J ORTHOP RES, V31, P1150, DOI 10.1002/jor.22320
   Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008
   Peiris H, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/520316
   Rahimi R, 2012, WORLD J GASTROENTERO, V18, P589, DOI 10.3748/wjg.v18.i7.589
   Rattan SIS, 2014, AGING DIS, V5, P196, DOI 10.14336/AD.2014.0500196
   Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132
   Sun Jiang-Hong, 2013, Shengli Xuebao, V65, P389
   Tatone C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/659687
   Wang M, 2011, CHIN J INTEGR MED, V17, P635, DOI 10.1007/s11655-011-0823-y
   Xiong DS, 2011, AM J CHINESE MED, V39, P719, DOI 10.1142/S0192415X11009159
   Yamashita S, 2012, BIOCHEM BIOPH RES CO, V417, P630, DOI 10.1016/j.bbrc.2011.12.021
   Ye Y, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/185716
   Yu WF, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-73
   Zhang XF, 2012, INT J MOL SCI, V13, P5866, DOI 10.3390/ijms13055866
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008
   Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483
NR 47
TC 25
Z9 33
U1 0
U2 21
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD JAN
PY 2016
VL 11
IS 1
BP 303
EP 308
DI 10.3892/etm.2015.2858
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Research & Experimental Medicine
GA CZ1VB
UT WOS:000366892600050
PM 26889258
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Pradhan-Sundd, T
   Kosar, K
   Saggi, H
   Zhang, R
   Vats, R
   Cornuet, P
   Green, S
   Singh, S
   Zeng, G
   Sundd, P
   Nejak-Bowen, K
AF Pradhan-Sundd, Tirthadipa
   Kosar, Karis
   Saggi, Harvinder
   Zhang, Rong
   Vats, Ravi
   Cornuet, Pamela
   Green, Sydney
   Singh, Sucha
   Zeng, Gang
   Sundd, Prithu
   Nejak-Bowen, Kari
TI Wnt/β-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout
   Murine Model of Cholestatic Liver Disease
SO HEPATOLOGY
LA English
DT Article; Early Access
ID FARNESOID-X-RECEPTOR; BETA-CATENIN; BILE-ACID; GAMMA-CATENIN; ADHERENS
   JUNCTIONS; MICE; INJURY; SUSCEPTIBILITY; HOMEOSTASIS; DISRUPTION
AB Background and Aims The Wnt/beta-catenin signaling pathway has a well-described role in liver pathobiology. Its suppression was recently shown to decrease bile acid (BA) synthesis, thus preventing the development of cholestatic liver injury and fibrosis after bile duct ligation (BDL). Approach and Results To generalize these observations, we suppressed beta-catenin in Mdr2 knockout (KO) mice, which develop sclerosing cholangitis due to regurgitation of BA from leaky ducts. When beta-catenin was knocked down (KD) in KO for 2 weeks, hepatic and biliary injury were exacerbated in comparison to KO given placebo, as shown by serum biochemistry, ductular reaction, inflammation, and fibrosis. Simultaneously, KO/KD livers displayed increased oxidative stress and senescence and an impaired regenerative response. Although the total liver BA levels were similar between KO/KD and KO, there was significant dysregulation of BA transporters and BA detoxification/synthesis enzymes in KO/KD compared with KO alone. Multiphoton intravital microscopy revealed a mixing of blood and bile in the sinusoids, and validated the presence of increased serum BA in KO/KD mice. Although hepatocyte junctions were intact, KO/KD livers had significant canalicular defects, which resulted from loss of hepatocyte polarity. Thus, in contrast to the protective effect of beta-catenin KD in BDL model, beta-catenin KD in Mdr2 KO aggravated rather than alleviated injury by interfering with expression of BA transporters, hepatocyte polarity, canalicular structure, and the regenerative response. Conclusions The resulting imbalance between ongoing injury and restitution led to worsening of the Mdr2 KO phenotype, suggesting caution in targeting beta-catenin globally for all cholestatic conditions.
C1 [Pradhan-Sundd, Tirthadipa; Kosar, Karis; Saggi, Harvinder; Zhang, Rong; Cornuet, Pamela; Singh, Sucha; Zeng, Gang; Nejak-Bowen, Kari] Univ Pittsburgh, Sch Med, Dept Pathol, S405A BST,200 Lothrop St, Pittsburgh, PA 15261 USA.
   [Vats, Ravi; Sundd, Prithu] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA USA.
   [Green, Sydney] Morehouse Sch Med, Atlanta, GA 30310 USA.
   [Nejak-Bowen, Kari] Univ Pittsburgh, Sch Med, Pittsburgh Liver Res Ctr, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Morehouse School of Medicine;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh
RP Nejak-Bowen, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, S405A BST,200 Lothrop St, Pittsburgh, PA 15261 USA.
EM knnst5@pitt.edu
RI Vats, Ravi/IUO-5437-2023
OI Vats, Ravi/0009-0009-9987-8828
FU National Institutes of Health [1R01DK103775, 5T32DK63922-13,
   1S10RR028478-01]
FX Supported by the National Institutes of Health (1R01DK103775 to K.N.B.,
   5T32DK63922-13 to T.P-S., and 1S10RR028478-01 for the Nikon
   multiphoton-excitation microscope).
CR Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222
   FALLON MB, 1995, AM J PHYSIOL-CELL PH, V269, pC1057, DOI 10.1152/ajpcell.1995.269.4.C1057
   Fickert P, 2002, GASTROENTEROLOGY, V123, P1238, DOI 10.1053/gast.2002.35948
   Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009
   Gissen P, 2015, J HEPATOL, V63, P1023, DOI 10.1016/j.jhep.2015.06.015
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924
   Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200
   Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080
   Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172
   Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051
   Matsumoto K, 2014, GASTROENTEROLOGY, V147, P1134, DOI 10.1053/j.gastro.2014.07.033
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056
   Nejak-Bowen KN, 2009, J BIOL CHEM, V284, P28115, DOI 10.1074/jbc.M109.047258
   Noroski LM, 2016, NEW ENGL J MED, V375, P2501, DOI 10.1056/NEJMc1613273
   Odenwald MA, 2017, J CELL SCI, V130, P243, DOI 10.1242/jcs.188185
   Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025
   Pradhan-Sundd T, 2018, HEPATOLOGY, V67, P2320, DOI 10.1002/hep.29585
   Russell JO, 2019, HEPATOLOGY, V69, P742, DOI 10.1002/hep.30270
   Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131
   Shousha S, 2004, HISTOPATHOLOGY, V45, P335, DOI 10.1111/j.1365-2559.2004.01927.x
   SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9
   SOKOL RJ, 1995, GASTROENTEROLOGY, V109, P1249, DOI 10.1016/0016-5085(95)90585-5
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Thompson MD, 2018, HEPATOLOGY, V67, P955, DOI 10.1002/hep.29371
   Torre C, 2011, J HEPATOL, V55, P86, DOI 10.1016/j.jhep.2010.10.021
   Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002
   Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039
   Wickline ED, 2013, NEOPLASIA, V15, P421, DOI 10.1593/neo.122098
   Wickline ED, 2011, J HEPATOL, V55, P1256, DOI 10.1016/j.jhep.2011.03.014
   Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5
   Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112
   Yeh TH, 2010, HEPATOLOGY, V52, P1410, DOI 10.1002/hep.23801
   Zhou LL, 2015, AM J PATHOL, V185, P3274, DOI 10.1016/j.ajpath.2015.08.019
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 38
TC 21
Z9 22
U1 0
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2020 MAY
PY 2020
VL 71
IS 5
BP 1732
EP 1749
DI 10.1002/hep.30927
EA DEC 2019
PG 18
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA LI2CK
UT WOS:000504926000001
PM 31489648
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Bloom, SI
   Liu, Y
   Tucker, JR
   Islam, MT
   Machin, DR
   Abdeahad, H
   Thomas, TG
   Bramwell, RC
   Lesniewski, LA
   Donato, AJ
AF Bloom, Samuel I.
   Liu, Yu
   Tucker, Jordan R.
   Islam, Md Torikul
   Machin, Daniel R.
   Abdeahad, Hossein
   Thomas, Tyler G.
   Bramwell, R. Colton
   Lesniewski, Lisa A.
   Donato, Anthony J.
TI Endothelial cell telomere dysfunction induces senescence and results in
   vascular and metabolic impairments
SO AGING CELL
LA English
DT Article; Early Access
DE aging; endothelial cell; metabolic function; senescence; telomeres;
   vascular function
ID DNA-DAMAGE; OXIDATIVE STRESS; MECHANISMS
AB In advanced age, increases in oxidative stress and inflammation impair endothelial function, which contributes to the development of cardiovascular disease (CVD). One plausible source of this oxidative stress and inflammation is an increase in the abundance of senescent endothelial cells. To test whether this results in senescence, we selectively reduced the telomere shelterin protein telomere repeat binding factor 2 (Trf2) from endothelial cells of young mice. Trf2 reduction increased endothelial cell telomere dysfunction and resulted in cellular senescence. Furthermore, induction of endothelial cell telomere dysfunction increased inflammatory signaling and oxidative stress, resulting in impairments in endothelial function. Finally, we demonstrate that endothelial cell telomere dysfunction-induced senescence impairs glucose tolerance. This likely occurs through increases in inflammatory signaling in the liver and adipose tissue, as well as reductions in microvascular density and vasodilation to metabolic stimuli. Cumulatively, the findings of the present study identify age-related telomere dysfunction as a mechanism that leads to endothelial cell senescence. Furthermore, these data provide compelling evidence that senescent endothelial cells contribute to age-related increases in oxidative stress and inflammation that impair arterial and metabolic function.
C1 [Bloom, Samuel I.; Islam, Md Torikul; Abdeahad, Hossein; Lesniewski, Lisa A.; Donato, Anthony J.] Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT 84148 USA.
   [Liu, Yu] Tongji Hosp, Dept Geriatr, Wuhan, Peoples R China.
   [Liu, Yu; Tucker, Jordan R.; Machin, Daniel R.; Thomas, Tyler G.; Bramwell, R. Colton; Lesniewski, Lisa A.; Donato, Anthony J.] Univ Utah, Dept Internal Med, Div Geriatr, Sch Med, Salt Lake City, UT 84148 USA.
   [Machin, Daniel R.] Florida State Univ, Dept Nutr & Integrat Physiol, Tallahassee, FL USA.
   [Lesniewski, Lisa A.; Donato, Anthony J.] Vet Affairs Med Ctr Salt Lake City, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA.
   [Lesniewski, Lisa A.; Donato, Anthony J.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training Ins, Salt Lake City, UT 84148 USA.
   [Donato, Anthony J.] Univ Utah, Dept Biochem, Salt Lake City, UT 84148 USA.
   [Donato, Anthony J.] Univ Utah, VA Med Ctr, Dept Internal Med, Div Geriatr, GRECC Bldg 2, RM 2D15A, 500 Foothill Dr, Salt Lake City, UT 84148 USA.
C3 Utah System of Higher Education; University of Utah; Huazhong University
   of Science & Technology; Utah System of Higher Education; University of
   Utah; State University System of Florida; Florida State University;
   Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Utah System of Higher Education; University of Utah;
   Utah System of Higher Education; University of Utah; Utah System of
   Higher Education; University of Utah
RP Donato, AJ (corresponding author), Univ Utah, VA Med Ctr, Dept Internal Med, Div Geriatr, GRECC Bldg 2, RM 2D15A, 500 Foothill Dr, Salt Lake City, UT 84148 USA.
EM tony.donato@utah.edu
RI LESNIEWSKI, LISA/ISV-5811-2023
OI LESNIEWSKI, LISA/0000-0002-2138-1450; Bloom, Samuel/0000-0003-1440-8122;
   Machin, Daniel/0000-0002-2509-4686; Abdeahad,
   Hossein/0000-0002-8021-5516
FU Veteran's Affairs Merit Review Award [I01 BX004492];  [R01 AG060395]; 
   [R01AG077751];  [R01AG050238];  [R00AT010017];  [R01 AG048366]; 
   [F31AG076312]
FX Anthony J Donato, Grant/Award Number: R01 AG060395, R01AG077751 and
   R01AG050238; Daniel R Machin, Grant/Award Number: R00AT010017; Lisa A
   Lesniewski, Grant/Award Number: R01 AG048366 and Veteran's Affairs Merit
   Review Award I01 BX004492; Samuel I Bloom, Grant/Award Number:
   F31AG076312
CR Anderson R, 2019, EMBO J, V38, DOI 10.15252/embj.2018100492
   Barinda AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14387-w
   Barnes RP, 2022, NAT STRUCT MOL BIOL, V29, P639, DOI 10.1038/s41594-022-00790-y
   Bautista-Niño PK, 2020, CLIN SCI, V134, P727, DOI 10.1042/CS20190124
   Bloom SI, 2022, GEROSCIENCE, V44, P2741, DOI 10.1007/s11357-022-00681-6
   Bloom SI, 2023, NAT REV CARDIOL, V20, P38, DOI 10.1038/s41569-022-00739-0
   Bloom SI, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14461
   Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352
   Chaib S, 2022, NAT MED, V28, P1556, DOI 10.1038/s41591-022-01923-y
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633
   Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048
   Donato AJ, 2018, CIRC RES, V123, P825, DOI 10.1161/CIRCRESAHA.118.312563
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Gasek NS, 2021, NATURE AGING, V1, P870, DOI 10.1038/s43587-021-00121-8
   González-Gualda E, 2021, FEBS J, V288, P56, DOI 10.1111/febs.15570
   Grosse Laurent, 2020, Cell Metab, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Jones RC, 2022, SCIENCE, V376, P711, DOI 10.1126/science.abl4896
   Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097
   Lafargue A, 2017, FREE RADICAL BIO MED, V108, P750, DOI 10.1016/j.freeradbiomed.2017.04.019
   Liu Y, 2019, MICROCIRCULATION, V26, DOI 10.1111/micc.12487
   Machin DR, 2018, AM J PHYSIOL-HEART C, V315, pH531, DOI 10.1152/ajpheart.00104.2018
   Morgan RG, 2019, J MOL CELL CARDIOL, V127, P74, DOI 10.1016/j.yjmcc.2018.11.014
   Morgan RG, 2018, AM J PHYSIOL-HEART C, V315, pH1, DOI 10.1152/ajpheart.00008.2018
   Morgan RG, 2013, AM J PHYSIOL-HEART C, V305, pH251, DOI 10.1152/ajpheart.00197.2013
   Nassour J, 2021, ANNU REV CANC BIOL, V5, P59, DOI 10.1146/annurev-cancerbio-050420-023410
   National Center for Health S. Health United States, 2017, HLTH US 2016 CHARTB
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6
   Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Rossiello F, 2022, NAT CELL BIOL, V24, P135, DOI 10.1038/s41556-022-00842-x
   Rossman MJ, 2017, AM J PHYSIOL-HEART C, V313, pH890, DOI 10.1152/ajpheart.00416.2017
   Uryga AK, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02123-z
   van der Feen DE, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw4974
   Van Ly D, 2018, MOL CELL, V71, P510, DOI 10.1016/j.molcel.2018.06.025
   Victorelli S, 2017, EBIOMEDICINE, V21, P14, DOI 10.1016/j.ebiom.2017.03.027
   Yokoyama M, 2014, CELL REP, V7, P1691, DOI 10.1016/j.celrep.2014.04.046
   Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094
   Zhu Y, 2017, AGING-US, V9, P955, DOI 10.18632/aging.101202
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 45
TC 6
Z9 6
U1 3
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 AUG
PY 2023
VL 22
IS 8
AR e13875
DI 10.1111/acel.13875
EA MAY 2023
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA O3QV1
UT WOS:001000178900001
PM 37259606
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kim, JH
   Lee, BR
   Choi, ES
   Lee, KM
   Choi, SK
   Cho, JH
   Jeon, WB
   Kim, E
AF Kim, Jung-Hee
   Lee, Bo-Ram
   Choi, Eun-Sook
   Lee, Kyeong-Min
   Choi, Seong-Kyoon
   Cho, Jung Hoon
   Jeon, Won Bae
   Kim, Eunjoo
TI Reverse Expression of Aging-Associated Molecules through Transfection of
   miRNAs to Aged Mice
SO MOLECULAR THERAPY-NUCLEIC ACIDS
LA English
DT Article
ID CELLULAR SENESCENCE; SHORT TELOMERES; MICRORNAS; BIOMARKER; PATHWAY;
   P16(INK4A); APOPTOSIS; CYTOKINES; EXOSOMES; CANCER
AB Molecular changes during aging have been studied to understand the mechanism of aging progress. Herein, changes in microRNA (miRNA) expression in the whole blood of mice were studied to systemically reverse aging and propose them as non-invasive biomarkers. Through next-generation sequencing analysis, we selected 27 differentially expressed miRNAs during aging. The most recognized function involved was liver steatosis, a type of non-alcoholic fatty liver disease (NAFLD). Among 27 miRNAs, six were predicted to be involved in NAFLD, miR-16-5p, miR-17-5p, miR-21a-5p, miR-30c-5p, miR-103-3p, and miR-130a-3p; alterations in their blood and liver levels were confirmed by real-time qPCR. The expression of the genes associated in the network of these miRNAs, Bcl2, Ppara, E2f1, E2f2, Akt, Ccnd1, and Smad2/3, also was altered in the liver of aged mice. Following transfection of these miRNAs into 18-month-old mice, levels of miR-21a-5p, miR-103-3p, and miR-30c-5p increased, and their related genes exhibited a reversed expression in the liver. Expression of Mre11a, p16INK4a, and Mtor, reported to be aging-associated molecules, also was reversed in the livers of miRNA-transfected mice. These miRNAs could be non-invasive biomarkers for aging, and they might induce a reverse regulation of aging-associated pathways. This study provides preliminary data on reverse aging, which could be applied further for treatments of adult diseases.
C1 [Kim, Jung-Hee; Lee, Bo-Ram; Choi, Eun-Sook; Lee, Kyeong-Min; Choi, Seong-Kyoon; Jeon, Won Bae; Kim, Eunjoo] Daegu Gyeongbuk Inst Sci & Technol, Div Nano & Energy Convergence Res, 50-1 Sang Ri, Daegu 711873, South Korea.
   [Cho, Jung Hoon] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea.
C3 Daegu Gyeongbuk Institute of Science & Technology (DGIST); Pohang
   University of Science & Technology (POSTECH)
RP Kim, E (corresponding author), Daegu Gyeongbuk Inst Sci & Technol, Div Nano & Energy Convergence Res, 50-1 Sang Ri, Daegu 711873, South Korea.
EM ejkim@dgist.ac.kr
FU Ministry of Science, ICT, & Future Planning of the Republic of Korea
   [16-BD-06, 2017010021, 2016R1A2B4014728]
FX This study was supported in part by the Ministry of Science, ICT, &
   Future Planning of the Republic of Korea (DGIST Basic Research Fund
   16-BD-06 and 2017010021 and 2016R1A2B4014728).
CR Aggarwal S, 1998, J IMMUNOL, V160, P1627
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Aucher A, 2013, J IMMUNOL, V191, P6250, DOI 10.4049/jimmunol.1301728
   Balistreri CR, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-24
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002
   Cho SH, 2015, J NEUROSCI, V35, P807, DOI 10.1523/JNEUROSCI.2939-14.2015
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Dhahbi JM, 2013, AGING-US, V5, P130, DOI 10.18632/aging.100540
   Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x
   Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115
   Gelinas DS, 2005, NEUROCHEM RES, V30, P1369, DOI 10.1007/s11064-005-8341-y
   Gramatges MM, 2013, TRANSL RES, V162, P353, DOI 10.1016/j.trsl.2013.05.003
   Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350
   Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240
   He ZP, 2013, STEM CELLS, V31, P2205, DOI 10.1002/stem.1474
   Hiraki M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.5
   Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006
   Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107
   Huang W, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.12
   Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Ju YJ, 2006, EXP MOL MED, V38, P686, DOI 10.1038/emm.2006.81
   Kato M, 2011, RNA, V17, P1804, DOI 10.1261/rna.2714411
   Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Krämer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lai CY, 2014, AGING CELL, V13, P679, DOI 10.1111/acel.12225
   Luo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047914
   Miniarikova J, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.7
   Noren Hooten N, 2013, AGING-US, V5, P725, DOI 10.18632/aging.100603
   Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724
   Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607
   Perl A, 2015, ANN NY ACAD SCI, V1346, P33, DOI 10.1111/nyas.12756
   Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105
   Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011
   Qu Z, 2015, INT J CLIN EXP MED, V8, P17088
   Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x
   Ritchie W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000513
   Sakaguchi AY, 1998, SOMAT CELL MOLEC GEN, V24, P157, DOI 10.1023/B:SCAM.0000007118.47691.d7
   van der Kraan PM, 2014, BIO-MED MATER ENG, V24, pS75, DOI 10.3233/BME-140976
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Wang Y, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/621414
   Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112
   Xie Q, 2014, J BIOL CHEM, V289, P34205, DOI 10.1074/jbc.M114.587170
   Xu D, 2013, ADV DRUG DELIVER REV, V65, P368, DOI 10.1016/j.addr.2012.07.010
   Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056
   Yao MH, 2014, J NEUROSCI, V34, P12039, DOI 10.1523/JNEUROSCI.0486-14.2014
   Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207
NR 50
TC 25
Z9 27
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2162-2531
J9 MOL THER-NUCL ACIDS
JI Mol. Ther.-Nucl. Acids
PD MAR 17
PY 2017
VL 6
BP 106
EP 115
DI 10.1016/j.omtn.2016.11.005
PG 10
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA EP0QP
UT WOS:000397092100009
PM 28325277
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Jamieson, HA
   Hilmer, SN
   Cogger, VC
   Warren, A
   Cheluvappa, R
   Abernethy, DR
   Everitt, AV
   Fraser, R
   de Cabo, R
   Le Couteur, DG
AF Jamieson, Hamish A.
   Hilmer, Sarah N.
   Cogger, Victoria C.
   Warren, Alessandra
   Cheluvappa, Rajkumar
   Abernethy, Darrell R.
   Everitt, Arthur V.
   Fraser, Robin
   de Cabo, Rafael
   Le Couteur, David G.
TI Caloric restriction reduces age-related pseudocapillarization of the
   hepatic sinusoid
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE liver sinusoidal endothelial cell; pseudocapillarization; caloric
   restriction; aging; caveolin-1; liver; fenestrations
ID OXIDATIVE STRESS; ATHEROSCLEROSIS; ENDOTHELIUM
AB Age-related changes in the hepatic sinusoid, called pseudocapillarization, may contribute to the pathogenesis of dyslipidemia. Caloric restriction (CR) is a powerful model for the study of aging because it extends lifespan. We assessed the effects of CR on the hepatic sinusoid to determine whether pseudocapillarization is preventable and hence a target for the prevention of age-related dyslipidemia. Livers from young (6 months) and old (24 months) CR and ad libitum fed (AL) F344 rats were examined using electron microscopy and immunohistochemistry. In old age, there was increased thickness of the liver sinusoidal endothelium and reduced endothelial fenestration porosity. In old CR rats, endothelial thickness was less and fenestration porosity was greater than in old AL rats. Immunohistochemistry showed that CR prevented age-related decrease in caveolin-1 expression and increase in peri-sinusoidal collagen IV staining, but did not alter the age-related increase of von Willebrand's factor. CR reduces age-related pseudocapillarization of the hepatic sinusoid and correlates with changes in caveolin-1 expression. (c) 2006 Elsevier Inc. All rights reserved.
C1 NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA.
   Concord Hosp, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia.
   Concord Hosp, ANZAC Med Res Inst, Concord, NSW 2139, Australia.
   Royal N Shore Hosp, Dept Aged Care & Clin Pharmacol, St Leonards, NSW 2065, Australia.
   NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA.
   Univ Otago, Christchurch Sch Med, Dept Pathol, Christchurch, New Zealand.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Concord Repatriation General Hospital; Concord Repatriation
   General Hospital; University of Sydney; ANZAC Research Institute; Royal
   North Shore Hospital; National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA); University of Otago
RP de Cabo, R (corresponding author), NIA, Lab Expt Gerontol, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
EM deCaboRa@grc.nia.nih.gov
RI Research Institute, ANZAC/CAE-9030-2022; Ekanayake,
   Kanchana/P-8817-2016; Hilmer, Sarah/AAW-8554-2020; de Cabo, Rafael
   Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI Hilmer, Sarah/0000-0002-5970-1501; de Cabo, Rafael
   Carlos/0000-0003-2830-5693; Cheluvappa, Rajkumar/0000-0002-3472-9591; de
   Cabo, Rafael/0000-0002-3354-2442; Le Couteur, David/0000-0002-4227-5817
FU Intramural NIH HHS [Z99 AG999999] Funding Source: Medline
CR Cho KA, 2003, J BIOL CHEM, V278, P27789, DOI 10.1074/jbc.M208105200
   Cogger VC, 2004, J HEPATOL, V41, P370, DOI 10.1016/j.jhep.2004.04.034
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2001, PHARMACOL TOXICOL, V89, P306, DOI 10.1034/j.1600-0773.2001.d01-165.x
   Everitt AV, 2005, AGE, V27, P39, DOI 10.1007/s11357-005-3284-4
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   McCuskey RS, 2006, CLIN HEMORHEOL MICRO, V34, P5
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Ogi Mariko, 2003, Medical Electron Microscopy, V36, P33, DOI 10.1007/s007950300004
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024
NR 18
TC 40
Z9 42
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2007
VL 42
IS 4
BP 374
EP 378
DI 10.1016/j.exger.2006.11.004
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 154AB
UT WOS:000245478100015
PM 17204388
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Maus, M
   López-Polo, V
   Mateo, L
   Lafarga, M
   Aguilera, M
   De Lama, E
   Meyer, K
   Sola, A
   Lopez-Martinez, C
   López-Alonso, I
   Guasch-Piqueras, M
   Hernandez-Gonzalez, F
   Chaib, S
   Rovira, M
   Sanchez, M
   Faner, R
   Agusti, A
   Diéguez-Hurtado, R
   Ortega, S
   Manonelles, A
   Engelhardt, S
   Monteiro, F
   Attolini, CSO
   Prats, N
   Albaiceta, G
   Cruzado, JM
   Serrano, M
AF Maus, Mate
   Lopez-Polo, Vanessa
   Mateo, Lidia
   Lafarga, Miguel
   Aguilera, Monica
   De Lama, Eugenia
   Meyer, Kathleen
   Sola, Anna
   Lopez-Martinez, Cecilia
   Lopez-Alonso, Ines
   Guasch-Piqueras, Marc
   Hernandez-Gonzalez, Fernanda
   Chaib, Selim
   Rovira, Miguel
   Sanchez, Mayka
   Faner, Rosa
   Agusti, Alvar
   Dieguez-Hurtado, Rodrigo
   Ortega, Sagrario
   Manonelles, Anna
   Engelhardt, Stefan
   Monteiro, Freddy
   Attolini, Camille Stephan-Otto
   Prats, Neus
   Albaiceta, Guillermo
   Cruzado, Josep M.
   Serrano, Manuel
TI Iron accumulation drives fibrosis, senescence and the
   senescence-associated secretory phenotype
SO NATURE METABOLISM
LA English
DT Article; Early Access
ID CELLULAR SENESCENCE; VASCULAR DYSFUNCTION; LIVER FIBROSIS; STELLATE
   CELLS; EXPRESSION; MYOFIBROBLAST; THALASSEMIA; MECHANISMS; GENERATION;
   INHIBITORS
AB Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases. Senescent cells are a main driver of fibrotic diseases through their secretome, known as senescence-associated secretory phenotype (SASP). Here, we report that cellular senescence, and multiple types of fibrotic diseases in mice and humans are characterized by the accumulation of iron. We show that vascular and hemolytic injuries are efficient in triggering iron accumulation, which in turn can cause senescence and promote fibrosis. Notably, we find that senescent cells persistently accumulate iron, even when the surge of extracellular iron has subdued. Indeed, under normal conditions of extracellular iron, cells exposed to different types of senescence-inducing insults accumulate abundant ferritin-bound iron, mostly within lysosomes, and present high levels of labile iron, which fuels the generation of reactive oxygen species and the SASP. Finally, we demonstrate that detection of iron by magnetic resonance imaging might allow non-invasive assessment of fibrotic burden in the kidneys of mice and in patients with renal fibrosis. Our findings suggest that iron accumulation plays a central role in senescence and fibrosis, even when the initiating events may be independent of iron, and identify iron metabolism as a potential therapeutic target for senescence-associated diseases.
   Iron is shown to have a central role in senescence, both by triggering senescence and through its accumulation in senescent cells, which is driving the senescence-associated secretory phenotype and, in turn, promotes fibrogenesis.
C1 [Maus, Mate; Lopez-Polo, Vanessa; Mateo, Lidia; Aguilera, Monica; Meyer, Kathleen; Hernandez-Gonzalez, Fernanda; Chaib, Selim; Rovira, Miguel; Monteiro, Freddy; Attolini, Camille Stephan-Otto; Prats, Neus; Serrano, Manuel] Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain.
   [Maus, Mate; Guasch-Piqueras, Marc] Vall dHebron Inst Oncol, Barcelona, Spain.
   [Lafarga, Miguel] Univ Cantabria IDIVAL, Dept Anat & Biol Celular, Santander, Spain.
   [De Lama, Eugenia] Hosp Univ Bellvitge, Radiol Dept, IDIBELL, Barcelona, Spain.
   [Meyer, Kathleen; Serrano, Manuel] Cambridge Inst Sci, Altos Labs, Cambridge, England.
   [Sola, Anna; Manonelles, Anna; Cruzado, Josep M.] Bellvitge Biomed Res Inst IDIBELL, Nephrol & Renal Transplantat Res Grp, Barcelona, Spain.
   [Lopez-Martinez, Cecilia; Albaiceta, Guillermo] Univ Oviedo, Inst Univ Oncol Principado Asturias, Dept Biol Func, Oviedo, Spain.
   [Lopez-Martinez, Cecilia; Albaiceta, Guillermo] Hosp Univ Cent Asturias, Unidad Cuidados Intens Cardiol, Inst Invest Sanitaria Principado Asturias, Oviedo, Spain.
   [Lopez-Martinez, Cecilia; Albaiceta, Guillermo] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.
   [Lopez-Alonso, Ines] Univ Oviedo, Dept Morfol & Biol Celular, Inst Invest Sanitaria Principado Asturias, Oviedo, Spain.
   [Hernandez-Gonzalez, Fernanda] Univ Barcelona, Hosp Clin, Resp Inst, Dept Pulm Med,IDIBAPS, Barcelona, Spain.
   [Sanchez, Mayka] Univ Int Catalunya UIC, Dept Basic Sci, Iron Metab Regulat & Dis Grp, Sant Cugat Del Valles, Spain.
   [Faner, Rosa] Univ Barcelona, Biomed Dept, IDIBAPS, CIBERES, Barcelona, Spain.
   [Agusti, Alvar] Univ Barcelona, Hosp Clin, Inst Resp, IDIBAPS,CIBERES, Barcelona, Spain.
   [Dieguez-Hurtado, Rodrigo] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany.
   [Ortega, Sagrario] Spanish Natl Canc Res Ctr CNIO, Transgen Unit, Madrid, Spain.
   [Manonelles, Anna; Cruzado, Josep M.] Bellvitge Univ Hosp, Nephrol Dept, Barcelona, Spain.
   [Manonelles, Anna; Cruzado, Josep M.] Univ Barcelona, Dept Clin Sci, Barcelona, Spain.
   [Engelhardt, Stefan] Tech Univ Munich TUM, Inst Pharmacol & Toxicol, Munich, Germany.
   [Engelhardt, Stefan] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany.
   [Serrano, Manuel] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain.
C3 Barcelona Institute of Science & Technology; Institute for Research in
   Biomedicine - IRB Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO);
   Universidad de Cantabria; University of Barcelona; Institut
   d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University
   Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL);
   University of Oviedo; Instituto Universitario de Oncologia de Asturias;
   Central University Hospital Asturias; Instituto de Investigacion
   Sanitaria del Principado de Asturias (ISPA); CIBER - Centro de
   Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III;
   University of Oviedo; Instituto de Investigacion Sanitaria del
   Principado de Asturias (ISPA); University of Barcelona; Hospital Clinic
   de Barcelona; IDIBAPS; Universitat Internacional de Catalunya (UIC);
   CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of
   Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERES; University of Barcelona;
   Hospital Clinic de Barcelona; IDIBAPS; Max Planck Society; Centro
   Nacional de Investigaciones Oncologicas (CNIO); Institut d'Investigacio
   Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital;
   University of Barcelona; University of Barcelona; Technical University
   of Munich; Munich Heart Alliance; German Centre for Cardiovascular
   Research; ICREA
RP Maus, M; Serrano, M (corresponding author), Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Serrano, M (corresponding author), Cambridge Inst Sci, Altos Labs, Cambridge, England.; Serrano, M (corresponding author), Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain.
EM matemaus@vhio.net; mserrano@altoslabs.com
RI Serrano, Manuel/H-2634-2015; Chaib, Selim/IQX-1760-2023; Monteiro,
   Freddy/E-4043-2019; Sanchez-Fernandez, Mayka/F-5140-2010
OI Chaib, Selim/0000-0003-0497-2002; Aguilera Pujabet,
   Monica/0000-0003-0763-7947; SOLA, ANNA/0000-0003-2379-9313;
   Sanchez-Fernandez, Mayka/0000-0002-6499-5989
FU European Union; Spanish Ministry of Science and Innovation (MCIN);
   Spanish Ministry of Education; German Cardiac; German Research
   Foundation; MCIN [794744]; PhD4MD Collaborative Research Training
   Program for Medical Doctors (IRB Barcelona/Hospital Clinic/IDIBAPS)
   [RYC2020-030652-I/AEI]; MCIN/AEI/FEDER, UE [FPU-18/05917]; MCIN/AEI;
   Spanish Ministry of Education; FEDER funds; Instituto de Salud Carlos
   III [PID2021-122436OB-I00]; European Regional Development Fund
   [RTC2019-007074-1, PI18/00910, PI21/00931]; IRB [FPU-18/02965]; The
   'laCaixa' Foundation [PI18/00910, PI21/00931, PI 20/01360]; Spanish
   Ministry of Science; European Research Council; MCIN/AEI; Secretaria
   d'Universitats i Recerca del Departament d'Empresa i Coneixement of
   Catalonia (Grup de Recerca consolidat)
FX We are grateful to K. Raj (Altos Laboratories) for his help with the
   experiments on replicative senescence. We thank D. Munoz Espin
   (University of Cambridge) for sending us the IMR90 cells stably
   transduced with tamoxifen inducible Ras-G12V. We thank R. Mendez (IRB)
   for the H5V and HUVEC cells. We thank staff at the TEM-SEM Electron
   Microscopy Unit from Scientific and Technological Centers (CCiTUB),
   Universitat de Barcelona for their support and advice on TEM techniques.
   We are thankful to the Magnetic Resonance Imaging Core Facility of the
   Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) for
   the scientific and technical support in MRI acquisition and analysis.
   M.M. received funding from the European Union's Horizon 2020 research
   and innovation program under the Marie Sklodowska-Curie grant agreement
   (no. 794744) and from the Spanish Ministry of Science and Innovation
   (MCIN) (RYC2020-030652-I/AEI/10.13039/501100011033). V.L.P. was a
   recipient of a predoctoral contract from the Spanish Ministry of
   Education (FPU-18/05917). K.M. was a recipient of fellowships from the
   German Cardiac, the German Research Foundation and a postdoctoral
   contract Juan de la Cierva from the MCIN. F.H.G. was supported by the
   PhD4MD Collaborative Research Training Program for Medical Doctors (IRB
   Barcelona/Hospital Clinic/IDIBAPS). M. Sanchez was funded by grants
   PID2021-122436OB-I00 from MCIN/AEI/10.13039/501100011033/FEDER, UE,
   RETOS COLABORACION RTC2019-007074-1 from MCIN/AEI/10.13039/501100011033.
   C.L.-M. was a recipient of a predoctoral contract from the Spanish
   Ministry of Education (FPU-18/02965). G.A. was funded by the Instituto
   de Salud Carlos III through project PI 20/01360, FEDER funds. J.M.C. was
   funded by the Instituto de Salud Carlos III through projects PI18/00910
   and PI21/00931 (co-funded by European Regional Development Fund, a way
   to build Europe) and thanks the CERCA Programme/Generalitat de Catalunya
   for institutional support. Work in the laboratory of M. Serrano was
   funded by the IRB and 'laCaixa' Foundation and by grants from the
   Spanish Ministry of Science co-funded by the European Regional
   Development Fund (SAF2017-82613-R), European Research Council
   (ERC-2014-AdG/669622) and grant RETOS COLABORACION RTC2019-007125-1 from
   MCIN/AEI and Secretaria d'Universitats i Recerca del Departament
   d'Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017
   SGR 282)
CR 10x Genomics, 2022, Interpreting single cell gene expression data with and without intronic reads
   Ali MK, 2020, J PATHOL, V251, P49, DOI 10.1002/path.5401
   Arthur MJP, 1998, J GASTROEN HEPATOL, V13, pS33
   Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5
   Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011
   Boor P, 2015, AM J TRANSPLANT, V15, P863, DOI 10.1111/ajt.13180
   Bronze-da-Rocha E, 2018, INT J BIOL SCI, V14, P1343, DOI 10.7150/ijbs.26111
   Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762
   BUJA LM, 1971, AM J MED, V51, P209, DOI 10.1016/0002-9343(71)90240-3
   Burnham EL, 2014, EUR RESPIR J, V43, P276, DOI 10.1183/09031936.00196412
   Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096
   Carthy JM, 2018, J CELL PHYSIOL, V233, P98, DOI 10.1002/jcp.25879
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Chen JY, 2022, CELL DEATH DIFFER, V29, P467, DOI 10.1038/s41418-022-00941-0
   Cook SA, 2020, ANNU REV MED, V71, P263, DOI 10.1146/annurev-med-041818-011649
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217
   Durkin Marian E, 2013, Bio Protoc, V3
   Ehling J, 2016, J AM SOC NEPHROL, V27, P520, DOI 10.1681/ASN.2015020204
   Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059
   Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW
   Franzén O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046
   Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014
   Ghio AJ, 2013, J CYST FIBROS, V12, P390, DOI 10.1016/j.jcf.2012.10.010
   Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Haas M, 2018, AM J TRANSPLANT, V18, P293, DOI 10.1111/ajt.14625
   Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1
   Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048
   Jacob J, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01011-2016
   Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939
   Joseph C, 2013, CURR OPIN PEDIATR, V25, P209, DOI 10.1097/MOP.0b013e32835df48a
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158
   Kim SR, 2020, AM J PHYSIOL-RENAL, V318, pF1167, DOI 10.1152/ajprenal.00535.2019
   Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487
   Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kushner J P, 2001, Hematology Am Soc Hematol Educ Program, P47
   LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7
   Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012
   López-Alonso I, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7598
   López-Antona I, 2022, AGING CELL, V21, DOI 10.1111/acel.13580
   López-Martínez C, 2023, EUR RESPIR J, V61, DOI 10.1183/13993003.00592-2022
   LOREAL O, 1992, J HEPATOL, V16, P122, DOI 10.1016/S0168-8278(05)80104-7
   Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015
   Mast AE, 2017, LANCET, V390, P2331, DOI 10.1016/S0140-6736(17)32156-6
   McDonough JE, 2019, THORAX, V74, P132, DOI 10.1136/thoraxjnl-2018-211929
   Meguro R, 2003, HISTOCHEM CELL BIOL, V120, P73, DOI 10.1007/s00418-003-0539-y
   Mehta KJ, 2019, WORLD J GASTROENTERO, V25, P521, DOI 10.3748/wjg.v25.i5.521
   Meyer K., 2022, Cellular Senescence in Disease, DOI [10.1016/B978-0-12-822514-1.00014-6, DOI 10.1016/B978-0-12-822514-1.00014-6]
   Meyer K, 2016, J AM COLL CARDIOL, V67, P2018, DOI 10.1016/j.jacc.2016.02.047
   Miwa S, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158447
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Naito Y, 2015, HYPERTENS RES, V38, P463, DOI 10.1038/hr.2015.14
   NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580, DOI 10.1016/S0272-6386(12)70222-6
   Nelsons G, 2018, MECH AGEING DEV, V170, P30, DOI 10.1016/j.mad.2017.08.005
   Ng B, 2020, EXP MOL MED, V52, P1871, DOI 10.1038/s12276-020-00531-5
   Panizo S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010408
   Papakonstantinou O, 2009, J MAGN RESON IMAGING, V29, P853, DOI 10.1002/jmri.21707
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pelaia C, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01514
   Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S
   Porter J, 2013, HEMATOL-AM SOC HEMAT, P447, DOI 10.1182/asheducation-2013.1.447
   Rehman SK, 2021, CELL, V184, P226, DOI 10.1016/j.cell.2020.11.018
   Rissanen TT, 2005, CIRCULATION, V112, P3937, DOI 10.1161/CIRCULATIONAHA.105.543124
   Riviello ED, 2016, AM J RESP CRIT CARE, V193, P52, DOI 10.1164/rccm.201503-0584OC
   Sangiuolo F, 2015, EUR RESPIR J, V45, P483, DOI 10.1183/09031936.00104814
   Satija Lab, 2021, Azimuth reference-human lung (1.0.0), DOI [10.5281/zenodo.4895404, DOI 10.5281/ZENODO.4895404]
   Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192
   Sato Y, 2020, SEMIN NEPHROL, V40, P206, DOI 10.1016/j.semnephrol.2020.01.011
   Saul D, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32552-1
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562
   Selman M, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.04507-2020
   Stancil IT, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abo5254
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Suda M, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12091296
   Trojanowska M, 2010, NAT REV RHEUMATOL, V6, P453, DOI 10.1038/nrrheum.2010.102
   van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061
   Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412
   Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
   Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049
NR 87
TC 0
Z9 0
U1 11
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2522-5812
J9 NAT METAB
JI Nat. Metab.
PD 2023 DEC 14
PY 2023
DI 10.1038/s42255-023-00928-2
EA DEC 2023
PG 40
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA CQ5Y1
UT WOS:001126734300001
PM 38097808
OA Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU TSUKAMOTO, I
   NAKATA, R
   KOJO, S
AF TSUKAMOTO, I
   NAKATA, R
   KOJO, S
TI EFFECT OF AGING ON RAT-LIVER REGENERATION AFTER PARTIAL-HEPATECTOMY
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
ID THYMIDINE KINASE; THYMIDYLATE SYNTHETASE; ENZYME-ACTIVITY; DNA-SYNTHESIS
C1 HYOGO UNIV TEACHERS EDUC,DEPT LIFE & HLTH SCI,YASHIRO,HYOGO 67314,JAPAN.
C3 Hyogo University of Teacher Education
RP TSUKAMOTO, I (corresponding author), NARA WOMENS UNIV,DEPT FOOD SCI & NUTR,NARA 630,JAPAN.
RI Kojo, Shosuke/GNP-0971-2022
CR BEYER HS, 1991, J LAB CLIN MED, V117, P101
   BEYER HS, 1992, J LAB CLIN MED, V119, P38
   BUCHER NLR, 1964, CANCER RES, V24, P509
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   ERY M, 1984, J CELL PHYSL, V118, P225
   HIGINS GM, 1931, ARCH PATHOL, V12, P186
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819
   NAKATA R, 1985, BIOCHEM PHARMACOL, V34, P586, DOI 10.1016/0006-2952(85)90195-9
   NAKATA R, 1987, CLIN SCI, V72, P455, DOI 10.1042/cs0720455
   NAKATA R, 1985, EUR J PHARMACOL, V114, P355, DOI 10.1016/0014-2999(85)90380-2
   SCHNEIDER WC, 1957, METHOD ENZYMOL, V3, P680, DOI 10.1016/S0076-6879(57)03442-4
   TSUKAMOTO I, 1987, BIOCHEM PHARMACOL, V36, P2871
   TSUKAMOTO I, 1991, BIOCHIM BIOPHYS ACTA, V1074, P52, DOI 10.1016/0304-4165(91)90038-I
   TSUKAMOTO I, 1990, BIOCHIM BIOPHYS ACTA, V1033, P287, DOI 10.1016/0304-4165(90)90135-J
   TSUKAMOTO I, 1989, GUT, V30, P387, DOI 10.1136/gut.30.3.387
   TSUKAMOTO I, 1987, CHEM LETT, P2313, DOI 10.1246/cl.1987.2313
   TSUKAMOTO I, 1988, BIOCHIM BIOPHYS ACTA, V964, P254, DOI 10.1016/0304-4165(88)90173-0
   TSUKAMOTO I, 1989, BIOCHIM BIOPHYS ACTA, V1009, P191, DOI 10.1016/0167-4781(89)90101-2
   TSUKAMOTO I, 1992, CLIN SCI, V82, P181, DOI 10.1042/cs0820181
   TSUKAMOTO I, EUR J PHARMACOL, V144, P159
NR 21
TC 38
Z9 38
U1 0
U2 1
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE NSW 2204, AUSTRALIA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD JUL
PY 1993
VL 30
IS 4
BP 773
EP 778
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA LT177
UT WOS:A1993LT17700022
PM 7691337
DA 2024-02-19
ER

PT J
AU Uziel, O
   Laish, I
   Bulcheniko, M
   Harif, Y
   Kochavi-Shalem, N
   Aharoni, M
   Braunstein, R
   Lahav, M
   Ben-Ari, Z
AF Uziel, Orit
   Laish, Ido
   Bulcheniko, Marina
   Harif, Yael
   Kochavi-Shalem, Naama
   Aharoni, Maya
   Braunstein, Rony
   Lahav, Meir
   Ben-Ari, Ziv
TI Telomere shortening in liver transplant recipients is not influenced by
   underlying disease or metabolic derangements
SO ANNALS OF TRANSPLANTATION
LA English
DT Article
DE telomeres; liver; transplant
ID CHRONIC HEPATITIS-C; RISK-FACTORS; OXIDATIVE STRESS; LENGTH; SENESCENCE;
   CELLS; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; DIAGNOSIS
AB Background: Telomeres are non-coding regions of DNA that cap the ends of chromosomes. Their length is considered a marker of human replicative senescence and premature aging. Given the high association of liver transplantation with the metabolic syndrome, we hypothesized that liver transplant recipients may exhibit premature and accelerated aging.
   Material/Methods: Telomere length in peripheral blood lymphocytes was measured by polymerase chain reaction in 62 consecutive liver-transplant recipients and 59 healthy control subjects aged 20-76 years. Clinical and laboratory parameters were collected from the medical files.
   Results: The liver transplant recipients were significantly older than the control subjects (p=0.012), with significantly higher rates of obesity (BMI >30 kg/m(2)), dyslipidemia, hypertension, diabetes, and fatty liver. Mean telomere length was significantly shorter in the transplant group (0.59 +/- 0.6 vs. 1.91 +/- 1.78 in the controls, p<0.0001). Within the transplant group, there was no significant association between mean telomere length and underlying liver disease or presence of the metabolic syndrome or its constituents. On multivariate analysis, telomere length was negatively associated with patient age (p=0.0001), male sex (p=0.04), acute rejection (p=0.005), and fatty liver (p=0.009), and was positively associated with time from transplantation (p=0.006).
   Conclusions: Liver transplantation is associated with shortened telomere length in peripheral blood lymphocytes, suggesting accelerated senescence.
C1 [Uziel, Orit; Bulcheniko, Marina; Kochavi-Shalem, Naama; Lahav, Meir] Felsentein Med Res Ctr, Petah Tiqwa, Israel.
   [Laish, Ido] Meir Med Ctr, Dept Gastroenterol, Kefar Sava, Israel.
   [Bulcheniko, Marina; Aharoni, Maya; Lahav, Meir] Dept Internal Med, Petah Tiqwa, Israel.
   [Bulcheniko, Marina; Harif, Yael; Aharoni, Maya; Lahav, Meir; Ben-Ari, Ziv] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
   [Harif, Yael; Ben-Ari, Ziv] Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel.
   [Braunstein, Rony] Biomed Res, Tel Aviv, Israel.
C3 Tel Aviv University; Sackler Faculty of Medicine; Sackler Faculty of
   Medicine; Rabin Medical Center
RP Ben-Ari, Z (corresponding author), Chaim Sheba Med Ctr, Liver Dis Ctr, IL-52621 Tel Hashomer, Israel.
EM ziv.ben-ari@sheba.health.gov.il
CR Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187
   Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106
   Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979
   Bauer ME, 2005, STRESS, V8, P69, DOI 10.1080/10253890500100240
   Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013
   Canzanello V J, 1997, Liver Transpl Surg, V3, P1
   Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chkhotua AB, 2003, TRANSPL INT, V16, P600, DOI 10.1007/s00147-003-0587-1
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Everhart JE, 1998, LIVER TRANSPLANT SUR, V4, P285, DOI 10.1002/lt.500040402
   Gelson W, 2010, LIVER TRANSPLANT, V16, P577, DOI 10.1002/lt.22033
   Georgin-Lavialle S, 2010, AUTOIMMUN REV, V9, P646, DOI 10.1016/j.autrev.2010.04.004
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Guckelberger O, 1997, CLIN TRANSPLANT, V11, P60
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hoare M, 2010, J HEPATOL, V53, P252, DOI 10.1016/j.jhep.2010.03.005
   Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894
   Kappei D, 2008, MECH AGEING DEV, V129, P17, DOI 10.1016/j.mad.2007.10.009
   Kiecolt-Glaser JK, 2010, BRAIN BEHAV IMMUN, V24, P529, DOI 10.1016/j.bbi.2010.02.002
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Laish I, 2011, LIVER TRANSPLANT, V17, P15, DOI 10.1002/lt.22198
   Laryea M, 2007, LIVER TRANSPLANT, V13, P1109, DOI 10.1002/lt.21126
   Li P, 2011, BIOCHEM BIOPH RES CO, V407, P599, DOI 10.1016/j.bbrc.2011.03.079
   Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012
   Maubaret CG, 2010, J MOL MED, V88, P785, DOI 10.1007/s00109-010-0624-3
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Remes K, 2000, BRIT J CANCER, V82, P601, DOI 10.1054/bjoc.1999.0970
   Ritter ML, 2009, TRANSPL INFECT DIS, V11, P290, DOI 10.1111/j.1399-3062.2009.00407.x
   Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715
   Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Uziel O, 2007, EXP GERONTOL, V42, P971, DOI 10.1016/j.exger.2007.07.005
   van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
NR 35
TC 9
Z9 9
U1 0
U2 3
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1425-9524
J9 ANN TRANSPL
JI Ann. Transpl.
PD OCT 21
PY 2013
VL 18
BP 567
EP 575
PG 9
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA 242KN
UT WOS:000326240000001
PM 24141383
DA 2024-02-19
ER

PT J
AU Ibdah, JA
   Perlegas, P
   Zhao, YW
   Angdisen, J
   Borgerink, H
   Shadoan, MK
   Wagner, JD
   Matern, D
   Rinaldo, P
   Cline, JM
AF Ibdah, JA
   Perlegas, P
   Zhao, YW
   Angdisen, J
   Borgerink, H
   Shadoan, MK
   Wagner, JD
   Matern, D
   Rinaldo, P
   Cline, JM
TI Mice heterozygous for a defect in mitochondrial trifunctional protein
   develop hepatic steatosis and insulin resistance
SO GASTROENTEROLOGY
LA English
DT Article
ID FATTY-ACID OXIDATION; LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS;
   ALPHA-SUBUNIT; IN-VIVO; DEFICIENCY; ENZYME; DISORDERS; MUTATIONS;
   PREGNANCY
AB Background & Aims: Little is known about the role of mitochondrial P-oxidation in development of nonalcoholic fatty liver disease (NAFLD). Mitochondrial trifunctional protein (MTP) catalyzes long-chain fatty acid oxidation. Recently, we generated a mouse model for MTP deficiency and reported that homozygous (MTPa-/-) mice suffer neonatal death,, In this study, we investigated effects of heterozygosity for the MTP defect on hepatic oxidative stress, insulin resistance, and development of NAFLD in mice. Methods: We evaluated liver histopathology, serum alanine aminotransferase (ALT), glucose, fatty acids, and insulin levels in MTPa+/- and MTPa+/+ littermates. Insulin resistance was evaluated using glucose tolerance test (GTT) and insulin tolerance test (ITT). Liver tissues were used to measure triglyceride and fatty acid content, activity of superoxide dismutases (SOD) and glutathione peroxidase (GPx), glutathione (GSH), and cytochrome P-450 2E1 expression. Results: Aging but not young; MTPa+/- mice developed hepatic steatosis with elevated ALT, basal hyperinsulinemia, and increased insulin area under curve (AUC) on GTT compared with MTPa+/+ littermates. In response to insulin challenge, aging MTPa+/- mice had slower rate of glucose disappearance and increased glucose AUC. Significant hepatic steatosis and insulin resistance developed concomitantly in the MTPa+/- mice at 9-10 months of age. Aging MTPa+/- mice had higher antioxidant activity of total SOD and GPx, lower GSH, and increased expression of cytochrome P-450 2E1, consistent with increased hepatic oxidative stress. Conclusions: Heterozygosity for P-oxidation defects predisposes to NAFLD and insulin resistance in aging mice. Impairment of mitochondrial P-oxidation may play an important role in pathogenesis of NAFLD.
C1 Wake Forest Univ, Sch Med, Div Gastroenterol, Winston Salem, NC 27157 USA.
   Wake Forest Univ, Sch Med, Div Comparat Med, Winston Salem, NC 27157 USA.
   Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA.
C3 Wake Forest University; Wake Forest University; Mayo Clinic
RP Ibdah, JA (corresponding author), Wake Forest Univ, Sch Med, Div Gastroenterol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jibdah@wfubmc.edu
OI Ibdah, Jamal/0000-0002-5646-9014
FU NIDDK NIH HHS [DK-56345] Funding Source: Medline
CR Aoyama T, 1997, CYTOGENET CELL GENET, V79, P221, DOI 10.1159/000134727
   BOLES RG, 1994, HUM PATHOL, V25, P735, DOI 10.1016/0046-8177(94)90240-2
   BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374
   BRACKETT JC, 1995, J CLIN INVEST, V95, P2076, DOI 10.1172/JCI117894
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X
   Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001
   Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926
   Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270
   Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590
   Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204
   Ibdah JA, 1998, J CLIN INVEST, V102, P1193, DOI 10.1172/JCI2091
   IJIST L, 1996, J CLIN INVEST, V98, P1028
   JACKSON S, 1992, J CLIN INVEST, V90, P1219, DOI 10.1172/JCI115983
   KAMIJO T, 1994, J CLIN INVEST, V93, P1740, DOI 10.1172/JCI117158
   KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Rashid M, 2000, J PEDIATR GASTR NUTR, V30, P48, DOI 10.1097/00005176-200001000-00017
   Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742
   SIMS HF, 1995, P NATL ACAD SCI USA, V92, P841, DOI 10.1073/pnas.92.3.841
   Ushikubo S, 1996, AM J HUM GENET, V58, P979
   Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121
   Wiesenthal SR, 1999, DIABETES, V48, P766, DOI 10.2337/diabetes.48.4.766
   Yang Z, 2002, AM J OBSTET GYNECOL, V187, P715, DOI 10.1067/mob.2002.125893
   Yang Z, 2002, JAMA-J AM MED ASSOC, V288, P2163, DOI 10.1001/jama.288.17.2163
   Zytkovicz TH, 2001, CLIN CHEM, V47, P1945
NR 30
TC 143
Z9 163
U1 0
U2 17
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD MAY
PY 2005
VL 128
IS 5
BP 1381
EP 1390
DI 10.1053/j.gastro.2005.02.001
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 926NP
UT WOS:000229130200024
PM 15887119
OA Bronze
DA 2024-02-19
ER

PT J
AU Nakajima, Y
   Yamazaki, Y
   Gao, X
   Hashimoto, M
   Nio, M
   Wada, M
   Fujishima, F
   Sasano, H
AF Nakajima, Yudai
   Yamazaki, Yuto
   Gao, Xin
   Hashimoto, Masatoshi
   Nio, Masaki
   Wada, Motoshi
   Fujishima, Fumiyoshi
   Sasano, Hironobu
TI Association between mitochondrial and nuclear DNA damages and cellular
   senescence in the patients with biliary atresia undergoing Kasai
   portoenterostomy and liver transplantation
SO MEDICAL MOLECULAR MORPHOLOGY
LA English
DT Article; Early Access
DE Senescence; Biliary atresia; Kasai portoenterostomy; Liver;
   Mitochondrial damage; DNA damage
ID SELECTIVE AUTOPHAGY; OXIDATIVE STRESS; P62; HETEROGENEITY; PATHOGENESIS;
   MAINTENANCE; INHIBITORS; MARKER; NUMBER; CELLS
AB Biliary atresia (BA) is a cholestatic disease with extrahepatic bile duct obstruction that requires early surgical intervention and occasionally liver transplantation (LT). Accumulation of toxic bile acids induces oxidative stress that results in cell damage, such as cell senescence, mitochondrial dysfunction and others. However, details of their reciprocal association and clinical significance are unexplored. Therefore, we used immuno-localization of markers for cell senescence (p16 and p21), nuclear double-strand DNA damage (gamma H2AX), autophagy (p62), and mtDNA damage (mtDNA copy number) in patients with BA who underwent Kasai portoenterostomy (KP) and LT. We studied liver biopsy specimens from 54 patients with BA, 14 who underwent LT and 11 from the livers of neonates and infants obtained at autopsy. In hepatocytes, p21 expression was significantly increased in KP. In cholangiocytes, p16 expression was significantly increased in LT, and p21 expression was significantly increased in KP. p62 expression was significantly increased in the KP hepatocytes and LT cholangiocytes. Furthermore, mtDNA copy number significantly decreased in KP and LT compared with the control. Cell senescence and mitochondrial DNA damage progression were dependent on the BA clinical stages and could possibly serve as the markers of indication of LT.
C1 [Nakajima, Yudai; Yamazaki, Yuto; Gao, Xin; Hashimoto, Masatoshi; Sasano, Hironobu] Tohoku Univ, Dept Pathol, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
   [Nakajima, Yudai; Hashimoto, Masatoshi; Nio, Masaki; Wada, Motoshi] Tohoku Univ, Dept Pediat Surg, Grad Sch Med, Sendai, Miyagi, Japan.
   [Nio, Masaki] Tohoku Kousai Hosp, Sendai, Miyagi, Japan.
   [Fujishima, Fumiyoshi; Sasano, Hironobu] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan.
C3 Tohoku University; Tohoku University; Tohoku University
RP Yamazaki, Y (corresponding author), Tohoku Univ, Dept Pathol, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM nakajima@ped-surg.med.tohoku.ac.jp;
   y.yamazaki@patholo2.med.tohoku.ac.jp; gaoxin0222@qq.com;
   hashimoto@ped-surg.med.tohoku.ac.jp; mnio@ped-surg.med.tohoku.ac.jp;
   wada@ped-surg.med.tohoku.ac.jp; ffujishima@patholo2.med.tohoku.ac.jp;
   hsasano@patholo2.med.tohoku.ac.jp
FU Health and Labor Sciences Research Grants [19FC1008]
FX We appreciate the skillful technical assistance of Mr. Katsuhiko Ono,
   Mr. Yoshiaki Onodera (Department of Pathology, Tohoku University
   Graduate School of Medicine, Sendai, Japan) and Ms. Yayoi Aoyama
   (Department of Pathology, Tohoku University Hospital, Sendai, Japan). We
   would like to thank Editage (www.edita ge.com) for English language
   editing. Supported by Health and Labor Sciences Research Grants
   (19FC1008).
CR Abate M, 2020, SEMIN CELL DEV BIOL, V98, P139, DOI 10.1016/j.semcdb.2019.05.022
   Arduini Alessandro, 2012, Front Biosci (Elite Ed), V4, P2233
   Auger C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00040
   Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   Bychkov IO, 2021, MITOCHONDRION, V57, P205, DOI 10.1016/j.mito.2021.01.004
   Cai SY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90780
   Coppedè F, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00086
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Dabravolski SA, 2021, BIOMED PHARMACOTHER, V142, DOI 10.1016/j.biopha.2021.112041
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Duregon E, 2011, AM J SURG PATHOL, V35, P1882, DOI 10.1097/PAS.0b013e31822da401
   Fazzini F, 2021, J INTERN MED, V290, P190, DOI 10.1111/joim.13242
   Gokon Y, 2020, VIRCHOWS ARCH, V477, P825, DOI 10.1007/s00428-020-02854-0
   González-Gualda E, 2021, FEBS J, V288, P56, DOI 10.1111/febs.15570
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Holmuhamedov E, 2003, MITOCHONDRION, V3, P13, DOI 10.1016/S1567-7249(03)00053-9
   Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8
   Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200
   Ikeda H, 2009, HUM PATHOL, V40, P1774, DOI 10.1016/j.humpath.2009.06.009
   Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036
   Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Kopp B, 2019, ARCH TOXICOL, V93, P2103, DOI 10.1007/s00204-019-02511-9
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Kuo FY, 2015, HUM PATHOL, V46, P1633, DOI 10.1016/j.humpath.2015.07.003
   Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Mehta AR, 2021, ACTA NEUROPATHOL, V141, P257, DOI 10.1007/s00401-020-02252-5
   Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Nio M, 2017, PEDIATR SURG INT, V33, P1319, DOI 10.1007/s00383-017-4160-x
   Nio M, 2016, J PEDIATR SURG, V51, P2105, DOI 10.1016/j.jpedsurg.2016.09.047
   Omata K, 2017, J ENDOCR SOC, V1, P787, DOI 10.1210/js.2017-00134
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Petrova NV, 2016, AGING CELL, V15, P999, DOI 10.1111/acel.12518
   Révész D, 2018, J CLIN ENDOCR METAB, V103, P148, DOI 10.1210/jc.2017-01625
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Sasaki H, 2014, PEDIATR SURG INT, V30, P871, DOI 10.1007/s00383-014-3552-4
   Sasaki M, 2018, HISTOPATHOLOGY, V72, P1164, DOI 10.1111/his.13476
   Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tiao MM, 2007, J PEDIATR GASTR NUTR, V45, P329, DOI 10.1097/MPG.0b013e3180cc2c0f
   Ueki S, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6652-7
   Wang JF, 2019, HEPATOL RES, V49, P695, DOI 10.1111/hepr.13324
   White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamazaki Y, 2016, HUM PATHOL, V53, P41, DOI 10.1016/j.humpath.2015.10.017
   Zagory JA, 2015, CURR OPIN PEDIATR, V27, P389, DOI 10.1097/MOP.0000000000000214
NR 63
TC 3
Z9 3
U1 1
U2 6
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 1860-1480
EI 1860-1499
J9 MED MOL MORPHOL
JI Med. Mol. Morphol.
PD 2022 JUN
PY 2022
VL 55
IS 2
BP 131
EP 145
DI 10.1007/s00795-022-00314-z
EA MAR 2022
PG 15
WC Biology; Microscopy; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology
GA 1M7SK
UT WOS:000763867100001
PM 35238992
DA 2024-02-19
ER

PT J
AU GALINSKY, RE
   JOHNSON, DH
   KANE, RE
   FRANKLIN, MR
AF GALINSKY, RE
   JOHNSON, DH
   KANE, RE
   FRANKLIN, MR
TI EFFECT OF AGING ON HEPATIC BIOTRANSFORMATION IN FEMALE FISCHER 344 RATS
   - CHANGES IN SULFOTRANSFERASE ACTIVITIES ARE CONSISTENT WITH KNOWN
   GENDER-RELATED CHANGES IN PITUITARY GROWTH-HORMONE SECRETION IN AGING
   ANIMALS
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
C1 UNIV UTAH,MED CTR,COLL MED,DEPT PHARMACOL & TOXICOL,SALT LAKE CITY,UT 84112.
   ST LOUIS UNIV,PEDIAT RES INST,ST LOUIS,MO 63103.
C3 Utah System of Higher Education; University of Utah; Saint Louis
   University
RP GALINSKY, RE (corresponding author), UNIV UTAH,MED CTR,COLL MED,DEPT PHARMACEUT,SALT LAKE CITY,UT 84112, USA.
FU NIA NIH HHS [AG 07135] Funding Source: Medline
CR ADELMAN RC, 1975, FED PROC, V34, P179
   [Anonymous], 1984, BIOSTATISTICAL ANAL
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   BORGHOFF SJ, 1988, TOXICOL APPL PHARM, V92, P453, DOI 10.1016/0041-008X(88)90185-8
   CORCORAN GB, 1985, J PHARMACOL EXP THER, V232, P857
   CROOKS J, 1976, Clinical Pharmacokinetics, V1, P280
   FRANKLIN MR, 1971, ARCH BIOCHEM BIOPHYS, V143, P318, DOI 10.1016/0003-9861(71)90213-X
   FUJITA S, 1982, LIVER AGING 1982, P55
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V236, P133
   GALINSKY RE, 1986, PHARMACOLOGY, V32, P313, DOI 10.1159/000138186
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   Gibaldi M, 1982, Pharmacokinetics, V15
   GREENBLATT DJ, 1989, PHARMACOLOGY, V38, P327, DOI 10.1159/000138553
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KANE RE, 1987, DRUG METAB DISPOS, V215, P725
   KAO J, 1980, BIOCHEM PHARMACOL, V29, P1191, DOI 10.1016/0006-2952(80)90417-7
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   LIU ZQ, 1984, ANAL BIOCHEM, V142, P340, DOI 10.1016/0003-2697(84)90474-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MINERS J, 1984, CLIN EXP PHARMACOL P, V11, P209, DOI 10.1111/j.1440-1681.1984.tb00258.x
   MODE A, 1982, ENDOCRINOLOGY, V111, P1692, DOI 10.1210/endo-111-5-1692
   MORGAN ET, 1985, MOL PHARMACOL, V27, P471
   MORGAN ET, 1985, J BIOL CHEM, V260, P1895
   MULDER GJ, 1986, CHEM-BIOL INTERACT, V57, P1, DOI 10.1016/0009-2797(86)90044-X
   NETTER KJ, 1964, J PHARMACOL EXP THER, V146, P61
   NIEDERMEYER TM, 1988, BIOCHEM PHARMACOL, V37, P241, DOI 10.1016/0006-2952(88)90724-1
   OMALLEY K, 1971, BMJ-BRIT MED J, V3, P607, DOI 10.1136/bmj.3.5775.607
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   RIKANS LE, 1984, MECH AGEING DEV, V25, P335, DOI 10.1016/0047-6374(84)90006-X
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   RIKANS LE, 1984, TOXICOL APPL PHARM, V73, P243, DOI 10.1016/0041-008X(84)90329-6
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   RIKANS LE, 1982, BIOCHEM PHARMACOL, V31, P2339, DOI 10.1016/0006-2952(82)90527-5
   RITTER JK, 1987, DRUG METAB DISPOS, V15, P335
   SINGER SS, 1976, ENDOCRINOLOGY, V98, P963, DOI 10.1210/endo-98-4-963
   SKETT P, 1988, PHARMACOL THERAPEUT, V38, P269, DOI 10.1016/0163-7258(88)90007-1
   SKETT P, 1987, PROGR DRUG METABOLIS, P87
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   SPEARMAN ME, 1984, DRUG METAB DISPOS, V12, P661
   TAKAHASHI S, 1987, NEUROENDOCRINOLOGY, V46, P137, DOI 10.1159/000124810
   WAXMAN DJ, 1989, MOL PHARMACOL, V35, P519
   YAMAZOE Y, 1987, J BIOL CHEM, V262, P7423
   YAMAZOE Y, 1986, JPN J PHARMACOL, V42, P371, DOI 10.1254/jjp.42.371
   YAMAZOE Y, 1987, MOL PHARMACOL, V32, P536
   YAMAZOE Y, 1989, MOL PHARMACOL, V35, P707
NR 46
TC 14
Z9 14
U1 0
U2 1
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0022-3565
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD NOV
PY 1990
VL 255
IS 2
BP 577
EP 583
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA EK016
UT WOS:A1990EK01600025
PM 2243343
DA 2024-02-19
ER

PT J
AU Zhang, XL
   Shi, GF
   Liu, XZ
   An, LJ
   Guan, S
AF Zhang, Xiuli
   Shi, Gui-Fang
   Liu, Xiu-zhen
   An, Li-jia
   Guan, Shui
TI Anti-ageing effects of protocatechuic acid from <i>Alpinia</i> on spleen
   and liver antioxidative system of senescent mice
SO CELL BIOCHEMISTRY AND FUNCTION
LA English
DT Article
DE Alpinia protocatechuic acid; antioxidants; lipid peroxide; ageing;
   spleen; liver
ID FUNCTIONAL LIFE-SPAN; PARKINSONS-DISEASE; OXIDATIVE STRESS;
   LIPID-PEROXIDATION; GINSENG EXTRACT; GINKGO-BILOBA; RAT; OXYPHYLLA;
   PHOSPHORYLATION; GLUTATHIONE
AB The effects of Alpinia protocatechuic acid (PCA) on spleen and liver antioxidant system in aged rats have been studied. Alpinia PCA, a phenolic compound, was first isolated from the dried fruits of Alpinia Oxyphylla Miq. in our laboratory. Young and aged rats were injected intraperitoneally with Alpinia PCA at single doses of 5 mg kg(-1) (low dose) or 10 mg kg(-1) (high dose) per day for 7 days. The activities of endogenous antioxidants and the content of lipid peroxide in spleen and liver were assayed. Compared with young group, aged rats had significantly lower splenic weights, lower activities of glutathione peroxidase (GSH-PX) and catalase (CAT), higher level of malondialdehyde (MDA) in spleen and liver. The results proved that Alpinia PCA significantly elevated the splenic weights, increased the activities of GSH-PX and CAT and decreased the MDA level of aged rats. All these suggested that Alpinia PCA was a potential anti-ageing agent, and its effects on spleen and liver were achieved at least partly by promoting endogenous antioxidant enzymatic activities and normalizing age-associated alterations. It may be therapeutically useful to minimize age-associated disorders where oxidative damage is the major cause. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Zhang, Xiuli; Liu, Xiu-zhen] Binzhou Med Univ, Sch Pharmaceut Sci, Yantai, Shandong, Peoples R China.
   [Shi, Gui-Fang] Dalian Meiluo Chinese Med Factory, Dalian, Liaoning, Peoples R China.
   [An, Li-jia] Dalian Univ Technol, Sch Environm & Biol Sci & Technol, Dalian, Liaoning, Peoples R China.
   [Guan, Shui] Dalian Univ Technol, Stem Cell & Tissue Engn Lab, Dalian, Liaoning, Peoples R China.
C3 Binzhou Medical University; Dalian University of Technology; Dalian
   University of Technology
RP Zhang, XL (corresponding author), Binzhou Med Univ, Sch Pharmaceut Sci, Yantai, Shandong, Peoples R China.
EM zhangxiuli2008@163.com; guanshui@dlut.edu.cn
RI Wang, Jinguo/JED-9233-2023; Guan, Shui/D-7759-2017; Guan,
   Shui/Y-1635-2019
OI Guan, Shui/0000-0001-7617-8081; Guan, Shui/0000-0001-7617-8081
FU Development Programs in Medicine & Health Science and Technology of
   Shandong Province of China [HW004]; National Natural Science Foundation
   of China [30800288]
FX This work was supported by the Development Programs in Medicine & Health
   Science and Technology of Shandong Province of China (HW004) and the
   National Natural Science Foundation of China (30800288).
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   An LJ, 2006, FOOD CHEM TOXICOL, V44, P436, DOI 10.1016/j.fct.2005.08.017
   BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074
   CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K
   Chong-Han K, 2010, CRIT REV FOOD SCI, V50, P931, DOI 10.1080/10408390903044073
   CINI M, 1994, NEUROCHEM RES, V19, P283, DOI 10.1007/BF00971576
   delaTorre R, 1996, NEUROCHEM RES, V21, P885
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   Harman D, 1996, ANN NY ACAD SCI, V786, P321, DOI 10.1111/j.1749-6632.1996.tb39074.x
   Ho YS, 1998, ENVIRON HEALTH PERSP, V106, P1219, DOI 10.2307/3433989
   HOLLEY AE, 1993, BRIT MED BULL, V49, P494, DOI 10.1093/oxfordjournals.bmb.a072626
   HUANG MT, 1992, ACS SYM SER, V507, P8
   Husain K, 2005, PHARMACOL RES, V51, P337, DOI 10.1016/j.phrs.2004.10.005
   Kitts DD, 2000, MOL CELL BIOCHEM, V203, P1, DOI 10.1023/A:1007078414639
   Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029
   NEWMARK HL, 1992, ACS SYM SER, V507, P48
   Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1
   SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B
   Srinivasan V, 1999, CURR SCI INDIA, V76, P46
   STROKA Z, 2003, FOOD CHEM TOXICOL, V41, P753
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   TIMENS W, 1992, ANN SURG, V215, P256, DOI 10.1097/00000658-199203000-00010
   Topic B, 2002, NEUROBIOL AGING, V23, P135, DOI 10.1016/S0197-4580(01)00241-X
   Tseng TH, 2000, BIOCHEM PHARMACOL, V60, P307, DOI 10.1016/S0006-2952(00)00322-1
   Tseng TH, 1998, CANCER LETT, V126, P199, DOI 10.1016/S0304-3835(98)00010-X
   Tseng TH, 1996, CHEM-BIOL INTERACT, V101, P137, DOI 10.1016/0009-2797(96)03721-0
   Van Kampen J, 2003, EXP NEUROL, V184, P521, DOI 10.1016/j.expneurol.2003.08.002
   Wong KK, 2004, NEUROBIOL AGING, V25, pS595, DOI 10.1016/S0197-4580(04)81983-3
   Yen GC, 2002, FOOD CHEM, V77, P449, DOI 10.1016/S0308-8146(01)00379-X
   Yu XY, 2003, TOXICOL LETT, V144, P205, DOI 10.1016/S0378-4274(03)00219-4
   Zhang ZS, 2001, J NUTR BIOCHEM, V12, P144, DOI 10.1016/S0955-2863(00)00137-6
NR 33
TC 48
Z9 53
U1 2
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0263-6484
EI 1099-0844
J9 CELL BIOCHEM FUNCT
JI Cell Biochem. Funct.
PD JUN
PY 2011
VL 29
IS 4
BP 342
EP 347
DI 10.1002/cbf.1757
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 783PC
UT WOS:000292095300009
PM 21491470
DA 2024-02-19
ER

PT J
AU Del Roso, A
   Vittorini, S
   Cavallini, G
   Donati, A
   Gori, Z
   Masini, M
   Pollera, M
   Bergamini, E
AF Del Roso, A
   Vittorini, S
   Cavallini, G
   Donati, A
   Gori, Z
   Masini, M
   Pollera, M
   Bergamini, E
TI Ageing-related changes in the in vivo function of rat liver
   macroautophagy and proteolysis
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE rat liver; ageing; autophagy; proteolysis; food restriction; insulin;
   antilipolytic agents
ID AGE-RELATED-CHANGES; OXIDATIVE STRESS; AUTOPHAGIC PROTEOLYSIS;
   PROTEIN-DEGRADATION; DIETARY RESTRICTION; FOOD RESTRICTION;
   ACCUMULATION; MECHANISM; DOLICHOL; DECLINE
AB Autophagy is a universal, highly regulated mechanism responsible for the degradation of long-lived proteins, cytomembranes and organelles during fasting and may be the cell repair mechanism that mediates the anti-ageing effects of calorie restriction (Bergamini and Gori, 1995). The function of autophagy was studied in vivo on male Sprague Dawley rats fed ad libitum or 40% food restricted. Autophagy was induced in overnight fasted rats by the injection of an anti-lipolytic agent and was investigated by electron microscopy. Changes in regulatory plasma nutrients and hormones were assessed and rate of proteolysis was calculated from the release of C-14(6)-valine from pre-labelled resident proteins. Results in rats fed ad libitum showed that autophagic-proteolytic response to antilypolitic agents was paramount in one month-old rats; was high but delayed in 2 month-old rats, decreased remarkably in 6 month-old rats and almost negligible at older age. Parallel ageing related changes were observed in the effects of treatment lowering glucose and insulin plasma levels. Calorie restriction prevented all changes. In view of the known suppressive effects of insulin, it may be concluded that the age-changes of autophagy are secondary to the ageing-related alteration in glucose metabolism and hormone levels, whose appearance is delayed by calorie restriction. Data may support the hypothesis that ad libitum feeding accelerates the rate of ageing by raising insulin plasma levels and suppressing autophagy and membrane maintenance, and that calorie restriction may break this vicious circle. (C) 2003 Elsevier Science Inc. All rights reserved.
C1 Univ Pisa, Ctr Ricera, Interdipartimentale Biol & Patol Invecchiamento, I-56123 Pisa, Italy.
C3 University of Pisa
RP Bergamini, E (corresponding author), Univ Pisa, Dipartimento Patol Sperimentale,Biotecnol Med,I, Via Roma 55, I-56126 Pisa, Italy.
EM ebergami@ipg.med.unipi.it
CR Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   BERGAMINI E, 1993, EXP MOL PATHOL, V59, P13, DOI 10.1006/exmp.1993.1023
   BERGAMINI E, 1994, AM J PHYSIOL, V266, pG118, DOI 10.1152/ajpgi.1994.266.1.G118
   BERGAMINI E, 1999, AGING CLIN EXP RES
   Bergamini E., 1990, PROTEIN METABOLISM A, V9, P361
   BERGAMINI E, 2002, G GERONTOL, V50, P135
   Bergamini E., 1987, PEROXISOMES BIOL MED, P295
   BERGAMINI E, 2002, G GERONTOL, V50, P181
   BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Cavallini G, 2002, AGING CLIN EXP RES, V14, P152
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   CUBEDDU TL, 1985, BIOCHIM BIOPHYS ACTA, V839, P96, DOI 10.1016/0304-4165(85)90186-2
   Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9
   DELROSO A, 1991, THESIS U FLORENCE IT
   Dini B, 2001, EXP GERONTOL, V37, P99, DOI 10.1016/S0531-5565(01)00156-5
   DIZDAROGLU M, 1999, METHODS AGING RES, P607
   DOLFI C, 2003, IN PRESS BIOGERONTOL
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Grune T, 2000, BIOGERONTOLOGY, V1, P31, DOI 10.1023/A:1010037908060
   Gupta G, 2000, AM J PHYSIOL-REG I, V278, pR111, DOI 10.1152/ajpregu.2000.278.1.R111
   Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   MORTIMOR.GE, 1970, J BIOL CHEM, V245, P2375
   MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Stadtman ER, 2002, FREE RADICAL BIO MED, V33, P597, DOI 10.1016/S0891-5849(02)00904-8
   STARKEREED PE, 1999, METHODS AGING RES, P637
   Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x
   Terman A, 1998, MECH AGEING DEV, V104, P277, DOI 10.1016/S0047-6374(98)00073-6
   Terman A, 1995, GERONTOLOGY, V41, P319
   THIRION J, 1991, BIOL CELL, V71, P267, DOI 10.1016/0248-4900(91)90269-S
   Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Ward Walter F, 2002, Prog Mol Subcell Biol, V29, P35
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WARD WF, 1994, MODULATION AGING PRO, P121
   Weibel E.R, 1979, STEREOLOGICAL METHOD, V1, P415
NR 42
TC 135
Z9 155
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAY
PY 2003
VL 38
IS 5
BP 519
EP 527
DI 10.1016/S0531-5565(03)00002-0
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 692CJ
UT WOS:000183642500007
PM 12742529
DA 2024-02-19
ER

PT J
AU MENDENHALL, CL
   ROUSTER, SD
   ROSELLE, GA
   GROSSMAN, CJ
   GHOSN, S
   GARTSIDE, P
AF MENDENHALL, CL
   ROUSTER, SD
   ROSELLE, GA
   GROSSMAN, CJ
   GHOSN, S
   GARTSIDE, P
TI IMPACT OF CHRONIC-ALCOHOLISM ON THE AGING RAT - CHANGES IN NUTRITION,
   LIVER COMPOSITION, AND MORTALITY
SO ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE ALCOHOLISM; AGING; NUTRITION; LIVER REGENERATION
ID PROTEIN-CALORIE MALNUTRITION; ETHANOL; HEPATITIS; REGENERATION; CELLS;
   MEN; AGE
AB The adverse effects of chronic alcohol consumption (mean 6.68 g/kg/d) were assessed in 150 male Sprague-Dawley rats over their life span (25 months). Evaluations were performed at 2, 3, 8, 13, 19, and 25 months of age for changes in nutrition status, biochemical tests for liver injury, compositional changes in liver, and hepatic regenerative capacity. In spite of nearly identical caloric intake, alcohol treatment was associated with nutritional levels 10-30% lower than controls.
   Maximal changes were observed at the two extremes of ages (2-3 months and 19-25 months). Hence, a nutritional contribution to other adverse changes could not be excluded. Fatty compositional increases (triglycerides) occurred early (5-fold increases after 1 month of treatment) then declined to levels only slightly above controls. Biochemical tests on sera for liver injury (AST and total bilirubin) were consistently higher with alcohol treatment. Regenerative capacity measured by [H-3]thymidine uptake after partial hepatectomy was initially elevated in the alcoholic then rapidly declined beyond 7 months of age. In control animals, an age-related decline was also observed but occurred later beyond 12 months of age. Consistent with these adverse effects, ethanol diet survival was poorer than the pair-fed control groups by 15% (median survival for alcoholics, 17 months vs. 20 months in controls).
C1 UNIV CINCINNATI,MED CTR,CINCINNATI,OH 45267.
   XAVIER UNIV,DEPT MED,CINCINNATI,OH 45207.
   XAVIER UNIV,DEPT PATHOL,CINCINNATI,OH 45207.
   XAVIER UNIV,DEPT BIOSTAT,CINCINNATI,OH 45207.
   XAVIER UNIV,DEPT PHYSIOL,CINCINNATI,OH 45207.
   XAVIER UNIV,DEPT BIOL,CINCINNATI,OH 45207.
C3 University System of Ohio; University of Cincinnati; University System
   of Ohio; Xavier University; University System of Ohio; Xavier
   University; University System of Ohio; Xavier University; University
   System of Ohio; Xavier University; University System of Ohio; Xavier
   University
RP MENDENHALL, CL (corresponding author), DEPT VET AFFAIRS MED CTR,3200 VINE ST,CINCINNATI,OH 45220, USA.
CR BEYER HS, 1991, J LAB CLIN MED, V117, P101
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   Carlsson A, 1980, Adv Biochem Psychopharmacol, V23, P295
   CHANYEUNG M, 1981, AM J CLIN PATHOL, V75, P320
   CHERNOFF R, 1988, MODERN NUTRITION HLT, P982
   DREOSTI IE, 1981, ALCOHOL CLIN EXP RES, V5, P357, DOI 10.1111/j.1530-0277.1981.tb04916.x
   DUGUAY L, 1981, GUT, V23, P8
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   ELLIS RJ, 1989, PSYCHOL BULL, V106, P128, DOI 10.1037/0033-2909.106.1.128
   FRANK WO, 1979, J LAB CLIN MED, V93, P402
   FRANK WO, 1980, GASTROENTEROLOGY, V78, P1167
   FRANK WO, 1980, J LAB CLIN MED, V78, P1167
   GOLDSMITH RH, 1983, J AM COLL NUTR, V2, P215
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   JAFFE JJ, 1954, ANAT REC, V120, P935, DOI 10.1002/ar.1091200408
   KANPMANN JP, 1975, GERIATRICS, V30, P91
   KUMAR I, 1959, NUTRITION, V13, P320
   LEGUILLY Y, 1973, GERONTOLOGY, V19, P303, DOI 10.1159/000211984
   Lieber C S, 1968, Adv Intern Med, V14, P151
   LIEBER CS, 1963, T ASSOC AM PHYSICIAN, V76, P289
   LIEBER CS, 1961, J CLIN INVEST, V40, P394, DOI 10.1172/JCI104266
   LIEBER CS, 1975, P NATL ACAD SCI USA, V72, P437, DOI 10.1073/pnas.72.2.437
   LIEBER CS, 1977, METABOLIC ASPECTS AL, P46
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAKOWKA L, 1981, PHARMACOLOGIST, V23, P221
   MANDENHALL CL, 1969, BIOCHIM BIOPHYS ACTA, V187, P501
   MCGANDY RB, 1966, J GERONTOL, V21, P581, DOI 10.1093/geronj/21.4.581
   MENDENHALL C, 1987, ALCOHOL ALCOHOLISM, V22, P375
   MENDENHALL CL, 1972, J LIPID RES, V13, P177
   MENDENHALL CL, 1986, AM J CLIN NUTR, V43, P213, DOI 10.1093/ajcn/43.2.213
   MENDENHALL CL, 1984, AM J MED, V76, P211, DOI 10.1016/0002-9343(84)90776-9
   MENDENHALL CL, 1974, AM J PHYSIOL, V227, P377, DOI 10.1152/ajplegacy.1974.227.2.377
   NOONBERG A, 1985, ALCOHOL CLIN EXP RES, V9, P334, DOI 10.1111/j.1530-0277.1985.tb05555.x
   PARIZKOVA J, 1971, HUM BIOL, V43, P318
   Parsons O. A., 1987, NEUROPSYCHOLOGY ALCO
   PIROLA RC, 1972, PHARMACOLOGY, V7, P185, DOI 10.1159/000136288
   POSO H, 1980, MED BIOL, V58, P329
   REBOUCAS G, 1961, J CLIN INVEST, V40, P1355, DOI 10.1172/JCI104366
   RYAN C, 1982, ALCOHOLISM CLIN EXPT, V6, P79
   VANHANDEL E, 1957, J LAB CLIN MED, V50, P152
   WIEBE T, 1989, J STUD ALCOHOL, V490, P476
   1985, SAS STATISTICS VERSI
NR 42
TC 11
Z9 11
U1 0
U2 0
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0145-6008
J9 ALCOHOL CLIN EXP RES
JI Alcoholism (NY)
PD AUG
PY 1993
VL 17
IS 4
BP 847
EP 853
DI 10.1111/j.1530-0277.1993.tb00852.x
PG 7
WC Substance Abuse
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Substance Abuse
GA LT753
UT WOS:A1993LT75300023
PM 8214425
DA 2024-02-19
ER

PT J
AU Hennebelle, M
   Roy, M
   St-Pierre, V
   Courchesne-Loyer, A
   Fortier, M
   Bouzier-Sore, AK
   Gallis, JL
   Beauvieux, MC
   Cunnane, SC
AF Hennebelle, Marie
   Roy, Maggie
   St-Pierre, Valerie
   Courchesne-Loyer, Alexandre
   Fortier, Melanie
   Bouzier-Sore, Anne-Karine
   Gallis, Jean-Louis
   Beauvieux, Marie-Christine
   Cunnane, Stephen C.
TI Energy restriction does not prevent insulin resistance but does prevent
   liver steatosis in aging rats on a Western-style diet
SO NUTRITION
LA English
DT Article
DE Calorie restriction; Aged rats; Fatty acid composition; HRMAS H-1-NMR;
   Sucrose; omega-3 PUFA
ID MAGNETIC-RESONANCE-SPECTROSCOPY; FRUCTOSE-ENRICHED DIETS;
   FATTY-ACID-COMPOSITION; AGE-RELATED-CHANGES; SUCROSE-RICH DIET; CALORIE
   RESTRICTION; METABOLIC SYNDROME; HEPATIC STEATOSIS; MEMBRANE-FLUIDITY;
   FOOD RESTRICTION
AB Objective: The aim of this study was to evaluate the effects of long-term energy restriction (ER) on plasma, liver, and skeletal muscle metabolite profiles in aging rats fed a Western-style diet.
   Methods: Three groups of male Sprague-Dawley rats were studied. Group 1 consisted of 2 mo old rats fed ad libitum; group 2 were 19 mo old rats also fed ad libitum; and group 3 were 19 mo old rats subjected to 40% ER for the last 11.5 mo. To imitate a Western-style diet, all rats were given a high-sucrose, very low omega-3 polyunsaturated fatty acid (PUFA) diet. High-resolution magic angle spinning-H-1 nuclear magnetic resonance spectroscopy was used for hepatic and skeletal muscle metabolite determination, and fatty acid profiles were measured by capillary gas chromatography on plasma, liver, and skeletal muscle.
   Results: ER coupled with a Western-style diet did not prevent age-induced insulin resistance or the increase in triacylglycerol content in plasma and skeletal muscle associated with aging. However, in the liver, ER did prevent steatosis and increased the percent of saturated and monounsaturated fatty acids relative to omega-6 and omega-3 PUFA.
   Conclusions: Although steatosis was reduced, the beneficial effects of ER on systemic insulin resistance and plasma and skeletal muscle metabolites observed elsewhere with a balanced diet seem to be compromised by high-sucrose and low omega-3 PUPA intake. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hennebelle, Marie; Roy, Maggie; St-Pierre, Valerie; Courchesne-Loyer, Alexandre; Fortier, Melanie; Cunnane, Stephen C.] Res Ctr Aging, Sherbrooke, PQ, Canada.
   [Roy, Maggie; St-Pierre, Valerie; Courchesne-Loyer, Alexandre; Cunnane, Stephen C.] Univ Sherbrooke, Dept Physiol & Biophys, Sherbrooke, PQ J1K 2R1, Canada.
   [Bouzier-Sore, Anne-Karine; Gallis, Jean-Louis; Beauvieux, Marie-Christine] Univ Victor Segalen, LabEx TRAIL IBIO, Ctr Resonance Magnet Syst Biol, Bordeaux, France.
   [Cunnane, Stephen C.] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada.
C3 University of Sherbrooke; Universite de Bordeaux; University of
   Sherbrooke
RP Hennebelle, M (corresponding author), Res Ctr Aging, Sherbrooke, PQ, Canada.
EM Marie.Hennebelle@USherbrooke.ca
RI Roy, Maggie/ABC-6221-2020; Hennebelle, Marie/AAC-7730-2020
OI Roy, Maggie/0000-0002-6503-6747; Bouzier-Sore,
   Anne-Karine/0000-0002-3470-0940; Hennebelle, Marie/0000-0002-2279-1400
FU Fonds de recherche du Quebec-Sante (FRQS); Natural Sciences and
   Engineering Research Council of Canada (NSERC) [3606-2008]; Canadian
   Foundation for Innovation (CFI); Universite de Sherbrooke; Quebec
   Network for Research on Aging
FX This study was financially supported by the Fonds de recherche du
   Quebec-Sante (FRQS), Natural Sciences and Engineering Research Council
   of Canada (NSERC) (3606-2008), Canadian Foundation for Innovation (CFI),
   Universite de Sherbrooke (SCC's University Chair) and the Quebec Network
   for Research on Aging. SCC, and MR conceived and designed the
   experiments. MH, MR, VSP, ACL, MCB, AKBS, JLG, and MF performed the
   experiments and analyses. MH and MR analyzed the data. All the authors
   contributed to writing and revising the article.
CR Ando S, 2002, J NEUROSCI RES, V70, P290, DOI 10.1002/jnr.10352
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166
   Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5
   Beauvieux MC, 2013, UNITED EUROPEAN GAST, V1, pA59
   Carrascosa JM, 2011, CURR PROTEIN PEPT SC, V12, P305
   Cefalu WT, 2000, EXP GERONTOL, V35, P331, DOI 10.1016/S0531-5565(00)00093-0
   Chen YN, 2013, BIOSCIENCE REP, V33, P83, DOI 10.1042/BSR20120060
   Chen YN, 2012, J GERONTOL A-BIOL, V67, P1121, DOI 10.1093/gerona/gls113
   CHOI JH, 1995, FREE RADICAL BIO MED, V18, P133, DOI 10.1016/0891-5849(94)00106-T
   Chouinard-Watkins R, 2013, BRIT J NUTR, V110, P1751, DOI 10.1017/S0007114513001268
   Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b
   Courchesne-Loyer A, 2013, NUTRITION, V29, P635, DOI 10.1016/j.nut.2012.09.009
   Cree MG, 2008, AM J PHYSIOL-ENDOC M, V294, pE1, DOI 10.1152/ajpendo.00562.2007
   Crescenzo R, 2013, EUR J NUTR, V52, P537, DOI 10.1007/s00394-012-0356-y
   D'Alessandro ME, 2013, PROSTAG LEUKOTR ESS, V88, P171, DOI 10.1016/j.plefa.2012.11.003
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   Erejuwa OO, 2012, MOLECULES, V17, P1900, DOI 10.3390/molecules17021900
   Faulks SC, 2006, J GERONTOL A-BIOL, V61, P781, DOI 10.1093/gerona/61.8.781
   Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951
   García-San Frutos M, 2007, ENDOCRINOLOGY, V148, P5238, DOI 10.1210/en.2007-0543
   Hein GJ, 2012, LIPIDS, V47, P141, DOI 10.1007/s11745-011-3623-4
   Higami Y, 2006, J GERONTOL A-BIOL, V61, P1099, DOI 10.1093/gerona/61.11.1099
   Huang CY, 2011, ANN NUTR METAB, V57, P169, DOI 10.1159/000321966
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   Idilman IS, 2013, RADIOLOGY, V267, P767, DOI 10.1148/radiol.13121360
   Jelinek D, 2013, NUTRITION, V29, P1159, DOI 10.1016/j.nut.2013.02.012
   Jeon TI, 2001, LIPIDS, V36, P589, DOI 10.1007/s11745-001-0761-1
   Karsenty J, 2013, EUR J NUTR, V52, P1865, DOI 10.1007/s00394-012-0488-0
   Kawasaki T, 2009, J NUTR, V139, P2067, DOI 10.3945/jn.109.105858
   Kim JY, 2009, AGE, V31, P127, DOI 10.1007/s11357-009-9089-0
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   Lane MA, 1999, TOXICOL SCI, V52, P41, DOI 10.1093/toxsci/52.2.41
   Lee J, 1999, FREE RADICAL BIO MED, V26, P260, DOI 10.1016/S0891-5849(98)00195-6
   LIEPA GU, 1980, AM J PHYSIOL, V238, pE253, DOI 10.1152/ajpendo.1980.238.3.E253
   Lombardo YB, 2007, LIPIDS, V42, P427, DOI 10.1007/s11745-007-3039-3
   Masoro EJ, 2009, BBA-GEN SUBJECTS, V1790, P1040, DOI 10.1016/j.bbagen.2009.02.011
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   Masson VR, 2008, J NUTR, V138, P1915, DOI 10.1093/jn/138.10.1915
   MCCAY CM, 1989, NUTRITION, V5, P155
   McCay CM, 1939, J NUTR, V18, P1
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002
   Moura LP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-2
   Nomura K, 2012, J NUTR BIOCHEM, V23, P203, DOI 10.1016/j.jnutbio.2011.09.006
   Pachikian BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023365
   Pallottini V, 2006, J CELL BIOCHEM, V98, P1044, DOI 10.1002/jcb.20951
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Paniagua JA, 2014, NUTRITION, V30, P177, DOI 10.1016/j.nut.2013.07.017
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Petersen KF, 2001, DIABETES, V50, P1263, DOI 10.2337/diabetes.50.6.1263
   Plourde M, 2009, NUTRITION, V25, P289, DOI 10.1016/j.nut.2008.09.006
   Roy M, 2013, NEUROCHEM INT, V63, P450, DOI 10.1016/j.neuint.2013.08.006
   Shulman GI, 2004, PHYSIOLOGY, V19, P183, DOI 10.1152/physiol.00007.2004
   Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080
   Simopoulos AP, 2013, NUTRIENTS, V5, P2901, DOI 10.3390/nu5082901
   Vos MB, 2013, HEPATOLOGY, V57, P2525, DOI 10.1002/hep.26299
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
   Zhong L, 2009, J DIG DIS, V10, P315, DOI 10.1111/j.1751-2980.2009.00402.x
   Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024
NR 65
TC 6
Z9 6
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD MAR
PY 2015
VL 31
IS 3
BP 523
EP 530
DI 10.1016/j.nut.2014.09.009
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CC3RT
UT WOS:000350267800016
PM 25701344
DA 2024-02-19
ER

PT J
AU Liu, ZH
   Jin, LG
   Yang, JK
   Wang, BL
   Wu, KKL
   Hallenborg, P
   Xu, AM
   Cheng, KKY
AF Liu, Zhuohao
   Jin, Leigang
   Yang, Jin-Kui
   Wang, Baile
   Wu, Kelvin K. L.
   Hallenborg, Philip
   Xu, Aimin
   Cheng, Kenneth K. Y.
TI The Dysfunctional MDM2-p53 Axis in Adipocytes Contributes to
   Aging-Related Metabolic Complications by Induction of Lipodystrophy
SO DIABETES
LA English
DT Article
ID PANCREATIC BETA-CELLS; ADIPOSE-TISSUE; CELLULAR SENESCENCE; SECRETORY
   PHENOTYPE; INSULIN-SECRETION; MUTANT MICE; P53; FAT; ACTIVATION; AGE
AB Profound loss and senescence of adipose tissues are hallmarks of advanced age, but the underlying cause and their metabolic consequences remain obscure. Proper function of the murine double minute 2 (MDM2)-p53 axis is known to prevent tumorigenesis and several metabolic diseases, yet its role in regulation of adipose tissue aging is still poorly understood. In this study, we show that the proximal p53 inhibitor MDM2 is markedly downregulated in subcutaneous white and brown adipose tissues of mice during aging. Genetic disruption of MDM2 in adipocytes triggers canonical p53-mediated apoptotic and senescent programs, leading to age-dependent lipodystrophy and its associated metabolic disorders, including type 2 diabetes, nonalcoholic fatty liver disease, hyperlipidemia, and energy imbalance. Surprisingly, this lipodystrophy mouse model also displays premature loss of physiological integrity, including impaired exercise capacity, multiple organ senescence, and shorter life span. Transplantation of subcutaneous fat rejuvenates the metabolic health of this aging-like lipodystrophy mouse model. Furthermore, senescence-associated secretory factors from MDM2-null adipocytes impede adipocyte progenitor differentiation via a non-cell-autonomous manner. Our findings suggest that tight regulation of the MDM2-p53 axis in adipocytes is required for adipose tissue dynamics and metabolic health during the aging process.
C1 [Liu, Zhuohao; Jin, Leigang; Wang, Baile; Xu, Aimin] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China.
   [Liu, Zhuohao; Wang, Baile; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.
   [Jin, Leigang; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.
   [Yang, Jin-Kui] Capital Med Univ, Beijing Key Lab Diabet Res & Care, Dept Endocrinol, Beijing Tongren Hosp, Beijing, Peoples R China.
   [Wu, Kelvin K. L.; Cheng, Kenneth K. Y.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.
   [Hallenborg, Philip] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.
C3 University of Hong Kong; University of Hong Kong; University of Hong
   Kong; Capital Medical University; Hong Kong Polytechnic University;
   University of Southern Denmark
RP Xu, AM (corresponding author), Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China.; Xu, AM (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.; Xu, AM (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.; Cheng, KKY (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.
EM amxu@hku.hk; kenneth.ky.cheng@polyu.edu.hk
RI Wu, Kelvin/JLL-7336-2023; Wang, Baile/HHM-9573-2022; Cheng,
   Yip/C-4551-2009; Wang, Baile/AFV-2216-2022
OI Wang, Baile/0000-0002-8080-2964; Wang, Baile/0000-0002-8080-2964;
   Leigang, Jin/0000-0002-6916-4009; Wu, Kelvin Ka Lok/0000-0002-7755-0671;
   Cheng, Kenneth King Yip/0000-0002-7274-0839
FU French National Research Agency, Research Grant Council of Hong Kong
   Joint Scheme [A-HKU705/13]; Research Grant Council of Hong Kong
   Collaborative Fund [C7055-14G]; General Research Fund [17100717]; Health
   Medical Research Fund [04151756]
FX This work was supported by the French National Research Agency, Research
   Grant Council of Hong Kong Joint Scheme (A-HKU705/13), Research Grant
   Council of Hong Kong Collaborative Fund (C7055-14G), General Research
   Fund (17100717), and Health Medical Research Fund (04151756).
CR Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382
   Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen YW, 2015, P NATL ACAD SCI USA, V112, pE4556, DOI 10.1073/pnas.1506954112
   Cheng KKY, 2012, P NATL ACAD SCI USA, V109, P8919, DOI 10.1073/pnas.1202435109
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005
   Findeisen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018532
   Gaulton KJ, 2008, DIABETES, V57, P3136, DOI 10.2337/db07-1731
   Gautheron J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11869
   Grier JD, 2002, GENESIS, V32, P145, DOI 10.1002/gene.10066
   Guillermier C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90349
   Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200
   Hallenborg P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.188
   Hallenborg P, 2012, CELL DEATH DIFFER, V19, P1381, DOI 10.1038/cdd.2012.15
   Harkema L, 2016, VET PATHOL, V53, P366, DOI 10.1177/0300985815625169
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037
   Kwok KHM, 2016, CLIN SCI, V130, P2087, DOI 10.1042/CS20160465
   Lessel D, 2017, J CLIN INVEST, V127, P3598, DOI 10.1172/JCI92171
   Li XM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11740
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luk CT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14360
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Marino S, 2000, GENE DEV, V14, P994
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262
   Reis FCG, 2016, AGING-US, V8, P1201, DOI 10.18632/aging.100970
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Sakaguchi M, 2017, CELL METAB, V25, P448, DOI 10.1016/j.cmet.2016.12.008
   Shu LL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14147
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Vergoni B, 2016, DIABETES, V65, P3062, DOI 10.2337/db16-0014
   Wang BL, 2018, EMBO REP, V19, DOI 10.15252/embr.201744977
   Wu DY, 2018, CELL DEATH DIFFER, V25, P169, DOI 10.1038/cdd.2017.187
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200
   Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125
   Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9
NR 43
TC 34
Z9 37
U1 0
U2 21
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD NOV
PY 2018
VL 67
IS 11
BP 2397
EP 2409
DI 10.2337/db18-0684
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA GY0UR
UT WOS:000448238400025
PM 30131393
OA Bronze
DA 2024-02-19
ER

PT J
AU MASSIE, HR
   GRECO, ME
   VADLAMUDI, L
AF MASSIE, HR
   GRECO, ME
   VADLAMUDI, L
TI THE BRAIN-TO-LIVER MERCURY RATIO INCREASES WITH AGING IN MICE
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE MERCURY; MICE; DROSOPHILA; AGING; LIFE SPAN; BRAIN
ID ALZHEIMERS-DISEASE; TROUT
AB There was no significant change in the total amount of mercury in organs (lung, heart, kidney, brain, and liver) from male C57BL/6J mice ranging in age from 133 to 904 days of age maintained under conventional conditions with no known source of mercury exposure other than background concentrations. The lowest values were found in the liver and the highest in the brain, with considerable variation in the mercury content between individual mice for all organs examined. The ratio of mercury in the brain to that in the liver, however, was found to significantly increase with aging in an exponential manner. A similar result was found for the ratio of brain to kidney mercury. We conclude that older mice are less able to maintain low brain-to-liver ratios of mercury regardless of the total body content of mercury.
   Dietary mercury ranging from 200 to 20 000 ppm Hg had little or no influence on the life span of Drosophila fruit flies, suggesting that the effect of mercury is probably not on life span itself but on other factors associated with the aging process such as neurolological disfunction.
RP MASSIE, HR (corresponding author), MASONIC MED RES LAB,UTICA,NY 13501, USA.
CR BACHE CA, 1971, SCIENCE, V172, P951, DOI 10.1126/science.172.3986.951
   COOK T A, 1969, British Dental Journal, V127, P553
   EHMANN WD, 1986, NEUROTOXICOLOGY, V7, P197
   ERK FC, 1971, DROS INF SERV, V47, P130
   HAHN LJ, 1989, FASEB J, V3, P2641, DOI 10.1096/fasebj.3.14.2636872
   JOENSUU OI, 1971, SCIENCE, V172, P1027, DOI 10.1126/science.172.3987.1027
   KLEIN R, 1971, SCIENCE, V172, P872, DOI 10.1126/science.172.3985.872
   MASSIE HR, 1991, AGE, V14, P53, DOI 10.1007/BF02434838
   SAJDELSULKOWSKA EM, 1984, SCIENCE, V225, P947, DOI 10.1126/science.6206567
   TEJNING S, 1969, ARCHENV HLTH, V19, P891
   WESTOO G, 1973, SCIENCE, V181, P567, DOI 10.1126/science.181.4099.567
   WESTOO G, 1967, VAR FODA, V19, P136
   WESTOO G, 1969, VAR FODA, V21, P17
NR 13
TC 3
Z9 4
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAR-APR
PY 1993
VL 28
IS 2
BP 161
EP 167
DI 10.1016/0531-5565(93)90005-X
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KU055
UT WOS:A1993KU05500005
PM 8325352
DA 2024-02-19
ER

PT J
AU FUJITA, T
   SHIRASAWA, T
   UCHIDA, K
   MARUYAMA, N
AF FUJITA, T
   SHIRASAWA, T
   UCHIDA, K
   MARUYAMA, N
TI ISOLATION OF CDNA CLONE ENCODING RAT SENESCENCE MARKER PROTEIN-30
   (SMP30) AND ITS TISSUE DISTRIBUTION
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE AGING; SENESCENCE; CDNA; SMP30; (RAT LIVER)
ID C-JUN; MESSENGER-RNA; LIVER; SEQUENCE; DEGRADATION; EXPRESSION; CALPAIN;
   FOS; AGE
AB We have isolated and characterized two cDNA clones encoding senescence marker protein-30 (SMP30), the amounts of which are known to decrease androgen-independently with aging in the livers of rats. Of these cDNA clones, one consisted of 1588 bp nucleotides and the other of 1195 bp nucleotides generated by alternative polyadenylation. These two cDNA clones shared the same open reading frame, but the larger species had 393 bp nucleotides of 3' untranslated region in addition to the first polyadenylation site of smaller species. Northern hybridization analysis showed that two species of mRNA (1.7 kb and 1.4 kb) located in the liver and kidney were consistent with these short and long forms of cDNA. The open reading frame, 897 bp could encode 299 amino acids. The estimated molecular weight and pI of the deduced polypeptide were 33 387 and 5.1, respectively. Furthermore, immunohistochemical analysis confirmed that SMP30 was preferentially localized in the hepatocytes and renal proximal tubular epithelium. Genomic Southern hybridization analysis demonstrated that SMP30 was widely conserved among higher animals. A computer-assisted homology analysis of nucleic acid and protein databases revealed no remarkable homology with other known proteins. Therefore, SMP30 seems to be a novel protein. In addition, the existence of putative A-U rich mRNA degradation signals and protein degradation signals (PEST sequence) in the structure of SMP30 may suggest important regulatory function of this unique protein manifested by changes in its concentrations.
C1 TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT MOLEC PATHOL,TOKYO 173,JAPAN.
   YAKULT INST MICROBIOL RES,TOKYO,JAPAN.
C3 Tokyo Metropolitan Institute of Gerontology; Yakult Honsha Company,
   Limited
RP FUJITA, T (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT MOLEC BIOL,35-2 SAKAECHO,ITABASHI KU,TOKYO 173,JAPAN.
CR BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241
   BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372
   BUTLER JA, 1989, J CELL PHYSIOL, V141, P400, DOI 10.1002/jcp.1041410222
   CARTER ND, 1985, ANN NY ACAD SCI, V429, P287
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   CHATTERJEE B, 1984, FEBS LETT, V170, P114, DOI 10.1016/0014-5793(84)81380-0
   CHATTERJEE B, 1981, J BIOL CHEM, V156, P5939
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   GILLIS P, 1991, J BIOL CHEM, V266, P3172
   GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5
   HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U
   KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2
   KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9830
   LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033
   MANNS MP, 1989, J CLIN INVEST, V83, P1066, DOI 10.1172/JCI113949
   MENDEL DB, 1991, J BIOL CHEM, V266, P677
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   RECHSTEINER M, 1987, TRENDS BIOCHEM SCI, V12, P390
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   RIZZETTO M, 1973, CLIN EXP IMMUNOL, V15, P331
   ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518
   ROY AK, 1983, J BIOL CHEM, V258, P123
   RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0
   SAKAI M, 1989, CANCER RES, V49, P5633
   Sambrook J., 1989, MOL CLONING LABORATO, V2nd
   Sanger F, 1977, P NATL ACAD SCI USA, V74, P5436
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   SHIGEMOTO K, 1992, MOL IMMUNOL, V29, P573
   SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583
   TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254
   TODA T, 1984, ELECTROPHORESIS, V5, P42, DOI 10.1002/elps.1150050108
   TODA T, 1984, ANAL BIOCHEM, V119, P167
   WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693
   YOST HJ, 1990, TRENDS GENET, V6, P223, DOI 10.1016/0168-9525(90)90183-7
NR 36
TC 86
Z9 106
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD OCT 20
PY 1992
VL 1132
IS 3
BP 297
EP 305
DI 10.1016/0167-4781(92)90164-U
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA JW756
UT WOS:A1992JW75600010
PM 1420310
DA 2024-02-19
ER

PT J
AU Delire, B
   Lebrun, V
   Selvais, C
   Henriet, P
   Bertrand, A
   Horsmans, Y
   Leclercq, IA
AF Delire, Benedicte
   Lebrun, Valerie
   Selvais, Charlotte
   Henriet, Patrick
   Bertrand, Amelie
   Horsmans, Yves
   Leclercq, Isabelle A.
TI Aging enhances liver fibrotic response in mice through hampering
   extracellular matrix remodeling
SO AGING-US
LA English
DT Article
DE macrophages; collagen crosslinking; fibrosis resolution; matrix
   metalloproteinase; inflammation
ID HEPATIC STELLATE CELLS; SCAR-ASSOCIATED MACROPHAGES; FIBROSIS
   PROGRESSION; CARBON-TETRACHLORIDE; CROSS-LINKING; RESOLUTION; AGE;
   REGRESSION; DISEASE; RECRUITMENT
AB Clinical data identify age as a factor for severe liver fibrosis. We evaluate whether and how aging modulates the fibrotic response in a mouse model. Liver fibrosis was induced by CCl4 injections (thrice weekly for 2 weeks) in 7 weeks-and 15 months-old mice (young and old, respectively). Livers were analyzed for fibrosis, inflammation and remodeling 48 and 96 hours after the last injection. Old mice developed more severe fibrosis compared to young ones as evaluated by sirius red morphometry. Expression of pro-fibrogenic genes was equally induced in the two age-groups but enhanced fibrolysis in young mice was demonstrated by a significantly higher Mmp13 induction and collagenase activity. While fibrosis resolution occurred in young mice within 96 hours, no significant fibrosis attenuation was observed in old mice. Although recruitment of monocytes-derived macrophages was similar in young and old livers, young macrophages had globally a remodeling phenotype while old ones, a pro-fibrogenic phenotype. Moreover, we observed a higher proportion of thick fibers and enhanced expression of enzymes involved in collagen maturation in old mice.
   Conclusion: Impaired fibrolysis of a matrix less prone to remodeling associated with a pro-inflammatory phenotype of infiltrated macrophages contribute to a more severe fibrosis in old mice.
C1 [Delire, Benedicte; Lebrun, Valerie; Selvais, Charlotte; Bertrand, Amelie; Horsmans, Yves; Leclercq, Isabelle A.] Catholic Univ Louvain, IREC, Lab Hepatogastroenterol, Brussels, Belgium.
   [Henriet, Patrick] Catholic Univ Louvain, Duve Inst, Cell Biol Unit, Brussels, Belgium.
   [Horsmans, Yves] Clin Univ St Luc, Dept Hepatogastroenterol, Brussels, Belgium.
   [Horsmans, Yves] Catholic Univ Louvain, Inst Clin Res, Brussels, Belgium.
C3 Universite Catholique Louvain; Universite Catholique Louvain; Universite
   Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite
   Catholique Louvain
RP Leclercq, IA (corresponding author), Catholic Univ Louvain, IREC, Lab Hepatogastroenterol, Brussels, Belgium.
EM isabelle.leclercq@uclouvain.be
OI Henriet, Patrick/0000-0003-4602-8888
FU D.G. Higher Education and Scientific Research of the French Community of
   Belgium [12/17-047]; FRS-FNRS (Belgium) [PDR T.1067.14]; Gilead Belgium;
   Janssens Pharmaceutica Belgium; Roche Belgium
FX The work was supported by grants from the D.G. Higher Education and
   Scientific Research of the French Community of Belgium (12/17-047), the
   FRS-FNRS (PDR T.1067.14) (Belgium) and unrestricted research grants from
   Gilead Belgium, Janssens Pharmaceutica Belgium, and Roche Belgium. IL is
   a FRS-FNRS senior research associate, BD is a FRS-FNRS PhD fellow. PH is
   a FRS-FNRS research associate.
CR Adhyatmika A, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00081
   Barnes MA, 2015, J LEUKOCYTE BIOL, V97, P161, DOI 10.1189/jlb.3A0614-280R
   Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Collins BH, 2013, LIVER INT, V33, P1175, DOI 10.1111/liv.12202
   DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843
   Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041
   Delire B, 2015, J CLIN TRANSL HEPATO, V3, P53, DOI 10.14218/JCTH.2014.00035
   Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024
   Endo H, 2011, PATHOBIOLOGY, V78, P239, DOI 10.1159/000328841
   Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0
   Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Imamura M, 2005, GASTROENTEROLOGY, V128, P138, DOI 10.1053/j.gastro.2004.10.005
   Iredale JP, 2013, BBA-MOL BASIS DIS, V1832, P876, DOI 10.1016/j.bbadis.2012.11.002
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548
   Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009
   Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894
   Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950
   Karsdal MA, 2016, J HEPATOL, V64, P103, DOI 10.1016/j.jhep.2015.08.014
   Kesteloot F, 2007, HEPATOLOGY, V46, P1620, DOI 10.1002/hep.21868
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787
   Liu SB, 2016, FASEB J, V30, P1599, DOI 10.1096/fj.14-268425
   Mahrouf-Yorgov M, 2011, REJUV RES, V14, P353, DOI 10.1089/rej.2010.1146
   McHutchison J, 2010, GASTROENTEROLOGY, V138, P1365, DOI 10.1053/j.gastro.2009.12.003
   Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632
   Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Popov Y, 2011, GASTROENTEROLOGY, V140, P1642, DOI 10.1053/j.gastro.2011.01.040
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   Sahin H, 2012, HEPATOLOGY, V55, P1610, DOI 10.1002/hep.25545
   Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30
   Starkel P, 2011, BEST PRACT RES CL GA, V25, P319, DOI 10.1016/j.bpg.2011.02.004
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248
   Warren Alessandra, 2011, Curr Gerontol Geriatr Res, V2011, P439835, DOI 10.1155/2011/439835
   Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053
   Watanabe T, 2000, J HEPATOL, V33, P224, DOI 10.1016/S0168-8278(00)80363-3
   Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412
   Yang L, 2014, GASTROENTEROLOGY, V146, P1339, DOI 10.1053/j.gastro.2014.01.061
   Yang X, 2016, ONCOTARGET, V7, P1084, DOI 10.18632/oncotarget.6744
NR 54
TC 31
Z9 35
U1 1
U2 10
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JAN
PY 2017
VL 9
IS 1
BP 112
EP 127
DI 10.18632/aging.101124
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EK8JW
UT WOS:000394170800010
PM 27941216
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Ferreira-Gonzalez, S
   Lu, WY
   Raven, A
   Dwyer, B
   Man, TY
   O'Duibhir, E
   Lewis, PJS
   Campana, L
   Kendall, TJ
   Bird, TG
   Tarrats, N
   Acosta, JC
   Boulter, L
   Forbes, SJ
AF Ferreira-Gonzalez, Sofia
   Lu, Wei-Yu
   Raven, Alexander
   Dwyer, Benjamin
   Man, Tak Yung
   O'Duibhir, Eoghan
   Lewis, Philip J. Starkey
   Campana, Lara
   Kendall, Tim J.
   Bird, Thomas G.
   Tarrats, Nuria
   Acosta, Juan-Carlos
   Boulter, Luke
   Forbes, Stuart J.
TI Paracrine cellular senescence exacerbates biliary injury and impairs
   regeneration
SO NATURE COMMUNICATIONS
LA English
DT Article
ID PROGENITOR CELLS; SECRETORY PHENOTYPE; EPITHELIAL-CELLS; BILE-DUCTS;
   LIVER; CIRRHOSIS; CANCER; HEPATOCYTES; EXPRESSION; INHIBITOR
AB Cellular senescence is a mechanism that provides an irreversible barrier to cell cycle progression to prevent undesired proliferation. However, under pathological circumstances, senescence can adversely affect organ function, viability and regeneration. We have developed a mouse model of biliary senescence, based on the conditional deletion of Mdm2 in bile ducts under the control of the Krt19 promoter, that exhibits features of biliary disease. Here we report that senescent cholangiocytes induce profound alterations in the cellular and signalling microenvironment, with recruitment of myofibroblasts and macrophages causing collagen deposition, TGF beta production and induction of senescence in surrounding cholangiocytes and hepatocytes. Finally, we study how inhibition of TGF beta-signalling disrupts the transmission of senescence and restores liver function. We identify cellular senescence as a detrimental mechanism in the development of biliary injury. Our results identify TGF beta as a potential therapeutic target to limit senescence-dependent aggravation in human cholangiopathies.
C1 [Ferreira-Gonzalez, Sofia; Lu, Wei-Yu; Raven, Alexander; Dwyer, Benjamin; Man, Tak Yung; O'Duibhir, Eoghan; Lewis, Philip J. Starkey; Campana, Lara; Bird, Thomas G.; Forbes, Stuart J.] Univ Edinburgh, MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.
   [Kendall, Tim J.; Bird, Thomas G.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland.
   [Bird, Thomas G.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.
   [Tarrats, Nuria; Acosta, Juan-Carlos] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland.
   [Boulter, Luke] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.
C3 University of Edinburgh; University of Edinburgh; Beatson Institute;
   University of Edinburgh; University of Edinburgh
RP Forbes, SJ (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.
EM stuart.forbes@ed.ac.uk
RI Bird, Tom/H-3840-2019; Lu, Wei-Yu/N-5884-2019; Acosta,
   Juan/AAE-6320-2021; Ferreira-Gonzalez, Sofia/AAL-9189-2021; Kendall,
   Tim/H-2698-2019; Gonzalez, Sofia/HRA-6915-2023; Campana,
   Lara/AAI-9372-2020; gonzalez, Sofia/JVZ-0275-2024; Oommen, Oommen
   P/H-9458-2013
OI Bird, Tom/0000-0002-6120-1581; Lu, Wei-Yu/0000-0002-0419-0257; Acosta,
   Juan/0000-0002-7989-7329; Ferreira-Gonzalez, Sofia/0000-0001-7776-287X;
   Kendall, Tim/0000-0002-4174-2786; Campana, Lara/0000-0003-1805-4755;
   Bozec, Laurent/0000-0001-6322-7817; Oommen, Oommen
   P/0000-0003-2768-0133; Gentleman, Eileen/0000-0003-0447-5137; Boulter,
   Luke/0000-0002-7954-6705; Motwani, Meghna/0000-0002-0667-2399; Snijders,
   Bram/0000-0002-5416-8592; Forbes, Stuart/0000-0003-3715-2561; Raven,
   Alexander/0000-0003-4409-9543; Dwyer, Benjamin/0000-0003-2527-5417
FU Principal's Career Development Ph.D. Scholarships for Ph.D. students;
   MRC Centre for Regenerative Medicine Centre grant; UK Medical Research
   MRC [MR/K017047/1]; Computational and Chemical Biology of Stem Cell
   Niche [MR/L012766/1]; UK Regenerative Medicine Platform [MR/K026666/1];
   MRC [MR/L012766/1, MR/K026666/1, MR/P016839/1, MR/K017047/1] Funding
   Source: UKRI; Cancer Research UK [16243] Funding Source: researchfish;
   Medical Research Council [MR/L012766/1, MR/K017047/1, MR/K026666/1,
   MR/K017047/1B, 1802904, MR/P016839/1] Funding Source: researchfish;
   Wellcome Trust [107492/Z/15/Z] Funding Source: researchfish; Wellcome
   Trust [107492/Z/15/Z] Funding Source: Wellcome Trust
FX The authors would like to thank Prof. Lozano (Department of Cancer
   Genetics, University of Texas) for Mdm2flox/flox mice; and F. Lemaigre
   and I. Leclercq for OPNi-CreERT2R26RYFP mice. S.F.-G. was funded by
   Principal's Career Development Ph.D. Scholarships for Ph.D. students and
   via the MRC Centre for Regenerative Medicine Centre grant. This work was
   supported by the UK Medical Research MRC (MR/K017047/1), the
   Computational and Chemical Biology of Stem Cell Niche (MR/L012766/1) and
   the UK Regenerative Medicine Platform (MR/K026666/1).
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133
   Gonçalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0
   Harada K, 2001, J HEPATOL, V34, P500, DOI 10.1016/S0168-8278(00)00075-1
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621
   Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006
   Lu W. Y., 2015, PROTOC EXCH
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Massagué J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5
   Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Misumi S, 2008, EUR J NEUROSCI, V28, P1049, DOI 10.1111/j.1460-9568.2008.06420.x
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Tabibian JH, 2016, HEPATOLOGY, V63, P185, DOI 10.1002/hep.27927
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Talwalkar JA, 2003, LANCET, V362, P53, DOI 10.1016/S0140-6736(03)13808-1
   Vleggaar FP, 2001, GUT, V49, P276, DOI 10.1136/gut.49.2.276
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
NR 45
TC 127
Z9 138
U1 0
U2 12
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 9
PY 2018
VL 9
AR 1020
DI 10.1038/s41467-018-03299-5
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FY7FN
UT WOS:000427027200008
PM 29523787
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lu, YC
   Rozengurt, E
   Zhukova, E
AF Lu, Yu-Chun
   Rozengurt, Enrique
   Zhukova, Elena
TI Transgenic insulin released from G cells preferentially signals in the
   liver
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Transgenic G-InsKi mice; insulin; G cell; diabetes; liver; hepatic
   insulin receptor phosphorylation; hepatic Akt phosphorylation; hepatic
   glucose production; senescence; Akita mice
ID GLUCOSE-PRODUCTION; INHIBITION
AB We have previously produced transgenic G-InsKi mice, a model allowing regulated portal insulin delivery from gastric G cells without using beta cells. Here, we report that in G-InsKi mice portal levels of transgenic human insulin are 6-fold higher than in peripheral circulation. Peptone-induced release of transgenic human insulin from G cells preferentially stimulated signaling cascades in the liver rather than in peripheral insulin-sensitive tissues, as judged by tyrosine phosphorylation of insulin receptor beta subunit and phosphorylation of protein kinase Akt/PKB at Thr-308. G-InsKi mice provide a novel animal model for elucidating direct effects of insulin on liver functions. (c) 2007 Published by Elsevier Inc.
C1 Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA.
   CURE, Digest Dis Res Ctr, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
RP Zhukova, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA.
EM ezhukova@ucla.edu
FU NIDDK NIH HHS [DK 41301, DK 63607] Funding Source: Medline
CR Buettner C, 2005, J CLIN INVEST, V115, P1306, DOI 10.1172/JCI200523109
   Cherrington AD, 2005, J CLIN INVEST, V115, P1136, DOI 10.1172/JCI200525152
   Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198
   Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200
   Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426
   Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013
   Girard J, 2006, DIABETES, V55, pS65, DOI 10.2337/db06-S009
   Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951
   Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958
   Lewis GF, 1997, DIABETES, V46, P1111, DOI 10.2337/diabetes.46.7.1111
   Lu YC, 2005, ENDOCRINOLOGY, V146, P2610, DOI 10.1210/en.2004-1109
   Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Mittelman SD, 2000, AM J PHYSIOL-ENDOC M, V279, pE630, DOI 10.1152/ajpendo.2000.279.3.E630
   Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798
   Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020
   Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431
   Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 30
PY 2007
VL 355
IS 1
BP 23
EP 27
DI 10.1016/j.bbrc.2007.01.059
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 142HX
UT WOS:000244641200005
PM 17291451
DA 2024-02-19
ER

PT J
AU Marmentini, C
   Soares, GM
   Bronczek, GA
   Piovan, S
   Mareze-Costa, CE
   Carneiro, EM
   Boschero, AC
   Kurauti, MA
AF Marmentini, Carine
   Soares, Gabriela M.
   Bronczek, Gabriela A.
   Piovan, Silvano
   Mareze-Costa, Cecilia E.
   Carneiro, Everardo M.
   Boschero, Antonio C.
   Kurauti, Mirian A.
TI Aging Reduces Insulin Clearance in Mice
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE CEACAM1; hepatic insulin clearance; hyperinsulinemia; insulin-degrading
   enzyme; insulin secretion; insulin sensitivity
ID DEGRADING ENZYME; RESISTANCE; EXPRESSION; GLUCOSE; TISSUE
AB Hyperinsulinemia is frequently associated with aging and may cause insulin resistance in elderly. Since insulin secretion and clearance decline with age, hyperinsulinemia seems to be maintained, primarily, due to a decrease in the insulin clearance. To investigate these aging effects, 3- and 18-month-old male C57BL/6 mice were subjected to intraperitoneal glucose and insulin tolerance tests (ipGTT and ipITT) and, during the ipGTT, plasma c-peptide and insulin were measure to evaluate in vivo insulin clearance. Glucose-stimulated insulin secretion in isolated pancreatic islets was also assessed, and liver samples were collected for molecular analyses (western blot). Although insulin sensitivity was not altered in the old mice, glucose tolerance, paradoxically, seems to be increased, accompanied by higher plasma insulin, during ipGTT. While insulin secretion did not increase, insulin clearance was reduced in the old mice, as suggested by the lower c-peptide:insulin ratio, observed during ipGTT. Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) and insulin-degrading enzyme (IDE), as well as the activity of this enzyme, were reduced in the liver of old mice, justifying the decreased insulin clearance observed in these mice. Therefore, loss of hepatic CEACAM1 and IDE function may be directly related to the decline in insulin clearance during aging.
C1 [Marmentini, Carine; Soares, Gabriela M.; Bronczek, Gabriela A.; Carneiro, Everardo M.; Boschero, Antonio C.; Kurauti, Mirian A.] Univ Campinas UNICAMP, Obes & Comorbid Res Ctr OCRC, Lab Endocrine Pancreas & Metab, Campinas, Brazil.
   [Piovan, Silvano; Mareze-Costa, Cecilia E.; Kurauti, Mirian A.] State Univ Maringa UEM, Biol Sci Ctr, Dept Physiol Sci, Maringa, Parana, Brazil.
C3 Universidade Estadual de Campinas; Universidade Estadual de Maringa
RP Kurauti, MA (corresponding author), Univ Campinas UNICAMP, Obes & Comorbid Res Ctr OCRC, Lab Endocrine Pancreas & Metab, Campinas, Brazil.; Kurauti, MA (corresponding author), State Univ Maringa UEM, Biol Sci Ctr, Dept Physiol Sci, Maringa, Parana, Brazil.
EM mirian.kurauti@hotmail.com
RI Carneiro, Everardo Magalhaes/D-4758-2012; Kurauti, Mirian/K-3309-2012;
   Boschero, Antonio C/O-7525-2014; Marmentini, Carine/GSD-1451-2022
OI Kurauti, Mirian/0000-0003-2431-8120; Boschero, Antonio
   C/0000-0003-3829-8570; Alves Bronczek, Gabriela/0000-0002-7641-6649;
   Marmentini, Carine/0000-0003-0884-1536
FU Sao Paulo Research Foundation (FAPESP) [13/07607-8, 15/12611-0,
   17/06475-1, 18/24368-0]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [13/07607-8, 17/06475-1, 15/12611-0] Funding Source:
   FAPESP
FX This research was founded by the Sao Paulo Research Foundation (FAPESP,
   grant numbers 13/07607-8, 15/12611-0, 17/06475-1 and 18/24368-0). The
   funder had no role in study design; in the collection, analysis, and
   interpretation of data; in the writing of the report; and in the
   decision to submit the manuscript for publication.
CR AMMON HPT, 1987, J PHYSIOL-LONDON, V384, P347, DOI 10.1113/jphysiol.1987.sp016458
   Barbieri M, 2001, DIABETES-METAB RES, V17, P19, DOI 10.1002/dmrr.178
   Brandimarti P, 2013, J ENDOCRINOL, V219, P173, DOI 10.1530/JOE-13-0177
   COORDT MC, 1995, P SOC EXP BIOL MED, V209, P213
   Cordes CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018138
   Cordes CM, 2009, BIOCHEM PHARMACOL, V77, P1064, DOI 10.1016/j.bcp.2008.12.006
   De Tata V, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00138
   DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379
   Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608
   Evans JL, 2013, DIABETES, V62, P346, DOI 10.2337/db12-1239
   Ferreira SM, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.599165
   FINK RI, 1985, DIABETES, V34, P275, DOI 10.2337/diabetes.34.3.275
   GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549
   Hamel FG, 2003, ENDOCRINOLOGY, V144, P2404, DOI 10.1210/en.2002-0007
   He W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20909-w
   Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kalyani RR, 2013, ENDOCRIN METAB CLIN, V42, P333, DOI 10.1016/j.ecl.2013.02.010
   Kim Min Sun, 2011, Lab Anim Res, V27, P29, DOI 10.5625/lar.2011.27.1.29
   KOBAYASHI M, 1978, AM J PHYSIOL, V235, pE53, DOI 10.1152/ajpendo.1978.235.1.E53
   Kochkina EG, 2015, BIOGERONTOLOGY, V16, P473, DOI 10.1007/s10522-015-9569-9
   Kurauti MA, 2019, J CELL PHYSIOL, V234, P9802, DOI 10.1002/jcp.27667
   Kurauti MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46750
   Kurauti MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160239
   Kurauti MA, 2016, J ENDOCRINOL, V229, P221, DOI 10.1530/JOE-15-0483
   MARTIN C, 1983, CAN J PHYSIOL PHARM, V61, P802, DOI 10.1139/y83-123
   Merino B, 2020, METABOLISM, V113, DOI 10.1016/j.metabol.2020.154352
   Moller N, 2003, HORM RES, V60, P102, DOI 10.1159/000071233
   NAJJAR SM, 1995, BIOCHEMISTRY-US, V34, P9341, DOI 10.1021/bi00029a009
   Najjar SM, 2019, PHYSIOLOGY, V34, P198, DOI 10.1152/physiol.00048.2018
   OHNEDA M, 1993, DIABETES, V42, P1065, DOI 10.2337/diabetes.42.7.1065
   Okabayashi Y, 1996, J BIOL CHEM, V271, P5265
   PACINI G, 1990, J AM GERIATR SOC, V38, P1283, DOI 10.1111/j.1532-5415.1990.tb03449.x
   Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840
   Reaven G, 2003, DIABETES CARE, V26, P539, DOI 10.2337/diacare.26.2.539
   Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264
   Soares GM, 2018, J CELL PHYSIOL, V233, P7112, DOI 10.1002/jcp.26527
   Templeman NM, 2017, CELL REP, V20, P451, DOI 10.1016/j.celrep.2017.06.048
   Vettorazzi JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13974-0
   Villa-Pérez P, 2018, METABOLISM, V88, P1, DOI 10.1016/j.metabol.2018.08.001
   Wei XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095399
   Young SE, 2006, DIABETES CARE, V29, P2688, DOI 10.2337/dc06-0915
NR 42
TC 21
Z9 24
U1 2
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD MAY 12
PY 2021
VL 12
AR 679492
DI 10.3389/fendo.2021.679492
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA SH6BT
UT WOS:000654220700001
PM 34054736
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Yang, WL
   Wang, JP
   Chen, ZZ
   Chen, J
   Meng, YH
   Chen, LM
   Chang, YS
   Geng, B
   Sun, LB
   Dou, L
   Li, J
   Guan, YF
   Cui, QH
   Yang, JC
AF Yang, Weili
   Wang, Junpei
   Chen, Zhenzhen
   Chen, Ji
   Meng, Yuhong
   Chen, Liming
   Chang, Yongsheng
   Geng, Bin
   Sun, Libo
   Dou, Lin
   Li, Jian
   Guan, Youfei
   Cui, Qinghua
   Yang, Jichun
TI NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by
   Repressing the Hepatic FAM3A-ATP-Akt Pathway
SO DIABETES
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; SKELETAL-MUSCLE; HEXOKINASE-II;
   INSULIN-RESISTANCE; LIPID-METABOLISM; CELLULAR SENESCENCE;
   SIGNAL-TRANSDUCTION; NIDDM SUBJECTS; AGING MUSCLE; EXPRESSION
AB Hepatic FAM3A expression is repressed under obese conditions, but the underlying mechanism remains unknown. This study determined the role and mechanism of miR-423-5p in hepatic glucose and lipid metabolism by repressing FAM3A expression. miR-423-5p expression was increased in the livers of obese diabetic mice and in patients with nonalcoholic fatty liver disease (NAFLD) with decreased FAM3A expression. miR-423-5p directly targeted FAM3A mRNA to repress its expression and the FAM3A-ATP-Akt pathway in cultured hepatocytes. Hepatic miR-423-5p inhibition suppressed gluconeogenesis and improved insulin resistance, hyperglycemia, and fatty liver in obese diabetic mice. In contrast, hepatic miR-423-5p overexpression promoted gluconeogenesis and hyperglycemia and increased lipid deposition in normal mice. miR-423-5p inhibition activated the FAM3A-ATP-Akt pathway and repressed gluconeogenic and lipogenic gene expression in diabetic mouse livers. The miR-423 precursor gene was further shown to be a target gene of NFE2, which induced miR-423-5p expression to repress the FAM3-AATP-Akt pathway in cultured hepatocytes. Hepatic NFE2 overexpression upregulated miR-423-5p to repress the FAM3A-ATP-Akt pathway, promoting gluconeogenesis and lipid deposition and causing hyperglycemia in normal mice. In conclusion, under the obese condition, activation of the hepatic NFE2/miR-423-5p axis plays important roles in the progression of type 2 diabetes and NAFLD by repressing the FAM3A-ATP-Akt signaling pathway.
C1 [Yang, Weili; Chen, Zhenzhen; Chen, Ji; Meng, Yuhong; Yang, Jichun] Peking Univ, Dept Physiol & Pathophysiol, Key Lab Cardiovasc Sci, Sch Basic Med Sci,Minist Educ,Hlth Sci Ctr,Ctr No, Beijing, Peoples R China.
   [Wang, Junpei; Chen, Zhenzhen; Cui, Qinghua] Peking Univ, Sch Basic Med Sci, Key Lab Cardiovasc Sci, Dept Biomed Informat,Minist Educ,Hlth Sci Ctr,Ctr, Beijing, Peoples R China.
   [Chen, Liming] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Dept Biophys & Mol Physiol,Key Lab Mol Biophys, Wuhan, Peoples R China.
   [Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China.
   [Chang, Yongsheng; Geng, Bin] Peking Union Med Coll, Beijing, Peoples R China.
   [Geng, Bin] Chinese Acad Med Sci, Fuwai Hosp, Hypertens Ctr, Beijing, Peoples R China.
   [Sun, Libo] Capital Med Univ, Beijing You An Hosp, Beijing, Peoples R China.
   [Dou, Lin; Li, Jian] Minist Hlth, Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China.
   [Dou, Lin; Li, Jian] Minist Hlth, Beijing Hosp, Beijing, Peoples R China.
   [Guan, Youfei] Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China.
C3 Peking University; Peking University; Huazhong University of Science &
   Technology; Institute of Basic Medical Sciences - CAMS; Chinese Academy
   of Medical Sciences - Peking Union Medical College; Chinese Academy of
   Medical Sciences - Peking Union Medical College; Peking Union Medical
   College; Chinese Academy of Medical Sciences - Peking Union Medical
   College; Fu Wai Hospital - CAMS; Capital Medical University; Beijing
   Hospital; Dalian Medical University
RP Yang, JC (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Key Lab Cardiovasc Sci, Sch Basic Med Sci,Minist Educ,Hlth Sci Ctr,Ctr No, Beijing, Peoples R China.
EM yangj@bjmu.edu.cn
RI Geng, Bin/ABB-6045-2020; Yang, Weili/D-3578-2011; Chen,
   Li-Ming/AAU-2363-2021
OI Geng, Bin/0000-0001-7573-8710; Chen, Li-Ming/0000-0002-8129-9563; guan,
   youfei/0000-0002-5231-0209
FU Ministry of Science and Technology [2016YFC1304800]; Natural Science
   Foundation of China [81471035, 81670748, 91339106, 81322011, 81422006,
   81390351]; Beijing Natural Science Foundation [7171006]
FX This study was supported by grants from the Ministry of Science and
   Technology (2016YFC1304800), the Natural Science Foundation of China
   (81471035/81670748/91339106/81322011/81422006/81390351), and Beijing
   Natural Science Foundation (7171006).
CR Al-Khalili L, 2004, ACTA PHYSIOL SCAND, V180, P395, DOI 10.1111/j.1365-201X.2004.01259.x
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bjornholm M, 1997, DIABETES, V46, P524, DOI 10.2337/diabetes.46.3.524
   Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09
   Cartee GD, 2016, CELL METAB, V23, P1034, DOI 10.1016/j.cmet.2016.05.007
   Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38
   Correia JC, 2015, TRENDS ENDOCRIN MET, V26, P305, DOI 10.1016/j.tem.2015.03.010
   Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010
   DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302
   Dooley J, 2016, DIABETES, V65, P53, DOI 10.2337/db15-0770
   Egan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074098
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   Egan B, 2011, PROTEOMICS, V11, P1413, DOI 10.1002/pmic.201000597
   Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005
   He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167
   Hu ZY, 2014, AGING-US, V6, P160, DOI 10.18632/aging.100643
   Kovanda A, 2014, WIRES RNA, V5, P509, DOI 10.1002/wrna.1227
   Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284
   Kruszynska YT, 1998, DIABETES, V47, P1107, DOI 10.2337/diabetes.47.7.1107
   Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014
   Kulkarni SS, 2011, J BIOL CHEM, V286, P34567, DOI 10.1074/jbc.M111.268292
   Kurtz CL, 2014, DIABETES, V63, P3141, DOI 10.2337/db13-1015
   Liang JC, 2013, J HEPATOL, V58, P535, DOI 10.1016/j.jhep.2012.10.024
   Massart J, 2016, BBA-MOL CELL BIOL L, V1861, P2130, DOI 10.1016/j.bbalip.2016.05.006
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mudry JM, 2015, J ENDOCRINOL, V224, P303, DOI 10.1530/JOE-14-0474
   Osawa H, 1996, J BIOL CHEM, V271, P16690, DOI 10.1074/jbc.271.28.16690
   PRINTZ RL, 1993, J BIOL CHEM, V268, P5209
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050
   Vestergaard H, 1995, J CLIN INVEST, V96, P2639, DOI 10.1172/JCI118329
   Yang WM, 2014, FEBS LETT, V588, P2170, DOI 10.1016/j.febslet.2014.05.011
   Zhou YH, 2016, INT J MOL MED, V37, P931, DOI 10.3892/ijmm.2016.2499
   Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x
   Zhu HM, 2015, DIABETOLOGIA, V58, P900, DOI 10.1007/s00125-015-3510-2
NR 37
TC 60
Z9 66
U1 3
U2 16
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD JUL 1
PY 2017
VL 66
IS 7
BP 1819
EP 1832
DI 10.2337/db16-1172
PG 14
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EY2DM
UT WOS:000403778600012
PM 28411267
OA Bronze
DA 2024-02-19
ER

PT J
AU Zhang, YM
   Chen, XM
   Wu, D
   Shi, SZ
   Yin, Z
   Ding, R
   Lü, Y
AF Zhang, Yu-Mei
   Chen, Xiang-Mei
   Wu, Di
   Shi, Suo-Zhu
   Yin, Zhong
   Ding, Rui
   Lu, Yang
TI Expression of tissue inhibitor of matrix metalloproteinases-1 during
   aging in rat liver
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE TIMP-1; Aging; Rat liver
ID CHRONIC HEPATITIS-C; EXTRACELLULAR-MATRIX; FIBROSIS; CANCER; CELLS;
   REVERSIBILITY; GENES
AB AIM: To investigate the expression and role of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) during natural aging in rat liver and to detect the expression of matrix metalloproteinase-2 (MMP-2) and MMP-9.
   METHODS: The rats were divided into 3-mo-old group (n = 5), 10-mo-old group (n = 5) and 24-mo-old group (n = 5). Histopathologic changes of liver were observed with HE and Masson stain. The location and protein expressions of TIMP-1 were determined by immunohistochemistry and Western blot; message RNA (mRNA) levels were measured in livers from rats of various ages by semi-quantitative reverse transcriptional polymerase chain reaction (RTPCR). In addition, the expression of MMP-2 and MMP-9 was assessed by RT-PCR and Western blot.
   RESULTS: Histologic examination showed that the aging liver had excessive fatty degeneration and collagen deposition. Immunohistochemical staining showed that TIMP-1 related antigen in livers was located in cytoplasm. The protein expression of TIMP-1 was significantly higher in the oldest animals and the mRNA expression was increased significantly in the 24-mo-old rats (t = 4.61, P = 0.002<0.05, 24-vs 10-mo-old rats; t = 4.31, P = 0.003<0.05, 24-vs 3-mo-old rats). The expression of MMP-2 and MMP-9 had no change during aging; the ratios TIMP-1/MMP-2 and TIMP-1/MMP-9 in aging liver were significantly higher than those in maturation and young livers.
   CONCLUSION: TIMP-1 may play an important role in the process of liver aging. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
C1 [Zhang, Yu-Mei; Chen, Xiang-Mei; Wu, Di; Shi, Suo-Zhu; Yin, Zhong; Ding, Rui; Lu, Yang] Gen Hosp PLA, Dept Nephrol, Beijing 100853, Peoples R China.
C3 Chinese People's Liberation Army General Hospital
RP Chen, XM (corresponding author), Gen Hosp PLA, Dept Nephrol, Beijing 100853, Peoples R China.
EM xmchen@public.bta.net.cn
RI SHI, SZ/IXN-9432-2023; Ding, Rui/JSL-0652-2023; Lyu, Yang/AAJ-5175-2021
OI , Yang/0000-0002-4353-0082
FU Major State Basic Research and Development Program of China, 973 Program
   [G2000057000]; Creative Research Group of the National Science
   Foundation of China [30121005]; Postdoctor Foundation of China
   [2004035048]
FX Supported by the Major State Basic Research and Development Program of
   China, 973 Program, No. G2000057000; Creative Research Group Fund of the
   National Science Foundation of China, No. 30121005; the Postdoctor
   Foundation of China, No. 2004035048
CR Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31
   Bodey B, 2001, IN VIVO, V15, P71
   Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003
   Chen Rong-Quan, 2004, Zhonghua Yi Xue Za Zhi, V84, P937
   Dudás J, 2001, AM J CLIN PATHOL, V115, P725
   Flisiak R, 2002, HEPATO-GASTROENTEROL, V49, P1369
   Gagliano N, 2000, J GERONTOL A-BIOL, V55, pB365, DOI 10.1093/gerona/55.8.B365
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Issa R, 2002, FASEB J, V16, P47, DOI 10.1096/fj.02-0494fje
   Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291
   John Anitha, 2001, Pathology and Oncology Research, V7, P14
   Kanoh Y, 2002, ANTICANCER RES, V22, P1813
   Lichtinghagen R, 2001, J HEPATOL, V34, P239, DOI 10.1016/S0168-8278(00)00037-4
   Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157
   Mannello F, 2001, APOPTOSIS, V6, P479, DOI 10.1023/A:1012493808790
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200
   Ninomiya T, 2001, INTERVIROLOGY, V44, P227, DOI 10.1159/000050052
   Okazaki I, 2000, J GASTROEN HEPATOL, V15, pD26, DOI 10.1046/j.1440-1746.2000.02185.x
   Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x
   Reed MJ, 2000, J CELL BIOCHEM, V77, P116, DOI 10.1002/(SICI)1097-4644(20000401)77:1<116::AID-JCB12>3.0.CO;2-7
   Roelle S, 2003, J BIOL CHEM, V278, P47307, DOI 10.1074/jbc.M304377200
   Schuppan D, 2001, SEMIN LIVER DIS, V21, P351, DOI 10.1055/s-2001-17556
   Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154
   Soo C, 2000, PLAST RECONSTR SURG, V105, P638, DOI 10.1097/00006534-200002000-00024
   Uhich D, 2004, PLAST RECONSTR SURG, V114, P229, DOI 10.1097/01.PRS.0000129079.19089.6C
   Vaillant B, 2001, J IMMUNOL, V167, P7017, DOI 10.4049/jimmunol.167.12.7017
   Vijg J, 2003, MECH AGEING DEV, V124, P3, DOI 10.1016/S0047-6374(02)00163-X
   Yata Y, 1999, J HEPATOL, V30, P425, DOI 10.1016/S0168-8278(99)80101-9
   Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521
NR 30
TC 8
Z9 9
U1 1
U2 7
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD JUN 28
PY 2005
VL 11
IS 24
BP 3696
EP 3700
DI 10.3748/wjg.v11.i24.3696
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA V19VE
UT WOS:000208099100010
PM 15968723
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Zhong, WZ
   Rao, ZQ
   Rao, JH
   Han, GY
   Wang, P
   Jiang, T
   Pan, XX
   Zhou, S
   Zhou, HM
   Wang, XH
AF Zhong, Weizhe
   Rao, Zhuqing
   Rao, Jianhua
   Han, Guoyong
   Wang, Ping
   Jiang, Tao
   Pan, Xiongxiong
   Zhou, Shun
   Zhou, Haoming
   Wang, Xuehao
TI Aging aggravated liver ischemia and reperfusion injury by promoting
   STING-mediated NLRP3 activation in macrophages
SO AGING CELL
LA English
DT Article; Early Access
DE aging; leucine-rich repeat containing protein 3; liver ischemia; and
   reperfusion injury; macrophage immune response; nucleotide-binding
   domain; stimulator of interferon genes
ID KUPFFER CELLS; INFLAMMASOME ACTIVATION; AGE; TRANSPLANTATION;
   METABOLISM; RECIPIENTS; PRIMES
AB Although aggravated liver injury has been reported in aged livers post-ischemia and reperfusion (IR), the underlying mechanism of innate immune activation of aged macrophages is not well understood. Here, we investigated whether and how Stimulator of interferon genes (STING) signaling regulated macrophage proinflammatory activation and liver IR injury. Mice were subjected to hepatic IR in vivo. Macrophages isolated from IR-stressed livers and bone marrow-derived macrophages (BMDMs) from young and aged mice were used for in vitro studies. Enhanced nucleotide-binding domain and leucine-rich repeat containing protein 3 (NLRP3) activation was found in both livers and macrophages of aged mice post-IR. NLRP3 knockdown in macrophages inhibited intrahepatic inflammation and liver injury in both young and aged mice. Interestingly, enhanced activation of the STING/ TANK-binding kinase 1 (TBK1) signaling pathway was observed in aged macrophages post-IR and mitochondria DNA (mtDNA) stimulation. STING suppression blocked over-activation of NLRP3 signaling and excessive secretion of proinflammatory cytokines/chemokines in the mtDNA-stimulated BMDMs from aged mice. More importantly, STING knockdown in macrophages abrogated the detrimental role of aging in aggravating liver IR injury and intrahepatic inflammation. Finally, peripheral blood from the recipients undergoing liver transplantation was collected and analyzed. The results showed that the elderly recipients had much higher levels of TNF-alpha, IL-6, IL-1 beta, and IL-18 post-transplantation, indicating increased NLRP3 activation in lR-stressed livers of elderly recipients. In summary, our study demonstrated that the STING-NLRP3 axis was critical for the proinflammatory response of aged macrophages and would be a novel therapeutic target to reduce IR injury in elderly patients.
C1 [Zhong, Weizhe; Rao, Jianhua; Han, Guoyong; Wang, Ping; Jiang, Tao; Zhou, Shun; Zhou, Haoming; Wang, Xuehao] Nanjing Med Univ, Hepatobiliary Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing 210029, Peoples R China.
   [Zhong, Weizhe; Rao, Jianhua; Han, Guoyong; Wang, Ping; Jiang, Tao; Zhou, Shun; Zhou, Haoming; Wang, Xuehao] Chinese Acad Med Sci, Res Unit Liver Transplantat & Transplant Immunol, Nanjing, Peoples R China.
   [Zhong, Weizhe; Rao, Jianhua; Han, Guoyong; Wang, Ping; Jiang, Tao; Zhou, Shun; Zhou, Haoming; Wang, Xuehao] Chinese Acad Med Sci, Key Lab Liver Transplantat, Nanjing, Peoples R China.
   [Rao, Zhuqing; Pan, Xiongxiong] Nanjing Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Nanjing, Peoples R China.
C3 Nanjing Medical University; Chinese Academy of Medical Sciences - Peking
   Union Medical College; Chinese Academy of Medical Sciences - Peking
   Union Medical College; Nanjing Medical University
RP Zhou, HM; Wang, XH (corresponding author), Nanjing Med Univ, Hepatobiliary Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing 210029, Peoples R China.
EM phil@njmu.edu.cn; zhuqingrao@njmu.edu.cn; raojh@njmu.edu.cn;
   hmzhou@njmu.edu.cn; wangxh@njmu.edu.cn
RI luo, yuan/JLS-6416-2023; zhou, haoming/HMV-1715-2023; xiongxiong,
   pan/GPP-4500-2022; lin, qing/JED-5250-2023
OI xiongxiong, pan/0000-0002-2747-3241; 
FU [2019-I2M-5-035];  [81870448];  [31930020];  [81600450];  [BK20191490]; 
   [2018-WSN-011];  [DG000D4007];  [81901628]
FX Xuehao Wang, Grant/Award Number: 2019-I2M-5-035, 81870448 and 31930020;
   Haoming Zhou, Grant/Award Number: 2019-I2M-5-035, 81600450, BK20191490,
   2018-WSN-011 and DG000D4007; Zhuqing Rao, Grant/Award Number: 81901628
CR Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657
   Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921
   Bauernfeind F, 2016, J IMMUNOL, V197, P2900, DOI 10.4049/jimmunol.1501336
   Chun SK, 2018, AGING CELL, V17, DOI 10.1111/acel.12761
   Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019
   Eufrásio P, 2011, TRANSPL P, V43, P117, DOI 10.1016/j.transproceed.2010.12.036
   FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950
   Hamann L, 2019, GERONTOLOGY, V65, P145, DOI 10.1159/000492972
   Huang H, 2013, J IMMUNOL, V191, P2665, DOI 10.4049/jimmunol.1202733
   Jiang T, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105711
   Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999
   Kim HY, 2015, FEBS J, V282, P259, DOI 10.1111/febs.13123
   Lan YY, 2019, AGING CELL, V18, DOI 10.1111/acel.12901
   Lei Z, 2018, AM J PHYSIOL-GASTR L, V314, pG655, DOI 10.1152/ajpgi.00326.2017
   Li CY, 2019, HEPATOLOGY, V70, P1714, DOI 10.1002/hep.30700
   Li N, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101215
   Liu R, 2018, MOL IMMUNOL, V103, P251, DOI 10.1016/j.molimm.2018.10.004
   Lu L, 2016, TRANSPLANTATION, V100, P2601, DOI 10.1097/TP.0000000000001411
   Luo XJ, 2018, GASTROENTEROLOGY, V155, P1971, DOI 10.1053/j.gastro.2018.09.010
   Mohamadi Y, 2023, J CELL BIOCHEM, V124, P755, DOI 10.1002/jcb.27368
   Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Niazi S, 2017, CURR OPIN ORGAN TRAN, V22, P588, DOI 10.1097/MOT.0000000000000469
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Sadeghi HM, 1999, EXP GERONTOL, V34, P959, DOI 10.1016/S0531-5565(99)00065-0
   Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30
   Selzner M, 2009, LIVER TRANSPLANT, V15, P1594, DOI 10.1002/lt.21864
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Stout-Delgado HW, 2016, AM J RESP CELL MOL, V55, P252, DOI 10.1165/rcmb.2015-0222OC
   Strey CW, 2010, INT J MOL MED, V26, P577, DOI 10.3892/ijmm_00000502
   Thomsen MK, 2016, HEPATOLOGY, V64, P746, DOI 10.1002/hep.28685
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   Xu Tao, 2018, Int J Physiol Pathophysiol Pharmacol, V10, P1
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
   Yu YS, 2019, J CLIN INVEST, V129, P546, DOI 10.1172/JCI121842
   Yue S, 2016, HEPATOLOGY, V64, P1683, DOI 10.1002/hep.28739
   Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225
   Zhang XF, 2019, LIFE SCI, V236, DOI 10.1016/j.lfs.2019.05.020
   Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zhu P, 2011, HUM GENE THER, V22, P853, DOI 10.1089/hum.2010.145
NR 42
TC 61
Z9 64
U1 3
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2020 AUG
PY 2020
VL 19
IS 8
AR e13186
DI 10.1111/acel.13186
EA JUL 2020
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NF6WG
UT WOS:000548842100001
PM 32666684
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Oliveira-cordeiro, B
   Fernandes-da-silva, A
   Silva-veiga, FM
   Miranda, CS
   Martins, FF
   Souza-mello, V
AF Oliveira-cordeiro, Brenda
   Fernandes-da-silva, Aline
   Silva-veiga, Flavia maria
   Miranda, Carolline s.
   Martins, Fabiane f.
   Souza-mello, Vanessa
TI Long-term hepatic damage in high-fructose-fed C57BL/6 mice: hepatic
   fibrogenesis, endoplasmic reticulum stress markers, and fibrosis
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE fructose; NAFLD; hepatic fibrogenesis; ER stress; aging; hepatic
   stellate cell
ID FATTY LIVER-DISEASE; BLOOD-PRESSURE; ER STRESS; PROTEIN; STEATOSIS;
   INFLAMMATION; LEPTIN; AXIS; ACCUMULATION; LIPOTOXICITY
AB The rising fructose intake in sugar-sweetened beverages and ultra-processed foods relates to the high incidence of nonalcoholic fatty liver disease. This study aimed to examine the effects of long-term high-fructose diet intake (for 16 or 20 weeks) on progressive hepatic damage, focusing on the endoplasmic reticulum stress markers and fibrogenesis as possible triggers of liver fibrosis. Forty 3-month-old male C57BL/6J mice were randomly divided into four nutritional groups: C16 (control diet for 16 weeks), C20 (control diet for 20 weeks), HFRU16 (high-fructose diet for 16 weeks), and HFRU20 (high-fructose diet for 20 weeks). Both HFRU groups showed oral glucose intolerance and insulin resistance, but only the HFRU20 group exhibited increased inflammation. The increased lipogenic and endoplasmic reticulum stress markers triggered hepatic fibrogenesis. Hence, time-dependent perivascular fibrosis with positive immunostaining for alpha-smooth muscle actin and reelin in HFRU mice was observed, ensuring fibrosis development in this mouse model. Our study showed time-dependent and progressive damage on hepatic cytoarchitecture, with maximization of hepatic steatosis without overweight in HFRU20 mice. ER stress and liver inflammation could mediate hepatic stellate cell activation and fibrogenesis, emerging as targets to prevent NAFLD progression and fibrosis onset in this dietary model.
C1 [Oliveira-cordeiro, Brenda; Fernandes-da-silva, Aline; Silva-veiga, Flavia maria; Miranda, Carolline s.; Martins, Fabiane f.; Souza-mello, Vanessa] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Morfometria Metab & Doencas Cardiovasc, Blvd 28 Setembro 87,fundos andar terreo,Vila Isabe, BR-20551030 Rio De Janeiro, RJ, Brazil.
C3 Universidade do Estado do Rio de Janeiro
RP Souza-mello, V (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Morfometria Metab & Doencas Cardiovasc, Blvd 28 Setembro 87,fundos andar terreo,Vila Isabe, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM souzamello.uerj@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil
   (CAPES) [001]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (Faperj) [303785/2020-9, 404446/2021-3];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [E-26/200.984/2022, E-26/010.002136/2019]
FX The authors would like to thank Aline de Carvalho and Andrea Bertoldo
   for their technical assistance. This study was financed in part by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil
   (CAPES) - Finance Code 001 (doctoral scholarships for AF-S, CSM, and
   FMS-V, and post-doctoral scholarship for FFM) , Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj - Master
   scholarship for BO-C) . The corresponding author is supported by
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   grant No 303785/2020-9, and 404446/2021-3) , and FAPERJ (Grants No
   E-26/200.984/2022, and E-26/010.002136/2019).
CR Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535
   Aibara D, 2020, ENDOCR J, V67, P37, DOI 10.1507/endocrj.EJ19-0296
   Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005
   Avrahami D, 2015, CELL METAB, V22, P619, DOI 10.1016/j.cmet.2015.07.025
   BRASIL, 2020, Vigitel Brasil 2019 : vigilancia de fatores de risco e protecao para doencas cronicas por inquerito telefonico : estimativas sobre frequencia e distribuicao sociodemografica de fatores de risco e protecao para doencas cronicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2019 [recurso eletronico] / Ministerio da Saude, Secretaria de Vigilancia em Saude, Departamento de Analise em Saude e Vigil ancia de Doencas nao Transmissiveis, V2020, P137
   Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989
   Camelo L, 2019, NUTR RES, V63, P51, DOI 10.1016/j.nutres.2018.12.005
   Cao Y, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04319-w
   Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1
   Chen N, 2023, CELL PROLIFERAT, V56, DOI 10.1111/cpr.13500
   De Minicis S, 2013, CURR PHARM DESIGN, V19, P5239
   Do MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060761
   DUNCAN MH, 1995, LANCET, V346, P120, DOI 10.1016/S0140-6736(95)92143-5
   DUNNETT CW, 1980, J AM STAT ASSOC, V75, P796, DOI 10.2307/2287161
   Fernandes-da-Silva A, 2021, EUR J NUTR, V60, P2949, DOI 10.1007/s00394-021-02542-y
   Ferré P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039
   Galligan JJ, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/207594
   George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8
   Gustafson B, 2015, ATHEROSCLEROSIS, V241, P27, DOI 10.1016/j.atherosclerosis.2015.04.812
   Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595
   Hao LY, 2021, GUT, V70, P1933, DOI 10.1136/gutjnl-2020-321548
   Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5
   Herman MA, 2016, TRENDS ENDOCRIN MET, V27, P719, DOI 10.1016/j.tem.2016.06.005
   Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698
   Im YR, 2021, HEPATOLOGY, V74, P1884, DOI 10.1002/hep.31897
   Ito M, 2010, J LIPID RES, V51, P1676, DOI 10.1194/jlr.M002147
   Jegatheesan P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030230
   Jin CJ, 2020, AM J PHYSIOL-GASTR L, V318, pG736, DOI 10.1152/ajpgi.00345.2018
   Kannt A, 2020, DIABETES OBES METAB, V22, P1328, DOI 10.1111/dom.14035
   Kazankov K, 2019, NAT REV GASTRO HEPAT, V16, P145, DOI 10.1038/s41575-018-0082-x
   Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210
   Lanaspa MA, 2018, P NATL ACAD SCI USA, V115, P3138, DOI 10.1073/pnas.1713837115
   Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787
   Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41
   Lua I, 2016, J HEPATOL, V64, P1137, DOI 10.1016/j.jhep.2016.01.010
   Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a
   Machado MV, 2015, J HEPATOL, V63, P962, DOI 10.1016/j.jhep.2015.05.031
   Magliano DC, 2015, ENDOCRINE, V50, P355, DOI 10.1007/s12020-015-0590-1
   Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011
   Martins FF, 2021, INT J MORPHOL, V39, P732
   Ohashi T, 2018, FOOD CHEM TOXICOL, V118, P190, DOI 10.1016/j.fct.2018.05.006
   Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373
   Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027
   Radhakrishnan S, 2021, CURR DEV NUTR, V5, DOI 10.1093/cdn/nzab138
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Rosa-Caldwell ME, 2020, APPL PHYSIOL NUTR ME, V45, P500, DOI 10.1139/apnm-2019-0407
   Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015
   Sá GD, 2017, LIFE SCI, V189, P8, DOI 10.1016/j.lfs.2017.09.012
   Schmidt NH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82208-1
   Sferra R, 2017, PATHOL RES PRACT, V213, P58, DOI 10.1016/j.prp.2016.11.004
   Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019
   Silva-Veiga FM, 2020, J ENDOCRINOL, V247, P11, DOI 10.1530/JOE-20-0139
   Smith-Cortinez N, 2021, FASEB J, V35, DOI 10.1096/fj.202001564RR
   Stahl EC, 2020, AM J PATHOL, V190, P372, DOI 10.1016/j.ajpath.2019.10.016
   TAPPY L, 1993, AM J CLIN NUTR, V58, P766
   Tian JM, 2013, ADV EXP MED BIOL, V793, P69, DOI 10.1007/978-1-4614-8289-5_5
   Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x
   Urtasun R, 2012, ALCOHOL CLIN EXP RES, V36, P1851, DOI 10.1111/j.1530-0277.2012.01798.x
   Vasques-Monteiro IML, 2021, NUTR RES, V91, P26, DOI 10.1016/j.nutres.2021.04.008
   Wang Y, 2013, HEPATOLOGY, V57, P1005, DOI 10.1002/hep.26107
   Wirth A, 2016, CARDIOVASC RES, V109, P131, DOI 10.1093/cvr/cvv249
   Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363
   Xiao GZ, 2013, J BIOL CHEM, V288, P25350, DOI 10.1074/jbc.M113.470526
   Yang Y, 2015, BBA-GEN SUBJECTS, V1850, P178, DOI 10.1016/j.bbagen.2014.10.014
   Zhang DM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040335
   Zhao Y, 2022, NUTRIENTS, V14, DOI 10.3390/nu14112181
NR 70
TC 0
Z9 0
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PY 2023
VL 95
SU 2
AR e20220784
DI 10.1590/0001-3765202320220784
PG 19
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DH1Z6
UT WOS:001131059900001
PM 38126519
DA 2024-02-19
ER

PT J
AU Hagopian, K
   Ramsey, JJ
   Weindruch, R
AF Hagopian, K
   Ramsey, JJ
   Weindruch, R
TI Serine utilization in mouse liver: Influence of caloric restriction and
   aging
SO FEBS LETTERS
LA English
DT Article
DE caloric restriction; serine dehydratase; serine : pyruvate transaminase;
   glycerate dehydrogenase; glycerate kinase
ID AMINO-ACID METABOLISM; RAT-LIVER; PYRUVATE AMINOTRANSFERASE;
   ENZYME-ACTIVITIES; GLYCERATE KINASE; NEONATAL RAT; GLUCONEOGENESIS;
   DIETARY; MITOCHONDRIAL; DEHYDRATASE
AB The influence of caloric restriction (CR) on the activities of hepatic serine metabolizing enzymes in young (3 months) and old (30 months) mice was studied. Serine dehydratase (SDH) activity increased markedly with age in both diet groups and in old mice was higher in the CR group. No effects of CR were observed in the young. Serine:pyruvate transaminase (SPT) and glycerate kinase activities were unaffected by age and diet. However, glycerate dehydrogenase activity was decreased in old CR mice but not in young CR. The results of this study show that long-term CR influenced serine utilization only in the pathway catalyzed by SDH. This suggests that in mouse liver this pathway is critical for serine utilization in gluconeogenesis, while the SPT pathway plays a minor role. The increase in SDH activity with long-term CR is consistent with sustained increase in gluconeogenesis. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
   Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53706 USA.
   William S Middleton Mem Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA.
C3 University of California System; University of California Davis;
   University of Wisconsin System; University of Wisconsin Madison; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   William S Middleton Memorial Veterans Hospital; Geriatric Research
   Education & Clinical Center
RP Hagopian, K (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1 Shields Ave, Davis, CA 95616 USA.
EM khagopian@ucdavis.edu
FU NIA NIH HHS [P01 AG11915, R01 AG17902] Funding Source: Medline
CR AIKAWA T, 1972, BIOCHIM BIOPHYS ACTA, V279, P234, DOI 10.1016/0304-4165(72)90139-0
   AIKAWA T, 1973, J BIOCHEM, V74, P1003
   BHATIA SC, 1975, LIFE SCI, V17, P267, DOI 10.1016/0024-3205(75)90514-7
   De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   FEUERS RJ, 1990, PROG CLIN BIOL RES, V341, P177
   FUKUSHIMA M, 1978, J BIOL CHEM, V253, P1187
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6
   Hagopian K, 2005, BBA-GEN SUBJECTS, V1721, P37, DOI 10.1016/j.bbagen.2004.10.001
   HOSHINO J, 1974, H-S Z PHYSIOL CHEM, V355, P4, DOI 10.1515/bchm2.1974.355.1.4
   JOHNSON BE, 1964, BIOCHIM BIOPHYS ACTA, V85, P202, DOI 10.1016/0926-6569(64)90241-X
   KATAYAMA H, 1983, J BIOCHEM-TOKYO, V93, P1669, DOI 10.1093/oxfordjournals.jbchem.a134307
   Kevork HA, 2004, EXP GERONTOL, V39, P1145, DOI 10.1016/j.exger.2004.04.009
   KITAGAWA Y, 1979, BIOCHIM BIOPHYS ACTA, V582, P260, DOI 10.1016/0304-4165(79)90389-1
   MASORO EJ, 1983, J NUTR, V113, P880, DOI 10.1093/jn/113.4.880
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   ODA T, 1982, J BIOCHEM, V91, P219, DOI 10.1093/oxfordjournals.jbchem.a133679
   Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3
   ROWSELL EV, 1979, COMP BIOCHEM PHYS B, V63, P543, DOI 10.1016/0305-0491(79)90061-0
   SALLACH HJ, 1972, ENDOCRINOLOGY, V91, P1054, DOI 10.1210/endo-91-4-1054
   SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9
   SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2
   SNELL K, 1974, BIOCHEM J, V142, P433, DOI 10.1042/bj1420433
   SNELL K, 1974, BIOCHEM J, V144, P519, DOI 10.1042/bj1440519
   SNELL K, 1980, BIOCHEM J, V190, P451, DOI 10.1042/bj1900451
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SUDA M, 1970, METHODS ENZYMOL B, V17, P346
   THIEDEN HID, 1972, EUR J BIOCHEM, V30, P250, DOI 10.1111/j.1432-1033.1972.tb02093.x
   VANSCHAFTINGEN E, 1989, FEBS LETT, V243, P127, DOI 10.1016/0014-5793(89)80113-9
   WADMAN SK, 1976, CLIN CHIM ACTA, V71, P477, DOI 10.1016/0009-8981(76)90099-1
   Weindruch R., 1988, RETARDATION AGING DI
   Xue HH, 1999, J BIOL CHEM, V274, P16028, DOI 10.1074/jbc.274.23.16028
   Xue HH, 1999, J BIOL CHEM, V274, P16020, DOI 10.1074/jbc.274.23.16020
NR 36
TC 12
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD MAR 28
PY 2005
VL 579
IS 9
BP 2009
EP 2013
DI 10.1016/j.febslet.2005.02.062
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 913LJ
UT WOS:000228152800021
PM 15792811
DA 2024-02-19
ER

PT J
AU Drosos, I
   Kolios, G
AF Drosos, Ioannis
   Kolios, George
TI Stem Cells in Liver Regeneration and Their Potential Clinical
   Applications
SO STEM CELL REVIEWS AND REPORTS
LA English
DT Article
DE Stem cells; Hepatocytes; Liver regeneration; Regenerative medicine
ID IN-VITRO DIFFERENTIATION; HEPATOCYTE-LIKE CELLS; MARROW-DERIVED CELLS;
   HEPATIC OVAL CELLS; LEUKEMIA INHIBITORY FACTOR; ADULT PROGENITOR CELLS;
   BONE-MARROW; RAT-LIVER; GENE-EXPRESSION; STROMAL CELLS
AB Stem cells constitute a population of "primitive cells" with the ability to divide indefinitely and give rise to specialized cells under special conditions. Because of these two characteristics they have received particular attention in recent decades. These cells are the primarily responsible factors for the regeneration of tissues and organs and for the healing of lesions, a feature that makes them a central key in the development of cell-based medicine, called Regenerative Medicine. The idea of wound and organ repair and body regeneration is as old as the mankind, reflecting the human desire for inhibiting aging and immortality and it is first described in the ancient Greek myth of Prometheus. It is of interest that the myth refers to liver, an organ with remarkable regenerative ability after loss of mass and function caused by liver injury or surgical resection. Over the last decade there has been an important progress in understanding liver physiology and the mechanisms underlying hepatic development and regeneration. As liver transplantation, despite its difficulties, remains the only effective therapy for advanced liver disease so far, scientific interest has nowadays been orientated towards Regenerative Medicine and the use of stem cells to repair damaged liver. This review is focused on the available literature concerning the role of stem cells in liver regeneration. It summarizes the results of studies concerning endogenous liver regeneration and stem cell experimental protocols. Moreover, this review discusses the clinical studies that have been conducted in humans so far.
C1 [Drosos, Ioannis; Kolios, George] Democritus Univ Thrace, Pharmacol Lab, Sch Med, Alexandroupolis 68100, Greece.
C3 Democritus University of Thrace
RP Kolios, G (corresponding author), Democritus Univ Thrace, Pharmacol Lab, Sch Med, Alexandroupolis 68100, Greece.
EM gkolios@med.duth.gr
RI Kolios, George/N-6641-2013
OI Kolios, George/0000-0002-2066-4782; Drosos, Ioannis/0000-0002-7437-8896
CR Abe K, 1996, EXP CELL RES, V229, P27, DOI 10.1006/excr.1996.0340
   Alison M, 1998, PHILOS T R SOC B, V353, P877, DOI 10.1098/rstb.1998.0252
   Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642
   Almeida-Porada G, 2004, BLOOD, V104, P2582, DOI 10.1182/blood-2004-01-0259
   Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069
   Amer MEM, 2011, EUR J GASTROEN HEPAT, V23, P936, DOI 10.1097/MEG.0b013e3283488b00
   Augello A, 2010, EUR CELLS MATER, V20, P121
   Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050
   Aziz MTA, 2007, CLIN BIOCHEM, V40, P893, DOI 10.1016/j.clinbiochem.2007.04.017
   Banas A, 2008, STEM CELLS, V26, P2705, DOI 10.1634/stemcells.2008-0034
   Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704
   Baumann U, 1999, HEPATOLOGY, V30, P112, DOI 10.1002/hep.510300140
   Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4
   BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   BUCHER NLR, 1964, CANCER RES, V24, P1611
   Cayo MA, 2012, HEPATOLOGY, V56, P2163, DOI 10.1002/hep.25871
   Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899
   Chang YJ, 2009, LIFE SCI, V85, P517, DOI 10.1016/j.lfs.2009.08.003
   Chen XS, 2011, PROTEIN CELL, V2, P180, DOI 10.1007/s13238-011-1023-4
   Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790
   Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136
   Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023
   Choi DH, 2002, CELL TRANSPLANT, V11, P359
   Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035
   Crosby HA, 1998, AM J PATHOL, V152, P771
   Crosby HA, 2001, GASTROENTEROLOGY, V120, P534, DOI 10.1053/gast.2001.21175
   Dezsö K, 2007, AM J PATHOL, V171, P1529, DOI 10.2353/ajpath.2007.070273
   DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27
   Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044
   Eggenhofer E, 2008, EXP HEMATOL, V36, P1507, DOI 10.1016/j.exphem.2008.05.010
   El-Ansary M, 2012, STEM CELL REV REP, V8, P972, DOI 10.1007/s12015-011-9322-y
   Endo Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031846
   ENGELHARDT NV, 1993, DIFFERENTIATION, V55, P19, DOI 10.1111/j.1432-0436.1993.tb00029.x
   Esch JSA, 2005, STEM CELLS, V23, P463, DOI 10.1634/stemcells.2004-0283
   Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   EVARTS RP, 1989, CANCER RES, V49, P1541
   EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737
   Fair JH, 2003, SURGERY, V134, P189, DOI 10.1067/msy.2003.225
   Fang BJ, 2004, TRANSPLANTATION, V78, P83, DOI 10.1097/01.TP.0000128326.95294.14
   FARBER E, 1956, CANCER RES, V16, P142
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6
   Fouraschen SMG, 2012, STEM CELLS DEV, V21, P2410, DOI 10.1089/scd.2011.0560
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Fürst G, 2007, RADIOLOGY, V243, P171, DOI 10.1148/radiol.2431060625
   FUJIO K, 1994, LAB INVEST, V70, P511
   Garg V, 2012, GASTROENTEROLOGY, V142, P505, DOI 10.1053/j.gastro.2011.11.027
   Gasbarrini A, 2007, DIGEST LIVER DIS, V39, P878, DOI 10.1016/j.dld.2006.06.037
   GERMAIN L, 1988, CANCER RES, V48, P4909
   Ghodsizadeh A, 2010, STEM CELL REV REP, V6, P622, DOI 10.1007/s12015-010-9189-3
   Gordon MY, 2006, STEM CELLS, V24, P1822, DOI 10.1634/stemcells.2005-0629
   GRISHAM JW, 1962, CANCER RES, V22, P842
   GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453
   Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1
   Han Y, 2008, CYTOTHERAPY, V10, P390, DOI 10.1080/14653240802129901
   Haque A, 2011, BIOMATERIALS, V32, P2032, DOI 10.1016/j.biomaterials.2010.11.045
   Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105
   Heo J, 2006, HEPATOLOGY, V44, P1478, DOI 10.1002/hep.21441
   Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477
   Hong SH, 2005, BIOCHEM BIOPH RES CO, V330, P1153, DOI 10.1016/j.bbrc.2005.03.086
   Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241
   Ishii T, 2005, EXP CELL RES, V309, P68, DOI 10.1016/j.yexcr.2005.05.028
   Ishii T, 2007, STEM CELLS, V25, P3252, DOI 10.1634/stemcells.2007-0199
   Ishii Takamichi, 2013, Methods Mol Biol, V946, P469, DOI 10.1007/978-1-62703-128-8_29
   Ishizaka S, 2002, FASEB J, V16, P1444, DOI 10.1096/fj.01-0806fje
   Ismail Alaa, 2010, J Gastrointest Cancer, V41, P17, DOI 10.1007/s12029-009-9092-9
   Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132
   Katayama S, 2001, AM J PATHOL, V158, P97, DOI 10.1016/S0002-9440(10)63948-X
   Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c
   Kolios G, 2013, RESPIRATION, V85, P3, DOI 10.1159/000345615
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Kuai XL, 2003, LIVER TRANSPLANT, V9, P1094, DOI 10.1053/jlts.2003.50207
   Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044
   Kumashiro Y, 2005, TRANSPLANTATION, V79, P550, DOI 10.1097/01.TP.0000153637.44069.C6
   Kung JWC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/984248
   Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015
   Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Lam SP, 2010, LIVER TRANSPLANT, V16, P1195, DOI 10.1002/lt.22136
   Lange C, 2005, TRANSPL P, V37, P276, DOI 10.1016/j.transproceed.2004.11.087
   Lange C, 2006, WORLD J GASTROENTERO, V12, P2394, DOI 10.3748/wjg.v12.i15.2394
   Lange C, 2005, WORLD J GASTROENTERO, V11, P4497, DOI 10.3748/wjg.v11.i29.4497
   Lee JH, 2012, ARCH PLAST SURG-APS, V39, P593
   Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469
   Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670
   Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004
   LEMIRE JM, 1991, AM J PATHOL, V139, P535
   Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042
   Li J, 2012, HEPATOLOGY, V56, P1044, DOI 10.1002/hep.25722
   Li WQ, 2010, J CELL PHYSIOL, V222, P492, DOI 10.1002/jcp.22000
   Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376
   Liu H, 2010, HEPATOLOGY, V51, P1810, DOI 10.1002/hep.23626
   Lyra AC, 2007, WORLD J GASTROENTERO, V13, P1067, DOI 10.3748/wjg.v13.i7.1067
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Menthena A, 2004, STEM CELLS, V22, P1049, DOI 10.1634/stemcells.22-6-1049
   Miki T, 2011, TISSUE ENG PART C-ME, V17, P557, DOI [10.1089/ten.tec.2010.0437, 10.1089/ten.TEC.2010.0437]
   Mohamadnejad M, 2007, WORLD J GASTROENTERO, V13, P3359, DOI 10.3748/wjg.v13.i24.3359
   Muraca M, 2007, GUT, V56, P1725, DOI 10.1136/gut.2007.127969
   NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223
   Newsome PN, 2003, GASTROENTEROLOGY, V124, P1891, DOI 10.1016/S0016-5085(03)00401-3
   Nikeghbalian S, 2011, ARCH IRAN MED, V14, P12, DOI 011141/AIM.004
   North TE, 2011, METHOD CELL BIOL, V101, P205, DOI 10.1016/B978-0-12-387036-0.00010-4
   O'Leary JG, 2008, GASTROENTEROLOGY, V134, P1764, DOI 10.1053/j.gastro.2008.02.028
   Oh SH, 2007, GASTROENTEROLOGY, V132, P1077, DOI 10.1053/j.gastro.2007.01.001
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Omori M, 1997, AM J PATHOL, V150, P1179
   Omori N, 1996, LAB INVEST, V75, P15
   Omori N, 1997, HEPATOLOGY, V26, P720, DOI 10.1053/jhep.1997.v26.pm0009303503
   Ong SY, 2006, TISSUE ENG, V12, P3477, DOI 10.1089/ten.2006.12.3477
   Pai M, 2008, AM J GASTROENTEROL, V103, P1952, DOI 10.1111/j.1572-0241.2008.01993.x
   Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Petersen BE, 1998, HEPATOLOGY, V27, P433, DOI 10.1002/hep.510270218
   Petersen BE, 2003, HEPATOLOGY, V37, P632, DOI 10.1053/jhep.2003.50104
   Piryaei A, 2011, STEM CELL REV REP, V7, P103, DOI 10.1007/s12015-010-9126-5
   Pournasr B, 2011, ARCH IRAN MED, V14, P244, DOI 0011144/AIM.004
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Qiao HX, 2011, PHARMAZIE, V66, P37, DOI 10.1691/ph.2011.9840
   Quintana-Bustamante O, 2006, HEPATOLOGY, V43, P108, DOI 10.1002/hep.21005
   Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122
   Reyes M, 2001, ANN NY ACAD SCI, V938, P231
   Rosenzweig A, 2010, NEW ENGL J MED, V363, P1471, DOI 10.1056/NEJMe1007902
   Saito Y., 2012, J SURG RES
   Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452
   Salama H, 2010, WORLD J GASTROENTERO, V16, P5297, DOI 10.3748/wjg.v16.i42.5297
   Sartipy P, 2011, STEM CELLS, V29, P744, DOI 10.1002/stem.631
   Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572
   Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182
   Schwerfeld-Bohr J, 2012, J INVEST SURG, V25, P220, DOI 10.3109/08941939.2011.627088
   Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158
   Sharma AD, 2008, CELL TRANSPLANT, V17, P313, DOI 10.3727/096368908784153896
   Sharma AD, 2006, STEM CELL REV, V2, P51, DOI 10.1007/s12015-006-0009-8
   SHEN MM, 1992, P NATL ACAD SCI USA, V89, P8240, DOI 10.1073/pnas.89.17.8240
   SHINOZUKA H, 1978, CANCER RES, V38, P1092
   Shiojiri N, 2001, LAB INVEST, V81, P17, DOI 10.1038/labinvest.3780208
   Shu SN, 2004, WORLD J GASTROENTERO, V10, P2818
   Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354
   Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V290, pG859, DOI 10.1152/ajpgi.00456.2005
   Snykers S, 2011, METHODS MOL BIOL, V698, P305, DOI 10.1007/978-1-60761-999-4_23
   Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107
   Spahr L, 2008, HEPATOLOGY, V48, P221, DOI 10.1002/hep.22317
   Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038
   Tarnowski M, 2006, MED SCI MONITOR, V12, pRA154
   Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542
   Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124
   Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135
   Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614
   Thorgeirsson SS, 2006, HEPATOLOGY, V43, P2, DOI 10.1002/hep.21015
   Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003
   Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715
   Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157
   van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245
   van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236
   Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539
   Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807
   Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5
   Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531
   Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100
   Wang XH, 2011, CELL BIOL INT, V35, P775, DOI 10.1042/CBI20100354
   Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338
   Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062
   Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030
   Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497
   Yamada T, 2002, STEM CELLS, V20, P146, DOI 10.1634/stemcells.20-2-146
   Yamamoto H, 2003, HEPATOLOGY, V37, P983, DOI 10.1053/jhep.2003.50202
   Yannaki E, 2006, EXP HEMATOL, V34, P1583, DOI 10.1016/j.exphem.2006.06.012
   Yu YD, 2011, J SURG RES, V170, pE253, DOI 10.1016/j.jss.2011.06.032
   Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424
   Zamule SM, 2011, CHEM-BIOL INTERACT, V190, P62, DOI 10.1016/j.cbi.2011.01.009
   Zhang BA, 2009, J SURG RES, V157, P71, DOI 10.1016/j.jss.2008.12.013
   Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516
   Zhang SC, 2012, TISSUE ENG PT A, V18, P1352, DOI [10.1089/ten.tea.2011.0516, 10.1089/ten.TEA.2011.0516]
   Zhang Z, 2012, J GASTROEN HEPATOL, V27, P112, DOI 10.1111/j.1440-1746.2011.07024.x
NR 178
TC 10
Z9 12
U1 1
U2 30
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2629-3269
EI 2629-3277
J9 STEM CELL REV REP
JI Stem Cell Rev. Rep.
PD OCT
PY 2013
VL 9
IS 5
BP 668
EP 684
DI 10.1007/s12015-013-9437-4
PG 17
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 226JG
UT WOS:000325031100012
PM 23526206
DA 2024-02-19
ER

PT J
AU Petrara, MR
   Shalaby, S
   Ruffoni, E
   Taborelli, M
   Carmona, F
   Giunco, S
   Del Bianco, P
   Piselli, P
   Serraino, D
   Cillo, U
   Dolcetti, R
   Burra, P
   De Rossi, A
AF Petrara, Maria Raffaella
   Shalaby, Sarah
   Ruffoni, Elena
   Taborelli, Martina
   Carmona, Francesco
   Giunco, Silvia
   Del Bianco, Paola
   Piselli, Pierluca
   Serraino, Diego
   Cillo, Umberto
   Dolcetti, Riccardo
   Burra, Patrizia
   De Rossi, Anita
TI Immune Activation, Exhaustion and Senescence Profiles as Possible
   Predictors of Cancer in Liver Transplanted Patients
SO FRONTIERS IN ONCOLOGY
LA English
DT Article
DE immune activation; immune senescence; post-transplant malignancy;
   hepatocellular carcinoma; biological predictors
ID HEPATOCELLULAR-CARCINOMA; CELLS; INFLAMMATION
AB Liver transplanted (LT) patients for hepatocellular carcinoma (LT-HCC) or for other causes (LT-no-HCC) may develop post-transplantation malignancies. Although immune activation and senescence are frequently implicated in cancer development, no data is available on their possible role as biomarkers predictive of tumor onset in this setting. A total of 116 patients were investigated: the 45 LT-HCC patients were older than the 71 LT-non-HCC (p=0.011), but comparable for sex, HCV, HBV infection and immunosuppressive treatment. At baseline, the numbers of activated and senescent-like circulating cells were significantly higher in LT-HCC patients than in LT-no-HCC ones. After a median follow-up of 26.8 months, 6 post-transplant malignancies (PTM) occurred: 4 in LT-HCC (8.9%) and 2 in LT-no-HCC (2.8%) patients. Overall, subjects with high percentages of activated and exhausted T and B cells at baseline were at higher risk of PTM. Notably, within the LT-HCC group, a higher percentage of senescence-like T cells was also associated with cancer development. Moreover, patients with PTM had higher telomere erosion and higher levels of circulating PAMPs (16S rDNA) and DAMPs (mtDNA) when compared with matched patients without PTM. Overall, these findings suggest that immune activation and exhaustion may be useful to predict the risk of PTM occurrence, regardless of the cause of transplantation. In LT-HCC, T-cell senescence represents an additional risk factor for tumor onset.
C1 [Petrara, Maria Raffaella; Giunco, Silvia; De Rossi, Anita] Univ Padua, Dept Surg, Oncol & Immunol Sect, Oncol & Gastroenterol, Padua, Italy.
   [Shalaby, Sarah; Burra, Patrizia] Padova Univ Hosp, Dept Surg, Multivisceral Transplant Unit, Oncol & Gastroenterol, Padua, Italy.
   [Ruffoni, Elena; Carmona, Francesco; Giunco, Silvia; De Rossi, Anita] Veneto Inst Oncol IOV IRCCS, Immunol & Diagnost Mol Oncol Unit, Padua, Italy.
   [Taborelli, Martina; Serraino, Diego] Ctr Riferimento Oncol Aviano CRO IRCCS, Canc Epidemiol Unit, Aviano, Italy.
   [Del Bianco, Paola] Veneto Inst Oncol IOV IRCCS, Clin Res Unit, Padua, Italy.
   [Piselli, Pierluca] Ist Nazl Malattie Infett INMI L Spallanzani IRCCS, Clin Epidemiol Unit, Rome, Italy.
   [Cillo, Umberto] Padova Univ Hosp, Dept Surg Oncol & Gastroenterol, Hepatobiliary Surg & Liver Transplantat Unit, Padua, Italy.
   [Dolcetti, Riccardo] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.
   [Dolcetti, Riccardo] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.
C3 University of Padua; University of Padua; Azienda Ospedaliera -
   Universita di Padova; IRCCS Istituto Oncologico Veneto (IOV); IRCCS
   Istituto Oncologico Veneto (IOV); University of Padua; Azienda
   Ospedaliera - Universita di Padova; University of Melbourne; Peter
   Maccallum Cancer Center; University of Melbourne
RP De Rossi, A (corresponding author), Univ Padua, Dept Surg, Oncol & Immunol Sect, Oncol & Gastroenterol, Padua, Italy.; De Rossi, A (corresponding author), Veneto Inst Oncol IOV IRCCS, Immunol & Diagnost Mol Oncol Unit, Padua, Italy.
EM anita.derossi@unipd.it
RI Shalaby, Sarah/AAX-3860-2020; Ruffoni, Elena/ISU-0992-2023; Taborelli,
   Martina/J-3595-2018; Dolcetti, Riccardo/O-3832-2015; Del Bianco,
   Paola/IUM-9339-2023; Del Bianco, Paola/F-4655-2014; Burra,
   Patrizia/AAB-2448-2019; Piselli, Pierluca/K-5337-2016; De Rossi,
   Anita/L-3128-2015; Petrara, Maria Raffaella/AAB-4806-2019
OI Shalaby, Sarah/0000-0002-8700-6282; Ruffoni, Elena/0000-0003-1574-5702;
   Taborelli, Martina/0000-0002-6731-7569; Dolcetti,
   Riccardo/0000-0003-1625-9853; Del Bianco, Paola/0000-0002-6597-0265; Del
   Bianco, Paola/0000-0002-6597-0265; Burra, Patrizia/0000-0002-8791-191X;
   Piselli, Pierluca/0000-0002-7342-0263; De Rossi,
   Anita/0000-0001-6435-7509; Petrara, Maria Raffaella/0000-0003-3609-6107
CR Acuna SA, 2018, TRANSPLANT REV-ORLAN, V32, P218, DOI 10.1016/j.trre.2018.07.001
   Acuna SA, 2016, JAMA ONCOL, V2, P463, DOI 10.1001/jamaoncol.2015.5137
   Aunan JR, 2017, AGING DIS, V8, P628, DOI 10.14336/AD.2017.0103
   Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38
   Boleslawski E, 2011, LIVER TRANSPLANT, V17, P299, DOI 10.1002/lt.22232
   Centro Nazionale Trapianti, MIN SAL
   Dwyer GK, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.611910
   European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
   Falci C, 2013, EXP GERONTOL, V48, P1436, DOI 10.1016/j.exger.2013.09.011
   Ferrara R, 2021, CLIN CANCER RES, V27, P492, DOI 10.1158/1078-0432.CCR-20-1420
   Gianesin K, 2016, AIDS, V30, P1363, DOI 10.1097/QAD.0000000000001093
   Giunco S, 2019, AGING-US, V11, P3864, DOI 10.18632/aging.102022
   Kong JJ, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.713637
   Liu WB, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.768098
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932
   Montanari NR, 2021, CANCERS, V13, DOI 10.3390/cancers13194876
   Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071
   Nielsen HB, 2012, NATURE, V486, P215, DOI [10.1038/nature11209, DOI 10.1038/NATURE11209]
   Niklander SE, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10123315
   Petrara MR, 2020, CANCER LETT, V469, P323, DOI 10.1016/j.canlet.2019.10.045
   Petrara MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185128
   Petrara MR, 2015, CANCER LETT, V369, P37, DOI 10.1016/j.canlet.2015.08.007
   Petrara MR, 2014, J INFECT DIS, V210, P392, DOI 10.1093/infdis/jiu099
   Ramakrishna G, 2013, LIVER CANCER, V2, P367, DOI 10.1159/000343852
   Rampazzo E, 2020, CANCERS, V12, DOI 10.3390/cancers12113115
   Rolles B, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.729207
   Seree O, 2018, LIVER TRANSPLANT, V24, P1425, DOI 10.1002/lt.25310
   Shalaby S, 2021, TRANSPL INT, V34, P743, DOI 10.1111/tri.13831
   Taborelli M, 2019, INT J CANCER, V144, P232, DOI 10.1002/ijc.31782
   Taborelli M, 2018, INT J CANCER, V143, P1588, DOI 10.1002/ijc.31552
   Todd JL, 2017, J CLIN INVEST, V127, P2464, DOI 10.1172/JCI90594
   Wareham NE, 2019, J CANCER RES CLIN, V145, P3125, DOI 10.1007/s00432-019-03039-2
   Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y
   Yang JD, 2017, CLIN GASTROENTEROL H, V15, P767, DOI 10.1016/j.cgh.2016.11.034
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu LX, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0048-z
   Zhang J, 2021, EBIOMEDICINE, V68, DOI 10.1016/j.ebiom.2021.103409
   Zhao YJ, 2020, CELL MOL IMMUNOL, V17, P27, DOI 10.1038/s41423-019-0344-8
NR 39
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2234-943X
J9 FRONT ONCOL
JI Front. Oncol.
PD JUN 13
PY 2022
VL 12
AR 899170
DI 10.3389/fonc.2022.899170
PG 10
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 2L2XI
UT WOS:000816882500001
PM 35769714
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU MOTE, PL
   GRIZZLE, JM
   WALFORD, RL
   SPINDLER, SR
AF MOTE, PL
   GRIZZLE, JM
   WALFORD, RL
   SPINDLER, SR
TI AGING ALTERS HEPATIC EXPRESSION OF INSULIN-RECEPTOR AND C-JUN
   MESSENGER-RNA IN THE MOUSE
SO MUTATION RESEARCH
LA English
DT Article
DE AGING; GENE EXPRESSION; TRANSCRIPTION FACTOR; INSULIN RECEPTOR; C-JUN;
   PROTOONCOGENE
ID DNA-BINDING PROTEINS; SUPEROXIDE-DISMUTASE; RAT-LIVER; TRANSCRIPTIONAL
   REGULATION; CULTURED LYMPHOCYTES; DIETARY RESTRICTION; GENE-EXPRESSION;
   DRUG-METABOLISM; GROWTH-FACTORS; S-II
AB The clear association between species and life span suggests that aging, like development, is genetically orchestrated. To explore this hypothesis, the expression of mRNA for a number of transcription regulatory and signal transduction proteins was investigated during aging of B1O.RIII, C57BL/10 and B1O.BR mice. mRNA for glucocorticoid receptor, CCAAT and enhancer binding protein, transcription factor Sp1 and RNA polymerase II elongation factor S-II were unchanged between 4 and 24 months of age in these mice. These factors are required for the normal transcription of many genes, perhaps explaining their steady rates of expression throughout life. Insulin-like growth factor I mRNA also remained unchanged.
   By contrast, mRNA for the insulin receptor and transcription factor c-jun changed significantly during aging. c-Jun mRNA decreased approximately 55% between 4 and 12 months of age and then increased by 24-25 months of age to levels approximately equal to those found in young mice. Insulin receptor mRNA increased approximately 30% by 24-25 months of age in all strains of mice. These results suggest that factors determining the steady state level of these mRNAs are altered in level or activity during aging. Assessing the causes and significance of these changes will require further study. However, our results demonstrate that alterations in the expression of specific regulatory genes occur during aging.
C1 UNIV CALIF RIVERSIDE, DEPT BIOCHEM, RIVERSIDE, CA 92521 USA.
   USDA, CLAY CTR, NE 68933 USA.
   UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL, LOS ANGELES, CA 90024 USA.
C3 University of California System; University of California Riverside;
   United States Department of Agriculture (USDA); University of California
   System; University of California Los Angeles; University of California
   Los Angeles Medical Center; David Geffen School of Medicine at UCLA
FU NIA NIH HHS [AG 04419] Funding Source: Medline
CR BELL GI, 1986, NUCLEIC ACIDS RES, V14, P7873, DOI 10.1093/nar/14.20.7873
   BOHMANN D, 1988, COLD SPRING HARB SYM, V53, P695, DOI 10.1101/SQB.1988.053.01.079
   BUKH A, 1990, J IMMUNOL, V144, P4835
   BURNSTEIN KL, 1989, ANNU REV PHYSIOL, V51, P683, DOI 10.1146/annurev.ph.51.030189.003343
   BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4
   DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x
   DEPAMPHILIS ML, 1988, CELL, V52, P635, DOI 10.1016/0092-8674(88)90398-4
   DRESSLER GR, 1989, TRENDS GENET, V5, P129, DOI 10.1016/0168-9525(89)90048-6
   DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0
   EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4
   GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726
   GLASS GA, 1983, OXY RADICALS THEIR S, V2, P1
   HIRAI H, 1988, FEBS LETT, V238, P119, DOI 10.1016/0014-5793(88)80239-4
   HIRASHIMA S, 1988, J BIOL CHEM, V263, P3858
   HORBACH GJMJ, 1990, MUTAT RES, V237, P117, DOI 10.1016/0921-8734(90)90017-L
   HORBACH GJMJ, 1990, BIOCHEM PHARMACOL, V40, P529, DOI 10.1016/0006-2952(90)90552-V
   IWAMA N, 1987, DIABETOLOGIA, V30, P899
   JAYARAJ A, 1985, J NATL CANCER I, V74, P95
   JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799
   KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786
   MAASSEN JA, 1987, BIOCHIM BIOPHYS ACTA, V930, P72, DOI 10.1016/0167-4889(87)90157-1
   MAMULA PW, 1990, DIABETES CARE, V13, P288, DOI 10.2337/diacare.13.3.288
   MCDONALD AR, 1987, DIABETES, V36, P779, DOI 10.2337/diabetes.36.6.779
   MCDONALD AR, 1988, J CLIN INVEST, V81, P499, DOI 10.1172/JCI113347
   MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136
   MORELLO D, 1990, MOL CELL BIOL, V10, P3185, DOI 10.1128/MCB.10.6.3185
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0
   RAPPAPORT J, 1987, J BIOL CHEM, V262, P5227
   RATH PC, 1988, BIOCHEM BIOPH RES CO, V157, P1403, DOI 10.1016/S0006-291X(88)81031-3
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464
   RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487
   RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0
   SALHANICK AI, 1983, J BIOL CHEM, V258, P4130
   SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0
   SCHISLER NJ, 1987, GENOME, V29, P748, DOI 10.1139/g87-127
   SCOTT MP, 1987, ANNU REV BIOCHEM, V56, P195, DOI 10.1146/annurev.biochem.56.1.195
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SHIBASAKI Y, 1988, BIOCHEM J, V249, P715, DOI 10.1042/bj2490715
   SMITH GS, 1977, NATURE, V270, P727, DOI 10.1038/270727a0
   SPINDLER SR, 1991, IN PRESS J GERONTOL
   STOHS SJ, 1980, AGE, V3, P88, DOI 10.1007/BF02432265
   SUN J, 1986, EXP GERONTOL, V21, P523, DOI 10.1016/0531-5565(86)90005-7
   VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088
   VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5
   WHITE BA, 1982, J BIOL CHEM, V257, P8569
   WILKINSON DG, 1989, DEVELOPMENT, V106, P465
   1985, SAS USERS GUIDE STAT
NR 54
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
JI Mutat. Res.
PD JAN
PY 1991
VL 256
IS 1
BP 7
EP 12
DI 10.1016/0921-8734(91)90027-9
PG 6
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA GP654
UT WOS:A1991GP65400002
PM 1944389
DA 2024-02-19
ER

PT J
AU Collins, DP
   Hapke, JH
   Aravalli, RN
   Steer, CJ
AF Collins, Daniel P.
   Hapke, Joel H.
   Aravalli, Rajagopal N.
   Steer, Clifford J.
TI Development of immortalized human hepatocyte-like hybrid cells by fusion
   of multi-lineage progenitor cells with primary hepatocytes
SO PLOS ONE
LA English
DT Article
ID MULTIPOTENT STEM-CELLS; LONG-TERM CULTURE; BONE-MARROW; LIVER;
   DIFFERENTIATION; THERAPY; TISSUE; MICE
AB Human primary hepatocytes (PHs) are critical to studying liver functions, drug metabolism and toxicity. PHs isolated from livers that are unacceptable for transplantation have limited expansion and culture viability in vitro, in addition to rapidly deteriorating enzymatic functions. The unsuitability of immortalized hepato-carcinoma cell lines for this function has prompted studies to develop hepatocyte-like cells from alternative sources like ESC, iPS, and other stem cell types using differentiation protocols. This study describes a novel technique to produce expandable and functional hepatocyte-like cells from the fusion of an immortalized human umbilical cord blood derived cell line (E12 MLPC) to normal human primary hepatocytes. Multi-lineage progenitor cells (MLPC) comprise a small subset of mesenchymal-like cells isolated from human umbilical cord blood. MLPC are distinguishable from other mesenchymal-like cells by their extended expansion capacity (up to 80 cell doublings before senescence) and the ability to be differentiated into cells representative of endo-, meso- and ectodermal origins. Transfection of MLPC with the gene for telomerase reverse transcriptase (TERT) resulted in clonal cell lines that were capable of differentiation to different cellular outcomes while maintaining their functional immortality. A methodology for the development of immortalized hepatocyte-like hybrid cells by the in vitro fusion of human MLPC with normal human primary hepatocytes is reported. The resultant hybrid cells exhibited homology with hepatocytes by morphology, immunohistochemistry, urea and albumin production and gene expression. A medium that allows stable long-term expansion of hepatocyte-like fusion cells is described.
C1 [Collins, Daniel P.; Hapke, Joel H.] CMDG LLC, St Paul, MN 55127 USA.
   [Aravalli, Rajagopal N.] Univ Minnesota, Coll Sci & Engn, Dept Elect & Comp Engn, Minneapolis, MN USA.
   [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.
   [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities
RP Collins, DP (corresponding author), CMDG LLC, St Paul, MN 55127 USA.
EM dc@cmdgiic.com
OI Collins, Daniel/0000-0003-2488-1108
FU CytoMedical Design Group, LLC (CMDG); BioE, LLC
FX CytoMedical Design Group, LLC (CMDG) provided funding for this study in
   the form of salaries for DPC and JHH. Additionally, funding was provided
   by BioE, LLC. The specific roles of these authors are articulated in the
   'author contributions' section. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059
   Berger MJ, 2006, CYTOTHERAPY, V8, P480, DOI 10.1080/14653240600941549
   Cadet P, 2007, J IMMUNOL, V179, P5839, DOI 10.4049/jimmunol.179.9.5839
   Chen HL, 1998, J BIOMED SCI, V5, P435, DOI 10.1007/BF02255932
   Chen ML, 2010, WORLD J GASTROENTERO, V16, P5092, DOI 10.3748/wjg.v16.i40.5092
   Collins DP, 2006, BIOL BLOOD MARROW TR, V12, P1227, DOI 10.1016/j.bbmt.2006.08.028
   Collins DP, 2007, STEM CELLS WORLD C
   Dahlke MH, 2004, LIVER TRANSPLANT, V10, P471, DOI 10.1002/lt.20121
   Deguchi S, 2019, DRUG METAB DISPOS, V47, P632, DOI 10.1124/dmd.119.086322
   Deurholt T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-89
   Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718
   Huang CJ, 2011, DIABETOLOGIA, V54, P1066, DOI 10.1007/s00125-011-2071-2
   Ishikawa F, 2003, ANN NY ACAD SCI, V996, P174, DOI 10.1111/j.1749-6632.2003.tb03245.x
   Katsura N, 2002, J SURG RES, V106, P115, DOI 10.1006/jsre.2002.6446
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Martínez JJG, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0453-z
   McKenna DH, 2010, US Patent, Patent No. [7,727,763, 7727763]
   Medvinsky A, 2003, NATURE, V422, P823, DOI 10.1038/422823a
   Mowbray C., 2015, EUR PHARM REV, V20, P8
   Newsome PN, 2003, GASTROENTEROLOGY, V124, P1891, DOI 10.1016/S0016-5085(03)00401-3
   Okamoto R, 2018, CELL TRANSPLANT, V27, P299, DOI 10.1177/0963689717751734
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Sakai K, 2015, ONCOL LETT, V9, P405, DOI 10.3892/ol.2014.2702
   Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572
   Sen S, 2003, SEMIN LIVER DIS, V23, P283
   Sprague SL, 2010, United State patent, Patent No. [7,670,596, 7670596]
   Sprague SL, 2009, United States patent, Patent No. [7,622,108, 7622108]
   Stefano GB, 2008, SEMIN CANCER BIOL, V18, P199, DOI 10.1016/j.semcancer.2007.12.003
   Theise ND, 2003, SCIENCE, V299, p1317A, DOI 10.1126/science.1078412
   van de Ven C, 2007, EXP HEMATOL, V35, P1753, DOI 10.1016/j.exphem.2007.08.017
   Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807
   Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531
   Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338
   Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064
NR 35
TC 6
Z9 8
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 4
PY 2020
VL 15
IS 6
AR e0234002
DI 10.1371/journal.pone.0234002
PG 18
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA MA6PX
UT WOS:000542035200072
PM 32497071
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bodyrev, AA
   Yuneva, MO
   Sorokina, EV
   Kramarenko, GG
   Fedorova, TN
   Konovalova, GG
   Lankin, VZ
AF Bodyrev, AA
   Yuneva, MO
   Sorokina, EV
   Kramarenko, GG
   Fedorova, TN
   Konovalova, GG
   Lankin, VZ
TI Antioxidant systems in tissues of senescence accelerated mice
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE senescence accelerated mice; brain; antioxidant system
ID CARNOSINE PROTECTS; GLUTATHIONE; DISMUTASE; DAMAGE; BRAIN
AB Significant decrease in the level of lipid antioxidants (measured from the kinetics of the induced chemiluminescence in brain homogenate) and of the hydrophilic antioxidant carnosine as well was observed in the brain of 14-16-month-old mice of SAMP1 line, which is characterized by accelerated accumulation of senile features, in comparison with the control line SAMR1. In the brain of SAMP1 animals the activity of cytosolic Cu/Zn-containing superoxide dismutase (SOD) was reduced, while the activity of membrane-bound Mn-SOD was at an extremely low level. The activity of glutathione-dependent enzymes (glutathione peroxidase, glutathione reductase, and glutathione transferase) did not differ ill the brain of SAMP1 and SAMR1 animals, and catalase activity was similarly low in both cases. At the same time, excess concentration of excitotoxic compounds, significantly exceeding that for the control line, was determined in the brain and blood of SAMP1 animals. The activity of glutathione enzymes in liver and heart as well as the activity of cytosolic Cu/Zn-SOD ill liver did not differ in the two studied lines, while the activity of erythrocyte glutathione peroxidase was slightly increased, and the activity of liver catalase and erythrocyte Cu/Zn-SOD was significantly decreased for SAMP1 compared with SAMR1. The results demonstrate that the accelerated ageing of SAMP1 animals is connected to a significant extent with the decreased efficiency of the systems utilizing reactive oxygen species (ROS) in tissues.
C1 Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119899, Russia.
   Russian Acad Med Sci, Inst Neurol, Moscow 123367, Russia.
   Cardiol Res Ctr, Moscow 121552, Russia.
C3 Lomonosov Moscow State University; Russian Academy of Medical Sciences;
   Research Center of Neurology; National Medical Research Center of
   Cardiology
RP Bodyrev, AA (corresponding author), Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119899, Russia.
EM aa_boldyrev@mail.ru
RI Fedorova, Tatiana N/B-4282-2012
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Alper G, 1999, EUR NEUROPSYCHOPHARM, V9, P247, DOI 10.1016/S0924-977X(98)00035-2
   BEUTLER E, 1963, BLOOD, V21, P573, DOI 10.1182/blood.V21.5.573.573
   Boldyrev A, 1999, NEUROSCIENCE, V94, P571, DOI 10.1016/S0306-4522(99)00273-0
   Boldyrev A., 2000, B EKSP BIOL MED, V130, P244
   BOLDYREV A, 1995, COMP BIOCH PHYSL B, V112, P546
   BULYGINA E, 1999, J ANTI-AGING MED, V2, P45
   Choi SY, 1999, BBA-GEN SUBJECTS, V1472, P651, DOI 10.1016/S0304-4165(99)00189-0
   Fedorova TN, 1999, BIOCHEMISTRY-MOSCOW+, V64, P75
   HALLIWELL B, 1999, FREE RADICAL BIO MED, P135
   Hosokawa M, 2000, MECH AGEING DEV, V118, P61, DOI 10.1016/S0047-6374(00)00158-5
   Hosokawa M, 1997, EXP GERONTOL, V32, P111, DOI 10.1016/S0531-5565(96)00078-2
   KEEN JH, 1978, J BIOL CHEM, V253, P5654
   LANKIN VZ, 1981, DOKL AKAD NAUK SSSR+, V261, P1467
   Lankin VZ, 2000, KARDIOLOGIYA, V40, P48
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Mori A, 1998, ANN NY ACAD SCI, V854, P239, DOI 10.1111/j.1749-6632.1998.tb09906.x
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   PACKER L, 1995, MCBU, P1
   Park JW, 1996, J GERONTOL A-BIOL, V51, pB337, DOI 10.1093/gerona/51A.5.B337
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   Stvolinsky S, 2000, BRAIN RES BULL, V53, P445, DOI 10.1016/S0361-9230(00)00366-X
   Sureda FX, 1996, BRAIN RES, V723, P110, DOI 10.1016/0006-8993(96)00230-2
   Takeda T., 1994, SAM MODEL SENESCENCE
   Trombley PQ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P807
   Tsay HJ, 2000, J BIOMED SCI, V7, P466
   Yuneva M.O., 1999, J ANTI-AGING MED, V2, P337, DOI [10.1089/rej.1.1999.2.337, DOI 10.1089/REJ.1.1999.2.337]
   YUNEVA MO, 2000, USPEKHI GERONTOL, V4, P147
   YUNEVA MO, 1998, NEIROKHIMIYA, V15, P276
NR 32
TC 31
Z9 37
U1 0
U2 4
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD OCT
PY 2001
VL 66
IS 10
BP 1157
EP 1163
DI 10.1023/A:1012441215506
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 494HK
UT WOS:000172275800012
PM 11736637
DA 2024-02-19
ER

EF